PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agarwal, N; Adhikari, AS; Iyer, SV; Hekmatdoost, K; Welch, DR; Iwakuma, T				Agarwal, N.; Adhikari, A. S.; Iyer, S. V.; Hekmatdoost, K.; Welch, D. R.; Iwakuma, T.			MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4	ONCOGENE			English	Article						MDM2; MTBP; ACTN4; filopodia; metastasis	ALPHA-ACTININ; GENE AMPLIFICATION; CANCER INVASION; METASTASIS; CARCINOMA; MOTILITY; MDM2; NETWORK; GROWTH	Murine double minute (MDM2) binding protein (MTBP) has been implicated in cancer progression. Here, we demonstrate one mechanism by which MTBP inhibits cancer metastasis. Overexpression of MTBP in human osteosarcoma cell lines lacking wildtype p53 did not alter primary tumor growth in mice, but significantly inhibited metastases. MTBP downregulation increased the migratory potential of MDM2(-/-)p53(-/-) mouse embryonic fibroblasts, suggesting that MTBP inhibited cell migration independently of the Mdm2-p53 pathway. Co-immunoprecipitation and mass spectrometric analysis identified alpha-actinin-4 (ACTN4) as an MTBP-interacting protein. Endogenous MTBP interacted with and partially colocalized with ACTN4. MTBP overexpression inhibited cell migration and filopodia formation mediated by ACTN4. Increased cell migration by MTBP downregulation was inhibited by concomitant downregulation of ACTN4. MTBP also inhibited ACTN4-mediated F-actin bundling. We furthermore demonstrated that nuclear localization of MTBP was dispensable for inhibiting ACTN4-mediated cell migration and filopodia formation. Thus, MTBP suppresses cell migration, at least partially, by inhibiting ACTN4 function. Our study not only provides a mechanism of metastasis suppression by MTBP, but also suggests MTBP as a potential biomarker for cancer progression. Oncogene (2013) 32, 462-470; doi:10.1038/onc.2012.69; published online 27 February 2012	[Agarwal, N.; Adhikari, A. S.; Iyer, S. V.; Hekmatdoost, K.; Iwakuma, T.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Agarwal, N.; Iyer, S. V.; Welch, D. R.; Iwakuma, T.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Kansas; University of Kansas Medical Center	Iwakuma, T (corresponding author), Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA.	tiwakuma@kumc.edu	Welch, Danny R/B-7310-2009; Agarwal, Neeraj/F-2834-2016	Welch, Danny R/0000-0002-1951-4947; Agarwal, Neeraj/0000-0001-7163-1043	LCRC start-up; National Foundation for Cancer Research-Center for Metastasis Research;  [P20 RR020152-02];  [RSG-09-169-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA134981] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER	LCRC start-up; National Foundation for Cancer Research-Center for Metastasis Research; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs Indu Kheterpal, Yuki Tochigi and Louis Marrero for their technical assistance. We also thank Ms Kristy-Le T Nguyen for her technical assistance and editing the manuscript. This work was supported by grants from P20 RR020152-02 (PLD), RSG-09-169-01-CSM (JI), LCRC start-up (TI) and National Foundation for Cancer Research-Center for Metastasis Research (DRW).	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Agarwal N, 2011, CELL DEATH DIFFER, V18, P1208, DOI 10.1038/cdd.2010.189; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Chen XP, 2011, INT J BIOL MARKER, V26, P1, DOI 10.5301/JBM.2011.6267; Choi HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-122; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Iwakuma T, 2008, ONCOGENE, V27, P1813, DOI 10.1038/sj.onc.1210827; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jia SF, 2002, ANTI-CANCER DRUG, V13, P155, DOI 10.1097/00001813-200202000-00007; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Koizumi T, 2010, UROLOGY, V75, P357, DOI 10.1016/j.urology.2009.09.037; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Odvody J, 2010, ONCOGENE, V29, P3287, DOI 10.1038/onc.2010.82; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Vlatkovic N, 2011, CANCER-AM CANCER SOC, V117, P2939, DOI 10.1002/cncr.25864; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234	35	43	44	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					462	470		10.1038/onc.2012.69	http://dx.doi.org/10.1038/onc.2012.69			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22370640	Green Accepted			2022-12-25	WOS:000315551300007
J	Cho, SJ; Jung, YS; Zhang, J; Chen, XB				Cho, Seong-Jun; Jung, Yong-Sam; Zhang, Jin; Chen, Xinbin			The RNA-binding Protein RNPC1 Stabilizes the mRNA Encoding the RNA-binding Protein HuR and Cooperates with HuR to Suppress Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; BREAST-CANCER; EXPRESSION; P53; PHOSPHORYLATION; TRANSLATION; CARCINOMA; ELEMENT; TARGET; CONTRIBUTES	The RNA-binding protein HuR, a member of the embryonic lethal abnormal vision/Hu protein family, plays a critical role in many cellular processes, including cell proliferation, angiogenesis, and inflammatory response. Despite significant progresses in understanding how HuR functions, the mechanism by which HuR expression is controlled is still poorly understood. Here, we showed that RNA-binding protein RNPC1 post-transcriptionally regulates HuR expression via mRNA stability. Specifically, we showed that overexpression of RNPC1 increases, whereas knockdown or knock-out of RNPC1 decreases, the level of HuR transcript and protein. Moreover, we showed that RNPC1, but not mutant RNPC1 deficient in RNA binding, stabilizes HuR transcript via binding to its 3'-untranslated region. Furthermore, to determine the biological significance of RNPC1-enhanced HuR expression, we showed that HuR, by repressing c-Myc expression, facilitates RNPC1-mediated growth suppression. Together, we have uncovered a novel mechanism by which HuR is regulated by RNPC1 via mRNA stability and HuR is a mediator of RNPC1-induced growth suppression.	[Cho, Seong-Jun; Jung, Yong-Sam; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health [R01 CA076069, R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA076069, R01CA081237, R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA076069 and R01 CA102188.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2010, CELL CYCLE, V9, P1354, DOI 10.4161/cc.9.7.11164; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2011, CARCINOGENESIS, V32, P676, DOI 10.1093/carcin/bgr024; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zou TT, 2010, MOL CELL BIOL, V30, P5021, DOI 10.1128/MCB.00807-10	36	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14535	14544		10.1074/jbc.M111.326827	http://dx.doi.org/10.1074/jbc.M111.326827			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22371495	Green Published, hybrid			2022-12-25	WOS:000304003200020
J	Roman-Vendrell, C; Yu, YJ; Yudowski, GA				Roman-Vendrell, Cristina; Yu, Y. Joy; Yudowski, Guillermo Ariel			Fast Modulation of mu-Opioid Receptor (MOR) Recycling Is Mediated by Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MYOSIN VB; POSTSYNAPTIC PLASTICITY; FLUORESCENCE MICROSCOPY; MORPHINE-TOLERANCE; PLASMA-MEMBRANE; AMPA RECEPTORS; ENDOCYTOSIS; TRAFFICKING; DESENSITIZATION	The mu-opioid receptor (MOR) is a member of the G protein-coupled receptor family and the main target of endogenous opioid neuropeptides and morphine. Upon activation by ligands, MORs are rapidly internalized via clathrin-coated pits in heterologous cells and dissociated striatal neurons. After initial endocytosis, resensitized receptors recycle back to the cell surface by vesicular delivery for subsequent cycles of activation. MOR trafficking has been linked to opioid tolerance after acute exposure to agonist, but it is also involved in the resensitization process. Several studies describe the regulation and mechanism of MOR endocytosis, but little is known about the recycling of resensitized receptors to the cell surface. To study this process, we induced internalization of MOR with [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO) and morphine and imaged in real time single vesicles recycling receptors to the cell surface. We determined single vesicle recycling kinetics and the number of receptors contained in them. Then we demonstrated that rapid vesicular delivery of recycling MORs to the cell surface was mediated by the actin-microtubule cytoskeleton. Recycling was also dependent on Rab4, Rab11, and the Ca2+-sensitive motor protein myosin Vb. Finally, we showed that recycling is acutely modulated by the presence of agonists and the levels of cAMP. Our work identifies a novel trafficking mechanism that increases the number of cell surface MORs during acute agonist exposure, effectively reducing the development of opioid tolerance.	[Roman-Vendrell, Cristina; Yudowski, Guillermo Ariel] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Roman-Vendrell, Cristina; Yudowski, Guillermo Ariel] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00901 USA; [Yu, Y. Joy] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Francisco	Yudowski, GA (corresponding author), Univ Puerto Rico, Inst Neurobiol, 201 Calle Norzagaray, San Juan, PR 00901 USA.	Guillermo.yudowski@upr.edu		Yudowski, Guillermo/0000-0001-5989-4131	National Institutes of Health (NIH) [K99/R00]; NIH, National Institute on Drug Abuse [DA023444]; NIH, American Recovery and Reinvestment Act [1P30NS069258]; Puerto Rico Science, Technology, and Research Trust; Kirschstein Predoctoral National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023444, K99DA023444] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH, American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puerto Rico Science, Technology, and Research Trust; Kirschstein Predoctoral National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant K99/R00; NIH, National Institute on Drug Abuse, Grant DA023444; and NIH, American Recovery and Reinvestment Act, Grant 1P30NS069258. This work was also supported by the Puerto Rico Science, Technology, and Research Trust Fund.; Supported by a Kirschstein Predoctoral National Research Service Award.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Archer-Lahlou E, 2009, J CELL MOL MED, V13, P147, DOI 10.1111/j.1582-4934.2008.00308.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Enquist J, 2011, J PHARMACOL EXP THER, V338, P633, DOI 10.1124/jpet.111.179754; Evans LL, 1998, J CELL SCI, V111, P2055; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Yu YJ, 2010, J NEUROSCI, V30, P11703, DOI 10.1523/JNEUROSCI.6282-09.2010; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Yudowski GA, 2011, METHODS MOL BIOL, V756, P325, DOI 10.1007/978-1-61779-160-4_19; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	45	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14782	14791		10.1074/jbc.M111.319616	http://dx.doi.org/10.1074/jbc.M111.319616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22378794	Green Published, hybrid			2022-12-25	WOS:000304003200043
J	Sarkar, J; Poruri, K; Boniecki, MT; McTavish, KK; Martinis, SA				Sarkar, Jaya; Poruri, Kiranmai; Boniecki, Michal T.; McTavish, Katherine K.; Martinis, Susan A.			Yeast Mitochondrial Leucyl-tRNA Synthetase CP1 Domain Has Functionally Diverged to Accommodate RNA Splicing at Expense of Hydrolytic Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-I INTRONS; MATURASE DEFICIENCY; CRYSTAL-STRUCTURE; PROTEIN; ACID; NAM2; CEREVISIAE; TRNA(LEU); SEQUENCES; REQUIRES	The yeast mitochondrial leucyl-tRNA synthetase (ymLeuRS) performs dual essential roles in group I intron splicing and protein synthesis. A specific LeuRS domain called CP1 is responsible for clearing noncognate amino acids that are misactivated during aminoacylation. The ymLeuRS CP1 domain also plays a critical role in splicing. Herein, the ymLeuRS CP1 domain was isolated from the full-length enzyme and was active in RNA splicing in vitro. Unlike its Escherichia coli LeuRS CP1 domain counterpart, it failed to significantly hydrolyze misaminoacylated tRNA(Leu). In addition and in stark contrast to the yeast domain, the editing-active E. coli LeuRS CP1 domain failed to recapitulate the splicing activity of the full-length E. coli enzyme. Although LeuRS-dependent splicing activity is rooted in an ancient adaptation for its aminoacylation activity, these results suggest that the ymLeuRS has functionally diverged to confer a robust splicing activity. This adaptation could have come at some expense to the protein's housekeeping role in aminoacylation and editing.	[Sarkar, Jaya; Poruri, Kiranmai; Boniecki, Michal T.; McTavish, Katherine K.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61820 USA.	martinis@life.illinois.edu		poruri, kiran/0000-0002-3127-0244; Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM063789, GM63107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789, R01GM063107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM063789 and GM63107.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2009, J BIOL CHEM, V284, P26243, DOI 10.1074/jbc.M109.031179; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HOU YM, 1991, P NATL ACAD SCI USA, V88, P976, DOI 10.1073/pnas.88.3.976; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; LABOUESSE M, 1984, EUR J BIOCHEM, V144, P85, DOI 10.1111/j.1432-1033.1984.tb08434.x; LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x; LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/BF02173972; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Nawaz M. H., 2008, WILEY ENCY CHEM BIOL, P1; Nawaz MH, 2007, J MOL BIOL, V367, P384, DOI 10.1016/j.jmb.2006.12.051; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rho SB, 2000, RNA, V6, P1882, DOI 10.1017/S1355838200001254; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Williams AM, 2006, P NATL ACAD SCI USA, V103, P3586, DOI 10.1073/pnas.0507362103	38	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14772	14781		10.1074/jbc.M111.322412	http://dx.doi.org/10.1074/jbc.M111.322412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383526	hybrid, Green Published			2022-12-25	WOS:000304003200042
J	Shao, QM; Yang, B; Xu, QY; Li, XQ; Lu, ZQ; Wang, CS; Huang, YP; Soderhall, K; Ling, EJ				Shao, Qimiao; Yang, Bing; Xu, Qiuyun; Li, Xuquan; Lu, Zhiqiang; Wang, Chengshu; Huang, Yongping; Soderhall, Kenneth; Ling, Erjun			Hindgut Innate Immunity and Regulation of Fecal Microbiota through Melanization in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM BOMBYX-MORI; MANDUCA-SEXTA; DROSOPHILA-MELANOGASTER; IN-VITRO; PHENOLOXIDASE; INFECTION; IDENTIFICATION; BACTERIA; DEFENSE; OXIDASE	Many insects eat the green leaves of plants but excrete black feces in an as yet unknown mechanism. Insects cannot avoid ingesting pathogens with food that will be specifically detected by the midgut immune system. However, just as in mammals, many pathogens can still escape the insect midgut immune system and arrive in the hindgut, where they are excreted out with the feces. Here we show that the melanization of hindgut content induced by prophenoloxidase, a key enzyme that induces the production of melanin around invaders and at wound sites, is the last line of immune defense to clear bacteria before feces excretion. We used the silkworm Bombyx mori as a model and found that prophenoloxidase produced by hindgut cells is secreted into the hindgut contents. Several experiments were done to clearly demonstrate that the blackening of the insect feces was due to activated phenoloxidase, which served to regulate the number of bacteria in the hindgut. Our analysis of the silkworm hindgut prophenoloxidase discloses the natural secret of why the phytophagous insect feces is black and provides insight into hindgut innate immunity, which is still rather unclear in mammals.	[Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75218 Uppsala, Sweden; [Shao, Qimiao; Yang, Bing; Xu, Qiuyun; Li, Xuquan; Wang, Chengshu; Huang, Yongping; Ling, Erjun] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Lu, Zhiqiang] NW A&F Univ, Coll Plant Protect, Yangling 712100, Shanxi, Peoples R China	Uppsala University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northwest A&F University - China	Soderhall, K (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18 A, S-75218 Uppsala, Sweden.	kenneth.soderhall@ebc.uu.se; erjunling@sippe.ac.cn	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466	National Natural Science Foundation of China [30970408]; National Basic Research Program of China [2012CB114605]; Chinese Academy of Sciences [KSCX2-EW-J-12, 2009OHTP05]; Swedish Science Research Council [319-2010-6250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Swedish Science Research Council	This work was supported by the National Natural Science Foundation of China (30970408), National Basic Research Program of China (2012CB114605), Chinese Academy of Sciences (KSCX2-EW-J-12 and 2009OHTP05), and the Swedish Science Research Council (319-2010-6250).	Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; ASHIDA M, 1971, ARCH BIOCHEM BIOPHYS, V144, P749, DOI 10.1016/0003-9861(71)90383-3; Ashida M., 1998, RECENT ADV RES INSEC; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; Fouda MMA, 2010, J INSECT PHYSIOL, V56, P1728, DOI 10.1016/j.jinsphys.2010.07.003; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Kanost M. R., 2008, PHENOLOXIDASES INSEC; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Lehane M. J., 1996, BIOL INSECT MIDGUT; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Ling E, 2006, DEV COMP IMMUNOL, V30, P531, DOI 10.1016/j.dci.2005.08.003; Ling EJ, 2008, MOL IMMUNOL, V45, P2598, DOI 10.1016/j.molimm.2007.12.021; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Nosanchuk JD, 2007, FUNGAL GENET BIOL, V44, P517, DOI 10.1016/j.fgb.2006.09.006; Ryazanova AD, 2012, J ENZYM INHIB MED CH, V27, P78, DOI 10.3109/14756366.2011.576010; Schoonhoven L. M., 2005, Insect-plant biology; Seisenbacher G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002168; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tan Anjiang, 2003, Journal of Insect Biotechnology and Sericology, V72, P41; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang ZX, 2011, EXP PARASITOL, V127, P135, DOI 10.1016/j.exppara.2010.07.005; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	34	86	91	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14270	14279		10.1074/jbc.M112.354548	http://dx.doi.org/10.1074/jbc.M112.354548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375003	Green Published, hybrid			2022-12-25	WOS:000303996300078
J	Dunlop, MH; Dray, E; Zhao, WX; Filippo, JS; Tsai, MS; Leung, SG; Schild, D; Wiese, C; Sung, P				Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Filippo, Joseph San; Tsai, Miaw-Sheue; Leung, Stanley G.; Schild, David; Wiese, Claudia; Sung, Patrick			Mechanistic Insights into RAD51-associated Protein 1 (RAD51AP1) Action in Homologous DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; RECOMBINASE; ENHANCEMENT; INTERACTS; DMC1	Homologous recombination catalyzed by the RAD51 recombinase is essential for maintaining genome integrity upon the induction of DNA double strand breaks and other DNA lesions. By enhancing the recombinase activity of RAD51, RAD51AP1 (RAD51-associated protein 1) serves a key role in homologous recombination-mediated chromosome damage repair. We show here that RAD51AP1 harbors two distinct DNA binding domains that are both needed for maximal protein activity under physiological conditions. We have finely mapped the two DNA binding domains in RAD51AP1 and generated mutant variants that are impaired in either or both of the DNA binding domains. Examination of these mutants reveals that both domains are indispensable for RAD51AP1 function in cells. These and other results illuminate the mechanistic basis of RAD51AP1 action in homologous DNA repair.	[Tsai, Miaw-Sheue; Leung, Stanley G.; Schild, David; Wiese, Claudia] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Filippo, Joseph San; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yale University	Wiese, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	CWiese@lbl.gov; Patrick.Sung@yale.edu	zhao, weixing/H-3154-2013; Classen, Scott/AAY-8176-2020; Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021	Dray, Eloise/0000-0001-6793-9838; zhao, weixing/0000-0001-5746-3696	National Institutes of Health [RO1ES015252, RO1ES015632, RO1ES07061, PO1CA129186, R01CA120315, P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA129186, R01CA120315, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, R01ES015252, R01ES015632, R01ES021454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1ES015252, RO1ES015632, RO1ES07061, PO1CA129186 (to P. S.), R01CA120315 (to D. S.), and P01CA092584 (to D. S. and P. S.).	Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	14	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12343	12347		10.1074/jbc.C112.352161	http://dx.doi.org/10.1074/jbc.C112.352161			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22375013	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000302782200073
J	Mundry, M; Bornberg-Bauer, E; Sammeth, M; Feulner, PGD				Mundry, Marvin; Bornberg-Bauer, Erich; Sammeth, Michael; Feulner, Philine G. D.			Evaluating Characteristics of De Novo Assembly Software on 454 Transcriptome Data: A Simulation Approach	PLOS ONE			English	Article							GENERATION; DIVERGENCE; EXPRESSION; REVEALS; GENES	Background: The quantity of transcriptome data is rapidly increasing for non-model organisms. As sequencing technology advances, focus shifts towards solving bioinformatic challenges, of which sequence read assembly is the first task. Recent studies have compared the performance of different software to establish a best practice for transcriptome assembly. Here, we adapted a simulation approach to evaluate specific features of assembly programs on 454 data. The novelty of our study is that the simulation allows us to calculate a model assembly as reference point for comparison. Findings: The simulation approach allows us to compare basic metrics of assemblies computed by different software applications (CAP3, MIRA, Newbler, and Oases) to a known optimal solution. We found MIRA and CAP3 are conservative in merging reads. This resulted in comparably high number of short contigs. In contrast, Newbler more readily merged reads into longer contigs, while Oases produced the overall shortest assembly. Due to the simulation approach, reads could be traced back to their correct placement within the transcriptome. Together with mapping reads onto the assembled contigs, we were able to evaluate ambiguity in the assemblies. This analysis further supported the conservative nature of MIRA and CAP3, which resulted in low proportions of chimeric contigs, but high redundancy. Newbler produced less redundancy, but the proportion of chimeric contigs was higher. Conclusion: Our evaluation of four assemblers suggested that MIRA and Newbler slightly outperformed the other programs, while showing contrasting characteristics. Oases did not perform very well on the 454 reads. Our evaluation indicated that the software was either conservative (MIRA) or liberal (Newbler) about merging reads into contigs. This suggested that in choosing an assembly program researchers should carefully consider their follow up analysis and consequences of the chosen approach to gain an assembly.	[Mundry, Marvin; Bornberg-Bauer, Erich; Feulner, Philine G. D.] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Sammeth, Michael] CNAG, Barcelona, Spain	University of Munster	Mundry, M (corresponding author), Univ Munster, Inst Evolut & Biodivers, Munster, Germany.	p.feulner@wwu.de	Sammeth, Michael/C-1157-2014; Bornberg-Bauer, Erich/A-1563-2013	Sammeth, Michael/0000-0002-6528-9883; Bornberg-Bauer, Erich/0000-0002-1826-3576; Mundry, Marvin/0000-0001-9188-6588; Feulner, Philine/0000-0002-8078-1788	German Science Foundation (DFG) [1399]; Deutsche Forschungsgemeinschaft; University of Muenster	German Science Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	MM was funded by the German Science Foundation (DFG) priority program 1399. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Cabrera AR, 2011, J INSECT PHYSIOL, V57, P52, DOI 10.1016/j.jinsphys.2010.09.006; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; de Boer TE, 2011, MOL ECOL, V20, P1144, DOI 10.1111/j.1365-294X.2010.04985.x; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Dicker AJ, 2011, EXP PARASITOL, V127, P351, DOI 10.1016/j.exppara.2010.08.019; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; IYENGAR SS, 1979, COMPUT PROG BIOMED, V9, P160, DOI 10.1016/0010-468X(79)90029-1; Jeukens J, 2010, MOL ECOL, V19, P5389, DOI 10.1111/j.1365-294X.2010.04934.x; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sammeth M, 2009, FLUX; Schulz M, 2010, OASES; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705	51	67	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31410	10.1371/journal.pone.0031410	http://dx.doi.org/10.1371/journal.pone.0031410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384018	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500024
J	Basile, LA; Ellefson, D; Gluzman-Poltorak, Z; Junes-Gill, K; Mar, V; Mendonca, S; Miller, JD; Tom, J; Trinh, A; Gallaher, TK				Basile, Lena A.; Ellefson, Dolph; Gluzman-Poltorak, Zoya; Junes-Gill, Katiana; Mar, Vernon; Mendonca, Sarita; Miller, Joseph D.; Tom, Jamie; Trinh, Alice; Gallaher, Timothy K.			HemaMax (TM), a Recombinant Human Interleukin-12, Is a Potent Mitigator of Acute Radiation Injury in Mice and Non-Human Primates	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELLS; INTERFERON-GAMMA; DOSE INTERLEUKIN-12; GROWTH-FACTOR; BONE-MARROW; PHASE-I; ERYTHROPOIETIN; IL-12; CYTOKINE	HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medical need for effective treatments against acute radiation syndrome due to radiological terrorism or accident when administered at least 24 hours after radiation exposure. This study investigated pharmacokinetics, pharmacodynamics, and efficacy of m-HemaMax (recombinant murine IL-12), and HemaMax to increase survival after total body irradiation (TBI) in mice and rhesus monkeys, respectively, with no supportive care. In mice, m-HemaMax at an optimal 20 ng/mouse dose significantly increased percent survival and survival time when administered 24 hours after TBI between 8-9 Gy (p<0.05 Pearson's chi-square test). This survival benefit was accompanied by increases in plasma interferon-gamma (IFN-gamma) and erythropoietin levels, recovery of femoral bone hematopoiesis characterized with the presence of IL-12 receptor beta(2) subunit-expressing myeloid progenitors, megakaryocytes, and osteoblasts. Mitigation of jejunal radiation damage was also examined. At allometrically equivalent doses, HemaMax showed similar pharmacokinetics in rhesus monkeys compared to m-HemaMax in mice, but more robustly increased plasma IFN-gamma levels. HemaMax also increased plasma erythropoietin, IL-15, IL-18, and neopterin levels. At non-human primate doses pharmacologically equivalent to murine doses, HemaMax (100 ng/Kg and 250 ng/Kg) administered at 24 hours after TBI (6.7 Gy/LD50/30) significantly increased percent survival of HemaMax groups compared to vehicle (p<0.05 Pearson's chi-square test). This survival benefit was accompanied by a significantly higher leukocyte (neutrophils and lymphocytes), thrombocyte, and reticulocyte counts during nadir (days 12-14) and significantly less weight loss at day 12 compared to vehicle. These findings indicate successful interspecies dose conversion and provide proof of concept that HemaMax increases survival in irradiated rhesus monkeys by promoting hematopoiesis and recovery of immune functions and possibly gastrointestinal functions, likely through a network of interactions involving dendritic cells, osteoblasts, and soluble factors such as IL-12, IFN-gamma, and cytoprotectant erythropoietin.	[Basile, Lena A.; Ellefson, Dolph; Gluzman-Poltorak, Zoya; Junes-Gill, Katiana; Mar, Vernon; Mendonca, Sarita; Tom, Jamie; Trinh, Alice; Gallaher, Timothy K.] Neumedicines Inc, Pasadena, CA USA; [Miller, Joseph D.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California	Basile, LA (corresponding author), Neumedicines Inc, Pasadena, CA USA.	basile@neumedicines.com	Wilson, Matthew H/K-3193-2013		Biomedical Advanced Research and Development Authority [HHS0100200800060C]	Biomedical Advanced Research and Development Authority	This study was funded with a contract from the Biomedical Advanced Research and Development Authority (Contract No. HHS0100200800060C). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 1999, STEM CELLS, V17, P92, DOI 10.1002/stem.170092; Akimoto T, 2000, KIDNEY INT, V58, P269, DOI 10.1046/j.1523-1755.2000.00162.x; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Basile LA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-26; Bekaii-Saab TS, 2009, MOL CANCER THER, V8, P2983, DOI 10.1158/1535-7163.MCT-09-0820; BELLONE G, 1994, J IMMUNOL, V153, P930; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cetin H, 2007, CLIN EXP PHARMACOL P, V34, P1181, DOI 10.1111/j.1440-1681.2007.04695.x; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; de Barros APDN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009093; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P73, DOI 10.1517/13543770903490429; FRASER JK, 1989, EXP HEMATOL, V17, P10; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gattoni A, 2006, Clin Ter, V157, P377; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; GIMBLE JM, 1993, EXP HEMATOL, V21, P224; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; HIRAYAMA F, 1994, BLOOD, V83, P92; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Kurz K, 2010, IMMUNOBIOLOGY, V215, P452, DOI 10.1016/j.imbio.2009.08.007; Lacy MQ, 2009, LEUKEMIA RES, V33, P1485, DOI 10.1016/j.leukres.2009.01.020; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lenzi R, 2002, CLIN CANCER RES, V8, P3686; Lenzi R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-66; Leonard JP, 1997, BLOOD, V90, P2541; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Little RF, 2007, BLOOD, V110, P4165, DOI 10.1182/blood-2007-06-097568; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_11.39; MEANS RT, 1991, BLOOD, V78, P2564; Melichar B, 2003, J IMMUNOTHER, V26, P270, DOI 10.1097/00002371-200305000-00010; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; NETA R, 1994, J IMMUNOL, V153, P4230; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; PLOEMACHER RE, 1993, LEUKEMIA, V7, P1381; PLOEMACHER RE, 1993, LEUKEMIA, V7, P1374; Sagiv SP, 2008, EXP HEMATOL, V36, P1682, DOI 10.1016/j.exphem.2008.07.010; Savino R, 2004, CELL DEATH DIFFER, V11, pS2, DOI 10.1038/sj.cdd.4401469; Sela S, 2001, NEPHRON, V88, P205, DOI 10.1159/000045991; Singh VK, 2005, EXP MOL PATHOL, V78, P156, DOI 10.1016/j.yexmp.2004.10.003; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; TERRELL TG, 1993, INT REV EXP PATHOL, V34, P73; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; U.S. Food and Drug Administration. Center for Drug Evaluation and Research, 2005, FDA GUID EST MAX SAF; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang ZY, 2009, FREE RADICAL BIO MED, V46, P1032, DOI 10.1016/j.freeradbiomed.2008.11.027; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zhang S, 2008, BIOCHEM BIOPH RES CO, V372, P509, DOI 10.1016/j.bbrc.2008.05.081; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252; ZOU JJ, 1995, J BIOL CHEM, V270, P5864, DOI 10.1074/jbc.270.11.5864; ZOUMBOS NC, 1984, J IMMUNOL, V133, P769	81	45	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30434	10.1371/journal.pone.0030434	http://dx.doi.org/10.1371/journal.pone.0030434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383962	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800004
J	Kozak, LP; Koza, RA; Anunciado-Koza, R; Mendoza, T; Newman, S				Kozak, Leslie P.; Koza, Robert A.; Anunciado-Koza, Rea; Mendoza, Tamra; Newman, Susan			Inherent Plasticity of Brown Adipogenesis in White Fat of Mice Allows for Recovery from Effects of Post-Natal Malnutrition	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE-TISSUE; INDUCED THERMOGENESIS; GENE-EXPRESSION; ENERGY-BALANCE; UCP1; ADIPOCYTES; INDUCTION; MUSCLE	Interscapular brown adipose tissue (iBAT) is formed during fetal development and stable for the life span of the mouse. In addition, brown adipocytes also appear in white fat depots (wBAT) between 10 and 21 days of age in mice maintained at a room temperature of 23 degrees C. However, this expression is transient. By 60 days of age the brown adipocytes have disappeared, but they can re-emerge if the adult mouse is exposed to the cold (5 degrees C) or treated with beta 3-adrenergic agonists. Since the number of brown adipocytes that can be induced in white fat influences the capacity of the mouse to resist the obese state, we determined the effects of the nutritional conditions on post-natal development (birth to 21 days) of wBAT and its long-term effects on diet-induced obesity (DIO). Under-nutrition caused essentially complete suppression of wBAT in inguinal fat at 21 days of age, as indicated by expression of Ucp1 and genes of mitochondrial structure and function based upon microarray and qRT-PCR analysis, whereas over-nutrition had no discernible effects on wBAT induction. Surprisingly, the suppression of wBAT at 21 days of age did not affect DIO in adult mice maintained at 23 degrees C, nor did it affect the reduction in obesity or cold tolerance when DIO mice were exposed to the cold at 5 degrees C for one week. Gene expression analysis indicated that mice raised under conditions that suppressed wBAT at 21 days of age were able to normally induce wBAT as adults. Therefore, neither severe hypoleptinemia nor hypoinsulinemia during suckling permanently impaired brown adipogenesis in white fat. In addition, energy balance studies of DIO mice exposed to cold indicates that mice with reduced adipose stores preferentially increased food intake, whereas those with larger adipose tissue depots preferred to utilize energy from their adipose stores.	[Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Koza, Robert A.; Anunciado-Koza, Rea; Mendoza, Tamra; Newman, Susan] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland.	l.kozak@pan.olsztyn.pl			Foundation for Polish Science; programme WELCOME [WELCOME/2010-4/3]; EU in Poland; EU in Poland within the REFRESH [FP7-REGPOT-2010-1-264103]; National Institutes of Health (NIH) [1P30-DK072476, P20-RR0021954]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); programme WELCOME; EU in Poland; EU in Poland within the REFRESH; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Foundation for Polish Science, programme WELCOME, no. WELCOME/2010-4/3 entitled "Nutrition and ambient temperature during early development can reduce susceptibility to obesity" financed by EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project (FP7-REGPOT-2010-1-264103). This research was also supported by National Institutes of Health (NIH) 1P30-DK072476 and NIH P20-RR0021954 to the Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; HIRNING U, 1989, CELL DIFFER DEV, V27, P243, DOI 10.1016/0922-3371(89)90704-1; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PROG MOL BIOL TRANSL, V94, P75, DOI 10.1016/S1877-1173(10)94004-0; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Landsberg L, 2006, CELL MOL NEUROBIOL, V26, P497, DOI 10.1007/s10571-006-9010-7; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30392	10.1371/journal.pone.0030392	http://dx.doi.org/10.1371/journal.pone.0030392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383960	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800003
J	Chagne, D; Crowhurst, RN; Troggio, M; Davey, MW; Gilmore, B; Lawley, C; Vanderzande, S; Hellens, RP; Kumar, S; Cestaro, A; Velasco, R; Main, D; Rees, JD; Iezzoni, A; Mockler, T; Wilhelm, L; Van de Weg, E; Gardiner, SE; Bassil, N; Peace, C				Chagne, David; Crowhurst, Ross N.; Troggio, Michela; Davey, Mark W.; Gilmore, Barbara; Lawley, Cindy; Vanderzande, Stijn; Hellens, Roger P.; Kumar, Satish; Cestaro, Alessandro; Velasco, Riccardo; Main, Dorrie; Rees, Jasper D.; Iezzoni, Amy; Mockler, Todd; Wilhelm, Larry; Van de Weg, Eric; Gardiner, Susan E.; Bassil, Nahla; Peace, Cameron			Genome-Wide SNP Detection, Validation, and Development of an 8K SNP Array for Apple	PLOS ONE			English	Article							X DOMESTICA BORKH.; TRANSCRIPTION FACTOR; SHELF-LIFE; FRUIT; DISCOVERY; GENE; TRANSFERABILITY; IDENTIFICATION; POLYMORPHISM; DIVERSITY	As high-throughput genetic marker screening systems are essential for a range of genetics studies and plant breeding applications, the International RosBREED SNP Consortium (IRSC) has utilized the Illumina Infinium (R) II system to develop a medium-to high-throughput SNP screening tool for genome-wide evaluation of allelic variation in apple (Malusxdomestica) breeding germplasm. For genome-wide SNP discovery, 27 apple cultivars were chosen to represent worldwide breeding germplasm and re-sequenced at low coverage with the Illumina Genome Analyzer II. Following alignment of these sequences to the whole genome sequence of 'Golden Delicious', SNPs were identified using SoapSNP. A total of 2,113,120 SNPs were detected, corresponding to one SNP to every 288 bp of the genome. The Illumina GoldenGate (R) assay was then used to validate a subset of 144 SNPs with a range of characteristics, using a set of 160 apple accessions. This validation assay enabled fine-tuning of the final subset of SNPs for the Illumina Infinium (R) II system. The set of stringent filtering criteria developed allowed choice of a set of SNPs that not only exhibited an even distribution across the apple genome and a range of minor allele frequencies to ensure utility across germplasm, but also were located in putative exonic regions to maximize genotyping success rate. A total of 7867 apple SNPs was established for the IRSC apple 8K SNP array v1, of which 5554 were polymorphic after evaluation in segregating families and a germplasm collection. This publicly available genomics resource will provide an unprecedented resolution of SNP haplotypes, which will enable marker-locus-trait association discovery, description of the genetic architecture of quantitative traits, investigation of genetic variation (neutral and functional), and genomic selection in apple.	[Chagne, David; Gardiner, Susan E.] Palmerston N Res Ctr, Palmerston North, New Zealand; [Crowhurst, Ross N.; Hellens, Roger P.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Troggio, Michela; Cestaro, Alessandro; Velasco, Riccardo] Fdn Edmund Mach, IASMA Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Davey, Mark W.; Vanderzande, Stijn] Katholieke Univ Leuven, Lab Fruit Breeding & Biotechnol, Dept Biosyst, Louvain, Belgium; [Gilmore, Barbara; Bassil, Nahla] ARS, USDA, Corvallis, OR USA; [Lawley, Cindy] Illumina Inc, Hayward, CA USA; [Kumar, Satish] Hawkes Bay Res Ctr, Havelock N, New Zealand; [Main, Dorrie; Peace, Cameron] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Rees, Jasper D.] Agr Res Council, Onderstepoort, South Africa; [Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Mockler, Todd] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Wilhelm, Larry] Oregon Hlth & Sci Univ, Portland, OR USA; [Van de Weg, Eric] Univ Wageningen & Res Ctr, Wageningen, Netherlands	New Zealand Institute for Plant & Food Research Ltd; Fondazione Edmund Mach; KU Leuven; United States Department of Agriculture (USDA); Illumina; Washington State University; Agricultural Research Council of South Africa; Michigan State University; Donald Danforth Plant Science Center; Oregon Health & Science University; Wageningen University & Research	Chagne, D (corresponding author), Palmerston N Res Ctr, Palmerston North, New Zealand.	cpeace@wsu.edu	Rees, David Jasper Gilbert/AAZ-8073-2020; Gardiner, Susan Elizabeth/A-2477-2010; Chagne, David/A-2596-2010; Van de Weg, Eric W/G-3225-2011; Crowhurst, Ross N/N-8892-2017; Mockler, Todd C/L-2609-2013; Rees, Jasper/D-9672-2011	Rees, David Jasper Gilbert/0000-0003-3321-1325; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Chagne, David/0000-0003-4018-0694; Van de Weg, Eric W/0000-0002-9443-5974; Crowhurst, Ross N/0000-0003-0608-2134; Mockler, Todd C/0000-0002-0462-5775; Rees, Jasper/0000-0003-3321-1325; Kumar, Satish/0000-0002-9857-5640; Hellens, Roger/0000-0003-2094-0887; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Davey, Mark/0000-0002-4633-0991	U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative [2009-51181-05808]; New Zealand Ministry of Science and Innovation [C06X0812]; PREVAR Ltd; Plant and Food Research's Pipfruit Internal Investment Project; research office of the Provincia autonoma di Trento	U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative; New Zealand Ministry of Science and Innovation; PREVAR Ltd; Plant and Food Research's Pipfruit Internal Investment Project; research office of the Provincia autonoma di Trento	This work was partially funded by the U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae'' (2009-51181-05808). Apple genomics at Plant and Food Research is partially supported by the New Zealand Ministry of Science and Innovation project C06X0812 "Exploiting Opportunities from Horticultural Genomics'', PREVAR Ltd, as well as Plant and Food Research's Pipfruit Internal Investment Project. Apple genome research at Istituto Agrarie San Michele Adige-Fundazione Edmund Mach is supported by the research office of the Provincia autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushakra JM, 2012, TREE GENET GENOMES, V8, P643, DOI 10.1007/s11295-011-0450-y; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Costa F, 2005, EUPHYTICA, V141, P181, DOI 10.1007/s10681-005-6805-4; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Han YP, 2009, GENOMICS, V93, P282, DOI 10.1016/j.ygeno.2008.11.005; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iezzoni A, 2010, ACTA HORTIC, V859, P389; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Peace Cameron, 2009, V6, P19, DOI 10.1007/978-0-387-77491-6_2; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Rowan DD, 2009, J AGR FOOD CHEM, V57, P7953, DOI 10.1021/jf901678v; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Van de Weg WE, 2004, ACTA HORTIC, P45, DOI 10.17660/ActaHortic.2004.663.1; van Dyk MM, 2009, ACTA HORTIC, V814, P681; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Wang AD, 2012, MOL BREEDING, V29, P379, DOI 10.1007/s11032-011-9554-1; Wang A, 2009, PLANT PHYSIOL, V151, P391, DOI 10.1104/pp.109.135822; Wang J, 2008, PROTOCOL EXCHANGE; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267	48	206	216	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31745	10.1371/journal.pone.0031745	http://dx.doi.org/10.1371/journal.pone.0031745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363718	Green Published, gold			2022-12-25	WOS:000302873700088
J	Cona, G; Arcara, G; Tarantino, V; Bisiacchi, PS				Cona, Giorgia; Arcara, Giorgio; Tarantino, Vincenza; Bisiacchi, Patrizia Silvia			Electrophysiological Correlates of Strategic Monitoring in Event-Based and Time-Based Prospective Memory	PLOS ONE			English	Article							TASK INTERFERENCE; PREFRONTAL CORTEX; RETRIEVAL; REALIZATION; DEMANDS; INVOLVEMENT; INTENTIONS; COMPONENT; COVARIES; REMEMBER	Prospective memory (PM) is the ability to remember to accomplish an action when a particular event occurs (i.e., event-based PM), or at a specific time (i.e., time-based PM) while performing an ongoing activity. Strategic Monitoring is one of the basic cognitive functions supporting PM tasks, and involves two mechanisms: a retrieval mode, which consists of maintaining active the intention in memory; and target checking, engaged for verifying the presence of the PM cue in the environment. The present study is aimed at providing the first evidence of event-related potentials (ERPs) associated with time-based PM, and at examining differences and commonalities in the ERPs related to Strategic Monitoring mechanisms between event-and time-based PM tasks. The addition of an event-based or a time-based PM task to an ongoing activity led to a similar sustained positive modulation of the ERPs in the ongoing trials, mainly expressed over prefrontal and frontal regions. This modulation might index the retrieval mode mechanism, similarly engaged in the two PM tasks. On the other hand, two further ERP modulations were shown specifically in an event-based PM task. An increased positivity was shown at 400-600 ms post-stimulus over occipital and parietal regions, and might be related to target checking. Moreover, an early modulation at 130-180 ms post-stimulus seems to reflect the recruitment of attentional resources for being ready to respond to the event-based PM cue. This latter modulation suggests the existence of a third mechanism specific for the event-based PM; that is, the "readiness mode''.	[Cona, Giorgia; Arcara, Giorgio; Tarantino, Vincenza; Bisiacchi, Patrizia Silvia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Arcara, Giorgio] Univ Padua, Dept Informat Engn, Padua, Italy; [Bisiacchi, Patrizia Silvia] Univ Padua, Dept Clin & Expt Med, Ctr Interdipartimentale Ric Modellist Alterazioni, Padua, Italy	University of Padua; University of Padua; University of Padua	Cona, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giorgia.cona@unipd.it	Arcara, Giorgio/K-6351-2016	Arcara, Giorgio/0000-0001-6270-6883; , Giorgia/0000-0003-1844-9327; bisiacchi, patrizia/0000-0003-2760-8000; Tarantino, Vincenza/0000-0002-5836-3811	Bial Foundation [146/08]; Italian government MIUR [200879eb93_002]	Bial Foundation(Bial Foundation); Italian government MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from the Bial Foundation (146/08) to PSB, and by a grant from Italian government MIUR number 200879eb93_002 to PSB; http://www.bial.com/pt/; http://www.istruzione.it/web/ricerca/home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; [Anonymous], 1983, CANADIAN PSYCHOL; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bisiacchi PS, 2011, NEUROPSYCHOLOGIA, V49, P2225, DOI 10.1016/j.neuropsychologia.2011.05.007; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Brandimonte M, 1996, PROSPECTIVE MEMORY T; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chen Y, 2007, NEUROREPORT, V18, P1951, DOI 10.1097/WNR.0b013e3282f202dd; Chen YZ, 2009, NEUROREPORT, V20, P81, DOI 10.1097/WNR.0b013e32831ac700; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Development Core Team, 2011, R LANG ENV STAT COMP; Duzel E, 2000, ACTA PSYCHOL, V105, P195, DOI 10.1016/S0001-6918(00)00061-5; Einstein G. O., 1996, PROSPECTIVE MEMORY T, P115; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; Goshke T., 1996, PROSPECTIVE MEMORY T, P53; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guynn M. J., 2008, PROSPECTIVE MEMORY C, P53; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; HARRIS JE, 1982, HUM LEARN, V1, P123; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kalpouzos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013304; Kliegel M, PROSPECTIVE MEMORY C; Knight JB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.005.2010; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; Mantyla T, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P191, DOI 10.1142/9789812707123_0008; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2000, APPL COGNITIVE PSYCH, V14, pS29, DOI 10.1002/acp.769.abs; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; McIntosh AR, 1997, HUM BRAIN MAPP, V5, P323, DOI 10.1002/(SICI)1097-0193(1997)5:4<323::AID-HBM20>3.0.CO;2-D; Morcom AM, 2002, NEUROREPORT, V13, P149, DOI 10.1097/00001756-200201210-00034; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P43; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Tarantino V, MONITORING MEC UNPUB; Tulving E, 1998, ADVANCES IN PSYCHOLOGICAL SCIENCE, VOL 2, P441; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2011, CAN J EXP PSYCHOL, V65, P38, DOI 10.1037/a0022810; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; West R, 2002, COGN AFFECT BEHAV NE, V2, P162, DOI 10.3758/CABN.2.2.162	71	30	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31659	10.1371/journal.pone.0031659	http://dx.doi.org/10.1371/journal.pone.0031659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363699	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700081
J	Huang, DC; Zhang, RZ; Kim, KC; Suarez, AV				Huang, Dingcheng; Zhang, Runzhi; Kim, Ke Chung; Suarez, Andrew V.			Spatial Pattern and Determinants of the First Detection Locations of Invasive Alien Species in Mainland China	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; STRATEGIES; TRADE	Background: The unintentional transport of species as a result of human activities has reached unprecedented rates. Once established, introduced species can be nearly impossible to eradicate. It is therefore essential to identify and monitor locations where invaders are most likely to establish new populations. Despite the obvious value of early detection, how does an agency identify areas that are most vulnerable to new invaders? Here we propose a novel approach by using the "first detection location'' (FDL) of introduced species in China to quantify characteristics of areas where introduced species are first reported. Methodology/Principal Findings: We obtained FDLs for 166 species (primarily agricultural and forestry pests) that were unintentionally introduced into China prior to 2008 from literature searches. The spatial pattern and determinants of FDLs were examined at the provincial level. The spatial pattern of FDLs varied among provinces with more commerce and trade and economically developed provinces in coastal regions having more FDLs than interior provinces. For example, 74.6% of FDLs were distributed in coastal regions despite that they only cover 15.6% of the total area in China. Variables that may be indicators of "introduction pressure'' (e.g. the amount of received commerce) had an overwhelming effect on the number of FDLs in each province (R-2 = 0.760). Conclusions/Significance: Our results suggest that "introduction pressure'' may be one of the most important factors that determine the locations where newly-introduced species are first detected, and that open and developed provinces in China should be prioritized when developing monitoring programs that focus on locating and managing new introductions. Our study illustrates that FDL approaches can contribute to the study and management of biological invasions not only for China but also for elsewhere.	[Huang, Dingcheng; Zhang, Runzhi] Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Huang, Dingcheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Kim, Ke Chung] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Dept Anim Biol, Urbana, IL 61801 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, RZ (corresponding author), Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhangrz@ioz.ac.cn			Natural Science Foundation of China [30525039]; Chinese Academy of Sciences [KSCX2-YW-N-42]; National research programs of China [2005DKA21402/2006FY110500]; Division Of Environmental Biology [1020979] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National research programs of China; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Natural Science Foundation of China program (30525039), Chinese Academy of Sciences program (KSCX2-YW-N-42) and National research programs of China (2005DKA21402/2006FY110500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Breiman L., 2017, CLASSIFICATION REGRE; China Association of Port-of-Entry, 2003, PRACT MAN PORTS ENTR; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Costello CJ, 2003, P NATL ACAD SCI USA, V100, P3321, DOI 10.1073/pnas.0636536100; DAISIE, 2008, HDB AL SPEC EUR; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Genovesi P., 2003, P CONV CONS EUR WILD; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Haack RA, 1997, J FOREST, V95, P11; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Leung B, 2007, P ROY SOC B-BIOL SCI, V274, P2603, DOI 10.1098/rspb.2007.0841; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Li Z., 2002, INVASIVE ALIEN SPECI; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Liu J, 2005, DIVERS DISTRIB, V11, P341, DOI 10.1111/j.1366-9516.2005.00162.x; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McBeath GA, 2006, ENVIRON GOV ASIA, P1; McNeely JA, 2001, GLOBAL STRATEGY INVA; Meentemeyer RK, 2008, ECOL APPL, V18, P377, DOI 10.1890/07-1150.1; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; National Bureau of Statistics of China, 1986, CHIN STAT YB; National Invasive Species Council, 2008, 2008 2012 NAT INV SP; RICHARDSON DM, 2008, DIVERS DISTRIB, V14, P161, DOI DOI 10.1111/J.1472-4642.2008.00464.X; Steinberg G, 1995, TREESTRUCTURED NONPA; SUN Y, 1982, J JIANGSU FOR SCI TE, V9, P47; Venette RC, 2002, ANNU REV ENTOMOL, V47, P143, DOI 10.1146/annurev.ento.47.091201.145147; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wan F, 2008, BIOL INVASIONS LEGIS; Wan FH, 2009, RES BIOL INVASIONS C; Wan FH, 2005, BIOL MANAGEMENT INVA; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wheeler Alfred G. Jr, 2009, P475, DOI 10.1002/9781444308211.ch21; Wu SH, 2010, BIOL INVASIONS, V12, P2179, DOI 10.1007/s10530-009-9620-3; Xie Y, 2008, BIOINVASION ECOLOGIC; Xu H, 2004, CHECKLIST INVASIVE A, P432; Xu Hai-Gen, 2004, Shengwu Duoyangxing, V12, P626; Xu HG, 2006, BIODIVERS CONSERV, V15, P2893, DOI 10.1007/s10531-005-2575-5; Zeng Ling, 2005, Chinese Bulletin of Entomology, V42, P144; 张润志, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P1095	47	31	39	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31734	10.1371/journal.pone.0031734	http://dx.doi.org/10.1371/journal.pone.0031734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363715	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700086
J	Blamires, SJ; Wu, CL; Tso, IM				Blamires, Sean J.; Wu, Chun-Lin; Tso, I-Min			Variation in Protein Intake Induces Variation in Spider Silk Expression	PLOS ONE			English	Article							CLAVIPES DRAGLINE SILK; MECHANICAL-PROPERTIES; AMPULLATE SILKS; C-13 NMR; WEB; EVOLUTION; SEQUENCE; PROLINE; FIBROIN; STOICHIOMETRY	Background: It is energetically expensive to synthesize certain amino acids. The proteins (spidroins) of spider major ampullate (MA) silk, MaSp1 and MaSp2, differ in amino acid composition. Glutamine and proline are prevalent in MaSp2 and are expensive to synthesize. Since most orb web spiders express high proline silk they might preferentially attain the amino acids needed for silk from food and shift toward expressing more MaSp1 in their MA silk when starved. Methodology/Principal Findings: We fed three spiders; Argiope aetherea, Cyrtophora moluccensis and Leucauge blanda, high protein, low protein or no protein solutions. A. aetherea and L. blanda MA silks are high in proline, while C. moluccesnsis MA silks are low in proline. After 10 days of feeding we determined the amino acid compositions and mechanical properties of each species' MA silk and compared them between species and treatments with pre-treatment samples, accounting for ancestry. We found that the proline and glutamine of A. aetherea and L. blanda silks were affected by protein intake; significantly decreasing under the low and no protein intake treatments. Glutmaine composition in C. moluccensis silk was likewise affected by protein intake. However, the composition of proline in their MA silk was not significantly affected by protein intake. Conclusions: Our results suggest that protein limitation induces a shift toward different silk proteins with lower glutamine and/or proline content. Contradictions to the MaSp model lie in the findings that C. moluccensis MA silks did not experience a significant reduction in proline and A. aetherea did not experience a significant reduction in serine on low/no protein. The mechanical properties of the silks could not be explained by a MaSp1 expressional shift. Factors other than MaSp expression, such as the expression of spidroin-like orthologues, may impact on silk amino acid composition and spinning and glandular processes may impact mechanics.	[Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Wu, Chun-Lin] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu, Taiwan; [Tso, I-Min] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	Tunghai University; Industrial Technology Research Institute - Taiwan; National Chung Hsing University	Blamires, SJ (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	spider@thu.edu.tw			National Science Council, Taiwan [NSC 98-2811-B-029-002]; NSC [NSC 97-2311-B-029-002-MY3, NSC 99-2621-B-029-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan)	The work was supported by a National Science Council, Taiwan postdoctoral grant to S.J.B. (NSC 98-2811-B-029-002) and NSC grants (NSC 97-2311-B-029-002-MY3; NSC 99-2621-B-029-002-MY3) to I.M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Blamires S. J., 2012, SILKS PROPERTIES PRO, P139; Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; Blamires SJ, 2010, ANIM BEHAV, V80, P947, DOI 10.1016/j.anbehav.2010.09.011; Blamires SJ, 2009, ECOL ENTOMOL, V34, P545, DOI 10.1111/j.1365-2311.2009.01095.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bonev B, 2006, BIOPOLYMERS, V82, P134, DOI 10.1002/bip.20471; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9; Craig CL, 2003, SPIDERWEBS SILK TRAC; Creager MS, 2011, COMP BIOCHEM PHYS A, V159, P219, DOI 10.1016/j.cbpa.2011.02.010; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; D'Mello J. P. F., 2003, Amino acids in animal nutrition, P71, DOI 10.1079/9780851996547.0071; Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fagan WF, 2004, ECOL LETT, V7, P876, DOI 10.1111/j.1461-0248.2004.00641.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guehrs KH, 2008, INSECT MOL BIOL, V17, P553, DOI 10.1111/j.1365-2583.2008.00826.x; Guhrs K H, 2000, J Biotechnol, V74, P121; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2002, MOL SYSTEMATICS EVOL; Higgins L, 1999, PHYSIOL ENTOMOL, V24, P263, DOI 10.1046/j.1365-3032.1999.00135.x; Higgins LE, 2007, INT J BIOL MACROMOL, V40, P201, DOI 10.1016/j.ijbiomac.2006.07.007; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland GP, 2008, BIOMACROMOLECULES, V9, P651, DOI 10.1021/bm700950u; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Maddison WP, 2000, J THEOR BIOL, V202, P195, DOI 10.1006/jtbi.1999.1050; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2003, OIKOS, V101, P631, DOI 10.1034/j.1600-0706.2003.12408.x; Mayntz D, 2009, BIOL LETTERS, V5, P735, DOI 10.1098/rsbl.2009.0431; Nelson D., 2005, LEHNINGER PRINCIPLES; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332; Quinn GP, 2003, EXPT DESIGN DATA ANA; Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; WORK RW, 1987, J ARACHNOL, V15, P65; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x	68	41	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31626	10.1371/journal.pone.0031626	http://dx.doi.org/10.1371/journal.pone.0031626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363691	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500066
J	Lieu, MH; Vallejos, MJ; Michael, E; Tsunoda, S				Lieu, Minh-Ha; Vallejos, Maximiliano J.; Michael, Emily; Tsunoda, Susan			Mechanisms Underlying Stage-1 TRPL Channel Translocation in Drosophila Photoreceptors	PLOS ONE			English	Article							INAD-SIGNALING COMPLEXES; SUBCELLULAR TRANSLOCATION; ACTIN-FILAMENTS; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLOCATION; VISUAL ARRESTIN; LIPID RAFTS; MYOSIN-III; CA2+ ENTRY; LIGHT	Background: channels function as key mediators of sensory transduction and other cellular signaling pathways. In Drosophila, TRP and TRPL are the light-activated channels in photoreceptors. While TRP is statically localized in the signaling compartment of the cell (the rhabdomere), TRPL localization is regulated by light. TRPL channels translocate out of the rhabdomere in two distinct stages, returning to the rhabdomere with dark-incubation. Translocation of TRPL channels regulates their availability, and thereby the gain of the signal. Little, however, is known about the mechanisms underlying this trafficking of TRPL channels. Methodology/Principal Findings: We first examine the involvement of de novo protein synthesis in TRPL translocation. We feed flies cycloheximide, verify inhibition of protein synthesis, and test for TRPL translocation in photoreceptors. We find that protein synthesis is not involved in either stage of TRPL translocation out of the rhabdomere, but that re-localization to the rhabdomere from stage-1, but not stage-2, depends on protein synthesis. We also characterize an ex vivo eye preparation that is amenable to biochemical and genetic manipulation. We use this preparation to examine mechanisms of stage-1 TRPL translocation. We find that stage-1 translocation is: induced with ATP depletion, unaltered with perturbation of the actin cytoskeleton or inhibition of endocytosis, and slowed with increased membrane sterol content. Conclusions/Significance: Our results indicate that translocation of TRPL out of the rhabdomere is likely due to protein transport, and not degradation/re-synthesis. Re-localization from each stage to the rhabdomere likely involves different strategies. Since TRPL channels can translocate to stage-1 in the absence of ATP, with no major requirement of the cytoskeleton, we suggest that stage-1 translocation involves simple diffusion through the apical membrane, which may be regulated by release of a light-dependent anchor in the rhabdomere.	[Lieu, Minh-Ha; Michael, Emily] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Vallejos, Maximiliano J.; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Boston University; Colorado State University	Lieu, MH (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	Susan.Tsunoda@colostate.edu			National Institutes of Health (NIH) [EY013751]; NATIONAL EYE INSTITUTE [R01EY013751] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by a National Institutes of Health (NIH) grant to ST (EY013751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Agam K, 2004, CELL CALCIUM, V35, P87, DOI 10.1016/j.ceca.2003.08.001; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Baumann O, 2001, NEUROSCI LETT, V306, P181, DOI 10.1016/S0304-3940(01)01900-0; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KEESLER GA, 1992, ARCH BIOCHEM BIOPHYS, V296, P474, DOI 10.1016/0003-9861(92)90600-2; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; Li LH, 2002, J GEN PHYSIOL, V119, P105, DOI 10.1085/jgp.119.1.105; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberegelsbacher C, 2011, EUR J CELL BIOL, V90, P620, DOI 10.1016/j.ejcb.2011.02.003; Orem NR, 2002, VISION RES, V42, P497, DOI 10.1016/S0042-6989(01)00229-2; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REDEGELD FAM, 1992, EUR J PHARM-ENVIRON, V228, P229, DOI 10.1016/0926-6917(92)90034-A; Richter D, 2011, J BIOL CHEM, V286, P34234, DOI 10.1074/jbc.M111.278564; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Sanxaridis PD, 2007, MOL CELL NEUROSCI, V36, P36, DOI 10.1016/j.mcn.2007.05.006; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SLATER EC, 1966, B SOC CHIM BIOL, V48, P1151; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; TROCHA PJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P45, DOI 10.1016/0003-9861(76)90322-2; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; WICK AN, 1957, J BIOL CHEM, V224, P963	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31622	10.1371/journal.pone.0031622	http://dx.doi.org/10.1371/journal.pone.0031622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363689	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500065
J	Alexander, J; Ward, S; Mendy, J; Manayani, DJ; Farness, P; Avanzini, JB; Guenther, B; Garduno, F; Jow, L; Snarsky, V; Ishioka, G; Dong, X; Vang, L; Newman, MJ; Mayall, T				Alexander, Jeff; Ward, Simone; Mendy, Jason; Manayani, Darly J.; Farness, Peggy; Avanzini, Jenny B.; Guenther, Ben; Garduno, Fermin; Jow, Lily; Snarsky, Victoria; Ishioka, Glenn; Dong, Xin; Vang, Lo; Newman, Mark J.; Mayall, Tim			Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; VIRAL VECTORS; AVIAN INFLUENZA; PREEXISTING IMMUNITY; PANDEMIC INFLUENZA; VIRUS-VACCINES; US MILITARY; B-VACCINE; IMMUNIZATION; IMMUNOGENICITY	Background: Influenza virus remains a significant health and social concern in part because of newly emerging strains, such as avian H5N1 virus. We have developed a prototype H5N1 vaccine using a recombinant, replication-competent Adenovirus serotype 4 (Ad4) vector, derived from the U. S. military Ad4 vaccine strain, to express the hemagglutinin (HA) gene from A/Vietnam/1194/2004 influenza virus (Ad4-H5-Vtn). Our hypothesis is that a mucosally-delivered replicating Ad4-H5-Vtn recombinant vector will be safe and induce protective immunity against H5N1 influenza virus infection and disease pathogenesis. Methodology/Principal Findings: The Ad4-H5-Vtn vaccine was designed with a partial deletion of the E3 region of Ad4 to accommodate the influenza HA gene. Replication and growth kinetics of the vaccine virus in multiple human cell lines indicated that the vaccine virus is attenuated relative to the wild type virus. Expression of the HA transgene in infected cells was documented by flow cytometry, western blot analysis and induction of HA-specific antibody and cellular immune responses in mice. Of particular note, mice immunized intranasally with the Ad4-H5-Vtn vaccine were protected against lethal H5N1 reassortant viral challenge even in the presence of pre-existing immunity to the Ad4 wild type virus. Conclusions/Significance: Several non-clinical attributes of this vaccine including safety, induction of HA-specific humoral and cellular immunity, and efficacy were demonstrated using an animal model to support Phase 1 clinical trial evaluation of this new vaccine.	[Alexander, Jeff; Ward, Simone; Mendy, Jason; Manayani, Darly J.; Farness, Peggy; Avanzini, Jenny B.; Guenther, Ben; Garduno, Fermin; Jow, Lily; Snarsky, Victoria; Ishioka, Glenn; Dong, Xin; Vang, Lo; Newman, Mark J.; Mayall, Tim] PaxVax Inc, San Diego, CA USA		Alexander, J (corresponding author), PaxVax Inc, San Diego, CA USA.	jalexander@paxvax.com		Newman, Mark J./0000-0002-0433-6690	Wellcome Trust, London, United Kingdom	Wellcome Trust, London, United Kingdom(Wellcome Trust)	This work was supported by The Wellcome Trust, London, United Kingdom (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaman M, 2011, EMERG INFECT DIS, V17, P1056; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Appaiahgari MB, 2006, MICROBES INFECT, V8, P92, DOI 10.1016/j.micinf.2005.05.023; Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belyakov IM, 1999, P NATL ACAD SCI USA, V96, P4512, DOI 10.1073/pnas.96.8.4512; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; CHENGALVALA MV, 1994, J GEN VIROL, V75, P125, DOI 10.1099/0022-1317-75-1-125; COUCH ROBERT B., 1963, AMER REV RESP DIS, V88, P394; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Gabitzsch ES, 2009, VACCINE, V27, P6394, DOI 10.1016/j.vaccine.2009.06.028; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; GAYDOS CA, 1995, MIL MED, V160, P300, DOI 10.1093/milmed/160.6.300; Gurwith M J, 1989, Semin Respir Infect, V4, P299; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; HSU KHL, 1994, VACCINE, V12, P607; Huang XP, 2009, HUM GENE THER, V20, P293, DOI 10.1089/hum.2008.141; JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405; Kajon AE, 2007, J INFECT DIS, V196, P67, DOI 10.1086/518442; Kaneko H, 2004, ANTIVIR RES, V61, P63, DOI 10.1016/j.antiviral.2003.08.003; Khanam S, 2009, VACCINE, V27, P6011, DOI 10.1016/j.vaccine.2009.07.073; Knowles MK, 2009, VACCINE, V27, P6619, DOI 10.1016/j.vaccine.2009.08.005; Limbach KJ, 2009, PARASITE IMMUNOL, V31, P501, DOI 10.1111/j.1365-3024.2009.01141.x; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; LUBECK MD, 1989, P NATL ACAD SCI USA, V86, P6763, DOI 10.1073/pnas.86.17.6763; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Lyons A, 2008, VACCINE, V26, P2890, DOI [10.1016/j.vaccine.2008.03.037, 10.1016/J.vaccine.2008.03.037]; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Narang A, 2009, HUM VACCINES, V5, P414, DOI 10.4161/hv.5.6.8176; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Park KS, 2009, VIROLOGY, V395, P182, DOI 10.1016/j.virol.2009.09.018; PEDREIRA FA, 1968, P SOC EXP BIOL MED, V129, P472; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Shabram PW, 1997, HUM GENE THER, V8, P453, DOI 10.1089/hum.1997.8.4-453; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Steitz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010492; TACKET CO, 1992, VACCINE, V10, P673, DOI 10.1016/0264-410X(92)90088-2; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; TOP FH, 1971, J INFECT DIS, V124, P148, DOI 10.1093/infdis/124.2.148; Tucker SN, 2008, EXPERT REV VACCINES, V7, P25, DOI 10.1586/14760584.7.1.25; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	60	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31177	10.1371/journal.pone.0031177	http://dx.doi.org/10.1371/journal.pone.0031177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363572	Green Published, gold			2022-12-25	WOS:000302853600120
J	Lee, J; Hong, SW; Chae, SW; Kim, DH; Choi, JH; Bae, JC; Park, SE; Rhee, EJ; Park, CY; Oh, KW; Park, SW; Kim, SW; Lee, WY				Lee, Jinmi; Hong, Seok-Woo; Chae, Seoung Wan; Kim, Dong Hoon; Choi, Ji Hun; Bae, Ji Cheol; Park, Se Eun; Rhee, Eun-Jung; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Kim, Sun-Woo; Lee, Won-Young			Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEPATIC STEATOSIS; GLP-1 RECEPTOR; FOOD-INTAKE; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; DIABETES-MELLITUS; SIGNALING PATHWAY; LIVER-DISEASE; RISK-FACTORS	The effects of exendin-4 on Sirt1 expression as a mechanism of reducing fatty liver have not been previously reported. Therefore, we investigated whether the beneficial effects of exendin-4 treatment on fatty liver are mediated via Sirt1 in high-fat (HF) diet-induced obese C57BL/6J mice and related cell culture models. Exendin-4 treatment decreased body weight, serum free fatty acid (FA), and triglyceride levels in HF-induced obese C57BL/6J mice. Histological analysis showed that exendin-4 reversed HF-induced hepatic accumulation of lipids and inflammation. Exendin-4 treatment increased mRNA and protein expression of Sirt1 and its downstream factor, AMPK, in vivo and also induced genes associated with FA oxidation and glucose metabolism. In addition, a significant increase in the hepatic expression of Lkb1 and Nampt mRNA was observed in exendin-4-treated groups. We also observed increased expression of phospho-Foxo1 and GLUT2, which are involved in hepatic glucose metabolism. In HepG2 and Huh7 cells, mRNA and protein expressions of GLP-1R were increased by exendin-4 treatment in a dose-dependent manner. Exendin-4 enhanced protein expression of Sirt1 and phospho-AMPK alpha in HepG2 cells treated with 0.4 mM palmitic acid. We also found that Sirt1 was an upstream regulator of AMPK in hepatocytes. A novel finding of this study was the observation that expression of GLP-1R is proportional to exendin-4 concentration and exendin-4 could attenuate fatty liver through activation of Sirt1.	[Lee, Jinmi; Hong, Seok-Woo] Sungkyunkwan Univ, Sch Med, Inst Med Res, Kangbuk Samsung Hosp, Seoul, South Korea; [Chae, Seoung Wan; Kim, Dong Hoon] Sungkyunkwan Univ, Sch Med, Dept Pathol, Kangbuk Samsung Hosp, Seoul, South Korea; [Choi, Ji Hun; Bae, Ji Cheol; Park, Se Eun; Rhee, Eun-Jung; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Kim, Sun-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Inst Med Res, Kangbuk Samsung Hosp, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018; Park, Cheol-Young/C-6690-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Park, Cheol-Young/0000-0002-9415-9965	Samsung Biomedical Research Institute [C-A8-223-2]; Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology [S-2010-1115-000]	Samsung Biomedical Research Institute(Samsung); Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology	This study was supported by a grant from Samsung Biomedical Research Institute # C-A8-223-2 (http://www.sbri.or.kr) and Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology # S-2010-1115-000 (http://www.mest.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Ahren B, 2004, HORM METAB RES, V36, P867, DOI 10.1055/s-2004-826178; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Arnes L, 2009, REGUL PEPTIDES, V153, P88, DOI 10.1016/j.regpep.2008.08.005; Awazawa M, 2009, BIOCHEM BIOPH RES CO, V382, P51, DOI 10.1016/j.bbrc.2009.02.131; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chaudhary N, 2009, CURR OPIN CLIN NUTR, V12, P431, DOI 10.1097/MCO.0b013e32832cdaae; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Donahey JCK, 1998, BRAIN RES, V779, P75, DOI 10.1016/S0006-8993(97)01057-3; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Giorgino F, 2006, DIABETES RES CLIN PR, V74, pS152, DOI 10.1016/S0168-8227(06)70021-3; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Park S, 2010, METABOLISM, V59, P123, DOI 10.1016/j.metabol.2009.06.026; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Song ZY, 2007, BASIC CLIN PHARMACOL, V101, P262, DOI 10.1111/j.1742-7843.2007.00116.x; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tiikkainen M, 2003, DIABETES, V52, P701, DOI 10.2337/diabetes.52.3.701; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	34	76	81	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31394	10.1371/journal.pone.0031394	http://dx.doi.org/10.1371/journal.pone.0031394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363635	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600145
J	Zhang, QW; Zhang, XM; Wu, H; Seto, D; Zhang, HJ; Chen, ZW; Wan, CS; Zheng, BJ				Zhang, Qiwei; Zhang, Xiaomin; Wu, Hao; Seto, Donald; Zhang, Hao-Jie; Chen, Zhiwei; Wan, Chengsong; Zheng, Bo-Jian			Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR TRANSCRIPTION FACTOR; CIRCULATING RECOMBINANT; FUNCTIONAL-ANALYSIS; SUBTYPE; EXPRESSION; RETROVIRUS; SEQUENCES; PROVINCE; TATA	Circulating recombinant forms (CRFs) of HIV-1 have been identified in southern China in recent years. CRF08_BC is one of the most predominant subtypes circulating in China. In order to study HIV subtype biology and to provide a tool for biotechnological applications, the first full-length replication-competent infectious molecular clone harboring CRF08_BC is reported. The construction of this clone pBRGX indicates that a moderate-copy number vector is required for its amplification in E. coli. In addition, it is shown that the parental CRF08_BC LTRs are important for generating this efficient replication-competent infectious clone. These observations may aid in the construction of infectious clones from other subtypes. Both the pBRGX-derived virus and its parental isolate contain CCR5 tropism. Their full-length genomes were also sequenced, analyzed, compared and deposited in GenBank (JF719819 and JF719818, respectively). The availability of pBRGX as the first replication-competent molecular clone of CRF08_BC provides a useful tool for a wide range of studies of this newly emergent HIV subtype, including the development of HIV vaccine candidates, antiviral drug screening and drug resistance analysis.	[Zhang, Qiwei; Zhang, Xiaomin; Wu, Hao; Zhang, Hao-Jie; Chen, Zhiwei; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Qiwei; Wan, Chengsong] So Med Univ, Dept Microbiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Seto, Donald] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Southern Medical University - China; George Mason University; University of Hong Kong	Zhang, QW (corresponding author), Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	zhang.qiwei@yahoo.com; bzheng@hkucc.hku.hk	Chen, Zhiwei/B-7793-2019; Zhang, Qiwei/D-9110-2012; Zhang, Qiwei/AAX-1977-2020	Chen, Zhiwei/0000-0002-4511-2888; Zhang, Qiwei/0000-0002-2770-111X; 	AIDS Trust; Hong Kong SAR Government; HKU [200907176015]	AIDS Trust; Hong Kong SAR Government; HKU(University of Hong Kong)	This work was financially supported by AIDS Trust Fund, Hong Kong SAR Government and HKU Small Project Funding (200907176015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Azzi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016001; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Chen L, 2011, AIDS RES HUM RETROVI; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KAWAMURA M, 1992, VIROLOGY, V188, P850, DOI 10.1016/0042-6822(92)90540-6; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Li L, 2010, AIDS RES HUM RETROV, V26, P711, DOI 10.1089/aid.2010.0001; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; Meng ZF, 2008, AIDS RES HUM RETROV, V24, P259, DOI 10.1089/aid.2007.0128; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 1998, J VIROL, V72, P8446, DOI 10.1128/JVI.72.10.8446-8452.1998; Mu YX, 2011, VIRUS RES, V156, P81, DOI 10.1016/j.virusres.2011.01.001; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Mukai T, 2002, AIDS RES HUM RETROV, V18, P585, DOI 10.1089/088922202753747932; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Novelli P, 2002, AIDS RES HUM RETROV, V18, P85, DOI 10.1089/088922202753394754; PEDEN KWC, 1992, J ACQ IMMUN DEF SYND, V5, P313; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PRAKASH K, 1991, BIOCHEM BIOPH RES CO, V179, P1377, DOI 10.1016/0006-291X(91)91725-R; Qiu J, 2011, SCIENCE, V332, P1253, DOI 10.1126/science.332.6035.1253; de Arellano ER, 2010, ANTIVIR RES, V88, P152, DOI 10.1016/j.antiviral.2010.08.007; Rodriguez MA, 2006, VIROLOGY, V345, P328, DOI 10.1016/j.virol.2005.09.053; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shi BS, 2004, AIDS RES HUM RETROV, V20, P1015, DOI 10.1089/aid.2004.20.1015; Su Qi-jian, 2010, Chinese Journal of Virology, V26, P290; Takeuchi H, 2002, AIDS RES HUM RETROV, V18, P1127, DOI 10.1089/088922202320567860; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebit DM, 2004, VIROLOGY, V326, P329, DOI 10.1016/j.virol.2004.05.027; Tebit DM, 2003, VIROLOGY, V313, P645, DOI 10.1016/S0042-6822(03)00381-7; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006666; van der Sluis RM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-73; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang Z, 2008, AIDS RES HUM RETROV, V24, P251, DOI 10.1089/aid.2007.0226; Wu S-I, 2010, ARCH VIROL, P1; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Yu G, 2009, AIDS RES HUM RETROV, V25, P869, DOI 10.1089/aid.2008.0312; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; ZENG Y, 1986, AIDS RES, V2, pS147; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang QW, 2009, VACCINE, V27, P1145, DOI 10.1016/j.vaccine.2008.12.039; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao XY, 2005, JAIDS-J ACQ IMM DEF, V38, P509, DOI 10.1097/01.qai.0000151004.19128.4a; Zhao XY, 2004, AIDS, V18, P1729, DOI 10.1097/01.aids.0000131382.15232.dc; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	59	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31233	10.1371/journal.pone.0031233	http://dx.doi.org/10.1371/journal.pone.0031233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363589	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600127
J	Habel, JC; Husemann, M; Schmitt, T; Zachos, FE; Honnen, AC; Petersen, B; Parmakelis, A; Stathi, I				Habel, Jan C.; Husemann, Martin; Schmitt, Thomas; Zachos, Frank E.; Honnen, Ann-Christin; Petersen, Britt; Parmakelis, Aristeidis; Stathi, Iasmi			Microallopatry Caused Strong Diversification in Buthus scorpions (Scorpiones: Buthidae) in the Atlas Mountains (NW Africa)	PLOS ONE			English	Article							MESOBUTHUS-GIBBOSUS SCORPIONES; GENETIC DIVERSITY; GENUS BUTHUS; NORTH-AFRICA; GIBRALTAR; STRAIT; POPULATIONS; SPECIATION; OCCITANUS; CO1	The immense biodiversity of the Atlas Mountains in North Africa might be the result of high rates of microallopatry caused by mountain barriers surpassing 4000 meters leading to patchy habitat distributions. We test the influence of geographic structures on the phylogenetic patterns among Buthus scorpions using mtDNA sequences. We sampled 91 individuals of the genus Buthus from 51 locations scattered around the Atlas Mountains (Antiatlas, High Atlas, Middle Atlas and Jebel Sahro). We sequenced 452 bp of the Cytochrome Oxidase I gene which proved to be highly variable within and among Buthus species. Our phylogenetic analysis yielded 12 distinct genetic groups one of which comprised three subgroups mostly in accordance with the orographic structure of the mountain systems. Main clades overlap with each other, while subclades are distributed parapatrically. Geographic structures likely acted as long-term barriers among populations causing restriction of gene flow and allowing for strong genetic differentiation. Thus, genetic structure and geographical distribution of genetic (sub) clusters follow the classical theory of allopatric differentiation where distinct groups evolve without range overlap until reproductive isolation and ecological differentiation has built up. Philopatry and low dispersal ability of Buthus scorpions are the likely causes for the observed strong genetic differentiation at this small geographic scale.	[Habel, Jan C.] Nat Hist Museum Luxembourg, Luxembourg, Luxembourg; [Husemann, Martin] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Schmitt, Thomas] Univ Trier, Dept Biogeog, Trier, Germany; [Zachos, Frank E.] Nat Hist Museum Vienna, Vienna, Austria; [Honnen, Ann-Christin] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Petersen, Britt] Univ Hosp SH Campus Kiel, Inst Clin Mol Biol, Kiel, Germany; [Parmakelis, Aristeidis] Natl & Kapodistrian Univ Athens, Dept Ecol & Taxon, Athens 11528, Greece; [Stathi, Iasmi] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece	Baylor University; Universitat Trier; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; National & Kapodistrian University of Athens; University of Crete	Habel, JC (corresponding author), Nat Hist Museum Luxembourg, Luxembourg, Luxembourg.	Janchristianhabel@gmx.de	Husemann, Martin/C-4414-2015; Parmakelis, Aristeidis/AAD-1162-2020; Löscher, Britt-Sabina/I-1671-2012; Habel, Jan Christian/H-2112-2019	Husemann, Martin/0000-0001-5536-6681; Parmakelis, Aristeidis/0000-0003-3092-4194; Löscher, Britt-Sabina/0000-0001-9022-9017; Stathi, Iasmi/0000-0003-0747-1203; Honnen, Ann-Christin/0000-0003-4355-7231; Habel, Jan Christian/0000-0003-1378-9381	Fonds National de la Recherche Luxembourg; German Academic Exchange Service	Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was performed by the "Fonds National de la Recherche Luxembourg'' and the "German Academic Exchange Service''; furthermore, the Natural History Museum Luxembourg supported field work and laboratory analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade F., 1990, Bulletin de la Societe Europeenne d'Arachnologie Hors Serie, P5; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Brownell PH, 2001, SCORPION BIOL RES, P448; Cosson JF, 2005, MOL ECOL, V14, P1151, DOI 10.1111/j.1365-294X.2005.02476.x; De Lattin G., 1949, VERHANDLUNGEN DTSCH, P143; Drummond AJ, 2006, GENEIOUS V5 0 3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; Froufe E, 2008, BIOLOGIA, V63, P1157, DOI 10.2478/s11756-008-0176-y; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gantenbein B, 2004, EVOLUTION, V58, P2486, DOI 10.1111/j.0014-3820.2004.tb00878.x; Gantenbein B, 2004, BIOL J LINN SOC, V81, P519, DOI 10.1111/j.1095-8312.2003.00295.x; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Habel JC, 2010, BIOL J LINN SOC, V99, P818, DOI 10.1111/j.1095-8312.2010.01394.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joger U, 2007, ZOOL ANZ, V246, P293, DOI 10.1016/j.jcz.2007.09.002; Kaltsas D, 2008, J NAT HIST, V42, P513, DOI 10.1080/00222930701835498; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lourenco Wilson R., 2002, Biogeographica (Paris), V78, P109; Lourenco WR, 2003, REV SUISSE ZOOL, V110, P875, DOI 10.5962/bhl.part.80218; Nylander JAA, 2004, MRMODELTEST 2 3; Polis G.A., 1990, P161; POLIS GA, 1985, OECOLOGIA, V67, P273, DOI 10.1007/BF00384298; Pollard DA, 2006, PLOS GENET, V2, P10; Rambaut A., 2007, TRACER RELEASE 1 4; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2006, MOL ECOL, V15, P1889, DOI 10.1111/j.1365-294X.2006.02900.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; Stockmann R., 2010, SCORPIONS WORLD; SWOFFORD DL, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vachon M, 1962, B MUSEUM NATL HIST 2, V34, P345; Vachon M, 1952, ETUDES SCORPIONS, P241; YAMASHITA T, 1995, J ARACHNOL, V23, P60	41	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29403	10.1371/journal.pone.0029403	http://dx.doi.org/10.1371/journal.pone.0029403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383951	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500004
J	Hansson, B; Tarka, M; Dawson, DA; Horsburgh, GJ				Hansson, Bengt; Tarka, Maja; Dawson, Deborah A.; Horsburgh, Gavin J.			Hybridization but No Evidence for Backcrossing and Introgression in a Sympatric Population of Great Reed Warblers and Clamorous Reed Warblers	PLOS ONE			English	Article							BIMODAL HYBRID ZONES; ACROCEPHALUS-ARUNDINACEUS; FEMALE CHOICE; SPECIATION; LOCI; DIFFERENTIATION; EFFICIENCY; PHYLOGENY; SYLVIIDAE; SELECTION	Hybridization is observed frequently in birds, but often it is not known whether the hybrids are fertile and if backcrossing occurs. The breeding ranges of the great reed warbler (Acrocephalus arundinaceus) and the clamorous reed warbler (A. stentoreus) overlap in southern Kazakhstan and a previous study has documented hybridization in a sympatric population. In the present study, we first present a large set of novel microsatellite loci isolated and characterised in great reed warblers. Secondly, we evaluate whether hybridization in the sympatric breeding population has been followed by backcrossing and introgression. We isolated 181 unique microsatellite loci in great reed warblers. Of 41 loci evaluated, 40 amplified and 30 were polymorphic. Bayesian clustering analyses based on genotype data from 23 autosomal loci recognised two well-defined genetic clusters corresponding to the two species. Individuals clustered to a very high extent to either of these clusters (admixture proportions >= 0.984) with the exception of four previously suggested arundinaceus-stentoreus hybrid birds that showed mixed ancestry (admixture proportions 0.495-0.619). Analyses of simulated hybrids and backcrossed individuals showed that the sampled birds do not correspond to first-fourth-generation backcrosses, and that fifth or higher generation backcrosses to a high extent resemble 'pure' birds at this set of markers. We conclude that these novel microsatellite loci provide a useful molecular resource for Acrocephalus warblers. The time to reach reproductive isolation is believed to be very long in birds, approximately 5 Myrs, and with an estimated divergence time of 2 Myrs between these warblers, some backcrossing and introgression could have been expected. However, there was no evidence for backcrossing and introgression suggesting that hybrids are either infertile or their progeny inviable. Very low levels of introgression cannot be excluded, which still may be an important factor as a source of new genetic variation.	[Hansson, Bengt; Tarka, Maja] Lund Univ, Dept Biol, Lund, Sweden; [Dawson, Deborah A.; Horsburgh, Gavin J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Lund University; University of Sheffield	Hansson, B (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	bengt.hansson@biol.lu.se	Hansson, Bengt/L-8874-2013; Tarka, Maja/L-8065-2013	Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council [621-2007-5381, 621-2692009-4945]; Oscar and Lili Lamm Foundation; Crafoord Foundation; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010001] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Oscar and Lili Lamm Foundation; Crafoord Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by grants from the Swedish Research Council (621-2007-5381; 621-2692009-4945), the Oscar and Lili Lamm Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2006, MOL PHYLOGENET EVOL, V38, P381, DOI 10.1016/j.ympev.2005.05.015; Anderson E., 1949, INTROGRESSIVE HYBRID; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; BARROWCLOUGH GF, 1980, AUK, V97, P655; Barton NH, 2001, TRENDS ECOL EVOL, V16, P325, DOI 10.1016/S0169-5347(01)02207-8; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beier J, 1997, J ORNITHOL, V138, P51, DOI 10.1007/BF01651651; Bensch S, 2002, MOL ECOL, V11, P473, DOI 10.1046/j.0962-1083.2001.01455.x; Cramp S., 1992, HDB BIRDS EUROPE MID; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glutz von Blotzheim, 1985, HDB VOGEL MITTELEURO; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2004, EVOLUTION, V58, P1588; Haas F, 2009, MOL ECOL, V18, P294, DOI 10.1111/j.1365-294X.2008.04017.x; Hansen MM, 2009, BIOL LETTERS, V5, P656, DOI 10.1098/rsbl.2009.0214; Hansson B, 2004, J ORNITHOL, V145, P159, DOI 10.1007/s10336-003-0011-8; Hansson Bengt, 2003, Avian Science, V3, P145; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Kennerley P, 2010, REED BUSH WARBLERS; Kovshar AF, 1972, BIRDS KAZAKHSTAN Y, VIY, P75; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; Lemaire F, 1977, BEHAVIOUR, V79, P215; Lopatin VV, 1993, FAUNA BIOLOGIYA P, P191; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Price T, 2008, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Redenbach Z, 2003, J EVOLUTION BIOL, V16, P1135, DOI 10.1046/j.1420-9101.2003.00619.x; Richardson DS, 2000, MOL ECOL, V9, P2226; RIESEBERG LH, 1995, CONSERV BIOL, V9, P199, DOI 10.1046/j.1523-1739.1995.09010199.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2002, MOL CLONING LAB MANU; Sanz N, 2009, CONSERV GENET, V10, P225, DOI 10.1007/s10592-008-9550-0; Secondi J, 2006, MOL ECOL, V15, P2463, DOI 10.1111/J.1365-294X.2006.02948.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144	51	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31667	10.1371/journal.pone.0031667	http://dx.doi.org/10.1371/journal.pone.0031667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384052	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000302918500034
J	Myers, EM; Frankino, WA				Myers, Erin M.; Frankino, W. Anthony			Time in a Bottle: The Evolutionary Fate of Species Discrimination in Sibling Drosophila Species	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; SEXUAL SELECTION; PREMATING ISOLATION; COURTSHIP SONGS; MATE PREFERENCE; D-PERSIMILIS; PSEUDOOBSCURA; SPECIATION; REINFORCEMENT; GENETICS	Disadvantageous hybridization favors the evolution of prezygotic isolating behaviors, generating a geographic pattern of interspecific mate discrimination where members of different species drawn from sympatric populations exhibit stronger preference for members of their own species than do individuals drawn from allopatric populations. Geographic shifts in species' boundaries can relax local selection against hybridization; under such scenarios the fate of enhanced species preference is unknown. Lineages established from populations in the region of sympatry that have been maintained as single-species laboratory cultures represent cases where allopatry has been produced experimentally. Using such cultures dating from the 1950s, we assess how Drosophila pseudoobscura and D. persimilis mate preferences respond to relaxed natural selection against hybridization. We found that the propensity to hybridize generally declines with increasing time in experimental allopatry, suggesting that maintaining enhanced preference for conspecifics may be costly. However, our data also suggest a strong role for drift in determining mating preferences once secondary allopatry has been established. Finally, we discuss the interplay between populations in establishing the presence or absence of patterns consistent with reinforcement.	[Myers, Erin M.; Frankino, W. Anthony] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Myers, EM (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	myers.erinm@gmail.com			National Science Foundation [0805818]; Integrative Organismal Systems [0920720]; University of Houston; Direct For Biological Sciences [0920720] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Integrative Organismal Systems; University of Houston; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	EMM was supported by a National Science Foundation Bioinformatics Postdoctoral Fellowship. This research was supported by National Science Foundation grants Division of Environmental Biology # 0805818, Integrative Organismal Systems # 0920720, and a University of Houston Grants to Enhance and Advance Research Award to WAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Barnwell CV, 2008, J HERED, V99, P653, DOI 10.1093/jhered/esn069; Blows MW, 2002, P ROY SOC B-BIOL SCI, V269, P1113, DOI 10.1098/rspb.2002.2002; BROWN R. G. B., 1964, BEHAVIOUR, V23, P61, DOI 10.1163/156853964X00094; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1936, GENETICS, V21, P113; DOBZHANSKY T, 1973, AM NAT, V107, P312, DOI 10.1086/282833; Dobzhansky T., 1937; GALIANA A, 1993, EVOLUTION, V47, P432, DOI 10.1111/j.1558-5646.1993.tb02104.x; Geyer LB, 2003, EVOLUTION, V57, P1049; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Higgie M, 2008, EVOLUTION, V62, P1192, DOI 10.1111/j.1558-5646.2008.00357.x; Higgie M, 2007, AM NAT, V170, P409, DOI 10.1086/519401; Jennings JH, 2010, EVOLUTION, V64, P587, DOI 10.1111/j.1558-5646.2009.00834.x; Kalmus H, 1941, DROSOPHILA INFORM SE, V14, P56; Kitano J, 2008, BEHAVIOUR, V145, P443, DOI 10.1163/156853908792451430; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Krebs RA, 2001, J EVOLUTION BIOL, V14, P75, DOI 10.1046/j.1420-9101.2001.00256.x; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Lewontin R. C., 1981, DOBZHANSKYS GENETICS; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Lorch PD, 2005, EVOLUTION, V59, P1039; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Matute DR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000341; MAYR E, 1946, P NATL ACAD SCI USA, V32, P128, DOI 10.1073/pnas.32.5.128; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; MEFFERT LM, 1992, EVOLUTION, V46, P1399, DOI 10.1111/j.1558-5646.1992.tb01132.x; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 2006, BEHAV GENET, V36, P322, DOI 10.1007/s10519-005-9033-8; Noor MAF, 1997, J INSECT BEHAV, V10, P305, DOI 10.1007/BF02765563; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Noor MAF, 1996, GENET RES, V68, P117, DOI 10.1017/S0016672300034005; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Ortiz-Barrientos D, 2006, GENET RES, V87, P23, DOI 10.1017/S0016672306007932; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Pezzullo JC, 2010, JAVASTAT BINOMIAL PO; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; PRAKASH S, 1972, GENETICS, V72, P143; Ptacek MB, 1998, ANIM BEHAV, V56, P1145, DOI 10.1006/anbe.1998.0909; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Spassky B, 1943, DROS INFORM SERV, V17, P67; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tukey J, 1953, DITTOED UNPUB; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x	57	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31759	10.1371/journal.pone.0031759	http://dx.doi.org/10.1371/journal.pone.0031759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384069	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500038
J	Aka, JA; Lin, SX				Aka, Juliette Adjo; Lin, Sheng-Xiang			Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7	PLOS ONE			English	Article							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; CATHEPSIN-D; 5-ALPHA-DIHYDROTESTOSTERONE; PROLIFERATION; EXPRESSION; PROFILE	T47D and MCF7 are two human hormone-dependent breast cancer cell lines which are widely used as experimental models for in vitro and in vivo (tumor xenografts) breast cancer studies. Several proteins involved in cancer development were identified in these cell lines by proteomic analyses. Although these studies reported the proteomic profiles of each cell line, until now, their differential protein expression profiles have not been established. Here, we used two-dimensional gel and mass spectrometry analyses to compare the proteomic profiles of the two cell lines, T47D and MCF7. Our data revealed that more than 164 proteins are differentially expressed between them. According to their biological functions, the results showed that proteins involved in cell growth stimulation, anti-apoptosis mechanisms and cancerogenesis are more strongly expressed in T47D than in MCF7. These proteins include G1/S-specific cyclin-D3 and prohibitin. Proteins implicated in transcription repression and apoptosis regulation, including transcriptional repressor NF-X1, nitrilase homolog 2 and interleukin-10, are, on the contrary, more strongly expressed in MCF7 as compared to T47D. Five proteins that were previously described as breast cancer biomarkers, namely cathepsin D, cathepsin B, protein S100-A14, heat shock protein beta-1 (HSP27) and proliferating cell nuclear antigen (PCNA), are found to be differentially expressed in the two cell lines. A list of differentially expressed proteins between T47D and MCF7 was generated, providing useful information for further studies of breast cancer mechanisms with these cell lines as models.	[Aka, Juliette Adjo; Lin, Sheng-Xiang] Univ Laval, CHUL Res Ctr CHUQ, Lab Endocrinol & Genom, Quebec City, PQ, Canada; [Aka, Juliette Adjo; Lin, Sheng-Xiang] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Aka, JA (corresponding author), Univ Laval, CHUL Res Ctr CHUQ, Lab Endocrinol & Genom, Quebec City, PQ, Canada.	Sheng-Xiang.Lin@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X	Canadian Institutes of Health Research [FRN57892]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research with a grant to SXL (Principal Investigator for FRN57892) [www.cihr-irsc.gc.ca]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; Aspinall SR, 2004, J STEROID BIOCHEM, V88, P37, DOI 10.1016/j.jsbmb.2003.10.011; Bianchi L, 2005, PROTEOMICS, V5, P2433, DOI 10.1002/pmic.200401283; Blamey R, 2004, HUM REPROD UPDATE, V10, P281, DOI 10.1093/humupd/dmh025; Canadian Cancer Society Steering Committee, 2009, CAN CANC STAT 2009; Day JM, 2008, INT J CANCER, V122, P1931, DOI 10.1002/ijc.23350; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Greeve MA, 2004, J MOL ENDOCRINOL, V32, P793, DOI 10.1677/jme.0.0320793; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Huber M, 2004, MOL CELL PROTEOMICS, V3, P43, DOI 10.1074/mcp.M300047-MCP200; Husen B, 2006, ENDOCRINOLOGY, V147, P5333, DOI 10.1210/en.2006-0778; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Journet A, 2004, MASS SPECTROM REV, V23, P393, DOI 10.1002/mas.20001; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Parl FF, 2000, BIOMEDICAL HLTH RES, V36; Sarvaiya HA, 2006, RAPID COMMUN MASS SP, V20, P3039, DOI 10.1002/rcm.2677; Sasco Annie J., 2003, Hormone Research (Basel), V60, P50, DOI 10.1159/000074500; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h	20	59	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31532	10.1371/journal.pone.0031532	http://dx.doi.org/10.1371/journal.pone.0031532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384035	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800016
J	Zelik, KE; Kuo, AD				Zelik, Karl E.; Kuo, Arthur D.			Mechanical Work as an Indirect Measure of Subjective Costs Influencing Human Movement	PLOS ONE			English	Article							TO-STEP TRANSITIONS; HUMAN WALKING; LOWER-EXTREMITY; ARTICULAR-CARTILAGE; ENERGY-DISSIPATION; LEVEL WALKING; LEG STIFFNESS; FORCE; LOCOMOTION; ENERGETICS	To descend a flight of stairs, would you rather walk or fall? Falling seems to have some obvious disadvantages such as the risk of pain or injury. But the preferred strategy of walking also entails a cost for the use of active muscles to perform negative work. The amount and distribution of work a person chooses to perform may, therefore, reflect a subjective valuation of the trade-offs between active muscle effort and other costs, such as pain. Here we use a simple jump landing experiment to quantify the work humans prefer to perform to dissipate the energy of landing. We found that healthy normal subjects (N = 8) preferred a strategy that involved performing 37% more negative work than minimally necessary (P<0.001) across a range of landing heights. This then required additional positive work to return to standing rest posture, highlighting the cost of this preference. Subjects were also able to modulate the amount of landing work, and its distribution between active and passive tissues. When instructed to land softly, they performed 76% more work than necessary (P<0.001), with a higher proportion from active muscles (89% vs. 84%, P<0.001). Stiff-legged landings, performed by one subject for demonstration, exhibited close to the minimum of work, with more of it performed passively through soft tissue deformations (at least 30% in stiff landings vs. 16% preferred). During jump landings, humans appear not to minimize muscle work, but instead choose to perform a consistent amount of extra work, presumably to avoid other subjective costs. The degree to which work is not minimized may indirectly quantify the relative valuation of costs that are otherwise difficult to measure.	[Zelik, Karl E.; Kuo, Arthur D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zelik, KE (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	kzelik@umich.edu	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709; Zelik, Karl/0000-0002-5054-2479	Department of Defense [DR081177]; National Institutes of Health [R44HD055706]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R44HD055706] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Department of Defense (DR081177), in part by the National Institutes of Health (R44HD055706) and in part by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; ARMSTRONG CG, 1979, J BONE JOINT SURG AM, V61, P744, DOI 10.2106/00004623-197961050-00016; BAUDINETTE RV, 1987, J EXP BIOL, V129, P251; BAUDINETTE RV, 1991, J EXP BIOL, V160, P209; BENNETT MB, 1990, J ANAT, V171, P131; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1; Cazzola D, 2010, INVESTIGATING METABO; Dean JC, 2011, J APPL PHYSIOL, V110, P873, DOI 10.1152/japplphysiol.00505.2010; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Eckstein F, 2001, ANAT EMBRYOL, V203, P147, DOI 10.1007/s004290000154; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Ferris DP, 1997, J APPL PHYSIOL, V82, P15, DOI 10.1152/jappl.1997.82.1.15; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Greenwood D. T., 1988, PRINCIPLES DYNAMICS; Hsu TC, 1998, ARCH PHYS MED REHAB, V79, P1101, DOI 10.1016/S0003-9993(98)90178-2; Hunter LC, 2010, J BIOMECH, V43, P1910, DOI 10.1016/j.jbiomech.2010.03.030; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; MCNITTGRAY JL, 1993, J BIOMECH, V26, P1037, DOI 10.1016/S0021-9290(05)80003-X; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; MINETTI AE, 1994, J BIOMECH, V27, P97, DOI 10.1016/0021-9290(94)90036-1; Minetti AE, 1998, ERGONOMICS, V41, P1771, DOI 10.1080/001401398185965; Moritz CT, 2005, J EXP BIOL, V208, P939, DOI 10.1242/jeb.01472; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Soo CH, 2010, J EXP BIOL, V213, P4265, DOI 10.1242/jeb.044214; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; VIRGIN WJ, 1951, J BONE JOINT SURG BR, V33, P607, DOI 10.1302/0301-620X.33B4.607; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7; Winter D, 2005, BIOMECHANICS MOTOR C; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080; Zatsiorsky VM, 1987, BIOMECHANICS B, P739; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zhang SN, 2000, MED SCI SPORT EXER, V32, P812, DOI 10.1097/00005768-200004000-00014	44	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31143	10.1371/journal.pone.0031143	http://dx.doi.org/10.1371/journal.pone.0031143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383998	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800010
J	Cebrian, E; Rodriguez-Prieto, C				Cebrian, Emma; Rodriguez-Prieto, Conxi			Marine Invasion in the Mediterranean Sea: The Role of Abiotic Factors When There Is No Biological Resistance	PLOS ONE			English	Article							RACEMOSA VAR. CYLINDRACEA; FRAGILE SSP TOMENTOSOIDES; CAULERPA-TAXIFOLIA; CHROMATIC ADAPTATION; VEGETATION PATTERNS; SEASONAL DYNAMICS; NORRIS RHODOPHYTA; ADRIATIC SEA; ALGAL FLORA; TEMPERATURE	The tropical red alga Womersleyella setacea (Rhodomelaceae, Rhodophyta) is causing increasing concern in the Mediterranean Sea because of its invasive behavior. After its introduction it has colonized most Mediterranean areas, but the mechanism underlying its acclimatization and invasion process remains unknown. To understand this process, we decided i) to assess in situ the seasonal biomass and phenological patterns of populations inhabiting the Mediterranean Sea in relation to the main environmental factors, and ii) to experimentally determine if the tolerance of W. setacea to different light and temperature conditions can explain its colonization success, as well as its bathymetric distribution range. The bathymetric distribution, biomass, and phenology of W. setacea were studied at two localities, and related to irradiance and temperature values recorded in situ. Laboratory experiments were set up to study survival, growth and reproduction under contrasting light and temperature conditions in the short, mid, and long term. Results showed that, in the studied area, the bathymetric distribution of W. setacea is restricted to a depth belt between 25 and 40 m deep, reaching maximum biomass values (126 g dw m(-2)) at 30 m depth. In concordance, although in the short term W. setacea survived and grew in a large range of environmental conditions, its life requirements for the mid and long term were dim light levels and low temperatures. Biomass of Womersleyella setacea did not show any clear seasonal pattern, though minimum values were reported in spring. Reproductive structures were always absent. Bearing in mind that no herbivores feed on Womersleyella setacea and that its thermal preferences are more characteristic of temperate than of tropical seaweeds, low light (50 mu mol photon m(-2) s(-1)) and low temperature (12 degrees C) levels are critical for W. setacea survival and growth, thus probably determining its spread and bathymetric distribution across the Mediterranean Sea.	[Cebrian, Emma; Rodriguez-Prieto, Conxi] Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain; [Cebrian, Emma] Ctr Estudis Avancats Blanes CSIC, Blanes, Spain	Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Cebrian, E (corresponding author), Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain.	emma.cebrian@udg.edu	Prieto, Conxi Rodriguez/AAG-6987-2019; Cebrian, Emma/J-9640-2012	Prieto, Conxi Rodriguez/0000-0003-4935-1250; Cebrian, Emma/0000-0001-7588-0135	European Union reintegration [ERG-2009-248252]; Spanish Ministry of Science and Innovation [CGL2004-05556-C02-01]; Spanish Science and Innovation Ministry [JCI-2008-02753]	European Union reintegration; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by an European Union reintegration grant (ERG-2009-248252) and a grant from the Spanish Ministry of Science and Innovation (CGL2004-05556-C02-01). Dr. Cebrian was funded by a Juan de la Cierva program (JCI-2008-02753) of the Spanish Science and Innovation Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIROLDI L, 1995, BOT MAR, V38, P227, DOI 10.1515/botm.1995.38.1-6.227; Airoldi L, 2000, ECOLOGY, V81, P798, DOI 10.2307/177378; Airoldi L, 1998, MAR ECOL PROG SER, V165, P271, DOI 10.3354/meps165271; Antoniadou C, 2007, J MAR BIOL ASSOC UK, V87, P629, DOI 10.1017/S0025315407048151; Athanasiadis A, 1997, BOT MAR, V40, P473, DOI 10.1515/botm.1997.40.1-6.473; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; Ballesteros E, 1983, HIST NATURAL ARXIPEL, P663; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Ballesteros E, 2009, ESTUAR COAST SHELF S, V82, P477, DOI 10.1016/j.ecss.2009.02.013; Battelli C, 2008, PLANT BIOSYST, V142, P120, DOI 10.1080/11263500701872747; Benedetti-Cecchi L, 1989, GIORNALE BOT ITALIAN, V123, P49; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Cebrian E, 2004, SCI MAR, V68, P69, DOI 10.3989/scimar.2004.68n169; Cebrian E, 2011, BIOL INVASIONS, V13, P1397, DOI 10.1007/s10530-010-9898-1; Cebrian E, 2010, AQUAT BOT, V92, P81, DOI 10.1016/j.aquabot.2009.10.007; Cebrian E, 2009, ESTUAR COAST SHELF S, V83, P469, DOI 10.1016/j.ecss.2009.04.026; Chisholm JRM, 2000, MAR ECOL PROG SER, V201, P189, DOI 10.3354/meps201189; Drew EA, 1983, SUBLITTORAL ECOLOGY, P10; DRING MJ, 1981, LIMNOL OCEANOGR, V26, P271, DOI 10.4319/lo.1981.26.2.0271; DROOP M. R., 1967, BRIT PHYCOL BULL, V3, P295; Garrabou J, 1997, THESIS U BARCELONA B; GARRIGUE C, 1994, OCEANOL ACTA, V17, P563; Gollan JR, 2006, MAR FRESHWATER RES, V57, P685, DOI 10.1071/MF05253; GUIRY MD, 1984, PHYCOLOGIA, V23, P357, DOI 10.2216/i0031-8884-23-3-357.1; Hata H, 2002, J EXP MAR BIOL ECOL, V270, P215, DOI 10.1016/S0022-0981(02)00029-1; Hewitt CL, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P456; HOLLENBERG GJ, 1968, PAC SCI, V22, P56; Ivesa L, 2006, AQUAT BOT, V85, P324, DOI 10.1016/j.aquabot.2006.06.009; Ivesa L, 2006, PERIOD BIOL, V108, P111; Izquierdo Ramirez C., 2003, MORFOLOGIA DESENVOLU, P115; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Komatsu T, 1997, MAR ECOL PROG SER, V146, P145, DOI 10.3354/meps146145; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Linares C, MAR ECOL PR IN PRESS; Littler DS, MARINE PLANTS CARIBB; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meinesz A, 1995, BOT MAR, V38, P499, DOI 10.1515/botm.1995.38.1-6.499; Mezgui Y, 2007, RAC SPA PUBL, P111; Morand P, 1996, BOT MAR, V39, P491, DOI 10.1515/botm.1996.39.1-6.491; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Piazzi L, 2002, BOT MAR, V45, P243, DOI 10.1515/BOT.2002.023; Piazzi L, 2001, BOT MAR, V44, P509, DOI 10.1515/BOT.2001.057; Piazzi L, 2009, BIOL INVASIONS, V11, P193, DOI 10.1007/s10530-008-9224-3; Pillen Thomas L., 1998, P327; RAMUS J, 1983, J PHYCOL, V19, P86, DOI 10.1111/j.0022-3646.1983.00086.x; Rindi F, 1999, HYDROBIOLOGIA, V399, P91; Rodriguez-Prieto C., 2005, ACT 15 S BOT CRIPT B, P54; Ruitton S, 2005, AQUAT BOT, V82, P55, DOI 10.1016/j.aquabot.2005.02.008; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sanchez N., 2005, THESIS U GIRONA GIRO, P227; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V355, P103, DOI 10.1016/j.jembe.2007.12.002; Serio D, 2006, BOT MAR, V49, P135, DOI 10.1515/BOT.2006.018; Strong JA, 2009, J MAR BIOL ASSOC UK, V89, P303, DOI 10.1017/S0025315408003226; Sumi CBT, 2005, MAR ECOL PROG SER, V292, P203, DOI 10.3354/meps292203; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thibaut T, 2004, AQUAT BOT, V80, P291, DOI 10.1016/j.aquabot.2004.07.009; Thresher R.E., 2000, MARINE BIOINVASIONS, P24; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Tomas F, 2011, BIOL INVASIONS, V13, P1559, DOI 10.1007/s10530-010-9913-6; VERLAQUE M, 1989, BOT MAR, V32, P101, DOI 10.1515/botm.1989.32.2.101; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Williams SL, 2002, MAR ECOL PROG SER, V233, P307, DOI 10.3354/meps233307; ZABALA M, 1989, Scientia Marina, V53, P3; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	65	10	12	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31135	10.1371/journal.pone.0031135	http://dx.doi.org/10.1371/journal.pone.0031135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363565	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700029
J	Bourez, S; Le Lay, S; Van den Daelen, C; Louis, C; Larondelle, Y; Thome, JP; Schneider, YJ; Dugail, I; Debier, C				Bourez, Sophie; Le Lay, Soazig; Van den Daelen, Carine; Louis, Caroline; Larondelle, Yvan; Thome, Jean-Pierre; Schneider, Yves-Jacques; Dugail, Isabelle; Debier, Cathy			Accumulation of Polychlorinated Biphenyls in Adipocytes: Selective Targeting to Lipid Droplets and Role of Caveolin-1	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; ADIPOSE-TISSUE; MEMBRANE-FLUIDITY; CELL-SURFACE; PCBS; 2,4,5,2',4',5'-HEXACHLOROBIPHENYL; LOCALIZATION; STIMULATION; TRAFFICKING; CHOLESTEROL	Background: Polychlorinated biphenyls (PCBs) are persistent environmental pollutants that preferentially accumulate in lipid-rich tissues of contaminated organisms. Although the adipose tissue constitutes a major intern reservoir of PCBs and recent epidemiological studies associate PCBs to the development of obesity and its related disorders, little is known about the mechanisms involved in their uptake by the adipose tissue and their intracellular localization in fat cells. Methodology/Principal Findings: We have examined the intracellular distribution of PCBs in mouse cultured adipocytes and tested the potential involvement of caveolin-1, an abundant adipocyte membrane protein, in the uptake of these compounds by fat cells. We show that 2,4,4'-trichlorobiphenyl (PCB-28), 2,3',4,4',5-pentachlorobiphenyl (PCB-118) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) congeners rapidly and extensively accumulate in 3T3-L1 or mouse embryonic fibroblast (MEF) derived cultured adipocytes. The dynamics of accumulation differed between the 3 congeners tested. By subcellular fractionation of primary adipocytes, we demonstrate that these pollutants were almost exclusively recovered within the lipid droplet fraction and practically not associated to cell membranes. The absence of caveolin-1 expression in primary adipocytes from cav-1 deficient mice did not modify lipid droplet selective targeting of PCBs. In cav-1 KO MEF differentiated adipocytes, PCB accumulation was decreased, which correlated with reduced cell triglyceride content. Conversely, adenoviral mediated cav-1 overexpressing in 3T3-L1 cells, which had no impact on total cell lipid content, did not change PCB accumulation. Conclusion/Significance: Our data indicate that caveolin-1 per se is not required for selective PCB accumulation, but rather point out a primary dependence on adipocyte triglyceride content. If the crucial role of lipid droplets in energy homeostasis is considered, the almost exclusive accumulation of PCBs in these organelles warrants future attention as the impairment of their function could be linked to the worldwide obesity epidemic.	[Bourez, Sophie; Van den Daelen, Carine; Louis, Caroline; Larondelle, Yvan; Schneider, Yves-Jacques; Debier, Cathy] UCLouvain, Inst Sci Vie, Louvain, Belgium; [Le Lay, Soazig; Dugail, Isabelle] Univ Paris 06, UMR S 872, Paris, France; [Thome, Jean-Pierre] Univ Liege, Lab Ecol Anim & Ecotoxicol, Liege, Belgium	Universite Catholique Louvain; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Liege	Bourez, S (corresponding author), UCLouvain, Inst Sci Vie, Louvain, Belgium.	cathy.debier@uclouvain.be	Le Lay, Soazig/N-6862-2018; Dugail, Isabelle/L-1567-2017; Le Lay, Soazig/AAI-2442-2021	Dugail, Isabelle/0000-0003-3631-2252; Le Lay, Soazig/0000-0003-2456-2422				Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; BECKER MM, 1982, J TOXICOL ENV HEALTH, V9, P225, DOI 10.1080/15287398209530157; BERANEK SR, 1984, ENVIRON RES, V34, P103, DOI 10.1016/0013-9351(84)90079-3; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Couet J, 2001, ADV DRUG DELIVER REV, V49, P223, DOI 10.1016/S0169-409X(01)00139-9; De Saeger S, 2005, CHEMOSPHERE, V58, P953, DOI 10.1016/j.chemosphere.2004.09.069; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; KODAVANTI PRS, 1993, TOXICOL APPL PHARM, V123, P97, DOI 10.1006/taap.1993.1226; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lim EJ, 2008, CHEM-BIOL INTERACT, V176, P71, DOI 10.1016/j.cbi.2008.08.007; LopezAparicio P, 1997, PESTIC BIOCHEM PHYS, V57, P54, DOI 10.1006/pest.1997.2256; MATTHEWS HB, 1984, FUND APPL TOXICOL, V4, P420, DOI 10.1016/0272-0590(84)90199-4; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Mullerova D, 2007, PHYSIOL RES, V56, P375, DOI 10.33549/physiolres.931022; Pelletier C, 2003, Obes Rev, V4, P17, DOI 10.1046/j.1467-789X.2003.00085.x; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; SPINDLERVOMACHKA M, 1984, TOXICOL APPL PHARM, V74, P70, DOI 10.1016/0041-008X(84)90271-0; Tan YS, 2004, TOXICOL SCI, V80, P54, DOI 10.1093/toxsci/kfh119; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Ulbrich B, 2004, ARCH TOXICOL, V78, P483, DOI 10.1007/s00204-004-0583-y; Wang N, 2010, ENVIRON SCI TECHNOL, V44, P4334, DOI 10.1021/es9038775; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Wong PW, 1996, MOL PHARMACOL, V49, P740; Yilmaz B, 2006, TOXICOLOGY, V217, P184, DOI 10.1016/j.tox.2005.09.008; Yu GW, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/417980	40	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31834	10.1371/journal.pone.0031834	http://dx.doi.org/10.1371/journal.pone.0031834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363745	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500092
J	Liu, YN; Yin, JJ; Abou-Kheir, W; Hynes, PG; Casey, OM; Fang, L; Yi, M; Stephens, RM; Seng, V; Sheppard-Tillman, H; Martin, P; Kelly, K				Liu, Y-N; Yin, J. J.; Abou-Kheir, W.; Hynes, P. G.; Casey, O. M.; Fang, L.; Yi, M.; Stephens, R. M.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K.			MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms	ONCOGENE			English	Article						prostate cancer; EMT; SLUG; miR-1; miR-200	EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; TGF-BETA; PROSTATE; INVASION; ZEB1; METASTASIS; REPRESSION; CADHERIN; FAMILY	Epithelial-mesenchymal transition (EMT) is a developmental program of signaling pathways that determine commitment to epithelial and mesenchymal phenotypes. In the prostate, EMT processes have been implicated in benign prostatic hyperplasia and prostate cancer progression. In a model of Pten- and TP53-null prostate adenocarcinoma that progresses via transforming growth factor beta-induced EMT, mesenchymal transformation is characterized by plasticity, leading to various mesenchymal lineages and the production of bone. Here we show that SLUG is a major regulator of mesenchymal differentiation. As microRNAs (miRs) are pleiotropic regulators of differentiation and tumorigenesis, we evaluated miR expression associated with tumorigenesis and EMT. Mir-1 and miR-200 were reduced with progression of prostate adenocarcinoma, and we identify Slug as one of the phylogenetically conserved targets of these miRs. We demonstrate that SLUG is a direct repressor of miR-1 and miR-200 transcription. Thus, SLUG and miR-1/miR-200 act in a self-reinforcing regulatory loop, leading to amplification of EMT. Depletion of Slug inhibited EMT during tumorigenesis, whereas forced expression of miR-1 or miR-200 inhibited both EMT and tumorigenesis in human and mouse model systems. Various miR targets were analyzed, and our findings suggest that miR-1 has roles in regulating EMT and mesenchymal differentiation through Slug and functions in tumor-suppressive programs by regulating additional targets. Oncogene (2013) 32, 296-306; doi:10.1038/onc.2012.58; published online 27 February 2012	[Liu, Y-N; Yin, J. J.; Abou-Kheir, W.; Hynes, P. G.; Casey, O. M.; Fang, L.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Yi, M.; Stephens, R. M.] NCI, Adv Biomed Comp Ctr, FCRDC, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kelly, K (corresponding author), NCI, Cell & Canc Biol Branch, NIH, 37 Convent Dr,Room 1068, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov	Abou-Kheir, Wassim/AAP-2587-2020; Liu, Yen-Nien/AAW-4698-2021; Tillman, Heather/N-2526-2018	Abou-Kheir, Wassim/0000-0001-9719-9324; Tillman, Heather/0000-0002-9623-2812; Yi, Ming/0000-0001-9098-1364	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, USA; NATIONAL CANCER INSTITUTE [ZIABC010802] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the support of the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, USA. We thank Dr Chi-Ping Day, Dr Yvona Ward and Ross Lake for assistance.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hansel DE, 2006, AM J SURG PATHOL, V30, P1316, DOI 10.1097/01.pas.0000209838.92842.bf; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jaggi M, 2006, PROSTATE, V66, P193, DOI 10.1002/pros.20334; Jones E, 2009, EXPERT OPIN THER TAR, V13, P227, DOI [10.1517/14728220802705696, 10.1517/14728220802705696 ]; Lambertini E, 2009, CELL MOL LIFE SCI, V66, P3641, DOI 10.1007/s00018-009-0149-5; Liu YN, 2011, MOL CELL BIOL, V32, P941; Martin P, 2011, AM J PATHOL, V179, P422, DOI 10.1016/j.ajpath.2011.03.035; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torreggiani E, 2012, J CELL MOL MED, V16, P740, DOI 10.1111/j.1582-4934.2011.01352.x; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	34	236	242	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					296	306		10.1038/onc.2012.58	http://dx.doi.org/10.1038/onc.2012.58			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370643	Green Accepted			2022-12-25	WOS:000314736600004
J	Sen, D; Nandakumar, D; Tang, GQ; Patel, SS				Sen, Doyel; Nandakumar, Divya; Tang, Guo-Qing; Patel, Smita S.			Human Mitochondrial DNA Helicase TWINKLE Is Both an Unwinding and Annealing Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA; STRUCTURE-FUNCTION DEFECTS; NUCLEOTIDE HYDROLYSIS; CENTRAL CHANNEL; GENE-4 PROTEIN; REPLICATION; BINDING; BACTERIOPHAGE-T7; PRIMASE	TWINKLE is a nucleus-encoded human mitochondrial (mt) DNA helicase. Point mutations in TWINKLE are associated with heritable neuromuscular diseases characterized by deletions in the mtDNA. To understand the biochemical basis of these diseases, it is important to define the roles of TWINKLE in mtDNA metabolism by studying its enzymatic activities. To this end, we purified native TWINKLE from Escherichia coli. The recombinant TWINKLE assembles into hexamers and higher oligomers, and addition of MgUTP stabilizes hexamers over higher oligomers. Probing into the DNA unwinding activity, we discovered that the efficiency of unwinding is greatly enhanced in the presence of a heterologous single strand-binding protein or a single-stranded (ss) DNA that is complementary to the unwound strand. We show that TWINKLE, although a helicase, has an antagonistic activity of annealing two complementary ssDNAs that interferes with unwinding in the absence of gp2.5 or ssDNA trap. Furthermore, only ssDNA and not double-stranded (ds)DNA competitively inhibits the annealing activity, although both DNAs bind with high affinities. This implies that dsDNA binds to a site that is distinct from the ssDNA-binding site that promotes annealing. Fluorescence anisotropy competition binding experiments suggest that TWINKLE has more than one ssDNA-binding sites, and we speculate that a surface-exposed ssDNA-specific site is involved in catalyzing DNA annealing. We propose that the strand annealing activity of TWINKLE may play a role in recombination-mediated replication initiation found in the mitochondria of mammalian brain and heart or in replication fork regression during repair of damaged DNA replication forks.	[Sen, Doyel; Nandakumar, Divya; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu	Nandakumar, Divya/K-6250-2014	Nandakumar, Divya/0000-0001-7672-0213	National Institutes of Health [GM55310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55310.	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; HALLER I, 1974, P NATL ACAD SCI USA, V71, P2018, DOI 10.1073/pnas.71.5.2018; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rasnik I, 2008, EMBO J, V27, P1727, DOI 10.1038/emboj.2008.106; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	38	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14545	14556		10.1074/jbc.M111.309468	http://dx.doi.org/10.1074/jbc.M111.309468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383523	hybrid, Green Published			2022-12-25	WOS:000304003200021
J	Calix, JJ; Saad, JS; Brady, AM; Nahm, MH				Calix, Juan J.; Saad, Jamil S.; Brady, Allison M.; Nahm, Moon H.			Structural Characterization of Streptococcus pneumoniae Serotype 9A Capsule Polysaccharide Reveals Role of Glycosyl 6-O-Acetyltransferase wcjE in Serotype 9V Capsule Biosynthesis and Immunogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLATION; PNEUMOCOCCAL SEROTYPE; CONJUGATE VACCINE; IDENTIFICATION; VALIDATION; RESPONSES; CARRIAGE; MODEL; ASSAY; LOCI	The putative capsule O-acetyltransferase gene wcjE is highly conserved across various Streptococcus pneumoniae serotypes, but the role of the gene in capsule biosynthesis and bacterial fitness remains largely unclear. Isolates expressing pneumococcal serotype 9A arise from precursors expressing wcjE-associated serotype 9V through loss-of-function mutation to wcjE. To define the biosynthetic role of 9V wcjE, we characterized the structure and serological properties of serotype 9V and 9A capsule polysaccharide (PS). NMR data revealed that both 9V and 9A PS are composed of an identical pentasaccharide repeat unit, as reported previously. However, in sharp contrast to previous studies on 9A PS being devoid of any O-acetylation, we identified O-acetylation of alpha-glucuronic acid and alpha-glucose in 9A PS. In addition, 9V PS also contained -CH2 O-acetylation of beta-N-acetylmannosamine, a modification that disappeared following in vitro recombinatorial deletion of wcjE. We also show that serotyping sera and monoclonal antibodies specific for 9V and 9A bound capsule PS in an O-acetate-dependent manner. Furthermore, IgG and to a lesser extent IgM from human donors immunized with serotype 9V PS displayed stronger binding to 9V compared with 9A PS. We conclude that serotype 9V wcjE mediates 6-O-acetylation of beta-N-acetylmannosamine. This PS modification can be selectively targeted by antibodies in immunized individuals, identifying a potential selective advantage for wcjE inactivation and serotype 9A emergence.	[Calix, Juan J.; Saad, Jamil S.; Brady, Allison M.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nahm, MH (corresponding author), BBRB 614,1530 3rd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu		Saad, Jamil/0000-0001-9503-6484; Brady, Allison/0000-0003-0606-1384; Nahm, Moon/0000-0002-6922-1042	National Institutes of Health [AI-93103, AI-31473]; Department of Microbiology at the University of Alabama at Birmingham; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, F31AI093103, R56AI031473, R01AI031473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology at the University of Alabama at Birmingham; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-93103 (to J. J. C.) and AI-31473 (to M. H. N.). This work was also supported by the Department of Microbiology at the University of Alabama at Birmingham (to J. S. S.). The University of Alabama at Birmingham has intellectual property rights for some of the reagents used in this study, and all authors are University of Alabama at Birmingham. MHN serves as a consultant to Merck Inc. for S. pneumoniae diagnosis assays.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; Fox KL, 2005, MOL MICROBIOL, V58, P207, DOI 10.1111/j.1365-2958.2005.04814.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Lemercinier X, 2006, CARBOHYD RES, V341, P68, DOI 10.1016/j.carres.2005.10.014; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; PERRY MB, 1982, MOL IMMUNOL, V19, P235, DOI 10.1016/0161-5890(82)90336-4; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; RUTHERFORD TJ, 1991, CARBOHYD RES, V218, P175, DOI 10.1016/0008-6215(91)84096-W; Skinner JM, 2011, VACCINE, V29, P8870, DOI 10.1016/j.vaccine.2011.09.078; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Sun Y, 1999, INFECT IMMUN, V67, P1172, DOI 10.1128/IAI.67.3.1172-1179.1999; Theilacker C, 2003, INFECT IMMUN, V71, P3875, DOI 10.1128/IAI.71.7.3875-3884.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Zartler ER, 2009, J BIOL CHEM, V284, P7318, DOI 10.1074/jbc.M807952200	32	26	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13996	14003		10.1074/jbc.M112.346924	http://dx.doi.org/10.1074/jbc.M112.346924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367197	Green Published, hybrid			2022-12-25	WOS:000303996300054
J	Murai, J; Huang, SYN; Das, BB; Dexheimer, TS; Takeda, S; Pommier, Y				Murai, Junko; Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Takeda, Shunichi; Pommier, Yves			Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLEAVAGE COMPLEXES; SPINOCEREBELLAR ATAXIA; COVALENT COMPLEXES; REPLICATION FORKS; AXONAL NEUROPATHY; ANTITUMOR DRUGS; TRANSCRIPTION; ENZYME; PHOSPHORYLATION	Tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs topoisomerase I cleavage complexes (Top1cc) by hydrolyzing their 3'-phosphotyrosyl DNA bonds and repairs bleomycin-induced DNA damage by hydrolyzing 3'-phosphoglycolates. Yeast Tdp1 has also been implicated in the repair of topoisomerase II-DNA cleavage complexes (Top2cc). To determine whether vertebrate Tdp1 is involved in the repair of various DNA end-blocking lesions, we generated Tdp1 knock-out cells in chicken DT40 cells (Tdp1(-/-)) and Tdp1-complemented DT40 cells with human TDP1. We found that Tdp1(-/-) cells were not only hypersensitive to camptothecin and bleomycin but also to etoposide, methyl methanesulfonate (MMS), H2O2, and ionizing radiation. We also show they were deficient in mitochondrial Tdp1 activity. In biochemical assays, recombinant human TDP1 was found to process 5'-phosphotyrosyl DNA ends when they mimic the 5'-overhangs of Top2cc. Tdp1 also processes 3'-deoxyribose phosphates generated from hydrolysis of abasic sites, which is consistent with the hypersensitivity of Tdp1(-/-) cells to MMS and H2O2. Because recent studies established that CtIP together with BRCA1 also repairs topoisomerase-mediated DNA damage, we generated dual Tdp1-CtIP-deficient DT40 cells. Our results show that Tdp1 and CtIP act in parallel pathways for the repair of Top1cc and MMS-induced lesions but are epistatic for Top2cc. Together, our findings reveal a broad involvement of Tdp1 in DNA repair and clarify the role of human TDP1 in the repair of Top2-induced DNA damage.	[Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Murai, Junko; Takeda, Shunichi] Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov	Das, Benu Brata/AAC-3452-2022; DAS, BENU BRATA BRATA/AAX-4347-2021; Murai, Junko/AAU-9516-2021	DAS, BENU BRATA BRATA/0000-0003-2519-7105; Takeda, Shunichi/0000-0002-7924-7991	National Institutes of Health through NCI Center for Cancer Research; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	National Institutes of Health through NCI Center for Cancer Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Program of the NCI Center for Cancer Research.; Recipient of a fellowship from the Japan Society for the Promotion of Science.	Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Dexheimer TS, 2008, ANTI-CANCER AGENT ME, V8, P381, DOI 10.2174/187152008784220357; Dexheimer TS, 2010, NUCLEIC ACIDS RES, V38, P2444, DOI 10.1093/nar/gkp1206; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; ENG WK, 1988, MOL PHARMACOL, V34, P755; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hawkins AJ, 2009, DNA REPAIR, V8, P654, DOI 10.1016/j.dnarep.2008.12.012; HENNER WD, 1983, J BIOL CHEM, V258, P711; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lebedeva NA, 2011, FEBS LETT, V585, P683, DOI 10.1016/j.febslet.2011.01.032; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marchand C, 2009, MOL CANCER THER, V8, P240, DOI 10.1158/1535-7163.MCT-08-0878; Miao ZH, 2006, DNA REPAIR, V5, P1489, DOI 10.1016/j.dnarep.2006.07.004; Nakamura K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000828; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; TSAO YP, 1993, CANCER RES, V53, P5908; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170; Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003	67	130	137	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12848	12857		10.1074/jbc.M111.333963	http://dx.doi.org/10.1074/jbc.M111.333963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375014	Green Published, hybrid			2022-12-25	WOS:000302903700024
J	Ichikawa, T; Sato, F; Terasawa, K; Tsuchiya, S; Toi, M; Tsujimoto, G; Shimizu, K				Ichikawa, Takehiro; Sato, Fumiaki; Terasawa, Kazuya; Tsuchiya, Soken; Toi, Masakazu; Tsujimoto, Gozoh; Shimizu, Kazuharu			Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; 1ST-LINE TREATMENT; LIVER-CANCER; TUMOR-CELLS; PHASE-II; EXPRESSION; MICRORNAS; CYCLIN; EZH2; DOCETAXEL	Objective: Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset of BC patients exhibited resistance to trastuzumab therapy. Thus, clarifying the molecular mechanism of trastuzumab treatment will be beneficial to improve the treatment of HER2-positive BC patients. In this study, we identified trastuzumab-responsive microRNAs that are involved in the therapeutic effects of trastuzumab. Methods and Results: RNA samples were obtained from HER2-positive (SKBR3 and BT474) and HER2-negetive (MCF7 and MDA-MB-231) cells with and without trastuzumab treatment for 6 days. Next, we conducted a microRNA profiling analysis using these samples to screen those microRNAs that were up-or down-regulated only in HER2-positive cells. This analysis identified miR-26a and miR-30b as trastuzumab-inducible microRNAs. Transfecting miR-26a and miR-30b induced cell growth suppression in the BC cells by 40% and 32%, respectively. A cell cycle analysis showed that these microRNAs induced G1 arrest in HER2-positive BC cells as trastuzumab did. An Annexin-V assay revealed that miR-26a but not miR-30b induced apoptosis in HER2-positive BC cells. Using the prediction algorithms for microRNA targets, we identified cyclin E2 (CCNE2) as a target gene of miR-30b. A luciferase-based reporter assay demonstrated that miR-30b post-transcriptionally reduced 27% (p = 0.005) of the gene expression by interacting with two binding sites in the 3'-UTR of CCNE2. Conclusion: In BC cells, trastuzumab modulated the expression of a subset of microRNAs, including miR-26a and miR-30b. The upregulation of miR-30b by trastuzumab may play a biological role in trastuzumab-induced cell growth inhibition by targeting CCNE2.	[Ichikawa, Takehiro; Sato, Fumiaki; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Sato, Fumiaki] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Kyoto, Japan; [Terasawa, Kazuya; Tsujimoto, Gozoh] Kyoto Univ, Dept Pharmacogenom, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ichikawa, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan.	fsatoh@kuhp.kyoto-u.ac.jp			Japan Society for Promotion of Science [20390342, 20591569]; Grants-in-Aid for Scientific Research [23659610] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by two grants (#20390342 and #20591569) from the Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Carlomagno C, 1996, J CLIN ONCOL, V14, P2702, DOI 10.1200/JCO.1996.14.10.2702; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dubska L, 2005, FEBS LETT, V579, P4149, DOI 10.1016/j.febslet.2005.06.047; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Gudas JM, 1999, MOL CELL BIOL, V19, P612; GUSTERSON BA, 1992, J CLIN ONCOL, V10, P1049, DOI 10.1200/JCO.1992.10.7.1049; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Ito T, 2007, ONCOLOGY-BASEL, V73, P366, DOI 10.1159/000136156; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kanehisa M, 2011, KEGG PATHWAY DATABAS; Kastl L, 2011, BREAST CANC RES TREA; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Liang ZX, 2010, BIOCHEM PHARMACOL, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Marches R, 2004, INT J CANCER, V112, P492, DOI 10.1002/ijc.20378; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P57, DOI 10.1007/s12282-007-0014-z; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; ROSEN PP, 1995, CANCER, V75, P1320, DOI 10.1002/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	39	98	104	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31422	10.1371/journal.pone.0031422	http://dx.doi.org/10.1371/journal.pone.0031422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384020	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500025
J	Cruaud, A; Jabbour-Zahab, R; Genson, G; Ungricht, S; Rasplus, JY				Cruaud, Astrid; Jabbour-Zahab, Roula; Genson, Gwenaelle; Ungricht, Stefan; Rasplus, Jean-Yves			Testing the Emergence of New Caledonia: Fig Wasp Mutualism as a Case Study and a Review of Evidence	PLOS ONE			English	Review							OBLIGATE POLLINATION MUTUALISM; PHYLOGENETIC-RELATIONSHIPS; HYMENOPTERA-CHALCIDOIDEA; SOLOMON-ISLANDS; PACIFIC; EVOLUTION; FICUS; BIOGEOGRAPHY; COLONIZATION; DIVERGENCE	While geologists suggest that New Caledonian main island (Grande Terre) was submerged until ca 37 Ma, biologists are struck by the presence of supposedly Gondwanan groups on the island. Among these groups are the Oreosycea fig trees (Ficus, Moraceae) and their Dolichoris pollinators (Hymenoptera, Agaonidae). These partners are distributed in the Paleotropics and Australasia, suggesting that their presence on New Caledonia could result from Gondwanan vicariance. To test this hypothesis, we obtained mitochondrial and nuclear markers (5.3 kb) from 28 species of Dolichoris, used all available sequences for Oreosycea, and conducted phylogenetic and dating analyses with several calibration strategies. All our analyses ruled out a vicariance scenario suggesting instead that New Caledonian colonization by Dolichoris and Oreosycea involved dispersal across islands from Sundaland ca 45.9-32.0 Ma. Our results show that successful long-distance dispersal of obligate mutualists may happen further suggesting that presence of intimate mutualisms on isolated islands should not be used as a priori evidence for vicariance. Comparing our results to a review of all the published age estimates for New Caledonian plant and animal taxa, we showed that support for a vicariant origin of the island biota is still lacking. Finally, as demonstrating a causal relationship between geology and biology requires independent evidence, we argue that a priori assumptions about vicariance or dispersal should not be used to constrain chronograms. This circular reasoning could lead to under or overestimation of age estimates.	[Cruaud, Astrid; Jabbour-Zahab, Roula; Genson, Gwenaelle; Rasplus, Jean-Yves] Montpellier SupAgro, CIRAD, IRD, INRA,CBGP,UMR Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Ungricht, Stefan] ETH, Zurich, Switzerland	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich	Cruaud, A (corresponding author), Montpellier SupAgro, CIRAD, IRD, INRA,CBGP,UMR Ctr Biol & Gest Populat, Campus Int Baillarguet, Montferrier Sur Lez, France.	cruaud@supagro.inra.fr	Rasplus, Jean-Yves/O-2873-2017	Rasplus, Jean-Yves/0000-0001-8614-6665	ANR (French National Research Agency)	ANR (French National Research Agency)(French National Research Agency (ANR))	This work was supported by ANR project "BioNEOCAL" (French National Research Agency) to JYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; AITCHISON JC, 1995, GEOLOGY, V23, P161, DOI 10.1130/0091-7613(1995)023<0161:EACCIN>2.3.CO;2; [Anonymous], 2003, EVOLUTION DYNAMICS A, DOI DOI 10.1130/0-8137-2372-8.383; Berg C.C., 1992, AFRICAN FIG TREES FI, P1; Berg CC, 2002, BLUMEA, V47, P299; Berg CC, 2005, FLORA MALESIANA 1, V17; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; Collot J, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002612; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; COMPTON SG, 1988, PHILOS T ROY SOC B, V322, P459, DOI 10.1098/rstb.1988.0138; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; CORNER E J H, 1985, Allertonia, V4, P125; CORNER EJH, 1970, PHILOS T ROY SOC B, V259, P383, DOI 10.1098/rstb.1970.0062; Corner EJH, 1963, PACIFIC BASIN BIOGEO, P233; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hall R., 1997, PETROLEUM SYSTEMS SE, P47; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heads M, 2008, J BIOGEOGR, V35, P2153, DOI 10.1111/j.1365-2699.2008.01977.x; Heads M, 2010, J BIOGEOGR, V37, P1179, DOI 10.1111/j.1365-2699.2010.02311.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Honza E, 2004, TECTONOPHYSICS, V384, P23, DOI 10.1016/j.tecto.2004.02.006; Kawakita A, 2004, AM J BOT, V91, P410, DOI 10.3732/ajb.91.3.410; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Keppel G, 2009, J BIOGEOGR, V36, P1035, DOI 10.1111/j.1365-2699.2009.02095.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kirchman JJ, 2007, MOL PHYLOGENET EVOL, V43, P14, DOI 10.1016/j.ympev.2006.12.013; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kumagai T., 2001, J FOREST RES, V6, P257, DOI [10.1007/BF02762466, DOI 10.1007/BF02762466]; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; LAMBERT FR, 1989, IBIS, V131, P521, DOI 10.1111/j.1474-919X.1989.tb04788.x; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewington A, 1999, ANCIENT TREES TREES, P161; Linder M, 2011, SYST BIOL, V60, P329, DOI 10.1093/sysbio/syr009; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; Mack KML, 2011, SELECTIVE F IN PRESS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McConkey KR, 2007, BIOTROPICA, V39, P436, DOI 10.1111/j.1744-7429.2007.00269.x; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Morat P, 1984, BIOGEOGRAPHY TROPICA, P71; Morat Ph., 1993, Biodiversity Letters, V1, P69, DOI 10.2307/2999749; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nylander J.A.A., 2004, MRAIC PL; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Peate DW, 1997, J PETROL, V38, P1331, DOI 10.1093/petrology/38.10.1331; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pemberton CE, 1934, P HAWAIIAN ENTOMOLOG, V8, P379; Penalver E, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3541[1:FWIDAH]2.0.CO;2; Petterson MG, 1999, TECTONOPHYSICS, V301, P35, DOI 10.1016/S0040-1951(98)00214-5; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ronsted N, 2008, SYMBIOSIS, V45, P45; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Shanahan M., 2001, Journal of Biogeography, V28, P1365, DOI 10.1046/j.1365-2699.2001.00638.x; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Shilton LA, 1999, P ROY SOC B-BIOL SCI, V266, P219, DOI 10.1098/rspb.1999.0625; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Stamatakis A, 2006, INT PAR DISTR PROC S; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steadman DW, 1997, J BIOGEOGR, V24, P737, DOI 10.1046/j.1365-2699.1997.00157.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE RF, 1969, PHILOS T ROY SOC B, V255, P595, DOI 10.1098/rstb.1969.0032; Trewick SA, 2007, J BIOGEOGR, V34, P1, DOI 10.1111/j.1365-2699.2006.01643.x; Ungricht S, 2004, THESIS U MONTPELLIER; UTZURRUM RCB, 1991, BIOTROPICA, V23, P311, DOI 10.2307/2388211; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; WIEBES JT, 1979, P K NED AKAD C BIOL, V82, P181; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	88	40	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30941	10.1371/journal.pone.0030941	http://dx.doi.org/10.1371/journal.pone.0030941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383982	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500007
J	Li, SM; Valo, Z; Wang, JH; Gao, HL; Bowers, CW; Singer-Sam, J				Li, Sierra M.; Valo, Zuzana; Wang, Jinhui; Gao, Hanlin; Bowers, Chauncey W.; Singer-Sam, Judith			Transcriptome-Wide Survey of Mouse CNS-Derived Cells Reveals Monoallelic Expression within Novel Gene Families	PLOS ONE			English	Article							ORIGIN ALLELIC EXPRESSION; ANNEXIN A1; ADHESION; BRAIN; CHL1; TRANSFERASES; RESOLUTION; ALCOHOL; CLUSTER; CANCER	Monoallelic expression is an integral component of regulation of a number of essential genes and gene families. To probe for allele-specific expression in cells of CNS origin, we used next-generation sequencing (RNA-seq) to analyze four clonal neural stem cell (NSC) lines derived from Mus musculus C57BL/6 (B6) x Mus musculus molossinus (JF1) adult female mice. We established a JF1 cSNP library, then ascertained transcriptome-wide expression from B6 vs. JF1 alleles in the NSC lines. Validating the assay, we found that 262 of 268 X-linked genes evaluable in at least one cell line showed monoallelic expression (at least 85% expression of the predominant allele, p-value<0.05). For autosomal genes 170 of 7,198 genes (2.4% of the total) showed monoallelic expression in at least 2 evaluable cell lines. The group included eight known imprinted genes with the expected pattern of allele-specific expression. Among the other autosomal genes with monoallelic expression were five members of the glutathione transferase gene superfamily, which processes xenobiotic compounds as well as carcinogens and cancer therapeutic agents. Monoallelic expression within this superfamily thus may play a functional role in the response to diverse and potentially lethal exogenous factors, as is the case for the immunoglobulin and olfactory receptor superfamilies. Other genes and gene families showing monoallelic expression include the annexin gene family and the Thy1 gene, both linked to inflammation and cancer, as well as genes linked to alcohol dependence (Gabrg1) and epilepsy (Kcnma1). The annotated set of genes will provide a resource for investigation of mechanisms underlying certain cases of these and other major disorders.	[Li, Sierra M.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biostat, Duarte, CA 91010 USA; [Valo, Zuzana; Wang, Jinhui; Gao, Hanlin; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Bowers, Chauncey W.] City Hope Natl Med Ctr, Beckman Res Inst, Div Computat Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Li, SM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biostat, Duarte, CA 91010 USA.	jsam@coh.org			NCI [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by NCI grant P30 CA033572. The work is solely the responsibility of the authors and does not represent the views of the NCI or NIH. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; BEUTLER E, 1975, AM J HUM GENET, V27, P628; Bjornsson HT, 2008, GENOME RES, V18, P771, DOI 10.1101/gr.073254.107; Cedar H, 2008, CURR OPIN IMMUNOL, V20, P308, DOI 10.1016/j.coi.2008.02.002; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Covault J, 2008, NEUROPSYCHOPHARMACOL, V33, P837, DOI 10.1038/sj.npp.1301456; Deng XX, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000318; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Hu LL, 2011, J BIOL CHEM, V286, P3119, DOI 10.1074/jbc.M110.157842; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Nair S, 2010, CANCER LETT, V294, P111, DOI 10.1016/j.canlet.2010.01.026; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ray LA, 2009, ALCOHOL CLIN EXP RES, V33, P1382, DOI 10.1111/j.1530-0277.2009.00968.x; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Tew KD, 2011, FREE RADIC BIOL MED; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Wang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013843; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	37	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31751	10.1371/journal.pone.0031751	http://dx.doi.org/10.1371/journal.pone.0031751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384067	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500037
J	Hartley, C; Berthouze, L; Mathieson, SR; Boylan, GB; Rennie, JM; Marlow, N; Farmer, SF				Hartley, Caroline; Berthouze, Luc; Mathieson, Sean R.; Boylan, Geraldine B.; Rennie, Janet M.; Marlow, Neil; Farmer, Simon F.			Long-Range Temporal Correlations in the EEG Bursts of Human Preterm Babies	PLOS ONE			English	Article							HUMAN BRAIN OSCILLATIONS; NEURONAL AVALANCHES; ACTIVITY PATTERNS; SOMATOSENSORY CORTEX; ELECTRICAL-ACTIVITY; THETA-OSCILLATIONS; PREMATURE-INFANTS; CORTICAL CIRCUITS; SPECTRAL-ANALYSIS; SCALING BEHAVIOR	The electrical activity in the very early human preterm brain, as recorded by scalp EEG, is mostly discontinuous and has bursts of high-frequency oscillatory activity nested within slow-wave depolarisations of high amplitude. The temporal organisation of the occurrence of these EEG bursts has not been previously investigated. We analysed the distribution of the EEG bursts in 11 very preterm (23-30 weeks gestational age) human babies through two estimates of the Hurst exponent. We found long-range temporal correlations (LRTCs) in the occurrence of these EEG bursts demonstrating that even in the very immature human brain, when the cerebral cortical structure is far from fully developed, there is non-trivial temporal structuring of electrical activity.	[Hartley, Caroline] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Hartley, Caroline; Berthouze, Luc] UCL, Inst Child Hlth, London, England; [Berthouze, Luc] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Mathieson, Sean R.; Rennie, Janet M.; Marlow, Neil] Elizabeth Garrett Anderson Univ Coll London, Inst Womens Hlth, London, England; [Boylan, Geraldine B.] Natl Univ Ireland Univ Coll Cork, Neonatal Brain Res Grp, Dept Paediat & Child Hlth, Cork, Ireland; [Farmer, Simon F.] UCL, Inst Neurol, London, England	University of London; University College London; University of London; University College London; University of Sussex; University of London; University College London; University College Cork; University of London; University College London	Hartley, C (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England.	s.farmer@ucl.ac.uk	Farmer, Simon F/D-1969-2012; Berthouze, Luc/C-4168-2008; Boylan, Geraldine B/F-3019-2012; Marlow, Neil/D-2918-2009	Farmer, Simon F/0000-0001-5193-8195; Berthouze, Luc/0000-0003-3774-2369; Marlow, Neil/0000-0001-5890-2953; Boylan, Geraldine/0000-0003-0920-5291; Hartley, Caroline/0000-0002-7981-0836	Wellcome Trust; CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; EPSRC (Engineering and Physical Sciences Research Council); UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre)	Wellcome Trust(Wellcome TrustEuropean Commission); CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre)	SM, JR and Neil Marlow are funded by the Wellcome Trust to SM, JR and NM are funded by the Wellcome Trust. CH was funded through CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London. LB was funded by the EPSRC (Engineering and Physical Sciences Research Council). SF was funded by UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre). (www.ucl.ac.uk/complex, www.epsrc.ac.uk, http://www.uclh.org/Research/CBRC/Pages/Home.aspx, www.wellcome.ac.uk). None of the funding was specifically for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CM, 1985, ELECTROEN CLIN NEURO, V60, P95, DOI 10.1016/0013-4694(85)90015-X; Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002; Beggs JM, 2003, J NEUROSCI, V23, P11167; BELL AH, 1991, J CLIN NEUROPHYSIOL, V8, P312, DOI 10.1097/00004691-199107010-00007; BENDA GI, 1989, ELECTROEN CLIN NEURO, V72, P189, DOI 10.1016/0013-4694(89)90243-5; Berthouze L, 2010, CLIN NEUROPHYSIOL, V121, P1187, DOI 10.1016/j.clinph.2010.02.163; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Biagioni E, 2000, CLIN NEUROPHYSIOL, V111, P2145, DOI 10.1016/S1388-2457(00)00479-X; BIAGIONI E, 1994, ELECTROEN CLIN NEURO, V91, P154, DOI 10.1016/0013-4694(94)90065-5; Chakrabarty S, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061706; Chan DWS, 2010, BRAIN DEV-JPN, V32, P482, DOI 10.1016/j.braindev.2009.07.006; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Eswaran H, 2007, CLIN NEUROPHYSIOL, V118, P1940, DOI 10.1016/j.clinph.2007.05.072; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Hayakawa M, 2001, ARCH DIS CHILD-FETAL, V84, pF163, DOI 10.1136/fn.84.3.F163; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Linkenkaer-Hansen K, 2007, J NEUROSCI, V27, P13882, DOI 10.1523/JNEUROSCI.3083-07.2007; McSharry PE, 2005, DFA MATLAB CODE FOUN; Niemarkt HJ, 2011, PEDIATR RES, V70, P529, DOI 10.1203/PDR.0b013e31822d748b; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Robinson PM, 1995, ANN STAT, V23, P1630, DOI 10.1214/aos/1176324317; Schumacher EM, 2011, PEDIATR RES, V69, P413, DOI 10.1203/PDR.0b013e31821267d2; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Vanhatalo S, 2002, CLIN NEUROPHYSIOL, V113, P1822, DOI 10.1016/S1388-2457(02)00292-4; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Victor S, 2005, PEDIATR RES, V57, P336, DOI 10.1203/01.PDR.0000153868.77623.43; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31543	10.1371/journal.pone.0031543	http://dx.doi.org/10.1371/journal.pone.0031543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363669	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302873700067
J	Koelsch, S; Enge, J; Jentschke, S				Koelsch, Stefan; Enge, Juliane; Jentschke, Sebastian			Cardiac Signatures of Personality	PLOS ONE			English	Article							HEART; DEPRESSION; DISORDER; SCHIZOPHRENIA; ALEXITHYMIA; ASSOCIATION; VARIABILITY; NEUROTICISM; SUBSTANCE; DOPAMINE	Background: There are well-established relations between personality and the heart, as evidenced by associations between negative emotions on the one hand, and coronary heart disease or chronic heart failure on the other. However, there are substantial gaps in our knowledge about relations between the heart and personality in healthy individuals. Here, we investigated whether amplitude patterns of the electrocardiogram (ECG) correlate with neurotisicm, extraversion, agreeableness, warmth, positive emotion, and tender-mindedness as measured with the Neuroticism-Extraversion-Openness (NEO) personality inventory. Specifically, we investigated (a) whether a cardiac amplitude measure that was previously reported to be related to flattened affectivity (referred to as E-k values) would explain variance of NEO scores, and (b) whether correlations can be found between NEO scores and amplitudes of the ECG. Methodology/Principal Findings: NEO scores and rest ECGs were obtained from 425 healthy individuals. Neuroticism and positive emotion significantly differed between individuals with high and low E-k values. In addition, stepwise cross-validated regressions indicated correlations between ECG amplitudes and (a) agreeableness, as well as (b) positive emotion. Conclusions/Significance: These results are the first to demonstrate that ECG amplitude patterns provide information about the personality of an individual as measured with NEO personality scales and facets. These findings open new perspectives for a more efficient personality assessment using cardiac measures, as well as for more efficient risk-stratification and pre-clinical diagnosis of individuals at risk for cardiac, affective and psychosomatic disorders.	[Koelsch, Stefan; Enge, Juliane; Jentschke, Sebastian] Free Univ Berlin, Berlin, Germany	Free University of Berlin	Koelsch, S (corresponding author), Free Univ Berlin, Berlin, Germany.	koelsch@cbs.mpg.de	Jentschke, Sebastian/C-1618-2008; Koelsch, Stefan/AAV-1556-2020	Jentschke, Sebastian/0000-0003-2576-5432; 	Freie University Berlin; Max Planck Society; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01EZ1024A]	Freie University Berlin; Max Planck Society(Max Planck SocietyFoundation CELLEX); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Freie University Berlin and by the Max Planck Society and by a grant from the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, grant-nr. 01EZ1024A, awareded to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D., 2004, BASIC CLIN NEUROCARD, P1; Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Agewall S, 1996, AM J HYPERTENS, V9, P545, DOI 10.1016/0895-7061(95)00355-X; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Barrick MR, 1996, J APPL PSYCHOL, V81, P261, DOI 10.1037/0021-9010.81.3.261; Berlin HA, 2005, AM J PSYCHIAT, V162, P2360, DOI 10.1176/appi.ajp.162.12.2360; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bruni R, 2006, ANN NY ACAD SCI, V1069, P208, DOI 10.1196/annals.1351.018; Camm AJ, 1996, CIRCULATION, V93, P1043; Canli T., 2006, BIOL PERSONALITY IND; Cardinal R, 2004, BASIC CLIN NEUROCARD, P315; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Chechetto D, 2004, BASIC CLIN NEUROCARD, P220; Cloninger CR, 2000, CURR OPIN PSYCHIATR, V13, P611, DOI 10.1097/00001504-200011000-00024; Cooper JE, 1994, POCKET GUIDE ICD 10; Costa P.T, 1992, REVISED NEOPERSONALI; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Damasio AR, 2000, ARCH GEN PSYCHIAT, V57, P128, DOI 10.1001/archpsyc.57.2.128; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davidson RJ, 2001, ANN NY ACAD SCI, V935, P191, DOI 10.1111/j.1749-6632.2001.tb03481.x; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Finholt T. A., 2003, EC INNOVATION NEW TE, V12, P5, DOI DOI 10.1080/10438590303119; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; Gagnon C, 2004, BASIC CLIN NEUROCARD, P393; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Horackova M, 2004, BASIC CLIN NEUROCARD, P61; Irwin MR, 2008, BRAIN BEHAV IMMUN, V22, P129, DOI 10.1016/j.bbi.2007.07.013; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Koelsch S, 2007, EUR J NEUROSCI, V26, P3328, DOI 10.1111/j.1460-9568.2007.05889.x; LANE RD, 1987, PSYCHOSOM MED, V49, P274, DOI 10.1097/00006842-198705000-00006; Luchner A, 2002, HYPERTENSION, V39, P99, DOI 10.1161/hy0102.100537; MCCRAE RR, 1983, J CONSULT CLIN PSYCH, V51, P882, DOI 10.1037/0022-006X.51.6.882; Mols F, 2010, HEART, V96, P30, DOI 10.1136/hrt.2009.170357; Ostendorf F., 2004, NEO PI R NEO PERSONL; Paulhus D.L., 1986, PERSONALITY ASSESSME, P143, DOI [DOI 10.1007/978-3-642-70751-3_8, 10.1007/978-3-642-70751-3_8]; Paulhus DL, 1998, J PERS, V66, P1025, DOI 10.1111/1467-6494.00041; Pauls CA, 2003, PERS INDIV DIFFER, V35, P263, DOI 10.1016/S0191-8869(02)00187-3; Riese H, 2007, PSYCHOL MED, V37, P257, DOI 10.1017/S0033291706009160; SANDER D, 1995, J NEUROL, V242, P313, DOI 10.1007/BF00878874; Schiffer AA, 2008, EUR J HEART FAIL, V10, P922, DOI 10.1016/j.ejheart.2008.07.010; Schlogl A., 2007, BRAIN COMPUTER INTER; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; SWERDLOW NR, 1987, BEHAV BRAIN SCI, V10, P197, DOI 10.1017/S0140525X00047488; Wolkowitz O. M., 2003, PSYCHONEUROENDOCRINO; Yeragani VK, 2000, PSYCHIAT RES, V93, P225, DOI 10.1016/S0165-1781(00)00119-0; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	53	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31441	10.1371/journal.pone.0031441	http://dx.doi.org/10.1371/journal.pone.0031441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363649	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700059
J	Takeuchi, D; Kerdsin, A; Pienpringam, A; Loetthong, P; Samerchea, S; Luangsuk, P; Khamisara, K; Wongwan, N; Areeratana, P; Chiranairadul, P; Lertchayanti, S; Petcharat, S; Yowang, A; Chaiwongsaen, P; Nakayama, T; Akeda, Y; Hamada, S; Sawanpanyalert, P; Dejsirilert, S; Oishi, K				Takeuchi, Dan; Kerdsin, Anusak; Pienpringam, Anupong; Loetthong, Phacharaphan; Samerchea, Sutit; Luangsuk, Pakkinee; Khamisara, Kasean; Wongwan, Nithita; Areeratana, Prasanee; Chiranairadul, Piphat; Lertchayanti, Suwat; Petcharat, Sininat; Yowang, Amara; Chaiwongsaen, Phanupong; Nakayama, Tatsuya; Akeda, Yukihiro; Hamada, Shigeyuki; Sawanpanyalert, Pathom; Dejsirilert, Surang; Oishi, Kazunori			Population-Based Study of Streptococcus suis Infection in Humans in Phayao Province in Northern Thailand	PLOS ONE			English	Article							MENINGITIS; OUTBREAK; SICHUAN	Background: Streptococcus suis infection in humans has received increasing worldwide recognition. Methods and Findings: A prospective study of S. suis infection in humans was conducted in Phayao Province in northern Thailand to determine the incidence and the risk behaviors of the disease in this region in 2010. Thirty-one cases were confirmed. The case fatality rate was 16.1%, and the estimated incidence rate was 6.2 per 100,000 in the general population. The peak incidence occurred in May. The median age of the patients was 53 years and 64.5% were men. Consumption of raw pork products was confirmed in 22 cases and the median incubation period (range) was 2 days (0-11) after consumption of raw pork products. Isolates from 31 patients were confirmed as serotype 2 in 23 patients (74.2%) and serotype 14 in eight patients (25.8%). The major se(uence types (STs) were ST1 (n = 20) for serotype 2 and ST105 (n = 8) for serotype 14. The epidemiological analysis suggested three possible clusters, which included 17 cases. In the largest possible cluster of 10 cases in Chiang Kham and its neighboring districts in May, the source of infection in four cases was identified as a raw pork dish served at the same restaurant in this district. Microbiological analysis confirmed that three of four cases associated with consumption of raw pork at this restaurant were attributable to an identical strain of serotype 2 with ST1 and pulsotype A2. Conclusions: Our data suggest a high incidence rate of S. suis infection in the general population in Phayao Province in 2010 and confirm a cluster of three cases in 31 human cases. Food safety control should be strengthened especially for raw pork products in northern Thailand.	[Takeuchi, Dan; Nakayama, Tatsuya; Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Lab Clin Res Infect Dis, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan; [Kerdsin, Anusak; Petcharat, Sininat; Sawanpanyalert, Pathom; Dejsirilert, Surang] Minist Publ Hlth, Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Pienpringam, Anupong; Luangsuk, Pakkinee; Khamisara, Kasean; Areeratana, Prasanee] Chiang Kham Gen Hosp, Phayao, Thailand; [Loetthong, Phacharaphan; Wongwan, Nithita; Chiranairadul, Piphat] Phayao Prov Hosp, Phayao, Thailand; [Samerchea, Sutit; Lertchayanti, Suwat] Phayao Publ Hlth Off, Phayao, Thailand; [Yowang, Amara; Chaiwongsaen, Phanupong] Chiang Rai Reg Med Sci Ctr, Chiang Rai, Thailand; [Hamada, Shigeyuki] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand	Osaka University; Ministry of Public Health - Thailand	Takeuchi, D (corresponding author), Osaka Univ, Lab Clin Res Infect Dis, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan.	oishik@biken.osaka-u.ac.jp	Kerdsin, Anusak/H-5360-2019; Nakayama, Tatsuya/AAU-5242-2020	Kerdsin, Anusak/0000-0003-1055-3656; 	Department of Medical Sciences, Ministry of Public Health of Thailand [21406027]; Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan; Research Centers for Emerging and Reemerging Infectious Diseases	Department of Medical Sciences, Ministry of Public Health of Thailand; Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan; Research Centers for Emerging and Reemerging Infectious Diseases	This work was supported by research grants from the Department of Medical Sciences, Ministry of Public Health of Thailand, and Grants-in-Aid for Scientific Research (B: 21406027), and the program of Research Centers for Emerging and Reemerging Infectious Diseases launched by a project commissioned by the Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Cheung PY, 2008, INT J FOOD MICROBIOL, V127, P316, DOI 10.1016/j.ijfoodmicro.2008.08.006; Fongcom A, 2009, SE ASIAN J TROP MED, V40, P511; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HO DTN, 2011, PLOS ONE, V0006; Kerdsin A, 2011, LANCET, V378, P960, DOI 10.1016/S0140-6736(11)60923-9; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; Khadthasrima N, 2008, HUMAN STREPTOCOCCUS; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Luey CKY, 2007, J MICROBIOL METH, V68, P648, DOI 10.1016/j.mimet.2006.10.010; Ma E, 2008, EPIDEMIOL INFECT, V136, P1691, DOI 10.1017/S0950268808000332; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; Navacharoen N, 2009, J LARYNGOL OTOL, V123, P857, DOI 10.1017/S0022215109004939; Hoa NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017943; Rehm T, 2007, J MED MICROBIOL, V56, P102, DOI 10.1099/jmm.0.46616-0; Wangsomboonsiri W, 2008, J INFECTION, V57, P392, DOI 10.1016/j.jinf.2008.08.006; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	21	47	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31265	10.1371/journal.pone.0031265	http://dx.doi.org/10.1371/journal.pone.0031265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363601	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700041
J	Bristow, CL; Babayeva, MA; LaBrunda, M; Mullen, MP; Winston, R				Bristow, Cynthia L.; Babayeva, Mariya A.; LaBrunda, Michelle; Mullen, Michael P.; Winston, Ronald			alpha(1)Proteinase Inhibitor Regulates CD4(+) Lymphocyte Levels and Is Rate Limiting in HIV-1 Disease	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN-LEUKOCYTE ELASTASE; MONOCLONAL-ANTIBODIES; NEUTROPHIL ELASTASE; GLYCOPROTEIN GP120; DIABETES-MELLITUS; SERINE PROTEASES; IMMUNE-COMPLEXES; LDL RECEPTOR; BONE-MARROW	Background: The regulation of adult stem cell migration through human hematopoietic tissue involves the chemokine CXCL12 (SDF-1) and its receptor CXCR4 (CD184). In addition, human leukocyte elastase (HLE) plays a key role. When HLE is located on the cell surface (HLECS), it acts not as a proteinase, but as a receptor for alpha(1)proteinase inhibitor (alpha 1PI, alpha(1)antitrypsin, SerpinA1). Binding of alpha 1PI to HLECS forms a motogenic complex. We previously demonstrated that alpha 1PI deficiency attends HIV-1 disease and that alpha 1PI augmentation produces increased numbers of immunocompetent circulating CD4(+) lymphocytes. Herein we investigated the mechanism underlying the alpha 1PI deficiency that attends HIV-1 infection. Methods and Findings: Active alpha 1PI in HIV-1 subjects (median 17 mu M, n = 35) was significantly below normal (median 36 mu M, p<0.001, n = 30). In HIV-1 uninfected subjects, CD4(+) lymphocytes were correlated with the combined factors alpha 1PI, HLECS+ lymphocytes, and CXCR4(+) lymphocytes (r(2) = 0.91, p<0.001, n = 30), but not CXCL12. In contrast, in HIV-1 subjects with >220 CD4 cells/mu l, CD4(+) lymphocytes were correlated solely with active alpha 1PI (r(2) = 0.93, p<0.0001, n = 26). The monoclonal anti-HIV-1 gp120 antibody 3F5 present in HIV-1 patient blood is shown to bind and inactivate human alpha 1PI. Chimpanzee alpha 1PI differs from human alpha 1PI by a single amino acid within the 3F5-binding epitope. Unlike human alpha 1PI, chimpanzee alpha 1PI did not bind 3F5 or become depleted following HIV-1 challenge, consistent with the normal CD4(+) lymphocyte levels and benign syndrome of HIV-1 infected chimpanzees. The presence of IgG-alpha 1PI immune complexes correlated with decreased CD4(+) lymphocytes in HIV-1 subjects. Conclusions: This report identifies an autoimmune component of HIV-1 disease that can be overcome therapeutically. Importantly, results identify an achievable vaccine modification with the novel objective to protect against AIDS as opposed to the current objective to protect against HIV-1 infection.	[Bristow, Cynthia L.; Babayeva, Mariya A.] Weill Cornell Med Coll, New York, NY USA; [Bristow, Cynthia L.; Babayeva, Mariya A.; Winston, Ronald] Inst Human Genet & Biochem, Vesenaz, Switzerland; [LaBrunda, Michelle] Holmes Reg Med Ctr, Melbourne, FL USA; [Mullen, Michael P.] Mt Sinai Sch Med, New York, NY USA	Cornell University; Icahn School of Medicine at Mount Sinai	Bristow, CL (corresponding author), Weill Cornell Med Coll, New York, NY USA.	cyb2005@med.cornell.edu			University of North Carolina Center for AIDS Research; Harry Winston Research Foundation	University of North Carolina Center for AIDS Research; Harry Winston Research Foundation	Research was supported by the University of North Carolina Center for AIDS Research and Harry Winston Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA A, 1994, CLIN EXP IMMUNOL, V96, P379, DOI 10.1111/j.1365-2249.1994.tb06038.x; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bristow CL, 2003, BLOOD, V102, P4479, DOI 10.1182/blood-2003-05-1635; BRISTOW CL, 1993, INT IMMUNOL, V5, P79, DOI 10.1093/intimm/5.1.79; Bristow CL, 2001, CLIN DIAGN LAB IMMUN, V8, P937, DOI 10.1128/CDLI.8.5.937-942.2001; BRISTOW CL, 1995, INT IMMUNOL, V7, P239, DOI 10.1093/intimm/7.2.239; Bristow CL, 1998, CLIN IMMUNOL IMMUNOP, V89, P247, DOI 10.1006/clin.1998.4605; Bristow CL, 2008, J IMMUNOL, V180, P492, DOI 10.4049/jimmunol.180.1.492; Bristow CL, 2010, SOLUBLE FACTORS MEDIATING INNATE IMMUNE RESPONSES TO HIV INFECTION, P102; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cepinskas G, 1999, J CELL SCI, V112, P1937; Cordelier P, 2003, BBA-MOL BASIS DIS, V1638, P197, DOI 10.1016/S0925-4439(03)00084-X; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Freissmuth D, 2003, FRONT BIOSCI-LANDMRK, V8, pS733, DOI 10.2741/1124; Garwicz D, 2005, HAEMATOLOGICA, V90, P38; Girard M, 1998, AIDS RES HUM RETROV, V14, P1357, DOI 10.1089/aid.1998.14.1357; Girard M, 1997, VIROLOGY, V232, P98, DOI 10.1006/viro.1997.8560; GOLDING H, 1988, J EXP MED, V167, P914, DOI 10.1084/jem.167.3.914; GULLBERG U, 1995, J BIOL CHEM, V270, P12912, DOI 10.1074/jbc.270.21.12912; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2004, TRENDS MOL MED, V10, P163, DOI 10.1016/j.molmed.2004.02.002; Janciauskiene S, 2001, ATHEROSCLEROSIS, V158, P41, DOI 10.1016/S0021-9150(00)00767-X; JEPPSSON JO, 1985, J CHROMATOGR, V327, P173, DOI 10.1016/S0021-9673(01)81646-0; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; Koito A, 1989, Int Immunol, V1, P613, DOI 10.1093/intimm/1.6.613; Kuiperij HB, 2009, EXP HEMATOL, V37, P641, DOI 10.1016/j.exphem.2009.02.004; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MARTODAM RR, 1981, BIOCHIM BIOPHYS ACTA, V667, P328, DOI 10.1016/0005-2795(81)90199-9; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; OWEN FL, 1984, IMMUNOL REV, V82, P29, DOI 10.1111/j.1600-065X.1984.tb01116.x; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rodman TC, 1999, HUM IMMUNOL, V60, P631, DOI 10.1016/S0198-8859(99)00052-X; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rubinstein DB, 1999, CLIN IMMUNOL, V90, P352, DOI 10.1006/clim.1998.4668; Rutjens E, 2003, FRONT BIOSCI-LANDMRK, V8, pD1134, DOI 10.2741/1125; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Strickland DK, 1997, TRENDS CARDIOVAS MED, V7, P9, DOI 10.1016/S1050-1738(96)00120-X; Tavor S, 2005, BLOOD, V106, P2120, DOI 10.1182/blood-2004-12-4964; VIRELLA G, 1981, DIABETOLOGIA, V21, P184; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Yahata T, 2006, BLOOD, V108, P2446, DOI 10.1182/blood-2006-02-002204	58	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31383	10.1371/journal.pone.0031383	http://dx.doi.org/10.1371/journal.pone.0031383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363634	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600144
J	Fiebig, T; Boll, H; Figueiredo, G; Kerl, HU; Nittka, S; Groden, C; Kramer, M; Brockmann, MA				Fiebig, Teresa; Boll, Hanne; Figueiredo, Giovanna; Kerl, Hans Ulrich; Nittka, Stefanie; Groden, Christoph; Kramer, Martin; Brockmann, Marc A.			Three-Dimensional In Vivo Imaging of the Murine Liver: A Micro-Computed Tomography-Based Anatomical Study	PLOS ONE			English	Article							MOUSE; HEPATECTOMY; MODEL; CT	Various murine models are currently used to study acute and chronic pathological processes of the liver, and the efficacy of novel therapeutic regimens. The increasing availability of high-resolution small animal imaging modalities presents researchers with the opportunity to precisely identify and describe pathological processes of the liver. To meet the demands, the objective of this study was to provide a three-dimensional illustration of the macroscopic anatomical location of the murine liver lobes and hepatic vessels using small animal imaging modalities. We analysed micro-CT images of the murine liver by integrating additional information from the published literature to develop comprehensive illustrations of the macroscopic anatomical features of the murine liver and hepatic vasculature. As a result, we provide updated three-dimensional illustrations of the macroscopic anatomy of the murine liver and hepatic vessels using micro-CT. The information presented here provides researchers working in the field of experimental liver disease with a comprehensive, easily accessable overview of the macroscopic anatomy of the murine liver.	[Fiebig, Teresa; Boll, Hanne; Figueiredo, Giovanna; Kerl, Hans Ulrich; Groden, Christoph; Brockmann, Marc A.] Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, D-6800 Mannheim, Germany; [Nittka, Stefanie] Heidelberg Univ, Med Fac Mannheim, Dept Clin Chem, D-6800 Mannheim, Germany; [Kramer, Martin] Univ Giessen, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Fiebig, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, D-6800 Mannheim, Germany.	brockmann@gmx.de			Federal Ministry of Education and Research; Land Baden-Wurttemberg (HBFG) [125-648]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wurttemberg (HBFG)	The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wurttemberg (HBFG grant # 125-648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; COOK M.J, 1965, ANATOMY LAB MOUSE; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Duan YN, 2011, PARASITOLOGY, V138, P1003, DOI 10.1017/S0031182011000667; Fernandez-Dominguez I, 2011, ULTRASOUND MED BIOL, V37, P1161, DOI 10.1016/j.ultrasmedbio.2011.04.012; Fox JG, 2007, MOUSE BIOMEDICAL RES, P1; Gabele E, 2011, ALCOHOL CLIN EXP RES, V35, P1361, DOI 10.1111/j.1530-0277.2011.01472.x; Galvez J, 2011, VISIBLE MOUSE PROJEC; Graham KC, 2008, INVEST RADIOL, V43, P488, DOI 10.1097/RLI.0b013e318172f5b5; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hedrich H., 2004, LAB MOUSE, P117; HOLLANDER CF, 1987, ARCH TOXICOL, P244; Hummel KP, 1966, BIOL LAB MOUSE; Hutchins GD, 2008, ILAR J, V49, P54, DOI 10.1093/ilar.49.1.54; Inderbitzin D, 2007, METHODS, V43, P46, DOI 10.1016/j.ymeth.2007.03.010; Jensen MR, 2003, HEPATOLOGY, V37, P862, DOI 10.1053/jhep.2003.50137; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kline TL, 2011, CELLS TISSUES ORGANS, V194, P431, DOI 10.1159/000323482; Kogure K, 1999, J Hepatobiliary Pancreat Surg, V6, P171, DOI 10.1007/s005340050101; Kolbekova P, 2011, PARASITOL RES, V108, P1007, DOI 10.1007/s00436-010-2145-y; Kuhara T, 2011, EUR J NUTR IN PRESS; Loudos G, 2011, EUR J RADIOL, V78, P287, DOI 10.1016/j.ejrad.2010.06.025; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Maronpot RR, 1999, PATHOLOGY MOUSE, P120; Martiniova L, 2010, METHODS, V50, P20, DOI 10.1016/j.ymeth.2009.05.016; Martins PNA, 2008, LIVER INT, V28, P3, DOI 10.1111/j.1478-3231.2007.01628.x; Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x; May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478; Nomenclature ICoVGA, 2005, NOM AN VET; Popesko P, 1992, COLOUR ATLAS ANATOMY, P107; RAUCH H, 1952, GENETICS, V37, P617; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Studer P, 2008, GASTROENTEROLOGY, V134, pA875; Takamasa I, 2001, COLOR ATLAS SECTIONA; Van Steenkiste C, 2010, LIVER INT, V30, P1211, DOI 10.1111/j.1478-3231.2010.02276.x; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	38	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31179	10.1371/journal.pone.0031179	http://dx.doi.org/10.1371/journal.pone.0031179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363574	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100052
J	Deutsch, C; El Yacoubi, B; de Crecy-Lagard, V; Iwata-Reuyl, D				Deutsch, Christopher; El Yacoubi, Basma; de Crecy-Lagard, Valerie; Iwata-Reuyl, Dirk			Biosynthesis of Threonylcarbamoyl Adenosine (t(6)A), a Universal tRNA Nucleoside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ENZYMATIC-SYNTHESIS; MASS-SPECTROMETRY; UNKNOWN FUNCTION; L-THREONINE; IN-VITRO; PROTEIN; N-(PURIN-6-YLCARBAMOYL)THREONINE	The anticodon stem-loop (ASL) of transfer RNAs (tRNAs) drives decoding by interacting directly with the mRNA through codon/anticodon pairing. Chemically complex nucleoside modifications found in the ASL at positions 34 or 37 are known to be required for accurate decoding. Although over 100 distinct modifications have been structurally characterized in tRNAs, only a few are universally conserved, among them threonylcarbamoyl adenosine (t(6)A), found at position 37 in the anticodon loop of a subset of tRNA. Structural studies predict an important role for t(6)A in translational fidelity, and in vivo work supports this prediction. Although pioneering work in the 1970s identified the fundamental substrates for t(6)A biosynthesis, the enzymes responsible for its biosynthesis have remained an enigma. We report here the discovery that in bacteria four proteins (YgjD, YrdC, YjeE, and YeaZ) are both necessary and sufficient for t(6)A biosynthesis in vitro. Notably, YrdC and YgjD are members of universally conserved families that were ranked among the top 10 proteins of unknown function in need of functional characterization, while YeaZ and YjeE are specific to bacteria. This latter observation, coupled with the essentiality of all four proteins in bacteria, establishes this pathway as a compelling new target for antimicrobial development.	[El Yacoubi, Basma; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Deutsch, Christopher; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	State University System of Florida; University of Florida; Portland State University	de Crecy-Lagard, V (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, POB 110700, Gainesville, FL 32611 USA.	vcrecy@ufl.edu; iwatareuyld@pdx.edu	de Crecy-Lagard, Valerie/AAN-8995-2020		National Institutes of Health [GM070641-01A3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM070641-01A3 from the National Institutes of Health (to V. de C.-L. and D. I.-R.).	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Allali-Hassani A, 2004, BIOCHEM J, V384, P577, DOI 10.1042/BJ20041082; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell TL, 2007, J BACTERIOL, V189, P3318, DOI 10.1128/JB.00131-06; CHHEDA GB, 1972, BIOCHEM J, V127, P515, DOI 10.1042/bj1270515; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; de Crecky-Lagard V, 2007, METHOD ENZYMOL, V425, P153; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; GARCIA GA, 1998, MODIFICATION EDITING, P135; Grosjean H., 2009, DNA RNA MODIFICATION, P1; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Harris KA, 2011, RNA, V17, P1678, DOI 10.1261/rna.2592411; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; KORNER A, 1974, FEBS LETT, V39, P301, DOI 10.1016/0014-5793(74)80135-3; Kuratani M, 2011, PROTEINS, V79, P2065, DOI 10.1002/prot.23026; Lei T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020163; Lescrinier E, 2006, NUCLEIC ACIDS RES, V34, P2878, DOI 10.1093/nar/gkl081; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Morin A, 1998, RNA, V4, P24; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; POWERS DM, 1972, BIOCHEM BIOPH RES CO, V46, P831, DOI 10.1016/S0006-291X(72)80216-X; POWERS DM, 1972, J BIOL CHEM, V247, P6394; Qian QA, 1998, J BACTERIOL, V180, P1808, DOI 10.1128/JB.180.7.1808-1813.1998; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Sherlin LD, 2001, RNA, V7, P1671; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x	46	86	92	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13666	13673		10.1074/jbc.M112.344028	http://dx.doi.org/10.1074/jbc.M112.344028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378793	Green Published, hybrid			2022-12-25	WOS:000303996300022
J	Ramos, SBV				Ramos, Silvia B. V.			Characterization of Delta N-Zfp36l2 Mutant Associated with Arrest of Early Embryonic Development and Female Infertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; EARLY RESPONSE GENE; C-ELEGANS EMBRYOS; AU-RICH ELEMENTS; MESSENGER-RNA; TRISTETRAPROLIN FAMILY; TNF-ALPHA; GERMLINE SPECIFICATION; PIE-1 PROTEIN; TIS11 FAMILY	The zinc finger protein 36-like 2, Zfp36l2, has been implicated in female mouse infertility, because an amino-terminal truncation mutation (Delta N-Zfp36l2) leads to two-cell stage arrest of embryos derived from the homozygous mutant female gamete. Zfp36l2 is a member of the tristetraprolin (TTP) family of CCCH tandem zinc finger proteins that can bind to transcripts containing AU-rich elements ( ARE), resulting in deadenylation and destabilization of these transcripts. I show here that the mouse Zfp36l2 is composed of two exons and a single intron, encoding a polypeptide of 484 amino acids. I observed that Delta N-Zfp36l2 protein is similar to both wild-type Zfp36l2 and TTP (Zfp36) in that it shuttles between the cytoplasm and nucleus, binds to RNAs containing AREs, and promotes deadenylation of a model ARE transcript in a cell-based co-transfection assay. Surprisingly, in contrast to TTP, Zfp36l2 mRNA and protein were rapidly down-regulated upon LPS exposure in bone marrow-derived macrophages. The Delta N-Zfp36l2 protein was substantially more resistant to stimulus-induced down-regulation than the WT. I postulate that the embryonic arrest linked to the Delta N-Zfp36l2 truncation might be related to its resistance to stimulus-induced down-regulation.	Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ramos, SBV (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 333 S Columbia St,255 MacNider Hall,CB 7570, Chapel Hill, NC 27599 USA.	sramos@med.unc.edu			National Institutes of Health from NIEHS; Nova Carta Foundation at University of North Carolina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069597] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; Nova Carta Foundation at University of North Carolina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health grant from Intramural Research Program, NIEHS (to the Blackshear laboratory). This work was also supported at University of North Carolina by the Nova Carta Foundation.	BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; BUSTIN SA, 1994, DNA CELL BIOL, V13, P449, DOI 10.1089/dna.1994.13.449; Cao H, 2008, J NUTR, V138, P833, DOI 10.1093/jn/138.5.833; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Guedes S, 1997, DEVELOPMENT, V124, P731; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Ino T, 1995, ONCOGENE, V11, P2705; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maclean KN, 1998, BRIT J BIOMED SCI, V55, P184; MACLEAN KN, 1995, GENOMICS, V30, P89, DOI 10.1006/geno.1995.0014; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Tabara H, 1999, DEVELOPMENT, V126, P1; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022	47	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13116	13127		10.1074/jbc.M111.330837	http://dx.doi.org/10.1074/jbc.M111.330837			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367205	Green Published, hybrid			2022-12-25	WOS:000302903700051
J	Wu-Zhang, AX; Schramm, CL; Nabavi, S; Malinow, R; Newton, AC				Wu-Zhang, Alyssa X.; Schramm, Cicely L.; Nabavi, Sadegh; Malinow, Roberto; Newton, Alexandra C.			Cellular Pharmacology of Protein Kinase M zeta (PKM zeta) Contrasts with Its in Vitro Profile IMPLICATIONS FOR PKM zeta AS A MEDIATOR OF MEMORY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM-MEMORY; C ISOZYMES; CHELERYTHRINE; INHIBITION; MECHANISM; PHOSPHORYLATION; MAINTENANCE; SPECIFICITY; APOPTOSIS	A number of recent studies have used pharmacological inhibitors to establish a role for protein kinase M zeta (PKM zeta) in synaptic plasticity and memory. These studies use zeta inhibitory peptide (ZIP) and chelerythrine as inhibitors of PKM zeta to block long term potentiation and memory; staurosporine is used as a negative control to show that a nonspecific kinase inhibitor does not block long term potentiation and memory. Here, we show that neither ZIP nor chelerythrine inhibits PKM zeta in cultured cells or brain slices. In contrast, staurosporine does block PKM zeta activity in cells and brain slices by inhibiting its upstream phosphoinositide-dependent kinase-1. These studies demonstrate that the effectiveness of drugs against purified PKM zeta may not be indicative of their specificity in the more complex environment of the cell and suggest that PKM zeta is unlikely to be the mediator of synaptic plasticity or memory.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Malinow, R (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu; anewton@ucsd.edu		Nabavi, Sadegh/0000-0002-3940-1210	National Institutes of Health [GM-43154, MH-049159]; Cure Alzheimer's Foundation; University of California San Diego (UCSD) through NIGMS, National Institutes of Health [T32 GM007752]; National Science Foundation (NSF) [0742551]; National Institutes of Health/NIDDK [5T32-DK007233]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, T32GM007752, R37GM043154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049159, R01MH091119, R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Foundation; University of California San Diego (UCSD) through NIGMS, National Institutes of Health; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-43154 (to A. C. N.) and MH-049159 (to R. M.). This work was also supported by Cure Alzheimer's Foundation (to R. M.).; Supported in part by the University of California San Diego (UCSD) Graduate Training Program in Cellular and Molecular Pharmacology through Institutional Training Grant T32 GM007752 from the NIGMS, National Institutes of Health, and in part by a National Science Foundation (NSF) GK-12 STEM fellowship in education at UCSD, PI Maarten Chrispeels, NSF 0742551.; Supported by the National Institutes of Health/NIDDK Hemoglobin and Blood Protein Chemistry Training Grant 5T32-DK007233.	Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Squire L., 2008, MEMORY MIND MOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yu R, 2000, J BIOL CHEM, V275, P9612, DOI 10.1074/jbc.275.13.9612	28	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12879	12885		10.1074/jbc.M112.357244	http://dx.doi.org/10.1074/jbc.M112.357244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378786	Green Published, hybrid			2022-12-25	WOS:000302903700027
J	Doss, CGP; NagaSundaram, N				Doss, C. George Priya; NagaSundaram, N.			Investigating the Structural Impacts of I64T and P311S Mutations in APE1-DNA Complex: A Molecular Dynamics Approach	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BASE EXCISION-REPAIR; PROTEIN STABILITY CHANGES; NON-SYNONYMOUS SNPS; DNA-REPAIR; COMPUTATIONAL ANALYSIS; SOLVENT ACCESSIBILITY; GENETIC-VARIATION; SEQUENCE; PREDICTION	Background: Elucidating the molecular dynamic behavior of Protein-DNA complex upon mutation is crucial in current genomics. Molecular dynamics approach reveals the changes on incorporation of variants that dictate the structure and function of Protein-DNA complexes. Deleterious mutations in APE1 protein modify the physicochemical property of amino acids that affect the protein stability and dynamic behavior. Further, these mutations disrupt the binding sites and prohibit the protein to form complexes with its interacting DNA. Principal Findings: In this study, we developed a rapid and cost-effective method to analyze variants in APE1 gene that are associated with disease susceptibility and evaluated their impacts on APE1-DNA complex dynamic behavior. Initially, two different in silico approaches were used to identify deleterious variants in APE1 gene. Deleterious scores that overlap in these approaches were taken in concern and based on it, two nsSNPs with IDs rs61730854 (I64T) and rs1803120 (P311S) were taken further for structural analysis. Significance: Different parameters such as RMSD, RMSF, salt bridge, H-bonds and SASA applied in Molecular dynamic study reveals that predicted deleterious variants I64T and P311S alters the structure as well as affect the stability of APE1-DNA interacting functions. This study addresses such new methods for validating functional polymorphisms of human APE1 which is critically involved in causing deficit in repair capacity, which in turn leads to genetic instability and carcinogenesis.	[Doss, C. George Priya; NagaSundaram, N.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Doss, CGP (corresponding author), VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	georgepriyadoss@vit.ac.in	Nagarajan, Nagasundaram/AAT-8337-2021; Alizadeh/AAK-1398-2021; C, George/ABE-4676-2021	C, George Priya Doss/0000-0002-5971-8290; Nagarajan, Nagasundaram/0000-0002-9581-4781				Abyzov A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000066; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Case DA, 2002, AMBER SIMULATION SOF; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; CHERFILS J, 1991, PROTEINS, V11, P271, DOI 10.1002/prot.340110406; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Creighton T. E., 1993, PROTEINS STRUCTURES; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Gromiha MM, 1999, PROTEIN ENG, V12, P549, DOI 10.1093/protein/12.7.549; GROMIHA MM, 1995, INT J PEPT PROT RES, V45, P225; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Jeffey GA, 1997, INTRO HYDROGEN BONDI; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Ma L, 2011, BIOCHEMISTRY-US, V50, P266, DOI 10.1021/bi101096k; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; NOVOTNY J, 1992, PROG BIOPHYS MOL BIO, V58, P203, DOI 10.1016/0079-6107(92)90006-R; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Ringe, 2004, PROTEIN STRUCTURE FU, P10; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; Sarakatsannis JN, 2005, PROTEINS, V60, P732, DOI 10.1002/prot.20549; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Synowiec E, 2008, MUTAT RES-FUND MOL M, V648, P65, DOI 10.1016/j.mrfmmm.2008.09.014; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yu E, 2010, BIOCHEMISTRY-US, V49, P3786, DOI 10.1021/bi901828t; Yu ET, 2011, MUTAT RES-GEN TOX EN, V722, P140, DOI 10.1016/j.mrgentox.2010.06.015; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2006, BMC BIOINFORMATICS, V22, P7; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	69	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31677	10.1371/journal.pone.0031677	http://dx.doi.org/10.1371/journal.pone.0031677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384055	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500035
J	Gordon, M; Seymour, J				Gordon, Matthew; Seymour, Jamie			Growth, Development and Temporal Variation in the Onset of Six Chironex fleckeri Medusae Seasons: A Contribution to Understanding Jellyfish Ecology	PLOS ONE			English	Article							JUVENILE BANANA PRAWNS; TRIPEDALIA-CYSTOPHORA CUBOZOA; NORTHERN AUSTRALIAN ESTUARY; PENAEUS-MERGUIENSIS; ENVIRONMENTAL VARIATION; BOX-JELLYFISH; LIFE-CYCLE; FISH; METAMORPHOSIS; POSTLARVAL	Despite the worldwide distribution, toxicity and commercial, industrial and medical impacts jellyfish present, many aspects of their ecology remain poorly understood. Quantified here are important ecological parameters of Chironex fleckeri medusae, contributing not only to the understanding of an understudied taxon, the cubozoa, but also to the broader understanding of jellyfish ecology. C. fleckeri medusae were collected across seven seasons (1999, 2000, 2003, 2005-07 and 2010), with growth rates, temporal variation in the medusae season onset and differences in population structure between estuarine and coastal habitats quantified. With a mean of 2 September +/- 2 d (mean +/- 95% confidence limits), the earliest date of metamorphosis was temporally constrained between seasons, varying by only 7 d (30 August to 5 September). Juvenile medusae appeared to be added over an extended period, suggesting polyp metamorphosis was an ongoing process once it commenced. At a maximum of 3 +/- 0.2 mm d(-1) IPD, medusae growth to an asymptotic size of,190 mm IPD was rapid, yet, with the oldest medusae estimated to be, similar to 78 d in age, medusae did not appear to accumulate along the coastline. Furthermore, a greater proportion of juveniles were observed along the coastline, with estuarine populations typified by larger medusae. With key aspects of C. fleckeri's ecology now quantified, medusae season management protocols can be further developed.	[Gordon, Matthew; Seymour, Jamie] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia	James Cook University	Gordon, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	matthew.gordon@jcu.edu.au	Seymour, Jamie E/C-9748-2013	Seymour, Jamie E/0000-0002-4805-3289; Gordon, Matthew/0000-0001-8074-1295	Mission Beach Tourism Commission; Lions Foundation of Australia; National Geographic; Australian Geographic; Cairns City Council; Cardwell Shire Council; Growing the Smart State Queensland; Comalco	Mission Beach Tourism Commission; Lions Foundation of Australia; National Geographic(National Geographic Society); Australian Geographic; Cairns City Council; Cardwell Shire Council; Growing the Smart State Queensland; Comalco	Mission Beach Tourism Commission (http://www.missionbeachtourism.com/), Lions Foundation of Australia (www.lionsclubs.org.au), National Geographic (www.nationalgeographic.com.au), Australian Geographic (www.australiangeographic.com.au), Cairns City Council (www.cairns.qld.gov.au), Cardwell Shire Council (www.csc.qld.gov.au), Growing the Smart State Queensland PhD grants (www.smartstate.qld.gov.au) and Comalco (http://www.riotintoalcan.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; BARNES J. H., 1960, MED JOUR AUSTRALIA II, V47, P993; Barnes J. H., 1965, North Queensland Naturalist, V32, P13; BARNES J. H., 1966, SYMP ZOOL SOC LONDON, V16, P307; BLABER SJM, 1989, ESTUAR COAST SHELF S, V29, P509, DOI 10.1016/0272-7714(89)90008-5; BLABER SJM, 1995, ESTUAR COAST SHELF S, V40, P177, DOI 10.1016/S0272-7714(05)80004-6; Brown T., 1973, CHIRONEX FLECKERI DI; Burnett JW, 2001, HYDROBIOLOGIA, V451, P1, DOI 10.1023/A:1011883019506; Burnett JW, 1996, VENOMOUS POISONOUS M, P98; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Cropp B, 1984, SCUBA DIVER, V3, P42; CYRUS DP, 1992, ESTUAR COAST SHELF S, V35, P545, DOI 10.1016/S0272-7714(05)80038-1; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon M, 1998, ECOPHYSIOLOGY TROPIC; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; GUEST WILLIAM C., 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P79; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; HAMNER WM, 1994, NATL GEOGR MAG, V186, P116; HARTWICK R, 1987, TOXIC PLANTS ANIMALS, P99; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; HOFMANN DK, 1981, MAR BIOL, V65, P25, DOI 10.1007/BF00397064; Jacups S, 2010, NO TERRITORY DIS CON, V17, P25; Jacups SP, 2010, ECOHEALTH, V7, P14, DOI 10.1007/s10393-010-0306-1; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Kawamura Mariko, 2003, Plankton Biology and Ecology, V50, P37; KEEN TEB, 1971, TOXICON, V9, P249, DOI 10.1016/0041-0101(71)90077-8; Kinsey BE, 1988, MORE BARNES BO UNPUB; Kinsey BE, 1986, BARNES BOX JEL UNPUB; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; LEONARD JL, 1980, NATURE, V284, P377, DOI 10.1038/284377a0; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Masilamoni JG, 2000, CURR SCI INDIA, V79, P567; Matsumura K, 2005, J MAR BIOL ASSOC UK, V85, P563, DOI 10.1017/S0025315405011483; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Rajagopal S., 1989, Mahasagar, V22, P151; Sachlikidis NG, 2005, NEW ZEAL J MAR FRESH, V39, P305, DOI 10.1080/00288330.2005.9517310; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; SOUTHCOTT R V, 1971, Australian Natural History, V17, P123; Southcott R.V., 1956, AUST J MAR FRESHW RE, V7, P254, DOI DOI 10.1071/MF9560254; Stangl K, 2002, VIE MILIEU, V52, P131; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I, 2011, ZOOTAXA, P36; Ueno S., 1997, P491; UENO S, 1995, J PLANKTON RES, V17, P1381, DOI 10.1093/plankt/17.6.1381; Ueno S, 2003, 7 INT C COEL BIOL; Vance DJ, 1996, MAR ECOL PROG SER, V131, P115, DOI 10.3354/meps131115; VANCE DJ, 1990, ESTUAR COAST SHELF S, V31, P689, DOI 10.1016/0272-7714(90)90020-R; Vance DJ, 1998, MAR ECOL PROG SER, V163, P21, DOI 10.3354/meps163021; Vance DJ, 1996, MAR ECOL PROG SER, V135, P43, DOI 10.3354/meps135043; WERNER B, 1973, MAR BIOL, V18, P212, DOI 10.1007/BF00367987; WERNER B, 1975, HELGOLAND WISS MEER, V27, P461, DOI 10.1007/BF01611150; WERNER B, 1976, EXPERIENTIA, V32, P1047, DOI 10.1007/BF01933964; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Yamaguchi M., 1980, P11	58	21	21	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31277	10.1371/journal.pone.0031277	http://dx.doi.org/10.1371/journal.pone.0031277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384009	Green Accepted, Green Published, gold			2022-12-25	WOS:000302918500022
J	Sax, PE; Meyers, JL; Mugavero, M; Davis, KL				Sax, Paul E.; Meyers, Juliana L.; Mugavero, Michael; Davis, Keith L.			Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States	PLOS ONE			English	Article							SINGLE-TABLET REGIMEN; INITIAL TREATMENT; MEDICATION ADHERENCE; DISOPROXIL FUMARATE; VIRAL SUPPRESSION; INHIBITOR THERAPY; SIMPLIFICATION; PROGRESSION; EFAVIRENZ; STRATEGY	Purpose: A lower daily pill burden may improve adherence to antiretroviral treatment (ART) and clinical outcomes in patients with human immunodeficiency virus (HIV). This study assessed differences in adherence using the number of pills taken per day, and evaluated how adherence correlated with hospitalization. Methodology: Commercially insured patients in the LifeLink database with an HIV diagnosis (International Classification of Diseases, 9th Revision, Clinical Modification code 042.xx) between 6/1/2006 and 12/31/2008 and receipt of a complete ART regimen were selected for inclusion. Patients were grouped according to their daily pill count and remained on ART for at least 60 days. Outcomes included adherence and rates of hospitalization. Adherence was measured as the proportion of days between the start and end of the regimen in which the patient maintained supply of all initiated ART components. Logistic regressions assessed the relationship between pills per day, adherence, and hospitalization, controlling for demographics, comorbidities, and ART-naive (vs. experienced) status. Results: 7,073 patients met the study inclusion criteria, and 33.4%, 5.8%, and 60.8% received an ART regimen comprising one, two, or three or more pills per day, respectively. Regression analysis showed patients receiving a single pill per day were significantly more likely to reach a 95% adherence threshold versus patients receiving three or more pills per day (odds ratio [OR] = 1.59; P<0.001). Regardless of the number of pills received per day, patients were over 40% less likely to have a hospitalization if they were adherent to therapy (OR = 0.57; P<0.001). Patients receiving a single pill per day were 24% less likely to have a hospitalization versus patients receiving three or more pills per day (OR = 0.76; P = 0.003). Conclusions: ART consisting of a single pill per day was associated with significantly better adherence and lower risk of hospitalization in patients with HIV compared to patients receiving three or more pills per day.	[Sax, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Meyers, Juliana L.; Davis, Keith L.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Mugavero, Michael] Univ Alabama Birmingham, Birmingham, AL USA	Harvard University; Brigham & Women's Hospital; Research Triangle Institute; University of Alabama System; University of Alabama Birmingham	Sax, PE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmeyers@rti.org		Meyers, Juliana/0000-0003-2938-2957; Davis, Keith/0000-0002-0044-7107	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was funded by Gilead Sciences. Gilead provided input on study design and analysis and reviewed the manuscript prior to submission.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BANGSBERG DR, 2010, 17 C RETR OPP INF SA; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen C, 2010, WORLD AIDS C VIENN A; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Fielden Sarah J, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P238, DOI 10.1177/1545109708323132; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Juday T, 2011, HIV CLIN TRIALS, V12, P71, DOI 10.1310/hct1202-71; Kitahata MM, 2004, INT J STD AIDS, V15, P803, DOI 10.1258/0956462042563666; Legorreta A, 2005, AIDS CARE, V17, P938, DOI 10.1080/09540120500100692; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	27	113	115	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31591	10.1371/journal.pone.0031591	http://dx.doi.org/10.1371/journal.pone.0031591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384040	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916800017
J	Tarasenko, N; Cutts, SM; Phillips, DR; Inbal, A; Nudelman, A; Kessler-Icekson, G; Rephaeli, A				Tarasenko, Nataly; Cutts, Suzanne M.; Phillips, Don R.; Inbal, Aida; Nudelman, Abraham; Kessler-Icekson, Gania; Rephaeli, Ada			Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor	PLOS ONE			English	Article							BUTYRIC-ACID; BREAST-CANCER; ANTICANCER PRODRUGS; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; TOPOISOMERASE-II; DNA ADDUCTS; IN-VIVO; C-KIT; EXPRESSION	The histone deacetylase inhibitor (HDACI) butyroyloxymethyl diethylphosphate (AN-7) synergizes the cytotoxic effect of doxorubicin (Dox) and anti-HER2 on mammary carcinoma cells while protecting normal cells against their insults. This study investigated the concomitant changes occurring in heart tissue and tumors of mice bearing a subcutaneous 4T1 mammary tumor following treatment with AN-7, Dox, or their combination. Dox or AN-7 alone led to inhibition of both tumor growth and lung metastases, whereas their combination significantly increased their anticancer efficacy and attenuated Doxtoxicity. Molecular analysis revealed that treatment with Dox, AN-7, and to a greater degree, AN-7 together with Dox increased tumor levels of gamma H2AX, the marker for DNA double-strand breaks and decreased the expression of Rad51, a protein needed for DNA repair. These events culminated in increased apoptosis, manifested by the appearance of cytochrome-c in the cytosol. In the myocardium, Dox-induced cardiomyopathy was associated with an increase in gamma H2AX expression and a reduction in Rad51 and MRE11 expression and increased apoptosis. The addition of AN-7 to the Dox treatment protected the heart from Dox insults as was manifested by a decrease in gamma H2AX levels, an increase in Rad51 and MRE11 expression, and a diminution of cytochrome-c release. Tumor fibrosis was high in untreated mice but diminished in Dox- and AN-7-treated mice and was almost abrogated in AN-7+Dox-treated mice. By contrast, in the myocardium, Dox alone induced a dramatic increase in fibrosis, and AN7+Dox attenuated it. The high expression levels of c-Kit, Ki-67, c-Myc, lo-FGF, and VEGF in 4T1 tumors were significantly reduced by Dox or AN-7 and further attenuated by AN-7+Dox. In the myocardium, Dox suppressed these markers, whereas AN-7+Dox restored their expression. In conclusion, the combination of AN-7 and Dox results in two beneficial effects, improved anticancer efficacy and cardioprotection.	[Tarasenko, Nataly; Inbal, Aida; Kessler-Icekson, Gania; Rephaeli, Ada] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Tarasenko, Nataly; Inbal, Aida] Beilinson Med Ctr, Rabin Med Ctr, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel; [Cutts, Suzanne M.; Phillips, Don R.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Nudelman, Abraham] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; La Trobe University; Bar Ilan University	Tarasenko, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Beilinson Campus, Petah Tiqwa, Israel.	adarep@post.tau.ac.il	Cutts, Suzanne/B-2467-2012	Cutts, Suzanne/0000-0002-6055-0405	Israel Cancer Association, Israel [20092001]	Israel Cancer Association, Israel	The work was supported by Israel Cancer Association (Grant No 20092001, Israel, URL:http://ica.cancer.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7; Blank-Porat D, 2007, CANCER LETT, V256, P39, DOI 10.1016/j.canlet.2007.05.011; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Charpin C, 2009, BRIT J CANCER, V101, P48, DOI 10.1038/sj.bjc.6605113; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Cook KL, 2010, CANCER RES, V70, P8319, DOI 10.1158/0008-5472.CAN-10-1136; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Cutts SM, 2005, IUBMB LIFE, V57, P73, DOI 10.1080/15216540500079093; Cutts SM, 2001, CANCER RES, V61, P8194; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Gabel Ralf, 2009, Interact Cardiovasc Thorac Surg, V9, P20, DOI 10.1510/icvts.2008.191916; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Kasukabe T, 1997, BRIT J CANCER, V75, P850, DOI 10.1038/bjc.1997.151; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Lin CW, 2008, MOL CANCER THER, V7, P1195, DOI 10.1158/1535-7163.MCT-07-2199; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Nudelman A, 2005, J MED CHEM, V48, P1042, DOI 10.1021/jm049428p; Nudelman A, 2001, EUR J MED CHEM, V36, P63, DOI 10.1016/S0223-5234(00)01199-5; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Rephaeli A, 2000, DRUG DEVELOP RES, V50, P379, DOI 10.1002/1098-2299(200007/08)50:3/4<379::AID-DDR20>3.0.CO;2-8; Rephaeli A, 2007, BRIT J CANCER, V96, P1667, DOI 10.1038/sj.bjc.6603781; Rephaeli A, 2006, INVEST NEW DRUG, V24, P383, DOI 10.1007/s10637-006-6213-1; Rephaeli A, 2005, INT J CANCER, V116, P226, DOI 10.1002/ijc.21030; REPHAELI A, 1991, INT J CANCER, V49, P66, DOI 10.1002/ijc.2910490113; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Rosato RR, 2004, EXPERT OPIN INV DRUG, V13, P21, DOI 10.1517/eoid.13.1.21.25283; Roussidis AE, 2007, CURR MED CHEM, V14, P735, DOI 10.2174/092986707780090963; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tarasenko N, 2011, INVEST NEW IN PRESS; Tarasenko N, 2008, CLIN EXP METASTAS, V25, P703, DOI 10.1007/s10585-008-9179-x; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	54	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31393	10.1371/journal.pone.0031393	http://dx.doi.org/10.1371/journal.pone.0031393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384017	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100021
J	Matsumoto, M; Ishige, A; Yazawa, Y; Kondo, M; Muramatsu, K; Watanabe, K				Matsumoto, Mitsuharu; Ishige, Atsushi; Yazawa, Yuka; Kondo, Manami; Muramatsu, Koji; Watanabe, Kenji			Promotion of Intestinal Peristalsis by Bifidobacterium spp. Capable of Hydrolysing Sennosides in Mice	PLOS ONE			English	Article							FECAL MICROBIOTA; UNITED-STATES; CONSTIPATION; METABOLISM; BACTERIA; PREVALENCE; MICROFLORA; LKM512; FLORA; RAT	Background: While there are a variety of identifiable causes of constipation, even idiopathic constipation has different possible mechanisms. Sennosides, the main laxative constituents of Daio, an ancient Kampo medicine, are prodrugs that are converted to an active principle, rheinanthrone, by intestinal microbiota. In this study, we aimed to determine the sennoside hydrolysis ability of lactic acid bacterial strains and bifidobacteria in the intestine and to investigate their effect on intestinal peristalsis in mice. Methodology/Principal Findings: A total of 88 lactic acid bacterial strains and 47 bifidobacterial strains were evaluated for their ability to hydrolyze sennosides. Our results revealed that 4 strains, all belonging to the genus Bifidobacterium, had strong sennoside hydrolysis ability, exhibiting a decrease of >70% of sennoside content. By thin-layer chromatography analysis, rheinanthrone was detected in the medium cultured with B. pseudocatenulatum LKM10070 and B. animalis subsp. lactis LKM512. The fecal sennoside contents significantly (P<0.001) decreased upon oral administration of these strains as compared with the control. Intestinal peristalsis activity was measured by the moved distance of the charcoal powder administered orally. The distance travelled by the charcoal powder in LKM512-treated mice was significantly longer than that of control (P<0.05). Intestinal microbiota were analysed by real-time PCR and terminal-restriction fragment length polymorphism. The diversity of the intestinal microbiota was reduced by kanamycin treatment and the diversity was not recovered by LKM512 treatment. Conclusion/Significance: We demonstrated that intestinal peristalsis was promoted by rheinanthrone produced by hydrolysis of sennoside by strain LKM512 and LKM10070.	[Matsumoto, Mitsuharu; Muramatsu, Koji] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan; [Ishige, Atsushi] Yokohama Coll Pharm, Sch Pharm, Lab Kampo Pharmacol, Yokohama, Kanagawa, Japan; [Yazawa, Yuka; Kondo, Manami] Kyodo Milk Ind Co Ltd, Analyt Res Ctr, Tokyo, Japan; [Watanabe, Kenji] Keio Univ, Sch Med, Ctr Kampo Med, Shinjuku Ku, Tokyo, Japan	Keio University	Matsumoto, M (corresponding author), Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Hinode Machi, Tokyo, Japan.	m-matumoto@meito.co.jp	Matsumoto, Mitsuharu/AHB-4023-2022	Matsumoto, Mitsuharu/0000-0002-0378-3077	Kyodo Milk Industry Co. Ltd.	Kyodo Milk Industry Co. Ltd.	This work was funded by Kyodo Milk Industry Co. Ltd. M. Matsumoto, Y. Yazawa, M. Kondo, and K. Muramatsu are employees of Kyodo Milk Industry Co. Ltd. The funder therefore had a role in study design, data analysis, preparation of the manuscript, and decision to publish the manuscript.	AKAO T, 1994, APPL ENVIRON MICROB, V60, P1041, DOI 10.1128/AEM.60.3.1041-1043.1994; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; DREESSEN M, 1981, J PHARM PHARMACOL, V33, P679, DOI 10.1111/j.2042-7158.1981.tb13903.x; DREESSEN M, 1982, PHARM ACTA HELV, V57, P350; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Ford AC, 2011, GUT, V60, P209, DOI 10.1136/gut.2010.227132; Foxx-Orenstein AE, 2008, CLEV CLIN J MED, V75, P813, DOI 10.3949/ccjm.75.11.813; HARDCASTLE JD, 1970, GUT, V11, P1038, DOI 10.1136/gut.11.12.1038; HATTORI M, 1982, CHEM PHARM BULL, V30, P1338; HATTORI M, 1988, PHARMACOLOGY, V36, P172, DOI 10.1159/000138437; KOBASHI K, 1980, PLANTA MED, V40, P225, DOI 10.1055/s-2008-1074963; Kozaki M, 1992, EXPT MANUAL LACTIC A, P6; LEMLI J, 1980, PHARMACOLOGY, V20, P50, DOI 10.1159/000137398; LEMLI J, 1988, PHARMACOLOGY, V36, P126, DOI 10.1159/000138431; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Matsumoto M, 2002, CURR MICROBIOL, V44, P212, DOI 10.1007/s00284-001-0087-4; Matsumoto M, 2001, J INTESTINAL MICROBI, V14, P97; Matsumoto M, 2009, MICROBIOL IMMUNOL, V53, P421, DOI 10.1111/j.1348-0421.2009.00140.x; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tada T, 1996, CELL IMMUNOL, V173, P155, DOI 10.1006/cimm.1996.0261; TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P781, DOI 10.1016/0016-5085(93)90896-K; Wald A, 2008, ALIMENT PHARM THER, V28, P917, DOI 10.1111/j.1365-2036.2008.03806.x; Walter S, 2002, SCAND J GASTROENTERO, V37, P911, DOI 10.1080/003655202760230865; ZWAVING JH, 1980, PHARMACOLOGY, V20, P65, DOI 10.1159/000137400	25	39	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31700	10.1371/journal.pone.0031700	http://dx.doi.org/10.1371/journal.pone.0031700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384059	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500036
J	Fields, RL; Ponzio, TA; Kawasaki, M; Gainer, H				Fields, Raymond L.; Ponzio, Todd A.; Kawasaki, Makoto; Gainer, Harold			Cell-Type Specific Oxytocin Gene Expression from AAV Delivered Promoter Deletion Constructs into the Rat Supraoptic Nucleus in vivo	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTOR; HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; MESSENGER RIBONUCLEIC-ACIDS; POLYMERASE-CHAIN-REACTION; MAGNOCELLULAR NEURONS; VASOPRESSIN GENE; RESPONSE ELEMENT; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; TRANSGENIC MICE; NERVOUS-SYSTEM	The magnocellular neurons (MCNs) in the hypothalamus selectively express either oxytocin (OXT) or vasopressin (AVP) neuropeptide genes, a property that defines their phenotypes. Here we examine the molecular basis of this selectivity in the OXT MCNs by stereotaxic microinjections of adeno-associated virus (AAV) vectors that contain various OXT gene promoter deletion constructs using EGFP as the reporter into the rat supraoptic nucleus (SON). Two weeks following injection of the AAVs, immunohistochemical assays of EGFP expression from these constructs were done to determine whether the EGFP reporter co-localizes with either the OXT- or AVP-immunoreactivity in the MCNs. The results show that the key elements in the OT gene promoter that regulate the cell-type specific expression the SON are located -216 to -100 bp upstream of the transcription start site. We hypothesize that within this 116 bp domain a repressor exists that inhibits expression specifically in AVP MCNs, thereby leading to the cell-type specific expression of the OXT gene only in the OXT MCNs.	[Fields, Raymond L.; Ponzio, Todd A.; Kawasaki, Makoto; Gainer, Harold] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Fields, RL (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	gainerh@ninds.nih.gov	Ponzio, Todd/AAV-2374-2021	Ponzio, Todd/0000-0002-3174-1229; Kawasaki, Makoto/0000-0001-8410-5800	Intramural Research Program of the National Institutes of Health; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002723] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN RAH, 1993, MOL ENDOCRINOL, V7, P47, DOI 10.1210/me.7.1.47; ADAN RAH, 1991, BIOCHEM BIOPH RES CO, V175, P117, DOI 10.1016/S0006-291X(05)81208-2; ADAN RAH, 1992, J BIOL CHEM, V267, P3771; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; BENBARAK Y, 1985, J NEUROSCI, V5, P81; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; BURBACH JPH, 1994, J BIOL CHEM, V269, P15046; Burger C, 2005, HUM GENE THER, V16, P781, DOI 10.1089/hum.2005.16.781; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Chu K, 1997, J MOL ENDOCRINOL, V19, P163, DOI 10.1677/jme.0.0190163; Chu K, 1999, J MOL ENDOCRINOL, V23, P337, DOI 10.1677/jme.0.0230337; Coulson JM, 2003, BIOCHEM J, V369, P549, DOI 10.1042/BJ20021176; DASILVA SL, 1995, TRENDS NEUROSCI, V18, P542, DOI 10.1016/0166-2236(95)98376-A; DASILVA SL, 1995, MOL BRAIN RES, V30, P131, DOI 10.1016/0169-328X(94)00289-Q; Davies J, 2003, J NEUROENDOCRINOL, V15, P42, DOI 10.1046/j.1365-2826.2003.00865.x; de Backer MWA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-81; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Doherty FC, 2011, J NEUROSCI METH, V197, P238, DOI 10.1016/j.jneumeth.2011.02.026; Fields RL, 2003, J NEUROSCI, V23, P7801; Gainer H, 1998, ADV EXP MED BIOL, V449, P15; Gainer H, 1995, ADV EXP MED BIOL, V395, P1; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Geller SF, 2007, MOL VIS, V13, P730; Glasgow E, 1999, ENDOCRINOLOGY, V140, P5391, DOI 10.1210/en.140.11.5391; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Ho MY, 2002, MOL CELL ENDOCRINOL, V186, P17, DOI 10.1016/S0303-7207(01)00677-3; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; IVELL R, 1984, EMBO J, V3, P2351, DOI 10.1002/j.1460-2075.1984.tb02139.x; Ivell R, 1998, ADV EXP MED BIOL, V449, P297; Jeong SW, 2001, EXP NEUROL, V171, P255, DOI 10.1006/exnr.2001.7785; Kim JK, 1996, MOL CELL ENDOCRINOL, V123, P179, DOI 10.1016/S0303-7207(96)03912-3; KIYAMA H, 1990, J NEUROENDOCRINOL, V2, P257, DOI 10.1111/j.1365-2826.1990.tb00401.x; Knobloch S, 2012, NEURON, V73, P1; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Li C, 2009, GENE THER, V16, P43, DOI 10.1038/gt.2008.134; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; LIPKIN SM, 1992, P NATL ACAD SCI USA, V89, P1209, DOI 10.1073/pnas.89.4.1209; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Negrete A, 2007, J GENE MED, V9, P938, DOI 10.1002/jgm.1092; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Okazaki T, 1997, J BIOL CHEM, V272, P32274, DOI 10.1074/jbc.272.51.32274; Osten P, 2007, Handb Exp Pharmacol, P177; Papale A, 2009, J NEUROSCI METH, V185, P1, DOI 10.1016/j.jneumeth.2009.08.013; Peter J, 2002, FRONT NEUROENDOCRIN, V23, P342, DOI 10.1016/S0091-3022(02)00005-5; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; RICHTER D, 1988, AM J PHYSIOL, V255, pF207, DOI 10.1152/ajprenal.1988.255.2.F207; Sladek CD, 2004, J NEUROENDOCRINOL, V16, P365, DOI 10.1111/j.0953-8194.2004.01187.x; Smith RH, 2009, MOL THER, V17, P1888, DOI 10.1038/mt.2009.128; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; WALTHER N, 1991, J NEUROENDOCRINOL, V3, P539, DOI 10.1111/j.1365-2826.1991.tb00315.x; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; WEHRENBERG U, 1994, P NATL ACAD SCI USA, V91, P1440, DOI 10.1073/pnas.91.4.1440; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Xi D, 1999, ENDOCRINOLOGY, V140, P4677, DOI 10.1210/en.140.10.4677; YOUNG WS, 1990, J NEUROENDOCRINOL, V2, P917, DOI 10.1111/j.1365-2826.1990.tb00660.x; Yue C, 2008, J NEUROENDOCRINOL, V20, P227, DOI 10.1111/j.1365-2826.2007.01640.x; Zhang B, 2001, J NEUROENDOCRINOL, V13, P29, DOI 10.1046/j.1365-2826.2001.00593.x; Zincarelli C, 2010, CTS-CLIN TRANSL SCI, V3, P81, DOI 10.1111/j.1752-8062.2010.00190.x	76	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32085	10.1371/journal.pone.0032085	http://dx.doi.org/10.1371/journal.pone.0032085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363799	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700141
J	Larsen, JM; Steen-Jensen, DB; Laursen, JM; Sondergaard, JN; Musavian, HS; Butt, TM; Brix, S				Larsen, Jeppe Madura; Steen-Jensen, Daniel Bisgaard; Laursen, Janne Marie; Sondergaard, Jonas Norskov; Musavian, Hanieh Sadat; Butt, Tariq Mahmood; Brix, Susanne			Divergent Pro-Inflammatory Profile of Human Dendritic Cells in Response to Commensal and Pathogenic Bacteria Associated with the Airway Microbiota	PLOS ONE			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; HAEMOPHILUS-INFLUENZAE; MORAXELLA-CATARRHALIS; BRONCHOALVEOLAR LAVAGE; FECAL MICROBIOTA; IMMUNE-RESPONSE; LIPID-A; EXACERBATIONS; CYTOKINES; ASTHMA	Recent studies using culture-independent methods have characterized the human airway microbiota and report microbial communities distinct from other body sites. Changes in these airway bacterial communities appear to be associated with inflammatory lung disease, yet the pro-inflammatory properties of individual bacterial species are unknown. In this study, we compared the immune stimulatory capacity on human monocyte-derived dendritic cells (DCs) of selected airway commensal and pathogenic bacteria predominantly associated with lungs of asthma or COPD patients (pathogenic Haemophillus spp. and Moraxella spp.), healthy lungs (commensal Prevotella spp.) or both (commensal Veillonella spp. and Actinomyces spp.). All bacteria were found to induce activation of DCs as demonstrated by similar induction of CD83, CD40 and CD86 surface expression. However, asthma and COPD-associated pathogenic bacteria provoked a 3-5 fold higher production of IL-23, IL-12p70 and IL-10 cytokines compared to the commensal bacteria. Based on the differential cytokine production profiles, the studied airway bacteria could be segregated into three groups (Haemophilus spp. and Moraxella spp. vs. Prevotella spp. and Veillonella spp. vs. Actinomyces spp.) reflecting their pro-inflammatory effects on DCs. Co-culture experiments found that Prevotella spp. were able to reduce Haemophillus influenzae-induced IL-12p70 in DCs, whereas no effect was observed on IL-23 and IL-10 production. This study demonstrates intrinsic differences in DC stimulating properties of bacteria associated with the airway microbiota.	[Larsen, Jeppe Madura; Steen-Jensen, Daniel Bisgaard; Laursen, Janne Marie; Sondergaard, Jonas Norskov; Musavian, Hanieh Sadat; Butt, Tariq Mahmood; Brix, Susanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Larsen, JM (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jeml@bio.dtu.dk	Pedersen, Susanne Brix/B-3484-2009; Nørskov Søndergaard, Jonas/P-6147-2015; Bisgaard, Hans/N-4761-2016; Larsen, Jeppe Madura/K-6518-2019; Moll, Janne Marie/AAT-8956-2021	Pedersen, Susanne Brix/0000-0001-8951-6705; Nørskov Søndergaard, Jonas/0000-0002-4438-6756; Bisgaard, Hans/0000-0003-4131-7592; Larsen, Jeppe Madura/0000-0003-1492-0708; Moll, Janne Marie/0000-0002-3514-4528; Musavian, Hanieh/0000-0002-0161-4392; Steen-Jensen, Daniel Bisgaard/0000-0002-7891-4502	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by a independent research grant to SB from the Lundbeck Foundation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors have no other competing interests to declare.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Alhawi M, 2009, J MED MICROBIOL, V58, P1015, DOI 10.1099/jmm.0.009936-0; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BAUGHMAN RP, 1987, CHEST, V91, P233, DOI 10.1378/chest.91.2.233; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2005, INFECT IMMUN, V73, P2728, DOI 10.1128/IAI.73.5.2728-2735.2005; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fink J, 2006, FEMS IMMUNOL MED MIC, V46, P198, DOI 10.1111/j.1574-695X.2005.00022.x; Galdiero M, 2004, INFECT IMMUN, V72, P1204, DOI 10.1128/IAI.72.2.1204-1209.2004; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hashimoto M, 2003, FEBS LETT, V543, P98, DOI 10.1016/S0014-5793(03)00414-9; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; KAHN FW, 1987, J INFECT DIS, V155, P862, DOI 10.1093/infdis/155.5.862; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Knobloch J, 2011, AM J RESP CRIT CARE, V183, P204, DOI 10.1164/rccm.201002-0199OC; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MASOUD H, 1994, EUR J BIOCHEM, V220, P209, DOI 10.1111/j.1432-1033.1994.tb18616.x; Matera G, 2009, CLIN VACCINE IMMUNOL, V16, P1804, DOI 10.1128/CVI.00310-09; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murphy TF, 2000, CHEST, V118, P204, DOI 10.1378/chest.118.1.204; PITTMAN MARGARET, 1931, JOUR EXP MED, V53, P471, DOI 10.1084/jem.53.4.471; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sartor RB, 2005, CURR OPIN GASTROEN, V21, P44; Schweda EKH, 2008, INNATE IMMUN-LONDON, V14, P199, DOI 10.1177/1753425908095958; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Sheil B, 2007, J NUTR, V137, p819S, DOI 10.1093/jn/137.3.819S; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; St Geme JW, 2002, CELL MICROBIOL, V4, P191; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	63	80	85	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31976	10.1371/journal.pone.0031976	http://dx.doi.org/10.1371/journal.pone.0031976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363778	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700129
J	Walker, J; Storch, G; Quach-Wong, B; Sonnenfeld, J; Aaron, G				Walker, Jeffrey; Storch, Gregory; Quach-Wong, Bonnie; Sonnenfeld, Julian; Aaron, Gloster			Propagation of Epileptiform Events across the Corpus Callosum in a Cingulate Cortical Slice Preparation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SEIZURES BEGET SEIZURES; INHIBITION CONTRIBUTES; FEEDFORWARD INHIBITION; PIRIFORM CORTEX; CEREBRAL-CORTEX; IN-VITRO; ANTERIOR; RAT; SYNCHRONY	We report on a novel mouse in vitro brain slice preparation that contains intact callosal axons connecting anterior cingulate cortices (ACC). Callosal connections are demonstrated by the ability to regularly record epileptiform events between hemispheres (bilateral events). That the correlation of these events depends on the callosum is demonstrated by the bisection of the callosum in vitro. Epileptiform events are evoked with four different methods: (1) bath application of bicuculline (a GABA-A antagonist); (2) bicuculline+MK801 (an NMDA receptor antagonist), (3) a zero magnesium extracellular solution (0Mg); (4) focal application of bicuculline to a single cortical hemisphere. Significant increases in the number of epileptiform events, as well as increases in the ratio of bilateral events to unilateral events, are observed during bath applications of bicuculline, but not during applications of bicuculline+MK-801. Long ictal-like events (defined as events > 20 seconds) are only observed in 0Mg. Whole cell patch clamp recordings of single neurons reveal strong feedforward inhibition during focal epileptiform events in the contralateral hemisphere. Within the ACC, we find differences between the rostral areas of ACC vs. caudal ACC in terms of connectivity between hemispheres, with the caudal regions demonstrating shorter interhemispheric latencies. The morphologies of many patch clamped neurons show callosally-spanning axons, again demonstrating intact callosal circuits in this in vitro preparation.	[Walker, Jeffrey; Storch, Gregory; Quach-Wong, Bonnie; Sonnenfeld, Julian; Aaron, Gloster] Wesleyan Univ, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA	Wesleyan University	Walker, J (corresponding author), Wesleyan Univ, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA.	gaaron@wesleyan.edu			Wesleyan University	Wesleyan University	All funds for this study were supplied by in-house grants from Wesleyan University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron G, 2006, SYNAPSE, V60, P437, DOI 10.1002/syn.20316; ANDERSON WW, 1986, BRAIN RES, V398, P215, DOI 10.1016/0006-8993(86)91274-6; Asadi-Pooya AA, 2008, EPILEPSY BEHAV, V13, P271, DOI 10.1016/j.yebeh.2008.04.020; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Berg AT, 1997, J CLIN NEUROPHYSIOL, V14, P102, DOI 10.1097/00004691-199703000-00003; Cisse Y, 2004, J NEUROPHYSIOL, V92, P3221, DOI 10.1152/jn.00537.2004; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; DECURTIS M, 1994, J NEUROPHYSIOL, V71, P2463, DOI 10.1152/jn.1994.71.6.2463; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Erickson TC, 1940, ARCH NEURO PSYCHIATR, V43, P429, DOI 10.1001/archneurpsyc.1940.02280030003001; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hauser WA, 2002, PROG BRAIN RES, V135, P215; HORNE AL, 1986, EUR J PHARMACOL, V122, P231, DOI 10.1016/0014-2999(86)90107-X; Kang J, 2010, NEUROSCIENCE, V169, P1601, DOI 10.1016/j.neuroscience.2010.06.020; KANTER ED, 1993, J NEUROSCI, V13, P2477, DOI 10.1523/JNEUROSCI.13-06-02477.1993; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Liauw Jason, 2003, Shengli Xuebao, V55, P373; MARCUS EM, 1966, ARCH NEUROL-CHICAGO, V14, P601, DOI 10.1001/archneur.1966.00470120033006; MARCUS EM, 1968, ARCH NEUROL-CHICAGO, V19, P99, DOI 10.1001/archneur.1968.00480010117010; MUSGRAVE J, 1980, EPILEPSIA, V21, P369, DOI 10.1111/j.1528-1157.1980.tb04084.x; Panuccio G, 2009, EPILEPSIA, V50, P521, DOI 10.1111/j.1528-1167.2008.01779.x; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; RALSTON BL, 1961, ELECTROEN CLIN NEURO, V13, P591, DOI 10.1016/0013-4694(61)90173-0; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Sills Graeme J, 2007, Epilepsy Curr, V7, P103, DOI 10.1111/j.1535-7511.2007.00189.x; SPENCER SS, 1988, EPILEPSIA, V29, pS85, DOI 10.1111/j.1528-1157.1988.tb05802.x; SPENCER SS, 1993, EPILEPSIA, V34, P561, DOI 10.1111/j.1528-1157.1993.tb02596.x; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TANAKA E, 1994, J NEUROSCI, V14, P1106, DOI 10.1523/JNEUROSCI.14-03-01106.1994; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; VOGT BA, 1981, J COMP NEUROL, V201, P265, DOI 10.1002/cne.902010210; Vogt BA, 2004, CINGULATE CORTEX DIS, P705; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; WHITTINGTON MA, 1995, J PHYSIOL-LONDON, V486, P723, DOI 10.1113/jphysiol.1995.sp020848	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31415	10.1371/journal.pone.0031415	http://dx.doi.org/10.1371/journal.pone.0031415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363643	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700057
J	Wilkars, W; Liu, ZQ; Lewis, AS; Stoub, TR; Ramos, EM; Brandt, N; Nicholson, DA; Chetkovich, DM; Bender, RA				Wilkars, Wiebke; Liu, Zhiqiang; Lewis, Alan S.; Stoub, Travis R.; Ramos, Elena M.; Brandt, Nicola; Nicholson, Daniel A.; Chetkovich, Dane M.; Bender, Roland A.			Regulation of Axonal HCN1 Trafficking in Perforant Path Involves Expression of Specific TRIP8b Isoforms	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; H-CHANNEL SUBUNITS; I-H; PACEMAKER CHANNELS; SURFACE EXPRESSION; LOCALIZATION; PLASTICITY; PHOSPHORYLATION; NEURONS; FAMILY	The functions of HCN channels in neurons depend critically on their subcellular localization, requiring fine-tuned machinery that regulates subcellular channel trafficking. Here we provide evidence that regulatory mechanisms governing axonal HCN channel trafficking involve association of the channels with specific isoforms of the auxiliary subunit TRIP8b. In the medial perforant path, which normally contains HCN1 channels in axon terminals in immature but not in adult rodents, we found axonal HCN1 significantly increased in adult mice lacking TRIP8b (TRIP8b(-/-)). Interestingly, adult mice harboring a mutation that results in expression of only the two most abundant TRIP8b isoforms (TRIP8b[1b/2](-/-)) exhibited an HCN1 expression pattern similar to wildtype mice, suggesting that presence of one or both of these isoforms (TRIP8b(1a), TRIP8b(1a-4)) prevents HCN1 from being transported to medial perforant path axons in adult mice. Concordantly, expression analyses demonstrated a strong increase of expression of both TRIP8b isoforms in rat entorhinal cortex with age. However, when overexpressed in cultured entorhinal neurons of rats, TRIP8b(1a), but not TRIP8b(1a-4), altered substantially the subcellular distribution of HCN1 by promoting somatodendritic and reducing axonal expression of the channels. Taken together, we conclude that TRIP8b isoforms are important regulators of HCN1 trafficking in entorhinal neurons and that the alternatively-spliced isoform TRIP8b(1a) could be responsible for the age-dependent redistribution of HCN channels out of perforant path axon terminals.	[Wilkars, Wiebke; Brandt, Nicola; Bender, Roland A.] Univ Hamburg, Med Ctr, Inst Neuroanat, Hamburg, Germany; [Liu, Zhiqiang; Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Stoub, Travis R.; Ramos, Elena M.; Nicholson, Daniel A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	University of Hamburg; Northwestern University; Feinberg School of Medicine; Rush University; Northwestern University; Feinberg School of Medicine	Wilkars, W (corresponding author), Univ Hamburg, Med Ctr, Inst Neuroanat, Hamburg, Germany.	rbender@uke.uni-hamburg.de	Chetkovich, Dane/AAV-5457-2021; Stoub, Travis/ABF-7039-2021; Lewis, Alan/AAV-9582-2021	Lewis, Alan/0000-0002-7165-5376; Brandt, Nicola/0000-0003-2483-9292; Bender, Ralf/0000-0001-7179-0626; Nicholson, Dan/0000-0002-1963-0569	Deutsche Forschungsgemeinschaft (DFG) [BE4107/2-1]; National Institutes of Health (NIH) [NS05595, NS059934, NS064757, AG031574, AG017139]; Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934, F30NS064757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031574, K99AG031574, RF1AG017139, R56AG017139, R01AG017139] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) grant BE4107/2-1 (RAB), National Institutes of Health (NIH) grants NS05595, NS059934 (DMC), NS064757 (ASL), AG031574 and AG017139 (DAN), and the Brain Research Foundation (DMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Banker G, CULTURING NERVE CELL; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bender RA, 2008, PROG NEUROBIOL, V86, P129, DOI 10.1016/j.pneurobio.2008.09.007; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Han Y, 2011, J BIOL CHEM; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	45	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32181	10.1371/journal.pone.0032181	http://dx.doi.org/10.1371/journal.pone.0032181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363812	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700153
J	Chiang, LL; Karvar, S; Hamm-Alvarez, SF				Chiang, Lilian; Karvar, Serhan; Hamm-Alvarez, Sarah F.			Direct Imaging of RAB27B-Enriched Secretory Vesicle Biogenesis in Lacrimal Acinar Cells Reveals Origins on a Nascent Vesicle Budding Site	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; MEMBRANE-BINDING PROPERTIES; POLARIZED EPITHELIAL-CELLS; STIMULATED SECRETION; CYTOPLASMIC DYNEIN; PLASMA-MEMBRANE; MYOSIN VB; MELANOSOME TRANSPORT; PROTEIN SECRETION; ZYMOGEN GRANULES	This study uses YFP-tagged Rab27b expression in rabbit lacrimal gland acinar cells, which are polarized secretory epithelial cells, to characterize early stages of secretory vesicle trafficking. Here we demonstrate the utility of YFP-Rab27b to delineate new perspectives on the mechanisms of early vesicle biogenesis in lacrimal gland acinar cells, where information is significantly limited. Protocols were developed to deplete the mature YFP-Rab27b-enriched secretory vesicle pool in the subapical region of the cell, and confocal fluorescence microscopy was used to track vesicle replenishment. This analysis revealed a basally-localized organelle, which we termed the "nascent vesicle site,'' from which nascent vesicles appeared to emerge. Subapical vesicular YFP-Rab27b was co-localized with p150(Glued), a component of the dynactin cofactor of cytoplasmic dynein. Treatment with the microtubule-targeted agent, nocodazole, did not affect release of mature secretory vesicles, although during vesicle repletion it significantly altered nascent YFP-Rab27b-enriched secretory vesicle localization. Instead of moving to the subapical region, these vesicles were trapped at the nascent vesicle site which was adjacent to, if not a sub-compartment of, the trans-Golgi network. Finally, YFP-Rab27b-enriched secretory vesicles which reached the subapical cytoplasm appeared to acquire the actin-based motor protein, Myosin 5C. Our findings show that Rab27b enrichment occurs early in secretory vesicle formation, that secretory vesicles bud from a visually discernable nascent vesicle site, and that transport from the nascent vesicle site to the subapical region requires intact microtubules.	[Chiang, Lilian; Hamm-Alvarez, Sarah F.] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Karvar, Serhan; Hamm-Alvarez, Sarah F.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chiang, LL (corresponding author), Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA.	shalvar@usc.edu		Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Institutes of Health [R01EY011386]; NATIONAL EYE INSTITUTE [R01EY011386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health R01EY011386 (to SHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BUSSONMABILLOT S, 1982, J CELL BIOL, V95, P105, DOI 10.1083/jcb.95.1.105; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; da Costa SR, 1998, J CELL SCI, V111, P1267; da Costa SR, 2002, ADV EXP MED BIOL, V506, P199; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661; Fukuda M, 2006, BIOCHEM BIOPH RES CO, V343, P666, DOI 10.1016/j.bbrc.2006.03.001; FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119; Gierow JP, 1996, AM J PHYSIOL-CELL PH, V271, pC1685, DOI 10.1152/ajpcell.1996.271.5.C1685; GIEROW JP, 1995, EXP EYE RES, V60, P511, DOI 10.1016/S0014-4835(05)80066-1; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jerdeva GV, 2005, J CELL SCI, V118, P4797, DOI 10.1242/jcs.02573; Jerdeva GV, 2005, AM J PHYSIOL-CELL PH, V289, pC1052, DOI 10.1152/ajpcell.00546.2004; Kogel T, 2010, RESULTS PROBL CELL D, V50, P1, DOI 10.1007/400_2009_31; Kraemer J, 1999, EUR J CELL BIOL, V78, P265, DOI 10.1016/S0171-9335(99)80060-0; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Lapierre LA, 2005, METHOD ENZYMOL, V403, P715, DOI 10.1016/S0076-6879(05)03062-4; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Marchelletta RR, 2008, AM J PHYSIOL-CELL PH, V295, pC13, DOI 10.1152/ajpcell.00330.2007; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Ngyen D, 2003, J CELL PHYSIOL, V197, P400, DOI 10.1002/jcp.10373; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Qian LM, 2004, EXP EYE RES, V79, P665, DOI 10.1016/j.exer.2004.07.007; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; ROBIN P, 1995, EUR J CELL BIOL, V67, P227; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rottger S, 1998, J CELL SCI, V111, P45; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Suda J, 2010, GASTROENTER IN PRESS; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Valentijn KM, 1999, J CELL SCI, V112, P81; VANSETTEN GB, 1989, GRAEF ARCH CLIN EXP, V227, P184, DOI 10.1007/BF02169794; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Vilalta PM, 1998, J CELL SCI, V111, P1841; Wang YR, 2003, J CELL SCI, V116, P2051, DOI 10.1242/jcs.00398; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 2001, J CELL SCI, V114, P1091; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Yoshie S, 2000, HISTOCHEM CELL BIOL, V113, P259, DOI 10.1007/s004180000130; Yoshino A, 2003, J CELL SCI, V116, P4441, DOI 10.1242/jcs.00746	71	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31789	10.1371/journal.pone.0031789	http://dx.doi.org/10.1371/journal.pone.0031789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363735	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500089
J	Guerra, SM; Rodriguez-Garcia, A; Santos-Aberturas, J; Vicente, CM; Payero, TD; Martin, JF; Aparicio, JF				Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.			LAL Regulators SCO0877 and SCO7173 as Pleiotropic Modulators of Phosphate Starvation Response and Actinorhodin Biosynthesis in Streptomyces coelicolor	PLOS ONE			English	Article							PHOR-PHOP SYSTEM; GENE-CLUSTER; ANTIBIOTIC PRODUCTION; IN-VIVO; MORPHOLOGICAL-DIFFERENTIATION; ESCHERICHIA-COLI; EXPRESSION; PROTEIN; IDENTIFICATION; METABOLISM	LAL regulators (Large ATP-binding regulators of the LuxR family) constitute a poorly studied family of transcriptional regulators. Several regulators of this class have been identified in antibiotic and other secondary metabolite gene clusters from actinomycetes, thus they have been considered pathway-specific regulators. In this study we have obtained two disruption mutants of LAL genes from S. coelicolor (Delta 0877 and Delta 7173). Both mutants were deficient in the production of the polyketide antibiotic actinorhodin, and antibiotic production was restored upon gene complementation of the mutants. The use of whole-genome DNA microarrays and quantitative PCRs enabled the analysis of the transcriptome of both mutants in comparison with the wild type. Our results indicate that the LAL regulators under study act globally affecting various cellular processes, and amongst them the phosphate starvation response and the biosynthesis of the blue-pigmented antibiotic actinorhodin. Both regulators act as negative modulators of the expression of the two-component phoRP system and as positive regulators of actinorhodin biosynthesis. To our knowledge this is the first characterization of LAL regulators with wide implications in Streptomyces metabolism.	[Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon, Spain; [Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.] Univ Leon, Area Microbiol, E-24071 Leon, Spain	Universidad de Leon	Guerra, SM (corresponding author), Inst Biotechnol INBIOTEC, Leon, Spain.	jesus.aparicio@unileon.es	Susana, Susana/L-9204-2015; Rodríguez-García, Antonio/A-9461-2011; Aparicio, Jesús F./K-8686-2014; Santos-Aberturas, Javier/AAE-8162-2021	Susana, Susana/0000-0003-2243-2376; Rodríguez-García, Antonio/0000-0001-8118-9762; Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon (Grupo de Excelencia) [GR117]; Ministerio de Ciencia e Innovacion [AP2005-3644, AP2007-02055]; University of Leon; Junta de Castilla y Leon [E-24-2009-0053914]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (Grupo de Excelencia)(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of Leon; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2007-67585 and BIO2010-19911 to JFA); and the Junta de Castilla y Leon (Grupo de Excelencia GR117). FPU fellowships of the Ministerio de Ciencia e Innovacion (AP2005-3644 to JSA, AP2007-02055 to T.D.P.); a fellowship from the University of Leon (to SMG); and a contract from the Junta de Castilla y Leon (E-24-2009-0053914 to CMV). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ainsa JA, 2000, J BACTERIOL, V182, P5470, DOI 10.1128/JB.182.19.5470-5478.2000; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; CHAMPNESS WC, 1994, REGULATION OF BACTERIAL DIFFERENTIATION, P61; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; FERNANDEZMORENO MA, 1994, J BIOL CHEM, V269, P24854; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Gehring AM, 2001, J BACTERIOL, V183, P5991, DOI 10.1128/JB.183.20.5991-5996.2001; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Lian W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-56; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manteca A, 2010, J PROTEOME RES, V9, P4801, DOI 10.1021/pr100513p; Martin JF, 2000, ENCY MICROBIOLOGY, V4, P213; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Rodriguez-Garcia A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni086; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Sambrook J, 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; VOGTLI M, 1994, MOL MICROBIOL, V14, P643, DOI 10.1111/j.1365-2958.1994.tb01303.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Wilson DJ, 2001, J BACTERIOL, V183, P3468, DOI 10.1128/JB.183.11.3468-3475.2001; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-191; Zotchev S, 2000, MICROBIOL-UK, V146, P611, DOI 10.1099/00221287-146-3-611	54	27	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31475	10.1371/journal.pone.0031475	http://dx.doi.org/10.1371/journal.pone.0031475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363654	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500047
J	Lucchi, NW; Poorak, M; Oberstaller, J; DeBarry, J; Srinivasamoorthy, G; Goldman, I; Xayavong, M; da Silva, AJ; Peterson, DS; Barnwell, JW; Kissinger, J; Udhayakumar, V				Lucchi, Naomi W.; Poorak, Mitra; Oberstaller, Jenna; DeBarry, Jeremy; Srinivasamoorthy, Ganesh; Goldman, Ira; Xayavong, Maniphet; da Silva, Alexandre J.; Peterson, David S.; Barnwell, John W.; Kissinger, Jessica; Udhayakumar, Venkatachalam			A New Single-Step PCR Assay for the Detection of the Zoonotic Malaria Parasite Plasmodium knowlesi	PLOS ONE			English	Article							COMPARATIVE GENOMICS; ANTIGENIC VARIATION; ANOPHELES-LATENS; HUMAN INFECTIONS; HUMANS; DIAGNOSIS; THAILAND; TRANSMISSION; VIETNAM; MACAQUES	Background: Recent studies in Southeast Asia have demonstrated substantial zoonotic transmission of Plasmodium knowlesi to humans. Microscopically, P. knowlesi exhibits several stage-dependent morphological similarities to P. malariae and P. falciparum. These similarities often lead to misdiagnosis of P. knowlesi as either P. malariae or P. falciparum and PCR-based molecular diagnostic tests are required to accurately detect P. knowlesi in humans. The most commonly used PCR test has been found to give false positive results, especially with a proportion of P. vivax isolates. To address the need for more sensitive and specific diagnostic tests for the accurate diagnosis of P. knowlesi, we report development of a new single-step PCR assay that uses novel genomic targets to accurately detect this infection. Methodology and Significant Findings: We have developed a bioinformatics approach to search the available malaria parasite genome database for the identification of suitable DNA sequences relevant for molecular diagnostic tests. Using this approach, we have identified multi-copy DNA sequences distributed in the P. knowlesi genome. We designed and tested several novel primers specific to new target sequences in a single-tube, non-nested PCR assay and identified one set of primers that accurately detects P. knowlesi. We show that this primer set has 100% specificity for the detection of P. knowlesi using three different strains (Nuri, H, and Hackeri), and one human case of malaria caused by P. knowlesi. This test did not show cross reactivity with any of the four human malaria parasite species including 11 different strains of P. vivax as well as 5 additional species of simian malaria parasites. Conclusions: The new PCR assay based on novel P. knowlesi genomic sequence targets was able to accurately detect P. knowlesi. Additional laboratory and field-based testing of this assay will be necessary to further validate its utility for clinical diagnosis of P. knowlesi.	[Lucchi, Naomi W.; Poorak, Mitra; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, Decatur, GA USA; [Lucchi, Naomi W.; Poorak, Mitra; Goldman, Ira; Xayavong, Maniphet; da Silva, Alexandre J.; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Oberstaller, Jenna; Kissinger, Jessica] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [DeBarry, Jeremy; Srinivasamoorthy, Ganesh; Peterson, David S.; Kissinger, Jessica] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kissinger, Jessica] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lucchi, NW (corresponding author), Atlanta Res & Educ Fdn, Decatur, GA USA.	vxu0@cdc.gov	Kissinger, Jessica/M-9920-2019; Kissinger, Jessica C/E-9610-2010	Kissinger, Jessica/0000-0002-6413-1101; Kissinger, Jessica C/0000-0002-6413-1101; Oberstaller, Jenna/0000-0002-3033-2212; Peterson, David/0000-0003-4394-6181; DeBarry, Jeremy/0000-0001-5718-2675; Lucchi, Naomi/0000-0001-8789-8041	Atlanta Research and Education Foundation; Centers for Disease Control and Prevention/University of Georgia Collaborative Seed; University of Georgia Research Computing Center; NIH [GM007103, R01 AI068908]; University of Georgia Department of Genetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	Atlanta Research and Education Foundation; Centers for Disease Control and Prevention/University of Georgia Collaborative Seed; University of Georgia Research Computing Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Department of Genetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Atlanta Research and Education Foundation, the Centers for Disease Control and Prevention/University of Georgia Collaborative Seed Grant, the University of Georgia Research Computing Center (a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer), NIH Training Grant T32 GM007103, an Alton Fellowship awarded through the University of Georgia Department of Genetics and by NIH grant R01 AI068908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Babady NE, 2009, AM J TROP MED HYG, V81, P516, DOI 10.4269/ajtmh.2009.81.516; Berry A, 2011, AM J TROP MED HYG, V84, P535, DOI 10.4269/ajtmh.2011.10-0622; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; *CDCP, 2008, MMWR-MORBID MORTAL W, V58, P229; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Coatneyi GR, 1971, PRIMATE MALARIAS, P381; Collins WE, 2012, ANNU REV ENTOMOL, V57, P107, DOI 10.1146/annurev-ento-121510-133540; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Cox-Singh J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-10; Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; DeBarry JD, 2011, MOL BIOL EVOL, V28, P2855, DOI 10.1093/molbev/msr103; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Eyles D. E., 1962, Indian Journal of Malariology, V16, P285; EYLES D. E., 1962, MED JOUR MALAYA, V17, P85; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hoosen A, 2011, TRAVEL MED INFECT DI; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lapp SA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-181; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee KS, 2009, INT J PARASITOL, V39, P1125, DOI 10.1016/j.ijpara.2009.03.003; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Ong CWM, 2009, AM J TROP MED HYG, V80, P927, DOI 10.4269/ajtmh.2009.80.927; Osman MMM, 2010, TROP MED INT HEALTH, V15, P1442, DOI 10.1111/j.1365-3156.2010.02659.x; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Sulistyaningsih E, 2010, EMERG INFECT DIS, V16, P1033, DOI 10.3201/eid1606.100022; Tang THT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-219; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-20; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26	44	36	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31848	10.1371/journal.pone.0031848	http://dx.doi.org/10.1371/journal.pone.0031848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363751	Green Published, gold			2022-12-25	WOS:000302871500095
J	Braido, F; Baiardini, I; Menoni, S; Gani, F; Senna, GE; Ridolo, E; Schoepf, V; Rogkakou, A; Canonica, GW				Braido, Fulvio; Baiardini, Ilaria; Menoni, Stefania; Gani, Federica; Senna, Gian Enrico; Ridolo, Erminia; Schoepf, Veruska; Rogkakou, Anthi; Canonica, Giorgio Walter			Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?	PLOS ONE			English	Article								Objectives: Asthma trials suggest that patients reaching total disease control have an optimal Health Related Quality of Life (HRQoL). Moreover, rhinitis is present in almost 80% of asthmatics and impacts asthma control and patient HRQoL. We explored whether optimal HRQoL was reachable in a real-life setting, and evaluated the disease and patient related patterns associated to optimal HRQoL achievement. Methods and Findings: Asthma and rhinitis HRQoL, illness perception, mood profiles, rhinitis symptoms and asthma control were assessed by means of validated tools in patients classified according to GINA and ARIA guidelines. Optimal HRQoL, identified by a Rhinasthma Global Summary (GS) score <= 20 (score ranging from 0 to 100, where 100 represents the worst possible HRQoL), was reached by 78/209 (37.32%). With the exception of age, no associations were found between clinical and demographic characteristics and optimal HRQoL achievement. Patients reaching an optimal HRQoL differed in disease perception and mood compared to those not reaching an optimal HRQoL. Asthma control was significantly associated with optimal HRQoL (chi(2) = 49.599; p < 0.001) and well-controlled and totally controlled patients significantly differed in achieving optimal HRQoL (chi(2) = 7.617; p < 0.006). Conclusion: Approximately one third of the patients in our survey were found to have an optimal HRQoL. While unsatisfactory disease control was the primary reason why the remainder failed to attain optimal HRQoL, it is clear that illness perception and mood also played parts. Therefore, therapeutic plans should be directed not only toward achieving the best possible clinical control of asthma and comorbid rhinitis, but also to incorporating individualized elements according to patient-related characteristics.	[Braido, Fulvio; Baiardini, Ilaria; Schoepf, Veruska; Rogkakou, Anthi; Canonica, Giorgio Walter] Osped S Martino Genoa, Allergy & Resp Dis Clin, Genoa, Italy; [Menoni, Stefania] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Gani, Federica] AOU San Luigi, Resp Dis Div, Allergy Unit, Turin, Italy; [Senna, Gian Enrico] Verona Major Hosp, Allergy Serv, Verona, Italy; [Ridolo, Erminia] Univ Parma, I-43100 Parma, Italy	University of Genoa; University of Parma	Braido, F (corresponding author), Osped S Martino Genoa, Allergy & Resp Dis Clin, Genoa, Italy.	fulvio.braido@unige.it	Senna, Gianenrico/AAC-5201-2022; /AAT-7555-2020; canonica, giorgio walter/ABF-2037-2020; braido, fulvio/C-5320-2012	Senna, Gianenrico/0000-0003-4172-3216; canonica, giorgio walter/0000-0001-8467-2557; braido, fulvio/0000-0003-2460-4709				Baiardini I, 2003, ALLERGY, V58, P289, DOI 10.1034/j.1398-9995.2003.00079.x; Bateman ED, 2007, EUR RESPIR J, V29, P56, DOI 10.1183/09031936.00128505; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2006, J ALLERGY CLIN IMMUN, V117, P158, DOI 10.1016/j.jaci.2005.09.047; Braido F, 2007, CLIN EXP ALLERGY, V37, P788, DOI 10.1111/j.1365-2222.2007.02702.x; Braido F, 2010, ALLERGY, V65, P959, DOI 10.1111/j.1398-9995.2010.02383.x; Braido F, 2009, ALLERGY, V64, P937, DOI 10.1111/j.1398-9995.2008.01932.x; Ford ES, 2004, J ASTHMA, V41, P327, DOI 10.1081/JAS-120026090; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Laforest L, 2005, INT ARCH ALLERGY IMM, V136, P281, DOI 10.1159/000083955; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; Lubetkin EI, 2005, QUAL LIFE RES, V14, P2187, DOI 10.1007/s11136-005-8028-5; McNair D.M., 1992, POMS MANUAL PROFILE; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Byrne PM, 2008, CHEST, V134, P1192, DOI 10.1378/chest.08-1018; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rothman ML, 2007, VALUE HEALTH, V10, pS66, DOI 10.1111/j.1524-4733.2007.00269.x; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Shen J, 2011, EXPERT REV PHARM OUT, V11, P447, DOI [10.1586/erp.11.48, 10.1586/ERP.11.48]; Valovirta Erkka, 2006, BMC Pulm Med, V6 Suppl 1, pS3, DOI 10.1186/1471-2466-6-S1-S3	23	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31178	10.1371/journal.pone.0031178	http://dx.doi.org/10.1371/journal.pone.0031178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363573	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600121
J	Muscedere, ML; Traniello, JFA				Muscedere, Mario L.; Traniello, James F. A.			Division of Labor in the Hyperdiverse Ant Genus Pheidole Is Associated with Distinct Subcaste- and Age-Related Patterns of Worker Brain Organization	PLOS ONE			English	Article							MUSHROOM BODIES; VOLUME CHANGES; ANTENNAL LOBE; EVOLUTION; HYMENOPTERA; PLASTICITY; SIZE; EXPERIENCE; FORMICIDAE; NUMBER	The evolutionary success of ants and other social insects is considered to be intrinsically linked to division of labor among workers. The role of the brains of individual ants in generating division of labor, however, is poorly understood, as is the degree to which interspecific variation in worker social phenotypes is underscored by functional neurobiological differentiation. Here we demonstrate that dimorphic minor and major workers of different ages from three ecotypical species of the hyperdiverse ant genus Pheidole have distinct patterns of neuropil size variation. Brain subregions involved in sensory input (optic and antennal lobes), sensory integration, learning and memory (mushroom bodies), and motor functions (central body and subesophageal ganglion) vary significantly in relative size, reflecting differential investment in neuropils that likely regulate subcaste- and age-correlated task performance. Worker groups differ in brain size and display patterns of altered isometric and allometric subregion scaling that affect brain architecture independently of brain size variation. In particular, mushroom body size was positively correlated with task plasticity in the context of both age-and subcaste-related polyethism, providing strong, novel support that greater investment in this neuropil increases behavioral flexibility. Our findings reveal striking levels of developmental plasticity and evolutionary flexibility in Pheidole worker neuroanatomy, supporting the hypothesis that mosaic alterations of brain composition contribute to adaptive colony structure and interspecific variation in social organization.	[Muscedere, Mario L.] Boston Univ, Program Neurosci, Dept Biol, Boston, MA 02215 USA	Boston University	Muscedere, ML (corresponding author), Boston Univ, Program Neurosci, Dept Biol, Boston, MA 02215 USA.	mario@bu.edu	Muscedere, Mario/A-6064-2011	Muscedere, Mario/0000-0002-4898-3961	National Science Foundation [IOB 0725013, IOB 0724591]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the following National Science Foundation (www.nsf.gov) grants: Graduate Research Fellowship to ML Muscedere; IOB 0725013 to JFA Traniello; IOB 0724591 to Wulfila Gronenberg (U. of AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bucher D, 2000, J NEUROSCI METH, V100, P135, DOI 10.1016/S0165-0270(00)00245-4; Byrne RW, 2004, P ROY SOC B-BIOL SCI, V271, P1693, DOI 10.1098/rspb.2004.2780; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Catania KC, 2002, P NATL ACAD SCI USA, V99, P5692, DOI 10.1073/pnas.072097999; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Darwin G., 1871, P423; Delgado J, 1997, PHYS REV E, V55, P2338, DOI 10.1103/PhysRevE.55.2338; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Ehmer B, 2004, J COMP NEUROL, V469, P198, DOI 10.1002/cne.11014; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Fahrbach SE, 2003, J NEUROBIOL, V57, P141, DOI 10.1002/neu.10256; Farris SM, 2011, ARTHROPOD STRUCT DEV, V40, P368, DOI 10.1016/j.asd.2011.02.004; Farris SM, 2011, P ROY SOC B-BIOL SCI, V278, P940, DOI 10.1098/rspb.2010.2161; Farris SM, 2005, P NATL ACAD SCI USA, V102, P17394, DOI 10.1073/pnas.0508430102; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Gronenberg Wulfila, 2009, P377; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Holldobler B., 1990, pi; Ishikawa Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002617; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2001, BRAIN BEHAV EVOLUT, V57, P87, DOI 10.1159/000047228; Kelber C, 2010, DEV NEUROBIOL, V70, P222, DOI 10.1002/dneu.20782; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Kuhn-Buhlmann S, 2006, J NEUROBIOL, V66, P511, DOI 10.1002/neu.20235; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Maleszka J, 2009, J COMP PHYSIOL A, V195, P733, DOI 10.1007/s00359-009-0449-0; Mertl AL, 2010, INSECT SOC, V57, P441, DOI 10.1007/s00040-010-0102-5; Mertl AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P1411, DOI 10.1007/s00265-009-0797-3; Molina Y, 2009, P ROY SOC B-BIOL SCI, V276, P3345, DOI 10.1098/rspb.2009.0817; Molina Y, 2008, DEV NEUROBIOL, V68, P950, DOI 10.1002/dneu.20633; Muscedere ML, 2011, NATURWISSENSCHAFTEN, V98, P783, DOI 10.1007/s00114-011-0828-6; Muscedere ML, 2009, ANIM BEHAV, V77, P911, DOI 10.1016/j.anbehav.2008.12.018; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; O'Donnell S, 2004, NEUROSCI LETT, V356, P159, DOI 10.1016/j.neulet.2003.11.053; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; PATEL A D, 1990, Psyche (Cambridge), V97, P181, DOI 10.1155/1990/56747; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; Robinson EJH, 2009, INSECT SOC, V56, P1, DOI 10.1007/s00040-008-1035-0; Roth TC, 2009, P R SOC B, V276, P401, DOI 10.1098/rspb.2008.1184; Seid MA, 2005, J COMP NEUROL, V488, P269, DOI 10.1002/cne.20545; Seid MA, 2005, NATURWISSENSCHAFTEN, V92, P198, DOI 10.1007/s00114-005-0610-8; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Sherry DF, 2006, ANNU REV PSYCHOL, V57, P167, DOI 10.1146/annurev.psych.56.091103.070324; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Smith AR, 2010, P ROY SOC B-BIOL SCI, V277, P2157, DOI 10.1098/rspb.2010.0269; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Sole RV, 2000, ARTIF LIFE, V6, P219, DOI 10.1162/106454600568843; Stieb SM, 2010, DEV NEUROBIOL, V70, P408, DOI 10.1002/dneu.20785; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1976, BEHAV ECOL SOCIOBIOL, V1, P63, DOI 10.1007/BF00299953; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	67	71	71	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31618	10.1371/journal.pone.0031618	http://dx.doi.org/10.1371/journal.pone.0031618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363686	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600149
J	Kim, JH; Yu, S; Chen, JD; Kong, AN				Kim, J-H; Yu, S.; Chen, J. D.; Kong, A. N.			The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains	ONCOGENE			English	Article						Nrf2; RAC3/SRC-3; HO-1	STEROID-RECEPTOR COACTIVATOR-1; ELECTROPHILE RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; CREB-BINDING-PROTEIN; INDUCIBLE EXPRESSION; OXIDATIVE STRESS; THYROID-HORMONE; GENE; AIB1; ANTIOXIDANT	Nuclear factor erythroid 2-related factor 2 (Nrf2, NM 006164, 605 AA) is essential for the antioxidant responsive element (ARE)-mediated expression of a group of detoxifying antioxidant genes that detoxify carcinogens and protect against oxidative stress. Several proteins have been identified as Nrf2-interacting molecules. In this study, we found that the overexpression of receptor-associated coactivator 3 (RAC3)/AIB-1/steroid receptor coactivator-3, a nuclear coregulator and oncogene frequently amplified in human breast cancers, induced heme oxygenase-1 (HO-1) through Nrf2 transactivation in HeLa cells. Next, we determined the interaction between RAC3 and Nrf2 proteins using a co-immunoprecipitation assay and fluorescence resonance energy transfer analysis. The results showed that RAC3 bound directly to the Nrf2 protein in the nucleus. Subsequently, we identified the interacting domains of Nrf2 and RAC3 using a gintathione S-transferase pull-down assay. The results showed that both the N-terminal RAC3-pasB and C-terminal RAC3-R3B3 domains were tightly bound to the Neh4 and Neh5 transactivation domains. Furthermore, chromatin immunoprecipitation showed that RAC3 bound tightly to the ARE enhancer region of the HO-1 promoter via Nrf2 binding. These data suggest that Nrf2 activation is modulated and directly controlled through interactions with the RAC3 protein in HeLa cells. Oncogene (2013) 32, 514-527; doi:10.1038/onc.2012.59; published online 27 February 2012	[Kim, J-H; Kong, A. N.] Rutgers State Univ, Grad Program Pharmaceut Sci, Piscataway, NJ 08854 USA; [Kim, J-H; Yu, S.; Kong, A. N.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA; [Chen, J. D.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kong, AN (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, 160 Frelinghuysen Rd,Room 228, Piscataway, NJ 08854 USA.	KongT@pharmacy.rutgers.edu	yu, Siwang/AAL-8059-2020; Kong, Ah-Ng Tony/AAX-2828-2020	Yu, Siwang/0000-0002-3336-202X; Kim, Jung Hwan/0000-0002-2975-4899	NIH [R01 NIH R01-CA-94828]; NATIONAL CANCER INSTITUTE [R01CA094828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Jianjie Ma (Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA) for help with confocal microscopy. This study was supported by NIH Grant R01 NIH R01-CA-94828.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arimura A, 2004, J BIOL CHEM, V279, P31105, DOI 10.1074/jbc.M404428200; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Gnanapragasam VJ, 2001, BRIT J CANCER, V85, P1928, DOI 10.1054/bjoc.2001.2179; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kong ANT, 2001, DRUG METAB REV, V33, P255, DOI 10.1081/DMR-120000652; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; LI Y, 1993, J BIOL CHEM, V268, P21454; Lin W, 2006, J BIOCHEM MOL BIOL, V39, P304; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McMahon M, 2001, CANCER RES, V61, P3299; MORSE MA, 1993, CARCINOGENESIS, V14, P1737, DOI 10.1093/carcin/14.9.1737; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sakakura C, 2000, INT J CANCER, V89, P217; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Xie D, 2005, HUM PATHOL, V36, P777, DOI 10.1016/j.humpath.2005.05.007; Xu FP, 2007, CANCER LETT, V245, P69, DOI 10.1016/j.canlet.2005.12.030; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Ying H, 2005, MOL CELL BIOL, V25, P7687, DOI 10.1128/MCB.25.17.7687-7695.2005; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003; Zhu M, 2001, BIOCHEM BIOPH RES CO, V289, P212, DOI 10.1006/bbrc.2001.5944	55	67	70	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					514	527		10.1038/onc.2012.59	http://dx.doi.org/10.1038/onc.2012.59			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22370642	Green Accepted			2022-12-25	WOS:000315551300012
J	van der Weyden, L; Rust, AG; McIntyre, RE; Robles-Espinoza, CD; Velasco-Herrera, MD; Strogantsev, R; Ferguson-Smith, AC; McCarthy, S; Keane, TM; Arends, MJ; Adams, DJ				van der Weyden, L.; Rust, A. G.; McIntyre, R. E.; Robles-Espinoza, C. D.; Velasco-Herrera, M. del Castillo; Strogantsev, R.; Ferguson-Smith, A. C.; McCarthy, S.; Keane, T. M.; Arends, M. J.; Adams, D. J.			Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity	ONCOGENE			English	Article						p53; Jdp2; transposon; heterozygosity; lymphoma; mice	RETROVIRAL INSERTIONAL MUTAGENESIS; JUN DIMERIZATION PROTEIN-2; AP-1 REPRESSOR PROTEIN; WILD-TYPE P53; BREAST-CANCER; CELL; MUTATIONS; GENES; SUPPRESSION; PROGRESSION	We performed a genetic screen in mice to identify candidate genes that are associated with leukaemogenesis in the context of Trp53 heterozygosity. To do this we generated Trp53 heterozygous mice carrying the T2/Onc transposon and SB11 transposase alleles to allow transposon-mediated insertional mutagenesis to occur. From the resulting leukaemias/lymphomas that developed in these mice, we identified nine loci that are potentially associated with tumour formation in the context of Trp53 heterozygosity, including AB041803 and the Jun dimerization protein 2 (Jdp2). We show that Jdp2 transcriptionally regulates the Trp53 promoter, via an atypical AP-1 site, and that Jdp2 expression negatively regulates Trp53 expression levels. This study is the first to identify a genetic mechanism for tumour formation in the context of Trp53 heterozygosity. Oncogene (2013) 32, 397-402; doi:10.1038/onc.2012.56; published online 27 February 2012	[van der Weyden, L.; Rust, A. G.; McIntyre, R. E.; Robles-Espinoza, C. D.; Velasco-Herrera, M. del Castillo; McCarthy, S.; Keane, T. M.; Adams, D. J.] Wellcome Trust Sanger Inst, Cambridge, England; [Strogantsev, R.; Ferguson-Smith, A. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Arends, M. J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1HH, Cambs, England.	da1@sanger.ac.uk	van der Weyden, Louise/AAV-5711-2021; Robles-Espinoza, Carla Daniela/L-2560-2019	van der Weyden, Louise/0000-0002-0645-1879; Robles-Espinoza, Carla Daniela/0000-0003-3277-7466; Adams, David/0000-0001-9490-0306; Del Castillo Velasco Herrera, Martin/0000-0001-5956-0211; Rust, Alistair/0000-0001-7287-192X; Ferguson-Smith, Anne/0000-0002-7608-5894; McCarthy, Shane/0000-0002-2715-4187	Cancer Research UK; Wellcome Trust; Kay Kendall Leukaemia Fund; Consejo Nacional de Ciencia y Tecnologia (CONACYT); MRC [G0800024] Funding Source: UKRI; Cancer Research UK [14356, 13031] Funding Source: researchfish; Medical Research Council [G0800024] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukaemia Fund; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DJA was supported by Cancer Research UK and the Wellcome Trust. LvdW was supported by the Kay Kendall Leukaemia Fund. CDRE was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) and the Wellcome Trust. MJA and REM were supported by Cancer Research UK.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bitton-Worms K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-54; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Donehower LA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001081; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Dube N, 2008, CELL SIGNAL, V20, P1608, DOI 10.1016/j.cellsig.2008.05.006; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Giguere A, 2011, GENE CHROMOSOME CANC, V50, P228, DOI 10.1002/gcc.20848; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Iwasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P413, DOI 10.1016/j.bbrc.2010.08.092; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pan J, 2010, ONCOGENE, V29, P6245, DOI 10.1038/onc.2010.355; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Rasmussen MH, 2009, NUCLEIC ACIDS RES, V37, P4657, DOI 10.1093/nar/gkp469; Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016; Sedlacek Z, 1998, BRIT J CANCER, V77, P1034, DOI 10.1038/bjc.1998.172; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; Wang SW, 2011, CURR PHARM DESIGN, V17, P2278, DOI 10.2174/138161211797052394; Xu YH, 2010, INT J BIOL MARKER, V25, P136, DOI 10.1177/172460081002500303; Zheng BH, 2002, CANCER BIOL THER, V1, P433, DOI 10.4161/cbt.1.4.24	42	18	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					397	402		10.1038/onc.2012.56	http://dx.doi.org/10.1038/onc.2012.56			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370638	Green Published, hybrid			2022-12-25	WOS:000314736600013
J	Stankiewicz, TR; Loucks, FA; Schroeder, EK; Nevalainen, MT; Tyler, KL; Aktories, K; Bouchard, RJ; Linseman, DA				Stankiewicz, Trisha R.; Loucks, F. Alexandra; Schroeder, Emily K.; Nevalainen, Marja T.; Tyler, Kenneth L.; Aktories, Klaus; Bouchard, Ron J.; Linseman, Daniel A.			Signal Transducer and Activator of Transcription-5 Mediates Neuronal Apoptosis Induced by Inhibition of Rac GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JANUS KINASE/SIGNAL TRANSDUCER; CEREBELLAR GRANULE NEURONS; CELL-DEATH; RHO-FAMILY; CUCURBITACIN-I; CANCER-CELLS; IFN-GAMMA; BCL-X; PATHWAY; STAT5	In several neuronal cell types, the small GTPase Rac is essential for survival. We have shown previously that the Rho family GTPase inhibitor Clostridium difficile toxin B (ToxB) induces apoptosis in primary rat cerebellar granule neurons (CGNs) principally via inhibition of Rac GTPase function. In the present study, incubation with ToxB activated a proapoptotic Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, and a pan-JAK inhibitor protected CGNs from Rac inhibition. STAT1 expression was induced by ToxB; however, CGNs from STAT1 knock-out mice succumbed to ToxB-induced apoptosis as readily as wild-type CGNs. STAT3 displayed enhanced tyrosine phosphorylation following treatment with ToxB, and a reputed inhibitor of STAT3, cucurbitacin (JSI-124), reduced CGN apoptosis. Unexpectedly, JSI-124 failed to block STAT3 phosphorylation, and CGNs were not protected from ToxB by other known STAT3 inhibitors. In contrast, STAT5A tyrosine phosphorylation induced by ToxB was suppressed by JSI-124. In addition, roscovitine similarly inhibited STAT5A phosphorylation and protected CGNs from ToxB-induced apoptosis. Consistent with these results, adenoviral infection with a dominant negative STAT5 mutant, but not wild-type STAT5, significantly decreased ToxB-induced apoptosis of CGNs. Finally, chromatin immunoprecipitation with a STAT5 antibody revealed increased STAT5 binding to the promoter region of prosurvival Bcl-xL. STAT5 was recruited to the Bcl-xL promoter region in a ToxB-dependent manner, and this DNA binding preceded Bcl-xL down-regulation, suggesting transcriptional repression. These data indicate that a novel JAK/STAT5 proapoptotic pathway significantly contributes to neuronal apoptosis induced by the inhibition of Rac GTPase.	[Loucks, F. Alexandra; Schroeder, Emily K.; Bouchard, Ron J.; Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Stankiewicz, Trisha R.; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Stankiewicz, Trisha R.; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Nevalainen, Marja T.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Nevalainen, Marja T.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Tyler, Kenneth L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Dept Med, Div Clin Pharmacol & Toxicol, Aurora, CO 80045 USA; Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Denver; University of Denver; Jefferson University; Jefferson University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Freiburg	Linseman, DA (corresponding author), Vet Affairs Med Ctr, Res Serv, 1055 Clermont St, Denver, CO 80220 USA.	Dan.Linseman@va.gov	Aktories, Klaus/CAJ-5682-2022; Tyler, Kenneth L./J-2420-2019; Linseman, Daniel/L-3846-2019	Aktories, Klaus/0000-0002-5397-0436; Tyler, Kenneth L./0000-0003-3294-5888; 	National Institutes of Health from NINDS [R01 NS062766]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062766] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062766 from the NINDS (to D. A. L.). This work was also supported by a merit review award from the Department of Veterans Affairs (to D. A. L.).	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; AlShami A, 1997, BLOOD, V89, P1035, DOI 10.1182/blood.V89.3.1035; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Blaskovich MA, 2003, CANCER RES, V63, P1270; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Cavalcanti E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/935764; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Chipoy C, 2007, ONCOGENE, V26, P6653, DOI 10.1038/sj.onc.1210492; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Colodner KJ, 2010, J NEUROSCI, V30, P16102, DOI 10.1523/JNEUROSCI.2491-10.2010; Contestabile A., 2002, CEREBELLUM, V1, P41; Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; Edamatsu H, 2000, ONCOGENE, V19, P3059, DOI 10.1038/sj.onc.1203625; Faderl S, 2003, BLOOD, V102, P630, DOI 10.1182/blood-2002-06-1890; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057; Graness A, 2006, BIOCHEM PHARMACOL, V72, P32, DOI 10.1016/j.bcp.2006.04.001; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaganoi J, 2007, ANN SURG ONCOL, V14, P1405, DOI 10.1245/s10434-006-9274-7; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kim WH, 2003, AM J PHYSIOL-GASTR L, V285, pG761, DOI 10.1152/ajpgi.00224.2003; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Mohapatra S, 2003, CANCER RES, V63, P8523; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Rocha-Viegas L, 2006, J BIOL CHEM, V281, P33959, DOI 10.1074/jbc.M602408200; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Sahni M, 2001, DEVELOPMENT, V128, P2119; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Soond SM, 2007, FEBS LETT, V581, P1217, DOI 10.1016/j.febslet.2007.02.049; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Tanaka T, 2000, J NEUROSCI, V20, P2852; Terstegen L, 2000, J BIOL CHEM, V275, P18810, DOI 10.1074/jbc.M904148199; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Vaudry D, 2003, J NEUROSCI RES, V72, P303, DOI 10.1002/jnr.10530; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Xu J, 2009, J NEUROSCI, V29, P2022, DOI 10.1523/JNEUROSCI.2621-08.2009; Yamauchi-Takihara K, 2000, INT J EXP PATHOL, V81, P1; Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	67	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16835	16848		10.1074/jbc.M111.302166	http://dx.doi.org/10.1074/jbc.M111.302166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22378792	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000304030900070
J	Carbonaro, M; Escuin, D; O'Brate, A; Thadani-Mulero, M; Giannakakou, P				Carbonaro, Marisa; Escuin, Daniel; O'Brate, Aurora; Thadani-Mulero, Maria; Giannakakou, Paraskevi			Microtubules Regulate Hypoxia-inducible Factor-1 alpha Protein Trafficking and Activity IMPLICATIONS FOR TAXANE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; TUBULIN-BINDING AGENTS; NUCLEAR ACCUMULATION; CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; PROSTATE-CANCER; GENE-EXPRESSION; TRANSPORT; BETA; RESISTANCE	Disruption of the microtubule cytoskeleton impairs tumor angiogenesis by inhibiting the hypoxia-inducible factor (HIF1 alpha) pathway. However, the signaling cascade linking microtubule disruption to HIF-1 alpha inactivation has not been elucidated. Here, we show that microtubule-targeting drug (MTD) treatment impaired HIF-1 alpha protein nuclear translocation, which significantly down-regulated HIF transcriptional activity. We provide strong evidence that HIF-1 alpha protein associates with polymerized microtubules and traffics to the nucleus, with the aid of the dynein motor protein. Together, these data suggest that microtubules are critically involved in the nuclear trafficking and transcriptional activity of HIF-1 alpha. We also show that the connection between the microtubule cytoskeleton and HIF-1 alpha regulation is lost in renal cell carcinoma (RCC), where HIF-1 alpha is overexpressed because of mutations in the von Hippel Lindau (VHL) tumor suppressor protein. Specifically, we show that MTD treatment of RCC cells did not impair HIF-1 alpha nuclear accumulation or transcriptional activity, and had no effect on the polysome association profile of HIF-1 alpha. Interestingly, we found that HIF-1 alpha protein did not bind microtubules in RCC. Moreover, restoration of VHL function failed to restore the ability of MTDs to inhibit HIF-1 alpha, suggesting that VHL does not contribute to this phenotype. Together, these results suggest that HIF-1 alpha regulation is microtubule-independent, and likely contributes to the chemoresistant nature of RCCs. Further understanding of the microtubule-dependent HIF-1 alpha regulation, and lack thereof in RCC, is essential given the impor-tance of HIF-1 alpha in tumor biology, and the widespread use of MTDs in clinical oncology.	[Carbonaro, Marisa; Escuin, Daniel; O'Brate, Aurora; Thadani-Mulero, Maria; Giannakakou, Paraskevi] Cornell Univ, Weill Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA	Cornell University	Giannakakou, P (corresponding author), Cornell Univ, Weill Med Coll, Div Hematol & Med Oncol, Dept Med, 1300 York Ave,C610C, New York, NY 10065 USA.	pag2015@med.cornell.edu		Escuin, Daniel/0000-0003-3538-0579	National Institutes of Health [R01 CA114335, R01 CA100202, R01 CA137020]; NCI [U54 CA143876, R01 CA86335]; Entremed, Inc. [659342]; Weill Cornell Medical College (WCMC) Clinical and Translational Science Center [TL1RR024998]; NATIONAL CANCER INSTITUTE [U54CA143876, R01CA114335, R01CA086335, R01CA137020, R01CA100202] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Entremed, Inc.; Weill Cornell Medical College (WCMC) Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA114335, R01 CA100202, R01 CA137020, NCI U54 CA143876, NCI Supplement to R01 CA86335; Entremed, Inc. Grant 659342 (to P. G.), and Grant TL1RR024998 of the Weill Cornell Medical College (WCMC) Clinical and Translational Science Center (to M. C.).	AMBRON RT, 1992, J NEUROSCI, V12, P2813; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Escuin D, 2004, CANCER BIOL THER, V3, P608, DOI 10.4161/cbt.3.7.954; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Ferguson RE, 2005, CLIN CANCER RES, V11, P3439, DOI 10.1158/1078-0432.CCR-04-2049; Ferguson RE, 2005, INT J CANCER, V115, P155, DOI 10.1002/ijc.20816; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith HMS, 1999, PLANT PHYSIOL, V119, P1157, DOI 10.1104/pp.119.4.1157; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zhuang SH, 2005, CANCER-AM CANCER SOC, V103, P1932, DOI 10.1002/cncr.20977	44	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11859	11869		10.1074/jbc.M112.345587	http://dx.doi.org/10.1074/jbc.M112.345587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22367210	Green Published, hybrid			2022-12-25	WOS:000302782200025
J	Caino, MC; Lopez-Haber, C; Kissil, JL; Kazanietz, MG				Caino, M. Cecilia; Lopez-Haber, Cynthia; Kissil, Joseph L.; Kazanietz, Marcelo G.			Non-Small Cell Lung Carcinoma Cell Motility, Rac Activation and Metastatic Dissemination Are Mediated by Protein Kinase C Epsilon	PLOS ONE			English	Article							RHO-GTPASES; PROTEOLYTIC-ENZYMES; CANCER CELLS; GROWTH; PHOSPHORYLATION; INHIBITION; MIGRATION; INVASION; DELTA; GEF	Background: Protein kinase C (PKC) epsilon, a key signaling transducer implicated in mitogenesis, survival, and cancer progression, is overexpressed in human primary non-small cell lung cancer (NSCLC). The role of PKC epsilon in lung cancer metastasis has not yet been established. Principal Findings: Here we show that RNAi-mediated knockdown of PKC epsilon in H358, H1299, H322, and A549 NSCLC impairs activation of the small GTPase Rac1 in response to phorbol 12-myristate 13-acetate (PMA), serum, or epidermal growth factor (EGF). PKC epsilon depletion markedly impaired the ability of NSCLC cells to form membrane ruffles and migrate. Similar results were observed by pharmacological inhibition of PKC epsilon with epsilon V1-2, a specific PKC epsilon inhibitor. PKC epsilon was also required for invasiveness of NSCLC cells and modulated the secretion of extracellular matrix proteases and protease inhibitors. Finally, we found that PKC epsilon-depleted NSCLC cells fail to disseminate to lungs in a mouse model of metastasis. Conclusions: Our results implicate PKC epsilon as a key mediator of Rac signaling and motility of lung cancer cells, highlighting its potential as a therapeutic target.	[Caino, M. Cecilia; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kissil, Joseph L.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Caino, MC (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Lopez Haber, Cynthia/0000-0001-9106-543X; Caino, M. Cecilia/0000-0001-8294-8070	National Institutes of Health [R01CA74197]; NATIONAL CANCER INSTITUTE [R01CA124495, R01CA074197, R01CA139120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in this paper has been supported by grant R01CA74197 from National Institutes of Health (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Binker MG, 2010, BIOCHEM BIOPH RES CO, V393, P371, DOI 10.1016/j.bbrc.2010.01.125; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Brantley-Sieders DM, 2009, MOL CANCER RES, V7, P615, DOI 10.1158/1541-7786.MCR-08-0401; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; Dallol A, 2005, CANCER RES, V65, P7653, DOI 10.1158/0008-5472.CAN-05-0247; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Felber M, 2007, PATHOL ONCOL RES, V13, P295, DOI 10.1007/BF02940308; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Goekjian PG, 2001, EXPERT OPIN INV DRUG, V10, P2117; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Griner EM, 2010, J BIOL CHEM, V285, P16931, DOI 10.1074/jbc.M109.099036; Grossoni VC, 2007, CLIN EXP METASTAS, V24, P513, DOI 10.1007/s10585-007-9088-4; Grossoni VC, 2009, BREAST CANCER RES TR, V118, P469, DOI 10.1007/s10549-008-0299-4; Gujdar A, 2003, CELL SIGNAL, V15, P307, DOI 10.1016/S0898-6568(02)00087-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huber RM, 2004, LUNG CANCER, V45, pS209, DOI 10.1016/j.lungcan.2004.07.973; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Ishida M, 2010, TOXICOLOGY, V275, P72, DOI 10.1016/j.tox.2010.06.005; Jansen AP, 2001, CANCER RES, V61, P808; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Koyanagi T, 2007, J MOL CELL CARDIOL, V43, P517, DOI 10.1016/j.yjmcc.2007.06.003; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perletti GP, 1996, ONCOGENE, V12, P847; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santibanez JF, 2010, FEBS LETT, V584, P2305, DOI 10.1016/j.febslet.2010.03.042; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Tachado SD, 2002, J CELL BIOCHEM, V85, P785, DOI 10.1002/jcb.10164; Takefuji M, 2007, BIOCHEM BIOPH RES CO, V355, P788, DOI 10.1016/j.bbrc.2007.02.028; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	66	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31714	10.1371/journal.pone.0031714	http://dx.doi.org/10.1371/journal.pone.0031714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384062	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500036
J	Heibel, SK; Lopez, GY; Panglao, M; Sodha, S; Marino-Ramirez, L; Tuchman, M; Caldovic, L				Heibel, Sandra Kirsch; Lopez, Giselle Yvette; Panglao, Maria; Sodha, Sonal; Marino-Ramirez, Leonardo; Tuchman, Mendel; Caldovic, Ljubica			Transcriptional Regulation of N-Acetylglutamate Synthase	PLOS ONE			English	Article							PHOSPHATE SYNTHETASE-I; UREA CYCLE ENZYMES; HEPATOCYTE NUCLEAR FACTOR-1; BOX-BINDING PROTEINS; GENE-EXPRESSION; RAT-LIVER; ARGININOSUCCINATE SYNTHETASE; ORNITHINE TRANSCARBAMYLASE; ASPARTATE-AMINOTRANSFERASE; BASAL TRANSCRIPTION	The urea cycle converts toxic ammonia to urea within the liver of mammals. At least 6 enzymes are required for ureagenesis, which correlates with dietary protein intake. The transcription of urea cycle genes is, at least in part, regulated by glucocorticoid and glucagon hormone signaling pathways. N-acetylglutamate synthase (NAGS) produces a unique cofactor, N-acetylglutamate (NAG), that is essential for the catalytic function of the first and rate-limiting enzyme of ureagenesis, carbamyl phosphate synthetase 1 (CPS1). However, despite the important role of NAGS in ammonia removal, little is known about the mechanisms of its regulation. We identified two regions of high conservation upstream of the translation start of the NAGS gene. Reporter assays confirmed that these regions represent promoter and enhancer and that the enhancer is tissue specific. Within the promoter, we identified multiple transcription start sites that differed between liver and small intestine. Several transcription factor binding motifs were conserved within the promoter and enhancer regions while a TATA-box motif was absent. DNA-protein pull-down assays and chromatin immunoprecipitation confirmed binding of Sp1 and CREB, but not C/EBP in the promoter and HNF-1 and NF-Y, but not SMAD3 or AP-2 in the enhancer. The functional importance of these motifs was demonstrated by decreased transcription of reporter constructs following mutagenesis of each motif. The presented data strongly suggest that Sp1, CREB, HNF-1, and NF-Y, that are known to be responsive to hormones and diet, regulate NAGS transcription. This provides molecular mechanism of regulation of ureagenesis in response to hormonal and dietary changes.	[Heibel, Sandra Kirsch; Tuchman, Mendel; Caldovic, Ljubica] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Heibel, Sandra Kirsch] Univ Maryland, Mol & Cellular Biol Program, College Pk, MD 20742 USA; [Lopez, Giselle Yvette] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Panglao, Maria] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Sodha, Sonal] Johns Hopkins Sch Med Baltimore, Baltimore, MD USA; [Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	Children's National Health System; University System of Maryland; University of Maryland College Park; Duke University; George Washington University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Heibel, SK (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	ljubica@cnmcresearch.org	Lopez, Giselle/M-2575-2019; Lopez, Giselle/GSM-7271-2022; Mariño-Ramírez, Leonardo/N-5395-2019; Mariño-Ramírez, Leonardo/I-5759-2013	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Caldovic, Ljubica/0000-0002-9140-5585; /0000-0001-5435-6668	Public Health Service from National Institutes of Health [R01DK064913]; NIH; NLM; NCBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Public Health Service from National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Public Health Service Grant R01DK064913 from the National Institutes of Health. This research was also supported in part by the Intramural Research Program of the NIH, NLM, NCBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Musa DMA, 1999, MOL GENET METAB, V68, P346, DOI 10.1006/mgme.1999.2905; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOYCE FM, 1989, SOMAT CELL MOLEC GEN, V15, P113, DOI 10.1007/BF01535071; BOYCE FM, 1986, MOL CELL BIOL, V6, P1244, DOI 10.1128/MCB.6.4.1244; BOYCE FM, 1989, SOMAT CELL MOLEC GEN, V15, P123, DOI 10.1007/BF01535072; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2002, BIOCHEM J, V364, P825, DOI 10.1042/BJ20020161; Callens N, 2003, BIOCHEM BIOPH RES CO, V312, P702, DOI 10.1016/j.bbrc.2003.10.176; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christoffels VM, 1996, J BIOL CHEM, V271, P31243, DOI 10.1074/jbc.271.49.31243; CHRISTOFFELS VM, 1995, J BIOL CHEM, V270, P24932, DOI 10.1074/jbc.270.42.24932; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; Convertini P, BIOCH BIOPHYS RES CO, V404, P376; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DUBOIS N, 1988, BIOCHIM BIOPHYS ACTA, V950, P321, DOI 10.1016/0167-4781(88)90128-5; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Emami KH, 1998, NUCLEIC ACIDS RES, V26, P839, DOI 10.1093/nar/26.3.839; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Geng M, AMINO ACIDS, V40, P1513; GOPING IS, 1994, J BIOL CHEM, V269, P3891; Guei TR, 2008, BIOCHEM BIOPH RES CO, V377, P257, DOI 10.1016/j.bbrc.2008.09.118; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hazra A, 2008, GENE REGUL SYST BIO, V2, P1; Heibel SK, 2011, HUM MUTAT, V32, P1153, DOI 10.1002/humu.21553; Heibel SK, HUM MUTAT, V32, P1153; HOWELL BW, 1989, MOL CELL BIOL, V9, P2928, DOI 10.1128/MCB.9.7.2928; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; JACKSON MJ, 1988, J BIOL CHEM, V263, P16388; JUANG HH, 1995, J BIOL CHEM, V270, P12629, DOI 10.1074/jbc.270.21.12629; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KAWAMOTO S, 1982, EUR J BIOCHEM, V123, P637; Kim HJ, BIOCH BIOPHYS ACTA, V1809, P184; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kimura T, 2001, FEBS LETT, V494, P105, DOI 10.1016/S0014-5793(01)02320-1; Klein H, 2007, GENOME INFORM SER, V18, P109; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAGACE M, 1992, GENE, V118, P231, DOI 10.1016/0378-1119(92)90193-S; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lomenick JP, 2009, J CLIN ENDOCR METAB, V94, P4463, DOI 10.1210/jc.2009-0949; LUKINIUS AIC, 1986, J HISTOCHEM CYTOCHEM, V34, P719, DOI 10.1177/34.6.3517149; Luksan O, 2010, HUM MUTAT, V31, pE1294, DOI 10.1002/humu.21215; LUNDBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4471, DOI 10.1073/pnas.79.14.4471; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; MATSUBASA T, 1994, J BIOCHEM, V116, P1044, DOI 10.1093/oxfordjournals.jbchem.a124626; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michels AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1220, DOI 10.1152/ajpcell.00348.2009; Mitchell S, 2008, MOL GENET METAB, V93, P258; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; MURAKAMI T, 1989, DEV GENET, V10, P393, DOI 10.1002/dvg.1020100507; MURAKAMI T, 1990, MOL CELL BIOL, V10, P1180, DOI 10.1128/MCB.10.3.1180; MyrsenAxcrona U, 1997, REGUL PEPTIDES, V68, P165, DOI 10.1016/S0167-0115(96)02113-1; NEBES VL, 1988, MOL ENDOCRINOL, V2, P444, DOI 10.1210/mend-2-5-444; Neill MA, 2009, MOL GENET METAB, V97, P121, DOI 10.1016/j.ymgme.2009.02.009; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; Pallai R, GENE, V459, P11; PAVEPREUX M, 1990, J BIOL CHEM, V265, P4444; Pollard KS, GENOME RES, V20, P110; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Renga B, BIOCH BIOPHYS ACTA, V1812, P1522; RYALL JC, 1986, EUR J BIOCHEM, V156, P453, DOI 10.1111/j.1432-1033.1986.tb09603.x; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SCHIMKE RT, 1963, J BIOL CHEM, V238, P1012; SCHIMKE RT, 1962, J BIOL CHEM, V237, P1921; Schoneveld OJLM, 2005, BIOCHIMIE, V87, P1033, DOI 10.1016/j.biochi.2005.02.015; Schoneveld OJLM, 2007, BIOCHIMIE, V89, P574, DOI 10.1016/j.biochi.2006.12.013; SHIGESADA K, 1978, EUR J BIOCHEM, V84, P285, DOI 10.1111/j.1432-1033.1978.tb12167.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SLADEK FM, 1993, RECEPTOR, V3, P223; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SNODGRASS PJ, 1991, ENZYME, V45, P30, DOI 10.1159/000468862; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Takiguchi M, 1995, BIOCHEM J, V312, P649, DOI 10.1042/bj3120649; TAKIGUCHI M, 1991, J BIOL CHEM, V266, P9186; TATIBANA M, 1982, ADV EXP MED BIOL, V153, P207; Tue NT, GENE, V473, P1; UCHIYAMA C, 1981, J BIOCHEM-TOKYO, V89, P1777, DOI 10.1093/oxfordjournals.jbchem.a133377; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; Wang Z., FEBS J, V277, P4066; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Zhang W, BIOCH BIOPHYS ACTA, V1809, P236	94	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29527	10.1371/journal.pone.0029527	http://dx.doi.org/10.1371/journal.pone.0029527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383952	Green Published, gold			2022-12-25	WOS:000302918500005
J	Puthucheary, SD; Puah, SM; Chua, KH				Puthucheary, S. D.; Puah, Suat Moi; Chua, Kek Heng			Molecular Characterization of Clinical Isolates of Aeromonas Species from Malaysia	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; VIRULENCE; IDENTIFICATION; EVOLUTIONARY; ENTEROTOXIN; AQUARIORUM; SPP.	Aeromonas species are common inhabitants of aquatic environments giving rise to infections in both fish and humans. Identification of aeromonads to the species level is problematic and complex due to their phenotypic and genotypic heterogeneity. Methodology/Principal Findings: Aeromonas hydrophila or Aeromonas sp were genetically re-identified using a combination of previously published methods targeting GCAT, 16S rDNA and rpoD genes. Characterization based on the genus specific GCAT-PCR showed that 94 (96%) of the 98 strains belonged to the genus Aeromonas. Considering the patterns obtained for the 94 isolates with the 16S rDNA-RFLP identification method, 3 clusters were recognised, i.e.A. caviae (61%), A. hydrophila (17%) and an unknown group (22%) with atypical RFLP restriction patterns. However, the phylogenetic tree constructed with the obtained rpoD sequences showed that 47 strains (50%) clustered with the sequence of the type strain of A. aquariorum, 18 (19%) with A. caviae, 16 (17%) with A. hydrophila, 12 (13%) with A. veronii and one strain (1%) with the type strain of A. trota. PCR investigation revealed the presence of 10 virulence genes in the 94 isolates as: lip (91%), exu (87%), ela (86%), alt (79%), ser (77%), fla (74%), aer (72%), act (43%), aexT (24%) and ast (23%). Conclusions/Significance: This study emphasizes the importance of using more than one method for the correct identification of Aeromonas strains. The sequences of the rpoD gene enabled the unambiguous identication of the 94 Aeromonas isolates in accordance with results of other recent studies. Aeromonas aquariorum showed to be the most prevalent species (50%) containing an important subset of virulence genes lip/alt/ser/fla/aer. Different combinations of the virulence genes present in the isolates indicate their probable role in the pathogenesis of Aeromonas infections.	[Puthucheary, S. D.] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Puah, Suat Moi; Chua, Kek Heng] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Puthucheary, SD (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	khchua@um.edu.my	CHUA, KEK HENG/B-5261-2010; Puah, Suat Moi/J-6296-2016	CHUA, KEK HENG/0000-0002-0452-9994; Puah, Suat Moi/0000-0003-1346-3787	University of Malaya	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya High Impact Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 1998, J CLIN MICROBIOL, V36, P1103, DOI 10.1128/JCM.36.4.1103-1104.1998; Aguilera-Arreola MG, 2007, CAN J MICROBIOL, V53, P877, DOI 10.1139/W07-051; Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P149, DOI 10.1016/j.syapm.2010.02.002; Bin Kingombe CI, 2010, APPL ENVIRON MICROB, V76, P425, DOI 10.1128/AEM.01357-09; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Borrell N, 1997, J CLIN MICROBIOL, V35, P1671, DOI 10.1128/JCM.35.7.1671-1674.1997; Castilho MCB, 2009, ANTON LEEUW INT J G, V96, P53, DOI 10.1007/s10482-009-9335-6; Chacon MR, 2003, ANTON LEEUW INT J G, V84, P269, DOI 10.1023/A:1026042125243; Chacon MR, 2002, DIAGN MICR INFEC DIS, V44, P221, DOI 10.1016/S0732-8893(02)00455-8; Chopra AK, 1996, MICROB PATHOGENESIS, V21, P357, DOI 10.1006/mpat.1996.0068; Figueras MJ, 2000, INT J SYST EVOL MICR, V50, P2069, DOI 10.1099/00207713-50-6-2069; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; Figueras MJ, 2011, ENV MICROBIOL REP, V3, P239, DOI 10.1111/j.1758-2229.2010.00216.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Lamy B, 2010, DIAGN MICR INFEC DIS, V67, P9, DOI 10.1016/j.diagmicrobio.2009.12.012; Lee W. S., 2001, SMJ Singapore Medical Journal, V42, P057; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Nam IY, 2007, J MICROBIOL, V45, P297; Nawaz M, 2010, FOOD MICROBIOL, V27, P327, DOI 10.1016/j.fm.2009.11.007; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Sha J, 2002, INFECT IMMUN, V70, P1924, DOI 10.1128/IAI.70.4.1924-1935.2002; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Soler L, 2003, J CLIN MICROBIOL, V41, P5732, DOI 10.1128/JCM.41.12.5732-5734.2003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VADIVELU J, 1992, SMJ Singapore Medical Journal, V33, P375; VADIVELU J, 1991, J MED MICROBIOL, V34, P363, DOI 10.1099/00222615-34-6-363; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Wu CJ, 2007, J INFECTION, V54, P151, DOI 10.1016/j.jinf.2006.04.002; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	38	68	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30205	10.1371/journal.pone.0030205	http://dx.doi.org/10.1371/journal.pone.0030205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383958	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500008
J	Richardson, E; Stockwell, SR; Li, H; Aherne, W; Cuomo, ME; Mittnacht, S				Richardson, Elizabeth; Stockwell, Simon R.; Li, He; Aherne, Wynne; Cuomo, Maria Emanuela; Mittnacht, Sibylle			Mechanism-Based Screen Establishes Signalling Framework for DNA Damage-Associated G1 Checkpoint Response	PLOS ONE			English	Article							P53-DEPENDENT G(1) ARREST; SYNTHETIC LETHAL INTERACTIONS; CELL-CYCLE CHECKPOINTS; RETINOBLASTOMA PROTEIN; RADIATION RESPONSE; CANCER-CELLS; IONIZING-RADIATION; KINASE; P53; CHK1	DNA damage activates checkpoint controls which block progression of cells through the division cycle. Several different checkpoints exist that control transit at different positions in the cell cycle. A role for checkpoint activation in providing resistance of cells to genotoxic anticancer therapy, including chemotherapy and ionizing radiation, is widely recognized. Although the core molecular functions that execute different damage activated checkpoints are known, the signals that control checkpoint activation are far from understood. We used a kinome-spanning RNA interference screen to delineate signalling required for radiation-mediated retinoblastoma protein activation, the recognized executor of G(1) checkpoint control. Our results corroborate the involvement of the p53 tumour suppressor (TP53) and its downstream targets p21(CIP1/WAF1) but infer lack of involvement of canonical double strand break (DSB) recognition known for its role in activating TP53 in damaged cells. Instead our results predict signalling involving the known TP53 phosphorylating kinase PRPK/TP53RK and the JNK/p38MAPK activating kinase STK4/MST1, both hitherto unrecognised for their contribution to DNA damage G(1) checkpoint signalling. Our results further predict a network topology whereby induction of p21(CIP1/WAF1) is required but not sufficient to elicit checkpoint activation. Our experiments document a role of the kinases identified in radiation protection proposing their pharmacological inhibition as a potential strategy to increase radiation sensitivity in proliferating cancer cells.	[Richardson, Elizabeth; Stockwell, Simon R.; Cuomo, Maria Emanuela; Mittnacht, Sibylle] UCL Canc Inst, Dept Canc Biol, London, England; [Richardson, Elizabeth; Stockwell, Simon R.; Li, He; Cuomo, Maria Emanuela; Mittnacht, Sibylle] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Aherne, Wynne] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Richardson, E (corresponding author), UCL Canc Inst, Dept Canc Biol, London, England.	sibylle.mittnacht@cancer.ucl.ac.uk		Stockwell, Simon/0000-0002-3345-8945	Cancer Research UK [CRC278X, CRM048]	Cancer Research UK(Cancer Research UK)	This work was supported through Cancer Research UK grant numbers CRC278X and CRM048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Agerbaek M, 2003, BRIT J CANCER, V89, P298, DOI 10.1038/sj.bjc.6601063; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Assoian RK, 2008, CELL CYCLE, V7, P24, DOI 10.4161/cc.7.1.5232; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chan TA, 2000, GENE DEV, V14, P1584; Chehab NH, 2000, GENE DEV, V14, P278; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chen ZH, 2003, MOL CANCER THER, V2, P543; Choo DW, 2009, BIOCHEM BIOPH RES CO, V378, P847, DOI 10.1016/j.bbrc.2008.11.132; Claudio P, 2002, GENOME BIOL, V3; Dahele M, 2010, J ROY COLL PHYS EDIN, V40, P136, DOI 10.4997/JRCPE.2010.209; DECKBAR D, CANC RES, V70, P4412; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DOU QP, 1995, P NATL ACAD SCI USA, V92, P9019, DOI 10.1073/pnas.92.20.9019; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elshaikh M, 2006, ANNU REV MED, V57, P19, DOI 10.1146/annurev.med.57.121304.131431; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; HAAPAJARVI T, 1995, ONCOGENE, V11, P151; HALL M, 1995, ONCOGENE, V11, P1581; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hitomi M, 2008, MOL CELL BIOL, V28, P5478, DOI 10.1128/MCB.02047-07; JAHNSON S, 1995, EUR UROL, V28, P135; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kalia VK, 2009, J CANCER RES THER, V5, P57, DOI 10.4103/0973-1482.55145; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kinsella TJ, 2009, SEMIN ONCOL, V36, pS42, DOI 10.1053/j.seminoncol.2009.02.004; Knudsen ES, 2006, CURR MOL MED, V6, P749; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Lindsay KJ, 2007, BRIT J RADIOL, V80, pS2, DOI 10.1259/bjr/60507340; Liu QH, 2000, GENE DEV, V14, P1448; LUDLOW JW, 1993, ONCOGENE, V8, P331; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Moonen L, 2001, INT J RADIAT ONCOL, V49, P1305, DOI 10.1016/S0360-3016(00)01503-0; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Petersen L, 2010, CELL PROLIFERAT, V43, P365, DOI 10.1111/j.1365-2184.2010.00685.x; Peterson D, 1953, CANCER RES, V70, P6325; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pollack A, 1997, CLIN CANCER RES, V3, P1823; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CELL CYCLE, V8, P3112, DOI 10.4161/cc.8.19.9626; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shieh SY, 2000, GENE DEV, V14, P289; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; SMITH ML, 1994, EXP CELL RES, V215, P386, DOI 10.1006/excr.1994.1356; Stewart ZA, 2001, CHEM RES TOXICOL, V14, P243, DOI 10.1021/tx000199t; Swanton C, 2007, CELL CYCLE, V6, P2001, DOI 10.4161/cc.6.16.4538; Tomida A, 1996, ONCOGENE, V13, P2699; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Warmerdam DO, 2010, MUTAT RES-REV MUTAT, V704, P2, DOI 10.1016/j.mrrev.2009.12.001; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	84	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31627	10.1371/journal.pone.0031627	http://dx.doi.org/10.1371/journal.pone.0031627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384045	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500032
J	Catucci, I; Colombo, M; Verderio, P; Bernard, L; Ficarazzi, F; Mariette, F; Barile, M; Peissel, B; Cattaneo, E; Manoukian, S; Radice, P; Peterlongo, P				Catucci, Irene; Colombo, Mara; Verderio, Paolo; Bernard, Loris; Ficarazzi, Filomena; Mariette, Frederique; Barile, Monica; Peissel, Bernard; Cattaneo, Elisa; Manoukian, Siranoush; Radice, Paolo; Peterlongo, Paolo			Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases	PLOS ONE			English	Article							GERMLINE MUTATIONS; MESSENGER-RNA; SUSCEPTIBILITY; PREDICTION; PROTEIN; BRCA2; SLX4	Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.	[Catucci, Irene; Ficarazzi, Filomena; Mariette, Frederique; Radice, Paolo; Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Catucci, Irene; Colombo, Mara; Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Verderio, Paolo] Fdn IRCCS Ist Nazl Tumori, Unit Med Stat & Biometry, Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Peissel, Bernard; Cattaneo, Elisa; Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Cattaneo, Elisa] Univ Milan, Dept Med Surg & Dent, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Catucci, I (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	paolo.radice@istitutotumori.mi.it	Colombo, Mara/D-2236-2017; Peissel, Bernard/E-8187-2017; Bernard, Loris/K-5953-2014; manoukian, siranoush/E-7132-2017; Verderio, Paolo/B-5034-2017; Peterlongo, Paolo/Q-4717-2018; Radice, Paolo/O-3119-2013	Colombo, Mara/0000-0001-5465-354X; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; Verderio, Paolo/0000-0002-9231-1281; Peterlongo, Paolo/0000-0001-6951-6855; Radice, Paolo/0000-0001-6298-4111	Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro [4017]; Ministero della Salute [RFPS-2006-3-340203]; Ministero dell'Universita e Ricerca [RBLAO3-BETH]; Istituto Superiore di Sanita [D/41]; Fondazione IRCCS Istituto Nazionale Tumori	Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Fondazione IRCCS Istituto Nazionale Tumori	This study was funded by grants from Fondazione Italiana per la Ricerca sul Cancro (Special Project "Hereditary tumors"), Associazione Italiana per la Ricerca sul Cancro (4017), Ministero della Salute (RFPS-2006-3-340203; Extraordinary National Cancer Program 2006, "Alleanza contro il Cancro"; "Progetto Tumori Femminili"), Ministero dell'Universita e Ricerca (RBLAO3-BETH), Istituto Superiore di Sanita (D/41), and by funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balia C, 2010, FAM CANCER, V9, P531, DOI 10.1007/s10689-010-9382-1; Brendel V, 2004, BIOINFORMATICS, V20, P1157, DOI 10.1093/bioinformatics/bth058; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hollestelle A, 2010, CURR OPIN GENET DEV, V20, P268, DOI 10.1016/j.gde.2010.02.009; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landwehr R, 2011, BREAST CANCER RES TR, V130, P1021, DOI 10.1007/s10549-011-1681-1; Manoukian S, 2007, EUR J CANCER, V43, P601, DOI 10.1016/j.ejca.2006.09.024; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Papi L, 2010, FAM CANCER, V9, P181, DOI 10.1007/s10689-009-9295-z; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31038	10.1371/journal.pone.0031038	http://dx.doi.org/10.1371/journal.pone.0031038			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383991	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100013
J	Chen, YT; Lee, JJ; Chiang, CY; Yang, GG; Tsai, YC; Lee, YS; Lin, CB				Chen, Yi-Ting; Lee, Jen-Jyh; Chiang, Chen-Yuan; Yang, Gee-Gow; Tsai, Yeong-Chu; Lee, Yeong-Sheng; Lin, Chih-Bin			Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004-2008	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEDICAL-CENTER; PATTERN	Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.	[Chen, Yi-Ting; Lee, Jen-Jyh; Yang, Gee-Gow; Lin, Chih-Bin] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen-Jyh; Lin, Chih-Bin] Tzu Chi Univ, Sch Med, Dept Internal Med, Hualien, Taiwan; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan] Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Sch Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Yeong-Chu] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan; [Lee, Yeong-Sheng] Ctr Dis Control, Branch Off 4, Tainan, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Municipal WanFang Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Centers For Disease Control - Taiwan	Chen, YT (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan.	ferlin@tzuchi.com.tw			Taiwan CDC	Taiwan CDC	We wish to thank Taiwan CDC for its support of the Regional Mycobacteriology Laboratory in Eastern Taiwan. We appreciate Prof. Lee Yi-Hwei for her helpful instruction on statistics.	[Anonymous], 2009, GUID SURV DRUG RES T; Armitage P, 1987, STATISTICAL METHODS, P455; Bureau of National Health Insurance Department of Health Executive Yuan, 2011, INS COV; Cheng SY, 2010, J HEALTHC QUAL, V4, P48; Department of Statistics Ministry of the Interior Executive Yuan, 2011, POP STAT YB INT; Hsu C-B, 2008, TAIWAN EPIDEMIOL B, V24, P230; Infectious Diseases Society of the Republic of China, 2004, J Microbiol Immunol Infect, V37, P382; Jou RW, 2006, EMERG INFECT DIS, V12, P871, DOI 10.3201/eid1205.051688; Kam KM, 2001, INT J TUBERC LUNG D, V5, P815; LEE JJ, 2003, TZU CHI MED J, V15, P229; Liaw YS, 2004, J FORMOS MED ASSOC, V103, P671; Liu WL, 2010, EUR J CLIN MICROBIOL, V29, P1413, DOI 10.1007/s10096-010-1019-7; Lu PL, 2003, INT J ANTIMICROB AG, V21, P239, DOI 10.1016/S0924-8579(02)00353-9; Su CT, 2010, TAIWAN EPIDEMIOLOGY, V26, P400; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P23; *WHO, 2008, 4 WHO IUATLD GLOB PR; Word Health Organization, 1997, ANT DRUG RES WORLD; Yu CC, 2010, J MICROBIOL IMMUNOL, V43, P285, DOI 10.1016/S1684-1182(10)60045-X	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31531	10.1371/journal.pone.0031531	http://dx.doi.org/10.1371/journal.pone.0031531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384034	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100025
J	Curtis, KA; Rudolph, DL; Nejad, I; Singleton, J; Beddoe, A; Weigl, B; LaBarre, P; Owen, SM				Curtis, Kelly A.; Rudolph, Donna L.; Nejad, Irene; Singleton, Jered; Beddoe, Andy; Weigl, Bernhard; LaBarre, Paul; Owen, S. Michele			Isothermal Amplification Using a Chemical Heating Device for Point-of-Care Detection of HIV-1	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION; RAPID DETECTION; INFECTION; VIRUS; DIAGNOSIS; TUBERCULOSIS; STATE; LAMP; DNA	Background: To date, the use of traditional nucleic acid amplification tests (NAAT) for detection of HIV-1 DNA or RNA has been restricted to laboratory settings due to time, equipment, and technical expertise requirements. The availability of a rapid NAAT with applicability for resource-limited or point-of-care (POC) settings would fill a great need in HIV diagnostics, allowing for timely diagnosis or confirmation of infection status, as well as facilitating the diagnosis of acute infection, screening and evaluation of infants born to HIV-infected mothers. Isothermal amplification methods, such as reverse-transcription, loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are ideal for POC settings, since they are typically quicker, easier to perform, and allow for integration into low-tech, portable heating devices. Methodology/Significant Findings: In this study, we evaluated the HIV-1 RT-LAMP assay using portable, non-instrumented nucleic acid amplification (NINA) heating devices that generate heat from the exothermic reaction of calcium oxide and water. The NINA heating devices exhibited stable temperatures throughout the amplification reaction and consistent amplification results between three separate devices and a thermalcycler. The performance of the NINA heaters was validated using whole blood specimens from HIV-1 infected patients. Conclusion: The RT-LAMP isothermal amplification method used in conjunction with a chemical heating device provides a portable, rapid and robust NAAT platform that has the potential to facilitate HIV-1 testing in resource-limited settings and POC.	[Curtis, Kelly A.; Rudolph, Donna L.; Nejad, Irene; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA; [Singleton, Jered; Beddoe, Andy; Weigl, Bernhard; LaBarre, Paul] PATH, Seattle, WA USA	Centers for Disease Control & Prevention - USA	Curtis, KA (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA.	czv2@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported with intramural funding from the Centers for Disease Control and Prevention. No external funding sources were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David A, 2011, Curr HIV/AIDS Rep, V8, P31, DOI 10.1007/s11904-010-0067-z; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; BUTERA ST, 1991, J VIROL, V65, P4645, DOI 10.1128/JVI.65.9.4645-4653.1991; Butto S, 2010, ANN I SUPER SANITA, V46, P24, DOI 10.4415/ANN_10_01_04; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Enosawa M, 2003, J CLIN MICROBIOL, V41, P4359, DOI 10.1128/JCM.41.9.4359-4365.2003; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Hara-Kudo Y, 2005, FEMS MICROBIOL LETT, V253, P155, DOI 10.1016/j.femsle.2005.09.032; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Ihira M, 2004, J CLIN MICROBIOL, V42, P140, DOI 10.1128/JCM.42.1.140-145.2004; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kurosaki Y, 2007, J VIROL METHODS, V141, P78, DOI 10.1016/j.jviromet.2006.11.031; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; MOK JYQ, 1989, ARCH DIS CHILD, V64, P1140, DOI 10.1136/adc.64.8.1140; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okamoto S, 2004, J MED VIROL, V74, P677, DOI 10.1002/jmv.20223; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Pandori Mark W, 2010, Expert Rev Anti Infect Ther, V8, P631, DOI 10.1586/eri.10.48; Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005; Schito ML, 2010, J INFECT DIS, V201, pS1, DOI 10.1086/650394; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Wesolowski LG, 2009, CLIN VACCINE IMMUNOL, V16, P1091, DOI 10.1128/CVI.00083-09	33	94	103	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31432	10.1371/journal.pone.0031432	http://dx.doi.org/10.1371/journal.pone.0031432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384022	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100022
J	Daidone, F; Montioli, R; Paiardini, A; Cellini, B; Macchiarulo, A; Giardina, G; Bossa, F; Voltattorni, CB				Daidone, Frederick; Montioli, Riccardo; Paiardini, Alessandro; Cellini, Barbara; Macchiarulo, Antonio; Giardina, Giorgio; Bossa, Francesco; Voltattorni, Carla Borri			Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors	PLOS ONE			English	Article							3,4-DIHYDROXYPHENYLALANINE DECARBOXYLASE; BENSERAZIDE; MUTATION; PLASMA; HOMOCYSTEINE; METABOLISM; CARBIDOPA; EFFICIENT; DOCKING; LEADS	Dopa decarboxylase (DDC), a pyridoxal 5'-phosphate (PLP) enzyme responsible for the biosynthesis of dopamine and serotonin, is involved in Parkinson's disease (PD). PD is a neurodegenerative disease mainly due to a progressive loss of dopamine-producing cells in the midbrain. Co-administration of L-Dopa with peripheral DDC inhibitors (carbidopa or benserazide) is the most effective symptomatic treatment for PD. Although carbidopa and trihydroxybenzylhydrazine (the in vivo hydrolysis product of benserazide) are both powerful irreversible DDC inhibitors, they are not selective because they irreversibly bind to free PLP and PLP-enzymes, thus inducing diverse side effects. Therefore, the main goals of this study were (a) to use virtual screening to identify potential human DDC inhibitors and (b) to evaluate the reliability of our virtual-screening (VS) protocol by experimentally testing the "in vitro" activity of selected molecules. Starting from the crystal structure of the DDC-carbidopa complex, a new VS protocol, integrating pharmacophore searches and molecular docking, was developed. Analysis of 15 selected compounds, obtained by filtering the public ZINC database, yielded two molecules that bind to the active site of human DDC and behave as competitive inhibitors with K-i values >= 10 mu M. By performing in silico similarity search on the latter compounds followed by a substructure search using the core of the most active compound we identified several competitive inhibitors of human DDC with K-i values in the low micromolar range, unable to bind free PLP, and predicted to not cross the blood-brain barrier. The most potent inhibitor with a K-i value of 500 nM represents a new lead compound, targeting human DDC, that may be the basis for lead optimization in the development of new DDC inhibitors. To our knowledge, a similar approach has not been reported yet in the field of DDC inhibitors discovery.	[Daidone, Frederick; Paiardini, Alessandro; Giardina, Giorgio; Bossa, Francesco] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Montioli, Riccardo; Cellini, Barbara; Voltattorni, Carla Borri] Univ Verona, Dept Life Sci & Reprod, I-37100 Verona, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Chem & Drug Technol, I-06100 Perugia, Italy	Sapienza University Rome; University of Verona; University of Perugia	Daidone, F (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy.	carla.borrivoltattorni@univr.it	Cellini, Barbara/AAC-6401-2019; Giardina, Giorgio/C-7529-2009; Giardina, Giorgio/M-8882-2019; Macchiarulo, Antonio/L-2846-2017	Cellini, Barbara/0000-0002-5221-9288; Giardina, Giorgio/0000-0002-0802-1370; Giardina, Giorgio/0000-0002-0802-1370; Macchiarulo, Antonio/0000-0001-9535-4183; Paiardini, Alessandro/0000-0001-9078-7545	Italian Ministero dell'Universita e della Ricerca; "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (CASPUR, Roma, Italy) [STD10-281]; Consorzio Interuniversitario per le Biotecnologie (CIB)	Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (CASPUR, Roma, Italy); Consorzio Interuniversitario per le Biotecnologie (CIB)	This work was supported by grants from the Italian Ministero dell'Universita e della Ricerca, from the "Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca" (STD10-281; CASPUR, Roma, Italy), and by the Consorzio Interuniversitario per le Biotecnologie (CIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN P, 1995, NEUROTOXICOLOGY, V16, P527; [Anonymous], MACCS STRUCT KEYS; BENDER DA, 1980, BIOCHEM PHARMACOL, V29, P707, DOI 10.1016/0006-2952(80)90544-4; BENDER DA, 1979, CLIN SCI MOL MED, V56, P89, DOI 10.1042/cs0560089; BENDER DA, 1980, BIOCHEM PHARMACOL, V29, P2099, DOI 10.1016/0006-2952(80)90179-3; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 2001, EUR J BIOCHEM, V268, P2975, DOI 10.1046/j.1432-1327.2001.02187.x; Bertoldi M, 1999, J BIOL CHEM, V274, P5514, DOI 10.1074/jbc.274.9.5514; Bertoldi M, 1996, J BIOL CHEM, V271, P23954, DOI 10.1074/jbc.271.39.23954; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; BORRIVOLTATTORNI C, 1977, FEBS LETT, V75, P277, DOI 10.1016/0014-5793(77)80102-6; BORRIVOLTATTORNI C, 1977, EXPERIENTIA, V33, P158, DOI 10.1007/BF02124039; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; CHARTERIS A, 1975, ANAL BIOCHEM, V66, P365, DOI 10.1016/0003-2697(75)90604-1; Chen Z, 2009, ACTA PHARMACOL SIN, V30, P1694, DOI 10.1038/aps.2009.159; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; DOMINICI P, 1993, BIOCHEM J, V295, P493, DOI 10.1042/bj2950493; Dominici P, 1997, PROTEIN SCI, V6, P2007, DOI 10.1002/pro.5560060921; DOMINICI P, 1985, J BIOL CHEM, V260, P583; EBADI MS, 1968, J NEUROCHEM, V15, P659, DOI 10.1111/j.1471-4159.1968.tb08964.x; Gardian G, 2010, INT J CLIN PHARM TH, V48, P633; HARTMAN WJ, 1955, J BIOL CHEM, V216, P507; Hauser RA, 2009, EUR NEUROL, V62, P1, DOI 10.1159/000215875; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Kuhn W, 1998, EUR NEUROL, V40, P225, DOI 10.1159/000007984; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; MCCORMICK D, 1961, J BIOL CHEM, V236, P2085; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Miller JW, 2003, NEUROLOGY, V60, P1125, DOI 10.1212/01.WNL.0000055899.24594.8E; Montioli R, 2011, J INHERIT METAB DIS; Moore PS, 1997, FEBS LETT, V412, P245, DOI 10.1016/S0014-5793(97)00788-6; Moriguchi IHS, 1992, CHEM PHARM BULL, V40, P4; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; OPACKAJUFFRY J, 1995, MOVEMENT DISORD, V10, P241, DOI 10.1002/mds.870100302; Perola E, 2010, J MED CHEM, V53, P2986, DOI 10.1021/jm100118x; SCHWARTZ DE, 1978, ARZNEIMITTEL-FORSCH, V28-1, P302; SHERALD AF, 1973, ANAL BIOCHEM, V56, P300, DOI 10.1016/0003-2697(73)90194-2; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Standaert DG, TREATMENT CENTRAL NE, P533; TANCINI B, 1985, ARCH BIOCHEM BIOPHYS, V238, P565, DOI 10.1016/0003-9861(85)90201-2; Tanimoto T.T., 1957, NOV, V17, P1957; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VOLTATTO.CB, 1971, FEBS LETT, V17, P231, DOI 10.1016/0014-5793(71)80153-9; VOLTATTORNI CB, 1981, LIFE SCI, V28, P103, DOI 10.1016/0024-3205(81)90372-6; VOLTATTORNI CB, 1983, BIOCHEMISTRY-US, V22, P2249, DOI 10.1021/bi00278a030; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x	48	50	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31610	10.1371/journal.pone.0031610	http://dx.doi.org/10.1371/journal.pone.0031610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384042	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100026
J	Hancioglu, B; Tyson, JJ				Hancioglu, Baris; Tyson, John J.			A Mathematical Model of Mitotic Exit in Budding Yeast: The Role of Polo Kinase	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; QUANTIZED CYCLE TIMES; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CDC14 RELEASE; FISSION YEAST; M-PHASE; PHOSPHATASE CDC14; SPINDLE CHECKPOINT; DNA-REPLICATION	Cell cycle progression in eukaryotes is regulated by periodic activation and inactivation of a family of cyclin-dependent kinases (Cdk's). Entry into mitosis requires phosphorylation of many proteins targeted by mitotic Cdk, and exit from mitosis requires proteolysis of mitotic cyclins and dephosphorylation of their targeted proteins. Mitotic exit in budding yeast is known to involve the interplay of mitotic kinases (Cdk and Polo kinases) and phosphatases (Cdc55/PP2A and Cdc14), as well as the action of the anaphase promoting complex (APC) in degrading specific proteins in anaphase and telophase. To understand the intricacies of this mechanism, we propose a mathematical model for the molecular events during mitotic exit in budding yeast. The model captures the dynamics of this network in wild-type yeast cells and 110 mutant strains. The model clarifies the roles of Polo-like kinase (Cdc5) in the Cdc14 early anaphase release pathway and in the G-protein regulated mitotic exit network.	[Hancioglu, Baris; Tyson, John J.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hancioglu, B (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	barish@rice.edu	Tyson, John J/A-2942-2014	Tyson, John J/0000-0001-7560-6013	National Institutes of Health [R01-GM079207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the National Institutes of Health Grant R01-GM079207 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; BOURNE HR, 1995, PHILOS T R SOC B, V349, P283, DOI 10.1098/rstb.1995.0114; Calzone L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100171; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Ciliberto A, 2000, B MATH BIOL, V62, P37, DOI 10.1006/bulm.1999.0129; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Csikasz-Nagy A, 2007, CURR GENET, V51, P245, DOI 10.1007/s00294-007-0123-4; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Gonze D, 2001, J THEOR BIOL, V210, P167, DOI 10.1006/jtbi.2000.2294; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Lee SE, 2001, J CELL SCI, V114, P2345; Liang FS, 2009, MOL BIOL CELL, V20, P3671, DOI 10.1091/mbc.E08-10-1049; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; NOVAK B, 1993, J CELL SCI, V106, P1153; NOVAK B, 1995, J THEOR BIOL, V173, P283, DOI 10.1006/jtbi.1995.0063; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shirayama M, 1996, MOL GEN GENET, V251, P176; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Steuer R, 2004, J THEOR BIOL, V228, P293, DOI 10.1016/j.jtbi.2004.01.012; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Vinod PK, 2011, J R SOC INTERFACE, V8, P1128, DOI 10.1098/rsif.2010.0649; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2003, MOL BIOL CELL; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	62	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30810	10.1371/journal.pone.0030810	http://dx.doi.org/10.1371/journal.pone.0030810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383977	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100009
J	Li, CW; Yu, S; Zhong, XL; Wu, JG; Li, XD				Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong			Circadian Rhythms of Fetal Liver Transcription Persist in the Absence of Canonical Circadian Clock Gene Expression Rhythms In Vivo	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; PERINATAL-PERIOD; OSCILLATORS; ONTOGENY; MOUSE; MICE; COORDINATION; ORGANIZATION; METABOLISM; PACEMAKER	The cellular circadian clock and systemic cues drive rhythmicity in the transcriptome of adult peripheral tissues. However, the oscillating status of the circadian clocks in fetal tissues, and their response to maternal cues, are less clear. Most clock genes do not cycle in fetal livers from mice and rats, although tissue level rhythms rapidly emerge when fetal mouse liver explants are cultured in vitro. Thus, in the fetal mouse liver, the circadian clock does not oscillate at the cellular level (but is induced to oscillate in culture). To gain a comprehensive overview of the clock status in the fetal liver during late gestation, we performed microarray analyses on fetal liver tissues. In the fetal liver we did not observe circadian rhythms of clock gene expression or many other transcripts known to be rhythmically expressed in the adult liver. Nevertheless, JTK_CYCLE analysis identified some transcripts in the fetal liver that were rhythmically expressed, albeit at low amplitudes. Upon data filtering by coefficient of variation, the expression levels for transcripts related to pancreatic exocrine enzymes and zymogen secretion were found to undergo synchronized daily fluctuations at high amplitudes. These results suggest that maternal cues influence the fetal liver, despite the fact that we did not detect circadian rhythms of canonical clock gene expression in the fetal liver. These results raise important questions on the role of the circadian clock, or lack thereof, during ontogeny.	[Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong] Wuhan Univ, Coll Life Sci, Natl Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Li, CW (corresponding author), Wuhan Univ, Coll Life Sci, Natl Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China.	xiaodli@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895; Zhong, Xiaoling/0000-0003-2963-4798	National Mega Project on Major Drug Development [2011ZX09401-302-1, 2009ZX09301-014-1]; National Basic Research Program of China [2009CB918304]; China Ministry of Education [20070486102]	National Mega Project on Major Drug Development; National Basic Research Program of China(National Basic Research Program of China); China Ministry of Education(Ministry of Education, China)	This research was supported by National Mega Project on Major Drug Development (2011ZX09401-302-1 and 2009ZX09301-014-1), the National Basic Research Program of China (2009CB918304), and by the China Ministry of Education grant 20070486102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2009, EUR J NEUROSCI, V29, P477, DOI 10.1111/j.1460-9568.2008.06605.x; BATTAGLIA FC, 1978, PHYSIOL REV, V58, P499, DOI 10.1152/physrev.1978.58.2.499; BOHME HJ, 1983, EXPERIENTIA, V39, P473; BRANNON PM, 1990, ANNU REV NUTR, V10, P85, DOI 10.1146/annurev.nu.10.070190.000505; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1977, AM J PHYSIOL, V232, pE456, DOI 10.1152/ajpendo.1977.232.5.E456; Grosse D, 1998, J NEUROSCI, V18, P8032; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sugino H, 2007, FEBS LETT, V581, P355, DOI 10.1016/j.febslet.2006.12.039; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; VISWANATHAN N, 1994, J NEUROSCI, V14, P5393; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wasle B, 2005, BIOCHEM J, V385, P721; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	44	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30781	10.1371/journal.pone.0030781	http://dx.doi.org/10.1371/journal.pone.0030781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383974	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100006
J	Tzeng, WN; Tseng, YH; Han, YS; Hsu, CC; Chang, CW; Di Lorenzo, E; Hsieh, CH				Tzeng, Wann-Nian; Tseng, Yu-Heng; Han, Yu-San; Hsu, Chih-Chieh; Chang, Chih-Wei; Di Lorenzo, Emanuele; Hsieh, Chih-hao			Evaluation of Multi-Scale Climate Effects on Annual Recruitment Levels of the Japanese Eel, Anguilla japonica, to Taiwan	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; TIME-SERIES; EL-NINO; INTERANNUAL VARIABILITY; LARVAL TRANSPORT; EUROPEAN EEL; SOLAR-CYCLE; COASTAL WATERS; OCEAN; FLUCTUATIONS	Long-term (1967-2008) glass eel catches were used to investigate climatic effects on the annual recruitment of Japanese eel to Taiwan. Specifically, three prevailing hypotheses that potentially explain the annual recruitment were evaluated. Hypothesis 1: high precipitation shifts the salinity front northward, resulting in favorable spawning locations. Hypothesis 2: a southward shift of the position of the North Equatorial Current (NEC) bifurcation provides a favorable larval transport route. Hypothesis 3: ocean conditions (eddy activities and productivity) along the larval migration route influence larval survival. Results of time series regression and wavelet analyses suggest that Hypothesis 1 is not supported, as the glass eel catches exhibited a negative relationship with precipitation. Hypothesis 2 is plausible. However, the catches are correlated with the NEC bifurcation with a one-year lag. Considering the time needed for larval transport (only four to six months), the one-year lag correlation does not support the direct transport hypothesis. Hypothesis 3 is supported indirectly by the results. Significant correlations were found between catches and climate indices that affect ocean productivity and eddy activities, such as the Quasi Biennial Oscillation (QBO), North Pacific Gyre Oscillation (NPGO), Pacific Decadal Oscillation (PDO), and Western Pacific Oscillation (WPO). Wavelet analysis reveals three periodicities of eel catches: 2.7, 5.4, and 10.3 years. The interannual coherence with QBO and the Nino 3.4 region suggests that the shorter-term climate variability is modulated zonally by equatorial dynamics. The low-frequency coherence with WPO, PDO, and NPGO demonstrates the decadal modulation of meridional teleconnection via ocean-atmosphere interactions. Furthermore, WPO and QBO are linked to solar activities. These results imply that the Japanese eel recruitment may be influenced by multi-timescale climate variability. Our findings call for investigation of extra-tropical ocean dynamics that affect survival of eels during transport, in addition to the existing efforts to study the equatorial system.	[Tzeng, Wann-Nian; Han, Yu-San] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Tzeng, Wann-Nian; Han, Yu-San] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Tzeng, Wann-Nian] Natl Taiwan Ocean Univ, Dept Environm Biol & Fisheries Sci, Keelung, Taiwan; [Tseng, Yu-Heng] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10764, Taiwan; [Hsu, Chih-Chieh] Natl Cheng Kung Univ, Earth Dynam Ctr, Tainan 70101, Taiwan; [Hsu, Chih-Chieh] Natl Changhua Univ Educ, Dept Geog, Changhua, Taiwan; [Chang, Chih-Wei] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan Ocean University; National Taiwan University; National Cheng Kung University; National Changhua University of Education; National Museum of Marine Biology & Aquarium; University System of Georgia; Georgia Institute of Technology; National Taiwan University; National Taiwan University	Tzeng, WN (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan.	yhtseng@as.ntu.edu.tw; chsieh@ntu.edu.tw	Di Lorenzo, Emanuele/E-9107-2012; Hsieh, Chih-hao/B-3797-2008	Di Lorenzo, Emanuele/0000-0002-1935-7363; Hsieh, Chih-hao/0000-0001-5935-7272; Tseng, Yu-heng/0000-0002-4816-4974; HAN, YU-SAN/0000-0002-9236-9045	National Taiwan University; National Science Council, Taiwan	National Taiwan University(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Taiwan University and the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Chhak KC, 2009, J CLIMATE, V22, P1255, DOI 10.1175/2008JCLI2639.1; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Dekker W., 2003, ICES NEWSLETTER, V40, P10; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2010, NAT GEOSCI, V3, P762, DOI [10.1038/NGEO984, 10.1038/ngeo984]; Durif CMF, 2011, P ROY SOC B-BIOL SCI, V278, P464, DOI 10.1098/rspb.2010.1547; FAO, 2011, CULT AQ SPEC INF PRO; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gleisner H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017129; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Haigh JD, 2003, PHILOS T ROY SOC A, V361, P95, DOI 10.1098/rsta.2002.1111; Han YS, 2000, J TAIWAN FISH RES, V8, P37; Han YS, 2008, MAR BIOL, V155, P613, DOI 10.1007/s00227-008-1057-1; Han YS, 2009, ZOOL STUD, V48, P632; Hancock D, 1996, DEV SUSTAINING WORLD, P85; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hsieh CH, 2006, ECOLOGY, V87, P1932, DOI 10.1890/0012-9658(2006)87[1932:BRTEFT]2.0.CO;2; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; Hsieh CH, 2009, FISH OCEANOGR, V18, P102, DOI 10.1111/j.1365-2419.2008.00498.x; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Klvana I, 2004, AM NAT, V164, P283, DOI 10.1086/423431; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kotake A, 2007, ZOOL SCI, V24, P1213, DOI 10.2108/zsj.24.1213; Labitzke K, 2000, J ATMOS SOL-TERR PHY, V62, P621, DOI 10.1016/S1364-6826(00)00047-X; Lean JL, 2010, WIRES CLIM CHANGE, V1, P111, DOI 10.1002/wcc.18; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Linkin ME, 2008, J CLIMATE, V21, P1979, DOI 10.1175/2007JCLI2048.1; Lu H, 2009, Q J ROY METEOR SOC, V135, P1030, DOI 10.1002/qj.419; Mantua N, 2004, PROG OCEANOGR, V60, P165, DOI 10.1016/j.pocean.2004.02.016; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marcogliese Lucian A., 2009, P191; McCann KS, 2003, CAN J FISH AQUAT SCI, V60, P971, DOI 10.1139/F03-078; Meehl GA, 2009, SCIENCE, V325, P1114, DOI 10.1126/science.1172872; Menard F, 2007, FISH OCEANOGR, V16, P95, DOI 10.1111/j.1365-2419.2006.00415.x; Miller MJ, 2009, AM FISH S S, V69, P231; Ottersen G, 2001, LIMNOL OCEANOGR, V46, P1774, DOI 10.4319/lo.2001.46.7.1774; Qiu B, 1996, J GEOPHYS RES-OCEANS, V101, P12315, DOI 10.1029/95JC03204; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Sasaki H., 2006, J EARTH SIMULATOR, V6, P35; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Shen ML, LONG TERM VARI UNPUB; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; SINCLAIR ARE, 1993, AM NAT, V141, P173, DOI 10.1086/285468; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tatsukawa K, 2003, EEL BIOLOGY, P293; Tesch F. W., 1977, The eel: biology and management of anguillid eels.; Tian YJ, 2006, PROG OCEANOGR, V68, P217, DOI 10.1016/j.pocean.2006.02.009; Tian YJ, 2011, FISH RES, V112, P140, DOI 10.1016/j.fishres.2011.01.034; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; TZENG WN, 1984, B I ZOOL ACAD SINICA, V23, P173; Tzeng WN., 1985, B JAP SOC FISH OCEAN, V47, P11; Visser ME, 2009, BIOL LETTERS, V5, P739, DOI 10.1098/rsbl.2009.0429; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Wang QY, 2009, SCI CHINA SER D, V52, P227, DOI 10.1007/s11430-009-0020-4; White WB, 1997, J GEOPHYS RES-OCEANS, V102, P3255, DOI 10.1029/96JC03549; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	84	44	50	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30805	10.1371/journal.pone.0030805	http://dx.doi.org/10.1371/journal.pone.0030805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383976	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100008
J	Bergstad, OA; Clark, L; Hansen, HO; Cousins, N				Bergstad, Odd Aksel; Clark, Laura; Hansen, Hege Overbo; Cousins, Nicola			Distribution, Population Biology, and Trophic Ecology of the Deepwater Demersal Fish Halosauropsis macrochir (Pisces: Halosauridae) on the Mid-Atlantic Ridge	PLOS ONE			English	Article							AGE-DETERMINATION; HOPLOSTETHUS-ATLANTICUS; MIDOCEAN RIDGE; ORANGE ROUGHY; VALIDATION; GROWTH; NOTACANTHIFORMES; TRACHICHTHYIDAE; STRATEGIES; DIVERSITY	Halosauropsis macrochir ranked amongst the most abundant and widespread demersal fishes on the mid-Atlantic Ridge of the North Atlantic (Iceland-Azores) with greatest abundance at 1700-3500 m. All sizes, ranging from 10-76 cm total length, occurred in the area without any apparent spatial pattern or depth trend. Using otolith sections displaying growth increments assumed to represent annuli, the age range recorded was 2-36 years, but most individuals were <20 years. Length and weight at age data were used to fit growth models. No differences between sexes in length and weight at age were observed. The majority of samples had a surplus of males. Diet analysis showed that H. macrochir feeds on Crustacea, Teleostei, Polychaeta, and Cephalopoda, but few prey could be identified to lower taxonomical levels. The mid-Atlantic Ridge constitutes a major portion of the North Atlantic living space of the abyssal halosaur where it completes its full life cycle, primarily as an actively foraging euryophagous micronekton/epibenthos and infauna feeder, becoming a partial piscivore with increasing size.	[Bergstad, Odd Aksel; Hansen, Hege Overbo] Inst Marine Res, Flodevigen, His, Norway; [Clark, Laura] Scottish Nat Heritage, Inverness, Scotland; [Cousins, Nicola] Univ Aberdeen, Aberdeen, Scotland	Institute of Marine Research - Norway; University of Aberdeen	Bergstad, OA (corresponding author), Inst Marine Res, Flodevigen, His, Norway.	oddaksel@imr.no		Bergstad, Odd Aksel/0000-0002-4096-0896	NERC [NE/C512961/1, NE/C512988/1, NE/C51297X/1, NE/C512996/1, NE/C51300X/1] Funding Source: UKRI; Natural Environment Research Council [NE/C51300X/1, NE/C512988/1, NE/C512961/1, NE/C512996/1, NE/C51297X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Albert O. T., 2009, J NW ATLANTIC FISHER, V40, P81, DOI DOI 10.2960/J.V40.M659; Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1339, DOI 10.1139/cjfas-56-8-1339; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P1, DOI 10.1016/j.dsr2.2007.10.001; BERGSTAD OA, 1990, MAR BIOL, V107, P25, DOI 10.1007/BF01313239; Bergstad OA, 1995, NATO ASI SERIES E, V296, P267; Cailliet GM, 2001, EXP GERONTOL, V36, P739, DOI 10.1016/S0531-5565(00)00239-4; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P163, DOI 10.1139/f90-017; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; CAMPBELL RA, 1977, J PARASITOL, V63, P76, DOI 10.2307/3280106; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; CRABTREE RE, 1985, B MAR SCI, V36, P235; ENGAS A, 1989, J CONSEIL, V45, P269; Felley JD, 2008, DEEP-SEA RES PT II, V55, P153, DOI 10.1016/j.dsr2.2007.09.021; FENTON GE, 1991, MAR BIOL, V109, P197, DOI 10.1007/BF01319387; Gartner John V. Jr, 1997, P115; Klimpel S, 2008, DEEP-SEA RES PT II, V55, P229, DOI 10.1016/j.dsr2.2007.09.006; Klimpel S, 2010, DEEP-SEA RES PT I, V57, P596, DOI 10.1016/j.dsr.2010.01.002; MACHIDA Y, 1988, JPN J ICHTHYOL, V35, P78; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MAUCHLINE J, 1985, J FISH BIOL, V26, P527, DOI 10.1111/j.1095-8649.1985.tb04293.x; Merrett N. R., 1997, FISH FISHERIES SERIE; SEDBERRY GR, 1978, MAR BIOL, V44, P357, DOI 10.1007/BF00390900; Smith DG, 2002, LIVING MARINE RESOUR, V2, P685; Sulak K.J., 1986, P593; SULAK KJ, 1977, COPEIA, P11; Sulak KJ, 1984, THESIS U MIAMI; Sulak KJ, 1990, CHECK LIST FISHES E, V1, P126; Swan S, 1996, J FISH BIOL, V49, P289; Swan SC, 2001, FISH RES, V51, P177, DOI 10.1016/S0165-7836(01)00244-2; Tracey DM, 1999, NEW ZEAL J MAR FRESH, V33, P67, DOI 10.1080/00288330.1999.9516858; Treble MA, 2008, CAN J FISH AQUAT SCI, V65, P1047, DOI 10.1139/F08-030; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017	33	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31493	10.1371/journal.pone.0031493	http://dx.doi.org/10.1371/journal.pone.0031493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384030	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500022
J	Gonzalez, LC; Wang, H; Livesay, DR; Jacobs, DJ				Gonzalez, Luis C.; Wang, Hui; Livesay, Dennis R.; Jacobs, Donald J.			Calculating Ensemble Averaged Descriptions of Protein Rigidity without Sampling	PLOS ONE			English	Article							QUANTITATIVE STABILITY/FLEXIBILITY RELATIONSHIPS; CRYSTAL-STRUCTURE; GENERIC RIGIDITY; THIOREDOXIN; NONADDITIVITY; PREDICTIONS; SYSTEMS; MODELS; GRAPHS	Previous works have demonstrated that protein rigidity is related to thermodynamic stability, especially under conditions that favor formation of native structure. Mechanical network rigidity properties of a single conformation are efficiently calculated using the integer body-bar Pebble Game (PG) algorithm. However, thermodynamic properties require averaging over many samples from the ensemble of accessible conformations to accurately account for fluctuations in network topology. We have developed a mean field Virtual Pebble Game (VPG) that represents the ensemble of networks by a single effective network. That is, all possible number of distance constraints (or bars) that can form between a pair of rigid bodies is replaced by the average number. The resulting effective network is viewed as having weighted edges, where the weight of an edge quantifies its capacity to absorb degrees of freedom. The VPG is interpreted as a flow problem on this effective network, which eliminates the need to sample. Across a nonredundant dataset of 272 protein structures, we apply the VPG to proteins for the first time. Our results show numerically and visually that the rigidity characterizations of the VPG accurately reflect the ensemble averaged (PG) over bar properties. This result positions the VPG as an efficient alternative to understand the mechanical role that chemical interactions play in maintaining protein stability.	[Gonzalez, Luis C.; Livesay, Dennis R.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Wang, Hui; Jacobs, Donald J.] Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Gonzalez, LC (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	drlivesa@uncc.edu; djacobs1@uncc.edu		Gonzalez-Gurrola, Luis-Carlos/0000-0003-1546-9752	NIH [R01 GM073082]; Mexico's National Council on Science and Technology (CONACYT); Department of Bioinformatics and Genomics at UNC Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mexico's National Council on Science and Technology (CONACYT); Department of Bioinformatics and Genomics at UNC Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Primary support for this work has come from NIH R01 GM073082. Luis C. Gonzalez is supported by a graduate fellowship from Mexico's National Council on Science and Technology (CONACYT) and from the Department of Bioinformatics and Genomics at UNC Charlotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CY, 2009, P NATL ACAD SCI; Cormen TH, 1991, INTRO ALGORITHMS; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Ford L. R. J., 1962, FLOWS NETWORKS; Fox N, 2011, 1 IEEE INT C COMP AD; Frey KM, 2010, P NATL ACAD SCI USA, V107, P13707, DOI 10.1073/pnas.1002162107; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Gabow H. N., 1988, Proceedings of the Twentieth Annual ACM Symposium on Theory of Computing, P407, DOI 10.1145/62212.62252; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Gonzalez LC, VIRTUAL PEB IN PRESS; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; GUYON E, 1990, REP PROG PHYS, V53, P373, DOI 10.1088/0034-4885/53/4/001; HENDRICKSON B, 1992, SIAM J COMPUT, V21, P65, DOI 10.1137/0221008; Hespenheide BM, 2004, J PHYS-CONDENS MAT, V16, pS5055, DOI 10.1088/0953-8984/16/44/003; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; IMAI H, 1985, DISCRETE APPL MATH, V10, P79, DOI 10.1016/0166-218X(85)90060-5; Istomin AY, 2008, PROTEINS, V70, P915, DOI 10.1002/prot.21620; Jacobs DJ, 2006, J MOL BIOL, V358, P882, DOI 10.1016/j.jmb.2006.02.015; Jacobs DJ, 2005, BIOPHYS J, V88, P903, DOI 10.1529/biophysj.104.048496; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1998, J PHYS A-MATH GEN, V31, P6653, DOI 10.1088/0305-4470/31/31/012; Jacobs DJ, 1999, RIGIDITY THEORY APPL, P357; Jacobs DJ, 2010, CURR OPIN PHARMACOL, V10, P760, DOI 10.1016/j.coph.2010.09.014; LAMAN G, 1970, J ENG MATH, V4, P331, DOI 10.1007/BF01534980; Lei M, 2004, J COMPUT CHEM, V25, P1133, DOI 10.1002/jcc.20041; Livesay DR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-17; Livesay DR, 2006, PROTEINS, V62, P130, DOI 10.1002/prot.20745; Livesay DR, 2004, FEBS LETT, V576, P468, DOI 10.1016/j.febslet.2004.09.057; Mottonen JM, 2010, BIOPHYS J, V99, P2245, DOI 10.1016/j.bpj.2010.07.043; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rader AJ, 2010, CURR OPIN PHARMACOL, V10, P753, DOI 10.1016/j.coph.2010.09.003; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Rader AJ, 2004, POLYMER, V45, P659, DOI 10.1016/j.polymer.2003.10.080; Rader AJ, 2002, PNAS, V99; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren B, 1998, NAT STRUCT BIOL, V5, P602, DOI 10.1038/862; Roberts KE, 2011, LECT N BIOINFORMAT, V6577, P361, DOI 10.1007/978-3-642-20036-6_35; Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016; Smith GD, 1997, ACTA CRYSTALLOGR D, V53, P551, DOI 10.1107/S0907444997005386; Sugihara K., 1980, Bulletin of the Electrotechnical Laboratory, V44, P376; Tan HP, 2009, PROTEINS, V74, P881, DOI 10.1002/prot.22196; TAY TS, 1984, J COMB THEORY B, V36, P95, DOI 10.1016/0095-8956(84)90016-9; Thorpe M., 2005, CURRENT TOPICS PHYS, P97; Verma D, 2010, CURR PROTEIN PEPT SC, V11, P562, DOI 10.2174/138920310794109210; Vorov OK, 2011, BIOPHYS J, V100, P1129, DOI 10.1016/j.bpj.2011.01.027; Vorov OK, 2009, BIOPHYS J, V97, P3000, DOI 10.1016/j.bpj.2009.09.013; Wells SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046005; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Zavodszky MI, 2004, PROTEINS, V57, P243, DOI 10.1002/prot.20179; Zwier MC, 2010, CURR OPIN PHARMACOL, V10, P745, DOI 10.1016/j.coph.2010.09.008	55	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e29176	10.1371/journal.pone.0029176	http://dx.doi.org/10.1371/journal.pone.0029176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383947	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500001
J	Guo, XG; Gao, XR; Wang, YS; Peng, LY; Zhu, YY; Wang, SM				Guo, Xiaogang; Gao, Xiuren; Wang, Yesong; Peng, Longyun; Zhu, Yingying; Wang, Shenming			I-Ks Protects from Ventricular Arrhythmia during Cardiac Ischemia and Reperfusion in Rabbits by Preserving the Repolarization Reserve	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; TORSADE-DE-POINTES; DELAYED RECTIFIER CURRENT; KCNQ1 POTASSIUM CHANNEL; EARLY AFTERDEPOLARIZATIONS; SIMULATED-ISCHEMIA; PURKINJE-FIBERS; QT PROLONGATION; LONG QT; HEART	Introduction: The function of the repolarization reserve in the prevention of ventricular arrhythmias during cardiac ischemia/reperfusion and the impact of ischemia on slowly activated delayed rectifier potassium current (I-Ks) channel subunit expression are not well understood. Methods and Results: The responses of monophasic action potential duration (MAPD) prolongation and triangulation were investigated following an L-768,673-induced blockade of I-Ks with or without ischemia/reperfusion in a rabbit model of left circumflex coronary artery occlusion/reperfusion. Ischemia/reperfusion and I-Ks blockade were found to significantly induce MAPD90 prolongation and increase triangulation at the epicardial zone at 45 min, 60 min, and 75 min after reperfusion, accompanied with an increase in premature ventricular beats (PVBs) during the same period. Additionally, I-Ks channel subunit expression was examined following transient ischemia or permanent infarction and changes in monophasic action potential (MAP) waveforms challenged by beta-adrenergic stimulation were evaluated using a rabbit model of transient or chronic cardiac ischemia. The epicardial MAP in the peri-infarct zone of hearts subjected to infarction for 2 days exhibited increased triangulation under adrenergic stimulation. KCNQ1 protein, the alpha subunit of the I-Ks channel, was downregulated in the same group. Both findings were consistent with an increased incidence of PVBs. Conclusion: Blockade of I-Ks caused MAP triangulation, which precipitated ventricular arrhythmias. Chronic ischemia increased the incidence of ventricular arrhythmias under adrenergic stimulation and was associated with increased MAP triangulation of the peri-infarct zone. Downregulation of KCNQ1 protein may be the underlying cause of these changes.	[Guo, Xiaogang; Gao, Xiuren; Wang, Yesong; Peng, Longyun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yingying] Cent Hosp, Intens Care Unit, Tai An, Shandong, Peoples R China; [Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Guo, XG (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	xiurengao@yahoo.com; shenmingwang@vip.shou.com	Guo, Xiao-gang/AAH-4293-2021		Guangdong Science and Technology Department of China [2008A030201011]; National Natural Science Foundation of China [81170172]	Guangdong Science and Technology Department of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Guangdong Science and Technology Department of China [grant number 2008A030201011] and National Natural Science Foundation of China [grant number 81170172]. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AGGARWAL R, 1995, CIRC RES, V77, P1180, DOI 10.1161/01.RES.77.6.1180; Bes S, 2005, EUR J PHARMACOL, V511, P109, DOI 10.1016/j.ejphar.2005.02.016; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Champeroux P, 2005, BRIT J PHARMACOL, V144, P376, DOI 10.1038/sj.bjp.0706070; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Ducroq J, 2006, EUR J PHARMACOL, V532, P279, DOI 10.1016/j.ejphar.2005.12.083; Dun W, 2005, AM J PHYSIOL-HEART C, V289, pH667, DOI 10.1152/ajpheart.00180.2005; FRANZ MR, 1991, PROG CARDIOVASC DIS, V33, P347, DOI 10.1016/0033-0620(91)90002-4; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Ganitkevich V, 2006, CIRC RES, V99, P165, DOI 10.1161/01.RES.0000232321.89714.0e; Guerard N. C., 2008, Journal of Pharmacological and Toxicological Methods, V58, P32, DOI 10.1016/j.vascn.2008.05.129; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Hondeghem LM, 2008, EUR J PHARMACOL, V584, P1, DOI 10.1016/j.ejphar.2008.01.016; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Liu GX, 2008, PFLUG ARCH EUR J PHY, V456, P541, DOI 10.1007/s00424-007-0436-7; Liu XS, 2007, AM J PHYSIOL-HEART C, V292, pH560, DOI 10.1152/ajpheart.00616.2006; Lu HR, 2002, EUR J PHARMACOL, V452, P183, DOI 10.1016/S0014-2999(02)02246-X; Lynch JJ, 1999, CIRCULATION, V100, P1917, DOI 10.1161/01.CIR.100.18.1917; Martin RL, 2006, J CARDIOVASC PHARM, V48, P199, DOI 10.1097/01.fjc.0000246853.15926.d4; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Milberg P, 2007, BASIC RES CARDIOL, V102, P42, DOI 10.1007/s00395-006-0609-0; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Ramakers C, 2003, CARDIOVASC RES, V57, P486, DOI 10.1016/S0008-6363(02)00717-4; Roden DM, 2005, CIRCULATION, V112, P1376, DOI 10.1161/CIRCULATIONAHA.105.562777; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; Salata JJ, 2004, CURR MED CHEM, V11, P29, DOI 10.2174/0929867043456214; Shieh RC, 1996, J PHYSIOL-LONDON, V494, P363, DOI 10.1113/jphysiol.1996.sp021498; Tsuji Y, 2006, CIRCULATION, V113, P345, DOI 10.1161/CIRCULATIONAHA.105.552968; Valverde CA, 2010, CARDIOVASC RES, V85, P671, DOI 10.1093/cvr/cvp371; Viitasalo M, 2005, PACE, V28, P219, DOI 10.1111/j.1540-8159.2005.09404.x; Volders PGA, 2003, CIRCULATION, V107, P2753, DOI 10.1161/01.CIR.0000068344.54010.B3; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Watanabe I, 1997, J CARDIOVASC ELECTR, V8, P1229, DOI 10.1111/j.1540-8167.1997.tb01012.x; Zicha S, 2003, AM J PHYSIOL-HEART C, V285, pH1641, DOI 10.1152/ajpheart.00346.2003	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31545	10.1371/journal.pone.0031545	http://dx.doi.org/10.1371/journal.pone.0031545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384037	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500025
J	Song, LJ; Li, JH; Xie, SY; Qian, CY; Wang, J; Zhang, W; Yin, XR; Hua, ZC; Yu, CX				Song, LiJun; Li, JiaHuang; Xie, ShuYing; Qian, ChunYan; Wang, Jie; Zhang, Wei; Yin, XuRen; Hua, ZiChun; Yu, ChuanXin			Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum	PLOS ONE			English	Article							CRASSICEPS METACESTODE CYSTICERCI; AFFINITY-CHROMATOGRAPHY; ANTISCHISTOSOMAL DRUGS; ESCHERICHIA-COLI; MANSONI; PRAZIQUANTEL; INFECTION; PURIFICATION; SELENIUM; SENEGAL	Background: Schistosomiasis remains a major public health concern affecting billions of people around the world. Currently, praziquantel is the only drug of choice for treatment of human schistosomiasis. The emergence of drug resistance to praziquantel in schistosomes makes the development of novel drugs an urgent task. Thioredoxin glutathione reductase (TGR) enzymes in Schistosoma mansoni and some other platyhelminths have been identified as alternative targets. The present study was designed to confirm the existense and the potential value of TGR as a target for development of novel antischistosomal agents in Schistosoma japonicum, a platyhelminth endemic in Asia. Methods and Findings: After cloning the S. japonicum TGR (SjTGR) gene, the recombinant SjTGR selenoprotein was purified and characterized in enzymatic assays as a multifunctional enzyme with thioredoxin reductase (TrxR), glutathione reductase (GR) and glutaredoxin (Grx) activities. Immunological and bioinformatic analyses confirmed that instead of having separate TrxR and GR proteins in mammalian, S. japonicum only encodes TGR, which performs the functions of both enzymes and plays a critical role in maintaining the redox balance in this parasite. These results were in good agreement with previous findings in Schistosoma mansoni and some other platyhelminths. Auranofin, a known inhibitor against TGR, caused fatal toxicity in S. japonicum adult worms in vitro and reduced worm and egg burdens in S. japonicum infected mice. Conclusions: Collectively, our study confirms that a multifunctional enzyme SjTGR selenoprotein, instead of separate TrxR and GR enzymes, exists in S. japonicum. Furthermore, TGR may be a potential target for development of novel agents against schistosomes. This assumption is strengthened by our demonstration that the SjTGR is an essential enzyme for maintaining the thiol-disulfide redox homeostasis of S. japonicum.	[Song, LiJun; Qian, ChunYan; Wang, Jie; Zhang, Wei; Yin, XuRen; Yu, ChuanXin] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Li, JiaHuang; Hua, ZiChun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xie, ShuYing] Jiangxi Inst Parasit Dis, Dept Schistosomiasis Diag, Nanchang, Jiangxi, Peoples R China	Nanjing University	Song, LJ (corresponding author), Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	huazc@nju.edu.cn; chxnyu@163.com	song, lijun/ABB-7049-2021		National Natural Science Foundation of China [30972581, 50973046, 30821006]; National Key Basic Research Program in China [2007CB513100, 2011CB933502]; Natural Science Foundation of Jiangsu Province [BK2008110, BK2010046]; Special Fund for Public Interest of Science and Technology Department in Jiangsu Province [BM2007704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program in China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Special Fund for Public Interest of Science and Technology Department in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (30972581, 50973046, 30821006), the National Key Basic Research Program in China (2007CB513100, 2011CB933502), the Natural Science Foundation of Jiangsu Province (BK2008110, BK2010046) and the Special Fund for Public Interest of Science and Technology Department in Jiangsu Province (BM2007704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Alonso D, 2006, AM J TROP MED HYG, V74, P342, DOI 10.4269/ajtmh.2006.74.342; Angelucci F, 2010, J BIOL CHEM, V285, P32557, DOI 10.1074/jbc.M110.141960; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; BOGGARAM V, 1979, ANAL BIOCHEM, V98, P335, DOI 10.1016/0003-2697(79)90150-7; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1981, ANAL BIOCHEM, V116, P531, DOI 10.1016/0003-2697(81)90398-5; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; Coura JR, 2010, MEM I OSWALDO CRUZ, V105, P598, DOI 10.1590/S0074-02762010000400040; da Silva IM, 2005, MEM I OSWALDO CRUZ, V100, P445, DOI 10.1590/S0074-02762005000400018; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; FALLON PG, 1995, AM J TROP MED HYG, V53, P61, DOI 10.4269/ajtmh.1995.53.61; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Guevara-Flores A, 2010, J PARASITOL RES; Guevara-Flores A, 2011, PARASITOL INT, V60, P156, DOI 10.1016/j.parint.2011.01.005; Hao Yang, 2010, Chinese Journal of Schistosomiasis Control, V22, P521; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Magalhaes LG, 2010, PARASITOL RES, V106, P395, DOI 10.1007/s00436-009-1674-8; Martinez-Gonzalez JJ, 2010, PARASITOL RES, V107, P227, DOI 10.1007/s00436-010-1867-1; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759; Pennington JD, 2007, CURR PHARM DESIGN, V13, P3368, DOI 10.2174/138161207782360528; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Segel IH, 1993, ENZYME KINETIC; Spiga O, 2011, BIOPOLYMERS, V95, P278, DOI 10.1002/bip.21577; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tchuente LAT, 2001, T ROY SOC TROP MED H, V95, P65, DOI 10.1016/S0035-9203(01)90335-9; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wang W, 2010, PARASITOLOGY, V137, P1905, DOI 10.1017/S0031182010001204; *WHO, 2002, WHO TRAD MED STRAT 2; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; Xiao SH, 2009, PARASITOL RES, V106, P237, DOI 10.1007/s00436-009-1656-x; YOLLES TK, 1947, J PARASITOL, V33, P419, DOI 10.2307/3273678; Zhang JS, 2003, CARCINOGENESIS, V24, P497, DOI 10.1093/carcin/24.3.497	46	56	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31456	10.1371/journal.pone.0031456	http://dx.doi.org/10.1371/journal.pone.0031456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384025	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500020
J	Zhang, WP; Zhang, CR; Lv, ZB; Fang, DL; Wang, D; Nie, ZM; Yu, W; Lan, HL; Jiang, CY; Zhang, YZ				Zhang, Wenping; Zhang, Changrong; Lv, Zhengbing; Fang, Dailing; Wang, Dan; Nie, Zuoming; Yu, Wei; Lan, Hanglian; Jiang, Caiying; Zhang, Yaozhou			Molecular Characterization, Tissue Distribution, Subcellular Localization and Actin-Sequestering Function of a Thymosin Protein from Silkworm	PLOS ONE			English	Article							MESSENGER-RNA; GENE-PRODUCT; EXPRESSION; PEPTIDE; BINDING; ALPHA-1; THYMUS; POLYPEPTIDE-BETA-1; CHEMISTRY; EVOLUTION	We identified a novel gene encoding a Bombyx mori thymosin (BmTHY) protein from a cDNA library of silkworm pupae, which has an open reading frame (ORF) of 399 bp encoding 132 amino acids. It was found by bioinformatics that BmTHY gene consisted of three exons and two introns and BmTHY was highly homologous to thymosin betas (T beta). BmTHY has a conserved motif LKHTET with only one amino acid difference from LKKTET, which is involved in Tb binding to actin. A His-tagged BmTHY fusion protein (rBmTHY) with a molecular weight of approximately 18.4 kDa was expressed and purified to homogeneity. The purified fusion protein was used to produce anti-rBmTHY polyclonal antibodies in a New Zealand rabbit. Subcellular localization revealed that BmTHY can be found in both Bm5 cell (a silkworm ovary cell line) nucleus and cytoplasm but is primarily located in the nucleus. Western blotting and real-time RT-PCR showed that during silkworm developmental stages, BmTHY expression levels are highest in moth, followed by instar larvae, and are lowest in pupa and egg. BmTHY mRNA was universally distributed in most of fifth-instar larvae tissues (except testis). However, BmTHY was expressed in the head, ovary and epidermis during the larvae stage. BmTHY formed complexes with actin monomer, inhibited actin polymerization and cross-linked to actin. All the results indicated BmTHY might be an actin-sequestering protein and participate in silkworm development.	[Zhang, Wenping; Zhang, Changrong; Lv, Zhengbing; Fang, Dailing; Wang, Dan; Nie, Zuoming; Yu, Wei; Jiang, Caiying; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Lan, Hanglian] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang University	Zhang, WP (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China.	yaozhou@zstu.edu.cn			Zhejiang Natural Science Foundation [Y3110051]; National High-tech R&D Program of China [2011AA100603]; Zhejiang Provincial Education Department [Y201019098]; Zhejiang Sci-Tech University [1016846-Y, SWYX0915]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Education Department; Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was supported by the financial grants from Zhejiang Natural Science Foundation (No. Y3110051), National High-tech R&D Program of China (863 Program, No. 2011AA100603), Zhejiang Provincial Education Department Program (Y201019098) and Zhejiang Sci-Tech University (No. 1016846-Y and No. SWYX0915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2000, GENE, V260, P37, DOI 10.1016/S0378-1119(00)00452-2; BEPLER G, 1994, CANCER INVEST, V12, P491, DOI 10.3109/07357909409021409; Bodey B, 2000, INT J IMMUNOPHARMACO, V22, P261, DOI 10.1016/S0192-0561(99)00084-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Carlier MF, 2007, ANN NY ACAD SCI, V1112, P67, DOI 10.1196/annals.1415.037; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; Chen JQ, 2008, CELL TISSUE RES, V331, P725, DOI 10.1007/s00441-007-0516-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dhaese S, 2009, J MOL BIOL, V387, P809, DOI 10.1016/j.jmb.2009.02.026; FRASCA D, 1987, EUR J IMMUNOL, V17, P727, DOI 10.1002/eji.1830170524; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; GOLDSTEIN AL, 1994, CANCER INVEST, V12, P545, DOI 10.3109/07357909409021415; HADDEN JW, 1992, INT J IMMUNOPHARMACO, V14, P345, DOI 10.1016/0192-0561(92)90163-F; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Jacinto A, 2003, MECH DEVELOP, V120, P1337, DOI 10.1016/j.mod.2003.06.006; Kaur H, BIOCH BIOPHYS ACTA, V1800, P1256; Kellici Sueli, 2009, Med Arh, V63, P48; Kim YW, 2008, BIOCHEM BIOPH RES CO, V371, P664, DOI 10.1016/j.bbrc.2008.04.112; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; LEICHTLING KD, 1990, INT J IMMUNOPHARMACO, V12, P19, DOI 10.1016/0192-0561(90)90064-T; LOW TLK, 1979, J BIOL CHEM, V254, P987; LOW TLK, 1979, J BIOL CHEM, V254, P981; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Moon HS, 2006, EXP CELL RES, V312, P3425, DOI 10.1016/j.yexcr.2006.07.021; Nicole M, 1991, BIOCHEMISTRY-US, V21, P523; Nie ZM, 2009, APPL BIOCHEM BIOTECH, V158, P59, DOI 10.1007/s12010-008-8302-4; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Shen YF, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/416040; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Turrini P, 1998, J NEUROIMMUNOL, V82, P64, DOI 10.1016/S0165-5728(97)00189-6; Windmill KF, 1999, J REPROD IMMUNOL, V44, P29, DOI 10.1016/S0165-0378(99)00006-6; YU FX, 1993, J BIOL CHEM, V268, P502; ZATZ MM, 1985, J IMMUNOL, V134, P1032; Zhang YZ, 2007, APPL BIOCHEM BIOTECH, V136, P327, DOI 10.1007/s12010-007-9029-3; Zimin AV, 2008, BIOINFORMATICS, V24, P42, DOI 10.1093/bioinformatics/btm542; Zoubek RE, 2007, ANN NY ACAD SCI, V1112, P442, DOI 10.1196/annals.1415.031	45	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31040	10.1371/journal.pone.0031040	http://dx.doi.org/10.1371/journal.pone.0031040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383992	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500011
J	Cornish, GH; Tung, SL; Marshall, D; Ley, S; Seddon, BP				Cornish, Georgina H.; Tung, Sim L.; Marshall, Daniel; Ley, Steve; Seddon, Benedict P.			Tissue Specific Deletion of Inhibitor of Kappa B Kinase 2 with OX40-Cre Reveals the Unanticipated Expression from the OX40 Locus in Skin Epidermis	PLOS ONE			English	Article							T-CELLS; IKK COMPLEX; MOLECULAR CHARACTERIZATION; INCONTINENTIA PIGMENTI; LIVER DEGENERATION; MICE LACKING; IN-VIVO; ACTIVATION; INFLAMMATION; COMPONENT	NF-kappa B signalling plays an essential role in T cell activation and generation of regulatory and memory populations in vivo. In the present study, we aimed to investigate the role of NF-kappa B signalling in post-activation T cells using tissue specific ablation of inhibitor of kappa-B kinase 2 expression, an important component of the inhibitor of kappa-B kinase complex in canonical NF-kappa B signalling. The OX40 antigen is expressed on activated T cells. Therefore, we used previously described mouse strain expressing Cre recombinase from the endogenous OX40 locus. Ablation of IKK2 expression using OX40(Cre) mice resulted in the development of an inflammatory response in the skin epidermis causing wide spread skin lesions. The inflammatory response was characterised by extensive leukocytic infiltrate in skin tissue, hyperplasia of draining lymph nodes and widespread activation in the T cell compartment. Surprisingly, disease development did not depend on T cells but was rather associated with an unanticipated expression of Cre in skin epidermis, and activation of the T cell compartment did not require Ikbk2 deletion in T cells. Employment of Cre reporter strains revealed extensive Cre activity in skin epidermis. Therefore, development of skin lesions was rather more likely explained by deletion of Ikbk2 in skin keratinocytes in OX40(Cre) mice.	[Cornish, Georgina H.] Kings Coll London, Acad Dept Rheumatol, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Tung, Sim L.; Marshall, Daniel; Ley, Steve; Seddon, Benedict P.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of London; King's College London; MRC National Institute for Medical Research	Cornish, GH (corresponding author), Kings Coll London, Acad Dept Rheumatol, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	bseddon@nimr.mrc.ac.uk		Seddon, Benedict/0000-0003-4352-3373; Cornish, Georgina/0000-0002-1984-6677	Medical Research Council, U.K., [U117573801]; MRC [MC_U117573801] Funding Source: UKRI; Medical Research Council [MC_U117573801] Funding Source: researchfish	Medical Research Council, U.K.,(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, U.K., under programme code U117573801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1978, CELL, V15, P887, DOI 10.1016/0092-8674(78)90273-8; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Marques Rute, 2009, Journal of Biology (London), V8, P93, DOI 10.1186/jbiol194; McGowan K, 1998, Subcell Biochem, V31, P173; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Smahi A, 2000, NATURE, V405, P466; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JQ, 2010, EMBO J, V29, P3421, DOI 10.1038/emboj.2010.214; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	45	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32193	10.1371/journal.pone.0032193	http://dx.doi.org/10.1371/journal.pone.0032193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363815	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700156
J	Hovden, AO; Karlsen, M; Jonsson, R; Appel, S				Hovden, Arnt-Ove; Karlsen, Marie; Jonsson, Roland; Appel, Silke			The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; CYTOTOXIC T-LYMPHOCYTES; STREPTOCOCCAL PREPARATION; OK-432; CANCER; IMMUNOTHERAPY; ANTICANCER; MATURATION; LIGAND; ACID	Dendritic cells (DC) used in therapeutic cancer immunotherapy have to be able to stimulate T cells resulting in an immune response that can efficiently target the cancer cells. One of the critical hurdles has been the lack of IL-12p70 production when maturating the DC, which is rectified by using the bacterial preparation OK432 (trade name Picibanil) to mature the cells. In order to identify the mechanism behind OK432 stimulation of DC, we investigated the contribution of different TLR to examine their involvement in IL-12p70 production. By combining different inhibitors of TLR signaling, we demonstrate here that TLR3 is responsible for the IL-12p70 production of DC induced by OK432. Moreover, our data suggest that the ligand triggering IL-12p70 secretion upon TLR3 stimulation is sensitive to proteinase and partly also RNAse treatment. The fact that a bacterial compound like OK432 can activate the TLR3 pathway in human DC is a novel finding. OK432 demonstrates a critical ability to induce IL-12p70 production, which is of great relevance in DC based cancer immunotherapy.	[Hovden, Arnt-Ove; Karlsen, Marie; Jonsson, Roland; Appel, Silke] Univ Bergen, Gade Inst, Broegelmann Res Lab, Bergen, Norway	University of Bergen	Hovden, AO (corresponding author), Bionor Pharma, Skien, Norway.	silke.appel@gades.uib.no		Appel, Silke/0000-0002-2199-2315	Bergen Translational Research Fund; Bergen Research Foundation; Norwegian Cancer Society; Kreftforeningens paraplystiftelse for kreftforskning; Broegelmann Legacy	Bergen Translational Research Fund; Bergen Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Kreftforeningens paraplystiftelse for kreftforskning; Broegelmann Legacy	This work was supported by grants from Bergen Translational Research Fund (to SA), Bergen Research Foundation (to SA), Norwegian Cancer Society (to SA), Kreftforeningens paraplystiftelse for kreftforskning (to A-OH), and Broegelmann Legacy (to RJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2004, J IMMUNOTHER, V27, P432, DOI 10.1097/00002371-200411000-00003; Aksoy E, 2005, J BIOL CHEM, V280, P277, DOI 10.1074/jbc.M411223200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Cristina GM, 2010, IMMUNOBIOLOGY, V215, P713; Derbigny WA, 2010, J IMMUNOL; EDY VG, 1976, EUR J BIOCHEM, V61, P563, DOI 10.1111/j.1432-1033.1976.tb10051.x; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hovden AO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-2; Itoh T, 2003, CANCER IMMUNOL IMMUN, V52, P207, DOI 10.1007/s00262-002-0337-8; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kim SY, 1998, CANCER-AM CANCER SOC, V83, P2054, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2054::AID-CNCR2>3.0.CO;2-1; Kontani K, 2007, ONCOL REP, V17, P895; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Naito K, 2006, INT J ONCOL, V28, P1481; Nakahara S, 2003, CANCER RES, V63, P4112; Nakamoto Y, 2011, CLIN EXP IMMUNOL, V163, P165, DOI 10.1111/j.1365-2249.2010.04246.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; OKAMOTO H, 1967, JPN J MICROBIOL, V11, P323, DOI 10.1111/j.1348-0421.1967.tb00350.x; OKAMOTO M, 1993, J IMMUNOTHER, V13, P232, DOI 10.1097/00002371-199305000-00002; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Okazaki T, 2007, J PEDIATR SURG, V42, P386, DOI 10.1016/j.jpedsurg.2006.10.012; Osada T, 2006, INT REV IMMUNOL, V25, P377, DOI 10.1080/08830180600992456; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pan K, 2009, IMMUNOBIOLOGY, V214, P350, DOI 10.1016/j.imbio.2008.10.008; Rescigno M, 2010, EUR J IMMUNOL, V40, P2119, DOI 10.1002/eji.201040474; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sakamoto J, 2002, J IMMUNOTHER, V25, P405, DOI 10.1097/00002371-200209000-00004; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Woolley SL, 2008, J LARYNGOL OTOL, P1	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31217	10.1371/journal.pone.0031217	http://dx.doi.org/10.1371/journal.pone.0031217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363584	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700034
J	Kawafune, K; Hongoh, Y; Hamaji, T; Nozaki, H				Kawafune, Kaoru; Hongoh, Yuichi; Hamaji, Takashi; Nozaki, Hisayoshi			Molecular Identification of Rickettsial Endosymbionts in the Non-Phagotrophic Volvocalean Green Algae	PLOS ONE			English	Article							RIBOSOMAL-RNA; CARTERIA VOLVOCALES; DNA; EVOLUTION; CHLOROPHYTA; BACTERIA; ULTRASTRUCTURE; PHYLOGENIES; PLEODORINA; CILIOPHORA	The order Rickettsiales comprises Gram-negative obligate intracellular bacteria (also called rickettsias) that are mainly associated with arthropod hosts. This group is medically important because it contains human-pathogenic species that cause dangerous diseases. Until now, there has been no report of non-phagotrophic photosynthetic eukaryotes, such as green plants, harboring rickettsias. Methodology/Principal Findings: We examined the bacterial endosymbionts of two freshwater volvocalean green algae: unicellular Carteria cerasiformis and colonial Pleodorina japonica. Epifluorescence microscopy using 4'-6-deamidino-2-phenylindole staining revealed the presence of endosymbionts in all C. cerasiformis NIES-425 cells, and demonstrated a positive correlation between host cell size and the number of endosymbionts. Strains both containing and lacking endosymbionts of C. cerasiformis (NIES-425 and NIES-424) showed > 10-fold increase in cell number and typical sigmoid growth curves over 192 h. A phylogenetic analysis of 16 S ribosomal (r) RNA gene sequences from the endosymbionts of C. cerasiformis and P. japonica demonstrated that they formed a robust clade (hydra group) with endosymbionts of various non-arthropod hosts within the family Rickettsiaceae. There were significantly fewer differences in the 16 S rRNA sequences of the rickettsiacean endosymbionts between C. cerasiformis and P. japonica than in the chloroplast 16 S rRNA or 18 S rRNA of the host volvocalean cells. Fluorescence in situ hybridization demonstrated the existence of the rickettsiacean endosymbionts in the cytoplasm of two volvocalean species. Conclusions/Significance: The rickettsiacean endosymbionts are likely not harmful to their volvocalean hosts and may have been recently transmitted from other non-arthropod organisms. Because rickettsias are the closest relatives of mitochondria, incipient stages of mitochondrial endosymbiosis may be deduced using both strains with and without C. cerasiformis endosymbionts.	[Kawafune, Kaoru; Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Hongoh, Yuichi] Tokyo Inst Technol, Dept Biol Sci, Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Hamaji, Takashi] Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kyoto, Japan	University of Tokyo; Tokyo Institute of Technology; Kyoto University	Kawafune, K (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@biol.s.u-tokyo.ac.jp	Hongoh, Yuichi/A-2303-2014; NOZAKI, HISAYOSHI/G-4926-2014	Hongoh, Yuichi/0000-0002-5901-9625; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498	Ministry of Education, Culture, Sports, Science and Technology, Japan [20247032, 22112505]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (nos. 20247032 and 22112505 to HN) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/english/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Becker B, 2007, INT REV CYTOL, V264, P1, DOI 10.1016/S0074-7696(07)64001-7; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Dumler JS, 2005, BERGEYS MANUAL SYSTE, V2, P96; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Fawley MW, 2004, J PHYCOL, V40, P223, DOI 10.1111/j.0022-3646.2004.03-081.x; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Ge Y, 2011, MICROBES INFECT, V13, P638, DOI 10.1016/j.micinf.2011.03.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hine PM, 2002, DIS AQUAT ORGAN, V49, P207, DOI 10.3354/dao049207; ICHIMURA T, 1977, Bulletin of the Japanese Society of Phycology, V25, P177; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kikuchi Y, 2005, MICROBIAL ECOL, V49, P265, DOI 10.1007/s00248-004-0140-5; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kim E, 2010, ISME J, V4, P1108, DOI 10.1038/ismej.2010.40; KOCHERT G, 1970, T AM MICROSC SOC, V89, P475, DOI 10.2307/3224556; KUROIWA T, 1981, EXPERIENTIA, V37, P969, DOI 10.1007/BF01971784; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Nakada T, 2007, EUR J PHYCOL, V42, P177, DOI 10.1080/09670260601145816; Nakazawa Atsushi, 2004, Journal of Japanese Botany, V79, P255; Noda S, 2003, APPL ENVIRON MICROB, V69, P625, DOI 10.1128/AEM.69.1.625-633.2003; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; NOZAKI H, 1994, PHYCOLOGIA, V33, P239, DOI 10.2216/i0031-8884-33-4-239.1; Nozaki H, 1997, J PHYCOL, V33, P864, DOI 10.1111/j.0022-3646.1997.00864.x; Nozaki H, 2002, MOL PHYLOGENET EVOL, V23, P326, DOI 10.1016/S1055-7903(02)00030-1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki Hisayoshi, 2003, P225, DOI 10.1016/B978-012741550-5/50007-6; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sun HY, 2009, APPL ENVIRON MICROB, V75, P7445, DOI 10.1128/AEM.00850-09; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vannini C, 2005, MICROB ECOL, V49, P434, DOI 10.1007/s00248-004-0055-1; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	52	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31749	10.1371/journal.pone.0031749	http://dx.doi.org/10.1371/journal.pone.0031749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363720	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700089
J	Lin, WY; Lee, WC				Lin, Wan-Yu; Lee, Wen-Chung			Presenting the Uncertainties of Odds Ratios Using Empirical-Bayes Prediction Intervals	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CONFIDENCE-INTERVALS; MAXIMUM-LIKELIHOOD; ASSOCIATION; SERIES	Quantifying exposure-disease associations is a central issue in epidemiology. Researchers of a study often present an odds ratio (or a logarithm of odds ratio, logOR) estimate together with its confidence interval (CI), for each exposure they examined. Here the authors advocate using the empirical-Bayes-based 'prediction intervals' (PIs) to bound the uncertainty of logORs. The PI approach is applicable to a panel of factors believed to be exchangeable (no extra information, other than the data itself, is available to distinguish some logORs from the others). The authors demonstrate its use in a genetic epidemiological study on age-related macular degeneration (AMD). The proposed PIs can enjoy straightforward probabilistic interpretations-a 95% PI has a probability of 0.95 to encompass the true value, and the expected number of true values that are being encompassed is 0.95m for a total of m 95% PIs. The PI approach is theoretically more efficient (producing shorter intervals) than the traditional CI approach. In the AMD data, the average efficiency gain is 51.2%. The PI approach is advocated to present the uncertainties of many logORs in a study, for its straightforward probabilistic interpretations and higher efficiency while maintaining the nominal coverage probability.	[Lin, Wan-Yu; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Wan-Yu] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; University of Alabama System; University of Alabama Birmingham; National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw	Huang, HsiaoYuan/F-5985-2012	LIN, WAN-YU/0000-0002-3385-4702; Lee, Wen-Chung/0000-0003-3171-7672	National Science Councils, Taiwan	National Science Councils, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Councils, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, STAT METHODS MED RES, V12, P3, DOI 10.1191/0962280203sm311ra; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cox DR, 1974, THEORETICAL STAT; Datta S, 2005, BIOINFORMATICS, V21, P1987, DOI 10.1093/bioinformatics/bti301; Datta S, 2004, BIOINFORMATICS, V20, P235, DOI 10.1093/bioinformatics/btg396; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B, 2009, J AM STAT ASSOC, V104, P1015, DOI 10.1198/jasa.2009.tm08523; Gelman A., 2004, BAYESIAN DATA ANAL; GREENLAND S, 1993, STAT MED, V12, P717, DOI 10.1002/sim.4780120802; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; He K., 1992, STAT-US, V10, P121; Heron EA, 2011, BIOSTATISTICS, V12, P445, DOI 10.1093/biostatistics/kxq072; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hwang JTG, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1587; Hwang JTG, 2009, J ROY STAT SOC B, V71, P265, DOI 10.1111/j.1467-9868.2008.00681.x; King EN, 2002, AM STAT, V56, P163, DOI 10.1198/00031300283; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraemer HC, 2004, STAT MED, V23, P257, DOI 10.1002/sim.1714; LAIRD NM, 1987, J AM STAT ASSOC, V82, P739, DOI 10.2307/2288778; LAIRD NM, 1989, BIOMETRICS, V45, P481, DOI 10.2307/2531491; Lin Wan-Yu, 2010, BMC Res Notes, V3, P26, DOI 10.1186/1756-0500-3-26; Lin Y, 2003, STAT APPL GENET MOL, V2; Morris C, 1983, PARAMETRIC EMPIRICAL, P25; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Qiu J, 2007, BIOMETRICS, V63, P767, DOI 10.1111/j.1541-0420.2007.00770.x; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Robbins H, 1956, P 3 BERK S MATH STAT, V1, P157; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schaid DJ, 2004, GENETICS, V166, P505, DOI 10.1534/genetics.166.1.505; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stromberg U, 2009, EUR J EPIDEMIOL, V24, P737, DOI 10.1007/s10654-009-9393-0; t Mannetje A, 2008, OCCUP ENVIRON MED, V65, P354, DOI 10.1136/oem.2007.035014; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Zaykin DV, 2004, GENET EPIDEMIOL, V27, P252, DOI 10.1002/gepi.20015; Zhao YJ, 2010, INT J ENV RES PUB HE, V7, P380, DOI 10.3390/ijerph7020380	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32022	10.1371/journal.pone.0032022	http://dx.doi.org/10.1371/journal.pone.0032022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363789	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700135
J	Ochs, MJ; Sorg, BL; Pufahl, L; Grez, M; Suess, B; Steinhilber, D				Ochs, Meike J.; Sorg, Bernd L.; Pufahl, Laura; Grez, Manuel; Suess, Beatrix; Steinhilber, Dieter			Post-Transcriptional Regulation of 5-Lipoxygenase mRNA Expression via Alternative Splicing and Nonsense-Mediated mRNA Decay	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; CELLS; LEUKOTRIENES; PROTEIN; NMD; DNA	5-Lipoxygenase (5-LO) catalyzes the two initial steps in the biosynthesis of leukotrienes (LT), a group of inflammatory lipid mediators derived from arachidonic acid. Here, we investigated the regulation of 5-LO mRNA expression by alternative splicing and nonsense-mediated mRNA decay (NMD). In the present study, we report the identification of 2 truncated transcripts and 4 novel 5-LO splice variants containing premature termination codons (PTC). The characterization of one of the splice variants, 5-LO Delta 3, revealed that it is a target for NMD since knockdown of the NMD factors UPF1, UPF2 and UPF3b in the human monocytic cell line Mono Mac 6 (MM6) altered the expression of 5-LO Delta 3 mRNA up to 2-fold in a cell differentiation-dependent manner suggesting that cell differentiation alters the composition or function of the NMD complex. In contrast, the mature 5-LO mRNA transcript was not affected by UPF knockdown. Thus, the data suggest that the coupling of alternative splicing and NMD is involved in the regulation of 5-LO gene expression.	[Ochs, Meike J.; Sorg, Bernd L.; Pufahl, Laura; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Ochs, Meike J.; Suess, Beatrix] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Ochs, MJ (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany.	suess@bio.uni-frankfurt.de; steinhilber@em.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012		Deutsche Forschungsgemeinschaft [GRK757]; CEF; ECCPS; Aventis Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CEF; ECCPS; Aventis Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt	The study was supported by the Deutsche Forschungsgemeinschaft (GRK757, CEF and ECCPS), (http://www.dfg.de), the Aventis Foundation (http://www.aventis-foundation.org), and LOEWE Center for Cell and Gene Therapy Frankfurt (B.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselta R, 2010, BLOOD, V115, P2065, DOI 10.1182/blood-2009-09-245092; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; COFFEY MJ, 1993, J LIPID MEDIATOR, V6, P43; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harle D, 1998, EUR J BIOCHEM, V254, P275, DOI 10.1046/j.1432-1327.1998.2540275.x; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Stoffers KL, 2010, J MOL BIOL, V395, P884, DOI 10.1016/j.jmb.2009.10.022; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Werz O, 2005, P NATL ACAD SCI USA, V102, P13164, DOI 10.1073/pnas.0505991102; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	26	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31363	10.1371/journal.pone.0031363	http://dx.doi.org/10.1371/journal.pone.0031363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363630	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700053
J	Tan, CW; Gardiner, BS; Hirokawa, Y; Layton, MJ; Smith, DW; Burgess, AW				Tan, Chin Wee; Gardiner, Bruce S.; Hirokawa, Yumiko; Layton, Meredith J.; Smith, David W.; Burgess, Antony W.			Wnt Signalling Pathway Parameters for Mammalian Cells	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; BETA-CATENIN DEGRADATION; APC TUMOR-SUPPRESSOR; FUNCTIONAL INTERACTION; PROTEIN ASSEMBLIES; COLORECTAL-CANCER; SYSTEMS BIOLOGY; CANINE KIDNEY; AXIN; ADHESION	Wnt/beta-catenin signalling regulates cell fate, survival, proliferation and differentiation at many stages of mammalian development and pathology. Mutations of two key proteins in the pathway, APC and beta-catenin, have been implicated in a range of cancers, including colorectal cancer. Activation of Wnt signalling has been associated with the stabilization and nuclear accumulation of beta-catenin and consequential up-regulation of beta-catenin/TCF gene transcription. In 2003, Lee et al. constructed a computational model of Wnt signalling supported by experimental data from analysis of time-dependent concentration of Wnt signalling proteins in Xenopus egg extracts. Subsequent studies have used the Xenopus quantitative data to infer Wnt pathway dynamics in other systems. As a basis for understanding Wnt signalling in mammalian cells, a confocal live cell imaging measurement technique is developed to measure the cell and nuclear volumes of MDCK, HEK293T cells and 3 human colorectal cancer cell lines and the concentrations of Wnt signalling proteins beta-catenin, Axin, APC, GSK3 beta and E-cadherin. These parameters provide the basis for formulating Wnt signalling models for kidney/intestinal epithelial mammalian cells. There are significant differences in concentrations of key proteins between Xenopus extracts and mammalian whole cell lysates. Higher concentrations of Axin and lower concentrations of APC are present in mammalian cells. Axin concentrations are greater than APC in kidney epithelial cells, whereas in intestinal epithelial cells the APC concentration is higher than Axin. Computational simulations based on Lee's model, with this new data, suggest a need for a recalibration of the model. A quantitative understanding of Wnt signalling in mammalian cells, in particular human colorectal cancers requires a detailed understanding of the concentrations of key protein complexes over time. Simulations of Wnt signalling in mammalian cells can be initiated with the parameters measured in this report.	[Tan, Chin Wee; Hirokawa, Yumiko; Layton, Meredith J.; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia; [Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Fac Engn Comp & Math, Perth, WA 6009, Australia; [Tan, Chin Wee] Univ Melbourne, Melbourne Sch Engn, Parkville, Vic 3052, Australia	Ludwig Institute for Cancer Research; University of Western Australia; University of Melbourne	Tan, CW (corresponding author), Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia.	chin.tan@ludwig.edu.au	Smith, David W/H-5856-2014; Tan, Chin Wee/B-1584-2015; Gardiner, Bruce/C-8593-2012	Smith, David W/0000-0003-4864-0288; Tan, Chin Wee/0000-0001-9695-7218; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council (NHMRC) [542531]; Victorian Government, Australia; Program Grant [487922]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government, Australia; Program Grant	This work was funded by the National Health and Medical Research Council (NHMRC) Project Grant 542531 "Wnt signalling in colon cancer'', Program Grant 487922 "Colorectal cancer - molecular basis to targeted therapeutics'', and by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally the manuscript is solely the responsibility of the institutions and individual authors and does not reflect the views of NHMRC.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bush PG, 2005, OSTEOARTHR CARTILAGE, V13, P54, DOI 10.1016/j.joca.2004.10.007; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X; FARINAS J, 1995, BIOPHYS J, V68, P1613, DOI 10.1016/S0006-3495(95)80335-8; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Faux MC, 2008, ONCOGENE; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; LEIGHTON J, 1969, SCIENCE, V163, P472, DOI 10.1126/science.163.3866.472; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mariadason JM, 2001, CANCER RES, V61, P3465; Mathworks, 2007, MATLAB VERS 7 4 0 28; Migita S, 2010, ANAL METHODS-UK, V2, P657, DOI 10.1039/c0ay00039f; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Polakis P, 2000, GENE DEV, V14, P1837; POOLE CA, 1993, J CELL SCI, V106, P685; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; ROY G, 1987, J MEMBRANE BIOL, V100, P83, DOI 10.1007/BF02209143; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun YC, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-13; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; YCAS M, 1965, J THEOR BIOL, V9, P444; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	76	80	86	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31882	10.1371/journal.pone.0031882	http://dx.doi.org/10.1371/journal.pone.0031882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363759	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700114
J	West, L; Vidwans, SJ; Campbell, NP; Shrager, J; Simon, GR; Bueno, R; Dennis, PA; Otterson, GA; Salgia, R				West, Lisandra; Vidwans, Smruti J.; Campbell, Nicholas P.; Shrager, Jeff; Simon, George R.; Bueno, Raphael; Dennis, Phillip A.; Otterson, Gregory A.; Salgia, Ravi			A Novel Classification of Lung Cancer into Molecular Subtypes	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; PLEURAL MALIGNANT MESOTHELIOMA; 188 CONSECUTIVE PATIENTS; EML4-ALK FUSION GENE; K-RAS; ACQUIRED-RESISTANCE; BCL-2 OVEREXPRESSION; MONOCLONAL-ANTIBODY; KRAS MUTATIONS; T790M MUTATION	The remarkably heterogeneous nature of lung cancer has become more apparent over the last decade. In general, advanced lung cancer is an aggressive malignancy with a poor prognosis. The discovery of multiple molecular mechanisms underlying the development, progression, and prognosis of lung cancer, however, has created new opportunities for targeted therapy and improved outcome. In this paper, we define "molecular subtypes'' of lung cancer based on specific actionable genetic aberrations. Each subtype is associated with molecular tests that define the subtype and drugs that may potentially treat it. We hope this paper will be a useful guide to clinicians and researchers alike by assisting in therapy decision making and acting as a platform for further study. In this new era of cancer treatment, the 'one-size-fits-all' paradigm is being forcibly pushed aside-allowing for more effective, personalized oncologic care to emerge.	[Campbell, Nicholas P.; Salgia, Ravi] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [West, Lisandra; Vidwans, Smruti J.; Shrager, Jeff] CollabRx Inc, Palo Alto, CA USA; [Shrager, Jeff] Stanford Univ, Symbol Syst Program Consulting, Stanford, CA 94305 USA; [Simon, George R.] Med Univ S Carolina, Dept Med, Hematol Oncol Sect, Charleston, SC 29425 USA; [Bueno, Raphael] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Otterson, Gregory A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Dennis, Phillip A.] NCI, Bethesda, MD 20892 USA	University of Chicago; Stanford University; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Salgia, R (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu			NATIONAL CANCER INSTITUTE [ZIASC010292, ZIABC010748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Amann JM, 2010, J THORAC ONCOL, V5, P169, DOI 10.1097/JTO.0b013e3181c8cbd9; Biroccio A, 2000, FASEB J, V14, P652, DOI 10.1096/fasebj.14.5.652; BOS JL, 1989, CANCER RES, V49, P4682; BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V; BOUTIN C, 1993, CANCER, V72, P394, DOI 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2009, CLIN LUNG CANCER, V10, P262, DOI 10.3816/CLC.2009.n.037; Carbone DP, 2010, LUNG CANCER, V69, P337, DOI 10.1016/j.lungcan.2009.11.019; Chung CH, 2010, CANCER EPIDEM BIOMAR, V19, P358, DOI 10.1158/1055-9965.EPI-09-0937; Cristaudo A, 2005, CANCER RES, V65, P3049, DOI 10.1158/0008-5472.CAN-04-2219; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Fernandez A, 2001, J NATL CANCER I, V93, P208, DOI 10.1093/jnci/93.3.208; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gordon MS, 2010, CLIN CANCER RES, V16, P699, DOI 10.1158/1078-0432.CCR-09-1365; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Hirsch FR, 2003, LUNG CANCER, V41, pS29, DOI 10.1016/S0169-5002(03)00137-5; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; IKEGAKI N, 1994, CANCER RES, V54, P6; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jassem J, 2010, J CLIN ONCOL, V28; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JIANG SX, 1995, J PATHOL, V177, P135, DOI 10.1002/path.1711770206; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kanteti R, 2009, J ENVIRON PATHOL TOX, V28, P89, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.10; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kelly K, 2009, EXPERT OPIN BIOL TH, V9, P817, DOI 10.1517/14712590903002039; Kim ES, 2009, J THORAC ONCOL, V4, P444, DOI 10.1097/JTO.0b013e31819d6f91; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Lucchi M, 2002, EUR J CARDIO-THORAC, V21, P1105, DOI 10.1016/S1010-7940(02)00112-4; Ludovini V, 2011, J THORAC ONCOL, V6, P707, DOI 10.1097/JTO.0b013e31820a3a6b; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Manfredi JJ, 2005, CANCER RES, V65, P2602, DOI 10.1158/0008-5472.CAN-04-2461; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mollberg N, 2011, ADV THER, V28, P173, DOI 10.1007/s12325-010-0103-9; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nakagawa M, 2012, CLIN LUNG CANCER, V13, P136, DOI 10.1016/j.cllc.2011.10.006; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Onitsuka T, 2010, LUNG CANCER, V68, P198, DOI 10.1016/j.lungcan.2009.05.022; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Przybojewska B, 2000, CANCER GENET CYTOGEN, V121, P73, DOI 10.1016/S0165-4608(00)00223-5; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Roushdy-Hammady I, 2001, LANCET, V357, P444, DOI 10.1016/S0140-6736(00)04013-7; Rudin Charles M, 2008, J Natl Compr Canc Netw, V6, P315; Rudin CM, 2004, J CLIN ONCOL, V22, P1110, DOI 10.1200/JCO.2004.10.148; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spigel DR, 2011, J CLIN ONCOL S, V29; Stefanaki K, 1998, ANTICANCER RES, V18, P1689; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Sudhir PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020199; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Toulany M, 2005, RADIOTHER ONCOL, V76, P143, DOI 10.1016/j.radonc.2005.06.024; Van Damme N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-189; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zangemeister-Wittke U, 1998, BRIT J CANCER, V78, P1035, DOI 10.1038/bjc.1998.624; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhu WG, 2001, CANCER RES, V61, P1327	92	82	89	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31906	10.1371/journal.pone.0031906	http://dx.doi.org/10.1371/journal.pone.0031906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363766	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700120
J	Wiese, M; Antebi, A; Zheng, H				Wiese, Mary; Antebi, Adam; Zheng, Hui			Regulation of Neuronal APL-1 Expression by Cholesterol Starvation	PLOS ONE			English	Article							BETA-AMYLOID PRECURSOR; CAENORHABDITIS-ELEGANS; APOLIPOPROTEIN-E; DAUER FORMATION; DISEASE; PROTEIN; GENE; REPRODUCTION; REQUIREMENT; RECEPTORS	Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of beta-amyloid plaques composed primarily of the amyloid-beta peptide, a cleavage product of amyloid precursor protein (APP). While mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), sporadic AD has only one clear genetic modifier: the epsilon 4 allele of the apolipoprotein E (ApoE) gene. Cholesterol starvation in Caenorhabditis elegans leads to molting and arrest phenotypes similar to loss-of-function mutants of the APP ortholog, apl-1 (amyloid precursor-like protein 1), and lrp-1 (lipoprotein receptor-related protein 1), suggesting a potential interaction between apl-1 and cholesterol metabolism. Methodology/Principal Findings: Previously, we found that RNAi knock-down of apl-1 leads to aldicarb hypersensitivity, indicating a defect in synaptic function. Here we find the same defect is recapitulated during lrp-1 knock-down and by cholesterol starvation. A cholesterol-free diet or loss of lrp-1 directly affects APL-1 levels as both lead to loss of APL-1::GFP fluorescence in neurons. However, loss of cholesterol does not affect global transcription or protein levels as seen by qPCR and Western blot. Conclusions: Our results show that cholesterol and lrp-1 are involved in the regulation of synaptic transmission, similar to apl-1. Both are able to modulate APL-1 protein levels in neurons, however cholesterol changes do not affect global apl-1 transcription or APL-1 protein indicating the changes are specific to neurons. Thus, regulation of synaptic transmission and molting by LRP-1 and cholesterol may be mediated by their ability to control APL-1 neuronal protein expression.	[Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Antebi, Adam] Max Planck Inst Biol Ageing, Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Wiese, M (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	aantebi@bcm.edu; huiz@bcm.edu			NIH [AG032051, AG033467, AG027498]; American Health and Assistance Foundation [A2008-052]; NATIONAL INSTITUTE ON AGING [R01AG033467, R01AG032051, R01AG027498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health and Assistance Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (AG032051, AG033467, and AG027498) and the American Health and Assistance Foundation (A2008-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi Adam, 2006, WormBook, P1; Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; BRENNER S, 1974, GENETICS, V77, P71; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Hada K, 2010, DEV BIOL, V344, P1100, DOI 10.1016/j.ydbio.2010.05.508; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sluder AE, 1999, GENOME RES, V9, P103; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sym M, 2000, CURR BIOL, V10, P527, DOI 10.1016/S0960-9822(00)00468-1; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Wiese M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012790; Wood WB, 1988, NEMATODE CAENORHABDI, Vxiii; Wustner D, 2010, TRAFFIC, V11, P440, DOI 10.1111/j.1600-0854.2010.01040.x; Yochem J, 1999, DEVELOPMENT, V126, P597	30	8	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32038	10.1371/journal.pone.0032038	http://dx.doi.org/10.1371/journal.pone.0032038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363792	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700137
J	Abela, E; Missimer, J; Wiest, R; Federspiel, A; Hess, C; Sturzenegger, M; Weder, B				Abela, Eugenio; Missimer, John; Wiest, Roland; Federspiel, Andrea; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno			Lesions to Primary Sensory and Posterior Parietal Cortices Impair Recovery from Hand Paresis after Stroke	PLOS ONE			English	Article							TACTILE OBJECT DISCRIMINATION; PREDICTS MOTOR IMPAIRMENT; ARM FUNCTION; FRONTOPARIETAL CIRCUIT; SERIAL MEASUREMENTS; CORTEX; PERFORMANCE; FMRI; CONNECTIVITY; STRENGTH	Background: Neuroanatomical determinants of motor skill recovery after stroke are still poorly understood. Although lesion load onto the corticospinal tract is known to affect recovery, less is known about the effect of lesions to cortical sensorimotor areas. Here, we test the hypothesis that lesions of somatosensory cortices interfere with the capacity to recover motor skills after stroke. Methods: Standardized tests of motor skill and somatosensory functions were acquired longitudinally over nine months in 29 patients with stroke to the pre- and postcentral gyrus, including adjacent areas of the frontal, parietal and insular cortices. We derived the recovery trajectories of each patient for five motor subtest using least-squares curve fitting and objective model selection procedures for linear and exponential models. Patients were classified into subgroups based on their motor recovery models. Lesions were mapped onto diffusion weighted imaging scans and normalized into stereotaxic space using cost-function masking. To identify critical neuranatomical regions, voxel-wise subtractions were calculated between subgroup lesion maps. A probabilistic cytoarchitectonic atlas was used to quantify of lesion extent and location. Results: Twenty-three patients with moderate to severe initial deficits showed exponential recovery trajectories for motor subtests that relied on precise distal movements. Those that retained a chronic motor deficit had lesions that extended to the center of the somatosensory cortex (area 2) and the intraparietal sulcus (areas hIP1, hIP2). Impaired recovery outcome correlated with lesion extent on this areas and somatosensory performance. The rate of recovery, however, depended on the lesion load onto the primary motor cortex (areas 4a, 4p). Conclusions: Our findings support a critical role of uni-and multimodal somatosensory cortices in motor skill recovery. Whereas lesions to these areas influence recovery outcome, lesions to the primary motor cortex affect recovery dynamics. This points to a possible dissociation of neural substrates for different aspects of post-stroke recovery.	[Abela, Eugenio; Weder, Bruno] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Missimer, John] Paul Scherrer Inst, Villigen, Switzerland; [Abela, Eugenio; Wiest, Roland] Univ Hosp Inselspital, SCAN, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Abela, Eugenio; Wiest, Roland; Federspiel, Andrea; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno] Univ Bern, Bern, Switzerland; [Abela, Eugenio; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno] Univ Hosp Inselspital, Dept Neurol, Bern, Switzerland; [Federspiel, Andrea] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland	Kantonsspital St. Gallen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Abela, E (corresponding author), Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.	bruno.weder@kssg.ch	Federspiel, Andrea/E-8342-2010	Federspiel, Andrea/0000-0003-3211-2675; Weder, Bruno/0000-0002-8106-9899; Abela, Eugenio/0000-0002-9356-1450	Swiss National Foundation [SNF 3200B0-118018]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was funded by a Swiss National Foundation grant (SNF 3200B0-118018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amunts K, 2001, NEUROIMAG CLIN N AM, V11, P151; Binkofski F, 2001, CEREBROVASC DIS, V11, P273, DOI 10.1159/000047650; Binkofski F, 2001, BRAIN, V124, P132, DOI 10.1093/brain/124.1.132; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bohlhalter S, 2002, BRAIN, V125, P2537, DOI 10.1093/brain/awf245; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; HIKOSAKA O, 1985, BRAIN RES, V325, P375, DOI 10.1016/0006-8993(85)90344-0; Homke L, 2009, HUM BRAIN MAPP, V30, P1444, DOI 10.1002/hbm.20617; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Karnath HO, 2010, BRAIN, V134, P903; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Luft AR, 2004, LEARN MEMORY, V11, P379, DOI 10.1101/lm.72604; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Lyden P D, 1998, J Stroke Cerebrovasc Dis, V7, P113; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nowak DA, 2008, NEUROSCI BIOBEHAV R, V32, P1439, DOI 10.1016/j.neubiorev.2008.05.021; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Papageorgiou E, 2008, NEUROLOGY, V70, P956, DOI 10.1212/01.wnl.0000305962.93520.ed; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Platz T, 1999, ARCH PHYS MED REHAB, V80, P270, DOI 10.1016/S0003-9993(99)90137-5; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; SENN S, 1990, BRIT MED J, V300, P680, DOI 10.1136/bmj.300.6725.680; STERN EB, 1992, AM J OCCUP THER, V46, P647, DOI 10.5014/ajot.46.7.647; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; SUNDERLAND A, 1989, J NEUROL NEUROSUR PS, V52, P1267, DOI 10.1136/jnnp.52.11.1267; Verheyden G, 2008, NEUROREHAB NEURAL RE, V22, P173, DOI 10.1177/1545968307305456; Vidoni ED, 2010, NEUROBIOL LEARN MEM, V93, P532, DOI 10.1016/j.nlm.2010.01.011; Vidoni ED, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-36; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Wu CY, 2000, ARCH PHYS MED REHAB, V81, P95, DOI 10.1053/apmr.2000.0810095; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	54	50	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31275	10.1371/journal.pone.0031275	http://dx.doi.org/10.1371/journal.pone.0031275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363604	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500030
J	Cheng, CY; Shaw, N; Zhang, XJ; Zhang, M; Ding, W; Wang, BC; Liu, ZJ				Cheng, Chongyun; Shaw, Neil; Zhang, Xuejun; Zhang, Min; Ding, Wei; Wang, Bi-Cheng; Liu, Zhi-Jie			Structural View of a Non Pfam Singleton and Crystal Packing Analysis	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECOGNITION; INFERENCE; CLEAVAGE; SEQUENCE; LIGANDS; ORIGIN; GENES; RNA	Background: Comparative genomic analysis has revealed that in each genome a large number of open reading frames have no homologues in other species. Such singleton genes have attracted the attention of biochemists and structural biologists as a potential untapped source of new folds. Cthe_2751 is a 15.8 kDa singleton from an anaerobic, hyperthermophile Clostridium thermocellum. To gain insights into the architecture of the protein and obtain clues about its function, we decided to solve the structure of Cthe_2751. Results: The protein crystallized in 4 different space groups that diffracted X-rays to 2.37 angstrom (P3(1)21), 2.17 angstrom (P2(1)2(1)2(1)), 3.01 angstrom (P4(1)22), and 2.03 angstrom (C222(1)) resolution, respectively. Crystal packing analysis revealed that the 3-D packing of Cthe_2751 dimers in P4(1)22 and C222(1) is similar with only a rotational difference of 2.69 degrees around the C axes. A new method developed to quantify the differences in packing of dimers in crystals from different space groups corroborated the findings of crystal packing analysis. Cthe_2751 is an all alpha-helical protein with a central hydrophobic core providing thermal stability via pi:cation and pi:pi interactions. A ProFunc analysis retrieved a very low match with a splicing endonuclease, suggesting a role for the protein in the processing of nucleic acids. Conclusions: Non-Pfam singleton Cthe_2751 folds into a known all alpha-helical fold. The structure has increased sequence coverage of non-Pfam proteins such that more protein sequences can be amenable to modelling. Our work on crystal packing analysis provides a new method to analyze dimers of the protein crystallized in different space groups. The utility of such an analysis can be expanded to oligomeric structures of other proteins, especially receptors and signaling molecules, many of which are known to function as oligomers.	[Cheng, Chongyun; Shaw, Neil; Ding, Wei; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Shaw, Neil; Liu, Zhi-Jie] Kunming Med Univ, Coll Stem Cell & Mol Clin Med, Kunming, Peoples R China; [Zhang, Xuejun] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China; [Zhang, Min] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China; [Wang, Bi-Cheng] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Kunming Medical University; Tianjin Medical University; Anhui University; University System of Georgia; University of Georgia	Cheng, CY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zjliu@ibp.ac.cn	Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [30870483, 31070660, 31021062, 31000334]; Ministry of Science and Technology of China [2009DFB30310, 2009CB918803, 2011CB911103]; CAS [YZ200839, KSCX2-EW-J-3]; University of Georgia Research Foundation; Georgia Research Alliance	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS(Chinese Academy of Sciences); University of Georgia Research Foundation; Georgia Research Alliance	This work was supported by the National Natural Science Foundation of China (grants: 30870483, 31070660, 31021062 and 31000334), Ministry of Science and Technology of China (grants: 2009DFB30310, 2009CB918803 and 2011CB911103), CAS Research Grant (YZ200839 and KSCX2-EW-J-3), the University of Georgia Research Foundation and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barton B, 2005, J EXP BIOL, V208, P549, DOI 10.1242/jeb.01425; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brooksbank C, 2005, NUCLEIC ACIDS RES, V33, pD46, DOI 10.1093/nar/gki026; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hollingworth D, 2006, RNA, V12, P555, DOI 10.1261/rna.2304506; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2010, ACTA CRYSTALLOGR F, V66, P1309, DOI 10.1107/S1744309110008092; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Okamura K, 2006, GENOMICS, V88, P690, DOI 10.1016/j.ygeno.2006.06.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; Shenoy SR, 2010, CURR PROTEIN PEPT SC, V11, P498; Shin Dong Hae, 2007, Journal of Structural and Functional Genomics, V8, P99, DOI 10.1007/s10969-007-9025-4; Shmuely H, 2004, BIOINFORMATICS, V20, P1248, DOI 10.1093/bioinformatics/bth075; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Speers AE, 2010, ACTA CRYSTALLOGR F, V66, P1306, DOI 10.1107/S1744309110035748; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Su J, 2010, PROTEIN CELL, V1, P453, DOI 10.1007/s13238-010-0045-7; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31673	10.1371/journal.pone.0031673	http://dx.doi.org/10.1371/journal.pone.0031673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363703	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500074
J	Cordero, F; Beccuti, M; Arigoni, M; Donatelli, S; Calogero, RA				Cordero, Francesca; Beccuti, Marco; Arigoni, Maddalena; Donatelli, Susanna; Calogero, Raffaele A.			Optimizing a Massive Parallel Sequencing Workflow for Quantitative miRNA Expression Analysis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BIOCONDUCTOR PACKAGE; RAPID ALIGNMENT; SEQ; GENES; NORMALIZATION; TOOLS; BIAS	Background: Massive Parallel Sequencing methods (MPS) can extend and improve the knowledge obtained by conventional microarray technology, both for mRNAs and short non-coding RNAs, e. g. miRNAs. The processing methods used to extract and interpret the information are an important aspect of dealing with the vast amounts of data generated from short read sequencing. Although the number of computational tools for MPS data analysis is constantly growing, their strengths and weaknesses as part of a complex analytical pipe-line have not yet been well investigated. Primary findings: A benchmark MPS miRNA dataset, resembling a situation in which miRNAs are spiked in biological replication experiments was assembled by merging a publicly available MPS spike-in miRNAs data set with MPS data derived from healthy donor peripheral blood mononuclear cells. Using this data set we observed that short reads counts estimation is strongly under estimated in case of duplicates miRNAs, if whole genome is used as reference. Furthermore, the sensitivity of miRNAs detection is strongly dependent by the primary tool used in the analysis. Within the six aligners tested, specifically devoted to miRNA detection, SHRiMP and MicroRazerS show the highest sensitivity. Differential expression estimation is quite efficient. Within the five tools investigated, two of them (DESseq, baySeq) show a very good specificity and sensitivity in the detection of differential expression. Conclusions: The results provided by our analysis allow the definition of a clear and simple analytical optimized workflow for miRNAs digital quantitative analysis.	[Cordero, Francesca; Arigoni, Maddalena; Calogero, Raffaele A.] Univ Turin, Dept Comp Sci, Turin, Italy; [Cordero, Francesca; Beccuti, Marco; Donatelli, Susanna] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin	Cordero, F (corresponding author), Univ Turin, Dept Comp Sci, Turin, Italy.	raffaele.calogero@unito.it	Cordero, Francesca/AAB-3655-2019; Beccuti, Marco/K-7881-2012; Calogero, Raffaele/K-9428-2019	Cordero, Francesca/0000-0002-3143-3330; Calogero, Raffaele/0000-0002-2848-628X; Arigoni, Maddalena/0000-0003-4629-3841; Beccuti, Marco/0000-0001-6125-9460	Italian Association for Cancer Research; Italian Ministero dell'Universita e della Ricerca; University of Torino; EUCAAD (European Consortium for Anticancer Antibody Development) [200755]; Regione Piemonte	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Torino; EUCAAD (European Consortium for Anticancer Antibody Development); Regione Piemonte(Regione Piemonte)	This study was funded under the auspices of EUCAAD 200755 (European Consortium for Anticancer Antibody Development). This work was also supported by grants from the Italian Association for Cancer Research; the Italian Ministero dell'Universita e della Ricerca; the University of Torino and Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Califano A, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P56; Della Beffa C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-571; Emde AK, 2010, BIOINFORMATICS, V26, P123, DOI 10.1093/bioinformatics/btp601; Farrar M, 2007, BIOINFORMATICS, V23, P156, DOI 10.1093/bioinformatics/btl582; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	34	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31630	10.1371/journal.pone.0031630	http://dx.doi.org/10.1371/journal.pone.0031630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363693	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500067
J	Joshi, N; Duhan, V; Lingwal, N; Bhaskar, S; Upadhyay, P				Joshi, Neha; Duhan, Vikas; Lingwal, Neelam; Bhaskar, Sangeeta; Upadhyay, Pramod			Adjuvant Properties of Thermal Component of Hyperthermia Enhanced Transdermal Immunization: Effect on Dendritic Cells	PLOS ONE			English	Article							WHOLE-BODY HYPERTHERMIA; EPIDERMAL LANGERHANS CELLS; CELLULAR IMMUNE-RESPONSE; HEAT-SHOCK; TRANSCUTANEOUS IMMUNIZATION; MICRONEEDLE ARRAYS; JET INJECTIONS; LYMPH-NODE; ACTIVATION; MURINE	Hyperthermia enhanced transdermal (HET) immunization is a novel needle free immunization strategy employing application of antigen along with mild local hyperthermia (42 degrees C) to intact skin resulting in detectable antigen specific Ig in serum. In the present study, we investigated the adjuvant effect of thermal component of HET immunization in terms of maturation of dendritic cells and its implication on the quality of the immune outcome in terms of antibody production upon HET immunization with tetanus toxoid (TT). We have shown that in vitro hyperthermia exposure at 42 degrees C for 30 minutes up regulates the surface expression of maturation markers on bone marrow derived DCs. This observation correlated in vivo with an increased and accelerated expression of maturation markers on DCs in the draining lymph node upon HET immunization in mice. This effect was found to be independent of the antigen delivered and depends only on the thermal component of HET immunization. In vitro hyperthermia also led to enhanced capacity to stimulate CD4+ T cells in allo MLR and promotes the secretion of IL-10 by BMDCs, suggesting a potential for Th2 skewing of T cell response. HET immunization also induced a systemic T cell response to TT, as suggested by proliferation of splenocytes from immunized animal upon in vitro stimulation by TT. Exposure to heat during primary immunization led to generation of mainly IgG class of antibodies upon boosting, similar to the use of conventional alum adjuvant, thus highlighting the adjuvant potential of heat during HET immunization. Lastly, we have shown that mice immunized by tetanus toxoid using HET route exhibited protection against challenge with a lethal dose of tetanus toxin. Thus, in addition to being a painless, needle free delivery system it also has an immune modulatory potential.	[Joshi, Neha; Duhan, Vikas; Lingwal, Neelam; Bhaskar, Sangeeta; Upadhyay, Pramod] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Joshi, N (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	pkumar@nii.ac.in	Duhan, Vikas/J-7163-2019	Duhan, Vikas/0000-0002-6337-8225; Joshi, Neha/0000-0002-1643-7341; Bhaskar, Sangeeta/0000-0001-7902-5267	Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the core grant from the Department of Biotechnology, Govt. of India to the National Institute of Immunology, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Basu S, 2003, INT IMMUNOL, V15, P1053, DOI 10.1093/intimm/dxg104; Baxter J, 2006, EXPERT REV MED DEVIC, V3, P565, DOI 10.1586/17434440.3.5.565; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; DeFillipo AM, 2004, MOL IMMUNOL, V41, P785, DOI 10.1016/j.molimm.2004.04.016; Ding Z, 2009, J CONTROL RELEASE, V136, P71, DOI 10.1016/j.jconrel.2009.01.025; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Karande P, 2009, J CONTROL RELEASE; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Martin MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010897; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Mukhopadhaya A, 2007, CANCER RES, V67, P7798, DOI 10.1158/0008-5472.CAN-07-0203; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Ostberg JR, 2001, J IMMUNOL, V167, P2666, DOI 10.4049/jimmunol.167.5.2666; Ostberg JR, 2000, CELL STRESS CHAPERON, V5, P458, DOI 10.1379/1466-1268(2000)005<0458:ROIABM>2.0.CO;2; Ostberg JR, 2003, INT J HYPERTHER, V19, P520, DOI 10.1080/02656730310001607986; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; Sallusto F, 2001, CURR OPIN ALLERGY CL, V1, P441, DOI 10.1097/00130832-200110000-00010; Schramm-Baxter J, 2004, J CONTROL RELEASE, V97, P527, DOI 10.1016/j.jconrel.2004.04.006; Schueller G, 2003, INT J ONCOL, V22, P1397; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tournier JN, 2003, J LEUKOCYTE BIOL, V73, P493, DOI 10.1189/jlb.1002506; Upadhyay P, 2006, VACCINE, V24, P5593, DOI 10.1016/j.vaccine.2006.04.039; Vandermeulen G, 2007, J CONTROL RELEASE, V124, P81, DOI 10.1016/j.jconrel.2007.08.010; Zheng H, 2003, EUR J IMMUNOL, V33, P1754, DOI 10.1002/eji.200323687; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	41	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32067	10.1371/journal.pone.0032067	http://dx.doi.org/10.1371/journal.pone.0032067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363798	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500109
J	Lillvis, JL; Gunaratne, CA; Katz, PS				Lillvis, Joshua L.; Gunaratne, Charuni A.; Katz, Paul S.			Neurochemical and Neuroanatomical Identification of Central Pattern Generator Neuron Homologues in Nudipleura Molluscs	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SEA SLUG PLEUROBRANCHAEA; FIXED ACTION PATTERN; MARINE MOLLUSK; NUDIBRANCH MOLLUSKS; TRITONIA-DIOMEDEA; OPISTHOBRANCHIA MOLLUSCA; RHYTHMIC BEHAVIORS; CEREBRAL NEURONS; CLIONE-LIMACINA	Certain invertebrate neurons can be identified by their behavioral functions. However, evolutionary divergence can cause some species to not display particular behaviors, thereby making it impossible to use physiological characteristics related to those behaviors for identifying homologous neurons across species. Therefore, to understand the neural basis of species-specific behavior, it is necessary to identify homologues using characteristics that are independent of physiology. In the Nudipleura mollusc Tritonia diomedea, Cerebral Neuron 2 (C2) was first described as being a member of the swim central pattern generator (CPG). Here we demonstrate that neurochemical markers, in conjunction with previously known neuroanatomical characteristics, allow C2 to be uniquely identified without the aid of electrophysiological measures. Specifically, C2 had three characteristics that, taken together, identified the neuron: 1) a white cell on the dorsal surface of the cerebral ganglion, 2) an axon that projected to the contralateral pedal ganglion and through the pedal commissure, and 3) immunoreactivity for the peptides FMRFamide and Small Cardioactive Peptide B. These same anatomical and neurochemical characteristics also uniquely identified the C2 homologue in Pleurobranchaea californica (called A1), which was previously identified by its analogous role in the Pleurobranchaea swim CPG. Furthermore, these characteristics were used to identify C2 homologues in Melibe leonina, Hermissenda crassicornis, and Flabellina iodinea, species that are phylogenetically closer to Tritonia than Pleurobranchaea, but do not display the same swimming behavior as Tritonia or Pleurobranchaea. These identifications will allow future studies comparing and contrasting the physiological properties of C2 across species that can and cannot produce the type of swimming behavior exhibited by Tritonia.	[Lillvis, Joshua L.; Gunaratne, Charuni A.; Katz, Paul S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Lillvis, JL (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	lillvis@gsu.edu	Lillvis, Joshua/GMX-3123-2022	Lillvis, Joshua/0000-0002-6235-8759	National Science Foundation [IOS-0814411, IOS-1120950, IOS-1011476]; Direct For Biological Sciences [1120950] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation (https://www.nsf.gov/): IOS-0814411, IOS-1120950, IOS-1011476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audesirk T., 1985, NEUROBIOLOGY BEHAV, V8; Bouchet P, 2005, MALACOLOGIA, V47, P1; BOYLE MB, 1983, BRAIN RES, V266, P305, DOI 10.1016/0006-8993(83)90662-5; Bullock T., 1965, STRUCTURE FUNCTION N; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Calin-Jageman RJ, 2007, J NEUROPHYSIOL, V98, P2382, DOI 10.1152/jn.00572.2007; CROLL RP, 1987, BRAIN RES, V405, P337, DOI 10.1016/0006-8993(87)90303-9; Croll RP, 2001, CELL TISSUE RES, V305, P417, DOI 10.1007/s004410100394; CROLL RP, 1987, NERVOUS SYSTEMS INVE, P41, DOI DOI 10.1007/978-1-4613-1955-9_4; Crow T, 2004, J NEUROPHYSIOL, V91, P2874, DOI 10.1152/jn.00028.2004; Crow T, 2009, J NEUROPHYSIOL, V101, P824, DOI 10.1152/jn.91079.2008; DAVIS WJ, 1971, Z VERGL PHYSIOL, V75, P207; DORSETT DA, 1969, NATURE, V224, P711, DOI 10.1038/224711a0; FARMER W M, 1970, Veliger, V13, P73; Fickbohm DJ, 2001, J COMP NEUROL, V437, P91; Getting P. A., 1989, NETWORK OSCILLATOR U, P215; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151, DOI 10.1152/jn.1980.44.1.151; GETTING PA, 1977, J COMP PHYSIOL, V121, P325, DOI 10.1007/BF00613012; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65, DOI 10.1152/jn.1981.46.1.65; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; GRANZOW B, 1981, J EXP BIOL, V90, P283; HUME RI, 1982, J NEUROPHYSIOL, V47, P60, DOI 10.1152/jn.1982.47.1.60; Jezzini SH, 2005, J NEUROSCI METH, V149, P15, DOI 10.1016/j.jneumeth.2005.05.007; Jing J, 2003, J NEUROSCI, V23, P3039; JING J, 1995, J NEUROPHYSIOL, V74, P1900, DOI 10.1152/jn.1995.74.5.1900; Jing J, 1999, J NEUROPHYSIOL, V81, P654, DOI 10.1152/jn.1999.81.2.654; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Katz PS, 2001, AM ZOOL, V41, P962, DOI 10.1668/0003-1569(2001)041[0962:ETTCPG]2.0.CO;2; Katz PS., 2009, SCHOLARPEDIA, V4, P3638, DOI [DOI 10.4249/SCHOLARPEDIA.3638, 10.4249/scholarpedia.3638]; Lawrence KA, 2002, BIOL BULL, V203, P144, DOI 10.2307/1543383; MASINOVSKY B, 1988, J COMP NEUROL, V273, P500, DOI 10.1002/cne.902730406; Newcomb JM, 2007, J COMP PHYSIOL A, V193, P425, DOI 10.1007/s00359-006-0196-4; Newcomb JM, 2006, J COMP NEUROL, V499, P485, DOI 10.1002/cne.21111; Newcomb JM, 2009, P R SOC B, V276, P99, DOI 10.1098/rspb.2008.0683; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1912, DOI 10.1152/jn.1995.73.5.1912; Pentreath V.W., 1982, P457; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; ROBERTS MH, 1988, PEPTIDES, V9, P1323, DOI 10.1016/0196-9781(88)90199-4; Sakurai A, 2011, CURR BIOL, V21, P1036, DOI 10.1016/j.cub.2011.04.040; Sakurai A, 2009, J NEUROSCI, V29, P13115, DOI 10.1523/JNEUROSCI.3485-09.2009; SATTERLIE RA, 1995, J EXP BIOL, V198, P917; SNOW RW, 1982, J NEUROBIOL, V13, P267, DOI 10.1002/neu.480130307; SOINILA S, 1991, BIOL BULL-US, V181, P484, DOI 10.2307/1542369; STRIEDTER GF, 1991, BRAIN BEHAV EVOLUT, V38, P177, DOI 10.1159/000114387; Sudlow LC, 1998, J COMP NEUROL, V395, P466; TAGHERT PH, 1978, J COMP PHYSIOL, V123, P253, DOI 10.1007/BF00656878; Tian LM, 2006, J NEUROPHYSIOL, V96, P327, DOI 10.1152/jn.00035.2006; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; WATSON WH, 1992, J NEUROBIOL, V23, P173, DOI 10.1002/neu.480230208; WEISS KR, 1976, BRAIN RES, V117, P33, DOI 10.1016/0006-8993(76)90554-0; Wentzell MM, 2009, BRAIN BEHAV EVOLUT, V74, P219, DOI 10.1159/000258668; Willows AOD, 2001, AM ZOOL, V41, P943; WILLOWS AOD, 1973, J NEUROBIOL, V4, P207, DOI 10.1002/neu.480040306; WILLOWS AOD, 1969, SCIENCE, V166, P1549, DOI 10.1126/science.166.3912.1549; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022; YOSHIDA M, 1994, COMP BIOCHEM PHYS A, V107, P269, DOI 10.1016/0300-9629(94)90380-8	60	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31737	10.1371/journal.pone.0031737	http://dx.doi.org/10.1371/journal.pone.0031737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363716	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500082
J	Lin, L; Tran, T; Hu, S; Cramer, T; Komuniecki, R; Steven, RM				Lin, Li; Thuy Tran; Hu, Shuang; Cramer, Todd; Komuniecki, Richard; Steven, Robert M.			RHGF-2 Is an Essential Rho-1 Specific RhoGEF that binds to the Multi-PDZ Domain Scaffold Protein MPZ-1 in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; INDUCED NEURITE RETRACTION; C-ELEGANS; EPIDERMAL MORPHOGENESIS; NEUROTRANSMITTER RELEASE; LYSOPHOSPHATIDIC ACID; MYOSIN PHOSPHATASE; TIGHT JUNCTIONS; CELL; RECEPTOR	RhoGEF proteins activate the Rho family of small GTPases and thus play a key role in regulating fundamental cellular processes such as cell morphology and polarity, cell cycle progression and gene transcription. We identified a Caenorhabditis elegans RhoGEF protein, RHGF-2, as a binding partner of the C. elegans multi-PDZ domain scaffold protein MPZ-1 (MUPP1 in mammals). RHGF-2 exhibits significant identity to the mammalian RhoGEFs PLEKHG5/Tech/Syx and contains a class I C-terminal PDZ binding motif (SDV) that interacts most strongly to MPZ-1 PDZ domain eight. RHGF-2 RhoGEF activity is specific to the C. elegans RhoA homolog RHO-1 as determined by direct binding, GDP/GTP exchange and serum response element-driven reporter activity. rhgf-2 is an essential gene since rhgf-2 deletion mutants do not elongate during embryogenesis and hatch as short immobile animals that arrest development. Interestingly, the expression of a functional rhgf-2::gfp transgene appears to be exclusively neuronal and rhgf-2 overexpression results in loopy movement with exaggerated body bends. Transient expression of RHGF-2 in N1E-115 neuroblastoma cells prevents neurite outgrowth similar to constitutive RhoA activation in these cells. Together, these observations indicate neuronally expressed RHGF-2 is an essential RHO-1 specific RhoGEF that binds most strongly to MPZ-1 PDZ domain eight and is required for wild-type C. elegans morphology and growth.	[Lin, Li; Thuy Tran; Hu, Shuang; Cramer, Todd; Komuniecki, Richard; Steven, Robert M.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Lin, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	robert.steven2@utoledo.edu			National Institutes of Health (NIH) [1R15NS062406, 1R01AI072644]; National Institutes of Health [NIH] National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062406] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health [NIH] National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants 1R15NS062406 to Dr. Steven and 1R01AI072644 to Dr. Komuniecki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank John Gray for assistance with bioinformatics, John Plenefisch and Vera Hapiak for microscopy assistance, Qing Zhao for assistance with the statistical analysis, Paul Mains for sharing unpublished data and Joe Culotti for jcIs1; him-5. Additional nematode strains were obtained from the Caenorhabditis Genetics Center (which is funded by the National Institutes of Health [NIH] National Center for Research Resources).	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Dooley R, 2009, FEBS J, V276, P7279, DOI 10.1111/j.1742-4658.2009.07435.x; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hu S, 2011, GENETICS, V189, P137, DOI 10.1534/genetics.111.131227; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kranenburg O, 1997, J CELL SCI, V110, P2417; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maystadt I, 2007, AM J HUM GENET, V81, P67, DOI 10.1086/518900; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; McMullan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017265; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Qadota H, 2008, J MOL BIOL, V383, P747, DOI 10.1016/j.jmb.2008.08.083; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Simske JS, 2001, BIOESSAYS, V23, P12, DOI 10.1002/1521-1878(200101)23:1&lt;12::AID-BIES1003&gt;3.0.CO;2-R; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tigyi G, 1996, J NEUROCHEM, V66, P537; Vockel M, 2010, EXP DERMATOL, V19, P888, DOI 10.1111/j.1600-0625.2010.01101.x; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	92	17	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31499	10.1371/journal.pone.0031499	http://dx.doi.org/10.1371/journal.pone.0031499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363657	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500048
J	Niu, HT; Zhao, LL; Lu, M; Zhang, S; Sun, JH				Niu, Hongtao; Zhao, Lilin; Lu, Min; Zhang, Shuai; Sun, Jianghua			The Ratio and Concentration of Two Monoterpenes Mediate Fecundity of the Pinewood Nematode and Growth of Its Associated Fungi	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; MONOCHAMUS-ALTERNATUS COLEOPTERA; BARK BEETLE; NEMATOCIDAL ACTIVITY; WILT DISEASE; ESSENTIAL OILS; APHELENCHOIDIDAE; HOST; CERAMBYCIDAE; VOLATILES	The pinewood nematode (PWN) Bursaphelenchus xylophilus, vectored primarily by the sawyer beetle, Monochamus alternatus, is an important invasive pest and causal agent of pine wilt disease of Chinese Masson pine, Pinus massoniana. Previous work demonstrated that the ratios and concentrations of alpha-pinene: beta-pinene differed between healthy trees and those trees containing blue-stain fungus (and M. alternatus pupae). However, the potential influence of the altered monoterpene ratios and concentrations on PWN and associated fungi remained unknown. Our current results show that low concentrations of the monoterpenes within petri dishes reduced PWN propagation, whereas the highest concentration of the monoterpenes increased PWN propagation. The propagation rate of PWN treated with the monoterpene ratio representative of blue-stain infected pine (alpha-pinene:beta-pinene = 1:0.8, 137.6 mg/ml) was significantly higher than that (alpha-pinene:beta-pinene = 1:0.1, 137.6 mg/ml) representative of healthy pines or those damaged by M. alternatus feeding, but without blue stain. Furthermore, inhibition of mycelial growth of associated fungi increased with the concentration of the monoterpenes alpha-pinene and beta-pinene. Additionally, higher levels of beta-pinene (alpha-pinene:beta-pinene = 1:0.8) resulted in greater inhibition of the growth of the associated fungi Sporothrix sp.2 and Ophiostoma ips strains, but had no significant effects on the growth of Sporothrix sp.1, which is the best food resource for PWN. These results suggest that host monoterpenes generally reduce the reproduction of PWN. However, PWN utilizes high monoterpene concentrations and native blue-stain fungus Sporothrix sp.1 to improve its own propagation and overcome host resistance, which may provide clues to understanding the ecological mechanisms of PWN's successful invasion.	[Niu, Hongtao; Zhao, Lilin; Lu, Min; Zhang, Shuai; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Niu, Hongtao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Niu, HT (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Natural Science Foundation of China [30730074, 30970369]; National Basic Science Research Program [2009CB119200, 2012CB114100]; Chinese Academy of Science [KSCX2-EW-J-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Research Program(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (30730074 and 30970369), National Basic Science Research Program (2009CB119200 and 2012CB114100) and Chinese Academy of Science Key Knowledge Innovation Program (KSCX2-EW-J-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Aikawa T, 1998, APPL ENTOMOL ZOOL, V33, P231, DOI 10.1303/aez.33.231; Blodgett JT, 1997, PHYTOPATHOLOGY, V87, P606, DOI 10.1094/PHYTO.1997.87.6.606; BRIDGES JR, 1987, PHYTOPATHOLOGY, V77, P83, DOI 10.1094/Phyto-77-83; Byun-McKay A, 2006, PLANT PHYSIOL, V140, P1009, DOI 10.1104/pp.105.071803; Camurca-Vasconcelos ALF, 2007, VET PARASITOL, V148, P288, DOI 10.1016/j.vetpar.2007.06.012; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Choi IH, 2007, RUSS J NEMATOL, V15, P35; DEGROOT RC, 1972, MYCOLOGIA, V64, P863, DOI 10.2307/3757941; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Fan JT, 2007, ANN FOREST SCI, V64, P67, DOI 10.1051/forest:2006089; Fu LG, 1999, CYCADACEAE FAGACEAE, V4, P453; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; KAWAZU K, 1980, AGR BIOL CHEM TOKYO, V44, P631, DOI 10.1080/00021369.1980.10864002; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kerlinger FN, 1973, MULTIPLE REGRESSION, P282; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; KLEPZIG KD, 1995, J CHEM ECOL, V21, P601, DOI 10.1007/BF02033704; Kong JO, 2007, J NEMATOL, V39, P237; Korsu K, 2010, BIOL INVASIONS, V12, P1363, DOI 10.1007/s10530-009-9553-x; KURODA K, 1991, EUR J FOREST PATHOL, V21, P82; Lei J, 2010, BIOCHEM PHARMACOL, V79, P1062, DOI 10.1016/j.bcp.2009.11.002; LEWINSOHN E, 1991, PLANT PHYSIOL, V96, P44, DOI 10.1104/pp.96.1.44; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Ludley KE, 2008, SOIL BIOL BIOCHEM, V40, P669, DOI 10.1016/j.soilbio.2007.10.001; Maehara N, 2005, NEMATOLOGY, V7, P161, DOI 10.1163/1568541054879557; Maehara N, 2000, APPL ENTOMOL ZOOL, V35, P413, DOI 10.1303/aez.2000.413; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Mumm R, 2006, TRENDS PLANT SCI, V11, P351, DOI 10.1016/j.tplants.2006.05.007; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; PAINE TD, 1994, J CHEM ECOL, V20, P2551, DOI 10.1007/BF02036191; Park IK, 2005, NEMATOLOGY, V7, P767, DOI 10.1163/156854105775142946; Raffa K.F., 1991, P245; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Richardson D. M., 1998, ECOLOGY BIOGEOGRAPHY; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Seifert K. A., 1999, TAXONOMY ECOLOGY PAT, P141; SMITH RH, 1961, J ECON ENTOMOL, V54, P365; Su JW, 2009, J PLANT RES, V122, P193, DOI 10.1007/s10265-008-0203-7; TOGASHI K, 1989, APPL ENTOMOL ZOOL, V24, P379, DOI 10.1303/aez.24.379; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tomlin ES, 2000, TREE PHYSIOL, V20, P1087; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; van Bezooijen J., 2006, METHODS TECHNIQUES N; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhao LL, 2007, J CHEM ECOL, V33, P1207, DOI 10.1007/s10886-007-9289-y; Zhao LL, 2009, FOREST ECOL MANAG, V258, P1932, DOI 10.1016/j.foreco.2009.07.040	54	32	37	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31716	10.1371/journal.pone.0031716	http://dx.doi.org/10.1371/journal.pone.0031716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363713	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500080
J	Pegoraro, G; Voss, TC; Martin, SE; Tuzmen, P; Guha, R; Misteli, T				Pegoraro, Gianluca; Voss, Ty C.; Martin, Scott E.; Tuzmen, Pinar; Guha, Rajarshi; Misteli, Tom			Identification of Mammalian Protein Quality Control Factors by High-Throughput Cellular Imaging	PLOS ONE			English	Article							20S PROTEASOME; ENDOPLASMIC-RETICULUM; IN-VIVO; DEGRADATION; UBIQUITIN; CELLS; TRANSLATION; EXPRESSION; MATURATION; TOXICITY	Protein Quality Control (PQC) pathways are essential to maintain the equilibrium between protein folding and the clearance of misfolded proteins. In order to discover novel human PQC factors, we developed a high-content, high-throughput cell-based assay to assess PQC activity. The assay is based on a fluorescently tagged, temperature sensitive PQC substrate and measures its degradation relative to a temperature insensitive internal control. In a targeted screen of 1591 siRNA genes involved in the Ubiquitin-Proteasome System (UPS) we identified 25 of the 33 genes encoding for 26S proteasome subunits and discovered several novel PQC factors. An unbiased genome-wide siRNA screen revealed the protein translation machinery, and in particular the EIF3 translation initiation complex, as a novel key modulator of misfolded protein stability. These results represent a comprehensive unbiased survey of human PQC components and establish an experimental tool for the discovery of genes that are required for the degradation of misfolded proteins under conditions of proteotoxic stress.	[Pegoraro, Gianluca; Voss, Ty C.] NCI, NCI High Throughput Imaging Facil, NIH, Bethesda, MD 20892 USA; [Martin, Scott E.; Tuzmen, Pinar; Guha, Rajarshi] NIH, Ctr Translat Therapeut, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Pegoraro, G (corresponding author), NCI, NCI High Throughput Imaging Facil, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pegoraro, Gianluca/K-4233-2016	Pegoraro, Gianluca/0000-0003-2843-9464	NIH; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Intramural Research Program of the NIH, NCI, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; CHOU JY, 1974, J VIROL, V13, P1101, DOI 10.1128/JVI.13.5.1101-1109.1974; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas PM, 2010, BIOPOLYMERS, V93, P229, DOI 10.1002/bip.21304; EDWARDS CAF, 1979, J VIROL, V29, P753, DOI 10.1128/JVI.29.2.753-762.1979; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hoefer MM, 2006, INT J BIOL MACROMOL, V38, P259, DOI 10.1016/j.ijbiomac.2006.03.015; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	58	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31684	10.1371/journal.pone.0031684	http://dx.doi.org/10.1371/journal.pone.0031684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363705	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500075
J	Martinez-Silva, AV; Aguirre-Martinez, C; Flores-Tinoco, CE; Alejandri-Ramirez, ND; Dinkova, TD				Valeria Martinez-Silva, Ana; Aguirre-Martinez, Cesar; Flores-Tinoco, Carlos E.; Alejandri-Ramirez, Naholi D.; Dinkova, Tzvetanka D.			Translation Initiation Factor AteIF(iso) 4E Is Involved in Selective mRNA Translation in Arabidopsis Thaliana Seedlings	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; EIF4E ISOFORMS; EXPRESSION; CAP; BINDING; GROWTH; PHO1; RECRUITMENT; GERMINATION; EIF(ISO)4E	One of the most regulated steps of translation initiation is the recruitment of mRNA by the translation machinery. In eukaryotes, this step is mediated by the 5'end cap-binding factor eIF4E bound to the bridge protein eIF4G and forming the eIF4F complex. In plants, different isoforms of eIF4E and eIF4G form the antigenically distinct eIF4F and eIF(iso)4F complexes proposed to mediate selective translation. Using a microarray analysis of polyribosome-and non-polyribosome-purified mRNAs from 15 day-old Arabidopsis thaliana wild type [WT] and eIF(iso) 4E knockout mutant [(iso)4E-1] seedlings we found 79 transcripts shifted from polyribosomes toward non-polyribosomes, and 47 mRNAs with the opposite behavior in the knockout mutant. The translationally decreased mRNAs were overrepresented in root-preferentially expressed genes and proteins from the endomembrane system, including several transporters such as the phosphate transporter PHOSPHATE1 (PHO1), Sucrose transporter 3 (SUC3), ABC transporter-like with ATPase activity (MRP11) and five electron transporters, as well as signal transduction, protein modification-and transcription-related proteins. Under normal growth conditions, eIF(iso) 4E expression under the constitutive promoter 35 S enhanced the polyribosomal recruitment of PHO1 supporting its translational preference for eIF(iso) 4E. Furthermore, under phosphate deficiency, the PHO1 protein increased in the eIF(iso) 4E overexpressing plants and decreased in the knockout mutant as compared to wild type. In addition, the knockout mutant had larger root, whereas the 35 S directed expression of eIF(iso) 4E caused shorter root under normal growth conditions, but not under phosphate deficiency. These results indicate that selective translation mediated by eIF(iso)4E is relevant for Arabidopsis root development under normal growth conditions.	[Valeria Martinez-Silva, Ana; Aguirre-Martinez, Cesar; Flores-Tinoco, Carlos E.; Alejandri-Ramirez, Naholi D.; Dinkova, Tzvetanka D.] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Quim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Martinez-Silva, AV (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Quim, Mexico City 04510, DF, Mexico.	cesy@servidor.unam.mx	Dinkova, Tzvetanka/AAE-6073-2020; Dinkova, Tzvetanka/L-5678-2019	Dinkova, Tzvetanka/0000-0001-7971-525X; Flores Tinoco, Carlos Eduardo/0000-0002-6485-8618; Aguirre, Cesar/0000-0001-6302-2600; Martinez-Silva, Ana Valeria/0000-0002-3016-7093	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [43669, 81708]; Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM) [204309]	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM)	This research was supported by Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) grants 43669 and 81708, and by Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM) grant 204309. AVMS was supported by CONACyT Ph.D. fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2001, DEVELOPMENT, V128, P3899; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; Bush MS, 2009, PLANT J, V59, P400, DOI 10.1111/j.1365-313X.2009.03882.x; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dinkova TD, 2003, BIOLOGY OF SEEDS: RECENT RESEARCH ADVANCES, P181, DOI 10.1079/9780851996530.0181; Dinkova TD, 2000, BIOCHEM J, V351, P825, DOI 10.1042/0264-6021:3510825; Dinkova TD, 1999, PHYSIOL PLANTARUM, V107, P419, DOI 10.1034/j.1399-3054.1999.100407.x; Dinkova TD, 2011, SEED SCI RES, V21, P85, DOI 10.1017/S0960258511000043; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kaye NM, 2009, J BIOL CHEM, V284, P17742, DOI 10.1074/jbc.M109.009001; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Ptushkina M, 2004, EMBO REP, V5, P311, DOI 10.1038/sj.embor.7400088; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Rouached H, 2011, PLANT J, V65, P557, DOI 10.1111/j.1365-313X.2010.04442.x; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Song AR, 2010, J CELL SCI, V123, P2228, DOI 10.1242/jcs.063107; Stefanovic A, 2011, PLANT J, V66, P689, DOI 10.1111/j.1365-313X.2011.04532.x; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31606	10.1371/journal.pone.0031606	http://dx.doi.org/10.1371/journal.pone.0031606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363683	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500060
J	Henk, DA; Fisher, MC				Henk, Daniel A.; Fisher, Matthew C.			The Gut Fungus Basidiobolus ranarum Has a Large Genome and Different Copy Numbers of Putatively Functionally Redundant Elongation Factor Genes	PLOS ONE			English	Article							EVOLUTION; ENTOMOPHTHORALES; CRYPTOMONADS; ZYGOMYCOTA; DIVISION; MITOSIS; GTPASE; EFL	Fungal genomes range in size from 2.3 Mb for the microsporidian Encephalitozoon intestinalis up to 8000 Mb for Entomophaga aulicae, with a mean genome size of 37 Mb. Basidiobolus, a common inhabitant of vertebrate guts, is distantly related to all other fungi, and is unique in possessing both EF-1 alpha and EFL genes. Using DNA sequencing and a quantitative PCR approach, we estimated a haploid genome size for Basidiobolus at 350 Mb. However, based on allelic variation, the nuclear genome is at least diploid, leading us to believe that the final genome size is at least 700 Mb. We also found that EFL was in three times the copy number of its putatively functionally overlapping paralog EF-1 alpha. This suggests that gene or genome duplication may be an important feature of B. ranarum evolution, and also suggests that B. ranarum may have mechanisms in place that favor the preservation of functionally overlapping genes.	[Henk, Daniel A.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Henk, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	d.henk@imperial.ac.uk	Fisher, Matthew/B-9094-2011	Fisher, Matthew/0000-0002-1862-6402	Wellcome Trust; Linnean Society of London and Systematics Association	Wellcome Trust(Wellcome TrustEuropean Commission); Linnean Society of London and Systematics Association	This work was supported by grants to Dr. Matthew Fisher's lab at Imperial College London from The Wellcome Trust [084616/A/08/Z] (http://www.wellcome.ac.uk/), and from the Systematics Research Fund supported by the Linnean Society of London and Systematics Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Armaleo D, 2009, SYMBIOSIS, V49, P43, DOI 10.1007/s13199-009-0012-3; Benny GL, 2001, MYCOTA, V7, P113; CHATURVEDI VP, 1984, SABOURAUDIA, V22, P185; COREMANS.J, 1973, MYCOPATH MYCOL APPL, V49, P173, DOI 10.1007/BF02050861; Gile GH, 2009, PLOS ONE, V4; Gile GH, 2006, PROTIST, V157, P435, DOI 10.1016/j.protis.2006.06.002; Goyal A, 2010, MYCOPATHOLOGIA, V170, P165, DOI 10.1007/s11046-010-9310-9; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; GUGNANI HC, 1980, MYKOSEN, V23, P260; Gugnani HC, 1999, EUR J EPIDEMIOL, V15, P923, DOI 10.1023/A:1007656818038; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; HUMBER RA, 1981, MYCOTAXON, V13, P191; HUTCHISON JA, 1970, MYCOLOGIA, V62, P585, DOI 10.2307/3757531; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamikawa R, 2008, P NATL ACAD SCI USA, V105, P6965, DOI 10.1073/pnas.0711084105; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; MURRIN F, 1986, EXP MYCOL, V10, P67, DOI 10.1016/0147-5975(86)90032-0; Noble GP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-82; Olive EW., 1907, ANN MYCOL, V5, P404; ROBINOW CF, 1963, J CELL BIOL, V17, P123, DOI 10.1083/jcb.17.1.123; Sakaguchi M, 2009, GENE, V441, P126, DOI 10.1016/j.gene.2008.05.010; SUN NC, 1972, CARYOLOGIA, V25, P471, DOI 10.1080/00087114.1972.10796501; Tanabe Y, 2005, J GEN APPL MICROBIOL, V51, P267, DOI 10.2323/jgam.51.267; TANAKA K, 1970, PROTOPLASMA, V70, P423, DOI 10.1007/BF01275768; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872; Wilhelm J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gkg056; Xue C, 2010, GENETICS, V186, P287, DOI 10.1534/genetics.110.118646	29	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31268	10.1371/journal.pone.0031268	http://dx.doi.org/10.1371/journal.pone.0031268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363602	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600134
J	Meng, YF; Zhang, F; Blair, T; Gu, HD; Feng, HQ; Wang, JN; Yuan, C; Zhang, ZQ; Qiu, BS; Yang, XM				Meng, Yanfeng; Zhang, Feng; Blair, Tiffany; Gu, Huidong; Feng, Hongqing; Wang, Jinnan; Yuan, Chun; Zhang, Zhaoqi; Qiu, Bensheng; Yang, Xiaoming			MRI of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries	PLOS ONE			English	Article							IRON-OXIDE; ATHEROSCLEROSIS; TRACKING; SEQUENCE; THERAPY; DISEASE; AGENT; MICE	Background: This study was to validate the feasibility of using clinical 3.0T MRI to monitor the migration of autotransplanted bone marrow (BM)-derived stem-progenitor cells (SPC) to the injured arteries of near-human sized swine for potential cell-based arterial repair. Methodology: The study was divided into two phases. For in vitro evaluation, BM cells were extracted from the iliac crests of 13 domestic pigs and then labeled with a T2 contrast agent, Feridex, and/or a fluorescent tissue marker, PKH26. The viability, the proliferation efficiency and the efficacies of Feridex and/or PKH26 labeling were determined. For in vivo validation, the 13 pigs underwent endovascular balloon-mediated intimal damages of the iliofemoral arteries. The labeled or un-labeled BM cells were autotransplanted back to the same pig from which the BM cells were extracted. Approximately three weeks post-cell transplantation, 3.0T T2-weighted MRI was performed to detect Feridex-created signal voids of the transplanted BM cells in the injured iliofemoral arteries, which was confirmed by subsequent histologic correlation. Principal Findings: Of the in vitro study, the viability of dual-labeled BM cells was 95-98%. The proliferation efficiencies of dual-labeled BM cells were not significantly different compared to those of non-labeled cells. The efficacies of Feridex- and PKH26 labeling were 90% and 100%, respectively. Of the in vivo study, 3.0T MRI detected the auto-transplanted BM cells migrated to the injured arteries, which was confirmed by histologic examinations. Conclusion: This study demonstrates the capability of using clinical 3.0T MRI to monitor the auto-transplantation of BM cells that migrate to the injured arteries of large animals, which may provide a useful MRI technique to monitor cell-based arterial repair.	[Meng, Yanfeng; Zhang, Feng; Blair, Tiffany; Gu, Huidong; Feng, Hongqing; Qiu, Bensheng; Yang, Xiaoming] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA; [Meng, Yanfeng; Zhang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Jinnan] Philips Res N Amer, Clin Sites Res Program, Briarcliff Manor, NY USA; [Yuan, Chun] Univ Washington, Sch Med, Dept Radiol, Vasc Imaging Lab, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Capital Medical University; Philips; Philips Research; University of Washington; University of Washington Seattle	Meng, YF (corresponding author), Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA.	xmyang@u.washington.edu	Meng, Yanfeng/D-1804-2013; Feng, Hongqing/I-5222-2019; Meng, Yanfeng/AAS-4532-2021	Feng, Hongqing/0000-0003-2767-3080; Wang, Jinnan/0000-0002-2882-914X	National Institutes of Health [RO1 HL078672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by a National Institutes of Health RO1 HL078672 grant. The funder's website is http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Anderson SA, 2006, INVEST RADIOL, V41, P332, DOI 10.1097/01.rli.0000192420.94038.9e; Aoki I, 2006, NMR BIOMED, V19, P50, DOI 10.1002/nbm.1000; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Cai JH, 2008, CONTRAST MEDIA MOL I, V3, P72, DOI 10.1002/cmmi.231; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Engberink RDO, 2010, MOL IMAGING, V9, P268, DOI 10.2310/7290.2010.00016; Gao FB, 2007, NMR BIOMED, V20, P673, DOI 10.1002/nbm.1128; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Meng Y, 2010, APPL MAGNETIC RESONA, V40, P105; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Qiu BS, 2008, NAT CLIN PRACT CARD, V5, P396, DOI 10.1038/ncpcardio1217; Qiu BS, 2007, J MAGN RESON IMAGING, V26, P339, DOI 10.1002/jmri.21016; Qiu BS, 2010, ACAD RADIOL, V17, P547, DOI 10.1016/j.acra.2010.02.004; Shimizu Koichi, 2003, Curr Atheroscler Rep, V5, P230, DOI 10.1007/s11883-003-0029-7; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Yu MX, 2010, EXP BIOL MED, V235, P1053, DOI 10.1258/ebm.2010.010058	22	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31137	10.1371/journal.pone.0031137	http://dx.doi.org/10.1371/journal.pone.0031137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363566	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600115
J	Voyatzis, S; Muzerelle, A; Gaspar, P; Nicol, X				Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier			Modeling Activity and Target-Dependent Developmental Cell Death of Mouse Retinal Ganglion Cells Ex Vivo	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SUPERIOR COLLICULUS; RETINOCOLLICULAR PROJECTION; RAT RETINA; POSTNATAL CHANGES; BETA-2 SUBUNIT; NEONATAL-RATS; MICE; AXONS	Programmed cell death is widespread during the development of the central nervous system and serves multiple purposes including the establishment of neural connections. In the mouse retina a substantial reduction of retinal ganglion cells (RGCs) occurs during the first postnatal week, coinciding with the formation of retinotopic maps in the superior colliculus (SC). We previously established a retino-collicular culture preparation which recapitulates the progressive topographic ordering of RGC projections during early post-natal life. Here, we questioned whether this model could also be suitable to examine the mechanisms underlying developmental cell death of RGCs. Brn3a was used as a marker of the RGCs. A developmental decline in the number of Brn3a-immunolabelled neurons was found in the retinal explant with a timing that paralleled that observed in vivo. In contrast, the density of photoreceptors or of starburst amacrine cells increased, mimicking the evolution of these cell populations in vivo. Blockade of neural activity with tetrodotoxin increased the number of surviving Brn3a-labelled neurons in the retinal explant, as did the increase in target availability when one retinal explant was confronted with 2 or 4 collicular slices. Thus, this ex vivo model reproduces the developmental reduction of RGCs and recapitulates its regulation by neural activity and target availability. It therefore offers a simple way to analyze developmental cell death in this classic system. Using this model, we show that ephrin-A signaling does not participate to the regulation of the Brn3a population size in the retina, indicating that eprhin-A-mediated elimination of exuberant projections does not involve developmental cell death.	[Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 839, Paris, France; [Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Univ Paris 06, Paris, France; [Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Inst Fer Moulin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Nicol, X (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 839, Paris, France.	xavier.nicol@inserm.fr	Gaspar, Patricia/G-8892-2011; Nicol, Xavier/D-6087-2012	Gaspar, Patricia/0000-0003-4217-5717; Nicol, Xavier/0000-0002-0310-8047	Fondation Internationale pour la Recherche en Paraplegie; Region Ile de France; IOF; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie	Fondation Internationale pour la Recherche en Paraplegie; Region Ile de France(Region Ile-de-France); IOF; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie	This work was supported by a grant from Fondation Internationale pour la Recherche en Paraplegie to PG, a Region Ile de France fellowship to SV, an IOF Marie Curie fellowship to XN, and by Institut National de la Sante et de la Recherche Medicale and Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Bytyqi AH, 2007, EUR J NEUROSCI, V26, P1560, DOI 10.1111/j.1460-9568.2007.05767.x; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; Cui Q, 1995, J NEUROSCI, V15, P8143; Dallimore EJ, 2010, EXP NEUROL, V225, P353, DOI 10.1016/j.expneurol.2010.07.007; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; EYSEL UT, 1983, NEUROSCI LETT, V39, P15, DOI 10.1016/0304-3940(83)90158-1; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Frade JM, 1997, DEVELOPMENT, V124, P3313; GALLIRESTA L, 1993, J NEUROSCI, V13, P243; GalliResta L, 1996, J NEUROSCI, V16, P2318; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HARVEY AR, 1992, J COMP NEUROL, V325, P83, DOI 10.1002/cne.903250108; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Ma YT, 1998, J NEUROSCI, V18, P2097; MCLOON LK, 1981, BRAIN RES, V226, P15; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; OLEARY DDM, 1986, DEV BRAIN RES, V30, P96, DOI 10.1016/0165-3806(86)90136-7; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SCHEETZ AJ, 1995, VISUAL NEUROSCI, V12, P605, DOI 10.1017/S0952523800008890; SIMINOFF R, 1966, J COMP NEUROL, V127, P435, DOI 10.1002/cne.901270402; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; Spalding KL, 2005, NEUROSCIENCE, V131, P387, DOI 10.1016/j.neuroscience.2004.11.027; Spalding KL, 2004, J NEUROBIOL, V60, P319, DOI 10.1002/neu.20028; THOMPSON I, 1989, J COMP NEUROL, V282, P371; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Wikler K C, 1986, Brain Res, V393, P11; Yakura T, 2002, NEUROSCIENCE, V110, P667, DOI 10.1016/S0306-4522(01)00610-8; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	49	7	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31105	10.1371/journal.pone.0031105	http://dx.doi.org/10.1371/journal.pone.0031105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363559	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600112
J	Yoshimura, Y; Zaima, N; Moriyama, T; Kawamura, Y				Yoshimura, Yukihiro; Zaima, Nobuhiro; Moriyama, Tatsuya; Kawamura, Yukio			Different Localization Patterns of Anthocyanin Species in the Pericarp of Black Rice Revealed by Imaging Mass Spectrometry	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE-FORMATION; SUCROSE-SPECIFIC INDUCTION; ANTIOXIDANT ACTIVITY; TISSUE-SECTIONS; SEED COATS; SUPPLEMENTATION; IDENTIFICATION; BIOSYNTHESIS; EXPRESSION; FRACTION	Black rice (Oryza sativa L. Japonica) contains high levels of anthocyanins in the pericarp and is considered an effective health-promoting food. Several studies have identified the molecular species of anthocyanins in black rice, but information about the localization of each anthocyanin species is limited because methodologies for investigating the localization such as determining specific antibodies to anthocyanin, have not yet been developed Matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) is a suitable tool for investigating the localization of metabolites. In this study, we identified 7 species of anthocyanin monoglycosides and 2 species of anthocyanin diglycosides in crude extracts from black rice by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) analysis. We also analyzed black rice sections by MALDI-IMS and found 2 additional species of anthocyanin pentosides and revealed different localization patterns of anthocyanin species composed of different sugar moieties. Anthocyanin species composed of a pentose moiety (cyanidin-3-O-pentoside and petunidin-3-O-pentoside) were localized in the entire pericarp, whereas anthocyanin species composed of a hexose moiety (cyanidin-3-O-hexoside and peonidin-3-O-hexoside) were focally localized in the dorsal pericarp. These results indicate that anthocyanin species composed of different sugar moieties exhibit different localization patterns in the pericarp of black rice. This is the first detailed investigation into the localization of molecular species of anthocyanins by MALDI-IMS.	[Yoshimura, Yukihiro; Zaima, Nobuhiro; Moriyama, Tatsuya; Kawamura, Yukio] Kinki Univ, Dept Appl Biol Chem, Grad Sch Agr, Nara, Japan	Kindai University (Kinki University)	Yoshimura, Y (corresponding author), Kinki Univ, Dept Appl Biol Chem, Grad Sch Agr, Nara, Japan.	zaimanobuhiro@gmail.com	Yoshimura, Yukihiro/AAJ-5213-2020	Moriyama, Tatsuya/0000-0002-6861-926X	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choung MG, 2001, J AGR FOOD CHEM, V49, P5848, DOI 10.1021/jf010550w; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; FEDOROFF NV, 1984, P NATL ACAD SCI-BIOL, V81, P3825, DOI 10.1073/pnas.81.12.3825; Garcia-Beneytez E, 2003, J AGR FOOD CHEM, V51, P5622, DOI 10.1021/jf0302207; Goto-Inoue N, 2010, ANAL SCI, V26, P821, DOI 10.2116/analsci.26.821; Goto-Inoue N, 2009, GLYCOBIOLOGY, V19, P950, DOI 10.1093/glycob/cwp089; Guo HH, 2007, PLANT FOOD HUM NUTR, V62, P1, DOI 10.1007/s11130-006-0031-7; Guo HH, 2011, J LIPID RES, V52, P908, DOI 10.1194/jlr.M013375; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hou ZH, 2010, J AGR FOOD CHEM, V58, P3191, DOI 10.1021/jf904407x; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Ke Z, 2011, J NEUROSCI RES; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kim Min-Kyoung, 2008, Nutr Res Pract, V2, P46, DOI 10.4162/nrp.2008.2.1.46; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Kubo H, 2007, J PLANT RES, V120, P445, DOI 10.1007/s10265-006-0067-7; Lee JH, 2010, FOOD SCI BIOTECHNOL, V19, P391, DOI 10.1007/s10068-010-0055-5; Ling WH, 2002, J NUTR, V132, P20, DOI 10.1093/jn/132.1.20; Lopez LL, 1999, RAPID COMMUN MASS SP, V13, P663, DOI 10.1002/(SICI)1097-0231(19990430)13:8<663::AID-RCM538>3.0.CO;2-H; Mazzuca P, 2005, J MASS SPECTROM, V40, P83, DOI 10.1002/jms.778; Min B, 2011, J FOOD SCI, V76, pC117, DOI 10.1111/j.1750-3841.2010.01929.x; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Ogawa K, 2008, J AGR FOOD CHEM, V56, P4457, DOI 10.1021/jf800406v; OPARKA KJ, 1981, PLANTA, V152, P388, DOI 10.1007/BF00385354; REDDY VS, 1994, PLANT PHYSIOL, V105, P1059, DOI 10.1104/pp.105.4.1059; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Speciale A, 2010, J AGR FOOD CHEM, V58, P12048, DOI 10.1021/jf1029515; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Stoeckli M, 2002, ANAL BIOCHEM, V311, P33, DOI 10.1016/S0003-2697(02)00386-X; Tamura S, 2010, BIOCHEM SYST ECOL, V38, P438, DOI 10.1016/j.bse.2010.01.017; Tanaka J, 2011, PHYTOTHER RES; Tanaka J, 2011, J AGR FOOD CHEM, V59, P528, DOI 10.1021/jf103186a; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Xia M, 2003, J NUTR, V133, P744, DOI 10.1093/jn/133.3.744; Xu BJ, 2008, J AGR FOOD CHEM, V56, P8365, DOI 10.1021/jf801196d; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121; Zaima N, 2011, J OLEO SCI, V60, P93, DOI 10.5650/jos.60.93; Zaima N, 2010, RAPID COMMUN MASS SP, V24, P2723, DOI 10.1002/rcm.4693; Zhang MW, 2010, J AGR FOOD CHEM, V58, P7580, DOI 10.1021/jf1007665; Zhang RF, 2011, J AGR FOOD CHEM, V59, P5935, DOI 10.1021/jf201593n	47	61	63	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31285	10.1371/journal.pone.0031285	http://dx.doi.org/10.1371/journal.pone.0031285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363605	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600135
J	Bais, MV; Nugent, MA; Stephens, DN; Sume, SS; Kirsch, KH; Sonenshein, GE; Trackman, PC				Bais, Manish V.; Nugent, Matthew A.; Stephens, Danielle N.; Sume, S. Selva; Kirsch, Kathrin H.; Sonenshein, Gail E.; Trackman, Philip C.			Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; TRANSFORMED PHENOTYPE; PHOSPHOHISTONE H3; PROLIFERATION; KI-67; CELLS; RAS; ACTIVATION; CARCINOMA; REPP86	Lysyl oxidase propeptide (LOX-PP) ectopic overexpression inhibits the growth of cancer xenografts. Here the ability and mode of action of purified recombinant LOX-PP (rLOX-PP) protein to inhibit the growth of pre-existing xenografts was determined. Experimental approaches employed were direct intratumoral injection (i.t.) of rLOX-PP protein into murine breast cancer NF639 xenografts, and application of a slow release formulation of rLOX-PP implanted adjacent to tumors in NCR nu/nu mice (n = 10). Tumors were monitored for growth, and after sacrifice were subjected to immunohistochemical and Western blot analyses for several markers of proliferation, apoptosis, and for rLOX-PP itself. Direct i.t. injection of rLOX-PP significantly reduced tumor volume on days 20, 22 and 25 and tumor weight at harvest on day 25 by 30% compared to control. Implantation of beads preloaded with 35 micrograms rLOX-PP (n = 10) in vivo reduced tumor volume and weight at sacrifice when compared to empty beads (p < 0.05). A 30% reduction of tumor volume on days 22 and 25 (p < 0.05) and final tumor weight on day 25 (p < 0.05) were observed with a reduced tumor growth rate of 60% after implantation. rLOX-PP significantly reduced the expression of proliferation markers and Erk1/2 MAP kinase activation, while prominent increases in apoptosis markers were observed. rLOX-PP was detected by immunohistochemistry in harvested rLOX-PP tumors, but not in controls. Data provide pre-clinical findings that support proof of principle for the therapeutic anti-cancer potential of rLOX-PP protein formulations.	[Bais, Manish V.; Stephens, Danielle N.; Sume, S. Selva; Trackman, Philip C.] Boston Univ, Div Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Nugent, Matthew A.; Kirsch, Kathrin H.; Trackman, Philip C.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Boston University; Boston University; Tufts University	Bais, MV (corresponding author), Boston Univ, Div Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Nugent, Matthew/0000-0002-8630-4712; Kirsch, Kathrin/0000-0003-1532-1715; Bais, Manish/0000-0003-4198-7377	NIH [R01 DE14066, RO1 CA82742, R01 HL088572]; Department of Defense [W81XWH-08-1-0349 PC073646]; NATIONAL CANCER INSTITUTE [R01CA082742, R01CA143108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIH grants: R01 DE14066, RO1 CA82742, and R01 HL088572, and Department of Defense Idea Award W81XWH-08-1-0349 PC073646. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Aune G, 2011, INT J CLIN EXP PATHO, V4, P444; BALKWILL FR, 1986, CANCER RES, V46, P3990; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Bossard C, 2006, J CLIN PATHOL, V59, P706, DOI 10.1136/jcp.2005.030452; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607; EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kantarci A, 2007, J DENT RES, V86, P888, DOI 10.1177/154405910708600916; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Kaul G, 2006, J GENE MED, V8, P100, DOI 10.1002/jgm.819; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Menke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014527; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Mohsenifar J, 2007, ARCH IRAN MED, V10, P27; Nehra A, 1999, J UROLOGY, V162, P910, DOI 10.1097/00005392-199909010-00089; Nishimura R, BREAST CANC, V17, P269; NUGENT MA, 1992, MATER RES SOC SYMP P, V252, P273; OZZELLO L, 1988, J INTERFERON RES, V8, P679, DOI 10.1089/jir.1988.8.679; OZZELLO L, 1988, J INTERFERON RES, V8, P207, DOI 10.1089/jir.1988.8.207; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Petrovic D, COLL ANTROPOL, V34, P93; Santana RB, 2006, INT J ORAL MAX IMPL, V21, P711; Santisteban M, 2010, BREAST CANCER RES TR, V121, P431, DOI 10.1007/s10549-009-0534-7; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; SHIRAI M, 1990, EUR J CANCER, V26, P1045, DOI 10.1016/0277-5379(90)90048-X; Skaland I, 2009, CELL ONCOL, V31, P261, DOI 10.3233/CLO-2009-0464; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Taheri ZM, 2008, ARCH PATHOL LAB MED, V132, P694, DOI 10.1043/1543-2165(2008)132[694:TDVOKA]2.0.CO;2; Tanei T, 2011, EJSO-EUR J SURG ONC, V37, P155, DOI 10.1016/j.ejso.2010.10.009; Ueda S, 2011, BREAST CANCER-TOKYO, V18, P299, DOI 10.1007/s12282-010-0212-y; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yu L, CANC CYTOPATHOL, V118, P47; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	53	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31188	10.1371/journal.pone.0031188	http://dx.doi.org/10.1371/journal.pone.0031188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363577	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100053
J	Koh, H; Kim, H; Kim, MJ; Park, J; Lee, HJ; Chung, J				Koh, Hyongjong; Kim, Hyunjin; Kim, Min Ju; Park, Jeehye; Lee, Hye-Jeong; Chung, Jongkyeong			Silent Information Regulator 2 (Sir2) and Forkhead Box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila PTEN-induced Kinase 1 (PINK1) Null Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; PARKINSONS-DISEASE; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; LIFE-SPAN; GENE; MUTATIONS; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION	PTEN-induced kinase 1 (PINK1), which is associated with early onset Parkinson disease, encodes a serine-threonine kinase that is critical for maintaining mitochondrial function. Moreover, another Parkinson disease-linked gene, parkin, functions downstream of PINK1 in protecting mitochondria and dopaminergic (DA) neuron. In our fly genetic screening, knockdown of Sir2 blocked PINK1 overexpression-induced phenotypes. Consistently, ectopic expression of Sir2 successfully rescued mitochondrial defects in PINK1 null mutants, but unexpectedly, failed in parkin mutants. In further genetic analyses, deletion of FOXO nullified the Sir2-induced mitochondrial restoration in PINK1 null mutants. Moreover, overexpression of FOXO or its downstream target gene such as SOD2 or Thor markedly ameliorated PINK1 loss-of-function defects, suggesting that FOXO mediates the mitochondrial protecting signal induced by Sir2. Consistent with its mitochondria-protecting role, Sir2 expression prevented the DA neuron loss of PINK1 null mutants in a FOXO-dependent manner. Loss of Sir2 or FOXO induced DA neuron degeneration, which is very similar to that of PINK1 null mutants. Furthermore, PINK1 deletion had no deleterious effect on the DA neuron loss in Sir2 or FOXO mutants, supporting the idea that Sir2, FOXO, and PINK1 protect DA neuron in a common pathway. Overall, these results strongly support the role of Sir2 and FOXO in preventing mitochondrial dysfunction and DA neuron loss, further suggesting that Sir2 and FOXO function downstream of PINK1 and independently of Parkin.	[Koh, Hyongjong; Kim, Hyunjin; Kim, Min Ju; Lee, Hye-Jeong] Dong A Univ, Coll Med, Dept Pharmacol, MHRC, Pusan 602714, South Korea; [Park, Jeehye; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Sch Biol Sci, Seoul 151744, South Korea; [Park, Jeehye; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151744, South Korea	Dong A University; Seoul National University (SNU); Seoul National University (SNU)	Koh, H (corresponding author), Dong A Univ, Coll Med, Dept Pharmacol, MHRC, Dongdaeshin Dong 3-1, Pusan 602714, South Korea.	hjkoh@dau.ac.kr; jkc@snu.ac.kr		Koh, Hyongjong/0000-0003-2594-4799	National Research Foundation of Korea (NRF) [2008-0059520, 2009-0093188]; Korean government (Ministry Of Education, Science And Technology (MEST); MEST [2010-0018291]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry Of Education, Science And Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (Grants 2008-0059520 and 2009-0093188) funded by the Korean government (Ministry Of Education, Science And Technology (MEST)) (to H. K.) and the National Creative Research Initiatives Program (Grant 2010-0018291) from MEST (to J. C.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Griswoldt AJ, 2008, P NATL ACAD SCI USA, V105, P8673, DOI 10.1073/pnas.0803837105; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	55	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12750	12758		10.1074/jbc.M111.337907	http://dx.doi.org/10.1074/jbc.M111.337907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378780	Green Published, hybrid			2022-12-25	WOS:000302903700014
J	Dittrich, CM; Kratz, K; Sendoel, A; Gruenbaum, Y; Jiricny, J; Hengartner, MO				Dittrich, Christina M.; Kratz, Katja; Sendoel, Ataman; Gruenbaum, Yosef; Jiricny, Josef; Hengartner, Michael O.			LEM-3-A LEM Domain Containing Nuclease Involved in the DNA Damage Response in C. elegans	PLOS ONE			English	Article							TO-AUTOINTEGRATION FACTOR; NUCLEOTIDE EXCISION-REPAIR; INDUCED APOPTOSIS; CELL-DIVISION; CHECKPOINT; ENVELOPE; DEATH; GENE; PATHWAY; EMERIN	The small nematode Caenorhabditis elegans displays a spectrum of DNA damage responses similar to humans. In order to identify new DNA damage response genes, we isolated in a forward genetic screen 14 new mutations conferring hypersensitivity to ionizing radiation. We present here our characterization of lem-3, one of the genes identified in this screen. LEM-3 contains a LEM domain and a GIY nuclease domain. We confirm that LEM-3 has DNase activity in vitro. lem-3(lf)mutants are hypersensitive to various types of DNA damage, including ionizing radiation, UV-C light and crosslinking agents. Embryos from irradiated lem-3 hermaphrodites displayed severe defects during cell division, including chromosome mis-segregation and anaphase bridges. The mitotic defects observed in irradiated lem-3 mutant embryos are similar to those found in baf-1 (barrier-to-autointegration factor) mutants. The baf-1 gene codes for an essential and highly conserved protein known to interact with the other two C. elegans LEM domain proteins, LEM-2 and EMR-1. We show that baf-1, lem-2, and emr-1 mutants are also hypersensitive to DNA damage and that loss of lem-3 sensitizes baf-1 mutants even in the absence of DNA damage. Our data suggest that BAF-1, together with the LEM domain proteins, plays an important role following DNA damage - possibly by promoting the reorganization of damaged chromatin.	[Dittrich, Christina M.; Sendoel, Ataman; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dittrich, Christina M.] Univ Zurich, Mol Life Sci PhD Program, Zurich, Switzerland; [Kratz, Katja; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Jiricny, Josef] ETH, Dept Biol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dittrich, CM (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X; Sendoel, Ataman/0000-0002-0381-9965	Swiss National Science Foundation; Ernst Hadorn Foundation; Roche Research Foundation; National Institute of Health (NIH) National Center for Research Resources (NCRR); National Bioresource Project in Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst Hadorn Foundation; Roche Research Foundation; National Institute of Health (NIH) National Center for Research Resources (NCRR); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Swiss National Science Foundation (MOH), the Ernst Hadorn Foundation (MOH), and the Roche Research Foundation (CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank P. Gonczy, M. Gotta, A. Hajnal and S. Ahmed for discussion and comments, and A. Spang, A. Hajnal, A. Spilker, M. Pellegrino, and M. Morf for technical help. We thank A. Brachner and R. Foisner for communication of results prior to publication. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health (NIH) National Center for Research Resources (NCRR), and from the Shohei Mitani mutant collection of the National Bioresource Project in Japan.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Astin JW, 2008, DNA REPAIR, V7, P267, DOI 10.1016/j.dnarep.2007.10.004; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; BRENNER S, 1974, GENETICS, V77, P71; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HARTMAN PS, 1989, GENETICS, V122, P379; HARTMAN PS, 1982, GENETICS, V102, P159; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Meyerzon M, 2009, DEV BIOL, V327, P433, DOI 10.1016/j.ydbio.2008.12.030; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Nehme R, 2008, ONCOGENE, V27, pS30, DOI 10.1038/onc.2009.41; O'Neil Nigel, 2006, WormBook, P1; Praitis V, 2001, GENETICS, V157, P1217; Schmutz C, 2005, EUR J CELL BIOL, V84, P75, DOI 10.1016/j.ejcb.2004.10.004; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	41	34	45	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e24555	10.1371/journal.pone.0024555	http://dx.doi.org/10.1371/journal.pone.0024555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383942	Green Accepted, Green Published, gold			2022-12-25	WOS:000302916100001
J	Satoh, M; Andoh, Y; Clingan, CS; Ogura, H; Fujii, S; Eshima, K; Nakayama, T; Taniguchi, M; Hirata, N; Ishimori, N; Tsutsui, H; Onoe, K; Iwabuchi, K				Satoh, Masashi; Andoh, Yasuhiro; Clingan, Christopher Stuart; Ogura, Hisako; Fujii, Satoshi; Eshima, Koji; Nakayama, Toshinori; Taniguchi, Masaru; Hirata, Noriyuki; Ishimori, Naoki; Tsutsui, Hiroyuki; Onoe, Kazunori; Iwabuchi, Kazuya			Type II NKT Cells Stimulate Diet-Induced Obesity by Mediating Adipose Tissue Inflammation, Steatohepatitis and Insulin Resistance	PLOS ONE			English	Article							KILLER T-CELLS; GUT MICROBIOTA; GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; PPAR-GAMMA; INKT CELLS; OB/OB MICE; FAT; LYMPHOCYTES; ACTIVATION	The progression of obesity is accompanied by a chronic inflammatory process that involves both innate and acquired immunity. Natural killer T (NKT) cells recognize lipid antigens and are also distributed in adipose tissue. To examine the involvement of NKT cells in the development of obesity, C57BL/6 mice (wild type; WT), and two NKT-cell-deficient strains, J alpha 18(-/-) mice that lack the type I subset and CD1d(-/-) mice that lack both the type I and II subsets, were fed a high fat diet (HFD). CD1d(-/-) mice gained the least body weight with the least weight in perigonadal and brown adipose tissue as well as in the liver, compared to WT or J alpha 18(-/-) mice fed an HFD. Histologically, CD1d(-/-) mice had significantly smaller adipocytes and developed significantly milder hepatosteatosis than WT or J alpha 8(-/-) mice. The number of NK1.1(+)TCR beta(+) cells in adipose tissue increased when WT mice were fed an HFD and were mostly invariant V alpha 14J alpha 18-negative. CD11b(+) macrophages (M phi) were another major subset of cells in adipose tissue infiltrates, and they were divided into F4/80(high) and F4/80(low) cells. The F4/80(low)-M phi subset in adipose tissue was increased in CD1d(-/-) mice, and this population likely played an anti-inflammatory role. Glucose intolerance and insulin resistance in CD1d(-/-) mice were not aggravated as in WT or J alpha 18(-/-) mice fed an HFD, likely due to a lower grade of inflammation and adiposity. Collectively, our findings provide evidence that type II NKT cells initiate inflammation in the liver and adipose tissue and exacerbate the course of obesity that leads to insulin resistance.	[Satoh, Masashi; Eshima, Koji; Iwabuchi, Kazuya] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Japan; [Satoh, Masashi; Andoh, Yasuhiro; Clingan, Christopher Stuart; Ogura, Hisako; Hirata, Noriyuki; Onoe, Kazunori; Iwabuchi, Kazuya] Hokkaido Univ, Inst Med Genet, Res Sect Pathophysiol, Div Immunobiol, Sapporo, Hokkaido, Japan; [Andoh, Yasuhiro; Ishimori, Naoki; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Clingan, Christopher Stuart] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Fujii, Satoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pathobiol & Therapeut, Nagoya, Aichi, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Taniguchi, Masaru] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Hirata, Noriyuki] Hokkaido Univ, Inst Med Genet, Res Sect Pathophysiol, Div Canc Biol, Sapporo, Hokkaido, Japan	Kitasato University; Hokkaido University; Hokkaido University; Vanderbilt University; Nagoya City University; Chiba University; RIKEN; Hokkaido University	Satoh, M (corresponding author), Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Japan.	akimari@kitasato-u.ac.jp	Ishimori, Naoki/A-8015-2012; Taniguchi, Masaru/N-7932-2015; Ishimori, Naoki/AAP-2349-2020; Nakayama, Toshinori/E-1067-2017; Tsutsui, Hiroyuki/A-4070-2012	Taniguchi, Masaru/0000-0001-7821-7179; Nakayama, Toshinori/0000-0002-1434-2007; 	Japan Society for the Promotion of Science (JSPS) [20390106]; Establishment of International Collaboration Center for Zoonosis Control; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labor and Welfare of Japan; Heisei Ijuku Tomakomai East Hospital; Parent's Association (Keyaki Kai) Grant of Kitasa; Grants-in-Aid for Scientific Research [24390192, 23591096, 23592073] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Establishment of International Collaboration Center for Zoonosis Control; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Heisei Ijuku Tomakomai East Hospital; Parent's Association (Keyaki Kai) Grant of Kitasa; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research(#B: #20390106) by the Japan Society for the Promotion of Science (JSPS), Global COE Program, Establishment of International Collaboration Center for Zoonosis Control, by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan, and a Grant by Heisei Ijuku Tomakomai East Hospital. MS is a recipient of a Parent's Association (Keyaki Kai) Grant of Kitasa to University School of Medicine. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lalazar G, 2008, MOL IMMUNOL, V45, P3517, DOI 10.1016/j.molimm.2008.05.009; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Miyazaki Y, 2008, SCAND J IMMUNOL, V67, P230, DOI 10.1111/j.1365-3083.2007.02062.x; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	43	76	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30568	10.1371/journal.pone.0030568	http://dx.doi.org/10.1371/journal.pone.0030568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383967	gold, Green Published			2022-12-25	WOS:000302875500005
J	Shi, C; Hu, N; Huang, H; Gao, J; Zhao, YJ; Gao, LZ				Shi, Chao; Hu, Na; Huang, Hui; Gao, Ju; Zhao, You-Jie; Gao, Li-Zhi			An Improved Chloroplast DNA Extraction Procedure for Whole Plastid Genome Sequencing	PLOS ONE			English	Article							RESOLVES; GENES	Background: Chloroplast genomes supply valuable genetic information for evolutionary and functional studies in plants. The past five years have witnessed a dramatic increase in the number of completely sequenced chloroplast genomes with the application of second-generation sequencing technology in plastid genome sequencing projects. However, costeffective high-throughput chloroplast DNA (cpDNA) extraction becomes a major bottleneck restricting the application, as conventional methods are difficult to make a balance between the quality and yield of cpDNAs. Methodology/Principal Findings: We first tested two traditional methods to isolate cpDNA from the three species, Oryza brachyantha, Leersia japonica and Prinsepia utihis. Both of them failed to obtain properly defined cpDNA bands. However, we developed a simple but efficient method based on sucrose gradients and found that the modified protocol worked efficiently to isolate the cpDNA from the same three plant species. We sequenced the isolated DNA samples with Illumina (Solexa) sequencing technology to test cpDNA purity according to aligning sequence reads to the reference chloroplast genomes, showing that the reference genome was properly covered. We show that 40-50% cpDNA purity is achieved with our method. Conclusion: Here we provide an improved method used to isolate cpDNA from angiosperms. The Illumina sequencing results suggest that the isolated cpDNA has reached enough yield and sufficient purity to perform subsequent genome assembly. The cpDNA isolation protocol thus will be widely applicable to the plant chloroplast genome sequencing projects.	[Shi, Chao; Hu, Na; Huang, Hui; Gao, Ju; Zhao, You-Jie; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Shi, Chao; Hu, Na] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China.	lgao@mail.kib.ac.cn		You-jie, Zhao/0000-0002-3198-0465	National Science Foundation of China [U0936603]; Natural Science Foundation of Yunnan Province [2008CC016]; Chinese Academy of Sciences (CAS) [KSCX2-YW-N-029]; Talent Program of Yunnan Province [20080A009]; Chinese Department of Science and Technology [2007CB815703]; Kunming Institute of Botany, CAS [672705232515]; Kunming Institute of Botany, CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Talent Program of Yunnan Province; Chinese Department of Science and Technology; Kunming Institute of Botany, CAS(Chinese Academy of Sciences); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (U0936603), Key Project of Natural Science Foundation of Yunnan Province (2008CC016), the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), Talent Program of Yunnan Province (20080A009), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703), Frontier Grant of Kunming Institute of Botany, CAS (672705232515), and a start-up grant from Kunming Institute of Botany, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DRUMMOND AJ, 2009, GENEIOUS V4 7; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nock CJ, 2010, PLANT BIOTECHNOL J, P1; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Shaffer C, 2007, NAT BIOTECHNOL, V25, P149, DOI 10.1038/nbt0207-149; Sugiura M, 1995, ESSAYS BIOCHEM, V30, P49; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025	20	116	124	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31468	10.1371/journal.pone.0031468	http://dx.doi.org/10.1371/journal.pone.0031468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384027	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500021
J	Pinheiro, FL; Pacheco, JM; Santos, FC				Pinheiro, Flavio L.; Pacheco, Jorge M.; Santos, Francisco C.			From Local to Global Dilemmas in Social Networks	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; INCLUSIVE FITNESS; COOPERATION; GAME; EMERGENCE; SELECTION; TEMPERATURE; FIXATION; BEHAVIOR; SPREAD	Social networks affect in such a fundamental way the dynamics of the population they support that the global, population-wide behavior that one observes often bears no relation to the individual processes it stems from. Up to now, linking the global networked dynamics to such individual mechanisms has remained elusive. Here we study the evolution of cooperation in networked populations and let individuals interact via a 2-person Prisoner's Dilemma - a characteristic defection dominant social dilemma of cooperation. We show how homogeneous networks transform a Prisoner's Dilemma into a population-wide evolutionary dynamics that promotes the coexistence between cooperators and defectors, while heterogeneous networks promote their coordination. To this end, we define a dynamic variable that allows us to track the self-organization of cooperators when co-evolving with defectors in networked populations. Using the same variable, we show how the global dynamics - and effective dilemma - co-evolves with the motifs of cooperators in the population, the overall emergence of cooperation depending sensitively on this co-evolution.	[Pinheiro, Flavio L.; Pacheco, Jorge M.; Santos, Francisco C.] Univ Lisbon, Inst Invest Interdisciplinar, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, P-1699 Lisbon, Portugal; [Pacheco, Jorge M.] Univ Minho, Dept Matemat & Aplicacoes, Braga, Portugal; [Santos, Francisco C.] Univ Tecn Lisboa, Inst Super Tecn, Dept Informat Engn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Universidade do Minho; Universidade de Lisboa; Instituto Superior Tecnico	Pinheiro, FL (corresponding author), Univ Lisbon, Inst Invest Interdisciplinar, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, P-1699 Lisbon, Portugal.	franciscocsantos@ist.utl.pt	Pacheco, Jorge M/B-6116-2008; Pinheiro, Flávio L./F-9214-2011; Santos, Francisco C./W-7781-2019; Pacheco, Jorge M./O-8184-2019; Santos, Francisco C./D-2394-2010	Pacheco, Jorge M/0000-0002-2579-8499; Pinheiro, Flávio L./0000-0002-0561-9641; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M./0000-0002-2579-8499; Santos, Francisco C./0000-0002-9103-2862	FCT-Portugal	FCT-Portugal(Portuguese Foundation for Science and Technology)	Financial support from FCT-Portugal is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bollobas B, RANDOM GRAPHS; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chalub FACC, 2011, SPRINGER PROC MATH, V1, P239, DOI 10.1007/978-3-642-11456-4_15; Chalub FACC, 2009, THEOR POPUL BIOL, V76, P268, DOI 10.1016/j.tpb.2009.08.006; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Dorogovtsev S, 2010, COMPLEX NETWORKS; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gintis H., 2000, GAME THEORY EVOLVING; Gokhale CS, 2010, P NATL ACAD SCI USA, V107, P5500, DOI 10.1073/pnas.0912214107; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Marshall JAR, 2010, BEHAV ECOL SOCIOBIOL, P1; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Maynard Smith J., 1982, pi; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Pacheco JM, 2009, P ROY SOC B-BIOL SCI, V276, P315, DOI 10.1098/rspb.2008.1126; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Santos FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056128; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schelling T.C, 2006, MICROMOTIVES MACROBE; Sigmund K., 2010, CALCULUS SELFISHNESS; Skyrms B., 2001, PROC ADDRESS AM PHIL, V75, P31, DOI DOI 10.2307/3218711; Skyrms B, STAG HUNT EVOLUTION; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Souza MO, 2009, J THEOR BIOL, V260, P581, DOI 10.1016/j.jtbi.2009.07.010; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Taylor PD, 2007, J THEOR BIOL, V249, P101, DOI 10.1016/j.jtbi.2007.07.006; Traulsen A, 2009, REV NONLINEAR DYNAMI; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021905; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	74	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32114	10.1371/journal.pone.0032114	http://dx.doi.org/10.1371/journal.pone.0032114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363804	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700145
J	Ma, CW; Xiu, ZL; Zeng, AP				Ma, Cheng-Wei; Xiu, Zhi-Long; Zeng, An-Ping			Discovery of Intramolecular Signal Transduction Network Based on a New Protein Dynamics Model of Energy Dissipation	PLOS ONE			English	Article							LYSINE-SENSITIVE ASPARTOKINASE; MOLECULAR-DYNAMICS; COMPLEX NETWORKS; ENZYME; IDENTIFICATION; DEREGULATION; INTEGRATION; INHIBITION	A novel approach to reveal intramolecular signal transduction network is proposed in this work. To this end, a new algorithm of network construction is developed, which is based on a new protein dynamics model of energy dissipation. A key feature of this approach is that direction information is specified after inferring protein residue-residue interaction network involved in the process of signal transduction. This enables fundamental analysis of the regulation hierarchy and identification of regulation hubs of the signaling network. A well-studied allosteric enzyme, E. coli aspartokinase III, is used as a model system to demonstrate the new method. Comparison with experimental results shows that the new approach is able to predict all the sites that have been experimentally proved to desensitize allosteric regulation of the enzyme. In addition, the signal transduction network shows a clear preference for specific structural regions, secondary structural types and residue conservation. Occurrence of super-hubs in the network indicates that allosteric regulation tends to gather residues with high connection ability to collectively facilitate the signaling process. Furthermore, a new parameter of propagation coefficient is defined to determine the propagation capability of residues within a signal transduction network. In conclusion, the new approach is useful for fundamental understanding of the process of intramolecular signal transduction and thus has significant impact on rational design of novel allosteric proteins.	[Ma, Cheng-Wei; Zeng, An-Ping] Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany; [Ma, Cheng-Wei; Xiu, Zhi-Long] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Hamburg University of Technology; Dalian University of Technology	Ma, CW (corresponding author), Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany.	aze@tu-harburg.de		Zeng, An-Ping/0000-0001-9768-7096	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Dr. Ma acknowledges financial support from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal MA, 2009, CURR PROTEIN PEPT SC, V10, P161, DOI 10.2174/138920309787847617; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; CASSAN M, 1986, J BIOL CHEM, V261, P1052; Chen Z, 2011, J BIOTECHNOL, V154, P248, DOI 10.1016/j.jbiotec.2011.05.005; Chen Z, 2011, APPL ENVIRON MICROB, V77, P4352, DOI 10.1128/AEM.02912-10; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar S, 2000, PROTEIN SCI, V9, P10; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Ma CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026453; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Miyata YO, 2001, BIOSCI BIOTECH BIOCH, V65, P1149; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360	43	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31529	10.1371/journal.pone.0031529	http://dx.doi.org/10.1371/journal.pone.0031529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363664	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500053
J	Timmers, MA; Bird, CE; Skillings, DJ; Smouse, PE; Toonen, RJ				Timmers, Molly A.; Bird, Christopher E.; Skillings, Derek J.; Smouse, Peter E.; Toonen, Robert J.			There's No Place Like Home: Crown-of-Thorns Outbreaks in the Central Pacific Are Regionally Derived and Independent Events	PLOS ONE			English	Article							STARFISH ACANTHASTER-PLANCI; GREAT-BARRIER-REEF; LIMPETS CELLANA SPP.; GENETIC-STRUCTURE; CORAL-REEFS; POPULATION-GENETICS; FEEDING PREFERENCES; HERBIVOROUS FISHES; SEQUENCE ALIGNMENT; ECHINODERMATA	One of the most significant biological disturbances on a tropical coral reef is a population outbreak of the fecund, corallivorous crown-of-thorns sea star, Acanthaster planci. Although the factors that trigger an initial outbreak may vary, successive outbreaks within and across regions are assumed to spread via the planktonic larvae released from a primary outbreak. This secondary outbreak hypothesis is predominantly based on the high dispersal potential of A. planci and the assertion that outbreak populations (a rogue subset of the larger population) are genetically more similar to each other than they are to low-density non-outbreak populations. Here we use molecular techniques to evaluate the spatial scale at which A. planci outbreaks can propagate via larval dispersal in the central Pacific Ocean by inferring the location and severity of gene flow restrictions from the analysis of mtDNA control region sequence (656 specimens, 17 non-outbreak and six outbreak locations, six archipelagos, and three regions). Substantial regional, archipelagic, and subarchipelagic-scale genetic structuring of A. planci populations indicate that larvae rarely realize their dispersal potential and outbreaks in the central Pacific do not spread across the expanses of open ocean. On a finer scale, genetic partitioning was detected within two of three islands with multiple sampling sites. The finest spatial structure was detected at Pearl & Hermes Atoll, between the lagoon and forereef habitats (<10 km). Despite using a genetic marker capable of revealing subtle partitioning, we found no evidence that outbreaks were a rogue genetic subset of a greater population. Overall, outbreaks that occur at similar times across population partitions are genetically independent and likely due to nutrient inputs and similar climatic and ecological conditions that conspire to fuel plankton blooms.	[Timmers, Molly A.] Natl Ocean & Atmospher Adm NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Bird, Christopher E.; Skillings, Derek J.; Toonen, Robert J.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Skillings, Derek J.] Univ Hawaii, Dept Zool, Honolulu, HI 96822 USA; [Smouse, Peter E.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii System; Rutgers State University New Brunswick	Timmers, MA (corresponding author), Natl Ocean & Atmospher Adm NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	molly.timmers@noaa.gov	Toonen, Rob/V-6230-2019; Toonen, Rob/K-2891-2012	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340	Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP); National Oceanic and Atmospheric Administration; National Science Foundation (OCE) [06-23678]; National Marine Sanctuaries CRER-HIMB [MOA-2005-008/6882]; Sigma-Xi; United States Department of Agriculture; New Jersey Agricultural Experiment Station [17111]; NSF, Division of Environmental Biology [0514956]	Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (OCE)(National Science Foundation (NSF)); National Marine Sanctuaries CRER-HIMB; Sigma-Xi; United States Department of Agriculture(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station; NSF, Division of Environmental Biology	This work was funded by Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP), the National Oceanic and Atmospheric Administration, the National Science Foundation (OCE #06-23678), the National Marine Sanctuaries CRER-HIMB partnership (MOA-2005-008/6882), and a Sigma-Xi Grant-in-Aid research scholarship. Dr. Smouse was supported by United States Department of Agriculture and the New Jersey Agricultural Experiment Station 17111, and the NSF, Division of Environmental Biology 0514956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Avise J.C., 2004, MOL MARKERS NATURAL; BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; BENZIE JAH, 1992, MAR BIOL, V112, P119, DOI 10.1007/BF00349735; BENZIE JAH, 1992, AUST J MAR FRESH RES, V43, P597, DOI 10.1071/MF9920597; Benzie JAH, 1997, MAR BIOL, V129, P149, DOI 10.1007/s002270050155; Benzie JAH, 1999, AM ZOOL, V39, P131; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; BLACK K, 1995, MAR ECOL PROG SER, V125, P185, DOI 10.3354/meps125185; BLACK KP, 1991, MAR ECOL PROG SER, V69, P55, DOI 10.3354/meps069055; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Chester RH, 1969, ACANTHASTER PLANCI I; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Crow J.F, 2010, INTRO POPULATION GEN; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENDEAN R, 1975, Environmental Conservation, V2, P247; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Faucci A, 2007, THESIS U HAWAII MANO; FAURE G, 1989, J COASTAL RES, V5, P295; GLYNN PW, 1985, MAR ECOL PROG SER, V26, P295, DOI 10.3354/meps026295; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hare MP, 1996, EVOLUTION, V50, P2305, DOI [10.2307/2410699, 10.1111/j.1558-5646.1996.tb03618.x]; Hart AM, 1996, MAR ECOL PROG SER, V132, P21, DOI 10.3354/meps132021; Hart AM, 1996, MAR ECOL PROG SER, V132, P11, DOI 10.3354/meps132011; Hart MW, 2010, INTEGR COMP BIOL, V50, P643, DOI 10.1093/icb/icq068; Hedgecock D, 2007, MAR BIOL, V150, P1173, DOI 10.1007/s00227-006-0441-y; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Houk P, 2010, J OCEANOGR, V66, P435, DOI 10.1007/s10872-010-0038-4; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Jessop H, 2008, THESIS U HAWAII HILO; JOHNSON LG, 1994, BIOL BULL-US, V187, P304, DOI 10.2307/1542287; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Kenchington RA, 1977, BIOL CONSERV, V11, P03; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kenyon JC, 2009, B MAR SCI, V84, P199; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; LUCAS J S, 1973, Micronesica, V9, P197; LUCAS JS, 1984, J EXP MAR BIOL ECOL, V79, P129, DOI 10.1016/0022-0981(84)90214-4; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Marko PB, 2012, EVOL ECOL, V26, P291, DOI 10.1007/s10682-011-9467-9; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; MORAN PJ, 1992, MAR BIOL, V113, P509, DOI 10.1007/BF00349178; MORAN PJ, 1988, CORAL REEFS, V7, P125, DOI 10.1007/BF00300972; MORAN PJ, 1985, P 5 INT COR REEF S T, V5, P321; NASH WJ, 1988, CORAL REEFS, V7, P11, DOI 10.1007/BF00301976; NISHIDA M, 1988, MAR BIOL, V98, P359, DOI 10.1007/BF00391112; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pearson RG, 1969, PRELIMINARY STUDY CO; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Pratchett MS, 2005, CORAL REEFS, V24, P453, DOI 10.1007/s00338-005-0006-4; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Sapp J., 1999, WHAT IS NATURAL CORA; Skillings DJ, 2010, P AM AC UND SCI DIV; Sokal R. R., 1981, BIOMETRY; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Timmers M, 2009, THESIS U HAWAII HILO; Timmers MA, 2011, J MARINE BIOL; Toonen RJ, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/460173; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; WILLIAMS DM, 1986, MAR ECOL PROG SER, V28, P157, DOI 10.3354/meps028157; Wright S, 1943, GENETICS, V28, P114; YAMAGUCHI M, 1987, Galaxea, V6, P277; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x	87	50	51	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31159	10.1371/journal.pone.0031159	http://dx.doi.org/10.1371/journal.pone.0031159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363570	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600118
J	Jung, MJ; Rho, JK; Kim, YM; Jung, JE; Jin, YB; Ko, YG; Lee, JS; Lee, SJ; Lee, JC; Park, MJ				Jung, M-J; Rho, J-K; Kim, Y-M; Jung, J. E.; Jin, Y. B.; Ko, Y-G; Lee, J-S; Lee, S-J; Lee, J. C.; Park, M-J			Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells	ONCOGENE			English	Article						non-small cell lung cancer; cancer stern cell; CXCR4; PI3K/PTEN/Akt/mTOR signaling; STAT3 signaling; tumorigenicity	GROWTH-FACTOR; CHEMOKINE RECEPTOR-4; TUMOR-GROWTH; EXPRESSION; IDENTIFICATION; ACTIVATION; A549; PROLIFERATION; POPULATION; INVASION	The hypothesis of cancer stem cells has been proposed to explain the therapeutic failure in a variety of cancers including lung cancers. Previously, we demonstrated acquisition of epithelial-mesenchymal transition, a feature highly reminiscent of cancer stem-like cells, in gefitinib-resistant A549 cells (A549/GR). Here, we show that A549/GR cells contain a high proportion of CXCR4+ cells that are responsible for having high potential of self-renewal activity in vitro and tumorigenicity in vivo. A549/GR cells exhibited strong sphere-forming activity and high CXCR4 expression and SDF-1 alpha secretion compared with parent cells. Pharmacological inhibition (AMD3100) and/or siRNA transfection targeting CXCR4 significantly suppressed sphere-forming activity in A549 and A549/GR cells, and in various non-small cell lung cancer (NSCLC) cell lines. A549/GR cells showed enhanced Akt, mTOR and STAT3 (Y705) phosphorylation. Pharmacological inhibition of phosphatidyl inositol 3-kinase or transfection with wild-type PTEN suppressed phosphorylation of Akt, mTOR and STAT3 (Y705), sphere formation, and CXCR4 expression in A549/GR cells, whereas mutant PTEN enhanced these events. Inhibition of STAT3 by WP1066 or siSTAT3 significantly suppressed the sphere formation, but not CXCR4 expression, indicating that STAT3 is a downstream effector of CXCR4-mediated signaling. FACS-sorted CXCR4+ A549/GR cells formed many large spheres, had self-renewal capacity, demonstrated radiation resistance in vitro and exhibited stronger tumorigenic potential in vivo than CXCR4 cells. Lentiviral-transduction of CXCR4 enhanced sphere formation and tumorigenicity in H460 and A549 cells, whereas introduction of siCXCR4 suppressed these activities in A549/GR cells. Our data indicate that CXCR4 NSCLC cells are strong candidates for tumorigenic stem-like cancer cells that maintain sternness through a CXCR4-medated STAT3 pathway and provide a potential therapeutic target for eliminating these malignant cells in NSCLC. Oncogene (2013) 32, 209-221; doi:10.1038/onc.2012.37; published online 27 February 2012	[Jung, M-J; Kim, Y-M; Jung, J. E.; Lee, J-S; Park, M-J] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Jung, M-J; Kim, Y-M; Ko, Y-G] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Rho, J-K] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul 138736, South Korea; [Jin, Y. B.] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Lee, S-J] Hanyang Univ, Dept Chem, Seoul 133791, South Korea; [Lee, S-J] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea; [Lee, J. C.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 138736, South Korea	Korea Institute of Radiological & Medical Sciences; Korea University; University of Ulsan; Asan Medical Center; Korea Institute of Radiological & Medical Sciences; Hanyang University; Hanyang University; University of Ulsan; Asan Medical Center	Park, MJ (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 215-4 Gongneung Dong, Seoul 139706, South Korea.	jclee@amc.seoul.kr; mjpark@kcch.re.kr	Lee, Jae Cheol/AAA-2678-2021		Mid-career Researcher Program through NRF [2009-0086438]; Nuclear Research and Development Program of Korea Science and Engineering foundation; Korean government (MEST) [2011-0030604]	Mid-career Researcher Program through NRF(National Research Foundation of Korea); Nuclear Research and Development Program of Korea Science and Engineering foundation; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Mid-career Researcher Program through NRF grant (2009-0086438) and the Nuclear Research and Development Program of Korea Science and Engineering foundation funded by the Korean government (MEST) (2011-0030604).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Belperio JA, 2004, CHEST, V125, p156S, DOI 10.1378/chest.125.5_suppl.156S; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cho HH, 2006, STEM CELLS DEV, V15, P853, DOI 10.1089/scd.2006.15.853; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kijima T, 2002, CANCER RES, V62, P6304; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Krohn A, 2009, CANCER LETT, V280, P65, DOI 10.1016/j.canlet.2009.02.005; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santer FR, 2006, CANCER RES, V66, P3024, DOI 10.1158/0008-5472.CAN-05-2013; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499	44	154	159	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					209	221		10.1038/onc.2012.37	http://dx.doi.org/10.1038/onc.2012.37			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22370645				2022-12-25	WOS:000314075500009
J	Basak, JM; Verghese, PB; Yoon, H; Kim, J; Holtzman, DM				Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.			Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of A beta Uptake and Degradation by Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; DIFFUSE PLAQUES; IN-VITRO; PEPTIDE; CLEARANCE; PROTEIN; APOE; MICROGLIA	Accumulation of the amyloid beta (A beta) peptide within the brain is hypothesized to be one of the main causes underlying the pathogenic events that occur in Alzheimer disease (AD). Consequently, identifying pathways by which A beta is cleared from the brain is crucial for better understanding of the disease pathogenesis and developing novel therapeutics. Cellular uptake and degradation by glial cells is one means by which A beta may be cleared from the brain. In the current study, we demonstrate that modulating levels of the low-density lipoprotein receptor (LDLR), a cell surface receptor that regulates the amount of apolipoprotein E (apoE) in the brain, altered both the uptake and degradation of A beta by astrocytes. Deletion of LDLR caused a decrease in A beta uptake, whereas increasing LDLR levels significantly enhanced both the uptake and clearance of A beta. Increasing LDLR levels also enhanced the cellular degradation of A beta and facilitated the vesicular transport of A beta to lysosomes. Despite the fact that LDLR regulated the uptake of apoE by astrocytes, we found that the effect of LDLR on A beta uptake and clearance occurred in the absence of apoE. Finally, we provide evidence that A beta can directly bind to LDLR, suggesting that an interaction between LDLR and A beta could be responsible for LDLR- mediated A beta uptake. Therefore, these results identify LDLR as a receptor that mediates A beta uptake and clearance by astrocytes, and provide evidence that increasing glial LDLR levels may promote A beta degradation within the brain.	[Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Basak, Jacob M.; Verghese, Philip B.; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	Yoon, Hyejin/AAI-8641-2021; Kim, Jungsu/F-2457-2012	Kim, Jungsu/0000-0002-6931-8581	National Institutes of Health [AG13956, NS034467, P30NS069329]; American Health Assistance Foundation AHAF; Neuroscience Blueprint Core Grant [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329, R37NS034467, P30NS057105, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation AHAF; Neuroscience Blueprint Core Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG13956, NS034467 (to D. M. H.), and P30NS069329 (to J. K.), an American Health Assistance Foundation AHAF centennial award (to D. M. H), and Neuroscience Blueprint Core Grant P30 NS057105 (to Washington University).	Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Elder GA, 2007, J NEUROCHEM, V102, P1220, DOI 10.1111/j.1471-4159.2007.04614.x; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Funato H, 1998, AM J PATHOL, V152, P983; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Katsouri L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021880; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Thal DR, 1999, CLIN NEUROPATHOL, V18, P226; Thal DR, 2000, ACTA NEUROPATHOL, V100, P608, DOI 10.1007/s004010000242; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	50	133	139	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13959	13971		10.1074/jbc.M111.288746	http://dx.doi.org/10.1074/jbc.M111.288746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383525	Green Published, hybrid			2022-12-25	WOS:000303996300051
J	Hwangpo, TA; Jordan, JD; Premsrirut, PK; Jayamaran, G; Licht, JD; Iyengar, R; Neves, SR				Hwangpo, Tracy Anh; Jordan, J. Dedrick; Premsrirut, Prem K.; Jayamaran, Gomathi; Licht, Jonathan D.; Iyengar, Ravi; Neves, Susana R.			G Protein-regulated Inducer of Neurite Outgrowth (GRIN) Modulates Sprouty Protein Repression of Mitogen-activated Protein Kinase (MAPK) Activation by Growth Factor Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; RGS 16 FUNCTION; TYROSINE-KINASE; NA+/H+ EXCHANGER; RECEPTOR STIMULATION; SIGNALING PATHWAYS; CYSTEINE RESIDUE; DIFFERENTIATION; CELL; PHOSPHORYLATION	G alpha(o/i) interacts directly with GRIN (G protein-regulated inducer of neurite outgrowth). Using the yeast two-hybrid system, we identified Sprouty2 as an interacting partner of GRIN. G alpha(o) and Sprouty2 bind to overlapping regions of GRIN, thus competing for GRIN binding. Imaging experiments demonstrated that G alpha(o) expression promoted GRIN translocation to the plasma membrane, whereas Sprouty2 expression failed to do so. Given the role of Sprouty2 in the regulation of growth factor-mediated MAPK activation, we examined the contribution of the GRIN-Sprouty2 interaction to CB1 cannabinoid receptor regulation of FGF receptor signaling. In Neuro-2A cells, a system that expresses all of the components endogenously, modulation of GRIN levels led to regulation of MAPK activation. Overexpression of GRIN potentiated FGF activation of MAPK and decreased tyrosine phosphorylation of Sprouty2. Pretreatment with G(o/i)-coupled CB1 receptor agonist attenuated subsequent FGF activation of MAPK. Decreased expression of GRIN both diminished FGF activation of MAPK and blocked CB1R attenuation of MAPK activation. These observations indicate that G alpha(o) interacts with GRIN and outcompetes GRIN from bound Sprouty. Free Sprouty then in turn inhibits growth factor signaling. Thus, here we present a novel mechanism of how G(o/i)-coupled receptors can inhibit growth factor signaling to MAPK.	[Hwangpo, Tracy Anh; Jordan, J. Dedrick; Premsrirut, Prem K.; Jayamaran, Gomathi; Iyengar, Ravi; Neves, Susana R.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Licht, Jonathan D.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Jordan, J. Dedrick] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine	Neves, SR (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	Susana.neves@mssm.edu	Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369; Jordan, Dedrick/0000-0002-0706-9583	National Institutes of Health [R01GM54508, 5R01DK087650, RO1 CA59998]; Systems Biology Center of New York [PSDGM071558]; Mount Sinai Medical Scientist Training Program; Cardiovascular Sciences Training Grant [HL-07824]; NATIONAL CANCER INSTITUTE [R01CA059998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, T32GM008444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Biology Center of New York; Mount Sinai Medical Scientist Training Program; Cardiovascular Sciences Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM54508 (to R. I.) and 5R01DK087650 (to R. I. and S. R. N.) and RO1 CA59998 (to J. D. L.). This work was also supported by the Systems Biology Center of New York (Grant PSDGM071558).; Supported by the Mount Sinai Medical Scientist Training Program and by a Cardiovascular Sciences Training Grant HL-07824.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; FAURE M, 1994, J BIOL CHEM, V269, P7851; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; INGLESE J, 1995, TRENDS BIOCHEM SCI, V20, P151, DOI 10.1016/S0968-0004(00)88992-6; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Jordan J. D, 2002, PHARM BIOL CHEM; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsuyama S, 2005, J PHARMACOL SCI, V98, P239, DOI 10.1254/jphs.FP0050211; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; NEER EJ, 1984, J BIOL CHEM, V259, P4222; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Osterhout JL, 2003, J BIOL CHEM, V278, P19309, DOI 10.1074/jbc.M210124200; Persengiev SP, 1999, MOL CELL BIOL, V19, P6048; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Slepkov E, 2002, BIOCHEM CELL BIOL, V80, P499, DOI 10.1139/O02-151; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914	41	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13674	13685		10.1074/jbc.M111.320705	http://dx.doi.org/10.1074/jbc.M111.320705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383529	Green Published, hybrid			2022-12-25	WOS:000303996300023
J	Wood, JF; Wang, JJ; Benovic, JL; Ferkey, DM				Wood, Jordan F.; Wang, Jianjun; Benovic, Jeffrey L.; Ferkey, Denise M.			Structural Domains Required for Caenorhabditis elegans G Protein-coupled Receptor Kinase 2 (GRK-2) Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; HETEROTRIMERIC G-PROTEINS; C-ELEGANS; HOMOLOGY DOMAIN; G-ALPHA; MOLECULAR-MECHANISMS; CHEMICAL REPELLENTS; MUTATIONAL ANALYSIS; ASH NEURONS; GENE	G protein-coupled receptor kinases (GRKs) are key regulators of signal transduction that specifically phosphorylate activated G protein-coupled receptors (GPCRs) to terminate signaling. Biochemical and crystallographic studies have provided great insight into mammalian GRK2/3 interactions and structure. However, despite extensive in vitro characterization, little is known about the in vivo contribution of these described GRK structural domains and interactions to proper GRK function in signal regulation. We took advantage of the disrupted chemosensory behavior characteristic of Caenorhabditis elegans grk-2 mutants to discern the interactions required for proper in vivo Ce-GRK-2 function. Informed by mammalian crystallographic and biochemical data, we introduced amino acid substitutions into the Ce-grk-2 coding sequence that are predicted to selectively disrupt GPCR phosphorylation, G alpha(q/11) binding, G beta gamma binding, or phospholipid binding. Changing the most amino-terminal residues, which have been shown in mammalian systems to be required specifically for GPCR phosphorylation but not phosphorylation of alternative substrates or recruitment to activated GPCRs, eliminated the ability of Ce-GRK-2 to restore chemosensory signaling. Disrupting interaction between the predicted Ce-GRK-2 amino-terminal alpha-helix and kinase domain, posited to stabilize GRKs in their active ATP- and GPCR-bound conformation, also eliminated Ce-GRK-2 chemosensory function. Finally, although changing residues within the RH domain, predicted to disrupt interaction with G alpha(q/11), did not affect Ce-GRK-2 chemosensory function, disruption of the predicted PH domain-mediated interactions with G beta gamma and phospholipids revealed that both contribute to Ce-GRK-2 function in vivo. Combined, we have demonstrated functional roles for broadly conserved GRK2/3 structural domains in the in vivo regulation of organismal behavior.	[Wood, Jordan F.; Ferkey, Denise M.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Wang, Jianjun; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Jefferson University	Ferkey, DM (corresponding author), SUNY Buffalo, Dept Biol Sci, 109 Cooke Hall, Buffalo, NY 14260 USA.	dmferkey@buffalo.edu			National Science Foundation [MCB-0917896]; National Institutes of Health [GM44944]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-0917896 (to D. M. F.). This work was also supported in part by National Institutes of Health Grant GM44944 (to J. L. B.).	BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Boughton AP, 2011, P NATL ACAD SCI USA, V108, pE667, DOI 10.1073/pnas.1108236108; BRENNER S, 1974, GENETICS, V77, P71; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KONG GH, 1994, J BIOL CHEM, V269, P13084; Liu JG, 2001, BRAIN RES REV, V38, P1, DOI 10.1016/S0165-0173(01)00057-1; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metaye T, 2002, J CLIN ENDOCR METAB, V87, P3279, DOI 10.1210/jc.87.7.3279; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; PAO CS, 2002, SCI STKE, pPE42; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; van der Linden AM, 2001, GENETICS, V158, P221; VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wood WB, 1988, NEMATODE CAENORHABDI; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang W, 2006, WORLD J GASTROENTERO, V12, P7753, DOI 10.3748/wjg.v12.i48.7753; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	64	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12634	12644		10.1074/jbc.M111.336818	http://dx.doi.org/10.1074/jbc.M111.336818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375004	hybrid, Green Published			2022-12-25	WOS:000302903700004
J	Kuznetsova, IM; Sulatskaya, AI; Uversky, VN; Turoverov, KK				Kuznetsova, Irina M.; Sulatskaya, Anna I.; Uversky, Vladimir N.; Turoverov, Konstantin K.			Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique	PLOS ONE			English	Article							MOLECULAR-MECHANISM; BETA-SHEET; AFFINITY; AGENTS; SITES	A new approach for the determination of the amyloid fibril - thioflavin T (ThT) binding parameters (the number of binding modes, stoichiometry, and binding constants of each mode) is proposed. This approach is based on the absorption spectroscopy determination of the concentration of free and bound to fibril dye in solutions, which are prepared by equilibrium microdialysis. Furthermore, the proposed approach allowed us, for the first time, to determine the absorption spectrum, molar extinction coefficient, and fluorescence quantum yield of the ThT bound to fibril by each binding modes. This approach is universal and can be used for determining the binding parameters of any dye interaction with a receptor, such as ANS binding to proteins in the molten globule state or to protein amorphous aggregates.	[Kuznetsova, Irina M.; Sulatskaya, Anna I.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Uversky, Vladimir N.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; State University System of Florida; University of South Florida; Russian Academy of Sciences	Kuznetsova, IM (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	vuversky@health.usf.edu; kkt@incras.ru	Uversky, Vladimir N./F-4515-2011; Kuznetsova, Irina M./R-9844-2017; Sulatskaya, Anna/I-6042-2014; Turoverov, Konstantin/S-2079-2016	Uversky, Vladimir N./0000-0002-4037-5857; Kuznetsova, Irina M./0000-0002-3336-4834; Sulatskaya, Anna/0000-0002-1207-3384; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences; Russian Foundation of Basic Research [12-04-90022_Bel]; Dmitry Zimin's Russian Charitable Foundation "Dynasty"	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Dmitry Zimin's Russian Charitable Foundation "Dynasty"	This work was supported in part by the Russian Academy of Sciences "Molecular and Cell Biology" Program (KKT, VNU), Russian Foundation of Basic Research, grant 12-04-90022_Bel (KKT) and Dmitry Zimin's Russian Charitable Foundation "Dynasty" (AIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; De Ferrari GV, 2001, J BIOL CHEM, V276, P23282, DOI 10.1074/jbc.M009596200; Dzwolak W, 2005, FEBS LETT, V579, P6601, DOI 10.1016/j.febslet.2005.10.048; Goers J, 2002, BIOCHEMISTRY-US, V41, P12546, DOI 10.1021/bi0262698; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Henriksen G, 2007, J MED CHEM, V50, P1087, DOI 10.1021/jm061466g; Klunk WE, 2003, J NEUROSCI, V23, P2086; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; Ono M, 2009, CHEM PHARM BULL, V57, P1029, DOI 10.1248/cpb.57.1029; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Sutharsan J, 2010, CHEMMEDCHEM, V5, P56, DOI 10.1002/cmdc.200900440; Turoverov K K, 1998, Tsitologiia, V40, P806; Turoverov KK, 2007, P SOC PHOTO-OPT INS, V6733, P1; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x	31	45	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30724	10.1371/journal.pone.0030724	http://dx.doi.org/10.1371/journal.pone.0030724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383971	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800006
J	Williams, PT				Williams, Paul T.			Attenuating Effect of Vigorous Physical Activity on the Risk for Inherited Obesity: A Study of 47,691 Runners	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; WAIST CIRCUMFERENCE; EXERCISE; FAT; ASSOCIATION; ADIPOSITY; AGE; LIPOPROTEINS; METAANALYSIS	Objective: Physical activity has been shown to attenuate the effect of the FTO polymorphism on body weight, and the heritability of body weight in twin and in family studies. The dose-response relationship between activity and the risk for inherited obesity is not well known, particularly for higher doses of vigorous exercise. Such information is needed to best prescribe an exercise dose for obesity prevention in those at risk due to their family history. Design: We therefore analyzed self-reported usual running distance, body mass index (BMI), waist circumference, and mother's and father's adiposity (1 = lean, 2 = normal, 3 = overweight, and 4 = very overweight) from survey data collected on 33,480 male and 14,211 female runners. Age-, education-, and alcohol-adjusted regression analyses were used to estimate the contribution of parental adiposities to the BMI and waist circumferences in runners who ran an average of <3, 3-6, 6-9, >= 9 km/day. Results: BMI and waist circumferences of runners who ran <3 km/day were significantly related to their parents adiposity (P<10(-15) and P<10(-11), respectively). These relationships (i.e., kg/m(2) or cm per increment in parental adiposity) diminished significantly with increasing running distance for both BMI (inheritancexexercise interaction, males: P<10(-10); females: P<10 25) and waist circumference (inheritancexexercise interaction, males: P<10(-9); females: P = 0.004). Compared to <3 km/day, the parental contribution to runners who averaged >= 9 km/day was diminished by 48% for male BMI, 58% for female BMI, 55% for male waist circumference, and 58% for female waist circumference. These results could not be attributed to self-selection. Conclusions: Exceeding the minimum exercise dose currently recommended for general health benefits (energy equivalent to running 2-3 km/day) may substantially diminish the risk for inherited obesity. The results are consistent with other research suggesting the physical activity dose required to prevent unhealthy weight gain is greater than that recommended for other health benefits.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [HL094717]; Institute of Aging [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant HL094717 from the National Heart, Lung, and Blood Institute and AG032004 from the Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bjorntorp P, 1999, DRUGS, V58, P13; BORAHGIDDENS J, 1993, J NUTR EDUC, V25, P102; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Francis LA, 2003, OBES RES, V11, P143, DOI 10.1038/oby.2003.23; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Juhan-Vague I, 2002, PATHOPHYSIOL HAEMO T, V32, P269, DOI 10.1159/000073579; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; OLIVERIA SA, 1992, AM J CLIN NUTR, V56, P593, DOI 10.1093/ajcn/56.3.593; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; POULIOT MC, 1989, METABOLISM, V38, P1244, DOI 10.1016/0026-0495(89)90166-2; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; ROMIJN JA, 1993, J APPL PHYSIOL, V75, P108, DOI 10.1152/jappl.1993.75.1.108; Samaras K, 1997, INT J OBESITY, V21, P839, DOI 10.1038/sj.ijo.0800502; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spiegelman D, 2005, STAT MED, V24, P1657, DOI 10.1002/sim.2055; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Sudi KM, 2000, J PEDIATR ENDOCR MET, V13, P505; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Waller K, 2008, INT J OBESITY, V32, P353, DOI 10.1038/sj.ijo.0803692; Williams PT, 2007, INT J OBESITY, V31, P652, DOI 10.1038/sj.ijo.0803457; Williams P. T., 2011, Medicine and Science in Sports & Exercise, V43, P2120, DOI 10.1249/MSS.0b013e31821cd128; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, ARTERIOSCL THROM VAS, V27, P1811, DOI 10.1161/ATVBAHA.107.141853; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2005, CIRCULATION, V112, P350, DOI 10.1161/CIRCULATIONAHA.105.534578; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2011, OBESITY SILVER SPRIN, DOI [10.1038/oby.2011.313, DOI 10.1038/OBY.2011.313.]	44	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31436	10.1371/journal.pone.0031436	http://dx.doi.org/10.1371/journal.pone.0031436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384023	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100023
J	Jacobs, RHAH; Renken, R; Cornelissen, FW				Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.			Neural Correlates of Visual Aesthetics - Beauty as the Coalescence of Stimulus and Internal State	PLOS ONE			English	Article							TACTILE PERCEPTION; MINDS EYE; CORTEX; FMRI; SELF; NEUROSCIENCE; JUDGMENT; REGIONS; TOUCH; FORM	How do external stimuli and our internal state coalesce to create the distinctive aesthetic pleasures that give vibrance to human experience? Neuroaesthetics has so far focused on the neural correlates of observing beautiful stimuli compared to neutral or ugly stimuli, or on neural correlates of judging for beauty as opposed to other judgments. Our group questioned whether this approach is sufficient. In our view, a brain region that assesses beauty should show beauty-level-dependent activation during the beauty judgment task, but not during other, unrelated tasks. We therefore performed an fMRI experiment in which subjects judged visual textures for beauty, naturalness and roughness. Our focus was on finding brain activation related to the rated beauty level of the stimuli, which would take place exclusively during the beauty judgment. An initial whole-brain analysis did not reveal such interactions, yet a number of the regions showing main effects of the judgment task or the beauty level of stimuli were selectively sensitive to beauty level during the beauty task. Of the regions that were more active during beauty judgments than roughness judgments, the frontomedian cortex and the amygdala demonstrated the hypothesized interaction effect, while the posterior cingulate cortex did not. The latter region, which only showed a task effect, may play a supporting role in beauty assessments, such as attending to one's internal state rather than the external world. Most of the regions showing interaction effects of judgment and beauty level correspond to regions that have previously been implicated in aesthetics using different stimulus classes, but based on either task or beauty effects alone. The fact that we have now shown that task-stimulus interactions are also present during the aesthetic judgment of visual textures implies that these areas form a network that is specifically devoted to aesthetic assessment, irrespective of the stimulus type.	[Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands; [Jacobs, Richard H. A. H.; Renken, Remco; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Jacobs, RHAH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands.	richardjacobs01@hotmail.com		Renken, Remco Jan/0000-0002-7777-9484	European Commission [043157]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the European Commission, under contract #043157 (Syntex). http://cordis.europa.eu/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Cant JS, 2009, EXP BRAIN RES, V192, P391, DOI 10.1007/s00221-008-1573-8; Cunningham WA, 2008, PSYCHOL SCI, V19, P152, DOI 10.1111/j.1467-9280.2008.02061.x; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Fiedler K, 2011, PERSPECT PSYCHOL SCI, V6, P163, DOI 10.1177/1745691611400237; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hofel L, 2003, PERCEPT MOTOR SKILL, V96, P30, DOI 10.2466/pms.2003.96.1.30; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobs RHAH, 2012, AESTHETICS NUM UNPUB; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; MORDKOFF AM, 1963, J VERB LEARN VERB BE, V2, P504, DOI 10.1016/S0022-5371(63)80057-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	30	42	44	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31248	10.1371/journal.pone.0031248	http://dx.doi.org/10.1371/journal.pone.0031248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384006	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500016
J	Heang, D; Sassa, H				Heang, Dany; Sassa, Hidenori			Antagonistic Actions of HLH/bHLH Proteins Are Involved in Grain Length and Weight in Rice	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; TRANSCRIPTION FACTOR FAMILY; SIGNAL-TRANSDUCTION; CELL ELONGATION; ALPHA-SUBUNIT; LAMINA JOINT; BHLH PROTEIN; DNA-BINDING; ARABIDOPSIS; GENE	Grain size is a major yield component in rice, and partly controlled by the sizes of the lemma and palea. Molecular mechanisms controlling the sizes of these organs largely remain unknown. In this study, we show that an antagonistic pair of basic helix-loop-helix (bHLH) proteins is involved in determining rice grain length by controlling cell length in the lemma/palea. Overexpression of an atypical bHLH, named POSITIVE REGULATOR OF GRAIN LENGTH 1 (PGL1), in lemma/palea increased grain length and weight in transgenic rice. PGL1 is an atypical non-DNA-binding bHLH and assumed to function as an inhibitor of a typical DNA-binding bHLH through heterodimerization. We identified the interaction partner of PGL1 and named it ANTAGONIST OF PGL1 (APG). PGL1 and APG interacted in vivo and localized in the nucleus. As expected, silencing of APG produced the same phenotype as overexpression of PGL1, suggesting antagonistic roles for the two genes. Transcription of two known grain-length-related genes, GS3 and SRS3, was largely unaffected in the PGL1-overexpressing and APG-silenced plants. Observation of the inner epidermal cells of lemma revealed that are caused by increased cell length. PGL1-APG represents a new grain length and weight-controlling pathway in which APG is a negative regulator whose function is inhibited by PGL1.	[Heang, Dany; Sassa, Hidenori] Chiba Univ, Grad Sch Hort, Chiba, Japan	Chiba University	Heang, D (corresponding author), Chiba Univ, Grad Sch Hort, Chiba, Japan.	sassa@faculty.chiba-u.jp	Sassa, Hidenori/Q-7561-2018		Chiba University	Chiba University	This study was supported by Chiba University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Fairchild CD, 2000, GENE DEV, V14, P2377; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hong SK, 1996, DEVELOPMENT, V122, P2051; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Oki K, 2009, PLANT CELL PHYSIOL, V50, P161, DOI 10.1093/pcp/pcn182; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Takakura Y, 2000, PLANT MOL BIOL, V42, P883, DOI 10.1023/A:1006401816145; Tanaka A, 2009, PLANT PHYSIOL, V151, P669, DOI 10.1104/pp.109.140806; TOKI S, 1992, PLANT PHYSIOL, V100, P1503, DOI 10.1104/pp.100.3.1503; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yokoi S, 1998, MOL BREEDING, V4, P269, DOI 10.1023/A:1009671231614; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441	41	94	121	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31325	10.1371/journal.pone.0031325	http://dx.doi.org/10.1371/journal.pone.0031325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363621	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700050
J	Jansson, L; Larsson, J				Jansson, Lina; Larsson, Jonas			Normal Hematopoietic Stem Cell Function in Mice with Enforced Expression of the Hippo Signaling Effector YAP1	PLOS ONE			English	Article							TUMOR-SUPPRESSOR LATS1; GROWTH-CONTROL; SELF-RENEWAL; PROTEIN YAP; DROSOPHILA; PATHWAY; KINASE; TAZ; SIZE; MST2	The Hippo pathway has recently been implicated in the regulation of organ size and stem cells in multiple tissues. The transcriptional cofactor yes-associated protein 1 (Yap1) is the most downstream effector of Hippo signaling and is functionally repressed by the upstream components of the pathway. Overexpression of YAP1 stimulates proliferation of stem and progenitor cells in many tissues, consistent with inhibition of Hippo signaling. To study the role of Hippo signaling in hematopoietic stem cells (HSCs), we created a transgenic model with inducible YAP1 expression exclusively within the hematopoietic system. Following 3 months induction, examination of blood and bone marrow in the induced mice revealed no changes in the distribution of the hematopoietic lineages compared to control mice. Moreover, the progenitor cell compartment was unaltered as determined by colony forming assays and immunophenotyping. To address whether YAP1 affects the quantity and function of HSCs we performed competitive transplantation experiments. We show that ectopic YAP1 expression does not influence HSC function neither during steady state nor in situations of hematopoietic stress. This is in sharp contrast to effects seen on stem-and progenitor cells in other organs and suggests highly tissue specific functions of the Hippo pathway in regulation of stem cells.	[Jansson, Lina; Larsson, Jonas] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden	Lund University	Jansson, L (corresponding author), Lund Univ, Lund Stem Cell Ctr, Lund, Sweden.	Jonas.Larsson@med.lu.se			Swedish Research Counci [325-2008-7549]; Swedish Cancer Foundation [KTR 09 071]; Swedish Pediatric Cancer Foundation [PROJ10/116]	Swedish Research Counci; Swedish Cancer Foundation; Swedish Pediatric Cancer Foundation	This work was supported by grants from the Swedish Research Council (325-2008-7549) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Swedish Cancer Foundation (KTR 09 071) (http://www.cancerfonden.se/sv/Information-in-English/) and the Swedish Pediatric Cancer Foundation (PROJ10/116) (http://www.barncancerfonden.se/Om-oss/In-English/) to J.L. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jansson L, 2010, BLOOD, V115, P47, DOI 10.1182/blood-2009-07-235622; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Larsson J, 2008, CELL STEM CELL, V3, P221, DOI 10.1016/j.stem.2008.06.005; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32013	10.1371/journal.pone.0032013	http://dx.doi.org/10.1371/journal.pone.0032013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363786	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700134
J	Ludlow, LE; Zhou, JK; Tippett, E; Cheng, WJ; Hasang, W; Rogerson, SJ; Jaworowski, A				Ludlow, Louise E.; Zhou, Jingling; Tippett, Emma; Cheng, Wan-Jung; Hasang, Wina; Rogerson, Stephen J.; Jaworowski, Anthony			HIV-1 Inhibits Phagocytosis and Inflammatory Cytokine Responses of Human Monocyte-Derived Macrophages to P-falciparum Infected Erythrocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VARIANT SURFACE-ANTIGENS; SUB-SAHARAN AFRICA; PLACENTAL MALARIA; CHONDROITIN SULFATE; PREGNANT-WOMEN; BIRTH-WEIGHT; GAMMA; PROTECTION; IMMUNITY	HIV-1 infection increases the risk and severity of malaria by poorly defined mechanisms. We investigated the effect of HIV-(1Ba-L) infection of monocyte-derived macrophages (MDM) on phagocytosis of opsonised P. falciparum infected erythrocytes (IE) and subsequent proinflammatory cytokine secretion. Compared to mock-infected MDM, HIV-1 infection significantly inhibited phagocytosis of IE (median (IQR) (10 (0-28) versus (34 (27-108); IE internalised/100 MDM; p = 0.001) and decreased secretion of IL-6 (1,116 (352-3,387) versus 1,552 (889-6,331); pg/mL; p = 0.0078) and IL-1 beta (16 (7-21) versus 33 (27-65); pg/mL; p = 0.0078). Thus inadequate phagocytosis and cytokine production may contribute to impaired control of malaria in HIV-1 infected individuals.	[Ludlow, Louise E.; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia; [Ludlow, Louise E.; Hasang, Wina; Rogerson, Stephen J.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Zhou, Jingling; Tippett, Emma; Cheng, Wan-Jung; Jaworowski, Anthony] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Jaworowski, Anthony] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Jaworowski, Anthony] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; Burnet Institute; Monash University; Monash University	Ludlow, LE (corresponding author), Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia.	lludlow@unimelb.edu.au		Hasang, Wina/0000-0001-8664-7558; Rogerson, Stephen/0000-0003-4287-1982; jaworowski, anthony/0000-0002-3844-805X	Australian NHMRC [400090, 628611]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by Australian NHMRC Project Grants 400090 and 628611 to AJ and SJR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Azzam R, 2006, AIDS RES HUM RETROV, V22, P619, DOI 10.1089/aid.2006.22.619; BIGGS BA, 1995, J IMMUNOL, V154, P6132; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; CAPSONI F, 1992, CLIN IMMUNOL IMMUNOP, V62, P176, DOI 10.1016/0090-1229(92)90070-5; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moore JM, 2000, J INFECT DIS, V182, P960, DOI 10.1086/315755; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	28	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32102	10.1371/journal.pone.0032102	http://dx.doi.org/10.1371/journal.pone.0032102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363802	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700143
J	Mehta, DR; Ashkar, AA; Mossman, KL				Mehta, Devangi R.; Ashkar, Ali A.; Mossman, Karen L.			The Nitric Oxide Pathway Provides Innate Antiviral Protection in Conjunction with the Type I Interferon Pathway in Fibroblasts	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HOST-DEFENSE; VIRAL REPLICATION; STIMULATED GENES; IFN-ALPHA/BETA; TARGET GENES; NO SYNTHASE; CELL-LINES; INHIBITION; INFECTION	The innate host response to virus infection is largely dominated by the production of type I interferon and interferon stimulated genes. In particular, fibroblasts respond robustly to viral infection and to recognition of viral signatures such as dsRNA with the rapid production of type I interferon; subsequently, fibroblasts are a key cell type in antiviral protection. We recently found, however, that primary fibroblasts deficient for the production of interferon, interferon stimulated genes, and other cytokines and chemokines mount a robust antiviral response against both DNA and RNA viruses following stimulation with dsRNA. Nitric oxide is a chemical compound with pleiotropic functions; its production by phagocytes in response to interferon-gamma is associated with antimicrobial activity. Here we show that in response to dsRNA, nitric oxide is rapidly produced in primary fibroblasts. In the presence of an intact interferon system, nitric oxide plays a minor but significant role in antiviral protection. However, in the absence of an interferon system, nitric oxide is critical for the protection against DNA viruses. In primary fibroblasts, NF-kappa B and interferon regulatory factor 1 participate in the induction of inducible nitric oxide synthase expression, which subsequently produces nitric oxide. As large DNA viruses encode multiple and diverse immune modulators to disable the interferon system, it appears that the nitric oxide pathway serves as a secondary strategy to protect the host against viral infection in key cell types, such as fibroblasts, that largely rely on the type I interferon system for antiviral protection.	[Mehta, Devangi R.; Ashkar, Ali A.; Mossman, Karen L.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Mehta, DR (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	mossk@mcmaster.ca		Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health [MOP 57669]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This study was funded by a Canadian Institutes of Health Research operating grant (MOP 57669) to KLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Auch CJ, 2004, FEBS LETT, V563, P223, DOI 10.1016/S0014-5793(04)00302-3; BANKS TA, 1992, CLIN INFECT DIS, V14, P933, DOI 10.1093/clinids/14.4.933; BI ZB, 1995, J VIROL, V69, P2208, DOI 10.1128/JVI.69.4.2208-2213.1995; Blair LA, 2002, J BIOL CHEM, V277, P359, DOI 10.1074/jbc.M109819200; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Charville GW, 2008, BIOMATERIALS, V29, P4039, DOI 10.1016/j.biomaterials.2008.07.005; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Colasanti M, 1999, IUBMB LIFE, V48, P25, DOI 10.1080/713803459; CROEN KD, 1993, J CLIN INVEST, V91, P2446, DOI 10.1172/JCI116479; DavisPoynter NJ, 1996, IMMUNOL CELL BIOL, V74, P513, DOI 10.1038/icb.1996.84; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; DeWitte-Orr SJ, 2010, FUTURE VIROL, V5, P325, DOI 10.2217/FVL.10.18; DeWitte-Orr SJ, 2009, J IMMUNOL, V183, P6545, DOI 10.4049/jimmunol.0900867; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Fujii S, 1999, VIROLOGY, V256, P203, DOI 10.1006/viro.1999.9610; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Laszlo F, 1994, BRIT J PHARMACOL, V111, P309; LAVNIKOVA N, 1995, J LEUKOCYTE BIOL, V58, P451, DOI 10.1002/jlb.58.4.451; Lee CS, 2009, BIOL PHARM BULL, V32, P1870, DOI 10.1248/bpb.32.1870; LePage C, 1996, IMMUNOLOGY, V89, P274, DOI 10.1046/j.1365-2567.1996.d01-728.x; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; MAHESHWARI RK, 1980, P NATL ACAD SCI-BIOL, V77, P2284, DOI 10.1073/pnas.77.4.2284; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; MELKOVA Z, 1995, J IMMUNOL, V155, P5711; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Minaker RL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-85; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Noyce R, 2008, NEW RES INNATE IMMUN, P261; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Paladino P, 2009, J INTERF CYTOK RES, V29, P599, DOI 10.1089/jir.2009.0074; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; PINKERTON KE, 1982, AM J ANAT, V164, P155, DOI 10.1002/aja.1001640206; Rasmussen TB, 2007, J GEN VIROL, V88, P481, DOI 10.1099/vir.0.82453-0; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Smith RS, 1997, AM J PATHOL, V151, P317; Spitsin SV, 1997, MOL MED, V3, P315, DOI 10.1007/BF03401810; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Uetani K, 2001, AM J RESP CELL MOL, V24, P720, DOI 10.1165/ajrcmb.24.6.4297; Umezawa K, 1997, INFECT IMMUN, V65, P2932, DOI 10.1128/IAI.65.7.2932-2940.1997; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wessely R, 2001, CIRCULATION, V103, P756; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X; Zaragoza C, 1999, J IMMUNOL, V163, P5497; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	67	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31688	10.1371/journal.pone.0031688	http://dx.doi.org/10.1371/journal.pone.0031688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363706	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700083
J	Bozyk, PD; Bentley, JK; Popova, AP; Anyanwu, AC; Linn, MD; Goldsmith, AM; Pryhuber, GS; Moore, BB; Hershenson, MB				Bozyk, Paul D.; Bentley, J. Kelley; Popova, Antonia P.; Anyanwu, Anuli C.; Linn, Marisa D.; Goldsmith, Adam M.; Pryhuber, Gloria S.; Moore, Bethany B.; Hershenson, Marc B.			Neonatal Periostin Knockout Mice Are Protected from Hyperoxia-Induced Alveolar Simplication	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; INDUCED LUNG INJURY; BRONCHOPULMONARY-DYSPLASIA; TRANSFORMING GROWTH-FACTOR-BETA-1; LYSYL OXIDASE; GROWTH-FACTOR; MOUSE LUNG; RESPONSES; EXPRESSION; TGF-BETA-1	In bronchopulmonary dysplasia (BPD), alveolar septae are thickened with collagen and alpha-smooth muscle actin, transforming growth factor (TGF)-beta-positive myofibroblasts. Periostin, a secreted extracellular matrix protein, is involved in TGF-beta-mediated fibrosis and myofibroblast differentiation. We hypothesized that periostin expression is required for hypoalveolarization and interstitial fibrosis in hyperoxia-exposed neonatal mice, an animal model for this disease. We also examined periostin expression in neonatal lung mesenchymal stromal cells and lung tissue of hyperoxia-exposed neonatal mice and human infants with BPD. Two-to-three day-old wild-type and periostin null mice were exposed to air or 75% oxygen for 14 days. Mesenchymal stromal cells were isolated from tracheal aspirates of premature infants. Hyperoxic exposure of neonatal mice increased alveolar wall periostin expression, particularly in areas of interstitial thickening. Periostin co-localized with alpha-smooth muscle actin, suggesting synthesis by myofibroblasts. A similar pattern was found in lung sections of infants dying of BPD. Unlike wild-type mice, hyperoxia-exposed periostin null mice did not show larger air spaces or alpha-smooth muscle-positive myofibroblasts. Compared to hyperoxia-exposed wild-type mice, hyperoxia-exposed periostin null mice also showed reduced lung mRNA expression of alpha-smooth muscle actin, elastin, CXCL1, CXCL2 and CCL4. TGF-beta treatment increased mesenchymal stromal cell periostin expression, and periostin treatment increased TGF-beta-mediated DNA synthesis and myofibroblast differentiation. We conclude that periostin expression is increased in the lungs of hyperoxia-exposed neonatal mice and infants with BPD, and is required for hyperoxia-induced hypoalveolarization and interstitial fibrosis.	[Bozyk, Paul D.; Moore, Bethany B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Bentley, J. Kelley; Popova, Antonia P.; Linn, Marisa D.; Goldsmith, Adam M.; Hershenson, Marc B.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Anyanwu, Anuli C.; Hershenson, Marc B.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Pryhuber, Gloria S.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rochester	Bozyk, PD (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	mhershen@umich.edu		Bentley, John Kelley/0000-0001-8865-7979; Moore, Bethany/0000-0003-3051-745X	NIH [HL79339, HL90134, HL07749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109149, T32HL007749, R01HL090134, R01HL079339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants HL79339 and HL90134 (MBH) and HL07749 (PDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMY RWM, 1977, J ANAT, V124, P131; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Bozyk PD, 2011, STEM CELLS IN PRESS; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Gauldie J, 2003, AM J PATHOL, V163, P2575, DOI 10.1016/S0002-9440(10)63612-7; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Hong HH, 1999, LAB INVEST, V79, P1655; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaarteenaho-Wiik R, 2004, J PATHOL, V203, P567, DOI 10.1002/path.1547; Kaarteenaho-Wiik R, 2002, J HISTOCHEM CYTOCHEM, V50, P423, DOI 10.1177/002215540205000313; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Li P, 2004, J APPL PHYSIOL, V97, P1550, DOI 10.1152/japplphysiol.01311.2003; Londhe VA, 2005, PEDIATR RES, V58, P919, DOI 10.1203/01.PDR.0000181377.78061.3E; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Popova AP, 2010, PEDIATRICS, V126, pE1127, DOI 10.1542/peds.2009-3445; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC	39	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31336	10.1371/journal.pone.0031336	http://dx.doi.org/10.1371/journal.pone.0031336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363622	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600140
J	Shi, Y; Frost, P; Hoang, B; Yang, Y; Fukunaga, R; Gera, J; Lichtenstein, A				Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Fukunaga, R.; Gera, J.; Lichtenstein, A.			MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells	ONCOGENE			English	Article						multiple myeloma; rapamycin; mTOR inhibitors; c-myc; IRES activity; MNK kinases	INTERNAL RIBOSOME ENTRY; INITIATION-FACTOR 4E; MAMMALIAN TARGET; CYCLIN D1; ENHANCED SENSITIVITY; PROTEIN-SYNTHESIS; BINDING-PROTEIN; SITE FUNCTION; AKT ACTIVITY; N-TERMINI	When mTOR inhibitor rapalogs prevent cap-dependent translation of cell-cycle proteins like c-myc, continuing tumor cell growth depends on cap-independent translation, which is mediated by internal ribosome entry sites (IRESes) located in the 5'-UTR (untranslated region) of transcripts. To investigate if rapalog-induced activation of MNK kinases had a role in such IRES activity, we studied multiple myeloma (MM) cells. Rapamycin (RAP)-activated MNK1 kinase activity in MM cell lines and primary specimens by a mitogen-activated protein kinase-dependent mechanism. Pharmacological inhibition of MNK activity or genetic silencing of MNK1 prevented a rapalog-induced upregulation of c-myc IRES activity. Although RAP, used alone, had little effect on myc protein expression, when combined with a MNK inhibitor, myc protein expression was abrogated. In contrast, there was no inhibition of myc RNA, consistent with an effect on myc translation. In a RAP-resistant MM cell lines as well as a resistant primary MM specimen, co-exposure to a MNK inhibitor or MNK1 knockdown significantly sensitized cells for RAP-induced cytoreduction. Studies in MNK-null murine embryonic fibroblasts additionally supported a role for MNK kinases in RAP-induced myc IRES stimulation. These results indicate that MNK kinase activity has a critical role in the fail-safe mechanism of IRES-dependent translation when mTOR is inhibited. As kinase activity also regulated sensitivity to RAP, the data also provide a rationale for therapeutically targeting MNK kinases for combined treatment with mTOR inhibitors. Oncogene (2013) 32, 190-197; doi:10.1038/onc.2012.43; published online 27 February 2012	[Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Fukunaga, R.; Gera, J.; Lichtenstein, A.] Univ Calif Los Angeles, Med Ctr, Dept Med, Greater Los Angeles VA Healthcare Ctr, Los Angeles, CA 90024 USA; [Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Fukunaga, R.; Gera, J.; Lichtenstein, A.] Univ Calif Los Angeles, Med Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Shi, Y.; Frost, P.; Hoang, B.; Yang, Y.; Fukunaga, R.; Gera, J.; Lichtenstein, A.] Osaka Univ Pharmaceut Sci, Dept Biochem, Biochem Lab, Takatsuki, Osaka, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Osaka University of Pharmaceutical Sciences	Lichtenstein, A (corresponding author), W LA VA Hosp, W111H,11301 Wilshire Blvd,Bldg 500,Rm 4237, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov	Fukunaga, Rikiro/CAG-2891-2022	Gera, Joseph/0000-0002-2908-6894; Frost, Patrick/0000-0003-3348-5983	Veteran's Administration; Multiple Myeloma Research Foundation; Department of Defense; NIH [RO1 CA109312, RO1 CA111448]; Grants-in-Aid for Scientific Research [24590105] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA109312, R01CA111448, R01CA168700, R01CA132778] Funding Source: NIH RePORTER	Veteran's Administration(US Department of Veterans Affairs); Multiple Myeloma Research Foundation; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the UCLA Jonsson Comprehensive Cancer Center vector core lab for assistance in generating the lentiviral shRNA vectors. This work was supported by research funds of the Veteran's Administration, the Multiple Myeloma Research Foundation and the Department of Defense and NIH Grants RO1 CA109312 and RO1 CA111448.	Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Farag SS, 2009, LEUKEMIA RES, V33, P1475, DOI 10.1016/j.leukres.2009.01.039; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Frost P, 2009, MOL CANCER THER, V8, P83, DOI 10.1158/1535-7163.MCT-08-0254; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Ogata A, 1997, J IMMUNOL, V159, P2212; Paquette RL, 1990, ONCOGENE, V5, P1569; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; Parra-Palau JL, 2003, J BIOL CHEM, V278, P44197, DOI 10.1074/jbc.M302398200; Paulin FEM, 1996, ONCOGENE, V13, P505; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shi YJ, 2002, CANCER RES, V62, P5027; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Zhu Y, 2002, NEUROSCIENCE, V110, P191, DOI 10.1016/S0306-4522(01)00522-X	32	19	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					190	197		10.1038/onc.2012.43	http://dx.doi.org/10.1038/onc.2012.43			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22370634	Green Accepted			2022-12-25	WOS:000314075500007
J	Xu, HB; Wang, XL; Pahar, B; Alvarez, X; Rasmussen, KK; Lackner, AA; Veazey, RS				Xu, Huanbin; Wang, Xiaolei; Pahar, Bapi; Alvarez, Xavier; Rasmussen, Kelsi K.; Lackner, Andrew A.; Veazey, Ronald S.			Rapid down-regulation of gamma(c) on T cells in early SIV infection correlates with impairment of T-cell function	FASEB JOURNAL			English	Article						cytokine; CD4(+); T cell; HIV; intestine; mucosal immunology	IMMUNODEFICIENCY-VIRUS-INFECTION; TRIPLE COMBINATION THERAPY; HIV-1 INFECTION; IN-VIVO; INTERLEUKIN-7 RECEPTOR; HOMEOSTATIC PROLIFERATION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; CD127 EXPRESSION; CHAIN CYTOKINES	The common gamma(c) subunit molecule is shared among all gamma(c) cytokines and clearly involved in T-cell function, but its role in HIV infection and immunity is not well understood. Here, we examined expression and function of gamma(c) on T cells during SIV infection in Rhesus macaques. Surface gamma(c) distribution was differentially expressed on CD4(+) and CD8(+) T cells, and CD4(+) naive/memory cell populations in various lymphoid tissues of normal macaques. However, surface gamma(c) expression was rapidly and significantly down-regulated on T cells in acute infection with pathogenic SIV, compared to infection with a less virulent SHIV or controls and did not recover on CD8(+) T cells in the chronic stage. Moreover, the peripheral and CD4(+) T cell loss was inversely correlated with gamma(+)(c) CD8(+) T cells in individual tissues. gamma(+)(c) T cells were mainly functional as evidenced by higher cytokine secretion and proliferative capacity. Further in vitro experiments found that surface gamma(c) expression could be down-regulated following high level of IL-7 treatment by both internalization and shedding. Down-regulation of gamma(c) during early HIV/SIV infection may inhibit T-cell function, particularly of CD8(+) T cells, and, may be linked with immune failure and loss of viral containment.-Xu, H., Wang, X., Pahar, B., Alvarez, X., Rasmussen, K. K., Lackner, A. A., Veazey, R. S. Rapid down-regulation of gamma(c) on T cells in early SIV infection correlates with impairment of T-cell function. FASEB J. 26, 2294-2305 (2012). www.fasebj.org	[Xu, Huanbin; Wang, Xiaolei; Pahar, Bapi; Alvarez, Xavier; Rasmussen, Kelsi K.; Lackner, Andrew A.; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA	Tulane University	Veazey, RS (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 3 Rivers Rd, Covington, LA 70433 USA.	rveazey@tulane.edu	Xu, Huanbin/S-4870-2019; Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X	U.S. National Institutes of Health [AI49080, AI084793, U19 AI084793, U19 AI76982, RR000164]; Tulane University (New Orleans, LA, USA); NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084793, U19AI076982, R01AI049080] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University (New Orleans, LA, USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Julie Bruhn, Calvin Lanclos, and Desiree Waguespachek for flow cytometry support and Janell LeBlanc, Maryjane Dodd, Linda Green, and Maury Duplantis for technical support. This work was supported by U.S. National Institutes of Health grants AI49080, AI084793, U19 AI084793, U19 AI76982, and RR000164, and a Faculty Enhancement grant from Tulane University (New Orleans, LA, USA). The authors declare no conflict of interests.	Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; Alves NL, 2007, IMMUNOL LETT, V108, P113, DOI 10.1016/j.imlet.2006.11.006; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bani L, 1997, EUR J IMMUNOL, V27, P2188, DOI 10.1002/eji.1830270911; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Chattopadhyay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007382; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; David D, 1998, P NATL ACAD SCI USA, V95, P11348, DOI 10.1073/pnas.95.19.11348; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gougeon ML, 2010, J INTERN MED, V267, P502, DOI 10.1111/j.1365-2796.2010.02221.x; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Jaleco S, 2003, J IMMUNOL, V171, P61, DOI 10.4049/jimmunol.171.1.61; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lazarevic V, 2005, INFECT IMMUN, V73, P2910, DOI 10.1128/IAI.73.5.2910-2922.2005; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Leone A, 2009, CURR HIV RES, V7, P83, DOI 10.2174/157016209787048519; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Llano A, 2001, J VIROL, V75, P10319, DOI 10.1128/JVI.75.21.10319-10325.2001; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Masse GX, 2007, EUR J IMMUNOL, V37, P2606, DOI 10.1002/eji.200737234; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mitsuyasu R, 2007, ARCH INTERN MED, V167, P597, DOI 10.1001/archinte.167.6.597; Monteiro M, 2007, BLOOD, V109, P2863, DOI 10.1182/blood-2006-06-027060; Muthukumar A, 2004, BLOOD, V103, P973, DOI 10.1182/blood-2003-03-0874; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Pahwa R, 2006, J INFECT DIS, V193, P879, DOI 10.1086/500471; Pahwa S, 2007, IMMUNOL RES, V38, P373, DOI 10.1007/s12026-007-0036-9; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Parkin NT, 1999, J INFECT DIS, V180, P865, DOI 10.1086/314928; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rose T, 2009, J IMMUNOL, V182, P7389, DOI 10.4049/jimmunol.0900190; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Sirskyj D, 2008, CYTOKINE, V43, P1, DOI 10.1016/j.cyto.2008.03.001; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017965; Xu HB, 2010, J IMMUNOL, V185, P7340, DOI 10.4049/jimmunol.1001642; Youle M, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010003	60	3	4	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2294	2305		10.1096/fj.11-195180	http://dx.doi.org/10.1096/fj.11-195180			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22375017	Green Published			2022-12-25	WOS:000305017200008
J	Knezevic, I; Patel, A; Sundaresan, NR; Gupta, MP; Solaro, RJ; Nagalingam, RS; Gupta, M				Knezevic, Ivana; Patel, Aalok; Sundaresan, Nagalingam R.; Gupta, Mahesh P.; Solaro, R. John; Nagalingam, Raghu S.; Gupta, Madhu			A Novel Cardiomyocyte-enriched MicroRNA, miR-378, Targets Insulin-like Growth Factor 1 Receptor IMPLICATIONS IN POSTNATAL CARDIAC REMODELING AND CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; FAILING HUMAN HEART; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; MYOCYTE APOPTOSIS; EXPRESSION; OVEREXPRESSION; HYPERTROPHY; FAILURE; PATHWAY	Postnatal cardiac remodeling is characterized by a marked decrease in the insulin-like growth factor 1 (IGF1) and IGF1 receptor (IGF1R) expression. The underlying mechanism remains unexplored. This study examined the role of microRNAs in postnatal cardiac remodeling. By expression profiling, we observed a 10-fold increase in miR-378 expression in 1-week-old neonatal mouse hearts compared with 16-day-old fetal hearts. There was also a 4-6-fold induction in expression of miR-378 in older (10 months) compared with younger (1 month) hearts. Interestingly, tissue distribution analysis identified miR-378 to be highly abundant in heart and skeletal muscles. In the heart, specific expression was observed in cardiac myocytes, which was inducible by a variety of stressors. Over-expression of miR-378 enhanced apoptosis of cardiomyocytes by direct targeting of IGF1R and reduced signaling in Akt cascade. The inhibition of miR-378 by its anti-miR protected cardiomyocytes against H2O2 and hypoxia reoxygenation-induced cell death by promoting IGF1R expression and downstream Akt signaling cascade. Additionally, our data show that miR-378 expression is inhibited by IGF1 in cardiomyocytes. In tissues such as fibroblasts and fetal hearts, where IGF1 levels are high, we found either absent or significantly low miR-378 levels, suggesting an inverse relationship between these two factors. Our study identifies miR-378 as a new cardioabundant microRNA that targets IGF1R. We also demonstrate the existence of a negative feedback loop between miR-378, IGF1R, and IGF1 that is associated with postnatal cardiac remodeling and with the regulation of cardiomyocyte survival during stress.	[Nagalingam, Raghu S.; Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Nagalingam, Raghu S.; Gupta, Madhu] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Comm Cellular & Mol Physiol, Dept Surg, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Gupta, M (corresponding author), Univ Illinois, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60607 USA.	guptam@uic.edu		Patel, Aalok/0000-0002-7635-8602	National Institutes of Health [2RO1 HL 22231, PO1 HL 062626, RO1 HL 83423, T32 HL 07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, R01HL022231, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant Multi P. I. Grants 2RO1 HL 22231 (to M. G. and R. J. S.), PO1 HL 062626-Project 1 (to R. J. S.), RO1 HL 83423 (to M. P. G.), and T32 HL 07692 (to I. K.).	Anversa P, 1996, CARDIOVASC RES, V32, P219, DOI 10.1016/0008-6363(96)00035-1; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CHENG W, 1995, LAB INVEST, V72, P646; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; KARDAMI E, 1990, MOL CELL BIOCHEM, V92, P129; Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Malhotra R, 2011, AM J PHYSIOL-HEART C, V300, pH1733, DOI 10.1152/ajpheart.01054.2010; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; Morales MP, 2000, BIOCHEM BIOPH RES CO, V270, P1029, DOI 10.1006/bbrc.2000.2550; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P2005, DOI 10.1006/jmcc.1996.0193; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; REISS K, 1995, AM J PHYSIOL-HEART C, V269, pH943, DOI 10.1152/ajpheart.1995.269.3.H943; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Samarel AM, 2002, CIRC RES, V90, P631, DOI 10.1161/01.RES.0000015425.11187.19; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664	44	108	120	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12913	12926		10.1074/jbc.M111.331751	http://dx.doi.org/10.1074/jbc.M111.331751			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367207	hybrid, Green Published			2022-12-25	WOS:000302903700031
J	Fong, JJ; Nguyen, BL; Bridger, R; Medrano, EE; Wells, L; Pan, SJ; Sifers, RN				Fong, Jerry J.; Nguyen, Brenda L.; Bridger, Robert; Medrano, Estela E.; Wells, Lance; Pan, Shujuan; Sifers, Richard N.			beta-N-Acetylglucosamine (O-GlcNAc) Is a Novel Regulator of Mitosis-specific Phosphorylations on Histone H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; AURORA-B; CAENORHABDITIS-ELEGANS; PROTEIN MODIFICATION; CYTOSOLIC PROTEINS; GLYCOSYLATION; CHROMATIN; KINASE; CYTOKINESIS; TRANSFERASE	O-Linked beta-N-acetylglucosamine, or O-GlcNAc, is a dynamic post-translational modification that cycles on and off serine and threonine residues of nucleocytoplasmic proteins. The O-GlcNAc modification shares a complex relationship with phosphorylation, as both modifications are capable of mutually inhibiting the occupation of each other on the same or nearby amino acid residue. In addition to diabetes, cancer, and neurodegenerative diseases, O-GlcNAc appears to play a significant role in cell growth and cell cycle progression, although the precise mechanisms are still not well understood. A recent study also found that all four core nucleosomal histones (H2A, H2B, H3, and H4) are modified with O-GlcNAc, although no specific sites on H3 were reported. Here, we describe that histone H3, a protein highly phosphorylated during mitosis, is modified with O-GlcNAc. Several biochemical assays were used to validate that H3 is modified with O-GlcNAc. Mass spectrometry analysis identified threonine 32 as a novel O-GlcNAc site. O-GlcNAc was detected at higher levels on H3 during interphase than mitosis, which inversely correlated with phosphorylation. Furthermore, increased O-GlcNAcylation was observed to reduce mitosis-specific phosphorylation at serine 10, serine 28, and threonine 32. Finally, inhibiting OGA, the enzyme responsible for removing O-GlcNAc, hindered the transition from G2 to M phase of the cell cycle, displaying a phenotype similar to preventing mitosis-specific phosphorylation on H3. Taken together, these data indicate that O-GlcNAcylation regulates mitosis-specific phosphorylations on H3, providing a mechanistic switch that orchestrates the G2-M transition of the cell cycle.	[Fong, Jerry J.; Nguyen, Brenda L.; Pan, Shujuan; Sifers, Richard N.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Medrano, Estela E.; Sifers, Richard N.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Fong, Jerry J.; Medrano, Estela E.; Sifers, Richard N.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Bridger, Robert; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Bridger, Robert; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, BCM T228,1 Baylor Plaza, Houston, TX 77030 USA.	rsifers@bcm.edu	Wells, Lance/H-3118-2013; Sifers, Richard Norman/AGQ-7262-2022	Wells, Lance/0000-0003-4956-5363; Bridger, Robert/0000-0003-2653-8813	National Institutes of Health [R01CA84282]; NATIONAL CANCER INSTITUTE [R01CA084282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA84282 (to E. E. M).	Caperta AD, 2008, CYTOGENET GENOME RES, V122, P73, DOI 10.1159/000151319; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Daly NL, 2000, BIOCHEMISTRY-US, V39, P9039, DOI 10.1021/bi0004807; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goldberg H., 2011, AM J PHYSIOL-ENDOC M, V4, pE713; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; SHOEMAKER CB, 1980, J BIOL CHEM, V255, P1048; Simanek EE, 1998, J AM CHEM SOC, V120, P11567, DOI 10.1021/ja982312w; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Tavana O, 2011, CELL CYCLE, V10, P2471, DOI 10.4161/cc.10.15.16741; Van Hooser A, 1998, J CELL SCI, V111, P3497; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	52	84	88	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12195	12203		10.1074/jbc.M111.315804	http://dx.doi.org/10.1074/jbc.M111.315804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22371497	Green Published, hybrid			2022-12-25	WOS:000302782200061
J	Arai, T; Oh-ishi, T; Yamamoto, H; Nunoi, H; Kamizono, J; Uehara, M; Kubota, T; Sakurai, T; Kizaki, T; Ohno, H				Arai, Takashi; Oh-ishi, Tsutomu; Yamamoto, Hideaki; Nunoi, Hiroyuki; Kamizono, Junji; Uehara, Masahiko; Kubota, Takeo; Sakurai, Takuya; Kizaki, Takako; Ohno, Hideki			Copy Number Variations Due to Large Genomic Deletion in X-Linked Chronic Granulomatous Disease	PLOS ONE			English	Article							DE-NOVO MUTATION; CHROMOSOME INACTIVATION; MUSCULAR-DYSTROPHY; CYBB GENE; FEMALE; REARRANGEMENTS; HYBRIDIZATION; DUPLICATIONS; MECHANISM	Mutations in genes for any of the six subunits of NADPH oxidase cause chronic granulomatous disease (CGD), but almost 2/3 of CGD cases are caused by mutations in the X-linked CYBB gene, also known as NAD (P) H oxidase 2. Approximately 260 patients with CGD have been reported in Japan, of whom 92 were shown to have mutations of the CYBB gene and 16 to have chromosomal deletions. However, there has been very little detailed analysis of the range of the deletion or close understanding of the disease based on this. We therefore analyzed genomic rearrangements in X-linked CGD using array comparative genomic hybridization analysis, revealing the extent and the types of the deletion genes. The subjects were five Japanese X-linked CGD patients estimated to have large base deletions of 1 kb or more in the CYBB gene (four male patients, one female patient) and the mothers of four of those patients. The five Japanese patients were found to range from a patient exhibiting deletions only of the CYBB gene to a female patient exhibiting an extensive DNA deletion and the DMD and CGD phenotype manifested. Of the other three patients, two exhibited CYBB, XK, and DYNLT3 gene deletions. The remaining patient exhibited both a deletion encompassing DNA subsequent to the CYBB region following intron 2 and the DYNLT3 gene and a complex copy number variation involving the insertion of an inverted duplication of a region from the centromere side of DYNLT3 into the deleted region.	[Arai, Takashi; Oh-ishi, Tsutomu; Yamamoto, Hideaki] Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Japan; [Oh-ishi, Tsutomu] Saitama Childrens Med Ctr, Div Infect Dis, Saitama, Japan; [Nunoi, Hiroyuki] Miyazaki Univ, Dept Pediat, Fac Med, Miyazaki, Japan; [Kamizono, Junji] Kitakyusyu City Yahata Hosp, Dept Pediat, Kitakyushu, Fukuoka, Japan; [Uehara, Masahiko] Hlth Insurance Hitoyoshi Gen Hosp, Dept Pediat, Hitoyoshi, Japan; [Kubota, Takeo] Univ Yamanashi, Dept Epigenet Med, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Sakurai, Takuya; Kizaki, Takako; Ohno, Hideki] Kyorin Univ, Sch Med, Dept Mol Predict Med & Sport Sci, Mitaka, Tokyo 181, Japan	Saitama Children's Medical Center; Saitama Children's Medical Center; University of Miyazaki; University of Yamanashi; Kyorin University	Arai, T (corresponding author), Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Japan.	ohnoh2o@kyorin-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for Specific Project Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; Bonaglia MC, 2009, EUR J HUM GENET, V17, P179, DOI 10.1038/ejhg.2008.160; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Gono T, 2008, INTERNAL MED, V47, P1053, DOI 10.2169/internalmedicine.47.0919; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Kabuki T, 2003, JAP J CLIN IMMUNOL, V26, P299; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lewis EM, 2008, CLIN IMMUNOL, V129, P372, DOI 10.1016/j.clim.2008.07.022; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Nunoi H, 2007, JAP J CLIN IMMUNOL, V30, P1; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Shchelochkov OA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-16; Shchelochkov OA, 2009, MOL GENET METAB, V96, P97, DOI 10.1016/j.ymgme.2008.11.167; Simon KC, 2005, J MOL DIAGN, V7, P183, DOI 10.1016/S1525-1578(10)60544-2; Srour M, 2008, SEMIN PEDIATR NEUROL, V15, P154, DOI 10.1016/j.spen.2008.09.002; Takada H, 2004, BLOOD, V103, P185, DOI 10.1182/blood-2003-06-1964; Yamada M, 2010, EUR J MED GENET, V53, P383, DOI 10.1016/j.ejmg.2010.08.003; Yoshida M, 1998, CLIN GENET, V52, P102	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e27782	10.1371/journal.pone.0027782	http://dx.doi.org/10.1371/journal.pone.0027782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383943	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500001
J	Bellini, R; Medici, A; Calzolari, M; Bonilauri, P; Cavrini, F; Sambri, V; Angelini, P; Dottori, M				Bellini, Romeo; Medici, Anna; Calzolari, Mattia; Bonilauri, Paolo; Cavrini, Francesca; Sambri, Vittorio; Angelini, Paola; Dottori, Michele			Impact of Chikungunya Virus on Aedes albopictus Females and Possibility of Vertical Transmission Using the Actors of the 2007 Outbreak in Italy	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; REUNION ISLAND; INFECTION; DIPTERA; CULICIDAE; STRAINS; VECTOR; PATTERNS; MOSQUITO; AEGYPTI	We investigated the impact of CHIKV strains on some Aedes albopictus (Skuse) reproductive parameters and the possibility of vertical transmission. Two strains were collected in the area where the epidemic occurred in 2007, one isolated from mosquitoes, the other one isolated from a viraemic patient. Different types of blood meals, either infected or non-infected, were offered to Ae. albopictus females, that were then analyzed at increasing time post infection. The virus titre, measured by two RT-PCR methods in the blood meals, influenced the rate of infection and the rate of dissemination of CHIKV in Ae. albopictus body. We found individual variability with respect to the infection/dissemination rates and their latency both considering the female's body and appendages. The hatching rate was significantly lower for the eggs laid by the infected females than for the control eggs, while the mortality during the larval development (from first instar larva to adult emergence) was similar among the progeny of infected and non-infected female groups. Our findings seem to support the hypothesis that the vertical transmission is a rare event under our conditions, and that a certain time period is required in order to get the ovarioles infected. Field observations conducted during the Spring 2008 showed no evidence of the presence of infected overwintering progeny produced by Ae. albopictus females infected during the 2007 outbreak.	[Bellini, Romeo; Medici, Anna] Ctr Agricoltura Ambiente G Nicoli, Bologna, Italy; [Calzolari, Mattia; Bonilauri, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Cavrini, Francesca; Sambri, Vittorio] Univ Bologna, Dept Haematol & Oncol, Reg Reference Ctr Microbiol Emergencies CRREM, Unit Clin Microbiol,S Orsola Malpighi Hosp, Bologna, Italy; [Angelini, Paola] Publ Hlth Serv, Bologna, Italy	IZS Lombardia e Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Bellini, R (corresponding author), Ctr Agricoltura Ambiente G Nicoli, Bologna, Italy.	rbellini@caa.it	Calzolari, Mattia/AAB-9487-2019; dottori, michele/AAB-3815-2019; Sambri, Vittorio/H-5372-2019	Calzolari, Mattia/0000-0001-7489-2556; Sambri, Vittorio/0000-0002-5012-7355; Dottori, Michele/0000-0002-9975-0367; Bonilauri, Paolo/0000-0002-2625-7993	Italian Ministry of Health [RFPS-2007-7-639191]	Italian Ministry of Health(Ministry of Health, Italy)	The work has been funded through the fund RFPS-2007-7-639191 of the Italian Ministry of Health managed by the Health Agency of the Emilia-Romagna Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 1999, INVERTEBR REPROD DEV, V36, P217, DOI 10.1080/07924259.1999.9652703; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; BEAMAN JR, 1991, J MED ENTOMOL, V28, P161, DOI 10.1093/jmedent/28.1.161; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; FOURIE ED, 1979, S AFR MED J, V56, P130; FULHORST CF, 1994, SCIENCE, V263, P676, DOI 10.1126/science.8303276; Haddad N, 2007, J AM MOSQUITO CONTR, V23, P226, DOI 10.2987/8756-971X(2007)23[226:POAAIL]2.0.CO;2; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Mahmood F, 2004, J MED ENTOMOL, V41, P982, DOI 10.1603/0022-2585-41.5.982; Medici A, 2011, J ECON ENTOMOL, V104, P266, DOI 10.1603/EC10108; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; MOURYA DT, 1987, INDIAN J MED RES, V85, P593; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pener H., 2003, European Mosquito Bulletin, V14, P32; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; ROSEN L, 1987, AM J TROP MED HYG, V37, pS69, DOI 10.4269/ajtmh.1987.37.69S; ROSS R. W., 1956, JOUR HYG, V54, P177; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Scott TW, 1998, AM J TROP MED HYG, V59, P341, DOI 10.4269/ajtmh.1998.59.341; Shroyer DA, 1986, J AM MOSQUITO CONTR, V7, P89; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille M, 2009, MEM I OSWALDO CRUZ, V104, P632, DOI 10.1590/S0074-02762009000400017; White DO, 1986, MED VIROLOGY, P284; Zhang H. L., 1993, Chinese Journal of Virology, V9, P222	42	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e28360	10.1371/journal.pone.0028360	http://dx.doi.org/10.1371/journal.pone.0028360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383945	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500002
J	Hall, KC; Blobel, CP				Hall, Katherine C.; Blobel, Carl P.			Interleukin-1 Stimulates ADAM17 through a Mechanism Independent of its Cytoplasmic Domain or Phosphorylation at Threonine 735	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-ALPHA; CONVERTING-ENZYME; TNF-ALPHA; ENDOTHELIAL-CELLS; DISINTEGRIN; ECTODOMAIN; EGFR; TACE; METALLOPROTEINASE	ADAM17 (a disintegrin and metalloproteinase) is a membrane-anchored metalloproteinase that regulates the release of EGFR-ligands, TNF alpha and other membrane proteins from cells. ADAM17 can be rapidly activated by a variety of signaling pathways, yet little is known about the underlying mechanism. Several studies have demonstrated that the cytoplasmic domain of ADAM17 is not required for its rapid activation by a variety of stimuli, including phorbol esters, tyrosine kinases and some G-protein coupled receptors. However, phosphorylation of cytoplasmic residue T735 was recently reported as a crucial step for activation of ADAM17 by IL-1 beta and by the p38 MAP-kinase pathway. One possible mechanism to reconcile these results would be that T735 has an inhibitory role and that it must be phosphorylated as a pre-requisite for the activation of ADAM17, which would then proceed via a mechanism that is independent of its cytoplasmic domain. To test this hypothesis, we performed rescue experiments of Adam17(-/-) cells with wild type and mutant forms of ADAM17. However, these experiments showed that an inactivating mutation (T735A) or an activating mutation (T735D) of cytoplasmic residue T735 or the removal of the cytoplasmic domain of ADAM17 did not significantly affect the stimulation of ADAM17 by IL-1 beta or by activation of MAP-kinase with anisomycin. Moreover, we found that the MAP-kinase inhibitor SB203580 blocked activation of cytoplasmic tail-deficient ADAM17 and of the T735A mutant by IL-1 beta or by anisomycin, providing further support for a model in which the activation mechanism of ADAM17 does not rely on its cytoplasmic domain or phosphorylation of T735.	[Hall, Katherine C.; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Hall, Katherine C.; Blobel, Carl P.] Cornell Univ, Weill Med Coll, Cell Biol & Genet Program, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Biophys & Syst Biol Program, Dept Physiol & Med, New York, NY 10021 USA	Cornell University; Cornell University	Hall, KC (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu			National Institutes of Health (NIH) [R01GM64750, 5T32AR007281-28]; National Center for Research Resources, National Institutes of Health [C06-RR12538-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (NIH) to CPB [R01GM64750], and by an NIH training grant in Musculoskeletal Research to KCH [5T32AR007281-28]. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06-RR12538-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bell J, 2007, J LEUKOC BIOL, V82; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li Xiaojin, 2011, World J Biol Chem, V2, P246, DOI 10.4331/wjbc.v2.i11.246; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	40	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31600	10.1371/journal.pone.0031600	http://dx.doi.org/10.1371/journal.pone.0031600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384041	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500030
J	Miniati, M; Cenci, C; Monti, S; Poli, D				Miniati, Massimo; Cenci, Caterina; Monti, Simonetta; Poli, Daniela			Clinical Presentation of Acute Pulmonary Embolism: Survey of 800 Cases	PLOS ONE			English	Article							CT ANGIOGRAPHY; COR-PULMONALE; PROBABILITY; DIAGNOSIS; PERFUSION; THROMBOSIS; SURVIVAL; MODEL	Background: Pulmonary embolism (PE) is a common and potentially fatal disease that is still underdiagnosed. The objective of our study was to reappraise the clinical presentation of PE with emphasis on the identification of the symptoms and signs that prompt the patients to seek medical attention. Methodology/Principal Findings: We studied 800 patients with PE from two different clinical settings: 440 were recruited in Pisa (Italy) as part of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISAPED); 360 were diagnosed with and treated for PE in seven hospitals of central Tuscany, and evaluated at the Atherothrombotic Disorders Unit, Firenze (Italy), shortly after hospital discharge. We interviewed the patients directly using a standardized, self-administered questionnaire originally utilized in the PISAPED. The two samples differed significantly as regards age, proportion of outpatients, prevalence of unprovoked PE, and of active cancer. Sudden onset dyspnea was the most frequent symptom in both samples (81 and 78%), followed by chest pain (56 and 39%), fainting or syncope (26 and 22%), and hemoptysis (7 and 5%). At least one of the above symptoms was reported by 756 (94%) of 800 patients. Isolated symptoms and signs of deep vein thrombosis occurred in 3% of the cases. Only 7 (1%) of 800 patients had no symptoms before PE was diagnosed. Conclusions/Significance: Most patients with PE feature at least one of four symptoms which, in decreasing order of frequency, are sudden onset dyspnea, chest pain, fainting (or syncope), and hemoptysis. The occurrence of such symptoms, if not explained otherwise, should alert the clinicians to consider PE in differential diagnosis, and order the appropriate objective test.	[Miniati, Massimo] Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy; [Miniati, Massimo; Cenci, Caterina; Poli, Daniela] Univ Careggi, Azienda Osped, Struttura Operat Dipartimentale SOD Malattie Ater, Florence, Italy; [Monti, Simonetta] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy; [Monti, Simonetta] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR)	Miniati, M (corresponding author), Univ Florence, Dipartimento Area Crit Med Chirurg, Florence, Italy.	massimo.miniati@unifi.it	MONTI, SIMONETTA/A-9766-2016	MONTI, SIMONETTA/0000-0001-7825-6987; Miniati, Massimo/0000-0002-6977-8916	Department of Medical and Surgical Critical Care, University of Firenze (Italy)	Department of Medical and Surgical Critical Care, University of Firenze (Italy)	This work was supported in part by funds from the Department of Medical and Surgical Critical Care, University of Firenze (Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bajc M, 2009, EUR J NUCL MED MOL I, V36, P1528, DOI 10.1007/s00259-009-1169-y; Bajc M, 2009, EUR J NUCL MED MOL I, V36, P1356, DOI 10.1007/s00259-009-1170-5; FLEISCHNER FG, 1967, NEW ENGL J MED, V276, P1213, DOI 10.1056/NEJM196706012762201; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Hurwitz LM, 2007, RADIOLOGY, V245, P742, DOI 10.1148/radiol.2453062046; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Mamlouk MD, 2010, RADIOLOGY, V256, P625, DOI 10.1148/radiol.10091624; McGinn SS, 1935, J AMER MED ASSOC, V104, P1473, DOI 10.1001/jama.1935.02760170011004; MEYER G, 1990, EUR J NUCL MED, V17, P315, DOI 10.1007/BF01268022; Miniati M, 2003, AM J MED, V114, P173, DOI 10.1016/S0002-9343(02)01478-X; Miniati M, 2001, AM J MED, V110, P528, DOI 10.1016/S0002-9343(01)00693-3; Miniati M, 1999, AM J RESP CRIT CARE, V159, P864, DOI 10.1164/ajrccm.159.3.9806130; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; Miniati M, 2008, AM J RESP CRIT CARE, V178, P290, DOI 10.1164/rccm.200802-207OC; Miniati M, 2006, MEDICINE, V85, P253, DOI 10.1097/01.md.0000236952.87590.c8; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Pistolesi M, 2010, RADIOLOGY, V256, P334, DOI 10.1148/radiol.10100662; Stein PD, 2007, AM J MED, V120, P871, DOI 10.1016/j.amjmed.2007.03.024; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Stein PD, 2007, PULMONARY EMBOLISM, 2ND EDITION, P3; STEIN PD, 1975, PROG CARDIOVASC DIS, V17, P247, DOI 10.1016/S0033-0620(75)80016-8; STEIN PD, 1979, AM J CARDIOL, V43, P669, DOI 10.1016/0002-9149(79)90031-6; The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by the International Society of Heart and Lung Transplantation (ISHLT), 2009, EUR HEART J, V30, P2495; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	24	55	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30891	10.1371/journal.pone.0030891	http://dx.doi.org/10.1371/journal.pone.0030891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383978	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500015
J	Yang, JJ; Cho, LY; Ko, KP; Shin, A; Ma, SH; Choi, BY; Han, DS; Song, KS; Kim, YS; Lee, JY; Han, BG; Chang, SH; Shin, HR; Kang, D; Yoo, KY; Park, SK				Yang, Jae Jeong; Cho, Lisa Y.; Ko, Kwang-Pil; Shin, Aesun; Ma, Seung Hyun; Choi, Bo Youl; Han, Dong Soo; Song, Kyu Sang; Kim, Yong Sung; Lee, Jong-Young; Han, Bok Ghee; Chang, Soung-Hoon; Shin, Hai-Rim; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Genetic Susceptibility on CagA-Interacting Molecules and Gene-Environment Interaction with Phytoestrogens: A Putative Risk Factor for Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; PROTEIN; MET; KINASE; CELLS; SRC; ASSOCIATION; EXPRESSION; RECEPTOR; FAMILY	Objectives: To evaluate whether genes that encode CagA-interacting molecules (SRC, PTPN11, CRK, CRKL, CSK, c-MET and GRB2) are associated with gastric cancer risk and whether an interaction between these genes and phytoestrogens modify gastric cancer risk. Methods: In the discovery phase, 137 candidate SNPs in seven genes were analyzed in 76 incident gastric cancer cases and 322 matched controls from the Korean Multi-Center Cancer Cohort. Five significant SNPs in three genes (SRC, c-MET and CRK) were re-evaluated in 386 cases and 348 controls in the extension phase. Odds ratios (ORs) for gastric cancer risk were estimated adjusted for age, smoking, H. pylori seropositivity and CagA strain positivity. Summarized ORs in the total study population (462 cases and 670 controls) were presented using pooled-and meta-analysis. Plasma concentrations of phytoestrogens (genistein, daidzein, equol and enterolactone) were measured using the time-resolved fluoroimmunoassay. Results: SRC rs6122566, rs6124914, c-MET rs41739, and CRK rs7208768 showed significant genetic effects for gastric cancer in both the pooled and meta-analysis without heterogeneity (pooled OR = 3.96 [95% CI 2.05-7.65], 1.24 [95% CI = 1.01-1.53], 1.19 [95% CI = 1.01-1.41], and 1.37 [95% CI = 1.15-1.62], respectively; meta OR = 4.59 [95% CI 2.74-7.70], 1.36 [95% CI = 1.09-1.70], 1.20 [95% CI = 1.00-1.44], and 1.32 [95% CI = 1.10-1.57], respectively). Risk allele of CRK rs7208768 had a significantly increased risk for gastric cancer at low phytoestrogen levels (p interaction<0.05). Conclusions: Our findings suggest that SRC, c-MET and CRK play a key role in gastric carcinogenesis by modulating CagA signal transductions and interaction between CRK gene and phytoestrogens modify gastric cancer risk.	[Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Ko, Kwang-Pil] Gachon Univ Med & Sci, Dept Prevent Med, Inchon, South Korea; [Shin, Aesun; Shin, Hai-Rim] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Dept Pathol, Coll Med, Taejon, South Korea; [Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Lee, Jong-Young; Han, Bok Ghee] Korea Natl Inst Hlth, Ctr Genome Sci, Osong, South Korea; [Chang, Soung-Hoon] Konkuk Univ, Dept Prevent Med, Chungju, South Korea; [Shin, Hai-Rim] Western Pacific Reg Off, World Hlth Org, Manila, Philippines; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University; National Cancer Center - Korea (NCC); Hanyang University; Hanyang University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Konkuk University; Konkuk University Medical Center; World Health Organization; Seoul National University (SNU)	Yang, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Park, Sue Kyung/J-2757-2012; Shin, Aesun/E-9145-2014; Yoo, Keun-Young/J-5548-2012; Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022; Kang, Dae Hee/E-8631-2012; Lee, Jong-Young/M-6319-2013	Shin, Aesun/0000-0002-6426-1969; Han, Dong Soo/0000-0001-7103-3318; Lee, Jong-Young/0000-0002-0092-9958; Kang, Daehee/0000-0003-4031-5878	Ministry of Health and Welfare, Republic of Korea [0520140]; National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0001564]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0520140), and the Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0001564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T., 2007, Inflammopharmacology, V15, P10, DOI 10.1007/s10787-006-1556-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; BLASER MJ, 1995, CANCER RES, V55, P2111; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Cho LY, 2009, ANN EPIDEMIOL, V19, P644, DOI 10.1016/j.annepidem.2009.04.011; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Goto Y, 2006, INT J CANCER, V118, P203, DOI 10.1002/ijc.21338; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Handa O, 2007, BIOCHEM PHARMACOL, V73, P1697, DOI 10.1016/j.bcp.2006.10.022; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2003, MICROBES INFECT, V5, P143, DOI 10.1016/S1286-4579(02)00085-0; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Herynk MH, 2007, J EXP THER ONCOL, V6, P205; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Ko KP, 2010, CANCER EPIDEM BIOMAR, V19, P1292, DOI 10.1158/1055-9965.EPI-09-1004; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Park CY, 2002, J CLIN MICROBIOL, V40, P4753, DOI 10.1128/JCM.40.12.4753-4756.2002; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Porter J, 2010, EXPERT OPIN THER PAT, V20, P159, DOI 10.1517/13543770903514137; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85; Zhou HB, 2004, WORLD J GASTROENTERO, V10, P1822	49	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31020	10.1371/journal.pone.0031020	http://dx.doi.org/10.1371/journal.pone.0031020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383989	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800008
J	Antonov, A; Stokke, BG; Fossoy, F; Ranke, PS; Liang, W; Yang, CC; Moksnes, A; Shykoff, J; Roskaft, E				Antonov, Anton; Stokke, Bard G.; Fossoy, Frode; Ranke, Peter S.; Liang, Wei; Yang, Canchao; Moksnes, Arne; Shykoff, Jacqui; Roskaft, Eivin			Are Cuckoos Maximizing Egg Mimicry by Selecting Host Individuals with Better Matching Egg Phenotypes?	PLOS ONE			English	Article							WARBLERS ACROCEPHALUS-PALUSTRIS; CUCULUS-CANORUS PARASITISM; GREAT REED WARBLERS; COMMON CUCKOOS; COLOR PATTERNS; REJECTION BEHAVIOR; BROOD PARASITISM; NESTS; EVOLUTION; BIRDS	Background: Avian brood parasites and their hosts are involved in complex offence-defense coevolutionary arms races. The most common pair of reciprocal adaptations in these systems is egg discrimination by hosts and egg mimicry by parasites. As mimicry improves, more advanced host adaptations evolve such as decreased intra-and increased interclutch variation in egg appearance to facilitate detection of parasitic eggs. As interclutch variation increases, parasites able to choose hosts matching best their own egg phenotype should be selected, but this requires that parasites know their own egg phenotype and select host nests correspondingly. Methodology/Principal Findings: We compared egg mimicry of common cuckoo Cuculus canorus eggs in naturally parasitized marsh warbler Acrocephalus palustris nests and their nearest unparasitized conspecific neighbors having similar laying dates and nest-site characteristics. Modeling of avian vision and image analyses revealed no evidence that cuckoos parasitize nests where their eggs better match the host eggs. Cuckoo eggs were as good mimics, in terms of background and spot color, background luminance, spotting pattern and egg size, of host eggs in the nests actually exploited as those in the neighboring unparasitized nests. Conclusions/Significance: We reviewed the evidence for brood parasites selecting better-matching host egg phenotypes from several relevant studies and argue that such selection probably cannot exist in host-parasite systems where host interclutch variation is continuous and overall low or moderate. To date there is also no evidence that parasites prefer certain egg phenotypes in systems where it should be most advantageous, i.e., when both hosts and parasites lay polymorphic eggs. Hence, the existence of an ability to select host nests to maximize mimicry by brood parasites appears unlikely, but this possibility should be further explored in cuckoo-host systems where the host has evolved discrete egg phenotypes.	[Antonov, Anton; Stokke, Bard G.; Fossoy, Frode; Ranke, Peter S.; Moksnes, Arne; Roskaft, Eivin] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Liang, Wei; Yang, Canchao] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Shykoff, Jacqui] Univ Paris 11, CNRS, AgroParisTech, Lab Ecol Systemat & Evolut,UMR 8079, F-91405 Orsay, France	Norwegian University of Science & Technology (NTNU); Hainan Normal University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Antonov, A (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	liangwei@hainnu.edu.cn	Fossoy, Frode/O-3073-2017; Røskaft, Eivin/N-7476-2019	Fossoy, Frode/0000-0002-7535-9574; Røskaft, Eivin/0000-0003-0262-8443; Ranke, Peter S./0000-0003-3757-8626	National Natural Science Foundation of China [31071938]; Program for New Century Excellent Talents in University [NCET-10-0111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (No 31071938 to WL, BGS and AA), and by Program for New Century Excellent Talents in University (NCET-10-0111 to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A, 2006, BEHAV ECOL SOCIOBIOL, V60, P11, DOI 10.1007/s00265-005-0132-6; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Antonov A, 2007, J AVIAN BIOL, V38, P390, DOI 10.1111/j.2007.0908-8857.03813.x; Antonov A, 2006, AUK, V123, P419, DOI 10.1642/0004-8038(2006)123[419:ERIMWA]2.0.CO;2; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2008, AM NAT, V171, P327, DOI 10.1086/527493; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1721, DOI 10.1007/s00265-011-1180-8; Aviles JM, 2009, AUK, V126, P431, DOI 10.1525/auk.2009.08162; Banks AJ, 2001, BEHAV ECOL, V12, P31, DOI 10.1093/oxfordjournals.beheco.a000375; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; Cherry MI, 2007, J EVOLUTION BIOL, V20, P1218, DOI 10.1111/j.1420-9101.2007.01308.x; Cherry MI, 2001, P ROY SOC B-BIOL SCI, V268, P565, DOI 10.1098/rspb.2000.1414; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; Gomez D., 2006, AVICOL PROGRAM ANAL, V1; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Honza M, 2002, ANIM BEHAV, V64, P861, DOI 10.1006/anbe.2002.1969; Hoyt OF, 1979, AUK, V96, P73; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Polacikova L, 2009, EVOL ECOL, V23, P879, DOI 10.1007/s10682-008-9278-9; Roskaft E, 2002, BEHAV ECOL, V13, P163, DOI 10.1093/beheco/13.2.163; Rothstein SI, 1998, PARASITIC BIRDS THEI; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke Bard G., 2005, Ornithological Science, V4, P17, DOI 10.2326/osj.4.17; Stokke BG, 2002, EVOLUTION, V56, P199; Takasu F, 2003, EVOL ECOL RES, V5, P345; Vikan JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019288; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wyllie I., 1981, CUCKOO; Yang CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010816	43	23	30	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31704	10.1371/journal.pone.0031704	http://dx.doi.org/10.1371/journal.pone.0031704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384060	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100029
J	Diallo, A; Ndam, NT; Moussiliou, A; Dos Santos, S; Ndonky, A; Borderon, M; Oliveau, S; Lalou, R; Le Hesran, JY				Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Moussiliou, Azizath; Dos Santos, Stephanie; Ndonky, Alphousseyni; Borderon, Marion; Oliveau, Sebastien; Lalou, Richard; Le Hesran, Jean-Yves			Asymptomatic Carriage of Plasmodium in Urban Dakar: The Risk of Malaria Should Not Be Underestimated	PLOS ONE			English	Article							REAL-TIME PCR; SOUTHERN SANITARY DISTRICT; SUB-SAHARAN AFRICA; BREEDING SITES; FALCIPARUM; TRANSMISSION; SENEGAL; URBANIZATION; RESISTANCE; BLOOD	Introduction: The objective of this study was to measure the rate of asymptomatic carriage of plasmodium in the Dakar region two years after the implementation of new strategies in clinical malaria management. Methodology: Between October and December 2008, 2952 households selected in 50 sites of Dakar area, were visited for interviews and blood sampling. Giemsa-stained thick blood smears (TBS) were performed for microscopy in asymptomatic adult women and children aged 2 to 10 years. To ensure the quality of the microscopy, we performed a polymerase chain reaction (PCR) with real time qPCR in all positive TBS by microscopy and in a sample of negative TBS and filter paper blood spots. Results: The analysis has concerned 2427 women and 2231 children. The mean age of the women was 35.6 years. The mean age of the children was 5.4 years. The parasite prevalence was 2.01% (49/2427) in women and 2.15% (48/2231) in children. Parasite prevalence varied from one study site to another, ranging from 0 to 7.41%. In multivariate analysis, reporting a malaria episode in 2008 was associated with plasmodium carriage (OR = 2.57, P = 0.002) in women; in children, a malaria episode (OR = 6.19, P < 0.001) and a travel out of Dakar during last 3 months (OR = 2.27, P = 0.023) were associated with plasmodium carriage. Among the positive TBS, 95.8% (93/97) were positive by plasmodium PCR. Among the negative TBS, 13.9% (41/293) were positive by PCR. In blood spots, 15.2% (76/500) were positive by PCR. We estimated at 16.5% the parasite prevalence if PCR were performed in 4658 TBS. Conclusion: Parasite prevalence in Dakar area seemed to be higher than the rate found by microscopy. PCR may be the best tool for measuring plasmodium prevalence in the context of low transmission. Environmental conditions play a major role in the heterogeneity of parasite prevalence within sites.	[Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Le Hesran, Jean-Yves] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Le Hesran, Jean-Yves] Univ Paris 05, Fac Pharmaceut Sci, Paris, France; [Dos Santos, Stephanie; Ndonky, Alphousseyni] Univ Cheikh Anta Diop, UMR151, Lab Populat Environm & Dev, Inst Rech Dev, Dakar, Senegal; [Dos Santos, Stephanie; Lalou, Richard] Univ Aix Marseille 1, UMR151, Lab Populat Environm & Dev, Inst Rech Dev, Marseille, France; [Ndam, Nicaise Tuikue; Moussiliou, Azizath] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Cotonou, Benin; [Borderon, Marion; Oliveau, Sebastien] Univ Aix Marseille 1, UFR Sci Geog & Amenagement, UMR ESPACE 6012, Aix En Provence, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite Cote d'Azur	Diallo, A (corresponding author), Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France.	diallaye@yahoo.fr	borderon, marion/AAF-6287-2020; Oliveau, Sebastien/D-4382-2015; LALOU, Richard/A-7322-2017	borderon, marion/0000-0002-1449-3665; Oliveau, Sebastien/0000-0003-1473-5051; Tuikue Ndam, Nicaise/0000-0003-2646-2513; LE HESRAN, Jean-Yves/0000-0003-4814-7952; LALOU, Richard/0000-0001-9489-7661	national agency of research of the French government (ANR-SEST); IRD	national agency of research of the French government (ANR-SEST)(French National Research Agency (ANR)); IRD	This project was funded by the national agency of research of the French government (ANR-SEST 2007). AD received financial support from IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Bereczky S, 2005, AM J TROP MED HYG, V72, P249, DOI 10.4269/ajtmh.2005.72.249; Bob NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009817; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P259; Diallo S, 1998, B SOC PATHOL EXOT, V91, P208; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Malhotra I, 2005, J CLIN MICROBIOL, V43, P3630, DOI 10.1128/JCM.43.8.3630-3635.2005; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Ministere de l'economie et des finances ANdlSedlD, 2008, 3 REC GEN POP HAB 20, P163; Ministere de la Sante et de la Prevention Medicale C, 2006, ENQ DEM SANT SEN 200; Ministere de la sante ' et de la prevention CdRplDHC, 2009, ENQ NAT DUR PAL SEN, P24; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Ndiaye P, 2006, Med Trop (Mars), V66, P74; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Parizot IPS, 2004, U444 INSERM, VU444, P203; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sabatinelli G, 1986, Parassitologia, V28, P17; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Soumare M, 1999, Dakar Med, V44, P8; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stepniewska K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-249; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; TRAPE JF, 1993, AM J TROP MED HYG, V48, P748, DOI 10.4269/ajtmh.1993.48.748; Unies N, 2008, WORLD URBANIZATION P, P32; VERCRUYSSE J, 1983, B WORLD HEALTH ORGAN, V61, P821; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; Wade S, TELEDETECTION CATAST, P5; WATTS TE, 1990, T ROY SOC TROP MED H, V84, P196, DOI 10.1016/0035-9203(90)90251-9	44	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31100	10.1371/journal.pone.0031100	http://dx.doi.org/10.1371/journal.pone.0031100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363558	Green Published, gold			2022-12-25	WOS:000302873700026
J	Gregoracci, GB; Nascimento, JR; Cabral, AS; Paranhos, R; Valentin, JL; Thompson, CC; Thompson, FL				Gregoracci, Gustavo B.; Nascimento, Juliana R.; Cabral, Anderson S.; Paranhos, Rodolfo; Valentin, Jean L.; Thompson, Cristiane C.; Thompson, Fabiano L.			Structuring of Bacterioplankton Diversity in a Large Tropical Bay	PLOS ONE			English	Article							GLOBAL PATTERNS; BACTERIAL; BIODIVERSITY; ENRICHMENT; VARIABLES; RESOURCE; ECOLOGY; VIBRIOS; ESTUARY; WATERS	Structuring of bacterioplanktonic populations and factors that determine the structuring of specific niche partitions have been demonstrated only for a limited number of colder water environments. In order to better understand the physical chemical and biological parameters that may influence bacterioplankton diversity and abundance, we examined their productivity, abundance and diversity in the second largest Brazilian tropical bay (Guanabara Bay, GB), as well as seawater physical chemical and biological parameters of GB. The inner bay location with higher nutrient input favored higher microbial (including vibrio) growth. Metagenomic analysis revealed a predominance of Gammaproteobacteria in this location, while GB locations with lower nutrient concentration favored Alphaproteobacteria and Flavobacteria. According to the subsystems (SEED) functional analysis, GB has a distinctive metabolic signature, comprising a higher number of sequences in the metabolism of phosphorus and aromatic compounds and a lower number of sequences in the photosynthesis subsystem. The apparent phosphorus limitation appears to influence the GB metagenomic signature of the three locations. Phosphorus is also one of the main factors determining changes in the abundance of planktonic vibrios, suggesting that nutrient limitation can be observed at community (metagenomic) and population levels (total prokaryote and vibrio counts).	[Gregoracci, Gustavo B.; Nascimento, Juliana R.; Thompson, Fabiano L.] Fed Univ Rio de Janeiro UFRJ, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil; [Cabral, Anderson S.; Paranhos, Rodolfo] Fed Univ Rio de Janeiro UFRJ, Lab Hydrobiol, Inst Biol, Rio De Janeiro, Brazil; [Valentin, Jean L.] Fed Univ Rio de Janeiro UFRJ, Lab Zooplankton, Inst Biol, Rio De Janeiro, Brazil; [Thompson, Cristiane C.] IOC FIOCRUZ, Lab Mol Genet Microorganisms, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Gregoracci, GB (corresponding author), Fed Univ Rio de Janeiro UFRJ, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil.	fabiano.thompson@biologia.ufrj.br	VALENTIN, JEAN L/I-9403-2012; Paranhos, Rodolfo/F-1927-2011; Gregoracci, Gustavo B/E-1848-2013; Thompson, Cristiane C/I-5783-2016	Thompson, Fabiano/0000-0002-7562-1683; Gregoracci, Gustavo/0000-0001-6896-1068	federal (CNPq); federal (CAPES); state (FAPERJ)	federal (CNPq)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); federal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); state (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors would like to thank federal (CNPq and CAPES) and state (FAPERJ) funding agencies for their support. RP acknowledges grants to the Microbial Observatory of Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Aiyar SE, 2002, J BACTERIOL, V184, P1349, DOI 10.1128/JB.184.5.1349-1358.2002; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Burkholder JM, 2006, LIMNOL OCEANOGR, V51, P463, DOI 10.4319/lo.2006.51.1_part_2.0463; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Christensen JH, 2010, ENVIRON POLLUT, V158, P3290, DOI 10.1016/j.envpol.2010.07.015; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; Eiler A, 2006, APPL ENVIRON MICROB, V72, P6004, DOI 10.1128/AEM.00917-06; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Ferguson Wood EJ, MICROBIOLOGY OCEANS; Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Grasshoff K., 1999, METHODS SEAWATER ANA; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; IBGE, 2010, I BRAS GEOGR EST CEN; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Kirchman D. L., MICROBIAL ECOLOGY OC; Leibold MA, 2008, NATURE, V454, P39, DOI 10.1038/454039a; Louis VR, 2003, APPL ENVIRON MICROB, V69, P2773, DOI 10.1128/AEM.69.5.2773-2785.2003; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424, DOI 10.4319/lo.2006.51.1_part_2.0424	46	48	49	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31408	10.1371/journal.pone.0031408	http://dx.doi.org/10.1371/journal.pone.0031408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363639	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700056
J	Miyazaki, A; Yogosawa, S; Murakami, A; Kitamura, D				Miyazaki, Atsuko; Yogosawa, Satomi; Murakami, Akikazu; Kitamura, Daisuke			Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor	PLOS ONE			English	Article							NON-ITAM TYROSINE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; PROTEIN BLNK; ACTIVATION; REQUIREMENT; BETA; BASH; ASSOCIATION; LYMPHOCYTES	BLNK is a pivotal adaptor protein in the signal transduction pathway from the IgM class B-cell receptor. BLNK is phosphorylated by Syk and binds various signaling intermediates, leading to cellular events including MAP-kinase activation, culminating in cellular activation. It remains unclear how BLNK is initially recruited to the surface IgM (sIgM) complex to which Syk is also recruited. Here we show that CMTM7, a tetra-spanning membrane protein of unknown function, co-localized with clathrin and sIgM at the plasma membrane. RNA-interference-mediated knockdown of CMTM7 expression in B cells resulted in an impairment of sIgM-ligation-induced tyrosine phosphorylation of BLNK, which was due to an impaired interaction of BLNK and Syk, and in a failure to activate JNK and ERK, but not upstream kinases such as Src-family kinases and Syk. CMTM7 was bound to BLNK in a membrane fraction, and their association was augmented after sIgM ligation. Exogenous CMTM7 or a mutant with an N-terminal deletion (Delta N), but not one with a C-terminal deletion (Delta C) that is defective in membrane localization, were able to restore BLNK-Syk binding, BLNK phosphorylation and ERK activation in the CMTM7-knockdown B cells. In addition, CMTM7 and the Delta N, but not the Delta C, were constitutively associated with sIgM, and this binding was required for BLNK recruitment to sIgM. From these data, we conclude that CMTM7 functions to link sIgM and BLNK in the plasma membrane, to recruit BLNK to the vicinity of Syk, and to initiate the BLNK- mediated signal transduction.	[Miyazaki, Atsuko; Yogosawa, Satomi; Kitamura, Daisuke] Tokyo Univ Sci, RIBS, Div Mol Biol Lab, Noda, Chiba 278, Japan; [Murakami, Akikazu] Tokyo Univ Sci, RIBS, Div Azuma Lab, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science	Miyazaki, A (corresponding author), Tokyo Univ Sci, RIBS, Div Mol Biol Lab, Noda, Chiba 278, Japan.	kitamura@rs.noda.tus.ac.jp		Murakami, Akikazu/0000-0003-3064-3237	Japan Society for the Promotion of Science [21113526, 22390097]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research(B) (22390097) and on Innovative Areas (21113526) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index. html) and Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/research_promotion/1303820.htm), respectively, to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kim JH, 2005, J IMMUNOL, V175, P147, DOI 10.4049/jimmunol.175.1.147; KIM KJ, 1979, J IMMUNOL, V122, P549; Kitamura D, 2007, IMMUNE SYSTEM RECOGN, P99; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kremyanskaya M, 2005, J IMMUNOL, V174, P1501, DOI 10.4049/jimmunol.174.3.1501; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Oda A, 2008, INT IMMUNOL, V20, P1417, DOI 10.1093/intimm/dxn101; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; Pike KA, 2005, J IMMUNOL, V174, P2012, DOI 10.4049/jimmunol.174.4.2012; Reth M, 1997, ANNU REV IMMUNOL, P15453; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Siemasko K, 2002, J IMMUNOL, V168, P2127, DOI 10.4049/jimmunol.168.5.2127; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	33	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31829	10.1371/journal.pone.0031829	http://dx.doi.org/10.1371/journal.pone.0031829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363743	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700104
J	Vonhoff, F; Williams, A; Ryglewski, S; Duch, C				Vonhoff, Fernando; Williams, Alison; Ryglewski, Stefanie; Duch, Carsten			Drosophila as a Model for MECP2 Gain of Function in Neurons	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; CPG BINDING DOMAIN; RETT-SYNDROME; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR; MOUSE MODEL; SYNAPTIC PLASTICITY; DUPLICATION; MOTOR; ABNORMALITIES	Methyl-CpG-binding protein 2 (MECP2) is a multi-functional regulator of gene expression. In humans loss of MECP2 function causes classic Rett syndrome, but gain of MECP2 function also causes mental retardation. Although mouse models provide valuable insight into Mecp2 gain and loss of function, the identification of MECP2 genetic targets and interactors remains time intensive and complicated. This study takes a step toward utilizing Drosophila as a model to identify genetic targets and cellular consequences of MECP2 gain-of function mutations in neurons, the principle cell type affected in patients with Rett-related mental retardation. We show that heterologous expression of human MECP2 in Drosophila motoneurons causes distinct defects in dendritic structure and motor behavior, as reported with MECP2 gain of function in humans and mice. Multiple lines of evidence suggest that these defects arise from specific MECP2 function. First, neurons with MECP2-induced dendrite loss show normal membrane currents. Second, dendritic phenotypes require an intact methyl-CpG-binding domain. Third, dendritic defects are amended by reducing the dose of the chromatin remodeling protein, osa, indicating that MECP2 may act via chromatin remodeling in Drosophila. MECP2-induced motoneuron dendritic defects cause specific motor behavior defects that are easy to score in genetic screening. In sum, our data show that some aspects of MECP2 function can be studied in the Drosophila model, thus expanding the repertoire of genetic reagents that can be used to unravel specific neural functions of MECP2. However, additional genes and signaling pathways identified through such approaches in Drosophila will require careful validation in the mouse model.	[Vonhoff, Fernando; Williams, Alison; Ryglewski, Stefanie; Duch, Carsten] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Vonhoff, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	carsten.duch@asu.edu	Vonhoff, Fernando/AAH-8909-2021	Vonhoff, Fernando/0000-0002-0679-1857; Duch, Carsten/0000-0002-6962-6023	National Institutes of Health [RO1NS072128]; Science Foundation Arizona; German Research Foundation (DFG) [RY117/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Arizona; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support by National Institutes of Health to CD (RO1NS072128), by the Science Foundation Arizona to AW, and by the German Research Foundation (DFG) to SR (RY117/1-1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boerner J, 2010, J COMP NEUROL, V518, P2437, DOI 10.1002/cne.22346; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Burrows M., 1996, NEUROBIOLOGY INSECT; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; Cukier HN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000179; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Duch C, 2004, J NEUROSCI, V24, P9826, DOI 10.1523/JNEUROSCI.3189-04.2004; Duch C, 2008, J NEUROPHYSIOL, V100, P2525, DOI 10.1152/jn.90758.2008; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Gatto CL, 2011, CURR OPIN NEURO 0517; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hartwig CL, 2008, DEV NEUROBIOL, V68, P1225, DOI 10.1002/dneu.20655; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hu KP, 2006, NAT GENET, V38, P962, DOI 10.1038/ng0906-962; IKEDA K, 1988, J COMP NEUROL, V273, P436, DOI 10.1002/cne.902730312; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Matarazzo V, 2004, MOL CELL NEUROSCI, V27, P44, DOI 10.1016/j.mcn.2004.05.005; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Percy AK, 2002, NEUROL CLIN, V20, P1125, DOI 10.1016/S0733-8619(02)00022-1; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Restifo LL, 2005, MENT RETARD DEV D R, V11, P286, DOI 10.1002/mrdd.20083; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryglewski S, 2011, J PHYSL         1219, V19; Ryglewski S, 2009, J NEUROPHYSIOL, V102, P3673, DOI 10.1152/jn.00693.2009; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Vonhoff F, 2010, J COMP NEUROL, V518, P2169, DOI 10.1002/cne.22380; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang YQ, 2005, TRENDS GENET, V21, P37, DOI 10.1016/j.tig.2004.11.003	68	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31835	10.1371/journal.pone.0031835	http://dx.doi.org/10.1371/journal.pone.0031835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363746	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700106
J	Zhong, LM; Zong, Y; Sun, L; Guo, JZ; Zhang, W; He, Y; Song, R; Wang, WM; Xiao, CJ; Lu, D				Zhong, Lian-Mei; Zong, Yi; Sun, Lin; Guo, Jia-Zhi; Zhang, Wei; He, Ying; Song, Rui; Wang, Wen-Min; Xiao, Chun-Jie; Lu, Di			Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells	PLOS ONE			English	Article							PROTEIN; ACTIVATION; DISEASE; CYTOKINES; BRAIN; PTEN; CYCLOOXYGENASE-2; CHONDROCYTES; PHOSPHATASE; EXPRESSION	Background: Resveratrol have been known to possess many pharmacological properties including antioxidant, cardioprotective and anticancer effects. Although current studies indicate that resveratrol produces neuroprotection against neurological disorders, the precise mechanisms for its beneficial effects are still not fully understood. We investigate the effect of anti-inflammatory and mechamisms of resveratrol by using lipopolysaccharide (LPS)-stimulated murine microglial BV-2 cells. Methodology/Principal Findings: BV-2 cells were treated with resveratrol (25, 50, and 100 mu M) and/or LPS (1 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of PTEN (phosphatase and tensin homolog deleted on chromosome 10), Akt, mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs) cascades, inhibitor kappa B-alpha (I kappa B-alpha) and cyclic AMP-responsive element-binding protein (CREB) were measured by western blot. Resveratrol significantly attenuated the LPS-induced expression of NO, PGE2, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and nuclear factor-kappa B (NF-kappa B) in BV-2 cells. Resveratrol increased PTEN, Akt and mTOR phosphorylation in a dose-dependent manner or a time-dependent manner. Rapamycin (10 nM), a specific mTOR inhibitor, blocked the effects of resveratrol on LPS-induced microglial activation. In addition, mTOR inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of I kappa B-alpha, CREB, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK). Conclusion and Implications: This study indicates that resveratrol inhibited LPS-induced proinflammatory enzymes and proinflammatory cytokines via down-regulation phosphorylation of NF-kappa B, CREB and MAPKs family in a mTOR-dependent manner. These findings reveal, in part, the molecular basis underlying the anti-inflammatory properties of resveratrol.	[Zhong, Lian-Mei; Xiao, Chun-Jie] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Zhong, Lian-Mei; Zhang, Wei; Wang, Wen-Min] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Zong, Yi; Guo, Jia-Zhi; He, Ying; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Sun, Lin; Song, Rui] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China	Yunnan University; Kunming Medical University; Kunming Medical University; Kunming Medical University	Zhong, LM (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	xiao2009cj@yahoo.com.cn; ludi20040609@126.com			National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2009CI033]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2008CD016, 2010CD156, 2011FB177]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, grants (2008CC007 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and grants (2008CD016, 2010CD156 and 2011FB177) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Ledesma MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012127; Lee KS, 2006, MOL PHARMACOL, V69, P1829, DOI 10.1124/mol.106.022228; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lim JY, 2010, EUR J PHARMACOL, V642, P10, DOI 10.1016/j.ejphar.2010.05.047; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Nakajima K, 1998, Hum Cell, V11, P141; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Olas B, 2008, PLATELETS, V19, P70, DOI 10.1080/09537100701708506; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	43	129	135	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32195	10.1371/journal.pone.0032195	http://dx.doi.org/10.1371/journal.pone.0032195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363816	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700157
J	Britton, JR				Britton, J. Robert			Testing Strength of Biotic Resistance against an Introduced Fish: Inter-Specific Competition or Predation through Facultative Piscivory?	PLOS ONE			English	Article							INVASION-RESISTANCE; TROPHIC POSITION; CONSEQUENCES; MODELS; TROUT	Biotic resistance is the process where aspects of the receiving environment inhibit the establishment and invasion of an introduced species. Resistance against an introduced fish can be through strong competition and/or predation from resident fishes. Here, the biotic resistance against introduced topmouth gudgeon Pseudorasbora parva (a highly invasive fish in Europe) by resident carp Cyprinus carpio was tested in experimental mesocosms. The introduction scenario was six adult P. parva (three male, three female) on a single occasion. Resistance to their establishment was provided by three and six resident C. carpio whose effects on P. parva growth and reproduction were compared to a Control (no resident fish at the time of introduction) and treatments containing three and six P. parva. After 120 days, the growth rates of the introduced P. parva were significantly depressed in C. carpio presence and in mesocosms with three C. carpio present, significantly decreased numbers of 0+P. parva were recorded. Where six C. carpio were present, no 0+P. parva were recorded, indicating resistance strength increased with carp abundance. In contrast, there were no differences in P. parva reproduction and growth rates between the Control and treatments containing conspecifics. Stable isotope analysis (delta N-15, delta C-13) revealed C. carpio were feeding at one trophic level above 0+P. parva, suggesting the process of resistance was predation (facultative piscivory) rather than competition. Thus, if P. parva are to establish and invade following an introduction, they must overcome this biotic resistance from cyprinid fishes such as C. carpio.	Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	Bournemouth University	Britton, JR (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	rbritton@bournemouth.ac.uk	Britton, Robert/AAO-6673-2020; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086	Natural Environment Research Council (NERC) [NE/H000429/1]; Natural Environment Research Council [NE/H000429/1] Funding Source: researchfish; NERC [NE/H000429/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC research grant reference number NE/H000429/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTZ DM, 1993, ECOL APPL, V3, P246, DOI 10.2307/1941827; Benjamin JR, 2007, T AM FISH SOC, V136, P875, DOI 10.1577/T06-115.1; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Britton JR, 2011, ECOL FRESHW FISH, V20, P74, DOI 10.1111/j.1600-0633.2010.00460.x; Britton JR, 2011, BIOL CONSERV, V144, P2177, DOI 10.1016/j.biocon.2011.05.008; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Britton JR, 2010, BIOL INVASIONS, V12, P125, DOI 10.1007/s10530-009-9436-1; Carlsson NOL, 2011, FRESHWATER BIOL, V56, P1630, DOI 10.1111/j.1365-2427.2011.02602.x; CASE TJ, 1991, BIOL J LINN SOC, V42, P239, DOI 10.1111/j.1095-8312.1991.tb00562.x; Crawley MJ, 1999, ECOL LETT, V2, P140; Cross WF, 2002, OIKOS, V96, P251, DOI 10.1034/j.1600-0706.2002.960207.x; Cucherousset J, 2012, FISHERIES MANAG ECOL, V19, P111, DOI 10.1111/j.1365-2400.2011.00824.x; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Dzialowski AR, 2007, BIOL INVASIONS, V9, P257, DOI 10.1007/s10530-006-9030-8; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Grey J, 2006, POL J ECOL, V54, P563; HERBOLD B, 1986, AM NAT, V128, P751, DOI 10.1086/284600; Jensen GC, 2007, MAR BIOL, V151, P2231, DOI 10.1007/s00227-007-0658-4; Korsu K, 2009, NATURWISSENSCHAFTEN, V96, P347, DOI 10.1007/s00114-008-0482-9; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Oyugi DO, 2012, REV FISH BIOL FISHER, V22, P499, DOI 10.1007/s11160-011-9243-5; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; ROBINSON JV, 1988, OECOLOGIA, V77, P445, DOI 10.1007/BF00377258; Simon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018560; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Vander Zanden MJ, 2000, CAN J FISH AQUAT SCI, V57, P725, DOI 10.1139/cjfas-57-4-725; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762	33	16	16	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31707	10.1371/journal.pone.0031707	http://dx.doi.org/10.1371/journal.pone.0031707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363711	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500078
J	Li, J; Yu, L; Tian, YM; Zhang, KQ				Li, Juan; Yu, Li; Tian, Yanmei; Zhang, Ke-Qin			Molecular Evolution of the Deuterolysin (M35) Family Genes in Coccidioides	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; SWISS-MODEL; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; LIKELIHOOD METHOD; SOFTWARE PACKAGE; SIDE-CHAIN; RATIO; METALLOPROTEINASE	Coccidioides is a primary fungal pathogen of humans, causing life-threatening respiratory disease known as coccidioidomycosis (Valley fever) in immunocompromised individuals. Recently, Sharpton et al (2009) found that the deuterolysin (M35) family genes were significantly expanded in both the Coccidioides genus and in U. reesii, and that Coccidioides has acquired three more M35 family genes than U. reesii. In the present work, phylogenetic analyses based on a total of 28 M35 family genes using different alignments and tree-building methods consistently revealed five clades with high nodal supports. Interestingly, likelihood ratio tests suggested significant differences in selective pressure on the ancestral lineage of three additional duplicated M35 family genes from Coccidioides species compared to the other lineages in the phylogeny, which may be associated with novel functional adaptations of M35 family genes in the Coccidioides species, e.g., recent pathogenesis acquisition. Our study adds to the expanding view of M35 family gene evolution and functions as well as establishes a theoretical foundation for future experimental investigations.	[Li, Juan] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China; Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China	Yunnan University; Yunnan University	Li, J (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China.	kqzhang111@yahoo.com.cn	zhang, ke/AAH-8217-2019		National Natural Science Foundation of China [31100894]; National Basic Research Program of China [2007CB411600]; Science Foundation of Yunnan University [2010C03Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of Yunnan University	This work is funded by the National Natural Science Foundation Program of China (31100894), the National Basic Research Program of China (2007CB411600), and the Science Foundation of Yunnan University (approved no. 2010C03Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Bonferroni C. E, 1935, STUDI ONORE PROFESSO, V13; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cole GT, 2004, MED MYCOL, V42, P189, DOI 10.1080/13693780410001687349; Creighton TE, 1993, PROTEINS STRUCTURES, P417; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; Dixon DM, 2001, J APPL MICROBIOL, V91, P602, DOI 10.1046/j.1365-2672.2001.01496.x; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Force A, 1999, GENETICS, V151, P1531; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hector RF, 2005, PLOS MED, V2, P15, DOI 10.1371/journal.pmed.0020002; Hector R, 2007, ANN NY ACAD SCI, V1111, P259, DOI 10.1196/annals.1406.035; Hori T, 2001, ACTA CRYSTALLOGR D, V57, P361, DOI 10.1107/S0907444900019740; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; McAuley KE, 2001, ACTA CRYSTALLOGR D, V57, P1571, DOI 10.1107/S090744490101335X; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; Nielsen R, 1998, GENETICS, V148, P929; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos OHP, 2001, GENET MOL BIOL, V24, P285, DOI 10.1590/S1415-47572001000100037; Saubolle MA, 2007, J CLIN MICROBIOL, V45, P26, DOI 10.1128/JCM.02230-06; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Smith CE, 1940, AM J PUBLIC HEALTH N, V30, P600, DOI 10.2105/AJPH.30.6.600; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	66	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31536	10.1371/journal.pone.0031536	http://dx.doi.org/10.1371/journal.pone.0031536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363666	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500055
J	Polo, LM; Gil-Ortiz, F; Cantin, A; Rubio, V				Mariano Polo, Luis; Gil-Ortiz, Fernando; Cantin, Angel; Rubio, Vicente			New Insight into the Transcarbamylase Family: The Structure of Putrescine Transcarbamylase, a Key Catalyst for Fermentative Utilization of Agmatine	PLOS ONE			English	Article							FURIOSUS ORNITHINE CARBAMOYLTRANSFERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STREPTOCOCCUS-FAECALIS; DEIMINASE SYSTEM; ENZYME-SYNTHESIS; GENE-CLUSTER; CARBAMYL-P; PROTEIN; ARGININE	Transcarbamylases reversibly transfer a carbamyl group from carbamylphosphate (CP) to an amine. Although aspartate transcarbamylase and ornithine transcarbamylase (OTC) are well characterized, little was known about putrescine transcarbamylase (PTC), the enzyme that generates CP for ATP production in the fermentative catabolism of agmatine. We demonstrate that PTC (from Enterococcus faecalis), in addition to using putrescine, can utilize L-ornithine as a poor substrate. Crystal structures at 2.5 angstrom and 2.0 angstrom resolutions of PTC bound to its respective bisubstrate analog inhibitors for putrescine and ornithine use, N-(phosphonoacetyl)-putrescine and delta-N-(phosphonoacetyl)-L-ornithine, shed light on PTC preference for putrescine. Except for a highly prominent C-terminal helix that projects away and embraces an adjacent subunit, PTC closely resembles OTCs, suggesting recent divergence of the two enzymes. Since differences between the respective 230 and SMG loops of PTC and OTC appeared to account for the differential preference of these enzymes for putrescine and ornithine, we engineered the 230-loop of PTC to make it to resemble the SMG loop of OTCs, increasing the activity with ornithine and greatly decreasing the activity with putrescine. We also examined the role of the C-terminal helix that appears a constant and exclusive PTC trait. The enzyme lacking this helix remained active but the PTC trimer stability appeared decreased, since some of the enzyme eluted as monomers from a gel filtration column. In addition, truncated PTC tended to aggregate to hexamers, as shown both chromatographically and by X-ray crystallography. Therefore, the extra C-terminal helix plays a dual role: it stabilizes the PTC trimer and, by shielding helix 1 of an adjacent subunit, it prevents the supratrimeric oligomerizations of obscure significance observed with some OTCs. Guided by the structural data we identify signature traits that permit easy and unambiguous annotation of PTC sequences.	[Mariano Polo, Luis; Gil-Ortiz, Fernando; Rubio, Vicente] Inst Biomed Valencia, Valencia, Spain; [Mariano Polo, Luis; Gil-Ortiz, Fernando; Rubio, Vicente] Ctr Invest Biomed Red Enfermedades Raras, Valencia, Spain; [Cantin, Angel] Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Polo, LM (corresponding author), Inst Biomed Valencia, Valencia, Spain.	rubio@ibv.csic.es	CANOS, AVELINO CORMA/A-3040-2013; Rubio, Vicente/K-7919-2014; Cantin, Angel/I-4282-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; Rubio, Vicente/0000-0001-8124-1196; Gil-Ortiz, Fernando/0000-0001-5897-2724; Cantin, Angel/0000-0002-3219-1919	Spanish Ministry for Science [BFU2008-05021]; Valencian Government [Prometeo/2009/051]; Consejo Superior de Investigaciones Cientificas-Banco de Santander; JAE-DOC of the Consejo Superior de Investigaciones Cientificas; European Union; European Molecular Biology Laboratory	Spanish Ministry for Science(Spanish Government); Valencian Government; Consejo Superior de Investigaciones Cientificas-Banco de Santander; JAE-DOC of the Consejo Superior de Investigaciones Cientificas; European Union(European Commission); European Molecular Biology Laboratory	This work was supported by grants BFU2008-05021 of the Spanish Ministry for Science and Prometeo/2009/051 of the Valencian Government. The European Union and the European Molecular Biology Laboratory funded synchrotron visits. LMP was supported by a Consejo Superior de Investigaciones Cientificas-Banco de Santander fellowship and FGO by a JAE-DOC contract of the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI Y, 1988, BIOCHEM J, V250, P735, DOI 10.1042/bj2500735; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P365, DOI 10.1089/fpd.2008.0207; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; de las Rivas B, 2009, J MOL BIOL, V393, P425, DOI 10.1016/j.jmb.2009.08.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DR, 1993, BIOCHEM SOC T, V21, P186, DOI 10.1042/bst0210186; Galkin A, 2009, PROTEINS, V76, P1049, DOI 10.1002/prot.22469; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Ha Y, 1997, P NATL ACAD SCI USA, V94, P9550, DOI 10.1073/pnas.94.18.9550; JONES ME, 1963, SCIENCE, V140, P1373, DOI 10.1126/science.140.3574.1373; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; Keefe AD, 1995, J MOL EVOL, V41, P693; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; Labedan B, 1999, J MOL EVOL, V49, P461, DOI 10.1007/PL00006569; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landete JM, 2010, INT MICROBIOL, V13, P169, DOI 10.2436/20.1501.01.123; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legrain C, 1997, EUR J BIOCHEM, V247, P1046, DOI 10.1111/j.1432-1033.1997.01046.x; Lipscomb WN, 2011, ACC CHEM RES IN PRES; Liu YL, 2009, J BACTERIOL, V191, P7363, DOI 10.1128/JB.01054-09; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Low DE, 2001, CLIN INFECT DIS, V32, pS133, DOI 10.1086/320185; MARSHALL M, 1972, J BIOL CHEM, V247, P1654; Massant J, 2003, ACTA CRYSTALLOGR D, V59, P2140, DOI 10.1107/S0907444903019231; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naumoff DG, 2004, MICROBIOL-SGM, V150, P3908, DOI 10.1099/mic.0.27640-0; Naumoff DG, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-52; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramon-Maiques S, 2002, BIOCHEMISTRY-US, V41, P3916, DOI 10.1021/bi011637d; ROBEY EA, 1985, P NATL ACAD SCI USA, V82, P361, DOI 10.1073/pnas.82.2.361; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Shi DS, 1998, J BIOL CHEM, V273, P34247, DOI 10.1074/jbc.273.51.34247; SIMON JP, 1982, J BACTERIOL, V150, P1085, DOI 10.1128/JB.150.3.1085-1090.1982; SIMON JP, 1982, J BACTERIOL, V152, P676; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIGIER H, 1965, BIOCHEM BIOPH RES CO, V19, P209, DOI 10.1016/0006-291X(65)90506-1; VANDERWAUVEN C, 1986, ARCH MICROBIOL, V145, P386, DOI 10.1007/BF00470876; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P10762, DOI 10.1073/pnas.92.23.10762; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; WARGNIES B, 1979, EUR J BIOCHEM, V101, P143, DOI 10.1111/j.1432-1033.1979.tb04226.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	57	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31528	10.1371/journal.pone.0031528	http://dx.doi.org/10.1371/journal.pone.0031528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363663	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500052
J	Sun, XQ; Zhu, YJ; Guo, JL; Peng, B; Bai, MM; Hang, YY				Sun, Xiao-Qin; Zhu, Ying-Jie; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu			DNA Barcoding the Dioscorea in China, a Vital Group in the Evolution of Monocotyledon: Use of matK Gene for Species Discrimination	PLOS ONE			English	Article							LAND PLANTS; PSBA-TRNH; PHYLOGENY; TAXONOMY; RBCL; IDENTIFICATION; STENOPHORA; REGION; SPACER	Background: Dioscorea is an important plant genus in terms of food supply and pharmaceutical applications. However, its classification and identification are controversial. DNA barcoding is a recent aid to taxonomic identification and uses a short standardized DNA region to discriminate plant species. In this study, the applicability of three candidate DNA barcodes (rbcL, matK, and psbA-trnH) to identify species within Dioscorea was tested. Methodology/Principal Findings: One-hundred and forty-eight individual plant samples of Dioscorea, encompassing 38 species, seven varieties and one subspecies, representing majority species distributed in China of this genus, were collected from its main distributing areas. Samples were assessed by PCR amplification, sequence quality, extent of specific genetic divergence, DNA barcoding gap, and the ability to discriminate between species. matK successfully identified 23.26% of all species, compared with 9.30% for rbcL and 11.63% for psbA-trnH. Therefore, matK is recommended as the best DNA barcoding candidate. We found that the combination of two or three loci achieved a higher success rate of species discrimination than one locus alone. However, experimental cost would be much higher if two or three loci, rather than a single locus, were assessed. Conclusions: We conclude that matK is a strong, although not perfect, candidate as a DNA barcode for Dioscorea identification. This assessment takes into account both its ability for species discrimination and the cost of experiments.	[Sun, Xiao-Qin; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu] Inst Bot, Jiangsu Prov Key Lab Plant Ex Situ Conservat, Nanjing, Jiangsu, Peoples R China; [Sun, Xiao-Qin; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu] Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China; [Zhu, Ying-Jie] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Sun, XQ (corresponding author), Inst Bot, Jiangsu Prov Key Lab Plant Ex Situ Conservat, Nanjing, Jiangsu, Peoples R China.	hangyueyu@yahoo.com.cn	Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019	Chinese Academy of Sciences [2009-LSF-GBOWS-01]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Research Fund for the Largescale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH J, 1988, CURR GENET, V14, P137, DOI 10.1007/BF00569337; Applezweig N, 1962, STEROID DRUGS; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BURKILL I. H., 1951, FLORA MALESIANA, V4, P293; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chin H. C., 1985, ACTA PHYTOTAXON SIN, V23, P11; CORRELL D. S., 1955, ECON BOT, V9, P307, DOI 10.1007/BF02985309; Coursey D. G., 1967, TROPICAL AGR SERIES; DAHLGREN G, 1989, BOT J LINN SOC, V100, P197, DOI 10.1111/j.1095-8339.1989.tb01717.x; Degras L., 1993, The yam: a tropical root crop.; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fujii K., 1936, J PHARM SOC JAPAN, V56, P408; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Huang Chun-hong, 2003, Acta Botanica Yunnanica, V25, P641; Kawabe A, 1997, GENES GENET SYST, V72, P253, DOI 10.1266/ggs.72.253; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; LAHAYE R, 2008, TEST PSBK PSBI ATPF; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; LAWTON J. R. W., 1967, PROC LINN SOC LONDON, V178, P153; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Logacheva MD, 2008, PLANT SYST EVOL, V270, P139, DOI 10.1007/s00606-007-0619-x; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Mast AR, 2002, AM J BOT, V89, P1311, DOI 10.3732/ajb.89.8.1311; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miege J, 1982, YAMS IGNAMES, P243; Miller JT, 2003, SYST BOT, V28, P558; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Okonkwo S. N. C., 1985, ADV YAM RES BIOCH TE, P3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; RAMACHANDRAN K, 1968, CYTOLOGIA, V33, P401, DOI 10.1508/cytologia.33.401; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schols P, 2005, SYST BOT, V30, P750, DOI 10.1600/036364405775097743; Schols P, 2003, BOT J LINN SOC, V143, P375, DOI 10.1111/j.1095-8339.2003.00227.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SMITH BEN W., 1937, BULL TORREY BOT CLUB, V64, P189, DOI 10.2307/2481142; Su P, 1987, ACTA PHYTOTAXONOMICA, V25, P357; Tate JA, 2003, SYST BOT, V28, P723; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Wan J.R., 1994, ACTA BOT BOREALI-OCC, V14, P128; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whipple IG, 2007, AM J BOT, V94, P551, DOI 10.3732/ajb.94.4.551; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Winkworth RC, 2005, AM J BOT, V92, P653, DOI 10.3732/ajb.92.4.653; Gao X, 2008, J SYST EVOL, V46, P315, DOI 10.3724/SP.J.1002.2008.08007; Yoo HS, 2006, MOL CELLS, V22, P323; Zhang MZ, 1982, COMP ANATOMY CHINESE, P1	60	26	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32057	10.1371/journal.pone.0032057	http://dx.doi.org/10.1371/journal.pone.0032057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363795	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500108
J	Wang, LZ; Beuerle, T; Timbilla, J; Ober, D				Wang, Linzhu; Beuerle, Till; Timbilla, James; Ober, Dietrich			Independent Recruitment of a Flavin-Dependent Monooxygenase for Safe Accumulation of Sequestered Pyrrolizidine Alkaloids in Grasshoppers and Moths	PLOS ONE			English	Article							N-OXIDE; CYTOCHROME-P450; SEQUESTRATION; METABOLISM; LEPIDOPTERA; DEFENSE; ENZYME	Several insect lineages have developed diverse strategies to sequester toxic pyrrolizidine alkaloids from food-plants for their own defense. Here, we show that in two highly divergent insect taxa, the hemimetabolous grasshoppers and the holometabolous butterflies, an almost identical strategy evolved independently for safe accumulation of pyrrolizidine alkaloids. This strategy involves a pyrrolizidine alkaloid N-oxygenase that transfers the pyrrolizidine alkaloids to their respective N-oxide, enabling the insects to avoid high concentrations of toxic pyrrolizidine alkaloids in the hemolymph. We have identified a pyrrolizidine alkaloid N-oxygenase, which is a flavin-dependent monooxygenase, of the grasshopper Zonocerus variegatus. After heterologous expression in E. coli, this enzyme shows high specificity for pyrrolizidine alkaloids of various structural types and for the tropane alkaloid atropine as substrates, a property that has been described previously for a pyrrolizidine alkaloid N-oxygenase of the arctiid moth Grammia geneura. Phylogenetic analyses of insect flavin-dependent monooxygenase sequences suggest that independent gene duplication events preceded the establishment of this specific enzyme in the lineages of the grasshoppers and of arctiid moths. Two further flavin-dependent monooxygenase sequences have been identified from Z. variegatus sharing amino acid identities of approximately 78% to the pyrrolizidine alkaloid N-oxygenase. After heterologous expression, both enzymes are also able to catalyze the N-oxygenation of pyrrolizidine alkaloids, albeit with a 400-fold lower specific activity. With respect to the high sequence identity between the three Z. variegatus sequences this ability to N-oxygenize pyrrolizidine alkaloids is interpreted as a relict of a former bifunctional ancestor gene of which one of the gene copies optimized this activity for the specific adaptation to pyrrolizidine alkaloid containing food plants.	[Wang, Linzhu; Ober, Dietrich] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Wang, Linzhu; Ober, Dietrich] Univ Kiel, Bot Garden, Kiel, Germany; [Beuerle, Till] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Timbilla, James] CUNY Queensborough Community Coll, New York, NY 11364 USA	University of Kiel; University of Kiel; Braunschweig University of Technology; City University of New York (CUNY) System	Wang, LZ (corresponding author), Univ Wurzburg, Wurzburg, Germany.	dober@bot.uni-kiel.de		Beuerle, Till/0000-0001-5037-6653				Ai JW, 2010, MOL BIOL REP, V37, P1657, DOI 10.1007/s11033-009-9580-9; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BERNAYS E, 1977, J ZOOL, V182, P85, DOI 10.1111/j.1469-7998.1977.tb04142.x; Bernays EA, 2000, J CHEM ECOL, V26, P1773, DOI 10.1023/A:1005578804865; Boppre M., 1994, NEW TRENDS LOCUST CO, P107; Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CHAPMAN RF, 1986, ANNU REV ENTOMOL, V31, P479, DOI 10.1146/annurev.en.31.010186.002403; Dobler S, 2000, J CHEM ECOL, V26, P1281, DOI 10.1023/A:1005444313447; EHMKE A, 1991, J CHEM ECOL, V17, P2367, DOI 10.1007/BF00994588; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feyereisen R., 2005, P1; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Hartmann T, 2000, TOP CURR CHEM, V209, P207; HARTMANN T, 1990, BIOCHEM SYST ECOL, V18, P549, DOI 10.1016/0305-1978(90)90127-2; Hartmann T, 2001, INSECT BIOCHEM MOLEC, V31, P1041, DOI 10.1016/S0965-1748(01)00052-2; Hartmann Thomas, 2009, P55; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Huan JY, 1998, TOXICOL LETT, V99, P127, DOI 10.1016/S0378-4274(98)00152-0; Hung CF, 1997, INSECT BIOCHEM MOLEC, V27, P377, DOI 10.1016/S0965-1748(97)00009-X; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kekeunou S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-17; Langel D, 2011, PHYTOCHEMIS IN PRESS, DOI [10.1016/j.phytochem.2010.012.1014, DOI 10.1016/J.PHYTOCHEM.2010.1012.1014]; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Narberhaus I, 2003, J COMP PHYSIOL B, V173, P483, DOI 10.1007/s00360-003-0356-6; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; PASTEELS JM, 1988, ENTOMOL EXP APPL, V49, P55, DOI 10.1111/j.1570-7458.1988.tb02476.x; PHILLIPS IR, 1995, CHEM-BIOL INTERACT, V96, P17, DOI 10.1016/0009-2797(94)03580-2; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; Sehlmeyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010435; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; VONNICKISCHROSENEGK E, 1993, J CHEM ECOL, V19, P1889, DOI 10.1007/BF00983794; WILLIAMS DE, 1989, DRUG METAB DISPOS, V17, P380	40	17	17	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31796	10.1371/journal.pone.0031796	http://dx.doi.org/10.1371/journal.pone.0031796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363737	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500090
J	Zhang, H; Van der Lee, T; Waalwijk, C; Chen, WQ; Xu, J; Xu, JS; Zhang, Y; Feng, J				Zhang, Hao; Van der Lee, Theo; Waalwijk, Cees; Chen, Wanquan; Xu, Jin; Xu, Jingsheng; Zhang, Ye; Feng, Jie			Population Analysis of the Fusarium graminearum Species Complex from Wheat in China Show a Shift to More Aggressive Isolates	PLOS ONE			English	Article							HEAD BLIGHT PATHOGEN; MYCOTOXIN CHEMOTYPES; GENETIC DIVERSITY; GIBBERELLA-ZEAE; F-ASIATICUM; BARLEY; CLADE; DEOXYNIVALENOL; RECOGNITION; RESISTANCE	A large number of Fusarium isolates was collected from blighted wheat spikes originating from 175 sampling sites, covering 15 provinces in China. Species and trichothecene chemotype determination by multilocus genotyping (MLGT) indicated that F. graminearum s. str. with the 15-acetyl deoxynivalenol (15ADON) chemotype and F. asiaticum with either the nivalenol (NIV) or the 3-acetyl deoxynivalenol (3ADON) chemotype were the dominant causal agents. Bayesian model-based clustering with allele data obtained with 12 variable number of tandem repeats (VNTR) markers, detected three genetic clusters that also show distinct chemotypes. High levels of population genetic differentiation and low levels of effective number of migrants were observed between these three clusters. Additional genotypic analyses revealed that F. graminearum s. str. and F. asiaticum are sympatric. In addition, composition analysis of these clusters indicated a biased gene flow from 3ADON to NIV producers in F. asiaticum. In phenotypic analyses, F. asiaticum that produce 3ADON revealed significant advantages over F. asiaticum that produce NIV in pathogenicity, growth rate, fecundity, conidial length, trichothecene accumulation and resistance to benzimidazole. These results suggest that natural selection drives the spread of a more vigorous, more toxigenic pathogen population which also shows higher levels of fungicide resistance.	[Zhang, Hao; Chen, Wanquan; Xu, Jin; Xu, Jingsheng; Zhang, Ye; Feng, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Van der Lee, Theo; Waalwijk, Cees] Plant Res Int, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, H (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wqchen@ippcaas.cn; jfeng@ippcaas.cn	Waalwijk, Cees/B-2522-2013; vanderlee, Theo A.J./J-7296-2013; Waalwijk, Cees/X-9439-2019	Waalwijk, Cees/0000-0001-5367-2108; Zhang, Hao/0000-0002-2155-0592	National Basic Research and Development Program (973 Program) [2009CB119200]; project of Special Fund for Agro-scientific Research in the Public Interest [nyhyzx07-048]; International Scientific and Technical Cooperation [2009DFA31980]	National Basic Research and Development Program (973 Program)(National Basic Research Program of China); project of Special Fund for Agro-scientific Research in the Public Interest; International Scientific and Technical Cooperation	This work was supported by the National Basic Research and Development Program (973 Program) (no. 2009CB119200), and a project of Special Fund for Agro-scientific Research in the Public Interest (nyhyzx07-048), and a project of International Scientific and Technical Cooperation (No. 2009DFA31980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; [Anonymous], 2000, P INT S WHEAT IMPROV; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Chen CJ, 2009, PHYTOPATHOLOGY, V99, P1403, DOI 10.1094/PHYTO-99-12-1403; CWSCG, 1984, J SHANGHAI NORMAL CO, P69; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Gale LR, 2011, PHYTOPATHOLOGY, V101, P124, DOI 10.1094/PHYTO-03-10-0067; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Guo XW, 2008, PLANT DIS, V92, P756, DOI 10.1094/PDIS-92-5-0756; Ji L, 2007, J PHYTOPATHOL, V155, P505, DOI 10.1111/j.1439-0434.2007.01270.x; Ji LJ, 2007, POPULATION GENETIC D, P8; Jurgenson JE, 2002, GENETICS, V160, P1451; Karugia GW, 2009, PLANT DIS, V93, P170, DOI 10.1094/PDIS-93-2-0170; Karugia GW, 2009, J GEN PLANT PATHOL, V75, P110, DOI 10.1007/s10327-009-0153-5; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Lee J, 2009, APPL ENVIRON MICROB, V75, P3289, DOI 10.1128/AEM.02287-08; Li Wei, 2010, Mycosystema, V29, P51; Liddell CM, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P35; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; MILLER JD, 1991, MYCOLOGIA, V83, P121, DOI 10.2307/3759927; Monds RD, 2005, MYCOL RES, V109, P410, DOI 10.1017/S0953756204002217; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pritchard JK, 2000, GENETICS, V155, P945; Puri KD, 2010, PHYTOPATHOLOGY, V100, P1007, DOI 10.1094/PHYTO-12-09-0332; Qu B, 2008, PLANT PATHOL, V57, P15, DOI 10.1111/j.1365-3059.2007.01711.x; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Suga H, 2008, PHYTOPATHOLOGY, V98, P159, DOI 10.1094/PHYTO-98-2-0159; Suga H, 2004, MOL ECOL NOTES, V4, P468, DOI 10.1111/j.1471-8286.2004.00703.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; UENO Y, 1973, J BIOCHEM-TOKYO, V74, P285; Vogelgsang S, 2009, EUR J PLANT PATHOL, V123, P477, DOI 10.1007/s10658-008-9379-x; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Yang L, 2008, PHYTOPATHOLOGY, V98, P719, DOI 10.1094/PHYTO-98-6-0719; Yli-Mattila T, 2009, MYCOLOGIA, V101, P841, DOI 10.3852/08-217; Zhang H, 2010, PHYTOPATHOLOGY, V100, P328, DOI 10.1094/PHYTO-100-4-0328; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008; Zhang Z, 2010, EUR J PLANT PATHOL, V127, P239, DOI 10.1007/s10658-010-9588-y; Zhuang QS., 2003, CHINESE WHEAT IMPROV	49	116	140	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31722	10.1371/journal.pone.0031722	http://dx.doi.org/10.1371/journal.pone.0031722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363714	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500081
J	Zhang, YH; Li, CM; Sun, XR; Kuang, XL; Ruan, XC				Zhang, Yuehong; Li, Chunmei; Sun, Xuerong; Kuang, Xielan; Ruan, Xiangcai			High Glucose Decreases Expression and Activity of p-glycoprotein in Cultured Human Retinal Pigment Epithelium Possibly through iNOS Induction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PREGNANE-X-RECEPTOR; BLOOD-BRAIN-BARRIER; INDUCED DIABETIC-RATS; MULTIDRUG-RESISTANCE; TRANSPORT FUNCTION; ABC-TRANSPORTERS; GENE-EXPRESSION; TIGHT JUNCTIONS; CELL-LINES	Inhibition of p-glycoprotein under hyperglycemic conditions has been reported in various barrier tissues including blood-brain barrier, intestine, and kidney, and has been linked to significant clinical complications. However, whether this is also true for the outer blood-retinal barrier constituted by retinal pigment epithelium, or has a role in pathogenesis of diabetic retinopathy is not yet clear. In this study, using cultured human retinal pigment epithelium cell line D407, we found that high glucose exposure induced a significant decrease in p-glycoprotein expression both at mRNA and at protein levels, accompanied by an attenuated p-glycoprotein activity determined by intracellular rhodamine 123 retention. In marked contrast, the expressions of both mRNA and protein levels of inducible nitrate oxide synthase (iNOS) increased, and were accompanied by increased extracellular nitrate/nitrite production by Griess reaction. In addition, mRNA levels of nuclear receptors revealed a decreased expression of pregnane X receptor after the exposure of high glucose. However, the subsequent alterations in production of nitrate/nitrite, functional expression of p-glycoprotein, and mRNA levels of pregnane X receptor were partially blocked when pretreated with S, S'-1,3-phenylene-bis(1,2-ethanediyl)-bis-isothiourea center dot 2HBr (PBITU), a selective iNOS inhibitor. Moreover, the effects of PBITU were antagonized with the addition of L-arginine, a substrate for NO synthesis. Our in vitro results suggest for the first time that iNOS induction plays a novel role in decreased p-glycoprotein expression and transport function at the human outer blood-retinal barrier under hyperglycemic conditions and further support the concept of inhibiting iNOS pathway as a therapeutic strategy for diabetic retinopathy.	[Zhang, Yuehong; Ruan, Xiangcai] Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuehong; Ruan, Xiangcai] Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Li, Chunmei; Sun, Xuerong; Kuang, Xielan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University	Zhang, YH (corresponding author), Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	xc_ruan@hotmail.com	Ruan, Xiangcai/L-9904-2016	Ruan, Xiangcai/0000-0001-6112-7994; Zhang, Yuehong/0000-0002-1990-9439	Natural Science Foundation of Guangdong Province [S2011010000587]; Natural Science Foundation of China [30700786]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of Guangdong Province (grant S2011010000587) and Natural Science Foundation of China (grant 30700786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2010, INVEST OPHTH VIS SCI, V52, P1156; Bauer B, 2005, EXP BIOL MED, V230, P118; Bauer B, 2004, MOL PHARMACOL, V66, P413; Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Constable PA, 2006, EXP EYE RES, V83, P24, DOI 10.1016/j.exer.2005.10.029; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; do Carmo A, 1998, GEN PHARMACOL, V30, P319, DOI 10.1016/S0306-3623(97)00363-7; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Dussault I, 2002, CRIT REV EUKAR GENE, V12, P53, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i1.30; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; FORD JM, 1990, CANCER RES, V50, P1748; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; GOUREAU O, 1994, BIOCHEM BIOPH RES CO, V198, P120, DOI 10.1006/bbrc.1994.1017; GOUREAU O, 1994, J NEUROCHEM, V63, P310; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartley DP, 2004, MOL PHARMACOL, V65, P1159, DOI 10.1124/mol.65.5.1159; Hartmann G, 2005, DRUG METAB DISPOS, V33, P820, DOI 10.1124/dmd.104.002568; Heemskerk S, 2007, PFLUG ARCH EUR J PHY, V454, P321, DOI 10.1007/s00424-007-0210-x; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Juan CC, 2008, OBESITY, V16, P1219, DOI 10.1038/oby.2008.200; Kalitsky-Szirtes J, 2004, DRUG METAB DISPOS, V32, P20, DOI 10.1124/dmd.32.1.20; Kennedy BG, 2002, MOL VIS, V8, P422; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kim YK, 2007, BIOCHEM BIOPH RES CO, V355, P136, DOI 10.1016/j.bbrc.2007.01.117; Kowluru RA, 2000, CURR EYE RES, V21, P814, DOI 10.1076/ceyr.21.4.814.5545; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; LEE JS, 1994, MOL PHARMACOL, V46, P627; Liu Y, 2008, NEUROSCIENCE, V153, P796, DOI 10.1016/j.neuroscience.2008.03.019; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Maeng HJ, 2007, DRUG METAB DISPOS, V35, P1996, DOI 10.1124/dmd.107.015800; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; Mitchell BF, 2005, AM J OBSTET GYNECOL, V192, P1304, DOI 10.1016/j.ajog.2005.01.040; MORIYAMA M, 1991, TOHOKU J EXP MED, V164, P191, DOI 10.1620/tjem.164.191; Naggar H, 2002, INVEST OPHTH VIS SCI, V43, P556; Nawa A, 2010, LIFE SCI, V86, P402, DOI 10.1016/j.lfs.2010.01.009; Nowicki Michael T, 2008, Drug Metab Lett, V2, P11; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; SPARROW JR, 1994, EXP EYE RES, V59, P129, DOI 10.1006/exer.1994.1091; Toell A, 2002, J CELL BIOCHEM, V85, P72, DOI 10.1002/jcb.10104; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; Uchiyama T, 2005, FEBS LETT, V579, P2499, DOI 10.1016/j.febslet.2005.03.065; van Waarde WM, 2002, GASTROENTEROLOGY, V122, P1842, DOI 10.1053/gast.2002.33582; Villarroel M, 2009, EXP EYE RES, V89, P913, DOI 10.1016/j.exer.2009.07.017; Wang JH, 2005, J NUCL MED, V46, P1537; Woo HB, 2005, BIOORG MED CHEM LETT, V15, P3782, DOI 10.1016/j.bmcl.2005.05.064; Wood JPM, 2004, INVEST OPHTH VIS SCI, V45, P1272, DOI 10.1167/iovs.03-0693; Wu KC, 2009, LIFE SCI, V85, P775, DOI 10.1016/j.lfs.2009.10.014; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	53	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31631	10.1371/journal.pone.0031631	http://dx.doi.org/10.1371/journal.pone.0031631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363694	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600150
J	Psallidas, I; Stathopoulos, GT; Maniatis, NA; Magkouta, S; Moschos, C; Karabela, SP; Kollintza, A; Simoes, DCM; Kardara, M; Vassiliou, S; Papiris, SA; Roussos, C; Kalomenidis, I				Psallidas, I.; Stathopoulos, G. T.; Maniatis, N. A.; Magkouta, S.; Moschos, C.; Karabela, S. P.; Kollintza, A.; Simoes, D. C. M.; Kardara, M.; Vassiliou, S.; Papiris, S. A.; Roussos, C.; Kalomenidis, I.			Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion	ONCOGENE			English	Article						osteopontin; pleural effusion; cancer; inflammation; angiogenesis	TUMOR PROGRESSION; OSTEOPONTIN ISOFORMS; LUNG-CANCER; IN-VIVO; MACROPHAGES; METASTASIS; INFLAMMATION; INVASION; GROWTH; CELLS	Secreted phosphoprotein-1 (SPP1) promotes cancer cell survival and regulates tumor-associated angiogenesis and inflammation, both central to the pathogenesis of malignant pleural effusion (MPE). Here, we examined the impact of tumor- and host-derived SPP1 in MPE formation and explored the mechanisms by which the cytokine exerts its effects. We used a syngeneic murine model of lung adenocarcinoma-induced MPE. To dissect the effects of tumor- versus host-derived SPP1, we intrapleurally injected wild-type and SPP1-knockout C57/BL/6 mice with either wild-type or SPP1-deficient syngeneic lung cancer cells. We demonstrated that both tumor- and host-derived SPP1 promoted pleural fluid accumulation and tumor dissemination in a synergistic manner (P<0.001). SPP1 of host origin elicited macrophage recruitment into the cancer-affected pleural cavity and boosted tumor angiogenesis, whereas tumor-derived SPP1 curtailed cancer cell apoptosis in vivo. Moreover, the cytokine directly promoted vascular hyper-permeability independently of vascular endothelial growth factor. In addition, SPP1 of tumor and host origin differentially affected the expression of proinflammatory and angiogenic mediators in the tumor microenvironment. These results suggest that SPP1 of tumor and host origin impact distinct aspects of MPE pathobiology to synergistically promote pleural fluid formation and pleural tumor progression. SPP1 may present an attractive target of therapeutic interventions for patients with MPE. Oncogene (2013) 32, 528-535; doi:10.1038/onc.2012.57; published online 27 February 2012	[Psallidas, I.; Stathopoulos, G. T.; Maniatis, N. A.; Magkouta, S.; Moschos, C.; Karabela, S. P.; Kollintza, A.; Simoes, D. C. M.; Kardara, M.; Papiris, S. A.; Roussos, C.; Kalomenidis, I.] Evangelismos Med Ctr, Athens Med Sch, Dept Crit Care & Pulm Serv 1, Marianthi Simou Lab, Athens, Greece; [Psallidas, I.; Moschos, C.; Papiris, S. A.; Kalomenidis, I.] Attikon Hosp, Athens Med Sch, Dept Pulm Med 2, Haidari, Greece; [Stathopoulos, G. T.] Univ Patras, Sch Med, Dept Physiol, Rion, Greece; [Vassiliou, S.] Euaggelismos Hosp, Dept Hematol & Lymphomas, Athens, Greece	Evangelismos Hospital; National & Kapodistrian University of Athens; University Hospital Attikon; University of Patras	Psallidas, I (corresponding author), Athens Med Sch, Dept Crit Care & Pulm Serv 1, Marianthi Simou Lab, 3 Ploutarhou St, Athens 10675, Greece.	jpsallidas@med.uoa.gr	Stathopoulos, Georgios/AAE-6884-2020; Kalomenidis, Ioannis/AAD-7521-2019; PAPIRIS, SPYROS/AAD-1825-2020; Stathopoulos, Georgios/D-6576-2013	Stathopoulos, Georgios/0000-0002-9215-6461; Psallidas, Ioannis/0000-0001-7284-0111; Simoes, Davina Camargo Madeira/0000-0002-7262-1784	'Thorax' Foundation (Athens, Greece); GlaxoSmithKline [12 000]	'Thorax' Foundation (Athens, Greece); GlaxoSmithKline(GlaxoSmithKline)	We thank Dr A Marantidou and Z Kollia for professional veterinarian and animal care assistance, respectively. We also thank L Liaw (Maine Medical Center Research Institute) for permission to use the Spp1 +1+ and Spp1-/- mice. This work was supported by the 'Thorax' Foundation (Athens, Greece) and by a research grant by GlaxoSmithKline (funding 12 000 to IP). GlaxoSmithKline had no involvement in study design, collection, analysis and interpretation of data, writing of the report and in the decision to submit the report for publication. IP and IK had full control of all of the data in this study and take complete responsibility for the integrity of the data and the accuracy of the data analysis.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Bourassa B, 2004, CELL IMMUNOL, V227, P1, DOI 10.1016/j.cellimm.2004.01.001; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Burgers JA, 2008, EUR RESPIR J, V32, P1321, DOI 10.1183/09031936.00165607; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Crawford HC, 1998, CANCER RES, V58, P5206; Cui R, 2009, LUNG CANCER, V63, P368, DOI 10.1016/j.lungcan.2008.06.020; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Du XL, 2009, GYNECOL ONCOL, V115, P371, DOI 10.1016/j.ygyno.2009.08.029; Ivanov SV, 2009, BIOCHEM BIOPH RES CO, V382, P514, DOI 10.1016/j.bbrc.2009.03.042; Kalomenidis I, 2011, RESPIROLOGY, V16, P1020, DOI 10.1111/j.1440-1843.2011.02023.x; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Liaw L, 1998, J CLIN INVEST, V101, P1468; Mason CK, 2008, MOL CANCER THER, V7, P548, DOI 10.1158/1535-7163.MCT-07-2251; Moschos C, 2009, RESPIROLOGY, V14, P716, DOI 10.1111/j.1440-1843.2009.01536.x; Moschos C, 2009, NEOPLASIA, V11, P298, DOI 10.1593/neo.81480; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Psallidas I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-56; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rittling SR, 2002, J BIOL CHEM, V277, P9175, DOI 10.1074/jbc.M109028200; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Sica A., 2010, Experimental Oncology, V32, P153; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Stathopoulos GT, 2008, AM J RESP CRIT CARE, V178, P50, DOI 10.1164/rccm.200710-1513OC; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2010, AM J RESP CRIT CARE, V182, P1273, DOI 10.1164/rccm.201001-0001OC; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Van Meter MEM, 2011, J GEN INTERN MED, V26, P70, DOI 10.1007/s11606-010-1472-0; Wai PY, 2006, SURGERY, V140, P132, DOI 10.1016/j.surg.2006.02.005; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Yamamoto Y, 1998, INFECT IMMUN, V56, P370; Yano S, 2000, AM J PATHOL, V157, P1893, DOI 10.1016/S0002-9440(10)64828-6; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312	42	37	37	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					528	535		10.1038/onc.2012.57	http://dx.doi.org/10.1038/onc.2012.57			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22370646				2022-12-25	WOS:000315551300013
J	Li, JW; Xia, LJ; Su, YH; Liu, HC; Xia, XQ; Lu, QX; Yang, CJ; Reheman, K				Li, Jiang-Wei; Xia, Lijie; Su, Youhong; Liu, Hongchun; Xia, Xueqing; Lu, Qinxia; Yang, Chunjin; Reheman, Kalbinur			Molecular Imprint of Enzyme Active Site by Camel Nanobodies RAPID AND EFFICIENT APPROACH TO PRODUCE ABZYMES WITH ALLIINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN ANTIBODY FRAGMENTS; HEAVY-CHAIN ANTIBODIES; FUNCTIONAL INTERNAL IMAGES; ANTIIDIOTYPIC ANTIBODIES; CATALYTIC ANTIBODIES; SPECTROPHOTOMETRIC ASSAY; CRYSTAL-STRUCTURE; ALLICIN; RECOGNITION; INHIBITORS	Screening of inhibitory Ab1 antibodies is a critical step for producing catalytic antibodies in the anti-idiotypic approach. However, the incompatible surface of the active site of the enzyme and the antigen-binding site of heterotetrameric conventional antibodies become the limiting step. Because camelid-derived nanobodies possess the potential to preferentially bind to the active site of enzymes due to their small size and long CDR3, we have developed a novel approach to produce antibodies with alliinase activities by exploiting the molecular mimicry of camel nanobodies. By screening the camelid-derived variable region of the heavy chain cDNA phage display library with alliinase, we obtained an inhibitory nanobody VHHA4 that recognizes the active site. Further screening with VHHA4 from the same variable domain of the heavy chain of a heavy-chain antibody library led to a higher incidence of anti-idiotypic Ab2 abzymes with alliinase activities. One of the abzymes, VHHC10, showed the highest activity that can be inhibited by Ab1VHHA4 and alliinase competitive inhibitor penicillamine and significantly suppressed the B16 tumor cell growth in the presence of alliin in vitro. The results highlight the feasibility of producing abzymes via anti-idiotypic nanobody approach.	[Li, Jiang-Wei] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Dept Biotechnol, Urumqi 830046, Peoples R China	Xinjiang University	Li, JW (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Dept Biotechnol, 14 Shengli Rd, Urumqi 830046, Peoples R China.	jwli67@sina.com			National Natural Science Foundation of China [31060132]; Science and Technology Support Project of Xinjiang, China [201091251]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Project of Xinjiang, China	This work was supported by National Natural Science Foundation of China Grant 31060132 and Science and Technology Support Project of Xinjiang, China, Grant 201091251 (to J. W. L.).	Avalle B, 1998, FASEB J, V12, P1055, DOI 10.1096/fasebj.12.11.1055; Avalle B, 1996, ANN NY ACAD SCI, V799, P172, DOI 10.1111/j.1749-6632.1996.tb33195.x; Avalle B, 2000, CHEM IMMUNOL, V77, P80, DOI 10.1159/000058798; Avalle S, 1998, ANN NY ACAD SCI, V864, P118, DOI 10.1111/j.1749-6632.1998.tb10294.x; Ban N, 1996, J MOL BIOL, V255, P617, DOI 10.1006/jmbi.1996.0051; Benedetti F, 2004, CHEMBIOCHEM, V5, P129, DOI 10.1002/cbic.200300738; BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0; Chong LT, 2003, J COMPUT CHEM, V24, P1371, DOI 10.1002/jcc.10293; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; FRIBOULET A, 1994, APPL BIOCHEM BIOTECH, V47, P229, DOI 10.1007/BF02787937; FRIBOULET A, 1995, ANN NY ACAD SCI, V750, P265, DOI 10.1111/j.1749-6632.1995.tb19963.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hu R, 1998, J BIOTECHNOL, V61, P109, DOI 10.1016/S0168-1656(98)00009-1; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Johnson G, 2002, J IMMUNOL METHODS, V269, P13, DOI 10.1016/S0022-1759(02)00222-3; Johnson G, 2000, MOL IMMUNOL, V37, P707, DOI 10.1016/S0161-5890(00)00104-8; JORON L, 1992, ANN NY ACAD SCI, V672, P216; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Kuettner EB, 2002, ARCH BIOCHEM BIOPHYS, V402, P192, DOI 10.1016/S0003-9861(02)00088-7; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lu Qing-xia, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P55; Manabe T, 1998, EUR J BIOCHEM, V257, P21, DOI 10.1046/j.1432-1327.1998.2570021.x; Miron T, 2003, MOL CANCER THER, V2, P1295; Miron T, 2002, ANAL BIOCHEM, V307, P76, DOI 10.1016/S0003-2697(02)00010-6; Miron T, 1998, ANAL BIOCHEM, V265, P317, DOI 10.1006/abio.1998.2924; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nguyen VK, 2001, ADV IMMUNOL, V79, P261, DOI 10.1016/S0065-2776(01)79006-2; Oommen S, 2004, EUR J PHARMACOL, V485, P97, DOI 10.1016/j.ejphar.2003.11.059; Pillet D, 2002, J IMMUNOL METHODS, V269, P5, DOI 10.1016/S0022-1759(02)00221-1; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Wolfson W, 2006, CHEM BIOL, V13, P1243, DOI 10.1016/j.chembiol.2006.12.003	45	19	26	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13713	13721		10.1074/jbc.M111.336370	http://dx.doi.org/10.1074/jbc.M111.336370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22374998	Green Published, hybrid			2022-12-25	WOS:000303996300027
J	Miller, DP; Bell, JK; McDowell, JV; Conrad, DH; Burgner, JW; Heroux, A; Marconi, RT				Miller, Daniel P.; Bell, Jessica K.; McDowell, John V.; Conrad, Daniel H.; Burgner, John W.; Heroux, Annie; Marconi, Richard T.			Structure of Factor H-binding Protein B (FhbB) of the Periopathogen, Treponema denticola INSIGHTS INTO PROGRESSION OF PERIODONTAL DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; C-REACTIVE PROTEIN; STRUCTURE VALIDATION; BACTERIAL DIVERSITY; REGULATORY PROTEIN; SURFACE PROTEIN; LYME-DISEASE; PATHOGEN; IDENTIFICATION; MOLPROBITY	Periodontitis is the most common disease of microbial etiology in humans. Periopathogen survival is dependent upon evasion of complement-mediated destruction. Treponema denticola, an important contributor to periodontitis, evades killing by the alternative complement cascade by binding factor H (FH) to its surface. Bound FH is rapidly cleaved by the T. denticola protease, dentilisin. In this report, the structure of the T. denticola FH-binding protein, FhbB, was solved to 1.7 angstrom resolution. FhbB possesses a unique fold that imparts high thermostability. The kinetics of the FH/FhbB interaction were assessed using surface plasmon resonance. A K-D value in the micromolar range (low affinity) was demonstrated, and rapid off kinetics were observed. Site-directed mutagenesis and sucrose octasulfate competition assays collectively indicate that the negatively charged face of FhbB binds within FH complement control protein module 7. This study provides significant new insight into the molecular basis of FH/FhbB interaction and advances our understanding of the role that T. denticola plays in the development and progression of periodontal disease.	[Miller, Daniel P.; Marconi, Richard T.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Coll Virginia, Richmond, VA 23298 USA; [Marconi, Richard T.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia, Richmond, VA 23298 USA; [Bell, Jessica K.; Burgner, John W.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia, Richmond, VA 23298 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; United States Department of Energy (DOE); Brookhaven National Laboratory	Marconi, RT (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Coll Virginia, POB 980678, Richmond, VA 23298 USA.	rmarconi@vcu.edu	Bell, Jessica/I-3893-2013	Bell, Jessica/0000-0003-1455-3274; Miller, Daniel/0000-0002-1332-5870; McDowell, John/0000-0003-1635-5124; Marconi, Richard/0000-0002-6035-7306	National Institutes of Health from the NIAID-NIDCR [DE017401, 5K22CA122828-03, P30CA160589]; American Chemical Society [IRG9922504]; Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy; National Institutes of Health NCRR [P41RR012408]; NATIONAL CANCER INSTITUTE [K22CA122828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017401] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017401 from the NIAID-NIDCR (to R. T. M.), Grant 5K22CA122828-03, and Grant P30CA160589 (to SPR-Flow Cytometry Core, Virginia Commonwealth University). This work was also supported by American Chemical Society Grant IRG9922504 (to J. K. B.).; Data for this study were measured at beamline X25 of the National Synchrotron Light Source, supported principally by the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy and by National Institutes of Health NCRR Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOACKLE RJ, 1991, CRIT REV ORAL BIOL M, V2, P355, DOI 10.1177/10454411910020030401; BOACKLE RJ, 1978, J DENT RES, V57, P103, DOI 10.1177/00220345780570010101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dewhirst FE, 2000, ORAL MICROBIOL IMMUN, V15, P196, DOI 10.1034/j.1399-302x.2000.150308.x; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Jarva H, 1999, J IMMUNOL, V163, P3957; Kang YH, 2012, IMMUNOBIOLOGY, V217, P455, DOI 10.1016/j.imbio.2011.10.008; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell JV, 2011, MOL ORAL MICROBIOL, V26, P140, DOI 10.1111/j.2041-1014.2010.00598.x; McDowell JV, 2007, INFECT IMMUN, V75, P1050, DOI 10.1128/IAI.01458-06; McDowell JV, 2009, INFECT IMMUN, V77, P1417, DOI 10.1128/IAI.01544-08; McDowell JV, 2005, INFECT IMMUN, V73, P7126, DOI 10.1128/IAI.73.11.7126-7132.2005; McDowell JV, 2005, J BACTERIOL, V187, P1317, DOI 10.1128/JB.187.4.1317-1323.2005; McDowell JV, 2004, J IMMUNOL, V173, P7471, DOI 10.4049/jimmunol.173.12.7471; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; Miller DP, 2011, ACTA CRYSTALLOGR F, V67, P678, DOI 10.1107/S1744309111011298; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; RUDDY S, 1971, J IMMUNOL, V107, P742; SCHENKEIN H A, 1991, Critical Reviews in Oral Biology and Medicine, V2, P65; SCHENKEIN HA, 1977, J PERIODONTOL, V48, P772, DOI 10.1902/jop.1977.48.12.772; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; UITTO VJ, 1988, INFECT IMMUN, V56, P2717, DOI 10.1128/IAI.56.10.2717-2722.1988; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	51	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12715	12722		10.1074/jbc.M112.339721	http://dx.doi.org/10.1074/jbc.M112.339721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371503	Green Published, hybrid			2022-12-25	WOS:000302903700011
J	Zhou, JF; Fang, WH; Yang, XL; Zhou, S; Hu, LL; Li, XC; Qi, XY; Su, H; Xie, LY				Zhou, Junfang; Fang, Wenhong; Yang, Xianle; Zhou, Shuai; Hu, Linlin; Li, Xincang; Qi, Xinyong; Su, Hang; Xie, Layue			A Nonluminescent and Highly Virulent Vibrio harveyi Strain Is Associated with "Bacterial White Tail Disease'' of Litopenaeus vannamei Shrimp	PLOS ONE			English	Article							PENAEUS-MONODON LARVAE; BASS LATES-CALCARIFER; LUMINESCENT VIBRIOS; GENE-EXPRESSION; RT-PCR; PHILIPPINES; HATCHERY; INDIA; WATER; SEA	Recurrent outbreaks of a disease in pond-cultured juvenile and subadult Litopenaeus vannamei shrimp in several districts in China remain an important problem in recent years. The disease was characterized by "white tail'' and generally accompanied by mass mortalities. Based on data from the microscopical analyses, PCR detection and 16S rRNA sequencing, a new Vibrio harveyi strain (designated as strain HLB0905) was identified as the etiologic pathogen. The bacterial isolation and challenge tests demonstrated that the HLB0905 strain was nonluminescent but highly virulent. It could cause mass mortality in affected shrimp during a short time period with a low dose of infection. Meanwhile, the histopathological and electron microscopical analysis both showed that the HLB0905 strain could cause severe fiber cell damages and striated muscle necrosis by accumulating in the tail muscle of L. vannamei shrimp, which led the affected shrimp to exhibit white or opaque lesions in the tail. The typical sign was closely similar to that caused by infectious myonecrosis (IMN), white tail disease (WTD) or penaeid white tail disease (PWTD). To differentiate from such diseases as with a sign of "white tail'' but of non-bacterial origin, the present disease was named as "bacterial white tail disease (BWTD)''. Present study revealed that, just like IMN and WTD, BWTD could also cause mass mortalities in pond-cultured shrimp. These results suggested that some bacterial strains are changing themselves from secondary to primary pathogens by enhancing their virulence in current shrimp aquaculture system.	[Zhou, Junfang; Fang, Wenhong; Zhou, Shuai; Hu, Linlin; Li, Xincang; Su, Hang; Xie, Layue] Chinese Acad Fisheries Sci, E China Sea Fisheries Res Inst, Key Lab Marine & Estuarine Fisheries Resources &, Shanghai, Peoples R China; [Yang, Xianle] Aquat Pathogen Collect Ctr Minist, Shanghai, Peoples R China; [Qi, Xinyong] Shanghai Anim Dis Control Ctr, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Zhou, JF (corresponding author), Chinese Acad Fisheries Sci, E China Sea Fisheries Res Inst, Key Lab Marine & Estuarine Fisheries Resources &, Shanghai, Peoples R China.	junfangzhou@yahoo.cn; whfang06@yahoo.com.cn	Yang, Xian/GVU-9087-2022		National Non-profit Institutes (East China Sea Fisheries Research Institute) [2009 T06, 2011 T03, 2007 M25]; Provincial Natural Science Foundation of Jiangsu [BK2010269]; Three-project for Aquaculture in Jiangsu Province [PJ2010-51]; China Postdoctoral Science Foundation [20080440654]	National Non-profit Institutes (East China Sea Fisheries Research Institute); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Three-project for Aquaculture in Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Special Research Fund for the National Non-profit Institutes (East China Sea Fisheries Research Institute, grant# 2009 T06, 2011 T03 and 2007 M25), the Provincial Natural Science Foundation of Jiangsu (grant# BK2010269), the Three-project for Aquaculture in Jiangsu Province (grant# PJ2010-51) and China Postdoctoral Science Foundation (grant# 20080440654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TJ, 2004, AQUACULTURE, V232, P81, DOI 10.1016/S0044-8486(03)00485-X; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Alavandi SV, 2006, LETT APPL MICROBIOL, V43, P566, DOI 10.1111/j.1472-765X.2006.01986.x; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Bell TA, 1988, HDB NORMAL PENAEID S; Chitov T, 2009, MAEJO INT J SCI TECH, V3, P88; Chrisolite B, 2008, AQUACULTURE, V275, P13, DOI 10.1016/j.aquaculture.2007.12.016; de la Pena LD, 2001, FISH PATHOL, V36, P133, DOI 10.3147/jsfp.36.133; Flegel T, 2005, DIS ASIAN AQUACULTUR, P329; Haldar S, 2010, MICROBIOL RES, V165, P639, DOI 10.1016/j.micres.2009.12.001; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; LAVILLAPITOGO CR, 1990, AQUACULTURE, V91, P1, DOI 10.1016/0044-8486(90)90173-K; Lee KK, 1997, REP FISH DIS RES, V18, P33; Lightner D.V., 2004, GLOB AQUACULT ADVOCA, V7, P85; Lightner DV, 1998, AQUACULTURE, V164, P201, DOI 10.1016/S0044-8486(98)00187-2; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Liu PC, 1999, LETT APPL MICROBIOL, V28, P428, DOI 10.1046/j.1365-2672.1999.00555.x; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Otta S. K., 1999, Journal of Aquaculture in the Tropics, V14, P309; Poulos BT, 2006, DIS AQUAT ORGAN, V73, P69, DOI 10.3354/dao073069; Qian D, 2003, J FISH DIS, V26, P521, DOI 10.1046/j.1365-2761.2003.00486.x; Ramasamy P, 2000, J FISH DIS, V23, P77, DOI 10.1046/j.1365-2761.2000.00208.x; Ransangan J, 2009, J AQUAT ANIM HEALTH, V21, P150, DOI 10.1577/H09-002.1; Ruangpan L, 1999, DIS AQUAT ORGAN, V35, P195, DOI 10.3354/dao035195; Ruwandeepika HAD, 2011, J APPL MICROBIOL, V110, P399, DOI 10.1111/j.1365-2672.2010.04892.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selvin J, 2004, AQUACULTURE, V236, P277, DOI 10.1016/j.aquaculture.2004.01.021; Shakibazadeh S, 2009, ANN MICROBIOL, V59, P425, DOI 10.1007/BF03175126; Shinoda S, 1999, J NAT TOXINS, V8, P259; Sung HH, 2001, AQUACULTURE, V192, P101, DOI 10.1016/S0044-8486(00)00458-0; Tang KFJ, 2007, DIS AQUAT ORGAN, V75, P183, DOI 10.3354/dao075183; Tendencia EA, 2002, AQUAC RES, V33, P455, DOI 10.1046/j.1365-2109.2002.00688.x; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Uma A., 2008, Tamilnadu Journal of Veterinary and Animal Sciences, V4, P188; Vandenberghe J, 1999, APPL ENVIRON MICROB, V65, P2592; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhong YB, 2006, INFECT IMMUN, V74, P6001, DOI 10.1128/IAI.00512-06; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	42	81	96	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29961	10.1371/journal.pone.0029961	http://dx.doi.org/10.1371/journal.pone.0029961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383954	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500006
J	Ching, KH; Burbelo, PD; Tipton, C; Wei, CW; Petri, M; Sanz, I; Iadarola, MJ				Ching, Kathryn H.; Burbelo, Peter D.; Tipton, Christopher; Wei, Chungwen; Petri, Michelle; Sanz, Ignacio; Iadarola, Michael J.			Two Major Autoantibody Clusters in Systemic Lupus Erythematosus	PLOS ONE			English	Article							ALPHA MONOCLONAL-ANTIBODY; 4-ANTIGEN MIXTURE; SJOGRENS-SYNDROME; PHASE-I; INTERFERON; INFECTION; DISEASE; ASSOCIATION; PROFILE; COHORT	Systemic lupus erythematosus is a chronic autoimmune disease of complex clinical presentation and etiology and is likely influenced by numerous genetic and environmental factors. While a large number of susceptibility genes have been identified, the production of antibodies against a distinct subset of nuclear proteins remains a primary distinguishing characteristic in disease diagnosis. However, the utility of autoantibody biomarkers for disease sub-classification and grouping remains elusive, in part, because of the difficulty in large scale profiling using a uniform, quantitative platform. In the present study serological profiles of several known SLE antigens, including Sm-D3, RNP-A, RNP-70k, Ro52, Ro60, and La, as well as other cytokine and neuronal antigens were obtained using the luciferase immunoprecipitation systems (LIPS) approach. The resulting autoantibody profiles revealed that 88% of a pilot cohort and 98% of a second independent cohort segregated into one of two distinct clusters defined by autoantibodies against Sm/anti-RNP or Ro/La autoantigens, proteins often involved in RNA binding activities. The Sm/RNP cluster was associated with a higher prevalence of serositis in comparison to the Ro/La cluster (P = 0.0022). However, from the available clinical information, no other clinical characteristics were associated with either cluster. In contrast, evaluation of autoantibodies on an individual basis revealed an association between anti-Sm (P = 0.006), RNP-A (P = 0.018) and RNP-70k (P = 0.010) autoantibodies and mucocutaneous symptoms and between anti-RNP-70k and musculoskeletal manifestations (P = 0.059). Serologically active, but clinically quiescent disease also had a higher prevalence of anti-IFN-alpha autoantibodies. Based on our findings that most SLE patients belong to either a Sm/RNP or Ro/La autoantigen cluster, these results suggest the possibility that alterations in RNA-RNA-binding protein interactions may play a critical role in triggering and/or the pathogenesis of SLE.	[Ching, Kathryn H.; Burbelo, Peter D.; Iadarola, Michael J.] Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, Bethesda, MD USA; [Tipton, Christopher; Wei, Chungwen; Sanz, Ignacio] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Rochester; Johns Hopkins University	Ching, KH (corresponding author), USDA, Albany, CA USA.	ching.kathryn@gmail.com			Division of Intramural Research; National Institute of Dental and Craniofacial Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR043727, U19AI56390, R37 AI049660-06A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049660, U19AI056390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090034] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research. This study was also supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR043727 (MP), U19AI56390 (IS) and R37 AI049660-06A1 (IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Burbelo PD, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-22; Burbelo PD, 2011, EXPERT REV PROTEOMIC, V8, P309, DOI [10.1586/EPR.11.23, 10.1586/epr.11.23]; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo PD, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-97; Burbelo PD, 2010, AM J TRANSL RES, V2, P145; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2009, AUTOIMMUNITY, V42, P515, DOI 10.1080/08916930902911738; Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438; Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P621, DOI 10.1128/CVI.00474-08; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hoffman IEA, 2004, ANN RHEUM DIS, V63, P1155, DOI 10.1136/ard.2003.013417; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; Jurencak R, 2009, J RHEUMATOL, V36, P416, DOI 10.3899/jrheum.080588; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Malik S, 2007, LUPUS, V16, P863, DOI 10.1177/0961203307083365; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Merrill JT, 2011, ANN RHEUM DIS, V70, P1905, DOI 10.1136/ard.2010.144485; Morimoto AM, 2011, ARTHRITIS RHEUM; Nikpour M, 2008, ANN RHEUM DIS, V67, P1069, DOI 10.1136/ard.2007.074765; Powell JJ, 1999, ENVIRON HEALTH PERSP, V107, P667; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Slavikova M, 2003, J INTERF CYTOK RES, V23, P143, DOI 10.1089/107999003321532475; Somers E, 2002, J RHEUMATOL, V29, P2531; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tang XH, 2010, MEDICINE, V89, P62, DOI 10.1097/MD.0b013e3181cb449c; To CH, 2005, ARTHRITIS RHEUM-US, V52, P4003, DOI 10.1002/art.21414; VONWUSSOW P, 1988, RHEUMATOL INT, V8, P225, DOI 10.1007/BF00269199; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557	37	74	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32001	10.1371/journal.pone.0032001	http://dx.doi.org/10.1371/journal.pone.0032001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363785	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700133
J	Justiniano, SE; Mathew, A; Mitra, S; Manivannan, SN; Simcox, A				Justiniano, Steven E.; Mathew, Anne; Mitra, Sayan; Manivannan, Sathiya N.; Simcox, Amanda			Loss of the Tumor Suppressor Pten Promotes Proliferation of Drosophila melanogaster Cells In Vitro and Gives Rise to Continuous Cell Lines	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE; GROWTH; CANCER; APOPTOSIS; RECEPTOR; KINASE; SIZE; POLARITY; ENCODES	In vivo analysis of Drosophila melanogaster has enhanced our understanding of many biological processes, notably the mechanisms of heredity and development. While in vivo analysis of mutants has been a strength of the field, analyzing fly cells in culture is valuable for cell biological, biochemical and whole genome approaches in which large numbers of homogeneous cells are required. An efficient genetic method to derive Drosophila cell lines using expression of an oncogenic form of Ras (Ras(V12)) has been developed. Mutations in tumor suppressors, which are known to cause cell hyperproliferation in vivo, could provide another method for generating Drosophila cell lines. Here we screened Drosophila tumor suppressor mutations to test if they promoted cell proliferation in vitro. We generated primary cultures and determined when patches of proliferating cells first emerged. These cells emerged on average at 37 days in wild-type cultures. Using this assay we found that a Pten mutation had a strong effect. Patches of proliferating cells appeared on average at 11 days and the cultures became confluent in about 3 weeks, which is similar to the timeframe for cultures expressing Ras(V12). Three Pten mutant cell lines were generated and these have now been cultured for between 250 and 630 cell doublings suggesting the life of the mutant cells is likely to be indefinite. We conclude that the use of Pten mutants is a powerful means to derive new Drosophila cell lines.	[Justiniano, Steven E.; Mathew, Anne; Mitra, Sayan; Manivannan, Sathiya N.; Simcox, Amanda] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Justiniano, SE (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	simcox.1@osu.edu		Justiniano, Steven/0000-0003-1381-9309; Manivannan, Sathiyanarayanan/0000-0002-9470-2390	National Institutes of Health [R01GM071856, 1R21HD063119-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (R01GM071856 and 1R21HD063119-01; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Echalier G., 1997, DROSOPHILA CELLS CUL; Frank DJ, 2002, DEVELOPMENT, V129, P399; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; GATEFF E, 1967, AM ZOOL, V7, P760; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Hayflick L, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1180; Huang H, 1999, DEVELOPMENT, V126, P5365; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; KRAEMER PM, 1986, J NATL CANCER I, V76, P703, DOI 10.1093/jnci/76.4.703; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Oldham S, 2002, DEVELOPMENT, V129, P4103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pardue ML, 2011, P NATL ACAD SCI US; Parsons LM, 2010, FLY, V4, P288, DOI 10.4161/fly.4.4.13116; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Simcox A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000142; Simcox AA, 2008, FLY, V2, P306, DOI 10.4161/fly.7427; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Willecke M, 2011, ONCOGENE; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU TA, 1995, DEVELOPMENT, V121, P1053	41	7	7	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31417	10.1371/journal.pone.0031417	http://dx.doi.org/10.1371/journal.pone.0031417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363644	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700058
J	Kim, M; Soontornniyomkij, V; Ji, BH; Zhou, XJ				Kim, MinJung; Soontornniyomkij, Virawudh; Ji, Baohu; Zhou, Xianjin			System-Wide Immunohistochemical Analysis of Protein Co-Localization	PLOS ONE			English	Article							HIPPOCAMPAL DENTATE GYRUS; ANTIBODY ELUTION; CALRETININ; EXPRESSION	Background: The analysis of co-localized protein expression in a tissue section is often conducted with immunofluorescence histochemical staining which is typically visualized in localized regions. On the other hand, chromogenic immunohistochemical staining, in general, is not suitable for the detection of protein co-localization. Here, we developed a new protocol, based on chromogenic immunohistochemical stain, for system-wide detection of protein co-localization and differential expression. Methodology/Principal Findings: In combination with a removable chromogenic stain, an efficient antibody stripping method was developed to enable sequential immunostaining with different primary antibodies regardless of antibody's host species. Sections were scanned after each staining, and the images were superimposed together for the detection of protein co-localization and differential expression. As a proof of principle, differential expression and co-localization of glutamic acid decarboxylase67 (GAD67) and parvalbumin proteins was examined in mouse cortex. Conclusions/Significance: All parvalbumin-containing neurons express GAD67 protein, and GAD67-positive neurons that do not express parvalbumin were readily visualized from thousands of other neurons across mouse cortex. The method provided a global view of protein co-localization as well as differential expression across an entire tissue section. Repeated use of the same section could combine assessments of co-localization and differential expression of multiple proteins.	[Kim, MinJung; Soontornniyomkij, Virawudh; Ji, Baohu; Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kim, M (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	xzhou@ucsd.edu	Ji, Baohu/A-1333-2013; Ji, Baohu/D-2281-2014; Soontornniyomkij, Virawudh/C-7852-2009	Soontornniyomkij, Virawudh/0000-0002-0471-7020	National Institute of Mental Health [R01MH073991]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073991] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health R01MH073991 (X.Z.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen, 2009, ED GUIDE IMMUNOHISTO; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Seress L, 2008, HIPPOCAMPUS, V18, P425, DOI 10.1002/hipo.20403; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x	8	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32043	10.1371/journal.pone.0032043	http://dx.doi.org/10.1371/journal.pone.0032043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363794	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700138
J	Marchetti, G; Nasta, P; Bai, F; Gatti, F; Bellistri, GM; Tincati, C; Borghi, F; Carosi, G; Puoti, M; Monforte, AD				Marchetti, Giulia; Nasta, Paola; Bai, Francesca; Gatti, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Borghi, Federica; Carosi, Giampiero; Puoti, Massimo; Monforte, Antonella d'Arminio			Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IMMUNODEFICIENCY-VIRUS INFECTION; GENOME-WIDE ASSOCIATION; T-CELL-ACTIVATION; HIV-INFECTION; LIVER-DISEASE; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; GENETIC-VARIATION; ANTIRETROVIRAL THERAPY	Objectives: Microbial translocation (MT) through the gut accounts for immune activation and CD4+ loss in HIV and may influence HCV disease progression in HIV/HCV co-infection. We asked whether increased MT and immune activation may hamper anti-HCV response in HIV/HCV patients. Methods: 98 HIV/HCV patients who received pegylated-alpha-interferon (peg-INF-alpha)/ribavirin were retrospectively analyzed. Baseline MT (lipopolysaccharide, LPS), host response to MT (sCD14), CD38+HLA-DR+CD4+/CD8+, HCV genotype, severity of liver disease were assessed according to Early Virological Response (EVR: HCV-RNA < 50 IU/mL at week 12 of therapy or >= 2 log(10) reduction from baseline after 12 weeks of therapy) and Sustained Virological Response (SVR: HCV-RNA < 50 IU/mL 24 weeks after end of therapy). Mann-Whitney/Chi-square test and Pearson's correlation were used. Multivariable regression was performed to determine factors associated with EVR/SVR. Results: 71 patients displayed EVR; 41 SVR. Patients with HCV genotypes 1-4 and cirrhosis presented a trend to higher sCD14, compared to patients with genotypes 2-3 (p = 0.053) and no cirrhosis (p = 0.052). EVR and SVR patients showed lower levels of circulating sCD14 (p = 0.0001, p = 0.026, respectively), but similar T-cell activation compared to Non-EVR (Null Responders, NR) and Non-SVR (N-SVR) subjects. sCD14 resulted the main predictive factor of EVR (0.145 for each sCD14 unit more, 95%CI 0.031-0.688, p = 0.015). SVR was associated only with HCV genotypes 2-3 (AOR 0.022 for genotypes 1-4 vs 2-3, 95%CI 0.001-0.469, p = 0.014). Conclusions: In HIV/HCV patients sCD14 correlates with the severity of liver disease and predicts early response to peg-INF-alpha/ribavirin, suggesting MT-driven immune activation as pathway of HIV/HCV co-infection and response to therapy.	[Marchetti, Giulia; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Dept Med Surg & Dent, Milan, Italy; [Nasta, Paola; Gatti, Francesca; Borghi, Federica; Carosi, Giampiero] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy; [Puoti, Massimo] AO Osped Niguarda Ca Granda, Dept Infect Dis, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; University of Brescia; Ospedale Niguarda Ca' Granda	Marchetti, G (corresponding author), Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Dept Med Surg & Dent, Milan, Italy.	giulia.marchetti@unimi.it	Bai, Francesca/K-4823-2018; Gori, Andrea/AAC-6078-2022; Marchetti, Giulia/GPX-7655-2022; Puoti, Massimo/AAA-6580-2020; TINCATI, CAMILLA/K-4501-2018; MARCHETTI, GIULIA CARLA/K-4384-2018	Puoti, Massimo/0000-0003-3278-7138; TINCATI, CAMILLA/0000-0002-3083-2962; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Universita degli Studi di Milano [PUR 2009]	Universita degli Studi di Milano	This work was funded by grant support (PUR 2009), Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Blackard JT, 2008, J VIRAL HEPATITIS, V15, P323, DOI 10.1111/j.1365-2893.2008.00970.x; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brettschneider J, 2002, J NEUROIMMUNOL, V133, P193, DOI 10.1016/S0165-5728(02)00353-3; Bruno R, 2002, AM J GASTROENTEROL, V97, P1598, DOI 10.1111/j.1572-0241.2002.05817.x; Bruno R, 2007, JAIDS-J ACQ IMM DEF, V46, P297, DOI 10.1097/QAI.0b013e31814be887; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Elefsiniotis IS, 2009, INTERVIROLOGY, V52, P247, DOI 10.1159/000228548; Enomoto N, 1999, HEPATOLOGY, V29, P1680, DOI 10.1002/hep.510290633; Farnik H, 2009, LIVER INT, V29, P23, DOI 10.1111/j.1478-3231.2008.01969.x; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; GAETA GB, 1982, DIGESTION, V23, P239, DOI 10.1159/000198756; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kamal SM, 2009, LIVER INT, V29, P39, DOI 10.1111/j.1478-3231.2008.01930.x; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McGovern BH, 2007, J ACQUIR IMMUNE D S2, V45, pS47; McGovern BH, 2007, J ACQUIR IMMUNE D S2, V45, pS66; Puoti M, 2003, J BIOL REG HOMEOS AG, V17, P144; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Rosenthal E, 2009, HIV MED, V10, P282, DOI 10.1111/j.1468-1293.2008.00686.x; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Wyles David L, 2010, Top HIV Med, V18, P132; Yu JW, 2007, J GASTROEN HEPATOL, V22, P832, DOI 10.1111/j.1440-1746.2007.04904.x	52	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32028	10.1371/journal.pone.0032028	http://dx.doi.org/10.1371/journal.pone.0032028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363790	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700136
J	Nielsen, SY; Hjollund, NH; Andersen, AMN; Henriksen, TB; Kantso, B; Krogfelt, KA; Molbak, K				Nielsen, Stine Yde; Hjollund, Niels Henrik; Andersen, Anne-Marie Nybo; Henriksen, Tine Brink; Kantso, Bjorn; Krogfelt, Karen Angeliki; Molbak, Kare			Presence of Antibodies Against Coxiella burnetii and Risk of Spontaneous Abortion: A Nested Case-Control Study	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; Q-FEVER; FOLLOW-UP; PREGNANCY; DIAGNOSIS; IMMUNOFLUORESCENCE; INFECTION; OUTBREAK; DENMARK; HUMANS	Background and Aims: Q fever is a bacterial zoonosis caused by infection with Coxiella burnetii. It is well established that Q fever causes fetal loss in small ruminants. The suspicion has been raised that pregnant women may also experience adverse pregnancy outcome when the infection is acquired or reactivated during pregnancy. The purpose of this study was to assess the potential association between serologic markers of infection with C. burnetii and spontaneous abortion. Methods: A nested case-control study within the Danish National Birth Cohort, a cohort of 100,418 pregnancies recruited from 1996-2002. Women were recruited in first trimester of pregnancy and followed prospectively. Median gestational age at enrolment was 8 weeks (25 and 75 percentiles: 7 weeks; 10 weeks). During pregnancy, a blood sample was collected at gestational week 6-12 and stored in a bio bank. For this study, a case sample of 218 pregnancies was drawn randomly among the pregnancies in the cohort which ended with a miscarriage before 22 gestational weeks, and a reference group of 482 pregnancies was selected in a random fashion among all pregnancies in the cohort. From these pregnancies, serum samples were screened for antibodies against C. burnetii in a commercial enzyme-linked immunosorbent assay (ELISA). Samples that proved IgG or IgM antibody positive were subsequently confirmatory tested by an immunofluorescence (IFA) test. Results: Among cases, 11 (5%) were C. burnetii positive in ELISA of which one was confirmed in the IFA assay compared to 29 (6%) ELISA positive and 3 IFA confirmed in the random sample. Conclusions: We found no evidence of a higher prevalence of C. burnetii antibodies in serum samples from women who later miscarried and the present study does not indicate a major association between Q fever infection and spontaneous abortion in humans. Very early first trimester abortions were, however, not included in the study.	[Nielsen, Stine Yde; Hjollund, Niels Henrik] Reg Hosp W Jutland, Dept Occupat Med, Herning, Denmark; [Nielsen, Stine Yde; Henriksen, Tine Brink] Aarhus Univ Hosp Skejby, Perinatal Epidemiol Res Unit, Aarhus, Denmark; [Hjollund, Niels Henrik] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Andersen, Anne-Marie Nybo] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp Skejby, Dept Pediat, Aarhus, Denmark; [Kantso, Bjorn] Statens Serum Inst, Dept Microbiol Diagnost, DK-2300 Copenhagen, Denmark; [Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Molbak, Kare] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Aarhus University; Statens Serum Institut; Statens Serum Institut; Statens Serum Institut	Nielsen, SY (corresponding author), Reg Hosp W Jutland, Dept Occupat Med, Herning, Denmark.	stineyde@dadlnet.dk	Andersen, Anne-Marie Nybo/E-4993-2013; Krogfelt, Karen Angeliki/P-2430-2018; Nybo Andersen, Anne-Marie/AAA-1997-2022; Krogfelt, Karen Angeliki A/O-8145-2016	Andersen, Anne-Marie Nybo/0000-0002-4296-8488; Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Molbak, Kare/0000-0002-3100-4990; Hjollund, Niels Henrik I/0000-0002-6697-6597	Danish Working Environment Research Fund; Danish Ramazzinicenter; Danish Veterinary Association; Danish Cattle Levy-fund; Milk Levy Fund; Viking Danmark	Danish Working Environment Research Fund; Danish Ramazzinicenter; Danish Veterinary Association; Danish Cattle Levy-fund; Milk Levy Fund; Viking Danmark	This study was partially supported by: Danish Working Environment Research Fund: http://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden/om-arbejdsmiljoforskningsfonden.aspx, Danish Ramazzinicenter: www. ramazzini. dk, The Danish Veterinary Association: www. ddd.dk, Danish Cattle Levy-fund: http://kvaegafgiftsfonden.dk, The Milk Levy Fund: www.maelkeafgiftsfonden.dk, and Viking Danmark: http://vikinggenetics.com. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JF, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-5; Andersen AG, 2001, THESIS U COPENHAGEN; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bacci S, 2011, ZOONOSES PUBLIC HLTH; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; Bosnjak E, 2010, CLIN MICROBIOL INFEC, V16, P1285, DOI 10.1111/j.1469-0691.2009.03062.x; Carcopino X, 2007, CLIN INFECT DIS, V45, P548, DOI 10.1086/520661; Carcopino X, 2009, ANN NY ACAD SCI, V1166, P79, DOI 10.1111/j.1749-6632.2009.04519.x; Field PR, 2000, J CLIN MICROBIOL, V38, P1645, DOI 10.1128/JCM.38.4.1645-1647.2000; Field PR, 2002, J CLIN MICROBIOL, V40, P3526, DOI 10.1128/JCM.40.9.3526-3529.2002; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Hansen MS, 2011, VET J; Healy B, 2011, CLIN INFECT DIS, V52, P1013, DOI 10.1093/cid/cir132; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; McCaughey C, 2008, ZOONOSES PUBLIC HLTH, V55, P189, DOI 10.1111/j.1863-2378.2008.01109.x; Nigro G, 2011, J MATERN FETAL NEONA; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Raoult D, 2002, ARCH INTERN MED, V162, P701, DOI 10.1001/archinte.162.6.701; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Tissot-Dupont H, 2007, CLIN INFECT DIS, V44, P232, DOI 10.1086/510389; Vaidya VM, 2008, J CLIN MICROBIOL, V46, P2038, DOI 10.1128/JCM.01874-07; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; Villumsen S, 2009, DIAGN MICR INFEC DIS, V65, P93, DOI 10.1016/j.diagmicrobio.2009.06.004; Wilcox AJ, 2010, FERTILITY PREGNANCY, P324	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31909	10.1371/journal.pone.0031909	http://dx.doi.org/10.1371/journal.pone.0031909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363769	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700123
J	Donoghue, JF; McGavigan, CJ; Lederman, FL; Cann, LM; Fu, L; Dimitriadis, E; Girling, JE; Rogers, PAW				Donoghue, Jacqueline F.; McGavigan, C. Jay; Lederman, Fiona L.; Cann, Leonie M.; Fu, Lulu; Dimitriadis, Eva; Girling, Jane E.; Rogers, Peter A. W.			Dilated Thin-Walled Blood and Lymphatic Vessels in Human Endometrium: A Potential Role for VEGF-D in Progestin-Induced Break-Through Bleeding	PLOS ONE			English	Article							GROWTH FACTOR-D; INTRAUTERINE SYSTEM; MICROVASCULAR DENSITY; ONLY CONTRACEPTIVES; NORPLANT(R) USERS; GENE-TRANSFER; TUMOR-CELLS; MOUSE MODEL; LEVONORGESTREL; WOMEN	Progestins provide safe, effective and cheap options for contraception as well as the treatment of a variety of gynaecological disorders. Episodes of irregular endometrial bleeding or breakthrough bleeding (BTB) are a major unwanted side effect of progestin treatment, such that BTB is the leading cause for discontinued use of an otherwise effective and popular medication. The cellular mechanisms leading to BTB are poorly understood. In this study, we make the novel finding that the large, dilated, thin walled vessels characteristic of human progestin-treated endometrium include both blood and lymphatic vessels. Increased blood and lymphatic vessel diameter are features of VEGF-D action in other tissues and we show by immunolocalisation and Western blotting that stromal cell decidualisation results in a significant increase in VEGF-D protein production, particularly of the proteolytically processed 21 kD form. Using a NOD/scid mouse model with xenografted human endometrium we were able to show that progestin treatment causes decidualisation, VEGF-D production and endometrial vessel dilation. Our results lead to a novel hypothesis to explain BTB, with stromal cell decidualisation rather than progestin treatment per se being the proposed causative event, and VEGF-D being the proposed effector agent.	[Donoghue, Jacqueline F.] Monash Univ, Monash Inst Med Res, Oncogen Signalling Lab, Clayton, Vic, Australia; [Donoghue, Jacqueline F.; McGavigan, C. Jay] Monash Univ, Dept Obstet & Gynaecol, Ctr Womens Hlth Res, Clayton, Vic 3168, Australia; [Lederman, Fiona L.; Cann, Leonie M.; Fu, Lulu; Girling, Jane E.] Univ Melbourne, Royal Womens Hosp, Gynaecol Res Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Dimitriadis, Eva] Monash Med Ctr, Embryo Implantat Lab, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Monash University; Monash University; University of Melbourne; Monash University; Prince Henry's Institute of Medical Research	Donoghue, JF (corresponding author), Monash Univ, Monash Inst Med Res, Oncogen Signalling Lab, Clayton, Vic, Australia.	parogers@unimelb.edu.au	dimitriadis, e/AAD-7601-2021; Rogers, Peter AW/C-2651-2008	Rogers, Peter AW/0000-0002-7399-8997; Girling, Jane/0000-0002-8154-2068; Donoghue, Jacqueline/0000-0003-1370-2469; dimitriadis, eva/0000-0003-1425-950X	Australian Postgraduate Award; National Health and Medical Research Council [384195, 550911, 334063]	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JFD was supported by an Australian Postgraduate Award. This study was funded by National Health and Medical Research Council Grant No. 384195 to PAWR and JEG. ED salary paid by National Health and Medical Research Council Career Development Award Grant No. 550911. PAWR salary paid by National Health and Medical Research Council Fellowship Grant No. 334063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Byzova TV, 2002, BLOOD, V99, P4434, DOI 10.1182/blood.V99.12.4434; Clark DA, 1996, HUM REPROD, V11, P1438; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; Critchley HOD, 1998, HUM REPROD, V13, P1210, DOI 10.1093/humrep/13.5.1210; d'Arcangues C, 2000, HUM REPROD, V15, P24, DOI 10.1093/humrep/15.suppl_3.24; Donoghue JF, 2007, HUM REPROD, V22, P1705, DOI 10.1093/humrep/dem037; Findlay JK, 1996, HUM REPROD, V11, P179, DOI 10.1093/humrep/11.suppl_2.179; Fraser IS, 2000, STEROIDS, V65, P665, DOI 10.1016/S0039-128X(00)00188-4; Girling JE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-84; Gonzalez MLA, 2009, HUM REPROD, V24, P2217, DOI 10.1093/humrep/dep203; Gonzalez MLA, 2009, HUM REPROD, V24, P697, DOI 10.1093/humrep/den437; Hickey M, 1998, HUM REPROD, V13, P3190, DOI 10.1093/humrep/13.11.3190; Hickey M, 1996, HUM REPROD, V11, P35, DOI 10.1093/humrep/11.suppl_2.35; Hickey M, 2000, HUM REPROD, V15, P1509, DOI 10.1093/humrep/15.7.1509; Irvine GA, 1998, BRIT J OBSTET GYNAEC, V105, P592, DOI 10.1111/j.1471-0528.1998.tb10172.x; Jones RL, 2000, HUM REPROD, V15, P162, DOI 10.1093/humrep/15.suppl_3.162; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kholova I, 2007, HUM GENE THER, V18, P232, DOI 10.1089/hum.2006.100; MARKEE JE, 1978, AM J OBSTET GYNECOL, V131, P558; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McGavigan CJ, 2003, HUM REPROD, V18, P77, DOI 10.1093/humrep/deg023; Menkhorst E, 2010, J REPROD IMMUNOL, V84, P124, DOI 10.1016/j.jri.2009.12.001; Morison NB, 2007, REPRODUCTION, V133, P309, DOI 10.1530/rep.1.01171; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rodgers AK, 2008, EXPERT OPIN PHARMACO, V9, P243, DOI [10.1517/14656566.9.2.243, 10.1517/14656566.9.2.243 ]; Rodriguez MI, 2010, AM J OBSTET GYNECOL, V202, P420, DOI 10.1016/j.ajog.2009.10.863; Rogers PAW, 2005, HUM REPROD, V20, P3341, DOI 10.1093/humrep/dei239; Rogers PAW, 1996, HUM REPROD, V11, P45, DOI 10.1093/humrep/11.suppl_2.45; ROGERS PAW, 1993, HUM REPROD, V8, P1396, DOI 10.1093/oxfordjournals.humrep.a138268; Rogers PAW, 2000, HUM REPROD, V15, P78, DOI 10.1093/humrep/15.suppl_3.78; Runic R, 2000, J CLIN ENDOCR METAB, V85, P3853, DOI 10.1210/jc.85.10.3853; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Song J Y, 1995, Obstet Gynecol Surv, V50, P385; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stephanie R, 2007, HUM REPROD, V22, P3084, DOI 10.1093/humrep/dem238; Stewart A, 2001, BRIT J OBSTET GYNAEC, V108, P74, DOI 10.1016/S0306-5456(00)00020-6; Veikkola T, 2000, CANCER RES, V60, P203; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Vincent AJ, 2002, HUM REPROD, V17, P1189, DOI 10.1093/humrep/17.5.1189; Volchek M, 2010, HUM REPROD, V25, P2455, DOI 10.1093/humrep/deq224; Wonodirekso S, 2000, HUM REPROD, V15, P189, DOI 10.1093/humrep/15.suppl_3.189; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yu J, 2011, MOL CELL ENDOCRINOL, V344, P25, DOI 10.1016/j.mce.2011.04.011	46	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30916	10.1371/journal.pone.0030916	http://dx.doi.org/10.1371/journal.pone.0030916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22383980	gold, Green Published			2022-12-25	WOS:000302853600088
J	Zhang, WZ; Shen, YJ; Wang, RJ; Liu, AQ; Ling, H; Li, YH; Cao, JP; Zhang, XY; Shu, J; Zhang, LX				Zhang, Weizhe; Shen, Yujuan; Wang, Rongjun; Liu, Aiqin; Ling, Hong; Li, Yihong; Cao, Jianping; Zhang, Xiaoyun; Shu, Jing; Zhang, Longxian			Cryptosporidium cuniculus and Giardia duodenalis in Rabbits: Genetic Diversity and Possible Zoonotic Transmission	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DAIRY-CATTLE; NEW-ZEALAND; GENOTYPES; IDENTIFICATION; HUMANS; PREVALENCE; CHINA; POPULATION; RUMINANTS	Background: Cryptosporidium and Giardia are the two important zoonotic pathogens causing diarrhea of humans and animals worldwide. Considering the human cryptosporidiosis outbreak and sporadic cases caused by C. cuniculus, the important public health significance of G. duodenalis and little obtained information regarding rabbit infected with Cryptosporidium and Giardia in China, the aim of this study is to determine the prevalence and molecularly characterize Cryptosporidium and Giardia in rabbits in Heilongjiang Province, China. Methodology/Principal Findings: 378 fecal samples were obtained from rabbits in Heilongjiang Province. Cryptosporidium oocysts and Giardia cysts were detected using Sheather's sugar flotation technique and Lugol's iodine stain method, respectively. The infection rates of Cryptosporidium and Giardia were 2.38% (9/378) and 7.41% (28/378), respectively. Genotyping of Cryptosporidium spp. was done by DNA sequencing of the small subunit rRNA (SSU rRNA) gene and all the nine isolates were identified as Cryptosporidium cuniculus. The nine isolates were further subtyped using the 60-kDa glycoprotein (gp60) gene and two subtypes were detected, including VbA32 (n = 3) and a new subtype VbA21 (n = 6). G. duodenalis genotypes and subtypes were identified by sequence analysis of the triosephosphate isomerase (TPI) gene. The assemblage B (belonging to eight different subtypes B-I to B-VIII) was found in 28 G. duodenalis-positive samples. Conclusions/Significance: The rabbits have been infected with Cryptosporidium and Giardia in Heilongjiang Province. The results show that the rabbits pose a threat to human health in the studied areas. Genotypes and subgenotypes of C. cuniculus and G. duodenalis in this study might present the endemic genetic characterization of population structure of the two parasites.	[Zhang, Weizhe; Liu, Aiqin; Ling, Hong; Li, Yihong; Zhang, Xiaoyun; Shu, Jing] Harbin Med Coll, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Shen, Yujuan; Cao, Jianping] World Hlth Org, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol, Natl Inst Parasit Dis,Minist Hlth,Collaborating C, Shanghai, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Zhang, WZ (corresponding author), Harbin Med Coll, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; zhanglx8999@yahoo.com.cn	Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019; Zhang, Longxian/R-7799-2019; Cao, Jianping/AFL-5468-2022	Zhang, Longxian/0000-0002-5706-131X; Cao, Jianping/0000-0002-1974-0047; ling, hong/0000-0002-1886-1242	Natural Science Foundation of Heilongjiang Province [D200628]; Chinese Special Program for Scientific Research of Public Health [200802012]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Chinese Special Program for Scientific Research of Public Health	AL was supported by the Natural Science Foundation of Heilongjiang Province (No. D200628) and YS was supported by grants from the Chinese Special Program for Scientific Research of Public Health (No. 200802012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Bouzid M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-213; Cama VA, 2003, J EUKARYOT MICROBIOL, V50, P531, DOI 10.1111/j.1550-7408.2003.tb00620.x; Castro-Hermida JA, 2007, PARASITOL RES, V101, P1443, DOI 10.1007/s00436-007-0624-6; Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Hoque M. Ekramul, 2002, International Journal of Infectious Diseases, V6, P191, DOI 10.1016/S1201-9712(02)90110-4; Hoque ME, 2003, EPIDEMIOL INFECT, V131, P655, DOI 10.1017/S0950268803008598; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Learmonth JJ, 2004, APPL ENVIRON MICROB, V70, P3973, DOI 10.1128/AEM.70.7.3973-3978.2004; Learmonth JJ, 2003, WATER SCI TECHNOL, V47, P21, DOI 10.2166/wst.2003.0150; Lu SQ, 1996, J PARASITOL, V82, P659, DOI 10.2307/3283799; Men Jing-tao, 2009, Journal of Jilin Agricultural University, V31, P447; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Monis PT, 2003, INFECT GENET EVOL, V3, P29, DOI 10.1016/S1567-1348(02)00149-1; Ni H, 2008, ACTA ACAD MED QINGDA, V42, P158; Nolan MJ, 2010, INFECT GENET EVOL, V10, P1179, DOI 10.1016/j.meegid.2010.07.020; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Robinson G, 2010, ZOONOSES PUBLIC HLTH, V57, pE1, DOI 10.1111/j.1863-2378.2009.01308.x; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Shi K, 2010, J CLIN MICROBIOL, V48, P3263, DOI 10.1128/JCM.00819-10; Shiibashi T, 2006, J VET MED SCI, V68, P281, DOI 10.1292/jvms.68.281; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tian Zong-cheng, 2002, Chinese Journal of Parasitology and Parasitic Diseases, V20, P72; Traub R, 2005, VET PARASITOL, V130, P317, DOI 10.1016/j.vetpar.2005.02.011; Traub RJ, 2004, PARASITOLOGY, V128, P253, DOI 10.1017/S0031182003004505; Tyzzer E. E., 1912, Archiv fuer Protistenkunde Jena, V26; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Xiao LH, 2002, INT J PARASITOL, V32, P1773, DOI 10.1016/S0020-7519(02)00197-2; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	40	38	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31262	10.1371/journal.pone.0031262	http://dx.doi.org/10.1371/journal.pone.0031262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363600	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600133
J	Han, GY; Mamedov, F; Styring, S				Han, Guangye; Mamedov, Fikret; Styring, Stenbjorn			Misses during Water Oxidation in Photosystem II Are S State-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; RAY-ABSORPTION SPECTROSCOPY; PHOTOSYNTHETIC O2 EVOLUTION; ELECTRON-PARAMAGNETIC-RES; MANGANESE COMPLEX; P680(+CENTER-DOT) REDUCTION; CENTERED OXIDATION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; ISOTOPE-EXCHANGE	The period of four oscillation of the S state intermediates of the water oxidizing complex in Photosystem II (PSII) is commonly analyzed by the Kok parameters. The important miss factor determines the efficiency for each S transition. Commonly, an equal miss factor has been used in the analysis. We have used EPR signals which probe all S states in the same sample during S cycle advancement. This allows, for the first time, to measure directly the miss parameter for each S state transition. Experiments were performed in PSII membrane preparations from spinach in the presence of electron acceptor at 1 degrees C and 20 degrees C. The data show that the miss parameter is different in different transitions and shows different temperature dependence. We found no misses at 1 degrees C and 10% misses at 20 degrees C during the S-1 -> S-2 transition. The highest miss factor was found in the S-2 -> S-3 transition which decreased from 23% to 16% with increasing temperature. For the S-3 -> S-0 transition the miss parameter was found to be 7% at 1 degrees C and decreased to 3% at 20 degrees C. For the S-0 -> S-1 transition the miss parameter was found to be approximately 10% at both temperatures. The contribution from the acceptor side in the form of recombination reactions as well as from the donor side of PSII to the uneven misses is discussed. It is suggested that the different transition efficiency in each S transition partly reflects the chemistry at the CaMn4O5 cluster. That consequently contributes to the uneven misses during S cycle turnover in PSII.	[Han, Guangye; Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Dept Chem Angstrom, S-75120 Uppsala, Sweden; [Han, Guangye] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Uppsala University; Umea University	Mamedov, F (corresponding author), Uppsala Univ, Dept Chem Angstrom, Box 523, S-75120 Uppsala, Sweden.	fikret.mamedov@fotomol.uu.se; stenbjorn.styring@fotomol.uu.se	Styring, Stenbjörn/L-8414-2016; Mamedov, Fikret/A-1761-2016	Styring, Stenbjörn/0000-0002-2803-9244; Mamedov, Fikret/0000-0002-6218-3039	Swedish Research Council; Swedish Energy Agency; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, the Swedish Energy Agency, and the Knut and Alice Wallenberg Foundation.	Ahrling KA, 1997, BIOCHEMISTRY-US, V36, P13148, DOI 10.1021/bi971815w; Bernat G, 2002, BIOCHEMISTRY-US, V41, P5830, DOI 10.1021/bi011691u; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Chen GY, 2012, BIOCHEMISTRY-US, V51, P138, DOI 10.1021/bi200627j; Christen G, 1999, BIOCHEMISTRY-US, V38, P6082, DOI 10.1021/bi9827520; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2002, PHOTOSYNTH RES, V72, P217, DOI 10.1023/A:1016128632704; DELRIEU MJ, 1983, Z NATURFORSCH C, V38, P247; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; Han G., 2008, BIOCHIM BIOPHYS ACTA, V1777, P495; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 2002, FEBS LETT, V512, P116, DOI 10.1016/S0014-5793(02)02237-8; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Havelius KGV, 2010, APPL MAGN RESON, V37, P151, DOI 10.1007/s00723-009-0045-z; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Isgandarova S, 2003, BIOCHEMISTRY-US, V42, P8929, DOI 10.1021/bi034744b; Iuzzolino L, 1998, BIOCHEMISTRY-US, V37, P17112, DOI 10.1021/bi9817360; Jeans C, 2002, BIOCHEMISTRY-US, V41, P15754, DOI 10.1021/bi020558e; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Joliot P., 1975, BIOENERG PHOTOSYNTH, P388; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lavergne J, 1998, BIOCHEMISTRY-US, V37, P7899, DOI 10.1021/bi9801210; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 1998, BIOCHEMISTRY-US, V37, P14245, DOI 10.1021/bi980194j; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; MESSINGER J, 1994, BIOCHEMISTRY-US, V33, P10896, DOI 10.1021/bi00202a008; Messinger J, 2007, COMPR SER PHOTOCH, V9, P291; Meunier PC, 1996, PHOTOSYNTH RES, V47, P61, DOI 10.1007/BF00017754; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; PACKHAM NK, 1988, PHOTOSYNTH RES, V15, P221, DOI 10.1007/BF00047354; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; REINMAN S, 1981, BIOCHIM BIOPHYS ACTA, V635, P249, DOI 10.1016/0005-2728(81)90024-4; Renger G, 2007, COMPR SER PHOTOCH, V9, P237; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Roelofs TA, 1996, P NATL ACAD SCI USA, V93, P3335, DOI 10.1073/pnas.93.8.3335; SAYGIN O, 1987, BIOCHIM BIOPHYS ACTA, V893, P452, DOI 10.1016/0005-2728(87)90097-1; Schlodder E, 1999, J BIOL CHEM, V274, P30387, DOI 10.1074/jbc.274.43.30387; Shevela D, 2011, P NATL ACAD SCI USA, V108, P3602, DOI 10.1073/pnas.1014249108; SHINKAREV VP, 1993, P NATL ACAD SCI USA, V90, P1834, DOI 10.1073/pnas.90.5.1834; Shinkarev VP, 2005, BIOPHYS J, V88, P412, DOI 10.1529/biophysj.104.050898; STYRING S, 1988, BIOCHIM BIOPHYS ACTA, V933, P378, DOI 10.1016/0005-2728(88)90046-1; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VOLKER M, 1985, BIOCHIM BIOPHYS ACTA, V806, P25, DOI 10.1016/0005-2728(85)90078-7; Wydrzynski T. J., 2005, PHOTOSYSTEM; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a	55	19	19	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13422	13429		10.1074/jbc.M112.342543	http://dx.doi.org/10.1074/jbc.M112.342543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22374999	Green Published, hybrid			2022-12-25	WOS:000302903700076
J	Garrido-Sanchez, L; Vendrell, J; Fernandez-Garcia, D; Ceperuelo-Mallafre, V; Chacon, MR; Ocana-Wilhelmi, L; Alcaide, J; Tinahones, FJ; Garcia-Fuentes, E				Garrido-Sanchez, Lourdes; Vendrell, Joan; Fernandez-Garcia, Diego; Ceperuelo-Mallafre, Victoria; Chacon, Matilde R.; Ocana-Wilhelmi, Luis; Alcaide, Juan; Tinahones, Francisco J.; Garcia-Fuentes, Eduardo			De Novo Lipogenesis in Adipose Tissue Is Associated with Course of Morbid Obesity after Bariatric Surgery	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; FATTY-ACID SYNTHESIS; INSULIN-RESISTANCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; WEIGHT-LOSS; ENZYME; GLYCERONEOGENESIS; OVEREXPRESSION; PROTECTS; ACETATE	Objective: De novo lipogenesis is involved in fatty acid biosynthesis and could be involved in the regulation of the triglyceride storage capacity of adipose tissue. However, the association between lipogenic and lipolytic genes and the evolution of morbidly obese subjects after bariatric surgery remains unknown. In this prospective study we analyze the association between the improvement in the morbidly obese patients as a result of bariatric surgery and the basal expression of lipogenic and lipolytic genes. Methods: We study 23 non diabetic morbidly obese patients who were studied before and 7 months after bariatric surgery. Also, we analyze the relative basal mRNA expression levels of lipogenic and lipolytic genes in epiploic visceral adipose tissue (VAT) and abdominal subcutaneous adipose tissue (SAT). Results: When the basal acetyl-CoA carboxylase 1 (ACC1), acetyl-CoA synthetase 2 (ACSS2) and ATP citrate lyase (ACL) expression in SAT was below percentile-50, there was a greater decrease in weight (P = 0.006, P = 0.034, P = 0.026), body mass index (P = 0.008, P = 0.033, P = 0.034) and hip circumference (P = 0.033, P = 0.021, P = 0.083) after bariatric surgery. In VAT, when the basal ACSS2 expression was below percentile-50, there was a greater decrease in hip circumference (P = 0.006). After adjusting for confounding variables in logistic regression models, only the morbidly obese patients with SAT or VAT ACSS2 expression >= P50 before bariatric surgery had a lower percentage hip circumference loss (<P50) after bariatric surgery (SAT: P = 0.039; VAT: P = 0.033). Conclusions: A lower basal ACSS2, ACC1 and ACL expression, genes involved in de novo lipogenesis, is associated with a better evolution of anthropometric variables after bariatric surgery. Thus, the previous state of the pathways involved in fatty acid metabolism may have repercussions on the improvement of these patients.	[Garrido-Sanchez, Lourdes; Vendrell, Joan; Chacon, Matilde R.] Hosp Univ Joan XXIII, IISPV, CIBERDEM, Tarragona, Spain; [Fernandez-Garcia, Diego; Ceperuelo-Mallafre, Victoria; Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Fernandez-Garcia, Diego; Tinahones, Francisco J.; Garcia-Fuentes, Eduardo] Ciber Fisiopatol Obesidad & Nutr CIBEROB, Malaga, Spain; [Ocana-Wilhelmi, Luis] Hosp Clin Virgen de la Victoria, Serv Cirugia, Malaga, Spain; [Alcaide, Juan; Garcia-Fuentes, Eduardo] Fdn IMABIS, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital Virgen de la Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; FIMABIS	Garrido-Sanchez, L (corresponding author), Hosp Univ Joan XXIII, IISPV, CIBERDEM, Tarragona, Spain.	fjtinahones@hotmail.com; edugf1@gmail.com	Vendrell, Joan j/V-4034-2018; Chacón, Matilde R./E-5574-2019; Garcia-Fuentes, Eduardo/AAB-1607-2020; Tinahones, Francisco José/AAB-2882-2020; Ceperuelo-Mallafré, Victòria/A-4615-2017	Vendrell, Joan j/0000-0002-6994-6115; Chacón, Matilde R./0000-0003-1531-2165; Ceperuelo-Mallafré, Victòria/0000-0002-4460-9761; Tinahones, Francisco J/0000-0001-6871-4403; GARCIA-FUENTES, EDUARDO/0000-0002-3491-2724	Instituto de Salud Carlos III [PS09/01060, PS09/00997, PI08/0733, CP06/00119, JCI-2009-04086, JCI-2010-06395]; Servicio Andaluz de Salud [PI0255/2007]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud	This work was supported in part by grants from the Instituto de Salud Carlos III (PS09/01060, PS09/00997, PI08/0733, CP06/00119, JCI-2009-04086 and JCI-2010-06395) and Servicio Andaluz de Salud (PI0255/2007). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELFIORE F, 1995, BIOCHEM MOL MED, V54, P19, DOI 10.1006/bmme.1995.1003; Benedetti G, 2000, J AM COLL NUTR, V19, P270, DOI 10.1080/07315724.2000.10718926; COLEMAN PS, 1986, ANN NY ACAD SCI, V488, P451; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Garcia-Fuentes E, 2007, OBESITY, V15, P2391, DOI 10.1038/oby.2007.284; Garcia-Fuentes E, 2006, OBES SURG, V16, P1179, DOI 10.1381/096089206778392383; Garrido-Sanchez L, 2011, SURG OBES RELAT 0331; Garrido-Sanchez L, 2008, DIABETES CARE, V31, P2258, DOI 10.2337/dc08-0930; Hall KD, 2008, INT J OBESITY, V32, P619; HOWARD BV, 1974, J BIOL CHEM, V249, P7912; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kreuz S, 2009, DIABETES-METAB RES, V25, P577, DOI 10.1002/dmrr.997; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Macias-Gonzalez M, 2009, EUR J CLIN INVEST, V39, P972, DOI 10.1111/j.1365-2362.2009.02198.x; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Mao JQ, 2003, P NATL ACAD SCI USA, V100, P7515, DOI 10.1073/pnas.1332670100; Murri M, 2010, OBES SURG, V20, P363, DOI 10.1007/s11695-009-0021-6; Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; Soriguer F, 2009, OBESITY, V17, P10, DOI 10.1038/oby.2008.475; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; STEINER G, 1966, CAN J BIOCHEM CELL B, V44, P1587, DOI 10.1139/o66-181; Swierczynski J, 2000, METABOLISM, V49, P594, DOI 10.1016/S0026-0495(00)80033-5; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Zhao LF, 2010, ENDOCR J, V57, P317, DOI 10.1507/endocrj.K09E-298	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31280	10.1371/journal.pone.0031280	http://dx.doi.org/10.1371/journal.pone.0031280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384010	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100017
J	Zhang, LM; Chen, YQ; Wong, HS; Zhou, SG; Mamitsuka, H; Zhu, SF				Zhang, Lianming; Chen, Yiqing; Wong, Hau-San; Zhou, Shuigeng; Mamitsuka, Hiroshi; Zhu, Shanfeng			TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules	PLOS ONE			English	Article							MHC CLASS-I; GENERATION; DATABASE; SERVERS	Motivation: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data, has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA DR molecules. Method: We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over HLA-DR molecules characterized by TEPITOPE. Result: The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints: predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules, TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.cn/Service/TEPITOPEpan/.	[Zhang, Lianming; Chen, Yiqing; Zhou, Shuigeng; Zhu, Shanfeng] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Zhang, Lianming; Chen, Yiqing; Zhou, Shuigeng; Zhu, Shanfeng] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Wong, Hau-San] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji 611, Japan	Fudan University; Fudan University; City University of Hong Kong; Kyoto University	Zhang, LM (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China.	zhusf@fudan.edu.cn	Mamitsuka, Hiroshi/R-1110-2016	Mamitsuka, Hiroshi/0000-0002-6607-5617; WONG, Hau-San/0000-0002-1530-7529	National Basic Research Program of China [2010CB126604]; National Nature Science Foundation of China [61170097, 60903076]; Japan Society for the Promotion of Science (JSPS); City University of Hong Kong [7008044]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); City University of Hong Kong(City University of Hong Kong)	Yiqing Chen and Shuigeng Zhou were supported in part by the National Basic Research Program of China under grant No. 2010CB126604. Shanfeng Zhu was supported by The National Nature Science Foundation of China (Grant No. 61170097 and No. 60903076) and the Japan Society for the Promotion of Science (JSPS) Invitation Fellowship. Hau-San Wong was supported by City University of Hong Kong [Project No. 7008044]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordner AJ, 2010, BMC BIOINFORMATICS, V11, P14; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-482; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lund O, 2005, IMMUNOLOGICAL BIOINF; Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Marsh SGE, 2001, HLA FACTSBOOK; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Pfeifer N, 2008, LECT N BIOINFORMAT, V5251, P210, DOI 10.1007/978-3-540-87361-7_18; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zaitlen N, 2008, J COMPUT BIOL, V15, P927, DOI 10.1089/cmb.2007.0183; Zhang GL, 2011, J IMMUNOL METHODS, V374, P18, DOI 10.1016/j.jim.2011.07.007; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060	34	63	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30483	10.1371/journal.pone.0030483	http://dx.doi.org/10.1371/journal.pone.0030483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383964	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100004
J	Matsen, FA; Hoffman, NG; Gallagher, A; Stamatakis, A				Matsen, Frederick A.; Hoffman, Noah G.; Gallagher, Aaron; Stamatakis, Alexandros			A Format for Phylogenetic Placements	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; READS	We have developed a unified format for phylogenetic placements, that is, mappings of environmental sequence data (e.g., short reads) into a phylogenetic tree. We are motivated to do so by the growing number of tools for computing and post-processing phylogenetic placements, and the lack of an established standard for storing them. The format is lightweight, versatile, extensible, and is based on the JSON format, which can be parsed by most modern programming languages. Our format is already implemented in several tools for computing and post-processing parsimony- and likelihood-based phylogenetic placements and has worked well in practice. We believe that establishing a standard format for analyzing read placements at this early stage will lead to a more efficient development of powerful and portable post-analysis tools for the growing applications of phylogenetic placement.	[Matsen, Frederick A.; Hoffman, Noah G.; Gallagher, Aaron] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Seattle, WA USA; [Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Heidelberg, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Heidelberg Institute for Theoretical Studies	Matsen, FA (corresponding author), Fred Hutchinson Canc Res Ctr, Program Computat Biol, 1124 Columbia St, Seattle, WA 98104 USA.	matsen@fhcrc.org	Stamatakis, Alexandros/B-8740-2009	Stamatakis, Alexandros/0000-0003-0353-0691	National Institutes of Health [HG005966-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	FAM, NGH, and AG were supported in part by National Institutes of Health grant HG005966-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crockford D., 2006, APPL JSON MEDIA TYPE; Evans S, 2010, ARXIV10051699; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Matsen F, 2011, ARXIV11075095V1; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mirarab S, 2012, PAC S BIOC PSB 2012; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Pirrung M, 2011, BIOINFORMATICS, V27, P3067, DOI 10.1093/bioinformatics/btr517; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Westesson O, 2011, ARXIV11034347; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	16	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31009	10.1371/journal.pone.0031009	http://dx.doi.org/10.1371/journal.pone.0031009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383988	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500010
J	Bernardes, A; Batista, FAH; Neto, MD; Figueira, ACM; Webb, P; Saidemberg, D; Palma, MS; Polikarpov, I				Bernardes, Amanda; Batista, Fernanda A. H.; Neto, Mario de Oliveira; Figueira, Ana Carolina M.; Webb, Paul; Saidemberg, Daniel; Palma, Mario S.; Polikarpov, Igor			Low-Resolution Molecular Models Reveal the Oligomeric State of the PPAR and the Conformational Organization of Its Domains in Solution	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; HYDROGEN-DEUTERIUM EXCHANGE; THYROID-HORMONE; DNA-BINDING; CRYSTAL-STRUCTURE; SCATTERING DATA; RXR-ALPHA; NUCLEAR; PROTEINS; DIMERS	The peroxisome proliferator-activated receptors (PPARs) regulate genes involved in lipid and carbohydrate metabolism, and are targets of drugs approved for human use. Whereas the crystallographic structure of the complex of full length PPAR gamma and RXR alpha is known, structural alterations induced by heterodimer formation and DNA contacts are not well understood. Herein, we report a small-angle X-ray scattering analysis of the oligomeric state of hPPAR gamma alone and in the presence of retinoid X receptor (RXR). The results reveal that, in contrast with other studied nuclear receptors, which predominantly form dimers in solution, hPPAR gamma remains in the monomeric form by itself but forms heterodimers with hRXR alpha. The low-resolution models of hPPAR gamma/RXR alpha complexes predict significant changes in opening angle between heterodimerization partners (LBD) and extended and asymmetric shape of the dimer (LBD-DBD) as compared with X-ray structure of the full-length receptor bound to DNA. These differences between our SAXS models and the high-resolution crystallographic structure might suggest that there are different conformations of functional heterodimer complex in solution. Accordingly, hydrogen/deuterium exchange experiments reveal that the heterodimer binding to DNA promotes more compact and less solvent-accessible conformation of the receptor complex.	[Bernardes, Amanda; Batista, Fernanda A. H.; Neto, Mario de Oliveira; Polikarpov, Igor] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil; [Figueira, Ana Carolina M.] CNPEM, Natl Lab Biosci, Sao Paulo, Brazil; [Webb, Paul] Methodist Hosp, Ctr Diabet, Houston, TX 77030 USA; [Webb, Paul] Methodist Hosp, Canc Res Unit, Houston, TX 77030 USA; [Saidemberg, Daniel; Palma, Mario S.] Univ Estadual Sao Paulo UNESP, Inst Biosci Rio Claro, Dept Biol, Ctr Study Social Insects CEIS, Sao Paulo, Brazil; [Saidemberg, Daniel; Palma, Mario S.] Natl Inst Sci & Technol Immunol INCT Iii, Sao Paulo, Brazil	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Estadual Paulista	Bernardes, A (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil.	ipolikarpov@ifsc.usp.br	Fapesp, Biota/F-8655-2017; Neto, Mario Oliveira/F-2717-2013; Bernardes, Amanda/H-8910-2012; Batista, Fernanda A.H./E-1633-2013; Polikarpov, Igor/D-2575-2012; Figueira, Ana Carolina/X-1649-2019; Palma, Mario Sergio/E-7800-2012; Palma, Mario/N-3903-2019	Fapesp, Biota/0000-0002-9887-8449; Figueira, Ana Carolina/0000-0002-7023-8490; Palma, Mario Sergio/0000-0002-7363-8211; Oliveira Neto, Mario/0000-0002-6226-7419; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/00182-8, 07/58443-4, 08/05637-9, 08/00078-1, 10/17048-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants 06/00182-8, 07/58443-4, 08/05637-9, 08/00078-1 and 10/17048-8, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We also thank the staff of the National Synchrotron Light Laboratory (LNLS, Brazil) for access to the SAXS beamline and others facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; Calgaro MR, 2007, PROTEIN SCI, V16, P1762, DOI 10.1110/ps.062692207; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Chiarelli F, 2008, VASC HEALTH RISK MAN, V4, P297; Cox SL, 2006, DRUG TODAY, V42, P139, DOI 10.1358/dot.2006.42.3.937961; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Figueira ACM, 2006, CELL BIOCHEM BIOPHYS, V44, P453, DOI 10.1385/CBB:44:3:453; Fischer H, 2003, J BIOL CHEM, V278, P16030, DOI 10.1074/jbc.M206953200; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glass CK, 2000, GENE DEV, V14, P121; Gronemeyer H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.273pe34; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenhard JM, 2001, RECEPTOR CHANNEL, V7, P249; Mahindroo N, 2005, J MED CHEM, V48, P8194, DOI 10.1021/jm0506930; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Figueira ACM, 2007, BIOCHEMISTRY-US, V46, P1273, DOI 10.1021/bi061698h; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Yan XG, 2004, BIOCHEMISTRY-US, V43, P909, DOI 10.1021/bi030183c; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	47	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31852	10.1371/journal.pone.0031852	http://dx.doi.org/10.1371/journal.pone.0031852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363753	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700108
J	Giron-Michel, J; Azzi, S; Khawam, K; Mortier, E; Caignard, A; Devocelle, A; Ferrini, S; Croce, M; Francois, H; Lecru, L; Charpentier, B; Chouaib, S; Azzarone, B; Eid, P				Giron-Michel, Julien; Azzi, Sandy; Khawam, Krystel; Mortier, Erwan; Caignard, Anne; Devocelle, Aurore; Ferrini, Silvano; Croce, Michela; Francois, Helene; Lecru, Lola; Charpentier, Bernard; Chouaib, Salem; Azzarone, Bruno; Eid, Pierre			Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the gamma c Signaling Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR-ALPHA-CHAIN; RENAL-CELL CARCINOMA; E-CADHERIN; HUMAN MONOCYTES; CELIAC-DISEASE; IL-2 RECEPTOR; BETA-CHAIN; T-CELLS; EXPRESSION	The ability of Interleukin-15 (IL-15) to activate many immune antitumor mechanisms renders the cytokine a good candidate for the therapy of solid tumors, particularly renal cell carcinoma. Although IL-15 is being currently used in clinical trials, the function of the cytokine on kidney's components has not been extensively studied; we thus investigated the role of IL-15 on normal and tumor renal epithelial cells. Herein, we analyzed the expression and the biological functions of IL-15 in normal renal proximal tubuli (RPTEC) and in their neoplastic counterparts, the renal clear cell carcinomas (RCC). This study shows that RPTEC express a functional heterotrimeric IL-15R alpha beta gamma c complex whose stimulation with physiologic concentrations of rhIL-15 is sufficient to inhibit epithelial mesenchymal transition (EMT) commitment preserving E-cadherin expression. Indeed, IL-15 is not only a survival factor for epithelial cells, but it can also preserve the renal epithelial phenotype through the gamma c-signaling pathway, demonstrating that the cytokine possess a wide range of action in epithelial homeostasis. In contrast, in RCC in vitro and in vivo studies reveal a defect in the expression of gamma c-receptor and JAK3 associated kinase, which strongly impacts IL-15 signaling. Indeed, in the absence of the gamma c/JAK3 couple we demonstrate the assembly of an unprecedented functional high affinity IL-15R alpha beta heterodimer, that in response to physiologic concentrations of IL-15, triggers an unbalanced signal causing the down-regulation of the tumor suppressor gene E-cadherin, favoring RCC EMT process. Remarkably, the rescue of IL-15/gamma c-dependent signaling (STAT5), by co-transfecting gamma c and JAK3 in RCC, inhibits EMT reversion. In conclusion, these data highlight the central role of IL-15 and gamma c-receptor signaling in renal homeostasis through the control of E-cadherin expression and preservation of epithelial phenotype both in RPTEC (up-regulation) and RCC (down-regulation).	[Giron-Michel, Julien; Azzi, Sandy; Khawam, Krystel; Devocelle, Aurore; Francois, Helene; Lecru, Lola; Charpentier, Bernard; Azzarone, Bruno; Eid, Pierre] Hop Paul Brousse, INSERM, UMR 1014, Villejuif, France; [Mortier, Erwan] Univ Nantes, INSERM, UMRS 892, Inst Rech Therapeut, Nantes, France; [Caignard, Anne] Univ Paris 05, Inst Cochin, INSERM, U1016, Paris, France; [Ferrini, Silvano; Croce, Michela] Inst Nazl Ric Canc, Lab Immunotherapy, Genoa, Italy; [Chouaib, Salem] Univ Paris 11, INSERM, UMR 753, Inst Gustave Roussy, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS AOU San Martino IST; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Giron-Michel, J (corresponding author), Hop Paul Brousse, INSERM, UMR 1014, Villejuif, France.	bazzarone@hotmail.com; pierre.eid@inserm.fr	Azzarone, Bruno/AAH-9251-2019; Mortier, Erwan/AAH-7925-2021; Giron-michel, Julien/GNP-7299-2022; Mortier, Erwan/B-2189-2009; Giron-Michel, Julien/Q-4503-2018; Mortier, Erwan/ABG-6465-2021; Caignard, Anne/F-8159-2013; Croce, Michela/AAA-8966-2020	Azzarone, Bruno/0000-0002-5962-3849; Giron-michel, Julien/0000-0001-6613-6099; Giron-Michel, Julien/0000-0001-6613-6099; Mortier, Erwan/0000-0002-6321-6488; Caignard, Anne/0000-0001-9923-6045; Croce, Michela/0000-0003-4683-4951; Ferrini, Silvano/0000-0001-7254-2616; Francois, Helene/0000-0001-7436-9554	Agence Francaise de Biomedicine; ARC (Association pour la Recherche sur le Cancer) [RAC11005LLA]; InCa; NRB-Vaincre le Cancer; AIRC (Associazione Italiana per la Ricerca sul Cancro) [5642]; Italian Ministry of Health; Societe Francaise de Nephrologie; Fondazione Italiana per la Lotta al Neuroblastoma	Agence Francaise de Biomedicine; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); InCa(Institut National du Cancer (INCA) France); NRB-Vaincre le Cancer; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Societe Francaise de Nephrologie; Fondazione Italiana per la Lotta al Neuroblastoma	This work was supported by grants from Agence Francaise de Biomedicine, ARC (Association pour la Recherche sur le Cancer) (N degrees RAC11005LLA), InCa, NRB-Vaincre le Cancer, AIRC (Associazione Italiana per la Ricerca sul Cancro) IG project 5642 and Italian Ministry of Health. S.A. was a recipient of ARC and NRB-Vaincre le Cancer doctoral fellowships. K.K. was a recipient of doctoral fellowships from Societe Francaise de Nephrologie, ARC and NRB-Vaincre le Cancer. M.C. was a recipient of a fellowship from Fondazione Italiana per la Lotta al Neuroblastoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi S, 2009, J IMMUNOL, V182, P3304, DOI 10.4049/jimmunol.0802400; ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; ATZPODIEN J, 1995, J CLIN ONCOL, V13, P497, DOI 10.1200/JCO.1995.13.2.497; BOSCO MC, 1994, BLOOD, V83, P2995, DOI 10.1182/blood.V83.10.2995.2995; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Eini H, 2009, J INTERFERON CYTOKIN, V30, P1; Fiorito S, 2005, RHEUMATOLOGY, V44, P164, DOI 10.1093/rheumatology/keh431; Franciszkiewicz K, 2009, CANCER RES, V69, P6249, DOI 10.1158/0008-5472.CAN-08-3571; Gambaro G, 2007, AM J PHYSIOL-RENAL, V293, pF1758, DOI 10.1152/ajprenal.00350.2007; Garcia-Tunon I, 2004, BREAST CANCER RES, V6, pR1, DOI 10.1186/bcr730; Ge N, 2004, INT ARCH ALLERGY IMM, V135, P235, DOI 10.1159/000081309; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Giron-Michel J, 2009, BLOOD, V113, P4541, DOI 10.1182/blood-2008-12-195289; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; LAI KS, 1995, J BIOL CHEM, V270, P25028, DOI 10.1074/jbc.270.42.25028; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; Nishiyama R, 2001, J BIOL CHEM, V276, P35571, DOI 10.1074/jbc.M106013200; Notarangelo LD, 2000, IMMUNOBIOLOGY, V202, P106, DOI 10.1016/S0171-2985(00)80058-3; Obermeier F, 2006, EUR J IMMUNOL, V36, P2691, DOI 10.1002/eji.200535173; Ogbomo H, 2010, BIOCHEM PHARMACOL, V79, P188, DOI 10.1016/j.bcp.2009.07.026; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Reichert TE, 2000, ONCOGENE, V19, P514, DOI 10.1038/sj.onc.1203391; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sasson R, 2003, BIOCHEM PHARMACOL, V66, P1393, DOI 10.1016/S0006-2952(03)00489-1; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Stone KP, 2011, J NEUROCHEM, V116, P544, DOI 10.1111/j.1471-4159.2010.07142.x; Tejman-Yarden N, 2005, NEPHROL DIAL TRANSPL, V20, P516, DOI 10.1093/ndt/gfh616; Tsukadaira A, 2002, EXP LUNG RES, V28, P123, DOI 10.1080/019021402753462040; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Viey E, 2005, EXPERT REV ANTICANC, V5, P973, DOI 10.1586/14737140.5.6.973; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weiler M, 1998, J AM SOC NEPHROL, V9, P1194; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wong WK, 2003, TRANSPLANTATION, V75, P505, DOI 10.1097/01.TP.0000045708.39879.C7; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Xu GS, 2008, NEPHROLOGY, V13, P694, DOI 10.1111/j.1440-1797.2008.00998.x; Yabu JM, 2007, SEMIN NEPHROL, V27, P479, DOI 10.1016/j.semnephrol.2007.03.009; Yanagita M, 2002, BIOCHEM BIOPH RES CO, V297, P329, DOI 10.1016/S0006-291X(02)02201-5; Zhang GQ, 2007, J AM SOC NEPHROL, V18, P846, DOI 10.1681/ASN.2006080886; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	59	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31624	10.1371/journal.pone.0031624	http://dx.doi.org/10.1371/journal.pone.0031624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363690	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700078
J	Jagadeesan, R; Collins, PJ; Daglish, GJ; Ebert, PR; Schlipalius, DI				Jagadeesan, Rajeswaran; Collins, Patrick J.; Daglish, Gregory J.; Ebert, Paul R.; Schlipalius, David I.			Phosphine Resistance in the Rust Red Flour Beetle, Tribolium castaneum (Coleoptera: Tenebrionidae): Inheritance, Gene Interactions and Fitness Costs	PLOS ONE			English	Article							LESSER GRAIN BORER; FUMIGATION	The recent emergence of heritable high level resistance to phosphine in stored grain pests is a serious concern among major grain growing countries around the world. Here we describe the genetics of phosphine resistance in the rust red flour beetle Tribolium castaneum (Herbst), a pest of stored grain as well as a genetic model organism. We investigated three field collected strains of T. castaneum viz., susceptible (QTC4), weakly resistant (QTC1012) and strongly resistant (QTC931) to phosphine. The dose-mortality responses of their test- and inter-cross progeny revealed that most resistance was conferred by a single major resistance gene in the weakly (3.2x) resistant strain. This gene was also found in the strongly resistant (431x) strain, together with a second major resistance gene and additional minor factors. The second major gene by itself confers only 12-206x resistance, suggesting that a strong synergistic epistatic interaction between the genes is responsible for the high level of resistance (431x) observed in the strongly resistant strain. Phosphine resistance is not sex linked and is inherited as an incompletely recessive, autosomal trait. The analysis of the phenotypic fitness response of a population derived from a single pair inter-strain cross between the susceptible and strongly resistant strains indicated the changes in the level of response in the strong resistance phenotype; however this effect was not consistent and apparently masked by the genetic background of the weakly resistant strain. The results from this work will inform phosphine resistance management strategies and provide a basis for the identification of the resistance genes.	[Jagadeesan, Rajeswaran; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Jagadeesan, Rajeswaran; Collins, Patrick J.; Daglish, Gregory J.; Schlipalius, David I.] Agrisci Queensland, Dept Employment Econ Dev & Innovat, Ecosci Precinct, Brisbane, Qld, Australia	University of Queensland	Jagadeesan, R (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	david.schlipalius@deedi.qld.gov.au	Jagadeesan, Rajeswaran/K-8804-2019; Schlipalius, David/B-8155-2011	Schlipalius, David/0000-0002-8102-7031; Ebert, Paul/0000-0002-4435-0737; Jagadeesan, Rajeswaran/0000-0002-9890-5953; Daglish, Gregory/0000-0003-1940-2643	Australian Government's Cooperative Research Centre for National Plant Biosecurity; University of Queensland International Postgraduate Scholarship	Australian Government's Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of Queensland International Postgraduate Scholarship	This work was supported by the Australian Government's Cooperative Research Centre for National Plant Biosecurity and a University of Queensland International Postgraduate Scholarship (awarded to Dr. Jagadeesan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abdi H, 2007, ENCYCL MEASUR STATIS, V1; ANDRES LA, 1960, J ECON ENTOMOL, V53, P626, DOI 10.1093/jee/53.4.626; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Ansell M. R., 1990, P 5 INT WORK C STOR, P961; Ansell MR, 1992, THESIS U READING REA; Athie I., 2005, Brazilian Journal of Food Technology, V8, P143; BEKON KA, 1988, AGRON TROP, V43, P59; Bell CH, 2000, CROP PROT, V19, P563, DOI 10.1016/S0261-2194(00)00073-9; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bui CH, 1999, P 7 INT WORK C STOR, P648; Collins P.J., 2001, P INT C CONTR ATM FU, P593; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Daglish GJ, 2002, PEST MANAG SCI, V58, P1015, DOI 10.1002/ps.532; Finney DJ, PROBIT ANAL; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; Hardstone MC, 2010, PESTIC BIOCHEM PHYS, V97, P123, DOI 10.1016/j.pestbp.2009.07.010; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; Li Yan-Sheng, 1994, Acta Entomologica Sinica, V37, P271; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Magnin M, 1986, RESISTANCE INSECTICI; NAKAKITA H, 1987, J PESTIC SCI, V12, P299; Payne RW, 2004, GENSTAT WINDOWS RELE; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; Rajendran S, 2004, PEST MANAG SCI, V60, P1114, DOI 10.1002/ps.931; Rajendran S, 2000, J STORED PROD RES, V36, P101, DOI 10.1016/S0022-474X(99)00038-7; RAYMOND M, 1989, GENETICS, V123, P543; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; Roush RT., 1990, PESTICIDE RESISTANCE, P97, DOI DOI 10.1007/978-1-4684-6429-0_5; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2002, GENETICS, V161, P773; Sokal R. R., 2012, BIOMETRY; Sousa AH, 2009, J STORED PROD RES, V45, P241, DOI 10.1016/j.jspr.2009.04.003; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Taylor R. W. D., 1986, 1986 British Crop Protection Conference. Pests and diseases. Volume 2. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986., P607; TSUKAMOTO MASUHISA, 1963, BOTYU KAGAKU BUL INST CONTR, V28, P91; Tyler P. S., 1983, International Pest Control, V25, P10; Wallbank B, 1998, AUSTR POSTH TECHN C, P295; Wang DX, 2006, J STORED PROD RES, V42, P207, DOI 10.1016/j.jspr.2005.02.001; Yang C, 1998, P 7 INT WORK C STOR, P617	43	95	100	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31582	10.1371/journal.pone.0031582	http://dx.doi.org/10.1371/journal.pone.0031582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363681	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000302873700077
J	Koguchi, Y; Buenafe, AC; Thauland, TJ; Gardell, JL; Bivins-Smith, ER; Jacoby, DB; Slifka, MK; Parker, DC				Koguchi, Yoshinobu; Buenafe, Abigail C.; Thauland, Timothy J.; Gardell, Jennifer L.; Bivins-Smith, Elizabeth R.; Jacoby, David B.; Slifka, Mark K.; Parker, David C.			Preformed CD40L Is Stored in Th1, Th2, Th17, and T Follicular Helper Cells as Well as CD4(+)8(-) Thymocytes and Invariant NKT Cells but Not in Treg Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; THYMIC EPITHELIAL-CELLS; DENDRITIC CELLS; IN-VIVO; IMMUNE-RESPONSES; EFFECTOR FUNCTION; POSTTRANSCRIPTIONAL REGULATION; SECRETORY LYSOSOMES; CD40-CD40 LIGAND; TRANSGENIC MICE	CD40L is essential for the development of adaptive immune responses. It is generally thought that CD40L expression in CD4(+) T cells is regulated transcriptionally and made from new mRNA following antigen recognition. However, imaging studies show that the majority of cognate interactions between effector CD4(+) T cells and APCs in vivo are too short to allow de novo CD40L synthesis. We previously showed that Th1 effector and memory cells store preformed CD40L (pCD40L) in lysosomal compartments and mobilize it onto the plasma membrane immediately after antigenic stimulation, suggesting that primed CD4(+) T cells may use pCD40L to activate APCs during brief encounters. Indeed, our recent study showed that pCD40L is sufficient to mediate selective activation of cognate B cells and trigger DC activation in vitro. In this study, we show that pCD40L is present in Th1 and follicular helper T cells developed during infection with lymphocytic choriomeningitis virus, Th2 cells in the airway of asthmatic mice, and Th17 cells from the CNS of animals with experimental autoimmune encephalitis (EAE). pCD40L is nearly absent in both natural and induced Treg cells, even in the presence of intense inflammation such as occurs in EAE. We also found pCD40L expression in CD4 single positive thymocytes and invariant NKT cells. Together, these results suggest that pCD40L may function in T cell development as well as an unexpectedly broad spectrum of innate and adaptive immune responses, while its expression in Treg cells is repressed to avoid compromising their suppressive activity.	[Koguchi, Yoshinobu; Thauland, Timothy J.; Gardell, Jennifer L.; Slifka, Mark K.; Parker, David C.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Buenafe, Abigail C.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Bivins-Smith, Elizabeth R.; Jacoby, David B.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Slifka, Mark K.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Koguchi, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	parkerd@ohsu.edu	Parker, David C/A-5428-2008	Jacoby, David/0000-0003-2195-9512; Parker, David/0000-0003-4456-2788; Koguchi, Yoshinobu/0000-0002-5733-5755	National Institutes of Health [ROI AI050823, R01 AI070934, R21 AI077032, AI054458, HL061013, HL071795, AI075064, T32 AI078903]; Oregon National Primate Research Center [RR000163]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061013, R01HL071795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070934, R01AI054458, R01AI050823, R01AI092080, T32AI078903, R21AI075064, R21AI077032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants ROI AI050823, R01 AI070934, and R21 AI077032 to DCP, AI054458 to MKS, HL061013, HL071795, and AI075064 to DBJ, and Oregon National Primate Research Center grant (RR000163) to MKS. JLG and TJT have been supported as trainees on an institutional training grant from the NIH (T32 AI078903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bolduc A, 2010, J IMMUNOL, V185, P220, DOI 10.4049/jimmunol.0901689; BOWEN F, 1995, EUR J IMMUNOL, V25, P2830, DOI 10.1002/eji.1830251018; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; Cohen GB, 2005, J IMMUNOL METHODS, V302, P103, DOI 10.1016/j.jim.2005.05.002; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kasprowicz DJ, 2003, J IMMUNOL, V171, P1216, DOI 10.4049/jimmunol.171.3.1216; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Koguchi Y, 2011, J IMMUNOL, V187, P626, DOI 10.4049/jimmunol.1004083; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Kweon MN, 1999, J IMMUNOL, V162, P1904; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee BO, 2002, J EXP MED, V196, P693, DOI 10.1084/jem.20020845; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Lettesjo H, 2000, J IMMUNOL, V165, P4095, DOI 10.4049/jimmunol.165.7.4095; Li W, 2011, INT IMMUNOPHARMACOL, V11, P1205, DOI 10.1016/j.intimp.2011.03.021; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vavassori S, 2009, RNA BIOL, V6, P259, DOI 10.4161/rna.6.3.8581; Vavassori S, 2009, EUR J IMMUNOL, V39, P2224, DOI 10.1002/eji.200839163; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yi YJ, 2000, J IMMUNOL, V165, P6627, DOI 10.4049/jimmunol.165.11.6627; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou F, 2005, HEPATOLOGY, V42, P372, DOI 10.1002/hep.20802; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	84	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31296	10.1371/journal.pone.0031296	http://dx.doi.org/10.1371/journal.pone.0031296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363608	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700044
J	Sarkar, S; Tang, XLL; Das, D; Spencer, JS; Lowary, TL; Suresh, MR				Sarkar, Susmita; Tang, Xinli L.; Das, Dipankar; Spencer, John S.; Lowary, Todd L.; Suresh, Mavanur R.			A Bispecific Antibody Based Assay Shows Potential for Detecting Tuberculosis in Resource Constrained Laboratory Settings	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; MONOCLONAL-ANTIBODIES; CLINICAL UTILITY; PULMONARY TUBERCULOSIS; SPUTUM SAMPLES; P24 ANTIGEN; LAM-ELISA; DIAGNOSIS; URINE; INFECTION	The re-emergence of tuberculosis (TB) as a global public health threat highlights the necessity of rapid, simple and inexpensive point-of-care detection of the disease. Early diagnosis of TB is vital not only for preventing the spread of the disease but also for timely initiation of treatment. The later in turn will reduce the possible emergence of multi-drug resistant strains of Mycobacterium tuberculosis. Lipoarabinomannan (LAM) is an important non-protein antigen of the bacterial cell wall, which is found to be present in different body fluids of infected patients including blood, urine and sputum. We have developed a bispecific monoclonal antibody with predetermined specificities towards the LAM antigen and a reporter molecule horseradish peroxidase (HRPO). The developed antibody was subsequently used to design a simple low cost immunoswab based assay to detect LAM antigen. The limit of detection for spiked synthetic LAM was found to be 5.0 ng/ml (bovine urine), 0.5 ng/ml (rabbit serum) and 0.005 ng/ml (saline) and that for bacterial LAM from M. tuberculosis H37Rv was found to be 0.5 ng/ml (rabbit serum). The assay was evaluated with 21 stored clinical serum samples (14 were positive and 7 were negative in terms of anti-LAM titer). In addition, all 14 positive samples were culture positive. The assay showed 100% specificity and 64% sensitivity (95% confidence interval). In addition to good specificity, the end point could be read visually within two hours of sample collection. The reported assay might be used as a rapid tool for detecting TB in resource constrained laboratory settings.	[Sarkar, Susmita; Tang, Xinli L.; Das, Dipankar; Suresh, Mavanur R.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Spencer, John S.] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; [Spencer, John S.] Colorado State Univ, Dept Immunol, Ft Collins, CO 80523 USA; [Spencer, John S.] Colorado State Univ, Dept Pathol, Ft Collins, CO 80523 USA; [Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Lowary, Todd L.] Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB, Canada	University of Alberta; Colorado State University; Colorado State University; Colorado State University; University of Alberta; University of Alberta	Sarkar, S (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	msuresh@pharmacy.ualberta.ca	Lowary, Todd L/F-9608-2019; Spencer, John S/G-6968-2017	Lowary, Todd L/0000-0002-8331-8211; Spencer, John S/0000-0002-8051-3038	Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada	Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada	The authors acknowledge the Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada, for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bhatnagar PK, 2008, J CHROMATOGR B, V863, P235, DOI 10.1016/j.jchromb.2008.01.003; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Campos M, 2008, AM J RESP CRIT CARE, V178, P300, DOI 10.1164/rccm.200803-381OC; Cao Y, 1998, BIOCONJUGATE CHEM, V9, P635, DOI 10.1021/bc980044l; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chaudhary M, 2010, INDIAN J MED MICROBI, V28, P281, DOI 10.4103/0255-0857.71805; Das D, 2005, METH MOLEC MED, V109, P329; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; Gadikota RR, 2003, J CARBOHYD CHEM, V22, P459, DOI 10.1081/CAR-120025322; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Guttikonda S, 2007, J IMMUNOL METHODS, V327, P1, DOI 10.1016/j.jim.2007.06.010; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kreutz FT, 1998, HYBRIDOMA, V17, P267, DOI 10.1089/hyb.1998.17.267; KRIJGER FW, 1994, ACTA TROP, V56, P55, DOI 10.1016/0001-706X(94)90040-X; Lalvani A, 2008, AUTOIMMUN REV, V8, P147, DOI 10.1016/j.autrev.2008.07.011; Lawn SD, 2011, LANCET INFECT D 1017; Lipman NS, 2005, ILAR J, V46, P258, DOI 10.1093/ilar.46.3.258; Luetkemeyer Anne F, 2010, Top HIV Med, V18, P143; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Madariaga MG, 2007, J AM BOARD FAM MED, V20, P540, DOI 10.3122/jabfm.2007.06.070109; Mahadevan S., 1997, Indian Journal of Pediatrics, V64, P97, DOI 10.1007/BF02795786; MILES SA, 1993, NEW ENGL J MED, V328, P297, DOI 10.1056/NEJM199302043280501; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Patel VB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015664; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Rademacher C, 2007, J AM CHEM SOC, V129, P10489, DOI 10.1021/ja0723380; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; Ritter MA, 2000, METH MOLEC MED, V40, P23, DOI 10.1385/1-59259-076-4:23; Russell D, 1998, KEYST C TB MOL MECH; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Sarkar S, 2011, J PHARM PHARM SCI, V14, P148, DOI 10.18433/J33591; Shahhosseini S, 2007, J VIROL METHODS, V143, P29, DOI 10.1016/j.jviromet.2007.02.004; Shahhosseini S, 2006, J PHARM PHARM SCI, V9, P26; Spencer JS, 2011, CLIN VACCINE IMMUNOL, V18, P260, DOI 10.1128/CVI.00472-10; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; SURESH MR, 1986, P NATL ACAD SCI USA, V83, P7989, DOI 10.1073/pnas.83.20.7989; Tang XL, 2004, CLIN DIAGN LAB IMMUN, V11, P752, DOI 10.1128/CDLI.11.4.752-757.2004; Theron G, 2011, EUR RESP J      1110; Tong M, 2005, J IMMUNOL METHODS, V301, P154, DOI 10.1016/j.jim.2005.04.004; VASUDEVACHARI MB, 1993, J CLIN IMMUNOL, V13, P185, DOI 10.1007/BF00919971	55	18	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32340	10.1371/journal.pone.0032340	http://dx.doi.org/10.1371/journal.pone.0032340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363820	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700161
J	Sharma, YV; Cojocaru, RI; Ritter, LM; Khattree, N; Brooks, M; Scott, A; Swaroop, A; Goldberg, AFX				Sharma, Yagya V.; Cojocaru, Radu I.; Ritter, Linda M.; Khattree, Nidhi; Brooks, Matthew; Scott, Alison; Swaroop, Anand; Goldberg, Andrew F. X.			Protective Gene Expression Changes Elicited by an Inherited Defect in Photoreceptor Structure	PLOS ONE			English	Article							NRL(-/-) MOUSE RETINA; RDS MUTANT MICE; CELL-DEATH; MESSENGER-RNA; ALTERED EXPRESSION; FACTOR MEF2C; DEGENERATION; LIGHT; IDENTIFICATION; MICROGLIA	Inherited defects in retinal photoreceptor structure impair visual transduction, disrupt relationship with the retinal pigment epithelium (RPE), and compromise cell viability. A variety of progressive retinal degenerative diseases can result, and knowledge of disease etiology remains incomplete. To investigate pathogenic mechanisms in such instances, we have characterized rod photoreceptor and retinal gene expression changes in response to a defined insult to photoreceptor structure, using the retinal degeneration slow (rds) mouse model. Global gene expression profiling was performed on flow-sorted rds and wild-type rod photoreceptors immediately prior and subsequent to times at which OSs are normally elaborated. Dysregulated genes were identified via microarray hybridization, and selected candidates were validated using quantitative PCR analyses. Both the array and qPCR data revealed that gene expression changes were generally modest and dispersed amongst a variety of known functional networks. Although genes showing major (> 5-fold) differential expression were identified in a few instances, nearly all displayed transient temporal profiles, returning to WT levels by postnatal day (P) 21. These observations suggest that major defects in photoreceptor cell structure may induce early homeostatic responses, which function in a protective manner to promote cell viability. We identified a single key gene, Egr1, that was dysregulated in a sustained fashion in rds rod photoreceptors and retina. Egr1 upregulation was associated with microglial activation and migration into the outer retina at times subsequent to the major peak of photoreceptor cell death. Interestingly, this response was accompanied by neurotrophic factor upregulation. We hypothesize that activation of Egr1 and neurotrophic factors may represent a protective immune mechanism which contributes to the characteristically slow retinal degeneration of the rds mouse model.	[Sharma, Yagya V.; Ritter, Linda M.; Khattree, Nidhi; Goldberg, Andrew F. X.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA; [Brooks, Matthew; Scott, Alison; Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Cojocaru, Radu I.; Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	Oakland University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sharma, YV (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	goldberg@oakland.edu		Swaroop, Anand/0000-0002-1975-1141; Scott, Alison/0000-0001-6969-4707	E. Matilda Zeigler Foundation; National Institutes of Health [EY013246, RR017890]; Foundation Fighting Blindness and intramural funds of the National Eye Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017890] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000473, R01EY013246] Funding Source: NIH RePORTER	E. Matilda Zeigler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness and intramural funds of the National Eye Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the E. Matilda Zeigler Foundation and the National Institutes of Health [EY013246 and RR017890] to AFXG, and by The Foundation Fighting Blindness and intramural funds of the National Eye Institute to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL N, 1994, FEBS LETT, V339, P253, DOI 10.1016/0014-5793(94)80426-5; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Brand C, 2005, MOL VIS, V11, P309; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Conley SM, 2009, EXP EYE RES, V89, P278, DOI 10.1016/j.exer.2009.03.023; Demos C, 2008, MOL VIS, V14, P1639; Escher P, 2011, INVEST OPHTH VIS SCI, V52, P5933, DOI 10.1167/iovs.10-6978; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Gehrig A, 2007, INVEST OPHTH VIS SCI, V48, P891, DOI 10.1167/iovs.06-0641; Goldberg AFX, 2007, INVEST OPHTH VIS SCI, V48, P2975, DOI 10.1167/iovs.07-0049; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hao H, 2011, J BIOL CHEM, V286, P34893, DOI 10.1074/jbc.M111.271072; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; Humphries A, 2004, BIOCHEM BIOPH RES CO, V320, P551, DOI 10.1016/j.bbrc.2004.06.006; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Langmann T, 2009, NEUROMOL MED, V11, P87, DOI 10.1007/s12017-009-8061-6; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Man PS, 2008, MOL VIS, V14, P1176; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Simon P, 2004, EUR J NEUROSCI, V20, P3371, DOI 10.1111/j.1460-9568.2004.03811.x; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Usukura J, 1995, PROG RETIN EYE RES, V15, P113, DOI 10.1016/1350-9462(95)00006-2; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Xue W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020326; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Yu JD, 2004, J BIOL CHEM, V279, P42211, DOI 10.1074/jbc.M408223200; Zhang C, 2005, MOL VIS, V11, P887	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31371	10.1371/journal.pone.0031371	http://dx.doi.org/10.1371/journal.pone.0031371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363631	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500037
J	Thakur, A; Chitoor, B; Goswami, AV; Pareek, G; Atreya, HS; D'Silva, P				Thakur, Anushikha; Chitoor, Balasubramanyam; Goswami, Arvind V.; Pareek, Gautam; Atreya, Hanudatta S.; D'Silva, Patrick			Structure and Mechanistic Insights into Novel Iron-mediated Moonlighting Functions of Human J-protein Cochaperone, Dph4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; J-DOMAIN; DIPHTHAMIDE BIOSYNTHESIS; BINDING; DNAJ; RUBREDOXIN; NMR; MATURATION; COMPLEXES; REQUIRES	J-proteins are obligate cochaperones of Hsp70s and stimulate their ATPase activity via the J-domain. Although the functions of J-proteins have been well understood in the context of Hsp70s, their additional co-evolved "physiological functions" are still elusive. We report here the solution structure and mechanism of novel iron-mediated functional roles of human Dph4, a type III J-protein playing a vital role in diphthamide biosynthesis and normal development. The NMR structure of Dph4 reveals two domains: a conserved J-domain and a CSL-domain connected via a flexible linker-helix. The linker-helix modulates the conformational flexibility between the two domains, regulating thereby the protein function. Dph4 exhibits a unique ability to bind iron in tetrahedral coordination geometry through cysteines of its CSL-domain. The oxidized Fe-Dph4 shows characteristic UV-visible and electron paramagnetic resonance spectral properties similar to rubredoxins. Iron-bound Dph4 (Fe-Dph4) also undergoes oligomerization, thus potentially functioning as a transient "iron storage protein," thereby regulating the intracellular iron homeostasis. Remarkably, Fe-Dph4 exhibits vital redox and electron carrier activity, which is critical for important metabolic reactions, including diphthamide biosynthesis. Further, we observed that Fe-Dph4 is conformationally better poised to perform Hsp70-dependent functions, thus underlining the significance of iron binding in Dph4. Yeast Jjj3, a functional ortholog of human Dph4 also shows a similar iron-binding property, indicating the conserved nature of iron sequestration across species. Taken together, our findings provide invaluable evidence in favor of additional co-evolved specialized functions of J-proteins, previously not well appreciated.	[Thakur, Anushikha; Atreya, Hanudatta S.] Indian Inst Sci, NMR Res Ctr, Bangalore 560012, Karnataka, India; [Thakur, Anushikha; Chitoor, Balasubramanyam; Goswami, Arvind V.; Pareek, Gautam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Thakur, Anushikha; Atreya, Hanudatta S.] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Atreya, HS (corresponding author), Indian Inst Sci, NMR Res Ctr, CV Raman Ave, Bangalore 560012, Karnataka, India.	hsatreya@sif.iisc.ernet.in; patrick@biochem.iisc.ernet.in	PAREEK, GAUTAM/AAN-4638-2020; D'Silva, Patrick/L-6653-2019	PAREEK, GAUTAM/0000-0001-8430-9870; 	University Grant Commission, India; Council for Scientific and Industrial Research, India; Department of Science and Technology; Wellcome Trust in Biomedical Science [WT081643MA]	University Grant Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Wellcome Trust in Biomedical Science	Supported by the University Grant Commission, India.; Supported by the Council for Scientific and Industrial Research, India.; Supported by a Department of Science and Technology research grants. To whom correspondence may be addressed: NMR Research Center, Indian Institute of Science, C. V. Raman Ave., Bangalore 560012, Karnataka, India. Tel.: 91-080-22933302; E-mail: hsatreya@sif.iisc.ernet.in.; Supported by Wellcome Trust International Senior Research Fellowship in Biomedical Science WT081643MA. To whom correspondence may be addressed: Dept. of Biochemistry, Indian Institute of Science, C. V. Raman Ave., Bangalore 560012, Karnataka, India. Tel.: 91-080-22932821; Fax: 91-080-23600814; E-mail: patrick@biochem.iisc.ernet.in.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Broderick JB, 2007, NAT CHEM BIOL, V3, P243, DOI 10.1038/nchembio0507-243; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Fewell SW, 2002, P NATL ACAD SCI USA, V99, P2002, DOI 10.1073/pnas.042670999; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pareek G, 2011, J BIOL CHEM, V286, P19001, DOI 10.1074/jbc.M110.197434; PETITDEMANGE H, 1979, BIOCHEM BIOPH RES CO, V91, P1258, DOI 10.1016/0006-291X(79)91202-6; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; RAO KK, 1972, BIOCHEM J, V129, P1063, DOI 10.1042/bj1291063; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2010, MOL CELL BIOL, V30, P33, DOI 10.1128/MCB.00842-09; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Whalen KA, 2005, J VIROL, V79, P9982, DOI 10.1128/JVI.79.15.9982-9990.2005; Wu FM, 2008, PROTEINS, V71, P514, DOI 10.1002/prot.21915; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; YANG SS, 1980, BIOCHIM BIOPHYS ACTA, V590, P24, DOI 10.1016/0005-2728(80)90143-7; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	49	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13194	13205		10.1074/jbc.M112.339655	http://dx.doi.org/10.1074/jbc.M112.339655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367199	Green Published, hybrid			2022-12-25	WOS:000302903700057
J	Zizak, M; Chen, T; Bartonicek, D; Sarker, R; Zachos, NC; Cha, BY; Kovbasnjuk, O; Korac, J; Mohan, S; Cole, R; Chen, YP; Tse, CM; Donowitz, M				Zizak, Mirza; Chen, Tiane; Bartonicek, Dorotea; Sarker, Rafiquel; Zachos, Nicholas C.; Cha, Boyoung; Kovbasnjuk, Olga; Korac, Jelena; Mohan, Sachin; Cole, Robert; Chen, Yueping; Tse, C. Ming; Donowitz, Mark			Calmodulin Kinase II Constitutively Binds, Phosphorylates, and Inhibits Brush Border Na+/H+ Exchanger 3 (NHE3) by a NHERF2 Protein-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; ISOFORM NHE3; ADENOMA DRA; PDZ DOMAIN; ACTIVATION; CALCIUM; COMPLEXES; REQUIRES; E3KARP; BASAL	The epithelial brush border (BB) Na+/H+ exchanger 3 (NHE3) accounts for most renal and intestinal Na+ absorption. Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibits NHE3 activity under basal conditions in intact intestine, acting in the BB, but the mechanism is unclear. We now demonstrate that in both PS120 fibroblasts and polarized Caco-2BBe cells expressing NHE3, CaMKII inhibits basal NHE3 activity, because the CaMKII-specific inhibitors KN-93 and KN-62 stimulate NHE3 activity. This inhibition requires NHERF2. CaMKII gamma associates with NHE3 between aa 586 and 605 in the NHE3 C terminus in a Ca2+-dependent manner, with less association when Ca2+ is increased. CaMKII inhibits NHE3 by an effect on its turnover number, not changing surface expression. Back phosphorylation demonstrated that NHE3 is phosphorylated by CaMKII under basal conditions. This overall phosphorylation of NHE3 is not affected by the presence of NHERF2. Amino acids downstream of NHE3 aa 690 are required for CaMKII to inhibit basal NHE3 activity, and mutations of the three putative CaMKII phosphorylation sites downstream of aa 690 each prevented KN-93 stimulation of NHE3 activity. These studies demonstrate that CaMKII gamma is a novel NHE3-binding protein, and this association is reduced by elevated Ca2+. CaMKII inhibits basal NHE3 activity associated with phosphorylation of NHE3 by effects requiring aa downstream of NHE3 aa 690 and of the CaMKII-binding site on NHE3. CaMKII binding to and phosphorylation of the NHE3 C terminus are parts of the physiologic regulation of NHE3 that occurs in fibroblasts as well as in the BB of an intestinal Na+-absorptive cell.	[Zizak, Mirza; Chen, Tiane; Sarker, Rafiquel; Zachos, Nicholas C.; Cha, Boyoung; Kovbasnjuk, Olga; Mohan, Sachin; Chen, Yueping; Tse, C. Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Physiol & Med, Baltimore, MD 21205 USA; [Cole, Robert] Johns Hopkins Univ, Sch Med, Dept Physiol Chem, Baltimore, MD 21205 USA; [Zizak, Mirza; Bartonicek, Dorotea; Korac, Jelena] Univ Zagreb, Sch Med, Dept Physiol, Zagreb 10000, Croatia	Johns Hopkins University; Johns Hopkins University; University of Zagreb	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Physiol & Med, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Prlic, Jelena Korac/AAJ-1029-2021; mohan, sachin/H-4017-2015; Zachos, Nicholas/GWC-7914-2022; Prlic, Jelena Korac/I-7988-2012	Prlic, Jelena Korac/0000-0002-7840-9979; Prlic, Jelena Korac/0000-0002-7840-9979; Mohan, Sachin/0000-0002-6798-4767	National Institutes of Health NIDDK [R01DK26523, R01DK61765, P01DK072084, R24DK64388, P30DK089502, K08DK088950, T32DK2007632]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK088950, R24DK064388, P30DK089502, R01DK061765, P01DK072084, R01DK026523] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R01DK26523, R01DK61765, P01DK072084, and R24DK64388 (to Hopkins Basic Research Digestive Diseases Development Core Center), P30DK089502 (to Hopkins Digestive Diseases Basic and Translational Core Center), and K08DK088950 and T32DK2007632 (to Hopkins Center for Epithelial Biology).	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B., 2007, GASTROENTEROLOGY, V132, P575; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COHEN ME, 1990, P NATL ACAD SCI USA, V87, P8990, DOI 10.1073/pnas.87.22.8990; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; EMMER E, 1989, J MEMBRANE BIOL, V108, P207, DOI 10.1007/BF01871735; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gangopadhyay SS, 2003, BIOCHEM J, V372, P347, DOI 10.1042/BJ20030015; Girardi ACC, 2001, J BIOL CHEM, V276, P46671, DOI 10.1074/jbc.M106897200; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Harada K, 2010, J BIOL CHEM, V285, P24044, DOI 10.1074/jbc.M109.072553; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; TSE CM, 1992, J BIOL CHEM, V267, P9340; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Yanaka A, 2002, AM J PHYSIOL-GASTR L, V282, pG866, DOI 10.1152/ajpgi.00150.2001; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Yoo BK, 2011, AM J PHYSIOL-CELL PH, V301, pC1008, DOI 10.1152/ajpcell.00231.2011; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2009, J BIOL CHEM, V284, P19437, DOI 10.1074/jbc.M109.006098; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	56	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13442	13456		10.1074/jbc.M111.307256	http://dx.doi.org/10.1074/jbc.M111.307256			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371496	Green Published, hybrid			2022-12-25	WOS:000302903700078
J	Boyapalle, S; Wong, T; Garay, J; Teng, M; Juan-Vergara, HS; Mohapatra, S; Mohapatra, S				Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; Teng, Michael; San Juan-Vergara, Homero; Mohapatra, Subhra; Mohapatra, Shyam			Respiratory Syncytial Virus NS1 Protein Colocalizes with Mitochondrial Antiviral Signaling Protein MAVS following Infection	PLOS ONE			English	Article							NF-KAPPA-B; ENHANCED PULMONARY HISTOPATHOLOGY; NONSTRUCTURAL PROTEINS; RIG-I; BALB/C MICE; RSV; INHIBITION; GENE; TRANSCRIPTION; EXPRESSION	Respiratory syncytial virus (RSV) nonstructural protein 1(NS1) attenuates type-I interferon (IFN) production during RSV infection; however the precise role of RSV NS1 protein in orchestrating the early host-virus interaction during infection is poorly understood. Since NS1 constitutes the first RSV gene transcribed and the production of IFN depends upon RLR (RIG-I-like receptor) signaling, we reasoned that NS1 may interfere with this signaling. Herein, we report that NS1 is localized to mitochondria and binds to mitochondrial antiviral signaling protein (MAVS). Live-cell imaging of rgRSV-infected A549 human epithelial cells showed that RSV replication and transcription occurs in proximity to mitochondria. NS1 localization to mitochondria was directly visualized by confocal microscopy using a cell-permeable chemical probe for His(6)-NS1. Further, NS1 colocalization with MAVS in A549 cells infected with RSV was shown by confocal laser microscopy and immunoelectron microscopy. NS1 protein is present in the mitochondrial fraction and co-immunoprecipitates with MAVS in total cell lysatesof A549 cells transfected with the plasmid pNS1-Flag. By immunoprecipitation with anti-RIG-I antibody, RSV NS1 was shown to associate with MAVS at an early stage of RSV infection, and to disrupt MAVS interaction with RIG-I (retinoic acid inducible gene) and the downstream IFN antiviral and inflammatory response. Together, these results demonstrate that NS1 binds to MAVS and that this binding inhibits the MAVS-RIG-I interaction required for IFN production.	[Boyapalle, Sandhya; Mohapatra, Subhra; Mohapatra, Shyam] James A Haley Vet Adm Hosp, Tampa, FL USA; [Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; Mohapatra, Subhra; Mohapatra, Shyam] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; San Juan-Vergara, Homero; Mohapatra, Subhra; Mohapatra, Shyam] Dept Internal Med, Div Translat Med, Tampa, FL USA; [Teng, Michael] Dept Allergy & Immunol, Tampa, FL USA; [Mohapatra, Subhra] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [San Juan-Vergara, Homero] Fdn Univ Norte, Dept Med, Barranquilla, Colombia	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Universidad del Norte	Boyapalle, S (corresponding author), James A Haley Vet Adm Hosp, Tampa, FL USA.	smohapat@health.usf.edu; smohapat@health.usf.edu	Teng, Michael N./I-5006-2012; Mohapatra, Subhra/A-1381-2012	Teng, Michael N./0000-0002-0722-3659; Tripp, Ralph/0000-0002-2924-9956; San Juan Vergara, Homero/0000-0002-3808-4647	Veterns Affairs (VA); University of South Florida (USF)	Veterns Affairs (VA); University of South Florida (USF)	This work is supported by a Veterns Affairs (VA) Career Scientist award and VA Merit Review award to Shyam Mohapatra, and a University of South Florida (USF) Health Development grant to Subhra Mohapatra. TW was supported by a USF Signature Research Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Blanchard SS, 2006, PEDIATR TRANSPLANT, V10, P826, DOI 10.1111/j.1399-3046.2006.00583.x; Boyapalle S, 2008, VIROLOGY, V375, P401, DOI 10.1016/j.virol.2008.02.008; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Ebbert JO, 2005, RESPIRATION, V72, P263, DOI 10.1159/000085367; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hainfeld JF, 1999, J STRUCT BIOL, V127, P185, DOI 10.1006/jsbi.1999.4149; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; KONG X, 2007, GENET VACCINES THER, V5, P1; Kong XY, 2003, BIOCHEM BIOPH RES CO, V306, P616, DOI 10.1016/S0006-291X(03)01008-8; Krishnan B, 2007, CHEM BIOL DRUG DES, V69, P31, DOI 10.1111/j.1747-0285.2007.00463.x; Kumar M, 1999, VACCINE, V18, P558, DOI 10.1016/S0264-410X(99)00185-1; Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schlender J, 2000, J VIROL, V74, P8234, DOI 10.1128/JVI.74.18.8234-8242.2000; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tran KC, 2004, J VIROL, V78, P692, DOI 10.1128/JVI.78.2.692-699.2004; WONG DT, 1983, MED CLIN N AM, V67, P1075, DOI 10.1016/S0025-7125(16)31167-1; Zamora MR, AM J RESP CRIT CARE; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	37	70	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29386	10.1371/journal.pone.0029386	http://dx.doi.org/10.1371/journal.pone.0029386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383950	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500003
J	Cao, H; Chu, YK; Lv, X; Qiu, PB; Liu, C; Zhang, HR; Li, D; Peng, S; Dou, ZY; Hua, JL				Cao, Hui; Chu, Yuankui; Lv, Xiao; Qiu, Pubin; Liu, Chao; Zhang, Huiru; Li, Dan; Peng, Sha; Dou, Zhongying; Hua, Jinlian			GSK3 Inhibitor-BIO Regulates Proliferation of Immortalized Pancreatic Mesenchymal Stem Cells (iPMSCs)	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CELLS; C-MYC; PHOSPHORYLATION; LITHIUM; PROTEIN; MAINTENANCE; GENERATION; SURVIVAL; INSULIN	Background: The small molecule 6-bromoindirubin-30-oxime (BIO), a glycogen synthase kinase 3 (GSK3) inhibitor, is a pharmacological agent known to maintain self-renewal in human and mouse embryonic stem cells (ESCs). However, the precise role of GSK3 in immortalized pancreatic mesenchymal stem cells (iPMSCs) growth and survival is not completely understood at present. Results: To determine whether this molecule is involved in controlling the proliferation of iPMSCs, we examined the effect of BIO on iPMSCs. We found that the inactivation of GSK3 by BIO can robustly stimulate iPMSCs proliferation and mass formation as shown by QRT-PCR, western blotting, 5-Bromo-2-deoxyuridine (BrdU) immunostaining assay and tunel assay. However, we did not find the related roles of BIO on beta cell differentiation by immunostaining, QRT-PCR assay, glucose-stimulated insulin release and C-peptide content analysis. Conclusions: These results suggest that BIO plays a key role in the regulation of cell mass proliferation and maintenance of the undifferentiated state of iPMSCs.	[Cao, Hui; Chu, Yuankui; Lv, Xiao; Qiu, Pubin; Liu, Chao; Peng, Sha; Dou, Zhongying; Hua, Jinlian] NW A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Key Lab Anim Biotechnol,Agr Minist China, Yangling, Shaanxi, Peoples R China; [Cao, Hui] Hope Biotechnol Su Zhou Co Ltd, Suzhou, Jiangsu, Peoples R China; [Zhang, Huiru; Li, Dan] Henan Univ Technol, Coll Bioengn, Zhengzhou 450000, Henan, Peoples R China	Northwest A&F University - China; Henan University of Technology	Cao, H (corresponding author), NW A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Key Lab Anim Biotechnol,Agr Minist China, Yangling, Shaanxi, Peoples R China.	jinlianhua@nwsuaf.edu.cn		zhang, hui ru/0000-0002-9030-1514	National Natural Science Foundation of China [30972097]; State Education Ministry [109148]; Program for New Century Excellent Talents in University [NCET-09-0654]; Scientific Research Program of Shaanxi Province [2008K02-05]; Fund for the Doctoral Program of Higher Education (SRFDP) [20100204120020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Education Ministry; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Program of Shaanxi Province; Fund for the Doctoral Program of Higher Education (SRFDP)	This work is supported by grants from National Natural Science Foundation of China (Program 30972097), Key Program of State Education Ministry (109148), Program for New Century Excellent Talents in University (NCET-09-0654), the Scientific Research Program of Shaanxi Province (2008K02-05), and Fund for the Doctoral Program of Higher Education (SRFDP, 20100204120020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 2007, CELL SIGNAL, V19, P378, DOI 10.1016/j.cellsig.2006.07.008; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Cao H, 2011, CELL PROLIFERAT, V44, P19, DOI 10.1111/j.1365-2184.2010.00714.x; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DENIS N, 1991, ONCOGENE, V6, P1453; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Elliott R B, 2008, United States Patent Application, Patent No. 20080070301; Feng RuoPeng, 2007, Agricultural Sciences in China, V6, P742, DOI 10.1016/S1671-2927(07)60107-2; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Klein PS, 1996, PNAS, V3, P8455; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Rogers SA, 2007, XENOTRANSPLANTATION, V14, P591, DOI 10.1111/j.1399-3089.2007.00429.x; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Schmidt MM, 2001, INT J DEV BIOL, V45, P421; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Silva AK, 2010, MOL VIS, V16, P36; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Wen J, 2010, REPRODUCTION, V139, P1039, DOI 10.1530/REP-09-0539; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wrobel KH, 1996, CELL TISSUE RES, V283, P191, DOI 10.1007/s004410050529; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042	36	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31502	10.1371/journal.pone.0031502	http://dx.doi.org/10.1371/journal.pone.0031502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384031	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100024
J	Kumar, R; Tran, LSP; Neelakandan, AK; Nguyen, HT				Kumar, Rajesh; Lam-Son Phan Tran; Neelakandan, Anjanasree K.; Nguyen, Henry T.			Higher Plant Cytochrome b5 Polypeptides Modulate Fatty Acid Desaturation	PLOS ONE			English	Article							OLEATE DESATURASE; LINOLENIC ACID; HETEROLOGOUS EXPRESSION; MICROSOMAL PREPARATIONS; DIFFERENT ISOFORMS; DEVELOPING SEEDS; B(5) REDUCTASE; BIOSYNTHESIS; GENES; IDENTIFICATION	Background: Synthesis of polyunsaturated fatty acids (PUFAs) in the endoplasmic reticulum of plants typically involves the fatty acid desaturases FAD2 and FAD3, which use cytochrome b(5) (Cb5) as an electron donor. Higher plants are reported to have multiple isoforms of Cb5, in contrast to a single Cb5 in mammals and yeast. Despite the wealth of information available on the roles of FAD2 and FAD3 in PUFA synthesis, information regarding the contributions of various Cb5 isoforms in desaturase-mediated reactions is limited. Results: The present functional characterization of Cb5 polypeptides revealed that all Arabidopsis Cb5 isoforms are not similarly efficient in omega-6 desaturation, as evidenced by significant variation in their product outcomes in yeast-based functional assays. On the other hand, characterization of Cb5 polypeptides of soybean (Glycine max) suggested that similar omega-6 desaturation efficiencies were shared by various isoforms. With regard to omega-3 desaturation, certain Cb5 genes of both Arabidopsis and soybean were shown to facilitate the accumulation of more desaturation products than others when co-expressed with their native FAD3. Additionally, similar trends of differential desaturation product accumulation were also observed with most Cb5 genes of both soybean and Arabidopsis even if co-expressed with non-native FAD3. Conclusions: The present study reports the first description of the differential nature of the Cb5 genes of higher plants in fatty acid desaturation and further suggests that omega-3/omega-6 desaturation product outcome is determined by the nature of both the Cb5 isoform and the fatty acid desaturases.	Univ Missouri, Div Plant Sci, Columbia, MO USA; Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kumar, R (corresponding author), NBPGR, Natl Res Ctr DNA Fingerprinting, New Delhi, India.	kraj.pgr@gmail.com; nguyenhenry@missouri.edu	Tran, Lam-Son P/A-1346-2009	Tran, Lam-Son P/0000-0001-9883-9768	Missouri Soybean Merchandising Council (MSMC)	Missouri Soybean Merchandising Council (MSMC)	This work was supported by a grant from Missouri Soybean Merchandising Council (MSMC) to the soybean genomics research program at the University of Missouri-Columbia. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR F, 1991, PLANT MOL BIOL, V17, P351, DOI 10.1007/BF00040630; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Anai T, 2005, PLANT SCI, V168, P1615, DOI 10.1016/j.plantsci.2005.02.016; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Cahoon EB, 2001, J BIOL CHEM, V276, P2637, DOI 10.1074/jbc.M009188200; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; de Vetten N, 1999, P NATL ACAD SCI USA, V96, P778, DOI 10.1073/pnas.96.2.778; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Dyer JM, 2008, PHYSIOL PLANTARUM, V132, P11, DOI 10.1111/j.1399-3054.2007.01021.x; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Fukuchi-Mizutani M, 1999, PLANT PHYSIOL, V119, P353, DOI 10.1104/pp.119.1.353; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kumar R, 2006, PLANT J, V48, P920, DOI 10.1111/j.1365-313X.2006.02925.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; LU GG, 1995, J MOL BIOL, V248, P931, DOI 10.1006/jmbi.1995.0273; Maggio C, 2007, J EXP BOT, V58, P1365, DOI 10.1093/jxb/erl303; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; NAGANO M, 2009, PLANT J; Nam JW, 2007, J EXP BOT, V58, P1421, DOI 10.1093/jxb/erm005; Napier JA, 2003, PROSTAG LEUKOTR ESS, V68, P135, DOI 10.1016/S0952-3278(02)00263-6; NAPIER JA, 1995, PLANTA, V197, P200, DOI 10.1007/BF00239957; Napier JA, 1997, BIOCHEM J, V328, P717; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pedrazzini E, 2009, J PLANT BIOL, V52, P88, DOI 10.1007/s12374-009-9014-1; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Rahier A, 1997, BIOCHEM BIOPH RES CO, V236, P434, DOI 10.1006/bbrc.1997.6974; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Sambrook J., 1989, MOL CLONING LAB MANU; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Shoemaker R, 2002, GENOME, V45, P329, DOI 10.1139/g01-150; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; SMITH MA, 1994, PLANT MOL BIOL, V25, P527, DOI 10.1007/BF00043880; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; SMITH MA, 1990, BIOCHEM J, V272, P23, DOI 10.1042/bj2720023; SMITH MA, 1992, BIOCHEM J, V287, P141, DOI 10.1042/bj2870141; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451	47	26	27	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31370	10.1371/journal.pone.0031370	http://dx.doi.org/10.1371/journal.pone.0031370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384013	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100019
J	Cartier-Michaud, A; Malo, M; Charriere-Bertrand, C; Gadea, G; Anguille, C; Supiramaniam, A; Lesne, A; Delaplace, F; Hutzler, G; Roux, P; Lawrence, DA; Barlovatz-Meimon, G				Cartier-Michaud, Amandine; Malo, Michel; Charriere-Bertrand, Cecile; Gadea, Gilles; Anguille, Christelle; Supiramaniam, Ajitha; Lesne, Annick; Delaplace, Franck; Hutzler, Guillaume; Roux, Pierre; Lawrence, Daniel A.; Barlovatz-Meimon, Georgia			Matrix-Bound PAI-1 Supports Cell Blebbing via RhoA/ROCK1 Signaling	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-RELATED PROTEIN; UROKINASE RECEPTOR; IN-VIVO; EPITHELIAL-CELLS; HUMAN CARCINOMA; RHO-KINASE; MIGRATION; CANCER; VITRONECTIN	The microenvironment of a tumor can influence both the morphology and the behavior of cancer cells which, in turn, can rapidly adapt to environmental changes. Increasing evidence points to the involvement of amoeboid cell migration and thus of cell blebbing in the metastatic process; however, the cues that promote amoeboid cell behavior in physiological and pathological conditions have not yet been clearly identified. Plasminogen Activator Inhibitor type-1 (PAI-1) is found in high amount in the microenvironment of aggressive tumors and is considered as an independent marker of bad prognosis. Here we show by immunoblotting, activity assay and immunofluorescence that, in SW620 human colorectal cancer cells, matrix-associated PAI-1 plays a role in the cell behavior needed for amoeboid migration by maintaining cell blebbing, localizing PDK1 and ROCK1 at the cell membrane and maintaining the RhoA/ROCK1/MLC-P pathway activation. The results obtained by modeling PAI-1 deposition around tumors indicate that matrix-bound PAI-1 is heterogeneously distributed at the tumor periphery and that, at certain spots, the elevated concentrations of matrix-bound PAI-1 needed for cancer cells to undergo the mesenchymal-amoeboid transition can be observed. Matrix-bound PAI-1, as a matricellular protein, could thus represent one of the physiopathological requirements to support metastatic formation.	[Cartier-Michaud, Amandine; Malo, Michel; Charriere-Bertrand, Cecile; Supiramaniam, Ajitha; Delaplace, Franck; Hutzler, Guillaume; Barlovatz-Meimon, Georgia] Evry Val Essonne Univ, IBISC EA 4526, Evry, France; [Charriere-Bertrand, Cecile; Barlovatz-Meimon, Georgia] Univ Paris Est Creteil, Creteil, France; [Gadea, Gilles; Anguille, Christelle; Roux, Pierre] Univ Montpellier, CRBM UMR CNRS 5237, F-34059 Montpellier, France; [Lesne, Annick] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Lesne, Annick] LPTMC UMR 7600 CNRS, Paris, France; [Lawrence, Daniel A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); University of Michigan System; University of Michigan	Cartier-Michaud, A (corresponding author), Evry Val Essonne Univ, IBISC EA 4526, Evry, France.	georgia.barlovatz@ibisc.fr	DELAPLACE, FRANCK/T-3979-2019; Roux, Pierre/D-8833-2017; Gilles, Gadea/M-9966-2015; Lesne, Annick/W-9444-2018	DELAPLACE, FRANCK/0000-0002-1035-7754; Gilles, Gadea/0000-0001-6325-4866; Lesne, Annick/0000-0002-6647-612X; Lawrence, Daniel/0000-0003-3126-1935; CHARRIERE-BERTRAND, Cecile/0000-0003-2522-1400	IBISC; Evry Genopole; CNRS ACI [050009DR11]; CNRS/Inserm [GDR 2647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079639] Funding Source: NIH RePORTER	IBISC; Evry Genopole; CNRS ACI; CNRS/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to the following for their financial support: IBISC (grant "Action Incitative''), Evry Genopole (grant "Aide a l'acquisition d'equipement semi-lourd''), the CNRS ACI Program "Complexite du vivant'' (grant # 050009DR11), and the GDR 2647 "STIC-Sante'' CNRS/Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Chorostowska-Wynimko J, 2004, INT J MOL MED, V13, P759; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Diehl HC, 2007, PROTEOM CLIN APPL, V1, P47, DOI 10.1002/prca.200600491; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; HEEGAARD CW, 1995, J BIOL CHEM, V270, P20855, DOI 10.1074/jbc.270.35.20855; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Malo M, 2010, MATH POPUL STUD, V17, P136, DOI 10.1080/08898480.2010.490996; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Maquerlot F, 2006, AM J PATHOL, V169, P1624, DOI 10.2353/ajpath.2006.051053; Minor KH, 2002, J BIOL CHEM, V277, P10337, DOI 10.1074/jbc.M109564200; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Planus E, 1997, J CELL SCI, V110, P1091; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rougier JP, 1998, KIDNEY INT, V54, P87, DOI 10.1046/j.1523-1755.1998.00955.x; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; SEEBACHER T, 1992, EXP CELL RES, V203, P504, DOI 10.1016/0014-4827(92)90029-8; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 1996, J BIOL CHEM, V271, P8215, DOI 10.1074/jbc.271.14.8215; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TOMASINIJOHANSSON BR, 1994, EXP CELL RES, V214, P303, DOI 10.1006/excr.1994.1262; Umeda T, 1997, J PATHOL, V183, P388; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vinot S, 2008, METHOD ENZYMOL, V439, P413, DOI 10.1016/S0076-6879(07)00429-6; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; WANG N, 1995, AM J PHYSIOL-CELL PH, V268, pC1062, DOI 10.1152/ajpcell.1995.268.4.C1062; Wang ZY, 2005, EXP EYE RES, V80, P1, DOI 10.1016/j.exer.2004.06.006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	57	23	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32204	10.1371/journal.pone.0032204	http://dx.doi.org/10.1371/journal.pone.0032204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363817	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700158
J	Gomez-Brandon, M; Lores, M; Dominguez, J				Gomez-Brandon, Maria; Lores, Marta; Dominguez, Jorge			Species-Specific Effects of Epigeic Earthworms on Microbial Community Structure during First Stages of Decomposition of Organic Matter	PLOS ONE			English	Article							FUNGAL GROWTH-RATES; LEUCINE INCORPORATION; ENZYME-ACTIVITIES; PIG SLURRY; SOIL; GUT; LUMBRICUS; BACTERIA; TRANSIT; BIOMASS	Background: Epigeic earthworms are key organisms in organic matter decomposition because of the interactions they establish with microorganisms. The earthworm species and the quality and/or substrate availability are expected to be major factors influencing the outcome of these interactions. Here we tested whether and to what extent the epigeic earthworms Eisenia andrei, Eisenia fetida and Perionyx excavatus, widely used in vermicomposting, are capable of altering the microbiological properties of fresh organic matter in the short-term. We also questioned if the earthworm-induced modifications to the microbial communities are dependent on the type of substrate ingested. Methodology/Principal Findings: To address these questions we determined the microbial community structure (phospholipid fatty acid profiles) and microbial activity (basal respiration and microbial growth rates) of three types of animal manure (cow, horse and rabbit) that differed in microbial composition, after being processed by each species of earthworm for one month. No differences were found between earthworm-worked samples with regards to microbial community structure, irrespective of type of manure, which suggests the existence of a bottleneck effect of worm digestion on microbial populations of the original material consumed. Moreover, in mesocosms containing cow manure the presence of E. andrei resulted not only in a decrease in bacterial and fungal biomass, but also in a reduced bacterial growth rate and total microbial activity, while no such reduction was found with E. fetida and P. excavatus. Conclusions/Significance: Our results point to the species of earthworm with its associated gut microbiota as a strong determinant of the process shaping the structure of microbial communities in the short-term. This must nonetheless be weighed against the fact that further knowledge is necessary to evaluate whether the changes in the composition of microbiota in response to the earthworm species is accompanied by a change in the microbial community diversity and/or function.	[Gomez-Brandon, Maria; Dominguez, Jorge] Univ Vigo, Dept Ecoloxia & Biol Anim, Fac Biol, Vigo 36310, Spain; [Gomez-Brandon, Maria] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria; [Lores, Marta] Fac Quim, Lab Invest & Desarrollo Soluc Analit, Dept Quim Analit, Santiago De Compostela, Spain	Universidade de Vigo; University of Innsbruck; Universidade de Santiago de Compostela	Gomez-Brandon, M (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	mariagomez@uvigo.es	Gómez-Brandón, Maria/D-7050-2011; Domínguez, Jorge/M-2046-2014; Domínguez, Jorge/T-7647-2019; Lores, Marta/F-9220-2015; Gomez-Brandon, Maria/Q-4421-2016	Domínguez, Jorge/0000-0002-4313-8582; Domínguez, Jorge/0000-0002-4313-8582; Lores, Marta/0000-0001-7683-8342; Gomez-Brandon, Maria/0000-0003-4744-535X	Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]; Fundacion Alfonso Martin Escudero	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Alfonso Martin Escudero	This research was financially supported by the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477). Maria Gomez Brandon was supported by a postdoctoral research grant from Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2006, BIOL FERT SOILS, V42, P371, DOI 10.1007/s00374-005-0047-4; Aira M, 2009, J HAZARD MATER, V161, P1234, DOI 10.1016/j.jhazmat.2008.04.073; Aira M, 2009, J HAZARD MATER, V162, P1404, DOI 10.1016/j.jhazmat.2008.06.031; Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; Aira M, 2007, MICROB ECOL, V54, P662, DOI 10.1007/s00248-007-9223-4; Aira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016354; Aira M, 2010, APPL SOIL ECOL, V46, P143, DOI 10.1016/j.apsoil.2010.06.001; Aira M, 2006, MICROB ECOL, V52, P738, DOI 10.1007/s00248-006-9109-x; BAATH E, 1994, BIOL FERT SOILS, V17, P147, DOI 10.1007/BF00337747; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P2011, DOI 10.1016/S0038-0717(01)00137-7; Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Berg B, 2006, ADV ECOL RES, V38, P1, DOI 10.1016/S0065-2504(05)38001-X; Byzov BA, 2007, EUR J SOIL BIOL, V43, pS149, DOI 10.1016/j.ejsobi.2007.08.012; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Daane LL, 1997, APPL ENVIRON MICROB, V63, P679, DOI 10.1128/AEM.63.2.679-686.1997; Dominguez J, 2010, MICROBES AT WORK: FROM WASTES TO RESOURCES, P93, DOI 10.1007/978-3-642-04043-6_5; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; Flegel M, 2000, SOIL BIOL BIOCHEM, V32, P1191, DOI 10.1016/S0038-0717(00)00035-3; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Gomez-Brandon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024786; Gomez-Brandon M, 2011, BIORESOURCE TECHNOL, V102, P4171, DOI 10.1016/j.biortech.2010.12.057; Gomez-Brandon M, 2010, APPL SOIL ECOL, V44, P237, DOI 10.1016/j.apsoil.2009.12.010; Hendriksen Niels Bohse, 1995, Acta Zoologica Fennica, V196, P115; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Lavelle P., 2001, SOIL ECOLOGY; Lores M, 2006, SOIL BIOL BIOCHEM, V38, P2993, DOI 10.1016/j.soilbio.2006.05.001; Manna MC, 2003, BIORESOURCE TECHNOL, V88, P197, DOI 10.1016/S0960-8524(02)00318-8; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Monroy F, 2011, PEDOBIOLOGIA, V54, P93, DOI 10.1016/j.pedobi.2010.10.003; Monroy F, 2009, SCI TOTAL ENVIRON, V407, P5411, DOI 10.1016/j.scitotenv.2009.06.048; NEWELL SY, 1991, ECOLOGY, V72, P1547, DOI 10.2307/1940954; Pawlett M, 2009, BIOL FERT SOILS, V45, P361, DOI 10.1007/s00374-008-0339-6; PEDERSEN JC, 1993, BIOL FERT SOILS, V16, P227, DOI 10.1007/BF00361413; Rousk J, 2007, SOIL BIOL BIOCHEM, V39, P2173, DOI 10.1016/j.soilbio.2007.03.023; Rudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007528; Sampedro L, 2008, APPL SOIL ECOL, V38, P91, DOI 10.1016/j.apsoil.2007.10.008; Scheu S, 2002, OECOLOGIA, V133, P254, DOI 10.1007/s00442-002-1023-4; Schonholzer F, 1999, FEMS MICROBIOL ECOL, V28, P235, DOI 10.1016/S0168-6496(98)00111-1; Seeber J, 2008, BIOL FERT SOILS, V44, P783, DOI 10.1007/s00374-008-0282-6; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; White David C., 1998, P255; Williams AP, 2006, FEMS MICROBIOL ECOL, V58, P54, DOI 10.1111/j.1574-6941.2006.00142.x; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang BG, 2000, SOIL BIOL BIOCHEM, V32, P2055, DOI 10.1016/S0038-0717(00)00111-5	52	53	57	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31895	10.1371/journal.pone.0031895	http://dx.doi.org/10.1371/journal.pone.0031895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363763	gold, Green Published			2022-12-25	WOS:000302873700117
J	Seong, I; Min, HJ; Lee, JH; Yeo, CY; Kang, DM; Oh, ES; Hwang, ES; Kim, J				Seong, Ikjoo; Min, Hyun Jung; Lee, Jung-Hyun; Yeo, Chang-Yeol; Kang, Dong Min; Oh, Eok-Soo; Hwang, Eun Sook; Kim, Jaesang			Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURONAL DIFFERENTIATION; METASTASIS; HYALURONAN; MELANOCYTES; MITF; INVOLVEMENT; EXPRESSION; PROTEIN; NESTIN	It is believed that the inherent differentiation program of melanocytes during embryogenesis predisposes melanoma cells to high frequency of metastasis. Sox10, a transcription factor expressed in neural crest stem cells and a subset of progeny lineages, plays a key role in the development of melanocytes. We show that B16F10 melanoma cells transfected with siRNAs specific for Sox10 display reduced migratory activity which in turn indicated that a subset of transcriptional regulatory target genes of Sox10 is likely to be involved in migration and metastasis of melanoma cells. We carried out a microarray-based gene expression profiling using a Sox10-specific siRNA to identify relevant regulatory targets and found that multiple genes including melanocortin-1 receptor (Mc1r) partake in the regulation of migration. We provide evidences that the effect of Sox10 on migration is mediated in large part by Mitf, a transcription factor downstream to Sox10. Among the mouse melanoma cell lines examined, however, only B16F10 showed robust down-regulation of Sox10 and inhibition of cell migration indicating that further dissection of dosage effects and/or cell line-specific regulatory networks is necessary. The involvement of Mc1r in migration was studied in detail in vivo using a murine metastasis model. Specifically, B16F10 melanoma cells treated with a specific siRNA showed reduced tendency in metastasizing to and colonizing the lung after being injected in the tail vein. These data reveal a cadre of novel regulators and mediators involved in migration and metastasis of melanoma cells that represents potential targets of therapeutic intervention.	[Seong, Ikjoo; Min, Hyun Jung; Lee, Jung-Hyun; Yeo, Chang-Yeol; Kang, Dong Min; Oh, Eok-Soo; Hwang, Eun Sook; Kim, Jaesang] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Ewha Womans University	Seong, I (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	jkim1964@ewha.ac.kr	Min, Hyunjung/ABA-8709-2020; Lee, Jung-Hyun/AAL-2954-2021	Lee, Jung-Hyun/0000-0003-1913-0027; Kang, Dongmin/0000-0001-5997-625X; Yeo, Chang-Yeol/0000-0002-4440-1215	National Research Foundation of Korea (NRF) [2010-0028042]; Brain Research Center [2010K000803]; Ministry of Education, Science and Technology (MEST), Republic of Korea; National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea [0620130]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; 2010-0028042) and by a grant (2010K000803) from Brain Research Center of the 21st Century Frontier Research Program, both funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea and by a grant (0620130) from the National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsdottir M, 2010, MELANOMA RES, V20, P468, DOI 10.1097/CMR.0b013e3283403ccd; Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lee KE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-408; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Liu GS, 2006, MOL PHARMACOL, V69, P440, DOI 10.1124/mol.105.015404; Lo LC, 2002, DEVELOPMENT, V129, P1553; Mitra D, 2009, HEMATOL ONCOL CLIN N, V23, P447, DOI 10.1016/j.hoc.2009.03.003; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Murata J, 1997, INVAS METAST, V17, P82; Piras F, 2010, ONCOL REP, V23, P17, DOI 10.3892/or_00000601; Roh J, 2006, DIFFERENTIATION, V74, P542, DOI 10.1111/j.1432-0436.2006.00084.x; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	39	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31477	10.1371/journal.pone.0031477	http://dx.doi.org/10.1371/journal.pone.0031477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363655	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700062
J	Suzuki, M; Tanaka, H; Tanimura, A; Tanabe, K; Oe, N; Rai, S; Kon, S; Fukumoto, M; Takei, K; Abe, T; Matsumura, I; Kanakura, Y; Watanabe, T				Suzuki, Mai; Tanaka, Hirokazu; Tanimura, Akira; Tanabe, Kenji; Oe, Natsuko; Rai, Shinya; Kon, Syunsuke; Fukumoto, Manabu; Takei, Kohji; Abe, Takaya; Matsumura, Itaru; Kanakura, Yuzuru; Watanabe, Toshio			The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LABILE IRON POOL; MEDIATED ENDOCYTOSIS; COATED PITS; RNA INTERFERENCE; CELL BIOLOGY; EPSIN 1; CALM; MUTATIONS; RECEPTOR	Phosphatidylinositol binding clathrin assembly protein (PICALM), also known as clathrin assembly lymphoid myeloid leukemia protein (CALM), was originally isolated as part of the fusion gene CALM/AF10, which results from the chromosomal translocation t(10;11)(p13;q14). CALM is sufficient to drive clathrin assembly in vitro on lipid monolayers and regulates clathrin-coated budding and the size and shape of the vesicles at the plasma membrane. However, the physiological role of CALM has yet to be elucidated. Here, the role of CALM in vivo was investigated using CALM-deficient mice. CALM-deficient mice exhibited retarded growth in utero and were dwarfed throughout their shortened life-spans. Moreover, CALM-deficient mice suffered from severe anemia, and the maturation and iron content in erythroid precursors were severely impaired. CALM-deficient erythroid cells and embryonic fibroblasts exhibited impaired clathrin-mediated endocytosis of transferrin. These results indicate that CALM is required for erythroid maturation and transferrin internalization in mice.	[Suzuki, Mai; Watanabe, Toshio] Nara Womens Univ, Dept Biol Sci, Grad Sch Humanities & Sci, Nara 630, Japan; [Tanaka, Hirokazu; Rai, Shinya; Matsumura, Itaru] Kinki Univ, Div Hematol, Dept Internal Med, Osaka, Japan; [Tanimura, Akira; Kanakura, Yuzuru] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Osaka, Japan; [Tanabe, Kenji; Oe, Natsuko; Takei, Kohji] Okayama Univ, Dept Neurosci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Kon, Syunsuke] Tohoku Univ, Dept Mol Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Fukumoto, Manabu] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Nara Womens University; Kindai University (Kinki University); Osaka University; Okayama University; Tohoku University; Tohoku University; RIKEN	Suzuki, M (corresponding author), Nara Womens Univ, Dept Biol Sci, Grad Sch Humanities & Sci, Nara 630, Japan.	toshiwatana@cc.nara-wu.ac.jp	Fukumoto, Manabu/L-1444-2019	Tanabe, Kenji/0000-0003-2645-9429; Tanimura, Akira/0000-0002-2039-5543; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Science, Sports, Culture and Technology, Japan; Kurokawa Cancer Research Foundation; Japan Health Foundation; Naito Foundation; Japan Science Society; Nara Women's University; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurokawa Cancer Research Foundation(Kurokawa Cancer Research Foundation); Japan Health Foundation(Japan Health Foundation); Naito Foundation(Naito Memorial Foundation); Japan Science Society; Nara Women's University(Nara Womens University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Science, Sports, Culture and Technology, Japan; Kurokawa Cancer Research Foundation; The Japan Health Foundation; The Naito Foundation; Sasakawa Scientific Research Grant from The Japan Science Society; and Nara Women's University Intramural Grant for Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Deshpande AJ, 2011, LEUKEMIA, V25, P1718, DOI 10.1038/leu.2011.153; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gillooly DJ, 2001, SCIENCE, V291, P993, DOI 10.1126/science.291.5506.993; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kon S, 2008, EXP CELL RES, V314, P1415, DOI 10.1016/j.yexcr.2007.11.006; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; POTTER MD, 1995, MAMM GENOME, V6, P70, DOI 10.1007/BF00303247; Potter MD, 1997, BLOOD, V90, P1850, DOI 10.1182/blood.V90.5.1850; Prus E, 2008, BRIT J HAEMATOL, V142, P301, DOI 10.1111/j.1365-2141.2008.07192.x; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schultze AE, 1997, COMP HAEMATOL INT, V7, P143, DOI 10.1007/BF02652592; Schultze AE, 1999, LAB ANIM SCI, V49, P260; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stoddart A, 2011, ONCOGENE        0627, DOI [10.1038/onc.2011.251, DOI 10.1038/ONC.2011.251]; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Vanden Broeck D, 2006, BIOTECHNIQUES, V41, P475, DOI 10.2144/000112265; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	48	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31854	10.1371/journal.pone.0031854	http://dx.doi.org/10.1371/journal.pone.0031854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363754	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700109
J	Yi, CX; Heppner, KM; Kirchner, H; Tong, J; Bielohuby, M; Gaylinn, BD; Muller, TD; Bartley, E; Davis, HW; Zhao, YM; Joseph, A; Kruthaupt, T; Ottaway, N; Kabra, D; Habegger, KM; Benoit, SC; Bidlingmaier, M; Thorner, MO; Perez-Tilve, D; Tschop, MH; Pfluger, PT				Yi, Chun-Xia; Heppner, Kristy M.; Kirchner, Henriette; Tong, Jenny; Bielohuby, Maximillian; Gaylinn, Bruce D.; Mueller, Timo D.; Bartley, Erin; Davis, Harold W.; Zhao, Yongmei; Joseph, Anupama; Kruthaupt, Traci; Ottaway, Nickki; Kabra, Dhiraj; Habegger, Kirk M.; Benoit, Stephen C.; Bidlingmaier, Martin; Thorner, Michael O.; Perez-Tilve, Diego; Tschoep, Matthias H.; Pfluger, Paul T.			The GOAT-Ghrelin System Is Not Essential for Hypoglycemia Prevention during Prolonged Calorie Restriction	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; UNACYLATED GHRELIN; INSULIN-SECRETION; ENERGY-BALANCE; PEPTIDE; ACYLTRANSFERASE; ADIPOSITY; STOMACH; HUMANS; MICE	Objective: Ghrelin acylation by ghrelin O-acyltransferase (GOAT) has recently been reported to be essential for the prevention of hypoglycemia during prolonged negative energy balance. Using a unique set of four different genetic loss-of-function models for the GOAT/ghrelin/growth hormone secretagogue receptor (GHSR) system, we thoroughly tested the hypothesis that lack-of-ghrelin activation or signaling would lead to hypoglycemia during caloric deprivation. Methodology: Male and female knockout (KO) mice for GOAT, ghrelin, GHSR, or both ghrelin and GHSR (dKO) were subjected to prolonged calorie restriction (40% of ad libitum chow intake). Body weight, fat mass, and glucose levels were recorded daily and compared to wildtype (WT) controls. Forty-eight hour blood glucose profiles were generated for each individual mouse when 2% or less body fat mass was reached. Blood samples were obtained for analysis of circulating levels of acyl-and desacyl-ghrelin, IGF-1, and insulin. Principal Findings: Chronic calorie restriction progressively decreased body weight and body fat mass in all mice regardless of genotype. When fat mass was depleted to 2% or less of body weight for 2 consecutive days, random hypoglycemic events occurred in some mice across all genotypes. There was no increase in the incidence of hypoglycemia in any of the four loss-of-function models for ghrelin signaling including GOAT KO mice. Furthermore, no differences in insulin or IGF-1 levels were observed between genotypes. Conclusion: The endogenous GOAT-ghrelin-GHSR system is not essential for the maintenance of euglycemia during prolonged calorie restriction.	[Yi, Chun-Xia; Mueller, Timo D.; Kabra, Dhiraj; Tschoep, Matthias H.; Pfluger, Paul T.] Helmholtz Ctr Munich, Inst Diabet & Obes, Neuherberg, Germany; [Heppner, Kristy M.; Kirchner, Henriette; Tong, Jenny; Bartley, Erin; Davis, Harold W.; Zhao, Yongmei; Joseph, Anupama; Kruthaupt, Traci; Ottaway, Nickki; Habegger, Kirk M.; Benoit, Stephen C.; Perez-Tilve, Diego] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH USA; [Bielohuby, Maximillian; Bidlingmaier, Martin] Univ Munich, Med Klin Innenstadt, Endocrine Res Unit, D-8000 Munich, Germany; [Gaylinn, Bruce D.; Thorner, Michael O.] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Ohio; University of Cincinnati; University of Munich; University of Virginia	Yi, CX (corresponding author), Helmholtz Ctr Munich, Inst Diabet & Obes, Neuherberg, Germany.	paul.pfluger@helmholtz-muenchen.de	Yi, Chun-Xia/J-4068-2016; Tschoep, Matthias H/I-5443-2014; Gaylinn, Bruce/AAD-4663-2020; Müller, Timo D./AAZ-4445-2020; Pfluger, Paul T/A-3770-2019	Yi, Chun-Xia/0000-0003-1184-4615; Pfluger, Paul T/0000-0002-8118-7588; Habegger, Kirk/0000-0002-0342-5480; Muller, Timo/0000-0002-0624-9339; Bidlingmaier, Martin/0000-0002-4681-6668; Perez-Tilve, Diego/0000-0002-0351-4133; Gaylinn, Bruce/0000-0003-1195-0864; Tschoep, Matthias/0000-0002-4744-371X	Hilda and Preston Davis Foundation; Davis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076037] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; Davis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Hilda and Preston Davis Foundation - Davis Foundation Postdoctoral Fellowship Program in Eating Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Gauna C, 2006, MOL CELL ENDOCRINOL, V251, P103, DOI 10.1016/j.mce.2006.03.040; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Kiewiet RM, 2009, EUR J ENDOCRINOL, V161, P567, DOI 10.1530/EJE-09-0339; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Liu JH, 2008, J CLIN ENDOCR METAB, V93, P1980, DOI 10.1210/jc.2007-2235; Lucidi P, 2002, DIABETES, V51, P2911, DOI 10.2337/diabetes.51.10.2911; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Reimer MK, 2003, ENDOCRINOLOGY, V144, P916, DOI 10.1210/en.2002-220819; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	19	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32100	10.1371/journal.pone.0032100	http://dx.doi.org/10.1371/journal.pone.0032100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363801	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700142
J	Zhao, Y; Ding, X; Ye, X; Dai, ZM; Yang, JS; Yang, WJ				Zhao, Yang; Ding, Xia; Ye, Xiang; Dai, Zhong-Min; Yang, Jin-Shu; Yang, Wei-Jun			Involvement of Cyclin K Posttranscriptional Regulation in the Formation of Artemia Diapause Cysts	PLOS ONE			English	Article							RNA-POLYMERASE-II; 38000-MR POLY(A)-BINDING PROTEIN; SHOCK/ALPHA-CRYSTALLIN PROTEIN; TERMINAL DOMAIN CTD; P-TEFB KINASE; MESSENGER RIBONUCLEOPROTEINS; CRYPTOBIOTIC GASTRULAE; INDUCED APOPTOSIS; ENCYSTED EMBRYOS; SUBUNIT STRUCTURE	Background: Artemia eggs tend to develop ovoviviparously to yield nauplius larvae in good rearing conditions; while under adverse situations, they tend to develop oviparously and encysted diapause embryos are formed instead. However, the intrinsic mechanisms regulating this process are not well understood. Principal Finding: This study has characterized the function of cyclin K, a regulatory subunit of the positive transcription elongation factor b (P-TEFb) in the two different developmental pathways of Artemia. In the diapause-destined embryo, Western blots showed that the cyclin K protein was down-regulated as the embryo entered dormancy and reverted to relatively high levels of expression once development resumed, consistent with the fluctuations in phosphorylation of position 2 serines (Ser2) in the C-terminal domain (CTD) of the largest subunit (Rpb1) of RNA polymerase II (RNAP II). Interestingly, the cyclin K transcript levels remained constant during this process. In vitro translation data indicated that the template activity of cyclin K mRNA stored in the postdiapause cyst was repressed. In addition, in vivo knockdown of cyclin K in developing embryos by RNA interference eliminated phosphorylation of the CTD Ser2 of RNAP II and induced apoptosis by inhibiting the extracellular signal-regulated kinase (ERK) survival signaling pathway. Conclusions/Significance: Taken together, these findings reveal a role for cyclin K in regulating RNAP II activity during diapause embryo development, which involves the post-transcriptional regulation of cyclin K. In addition, a further role was identified for cyclin K in regulating the control of cell survival during embryogenesis through ERK signaling pathways.	[Zhao, Yang; Ye, Xiang; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Yang; Ye, Xiang; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Xia] Nanchang Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Dai, Zhong-Min] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Nanchang University; Hangzhou Normal University	Zhao, Y (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn	ding, xia/CAG-9445-2022	ding, xia/0000-0003-1535-2642; Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737; Dai, Zhong-Min/0000-0003-4083-1901	National Natural Sciences Foundation of China [40730212, 40876069]; National Basic Research Program of China (973) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Natural Sciences Foundation of China (40730212 and 40876069) and National Basic Research Program of China (973 Program, 2010CB833803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAW JC, 1976, NUCLEIC ACIDS RES, V3, P1449, DOI 10.1093/nar/3.6.1449; BAGSHAW JC, 1978, DIFFERENTIATION, V10, P13, DOI 10.1111/j.1432-0436.1978.tb00940.x; Bensaude O, 1999, BIOCHEM CELL BIOL, V77, P249, DOI 10.1139/bcb-77-4-249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; Cho HS, 2009, J VET SCI, V10, P23, DOI 10.4142/jvs.2009.10.1.23; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; CRUCES J, 1984, EUR J BIOCHEM, V141, P279, DOI 10.1111/j.1432-1033.1984.tb08189.x; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; DALESSIO JM, 1977, DIFFERENTIATION, V8, P53, DOI 10.1111/j.1432-0436.1977.tb00920.x; DALESSIO JM, 1979, DEV BIOL, V70, P71, DOI 10.1016/0012-1606(79)90007-1; DEHERDT E, 1984, EUR J BIOCHEM, V139, P155; DEHERDT E, 1982, EUR J BIOCHEM, V122, P453; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Leucci E, 2007, J CELL PHYSIOL, V212, P411, DOI 10.1002/jcp.21032; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Liu QY, 2007, CELL RES, V17, P163, DOI 10.1038/sj.cr.7310144; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Moon DO, 2006, INT IMMUNOPHARMACOL, V6, P1796, DOI 10.1016/j.intimp.2006.07.027; Napolitano G, 2000, GENE, V254, P139, DOI 10.1016/S0378-1119(00)00278-X; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Ostrakhovitch EA, 2005, J CELL BIOCHEM, V95, P1120, DOI 10.1002/jcb.20484; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Palancade B, 2001, J CELL SCI, V114, P2483; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poele RHT, 1999, ONCOGENE, V18, P5765, DOI 10.1038/sj.onc.1202961; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; RENART J, 1976, CELL DIFFER DEV, V5, P97, DOI 10.1016/0045-6039(76)90003-8; Robert AB, 1991, ARTEMIA BIOL; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SLEGERS H, 1981, EUR J BIOCHEM, V117, P111; SLEGERS H, 1977, FEBS LETT, V80, P390, DOI 10.1016/0014-5793(77)80483-3; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Willsie JK, 2001, J EXP BIOL, V204, P2339; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhu XJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-21	51	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32129	10.1371/journal.pone.0032129	http://dx.doi.org/10.1371/journal.pone.0032129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363807	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700148
J	Almen, MS; Bringeland, N; Fredriksson, R; Schioth, HB				Almen, Markus Sallman; Bringeland, Nathalie; Fredriksson, Robert; Schioth, Helgi B.			The Dispanins: A Novel Gene Family of Ancient Origin That Contains 14 Human Members	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; WEST NILE VIRUS; SEQUENCE; IDENTIFICATION; PREDICTION; MARKER	The Interferon induced transmembrane proteins (IFITM) are a family of transmembrane proteins that is known to inhibit cell invasion of viruses such as HIV-1 and influenza. We show that the IFITM genes are a subfamily in a larger family of transmembrane (TM) proteins that we call Dispanins, which refers to a common 2TM structure. We mined the Dispanins in 36 eukaryotic species, covering all major eukaryotic groups, and investigated their evolutionary history using Bayesian and maximum likelihood approaches to infer a phylogenetic tree. We identified ten human genes that together with the known IFITM genes form the Dispanin family. We show that the Dispanins first emerged in eukaryotes in a common ancestor of choanoflagellates and metazoa, and that the family later expanded in vertebrates where it forms four subfamilies (A-D). Interestingly, we also find that the family is found in several different phyla of bacteria and propose that it was horizontally transferred to eukaryotes from bacteria in the common ancestor of choanoflagellates and metazoa. The bacterial and eukaryotic sequences have a considerably conserved protein structure. In conclusion, we introduce a novel family, the Dispanins, together with a nomenclature based on the evolutionary origin.	[Almen, Markus Sallman; Bringeland, Nathalie; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, BMC, Uppsala, Sweden	Uppsala University	Almen, MS (corresponding author), Uppsala Univ, Dept Neurosci, BMC, Uppsala, Sweden.	markus.sallman-almen@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Fredriksson, Robert/0000-0002-2810-3226; Sallman Almen, Markus/0000-0001-9591-9228	Swedish Research Council; Novo Nordisk Foundation; Swedish Royal Academy of Sciences; Magnus Bergvall Foundation; Goran Gustafssons foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Royal Academy of Sciences; Magnus Bergvall Foundation; Goran Gustafssons foundation	The studies were supported by the Swedish Research Council, The Novo Nordisk Foundation, Swedish Royal Academy of Sciences, and Magnus Bergvall Foundation. RF was supported by the Goran Gustafssons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; de Chaldee M, 2006, GENOMICS, V87, P200, DOI 10.1016/j.ygeno.2005.10.009; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Hanagata N, 2010, J BONE MINER METAB; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knotts TA, 2009, PPAR RES, V2009, DOI 10.1155/2009/867678; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	33	63	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31961	10.1371/journal.pone.0031961	http://dx.doi.org/10.1371/journal.pone.0031961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363774	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500098
J	Askins, RA; Folsom-O'Keefe, CM; Hardy, MC				Askins, Robert A.; Folsom-O'Keefe, Corrine M.; Hardy, Margaret C.			Effects of Vegetation, Corridor Width and Regional Land Use on Early Successional Birds on Powerline Corridors	PLOS ONE			English	Article							RIGHTS-OF-WAY; REPRODUCTIVE SUCCESS; CONSERVATION VALUE; SHRUBLAND BIRDS; FOREST; HABITAT; BIODIVERSITY; LANDSCAPE; FRAGMENTATION; COMMUNITIES	Powerline rights-of-way (ROWs) often provide habitat for early successional bird species that have suffered long-term population declines in eastern North America. To determine how the abundance of shrubland birds varies with habitat within ROW corridors and with land use patterns surrounding corridors, we ran Poisson regression models on data from 93 plots on ROWs and compared regression coefficients. We also determined nest success rates on a 1-km stretch of ROW. Seven species of shrubland birds were common in powerline corridors. However, the nest success rates for prairie warbler (Dendroica discolor) and field sparrow (Spizella pusilla) were < 21%, which is too low to compensate for estimated annual mortality. Some shrubland bird species were more abundant on narrower ROWs or at sites with lower vegetation or particular types of vegetation, indicating that vegetation management could be refined to favor species of high conservation priority. Also, several species were more abundant in ROWs traversing unfragmented forest than those near residential areas or farmland, indicating that corridors in heavily forested regions may provide better habitat for these species. In the area where we monitored nests, brood parasitism by brown-headed cowbirds (Molothrus ater) occurred more frequently close to a residential area. Although ROWs support dense populations of shrubland birds, those in more heavily developed landscapes may constitute sink habitat. ROWs in extensive forests may contribute more to sustaining populations of early successional birds, and thus may be the best targets for habitat management.	[Askins, Robert A.; Folsom-O'Keefe, Corrine M.; Hardy, Margaret C.] Connecticut Coll, Dept Biol, New London, CT 06320 USA	Connecticut College	Askins, RA (corresponding author), Connecticut Coll, Dept Biol, New London, CT 06320 USA.	raask@conncoll.edu	Hardy, Margaret C/A-5576-2009	Hardy, Margaret C/0000-0001-5033-4322	State Wildlife; Connecticut Department of Environmental Protection Wildlife Division [2008-8086]; Connecticut Light and Power Company; Northeast Utilities Foundation; Connecticut College; Northeast Utilities Transmission	State Wildlife; Connecticut Department of Environmental Protection Wildlife Division; Connecticut Light and Power Company; Northeast Utilities Foundation; Connecticut College; Northeast Utilities Transmission	Funding was provided by the State Wildlife Grants Program administered by the Connecticut Department of Environmental Protection Wildlife Division (Grant No. 2008-8086, http://www.ct.gov/dep/cwp/view.asp?a = 2723&q=326164&depNav_GID = 1655#SWG); Connecticut Light and Power Company, Northeast Utilities Transmission (http://www.transmission-nu.com/default.asp), Northeast Utilities Foundation (http://northeastutilitiesfoundation.org/what/index.html) and the Andrew W. Mellon Undergraduate Research Fund, Environmental Studies Program, Connecticut College (http://www.conncoll.edu/departments/envirostudies/7338.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2008, J APPL ECOL, V45, P1349, DOI 10.1111/j.1365-2664.2008.01517.x; ANDERSON SH, 1977, AM MIDL NAT, V97, P216, DOI 10.2307/2424698; ASKINS RA, 1994, WILDLIFE SOC B, V22, P339; Askins RA, 2001, WILDLIFE SOC B, V29, P407; Askins RA, 2007, FOREST ECOL MANAG, V250, P137, DOI 10.1016/j.foreco.2007.05.009; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bramble W. C., 1994, Journal of Arboriculture, V20, P124; BRAMBLE W C, 1992, Journal of Arboriculture, V18, P23; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brower J.E., 1998, FIELD LAB METHODS GE; Burhans DE, 2006, ECOL APPL, V16, P394, DOI 10.1890/04-0927; Carey M, 1994, BIRDS N AM; Clarke DJ, 2008, LANDSCAPE URBAN PLAN, V86, P257, DOI 10.1016/j.landurbplan.2008.03.005; Clarke DJ, 2006, WILDLIFE RES, V33, P615, DOI 10.1071/WR05085; CLEAR, 2008, CONN CHANG LANDSC; Confer JL, 2003, FOREST ECOL MANAG, V185, P193, DOI 10.1016/S0378-1127(03)00255-X; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; DeGraaf RM, 1996, CONSERVATION FAUNAL, P3, DOI DOI 10.1007/978-94-009-1521-31; Dessecker DR, 1997, NC195 DEP AGR FOR SE; Dettmers R, 1999, J WILDLIFE MANAGE, V63, P815, DOI 10.2307/3802794; Dettmers R, 2003, FOREST ECOL MANAG, V185, P81, DOI 10.1016/S0378-1127(03)00248-2; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Flaspohler DJ, 2001, CONSERV BIOL, V15, P173, DOI 10.1046/j.1523-1739.2001.99397.x; Ford TB, 2001, AUK, V118, P864, DOI 10.1642/0004-8038(2001)118[0864:RSOFDS]2.0.CO;2; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gale GA, 1997, CONSERV BIOL, V11, P246, DOI 10.1046/j.1523-1739.1997.95141.x; GUREVITCH J, 2006, ECOLOGY PLANTS; Hewson CM, 2009, IBIS, V151, P464, DOI 10.1111/j.1474-919X.2009.00937.x; Hutto RL, 2003, WILDLIFE SOC B, V31, P903; JOHNSON DH, 1979, AUK, V96, P651; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; King DI, 2009, BIOL CONSERV, V142, P2672, DOI 10.1016/j.biocon.2009.06.016; King DI, 2002, WILDLIFE SOC B, V30, P868; King DI, 2001, J WILDLIFE MANAGE, V65, P345, DOI 10.2307/3802914; Kubel JE, 2008, WILSON J ORNITHOL, V120, P801, DOI 10.1676/06-114.1; Lensu T, 2011, J ENVIRON MANAGE, V92, P2539, DOI 10.1016/j.jenvman.2011.05.019; Lowther P. E., 1993, BIRDS N AM ONLINE; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Meehan Amy L., 1997, Virginia Journal of Science, V48, P259; NIERING WA, 1974, ECOLOGY, V55, P784, DOI 10.2307/1934414; Nolan V., 1978, ORNITHOL MONOGR, V26, P1; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; R Core Team, 2022, R LANG ENV STAT COMP; RICH AC, 1994, CONSERV BIOL, V8, P1109, DOI 10.1046/j.1523-1739.1994.08041109.x; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rodewald AD, 2005, J WILDLIFE MANAGE, V69, P681, DOI 10.2193/0022-541X(2005)069[0681:EAAOSB]2.0.CO;2; Rubolini D, 2005, BIRD CONSERV INT, V15, P131, DOI 10.1017/S0959270905000109; Rudd H, 2002, RESTOR ECOL, V10, P368, DOI 10.1046/j.1526-100X.2002.02041.x; RUDNICKY TC, 1993, ECOL APPL, V3, P357, DOI 10.2307/1941838; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; Sauer J.R., 2008, N AM BREEDING BIRD S; Schlossberg S, 2011, LANDSCAPE URBAN PLAN, V103, P64, DOI 10.1016/j.landurbplan.2011.06.001; Slay C., 2010, THESIS U ARKANSAS FA; Stevens DW, 1996, ENVIRON MANAGE, V20, P873; Temple SA, 1996, ENVIRON MANAGE, V20, P873, DOI 10.1007/BF01205967; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; Yahner Richard H., 2003, Journal of Arboriculture, V29, P156; Yahner Richard H., 2002, Journal of Arboriculture, V28, P123; Yahner Richard H., 2001, Journal of Arboriculture, V27, P215; Yahner Richard H., 2004, Journal of Arboriculture, V30, P288; Yamaura Y, 2009, ANIM CONSERV, V12, P110, DOI 10.1111/j.1469-1795.2008.00227.x; Zuckerberg B, 2012, J WILDLIFE MANAGE, V76, P1072, DOI 10.1002/jwmg.326; [No title captured]	65	26	26	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31520	10.1371/journal.pone.0031520	http://dx.doi.org/10.1371/journal.pone.0031520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363660	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500050
J	Chiu, HW; Chen, YA; Ho, SY; Wang, YJ				Chiu, Hui-Wen; Chen, Yi-An; Ho, Sheng-Yow; Wang, Ying-Jan			Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; INCREASED MITOTIC ARREST; MALIGNANT GLIOMA-CELLS; COMBINATION TREATMENT; IONIZING-RADIATION; CLINICAL-EFFICACY; INDUCED AUTOPHAGY; UP-REGULATION; IN-VITRO; APOPTOSIS	Prostate cancer is the most common malignancy in men. In the present study, LNCaP (androgen-sensitive human prostate cancer cells) and PC-3 cells (androgen-independent human prostate cancer cells) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with arsenic trioxide (ATO) and to determine the underlying mechanisms in vitro and in vivo. We found that IR combined with ATO increases the therapeutic efficacy compared to individual treatments in LNCaP and PC-3 human prostate cancer cells. In addition, combined treatment showed enhanced reactive oxygen species (ROS) generation compared to treatment with ATO or IR alone in PC-3 cells. Combined treatment induced autophagy and apoptosis in LNCaP cells, and mainly induced autophagy in PC-3 cells. The cell death that was induced by the combined treatment was primarily the result of inhibition of the Akt/mTOR signaling pathways. Furthermore, we found that the combined treatment of cells pre-treated with 3-MA resulted in a significant change in AO-positive cells and cytotoxicity. In an in vivo study, the combination treatment had anti-tumor growth effects. These novel findings suggest that combined treatment is a potential therapeutic strategy not only for androgen-dependent prostate cancer but also for androgen-independent prostate cancer.	[Chiu, Hui-Wen; Chen, Yi-An; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Ho, Sheng-Yow] Sinlau Christian Hosp, Tainan, Taiwan	National Cheng Kung University	Chiu, HW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	yjwang@mail.ncku.edu.tw			National Science Council, Taiwan (NSC) [98-2314-B-006-034-MY2]; Sinlau Christian Hospital, Tainan, Taiwan	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan	This study was supported by the National Science Council, Taiwan (NSC 98-2314-B-006-034-MY2) and the Sinlau Christian Hospital, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaei M, 2011, PROSTATE; Antman KH, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_2-1; Basu Sujit, 2010, Hormones & Cancer, V1, P223, DOI 10.1007/s12672-010-0044-4; Befani CD, 2011, J MOL MED BERL; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Chun YJ, 2002, FEBS LETT, V519, P195, DOI 10.1016/S0014-5793(02)02765-5; Corcelle EA, 2009, FEBS J, V276, P6084, DOI 10.1111/j.1742-4658.2009.07332.x; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Friedrichs W, 2011, NUTR CANCER, V63, P771, DOI 10.1080/01635581.2011.570892; Ho SY, 2009, CHEM-BIOL INTERACT, V179, P304, DOI 10.1016/j.cbi.2008.12.015; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Kang YH, 2008, ONCOL REP, V20, P637, DOI 10.3892/or_00000053; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Lian JQ, 2010, AUTOPHAGY, V6, P1201, DOI [10.1038/cdd.2010.74, 10.4161/auto.6.8.13549]; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McCubrey JA, 2006, MOL PHARMACOL, V70, P437, DOI 10.1124/mol.106.026252; MCDONNELL TJ, 1995, SEMIN CANCER BIOL, V6, P53, DOI 10.1006/scbi.1995.0007; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; OSBORNE CK, 1987, EUR J CANCER CLIN ON, V23, P1189; Paglin S, 2001, CANCER RES, V61, P439; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; PROBERT JC, 1975, RADIOLOGY, V114, P155, DOI 10.1148/114.1.155; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Toepfer N, 2011, CANCER BIOL THER, V12, P691, DOI 10.4161/cbt.12.8.15978; Vorotnikova E, 2010, RADIAT RES, V173, P748, DOI 10.1667/RR1948.1; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wen Y, 2000, CANCER RES, V60, P6841; Westervelt P, 2002, P NATL ACAD SCI USA, V99, P9468, DOI 10.1073/pnas.132657799; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V71, P1028, DOI 10.1016/j.ijrobp.2007.11.066; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	45	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31579	10.1371/journal.pone.0031579	http://dx.doi.org/10.1371/journal.pone.0031579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363680	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500058
J	Floerl, S; Majcherczyk, A; Possienke, M; Feussner, K; Tappe, H; Gatz, C; Feussner, I; Kues, U; Polle, A				Floerl, Saskia; Majcherczyk, Andrzej; Possienke, Mareike; Feussner, Kirstin; Tappe, Hella; Gatz, Christiane; Feussner, Ivo; Kuees, Ursula; Polle, Andrea			Verticillium longisporum Infection Affects the Leaf Apoplastic Proteome, Metabolome, and Cell Wall Properties in Arabidopsis thaliana	PLOS ONE			English	Article							XYLEM SAP PROTEOME; GERMIN-LIKE PROTEINS; SPRUCE PICEA-ABIES; DISEASE RESISTANCE; SECRETED PROTEINS; OILSEED RAPE; GENE FAMILY; DIFFERENTIAL INTERACTIONS; SERINE-CARBOXYPEPTIDASE; POLYACRYLAMIDE GELS	Verticillium longisporum (VL) is one of the most devastating diseases in important oil crops from the family of Brassicaceae. The fungus resides for much time of its life cycle in the extracellular fluid of the vascular system, where it cannot be controlled by conventional fungicides. To obtain insights into the biology of VL-plant interaction in the apoplast, the secretome consisting of the extracellular proteome and metabolome as well as cell wall properties were studied in the model Brassicaceae, Arabidopsis thaliana. VL infection resulted in increased production of cell wall material with an altered composition of carbohydrate polymers and increased lignification. The abundance of several hundred soluble metabolites changed in the apoplast of VL-infected plants including signalling and defence compounds such as glycosides of salicylic acid, lignans and dihydroxybenzoic acid as well as oxylipins. The extracellular proteome of healthy leaves was enriched in antifungal proteins. VL caused specific increases in six apoplast proteins (three peroxidases PRX52, PRX34, P37, serine carboxypeptidase SCPL20, alpha-galactosidase AGAL2 and a germin-like protein GLP3), which have functions in defence and cell wall modification. The abundance of a lectin-like, chitin-inducible protein (CILLP) was reduced. Since the transcript levels of most of the induced proteins were not elevated until late infection time points (> 20 dpi), whereas those of CILLP and GLP3 were reduced at earlier time points, our results may suggest that VL enhances its virulence by rapid down-regulation and delay of induction of plant defence genes.	[Floerl, Saskia; Polle, Andrea] Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, Gottingen, Germany; [Majcherczyk, Andrzej; Kuees, Ursula] Univ Gottingen, Dept Mol Wood Biotechnol & Tech Mycol, Busgen Inst, Gottingen, Germany; [Possienke, Mareike; Feussner, Kirstin; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst, Gottingen, Germany; [Tappe, Hella; Gatz, Christiane] Univ Gottingen, Dept Mol Biol & Physiol Plants, Albrecht von Haller Inst, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Floerl, S (corresponding author), Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, Gottingen, Germany.	apolle@gwdg.de	Majcherczyk, Andrzej/B-8267-2008; Kües, Ursula/B-8280-2008; Feussner, Ivo/H-9320-2013	Majcherczyk, Andrzej/0000-0002-1616-6983; Kües, Ursula/0000-0001-9180-4079; Feussner, Ivo/0000-0002-9888-7003; Polle, Andrea/0000-0001-8697-6394	German Science Foundation [Po 362/15, Fe 446/6-1, FOR 546]	German Science Foundation(German Research Foundation (DFG))	The authors would like to thank the German Science Foundation for financial support to FOR 546, Po 362/15 and Fe 446/6-1. The funder has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Alvarez S, 2006, J PROTEOME RES, V5, P963, DOI 10.1021/pr050471q; Bartsch M, 2010, J BIOL CHEM, V285, P25654, DOI 10.1074/jbc.M109.092569; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Bergmeyer HU, 1974, METHODEN ENZYMATISCH, VI, P649; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; BINNS AN, 1987, P NATL ACAD SCI USA, V84, P980, DOI 10.1073/pnas.84.4.980; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Brinkmann K, 2002, J CHEM ECOL, V28, P2483, DOI 10.1023/A:1021484002582; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Charmont S, 2005, PHYTOCHEMISTRY, V66, P453, DOI 10.1016/j.phytochem.2004.12.013; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Cowley T, 2005, PEST MANAG SCI, V61, P572, DOI 10.1002/ps.1026; Cui YX, 2000, PHYSIOL MOL PLANT P, V56, P25, DOI 10.1006/pmpp.1999.0245; Demont-Caulet N, 2010, PHYTOCHEMISTRY, V71, P1673, DOI 10.1016/j.phytochem.2010.06.011; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Druebert G, 2011, THESIS U GOTTINGEN G; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubery IA, 1997, PHYTOCHEMISTRY, V44, P1429, DOI 10.1016/S0031-9422(96)00635-8; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Eynck C, 2009, PHYTOPATHOLOGY, V99, P802, DOI 10.1094/PHYTO-99-7-0802; Eynck C, 2009, J PLANT DIS PROTECT, V116, P63, DOI 10.1007/BF03356288; Floerl S, 2010, J PLANT PATHOL, V92, P693; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Haffner E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-235; Hano C, 2006, PLANTA, V223, P975, DOI 10.1007/s00425-005-0156-1; HRUZ T, 2008, BIOINFORMATICS; Hwang B, 2010, MOLECULES, V15, P3507, DOI 10.3390/molecules15053507; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Johansson A, 2006, EUR J PLANT PATHOL, V114, P139, DOI 10.1007/s10658-005-2333-2; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kaever A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-92; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kruger W., 1989, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V41, P49; Lichtenthaler H.K., 1983, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Ligat L, 2011, PROTEOMICS, V11, P1798, DOI 10.1002/pmic.201000781; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Ludwikow A, 2004, CELL MOL BIOL LETT, V9, P829; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Naumann A, 2005, FUNGAL GENET BIOL, V42, P829, DOI 10.1016/j.fgb.2005.06.003; NEUHOFF V, 1990, BIOL CHEM H-S, V371, pA10; Njoroge SMC, 2011, PHYTOPATHOLOGY, V101, P523, DOI 10.1094/PHYTO-08-10-0219; Otter T, 1997, PLANT CELL PHYSIOL, V38, P595, DOI 10.1093/oxfordjournals.pcp.a029209; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POLLE A, 1990, PLANT PHYSIOL, V94, P312, DOI 10.1104/pp.94.1.312; Pomar F, 2004, NEW PHYTOL, V163, P111, DOI 10.1111/j.1469-8137.2004.01092.x; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Ratzinger A, 2009, J PLANT RES, V122, P571, DOI 10.1007/s10265-009-0237-5; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmitz G, 2010, MOL PLANT MICROBE IN, V23, P1584, DOI 10.1094/MPMI-02-10-0045; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Smit F, 1997, PHYTOCHEMISTRY, V44, P811, DOI 10.1016/S0031-9422(96)00595-X; Subramanian S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-119; Talboys P.W., 1958, T BRIT MYCOL SOC, V41, P249, DOI [10.1016/S0007-1536(58)80037-6, DOI 10.1016/S0007-1536(58)80037-6]; TEUTONICO RA, 1991, PLANT PHYSIOL, V97, P288, DOI 10.1104/pp.97.1.288; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980, DOI 10.1093/oxfordjournals.pcp.a029262; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhou AF, 2005, J BIOL CHEM, V280, P35554, DOI 10.1074/jbc.M503299200; Zhou GW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-9; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	91	86	90	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31435	10.1371/journal.pone.0031435	http://dx.doi.org/10.1371/journal.pone.0031435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363647	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500044
J	Jasmine, F; Rahaman, R; Dodsworth, C; Roy, S; Paul, R; Raza, M; Paul-Brutus, R; Kamal, M; Ahsan, H; Kibriya, MG				Jasmine, Farzana; Rahaman, Ronald; Dodsworth, Charlotte; Roy, Shantanu; Paul, Rupash; Raza, Maruf; Paul-Brutus, Rachelle; Kamal, Mohammed; Ahsan, Habibul; Kibriya, Muhammad G.			A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment	PLOS ONE			English	Article							COPY NUMBER CHANGES; LOSS-OF-HETEROZYGOSITY; CHROMOSOMAL INSTABILITY; UNIPARENTAL DISOMY; MICROSATELLITE INSTABILITY; DISEASE PROGRESSION; TUMOR-SUPPRESSOR; IN-SITU; HYBRIDIZATION; COLON	In colorectal cancer (CRC), chromosomal instability (CIN) is typically studied using comparative-genomic hybridization (CGH) arrays. We studied paired (tumor and surrounding healthy) fresh frozen tissue from 86 CRC patients using Illumina's Infinium-based SNP array. This method allowed us to study CIN in CRC, with simultaneous analysis of copy number (CN) and B-allele frequency (BAF) - a representation of allelic composition. These data helped us to detect mono-allelic and bi-allelic amplifications/deletion, copy neutral loss of heterozygosity, and levels of mosaicism for mixed cell populations, some of which can not be assessed with other methods that do not measure BAF. We identified associations between CN abnormalities and different CRC phenotypes (histological diagnosis, location, tumor grade, stage, MSI and presence of lymph node metastasis). We showed commonalities between regions of CN change observed in CRC and the regions reported in previous studies of other solid cancers (e.g. amplifications of 20q, 13q, 8q, 5p and deletions of 18q, 17p and 8p). From Therapeutic Target Database, we identified relevant drugs, targeted to the genes located in these regions with CN changes, approved or in trials for other cancers and common diseases. These drugs may be considered for future therapeutic trials in CRC, based on personalized cytogenetic diagnosis. We also found many regions, harboring genes, which are not currently targeted by any relevant drugs that may be considered for future drug discovery studies. Our study shows the application of high density SNP arrays for cytogenetic study in CRC and its potential utility for personalized treatment.	[Jasmine, Farzana; Rahaman, Ronald; Dodsworth, Charlotte; Roy, Shantanu; Paul-Brutus, Rachelle; Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Paul, Rupash; Raza, Maruf; Kamal, Mohammed] BSMMU, Dept Pathol, Dhaka, Bangladesh	University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Jasmine, F (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	kibriya@uchicago.edu	RAZA, AKM MARUF/S-6883-2016; RAZA, AKM MARUF/P-2736-2019	RAZA, AKM MARUF/0000-0003-0251-4518; RAZA, AKM MARUF/0000-0003-0251-4518; Rahaman, Ronald/0000-0002-8917-8934	National Institutes of Health [U01 CA122171, P30 CA 014599, P42ES010349, R01CA102484, R01CA107431]; NATIONAL CANCER INSTITUTE [R01CA107431, R01CA102484, P30CA014599, U01CA122171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants U01 CA122171, P30 CA 014599, P42ES010349, R01CA102484, and R01CA107431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2005, COLORECTAL DIS, V7, P571, DOI 10.1111/j.1463-1318.2005.00818.x; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Aragane H, 2001, INT J CANCER, V94, P623, DOI 10.1002/ijc.1522; BARDI G, 1993, CANCER, V71, P306, DOI 10.1002/1097-0142(19930115)71:2<306::AID-CNCR2820710207>3.0.CO;2-C; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Bianchi F, 2009, J MOL DIAGN, V11, P248, DOI 10.2353/jmoldx.2009.080155; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Brenner BM, 2010, MUTAT RES-FUND MOL M, V693, P46, DOI 10.1016/j.mrfmmm.2010.04.002; Chalmers IJ, 2001, CANCER GENET CYTOGEN, V126, P39, DOI 10.1016/S0165-4608(00)00376-9; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; De Angelis PM, 1999, BRIT J CANCER, V80, P526; DELATTRE O, 1989, LANCET, V2, P353; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Ghadimi BM, 2003, CLIN CANCER RES, V9, P1808; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Grade M, 2006, CELL ONCOL, V28, P71; Grade M, 2009, CANCER GENET CYTOGEN, V193, P19, DOI 10.1016/j.cancergencyto.2009.03.016; Gu GY, 2011, CANCER GENET-NY, V204, P57, DOI 10.1016/j.cancergencyto.2010.10.003; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janavicius R, 2010, CLIN CHEM, V56, P1750, DOI 10.1373/clinchem.2010.150680; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jenkins RB, 1997, CANCER RES, V57, P524; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kazama Y, 2005, CANCER, V103, P2023, DOI 10.1002/cncr.21022; Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50; Knosel T, 2002, VIRCHOWS ARCH, V440, P187, DOI 10.1007/s004280100493; Knosel T, 2003, HISTOPATHOLOGY, V43, P323, DOI 10.1046/j.1365-2559.2003.01720.x; Lanza G, 2011, DIGEST LIVER DIS, V43, pS344, DOI 10.1016/S1590-8658(11)60590-2; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; LOTHE RA, 1993, CANCER RES, V53, P5849; Matsuyama H, 2001, CLIN CANCER RES, V7, P3139; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Middeldorp A, 2011, INT J CANC; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P49; Moskaluk CA, 1998, GENE CHROMOSOME CANC, V22, P305, DOI 10.1002/(SICI)1098-2264(199808)22:4<305::AID-GCC6>3.3.CO;2-U; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nymark P, 2006, CANCER RES, V66, P5737, DOI 10.1158/0008-5472.CAN-06-0199; Peng DF, 2003, J PATHOL, V201, P439, DOI 10.1002/path.1459; Pettus JA, 2004, CANCER GENET CYTOGEN, V154, P110, DOI 10.1016/j.cancergencyto.2004.05.019; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Zhang C, 2010, ACTA BIOCH BIOPH SIN, V42, P834, DOI 10.1093/abbs/gmq088; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	62	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31968	10.1371/journal.pone.0031968	http://dx.doi.org/10.1371/journal.pone.0031968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363777	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500100
J	Shenfeld, M; Hachmo, Y; Frenkel, M; Dafni, N; Boettcher, M; Hoheisel, JD; Dotan, I; Canaani, D				Shenfeld, Michal; Hachmo, Yafit; Frenkel, Moran; Dafni, Naomi; Boettcher, Michael; Hoheisel, Joerg D.; Dotan, Iris; Canaani, Dan			ER-Alpha-cDNA As Part of a Bicistronic Transcript Gives Rise to High Frequency, Long Term, Receptor Expressing Cell Clones	PLOS ONE			English	Article							BREAST-CANCER; SYNTHETIC LETHALITY; GENE-EXPRESSION; IRES; ACTIVATION; RESISTANT; CONSENSUS; CREATION; VECTORS; THERAPY	Within the large group of Estrogen Receptor alpha (ER alpha)-negative breast cancer patients, there is a subgroup carrying the phenotype ER alpha(-), PR-, and Her2(-), named accordingly "Triple-Negative'' (TN). Using cell lines derived from this TN group, we wished to establish cell clones, in which ER alpha is ectopically expressed, forming part of a synthetic lethality screening system. Initially, we generated cell transfectants expressing a mono-cistronic ER alpha transcription unit, adjacent to a separate dominant selectable marker transcription unit. However, the yield of ER alpha expressing colonies was rather low (5-12.5%), and only about half of these displayed stable ectopic ER alpha expression over time. Generation and maintenance of such cell clones under minimal exposure to the ER alpha ligand, did not improve yield or expression stability. Indeed, other groups have also reported grave difficulties in obtaining ectopic expression of ER alpha in ER alpha-deficient breast carcinoma cells. We therefore switched to transfecting these cell lines with pER alpha-IRES, a plasmid vector encoding a bicistronic translation mRNA template: ER alpha Open Reading Frame (ORF) being upstream followed by a dominant-positive selectable marker (hygro(R)) ORF, directed for translation from an Internal Ribosome Entry Site (IRES). Through usage of this bicistronic vector linkage system, it was possible to generate a very high yield of ER alpha expressing cell clones (50-100%). The stability over time of these clones was also somewhat improved, though variations between individual cell clones were evident. Our successful experience with ER alpha in this system may serve as a paradigm for other genes where ectopic expression meets similar hardships.	[Shenfeld, Michal; Hachmo, Yafit; Frenkel, Moran; Dafni, Naomi; Dotan, Iris; Canaani, Dan] Tel Aviv Univ, Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel; [Boettcher, Michael; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum, Dept Funct Genome Anal, D-6900 Heidelberg, Germany	Tel Aviv University; Helmholtz Association; German Cancer Research Center (DKFZ)	Shenfeld, M (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel.	canaani@post.tau.ac.il		Boettcher, Michael/0000-0003-0986-4465	German-Israeli Foundation for Scientific Development; Israel Cancer Research Fund; David Orgler Fund for Cancer Research	German-Israeli Foundation for Scientific Development(German-Israeli Foundation for Scientific Research and Development); Israel Cancer Research Fund; David Orgler Fund for Cancer Research	This work was funded by a grant to DC and JDH from the G.I.F., the German-Israeli Foundation for Scientific Development. DC was also supported by Israel Cancer Research Fund project grant, and the David Orgler Fund for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettcher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-7; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Canaani D, 2009, BRIT J CANCER, V100, P1213, DOI 10.1038/sj.bjc.6605000; Douin V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-16; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Lev DC, 2003, CLIN EXP METASTAS, V20, P515; Lewis JS, 2005, J STEROID BIOCHEM, V94, P131, DOI 10.1016/j.jsbmb.2004.12.032; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mak HY, 2001, MOL CELL BIOL, V21, P4379, DOI 10.1128/MCB.21.13.4379-4390.2001; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Planas-Silva MD, 1999, CANCER RES, V59, P4788; PRICE JE, 1990, CANCER RES, V50, P717; Rees S, 1996, BIOTECHNIQUES, V20, P102; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; WANG H, 1995, J BIOL CHEM, V270, P23322, DOI 10.1074/jbc.270.40.23322; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31977	10.1371/journal.pone.0031977	http://dx.doi.org/10.1371/journal.pone.0031977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363779	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500101
J	Thoby-Brisson, M; Bouvier, J; Glasco, DM; Stewart, ME; Dean, C; Murdoch, JN; Champagnat, J; Fortin, G; Chandrasekhar, A				Thoby-Brisson, Muriel; Bouvier, Julien; Glasco, Derrick M.; Stewart, Michelle E.; Dean, Charlotte; Murdoch, Jennifer N.; Champagnat, Jean; Fortin, Gilles; Chandrasekhar, Anand			Brainstem Respiratory Oscillators Develop Independently of Neuronal Migration Defects in the Wnt/PCP Mouse Mutant looptail	PLOS ONE			English	Article							BRANCHIOMOTOR NEURONS; MOTOR-NEURONS; NEURAL-TUBE; HINDBRAIN; PHOX2B; RHYTHM; GENE; CHEMOSENSITIVITY; ZEBRAFISH; IDENTIFICATION	The proper development and maturation of neuronal circuits require precise migration of component neurons from their birthplace (germinal zone) to their final positions. Little is known about the effects of aberrant neuronal position on the functioning of organized neuronal groups, especially in mammals. Here, we investigated the formation and properties of brainstem respiratory neurons in looptail (Lp) mutant mice in which facial motor neurons closely apposed to some respiratory neurons fail to migrate due to loss of function of the Wnt/Planar Cell Polarity (PCP) protein Vangl2. Using calcium imaging and immunostaining on embryonic hindbrain preparations, we found that respiratory neurons constituting the embryonic parafacial oscillator (e-pF) settled at the ventral surface of the medulla in Vangl2(Lp/+) and Vangl2(Lp/Lp) embryos despite the failure of tangential migration of its normally adjacent facial motor nucleus. Anatomically, the e-pF neurons were displaced medially in Lp/+ embryos and rostro-medially Lp/Lp embryos. Pharmacological treatments showed that the e-pF oscillator exhibited characteristic network properties in both Lp/+ and Lp/Lp embryos. Furthermore, using hindbrain slices, we found that the other respiratory oscillator, the preBotzinger complex, was also anatomically and functionally established in Lp mutants. Importantly, the displaced e-pF oscillator established functional connections with the preBotC oscillator in Lp/+ mutants. Our data highlight the robustness of the developmental processes that assemble the neuronal networks mediating an essential physiological function.	[Thoby-Brisson, Muriel; Bouvier, Julien; Champagnat, Jean; Fortin, Gilles] CNRS Inst Neurobiol A Fessard, Neurobiol & Dev UPR 3294, Gif Sur Yvette, France; [Glasco, Derrick M.; Chandrasekhar, Anand] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Glasco, Derrick M.; Chandrasekhar, Anand] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA; [Stewart, Michelle E.; Dean, Charlotte; Murdoch, Jennifer N.] Med Res Council Harwell, Mammalian Genet Unit, Oxford, England; [Chandrasekhar, Anand] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Missouri System; University of Missouri Columbia	Thoby-Brisson, M (corresponding author), Univ Bordeaux 2, CNRS Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, F-33076 Bordeaux, France.	muriel.thoby-brisson@u-bordeaux2.fr; AnandC@missouri.edu	Thoby-Brisson, Muriel/E-1167-2014; Bouvier, Julien/C-1018-2017	Thoby-Brisson, Muriel/0000-0003-3214-1724; Bouvier, Julien/0000-0002-1307-4426; Fortin, Gilles/0000-0002-2123-8603	Centre National de la Recherche Scientifique; Medical Research Council; Institut National de la Sante et de la Recherche Medicale; ANR [ANR-07-Neuro-007-01]; University of Missouri; National Institutes of Health [NS040449]; MRC [G120/861, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [G120/861, MC_UP_1502/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040449, R56NS040449] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR(French National Research Agency (ANR)); University of Missouri; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Centre National de la Recherche Scientifique, the Medical Research Council, Institut National de la Sante et de la Recherche Medicale (M.T.-B.), ANR grant ANR-07-Neuro-007-01 (G. F.), Research Leave (RL-08-013) and Research Council (URC-08-030) grants from the University of Missouri (A. C.), and a National Institutes of Health (NS040449) grant (A. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2000, MECH DEVELOP, V95, P253, DOI 10.1016/S0925-4773(00)00346-4; AICARDI J, 1994, CAN J NEUROL SCI, V21, P185, DOI 10.1017/S0317167100041159; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Borday C, 2005, RESP PHYSIOL NEUROBI, V149, P63, DOI 10.1016/j.resp.2005.02.014; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Chandrasekhar A, 2004, DEV DYNAM, V229, P143, DOI 10.1002/dvdy.10444; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Garel S, 2000, DEVELOPMENT, V127, P5297; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Song MR, 2007, ARCH PHARM RES, V30, P1273, DOI 10.1007/BF02980268; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Verrotti A, 2010, EUR J PAEDIATR NEURO, V14, P1, DOI 10.1016/j.ejpn.2009.01.005; Vivancos V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-7	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31140	10.1371/journal.pone.0031140	http://dx.doi.org/10.1371/journal.pone.0031140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363567	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600116
J	Zuno-Floriano, FG; Miller, MG; Aldana-Madrid, ML; Hengel, MJ; Gaikwad, NW; Tolstikov, V; Contreras-Cortes, AG				Zuno-Floriano, Fabiola G.; Miller, Marion G.; Aldana-Madrid, Maria L.; Hengel, Matt J.; Gaikwad, Nilesh W.; Tolstikov, Vladimir; Contreras-Cortes, Ana G.			Effect of Acinetobacter sp on Metalaxyl Degradation and Metabolite Profile of Potato Seedlings (Solanum tuberosum L.) Alpha Variety	PLOS ONE			English	Article							PLANT-GROWTH; PSEUDOMONAS-FLUORESCENS; BACTERIAL ENDOPHYTES; SUSPENSION-CULTURES; 16S RDNA; COLONIZATION; ROOTS; BIODEGRADATION; MICROORGANISMS; IDENTIFICATION	One of the most serious diseases in potato cultivars is caused by the pathogen Phytophthora infestans, which affects leaves, stems and tubers. Metalaxyl is a fungicide that protects potato plants from Phytophthora infestans. In Mexico, farmers apply metalaxyl 35 times during the cycle of potato production and the last application is typically 15 days before harvest. There are no records related to the presence of metalaxyl in potato tubers in Mexico. In the present study, we evaluated the effect of Acinetobacter sp on metalaxyl degradation in potato seedlings. The effect of bacteria and metalaxyl on the growth of potato seedlings was also evaluated. A metabolite profile analysis was conducted to determine potential molecular biomarkers produced by potato seedlings in the presence of Acinetobacter sp and metalaxyl. Metalaxyl did not affect the growth of potato seedlings. However, Acinetobacter sp strongly affected the growth of inoculated seedlings, as confirmed by plant length and plant fresh weights which were lower in inoculated potato seedlings (40% and 27%, respectively) compared to the controls. Acinetobacter sp also affected root formation. Inoculated potato seedlings showed a decrease in root formation compared to the controls. LC-MS/MS analysis of metalaxyl residues in potato seedlings suggests that Acinetobacter sp did not degrade metalaxyl. GC-TOF-MS platform was used in metabolic profiling studies. Statistical data analysis and metabolic pathway analysis allowed suggesting the alteration of metabolic pathways by both Acinetobacter sp infection and metalaxyl treatment. Several hundred metabolites were detected, 137 metabolites were identified and 15 metabolic markers were suggested based on statistical change significance found with PLS-DA analysis. These results are important for better understanding the interactions of putative endophytic bacteria and pesticides on plants and their possible effects on plant metabolism.	[Zuno-Floriano, Fabiola G.; Miller, Marion G.; Hengel, Matt J.; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Aldana-Madrid, Maria L.] Univ Sonora, Dept Invest & Posgrad Alimentos, Hermosillo 83000, Sonora, Mexico; [Contreras-Cortes, Ana G.] Ctr Interdisciplinario Invest Desarrollo Integral, Dept Biotecnol, Morelia, Michoacan, Mexico; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; Universidad de Sonora; University of California System; University of California Davis; University of California System; University of California Davis	Zuno-Floriano, FG (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	fgzuno@ucdavis.edu	Tolstikov, Vladimir/P-2465-2019	Tolstikov, Vladimir/0000-0002-0445-884X	National Institute of Environmental Health Science (NIEHS) [T32E507059]; University of California Institute for Mexico; United States (UC MEXUS-CONACyT) [CN-07-55]	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of California Institute for Mexico; United States (UC MEXUS-CONACyT)	This study has been carried out with financial support from the National Institute of Environmental Health Science (NIEHS) Postdoctoral Training Grant T32E507059 and University of California Institute for Mexico and the United States (UC MEXUS-CONACyT) No. CN-07-55. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna IB, 2008, MANEJO INTEGRADO TIZ; Adachi K, 2002, SOIL SCI PLANT NUTR, V48, P889, DOI 10.1080/00380768.2002.10408717; Alonso FA, 2002, CULTIVO PATATA, P155; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; BAILEY AM, 1986, CAN J MICROBIOL, V32, P562, DOI 10.1139/m86-105; Barka EA, 2000, FEMS MICROBIOL LETT, V186, P91, DOI 10.1111/j.1574-6968.2000.tb09087.x; BioRad, 1994, BIORAD B; Borba N., 2008, PAPA ALIMENTO BASICO; BUSINELLI M, 1984, J AGR FOOD CHEM, V32, P644, DOI 10.1021/jf00123a054; Chanika E, 2011, BIORESOURCE TECHNOL, V102, P3184, DOI 10.1016/j.biortech.2010.10.145; Claassens MMJ, 2000, POTATO RES, V43, P347, DOI 10.1007/BF02360540; COLE DJ, 1987, PESTIC BIOCHEM PHYS, V28, P354, DOI 10.1016/0048-3575(87)90131-3; Defernez M, 2004, J AGR FOOD CHEM, V52, P6075, DOI 10.1021/jf049522e; Dini FA, 2009, APPL ENVIRON MICROB, V75, P3396; Elvira-Recuenco M, 2000, CAN J MICROBIOL, V46, P1036, DOI 10.1139/cjm-46-11-1036; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Food and Agriculture Organization of the United Nations, 1995, PEST RES FOOD 1995 1; FROMMEL MI, 1993, PLANT SOIL, V150, P51, DOI 10.1007/BF00779175; Garbeva P, 2001, MICROBIAL ECOL, V41, P369, DOI 10.1007/s002480000096; Garcia-Gonzalez M. M., 2005, Terra, V23, P65; Germaine K, 2004, FEMS MICROBIOL ECOL, V48, P109, DOI 10.1016/j.femsec.2003.12.009; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; GRIFONI A, 1995, FEMS MICROBIOL LETT, V127, P85, DOI 10.1111/j.1574-6968.1995.tb07454.x; GROSS D, 1986, 6 INT C PEST CHEM OT; Hamilton D, 2004, METALAXYL M 212; Hansen M, 1997, FEMS MICROBIOL ECOL, V23, P353, DOI 10.1111/j.1574-6941.1997.tb00416.x; Hartmann A, 2000, ANAL PRESENCE DIVERS, P927; Holland MA, 1997, PLANT PHYSIOL, V115, P865, DOI 10.1104/pp.115.3.865; Hongsawat P, 2011, J HAZARD MATER, V186, P1300, DOI 10.1016/j.jhazmat.2010.12.002; Kamrin MA, 1997, PESTICIDE PROFILES T, P437; Liu FY, 2007, J ENVIRON SCI, V19, P1257, DOI 10.1016/S1001-0742(07)60205-8; Ma Y, 2011, J HAZARD MATER, V195, P230, DOI 10.1016/j.jhazmat.2011.08.034; Martinez L, 2003, PLANT SOIL, V257, P35, DOI 10.1023/A:1026283311770; Massoud AH, 2008, J ENVIRON SCI, V20, P262, DOI 10.1016/S1001-0742(08)60041-8; McGuinness MC, 2007, ENG LIFE SCI, V7, P611, DOI 10.1002/elsc.200720218; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; Mehta N, 1997, ECOTOX ENVIRON SAFE, V37, P119, DOI 10.1006/eesa.1997.1533; NELSON LM, 2004, PLANT GROWTH PROMOTI; Nowak J, 1999, POTATO RES, V42, P505, DOI 10.1007/BF02358167; OWEN WJ, 1986, PESTIC BIOCHEM PHYS, V26, P75, DOI 10.1016/0048-3575(86)90064-7; Pelczar M, 1988, ELEMENTOS MICROBIOLO, P95; Pelczar M, 1998, MICROBIOLOGIA, P60; Pena HB, 2007, INTERCIENCIA, V32, P560; Prieto P, 2008, FEMS MICROBIOL ECOL, V64, P297, DOI 10.1111/j.1574-6941.2008.00450.x; Purez W., 2008, MANUAL TECNICO TIZON; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Riveros B. F., 2003, Agricultura Tecnica, V63, P117; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Sahay NS, 1999, FEMS MICROBIOL LETT, V181, P297, DOI 10.1111/j.1574-6968.1999.tb08858.x; Singh P, 2004, BIOCHEM BIOPH RES CO, V317, P697, DOI 10.1016/j.bbrc.2004.03.112; Staden J. Van, 1979, Plant, Cell and Environment, V2, P93, DOI 10.1111/j.1365-3040.1979.tb00780.x; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; STURZ AV, 1995, PLANT SOIL, V175, P257, DOI 10.1007/BF00011362; Sukul P, 2000, REV ENVIRON CONTAM T, V164, P1; Thurston HD, 1990, LATE BLIGHT COMPENDI, P40; Tolstikov V, 2011, MET BIOM DISC PROJ M; Torres-Rubio M. G., 2000, Revista Latinoamericana de Microbiologia, V42, P171; Turnbull GA, 2001, FEMS MICROBIOL ECOL, V36, P21, DOI 10.1111/j.1574-6941.2001.tb00822.x; Verma SC, 2004, BIOTECHNOL LETT, V26, P425, DOI 10.1023/B:BILE.0000018263.94440.ab; VISSER RGF, 1994, PHYSIOL PLANTARUM, V90, P285, DOI [10.1111/j.1399-3054.1994.tb00389.x, 10.1034/j.1399-3054.1994.900207.x]; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; World Health Organization and Food and Agriculture Organization of the United Nations, 2004, ORGANIZATION; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Zadra C, 2002, J AGR FOOD CHEM, V50, P5373, DOI 10.1021/jf020310w; Zuno-Floriano Fabiola G., 2009, Terra Latinoam, V27, P207	72	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31221	10.1371/journal.pone.0031221	http://dx.doi.org/10.1371/journal.pone.0031221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363586	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600125
J	Seki, T; Yoshino, K; Tanaka, S; Dohi, E; Onji, T; Yamamoto, K; Hide, I; Paulson, HL; Saito, N; Sakai, N				Seki, Takahiro; Yoshino, Ken-ich; Tanaka, Shigeru; Dohi, Eisuke; Onji, Tomoya; Yamamoto, Kazuhiro; Hide, Izumi; Paulson, Henry L.; Saito, Naoaki; Sakai, Norio			Establishment of a Novel Fluorescence-Based Method to Evaluate Chaperone-Mediated Autophagy in a Single Neuron	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-14; PROTEIN-DEGRADATION; OXIDATIVE STRESS; TRANSGENIC MICE; ALPHA-SYNUCLEIN; PKC-GAMMA; CELLS; DISEASE; IDENTIFICATION; NEURODEGENERATION	Background: Chaperone-mediated autophagy (CMA) is a selective autophagy-lysosome protein degradation pathway. The role of CMA in normal neuronal functions and in neural disease pathogenesis remains unclear, in part because there is no available method to monitor CMA activity at the single-cell level. Methodology/Principal Findings: We sought to establish a single-cell monitoring method by visualizing translocation of CMA substrates from the cytosol to lysosomes using the HaloTag (HT) system. GAPDH, a CMA substrate, was fused to HT (GAPDH-HT); this protein accumulated in the lysosomes of HeLa cells and cultured cerebellar Purkinje cells (PCs) after labeling with fluorescent dye-conjugated HT ligand. Lysosomal accumulation was enhanced by treatments that activate CMA and prevented by siRNA-mediated knockdown of LAMP2A, a lysosomal receptor for CMA, and by treatments that inactivate CMA. These results suggest that lysosomal accumulation of GAPDH-HT reflects CMA activity. Using this method, we revealed that mutant gamma PKC, which causes spinocerebellar ataxia type 14, decreased CMA activity in cultured PCs. Conclusion/Significance: In the present study, we established a novel fluorescent-based method to evaluate CMA activity in a single neuron. This novel method should be useful and valuable for evaluating the role of CMA in various neuronal functions and neural disease pathogenesis.	[Seki, Takahiro; Tanaka, Shigeru; Dohi, Eisuke; Onji, Tomoya; Yamamoto, Kazuhiro; Hide, Izumi; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima, Japan; [Seki, Takahiro; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Yoshino, Ken-ich; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan	Hiroshima University; University of Michigan System; University of Michigan; Kobe University	Seki, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima, Japan.	tseki@hiroshima-u.ac.jp	Sakai, Norio/AAM-5822-2021; Dohi, Eisuke/I-7197-2019; Tanaka, Shigeru/O-3908-2015	Sakai, Norio/0000-0002-6648-8761; Tanaka, Shigeru/0000-0003-3247-9098; Seki, Takahiro/0000-0002-9894-4768	Ministry of Education, Sports and Culture; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association; Grants-in-Aid for Scientific Research [21591086] Funding Source: KAKEN	Ministry of Education, Sports and Culture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Sports and Culture and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Foundation, Suzuken Memorial Foundation, the Tokyo Biochemical Research Foundation and the Japanese Smoking Research Association. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Chen DH, 2005, NEUROLOGY, V64, P1258, DOI 10.1212/01.WNL.0000156801.64549.6B; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; DICE JF, 1982, J BIOL CHEM, V257, P4624; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Suvorova ES, 2005, TRAFFIC, V6, P100, DOI 10.1111/j.1600-0854.2004.00256.x; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	41	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31232	10.1371/journal.pone.0031232	http://dx.doi.org/10.1371/journal.pone.0031232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363588	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600032
J	Yuan, G; Regel, I; Lian, F; Friedrich, T; Hitkova, I; Hofheinz, RD; Strobel, P; Langer, R; Keller, G; Rocken, C; Zimmermann, W; Schmid, RM; Ebert, MPA; Burgermeister, E				Yuan, G.; Regel, I.; Lian, F.; Friedrich, T.; Hitkova, I.; Hofheinz, R. D.; Stroebel, P.; Langer, R.; Keller, G.; Roecken, C.; Zimmermann, W.; Schmid, R. M.; Ebert, M. P. A.; Burgermeister, E.			WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells	ONCOGENE			English	Article						WNT; caveolin; stomach; gastric cancer; epirubicin	ACTIVATED-RECEPTOR-GAMMA; BETA-CATENIN; SIGNALING PATHWAY; UP-REGULATION; P53 ACTIVATION; POOR-PROGNOSIS; NEOADJUVANT CHEMOTHERAPY; DIFFERENTIAL EXPRESSION; DRUG-RESISTANCE; CARCINOMA-CELLS	Resistance to chemotherapy is a major obstacle for curative treatment of human gastric cancer (GC). However, the underlying molecular mechanisms are largely unknown. Wingless-type MMTV integration site family members (WNTs) are secreted glycoproteins involved in embryogenesis and, on inappropriate expression in the adult, in cancer. Here, we show expression of WNT6 in GC patient specimens, human GC cell lines and in a mouse model of GC. In human GC cells, WNT6 expression was enhanced by caveolin-1 (Cav1), a scaffold protein of plasma membrane caveolae. WNT6 knock-down and overexpression experiments demonstrated that WNT6 increased the resistance to apoptotic cell death induced by the anthracycline chemotherapeutics epirubicin (Epi) and doxorubicin (Dox). Epi increased the activity of the human WNT6 promoter through Cav1-dependent binding of beta-catenin to the proximal WNT6 promoter. Epi increased both WNT6/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg). In GC patients, WNT6 expression was positively associated with the tumor stage and the nodal status, and inversely correlated with the response to ECF (Epi, cisplatin, 5-fluorouracil) chemotherapy. These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs. Understanding the molecular mechanisms driving WNT6/Cav1-induced drug resistance will provide benefits in developing new therapies for GC. Oncogene (2013) 32, 375-387; doi:10.1038/onc.2012.40; published online 27 February 2012	[Yuan, G.; Regel, I.; Friedrich, T.; Schmid, R. M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-80290 Munich, Germany; [Yuan, G.; Lian, F.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Hitkova, I.; Ebert, M. P. A.; Burgermeister, E.] Heidelberg Univ, Univ Klinikum Mannheim, Dept Med 2, D-68167 Mannheim, Baden Wurttembe, Germany; [Hofheinz, R. D.] Heidelberg Univ, Univ Klinikum Mannheim, Dept Med 3, D-68167 Mannheim, Baden Wurttembe, Germany; [Stroebel, P.] Heidelberg Univ, Univ Klinikum Mannheim, Inst Pathol, D-68167 Mannheim, Baden Wurttembe, Germany; [Langer, R.; Keller, G.] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, D-80290 Munich, Germany; [Roecken, C.] Univ Kiel, Inst Pathol, Kiel, Germany; [Zimmermann, W.] Univ Munich, Tumor Immunol Lab, LIFE Ctr, Munich, Germany	Technical University of Munich; Sun Yat Sen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Kiel; University of Munich	Burgermeister, E (corresponding author), Heidelberg Univ, Univ Klinikum Mannheim, Dept Med 2, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Baden Wurttembe, Germany.	elke.burgermeister@medma.uni-heidelberg.de	Langer, Rupert/AAU-1174-2021; Regel, Ivonne/AFS-1831-2022; Röcken, Christoph/A-9239-2010	Langer, Rupert/0000-0001-9491-3609; Röcken, Christoph/0000-0002-6989-8002	Deutsche Krebshilfe [107885, 108096, 108287]; DFG [SFB 824, TP B1, BU-2285]; Else Kroner Stiftung [P14/07//A104/06]; BMBF (Mobimed) [01EZ0802]; BMBF (KMU-innovativ Initiative of the BMBF) [0315116B]	Deutsche Krebshilfe(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); Else Kroner Stiftung; BMBF (Mobimed)(Federal Ministry of Education & Research (BMBF)); BMBF (KMU-innovativ Initiative of the BMBF)(Federal Ministry of Education & Research (BMBF))	We are grateful to Minhu Chen, Xiao Chen, Jie Chen for support on collaborations. M Ebert is supported by grants from the Deutsche Krebshilfe (107885, 108096), the DFG (SFB 824, TP B1), the Else Kroner Stiftung (Nr P14/07//A104/06), the BMBF (Mobimed 01EZ0802 and KMU-innovativ Initiative of the BMBF No 0315116B). E Burgermeister receives funds from the Deutsche Krebshilfe (108287) and DFG (BU-2285).	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Asciutti S, 2011, ONCOGENE, V30, P956, DOI 10.1038/onc.2010.475; Barresi V, 2006, ACTA NEUROPATHOL, V112, P617, DOI 10.1007/s00401-006-0097-1; Becker K, 2003, CANCER-AM CANCER SOC, V98, P1521, DOI 10.1002/cncr.11660; Becker K, 2011, ANN SURG, V253, P934, DOI 10.1097/SLA.0b013e318216f449; Belanger MM, 2004, CANCER BIOL THER, V3, P954, DOI 10.4161/cbt.3.10.1112; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bourquin C, 2010, J IMMUNOL, V185, P2580, DOI 10.4049/jimmunol.0903231; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Burgermeister E, 2011, MOL CELL BIOL, V31, P3497, DOI 10.1128/MCB.01421-10; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Chen J, 2005, GUT, V54, P920, DOI 10.1136/gut.2004.047340; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Du ZM, 2009, INT J CANCER, V125, P1832, DOI 10.1002/ijc.24531; Dvory-Sobol H, 2007, CANCER-AM CANCER SOC, V109, P188, DOI 10.1002/cncr.22416; Ebert MPA, 2002, CARCINOGENESIS, V23, P87, DOI 10.1093/carcin/23.1.87; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Flahaut M, 2009, ONCOGENE, V28, P2245, DOI 10.1038/onc.2009.80; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Karam JA, 2007, PROSTATE, V67, P614, DOI 10.1002/pros.20557; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Krawetz R, 2008, CELL SIGNAL, V20, P506, DOI 10.1016/j.cellsig.2007.11.001; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Nyeng P, 2007, DEV BIOL, V303, P295, DOI 10.1016/j.ydbio.2006.11.017; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Shatz M, 2004, LEUKEMIA RES, V28, P907, DOI 10.1016/j.leukres.2004.03.013; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Thompson J, 2000, INT J CANCER, V86, P863, DOI 10.1002/(SICI)1097-0215(20000615)86:6<863::AID-IJC16>3.0.CO;2-4; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4	58	63	68	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 17	2013	32	3					375	387		10.1038/onc.2012.40	http://dx.doi.org/10.1038/onc.2012.40			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370641	Bronze			2022-12-25	WOS:000314736600011
J	Chen, BY; Li, Y; Jiang, SX; Xie, YP; Guo, A; Kutschke, W; Zimmerman, K; Weiss, RM; Miller, FJ; Anderson, ME; Song, LS				Chen, Biyi; Li, Yue; Jiang, Shuxia; Xie, Yu-Ping; Guo, Ang; Kutschke, William; Zimmerman, Kathy; Weiss, Robert M.; Miller, Francis J.; Anderson, Mark E.; Song, Long-Sheng			beta-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction	FASEB JOURNAL			English	Article						heart failure; beta-AR blockers	CHRONIC HEART-FAILURE; VENTRICULAR MYOCYTES; CA2+ RELEASE; ADRENOCEPTOR ANTAGONISTS; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTORS; REDUCED SYNCHRONY; CARDIAC MYOCYTES; RAT-HEART; CARVEDILOL	beta-Adrenergic receptor (AR) blockers provide substantial clinical benefits, including improving overall survival and left ventricular (LV) function following myocardial infarction (MI), though the mechanisms remain incompletely defined. The transverse-tubule (T-tubule) system of ventricular myocytes is an important determinant of cardiac excitation-contraction function. T-tubule remodeling occurs early during LV failure. We hypothesized that beta-AR blockers prevent T-tubule remodeling and thereby provide therapeutic benefits. A murine model of MI was utilized to examine the effect of beta-AR blockers on T-tubule remodeling following LV MI. We applied the in situ imaging of T-tubule structure from Langendorff-perfused intact hearts with laser scanning confocal microscopy. We found that MI caused remarkable T-tubule remodeling near the infarction border zone and moderate LV remodeling remote from the MI. Metoprolol and carvedilol administered 6 d after MI for 4 wk each increased the T-tubule integrity at the remote and border zones. At the molecular level, both beta-AR blockers restored border and remote zone expression of junctophilin-2 (JP-2), which is involved in T-tubule organization and formation of the T-tubule/sarcoplasmic reticulum junctions. In contrast, beta-AR blockers had no significant effects on caveolin-3 expression. In summary, our data show that beta-AR antagonists can protect against T-tubule remodeling after MI, suggesting a novel therapeutic mechanism of action for this drug class. Preservation of JP-2 expression may contribute to the beneficial effects of metoprolol and carvedilol on T-tubule remodeling.-Chen, B., Li, Y., Jiang, S., Xie, Y.-P., Guo, A., Kutschke, W., Zimmerman, K., Weiss, R. M., Miller, F. J., Anderson, M. E., Song, L.-S. beta-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction. FASEB J. 26, 2531-2537 (2012). www.fasebj.org	[Chen, Biyi; Li, Yue; Jiang, Shuxia; Xie, Yu-Ping; Guo, Ang; Kutschke, William; Weiss, Robert M.; Miller, Francis J.; Anderson, Mark E.; Song, Long-Sheng] Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Carver Coll Med, Iowa City, IA 52242 USA; [Zimmerman, Kathy; Miller, Francis J.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Song, LS (corresponding author), Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Carver Coll Med, Iowa City, IA 52242 USA.	long-sheng-song@uiowa.edu	Miller Jr, Francis/N-7312-2015; Chen, Biyi/AAF-3077-2021; Guo, Ang/M-3549-2013; Miller, Francis J/F-3801-2017	Miller Jr, Francis/0000-0001-5822-0549; Guo, Ang/0000-0002-5551-2279; Miller, Francis J/0000-0001-5822-0549; Song, Long-Sheng/0000-0002-6035-8106; Weiss, Robert/0000-0003-1307-2647	U.S. National Institutes of Health [NIH R01 HL090905, RR026293]; American Heart Association [0635056N, 11POST7640011]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026293] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grants NIH R01 HL090905 (L. S. S.) and RR026293 (R. M. W.) and American Heart Association Scientific Development grant 0635056N (L. S. S.). S. J. was supported in part by an American Heart Association postdoctoral fellowship award (11POST7640011). The authors declare no conflicts of interest.	Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Bito V, 2008, CARDIOVASC RES, V77, P315, DOI 10.1093/cvr/cvm063; Brette F, 2005, J MOL CELL CARDIOL, V39, P804, DOI 10.1016/j.yjmcc.2005.08.005; Brette F, 2004, J MOL CELL CARDIOL, V36, P265, DOI 10.1016/j.yjmcc.2003.11.002; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Doughty RN, 1997, J AM COLL CARDIOL, V29, P1060, DOI 10.1016/S0735-1097(97)00012-0; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; EPSTEIN SE, 1965, J CLIN INVEST, V44, P1745, DOI 10.1172/JCI105282; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Franzini-Armstrong C, 1999, FASEB J, V13, pS266, DOI 10.1096/fasebj.13.9002.S266; Gheorghiade M, 2003, CIRCULATION, V107, P1570, DOI 10.1161/01.CIR.0000065187.80707.18; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Ibrahim M, 2010, FASEB J, V24, P3321, DOI 10.1096/fj.10-156638; Janosi A, 2003, AM HEART J, V146, P721, DOI 10.1016/S0002-8703(03)00163-7; Kemi OJ, 2011, J CELL PHYSIOL, V226, P2235, DOI 10.1002/jcp.22559; Khattar RS, 2001, AM HEART J, V142, P704, DOI 10.1067/mhj.2001.116768; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Maczewski M, 2008, CARDIOVASC RES, V79, P42, DOI 10.1093/cvr/cvn057; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Rehsia NS, 2010, EXP CLIN CARDIOL, V15, pE86; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Song LS, 2005, ANN NY ACAD SCI, V1047, P99, DOI 10.1196/annals.1341.009; Song LS, 2001, CIRC RES, V88, P794, DOI 10.1161/hh0801.090461; Sun YL, 2005, CHEST, V128, P1812, DOI 10.1378/chest.128.3.1812; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wu CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024404; Xie YP, 2012, HYPERTENSION, V59, P355, DOI 10.1161/HYPERTENSIONAHA.111.180968; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Ziman AP, 2010, J MOL CELL CARDIOL, V48, P379, DOI 10.1016/j.yjmcc.2009.09.016	45	48	49	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2531	2537		10.1096/fj.11-199505	http://dx.doi.org/10.1096/fj.11-199505			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22375019	Green Published, Bronze			2022-12-25	WOS:000305017200029
J	Kennedy, EM; Amie, SM; Bambara, RA; Kim, B				Kennedy, Edward M.; Amie, Sarah M.; Bambara, Robert A.; Kim, Baek			Frequent Incorporation of Ribonucleotides during HIV-1 Reverse Transcription and Their Attenuated Repair in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; CRYSTAL-STRUCTURE; CELL-CYCLE; INFECTION; SUBSTRATE; FIDELITY; MUTAGENESIS; SELECTION; DEMENTIA	Macrophages are well known long-lived reservoirs of HIV-1. Unlike activated CD4(+) T cells, this nondividing HIV-1 target cell type contains a very low level of the deoxynucleoside triphosphates (dNTPs) required for proviral DNA synthesis whereas the ribonucleoside triphosphate (rNTP) levels remain in the millimolar range, resulting in an extremely low dNTP/rNTP ratio. Biochemical simulations demonstrate that HIV-1 reverse transcriptase (RT) efficiently incorporates ribonucleoside monophosphates (rNMPs) during DNA synthesis at this ratio, predicting frequent rNMP incorporation by the virus specifically in macrophages. Indeed, HIV-1 RT incorporates rNMPs at a remarkable rate of 1/146 nucleotides during macrophage infection. This greatly exceeds known rates for cellular replicative polymerases. In contrast, little or no rNMP incorporation is detected in CD4(+) T cells. Repair of these rNMP lesions is also substantially delayed in macrophages compared with CD4(+) T cells. Single rNMPs embedded in a DNA template are known to induce cellular DNA polymerase pausing, which mechanistically contributes to mutation synthesis. Indeed, we also observed that embedded rNMPs in a dsDNA template also induce HIV-1 RT DNA synthesis pausing. Moreover, unrepaired rNMPs incorporated into the provirus during HIV-1 reverse transcription would be generally mutagenic as was shown in Saccharomyces cerevisiae. Most importantly, the frequent incorporation of rNMPs makes them an ideal candidate for development of a new class of HIV RT inhibitors.	[Kennedy, Edward M.; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Amie, Sarah M.; Bambara, Robert A.] Univ Rochester, Dept Biochem & Biophys, Med Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI077401, AI049781, GM0495763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077401, R01AI049781, R56AI049781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077401 (to B. K.), AI049781 (to B. K.), and GM0495763 (to R. A. B.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; ACHIM CL, 1993, J CLIN INVEST, V91, P2769, DOI 10.1172/JCI116518; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bagasra O, 1996, J INFECT DIS, V173, P550, DOI 10.1093/infdis/173.3.550; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gendelman HE, 1998, J INFECT DIS, V178, P1000, DOI 10.1086/515693; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Jamburuthugoda VK, 2005, BIOCHEMISTRY-US, V44, P10635, DOI 10.1021/bi050611+; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200	34	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14280	14288		10.1074/jbc.M112.348482	http://dx.doi.org/10.1074/jbc.M112.348482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383524	Green Published, hybrid			2022-12-25	WOS:000303996300079
J	Petropoulos, AD; Green, R				Petropoulos, Alexandros D.; Green, Rachel			Further in Vitro Exploration Fails to Support the Allosteric Three-site Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA BINDING; RIBOSOMAL ELONGATION CYCLE; PEPTIDE-BOND FORMATION; E-SITE; ESCHERICHIA-COLI; MESSENGER-RNA; EXIT-SITE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; READING FRAME	Ongoing debate in the ribosome field has focused on the role of bound E-site tRNA and the Shine-Dalgarno-anti-Shine-Dalgarno (SD-aSD) interaction on A-site tRNA interactions and the fidelity of tRNA selection. Here we use an in vitro reconstituted Escherichia coli translation system to explore the reported effects of E-site-bound tRNA and SD-aSD interactions on tRNA selection events and find no evidence for allosteric coupling. A large set of experiments exploring the role of the E-site tRNA in miscoding failed to recapitulate the observations of earlier studies (Di Giacco, V., Marquez, V., Qin, Y., Pech, M., Triana-Alonso, F. J., Wilson, D. N., and Nierhaus, K. H. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 10715-10720 and Geigenmuller, U., and Nierhaus, K. H. (1990) EMBO J. 9, 4527-4533); the frequency of miscoding was unaffected by the presence of E-site-bound cognate tRNA. Moreover, our data provide clear evidence that the reported effects of the SD-aSD interaction on fidelity can be attributed to the binding of ribosomes to an unanticipated site on the mRNA (in the absence of the SD sequence) that provides a cognate pairing codon leading naturally to incorporation of the purported "noncognate" amino acid.	[Petropoulos, Alexandros D.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 702 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			University of Patras (Greece); Johns Hopkins University School of Medicine; National Institutes of Health [GM059425]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	University of Patras (Greece); Johns Hopkins University School of Medicine(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a fellowship sponsored by collaboration between the University of Patras (Greece) and The Johns Hopkins University School of Medicine.; Supported by grants from the National Institutes of Health (GM059425) and the Howard Hughes Medical Institute. To whom correspondence should be addressed: Dept. of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, 702 PCTB, 725 N. Wolfe St., Baltimore, MD 21205. Tel.: 410-614-4922; Fax: 410-955-9124; E-mail: ragreen@jhmi.edu.	BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Chen CL, 2011, P NATL ACAD SCI USA, V108, P16980, DOI 10.1073/pnas.1106999108; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Di Giacco V, 2008, P NATL ACAD SCI USA, V105, P10715, DOI 10.1073/pnas.0801974105; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Nierhaus KH, 2006, BIOCHIMIE, V88, P1013, DOI 10.1016/j.biochi.2006.02.009; RHEINBERGER HJ, 1983, EUR J BIOCHEM, V134, P421, DOI 10.1111/j.1432-1033.1983.tb07584.x; ROBERTSON JM, 1987, J MOL BIOL, V196, P525, DOI 10.1016/0022-2836(87)90030-1; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	28	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11642	11648		10.1074/jbc.C111.330068	http://dx.doi.org/10.1074/jbc.C111.330068			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22378789	Green Published, hybrid			2022-12-25	WOS:000302782200004
J	Lapalikar, GV; Taylor, MC; Warden, AC; Scott, C; Russell, RJ; Oakeshott, JG				Lapalikar, Gauri V.; Taylor, Matthew C.; Warden, Andrew C.; Scott, Colin; Russell, Robyn J.; Oakeshott, John G.			F420H2-Dependent Degradation of Aflatoxin and other Furanocoumarins Is Widespread throughout the Actinomycetales	PLOS ONE			English	Article							COENZYME F-420; F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; RHODOCOCCUS-ERYTHROPOLIS; BIOSYNTHESIS; STREPTOMYCES; 2,4,6-TRINITROPHENOL; FLAVIN; B-1; 2,4-DINITROPHENOL	Two classes of F-420-dependent reductases (FDR-A and FDR-B) that can reduce aflatoxins and thereby degrade them have previously been isolated from Mycobacterium smegmatis. One class, the FDR-A enzymes, has up to 100 times more activity than the other. F-420 is a cofactor with a low reduction potential that is largely confined to the Actinomycetales and some Archaea and Proteobacteria. We have heterologously expressed ten FDR-A enzymes from diverse Actinomycetales, finding that nine can also use F420H2 to reduce aflatoxin. Thus FDR-As may be responsible for the previously observed degradation of aflatoxin in other Actinomycetales. The one FDR-A enzyme that we found not to reduce aflatoxin belonged to a distinct clade (herein denoted FDR-AA), and our subsequent expression and analysis of seven other FDR-AAs from M. smegmatis found that none could reduce aflatoxin. Certain FDR-A and FDR-B enzymes that could reduce aflatoxin also showed activity with coumarin and three furanocoumarins (angelicin, 8-methoxysporalen and imperatorin), but none of the FDR-AAs tested showed any of these activities. The shared feature of the compounds that were substrates was an alpha,beta-unsaturated lactone moiety. This moiety occurs in a wide variety of otherwise recalcitrant xenobiotics and antibiotics, so the FDR-As and FDR-Bs may have evolved to harness the reducing power of F-420 to metabolise such compounds. Mass spectrometry on the products of the FDR-catalyzed reduction of coumarin and the other furanocoumarins shows their spontaneous hydrolysis to multiple products.	[Lapalikar, Gauri V.; Taylor, Matthew C.; Warden, Andrew C.; Scott, Colin; Russell, Robyn J.; Oakeshott, John G.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lapalikar, GV (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	m.taylor@csiro.au	Russell, Robyn/C-5449-2008; Warden, Andrew C/C-1484-2008; Taylor, Matthew/B-5903-2009; Scott, Colin/A-4682-2009; Oakeshott, John G/B-5365-2009	Russell, Robyn/0000-0001-5600-3305; Warden, Andrew C/0000-0003-2683-9798; Taylor, Matthew/0000-0001-9576-1555; Scott, Colin/0000-0001-6110-6982; Oakeshott, John G/0000-0001-8324-7874	CSIRO Synthetic Enzymes Emerging Science Initiative	CSIRO Synthetic Enzymes Emerging Science Initiative	This project was funded under CSIRO Synthetic Enzymes Emerging Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JF, 2006, INT J FOOD MICROBIOL, V109, P121, DOI 10.1016/j.ijfoodmicro.2006.01.019; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Barnes MR, 1997, J BACTERIOL, V179, P6145, DOI 10.1128/jb.179.19.6145-6153.1997; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Berkessel A, 2005, ANGEW CHEM INT EDIT, V44, P807, DOI 10.1002/anie.200461442; Bornemann C, 1997, BIOCHEM J, V325, P623, DOI 10.1042/bj3250623; BRODERSEN R, 1946, ACTA PHARMACOL TOX, V2, P109; Bugg TDH, 1997, BIOCHEM SOC T, V25, P81, DOI 10.1042/bst0250081; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; CIEGLER A, 1966, APPL MICROBIOL, V14, P934, DOI 10.1128/AEM.14.6.934-939.1966; de Poorter LMI, 2005, MICROBIOL-SGM, V151, P1697, DOI 10.1099/mic.0.27679-0; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Ebert S, 1999, J BACTERIOL, V181, P2669, DOI 10.1128/JB.181.9.2669-2674.1999; Ebert S, 2001, BIODEGRADATION, V12, P367, DOI 10.1023/A:1014447700775; Gerratana B, 2010, MED RES REV; Griese JJ, 2006, J MOL BIOL, V361, P140, DOI 10.1016/j.jmb.2006.06.007; Grill S, 2008, J BACTERIOL, V190, P1546, DOI 10.1128/JB.01586-07; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; HAMAMOTO T, 1985, J ANTIBIOT, V38, P533, DOI 10.7164/antibiotics.38.533; Heiss G, 2002, MICROBIOL-SGM, V148, P799, DOI 10.1099/00221287-148-3-799; Hormisch D, 2004, SYST APPL MICROBIOL, V27, P653, DOI 10.1078/0723202042369866; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON F, 1984, BIOCHEMISTRY-US, V23, P979, DOI 10.1021/bi00300a028; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; Kaneko M, 2003, J BACTERIOL, V185, P20, DOI 10.1128/JB.185.1.20-27.2003; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; LYNEN F, 1953, BIOCHIM BIOPHYS ACTA, V12, P299, DOI 10.1016/0006-3002(53)90149-8; Mack M, 2006, APPL MICROBIOL BIOT, V71, P265, DOI 10.1007/s00253-006-0421-7; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Oja T, 2008, CHEM BIOL, V15, P1046, DOI 10.1016/j.chembiol.2008.07.022; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; PITTS JN, 1983, ENVIRON HEALTH PERSP, V47, P115, DOI 10.2307/3429504; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; STRICKLAND S, 1973, J BIOL CHEM, V248, P2944; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; Teniola OD, 2005, INT J FOOD MICROBIOL, V105, P111, DOI 10.1016/j.ijfoodmicro.2005.05.004; Wagacha JM, 2008, INT J FOOD MICROBIOL, V124, P1, DOI 10.1016/j.ijfoodmicro.2008.01.008	44	43	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30114	10.1371/journal.pone.0030114	http://dx.doi.org/10.1371/journal.pone.0030114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383957	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500007
J	Liu, Y; Chen, XH; Si, YJ; Li, ZJ; Gao, L; Gao, L; Zhang, C; Zhang, X				Liu, Yao; Chen, Xing-hua; Si, Ying-jian; Li, Zhong-jun; Gao, Lei; Gao, Li; Zhang, Cheng; Zhang, Xi			Reconstruction of Hematopoietic Inductive Microenvironment after Transplantation of VCAM-1-Modified Human Umbilical Cord Blood Stromal Cells	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; PROGENITOR CELLS; IN-VITRO; MICE; ENGRAFTMENT; ADHESION; LIGAND	The hematopoietic inductive microenvironment (HIM) is where hematopoietic stem/progenitor cells grow and develop. Hematopoietic stromal cells were the key components of the HIM. In our previous study, we had successfully cultured and isolated human cord blood-derived stromal cells (HUCBSCs) and demonstrated that they could secret hemopoietic growth factors such as GM-CSF, TPO, and SCF. However, it is still controversial whether HUCBSCs can be used for reconstruction of HIM. In this study, we first established a co-culture system of HUCBSCs and cord blood CD34(+) cells and then determined that using HUCBSCs as the adherent layer had significantly more newly formed colonies of each hematopoietic lineage than the control group, indicating that HUCBSCs had the ability to promote the proliferation of hematopoietic stem cells/progenitor cells. Furthermore, the number of colonies was significantly higher in vascular cell adhesion molecule-1 (VCAM-1)-modified HUCBSCs, suggesting that the ability of HUCBSCs in promoting the proliferation of hematopoietic stem cells/progenitor cells was further enhanced after having been modified with VCAM-1. Next, HUCBSCs were infused into a radiation-damaged animal model, in which the recovery of hematopoiesis was observed. The results demonstrate that the transplanted HUCBSCs were "homed in" to bone marrow and played roles in promoting the recovery of irradiation-induced hematopoietic damage and repairing HIM. Compared with the control group, the HUCBSC group had significantly superior effectiveness in terms of the recovery time for hemogram and myelogram, CFU-F, CFU-GM, BFU-E, and CFU-Meg. Such differences were even more significant in VCAM-1-modified HUCBSCs group. We suggest that HUCBSCs are able to restore the functions of HIM and promote the recovery of radiation-induced hematopoietic damage. VCAM-1 plays an important role in supporting the repair of HIM damage.	[Liu, Yao; Chen, Xing-hua; Si, Ying-jian; Gao, Lei; Gao, Li; Zhang, Cheng; Zhang, Xi] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China; [Li, Zhong-jun] Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China; [Si, Ying-jian] Mil Gen Hosp Beijing, BaYi Childrens Hosp, Dept Pediat Hematol Oncol, Beijing, Peoples R China	Army Medical University; Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China.	zhangxxi@sina.com			National Natural Science Foundation of China [30500220, 81070388, 81000194, 30670890]; Chongqing Key Discipline of Natural Science [2009BA5056, 2009BA5011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Key Discipline of Natural Science	This work was supported in part by the National Natural Science Foundation of China (No. 30500220 (to XZ), 81070388 (to XZ), 81000194 (to YL), 30670890 (to XHC)) and Chongqing Key Discipline of Natural Science (No. 2009BA5056 (to ZX), 2009BA5011 (to XHC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak Pratima, 2010, Chin J Cancer, V29, P969; Dorshkind K, 2007, GENE DEV, V21, P2249, DOI 10.1101/gad.1600307; FUKUSHIMA N, 1995, CRIT REV ONCOL HEMAT, V20, P255, DOI 10.1016/1040-8428(94)00163-N; Gao L, 2006, BLOOD CELL MOL DIS, V36, P322, DOI 10.1016/j.bcmd.2005.12.036; Gao L, 2010, CELL CYCLE, V9, P1342, DOI 10.4161/cc.9.7.11146; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Hao Jing, 2001, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V9, P56; Hao L, 2009, CROAT MED J, V50, P351, DOI 10.3325/cmj.2009.50.351; Isomura H, 2003, J MED VIROL, V70, P444, DOI 10.1002/jmv.10415; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Konstandin MH, 2006, J IMMUNOL METHODS, V310, P67, DOI 10.1016/j.jim.2005.12.005; Lee YH, 2004, J KOREAN MED SCI, V19, P523, DOI 10.3346/jkms.2004.19.4.523; Liu Y, 2011, CANCER BIOL THER, V11, P84, DOI 10.4161/cbt.11.1.13956; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; OFLAHERTY E, 1995, BONE MARROW TRANSPL, V15, P207; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; PERKINS S, 1988, J CLIN INVEST, V81, P1072, DOI 10.1172/JCI113419; Ramakrishnan A, 2009, EXPERT OPIN BIOL TH, V9, P21, DOI [10.1517/14712590802603093, 10.1517/14712590802603093 ]; Schmitz N, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.29245; Shipounova IN, 2009, CTS-CLIN TRANSL SCI, V2, P67, DOI 10.1111/j.1752-8062.2008.00074.x; Tada T, 2008, EXP ANIM TOKYO, V57, P347, DOI 10.1538/expanim.57.347; Wagner W, 2007, EXP HEMATOL, V35, P314, DOI 10.1016/j.exphem.2006.10.003; WOLF NS, 1982, EXP HEMATOL, V10, P108; Yanai N, 2000, BLOOD, V96, P139, DOI 10.1182/blood.V96.1.139.013k15_139_144; Zhang C, 2011, J BIOL CHEM, V286, P13723, DOI 10.1074/jbc.M110.144691; Zhang Xi, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P598	27	10	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31741	10.1371/journal.pone.0031741	http://dx.doi.org/10.1371/journal.pone.0031741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384064	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100032
J	Armstrong, G; Phillips, B				Armstrong, Graeme; Phillips, Ben			Fire History from Life-History: Determining the Fire Regime that a Plant Community Is Adapted Using Life-Histories	PLOS ONE			English	Article							NORTHERN AUSTRALIA; PERSISTENCE; MANAGEMENT; KIMBERLEY; CLIMATE; BIODIVERSITY; COEXISTENCE; SAVANNA; IMPACTS; ECOLOGY	Wildfire is a fundamental disturbance process in many ecological communities, and is critical in maintaining the structure of some plant communities. In the past century, changes in global land use practices have led to changes in fire regimes that have radically altered the composition of many plant communities. As the severe biodiversity impacts of inappropriate fire management regimes are recognized, attempts are being made to manage fires within a more 'natural' regime. In this aim, the focus has typically been on determining the fire regime to which the community has adapted. Here we take a subtly different approach and focus on the probability of a patch being burnt. We hypothesize that competing sympatric taxa from different plant functional groups are able to coexist due to the stochasticity of the fire regime, which creates opportunities in both time and space that are exploited differentially by each group. We exploit this situation to find the fire probability at which three sympatric grasses, from different functional groups, are able to co-exist. We do this by parameterizing a spatio-temporal simulation model with the life-history strategies of the three species and then search for the fire frequency and scale at which they are able to coexist when in competition. The simulation gives a clear result that these species only coexist across a very narrow range of fire probabilities centred at 0.2. Conversely, fire scale was found only to be important at very large scales. Our work demonstrates the efficacy of using competing sympatric species with different regeneration niches to determine the probability of fire in any given patch. Estimating this probability allows us to construct an expected historical distribution of fire return intervals for the community; a critical resource for managing fire-driven biodiversity in the face of a growing carbon economy and ongoing climate change.	[Armstrong, Graeme] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Phillips, Ben] James Cook Univ, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	Charles Darwin University; James Cook University	Armstrong, G (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	graeme.armstrong@fba.org.au	Phillips, Ben/C-7957-2009	Phillips, Ben/0000-0003-2580-2336	Australian Wildlife Conservancy; Holsworth Wildlife Research Endowment; Northern Territory Research and Innovation Fund; Australian Research Council	Australian Wildlife Conservancy; Holsworth Wildlife Research Endowment; Northern Territory Research and Innovation Fund; Australian Research Council(Australian Research Council)	Financial support was provided by Australian Wildlife Conservancy, Australian Research Council, Holsworth Wildlife Research Endowment, and the Northern Territory Research and Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, S PLUS; Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Armstrong G, 2011, HEREDITY, V107, P558, DOI 10.1038/hdy.2011.42; Armstrong G, 2011, INT J WILDLAND FIRE, V20, P974, DOI 10.1071/WF10130; Armstrong G, 2011, AUSTRAL ECOL, V36, P849, DOI 10.1111/j.1442-9993.2010.02228.x; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Bunk S, 2004, PLOS BIOL, V2, P154, DOI 10.1371/journal.pbio.0020054; Crowley G, 2009, AUSTRAL ECOL, V34, P196, DOI 10.1111/j.1442-9993.2008.01921.x; Duren OC, 2010, FIRE ECOL, V6, P76, DOI 10.4996/fireecology.0602076; Enright NJ, 2008, GEOGR COMPASS, V2, P979, DOI 10.1111/j.1749-8198.2008.00126.x; ERNST WHO, 1992, VEGETATIO, V102, P1, DOI 10.1007/BF00031700; Fensham RJ, 1997, J BIOGEOGR, V24, P11, DOI 10.1111/j.1365-2699.1997.tb00046.x; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Groeneveld J, 2002, J ECOL, V90, P762, DOI 10.1046/j.1365-2745.2002.00712.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; Higuera PE, 2011, HOLOCENE, V21, P327, DOI 10.1177/0959683610374882; Jongejans E, 1999, OIKOS, V87, P362, DOI 10.2307/3546752; Keith David, 1996, Proceedings of the Linnean Society of New South Wales, V116, P37; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Legge Sarah, 2011, Ecological Management & Restoration, V12, P84, DOI 10.1111/j.1442-8903.2011.00595.x; Lehmann CER, 2008, J APPL ECOL, V45, P1304, DOI 10.1111/j.1365-2664.2008.01496.x; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Noble IR, 1996, J VEG SCI, V7, P329, DOI 10.2307/3236276; ODOWD DJ, 1984, ECOLOGY, V65, P1052, DOI 10.2307/1938313; Ooi MKJ, 2006, INT J WILDLAND FIRE, V15, P261, DOI 10.1071/WF05024; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Preece N, 2002, J BIOGEOGR, V29, P321, DOI 10.1046/j.1365-2699.2002.00677.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2010, AUST J BOT, V58, P300, DOI 10.1071/BT99210; RussellSmith J, 1997, HUM ECOL, V25, P159, DOI 10.1023/A:1021970021670; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000938; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vigilante T, 2004, AUST J BOT, V52, P405, DOI 10.1071/BT03157; WESTOBY M, 1988, AUST J ECOL, V13, P161, DOI 10.1111/j.1442-9993.1988.tb00965.x; Wood SW, 2010, FOREST ECOL MANAG, V260, P438, DOI 10.1016/j.foreco.2010.04.037; Yates CP, 2008, INT J WILDLAND FIRE, V17, P768, DOI 10.1071/WF07150; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	46	4	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31544	10.1371/journal.pone.0031544	http://dx.doi.org/10.1371/journal.pone.0031544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363670	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000302873700068
J	Piecewicz, SM; Pandey, A; Roy, B; Xiang, SH; Zetter, BR; Sengupta, S				Piecewicz, Stephanie M.; Pandey, Ambarish; Roy, Bhaskar; Xiang, Soh Hua; Zetter, Bruce R.; Sengupta, Shiladitya			Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells	PLOS ONE			English	Article							FACTOR-I RECEPTOR; HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; PROGENITOR CELLS; CYCLOLIGNAN PPP; FACTOR 1-ALPHA; MOUSE MODEL; IGF-I; EXPRESSION	The ability of embryonic stem cells to differentiate into endothelium and form functional blood vessels has been well established and can potentially be harnessed for therapeutic angiogenesis. However, after almost two decades of investigation in this field, limited knowledge exists for directing endothelial differentiation. A better understanding of the cellular mechanisms regulating vasculogenesis is required for the development of embryonic stem cell-based models and therapies. In this study, we elucidated the mechanistic role of insulin-like growth factors (IGF1 and 2) and IGF receptors (IGFR1 and 2) in endothelial differentiation using an embryonic stem cell embryoid body model. Both IGF1 or IGF2 predisposed embryonic stem to differentiate towards a mesodermal lineage, the endothelial precursor germ layer, as well as increased the generation of significantly more endothelial cells at later stages. Inhibition of IGFR1 signaling using neutralizing antibody or a pharmacological inhibitor, picropodophyllin, significantly reduced IGF-induced mesoderm and endothelial precursor cell formation. We confirmed that IGF-IGFR1 signaling stabilizes HIF1 alpha and leads to up-regulation of VEGF during vasculogenesis in embryoid bodies. Understanding the mechanisms that are critical for vasculogenesis in various models will bring us one step closer to enabling cell based therapies for neovascularization.	[Piecewicz, Stephanie M.; Pandey, Ambarish; Roy, Bhaskar; Xiang, Soh Hua; Sengupta, Shiladitya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Piecewicz, Stephanie M.; Sengupta, Shiladitya] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Roy, Bhaskar] Indian Inst Technol, Dept Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Zetter, Bruce R.] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Zetter, Bruce R.] Harvard Univ, Childrens Hosp, Sch Med, Vasc Biol Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Piecewicz, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	stephanie.piecewicz@gmail.com; shiladit@mit.edu			Department of Defense Era of Hope [W81XWH-07-1-0482]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	Department of Defense Era of Hope; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SS is supported by a Department of Defense Era of Hope Scholar award (W81XWH-07-1-0482). This work was supported by an American Heart Association Scientist Development Grant to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; ARAI T, 1994, J BIOL CHEM, V269, P20388; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Catrina SB, 2005, BRIT J CANCER, V92, P1467, DOI 10.1038/sj.bjc.6602408; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Feldser D, 1999, CANCER RES, V59, P3915; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GRANT MB, 1993, ANN NY ACAD SCI, V692, P230; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Hanjaya-Putra D, 2009, BIOTECHNOL PROGR, V25, P2, DOI 10.1002/btpr.129; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Humpert PM, 2008, MOL MED, V14, P301, DOI 10.2119/2007-00052.Humpert; IKEZU T, 1995, J BIOL CHEM, V270, P29224, DOI 10.1074/jbc.270.49.29224; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaufman DS, 2004, BLOOD, V103, P1325, DOI 10.1182/blood-2003-03-0799; Koch H, 2005, STEM CELLS DEV, V14, P621, DOI 10.1089/scd.2005.14.621; Kouroupi G, 2010, J NEUROCHEM, V115, P460, DOI 10.1111/j.1471-4159.2010.06939.x; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; McCloskey KE, 2009, METHOD MOL BIOL, V330, P287; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Morali OG, 2000, DEV BIOL, V227, P133, DOI 10.1006/dbio.2000.9875; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Paye JMD, 2006, ANN BIOMED ENG, V34, P618, DOI 10.1007/s10439-005-9064-6; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RISAU W, 1988, DEVELOPMENT, V102, P471; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmid C, 1995, CELL BIO INT, V19; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Sun X, 2009, CELL BIOL INT, V33, P1201, DOI 10.1016/j.cellbi.2009.08.005; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424	50	56	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32191	10.1371/journal.pone.0032191	http://dx.doi.org/10.1371/journal.pone.0032191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363814	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700155
J	Bengtsson, JM; Trona, F; Montagne, N; Anfora, G; Ignell, R; Witzgall, P; Jacquin-Joly, E				Bengtsson, Jonas M.; Trona, Federica; Montagne, Nicolas; Anfora, Gianfranco; Ignell, Rickard; Witzgall, Peter; Jacquin-Joly, Emmanuelle			Putative Chemosensory Receptors of the Codling Moth, Cydia pomonella, Identified by Antennal Transcriptome Analysis	PLOS ONE			English	Article							CANDIDATE PHEROMONE RECEPTORS; SEX-PHEROMONE; SPODOPTERA-LITTORALIS; OLFACTORY RECEPTORS; SEQUENCE ALIGNMENT; ODORANT RECEPTORS; LEPIDOPTERA; FEMALE; PLANT; TORTRICIDAE	The codling moth, Cydia pomonella, is an important fruit pest worldwide. As nocturnal animals, adults depend to a large extent on olfactory cues for detection of food and mates, and, for females, oviposition sites. In insects, odor detection is mediated by odorant receptors (ORs) and ionotropic receptors (IRs), which ensure the specificity of the olfactory sensory neuron responses. In this study, our aim was to identify chemosensory receptors in the codling moth as a means to uncover new targets for behavioral interference. Using next-generation sequencing techniques, we identified a total of 43 candidate ORs, one gustatory receptor and 15 IRs in the antennal transcriptome. Through Blast and sequence similarity analyses we annotated the insect obligatory co-receptor ORco, five genes clustering in a conserved clade containing sex pheromone receptors, one homolog of the Bombyx mori female-enriched receptor BmorOR30 (but no homologs of the other B. mori female-enriched receptors) and one gene clustering in the sugar receptor family. Among the candidate IRs, we identified homologs of the two highly conserved co-receptors IR8a and IR25a, and one homolog of an IR involved in phenylethyl amine detection in Drosophila. Our results open for functional characterization of the chemosensory receptors of C. pomonella, with potential for new or refined applications of semiochemicals for control of this pest insect.	[Bengtsson, Jonas M.; Trona, Federica; Anfora, Gianfranco] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Montagne, Nicolas; Jacquin-Joly, Emmanuelle] INRA, UMR Physiol Insecte Signalisat & Commun A 1272, F-78026 Versailles, France; [Montagne, Nicolas; Jacquin-Joly, Emmanuelle] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun A 1272, Paris, France; [Ignell, Rickard; Witzgall, Peter] Swedish Univ Agr Sci, Div Chem Ecol, Dept Plant Protect Biol, Alnarp, Sweden	Fondazione Edmund Mach; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Swedish University of Agricultural Sciences	Bengtsson, JM (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	Jonas.Bengtsson@Fmach.it	Witzgall, Peter/N-6429-2013	Witzgall, Peter/0000-0002-4697-3380; Jacquin-Joly, Emmanuelle/0000-0002-6904-2036; Montagne, Nicolas/0000-0001-8810-3853; Bengtsson, Jonas M/0000-0003-1995-5950; ANFORA, Gianfranco/0000-0003-2545-1409	Trentino region and Marie Curie [COFUND - Trentino] [226070]; Linnaeus initiative; Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC]; Agence Nationale de la Recherche, France [ANR-09-BLAN-0239-01]	Trentino region and Marie Curie [COFUND - Trentino]; Linnaeus initiative; Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC]; Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported by a project cofunded by the Trentino region and Marie Curie [COFUND - Trentino, 226070], the Linnaeus initiative "Insect Chemical Ecology, Ethology and Evolution'' IC-E3 [Formas, SLU], the Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC] and Agence Nationale de la Recherche [ANR-09-BLAN-0239-01, France]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Ansebo L, 2005, J INSECT PHYSIOL, V51, P1066, DOI 10.1016/j.jinsphys.2005.05.003; ARN H, 1985, EXPERIENTIA, V41, P1482, DOI 10.1007/BF01950048; Backman AC, 2000, J COMP PHYSIOL A, V186, P513, DOI 10.1007/s003590000101; Bengtsson M, 2006, ENTOMOL EXP APPL, V118, P77, DOI 10.1111/j.1570-7458.2006.00359.x; Bengtsson M, 2001, J AGR FOOD CHEM, V49, P3736, DOI 10.1021/jf0100548; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brigaud I, 2009, FEBS J, V276, P6537, DOI 10.1111/j.1742-4658.2009.07351.x; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Ebbinghaus D, 1998, J INSECT PHYSIOL, V44, P49, DOI 10.1016/S0022-1910(97)00101-7; EINHORN J, 1984, CR ACAD SCI III-VIE, V299, P773; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Garczynski SF, 2011, INSECT SCI; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Ioriatti C, 2009, PEST MANAG SCI, V65, P306, DOI 10.1002/ps.1689; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; PALANASWAMY P, 1978, J CHEM ECOL, V4, P649, DOI 10.1007/BF00990275; ROELOFS W, 1971, SCIENCE, V174, P297, DOI 10.1126/science.174.4006.297; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; Tanaka K, 2009, CURRENT BIOL; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Trona F, 2010, J EXP BIOL, V213, P4291, DOI 10.1242/jeb.047365; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Witzgall P, 2001, ENTOMOL EXP APPL, V101, P131, DOI 10.1023/A:1019270515505; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Yang ZH, 2004, J CHEM ECOL, V30, P619, DOI 10.1023/B:JOEC.0000018633.94002.af	61	132	151	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31620	10.1371/journal.pone.0031620	http://dx.doi.org/10.1371/journal.pone.0031620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363688	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500064
J	Cao, GL; Gu, MX; Zhu, M; Gao, JY; Yin, Y; Marshall, C; Xiao, M; Ding, J; Miao, DS				Cao, Guangliang; Gu, Minxia; Zhu, Min; Gao, Junying; Yin, Ying; Marshall, Charles; Xiao, Ming; Ding, Jiong; Miao, Dengshun			Bmi-1 Absence Causes Premature Brain Degeneration	PLOS ONE			English	Article							CELL SELF-RENEWAL; HUMAN EPILEPTOGENIC HIPPOCAMPUS; HEMATOPOIETIC STEM-CELLS; GLUTAMINE-SYNTHETASE; EXTRACELLULAR GLUTAMATE; OXIDATIVE STRESS; ASTROGLIAL CELLS; PROLIFERATION; INK4A; NEURODEGENERATION	Bmi-1, a polycomb transcriptional repressor, is implicated in cell cycle regulation and cell senescence. Its absence results in generalized astrogliosis and epilepsy during the postnatal development, but the underlying mechanisms are poorly understood. Here, we demonstrate the occurrence of oxidative stress in the brain of four-week-old Bmi-1 null mice. The mice showed various hallmarks of neurodegeneration including synaptic loss, axonal demyelination, reactive gliosis and brain mitochondrial damage. Moreover, astroglial glutamate transporters and glutamine synthetase decreased in the Bmi-1 null hippocampus, which might contribute to the sporadic epileptic-like seizures in these mice. These results indicate that Bmi-1 is required for maintaining endogenous antioxidant defenses in the brain, and its absence subsequently causes premature brain degeneration.	[Cao, Guangliang; Gu, Minxia; Gao, Junying; Xiao, Ming; Ding, Jiong] Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China; [Zhu, Min; Yin, Ying; Miao, Dengshun] Nanjing Med Univ, Dept Anat, Res Ctr Bone & Stem Cells, Nanjing, Jiangsu, Peoples R China; [Marshall, Charles] Univ Kentucky, Ctr Excellence Rural Hlth, Dept Rehabil Sci, Hazard, KY USA	Nanjing Medical University; Nanjing Medical University; University of Kentucky	Cao, GL (corresponding author), Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	mingx@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; Xiao, Ming/0000-0001-5528-9102	National Nature and Scientific Foundation of China [30971020, 30830103]; Natural Science Foundation of Jiangsu Educational Department [09KJA310003]	National Nature and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Educational Department	This work was supported by grants from the National Nature and Scientific Foundation of China Key Project (No. 30971020 to M. Xiao, No. 30830103 to D. Miao) and the Natural Science Foundation of Jiangsu Educational Department (09KJA310003 to M. Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMA MJ, 1993, HUM MOL GENET, V2, P1597, DOI 10.1093/hmg/2.10.1597; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bjornsen LP, 2007, NEUROBIOL DIS, V25, P319, DOI 10.1016/j.nbd.2006.09.014; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Butterfield DA, 1997, J NEUROCHEM, V68, P2451; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Demarque M, 2004, J NEUROSCI, V24, P3289, DOI 10.1523/JNEUROSCI.5338-03.2004; Dimri GP, 2002, CANCER RES, V62, P4736; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Grinstein Edgar, 2009, J Stem Cells, V4, P141; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu L, 2010, NEUROSCIENCE, V169, P596, DOI 10.1016/j.neuroscience.2010.05.028; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812	48	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32015	10.1371/journal.pone.0032015	http://dx.doi.org/10.1371/journal.pone.0032015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363787	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500104
J	Kunisawa, J; Hashimoto, E; Ishikawa, I; Kiyono, H				Kunisawa, Jun; Hashimoto, Eri; Ishikawa, Izumi; Kiyono, Hiroshi			A Pivotal Role of Vitamin B9 in the Maintenance of Regulatory T Cells In Vitro and In Vivo	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; WATER-SOLUBLE VITAMINS; RETINOIC-ACID; INTESTINAL-ABSORPTION; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; INDUCTION; RESPONSES; DIFFERENTIATION; INTERLEUKIN-2	Dietary factors regulate immunological function, but the underlying mechanisms remain elusive. Here we show that vitamin B9 is a survival factor for regulatory T (Treg) cells expressing high levels of vitamin B9 receptor (folate receptor 4). In vitamin B9-reduced condition in vitro, Treg cells could be differentiated from native T cells but failed to survive. The impaired survival of Treg cells was associated with decreased expression of anti-apoptotic Bcl2 and independent of IL-2. In vivo depletion of dietary vitamin B9 resulted in the reduction of Treg cells in the small intestine, a site for the absorption of dietary vitamin B9. These findings provide a new link between diet and the immune system, which could maintain the immunological homeostasis in the intestine.	[Kunisawa, Jun; Hashimoto, Eri; Ishikawa, Izumi; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Kunisawa, J (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kunisawa@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [22689015, 23116506, 23229004, 19059003, 021-07124]; Ministry of Health and Welfare of Japan; Global Center of Excellence of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation	This work was supported by grants from: the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists A [22689015 to J.K.] for Scientific Research on Innovative Areas [23116506 to J.K.], for Scientific Research S [23229004 to H. K.], for Scientific Research on Priority Area [19059003 to H. K.], and for JSPS Fellows (021-07124 to Y.K.); the Ministry of Health and Welfare of Japan (to J.K. and H. K.); the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (to H. K.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN; to J.K.); and the Yakult Bio-Science Foundation (to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Aufreiter S, 2009, AM J CLIN NUTR, V90, P116, DOI 10.3945/ajcn.2008.27345; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Biswal BK, 2009, J BIOCHEM, V146, P693, DOI 10.1093/jb/mvp130; Bourre-Tessier J, 2010, J RHEUMATOL, V37, P1416, DOI 10.3899/jrheum.090153; Cebra JJ, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P335, DOI 10.1016/B978-012491543-5/50022-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Hanson LA, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1159, DOI 10.1016/B978-012491543-5/50069-3; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; JANSEN G, 1990, J BIOL CHEM, V265, P18272; Jia ZC, 2009, IMMUNOL INVEST, V38, P718, DOI 10.3109/08820130903171003; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; MILLER LT, 1990, ANN NY ACAD SCI, V587, P49, DOI 10.1111/j.1749-6632.1990.tb00132.x; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Said HM, 2006, CURR OPIN GASTROEN, V22, P140, DOI 10.1097/01.mog.0000203870.22706.52; Salazar MD, 2007, CANCER METAST REV, V26, P141, DOI 10.1007/s10555-007-9048-0; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	41	84	90	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32094	10.1371/journal.pone.0032094	http://dx.doi.org/10.1371/journal.pone.0032094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363800	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500110
J	Van Wielendaele, P; Dillen, S; Marchal, E; Badisco, L; Vanden Broeck, J				Van Wielendaele, Pieter; Dillen, Senne; Marchal, Elisabeth; Badisco, Liesbeth; Vanden Broeck, Jozef			CRF-Like Diuretic Hormone Negatively Affects Both Feeding and Reproduction in the Desert Locust, Schistocerca gregaria	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; OVARY MATURATING PARSIN; CENTRAL-NERVOUS-SYSTEM; TOBACCO HORNWORM; CORPORA CARDIACA; MANDUCA-SEXTA; ECDYSTEROID-PHOSPHATES; HEMOLYMPH ECDYSTEROIDS; ENZYME-IMMUNOASSAY; MATURING PARSIN	Diuretic hormones (DH) related to the vertebrate Corticotropin Releasing Factor (CRF) have been identified in diverse insect species. In the migratory locust, Locusta migratoria, the CRF-like DH (CRF/DH) is localized in the same neurosecretory cells as the Ovary Maturating Parsin (OMP), a neurohormone that stimulates oocyte growth, vitellogenesis and hemolymph ecdysteroid levels in adult female locusts. In this study, we investigated whether CRF-like DH can influence feeding and reproduction in the desert locust, Schistocerca gregaria. We identified two highly similar S. gregaria CRF-like DH precursor cDNAs, each of which also encodes an OMP isoform. Alignment with other insect CRF-like DH precursors shows relatively high conservation of the CRF/DH sequence while the precursor region corresponding to OMP is not well conserved. Quantitative real-time RT-PCR revealed that the precursor transcripts mainly occur in the central nervous system and their highest expression level was observed in the brain. Injection of locust CRF/DH caused a significantly reduced food intake, while RNAi knockdown stimulated food intake. Therefore, our data indicate that CRF-like DH induces satiety. Furthermore, injection of CRF/DH in adult females retarded oocyte growth and caused lower ecdysteroid titers in hemolymph and ovaries, while RNAi knockdown resulted in opposite effects. The observed effects of CRF/DH may be part of a wider repertoire of neurohormonal activities, constituting an integrating control system that affects food intake and excretion, as well as anabolic processes like oocyte growth and ecdysteroidogenesis, following a meal. Our discussion about the functional relationship between CRF/DH and OMP led to the hypothesis that OMP may possibly act as a monitoring peptide that can elicit negative feedback effects.	[Van Wielendaele, Pieter; Dillen, Senne; Marchal, Elisabeth; Badisco, Liesbeth; Vanden Broeck, Jozef] Katholieke Univ Leuven, Div Anim Physiol & Neurobiol, Inst Zool, Louvain, Belgium	KU Leuven	Van Wielendaele, P (corresponding author), Katholieke Univ Leuven, Div Anim Physiol & Neurobiol, Inst Zool, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be		Vanden Broeck, Jozef/0000-0001-7653-0516; Marchal, Elisabeth/0000-0003-1310-4792; Van Wielendaele, Pieter/0000-0003-1492-6165	K.U. Leuven Research Foundation [GOA/11/02]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [IAP P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the K.U. Leuven Research Foundation (Grant GOA/11/02, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy, Grant IAP P6/14, www.belspo.be). P.V.W., E.M. and L.B. were supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; ARASE K, 1989, PHYSIOL BEHAV, V45, P565, DOI 10.1016/0031-9384(89)90074-7; Audsley N, 1997, PEPTIDES, V18, P59, DOI 10.1016/S0196-9781(96)00234-3; Audsley N, 1997, REGUL PEPTIDES, V69, P25, DOI 10.1016/S0167-0115(96)02125-8; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Badisco L, 2011, PEPTIDES, V32, P573, DOI 10.1016/j.peptides.2010.11.008; Baldwin DC, 2001, PEPTIDES, V22, P147, DOI 10.1016/S0196-9781(00)00371-5; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonte M, 2008, J ECON ENTOMOL, V101, P1127, DOI 10.1603/0022-0493(2008)101[1127:DARFOO]2.0.CO;2; BOWNES M, 1988, P NATL ACAD SCI USA, V85, P1554, DOI 10.1073/pnas.85.5.1554; Brugge VAT, 1999, J EXP BIOL, V202, P2017; Cabrero P, 2002, J EXP BIOL, V205, P3799; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; CHEN YT, 1994, CELL TISSUE RES, V278, P493, DOI 10.1007/BF00331367; COAST GM, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P67; COOPER RA, 1992, J ECON ENTOMOL, V85, P838, DOI 10.1093/jee/85.3.838; DIGAN ME, 1992, P NATL ACAD SCI USA, V89, P11074, DOI 10.1073/pnas.89.22.11074; Downer KE, 2007, J INSECT PHYSIOL, V53, P106, DOI 10.1016/j.jinsphys.2006.10.013; FERIN M, 1993, ANN NY ACAD SCI, V697, P106, DOI 10.1111/j.1749-6632.1993.tb49927.x; FURUTANI Y, 1983, NATURE, V301, P537, DOI 10.1038/301537a0; Furuya K, 1998, PEPTIDES, V19, P619, DOI 10.1016/S0196-9781(97)00475-0; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Girardie J, 1998, J INSECT PHYSIOL, V44, P1063, DOI 10.1016/S0022-1910(98)00066-3; GIRARDIE J, 1991, EUR J BIOCHEM, V202, P1121, DOI 10.1111/j.1432-1033.1991.tb16479.x; Girardie J, 1996, J INSECT PHYSIOL, V42, P215, DOI 10.1016/0022-1910(95)00097-6; Girardie J, 1998, INSECT BIOCHEM MOLEC, V28, P641, DOI 10.1016/S0965-1748(98)00053-8; GJ Goldsworthy, 1999, RECENT DEV COMP ENDO, P231; Glinwood R, 2011, OECOLOGIA, V166, P637, DOI 10.1007/s00442-010-1892-x; Goldsworthy GJ, 2003, PEPTIDES, V24, P1607, DOI 10.1016/j.peptides.2003.09.010; Hatle JD, 2003, ARCH INSECT BIOCHEM, V52, P45, DOI 10.1002/arch.10067; Hatle JD, 1979, J INSECT PHYSL, V25, P701; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; ISAAC RE, 1984, BIOCHEM J, V221, P459, DOI 10.1042/bj2210459; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; KATAOKA H, 1989, P NATL ACAD SCI USA, V86, P2976, DOI 10.1073/pnas.86.8.2976; KAY I, 1991, BIOL CHEM H-S, V372, P929, DOI 10.1515/bchm3.1991.372.2.929; KEELEY LL, 1992, EXPERIENTIA, V48, P1145, DOI 10.1007/BF01948010; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; LEHMBERG E, 1991, BIOCHEM BIOPH RES CO, V179, P1036, DOI 10.1016/0006-291X(91)91923-Z; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Li XF, 2010, BRAIN RES, V1364, P153, DOI 10.1016/j.brainres.2010.08.036; Lopez-Arias B, 2011, PEPTIDES, V32, P545, DOI 10.1016/j.peptides.2010.07.002; Lu WQ, 2004, ENDOCRINOLOGY, V145, P5786, DOI 10.1210/en.2004-0144; Ma M, 2000, GEN COMP ENDOCR, V118, P1, DOI 10.1006/gcen.1999.7435; Maeno K, 2011, J INSECT PHYSIOL, V57, P514, DOI 10.1016/j.jinsphys.2011.02.004; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsuda K, 2011, ANN NY ACAD SCI, V1220, P117, DOI 10.1111/j.1749-6632.2010.05884.x; Montuenga LM, 1996, CELL TISSUE RES, V285, P331, DOI 10.1007/s004410050650; Opstad R, 2004, J INSECT PHYSIOL, V50, P725, DOI 10.1016/j.jinsphys.2004.05.010; Pascual N, 1995, Z NATURFORSCH C, V50, P862; PATEL M, 1994, PEPTIDES, V15, P591, DOI 10.1016/0196-9781(94)90081-7; PORCHERON P, 1989, INSECT BIOCHEM, V19, P117, DOI 10.1016/0020-1790(89)90081-4; RICHARD O, 1992, CELL TISSUE RES, V270, P587, DOI 10.1007/BF00645062; RICHARD O, 1994, HISTOCHEMISTRY, V102, P233, DOI 10.1007/BF00268900; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Ronan PJ, 2011, PROG MOL BIOL TRANSL, V98, P235, DOI 10.1016/B978-0-12-385506-0.00006-5; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Shobana K, 2010, J INSECT PHYSIOL, V56, P1065, DOI 10.1016/j.jinsphys.2010.02.018; Stengel A, 2009, ENDOCRINOLOGY, V150, P153, DOI 10.1210/en.2008-0723; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tamarelle M, 2000, PEPTIDES, V21, P737, DOI 10.1016/S0196-9781(00)00187-X; Tawfik AI, 1997, J INSECT PHYSIOL, V43, P485, DOI 10.1016/S0022-1910(96)00116-3; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Te Brugge V, 2011, J EXP BIOL, V214, P371, DOI 10.1242/jeb.046292; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; UVAROV BP, 1966, GRASSHOPPERS LOCUSTS, P332; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; van Hoef V, 2011, INSECT BIOCHEM MOLEC, V41, P688, DOI 10.1016/j.ibmb.2011.04.012; van Huis A, 2008, ENTOMOL EXP APPL, V127, P144, DOI 10.1111/j.1570-7458.2008.00682.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wada-Katsumata A, 2011, CHEM SENSES, V36, P589, DOI 10.1093/chemse/bjr023; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Yamada R, 2005, ZOOL SCI, V22, P187, DOI 10.2108/zsj.22.187; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	78	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31425	10.1371/journal.pone.0031425	http://dx.doi.org/10.1371/journal.pone.0031425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363645	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500043
J	Sircar, K; Huang, H; Hu, LM; Liu, YX; Dhillon, J; Cogdell, D; Aprikian, A; Efstathiou, E; Navone, N; Troncoso, P; Zhang, W				Sircar, Kanishka; Huang, Heng; Hu, Limei; Liu, Yuexin; Dhillon, Jasreman; Cogdell, David; Aprikian, Armen; Efstathiou, Eleni; Navone, Nora; Troncoso, Patricia; Zhang, Wei			Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CENTROSOME HYPERAMPLIFICATION; TUMOR AGGRESSIVENESS; SOLID TUMORS; DOCETAXEL; INHIBITOR; EG5; PHOSPHORYLATION; OVEREXPRESSION; MITOXANTRONE	The recently described transcriptomic switch to a mitosis program in castration-resistant prostate cancer (CRPC) suggests that mitotic proteins may be rationally targeted at this lethal stage of the disease. In this study, we showed upregulation of the mitosis-phase at the protein level in our cohort of 51 clinical CRPC cases and found centrosomal aberrations to also occur preferentially in CRPC compared with untreated, high Gleason-grade hormone-sensitive prostate cancer (P<0.0001). Expression profiling of chemotherapy-resistant CRPC samples (n = 25) was performed, and the results were compared with data from primary chemotherapy-naive CRPC (n = 10) and hormone-sensitive prostate cancer cases (n = 108). Our results showed enrichment of mitosis-phase genes and pathways, with progression to both castration-resistant and chemotherapy-resistant disease. The mitotic centromere-associated kinesin (MCAK) was identified as a novel mitosis-phase target in prostate cancer that was overexpressed in multiple CRPC gene-expression datasets. We found concordant gene expression of MCAK between our parent and murine CRPC xenograft pairs and increased MCAK protein expression with clinical progression of prostate cancer to a castration-resistant disease stage. Knockdown of MCAK arrested the growth of prostate cancer cells suggesting its utility as a potential therapeutic target.	[Sircar, Kanishka; Hu, Limei; Liu, Yuexin; Dhillon, Jasreman; Cogdell, David; Troncoso, Patricia; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Huang, Heng] Univ Texas Arlington, Dept Comp Sci & Engn, Arlington, TX 76019 USA; [Efstathiou, Eleni; Navone, Nora] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Efstathiou, Eleni; Navone, Nora] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA; [Aprikian, Armen] McGill Univ, Div Urol, Montreal, PQ, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Arlington; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; McGill University	Sircar, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	ksircar@mdanderson.org; wzhang@mdanderson.org	Sircar, Kanishka/E-4106-2012		MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This paper is supported by institutional funds from MD Anderson Cancer Center (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal N, 2011, NOVEL MOL TARGETS TH; Beer TM, 2008, CLIN GENITOURIN CANC, V6, P103, DOI 10.3816/CGC.2008.n.016; Blagden SP, 2008, BRIT J CANCER, V98, P894, DOI 10.1038/sj.bjc.6604264; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Davis DA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-22; De S, 2009, CANCER RES, V69, P8035, DOI 10.1158/0008-5472.CAN-09-1224; Efstathiou E, 2007, CLIN CANCER RES, V13, P1224, DOI 10.1158/1078-0432.CCR-06-1938; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gustafson LM, 2000, LARYNGOSCOPE, V110, P1798; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hayashi N, 2008, PROSTATE, V68, P1283, DOI 10.1002/pros.20783; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Jabbur JR, 2002, CANCER BIOL THER, V1, P277, DOI 10.4161/cbt.81; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Liu Qingxin, 2011, Chin J Cancer, V30, P612, DOI 10.5732/cjc.011.10225; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Syed ML, 2009, OTOLARYNG HEAD NECK, V140, P498, DOI 10.1016/j.otohns.2008.12.049; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wiltshire C, 2010, MOL CANCER THER, V9, P1730, DOI 10.1158/1535-7163.MCT-09-1103; Yamamoto Y, 2004, CLIN CANCER RES, V10, P6449, DOI 10.1158/1078-0432.CCR-04-0773	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31259	10.1371/journal.pone.0031259	http://dx.doi.org/10.1371/journal.pone.0031259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363599	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600132
J	Schertl, P; Sunderhaus, S; Klodmann, J; Grozeff, GEG; Bartoli, CG; Braun, HP				Schertl, Peter; Sunderhaus, Stephanie; Klodmann, Jennifer; Gergoff Grozeff, Gustavo E.; Bartoli, Carlos G.; Braun, Hans-Peter			L-Galactono-1,4-lactone dehydrogenase (GLDH) Forms Part of Three Subcomplexes of Mitochondrial Complex I in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LACTONE DEHYDROGENASE; CARBONIC-ANHYDRASE SUBUNITS; ASCORBIC-ACID; POLYACRYLAMIDE-GELS; VITAMIN-C; 3-DIMENSIONAL STRUCTURE; PROTEOMIC APPROACH; INNER MEMBRANE; SWEET-POTATO; PLANTS	L-Galactono-1,4-lactone dehydrogenase (GLDH) catalyzes the terminal step of the Smirnoff-Wheeler pathway for vitamin C (L-ascorbate) biosynthesis in plants. A GLDH in gel activity assay was developed to biochemically investigate GLDH localization in plant mitochondria. It previously has been shown that GLDH forms part of an 850-kDa complex that represents a minor form of the respiratory NADH dehydrogenase complex (complex I). Because accumulation of complex I is disturbed in the absence of GLDH, a role of this enzyme in complex I assembly has been proposed. Here we report that GLDH is associated with two further protein complexes. Using native gel electrophoresis procedures in combination with the in gel GLDH activity assay and immunoblotting, two mitochondrial complexes of 470 and 420 kDa were identified. Both complexes are of very low abundance. Protein identifications by mass spectrometry revealed that they include subunits of complex I. Finally, the 850-kDa complex was further investigated and shown to include the complete "peripheral arm" of complex I. GLDH is attached to a membrane domain, which represents a major fragment of the "membrane arm" of complex I. Taken together, our data further support a role of GLDH during complex I formation, which is based on its binding to specific assembly intermediates.	[Schertl, Peter; Sunderhaus, Stephanie; Klodmann, Jennifer; Braun, Hans-Peter] Leibniz Univ Hannover, Inst Pflanzengenet, Abt Pflanzenprote, D-30419 Hannover, Germany; [Gergoff Grozeff, Gustavo E.; Bartoli, Carlos G.] Univ Nacl La Plata CCT CONICET La Plata, Inst Fisiol Vegetal, Fac Ciencias Agr & Forestales, RA-1900 La Plata, Buenos Aires, Argentina	Leibniz University Hannover	Braun, HP (corresponding author), Leibniz Univ Hannover, Inst Pflanzengenet, Abt Pflanzenprote, Herrenhauser Str 2, D-30419 Hannover, Germany.	braun@genetik.uni-hannover.de	Braun, Hans-Peter/E-7149-2011; Grozeff, Gustavo Esteban Gergoff/AED-8418-2022; Grozeff, Gustavo Esteban Gergoff/L-7800-2019; Klodmann, Jennifer/B-2131-2013	Braun, Hans-Peter/0000-0002-4459-9727; Grozeff, Gustavo Esteban Gergoff/0000-0003-1175-3473; Senkler, Jennifer/0000-0002-1377-3841; Schertl, Peter/0000-0002-4211-1695	Deutsche Forschungsgemeinschaft (DFG) [Br 1829/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant Br 1829/10-1.	Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Barth C, 2006, J EXP BOT, V57, P1657, DOI 10.1093/jxb/erj198; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun HP, 2007, PHYSIOL PLANTARUM, V129, P114, DOI 10.1111/j.1399-3054.2006.00773.x; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; EADIE MJ, 1970, HISTOCHEMISTRY, V21, P170, DOI 10.1007/BF00306184; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Heinemeyer Jesco, 2007, V355, P343; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Imai T, 1998, PLANT CELL PHYSIOL, V39, P1350, DOI 10.1093/oxfordjournals.pcp.a029341; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Klodmann J, 2011, PHYTOCHEMISTRY, V72, P1071, DOI 10.1016/j.phytochem.2010.11.012; Klodmann J, 2011, PROTEOMICS, V11, P1834, DOI 10.1002/pmic.201000638; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Leferink NGH, 2009, FEBS LETT, V583, P3199, DOI 10.1016/j.febslet.2009.09.004; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; MAPSON LW, 1954, BIOCHEM J, V56, P21, DOI 10.1042/bj0560021; MAPSON LW, 1958, BIOCHEM J, V68, P395, DOI 10.1042/bj0680395; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Millar AH, 2003, PLANT PHYSIOL, V133, P443, DOI 10.1104/pp.103.028399; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Ostergaard J, 1997, J BIOL CHEM, V272, P30009, DOI 10.1074/jbc.272.48.30009; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Peters K, 2008, BBA-BIOENERGETICS, V1777, P84, DOI 10.1016/j.bbabio.2007.10.012; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5; Siendones E, 1999, PLANT PHYSIOL, V120, P907, DOI 10.1104/pp.120.3.907; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Sunderhaus Stephanie, 2007, Methods Mol Biol, V372, P315, DOI 10.1007/978-1-59745-365-3_23; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	53	58	60	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14412	14419		10.1074/jbc.M111.305144	http://dx.doi.org/10.1074/jbc.M111.305144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22378782	Green Published, hybrid			2022-12-25	WOS:000304003200009
J	di Tommaso, A; Juste, MO; Martin-Eauclaire, MF; Dimier-Poisson, I; Billiald, P; Aubrey, N				di Tommaso, Anne; Juste, Matthieu O.; Martin-Eauclaire, Marie-France; Dimier-Poisson, Isabelle; Billiald, Philippe; Aubrey, Nicolas			Diabody Mixture Providing Full Protection against Experimental Scorpion Envenoming with Crude Androctonus australis Venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUTHUS-OCCITANUS-TUNETANUS; CHAIN ANTIBODY FRAGMENT; CLINICAL CHARACTERISTICS; ANTIVENOM IMMUNOTHERAPY; FUNCTIONAL-EVALUATION; HECTOR; TOXIN; ENVENOMATION; PHARMACOKINETICS; OPTIMIZATION	Androctonus australis is primarily involved in envenomations in North Africa, notably in Tunisia and Algeria, and constitutes a significant public health problem in this region. The toxicity of the venom is mainly due to various neurotoxins that belong to two distinct structural and immunological groups, group I (the AahI and AahIII toxins) and group II (AahII). Here, we report the use of a diabody mixture in which the molar ratio matches the characteristics of toxins and polymorphism of the venom. The mixture consists of the Db9C2 diabody (anti-group I) and the Db4C1op diabody (anti-AahII), the latter being modified to facilitate in vitro production and purification. The effectiveness of the antivenom was tested in vivo under conditions simulating scorpion envenomation. The intraperitoneal injection of 30 mu g of the diabody mixture protected almost all the mice exposed to 3 LD50 s.c. of venom. We also show that the presence of both diabodies is necessary for the animals to survive. Our results are the first demonstration of the strong protective power of small quantities of antivenom used in the context of severe envenomation with crude venom.	[Aubrey, Nicolas] Univ Tours, Fac Pharm, Infectiol & Sante Publ UMR1282, F-37200 Tours, France; [di Tommaso, Anne; Juste, Matthieu O.; Dimier-Poisson, Isabelle; Aubrey, Nicolas] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Martin-Eauclaire, Marie-France] Univ Mediterranee, CRN2M, CNRS UMR6231, F-13344 Marseille 15, France; [Billiald, Philippe] Univ Paris 11, IFR 141, F-92260 Chatenay Malabry, France	Universite de Tours; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Aubrey, N (corresponding author), Univ Tours, Fac Pharm, Infectiol & Sante Publ UMR1282, 31 Ave Monge, F-37200 Tours, France.	aubrey@univ-tours.fr	BILLIALD, Philippe/ABF-7417-2021	BILLIALD, Philippe/0000-0001-8148-5297; , nicolas/0000-0003-3211-0186				Abroug F, 1999, LANCET, V354, P906, DOI 10.1016/S0140-6736(98)12083-4; Adi-Bessalem S, 2008, EXP TOXICOL PATHOL, V60, P373, DOI 10.1016/j.etp.2008.03.006; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Benguedda AC, 2002, B SOC PATHOL EXOT, V95, P205; Benkhadir K, 2004, PEPTIDES, V25, P151, DOI 10.1016/j.peptides.2004.01.009; Bouaziz M, 2008, TOXICON, V52, P918, DOI 10.1016/j.toxicon.2008.09.004; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; Chowell G, 2006, TOXICON, V47, P753, DOI 10.1016/j.toxicon.2006.02.004; Dart RC, 2001, ANN EMERG MED, V37, P181, DOI 10.1067/mem.2001.113372; DELORI P, 1981, TOXICON, V19, P393, DOI 10.1016/0041-0101(81)90044-1; Devaux C, 2004, TOXICON, V43, P661, DOI 10.1016/j.toxicon.2004.02.021; Devaux C, 2002, J IMMUNOL METHODS, V271, P37, DOI 10.1016/S0022-1759(02)00338-1; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; ELAYEB M, 1985, TOXICON, V23, P755, DOI 10.1016/0041-0101(85)90005-4; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Hammoudi-Triki D, 2007, TOXICOL APPL PHARM, V218, P205, DOI 10.1016/j.taap.2006.11.003; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Ismail M, 1998, TOXICON, V36, P1523, DOI 10.1016/S0041-0101(98)00144-5; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Juste M, 2007, CELL MOL LIFE SCI, V64, P206, DOI 10.1007/s00018-006-6401-3; Krifi MN, 2005, TOXICON, V45, P187, DOI 10.1016/j.toxicon.2004.10.007; Krifi MN, 2001, TOXICON, V39, P1317, DOI 10.1016/S0041-0101(01)00083-6; Mansour N, 2001, Arch Inst Pasteur Tunis, V78, P25; MARTIN MF, 1986, TOXICON, V24, P1131, DOI 10.1016/0041-0101(86)90139-X; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; MIRANDA F, 1970, EUR J BIOCHEM, V16, P514, DOI 10.1111/j.1432-1033.1970.tb01111.x; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Muyldermans S, 2001, J Biotechnol, V74, P277; Muzard J, 2009, ANAL BIOCHEM, V388, P331, DOI 10.1016/j.ab.2009.02.035; Njah M, 2001, Sante, V11, P57; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Sambrook J, 2001, MOL CLONING LAB MANU; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7	40	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14149	14156		10.1074/jbc.M112.348912	http://dx.doi.org/10.1074/jbc.M112.348912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375011	Green Published, hybrid			2022-12-25	WOS:000303996300067
J	Yin, L; Dragnea, V; Bauer, CE				Yin, Liang; Dragnea, Vladimira; Bauer, Carl E.			PpsR, a Regulator of Heme and Bacteriochlorophyll Biosynthesis, Is a Heme-sensing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHESIS GENE-EXPRESSION; RHODOBACTER-CAPSULATUS; OXYGEN SENSOR; DEPENDENT DEGRADATION; BINDING-SITES; IRR PROTEIN; DNA-BINDING; SPHAEROIDES; KINASE; REDOX	Heme-mediated regulation, presented in many biological processes, is achieved in part with proteins containing heme regulatory motif. In this study, we demonstrate that FLAG-tagged PpsR isolated from Rhodobacter sphaeroides cells contains bound heme. In vitro heme binding studies with tagless apo-PpsR show that PpsR binds heme at a near one-to-one ratio with a micromolar binding constant. Mutational and spectral assays suggest that both the second Per-Arnt-Sim (PAS) and DNA binding domains of PpsR are involved in the heme binding. Furthermore, we show that heme changes the DNA binding patterns of PpsR and induces different responses of photosystem genes expression. Thus, PpsR functions as both a redox and heme sensor to coordinate the amount of heme, bacteriochlorophyll, and photosystem apoprotein synthesis thereby providing fine tune control to avoid excess free tetrapyrrole accumulation.	[Yin, Liang; Dragnea, Vladimira; Bauer, Carl E.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bauer, CE (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Simon Hall MSB,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	bauer@indiana.edu	Yin, Liang/H-8171-2013	Yin, Liang/0000-0001-6957-6903	National Institutes of Health [R37 GM040941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM040941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM040941 (to C. E. B.).	Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Dawson R.M., 1969, DATA BIOCH RES, P316; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Elsen S, 1998, J BIOL CHEM, V273, P30762, DOI 10.1074/jbc.273.46.30762; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; IRACE G, 1986, ARCH BIOCHEM BIOPHYS, V244, P459, DOI 10.1016/0003-9861(86)90614-4; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Marks G. S., 1969, HEME CHLOROPHYLL, P6; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; MENDEZ R, 1992, J BIOL CHEM, V267, P11500; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Moskvin OV, 2005, J BACTERIOL, V187, P2148, DOI 10.1128/JB.187.6.2148-2156.2005; Nickens DG, 1998, J BACTERIOL, V180, P4270, DOI 10.1128/JB.180.16.4270-4277.1998; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	37	30	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13850	13858		10.1074/jbc.M112.346494	http://dx.doi.org/10.1074/jbc.M112.346494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378778	Green Published, hybrid			2022-12-25	WOS:000303996300040
J	Storchova, H; Muller, K; Lau, S; Olson, MS				Storchova, Helena; Mueller, Karel; Lau, Steffen; Olson, Matthew S.			Mosaic Origins of a Complex Chimeric Mitochondrial Gene in Silene vulgaris	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; OPEN READING FRAME; COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL; GYNODIOECIOUS PLANT; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; FLOWERING PLANTS; PATERNAL LEAKAGE; DNA	Chimeric genes are significant sources of evolutionary innovation that are normally created when portions of two or more protein coding regions fuse to form a new open reading frame. In plant mitochondria astonishingly high numbers of different novel chimeric genes have been reported, where they are generated through processes of rearrangement and recombination. Nonetheless, because most studies do not find or report nucleotide variation within the same chimeric gene, evolution after the origination of these chimeric genes remains unstudied. Here we identify two alleles of a complex chimera in Silene vulgaris that are divergent in nucleotide sequence, genomic position relative to other mitochondrial genes, and expression patterns. Structural patterns suggest a history partially influenced by gene conversion between the chimeric gene and functional copies of subunit 1 of the mitochondrial ATP synthase gene (atp1). We identified small repeat structures within the chimeras that are likely recombination sites allowing generation of the chimera. These results establish the potential for chimeric gene divergence in different plant mitochondrial lineages within the same species. This result contrasts with the absence of diversity within mitochondrial chimeras found in crop species.	[Storchova, Helena; Mueller, Karel] Acad Sci Czech Republic, Inst Expt Bot, Prague, Czech Republic; [Storchova, Helena; Lau, Steffen; Olson, Matthew S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Storchova, Helena; Lau, Steffen; Olson, Matthew S.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Lau, Steffen] Max Planck Inst Dev Biol, Dept Cell Biol, Tubingen, Germany; [Olson, Matthew S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Max Planck Society; Texas Tech University System; Texas Tech University	Storchova, H (corresponding author), Acad Sci Czech Republic, Inst Expt Bot, Prague, Czech Republic.	matt.olson@ttu.edu	STORCHOVA, Helena/F-4723-2010; Olson, Matthew S./ABI-7695-2020; Muller, Karel/F-7332-2014	STORCHOVA, Helena/0000-0001-6701-179X; Muller, Karel/0000-0002-0817-8810	United States National Science Foundation [DEB-031637]; Grant Agency of the Czech Republic [521/09/0261]; Ministry of Education, Youth and Sports, Czech Republic (MSMT) [LC06004]; MSMT Kontakt [ME09035]	United States National Science Foundation(National Science Foundation (NSF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports, Czech Republic (MSMT); MSMT Kontakt(Ministry of Education, Youth & Sports - Czech Republic)	Funding was graciously provided through a United States National Science Foundation grant DEB-031637 to MSO, and Grant Agency of the Czech Republic grant 521/09/0261, Ministry of Education, Youth and Sports, Czech Republic (MSMT) grant LC06004, and a MSMT Kontakt grant ME09035 to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Archibald JM, 2010, BMC BIOL, V8; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; BONEN L, 1984, EMBO J, V3, P2531, DOI 10.1002/j.1460-2075.1984.tb02168.x; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; CORRENS C, 1906, BER DEUT BOT GES, V24, P459; Darracq A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-233; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Elansary HO, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-11; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; FRAGOSO LL, 1989, GENOME, V31, P160, DOI 10.1139/g89-028; Fujii S, 2009, P NATL ACAD SCI USA, V106, P9513, DOI 10.1073/pnas.0901860106; GUALBERTO JM, 1991, PLANT CELL, V3, P1109, DOI 10.1105/tpc.3.10.1109; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANDA H, 1995, CURR GENET, V28, P546, DOI 10.1007/BF00518167; Hanson MR, 1999, J HERED, V90, P362, DOI 10.1093/jhered/90.3.362; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Hao WL, 2009, P NATL ACAD SCI USA, V106, P16728, DOI 10.1073/pnas.0908766106; Hazle T, 2007, MOL BIOL EVOL, V24, P1101, DOI 10.1093/molbev/msm030; Hedgcoth C, 2002, CURR GENET, V41, P357, DOI 10.1007/s00294-002-0315-x; Houliston GJ, 2006, GENETICS, V174, P1983, DOI 10.1534/genetics.106.060202; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Manchekar M, 2009, PLANT SCI, V177, P629, DOI 10.1016/j.plantsci.2009.08.002; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; NEWTON KJ, 1988, ANNU REV PLANT PHYS, V39, P503, DOI 10.1146/annurev.arplant.39.1.503; Olson MS, 2006, J EVOLUTION BIOL, V19, P1190, DOI 10.1111/j.1420-9101.2006.01103.x; Olson MS, 2002, EVOLUTION, V56, P253, DOI 10.1111/j.0014-3820.2002.tb01335.x; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sloan DB, 2008, MOL BIOL EVOL, V25, P243, DOI 10.1093/molbev/msm266; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Sloan DB, 2010, BMC EVOLUTIONARY BIO, V10; Storchova H, 2004, MOL ECOL, V13, P2909, DOI 10.1111/j.1365-294X.2004.02278.x; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Swofford DL, 2002, PHYLOGENETIC ANAL US; Tang HV, 1996, PLANT J, V10, P123, DOI 10.1046/j.1365-313X.1996.10010123.x; Terachi T, 2001, CURR GENET, V40, P276, DOI 10.1007/s00294-001-0256-9; Touzet P, 2009, GENETICS, V181, P631, DOI 10.1534/genetics.108.092411; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woloszynska M, 2009, PLANT MOL BIOL, V70, P511, DOI 10.1007/s11103-009-9488-8; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	63	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30401	10.1371/journal.pone.0030401	http://dx.doi.org/10.1371/journal.pone.0030401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383961	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500009
J	Miller, MA; Stabenow, JM; Parvathareddy, J; Wodowski, AJ; Fabrizio, TP; Bina, XWR; Zalduondo, L; Bina, JE				Miller, Mark A.; Stabenow, Jennifer M.; Parvathareddy, Jyothi; Wodowski, Andrew J.; Fabrizio, Thomas P.; Bina, Xiaowen R.; Zalduondo, Lillian; Bina, James E.			Visualization of Murine Intranasal Dosing Efficiency Using Luminescent Francisella tularensis: Effect of Instillation Volume and Form of Anesthesia	PLOS ONE			English	Article							ENDOTRACHEAL INTUBATION; PSEUDOMONAS-AERUGINOSA; TISSUE DISTRIBUTION; TULAREMIA VACCINE; INFECTION; MICE; MOUSE; DELIVERY; MODEL; LIVE	Intranasal instillation is a widely used procedure for pneumonic delivery of drugs, vaccine candidates, or infectious agents into the respiratory tract of research mice. However, there is a paucity of published literature describing the efficiency of this delivery technique. In this report we have used the murine model of tularemia, with Francisella tularensis live vaccine strain (FTLVS) infection, to evaluate the efficiency of pneumonic delivery via intranasal dosing performed either with differing instillation volumes or different types of anesthesia. FTLVS was rendered luminescent via transformation with a reporter plasmid that constitutively expressed the Photorhabdus luminescens lux operon from a Francisella promoter. We then used an IVIS Spectrum whole animal imaging system to visualize FT dissemination at various time points following intranasal instillation. We found that instillation of FT in a dose volume of 10 mu l routinely resulted in infection of the upper airways but failed to initiate infection of the pulmonary compartment. Efficient delivery of FT into the lungs via intranasal instillation required a dose volume of 50 mu l or more. These studies also demonstrated that intranasal instillation was significantly more efficient for pneumonic delivery of FTLVS in mice that had been anesthetized with inhaled (isoflurane) vs. parenteral (ketamine/xylazine) anesthesia. The collective results underscore the need for researchers to consider both the dose volume and the anesthesia type when either performing pneumonic delivery via intranasal instillation, or when comparing studies that employed this technique.	[Miller, Mark A.; Stabenow, Jennifer M.; Parvathareddy, Jyothi; Wodowski, Andrew J.; Fabrizio, Thomas P.; Bina, Xiaowen R.; Zalduondo, Lillian; Bina, James E.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Fabrizio, Thomas P.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Miller, MA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA.	mamiller@uthsc.edu	Fabrizio, Thomas/J-9935-2013; Bina, Xiaowen/AAE-9100-2022	Fabrizio, Thomas/0000-0002-8960-0728; 	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [AI074582, AI079482, AI061260]; Department of Defense Army [W81XHW-05-1-0227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R21AI074582, R21AI079482] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Army(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health (NIH) grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (www.serceb.org/), by NIH (www.niaid.nih.gov/) grants AI074582 and AI079482 (to JEB) and AI061260 (to MAM), and by Department of Defense Army grant W81XHW-05-1-0227 (usacehr.amedd.army.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SD, 1994, J ANTIMICROB CHEMOTH, V34, P1001, DOI 10.1093/jac/34.6.1001; Asensio CJA, 2011, VACCINE, V29, P1649, DOI 10.1016/j.vaccine.2010.12.068; Ayala VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019016; Balogh EP, 2011, INT J MED MICROBIOL, V301, P252, DOI 10.1016/j.ijmm.2010.08.020; Bina XR, 2010, PLASMID, V64, P156, DOI 10.1016/j.plasmid.2010.07.001; Chapoval SP, 1999, J CLIN INVEST, V103, P1707, DOI 10.1172/JCI6175; Cheng CM, 2011, VACCINE, V29, P2437, DOI 10.1016/j.vaccine.2011.01.031; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Easton A, 2011, J INFECT DIS, V204, P636, DOI 10.1093/infdis/jir301; Ebino K, 1999, INHAL TOXICOL, V11, P171, DOI 10.1080/089583799197131; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Eyles JE, 2001, J PHARM PHARMACOL, V53, P601, DOI 10.1211/0022357011775929; Ezoe H, 2011, VACCINE, V29, P1754, DOI 10.1016/j.vaccine.2010.12.117; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Gonzalez A, 2011, MICROB PATHOGENESIS, V51, P161, DOI 10.1016/j.micpath.2011.03.013; Hamacher J, 2008, LAB ANIM-UK, V42, P222, DOI 10.1258/la.2007.006068; He XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020846; Hilliard JJ, 2011, ANTIMICROB AGENTS CH, V55, P836, DOI 10.1128/AAC.00670-10; Hoogendijk AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018519; Hrvacic B, 2006, PHARM RES-DORDR, V23, P1765, DOI 10.1007/s11095-006-9029-y; Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533; Kamei A, 2011, INFECT IMMUN, V79, P1289, DOI 10.1128/IAI.01139-10; KuoLee R, 2011, MICROBES INFECT, V13, P447, DOI 10.1016/j.micinf.2011.01.010; Lange M, 2011, BIOCHEM BIOPH RES CO, V404, P877, DOI 10.1016/j.bbrc.2010.12.078; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; MacDonald KD, 2009, J APPL PHYSIOL, V106, P984, DOI 10.1152/japplphysiol.91376.2008; Mares CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014088; Margolis DA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-71; Matsuo K, 2000, VACCINE, V18, P1344, DOI 10.1016/S0264-410X(99)00401-6; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Mendez MP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-12; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; Onischuk AA, 2009, J AEROSOL MED PULM D, V22, P245, DOI 10.1089/jamp.2008.0721; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rivera B, 2005, CONTEMP TOP LAB ANIM, V44, P52; Rouf R, 2011, MICROBIOL-SGM, V157, P2133, DOI 10.1099/mic.0.048157-0; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; SCHOOK LB, 1977, CAN J MICROBIOL, V23, P823, DOI 10.1139/m77-120; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Spoelstra EN, 2007, LAB ANIM-UK, V41, P128, DOI 10.1258/002367707779399400; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Surendran N, 2011, VACCINE, V29, P2749, DOI 10.1016/j.vaccine.2011.01.090; Thomas RJ, 2008, APPL ENVIRON MICROB, V74, P6437, DOI 10.1128/AEM.01194-08; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; Vergari A, 2003, LAB ANIM-UK, V37, P204, DOI 10.1258/002367703766453047; Visweswaraiah A, 2002, VACCINE, V20, P3209, DOI 10.1016/S0264-410X(02)00247-5; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Zhao L, 2011, INT IMMUNOPHARMACOL, V11, P1378, DOI 10.1016/j.intimp.2011.03.024	55	50	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31359	10.1371/journal.pone.0031359	http://dx.doi.org/10.1371/journal.pone.0031359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384012	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800013
J	Syed, F; Thomas, AN; Singh, S; Kolluru, V; Hart, SGE; Bayat, A				Syed, Farhatullah; Thomas, Alexis N.; Singh, Subir; Kolluru, Venkatesh; Hart, Susan G. Emeigh; Bayat, Ardeshir			In Vitro Study of Novel Collagenase (XIAFLEX (R)) on Dupuytren's Disease Fibroblasts Displays Unique Drug Related Properties	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GROWTH-FACTOR GENE; CLOSTRIDIUM-HISTOLYTICUM; CONNECTIVE-TISSUE; NONSURGICAL TREATMENT; FREE-RADICALS; CONTRACTURE; EXPRESSION; MATRIX; SKIN	Dupuytren's disease (DD) is a benign, fibroproliferative disease of the palmar fascia, with excessive extracellular matrix (ECM) deposition and over-production of cytokines and growth factors, resulting in digital fixed flexion contractures limiting hand function and patient quality of life. Surgical fasciectomy is the gold standard treatment but is invasive and has associated morbidity without limiting disease recurrence. Injectable Collagenase Clostridium histolyticum (CCH) - Xiaflex(R) - is a novel, nonsurgical option with clinically proven in vivo reduction of DD contractures but with limited in vitro data demonstrating its cellular and molecular effects. The aim of this study was to delineate the effects of CCH on primary fibroblasts isolated from DD and non-DD anatomical sites (using RTCA, LDH, WST-1, FACS, qRT-PCR, ELISA and In-Cell Quantitative Western Blotting) to compare the efficacy of varying concentrations of Xiaflex(R) against a reagent grade Collagenase, Collagenase A. Results demonstrated that DD nodule and cord fibroblasts had greater proliferation than those from fat and skin. Xiaflex(R) exposure resulted in dose-and time-dependent inhibition of cellular spreading, attachment and proliferation, with cellular recovery after enzyme removal. Unlike Collagenase A, Xiaflex(R) did not cause apoptosis. Collagen expression patterns were significantly (p<0.05) different in DD fibroblasts across anatomical sites - the highest levels of collagen I and III were detected in DD nodule, with DD cord and fat fibroblasts demonstrating a smaller increase in both collagen expression relative to DD skin. Xiaflex(R) significantly (p<0.05) down-regulated ECM components, cytokines and growth factors in a dose-dependent manner. An in vitro scratch wound assay model demonstrated that, at low concentrations, Xiaflex(R) enabled a faster fibroblast reparatory migration into the wound, whereas, at high concentrations, this process was significantly (p<0.05) inhibited. This is the first report elucidating potential mechanisms of action of Xiaflex(R) on Dupuytren fibroblasts, offering a greater insight and a better understanding of its effect in DD.	[Syed, Farhatullah; Thomas, Alexis N.; Singh, Subir; Kolluru, Venkatesh; Bayat, Ardeshir] Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Translat Med, Manchester, Lancs, England; [Syed, Farhatullah; Bayat, Ardeshir] Univ Manchester, Sch Translat Med, Inflammat Sci Grp, Manchester, Lancs, England; [Bayat, Ardeshir] Wythenshawe Hosp, Univ Hosp S Manchester NHS Fdn Trust, Dept Plast & Reconstruct Surg, Manchester M23 9LT, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Wythenshawe Hosp, Manchester Acad Hlth Sci Ctr, Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England; [Hart, Susan G. Emeigh] Auxilium Pharmaceut Inc, Malvern, PA USA	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Syed, F (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Translat Med, Manchester, Lancs, England.	Ardeshir.Bayat@manchester.ac.uk	Kolluru, Venkatesh/AAJ-7912-2020	Kolluru, Venkatesh/0000-0002-7318-2090; Thomas, Alexis/0000-0002-9112-9904; BAYAT, ARDESHIR/0000-0002-4116-6491				Al-Qattan MM, 2006, J HAND SURG-AM, V31A, P1527, DOI 10.1016/j.jhsa.2006.08.012; AN HS, 1988, J HAND SURG-AM, V13A, P872, DOI 10.1016/0363-5023(88)90262-6; Arkkila PET, 1997, J RHEUMATOL, V24, P153; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; ATKINSON RK, 1992, COMP BIOCHEM PHYS C, V102, P125, DOI 10.1016/0742-8413(92)90053-A; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; BADALAMENTE MA, 1992, J HAND SURG-AM, V17A, P317, DOI 10.1016/0363-5023(92)90414-K; Badalamente MA, 2002, J HAND SURG-AM, V27A, P788, DOI 10.1053/jhsu.2002.35299; Badalamente MA, 2007, J HAND SURG-AM, V32A, P767, DOI 10.1016/j.jhsa.2007.04.002; BAIRD KS, 1993, J CLIN PATHOL, V46, P425, DOI 10.1136/jcp.46.5.425; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Bayat A, 2002, J BONE JOINT SURG BR, V84B, P211, DOI 10.1302/0301-620X.84B2.12083; Bayat A, 2010, NAT REV RHEUMATOL, V6, P7, DOI 10.1038/nrrheum.2009.255; BAZIN S, 1980, EUR J CLIN INVEST, V10, P9, DOI 10.1111/j.1365-2362.1980.tb00317.x; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BRICKLEYPARSONS D, 1981, J BONE JOINT SURG AM, V63, P787, DOI 10.2106/00004623-198163050-00014; Caufield RJ, 2008, CURR ORTHOP PRACT, V19, P499, DOI 10.1097/BCO.0b013e3283025e78; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Dave SA, 2001, EXP MOL PATHOL, V71, P147, DOI 10.1006/exmp.2001.2385; Degreef I, 2008, ACTA ORTHOP BELG, V74, P456; Del Carlo M, 2009, J UROLOGY, V181, P279, DOI 10.1016/S0022-5347(09)60794-1; Desai SS, 2010, EXPERT OPIN BIOL TH, V10, P1395, DOI 10.1517/14712598.2010.510509; Duong HS, 2005, CELLS TISSUES ORGANS, V181, P89, DOI 10.1159/000091098; Dupuytren B, 1834, LANCET, V2, P222; French M F, 1992, Matrix Suppl, V1, P134; Gabbiani GaM D, 1985, DUPUYTRENS DISEASE, P86; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gudmundsson KG, 2000, J CLIN EPIDEMIOL, V53, P291, DOI 10.1016/S0895-4356(99)00145-6; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; Hart MG, 2005, POSTGRAD MED J, V81, P425, DOI 10.1136/pgmj.2004.027425; HERRMANN H, 1980, EUR J BIOCHEM, V105, P63, DOI 10.1111/j.1432-1033.1980.tb04474.x; Hindman HB, 2003, J BONE JOINT SURG BR, V85B, P448, DOI 10.1302/0301-620X.85B3.13219; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Hindocha S, 2011, BRIT J SURG, V98, P308, DOI 10.1002/bjs.7307; Howard JC, 2004, J SURG RES, V117, P232, DOI 10.1016/j.jss.2004.01.013; Hurst LC, 2009, NEW ENGL J MED, V361, P2579; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Kim HA, 2001, J RHEUMATOL, V28, P2038; Liss GM, 1996, AM J IND MED, V29, P521; Livingstone JA, 1999, J HAND SURG-BRIT EUR, V24B, P199, DOI 10.1054/jhsb.1998.0011; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; MALLYA SK, 1992, J PROTEIN CHEM, V11, P99, DOI 10.1007/BF01025096; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; Mookhtiar K A, 1992, Matrix Suppl, V1, P116; MURRELL GAC, 1987, BMJ-BRIT MED J, V295, P1373, DOI 10.1136/bmj.295.6610.1373; MURRELL GAC, 1990, AUST NZ J SURG, V60, P247, DOI 10.1111/j.1445-2197.1990.tb07362.x; MURRELL GAC, 1991, J HAND SURG-BRIT EUR, V16B, P263, DOI 10.1016/0266-7681(91)90050-X; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; MURRELL GAC, 1989, J BONE JOINT SURG BR, V71, P367, DOI 10.1302/0301-620X.71B3.2722922; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rayan Ghazi M, 2007, Instr Course Lect, V56, P101; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Riley Kathleen N, 2005, J Burns Wounds, V4, pe8; SANDERSON PL, 1992, J BONE JOINT SURG BR, V74, P923, DOI 10.1302/0301-620X.74B6.1447259; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Shi L, 2010, INT WOUND J, V7, P87, DOI 10.1111/j.1742-481X.2010.00659.x; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; STEINBRINK DR, 1985, J BIOL CHEM, V260, P2771; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; TEREK RM, 1995, J BONE JOINT SURG AM, V77A, P1; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Thurston AJ, 2003, J BONE JOINT SURG BR, V85B, P469, DOI 10.1302/0301-620X.85B4.14215; Tomasek JJ, 1999, HAND CLIN, V15, P21; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Verjee LS, 2010, J CELL PHYSIOL, V224, P681, DOI 10.1002/jcp.22167; Verjee LS, 2009, J HAND SURG-AM, V34A, P1785, DOI 10.1016/j.jhsa.2009.08.005; Watt AJ, 2010, J HAND SURG-AM, V35A, P534, DOI 10.1016/j.jhsa.2010.01.003; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zhang AY, 2008, J HAND SURG-EUR VOL, V33E, P783, DOI 10.1177/1753193408091352	80	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31430	10.1371/journal.pone.0031430	http://dx.doi.org/10.1371/journal.pone.0031430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384021	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916800014
J	Morley, AP; Narayanan, M; Mines, R; Molokhia, A; Baxter, S; Craig, G; Lewis, CM; Craig, I				Morley, Andrew P.; Narayanan, Madan; Mines, Rebecca; Molokhia, Ashraf; Baxter, Sebastian; Craig, Gavin; Lewis, Cathryn M.; Craig, Ian			AVPR1A and SLC6A4 Polymorphisms in Choral Singers and Non-Musicians: A Gene Association Study	PLOS ONE			English	Article							SEROTONIN-TRANSPORTER GENE; OBSESSIVE-COMPULSIVE DISORDER; STIN2 VNTR POLYMORPHISM; ANTIDEPRESSANT RESPONSE; PERSONALITY-TRAITS; IMMUNOGLOBULIN-A; COMPLEX TRAITS; MIGRAINE; DEPRESSION; VARIANTS	Amateur choral singing is a common pastime and worthy of study, possibly conferring benefits to health and social behaviour. Participants might be expected to possess musical ability and share some behavioural characteristics. Polymorphisms in genes concerned with serotonergic neurotransmission are associated with both behaviour and musical aptitude. Those investigated previously include the variable number tandem repeats RS1, RS3 and AVR in the AVPR1A (arginine vasopressin receptor 1a) gene and STin2 in the SLC6A4 (solute carrier family 6 [ neurotransmitter transporter, serotonin], member 4) gene, as well as the SLC6A4 promoter region polymorphism, 5-HTTLPR. We conducted a genetic association study on 523 participants to establish whether alleles at these polymorphisms occur more commonly in choral singers than in those not regularly participating in organised musical activity (non-musicians). We also analysed tagging single nucleotide polymorphisms (SNPs) for AVPR1A and SLC6A4 to determine whether other variants in these genes were associated with singer/non-musician status. At the STin2 polymorphism, overall association with singer/non-musician status was evident at P = 0.006. The 9-repeat (P = 0.04) and 12-repeat (P = 0.04) alleles were more common in singers and the 10-repeat allele less so (P = 0.009). Odds ratios were 0.73 (95% Cl 0.57-0.94) for the 10-repeat allele and 2.47 (95% Cl 0.88-6.94) for the rarer 9-repeat allele. No overall association was detected at P<0.05 between any other polymorphism and singer/non-musician status. Our null findings with respect to RS3, RS1 and AVR, polymorphisms associated with musical ability by other authors, suggest that choir membership may depend partly on factors other than musical ability. In a related musical project involving one participating choir, a new 40-part unaccompanied choral work, "Allele'', was composed and broadcast on national radio. In the piece, each singer's part incorporated their personal RS3 genotype.	[Morley, Andrew P.; Narayanan, Madan; Mines, Rebecca; Molokhia, Ashraf; Baxter, Sebastian] Kings Hlth Partners Acad Hlth Sci Ctr, London, England; [Craig, Gavin; Lewis, Cathryn M.; Craig, Ian] Kings Coll London, Inst Psychiat, Med Res Council Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England	King's Health Partners; University of London; King's College London; University of London; King's College London	Morley, AP (corresponding author), Kings Hlth Partners Acad Hlth Sci Ctr, London, England.	andrew.morley@gstt.nhs.uk	Craig, Ian/AAF-9167-2019; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Craig, Ian/0000-0002-4063-1005	Wellcome Trust Arts Award [WT089550A, WT089550Z]; Medical Research Council [G9817803B] Funding Source: researchfish	Wellcome Trust Arts Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by a Wellcome Trust Arts Award and a related Extension Award, respectively WT089550A and WT089550Z (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saiz PA, 2010, PSYCHIAT GENET, V20, P171, DOI 10.1097/YPG.0b013e32833a20b9; Ali FR, 2010, J NEUROCHEM, V112, P296, DOI 10.1111/j.1471-4159.2009.06453.x; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bah J, 2008, PSYCHIAT RES-NEUROIM, V162, P221, DOI 10.1016/j.pscychresns.2007.07.004; Bellivier F, 2002, NEUROSCI LETT, V334, P17, DOI 10.1016/S0304-3940(02)01029-7; Bloch MH, 2008, AM J MED GENET B, V147B, P850, DOI 10.1002/ajmg.b.30699; Clift SM, 2001, J R SOC PROMO HEALTH, V121, P248, DOI 10.1177/146642400112100409; Coutinho AM, 2004, MOL PSYCHIATR, V9, P264, DOI 10.1038/sj.mp.4001409; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drago Antonio, 2009, Human Genomics, V3, P257; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fan JB, 2005, MOL PSYCHIATR, V10, P928, DOI 10.1038/sj.mp.4001690; Fiskerstrand CE, 1999, FEBS LETT, V458, P171, DOI 10.1016/S0014-5793(99)01150-3; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; GREEN RG, 1987, PSYCHOL REP, V61, P623, DOI 10.2466/pr0.1987.61.2.623; Harrison PA, 2003, J SCHOOL HEALTH, V73, P113, DOI 10.1111/j.1746-1561.2003.tb03585.x; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Huang CH, 2008, AM J MED GENET B, V147B, P903, DOI 10.1002/ajmg.b.30720; Huezo-Diaz P, 2009, BRIT J PSYCHIAT, V195, P30, DOI 10.1192/bjp.bp.108.062521; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Kazantseva AV, 2008, PSYCHIAT GENET, V18, P167, DOI 10.1097/YPG.0b013e328304deb8; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Li J, 2007, AM J MED GENET B, V144B, P14, DOI 10.1002/ajmg.b.30373; Lopez de LC, 2006, BIOL PSYCHIAT, V59, P114; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; MARTIN RA, 1988, INT J PSYCHIAT MED, V18, P93, DOI 10.2190/724B-3V06-QC5N-6587; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Niesler B, 2010, EUR J GASTROEN HEPAT, V22, P856, DOI 10.1097/MEG.0b013e32832e9d6b; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Park JW, 2006, HEADACHE, V46, P991, DOI 10.1111/j.1526-4610.2006.00439.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pritchard AL, 2007, DEMENT GERIATR COGN, V24, P201, DOI 10.1159/000107081; Proitsi P, 2012, NEUROBIOL A IN PRESS; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Safarinejad MR, 2010, BJU INT, V105, P73, DOI 10.1111/j.1464-410X.2009.08714.x; Saiz PA, 2008, PROG NEURO-PSYCHOPH, V32, P765, DOI 10.1016/j.pnpbp.2007.12.005; Sanjuan J, 2008, BRIT J PSYCHIAT, V193, P383, DOI 10.1192/bjp.bp.107.045427; Sarosi A, 2008, PROG NEURO-PSYCHOPH, V32, P1667, DOI 10.1016/j.pnpbp.2008.06.014; Schurks M, 2010, J HEADACHE PAIN, V11, P317, DOI 10.1007/s10194-010-0230-3; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Szilagyi A, 2006, HEADACHE, V46, P478, DOI 10.1111/j.1526-4610.2006.00379.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Terrazzino S, 2010, EUR J PHARMACOL, V641, P82, DOI 10.1016/j.ejphar.2010.04.049; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wendland JR, 2007, NEUROPSYCHOPHARMACOL, V32, P2543, DOI 10.1038/sj.npp.1301394; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	54	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31763	10.1371/journal.pone.0031763	http://dx.doi.org/10.1371/journal.pone.0031763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384070	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500038
J	Jacob, F; Ukegjini, K; Nixdorf, S; Ford, CE; Olivier, J; Caduff, R; Scurry, JP; Guertler, R; Hornung, D; Mueller, R; Fink, DA; Hacker, NF; Heinzelmann-Schwarz, VA				Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E.; Olivier, Jake; Caduff, Rosmarie; Scurry, James P.; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A.; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.			Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients	PLOS ONE			English	Article							WNT PATHWAY; INHIBITS PROLIFERATION; SIGNALING PATHWAY; EXPRESSION; BREAST; GENE; PROSTATE; RECEPTOR; DISTINCT; MECHANISMS	Background: Activation of the Wnt signaling pathway is implicated in aberrant cellular proliferation in various cancers. In 40% of endometrioid ovarian cancers, constitutive activation of the pathway is due to oncogenic mutations in beta-catenin or other inactivating mutations in key negative regulators. Secreted frizzled-related protein 4 (SFRP4) has been proposed to have inhibitory activity through binding and sequestering Wnt ligands. Methodology/Principal Findings: We performed RT-qPCR and Western-blotting in primary cultures and ovarian cell lines for SFRP4 and its key downstream regulators activated beta-catenin, beta-catenin and GSK3 beta. SFRP4 was then examined by immunohistochemistry in a cohort of 721 patients and due to its proposed secretory function, in plasma, presenting the first ELISA for SFRP4. SFRP4 was most highly expressed in tubal epithelium and decreased with malignant transformation, both on RNA and on protein level, where it was even more profound in the membrane fraction (p<0.0001). SFRP4 was expressed on the protein level in all histotypes of ovarian cancer but was decreased from borderline tumors to cancers and with loss of cellular differentiation. Loss of membrane expression was an independent predictor of poor survival in ovarian cancer patients (p = 0.02 unadjusted; p = 0.089 adjusted), which increased the risk of a patient to die from this disease by the factor 1.8. Conclusions/Significance: Our results support a role for SFRP4 as a tumor suppressor gene in ovarian cancers via inhibition of the Wnt signaling pathway. This has not only predictive implications but could also facilitate a therapeutic role using epigenetic targets.	[Jacob, Francis; Ukegjini, Kristjan; Heinzelmann-Schwarz, Viola A.] Univ Zurich Hosp, Translat Res Grp, CH-8091 Zurich, Switzerland; [Jacob, Francis; Nixdorf, Sheri; Guertler, Rea; Heinzelmann-Schwarz, Viola A.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Gynaecol Canc Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Ford, Caroline E.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Wnt Signaling & Metastasis Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Olivier, Jake] Univ New S Wales, Prince Wales Clin Sch, Fac Med, Biostat Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Caduff, Rosmarie] Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; [Scurry, James P.] Univ Newcastle, John Hunter Hosp, Hunter Area Pathol Serv, Callaghan, NSW 2308, Australia; [Hornung, Daniela] Univ Schleswig Holstein, Dept Obstet & Gynecol, Lubeck, Germany; [Mueller, Renato] Spital Limmattal, Dept Gynecol & Obstet, Zurich, Switzerland; [Fink, Daniel A.] Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland; [Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.] Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia	University of Zurich; University Zurich Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Zurich; University Zurich Hospital; John Hunter Hospital; University of Newcastle; University of Kiel; Schleswig Holstein University Hospital; University of Zurich; University Zurich Hospital	Jacob, F (corresponding author), Univ Zurich Hosp, Translat Res Grp, CH-8091 Zurich, Switzerland.	viola@heinzelmann.ch	Ford, Caroline E/A-7850-2010; Nixdorf, Sheri/F-3269-2013; Olivier, Jake/D-2034-2012; Jacob, Francis/C-7910-2009	Ford, Caroline E/0000-0002-4438-2309; Olivier, Jake/0000-0002-3144-4507; Jacob, Francis/0000-0002-0446-1942; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225; Hacker, Neville/0000-0002-1445-2302	Cancer League Canton Zurich; Oncosuisse [02115-08-2007]; Swiss National Foundation [320000-12543, PBZHP3-133289]; European Science Foundation; Cancer Institute New South Wales [09/CRF/2-02]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	Cancer League Canton Zurich; Oncosuisse; Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Science Foundation(European Science Foundation (ESF)European Commission); Cancer Institute New South Wales; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	This work was supported by Cancer League Canton Zurich (to V.H.S.); Oncosuisse (02115-08-2007 to V.H.S.); Swiss National Foundation (320000-12543 to V.H.S.; PBZHP3-133289 to F.J.); European Science Foundation (to V.H.S.); Cancer Institute New South Wales (09/CRF/2-02 to V.H.S.); Royal Australian and New Zealand College of Obstetricians and Gynaecologists (to V.H.S.); William Maxwell Trust (to V.H.S.) and the Royal Hospital for Women Foundation (to V.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, EJSO-EUR J SURG ONC, V32, P875, DOI 10.1016/j.ejso.2006.03.041; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bali A, 2004, CLIN CANCER RES, V10, P5168, DOI 10.1158/1078-0432.CCR-03-0751; Bast RC, 1998, HYBRIDOMA, V17, P313, DOI 10.1089/hyb.1998.17.313; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Crijns APG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-232; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Drake J, 2009, EUR J GYNAECOL ONCOL, V30, P133; Fishman P, 2002, ONCOGENE, V21, P4060, DOI 10.1038/sj.onc.1205531; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; He QY, 2005, GYNECOL ONCOL, V98, P68, DOI 10.1016/j.ygyno.2005.04.002; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Horvath LG, 2007, PROSTATE, V67, P1081, DOI 10.1002/pros.20607; Huang Y, 2010, ONCOL REP, V23, P177, DOI 10.3892/or_00000620; Jacob F, 2011, GYNECOL ONCOL, V121, P487, DOI 10.1016/j.ygyno.2011.02.022; Janssens N, 2004, TUMOR BIOL, V25, P161, DOI 10.1159/000081098; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Liu HY, 2007, FERTIL STERIL, V87, P988, DOI 10.1016/j.fertnstert.2006.08.095; Millar JBA, 2002, GENOME BIOL, V3; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Polakis P, 2000, GENE DEV, V14, P1837; Risinger JI, 2005, CANCER RES, V65, P5031, DOI 10.1158/0008-5472.CAN-04-0850; Russell W, 2002, JNCI-J NATL CANCER I, V94, P706; Schwartz DR, 2003, CANCER RES, V63, P2913; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Takada T, 2004, CANCER SCI, V95, P741, DOI 10.1111/j.1349-7006.2004.tb03255.x; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Wu R, 2001, CANCER RES, V61, P8247; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3	46	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31885	10.1371/journal.pone.0031885	http://dx.doi.org/10.1371/journal.pone.0031885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363760	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000302873700115
J	Liang, XB; Bhattacharya, S; Bajaj, G; Guha, G; Wang, ZX; Jang, HS; Leid, M; Indra, AK; Ganguli-Indra, G				Liang, Xiaobo; Bhattacharya, Shreya; Bajaj, Gaurav; Guha, Gunjan; Wang, Zhixing; Jang, Hyo-Sang; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali			Delayed Cutaneous Wound Healing and Aberrant Expression of Hair Follicle Stem Cell Markers in Mice Selectively Lacking Ctip2 in Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; KERATIN 15 EXPRESSION; DERMAL PAPILLA CELLS; IN-VITRO; MOUSE SKIN; BASAL LAYER; E-CADHERIN; MIGRATION; PROLIFERATION; DISTINCT	Background: COUP-TF interacting protein 2 [(Ctip2), also known as Bcl11b] is an important regulator of skin homeostasis, and is overexpressed in head and neck cancer. Ctip2(ep-/-) mice, selectively ablated for Ctip2 in epidermal keratinocytes, exhibited impaired terminal differentiation and delayed epidermal permeability barrier (EPB) establishment during development, similar to what was observed in Ctip2 null (Ctip2(-/-)) mice. Considering that as an important role of Ctip2, and the fact that molecular networks which underlie cancer progression partially overlap with those responsible for tissue remodeling, we sought to determine the role of Ctip2 during cutaneous wound healing. Methodology/Principal Findings: Full thickness excisional wound healing experiments were performed on Ctip2(L2/L2) and Ctip2(ep-/-) animals per time point and used for harvesting samples for histology, immunohistochemistry (IHC) and immunoblotting. Results demonstrated inherent defects in proliferation and migration of Ctip2 lacking keratinocytes during re-epithelialization. Mutant mice exhibited reduced epidermal proliferation, delayed keratinocyte activation, altered cell-cell adhesion and impaired ECM development. Post wounding, Ctip2(ep-/-) mice wounds displayed lack of E-Cadherin suppression in the migratory tongue, insufficient expression of alpha smooth muscle actin (alpha SMA) in the dermis, and robust induction of K8. Importantly, dysregulated expression of several hair follicle (HF) stem cell markers such as K15, NFATc1, CD133, CD34 and Lrig1 was observed in mutant skin during wound repair. Conclusions/Significance: Results confirm a cell autonomous role of keratinocytic Ctip2 to modulate cell migration, proliferation and/or differentiation, and to maintain HF stem cells during cutaneous wounding. Furthermore, Ctip2 in a non-cell autonomous manner regulated granulation tissue formation and tissue contraction during wound closure.	[Liang, Xiaobo; Bajaj, Gaurav; Guha, Gunjan; Wang, Zhixing; Jang, Hyo-Sang; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Bhattacharya, Shreya; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Mol & Cell Biol Program, Corvallis, OR 97331 USA; [Leid, Mark; Indra, Arup Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Indra, Arup Kumar] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon State University; Oregon Health & Science University	Liang, XB (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu; indrag@onid.orst.edu	Indra, Arup/AAG-2376-2019; Guha, Gunjan/D-8197-2011; Indra, Gitali/G-2963-2016	Indra, Arup/0000-0001-6137-7555; Guha, Gunjan/0000-0002-9224-0241; Bhattacharya, Shreya/0000-0003-4248-2362; Jang, Hyo Sang/0000-0003-0460-9924	National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R01AR056008-02]; Oregon Health & Science University Medical Research Foundation; National Institute of Environmental Health Sciences Center [ES00210]; OSU College of Pharmacy; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Oregon Health & Science University Medical Research Foundation; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OSU College of Pharmacy; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were partly supported by grant 5R01AR056008-02 (AI) from National Institute of Arthritis and Musculoskeletal and Skin Diseases, by an Oregon Health & Science University Medical Research Foundation grant to GGI, and by a National Institute of Environmental Health Sciences Center grant (ES00210) to Oregon State University Environmental Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Stephen Hyter, Ling-Juan Zhang and Talicia Savage for help with breeding, genotyping and tape stripping, experiments. We also thank Dr. Daniel Metzger and Jean-Marc Bornert (IGBMC, Illkirch, France) for help in making the Ctip2 mutant mice and Drs. Mark Zabriskie and Gary DeLander of the OSU College of Pharmacy for continuous support and encouragement.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; Chu YW, 1996, AM J PATHOL, V148, P63; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ganguli G, 2000, EMBO J, V19, P5135, DOI 10.1093/emboj/19.19.5135; Ganguli-Indra G, 2009, EXP DERMATOL, V18, P994, DOI 10.1111/j.1600-0625.2009.00876.x; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; Gerritsen MJP, 1997, J DERMATOL SCI, V14, P179, DOI 10.1016/S0923-1811(96)00570-1; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Grose R, 2002, DEVELOPMENT, V129, P2303; Guo AH, 2009, EXP DERMATOL, V18, P720, DOI 10.1111/j.1600-0625.2009.00900.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hardy MM, 2003, J PHARMACOL EXP THER, V304, P959, DOI 10.1124/jpet.102.044545; HIROBE T, 1983, J EXP ZOOL, V227, P423, DOI 10.1002/jez.1402270311; HIROBE T, 1988, GENETICS, V120, P551; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito Y, 2007, J INVEST DERMATOL, V127, P1052, DOI 10.1038/sj.jid.5700665; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kazerounian S, 2002, EXP DERMATOL, V11, P428, DOI 10.1034/j.1600-0625.2002.110506.x; Koizumi M, 2005, DEV GROWTH DIFFER, V47, P75; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Morasso MI, 2005, BIOL CELL, V97, P173; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Myers SR, 2007, WOUND REPAIR REGEN, V15, P693, DOI 10.1111/j.1524-475X.2007.00297.x; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Patel GK, 2006, J INVEST DERMATOL, V126, P497, DOI 10.1038/sj.jid.5700101; Pedroso DC, 2007, PLOS ONE, V6; Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180; Repertinger SK, 2004, J INVEST DERMATOL, V123, P982, DOI 10.1111/j.0022-202X.2004.23478.x; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Wang ZX, 2011, J INVEST DERMATOL, V131, P177, DOI 10.1038/jid.2010.290; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2000, HUM GENE THER, V11, P2261, DOI 10.1089/104303400750035799; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2000, EXP CELL RES, V254, P80, DOI 10.1006/excr.1999.4726; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X.2006.00189.x	83	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29999	10.1371/journal.pone.0029999	http://dx.doi.org/10.1371/journal.pone.0029999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22383956	gold, Green Published			2022-12-25	WOS:000302873700006
J	Mondoulet, L; Dioszeghy, V; Larcher, T; Ligouis, M; Dhelft, V; Puteaux, E; Cherel, Y; Letourneur, F; Dupont, C; Benhamou, PH				Mondoulet, Lucie; Dioszeghy, Vincent; Larcher, Thibaut; Ligouis, Melanie; Dhelft, Veronique; Puteaux, Emilie; Cherel, Yan; Letourneur, Franck; Dupont, Christophe; Benhamou, Pierre-Henri			Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice	PLOS ONE			English	Article							EXPERIMENTAL EOSINOPHILIC ESOPHAGITIS; FOOD ALLERGY; DELIVERY-SYSTEM; GENE-EXPRESSION; MURINE MODEL; T-CELLS; IN-VIVO; CHILDREN; IL-13; ANAPHYLAXIS	Background: Food allergy may affect the gastrointestinal tract and eosinophilia is often associated with allergic gastrointestinal disorders. Allergy to peanuts is a life-threatening condition and effective and safe treatments still need to be developed. The present study aimed to evaluate the effects of sustained oral exposure to peanuts on the esophageal and jejunal mucosa in sensitized mice. We also evaluated the effects of desensitization with epicutaneous immunotherapy (EPIT) on these processes. Methods: Mice were sensitized by gavages with whole peanut protein extract (PPE) given with cholera toxin. Sensitized mice were subsequently exposed to peanuts via a specific regimen and were then analysed for eosinophilia in the esophagus and gut. We also assessed mRNA expression in the esophagus, antibody levels, and peripheral T-cell response. The effects of EPIT were tested when intercalated with sensitization and sustained oral peanut exposure. Results: Sustained oral exposure to peanuts in sensitized mice led to severe esophageal eosinophilia and intestinal villus sub-atrophia, i.e. significantly increased influx of eosinophils into the esophageal mucosa (136 eosinophils/mm(2)) and reduced villus/crypt ratios (1.6 +/- 0.15). In the sera, specific IgE levels significantly increased as did secretion of Th2 cytokines by peanut-reactivated splenocytes. EPIT of sensitized mice significantly reduced Th2 immunological response (IgE response and splenocyte secretion of Th2 cytokines) as well as esophageal eosinophilia (50 eosinophils/mm(2), p < 0.05), mRNA expression of Th2 cytokines in tissue - eotaxin (p < 0.05), IL-5 (p < 0.05), and IL-13 (p < 0.05) -, GATA-3 (p < 0.05), and intestinal villus sub-atrophia (2.36 +/- 0.15). EPIT also increased specific IgG2a (p < 0.05) and mRNA expression of Foxp3 (p < 0.05) in the esophageal mucosa. Conclusions: Gastro-intestinal lesions induced by sustained oral exposure in sensitized mice are efficaciously treated by allergen specific EPIT.	[Mondoulet, Lucie; Dioszeghy, Vincent; Ligouis, Melanie; Dhelft, Veronique; Puteaux, Emilie; Benhamou, Pierre-Henri] DBV Technol, Pepiniere Sante Paris Cochin, Paris, France; [Larcher, Thibaut; Cherel, Yan] INRA, Natl Vet Sch, UMR703, F-44026 Nantes, France; [Letourneur, Franck] Univ Paris 05, Inst Cochin, INSERM, U567, Paris, France; [Dupont, Christophe] Univ Paris 05, Hop Necker Enfants Malad, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Mondoulet, L (corresponding author), DBV Technol, Pepiniere Sante Paris Cochin, Paris, France.	lucie.mondoulet@dbv-technologies.com	Larcher, Thibaut/M-9160-2013; Larcher, Thibaut/X-8500-2019	Larcher, Thibaut/0000-0002-0396-3190; Mondoulet, Lucie/0000-0003-0110-0321	DBV Technologies; Viaskin(R) technology	DBV Technologies; Viaskin(R) technology	This study was supported by DBV Technologies, owner of the Viaskin (R) technology. Lucie Mondoulet, Vincent Dioszeghy, Melanie Ligouis, Veronique Dhelft and Emilie Puteaux are DBV Technologies employees. Thibaut Larcher, Yan Cherel, Franck Letourneur, Christophe Dupont and Pierre-Henri Benhamou have received honoraria and/or compensation in regards to the study, as investigators, coordinators or experts, in relation with the time spent on the study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard Carine, 2008, Gastrointest Endosc Clin N Am, V18, P133, DOI 10.1016/j.giec.2007.09.016; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Dioszeghy V, 2011, ALLERGY, V66, P509; Dioszeghy V, 2011, J IMMUNOL IN PRESS; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Kalach N, 2005, J ALLERGY CLIN IMMUN, V116, P1321, DOI 10.1016/j.jaci.2005.08.033; Liacouras CA, 2005, CLIN GASTROENTEROL H, V3, P1198, DOI 10.1016/S1542-3565(05)00885-2; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Mondoulet L, 2011, INT ARCH ALLERGY IMM, V154, P299, DOI 10.1159/000321822; Narisety SD, 2009, J ALLERGY CLIN IMMUN, V124, P610, DOI 10.1016/j.jaci.2009.06.025; Romagnani S, 2000, J ALLERGY CLIN IMMUN, V105, P399, DOI 10.1067/mai.2000.104575; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; SAAVEDRADELGADO AM, 1985, ANN ALLERGY, V55, P694; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Savilahti E, 2000, J PEDIATR GASTR NUTR, V30, pS61, DOI 10.1097/00005176-200001001-00010; Schaefer ET, 2008, CLIN GASTROENTEROL H, V6, P165, DOI 10.1016/j.cgh.2007.11.008; Senti G, 2009, J ALLERGY CLIN IMMUN; Simon D, 2010, J ALLERGY CLIN IMMUN, V126, P3, DOI 10.1016/j.jaci.2010.01.055; Spergel JM, 2005, ANN ALLERG ASTHMA IM, V95, P336, DOI 10.1016/S1081-1206(10)61151-9; Srivastava KD, 2009, J ALLERGY CLIN IMMUN, V123, P443, DOI 10.1016/j.jaci.2008.12.1107; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Wasserman RL, 2011, J ALLERGY CLIN IMMUN, V127, pAB28, DOI 10.1016/j.jaci.2010.12.121; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	34	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31967	10.1371/journal.pone.0031967	http://dx.doi.org/10.1371/journal.pone.0031967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363776	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700128
J	Martinez-Granero, F; Navazo, A; Barahona, E; Redondo-Nieto, M; Rivilla, R; Martin, M				Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta			The Gac-Rsm and SadB Signal Transduction Pathways Converge on AlgU to Downregulate Motility in Pseudomonas fluorescens	PLOS ONE			English	Article							COMPETITIVE COLONIZATION ABILITY; MESSENGER-RNA RECOGNITION; RESPONSE REGULATOR; BIOFILM FORMATION; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; FLAGELLUM BIOSYNTHESIS; SECONDARY METABOLISM; ALGINATE PRODUCTION; 2-COMPONENT SYSTEM	Flagella mediated motility in Pseudomonas fluorescens F113 is tightly regulated. We have previously shown that motility is repressed by the GacA/GacS system and by SadB through downregulation of the fleQ gene, encoding the master regulator of the synthesis of flagellar components, including the flagellin FliC. Here we show that both regulatory pathways converge in the regulation of transcription and possibly translation of the algU gene, which encodes a sigma factor. AlgU is required for multiple functions, including the expression of the amrZ gene which encodes a transcriptional repressor of fleQ. Gac regulation of algU occurs during exponential growth and is exerted through the RNA binding proteins RsmA and RsmE but not RsmI. RNA immunoprecipitation assays have shown that the RsmA protein binds to a polycistronic mRNA encoding algU, mucA, mucB and mucD, resulting in lower levels of algU. We propose a model for repression of the synthesis of the flagellar apparatus linking extracellular and intracellular signalling with the levels of AlgU and a new physiological role for the Gac system in the downregulation of flagella biosynthesis during exponential growth.	[Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Martinez-Granero, F (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	m.martin@uam.es	Barahona, Emma/L-6421-2014; Rivilla, Rafael/A-1659-2008; Basanta, Marta Martin/AAI-5459-2020; martin, marta/H-2169-2015; Redondo-Nieto, Miguel/A-6169-2011	Rivilla, Rafael/0000-0003-0701-2939; Basanta, Marta Martin/0000-0003-2498-9768; martin, marta/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X	Spanish Ministry of Science and Education [BIO2009-08596]; Comunidad de Madrid	Spanish Ministry of Science and Education(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the Spanish Ministry of Science and Education grant BIO2009-08596, and by the Research Program MICROAMBIENTE-CM from Comunidad de Madrid. AN is the recipient of an FPI fellowship from the Spanish Ministry of Science and Education. EB is the recipient of a predoctoral contract from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons S, 2000, J BACTERIOL, V182, P3913, DOI 10.1128/JB.182.14.3913-3919.2000; Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Burrowes E, 2005, RES MICROBIOL, V156, P7, DOI 10.1016/j.resmic.2004.07.004; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2002, J BACTERIOL, V184, P5240, DOI 10.1128/JB.184.19.5240-5250.2002; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; de Souza JT, 2003, ENVIRON MICROBIOL, V5, P1328, DOI 10.1111/j.1462-2920.2003.00438.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; Dubern JF, 2006, FEMS MICROBIOL LETT, V263, P169, DOI 10.1111/j.1574-6968.2006.00406.x; Dubern JF, 2005, J BACTERIOL, V187, P5967, DOI 10.1128/JB.187.17.5967-5976.2005; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kinscherf TG, 1999, J BACTERIOL, V181, P4133, DOI 10.1128/JB.181.13.4133-4136.1999; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Koch B, 2002, APPL ENVIRON MICROB, V68, P4509, DOI 10.1128/AEM.68.9.4509-4516.2002; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lapouge K, 2007, MOL MICROBIOL, V66, P341, DOI 10.1111/j.1365-2958.2007.05909.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Liao CH, 1996, CAN J MICROBIOL, V42, P177, DOI 10.1139/m96-026; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Ma S, 1997, J BIOL CHEM, V272, P17952, DOI 10.1074/jbc.272.29.17952; Martinez-Granero F, 2005, MICROBIOL-SGM, V151, P975, DOI 10.1099/mic.0.27583-0; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; RICH JJ, 1994, J BACTERIOL, V176, P7468, DOI 10.1128/JB.176.24.7468-7475.1994; SACHERER P, 1994, FEMS MICROBIOL LETT, V116, P155, DOI 10.1111/j.1574-6968.1994.tb06694.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Valverde C, 2004, J BIOL CHEM, V279, P25066, DOI 10.1074/jbc.M401870200; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Willis DK, 2001, APPL ENVIRON MICROB, V67, P1400, DOI 10.1128/AEM.67.3.1400-1403.2001; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	73	48	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31765	10.1371/journal.pone.0031765	http://dx.doi.org/10.1371/journal.pone.0031765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363726	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500085
J	Nyqvist, MJ; Gozlan, RE; Cucherousset, J; Britton, JR				Nyqvist, Marina J.; Gozlan, Rodolphe E.; Cucherousset, Julien; Britton, J. Robert			Behavioural Syndrome in a Solitary Predator Is Independent of Body Size and Growth Rate	PLOS ONE			English	Article							PIKE ESOX-LUCIUS; INDIVIDUAL-DIFFERENCES; LIFE-HISTORY; PERSONALITY-TRAITS; PRACTICAL GUIDE; TRADE-OFFS; PREY-SIZE; EVOLUTIONARY; BOLDNESS; STICKLEBACKS	Models explaining behavioural syndromes often focus on state-dependency, linking behavioural variation to individual differences in other phenotypic features. Empirical studies are, however, rare. Here, we tested for a size and growth-dependent stable behavioural syndrome in the juvenile-stages of a solitary apex predator ( pike, Esox lucius), shown as repeatable foraging behaviour across risk. Pike swimming activity, latency to prey attack, number of successful and unsuccessful prey attacks was measured during the presence/absence of visual contact with a competitor or predator. Foraging behaviour across risks was considered an appropriate indicator of boldness in this solitary predator where a trade-off between foraging behaviour and threat avoidance has been reported. Support was found for a behavioural syndrome, where the rank order differences in the foraging behaviour between individuals were maintained across time and risk situation. However, individual behaviour was independent of body size and growth in conditions of high food availability, showing no evidence to support the state-dependent personality hypothesis. The importance of a combination of spatial and temporal environmental variation for generating growth differences is highlighted.	[Nyqvist, Marina J.; Gozlan, Rodolphe E.; Cucherousset, Julien; Britton, J. Robert] Bournemouth Univ, Ctr Conservat Ecol & Environm Sci, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Cucherousset, Julien] CNRS, UPS, ENFA, EDB Lab Evolut & Diversite Biol UMR5174, Toulouse, France; [Cucherousset, Julien] Univ Toulouse, UPS, EDB UMR5174, Toulouse, France	Bournemouth University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nyqvist, MJ (corresponding author), Bournemouth Univ, Ctr Conservat Ecol & Environm Sci, Sch Appl Sci, Poole BH12 5BB, Dorset, England.	mnyqvist@bournemouth.ac.uk	Britton, Robert/AAO-6673-2020; Cucherousset, Julien/B-5709-2011; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; Cucherousset, Julien/0000-0003-0533-9479	Bournemouth University	Bournemouth University	Funding was received from a Ph.D. Scholarship awarded to the corresponding author from Bournemouth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adriaenssens B, 2011, APPL ANIM BEHAV SCI, V132, P90, DOI 10.1016/j.applanim.2011.03.005; Adriaenssens B, 2009, TRENDS ECOL EVOL, V24, P179, DOI 10.1016/j.tree.2008.12.003; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Baras E, 2010, J FISH BIOL, V77, P985, DOI 10.1111/j.1095-8649.2010.02740.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; BRY C, 1995, J FISH BIOL, V46, P99, DOI 10.1111/j.1095-8649.1995.tb05949.x; Budaev S., 2011, FISH COGNITION BEHAV, P135, DOI DOI 10.1002/9781444342536.CH7; Carey MP, 2010, OECOLOGIA, V162, P443, DOI 10.1007/s00442-009-1461-3; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Conrad JL, 2009, J FISH BIOL, V75, P1410, DOI 10.1111/j.1095-8649.2009.02372.x; Cucherousset J, 2007, FISH RES, V85, P159, DOI 10.1016/j.fishres.2007.01.011; CUI YB, 1990, COMP BIOCHEM PHYS A, V97, P551, DOI 10.1016/0300-9629(90)90126-D; DAVENPORT J, 1993, HERPETOL J, V3, P19; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Engstrom-Ost J, 2004, J FISH BIOL, V65, P251, DOI 10.1111/j.0022-1112.2004.00448.x; Gabriel PO, 2010, ANIM BEHAV, V80, P689, DOI 10.1016/j.anbehav.2010.07.004; Galarowicz TL, 2005, CAN J FISH AQUAT SCI, V62, P2330, DOI 10.1139/F05-148; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; GILES N, 1986, J FISH BIOL, V29, P107, DOI 10.1111/j.1095-8649.1986.tb04930.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; GRIMM MP, 1981, FISH MANAGE, V12, P61; GRIMM MP, 1981, FISH MANAGE, V12, P77; Houston AI, 1999, MODELS ADAPTIVE BEHA; Ivanova M, 1995, J ICHTYOLOGY, V35, P379; KAUSHIK SJ, 1985, J FISH BIOL, V26, P171, DOI 10.1111/j.1095-8649.1985.tb04254.x; Lee JSF, 2008, ENVIRON BIOL FISH, V82, P179, DOI 10.1007/s10641-007-9288-4; Lehtiniemi M, 2005, J FISH BIOL, V66, P1285, DOI 10.1111/j.0022-1112.2005.00681.x; Logue DM, 2009, BEHAV ECOL, V20, P781, DOI 10.1093/beheco/arp061; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Mangel M, 2001, EVOL ECOL RES, V3, P583; MANN R H K, 1990, Aquaculture and Fisheries Management, V21, P471, DOI 10.1111/j.1365-2109.1990.tb00485.x; MANN RHK, 1982, J ANIM ECOL, V51, P81, DOI 10.2307/4312; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; Mas-Munoz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021393; Monclus R, 2009, OECOLOGIA, V158, P615, DOI 10.1007/s00442-008-1201-0; Moya-Larano J, 2011, PHILOS T R SOC B, V366, P1425, DOI 10.1098/rstb.2010.0241; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nilsson PA, 1999, BEHAV ECOL, V10, P557, DOI 10.1093/beheco/10.5.557; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; R Development Core Team, 2009, R FDN STAT COMP; Raat A, 1988, FAO FISH SYNOPSIS; Ragland GJ, 2004, HEREDITY, V92, P569, DOI 10.1038/sj.hdy.6800462; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schurch R, 2010, BEHAV ECOL, V21, P588, DOI 10.1093/beheco/arq024; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps JA, 1998, AM NAT, V152, P470, DOI 10.1086/286183; STAMPS JA, 1991, AM ZOOL, V31, P338; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; Wang HP, 2003, J WORLD AQUACULT SOC, V34, P379, DOI 10.1111/j.1749-7345.2003.tb00075.x; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wilson ADM, 2005, ETHOLOGY, V111, P849, DOI 10.1111/j.1439-0310.2005.01110.x; Wilson ADM, 2007, ANIM BEHAV, V74, P689, DOI 10.1016/j.anbehav.2007.01.009; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2010, PHILOS T R SOC B, V365, P3959, DOI 10.1098/rstb.2010.0215; Ziliukiene V, 2006, AQUACULTURE, V258, P378, DOI 10.1016/j.aquaculture.2006.04.010	75	20	20	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31619	10.1371/journal.pone.0031619	http://dx.doi.org/10.1371/journal.pone.0031619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363687	Green Published, Green Accepted, gold			2022-12-25	WOS:000302871500063
J	Hafner, C; Houben, R; Baeurle, A; Ritter, C; Schrama, D; Landthaler, M; Becker, JC				Hafner, Christian; Houben, Roland; Baeurle, Anne; Ritter, Cathrin; Schrama, David; Landthaler, Michael; Becker, Juergen C.			Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma	PLOS ONE			English	Article							T-ANTIGEN; PIK3CA MUTATIONS; SQUAMOUS-CELL; MELANOMA; POLYOMAVIRUS; CANCER; TUMORS; AKT; EXPRESSION; RARE	Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients.	[Hafner, Christian; Landthaler, Michael] Univ Regensburg, Dept Dermatol, Regensburg, Germany; [Houben, Roland; Baeurle, Anne; Ritter, Cathrin] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Schrama, David; Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Regensburg; University of Wurzburg; Medical University of Graz	Hafner, C (corresponding author), Univ Regensburg, Dept Dermatol, Regensburg, Germany.	christian.hafner@klinik.uni-regensburg.de		Schrama, David/0000-0002-6931-8194; Houben, Roland/0000-0003-4538-2324	DFG [HA 5531/1-1]; Wilhelm-Sander-Stiftung [2007.057.2]	DFG(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung	This project was supported in part by the DFG grant HA 5531/1-1 (www.dfg.de) and by Wilhelm-Sander-Stiftung (2007.057.2; www.sanst.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Becker J, 2009, CELL MOL LIFE SCI, V66, P1, DOI 10.1007/s00018-008-8483-6; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Dhawan P, 2002, CANCER RES, V62, P7335; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Figueras MT, 2007, MODERN PATHOL, V20, P90, DOI 10.1038/modpathol.3800717; Gaitonde S, 2009, PIGM CELL MELANOMA R, V22, P187, DOI 10.1111/j.1755-148X.2009.00544.x; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Houben R, 2006, J INVEST DERMATOL, V126, P1135, DOI 10.1038/sj.jid.5700170; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Lassacher A, 2008, J INVEST DERMATOL, V128, P1788, DOI 10.1038/sj.jid.5701256; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Leonard JH, 1997, GENE CHROMOSOME CANC, V20, P93, DOI 10.1002/(SICI)1098-2264(199709)20:1<93::AID-GCC14>3.0.CO;2-G; LEONARD JH, 1995, INT J CANCER, V60, P100, DOI 10.1002/ijc.2910600115; Lin NX, 2007, J DERMATOL SCI, V48, P71, DOI 10.1016/j.jdermsci.2007.06.011; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Paulson KG, 2009, J INVEST DERMATOL, V129, P1547, DOI 10.1038/jid.2008.365; Pollock PM, 2002, MELANOMA RES, V12, P565, DOI 10.1097/00008390-200212000-00006; Popp S, 2002, INT J CANCER, V99, P352, DOI 10.1002/ijc.10321; Rittie L, 2007, AM J PATHOL, V170, P2089, DOI 10.2353/ajpath.2007.060537; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; ROSEN ST, 1987, LAB INVEST, V56, P302; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Van Gele M, 2000, BRIT J CANCER, V82, P823; Van Gele M, 2001, INT J CANCER, V92, P409, DOI 10.1002/ijc.1209; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002	37	59	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31255	10.1371/journal.pone.0031255	http://dx.doi.org/10.1371/journal.pone.0031255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363598	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600131
J	Xu, XR; Gammon, MD; Hernandez-Vargas, H; Herceg, Z; Wetmur, JG; Teitelbaum, SL; Bradshaw, PT; Neugut, AI; Santella, RM; Chen, J				Xu, Xinran; Gammon, Marilie D.; Hernandez-Vargas, Hector; Herceg, Zdenko; Wetmur, James G.; Teitelbaum, Susan L.; Bradshaw, Patrick T.; Neugut, Alfred I.; Santella, Regina M.; Chen, Jia			DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study	FASEB JOURNAL			English	Article						epigenetics; biomarker; 1-carbon metabolism	ONE-CARBON METABOLISM; RISK-FACTORS; LONG-ISLAND; HYPOMETHYLATION; POLYMORPHISM; SUSCEPTIBILITY; LEUKOCYTES; BIOMARKER; LINE-1; MTHFR	Our purpose was to identify epigenetic markers of breast cancer risk, which can be reliably measured in peripheral blood and are amenable for large population screening. We used 2 independent assays, luminometric methylation assay (LUMA) and long interspersed elements-1 (LINE-1) to measure "global methylation content" in peripheral blood DNA from a well-characterized population-based case-control study. We examined associations between methylation levels and breast cancer risk among 1055 cases and 1101 controls and potential influences of 1-carbon metabolism on global methylation. Compared with women in the lowest quintile of LUMA methylation, those in the highest quintile had a 2.41-fold increased risk of breast cancer (95% confidence interval: 1.83-3.16; P, trend<0.0001). The association did not vary by other key tumor characteristics and lifestyle risk factors. Consistent with LUMA findings, genome-wide methylation profiling of a subset of samples revealed greater promoter hypermethylation in breast cancer case participants (P=0.04); higher LUMA was associated with higher promoter methylation in the controls (P=0.05). LUMA levels were also associated with functional sodium nitroprusside in key 1-carbon metabolizing genes, MTHFR C677T (P=0.001) and MTRR A66G (P=0.018). LINE-1 methylation was associated with neither breast cancer risk nor 1-carbon metabolism. Our results show that global promoter hypermethylation measured in peripheral blood was associated with breast cancer risk.-Xu, X., Gammon, M. D., Hernandez-Vargas, H., Herceg, Z., Wetmur, J. G., Teitelbaum, S. L., Bradshaw, P. T., Neugut, A. I., Santella, R. M., Chen, J. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J. 26, 2657-2666 (2012). www.fasebj.org	[Xu, Xinran; Teitelbaum, Susan L.; Chen, Jia] Mt Sinai Sch Med, Dept Prevent Med, New York, NY 10029 USA; [Wetmur, James G.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Wetmur, James G.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Jia] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Xu, Xinran] Tongji Univ, Shanghai E Hosp, Sch Med, Res Ctr Translat Med,Minist Educ, Shanghai 200120, Peoples R China; [Xu, Xinran] Tongji Univ, Shanghai E Hosp, Sch Med, Minist Educ,Key Lab Arrhythmias, Shanghai 200120, Peoples R China; [Gammon, Marilie D.; Bradshaw, Patrick T.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Neugut, Alfred I.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Neugut, Alfred I.] Columbia Univ, Dept Med, New York, NY USA; [Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Hernandez-Vargas, Hector; Herceg, Zdenko] Int Agcy Res Canc, Epigenet Grp, F-69372 Lyon, France	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Tongji University; Tongji University; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Columbia University; Columbia University; World Health Organization; International Agency for Research on Cancer (IARC)	Chen, J (corresponding author), Mt Sinai Sch Med, Dept Prevent Med, Box 1057,1 Gustave L Levy Pl, New York, NY 10029 USA.	xu_xinran@hotmail.com; jia.chen@mssm.edu	Bradshaw, Patrick/AAJ-7529-2021	Bradshaw, Patrick/0000-0001-7761-3129; Hernandez-Vargas, Hector/0000-0001-6045-2103; Xu, Xinran/0000-0001-6435-8181	U.S. National Cancer Institute [R01CA109753, 3R01CA109753-04S1]; Department of Defense [BC031746, W81XWH-06-1-0298]; National Cancer Institute; National Institute of Environmental Health and Sciences [UO1CA/ES66572, UO1CA66572, P30CA013696, P30ES009089, P30ES10126]; NATIONAL CANCER INSTITUTE [R01CA109753, U01CA066572, P30CA013696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health and Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the U.S. National Cancer Institute (R01CA109753 and 3R01CA109753-04S1) and in part by grants from Department of Defense (BC031746 and W81XWH-06-1-0298) and National Cancer Institute and National Institute of Environmental Health and Sciences (UO1CA/ES66572, UO1CA66572, P30CA013696, P30ES009089, and P30ES10126). The authors acknowledge the invaluable help of Dr. Thomas Kraus, who performed cell fractionation, and Alexander Rialdi, who performed the LUMA assay for the fractionated cells.	Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Brody T., 1994, NUTR BIOCH; Brooks JD, 2010, CANCER EPIDEMIOL, V34, P717, DOI 10.1016/j.canep.2010.05.006; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cho YH, 2010, ANTICANCER RES, V30, P2489; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677; Gaudet MM, 2004, CANCER EPIDEM BIOMAR, V13, P1485; Graziano F, 2006, INT J CANCER, V118, P628, DOI 10.1002/ijc.21397; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Matthews RG, 2007, CLIN CHEM LAB MED, V45, P1700, DOI 10.1515/CCLM.2007.324; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1026, DOI 10.1002/mnfr.201100008; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; RUSSO J, 1998, FRONT BIOSCI, V3, P944, DOI DOI 10.2741/A335; Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Willett W., 2012, NUTR EPIDEMIOLOGY; Xu XR, 2008, CANCER EPIDEM BIOMAR, V17, P2109, DOI 10.1158/1055-9965.EPI-07-2900; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Xu XR, 2007, CARCINOGENESIS, V28, P1504, DOI 10.1093/carcin/bgm061; Xu XR, 2007, AM J CLIN NUTR, V85, P1098, DOI 10.1093/ajcn/85.4.1098; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zeisel SH, 2003, J NUTR, V133, P1302	41	68	71	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2657	2666		10.1096/fj.11-197251	http://dx.doi.org/10.1096/fj.11-197251			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22371529	Green Published			2022-12-25	WOS:000305017200041
J	Liu, JL; Liang, XH; Su, RW; Lei, W; Jia, B; Feng, XH; Li, ZX; Yang, ZM				Liu, Ji-Long; Liang, Xiao-Huan; Su, Ren-Wei; Lei, Wei; Jia, Bo; Feng, Xu-Hui; Li, Zhi-Xiong; Yang, Zeng-Ming			Combined Analysis of MicroRNome and 3 '-UTRome Reveals a Species-specific Regulation of Progesterone Receptor Expression in the Endometrium of Rhesus Monkey	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; EMBRYO IMPLANTATION; NONCODING RNAS; DNA-SEQUENCES; MOUSE UTERUS; ESTROGEN; PREGNANCY; TARGETS; GENOME; CELLS	The establishment of endometrial receptivity is a prerequisite for successful pregnancy, which is controlled by a complex mechanism. MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as important regulators of gene expression. However, the contribution of miRNAs in endometrial receptivity is still unknown. Here we used rhesus monkey as an animal model and compared the endometrial miRNA expression profiles during early-secretory (pre-receptive) phase and mid-secretory (receptive) phase by deep sequencing. A set of differentially expressed miRNAs were identified, 8 of which were selected and validated using quantitative RT-PCR. To facilitate the prediction of their target genes, the 3'-UTRome was also determined using tag sequencing of mRNA 3'-termini. Surprisingly, about 50% of the 10,677 genes expressed in the rhesus monkey endometrium exhibited alternative 3'-UTRs. Of special interest, the progesterone receptor (PGR) gene, which is necessary for endometrial receptivity, processes an ultra long 3'-UTR (similar to 10 kb) along with a short variant (similar to 2.5 kb). Evolutionary analysis showed that the 3'-UTR sequences of PGR are poorly conserved between primates and rodents, suggesting a species-biased miRNA binding pattern. We further demonstrated that PGR is a valid target of miR-96 in rhesus monkey and human but not in rodents, whereas the regulation of PGR by miR-375 is rhesus monkey-specific. Additionally, we found that miR-219-5p regulates PGR expression through a primate-specific long non-coding RNA immediately downstream of the PGR locus. Our study provides new insights into the molecular mechanisms underlying endometrial receptivity and presents intriguing species-specific regulatory roles of miRNAs.	[Liu, Ji-Long; Liang, Xiao-Huan; Yang, Zeng-Ming] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Su, Ren-Wei; Lei, Wei] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Jia, Bo; Feng, Xu-Hui; Yang, Zeng-Ming] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China; [Li, Zhi-Xiong] Fujian Family Planning Inst, Fujian Nonhuman Primate Res Ctr, Fuzhou 350011, Peoples R China	Shantou University; Northeast Agricultural University - China; Xiamen University	Yang, ZM (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.	zmyang@stu.edu.cn	Lei, Wei/I-3640-2014; feng, xuhui/AAD-9832-2019; Lei, Wei/N-7611-2013; feng, xuhui/D-9450-2017; Yang, ZM/G-4627-2010	Lei, Wei/0000-0002-8342-8859; feng, xuhui/0000-0003-4649-183X; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [30930013, 31071276]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB944402) and the National Natural Science Foundation of China (30930013 and 31071276).	Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Aplin JD, 1999, HUM REPROD, V14, P17, DOI 10.1093/humrep/14.suppl_2.17; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; DEZIEGLER D, 1992, J CLIN ENDOCR METAB, V74, P322, DOI 10.1210/jc.74.2.322; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GHOSH D, 1994, HUM REPROD, V9, P629, DOI 10.1093/oxfordjournals.humrep.a138561; Gidley-Baird A A, 1981, J Reprod Fertil Suppl, V29, P97; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Ho P C, 2001, Expert Opin Pharmacother, V2, P1383, DOI 10.1517/14656566.2.9.1383; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Horne AW, 2005, MOL REPROD DEV, V72, P216, DOI 10.1002/mrd.20307; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jensen KP, 2011, NUCLEIC ACIDS RES, V39, P701, DOI 10.1093/nar/gkq798; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Julian J, 2005, HUM REPROD, V20, P1493, DOI 10.1093/humrep/deh801; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; OMALLEY BW, 1992, BIOL REPROD, V46, P163, DOI 10.1095/biolreprod46.2.163; Palomino WA, 2005, FERTIL STERIL, V83, P587, DOI 10.1016/j.fertnstert.2004.11.020; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; PAUERSTEIN CJ, 1978, AM J OBSTET GYNECOL, V130, P876, DOI 10.1016/0002-9378(78)90264-8; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; Yue XA, 2010, NAT CHEM BIOL, V6, P621, DOI [10.1038/NCHEMBIO.400, 10.1038/nchembio.400]	54	27	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13899	13910		10.1074/jbc.M111.301275	http://dx.doi.org/10.1074/jbc.M111.301275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378788	Green Published, hybrid			2022-12-25	WOS:000303996300045
J	Chen, YL; Chen, YS; Chan, H; Tseng, YH; Yang, SR; Tsai, HY; Liu, HY; Sun, DS; Chang, HH				Chen, Ya-Lei; Chen, Yao-Shen; Chan, Hao; Tseng, Yao-Hsuan; Yang, Shu-Ru; Tsai, Hsin-Ying; Liu, Hong-Yi; Sun, Der-Shan; Chang, Hsin-Hou			The Use of Nanoscale Visible Light-Responsive Photocatalyst TiO2-Pt for the Elimination of Soil-Borne Pathogens	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CENOCEPACIA; PSEUDOMALLEI; MELIOIDOSIS; WATER; COLONIZATION; DISINFECTION; PENETRATION	Exposure to the soil-borne pathogens Burkholderia pseudomallei and Burkholderia cenocepacia can lead to severe infections and even mortality. These pathogens exhibit a high resistance to antibiotic treatments. In addition, no licensed vaccine is currently available. A nanoscale platinum-containing titania photocatalyst (TiO2-Pt) has been shown to have a superior visible light-responsive photocatalytic ability to degrade chemical contaminants like nitrogen oxides. The antibacterial activity of the catalyst and its potential use in soil pathogen control were evaluated. Using the plating method, we found that TiO2-Pt exerts superior antibacterial performance against Escherichia coli compared to other commercially available and laboratory prepared ultraviolet/ visible light-responsive titania photocatalysts. TiO2-Pt-mediated photocatalysis also affectively eliminates the soil-borne bacteria B. pseudomallei and B. cenocepacia. An air pouch infection mouse model further revealed that TiO2-Pt-mediated photocatalysis could reduce the pathogenicity of both strains of bacteria. Unexpectedly, water containing up to 10% w/v dissolved soil particles did not reduce the antibacterial potency of TiO2-Pt, suggesting that the TiO2-Pt photocatalyst is suitable for use in soil-contaminated environments. The TiO2-Pt photocatalyst exerted superior antibacterial activity against a broad spectrum of human pathogens, including B. pseudomallei and B. cenocepacia. Soil particles (<10% w/v) did not significantly reduce the antibacterial activity of TiO2-Pt in water. These findings suggest that the TiO2-Pt photocatalyst may have potential applications in the development of bactericides for soilborne pathogens.	[Chen, Ya-Lei; Yang, Shu-Ru; Tsai, Hsin-Ying; Liu, Hong-Yi] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Chan, Hao] Tzu Chi Univ, Grad Inst Med Sci, Hualien, Taiwan; [Tseng, Yao-Hsuan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chen, Yao-Shen] Natl Yung Ming Univ, Dept Internal Med, Taipei, Taiwan	National Kaohsiung Normal University; Kaohsiung Veterans General Hospital; Tzu Chi University; National Taiwan University of Science & Technology; Tzu Chi University; National Yang Ming Chiao Tung University	Chen, YL (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council, Taiwan, People's Republic of China [95-2314-B-320-009-MY3, 98-2320-B-0.17-001-MY3, 99-2320-B-017-002-MY3]; Ministry of Economic Affairs, Taiwan, People's Republic of China [98-EC-17-A-19-S2-0111]; Tzu-Chi University [TCIRP 95002-02, TCIRP 98001-01, TCRPP 99020, TCRPP 100003]	National Science Council, Taiwan, People's Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan, People's Republic of China(Ministry of Economic Affairs, Taiwan); Tzu-Chi University	This work is supported by the National Science Council, Taiwan, People's Republic of China, under grant numbers 95-2314-B-320-009-MY3, 98-2320-B-0.17-001-MY3 and 99-2320-B-017-002-MY3, by the Ministry of Economic Affairs, Taiwan, People's Republic of China, under grant number 98-EC-17-A-19-S2-0111 and by Tzu-Chi University under grant numbers TCIRP 95002-02, TCIRP 98001-01, TCRPP 99020 and TCRPP 100003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERTHUM F, 1989, APPL ENVIRON MICROB, V55, P1943, DOI 10.1128/AEM.55.8.1943-1948.1989; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; BENVENUTI S, 1995, WEED SCI, V43, P389, DOI 10.1017/S0043174500081376; Bevivino A, 2005, RES MICROBIOL, V156, P974, DOI 10.1016/j.resmic.2005.05.007; Brett PJ, 2000, ACTA TROP, V74, P201, DOI 10.1016/S0001-706X(99)00071-6; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Chang WK, 2012, NANOMEDICIN IN PRESS, V8; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09; Chen YS, 2009, JPN J INFECT DIS, V62, P155; Chen YS, 2009, MICROBIOL IMMUNOL, V53, P184, DOI 10.1111/j.1348-0421.2009.00105.x; Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Chou PW, 2006, OBSERVATION CA UNPUB; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Frojd V, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-8; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694; Jin X, 1996, SOIL SCI, V161, P509, DOI 10.1097/00010694-199608000-00006; Kaiser K, 2000, SOIL SCI, V165, P305, DOI 10.1097/00010694-200004000-00002; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Lin HH, 2007, J HAZARD MATER, V145, P431, DOI 10.1016/j.jhazmat.2006.11.043; Lin HH, 2006, J CLIN MICROBIOL, V44, P4596, DOI 10.1128/JCM.01531-06; Lin YM, 2006, ENVIRON SCI TECHNOL, V40, P1616, DOI 10.1021/es051007p; Liou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019982; LO SJ, 1979, BIOCHEM BIOPH RES CO, V86, P748, DOI 10.1016/0006-291X(79)91776-5; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mann T, 2010, INFECTION, V38, P187, DOI 10.1007/s15010-010-0017-0; Matsuzawa S, 2008, APPL CATAL B-ENVIRON, V83, P39, DOI 10.1016/j.apcatb.2008.01.036; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Peeters E, 2008, J HOSP INFECT, V70, P361, DOI 10.1016/j.jhin.2008.08.015; Rajagopal G, 2006, COLLOID SURFACE B, V51, P107, DOI 10.1016/j.colsurfb.2006.06.003; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sano T, 2008, J MOL CATAL A-CHEM, V284, P127, DOI 10.1016/j.molcata.2008.01.014; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Stone R, 2007, SCIENCE, V317, P1022, DOI 10.1126/science.317.5841.1022; Su HP, 2007, J CLIN MICROBIOL, V45, P2599, DOI 10.1128/JCM.00228-07; Wattanaphon HT, 2008, J APPL MICROBIOL, V105, P416, DOI 10.1111/j.1365-2672.2008.03755.x; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597; Yue QL, 2008, J FLUORESC, V18, P11, DOI 10.1007/s10895-007-0228-7	58	26	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31212	10.1371/journal.pone.0031212	http://dx.doi.org/10.1371/journal.pone.0031212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384003	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500014
J	Klinke, T; Daboul, A; Maron, J; Gredes, T; Puls, R; Jaghsi, A; Biffar, R				Klinke, Thomas; Daboul, Amro; Maron, Juliane; Gredes, Tomasz; Puls, Ralf; Jaghsi, Ahmad; Biffar, Reiner			Artifacts In Magnetic Resonance Imaging and Computed Tomography Caused By Dental Materials	PLOS ONE			English	Article							METALLIC OBJECTS; MR-IMAGES; CT; SUSCEPTIBILITY; IMPLANTS; DEVICES; ALLOYS; PET/CT; IMPACT	Background: Artifacts caused by dental restorations, such as dental crowns, dental fillings and orthodontic appliances, are a common problem in MRI and CT scans of the head and neck. The aim of this in-vitro study was to identify and evaluate the artifacts produced by different dental restoration materials in CT and MRI images. Methods: Test samples of 44 materials (Metal and Non-Metal) commonly used in dental restorations were fabricated and embedded with reference specimens in gelatin moulds. MRI imaging of 1.5T and CT scan were performed on the samples and evaluated in two dimensions. Artifact size and distortions were measured using a digital image analysis software. Results: In MRI, 13 out of 44 materials produced artifacts, while in CT 41 out of 44 materials showed artifacts. Artifacts produced in both MRI and CT images were categorized according to the size of the artifact. Significance: Metal based restoration materials had strong influence on CT and less artifacts in MRI images. Rare earth elements such as Ytterbium trifluoride found in composites caused artifacts in both MRI and CT. Recognizing these findings would help dental materials manufacturers and developers to produce materials which can cause less artifacts in MRI and CT images.	[Klinke, Thomas; Daboul, Amro; Maron, Juliane; Jaghsi, Ahmad; Biffar, Reiner] Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany; [Gredes, Tomasz] Ernst Moritz Arndt Univ Greifswald, Polyclin Orthodont, Greifswald, Germany; [Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Klinke, T (corresponding author), Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany.	daboulamro@gmail.com	Gredes, Tomasz/AAR-1180-2021	Gredes, Tomasz/0000-0002-0492-3422; Al Jaghsi, Ahmad/0000-0002-7888-1149				Abbaszadeh K, 2000, ORAL SURG ORAL MED O, V89, P759, DOI 10.1067/moe.2000.105942; Allen F, 2000, CLIN ORAL IMPLAN RES, V11, P34, DOI 10.1034/j.1600-0501.2000.011001034.x; Baek CH, 2008, J NUCL MED, V49, P1422, DOI 10.2967/jnumed.108.051649; Bartels LW, 2001, J VASC INTERV RADIOL, V12, P365, DOI 10.1016/S1051-0443(07)61918-6; Behr M, 1996, Eur J Prosthodont Restor Dent, V4, P111; BEUF O, 1994, DENT MATER, V10, P265, DOI 10.1016/0109-5641(94)90072-8; BouSerhal Charbel, 2002, Clin Implant Dent Relat Res, V4, P156, DOI 10.1111/j.1708-8208.2002.tb00167.x; Bui FM, 2000, J MED ENG TECHNOL, V24, P20, DOI 10.1080/030919000294003; CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115; Cao Zheng, 2008, Zhonghua Yi Xue Za Zhi, V88, P1855; Carlsson A, 2009, THESIS U GOTHENBURG, P5; Destine Darline, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P205, DOI 10.2186/jjps.52.205; Eggers G, 2005, MAGN RESON MATER PHY, V18, P103, DOI 10.1007/s10334-005-0101-0; FACHE JS, 1987, AM J NEURORADIOL, V8, P837; FIALA TGS, 1993, PLAST RECONSTR SURG, V92, P1227; HINSHAW DB, 1988, RADIOLOGY, V166, P777, DOI 10.1148/radiology.166.3.3340777; Hopper TAJ, 2006, MAGN RESON IMAGING, V24, P1077, DOI 10.1016/j.mri.2006.04.019; Hubalkova H, 2006, INT DENT J, V56, P135; Hubalkova Hana, 2002, Eur J Prosthodont Restor Dent, V10, P125; Kamel EM, 2003, EUR RADIOL, V13, P724, DOI 10.1007/s00330-002-1564-2; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719; Odlum O, 2001, Spec Care Dentist, V21, P72; Shafiei F, 2003, J DENT RES, V82, P602, DOI 10.1177/154405910308200806; Starcukova J, 2008, DENT MATER, V24, P715, DOI 10.1016/j.dental.2007.07.002; Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5	26	72	76	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31766	10.1371/journal.pone.0031766	http://dx.doi.org/10.1371/journal.pone.0031766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384071	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500039
J	Zafeiropoulou, K; Bita, T; Polykratis, A; Karabina, S; Vlachojannis, J; Katsoris, P				Zafeiropoulou, Kalliopi; Bita, Theodora; Polykratis, Apostolos; Karabina, Stella; Vlachojannis, John; Katsoris, Panagiotis			Hemodialysis Removes Uremic Toxins That Alter the Biological Actions of Endothelial Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; GLYCATION END-PRODUCTS; MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; REGULATORY FUNCTIONS; MATRIX METALLOPROTEINASES; CAROTID ATHEROSCLEROSIS; PARACRINE FUNCTIONS	Chronic kidney disease is linked to systemic inflammation and to an increased risk of ischemic heart disease and atherosclerosis. Endothelial dysfunction associates with hypertension and vascular disease in the presence of chronic kidney disease but the mechanisms that regulate the activation of the endothelium at the early stages of the disease, before systemic inflammation is established remain obscure. In the present study we investigated the effect of serum derived from patients with chronic kidney disease either before or after hemodialysis on the activation of human endothelial cells in vitro, as an attempt to define the overall effect of uremic toxins at the early stages of endothelial dysfunction. Our results argue that uremic toxins alter the biological actions of endothelial cells and the remodelling of the extracellular matrix before signs of systemic inflammatory responses are observed. This study further elucidates the early events of endothelial dysfunction during toxic uremia conditions allowing more complete understanding of the molecular events as well as their sequence during progressive renal failure.	[Zafeiropoulou, Kalliopi; Polykratis, Apostolos; Karabina, Stella; Katsoris, Panagiotis] Univ Patras, Dept Biol, Patras, Achaia, Greece; [Bita, Theodora; Vlachojannis, John] Univ Hosp Patras, Dept Internal Med Nephrol, Patras, Achaia, Greece	University of Patras; University of Patras	Zafeiropoulou, K (corresponding author), Univ Patras, Dept Biol, Patras, Achaia, Greece.	katsopan@upatras.gr		Polykratis, Apostolos/0000-0001-6720-3302				Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; ANGGARD EE, 1992, JPN J PHARMACOL, V58, pP200; Annuk M, 2003, KIDNEY INT, V63, pS50, DOI 10.1046/j.1523-1755.63.s84.2.x; Baradaran A, 2005, SAUDI J KIDNEY DIS T, V16, P288; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Caramelo C, 1996, CIRC RES, V79, P1031, DOI 10.1161/01.RES.79.5.1031; Caron A, 2005, CAN J PHYSIOL PHARM, V83, P287, DOI 10.1139/Y05-011; Chappey O, 1997, Rev Prat, V47, P2223; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Chung TW, 2004, J GASTROEN HEPATOL, V19, P565, DOI 10.1111/j.1440-1746.2004.03344.x; Costa-Hong V, 2009, ARQ BRAS CARDIOL, V92, P381; Cross J, 2002, BLOOD PURIFICAT, V20, P459, DOI 10.1159/000063552; de Nooijer R, 2006, ARTERIOSCL THROM VAS, V26, P340, DOI 10.1161/01.ATV.0000197795.56960.64; Djuric T, 2008, CLIN BIOCHEM, V41, P1326, DOI 10.1016/j.clinbiochem.2008.08.081; Fleming I, 1996, MOL CELL BIOCHEM, V157, P137; Florys Bozena, 2006, Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, V12, P184; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; GUERRA R, 1989, BLOOD VESSELS, V26, P300; Hansson G, 1997, Lakartidningen, V94, P852; HANSSON GK, 1987, ACTA MED SCAND, P11; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson J, 2009, EUR J CARDIOV PREV R, V16, P297, DOI 10.1097/HJR.0b013e3283213108; Hayakawa H, 1999, J HYPERTENS, V17, P611, DOI 10.1097/00004872-199917050-00004; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Ho FM, 2007, J CELL BIOCHEM, V101, P442, DOI 10.1002/jcb.21192; Ishikawa M, 2001, AM J CARDIOL, V88, P1203, DOI 10.1016/S0002-9149(01)02064-1; Jaconbson SH, 2002, AM J NEPHROL, V22, P42, DOI 10.1159/000046673; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P557, DOI 10.1016/j.atherosclerosis.2009.08.018; Johnson TS, 2002, EXP NEPHROL, V10, P182; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Karbowska A, 2009, TRANSPL P, V41, P3052, DOI 10.1016/j.transproceed.2009.07.080; Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009; Kharbanda RK, 2001, CORONARY ARTERY DIS, V12, P485, DOI 10.1097/00019501-200109000-00007; KITAGAWA S, 1994, LIFE SCI, V55, P491, DOI 10.1016/0024-3205(94)00741-1; KORNERUP HJ, 1976, ACTA MED SCAND, V200, P257; Kunz K, 1999, NEPHROL DIAL TRANSPL, V14, P1934, DOI 10.1093/ndt/14.8.1934; LAZARUS JM, 1974, ARCH INTERN MED, V133, P1059, DOI 10.1001/archinte.133.6.1059; Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031; Lehrke M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-50; Libby P, 2006, Handb Exp Pharmacol, P285; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; Lindsey ML, 2004, HEART FAIL REV, V9, P7, DOI 10.1023/B:HREV.0000011390.44039.b7; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P13, DOI 10.1016/j.bbadis.2004.01.002; Matsuda H, 2004, HYPERTENSION, V43, P603, DOI 10.1161/01.HYP.0000118053.42262.71; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Matsusaka H, 2005, AM J PHYSIOL-HEART C, V289, pH1858, DOI 10.1152/ajpheart.00216.2005; Ruilope LM, 2007, VASC HEALTH RISK MAN, V3, P1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musial K, 2011, CELL STRESS CHAPERON, V16, P97, DOI 10.1007/s12192-010-0214-x; Mysliwiec M, 2004, Rocz Akad Med Bialymst, V49, P151; Napoli C, 2002, STROKE, V33, P2864; Nin JWM, 2009, DIABETOLOGIA, V52, P705, DOI 10.1007/s00125-009-1263-5; Pawlak K, 2011, CLIN BIOCHEM, V44, P838, DOI 10.1016/j.clinbiochem.2011.03.143; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Pradhan-Palikhe P, 2010, SCAND J IMMUNOL, V72, P150, DOI 10.1111/j.1365-3083.2010.02418.x; RYAN JW, 1982, ADV VET SCI COMP MED, V26, P79; Sahin G, 2007, BLOOD PURIFICAT, V25, P309, DOI 10.1159/000106103; Schaefer L, 1996, KIDNEY INT, V49, P75, DOI 10.1038/ki.1996.10; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Song GD, 2010, WOUND REPAIR REGEN, V18, P426, DOI 10.1111/j.1524-475X.2010.00595.x; Szczepanska Maria, 2005, Pol Merkur Lekarski, V18, P17; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; TAKAGI M, 1994, BLOOD COAGUL FIBRIN, V5, P713, DOI 10.1097/00001721-199410000-00006; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; VANE JR, 1990, NEW ENGL J MED, V323, P27; VANHINSBERGH VWM, 1992, MOL CELL BIOCHEM, V116, P163, DOI 10.1007/BF01270584; Wakatsuki S, 2008, EXPERT OPIN THER TAR, V12, P1469, DOI 10.1517/14728220802551140 ; Wang Chang-qian, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P405; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS64, DOI 10.1681/ASN.2005121345; Zureik M, 2005, J HYPERTENS, V23, P2263, DOI 10.1097/01.hjh.0000191245.68443.24	78	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30975	10.1371/journal.pone.0030975	http://dx.doi.org/10.1371/journal.pone.0030975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383985	gold, Green Submitted, Green Published			2022-12-25	WOS:000302875500008
J	Domeier, ML; Speare, P				Domeier, Michael L.; Speare, Peter			Dispersal of Adult Black Marlin (Istiompax indica) from a Great Barrier Reef Spawning Aggregation	PLOS ONE			English	Article							MAKAIRA-NIGRICANS; BLUE MARLIN; TRACKING; GROWTH; ISLAND; SEA	The black marlin (Istiompax indica) is one of the largest bony fishes in the world with females capable of reaching a mass of over 700 kg. This highly migratory predator occurs in the tropical regions of the Pacific and Indian Oceans, and is the target of regional recreational and commercial fisheries. Through the sampling of ichthyoplankton and ovaries we provide evidence that the relatively high seasonal abundance of black marlin off the Great Barrier Reef is, in fact, a spawning aggregation. Furthermore, through the tracking of individual black marlin via satellite popup tags, we document the dispersal of adult black marlin away from the spawning aggregation, thereby identifying the catchment area for this spawning stock. Although tag shedding is an issue when studying billfish, we tentatively identify the catchment area for this stock of black marlin to extend throughout the Coral Sea, including the waters of Papua New Guinea, the Solomon Islands, Micronesia, New Caledonia, Kiribati, Vanuatu, Fiji, Tuvalu and Nauru.	[Domeier, Michael L.] Marine Conservat Sci Inst, Fallbrook, CA USA; [Speare, Peter] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Domeier, ML (corresponding author), Marine Conservat Sci Inst, Fallbrook, CA USA.	ml.domeier@gmail.com			Offield Family Foundation	Offield Family Foundation	This work was funded by a grant from the Offield Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocha F, 2002, J FISH BIOL, V60, P13, DOI 10.1006/jfbi.2001.1805; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Choukroun S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005761; Domeier M.L., 2002, TRANSFORMING CORAL R; Domeier ML, 2006, B MAR SCI, V79, P811; Domeier ML, 1997, B MAR SCI, V60, P698; Domeier ML, 2005, FISH B-NOAA, V103, P292; Falterman B, 1999, THESIS VIRGINIA I MA; Gorbunova N.N, 1969, J ICHTHYOL, V9, P375; Govoni JJ, 2003, FISH B-NOAA, V101, P778; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; LEIS JM, 1987, FISH B-NOAA, V85, P757; Nakamura H., 1941, ZOOL MAG, V53, P17; Nakamura H, 1942, SUISAN GAKKAI HO, V9, P45; Nakamura H, 1944, T NAT HIST SOC TAIWA, V34, P293; Nakamura I, 1985, FAO SPECIES CATALOGU, V125; Nakamura I., 1975, SPEC SCI REP FISH 3, P17; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Pepperell J.G., 1990, Marine Recreational Fisheries, V13, P51; PRINCE ED, 1991, FISH B-NOAA, V89, P441; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Serafy JE, 2003, MAR FRESHWATER RES, V54, P299, DOI 10.1071/MF01273; Shimose T, 2008, ICHTHYOL RES, V55, P90, DOI 10.1007/s10228-007-0004-3; Speare P, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P237; Sponaugle S, 2005, J FISH BIOL, V66, P822, DOI 10.1111/j.0022-1112.2005.00657.x; Suzuki Z, 1990, P 2 INT BILLF S KA 1; Ueyanagi S., 1964, Proceedings Symp Scombroid fishes Mar Biol Ass India (Ser 1), VPt. I, P499; Ueyanagi S., 1960, Records of Oceanographic Works in Japan NS, V5, P167; Ueyanagi S, 1960, REP NANKAI REG FISH, V12, P85; Williams D, 1993, TRENDS MARLIN ABUNDA, P81; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2; YOUNG IR, 1994, CONT SHELF RES, V14, P117, DOI 10.1016/0278-4343(94)90009-4	33	30	30	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31629	10.1371/journal.pone.0031629	http://dx.doi.org/10.1371/journal.pone.0031629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363692	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700079
J	Gatta, L; Piscitelli, F; Giordano, C; Boccella, S; Lichtman, A; Maione, S; Di Marzo, V				Gatta, Luisa; Piscitelli, Fabiana; Giordano, Catia; Boccella, Serena; Lichtman, Aron; Maione, Sabatino; Di Marzo, Vincenzo			Discovery of Prostamide F-2 alpha and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability	PLOS ONE			English	Article							ENDOCANNABINOID OXYGENATION; MURINE MODEL; ANANDAMIDE; FAAH; PROSTAGLANDINS; HYPERALGESIA; MAINTENANCE; METABOLISM; INHIBITORS; RECEPTORS	It was suggested that endocannabinoids are metabolized by cyclooxygenase (COX)-2 in the spinal cord of rats with kaolin/lambda-carrageenan-induced knee inflammation, and that this mechanism contributes to the analgesic effects of COX-2 inhibitors in this experimental model. We report the development of a specific method for the identification of endocannabinoid COX-2 metabolites, its application to measure the levels of these compounds in tissues, and the finding of prostamide F-2 alpha (PMF2 alpha) in mice with knee inflammation. Whereas the levels of spinal endocannabinoids were not significantly altered by kaolin/lambda-carrageenan-induced knee inflammation, those of the COX-2 metabolite of AEA, PMF2 alpha, were strongly elevated. The formation of PMF2 alpha was reduced by indomethacin (a non-selective COX inhibitor), NS-398 (a selective COX-2 inhibitor) and SC-560 (a selective COX-1 inhibitor). In healthy mice, spinal application of PMF2 alpha increased the firing of nociceptive (NS) neurons, and correspondingly reduced the threshold of paw withdrawal latency (PWL). These effects were attenuated by the PMF2 alpha receptor antagonist AGN211336, but not by the FP receptor antagonist AL8810. Also prostaglandin F-2 alpha increased NS neuron firing and reduced the threshold of PWL in healthy mice, and these effects were antagonized by AL8810, and not by AGN211336. In mice with kaolin/lambda-carrageenan-induced knee inflammation, AGN211336, but not AL8810, reduced the inflammation-induced NS neuron firing and reduction of PWL. These findings suggest that inflammation-induced, and prostanoid-mediated, enhancement of dorsal horn NS neuron firing stimulates the production of spinal PMF2 alpha, which in turn contributes to further NS neuron firing and pain transmission by activating specific receptors.	[Gatta, Luisa; Giordano, Catia; Boccella, Serena; Maione, Sabatino] Univ Naples 2, Endocannabinoid Res Grp, Dept Expt Med, Div Pharmacol L Donatelli, Naples, Italy; [Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Inst Biomol Chem, Pozzuoli, Italy; [Lichtman, Aron] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Sch Med, Richmond, VA USA	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Virginia Commonwealth University	Gatta, L (corresponding author), Univ Naples 2, Endocannabinoid Res Grp, Dept Expt Med, Div Pharmacol L Donatelli, Naples, Italy.	sabatino.maione@unina2.it; vdimarzo@icmib.na.cnr.it	Piscitelli, Fabiana/A-7100-2014; Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Maione, Sabatino/0000-0003-3850-6704; Piscitelli, Fabiana/0000-0001-9343-4622	NIH [DA009789]; Allergan, Irvine, CA, USA; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan, Irvine, CA, USA(AbbVieAllergan); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was partly supported by NIH grants (grant no. DA009789 to AHL and VD) and by Allergan, Irvine, CA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Davidova A, 2009, CELL MOL NEUROBIOL, V29, P879, DOI 10.1007/s10571-009-9370-x; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Khasabov SG, 2007, BRAIN RES, V1180, P7, DOI 10.1016/j.brainres.2007.08.075; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; Petrosino S, 2007, NEUROPHARMACOLOGY, V52, P415, DOI 10.1016/j.neuropharm.2006.08.011; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Pitcher MH, 2010, PAIN, V151, P756, DOI 10.1016/j.pain.2010.09.008; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Simone Donald A., 2008, Shengli Xuebao, V60, P635; Staniaszek LE, 2010, BRIT J PHARMACOL, V160, P669, DOI 10.1111/j.1476-5381.2010.00703.x; Straiker A, 2011, BR J PHARM; Telleria-Diaz A, 2010, PAIN, V148, P26, DOI 10.1016/j.pain.2009.08.013; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Yang W, 2005, J LIPID RES, V46, P2745, DOI 10.1194/jlr.M500374-JLR200; Yoshikawa K, 2011, BRAIN RES, V1367, P22, DOI 10.1016/j.brainres.2010.10.019	30	80	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31111	10.1371/journal.pone.0031111	http://dx.doi.org/10.1371/journal.pone.0031111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363560	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700027
J	Kruger, D; Kapturska, D; Fischer, C; Daniel, R; Wubet, T				Krueger, Dirk; Kapturska, Danuta; Fischer, Christiane; Daniel, Rolf; Wubet, Tesfaye			Diversity Measures in Environmental Sequences Are Highly Dependent on Alignment Quality-Data from ITS and New LSU Primers Targeting Basidiomycetes	PLOS ONE			English	Article							RIBOSOMAL-RNA; FUNGAL COMMUNITIES; MICROBIAL COMMUNITIES; NUCLEOTIDE-SEQUENCE; CONCERTED EVOLUTION; SECONDARY STRUCTURE; VERSION 4; SUBSTITUTIONS; ABUNDANCE; TREE	The ribosomal DNA comprised of the ITS1-5.8S-ITS2 regions is widely used as a fungal marker in molecular ecology and systematics but cannot be aligned with confidence across genetically distant taxa. In order to study the diversity of Agaricomycotina in forest soils, we designed primers targeting the more alignable 28S (LSU) gene, which should be more useful for phylogenetic analyses of the detected taxa. This paper compares the performance of the established ITS1F/4B primer pair, which targets basidiomycetes, to that of two new pairs. Key factors in the comparison were the diversity covered, off-target amplification, rarefaction at different Operational Taxonomic Unit (OTU) cutoff levels, sensitivity of the method used to process the alignment to missing data and insecure positional homology, and the congruence of monophyletic clades with OTU assignments and BLAST-derived OTU names. The ITS primer pair yielded no off-target amplification but also exhibited the least fidelity to the expected phylogenetic groups. The LSU primers give complementary pictures of diversity, but were more sensitive to modifications of the alignment such as the removal of difficult-to align stretches. The LSU primers also yielded greater numbers of singletons but also had a greater tendency to produce OTUs containing sequences from a wider variety of species as judged by BLAST similarity. We introduced some new parameters to describe alignment heterogeneity based on Shannon entropy and the extent and contents of the OTUs in a phylogenetic tree space. Our results suggest that ITS should not be used when calculating phylogenetic trees from genetically distant sequences obtained from environmental DNA extractions and that it is inadvisable to define OTUs on the basis of very heterogeneous alignments.	[Krueger, Dirk; Kapturska, Danuta; Wubet, Tesfaye] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Kapturska, Danuta] Int Grad Sch Zittau, Zittau, Germany; [Fischer, Christiane; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Gottingen, Germany; [Fischer, Christiane; Daniel, Rolf] Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technische Universitat Dresden; University of Gottingen	Kruger, D (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	dirk.krueger@ufz.de	Wubet, Tesfaye/C-6241-2012; Krüger, Dirk/C-3316-2012; Daniel, Rolf/AAQ-5933-2021	Wubet, Tesfaye/0000-0001-8572-4486; Krüger, Dirk/0000-0002-7305-5104; Daniel, Rolf/0000-0002-8646-7925	DFG [KA 1241/15-1, KR 3587/1-1]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE).	DFG(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE).	This work was funded in part by DFG Priority Program 1374 on "nfrastructure-Biodiversity-Exploratories'' (KA 1241/15-1 and KR 3587/1-1). D. Kapturska also was kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Blaskowski J, 2008, MYCOTAXON, V106, P247; Cerchio S, 1998, SYST BIOL, V47, P336, DOI 10.1080/106351598260941; CHAO A, 1984, SCAND J STAT, V11, P265; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cho KM, 2009, J MICROBIOL BIOTECHN, V19, P743, DOI 10.4014/jmb.0807.455; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dwivedi B, 2009, BIOL MED, V1, P50; Dwivedi Bhakti, 2009, BMC Evolutionary Biology, V9; Edwards IP, 2010, MOL ECOL, V19, P1469, DOI 10.1111/j.1365-294X.2010.04566.x; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gargas A, 1996, MYCOLOGIA, V88, P745, DOI 10.2307/3760969; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Goremykin VV, 2010, J MOL EVOL, V71, P319, DOI 10.1007/s00239-010-9398-z; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Halanych KM, 1999, J MOL EVOL, V48, P369, DOI 10.1007/PL00006481; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P377; Hanson CA, 2008, ECOSYSTEMS, V11, P1157, DOI 10.1007/s10021-008-9186-4; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hibbett DS, 2006, MYCOLOGIA, V98, P917, DOI 10.3852/mycologia.98.6.917; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Innis MA, 1990, PCR PROTOCOLS GUIDE; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ki JS, 2007, J EUKARYOT MICROBIOL, V54, P210, DOI 10.1111/j.1550-7408.2007.00251.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kruger D, 2006, BIOINFORMATION, V1, P327; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Landeweert R, 2003, APPL ENVIRON MICROB, V69, P327, DOI 10.1128/AEM.69.1.327-333.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Martin MP, 2004, MYCOTAXON, V90, P133; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Morrison DA, 2010, MOL BIOL EVOL, V27, P1044, DOI 10.1093/molbev/msp309; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nakatsu CH, 2007, SOIL SCI SOC AM J, V71, P562, DOI 10.2136/sssaj2006.0080; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parker J, 2011, SHANNON HETEROGENEIT, V1.0; Pivato B, 2007, NEW PHYTOL, V176, P197, DOI 10.1111/j.1469-8137.2007.02151.x; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; Robinson CH, 2009, SOIL BIOL BIOCHEM, V41, P414, DOI 10.1016/j.soilbio.2008.10.021; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rosendahl S, 2004, MOL ECOL, V13, P3179, DOI 10.1111/j.1365-294X.2004.02295.x; Rossman A. Y., 2007, INOCULUM, V58, P1; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; Ryberg M, 2008, BMC EVOLUTIONARY BIO, V8, P14; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seguritan V, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-9; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shannon CE., 1949, MATH THEORY COMMUNIC; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smith AD, 2004, MOL BIOL EVOL, V21, P419; Soltis DE, 1996, SYST BOT, V21, P169, DOI 10.2307/2419746; SRIKANTHA T, 1994, CURR GENET, V26, P321, DOI 10.1007/BF00310496; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torzilli AP, 2006, MYCOLOGIA, V98, P690, DOI 10.3852/mycologia.98.5.690; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; White WT, 2007, MOL BIOL EVOL, V24, P2029, DOI 10.1093/molbev/msm139; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yarwood SA, 2010, MICROB ECOL, V60, P606, DOI 10.1007/s00248-010-9675-9; Yu JY, 2006, MOL BIOL EVOL, V23, P1525, DOI 10.1093/molbev/msl015; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005	96	12	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32139	10.1371/journal.pone.0032139	http://dx.doi.org/10.1371/journal.pone.0032139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363808	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700149
J	Marangi, M; Morelli, V; Pati, S; Camarda, A; Cafiero, MA; Giangaspero, A				Marangi, Marianna; Morelli, Vincenzo; Pati, Sandra; Camarda, Antonio; Cafiero, Maria Assunta; Giangaspero, Annunziata			Acaricide Residues in Laying Hens Naturally Infested by Red Mite Dermanyssus gallinae	PLOS ONE			English	Article							ORGANOCHLORINE PESTICIDE-RESIDUES; NORTHERN FOWL MITE; POULTRY FARM; CHICKEN MITE; PREVALENCE; RESISTANCE; EGGS; EXPOSURE; SYSTEMS; ACARINA	In the poultry industry, control of the red mite D. gallinae primarily relies worldwide on acaricides registered for use in agriculture or for livestock, and those most widely used are carbamates, followed by amidines, pyrethroids and organophosphates. Due to the repeated use of acaricides sometimes in high concentrations to control infestation, red mites may become resistant, and acaricides may accumulate in chicken organs and tissues, and also in eggs. To highlight some situations of misuse/abuse of chemicals and of risk to human health, we investigated laying hens, destined to the slaughterhouse, for the presence of acaricide residues in their organs and tissues. We used 45 hens from which we collected a total of 225 samples from the following tissues and organs: skin, fat, liver, muscle, hearth, and kidney. In these samples we analyzed the residual contents of carbaryl and permethrin by LC-MS/MS. Ninety-one (40.4%) samples were positive to carbaryl and four samples (1.7%) were positive to permethrin. Concentrations of carbaryl exceeding the detection limit (0.005 ppm) were registered in the skin and fat of birds from two farms (p<0.01), although these concentrations remained below the maximum residue limit (MRLs) (0.05 ppm) (p<0.01). All organs/tissues of hens from a third farm were significantly more contaminated, with skin and muscle samples exceeding the MRL (0.05 ppm) (p<0.01) of carbaryl in force before its use was banned. Out of 45 chickens tested, 37 (82.2%) were found to be contaminated by carbaryl, and 4 (8.8%) by permethrin. The present study is the first report on the presence of pesticides banned by the EU (carbaryl) or not licensed for use (permethrin) in the organs and tissues of laying hens, which have been treated against red mites, and then slaughtered for human consumption at the end of their life cycle.	[Marangi, Marianna; Giangaspero, Annunziata] Univ Foggia, Dipartimento Sci Prod Ingegneria & Meccan & Econ, Foggia, Italy; [Morelli, Vincenzo] Consorzio ASI, Lab Bonassisa, Foggia, Italy; [Pati, Sandra] Univ Foggia, Dipartimento Sci Alimenti, Foggia, Italy; [Camarda, Antonio] Univ Bari, Dipartimento Sanita Pubbl & Zootecnia, Bari, Italy; [Cafiero, Maria Assunta] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy	University of Foggia; University of Foggia; Universita degli Studi di Bari Aldo Moro; IZS Puglia e Basilicata	Giangaspero, A (corresponding author), Univ Foggia, Dipartimento Sci Prod Ingegneria & Meccan & Econ, Foggia, Italy.	a.giangaspero@unifg.it	Giangaspero, Annunziata/ABB-3727-2021; Smith, Keely/AAL-4913-2020	Camarda, Antonio/0000-0002-3961-585X; Giangaspero, Annunziata/0000-0002-3357-8672; PATI, SANDRA/0000-0003-4453-0540	Fondazione Cassa di Risparmio di Puglia, Bari, Italy	Fondazione Cassa di Risparmio di Puglia, Bari, Italy	This work was supported by the following Research Grant: Fondazione Cassa di Risparmio di Puglia, 2010-2011, Bari, Italy. The funder had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad R, 2010, CHEMOSPHERE, V78, P667, DOI 10.1016/j.chemosphere.2009.12.012; Balali-Mood M, 2008, ARCH IRAN MED, V11, P65; Beugnet F, 1997, VET REC, V140, P577, DOI 10.1136/vr.140.22.577; Biggs ML, 2008, CANCER EPIDEM BIOMAR, V17, P2012, DOI 10.1158/1055-9965.EPI-08-0032; Cencek T, 2003, B VET I PULAWY, V47, P465; Charles LE, 2010, WORK, V37, P205, DOI 10.3233/WOR-2010-1071; Chauve C, 1998, VET PARASITOL, V79, P239, DOI 10.1016/S0304-4017(98)00167-8; Chirico J, 2002, VET PARASITOL, V110, P109, DOI 10.1016/S0304-4017(02)00310-2; Covaci A, 2001, SCI TOTAL ENVIRON, V280, P143, DOI 10.1016/S0048-9697(01)00820-8; de Siqueira MT, 2010, B ENVIRON CONTAM TOX, V84, P647, DOI 10.1007/s00128-010-0027-8; Doucet J, 2009, ENVIRON HEALTH PERSP, V117, P605, DOI 10.1289/ehp.0800205; Farkas R, 2005, MAGY ALLATORVOSOK, V127, P348; Fiddes MD, 2005, VET REC, V157, P233, DOI 10.1136/vr.157.8.233; FLETCHER MG, 1991, EXP APPL ACAROL, V13, P137, DOI 10.1007/BF01193664; Fu S, 2001, B ENVIRON CONTAM TOX, V66, P171, DOI 10.1007/s001280000221; Gamlin J, 2007, CHILD CARE HLTH DEV, V33, P246, DOI 10.1111/j.1365-2214.2006.00702.x; GENCHI C, 1984, ARCH VET ITAL, V35, P125; Glynn AW, 2000, SCI TOTAL ENVIRON, V246, P195, DOI 10.1016/S0048-9697(99)00458-1; Guitart R, 2010, VET J, V183, P260, DOI 10.1016/j.tvjl.2009.03.033; Herrero-Mercado M, 2010, B ENVIRON CONTAM TOX, V85, P367, DOI 10.1007/s00128-010-0108-8; HOGLUND J, 1995, POULTRY SCI, V74, P1793, DOI 10.3382/ps.0741793; IVEY MC, 1984, POULTRY SCI, V63, P61, DOI 10.3382/ps.0630061; KAN CA, 1978, J AGR FOOD CHEM, V26, P1051, DOI 10.1021/jf60219a006; Keita A, 2006, REV MED VET-TOULOUSE, V157, P588; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Khajavi M, 2004, BR POULT SCI S, V45, P15; Kilpinen O, 2005, PHYSIOL ENTOMOL, V30, P232, DOI 10.1111/j.1365-3032.2005.00452.x; Kishimba MA, 2004, TALANTA, V64, P48, DOI 10.1016/j.talanta.2003.11.047; Kumar V, 2010, CHEMOSPHERE, V81, P464, DOI 10.1016/j.chemosphere.2010.07.067; LAKE CA, 1995, ARCH ENVIRON CON TOX, V29, P128, DOI 10.1007/BF00213097; LIEBISH A, 2001, SCHADLINGSBEKAMPFER, V3, P11; Magdas C, 2006, B U AGR MED VET M-VE, V63, P309; Marangi M, 2009, EXP APPL ACAROL, V48, P11, DOI 10.1007/s10493-008-9224-0; Mariscal-Arcas M, 2010, FOOD CHEM TOXICOL, V48, P1311, DOI 10.1016/j.fct.2010.02.029; Nordenfors H, 2001, VET PARASITOL, V102, P121, DOI 10.1016/S0304-4017(01)00528-3; Singh S, 2011, TOXICOL APPL PHARM, V252, P130, DOI 10.1016/j.taap.2011.01.014; Sparagano O, 2009, EXP APPL ACAROL, V48, P3, DOI 10.1007/s10493-008-9233-z; Tao S, 2009, ENVIRON POLLUT, V157, P497, DOI 10.1016/j.envpol.2008.09.005; Turi MS, 2000, ACTA VET HUNG, V48, P139; ZEMAN P, 1985, Experimental and Applied Acarology, V1, P17, DOI 10.1007/BF01262196; ZEMAN P, 1987, FOLIA PARASIT, V34, P369	41	51	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31795	10.1371/journal.pone.0031795	http://dx.doi.org/10.1371/journal.pone.0031795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363736	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700099
J	Persson, HT; Aksaas, AK; Kvissel, AK; Punga, T; Engstrom, A; Skalhegg, BS; Akusjarvi, G				Persson, Heidi Tormanen; Aksaas, Anne Kristin; Kvissel, Anne Katrine; Punga, Tanel; Engstrom, Ake; Skalhegg, Bjorn Steen; Akusjarvi, Goran			Two Cellular Protein Kinases, DNA-PK and PKA, Phosphorylate the Adenoviral L4-33K Protein and Have Opposite Effects on L1 Alternative RNA Splicing	PLOS ONE			English	Article							MAJOR LATE TRANSCRIPTION; STRAND BREAK REPAIR; C-TERMINAL DOMAIN; CATALYTIC SUBUNIT; DEPENDENT MANNER; GENE-EXPRESSION; CYCLIC-AMP; BINDING; NUCLEUS; COMPLEX	Accumulation of the complex set of alternatively processed mRNA from the adenovirus major late transcription unit (MLTU) is subjected to a temporal regulation involving both changes in poly (A) site choice and alternative 3' splice site usage. We have previously shown that the adenovirus L4-33K protein functions as an alternative splicing factor involved in activating the shift from L1-52,55K to L1-IIIa mRNA. Here we show that L4-33K specifically associates with the catalytic subunit of the DNA-dependent protein kinase (DNA-PK) in uninfected and adenovirus-infected nuclear extracts. Further, we show that L4-33K is highly phosphorylated by DNA-PK in vitro in a double stranded DNA-independent manner. Importantly, DNA-PK deficient cells show an enhanced production of the L1-IIIa mRNA suggesting an inhibitory role of DNA-PK on the temporal switch in L1 alternative RNA splicing. Moreover, we show that L4-33K also is phosphorylated by protein kinase A (PKA), and that PKA has an enhancer effect on L4-33K-stimulated L1-IIIa splicing. Hence, we demonstrate that these kinases have opposite effects on L4-33K function; DNA-PK as an inhibitor and PKA as an activator of L1-IIIa mRNA splicing. Taken together, this is the first report identifying protein kinases that phosphorylate L4-33K and to suggest novel regulatory roles for DNA-PK and PKA in adenovirus alternative RNA splicing.	[Persson, Heidi Tormanen; Punga, Tanel; Engstrom, Ake; Akusjarvi, Goran] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Aksaas, Anne Kristin; Kvissel, Anne Katrine; Skalhegg, Bjorn Steen] Univ Oslo, Dept Nutr, Oslo, Norway	Uppsala University; University of Oslo	Persson, HT (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Skålhegg, Bjørn Steen/AAZ-2976-2021; Punga, Tanel/K-9844-2019	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Punga, Tanel/0000-0002-0561-367X	Swedish Cancer Society [CF100365]; Norweigan Cancer Society [DNK 419114, DNK 418817]; Uppsala RNA Research Center; European Alternative Splicing Network	Swedish Cancer Society(Swedish Cancer Society); Norweigan Cancer Society; Uppsala RNA Research Center; European Alternative Splicing Network	Funding was provided by the Swedish Cancer Society (CF100365; http://cancerfonden.se), the Norweigan Cancer Society (DNK 419114, DNK 418817; http://www.kreftforeningen.no/english), the Uppsala RNA Research Center (http://www.urrc-linnaeuscentre.uu.se/about.html), and the European Alternative Splicing Network (http://www.eurasnet.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksaas AK, 2011, J MOL SIGNA IN PRESS; Akusjarvi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5006, DOI 10.2741/3059; Ali H, 2007, J VIROL, V81, P1327, DOI 10.1128/JVI.01584-06; ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Anderson CW, 2001, RADIAT RES, V156, P2, DOI 10.1667/0033-7587(2001)156[0002:FMIPTG]2.0.CO;2; AXELROD N, 1978, VIROLOGY, V87, P366, DOI 10.1016/0042-6822(78)90141-1; Backstrom E, 2010, VIRUS RES, V151, P220, DOI 10.1016/j.virusres.2010.05.013; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Berenjian S, 2006, VIRUS RES, V115, P16, DOI 10.1016/j.virusres.2005.07.001; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bosilevac JM, 1998, J BIOL CHEM, V273, P16874, DOI 10.1074/jbc.273.27.16874; Boyer J, 1999, VIROLOGY, V263, P307, DOI 10.1006/viro.1999.9866; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Ewing SG, 2007, J VIROL, V81, P12450, DOI 10.1128/JVI.01470-07; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; Fax P, 2001, VIROLOGY, V285, P30, DOI 10.1006/viro.2001.0926; Fessler SP, 1999, VIROLOGY, V263, P507, DOI 10.1006/viro.1999.9951; Finnen RL, 2001, VIROLOGY, V289, P388, DOI 10.1006/viro.2001.1130; Gallagher SR., 2007, CURR PROTOC CELL BIO; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Han I, 2002, MOL CELL BIOL, V22, P2136, DOI 10.1128/MCB.22.7.2136-2146.2002; Han I, 2001, J VIROL, V75, P2475, DOI 10.1128/JVI.75.5.2475-2481.2001; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jarnaess E, 2009, J BIOL CHEM, V284, P35154, DOI 10.1074/jbc.M109.056465; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Labugger R, 2000, CIRCULATION, V102, P1221, DOI 10.1161/01.CIR.102.11.1221; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Mo XM, 2002, MOL CELL BIOL, V22, P8088, DOI 10.1128/MCB.22.22.8088-8099.2002; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Moore DD, 1995, GLOB MOB SURV; Morris SJ, 2009, J VIROL, V83, P3049, DOI 10.1128/JVI.02455-08; Muhlemann Oliver, 2007, Methods Mol Med, V131, P33; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; Orstavik S, 2005, FEBS J, V272, P1559, DOI 10.1111/j.1742-4658.2005.04568.x; Ostapchuk P, 2006, J VIROL, V80, P6973, DOI 10.1128/JVI.00123-06; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Punga T, 2003, FEBS LETT, V552, P214, DOI 10.1016/S0014-5793(03)00927-X; RANNELS SR, 1980, J BIOL CHEM, V255, P7085; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Skalhegg BS, 2005, CURR DRUG TARGETS, V6, P655, DOI 10.2174/1389450054863644; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tormanen H, 2006, J BIOL CHEM, V281, P36510, DOI 10.1074/jbc.M607601200; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Woodard RL, 1999, J BIOL CHEM, V274, P478, DOI 10.1074/jbc.274.1.478; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	68	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31871	10.1371/journal.pone.0031871	http://dx.doi.org/10.1371/journal.pone.0031871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363758	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700113
J	Rudge, JW; Hanvoravongchai, P; Krumkamp, R; Chavez, I; Adisasmito, W; Chau, PN; Phommasak, B; Putthasri, W; Shih, CS; Stein, M; Timen, A; Touch, S; Reintjes, R; Coker, R				Rudge, James W.; Hanvoravongchai, Piya; Krumkamp, Ralf; Chavez, Irwin; Adisasmito, Wiku; Pham Ngoc Chau; Phommasak, Bounlay; Putthasri, Weerasak; Shih, Chin-Shui; Stein, Mart; Timen, Aura; Touch, Sok; Reintjes, Ralf; Coker, Richard		AsiaFluCap Project Consortium	Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories	PLOS ONE			English	Article							CRITICAL-CARE RESOURCES; DEVELOPING-COUNTRIES; INFECTIOUS-DISEASES; HOSPITAL SERVICES; SURGE CAPACITY; DEMAND; INTERVENTIONS; PREPAREDNESS; CHALLENGES; TRIAGE	Background: Southeast Asia has been the focus of considerable investment in pandemic influenza preparedness. Given the wide variation in socio-economic conditions, health system capacity across the region is likely to impact to varying degrees on pandemic mitigation operations. We aimed to estimate and compare the resource gaps, and potential mortalities associated with those gaps, for responding to pandemic influenza within and between six territories in Asia. Methods and Findings: We collected health system resource data from Cambodia, Indonesia (Jakarta and Bali), Lao PDR, Taiwan, Thailand and Vietnam. We applied a mathematical transmission model to simulate a "mild-to-moderate'' pandemic influenza scenario to estimate resource needs, gaps, and attributable mortalities at province level within each territory. The results show that wide variations exist in resource capacities between and within the six territories, with substantial mortalities predicted as a result of resource gaps (referred to here as "avoidable'' mortalities), particularly in poorer areas. Severe nationwide shortages of mechanical ventilators were estimated to be a major cause of avoidable mortalities in all territories except Taiwan. Other resources (oseltamivir, hospital beds and human resources) are inequitably distributed within countries. Estimates of resource gaps and avoidable mortalities were highly sensitive to model parameters defining the transmissibility and clinical severity of the pandemic scenario. However, geographic patterns observed within and across territories remained similar for the range of parameter values explored. Conclusions: The findings have important implications for where (both geographically and in terms of which resource types) investment is most needed, and the potential impact of resource mobilization for mitigating the disease burden of an influenza pandemic. Effective mobilization of resources across administrative boundaries could go some way towards minimizing avoidable deaths.	[Rudge, James W.; Hanvoravongchai, Piya; Coker, Richard] London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, Bangkok, Thailand; [Krumkamp, Ralf; Reintjes, Ralf] Hamburg Univ Appl Sci, Dept Hlth Sci, Hamburg, Germany; [Chavez, Irwin] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Adisasmito, Wiku] Univ Indonesia, Fac Publ Hlth, Depok, Indonesia; [Pham Ngoc Chau] Vietnam Mil Med Univ, Hanoi, Vietnam; [Phommasak, Bounlay] Minist Hlth, Natl Emerging Infect Dis Coordinat Off, Viangchan, Laos; [Putthasri, Weerasak] Int Hlth Policy Programme Thailand, Nonthaburi, Thailand; [Shih, Chin-Shui] Taiwan Ctr Dis Control, Taipei, Taiwan; [Stein, Mart; Timen, Aura] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Touch, Sok] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia	Hochschule Angewandte Wissenschaft Hamburg; Mahidol University; University of Indonesia; Netherlands National Institute for Public Health & the Environment	Rudge, JW (corresponding author), London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, Bangkok, Thailand.	james.rudge@lshtm.ac.uk	Hanvoravongchai, Piya/A-1569-2012; Stein, Mart/U-8914-2019; Timen, Aura/GLV-4130-2022; Shih, Chin-Shui/V-2934-2019	Hanvoravongchai, Piya/0000-0003-4256-1271; Shih, Chin-Shui/0000-0001-7230-2356; Stein, Mart L./0000-0003-0502-7993	Rockefeller Foundation [2008 DSN 2001]; European Commission [Health-F3-2008-201823]	Rockefeller Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was conducted as part of "AsiaFluCap: Heath system analysis to support capacity development in response to the threat of pandemic influenza in Asia'', a project funded within the European Commission Seventh Framework Programme (FP7/2007-2013), grant agreement number: Health-F3-2008-201823; and the Rockefeller Foundation Grant 2008 DSN 2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TA, 2003, J CRIT CARE, V18, P173, DOI 10.1016/j.jcrc.2003.08.008; Balcan D, 2009, PLOS CURR INFLUENZA; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Corley A, 2010, INT J NURS STUD, V47, P577, DOI 10.1016/j.ijnurstu.2009.11.015; Ercole A, 2009, ANAESTHESIA, V64, P937, DOI 10.1111/j.1365-2044.2009.06070.x; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Hanvoravongchai P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-322; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kanter RK, 2007, ANN EMERG MED, V50, P314, DOI 10.1016/j.annemergmed.2006.10.019; Krumkamp R, 2011, EPIDEMIOL INFECT, V139, P59, DOI 10.1017/S0950268810002220; Limwattananon C, 2011, SE ASIA J T IN PRESS; Lunelli A, 2009, MATH BIOSCI; Menon DK, 2005, ANAESTHESIA, V60, P952, DOI 10.1111/j.1365-2044.2005.04372.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nap RE, 2007, EMERG INFECT DIS, V13, P1714, DOI 10.3201/eid1311.070103; Niska Richard W, 2007, Adv Data, P1; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PETZOLDT T, 2007, J STAT SOFTWARE, V22; Putthasri W, 2009, EMERG INFECT DIS, V15, P423, DOI 10.3201/eid1503.080872; Schull MJ, 2006, ACAD EMERG MED, V13, P1228, DOI [10.1197/j.aem.2006.04.011, 10.1111/j.1553-2712.2006.tb01653.x]; Sobieraj JA, 2007, MIL MED, V172, P486, DOI 10.7205/MILMED.172.5.486; Takeuchi Shouhei, 2010, Nihon Eiseigaku Zasshi, V65, P48; Talmor D, 2007, CRIT CARE MED, V35, P1251, DOI 10.1097/01.CCM.0000262385.95721.CC; Ten Eyck RP, 2008, PREHOSPITAL DISASTER, V23, P103, DOI 10.1017/S1049023X00005707; TUITE AR, 2009, CMAJ; [United Nations System Influenza Coordination World Bank], 2010, INT MIN C A IN PRESS; United Nations System Influenza Coordinator and World Bank, 2008, RESP AV INFL STAT PA; Valdmanis V, 2004, HEALTH SERV RES, V39, P2117, DOI 10.1111/j.1475-6773.2004.00335.x; Vidondo B, 2009, SWISS MED WKLY, V139, P505, DOI smw-12737; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang XZ, 2006, MED DECIS MAKING, V26, P617, DOI 10.1177/0272989X06295359	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31800	10.1371/journal.pone.0031800	http://dx.doi.org/10.1371/journal.pone.0031800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363739	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700101
J	Wang, JL; Shaffer, ML; Eslinger, PJ; Sun, XY; Weitekamp, CW; Patel, MM; Dossick, D; Gill, DJ; Connor, JR; Yang, QX				Wang, Jianli; Shaffer, Michele L.; Eslinger, Paul J.; Sun, Xiaoyu; Weitekamp, Christopher W.; Patel, Megha M.; Dossick, Deborah; Gill, David J.; Connor, James R.; Yang, Qing X.			Maturational and Aging Effects on Human Brain Apparent Transverse Relaxation	PLOS ONE			English	Article							WHITE-MATTER; T-2 RELAXATION; 3.0 T; AGE; TIMES; TISSUE; ADOLESCENCE; RELAXOMETRY; IRON; VISUALIZATION	The goal of this study was to address the need for comprehensive reference data regarding maturational and aging effects on regional transverse relaxation rates (R-2) of the brain in normal humans. Regional R(2)s were measured in twenty-five brain structures from a sample of seventy-seven normal volunteers 9 to 85 years of age. The relationships between regional R-2 and age were determined using generalized additive models, without the constraint of a specified a priori model. Data analysis demonstrated that the brain tissue R-2-age correlations followed various time courses with both linear and non-linear characteristics depending on the particular brain structure. Most anatomical structures studied exhibited non-linear characteristics, including the amygdala, hippocampus, thalamus, globus pallidus, putamen, caudate nucleus, red nucleus, substantia nigra, orbitofrontal white matter and temporal white matter. Linear trends were detected in occipital white matter and in the genu of corpus callosum. These results indicate the complexity of age-related R-2 changes in the brain while providing normative reference data that can be utilized in clinical examinations and studies utilizing quantitative transverse relaxation.	[Wang, Jianli; Eslinger, Paul J.; Sun, Xiaoyu; Weitekamp, Christopher W.; Patel, Megha M.; Dossick, Deborah; Yang, Qing X.] Penn State Univ, Coll Med, Dept Radiol, Hershey, PA USA; [Shaffer, Michele L.; Eslinger, Paul J.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Eslinger, Paul J.; Gill, David J.] Penn State Univ, Coll Med, Dept Neurol, Hershey, PA USA; [Connor, James R.; Yang, Qing X.] Penn State Univ, Coll Med, Dept Neurosurg, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wang, JL (corresponding author), Penn State Univ, Coll Med, Dept Radiol, Hershey, PA USA.	jxw73@psu.edu	Yang, Heroine/GRY-2630-2022		Charles A. Dana Foundation [DANAFDN-01]; National Institutes of Health [RO1 EB00454]; G.M. Leader Family Foundation; Pennsylvania Department of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000454] Funding Source: NIH RePORTER	Charles A. Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G.M. Leader Family Foundation; Pennsylvania Department of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by the Charles A. Dana Foundation (DANAFDN-01), National Institutes of Health (RO1 EB00454), the G.M. Leader Family Foundation, and the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha R, 2002, MAGNET RESON MED, V47, P742, DOI 10.1002/mrm.10112; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Carmody DP, 2004, NEURORADIOLOGY, V46, P781, DOI 10.1007/s00234-004-1241-z; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Hasan KM, 2010, MAGN RESON MED, V64, P1382, DOI 10.1002/mrm.22515; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hendry J, 2006, NEUROIMAGE, V29, P1049, DOI 10.1016/j.neuroimage.2005.08.039; Kim EY, 2007, INT J DEV NEUROSCI, V25, P409, DOI 10.1016/j.ijdevneu.2007.05.005; Kumar R, 2011, MAGN RESON IMAGING, V29, P185, DOI 10.1016/j.mri.2010.08.006; Ma JF, 1996, J MAGN RESON SER B, V111, P61, DOI 10.1006/jmrb.1996.0060; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MENON RS, 1991, MAGNET RESON MED, V20, P214, DOI 10.1002/mrm.1910200205; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NGO F Q H, 1985, Magnetic Resonance Imaging, V3, P145, DOI 10.1016/0730-725X(85)90251-6; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Pfefferbaum A, 1999, PSYCHIAT RES-NEUROIM, V91, P93, DOI 10.1016/S0925-4927(99)00023-2; Saito N, 2009, MAGN RESON IMAGING, V27, P895, DOI 10.1016/j.mri.2009.05.006; Sharkey RJ, 2010, EPILEPSY RES, V92, P41, DOI 10.1016/j.eplepsyres.2010.08.005; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Steen RG, 1997, AM J NEURORADIOL, V18, P819; Stevenson VL, 2000, J NEUROL SCI, V178, P81, DOI 10.1016/S0022-510X(00)00339-7; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Williams LA, 2005, RADIOLOGY, V235, P595, DOI 10.1148/radiol.2352031769	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31907	10.1371/journal.pone.0031907	http://dx.doi.org/10.1371/journal.pone.0031907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363767	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700121
J	Harbi, D; Parthiban, M; Gendoo, DMA; Ehsani, S; Kumar, M; Schmitt-Ulms, G; Sowdhamini, R; Harrison, PM				Harbi, Djamel; Parthiban, Marimuthu; Gendoo, Deena M. A.; Ehsani, Sepehr; Kumar, Manish; Schmitt-Ulms, Gerold; Sowdhamini, Ramanathan; Harrison, Paul M.			PrionHome: A Database of Prions and Other Sequences Relevant to Prion Phenomena	PLOS ONE			English	Article							COMPOSITIONAL BIAS; GENETIC-VARIATION; APLYSIA CPEB; PROTEIN; YEAST; PROPAGATION; REGIONS; FORM; DOMAINS; SCRAPIE	Prions are units of propagation of an altered state of a protein or proteins; prions can propagate from organism to organism, through cooption of other protein copies. Prions contain no necessary nucleic acids, and are important both as both pathogenic agents, and as a potential force in epigenetic phenomena. The original prions were derived from a misfolded form of the mammalian Prion Protein PrP. Infection by these prions causes neurodegenerative diseases. Other prions cause non-Mendelian inheritance in budding yeast, and sometimes act as diseases of yeast. We report the bioinformatic construction of the PrionHome, a database of >2000 prion-related sequences. The data was collated from various public and private resources and filtered for redundancy. The data was then processed according to a transparent classification system of prionogenic sequences (i.e., sequences that can make prions), prionoids (i.e., proteins that propagate like prions between individual cells), and other prion-related phenomena. There are eight PrionHome classifications for sequences. The first four classifications are derived from experimental observations: prionogenic sequences, prionoids, other prion-related phenomena, and prion interactors. The second four classifications are derived from sequence analysis: orthologs, paralogs, pseudogenes, and candidate-prionogenic sequences. Database entries list: supporting information for PrionHome classifications, prion-determinant areas (where relevant), and disordered and compositionally-biased regions. Also included are literature references for the PrionHome classifications, transcripts and genomic coordinates, and structural data (including comparative models made for the PrionHome from manually curated alignments). We provide database usage examples for both vertebrate and fungal prion contexts. Using the database data, we have performed a detailed analysis of the compositional biases in known budding-yeast prionogenic sequences, showing that the only abundant bias pattern is for asparagine bias with subsidiary serine bias. We anticipate that this database will be a useful experimental aid and reference resource. It is freely available at: http://libaio.biol.mcgill.ca/prion.	[Harbi, Djamel; Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Kumar, Manish] Univ Delhi, Dept Biophys, New Delhi, India; [Sowdhamini, Ramanathan] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Ehsani, Sepehr; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ehsani, Sepehr; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Parthiban, Marimuthu] Abo Akad Univ, Dept Biosci, Turku, Finland	McGill University; University of Delhi; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Toronto; University of Toronto; Abo Akademi University	Harbi, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca	Ehsani, Sepehr/E-9257-2010; Marimuthu, Parthiban/AAU-6138-2021; Kumar, Manish/AGP-1250-2022	Ehsani, Sepehr/0000-0002-9613-6898; Marimuthu, Parthiban/0000-0003-4960-2160; Kumar, Manish/0000-0002-7936-9892; Gendoo, Deena/0000-0001-8891-4138	PrioNet Canada Network of Centres of Excellence; Medical Research Council [MC_G1000734] Funding Source: researchfish; MRC [MC_G1000734] Funding Source: UKRI	PrioNet Canada Network of Centres of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the PrioNet Canada Network of Centres of Excellence (http://www.prionetcanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Gendoo DMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027342; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Harbi D, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq031; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; Harrison PM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-441; Harrison PM, 2010, GENOMICS, V95, P268, DOI 10.1016/j.ygeno.2010.02.008; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moore R, 1997, J MOL BIOL, V292, P797; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Watts J, 2007, EMBO J; Westaway D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002391; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	72	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31785	10.1371/journal.pone.0031785	http://dx.doi.org/10.1371/journal.pone.0031785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363733	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500088
J	Richard, G; Belta, C; Julius, AA; Amar, S				Richard, Guilhem; Belta, Calin; Julius, A. Agung; Amar, Salomon			Controlling the Outcome of the Toll-Like Receptor Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; MODELS; FAMILY	The Toll-Like Receptors (TLRs) are proteins involved in the immune system that increase cytokine levels when triggered. While cytokines coordinate the response to infection, they appear to be detrimental to the host when reaching too high levels. Several studies have shown that the deletion of specific TLRs was beneficial for the host, as cytokine levels were decreased consequently. It is not clear, however, how targeting other components of the TLR pathways can improve the responses to infections. We applied the concept of Minimal Cut Sets (MCS) to the ihsTLR v1.0 model of the TLR pathways to determine sets of reactions whose knockouts disrupt these pathways. We decomposed the TLR network into 34 modules and determined signatures for each MCS, i.e. the list of targeted modules. We uncovered 2,669 MCS organized in 68 signatures. Very few MCS targeted directly the TLRs, indicating that they may not be efficient targets for controlling these pathways. We mapped the species of the TLR network to genes in human and mouse, and determined more than 10,000 Essential Gene Sets (EGS). Each EGS provides genes whose deletion suppresses the network's outputs.	[Richard, Guilhem; Belta, Calin; Amar, Salomon] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Julius, A. Agung] Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA	Boston University; Rensselaer Polytechnic Institute; Boston University	Richard, G (corresponding author), Boston Univ, Program Bioinformat, Boston, MA 02215 USA.	samar@bu.edu		Richard, Guilhem/0000-0002-6544-4257; Amar, Salomon/0000-0002-0017-5930	National Insititues of Health/National Institute of Dental and Craniofacial Reasearch [R01DE015989-S1]; National Science Foundation [EF-1137906, EF-1137900]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015989] Funding Source: NIH RePORTER	National Insititues of Health/National Institute of Dental and Craniofacial Reasearch; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research presented in this paper is supported by the National Insititues of Health/National Institute of Dental and Craniofacial Reasearch under grant number R01DE015989-S1, and the National Science Foundation under grant numbers EF-1137906 and EF-1137900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Imielinski M, 2010, CHAOS, V20, DOI 10.1063/1.3456056; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292; Lu RQ, 2001, J BIOL CHEM, V276, P45491, DOI 10.1074/jbc.C100421200; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Papin JA, 2004, BIOPHYS J, V87, P37, DOI 10.1529/biophysj.103.029884; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	35	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31341	10.1371/journal.pone.0031341	http://dx.doi.org/10.1371/journal.pone.0031341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363624	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500036
J	Ma, BY; Qian, D; Nan, Q; Tan, C; An, LZ; Xiang, Y				Ma, Binyun; Qian, Dong; Nan, Qiong; Tan, Chang; An, Lizhe; Xiang, Yun			Arabidopsis Vacuolar H+-ATPase (V-ATPase) B Subunits Are Involved in Actin Cytoskeleton Remodeling via Binding to, Bundling, and Stabilizing F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLLEN-TUBE GROWTH; PROTON PUMPS; PROTEIN; FILAMENTS; THALIANA; COMPLEX; CELLS; ORGANIZATION; POLYMERIZATION; MICROFILAMENTS	VacuolarH(+)-ATPase (V-ATPase) is a membrane-bound multisubunit enzyme complex composed of at least 14 different subunits. The complex regulates the physiological processes of a cell by controlling the acidic environment, which is necessary for certain activities and the interaction with the actin cytoskeleton through its B and C subunits in both humans and yeast. Arabidopsis V-ATPase has three B subunits (AtVAB1, AtVAB2, and AtVAB3), which share 97.27% sequence identity and have two potential actin-binding sites, indicating that these AtVABs may have crucial functions in actin cytoskeleton remodeling and plant cell development. However, their biochemical functions are poorly understood. In this study, we demonstrated that AtVABs bind to and co-localize with F-actin, bundle F-actin to form higher order structures, and stabilize actin filaments in vitro. In addition, the AtVABs also show different degrees of activities in capping the barbed ends but no nucleating activities, and these activities were not regulated by calcium. The functional similarity and differences of the AtVABs implied that they may play cooperative and distinct roles in Arabidopsis cells.	[Ma, Binyun; Qian, Dong; Nan, Qiong; Tan, Chang; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, Lanzhou 730070, Peoples R China	Lanzhou University	An, LZ (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730070, Peoples R China.	lizhean@lzu.edu.cn; xiangy@lzu.edu.cn	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921; Xiang, Yun/0000-0002-5178-0700	National Basic Research Program of China (973 Program) [2007CB108902]; Chinese Transgenic Project [2009ZX08009-029B]; National Natural Science Foundation of China [30800079]; China Postdoctoral Science Foundation [200902311]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Transgenic Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Basic Research Program of China (973 Program) Grant 2007CB108902 and Chinese Transgenic Project Grant 2009ZX08009-029B (to L. A.), National Natural Science Foundation of China Grant 30800079, and China Postdoctoral Science Foundation Grant 200902311 (to Y. X.).	Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Holliday LS, 2005, J BIOENERG BIOMEMBR, V37, P419, DOI 10.1007/s10863-005-9483-y; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Kim H, 2005, PLANT CELL, V17, P888, DOI 10.1105/tpc.104.028829; Li Y, 2001, PLANTA, V213, P722, DOI 10.1007/s004250100543; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Shimaoka T, 2004, PLANT CELL PHYSIOL, V45, P672, DOI 10.1093/pcp/pch099; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; WALSH TP, 1984, BIOCHEMISTRY-US, V23, P2613, DOI 10.1021/bi00307a012; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yang WB, 2011, PLANT CELL, V23, P661, DOI 10.1105/tpc.110.081802; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2011, NEW PHYTOL, V190, P667, DOI 10.1111/j.1469-8137.2010.03632.x; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	51	32	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19008	19017		10.1074/jbc.M111.281873	http://dx.doi.org/10.1074/jbc.M111.281873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22371505	hybrid, Green Published			2022-12-25	WOS:000306411900012
J	Yu, WF; Chen, J; Xiong, Y; Pixley, FJ; Yeung, YG; Stanley, ER				Yu, Wenfeng; Chen, Jian; Xiong, Ying; Pixley, Fiona J.; Yeung, Yee-Guide; Stanley, E. Richard			Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING FACTOR-I; GROWTH-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; KINASE-ACTIVITY; PROTEIN-KINASE; JUXTAMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; ONCOGENE PRODUCT; INSULIN-RECEPTOR	Colony-stimulatingfactor-1(CSF-1)-stimulated CSF-1 receptor (CSF-1R) tyrosine phosphorylation initiates survival, proliferation, and differentiation signaling pathways in macrophages. Either activation loop Y807F or juxtamembrane domain (JMD) Y559F mutations severely compromise CSF-1-regulated proliferation and differentiation. YEF, a CSF-1R in which all eight tyrosines phosphorylated in the activated receptor were mutated to phenylalanine, lacks in vitro kinase activity and in vivo CSF-1-regulated tyrosine phosphorylation. The addition of Tyr-807 alone to the YEF backbone (Y807AB) led to CSF-1-independent but receptor kinase-dependent proliferation, without detectable activation loop Tyr-807 phosphorylation. The addition of Tyr-559 alone (Y559AB) supported a low level of CSF-1-independent proliferation that was slightly enhanced by CSF-1, indicating that Tyr-559 has a positive Tyr-807-independent effect. Consistent with the postulated autoinhibitory role of the JMD Tyr-559 and its relief by ligand-induced Tyr-559 phosphorylation, the addition of Tyr-559 to the Y807AB background suppressed proliferation in the absence of CSF-1, but restored most of the CSF-1-stimulated proliferation. Full restoration of kinase activation and proliferation required the additional add back of JMD Tyr-544. Inhibitor experiments indicate that the constitutive proliferation of Y807AB macrophages is mediated by the phosphatidylinositol 3-kinase (PI3K) and ERK1/2 pathways, whereas proliferation of WT and Y559,807AB macrophagesis, inaddition, contributed to by Srcfamily kinase (SFK)-dependent pathways. Thus Tyr-807 confers sufficient kinase activity for strong CSF-1-independent proliferation, whereas Tyr-559 maintains the receptor in an inactive state. Tyr-559 phosphorylation releases this restraint and may also contribute to the CSF-1-regulated proliferative response by activating Src family kinase.	[Yu, Wenfeng; Chen, Jian; Xiong, Ying; Pixley, Fiona J.; Yeung, Yee-Guide; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@einstein.yu.edu	Pixley, Fiona/ABD-5567-2020; Stanley, Evan R/J-9154-2013	Pixley, Fiona/0000-0002-1571-2532; Stanley, Evan R/0000-0002-2910-2065	National Institutes of Health [CA26504, PO1 CA100324]; Albert Einstein College of Medicine Cancer Center [5P30-CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330, P01CA100324, R37CA026504, R01CA026504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants, CA26504 and PO1 CA100324 (to E. R. S.). This work was also supported by the Albert Einstein College of Medicine Cancer Center Grant 5P30-CA13330.	Aharinejad S, 2002, CANCER RES, V62, P5317; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; ENGLISH BK, 1993, J EXP MED, V178, P1017, DOI 10.1084/jem.178.3.1017; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jaworowski A, 1999, J BIOL CHEM, V274, P15127, DOI 10.1074/jbc.274.21.15127; Joos H, 1996, J BIOL CHEM, V271, P24476, DOI 10.1074/jbc.271.40.24476; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; OHTSUKA M, 1990, MOL CELL BIOL, V10, P1664, DOI 10.1128/MCB.10.4.1664; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Valledor AF, 2000, J BIOL CHEM, V275, P7403, DOI 10.1074/jbc.275.10.7403; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171	51	56	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13694	13704		10.1074/jbc.M112.355610	http://dx.doi.org/10.1074/jbc.M112.355610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375015	Green Published, hybrid			2022-12-25	WOS:000303996300025
J	Aoki, R; Takeda, T; Omata, T; Ihara, K; Fujita, Y				Aoki, Rina; Takeda, Tomoya; Omata, Tatsuo; Ihara, Kunio; Fujita, Yuichi			MarR-type Transcriptional Regulator ChlR Activates Expression of Tetrapyrrole Biosynthesis Genes in Response to Low-oxygen Conditions in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CHLOROPHYLL BIOSYNTHESIS; DIFFERENTIAL OPERATION; PROTEIN; FAMILY; OHRR; HEME; IDENTIFICATION; MECHANISMS; REDUCTASE	Oxygen is required for three enzyme reactions in chlorophyll and bilin biosynthesis pathways: coproporphyrinogen III oxidase (HemF), heme oxygenase (HO1), and Mg-protoporphyrin IX monomethylester cyclase (ChlA(I)). The cyanobacterium Synechocystis sp. PCC 6803 has alternative enzymes, HemN, HO2, and ChlA(II), to supply chlorophyll/bilins even under low-oxygen environments. The three genes form an operon, chlA(II)-ho2-hemN, that is induced in response to low-oxygen conditions to bypass the oxygen-dependent reactions. Here we identified a transcriptional regulator for the induction of the operon in response to low-oxygen conditions. A pseudorevertant, Delta ho1R, was isolated from a HO1-lacking mutant Delta ho1 that is lethal under aerobic conditions. Delta ho1R grew well even under aerobic conditions. In Delta ho1R, HO2 that is induced only under low-oxygen conditions was anomalously expressed under aerobic conditions to complement the loss of HO1. A G-to-C transversion in sll1512 causing the amino acid change from aspartate 35 to histidine was identified as the relevant mutation by resequencing of the Delta ho1R genome. Sll1512 is a MarR-type transcriptional regulator. An sll1512-lacking mutant grew poorly under low-oxygen conditions with a remarked decrease in Chl content that would be caused by the suppressed induction of the chlA(II) and hemN genes in Chl biosynthesis under low-oxygen conditions. These results demonstrated that Sll1512 is an activator in response to low-oxygen environments and that the D35H variant becomes a constitutive activator. This hypothesis was supported by a gel shift assay showing that the Sll1512-D35H variant binds to the DNA fragment upstream of the operon. We propose to name sll1512 chlR.	[Aoki, Rina; Takeda, Tomoya; Omata, Tatsuo; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Fujita, Yuichi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Fujita, Yuichi/G-8908-2013		Japan Society for the Promotion of Science (JSPS) [19570036, 20200063]; Advanced Low Carbon Technology Research and Development Program (ALCA); Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Low Carbon Technology Research and Development Program (ALCA); Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid for Scientific Research 19570036 and 20200063 from Japan Society for the Promotion of Science (JSPS), by the Advanced Low Carbon Technology Research and Development Program (ALCA), and by Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST).	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; Bernroitner M, 2008, CHEM BIODIVERS, V5, P1927, DOI 10.1002/cbdv.200890180; Chi BK, 2010, J BACTERIOL, V192, P4571, DOI 10.1128/JB.00409-10; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JORGENSEN BB, 1979, APPL ENVIRON MICROB, V38, P46; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Keeley J.F., 1988, PLANTS TODAY, V1, P127; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Nishimura T, 2008, MOL MICROBIOL, V68, P98, DOI 10.1111/j.1365-2958.2008.06137.x; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; STAL LJ, 1995, NEW PHYTOL, V131, P1, DOI 10.1111/j.1469-8137.1995.tb03051.x; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Stal Lucas J., 2008, P423; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tajima N, 2011, DNA RES, V18, P393, DOI 10.1093/dnares/dsr026; Yamamoto H, 2008, PHOTOCH PHOTOBIO SCI, V7, P1238, DOI 10.1039/b802427h; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Yurimoto H, 2005, MOL MICROBIOL, V57, P511, DOI 10.1111/j.1365-2958.2005.04702.x	33	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13500	13507		10.1074/jbc.M112.346205	http://dx.doi.org/10.1074/jbc.M112.346205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375005	Green Published, hybrid			2022-12-25	WOS:000302903700083
J	Carattino, MD; Della Vecchia, MC				Carattino, Marcelo D.; Della Vecchia, Margaret C.			Contribution of Residues in Second Transmembrane Domain of ASIC1a Protein to Ion Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; TOAD URINARY-BLADDER; MONO-VALENT CATIONS; NA+ CHANNEL; PORE REGION; ALPHA-SUBUNIT; AMILORIDE; ENAC; FILTER; BLOCK	Acid-sensing ion channels (ASICs) are proton-gated cation-selective channels expressed in the peripheral and central nervous systems. The ion permeation pathway of ASIC1a is defined by residues 426-450 in the second transmembrane (TM2) segment. The gate, formed by the intersection of the TM2 segments, localizes near the extracellular boundary of the plasma membrane. We explored the contribution to ion permeation and selectivity of residues in the TM2 segment of ASIC1a. Studies of accessibility with positively charged methanethiosulfonate reagents suggest that the permeation pathway in the open state constricts below the gate, restricting the passage to large ions. Substitution of residues in the intracellular vestibule at positions 437, 438, 443, or 446 significantly increased the permeability to K+ versus Na+. ASIC1a shows a selectivity sequence for alkali metals of Na+ > Li+ > K+ >> Rb+ > Cs+. Alanine and cysteine substitutions at position 438 increased, to different extents, the relative permeability to Li+, K+, Rb+, and Cs+. For these mutants, ion permeation was not a function of the diameter of the nonhydrated ion, suggesting that Gly-438 encompasses an ion coordination site that is essential for ion selectivity. M437C and A443C mutants showed slightly increased permeability to K+, Rb+, and Cs+, suggesting that substitutions at these positions influence ion discrimination by altering molecular sieving. Our results indicate that ion selectivity is accomplished by the contribution of multiple sites in the pore of ASIC1a.	[Carattino, Marcelo D.; Della Vecchia, Margaret C.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [R01 DK084060-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084060-02 (to M. D. C.).	Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; EISENMAN G, 1962, Biophys J, V2, P259; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; LAUGER P, 1982, BIOPHYS CHEM, V15, P89, DOI 10.1016/0301-4622(82)80021-5; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; PALMER LG, 1984, J MEMBRANE BIOL, V80, P153, DOI 10.1007/BF01868771; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700	40	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12927	12934		10.1074/jbc.M111.329284	http://dx.doi.org/10.1074/jbc.M111.329284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371494	hybrid, Green Published			2022-12-25	WOS:000302903700032
J	Li, MD; Ruan, HB; Singh, JP; Zhao, L; Zhao, TT; Azarhoush, S; Wu, J; Evans, RM; Yang, XY				Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Evans, Ronald M.; Yang, Xiaoyong			O-GlcNAc Transferase Is Involved in Glucocorticoid Receptor-mediated Transrepression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RNA-POLYMERASE-II; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOID-CELL LINE; TRANSCRIPTION FACTORS; TERMINAL DOMAIN; INDUCED APOPTOSIS; RETINOIC-ACID; PPAR-ALPHA; CROSS-TALK	Recruitment of O-GlcNAc transferase (OGT) to promoters plays an important role in gene repression. Glucocorticoid signaling represses the transcriptional activities of NF-kappa B and AP-1 through direct binding, yet the molecular mechanisms remain to be elucidated. Here we report that OGT is an important component of GR-mediated transrepression. OGT associates with ligand-bound GR in a multi-protein repression complex. Overexpression of OGT potentiates the GR transrepression pathway, whereas depletion of endogenous OGT by RNA interference abolishes the repression. The recruitment of OGT by GR leads to increased O-GlcNAcylation and decreased phosphorylation of RNA polymerase II on target genes. Functionally, overexpression of OGT enhances glucocorticoid-induced apoptosis in resistant cell lines while knockdown of OGT prevents sensitive cell lines from apoptosis. These studies identify a molecular mechanism of GR transrepression, and highlight the function of O-GlcNAc in hormone signaling.	[Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, Comparat Med Sect, New Haven, CT 06520 USA; [Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Zhao, Lin; Wu, Jing] Xi An Jiao Tong Univ, Sch Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Azarhoush, Sascha] Univ Cologne, Sch Med, D-50931 Cologne, Germany; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Yale University; Yale University; Xi'an Jiaotong University; University of Cologne; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Yang, XY (corresponding author), 375 Congress Ave,LSOG 204C,POB 208016, New Haven, CT 06520 USA.	xiaoyong.yang@yale.edu	Zhao, Lin/AHD-2506-2022; Ruan, Hai-Bin/G-9907-2012; Ruan, Hai-Bin/AAN-7777-2021; Evans, Ronald/AAF-4001-2019; Li, Min-Dian/F-1721-2015	Zhao, Lin/0000-0002-6056-8787; Ruan, Hai-Bin/0000-0002-3858-1272; Ruan, Hai-Bin/0000-0002-3858-1272; Evans, Ronald/0000-0002-9986-5965; Li, Min-Dian/0000-0002-3650-1507	National Institutes of Health [DK066971, DK089098, DK062434, CA014195-38, HL105278]; American Diabetes Association; Ellison Medical Foundation; Helmsley Charitable Trust; China Scholarship Council; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089098, U19DK062434, F32DK066971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK066971 and DK089098, American Diabetes Association, and Ellison Medical Foundation (to X. Y.), National Institutes of Health Grants DK062434, CA014195-38, and HL105278, the Ellison Medical Foundation, and the Helmsley Charitable Trust (to R. M. E.), and a fellowship from the China Scholarship Council-Yale World Scholars in the Biomedical Sciences (to M. L.).	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bougarne N, 2009, CELL CYCLE, V8, P2311, DOI 10.4161/cc.8.15.9220; Bougarne N, 2009, P NATL ACAD SCI USA, V106, P7397, DOI 10.1073/pnas.0806742106; Chinenov Y, 2008, P NATL ACAD SCI USA, V105, P20185, DOI 10.1073/pnas.0810863105; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2001, MOL ENDOCRINOL, V15, P219, DOI 10.1210/me.15.2.219; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hartmann BL, 1999, WIEN KLIN WOCHENSCHR, V111, P360; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; NORMAN MR, 1977, CANCER RES, V37, P3785; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016	43	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12904	12912		10.1074/jbc.M111.303792	http://dx.doi.org/10.1074/jbc.M111.303792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371499	hybrid, Green Published			2022-12-25	WOS:000302903700030
J	Costello, DA; Claret, M; Al-Qassab, H; Plattner, F; Irvine, EE; Choudhury, AI; Giese, KP; Withers, DJ; Pedarzani, P				Costello, Derek A.; Claret, Marc; Al-Qassab, Hind; Plattner, Florian; Irvine, Elaine E.; Choudhury, Agharul I.; Giese, K. Peter; Withers, Dominic J.; Pedarzani, Paola			Brain Deletion of Insulin Receptor Substrate 2 Disrupts Hippocampal Synaptic Plasticity and Metaplasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; PROTEIN-KINASE-C; STREPTOZOTOCIN-DIABETIC RATS; GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASE; XENOPUS OOCYTES; NMDA RECEPTORS; CA1 REGION	Objective: Diabetes mellitus is associated with cognitive deficits and an increased risk of dementia, particularly in the elderly. These deficits and the corresponding neurophysiological structural and functional alterations are linked to both metabolic and vascular changes, related to chronic hyperglycaemia, but probably also defects in insulin action in the brain. To elucidate the specific role of brain insulin signalling in neuronal functions that are relevant for cognitive processes we have investigated the behaviour of neurons and synaptic plasticity in the hippocampus of mice lacking the insulin receptor substrate protein 2 (IRS-2). Research Design and Methods: To study neuronal function and synaptic plasticity in the absence of confounding factors such as hyperglycaemia, we used a mouse model with a central nervous system-(CNS)-restricted deletion of IRS-2 (NesCreIrs2KO). Results: We report a deficit in NMDA receptor-dependent synaptic plasticity in the hippocampus of NesCreIrs2KO mice, with a concomitant loss of metaplasticity, the modulation of synaptic plasticity by the previous activity of a synapse. These plasticity changes are associated with reduced basal phosphorylation of the NMDA receptor subunit NR1 and of downstream targets of the PI3K pathway, the protein kinases Akt and GSK-3 beta. Conclusions: These findings reveal molecular and cellular mechanisms that might underlie cognitive deficits linked to specific defects of neuronal insulin signalling.	[Costello, Derek A.; Pedarzani, Paola] UCL, Res Dept Neurosci, London, England; [Claret, Marc; Al-Qassab, Hind; Irvine, Elaine E.; Choudhury, Agharul I.; Withers, Dominic J.] UCL, Dept Med, London, England; [Plattner, Florian; Irvine, Elaine E.; Giese, K. Peter] UCL, Wolfson Inst Biomed Res, London, England; [Irvine, Elaine E.; Choudhury, Agharul I.; Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Metab Signalling Grp, MRC Clin Sci Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Costello, DA (corresponding author), Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin, Ireland.	p.pedarzani@ucl.ac.uk	Giese, Karl P/A-3112-2011; Withers, Dominic J/D-7671-2014	Giese, Karl P/0000-0003-4503-7344; Withers, Dominic J/0000-0002-8009-7521; Claret, Marc/0000-0001-7766-9296; Irvine, Elaine/0000-0001-5508-8140; Costello, Derek/0000-0002-5449-6166; Plattner, Florian/0000-0002-3150-1866	Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/B/16143]; Medical Research Council (MRC) [G0100066]; European Neuroscience Institute Network (ENI-Net); Wellcome Trust [WT081394MA]; MRC [G0100066, MC_U120097114] Funding Source: UKRI; Alzheimers Research UK [ART-PG2003-2] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/B/16143] Funding Source: researchfish; Medical Research Council [MC_U120097114, G0100066] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Neuroscience Institute Network (ENI-Net); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BBS/B/16143 to Dr. Withers, Dr. Pedarzani and Dr. Giese. Dr. Pedarzani acknowledges additional support by the Medical Research Council (MRC) (Career Establishment Grant G0100066) and European Neuroscience Institute Network (ENI-Net). Dr. Withers was also supported by a Wellcome Trust Strategic Award WT081394MA (awarded to Professor's Partridge, Withers and Thornton and Dr. Gems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Artola A, 2005, EUR J NEUROSCI, V22, P169, DOI 10.1111/j.1460-9568.2005.04205.x; Artola A, 2008, EUR J PHARMACOL, V585, P153, DOI 10.1016/j.ejphar.2007.11.084; BASKIN DG, 1994, ENDOCRINOLOGY, V134, P1952, DOI 10.1210/en.134.4.1952; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 2005, BIOL PSYCHIAT, V57, P113, DOI 10.1016/j.biopsych.2004.02.031; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Christie JM, 1999, J NEUROCHEM, V72, P1523, DOI 10.1046/j.1471-4159.1999.721523.x; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Di Luca M, 1999, DIABETOLOGIA, V42, P693, DOI 10.1007/s001250051217; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; FLOOD JF, 1990, DIABETES, V39, P1391, DOI 10.2337/diabetes.39.11.1391; FOLLI F, 1994, J NEUROSCI, V14, P6412; Freude S, 2008, J NEUROCHEM, V107, P907, DOI 10.1111/j.1471-4159.2008.05631.x; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gardoni F, 2002, J NEUROCHEM, V80, P438, DOI 10.1046/j.0022-3042.2001.00713.x; Giese KP, 2009, IUBMB LIFE, V61, P516, DOI 10.1002/iub.187; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Huang CC, 2003, MOL CELL NEUROSCI, V24, P831, DOI 10.1016/S1044-7431(03)00238-0; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karpova A, 2006, NEUROSCIENCE, V137, P833, DOI 10.1016/j.neuroscience.2005.10.012; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kneussel M, 2002, BRAIN RES REV, V39, P74, DOI 10.1016/S0165-0173(02)00159-5; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota T, 2003, CIRCULATION, V107, P3073, DOI 10.1161/01.CIR.0000070937.52035.25; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liao GY, 1999, J NEUROCHEM, V73, P1510, DOI 10.1046/j.1471-4159.1999.0731510.x; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; LIU LF, 1995, NEUROSCI LETT, V192, P5, DOI 10.1016/0304-3940(95)11593-L; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Ma XH, 2003, J NEUROSCI, V23, P1159, DOI 10.1523/JNEUROSCI.23-04-01159.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin ED, 2011, CEREB CORTEX; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; O'Malley D, 2003, NEUROPHARMACOLOGY, V44, P855, DOI 10.1016/S0028-3908(03)00081-9; O'Malley D, 2004, MOL PHARMACOL, V65, P1352, DOI 10.1124/mol.65.6.1352; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Opazo P, 2003, J NEUROSCI, V23, P3679; Pardini AW, 2006, BRAIN RES, V1112, P169, DOI 10.1016/j.brainres.2006.06.109; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; THOMAS KL, 1994, NEUROREPORT, V6, P119, DOI 10.1097/00001756-199412300-00031; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; URUSHIHARA H, 1992, J BIOL CHEM, V267, P11697; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xing CH, 2006, BRAIN RES, V1072, P30, DOI 10.1016/j.brainres.2005.10.091; Xing CH, 2007, EXP NEUROL, V205, P222, DOI 10.1016/j.expneurol.2007.01.029	104	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31124	10.1371/journal.pone.0031124	http://dx.doi.org/10.1371/journal.pone.0031124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383997	gold, Green Submitted, Green Published			2022-12-25	WOS:000302918500019
J	Guo, YL; Tomlinson, B; Chu, TY; Fang, YJ; Gui, HS; Tang, CS; Yip, BH; Cherny, SS; Hur, YM; Sham, PC; Lam, TH; Thomas, NG				Guo, Youling; Tomlinson, Brian; Chu, Tanya; Fang, Yu Jing; Gui, Hongsheng; Tang, Clara S.; Yip, Benjamin H.; Cherny, Stacey S.; Hur, Yoon-Mi; Sham, Pak Chung; Lam, Tai Hing; Thomas, Neil G.			A Genome-Wide Linkage and Association Scan Reveals Novel Loci for Hypertension and Blood Pressure Traits	PLOS ONE			English	Article							FACTOR GDNF GENE; QUANTITATIVE TRAITS; CHINESE POPULATION; PAIR ANALYSIS; PHOSDUCIN; PROTEIN; HERITABILITY; POLYMORPHISM; SCHIZOPHRENIA; PHENOTYPES	Hypertension is caused by the interaction of environmental and genetic factors. The condition which is very common, with about 18% of the adult Hong Kong Chinese population and over 50% of older individuals affected, is responsible for considerable morbidity and mortality. To identify genes influencing hypertension and blood pressure, we conducted a combined linkage and association study using over 500,000 single nucleotide polymorphisms (SNPs) genotyped in 328 individuals comprising 111 hypertensive probands and their siblings. Using a family-based association test, we found an association with SNPs on chromosome 5q31.1 (rs6596140; P<9 x 10(-8)) for hypertension. One candidate gene, PDC, was replicated, with rs3817586 on 1q31.1 attaining P = 2.5 x 10(-4) and 2.9 x 10(-5) in the within-family tests for DBP and MAP, respectively. We also identified regions of significant linkage for systolic and diastolic blood pressure on chromosomes 2q22 and 5p13, respectively. Further family-based association analysis of the linkage peak on chromosome 5 yielded a significant association (rs1605685, P<7 x 10(-5)) for DBP. This is the first combined linkage and association study of hypertension and its related quantitative traits with Chinese ancestry. The associations reported here account for the action of common variants whereas the discovery of linkage regions may point to novel targets for rare variant screening.	[Guo, Youling; Gui, Hongsheng; Tang, Clara S.; Yip, Benjamin H.; Cherny, Stacey S.; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Tomlinson, Brian; Chu, Tanya; Fang, Yu Jing] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Hur, Yoon-Mi] Mokpo Natl Univ, Seoul, South Korea; [Thomas, Neil G.] Univ Birmingham, Unit Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Mokpo National University; University of Birmingham	Guo, YL (corresponding author), Univ Hong Kong, Dept Psychiat, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	cherny@hku.hk; hrmrlth@hkucc.hku.hk; g.n.thomas@bham.ac.uk	Gui, Hongsheng/D-1063-2013; Tomlinson, Brian/P-5365-2015; YIP, Benjamin HK/I-2336-2013; Thomas, G. Neil/A-1879-2013; Tomlinson, Brian/AAD-9404-2019; Cherny, Stacey S/B-3315-2008; Yip, Benjamin/AAC-7845-2019; Lam, Tai Hing/C-4317-2009	Gui, Hongsheng/0000-0002-0460-7446; Thomas, G. Neil/0000-0002-2777-1847; Tomlinson, Brian/0000-0001-6717-5444; Cherny, Stacey S/0000-0002-0269-3352; Yip, Benjamin/0000-0002-4749-7611; Lam, Tai Hing/0000-0002-2033-9971; Tang, Clara/0000-0003-0265-2638	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 4095/00M, CUHK 4438/03M, HKU 7672/06M]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Projects no. CUHK 4095/00M, CUHK 4438/03M, HKU 7672/06M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Baker PRS, 2004, AM J PHYSIOL-CELL PH, V287, pC1359, DOI 10.1152/ajpcell.00238.2004; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bell JT, 2006, HUM MOL GENET, V15, P1365, DOI 10.1093/hmg/ddl058; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2000, BEHAV GENET, V30, P235, DOI 10.1023/A:1001970425822; Cho Kelly, 2007, BMC Proc, V1 Suppl 1, pS161; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Fang YJ, 2010, J HYPERTENS, V28, P1203, DOI 10.1097/HJH.0b013e3283384b07; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; Gu DF, 2007, HYPERTENSION, V50, P116, DOI 10.1161/HYPERTENSIONAHA.107.088310; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Hamet P, 1998, J HYPERTENS, V16, P397, DOI 10.1097/00004872-199816040-00001; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, J HUM GENET, V55, P336; Kardia SLR, 2003, AM J HYPERTENS, V16, P154, DOI 10.1016/S0895-7061(02)03249-1; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lee KB, 2001, PSYCHIAT RES, V104, P11, DOI 10.1016/S0165-1781(01)00294-3; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Luke MM, 2009, STROKE, V40, P363, DOI 10.1161/STROKEAHA.108.521328; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Michelato A, 2004, NEUROSCI LETT, V357, P235, DOI 10.1016/j.neulet.2003.12.089; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Munroe PB, 2006, HYPERTENSION, V48, P105, DOI 10.1161/01.HYP.0000228324.74255.f1; Newton-Cheh C., 2009, NAT GENET, V41, P666, DOI [10.1038/ng.361, DOI 10.1038/NG.361]; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; SPARKES RS, 1993, GENOMICS, V18, P426, DOI 10.1006/geno.1993.1490; St-Pierre J, 2001, MOL GENET METAB, V72, P209, DOI 10.1006/mgme.2000.3144; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Thomas GN, 1999, CLIN EXP HYPERTENS, V21, P1161, DOI 10.3109/10641969909052195; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31489	10.1371/journal.pone.0031489	http://dx.doi.org/10.1371/journal.pone.0031489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384028	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800015
J	Usami, S; Nishio, S; Nagano, M; Abe, S; Yamaguchi, T				Usami, Shin-ichi; Nishio, Shin-ya; Nagano, Makoto; Abe, Satoko; Yamaguchi, Toshikazu		Deafness Gene Study Consortium	Simultaneous Screening of Multiple Mutations by Invader Assay Improves Molecular Diagnosis of Hereditary Hearing Loss: A Multicenter Study	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; CLINICAL-FEATURES; PENDRED-SYNDROME; GJB2 MUTATIONS; DEAFNESS; SPECTRUM; JAPANESE; SLC26A4	Although etiological studies have shown genetic disorders to be a common cause of congenital/early-onset sensorineural hearing loss, there have been no detailed multicenter studies based on genetic testing. In the present report, 264 Japanese patients with bilateral sensorineural hearing loss from 33 ENT departments nationwide participated. For these patients, we first applied the Invader assay for screening 47 known mutations of 13 known deafness genes, followed by direct sequencing as necessary. A total of 78 (29.5%) subjects had at least one deafness gene mutation. Mutations were more frequently found in the patients with congenital or early-onset hearing loss, i.e., in those with an awareness age of 0-6 years, mutations were significantly higher (41.8%) than in patients with an older age of awareness (16.0%). Among the 13 genes, mutations in GJB2 and SLC26A4 were mainly found in congenital or early-onset patients, in contrast with mitochondrial mutations (12S rRNA m.1555A>G, tRNA(Leu(UUR)) m.3243A>G), which were predominantly found in older-onset patients. The present method of simultaneous screening of multiple deafness mutations by Invader assay followed by direct sequencing will enable us to detect deafness mutations in an efficient and practical manner for clinical use.	[Usami, Shin-ichi; Nishio, Shin-ya] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan; [Nagano, Makoto; Abe, Satoko; Yamaguchi, Toshikazu] Biomed Labs Inc, Dept Clin Genom, Kawagoe, Saitama, Japan	Shinshu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp	Ito, Tsukasa/R-7201-2016	Ito, Tsukasa/0000-0002-4237-3564; Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health and Welfare, Japan; Ministry of Education, Science and Culture of Japan	Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the (then) Ministry of Health and Welfare, Japan (http://www.mhlw.go.jp/english/) (S. U.) and a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1997, ANN OTO RHINOL LARYN, V106, P1063, DOI 10.1177/000348949710601210; Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Azaiez H, 2004, HUM MUTAT, V24, P305, DOI 10.1002/humu.20084; den Ouweland JM, 1992, NAT GENET, V1, P368; Fukushima K, 2002, INT J PEDIATR OTORHI, V62, P151, DOI 10.1016/S0165-5876(01)00619-X; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; Kimberling WJ, 2005, HUM MUTAT, V26, P462, DOI 10.1002/humu.20221; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Oshima T, 1996, LARYNGOSCOPE, V106, P43, DOI 10.1097/00005537-199601000-00009; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Suzuki H, 2000, ACTA OTO-LARYNGOL, V127, P1292; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 1997, LARYNGOSCOPE, V107, P483, DOI 10.1097/00005537-199704000-00011; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314	22	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31276	10.1371/journal.pone.0031276	http://dx.doi.org/10.1371/journal.pone.0031276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384008	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800012
J	Zhang, EY; Xiong, Q; Ye, L; Suntharalingam, P; Wang, XH; Astle, CM; Zhang, JY; Harrison, DE				Zhang, Eric Y.; Xiong, Qiang; Ye, Lei; Suntharalingam, Piradeep; Wang, Xiaohong; Astle, C. Michael; Zhang, Jianyi; Harrison, David E.			Fetal Myocardium in the Kidney Capsule: An In Vivo Model of Repopulation of Myocytes by Bone Marrow Cells	PLOS ONE			English	Article							CARDIAC STEM-CELLS; INFARCTED MYOCARDIUM; GENETIC-REGULATION; HEART-FAILURE; REGENERATION; DIFFERENTIATION; TRANSPLANTATION; SENESCENCE; GROWTH; POPULATION	Debate surrounds the question of whether the heart is a post-mitotic organ in part due to the lack of an in vivo model in which myocytes are able to actively regenerate. The current study describes the first such mouse model - a fetal myocardial environment grafted into the adult kidney capsule. Here it is used to test whether cells descended from bone marrow can regenerate cardiac myocytes. One week after receiving the fetal heart grafts, recipients were lethally irradiated and transplanted with marrow from green fluorescent protein (GFP)-expressing C57Bl/6J (B6) donors using normal B6 recipients and fetal donors. Levels of myocyte regeneration from GFP marrow within both fetal myocardium and adult hearts of recipients were evaluated histologically. Fetal myocardium transplants had rich neovascularization and beat regularly after 2 weeks, continuing at checkpoints of 1, 2, 4, 6, 8 and 12 months after transplantation. At each time point, GFP-expressing rod-shaped myocytes were found in the fetal myocardium, but only a few were found in the adult hearts. The average count of repopulated myocardium with green rod-shaped myocytes was 996.8 cells per gram of fetal myocardial tissue, and 28.7 cells per adult heart tissue, representing a thirty-five fold increase in fetal myocardium compared to the adult heart at 12 months (when numbers of green rod-shaped myocytes were normalized to per gram of myocardial tissue). Thus, bone marrow cells can differentiate to myocytes in the fetal myocardial environment. The novel in vivo model of fetal myocardium in the kidney capsule appears to be valuable for testing repopulating abilities of potential cardiac progenitors.	[Zhang, Eric Y.; Astle, C. Michael; Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Xiong, Qiang; Ye, Lei; Suntharalingam, Piradeep; Wang, Xiaohong; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA	Jackson Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Zhang, EY (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	zhang047@umn.edu; david.harrison@.jax.org	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Ye, Lei/0000-0001-5039-6224	National Institutes of Health (NIH) [R01 HL-95077]; American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL095077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant R01 HL-95077 and the American Heart Association (AHA)-Jon DeHaan Myogenesis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2004, CIRCULATION, V109, P2832, DOI 10.1161/01.CIR.0000132469.85026.46; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kajstura J, 2008, J MOL CELL CARDIOL, V45, P505, DOI 10.1016/j.yjmcc.2008.05.025; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Nakamura Y, 2007, STEM CELLS, V25, P612, DOI 10.1634/stemcells.2006-0168; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31099	10.1371/journal.pone.0031099	http://dx.doi.org/10.1371/journal.pone.0031099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383995	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100014
J	Prole, DL; Marrion, NV				Prole, David L.; Marrion, Neil V.			Identification of Putative Potassium Channel Homologues in Pathogenic Protozoa	PLOS ONE			English	Article							K-ATP CHANNELS; PLASMODIUM-FALCIPARUM; ION CHANNELS; GENOME SEQUENCE; PHYLOGENETIC ANALYSES; SIGNATURE SEQUENCE; CRYSTAL-STRUCTURES; ADENYLYL-CYCLASE; VOLTAGE SENSOR; D-TUBOCURARINE	K+ channels play a vital homeostatic role in cells and abnormal activity of these channels can dramatically alter cell function and survival, suggesting that they might be attractive drug targets in pathogenic organisms. Pathogenic protozoa lead to diseases such as malaria, leishmaniasis, trypanosomiasis and dysentery that are responsible for millions of deaths each year worldwide. The genomes of many protozoan parasites have recently been sequenced, allowing rational design of targeted therapies. We analyzed the genomes of pathogenic protozoa and show the existence within them of genes encoding putative homologues of K+ channels. These protozoan K+ channel homologues represent novel targets for anti-parasitic drugs. Differences in the sequences and diversity of human and parasite proteins may allow pathogen-specific targeting of these K+ channel homologues.	[Prole, David L.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Marrion, Neil V.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Cambridge; University of Bristol	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk		Prole, David/0000-0003-2782-6665	St. John's College, Cambridge	St. John's College, Cambridge	This work was funded by a Meres Senior Research Associateship from St. John's College, Cambridge (to DLP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Bernal RM, 1998, PARASITOL RES, V84, P687, DOI 10.1007/s004360050471; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chapman M, 2006, PFLUG ARCH EUR J PHY, V451, P776, DOI 10.1007/s00424-005-1515-2; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; Czuczwar P, 2010, PHARMACOL REP, V62, P211, DOI 10.1016/S1734-1140(10)70260-7; de Boer TP, 2010, BRIT J PHARMACOL, V159, P1532, DOI 10.1111/j.1476-5381.2010.00658.x; Decher N, 2010, EMBO J, V29, P2101, DOI 10.1038/emboj.2010.88; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devulder J, 2010, CNS DRUGS, V24, P867, DOI 10.2165/11536230-000000000-00000; DUNN MJ, 1969, J CLIN INVEST, V48, P674, DOI 10.1172/JCI106025; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Ellekvist P, 2004, BIOCHEM BIOPH RES CO, V318, P477, DOI 10.1016/j.bbrc.2004.04.049; Ellekvist P, 2008, P NATL ACAD SCI USA, V105, P6398, DOI 10.1073/pnas.0802384105; EVANS SG, 1993, BIOCHEM PHARMACOL, V45, P1168, DOI 10.1016/0006-2952(93)90264-W; Fairman C, 1999, J MEMBRANE BIOL, V168, P149, DOI 10.1007/s002329900505; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gajdanowicz P, 2011, P NATL ACAD SCI USA, V108, P864, DOI 10.1073/pnas.1009777108; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; GINSBURG H, 1986, Z PARASITENKD, V72, P185, DOI 10.1007/BF00931146; GLASER TA, 1992, MOL BIOCHEM PARASIT, V51, P9, DOI 10.1016/0166-6851(92)90195-P; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Haynes WJ, 2003, EUKARYOT CELL, V2, P737, DOI 10.1128/EC.2.4.737-745.2003; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B., 1992, IONIC CHANNELS EXCIT; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Isayenkov S, 2011, PLANT CELL, V23, P756, DOI 10.1105/tpc.110.081463; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jarmuszkiewicz W, 2010, FEBS LETT, V584, P2057, DOI 10.1016/j.febslet.2010.01.023; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; Jimenez V, 2011, J CELL BIOCHEM, V112, P1093, DOI 10.1002/jcb.23023; Kelly ML, 2005, PANCREATOLOGY, V5, P443, DOI 10.1159/000086556; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KIRSCH GE, 1995, BIOPHYS J, V68, P1804, DOI 10.1016/S0006-3495(95)80357-7; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409; Lamy C, 2010, J BIOL CHEM, V285, P27067, DOI 10.1074/jbc.M110.110072; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Leung YM, 2010, LIFE SCI, V86, P775, DOI 10.1016/j.lfs.2010.04.004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi H, 2008, ANNOTATION TOXOPLASM; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Madeja M, 2010, J BIOL CHEM, V285, P33898, DOI 10.1074/jbc.M110.159897; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Mangubat EZ, 2003, J MOL MICROB BIOTECH, V5, P216, DOI 10.1159/000071073; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Martin RJ, 2011, EXP PARASIT IN PRESS; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; MAZUMDER S, 1992, J BIOL CHEM, V267, P18440; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MILLER C, 2000, GENOME BIOL, V1, P4; Mitcheson John, 2005, V266, P136; Monzote Lianet, 2011, Open Med Chem J, V5, P1, DOI 10.2174/1874104501105010001; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nagamune Kisaburo, 2008, V47, P70; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; OVERMAN RB, 1948, AM J PHYSIOL, V152, P113, DOI 10.1152/ajplegacy.1947.152.1.113; Pau VPT, 2011, P NATL ACAD SCI USA, V108, P17684, DOI 10.1073/pnas.1107229108; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Pezzella N, 1997, EUR J CELL BIOL, V74, P92; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Quesada I, 2002, P NATL ACAD SCI USA, V99, P9544, DOI 10.1073/pnas.142039299; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; ROJAS MO, 1995, J BIOCHEM, V118, P1118, DOI 10.1093/oxfordjournals.jbchem.a124996; Rossokhin A, 2006, MOL PHARMACOL, V69, P1356, DOI 10.1124/mol.105.017970; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanguinetti Michael C., 2005, V266, P159; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Serrano-Martin X, 2006, ANTIMICROB AGENTS CH, V50, P4214, DOI 10.1128/AAC.00617-06; Serrano-Martin X, 2009, ANTIMICROB AGENTS CH, V53, P1403, DOI 10.1128/AAC.01215-08; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; So I, 2001, J PHYSIOL-LONDON, V531, P37, DOI 10.1111/j.1469-7793.2001.0037j.x; Song Hyun-Ouk, 2004, Korean Journal of Parasitology, V42, P185, DOI 10.3347/kjp.2004.42.4.185; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waller KL, 2008, EXP PARASITOL, V120, P280, DOI 10.1016/j.exppara.2008.07.010; Waller KL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-19; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WARD JM, 1994, PLANT CELL, V6, P669; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Weatherall KL, 2011, P NATL ACAD SCI USA, V108, P18494, DOI 10.1073/pnas.1110724108; Weatherall KL, 2010, PROG NEUROBIOL, V91, P242, DOI 10.1016/j.pneurobio.2010.03.002; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; YAKUBU MA, 1994, MOL BIOCHEM PARASIT, V66, P119, DOI 10.1016/0166-6851(94)90042-6; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yang H, 2007, P NATL ACAD SCI USA, V104, P18270, DOI 10.1073/pnas.0705873104; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	149	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32264	10.1371/journal.pone.0032264	http://dx.doi.org/10.1371/journal.pone.0032264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363819	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700160
J	Moen, GK; Stoen, OG; Sahlen, V; Swenson, JE				Moen, Gro Kvelprud; Stoen, Ole-Gunnar; Sahlen, Veronica; Swenson, Jon E.			Behaviour of Solitary Adult Scandinavian Brown Bears (Ursus arctos) when Approached by Humans on Foot	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; HUMAN DISTURBANCE; NATIONAL-PARK; LARGE CARNIVORES; HUMAN ATTITUDES; RESPONSES; HABITAT; PREDATORS; PATTERNS; RISK	Successful management has brought the Scandinavian brown bear (Ursus arctos L.) back from the brink of extinction, but as the population grows and expands the probability of bear-human encounters increases. More people express concerns about spending time in the forest, because of the possibility of encountering bears, and acceptance for the bear is decreasing. In this context, reliable information about the bear's normal behaviour during bear-human encounters is important. Here we describe the behaviour of brown bears when encountering humans on foot. During 2006-2009, we approached 30 adult (21 females, 9 males) GPS-collared bears 169 times during midday, using 1-minute positioning before, during and after the approach. Observer movements were registered with a handheld GPS. The approaches started 869 +/- 348 m from the bears, with the wind towards the bear when passing it at approximately 50 m. The bears were detected in 15% of the approaches, and none of the bears displayed any aggressive behaviour. Most bears (80%) left the initial site during the approach, going away from the observers, whereas some remained at the initial site after being approached (20%). Young bears left more often than older bears, possibly due to differences in experience, but the difference between ages decreased during the berry season compared to the pre-berry season. The flight initiation distance was longer for active bears (115 +/- 94 m) than passive bears (69 +/- 47 m), and was further affected by horizontal vegetation cover and the bear's age. Our findings show that bears try to avoid confrontations with humans on foot, and support the conclusions of earlier studies that the Scandinavian brown bear is normally not aggressive during encounters with humans.	[Moen, Gro Kvelprud; Stoen, Ole-Gunnar; Sahlen, Veronica; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Stoen, Ole-Gunnar] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Moen, GK (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	ole.stoen@umb.no	Swenson, Jon/AAE-2890-2019; Swenson, Jon/E-2883-2013; Støen, Ole-Gunnar/AAY-6457-2020	Chiaradia, Andre/0000-0002-6178-4211	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway; research program "Adaptive Management of Fish and Wildlife'	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway(Research Council of Norway); research program "Adaptive Management of Fish and Wildlife'	The Scandinavian Brown Bear Research Project is funded by the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, WWF Sweden and the Research Council of Norway. This study received additional financial support from the research program "Adaptive Management of Fish and Wildlife'' and the Norwegian Directorate for Nature Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBERT DM, 1991, WILDLIFE SOC B, V19, P339; ALTMANN MARGARET, 1958, JOUR WILDLIFE MANAGEMENT, V22, P207, DOI 10.2307/3797334; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bischof R, 2008, J WILDLIFE MANAGE, V72, P79, DOI 10.2193/2007-149; BURGER J, 1981, BIOL CONSERV, V21, P231, DOI 10.1016/0006-3207(81)90092-6; Clark JD, 2002, URSUS, V13, P335; Cooper WE, 2008, ANIM BEHAV, V76, P1365, DOI 10.1016/j.anbehav.2008.03.029; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; De Giorgio F, 2007, FORENSIC SCI INT, V173, P64, DOI 10.1016/j.forsciint.2006.08.026; ELGMORK K, 1978, BIOL CONSERV, V13, P81, DOI 10.1016/0006-3207(78)90063-0; Ericsson G, 2009, 20091 I VILT  FISK M, P55; ESRI Inc, 1999, ESRI ARCVIEW 9 2; Frid A, 2002, CONSERV ECOL, V6; Gander H, 1997, BIOL CONSERV, V79, P107, DOI 10.1016/S0006-3207(96)00102-4; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Giese M, 1996, BIOL CONSERV, V75, P157, DOI 10.1016/0006-3207(95)00060-7; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Karlsson J, 2007, CAN J ZOOL, V85, P1193, DOI 10.1139/Z07-099; Karlsson J, 2007, BIOL CONSERV, V137, P610, DOI 10.1016/j.biocon.2007.03.023; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kitchen AM, 2000, CAN J ZOOL, V78, P853, DOI 10.1139/cjz-78-5-853; Loehr J, 2005, CAN J ZOOL, V83, P1602, DOI 10.1139/Z05-162; LONNBERG E, 1923, SVERIGES JAKTBARA DJ; MACARTHUR RA, 1982, J WILDLIFE MANAGE, V46, P351, DOI 10.2307/3808646; Matson G., 1993, LAB MANUAL CEMENTUM; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; Moe TF, 2007, CAN J ZOOL, V85, P518, DOI 10.1139/Z07-034; Montgomery DC., 2019, INTRO STAT QUALITY C; Myrberget S, 1978, NATUREN, V5, P219; Nellemann C, 2003, BIOL CONSERV, V113, P307, DOI 10.1016/S0006-3207(03)00048-X; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Olson TL, 1997, BIOL CONSERV, V82, P95, DOI 10.1016/S0006-3207(96)00151-6; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Ordiz A, 2009, URSUS, V20, P109, DOI 10.2192/08SC031.1; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; PULLIAINEN E, 1972, Annales Zoologici Fennici, V9, P199; R Development Core Team, 2009, R FDN STAT COMP; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Schleyer BO, 1984, EFFECTS NONMOTORIZED; Smith TS, 2005, URSUS, V16, P1, DOI 10.2192/1537-6176(2005)016[0001:ABBHAH]2.0.CO;2; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; STALMASTER MV, 1978, J WILDLIFE MANAGE, V42, P506, DOI 10.2307/3800811; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stevens MA, 2003, J ZOOL, V260, P145, DOI 10.1017/S0952836903003583; Sunde P, 1998, WILDLIFE BIOL, V4, P177, DOI 10.2981/wlb.1998.020; SUTHERLAND WJ, 1993, BIOL CONSERV, V63, P61, DOI 10.1016/0006-3207(93)90074-B; Swenson J.E., 1999, BIOSPH CONS, V2, P1; Swenson JE, 1998, URSUS-SERIES, V10, P17; Swenson JE, 1999, CAN J ZOOL, V77, P551, DOI 10.1139/cjz-77-4-551; Swenson JE., 2000, CONV CONS EUR WILDL; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Swenson Jon E., 1999, Ursus, V11, P157; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Tobiassen C, 2011, 649 BIOF, V6, P49; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wauters LA, 1997, BIOL CONSERV, V82, P101, DOI 10.1016/S0006-3207(97)00007-4; Wesslen S, 1996, LAPPLANDSFJALLEN BLA, P172; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1	69	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31699	10.1371/journal.pone.0031699	http://dx.doi.org/10.1371/journal.pone.0031699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363710	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500077
J	Tao, XL; Zheng, DQ; Liu, TZ; Wang, PM; Zhao, WP; Zhu, MY; Jiang, XH; Zhao, YH; Wu, XC				Tao, Xianglin; Zheng, Daoqiong; Liu, Tianzhe; Wang, Pinmei; Zhao, Wenpeng; Zhu, Muyuan; Jiang, Xinhang; Zhao, Yuhua; Wu, Xuechang			A Novel Strategy to Construct Yeast Saccharomyces cerevisiae Strains for Very High Gravity Fermentation	PLOS ONE			English	Article							ETHANOL TOLERANCE; LIPID-COMPOSITION; TREHALOSE METABOLISM; EXPRESSION ANALYSIS; PLASMA-MEMBRANE; ADAPTATION; STRESS; ACID; OPTIMIZATION; ACCUMULATION	Very high gravity (VHG) fermentation is aimed to considerably increase both the fermentation rate and the ethanol concentration, thereby reducing capital costs and the risk of bacterial contamination. This process results in critical issues, such as adverse stress factors (ie., osmotic pressure and ethanol inhibition) and high concentrations of metabolic byproducts which are difficult to overcome by a single breeding method. In the present paper, a novel strategy that combines metabolic engineering and genome shuffling to circumvent these limitations and improve the bioethanol production performance of Saccharomyces cerevisiae strains under VHG conditions was developed. First, in strain Z5, which performed better than other widely used industrial strains, the gene GPD2 encoding glycerol 3-phosphate dehydrogenase was deleted, resulting in a mutant (Z5 Delta GPD2) with a lower glycerol yield and poor ethanol productivity. Second, strain Z5 Delta GPD2 was subjected to three rounds of genome shuffling to improve its VHG fermentation performance, and the best performing strain SZ3-1 was obtained. Results showed that strain SZ3-1 not only produced less glycerol, but also increased the ethanol yield by up to 8% compared with the parent strain Z5. Further analysis suggested that the improved ethanol yield in strain SZ3-1 was mainly contributed by the enhanced ethanol tolerance of the strain. The differences in ethanol tolerance between strains Z5 and SZ3-1 were closely associated with the cell membrane fatty acid compositions and intracellular trehalose concentrations. Finally, genome rearrangements in the optimized strain were confirmed by karyotype analysis. Hence, a combination of genome shuffling and metabolic engineering is an efficient approach for the rapid improvement of yeast strains for desirable industrial phenotypes.	[Tao, Xianglin; Zheng, Daoqiong; Liu, Tianzhe; Wang, Pinmei; Zhao, Wenpeng; Zhu, Muyuan; Jiang, Xinhang; Zhao, Yuhua; Wu, Xuechang] Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, XC (corresponding author), Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mblab@163.com			State Key Laboratory of Motor Vehicle Biofuel Technology, China	State Key Laboratory of Motor Vehicle Biofuel Technology, China	This work was supported by State Key Laboratory of Motor Vehicle Biofuel Technology, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; AGUDO LD, 1992, APPL MICROBIOL BIOT, V37, P647, DOI 10.1007/BF00240742; Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002; Belviso S, 2004, CAN J MICROBIOL, V50, P669, DOI [10.1139/w04-051, 10.1139/W04-051]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chi Z, 1999, J APPL MICROBIOL, V86, P1047, DOI 10.1046/j.1365-2672.1999.00793.x; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Dinh TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002623; Dong YS, 2007, BIOCHEM ENG J, V37, P226, DOI 10.1016/j.bej.2007.04.004; Fiedurek J, 2011, POL J MICROBIOL, V60, P51, DOI 10.33073/pjm-2011-007; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gong JX, 2009, BIOTECHNOL ADV, V27, P996, DOI 10.1016/j.biotechadv.2009.05.016; Graves T, 2007, APPL MICROBIOL BIOT, V73, P1190, DOI 10.1007/s00253-006-0573-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hallsworth JE, 1998, J FERMENT BIOENG, V85, P125, DOI 10.1016/S0922-338X(97)86756-6; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; Hou LH, 2010, APPL BIOCHEM BIOTECH, V160, P1084, DOI 10.1007/s12010-009-8552-9; Hou LH, 2009, BIOTECHNOL LETT, V31, P671, DOI 10.1007/s10529-009-9916-5; Ingledew W.M., 1999, ALCOHOL PRODUCTION S; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kim HS, 2011, BIOTECHNOL LETT, P1; Lei J, 2007, J BIOTECHNOL, V131, P270, DOI 10.1016/j.jbiotec.2007.07.937; Li LL, 2009, BIOCHEM BIOPH RES CO, V387, P778, DOI 10.1016/j.bbrc.2009.07.113; Liang LK, 2007, APPL MICROBIOL BIOT, V74, P1084, DOI 10.1007/s00253-006-0688-8; Mannazzu I, 2008, INT J FOOD MICROBIOL, V121, P84, DOI 10.1016/j.ijfoodmicro.2007.11.003; Mizoguchi H, 1996, J FERMENT BIOENG, V81, P406, DOI 10.1016/0922-338X(96)85141-5; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Otte B, 2009, APPL ENVIRON MICROB, V75, P7610, DOI 10.1128/AEM.01774-09; Shi DJ, 2009, J IND MICROBIOL BIOT, V36, P139, DOI 10.1007/s10295-008-0481-z; Shobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P2381, DOI 10.1271/bbb.69.2381; Tan HD, 2010, INT J MOL SCI, V11, P4962, DOI 10.3390/ijms11124962; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Valadi H, 1998, APPL MICROBIOL BIOT, V50, P434, DOI 10.1007/s002530051317; Vianna CR, 2008, ANTON LEEUW INT J G, V93, P205, DOI 10.1007/s10482-007-9194-y; Wang FQ, 2007, BIOTECHNOL LETT, V29, P233, DOI 10.1007/s10529-006-9220-6; Wu H, 2006, APPL ENVIRON MICROB, V72, P7353, DOI 10.1128/AEM.01097-06; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	45	51	55	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31235	10.1371/journal.pone.0031235	http://dx.doi.org/10.1371/journal.pone.0031235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363590	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600128
J	Cheng, SB; Filardo, EJ				Cheng, Shi-Bin; Filardo, Edward J.			Trans-Golgi Network (TGN) as a Regulatory Node for beta 1-Adrenergic Receptor (beta 1AR) Down-modulation and Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN BETA(1)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; HEART-FAILURE; MEDIATED ENDOCYTOSIS; ESTROGEN-RECEPTOR; CARDIAC MYOCYTES; ARRESTIN; TRAFFICKING; ACTIVATION	Receptor down-modulation is the key mechanism by which G protein-coupled receptors (GPCRs) prevent excessive receptor signaling in response to agonist stimulation. Recently, the trans-Golgi network (TGN) has been implicated as a key checkpoint for receptor endocytosis and degradation. Here, we investigated the involvement of the TGN in down-modulation of beta 1-adrenergic receptor in response to persistent isoprotenerol stimulation. Immunofluorescent staining showed that similar to 50% of endocytosed beta 1AR colocalized with TGN-46 at 5 h. Disruption of the TGN by brefeldin A (BFA) led to the robust accumulation of endocytosed beta 1AR in Rab11(+) recycling endosomes, inhibited beta 1AR entry into LAMP1(+) lysosomes, and as a result enhanced beta 1AR recycling to the plasma membrane. The lysosomotropic agent, chloroquine arrested the majority of endocytosed beta 1AR in the TGN by 4 h. Immunoblot analysis showed that either disruption of the TGN or blockage of the lysosome prevented beta 1AR degradation. Co-expression of GFP-arrestin-3 in beta 1AR cells increased the endocytosis of beta 1AR and facilitated its entry to the TGN but inhibited recycling to the plasma membrane. Arrestin-3-induced inhibition of beta 1AR recycling was reversed by BFA treatment, whereas chloroquine induced the accumulation of arrestin-3 with beta 1AR in the TGN. These results demonstrate for the first time that the TGN acts as a checkpoint for both the recycling and down-regulation of beta 1AR and that arrestin-3 not only mediates beta 1AR endocytosis but also its recycling through the TGN.	[Filardo, Edward J.] Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; Brown Univ, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Filardo, EJ (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, 593 Eddy St,Aldrich Bldg,Rm 708, Providence, RI 02903 USA.	edward_filardo@brown.edu		Filardo, Edward/0000-0002-3930-324X	National Institutes of Health [R01 CA119165-01A2]; NATIONAL CANCER INSTITUTE [R01CA119165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA119165-01A2 (to E. J. F.).	CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Kreuzer OJ, 2001, J NEUROENDOCRINOL, V13, P279, DOI 10.1046/j.1365-2826.2001.00630.x; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Limbird LE, 1999, P NATL ACAD SCI USA, V96, P7125, DOI 10.1073/pnas.96.13.7125; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Vatner SF, 2000, CIRC RES, V86, P502, DOI 10.1161/01.RES.86.5.502; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1	31	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14178	14191		10.1074/jbc.M111.323782	http://dx.doi.org/10.1074/jbc.M111.323782			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378779	hybrid, Green Published			2022-12-25	WOS:000303996300070
J	Do, HT; Tselykh, TV; Makela, J; Ho, TH; Olkkonen, VM; Bornhauser, BC; Korhonen, L; Zelcer, N; Lindholm, D				Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Ho, Tho Huu; Olkkonen, Vesa M.; Bornhauser, Beat C.; Korhonen, Laura; Zelcer, Noam; Lindholm, Dan			Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED INHIBITOR; PPAR-ALPHA; DEGRADATION; FGF-21; DOMAINS; CHAIN; ERM; MIR	The LDLR is a critical factor in the regulation of blood cholesterol levels that are altered in different human diseases. The level of LDLR in the cell is regulated by both transcriptional and post-transcriptional events. The E3 ubiquitin ligase, myosin regulatory light chain-interacting protein (Mylip)/inducible degrader of the LDL-R (Idol) was shown to induce degradation of LDLR via protein ubiquitination. We have here studied novel factors and mechanisms that may regulate Mylip/Idol in human hepatocyte cells and in mouse macrophages. We observed that FGF21 that is present in serum in different conditions reduced Mylip/Idol at the RNA and protein level, and increased LDLR levels and stability in the cells. FGF21 also enhanced expression of Canopy2 (Cnpy2)/MIR-interacting Saposin-like protein (Msap) that is known to interact with Mylip/Idol. Overexpression of Cnpy2/Msap increased LDLRs, and knockdown experiments showed that Cnpy2/Msap is crucial for the FGF21 effect on LDLRs. Experiments using DiI-labeled LDL particles showed that FGF21 increased lipoprotein uptake and the effect of FGF21 was additive to that of statins. Our results are consistent with an important role of FGF21 and Cnpy2/Msap in the regulation of LDLRs in cultured cells, which warrants further studies using human samples.	[Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Ho, Tho Huu; Olkkonen, Vesa M.; Korhonen, Laura; Lindholm, Dan] Minerva Fdn, Inst Med Res, Biomedicum 2, FIN-00290 Helsinki, Finland; [Bornhauser, Beat C.] Univ Zurich, Childrens Hosp, Dept Oncol, CH-8032 Zurich, Switzerland; [Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Helsinki; University Children's Hospital Zurich; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Korhonen, Laura/AAW-3256-2020; Lindholm, Dan/B-3777-2014; Bornhauser, Beat/M-4437-2014	Olkkonen, Vesa/0000-0001-5553-7997; Korhonen, Laura/0000-0002-1837-5930; Ho, Tho/0000-0002-8363-1427; Bornhauser, Beat/0000-0003-2890-3191; Zelcer, Noam/0000-0001-6935-7532	Finska Lakaresallskapet; Sigrid Juselius Foundation; Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland(Academy of Finland)	This work was supported by Finska Lakaresallskapet, Sigrid Juselius Foundation, Liv och Halsa, Magnus Ehrnrooth, Minerva Foundation, and the Academy of Finland.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2005, CELL MOL LIFE SCI, V62, P1260, DOI 10.1007/s00018-005-5055-x; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; Lindholm D, 2009, CELL MOL LIFE SCI, V66, P3399, DOI 10.1007/s00018-009-0127-y; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ryden M, 2009, CELL MOL LIFE SCI, V66, P2067, DOI 10.1007/s00018-009-0003-9; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	33	49	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12602	12611		10.1074/jbc.M112.341248	http://dx.doi.org/10.1074/jbc.M112.341248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378787	Green Published, hybrid			2022-12-25	WOS:000302903700001
J	Lonn, P; Vanlandewijck, M; Raja, E; Kowanetz, M; Watanabe, Y; Kowanetz, K; Vasilaki, E; Heldin, CH; Moustakas, A				Lonn, Peter; Vanlandewijck, Michael; Raja, Erna; Kowanetz, Marcin; Watanabe, Yukihide; Kowanetz, Katarzyna; Vasilaki, Eleftheria; Heldin, Carl-Henrik; Moustakas, Aristidis			Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor beta Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR SMAD4; BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; TGF; DEGRADATION; POLARITY; SIK1; PHOSPHORYLATION; IDENTIFICATION; METASTASIS	Transforming growth factor beta (TGF beta) regulates many physiological processes and requires control mechanisms to safeguard proper and timely action. We have previously described how negative regulation of TGF beta signaling is controlled by the serine/threonine kinase salt-inducible kinase 1 (SIK1). SIK1 forms complexes with the TGF beta type I receptor and with the inhibitory Smad7 and down-regulates the type I receptor. We now demonstrate that TGF beta induces SIK1 levels via a direct transcriptional mechanism that implicates the Smad proteins, and we have mapped a putative enhancer element on the SIK1 gene. We provide evidence that the ubiquitin ligase Smurf2 forms complexes and functionally cooperates with SIK1. Both the kinase activity of SIK1 and the ubiquitin ligase activity of Smurf2 are important for proper type I receptor turnover. We also show that knockdown of endogenous SIK1 and Smurf2 enhances physiological signaling by TGF beta that leads to epithelial growth arrest. In conclusion, TGF beta induces expression of Smad7, Smurf2, and SIK1, the products of which physically and functionally interlink to control the activity of this pathway.	[Lonn, Peter; Vanlandewijck, Michael; Raja, Erna; Kowanetz, Marcin; Watanabe, Yukihide; Kowanetz, Katarzyna; Vasilaki, Eleftheria; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Box 595 Biomed Ctr, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Vasilaki, Eleftheria/AAY-6392-2020	Vanlandewijck, Michael/0000-0002-0709-7808	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC]; Natural Sciences Foundation of Sweden [K2007-66X-14936-04-03, K2010-67X-14936-07-03]; Swedish Agency for Innovation Systems [26575-1]; Swedish Foundation for Strategic Research; Tsukuba University, Japan	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Natural Sciences Foundation of Sweden; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Tsukuba University, Japan	The work was supported by the Ludwig Institute for Cancer Research, the Swedish Cancer Society (project 4855-B03-01XAC), the Natural Sciences Foundation of Sweden (project K2007-66X-14936-04-03 and K2010-67X-14936-07-03), and the Strategic Japanese-Swedish Cooperative Program "Multidisciplinary BIO" (Project 26575-1) supported by the Swedish Agency for Innovation Systems and the Swedish Foundation for Strategic Research.; Supported by a post-doctoral fellowship from Tsukuba University, Japan.	Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Maduzia LL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-8; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	43	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12867	12878		10.1074/jbc.M111.307249	http://dx.doi.org/10.1074/jbc.M111.307249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378783	Green Published, hybrid			2022-12-25	WOS:000302903700026
J	Oot, RA; Wilkens, S				Oot, Rebecca A.; Wilkens, Stephan			Subunit Interactions at the V-1-V-o Interface in Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; V-ATPASE; H+-ATPASE; CRYSTAL-STRUCTURE; PERIPHERAL STATOR; C VMA5P; V-1; STOICHIOMETRY; COMPLEX; PH	Eukaryotic vacuolar ATPase (V-ATPase) is regulated by a reversible dissociation mechanism that involves breaking and reforming of protein-protein interactions at the interface of the V-1-ATPase and V-o-proton channel domains. We found previously that the head domain of the single copy C subunit (C-head) binds one subunit EG heterodimer with high affinity (Oot, R.A. and Wilkens, S. (2010) J. Biol. Chem. 285, 24654-24664). Here we generated a water-soluble construct of the N-terminal domain of the V-o "a" subunit composed of amino acid residues 104-372 (a(NT(104-372))). Analytical gel filtration chromatography and sedimentation velocity analysis revealed that a(NT(104-372)) undergoes reversible dimerization in a concentration-dependent manner. A low-resolution molecular envelope was calculated for the a(NT(104-372)) dimer using small angle x-ray scattering data. Isothermal titration calorimetry experiments revealed that a(NT(104-372)) binds the C-foot and EG heterodimer with dissociation constants of 22 and 33 mu M, respectively. We speculate that the spatial closeness of the a(NT), C-foot, and EG binding sites in the intact V-ATPase results in a high-avidity interaction that is able to resist the torque of rotational catalysis, and that reversible enzyme dissociation is initiated by breaking either the a(NT(104-372))-C-foot or a(NT(104-372))-EG interaction by an as-yet unknown signaling mechanism.	[Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; National Science Foundation (NSF); National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF [DMR-093684]; NIGMS [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM058600 (to S. W.). CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF award DMR-093684, and the MacCHESS resource is supported by NIGMS award GM-103485.	Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Dechant R, 2011, CHANNELS, V5, P4, DOI 10.4161/chan.5.1.13846; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	56	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13396	13406		10.1074/jbc.M112.343962	http://dx.doi.org/10.1074/jbc.M112.343962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367203	Green Published, hybrid			2022-12-25	WOS:000302903700074
J	Sapp, E; Valencia, A; Li, XY; Aronin, N; Kegel, KB; Vonsattel, JP; Young, AB; Wexler, N; DiFiglia, M				Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Aronin, Neil; Kegel, Kimberly B.; Vonsattel, Jean-Paul; Young, Anne B.; Wexler, Nancy; DiFiglia, Marian			Native Mutant Huntingtin in Human Brain EVIDENCE FOR PREVALENCE OF FULL-LENGTH MONOMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN MOUSE MODEL; INTRANUCLEAR INCLUSIONS; TRANSGENIC MICE; POLYGLUTAMINE REPEAT; WILD-TYPE; DISEASE; PROTEIN; FRAGMENTS; EXPRESSION; PROTEOLYSIS	Huntington disease (HD) is caused by polyglutamine expansion in theNterminus of huntingtin (htt). Analysis of human postmortem brain lysates by SDS-PAGE and Western blot reveals htt as full-lengthandfragmented. HereweusedBlueNativePAGE(BNP) and Western blots to study native htt in human postmortem brain. Antisera against htt detected a single band broadly migrating at 575-850 kDa in control brain and at 650-885 kDa in heterozygous and Venezuelan homozygousHDbrains. Anti-polyglutamine antisera detected full-length mutant htt in HD brain. There was little htt cleavage even if lysates were pretreated with trypsin, indicating a property of native htt to resist protease cleavage. Asoluble mutant htt fragment of about 180 kDa was detected with anti-htt antibody Ab1 (htt-(1-17)) and increased when lysates were treated with denaturants (SDS, 8 M urea, DTT, or trypsin) before BNP. Wild-type htt was more resistant to denaturants. Based on migration of in vitro translated htt fragments, the 180-kDa segment terminated approximate to htt 670-880 amino acids. If second dimension SDSPAGE followed BNP, the 180-kDa mutant htt was absent, and 43-50 kDa htt fragments appeared. Brain lysates from two HD mouse models expressed native full-length htt; a mutant fragment formed if lysates were pretreated with 8 M urea + DTT. Native full-length mutant htt in embryonic HD140Q/140Q mouse primary neurons was intact during cell death and when cell lysates were exposed to denaturants before BNP. Thus, native mutant htt occurs in brain and primary neurons as a soluble full-length monomer.	[Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Kegel, Kimberly B.; DiFiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Kegel, Kimberly B.; DiFiglia, Marian] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Aronin, Neil] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Aronin, Neil] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Vonsattel, Jean-Paul] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Vonsattel, Jean-Paul] New York Presbyterian Hosp, New York, NY 10032 USA; [Vonsattel, Jean-Paul] Columbia Univ Coll Phys & Surg, New York Brain Bank, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Young, Anne B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wexler, Nancy] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Wexler, Nancy] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Wexler, Nancy] Hereditary Dis Fdn, New York, NY 10032 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University	DiFiglia, M (corresponding author), Massachusetts Gen Hosp E, Dept Neurol, 114 16th St,Rm 2002, Charlestown, MA 02129 USA.	difiglia@helix.mgh.harvard.edu	Young, Anne/AAF-4283-2020		National Institutes of Health (NINDS) [38194]; National Institutes of Health (NIA) [P01-AG07232, R37-AG15473, P50-AG08702]; Huntington Disease Society of America Coalition for the Cure; UMass DERC [DIC 32520]; Iseman Fund; Louis and Rachel Rudin Foundation; Hereditary Disease Foundation; W. M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007232, R37AG015473, P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Huntington Disease Society of America Coalition for the Cure; UMass DERC; Iseman Fund; Louis and Rachel Rudin Foundation; Hereditary Disease Foundation; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 38194 (NINDS; to N. A. and M. D.) and P01-AG07232, R37-AG15473, and P50-AG08702 (NIA; to J. P. V.). This work was also supported by the Huntington Disease Society of America Coalition for the Cure (to M. D.), the UMass DERC (DIC 32520) (to N. A.), The Iseman Fund, The Louis and Rachel Rudin Foundation (to J. P. V.), Hereditary Disease Foundation (to J. P. V. and N. W.), and the W. M. Keck Foundation (to A. B. Y. and N. W.).	ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Babavali M, 2009, BIOCHEMISTRY-US, V48, P9022, DOI 10.1021/bi901124j; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Bhide PG, 1996, J NEUROSCI, V16, P5523; Burre Jacqueline, 2009, Methods Mol Biol, V564, P33, DOI 10.1007/978-1-60761-157-8_3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel KB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-58; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Sandberg A, 2008, J MOL BIOL, V377, P1117, DOI 10.1016/j.jmb.2008.01.051; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Wexler NS, 2012, ANNU REV MED, V63, P1, DOI 10.1146/annurev-med-050710-134457; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	52	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13487	13499		10.1074/jbc.M111.286609	http://dx.doi.org/10.1074/jbc.M111.286609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375012	Green Published, hybrid			2022-12-25	WOS:000302903700082
J	Youn, MY; Yokoyama, A; Fujiyama-Nakamura, S; Ohtake, F; Minehata, K; Yasuda, H; Suzuki, T; Kato, S; Imai, Y				Youn, Min-Young; Yokoyama, Atsushi; Fujiyama-Nakamura, Sally; Ohtake, Fumiaki; Minehata, Ken-ichi; Yasuda, Hisataka; Suzuki, Takeshi; Kato, Shigeaki; Imai, Yuuki			JMJD5, a Jumonji C (JmjC) Domain-containing Protein, Negatively Regulates Osteoclastogenesis by Facilitating NFATc1 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; INHIBITING-HIF FIH; HISTONE DEMETHYLATION; ASPARAGINYL HYDROXYLASE; ANDROGEN RECEPTOR; BONE HOMEOSTASIS; CYCLOSPORINE-A; GIANT-CELLS; FAMILY; DIFFERENTIATION	Osteoclastogenesis is a highly regulated process governed by diverse classes of regulators. Among them, nuclear factor of activated T-cells calcineurin-dependent 1 (NFATc1) is the primary osteoclastogenic transcription factor, and its expression is transcriptionally induced during early osteoclastogenesis by receptor activation of nuclear factor kappa B ligand (RANKL), an osteoclastogenic cytokine. Here, we report the novel enzymatic function of JMJD5, which regulates NFATc1 protein stability. Among the tested Jumonji C (JmjC) domain-containing proteins, decreased mRNA expression levels during osteoclastogenesis were found for JMJD5 in RAW264 cells stimulated by RANKL. To examine the functional role of JMJD5 in osteoclast differentiation, we established stable JMJD5 knockdown cells, and osteoclast formation was assessed. Down-regulated expression of JMJD5 led to accelerated osteoclast formation together with induction of several osteoclast-specific genes such as Ctsk and DC-STAMP, suggesting that JMJD5 is a negative regulator in osteoclast differentiation. Although JMJD5 was recently reported as a histone demethylase for histone H3K36me2, no histone demethylase activity was detected in JMJD5 in vitro or in living cells, even for other methylated histone residues. Instead, JMJD5 co-repressed transcriptional activity by destabilizing NFATc1 protein. Protein hydroxylase activity mediated by the JmjC domain in JMJD5 was required for the observed functions of JMJD5. JMJD5 induced the association of hydroxylated NFATc1 with the E3 ubiquitin ligase Von Hippel-Lindau tumor suppressor (VHL), thereby presumably facilitating proteasomal degradation of NFATc1 via ubiquitination. Taken together, the present study demonstrated that JMJD5 is a post-translational co-repressor for NFATc1 that attenuates osteoclastogenesis.	[Kato, Shigeaki] Univ Tokyo, Shigeaki Kato Lab Nucl Signaling, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Minehata, Ken-ichi; Suzuki, Takeshi] Kanazawa Univ, Div Funct Genom, Mol & Cellular Targeting Translat Oncol Ctr, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan	University of Tokyo; Kanazawa University; Oriental Yeast Co., Ltd.	Kato, S (corresponding author), Univ Tokyo, Shigeaki Kato Lab Nucl Signaling, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp; yimai@iam.u-tokyo.ac.jp	Yokoyama, Atsushi/W-3519-2019; Imai, Yuuki/ABC-4687-2020	Yokoyama, Atsushi/0000-0003-2842-4334	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [23689066, 23659712]; Grants-in-Aid for Scientific Research [24590346, 23659712] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a postdoctoral fellowship for foreign researchers (to M.-Y. Y.) and a grant for specially promoted research (to S. K.) from the Japan Society for the Promotion of Science and Grants-in-aid 23689066 and 23659712 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. I.).	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Day CJ, 2004, J CELL BIOCHEM, V91, P303, DOI 10.1002/jcb.10780; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Harrison P R, 1990, Immunol Ser, V49, P411; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Miyamoto J, 2007, MOL CELL BIOL, V27, P4807, DOI 10.1128/MCB.02039-06; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sawatsubashi S, 2010, GENE DEV, V24, P159, DOI 10.1101/gad.1857410; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Youn MY, 2010, GENES CELLS, V15, P1025, DOI 10.1111/j.1365-2443.2010.01441.x; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	43	43	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12994	13004		10.1074/jbc.M111.323105	http://dx.doi.org/10.1074/jbc.M111.323105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375008	Green Published, hybrid			2022-12-25	WOS:000302903700038
J	Parma, V; Tirindelli, R; Bisazza, A; Massaccesi, S; Castiello, U				Parma, Valentina; Tirindelli, Roberto; Bisazza, Angelo; Massaccesi, Stefano; Castiello, Umberto			Subliminally Perceived Odours Modulate Female Intrasexual Competition: An Eye Movement Study	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; HUMAN PHEROMONES; MENSTRUAL-CYCLE; EVOLUTIONARY PSYCHOLOGY; STEROID ANDROSTADIENONE; PUTATIVE PHEROMONES; HUMAN CHEMOSIGNAL; SEX-DIFFERENCES; BRAIN RESPONSE; MALE FACES	Background: Evidence suggests that subliminal odorants influence human perception and behavior. It has been hypothesized that the human sex-steroid derived compound 4,16-androstadien-3-one (androstadienone) functions as a human chemosignal. The most intensively studied steroid compound, androstadienone is known to be biologically relevant since it seems to convey information about male mate quality to women. It is unclear if the effects of androstadienone are menstrual cycle related. Methodology/Principal Findings: In the first experiment, heterosexual women were exposed to androstadienone or a control compound and asked to view stimuli such as female faces, male faces and familiar objects while their eye movements were recorded. In the second experiment the same women were asked to rate the level of stimuli attractiveness following exposure to the study or control compound. The results indicated that women at high conception risk spent more time viewing the female than the male faces regardless of the compound administered. Women at a low conception risk exhibited a preference for female faces only following exposure to androstadienone. Conclusions/Significance: We contend that a woman's level of fertility influences her evaluation of potential competitors (e.g., faces of other women) during times critical for reproduction. Subliminally perceived odorants, such as androstadienone, might similarly enhance intrasexual competition strategies in women during fertility phases not critical for conception. These findings offer a substantial contribution to the current debate about the effects that subliminally perceived body odors might have on behavior.	[Parma, Valentina; Bisazza, Angelo; Massaccesi, Stefano; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Tirindelli, Roberto] Univ Parma, Dept Neurosci, I-43100 Parma, Italy	University of Padua; University of Parma	Parma, V (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	Parma, Valentina/AAR-7176-2020; Parma, Valentina/K-3268-2016	Castiello, Umberto/0000-0003-0629-1286; Bisazza, Angelo/0000-0003-0209-7638; Parma, Valentina/0000-0003-0276-7072				Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; BERNSTEIN IH, 1982, PERCEPT PSYCHOPHYS, V32, P495, DOI 10.3758/BF03204202; BIRD S, 1983, EXPERIENTIA, V39, P790, DOI 10.1007/BF01990330; Boulkroune N, 2007, NEUROPSYCHOPHARMACOL, V32, P1822, DOI 10.1038/sj.npp.1301303; BROOKSBANK BW, 1972, J ENDOCRINOL, V52, P239, DOI 10.1677/joe.0.0520239; Buss DM, 1997, CLIN PSYCHOL REV, V17, P605, DOI 10.1016/S0272-7358(97)00037-8; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1990, J SOC PERS RELAT, V7, P395, DOI 10.1177/0265407590073006; Chopra A, 2008, NEUROIMAGE, V40, P1257, DOI 10.1016/j.neuroimage.2008.01.015; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Doty R., 2010, GREAT PHEROMONE MYTH; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Fisher ML, 2004, P ROY SOC B-BIOL SCI, V271, pS283, DOI 10.1098/rsbl.2004.0160; Garver-Apgar CE, 2008, EVOL HUM BEHAV, V29, P223, DOI 10.1016/j.evolhumbehav.2007.12.007; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hays WST, 2003, BEHAV ECOL SOCIOBIOL, V54, P89, DOI 10.1007/s00265-003-0613-4; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; KWAN TK, 1992, J STEROID BIOCHEM, V43, P549, DOI 10.1016/0960-0760(92)90243-C; Lundstrom JN, 2006, NEUROIMAGE, V30, P1340, DOI 10.1016/j.neuroimage.2005.10.040; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Mazzatenta A, 2010, THERMAL SIGNATURES H; NIXON A, 1988, J STEROID BIOCHEM, V29, P505, DOI 10.1016/0022-4731(88)90185-9; Pause BM, 2004, PHYSIOL BEHAV, V83, P21, DOI 10.1016/j.physbeh.2004.07.019; Pawlowski B, 2008, COLLEGIUM ANTROPOL, V32, P457; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schmitt DP, 1996, J PERS SOC PSYCHOL, V70, P1185, DOI 10.1037/0022-3514.70.6.1185; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; VANTOLLER C, 1983, BIOL PSYCHOL, V16, P85, DOI 10.1016/0301-0511(83)90056-X; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; World Medical Association Declaration of Helsinki, ETH PRIC MED RES INV; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; ZAJONC RB, 1984, AM PSYCHOL, V39, P117, DOI 10.1037/0003-066X.39.2.117; [No title captured]	67	42	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30645	10.1371/journal.pone.0030645	http://dx.doi.org/10.1371/journal.pone.0030645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383968	gold, Green Published			2022-12-25	WOS:000302918500012
J	Roberts, SB; Hauser, L; Seeb, LW; Seeb, JE				Roberts, Steven B.; Hauser, Lorenz; Seeb, Lisa W.; Seeb, James E.			Development of Genomic Resources for Pacific Herring through Targeted Transcriptome Pyrosequencing	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; HEMORRHAGIC SEPTICEMIA VIRUS; RESOLUTION MELTING ANALYSIS; VALDEZ OIL-SPILL; CLUPEA-PALLASI; POPULATION-GENETICS; SNP DISCOVERY; ALASKA; DISEASE; MODELS	Pacific herring (Clupea pallasii) support commercially and culturally important fisheries but have experienced significant additional pressure from a variety of anthropogenic and environmental sources. In order to provide genomic resources to facilitate organismal and population level research, high-throughput pyrosequencing (Roche 454) was carried out on transcriptome libraries from liver and testes samples taken in Prince William Sound, the Bering Sea, and the Gulf of Alaska. Over 40,000 contigs were identified with an average length of 728 bp. We describe an annotated transcriptome as well as a workflow for single nucleotide polymorphism (SNP) discovery and validation. A subset of 96 candidate SNPs chosen from 10,933 potential SNPs, were tested using a combination of Sanger sequencing and high-resolution melt-curve analysis. Five SNPs supported between-ocean-basin differentiation, while one SNP associated with immune function provided high differentiation between Prince William Sound and Kodiak Island within the Gulf of Alaska. These genomic resources provide a basis for environmental physiology studies and opportunities for marker development and subsequent population structure analysis.	[Roberts, Steven B.; Hauser, Lorenz; Seeb, Lisa W.; Seeb, James E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Roberts, SB (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	sr320@uw.edu	Seeb, Lisa W/GSN-3076-2022; Hauser, Lorenz/E-4365-2010	Roberts, Steven/0000-0001-8302-1138	Exxon Valdez Oil Spill Trustee Council [10100165-A]	Exxon Valdez Oil Spill Trustee Council(Exxon Mobil Corporation)	The research described in this paper was supported by the Exxon Valdez Oil Spill Trustee Council project 10100165-A (http://www.evostc.state.ak.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Carls MG, 2002, CAN J FISH AQUAT SCI, V59, P153, DOI 10.1139/F01-200; Deriso RB, 2008, ECOL APPL, V18, P1270, DOI 10.1890/07-0708.1; Elston RA, 2009, DIS AQUAT ORGAN, V83, P223, DOI 10.3354/dao02005; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; EVOSTC, 2008, PRINC WILL SOUND INT; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Goetz F, 2010, MOL ECOL, V19, P176, DOI 10.1111/j.1365-294X.2009.04481.x; GRANT WS, 1984, CAN J FISH AQUAT SCI, V41, P856, DOI 10.1139/f84-102; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Marty GD, 2010, DIS AQUAT ORGAN, V90, P1, DOI 10.3354/dao02210; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; Marty GD, 1998, DIS AQUAT ORGAN, V32, P15, DOI 10.3354/dao032015; McGlauflin MT, 2010, T AM FISH SOC, V139, P676, DOI 10.1577/T09-103.1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; O'Connell M, 1998, J FISH BIOL, V53, P150; Roberts SB, 2012, HERRING HEPATIC TRAN; Roberts SB, 2012, HERRING TESTICULAR T; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Seeb JE, 1999, GENETIC DISCRIMINATI; Stegeman JJ, 1993, AQUATIC TOXICOLOGY M, P87; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; WHITEHEAD AS, 1985, IMMUNOL REV, V87, P185, DOI 10.1111/j.1600-065X.1985.tb01150.x; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8	33	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30908	10.1371/journal.pone.0030908	http://dx.doi.org/10.1371/journal.pone.0030908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383979	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500016
J	Wallstrom, P; Sonestedt, E; Hlebowicz, J; Ericson, U; Drake, I; Persson, M; Gullberg, B; Hedblad, B; Wirfalt, E				Wallstrom, Peter; Sonestedt, Emily; Hlebowicz, Joanna; Ericson, Ulrika; Drake, Isabel; Persson, Margaretha; Gullberg, Bo; Hedblad, Bo; Wirfalt, Elisabet			Dietary Fiber and Saturated Fat Intake Associations with Cardiovascular Disease Differ by Sex in the Malmo Diet and Cancer Cohort: A Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOOD HABIT CHANGE; MYOCARDIAL-INFARCTION; POOLED ANALYSIS; HISTORY METHOD; BREAST-CANCER; RISK; MORTALITY; TIME; MEN	Background: The aim of the study was to examine associations between intake of macronutrients and dietary fiber and incident ischemic cardiovascular disease (iCVD) in men and women. Methods: We used data from 8,139 male and 12,535 female participants (aged 44-73 y) of the Swedish population-based Malmo Diet and Cancer cohort. The participants were without history of CVD and diabetes mellitus, and had reported stable dietary habits in the study questionnaire. Diet was assessed by a validated modified diet history method, combining a 7-d registration of cooked meals and cold beverages, a 168-item food questionnaire (covering other foods and meal patterns), and a 1-hour diet interview. Sociodemographic and lifestyle data were collected by questionnaire. iCVD cases, which included coronary events (myocardial infarctions or deaths from chronic ischemic heart disease) and ischemic strokes, were ascertained via national and local registries. Nutrient-disease associations were examined by multivariate Cox regressions. Results: During a mean follow-up of 13.5 years, we identified 1,089 male and 687 female iCVD cases. High fiber intakes were associated with lower incidence rates of iCVD in women and of ischemic stroke in men. In post-hoc analysis, we discovered statistically significant interactions between intake of fiber and saturated fat; these interactions also differed between men and women (p < 0.001). Conclusions: In this well-defined population, a high fiber intake was associated with lower risk of iCVD, but there were no robust associations between other macronutrients and iCVD risk. Judging from this study, gender-specific nutrient analysis may be preferable in epidemiology.	[Wallstrom, Peter; Drake, Isabel; Gullberg, Bo; Wirfalt, Elisabet] Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden; [Hlebowicz, Joanna] Lund Univ, Dept Clin Sci, Expt Cardiovasc Res Unit, Malmo, Sweden; [Persson, Margaretha] Lund Univ, Dept Clin Sci, Internal Med Res Unit, Malmo, Sweden	Lund University; Lund University; Lund University	Wallstrom, P (corresponding author), Lund Univ, Dept Clin Sci, Nutr Epidemiol Res Grp, Malmo, Sweden.	peter.wallstrom@med.lu.se	Sonestedt, Emily/I-3814-2016	Sonestedt, Emily/0000-0002-0747-4562; Persson, Margaretha/0000-0001-8188-5792; Drake, Isabel/0000-0002-6500-6310; Ericson, Ulrika/0000-0003-4629-4318	Swedish governmental funds for clinical research (ALF); Heart-Lung Foundation, Region Skane; Skane University Hospital; Ernhold Lundstrom Foundation	Swedish governmental funds for clinical research (ALF); Heart-Lung Foundation, Region Skane; Skane University Hospital; Ernhold Lundstrom Foundation	This paper was funded by grants from Swedish governmental funds for clinical research (ALF), the Heart-Lung Foundation, Region Skane, the research funds of the Skane University Hospital and the Ernhold Lundstrom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bingham SA, 2006, INT J EPIDEMIOL, V35, P1022, DOI 10.1093/ije/dyl142; Byers T, 1997, AM J CLIN NUTR, V66, P1541; Cust AE, 2009, EUR J CLIN NUTR, V63, pS37, DOI 10.1038/ejcn.2009.74; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134; Eshak ES, 2010, J NUTR, V140, P1445, DOI 10.3945/jn.110.122358; Food and Agriculture Organization/World Health Organization (FAO/WHO), 2010, 91 FAOWHO; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hlebowicz J, 2011, J INTERN MED, V270, P365, DOI 10.1111/j.1365-2796.2011.02382.x; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Jacobs DR, 2007, NUTR REV, V65, P439, DOI [10.1111/j.1753-4887.2007.tb00269.x, 10.1301/nr.2007.oct.439-450]; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; Leosdottir M, 2007, EUR J CARDIOV PREV R, V14, P701, DOI 10.1097/HJR.0b013e3282a56c45; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Macintyre S, 1997, DESIGN CONCEPTS NUTR, P273; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Manjer J, 2002, SCAND J PUBLIC HEALT, V30, P103, DOI 10.1080/14034940210133771; Mattisson I, 2005, BRIT J NUTR, V94, P832, DOI 10.1079/BJN20051573; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Board of Health and Welfare, 2000, VARD DIAGN AK HJART; National Food Administration, 2010, T FAT; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sonestedt E, 2005, PUBLIC HEALTH NUTR, V8, P876, DOI 10.1079/PHN2005736; Sonestedt E, 2007, PUBLIC HEALTH NUTR, V10, P769, DOI 10.1017/S1368980007246646; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Thiebaut ACM, 2008, CANCER INVEST, V26, P68, DOI 10.1080/07357900701527918; Warensjo E, 2010, AM J CLIN NUTR, V92, P194, DOI 10.3945/ajcn.2009.29054; WHO, 1985, ENERGY PROTEIN REQUI; Willett W., 1998, NUTR EPIDEMIOL, V122, P101; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; World Health Organization, 2000, WHO TECHN REP SER, V894; Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007	49	47	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31637	10.1371/journal.pone.0031637	http://dx.doi.org/10.1371/journal.pone.0031637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384046	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500033
J	Yan, C; Ding, XC; Dasgupta, N; Wu, LY; Du, H				Yan, Cong; Ding, Xinchun; Dasgupta, Nupur; Wu, Lingyan; Du, Hong			Gene Profile of Myeloid-Derived Suppressive Cells from the Bone Marrow of Lysosomal Acid Lipase Knock-Out Mice	PLOS ONE			English	Article							MAMMALIAN PROTEIN; IMMUNE-SYSTEM; LAL(-/-) MICE; INFLAMMATION; CANCER; EXPRESSION; RAPAMYCIN; MTOR; LUNG; YEAST	Background: Lysosomal acid lipase (LAL) controls development and homeostasis of myeloid lineage cells. Loss of the lysosomal acid lipase (LAL) function leads to expansion of myeloid-derived suppressive cells (MDSCs) that cause myeloproliferative neoplasm. Methodology/Principal Findings: Affymetrix GeneChip microarray analysis identified detailed intrinsic defects in Ly6G(+) myeloid lineage cells of LAL knock-out (lal(-/-)) mice. Ingenuity Pathway Analysis revealed activation of the mammalian target of rapamycin (mTOR) signaling, which functions as a nutrient/energy/redox sensor, and controls cell growth, cell cycle entry, cell survival, and cell motility. Loss of the LAL function led to major alteration of large GTPase and small GTPase signal transduction pathways. lal(-/-) Ly6G(+) myeloid cells in the bone marrow showed substantial increase of cell proliferation in association with up-regulation of cyclin and cyclin-dependent kinase (cdk) genes. The epigenetic microenvironment was significantly changed due to the increased expression of multiple histone cluster genes, centromere protein genes and chromosome modification genes. Gene expression of bioenergetic pathways, including glycolysis, aerobic glycolysis, mitochondrial oxidative phosphorylation, and respiratory chain proteins, was also increased, while the mitochondrial function was impaired in lal(-/-) Ly6G(+) myeloid cells. The concentration of reactive oxygen species (ROS) was significantly increased accompanied by up-regulation of nitric oxide/ROS production genes in these cells. Conclusions/Significance: This comprehensive gene profile study for the first time identifies and defines important gene pathways involved in the myeloid lineage cells towards MDSCs using lal(-/-) mouse model.	[Yan, Cong; Ding, Xinchun; Wu, Lingyan] Indiana Univ, Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Du, Hong] Indiana Univ, Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA; [Yan, Cong; Ding, Xinchun; Wu, Lingyan; Du, Hong] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Dasgupta, Nupur] Cincinnati Childrens Hosp, Div Human Genet, Med Ctr, Cincinnati, OH USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center	Yan, C (corresponding author), Indiana Univ, Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA.	hongdu@iupui.edu	ding, xinchun/P-5490-2017		National Institutes of Health [CA138759, CA152099, HL087001]; NATIONAL CANCER INSTITUTE [R01CA152099, R01CA138759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grants CA138759, CA152099 (CY) and HL087001 (HD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Kaipparettu BA, 2011, ANN NY ACAD SCI, V1201, P137; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Qu P, 2011, BLOOD, V117, P4476, DOI 10.1182/blood-2010-07-298380; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Recher C, 2005, CELL CYCLE, V4, P1540; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Scheele JS, 2007, IMMUNOL REV, V218, P92, DOI 10.1111/j.1600-065X.2007.00530.x; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Wu L, 2011, AM J PATHOL; Wu L, 2011, BLOOD; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30701	10.1371/journal.pone.0030701	http://dx.doi.org/10.1371/journal.pone.0030701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383970	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500014
J	Sanz, LM; Crespo, B; De-Cozar, C; Ding, XC; Llergo, JL; Burrows, JN; Garcia-Bustos, JF; Gamo, FJ				Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier			P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action	PLOS ONE			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; SEMIAUTOMATED MICRODILUTION TECHNIQUE; PLASMODIUM-VIVAX MALARIA; DRUG-SENSITIVITY; ARTEMISININ RESISTANCE; SULFADOXINE-PYRIMETHAMINE; TREATMENT FAILURE; CHLOROQUINE; MECHANISM; PARASITE	Chemotherapy is still the cornerstone for malaria control. Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately determine the parasite killing rate in response to treatment. Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability. However, these approaches are susceptible to artefacts, as viability and metabolism are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions. Moreover, traditional techniques do not allow to measure the speed-of-action of compounds on parasite viability, which is an essential efficacy determinant. We present here a comprehensive methodology to measure in vitro the direct effect of antimalarial compounds over the parasite viability, which is based on limiting serial dilution of treated parasites and re-growth monitoring. This methodology allows to precisely determine the killing rate of antimalarial compounds, which can be quantified by the parasite reduction ratio and parasite clearance time, which are key mode-of-action parameters. Importantly, we demonstrate that this technique readily permits to determine compound killing activities that might be otherwise missed by traditional, metabolism-based techniques. The analysis of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compounds based on their antimalarial mode-of-action. This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compounds, which are crucially needed for the control and possibly the eradication of malaria.	[Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Llergo, Jose L.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier] GlaxoSmithKline, Dis Dev World, Tres Cantos, Madrid, Spain; [Ding, Xavier C.; Burrows, Jeremy N.] Med Malaria Venture, Geneva, Switzerland	GlaxoSmithKline	Sanz, LM (corresponding author), GlaxoSmithKline, Dis Dev World, Tres Cantos, Tres Cantos Med Dev Campus, Madrid, Spain.	francisco-javier.b.gamo@gsk.com		Garcia-Bustos, Jose/0000-0002-6310-796X				Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Burkhardt D, 2007, INT J PARASITOL, V37, P777, DOI 10.1016/j.ijpara.2006.12.010; Bustos DG, 1999, J INFECT DIS, V179, P1587, DOI 10.1086/314770; Codd A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-56; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ding XC, 2011, TRENDS PARASITOL, V27, P73, DOI 10.1016/j.pt.2010.11.006; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dunne MW, 2005, AM J TROP MED HYG, V73, P1108; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Frita R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-74; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gomes M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-39; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; HIEN TT, 1993, LANCET, V341, P603; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-294; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; KREMSNER PG, 1993, AM J TROP MED HYG, V49, P650, DOI 10.4269/ajtmh.1993.49.650; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2003, TRENDS PARASITOL, V19, P175, DOI 10.1016/S1471-4922(03)00028-X; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; RIECKMANN KH, 1978, LANCET, V1, P22; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Thapa S, 2007, AM J TROP MED HYG, V77, P423, DOI 10.4269/ajtmh.2007.77.423; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Xiang H, 2006, J PHARM SCI-US, V95, P2657, DOI 10.1002/jps.20681; YOUNG RD, 1993, ANTIMICROB AGENTS CH, V37, P1102, DOI 10.1128/AAC.37.5.1102; ZHANEL GG, 1991, DICP ANN PHARMAC, V25, P153, DOI 10.1177/106002809102500210	48	125	127	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30949	10.1371/journal.pone.0030949	http://dx.doi.org/10.1371/journal.pone.0030949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383983	Green Published, gold			2022-12-25	WOS:000302916100010
J	Dodson, ML; Walker, RC; Lloyd, RS				Dodson, M. L.; Walker, Ross C.; Lloyd, R. Stephen			Carbinolamine Formation and Dehydration in a DNA Repair Enzyme Active Site	PLOS ONE			English	Article							BASE EXCISION-REPAIR; FREE-ENERGY DIFFERENCES; MOLECULAR-DYNAMICS; PROTEIN; GLYCOSYLASE; SIMULATIONS; MECHANISMS; SUBSTRATE; CHARGES; COMPLEX	In order to suggest detailed mechanistic hypotheses for the formation and dehydration of a key carbinolamine intermediate in the T4 pyrimidine dimer glycosylase (T4PDG) reaction, we have investigated these reactions using steered molecular dynamics with a coupled quantum mechanics-molecular mechanics potential (QM/MM). We carried out simulations of DNA abasic site carbinolamine formation with and without a water molecule restrained to remain within the active site quantum region. We recovered potentials of mean force (PMF) from thirty replicate reaction trajectories using Jarzynski averaging. We demonstrated feasible pathways involving water, as well as those independent of water participation. The water-independent enzyme-catalyzed reaction had a bias-corrected Jarzynski-average barrier height of approximately 6.5 kcal mol(-1) (27.2 kJ mol(-1)) for the carbinolamine formation reaction and 44.5 kcal mol(-1) (186 kJ mol(-1)) for the reverse reaction at this level of representation. When the proton transfer was facilitated with an intrinsic quantum water, the barrier height was approximately 15 kcal mol(-1) (62.8 kJ mol(-1)) in the forward (formation) reaction and 19 kcal mol(-1) (79.5 kJ mol(-1)) for the reverse. In addition, two modes of unsteered (free dynamics) carbinolamine dehydration were observed: in one, the quantum water participated as an intermediate proton transfer species, and in the other, the active site protonated glutamate hydrogen was directly transferred to the carbinolamine oxygen. Water-independent unforced proton transfer from the protonated active site glutamate carboxyl to the unprotonated N-terminal amine was also observed. In summary, complex proton transfer events, some involving water intermediates, were studied in QM/MM simulations of T4PDG bound to a DNA abasic site. Imine carbinolamine formation was characterized using steered QM/MM molecular dynamics. Dehydration of the carbinolamine intermediate to form the final imine product was observed in free, unsteered, QM/MM dynamics simulations, as was unforced acid-base transfer between the active site carboxylate and the N-terminal amine.	[Dodson, M. L.] Act Site Dynam LLC, Houston, TX USA; [Walker, Ross C.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Walker, Ross C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Oregon Health & Science University	Dodson, ML (corresponding author), Act Site Dynam LLC, Houston, TX USA.	mldodson@comcast.net		Lloyd, R. Stephen/0000-0001-7273-372X	National Science Foundation through TeraGrid Supercomputer resources; Purdue University Steele cluster; Advanced User Support; San Diego Supercomputer Center under TeraGrid [TG-MCB090181, TG-MCB090110]; National Science Foundation [NSF1047875]; University of California [09-LR-06-117792-WALR];  [R01-ES004091-20]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004091] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1047875] Funding Source: National Science Foundation	National Science Foundation through TeraGrid Supercomputer resources(National Science Foundation (NSF)); Purdue University Steele cluster; Advanced User Support; San Diego Supercomputer Center under TeraGrid; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported in part by grant R01-ES004091-20 to RSL and a subcontract of that grant to Active Site Dynamics LLC (Limited Liability Company). This research was also supported in part by the National Science Foundation through TeraGrid Supercomputer resources provided by the Purdue University Steele cluster and Advanced User Support provided by the San Diego Supercomputer Center under TeraGrid grant numbers TG-MCB090181 and TG-MCB090110. RCW also acknowledges support in part by grants NSF1047875 from the National Science Foundation and 09-LR-06-117792-WALR from the University of California Lab Fees program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akola J, 2003, J PHYS CHEM B, V107, P11774, DOI 10.1021/jp035538g; [Anonymous], 2008, AMBER 10; Babin V, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2844595; Bhagwat M, 1996, BIOCHEMISTRY-US, V35, P659, DOI 10.1021/bi9522662; Bustamante C, 2005, PHYS TODAY, V58, P43, DOI 10.1063/1.2012462; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; CORDES EH, 1962, J AM CHEM SOC, V84, P832, DOI 10.1021/ja00864a031; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fuxreiter M, 1999, BIOCHEMISTRY-US, V38, P9577, DOI 10.1021/bi9901937; Golan G, 2006, J MOL BIOL, V362, P241, DOI 10.1016/j.jmb.2006.06.059; Guo H, 2001, P NATL ACAD SCI USA, V98, P9032, DOI 10.1073/pnas.141230998; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jarzynski C, 2001, P NATL ACAD SCI USA, V98, P3636, DOI 10.1073/pnas.081074598; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Kleinert H, 1995, PATH INTEGRALS QUANT; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Meijer EJ, 1998, J AM CHEM SOC, V120, P6345, DOI 10.1021/ja972935u; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; POREZAG D, 1995, PHYS REV B, V51, P12947, DOI 10.1103/PhysRevB.51.12947; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Walker RK, 2006, BIOCHEMISTRY-US, V45, P14192, DOI 10.1021/bi060802s; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xiong H, 2006, THEOR CHEM ACC, V116, P338, DOI 10.1007/s00214-005-0072-2	39	6	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31377	10.1371/journal.pone.0031377	http://dx.doi.org/10.1371/journal.pone.0031377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384015	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500017
J	Glendorf, T; Knudsen, L; Stidsen, CE; Hansen, BF; Hegelund, AC; Sorensen, AR; Nishimura, E; Kjeldsen, T				Glendorf, Tine; Knudsen, Louise; Stidsen, Carsten E.; Hansen, Bo F.; Hegelund, Anne Charlotte; Sorensen, Anders R.; Nishimura, Erica; Kjeldsen, Thomas			Systematic Evaluation of the Metabolic to Mitogenic Potency Ratio for B10-Substituted Insulin Analogues	PLOS ONE			English	Article							GROWTH-FACTOR-I; RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; IGF-1 RECEPTOR; LIGAND-BINDING; B-CHAIN; ACTIVATION; AFFINITY; REGIONS	Background: Insulin analogues comprising acidic amino acid substitutions at position B10 have previously been shown to display increased mitogenic potencies compared to human insulin and the underlying molecular mechanisms have been subject to much scrutiny and debate. However, B10 is still an attractive position for amino acid substitutions given its important role in hexamer formation. The aim of this study was to investigate the relationships between the receptor binding properties as well as the metabolic and mitogenic potencies of a series of insulin analogues with different amino acid substitutions at position B10 and to identify a B10-substituted insulin analogue without an increased mitogenic to metabolic potency ratio. Methodology/Principal Findings: A panel of ten singly-substituted B10 insulin analogues with different amino acid side chain characteristics were prepared and insulin receptor (both isoforms) and IGF-I receptor binding affinities using purified receptors, insulin receptor dissociation rates using BHK cells over-expressing the human insulin receptor, metabolic potencies by lipogenesis in isolated rat adipocytes, and mitogenic potencies using two different cell types predominantly expressing either the insulin or the IGF-I receptor were systematically investigated. Only analogues B10D and B10E with significantly increased insulin and IGF-I receptor affinities as well as decreased insulin receptor dissociation rates displayed enhanced mitogenic potencies in both cell types employed. For the remaining analogues with less pronounced changes in receptor affinities and insulin receptor dissociation rates, no apparent correlation between insulin receptor occupancy time and mitogenicity was observed. Conclusions/Significance: Several B10-substituted insulin analogues devoid of disproportionate increases in mitogenic compared to metabolic potencies were identified. In the present study, receptor binding affinity rather than insulin receptor off-rate appears to be the major determinant of both metabolic and mitogenic potency. Our results also suggest that the increased mitogenic potency is attributable to both insulin and IGF-I receptor activation.	[Glendorf, Tine; Stidsen, Carsten E.; Hansen, Bo F.; Hegelund, Anne Charlotte; Sorensen, Anders R.; Nishimura, Erica; Kjeldsen, Thomas] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Knudsen, Louise] Novo Nordisk AS, Diabet Res Unit, DK-2820 Gentofte, Denmark	Novo Nordisk; Novo Nordisk	Glendorf, T (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	tgle@novonordisk.com		Kjeldsen, Thomas/0000-0003-0094-9286; Nishimura, Erica/0000-0001-5741-3648	Danish Ministry of Science, Technology and Innovation; Novo Nordisk Training and Research Program; Novo Nordisk A/S	Danish Ministry of Science, Technology and Innovation; Novo Nordisk Training and Research Program; Novo Nordisk A/S(Novo Nordisk)	This work was supported by the Danish Ministry of Science, Technology and Innovation, the Novo Nordisk Training and Research Program, and Novo Nordisk A/S. The commercial funders of the study did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as the authors are employed by Novo Nordisk A/S.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; FUJITAYAMAGUCHI Y, 1983, J BIOL CHEM, V258, P5045; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hamel FG, 1999, METABOLISM, V48, P611, DOI 10.1016/S0026-0495(99)90059-8; Hansen BF, 2008, HORM METAB RES, V40, P431, DOI 10.1055/s-2008-1062740; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 2010, DIABETOLOGIA, V53, pS22; Hansen BF, 1996, BIOCHEM J, V315, P271; HEINEMANN L, 1990, DIABETOLOGIA, V33, P384, DOI 10.1007/BF00404644; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; Jensen M, 2009, VITAM HORM, V80, P51, DOI 10.1016/S0083-6729(08)00603-1; JORGENSEN LN, 1992, DIABETOLOGIA, V35, pA3; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Rakatzi I, 2003, DIABETES, V52, P2227, DOI 10.2337/diabetes.52.9.2227; RODBELL M, 1964, J BIOL CHEM, V239, P375; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598	54	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e29198	10.1371/journal.pone.0029198	http://dx.doi.org/10.1371/journal.pone.0029198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383948	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500002
J	Bright, JA				Bright, Jen A.			The Importance of Craniofacial Sutures in Biomechanical Finite Element Models of the Domestic Pig	PLOS ONE			English	Article							CRANIAL SUTURES; GEOMETRIC MORPHOMETRICS; FUNCTIONAL IMPLICATIONS; PERIODONTAL-LIGAMENT; ELASTIC PROPERTIES; ZYGOMATIC ARCH; SURFACE STRAIN; CORTICAL BONE; SENSITIVITY; VALIDATION	Craniofacial sutures are a ubiquitous feature of the vertebrate skull. Previous experimental work has shown that bone strain magnitudes and orientations often vary when moving from one bone to another, across a craniofacial suture. This has led to the hypothesis that craniofacial sutures act to modify the strain environment of the skull, possibly as a mode of dissipating high stresses generated during feeding or impact. This study tests the hypothesis that the introduction of craniofacial sutures into finite element (FE) models of a modern domestic pig skull would improve model accuracy compared to a model without sutures. This allowed the mechanical effects of sutures to be assessed in isolation from other confounding variables. These models were also validated against strain gauge data collected from the same specimen ex vivo. The experimental strain data showed notable strain differences between adjacent bones, but this effect was generally not observed in either model. It was found that the inclusion of sutures in finite element models affected strain magnitudes, ratios, orientations and contour patterns, yet contrary to expectations, this did not improve the fit of the model to the experimental data, but resulted in a model that was less accurate. It is demonstrated that the presence or absence of sutures alone is not responsible for the inaccuracies in model strain, and is suggested that variations in local bone material properties, which were not accounted for by the FE models, could instead be responsible for the pattern of results.	Univ Bristol, Dept Earth Sci, Bristol, Avon, England	University of Bristol	Bright, JA (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	j.bright@bristol.ac.uk	Bright, Jen/AAK-8750-2020	Bright, Jen/0000-0002-9284-9591	Natural Environmental Research Council [NE/F007310/1]	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by Natural Environmental Research Council Studentship, NE/F007310/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2011, BIOL LETT IN PRESS, DOI [10.1098/rsbl.2011.0674, DOI 10.1098/RSBL.2011.0674.IN]; Bright JA, 2011, J MORPHOL, V272, P1388, DOI 10.1002/jmor.10991; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; Byron CD, 2009, J HUM EVOL, V57, P649, DOI 10.1016/j.jhevol.2008.11.006; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Dechow PC, 2010, ANAT REC, V293, P618, DOI 10.1002/ar.21124; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Hall Brian, 2005, P1; Herrel A, 2000, J EXP BIOL, V203, P1415; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; HERRING SW, 1972, ACTA ANAT, V83, P222; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1973, J MORPHOL, V141, P427, DOI 10.1002/jmor.1051410405; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Nicolay CW, 2006, J MORPHOL, V267, P841, DOI 10.1002/jmor.10445; Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Popowics TE, 2007, J BIOMECH, V40, P837, DOI 10.1016/j.jbiomech.2006.03.011; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Rayfield EJ, 2011, J ANAT, V218, P47, DOI 10.1111/j.1469-7580.2010.01296.x; Reed DA, 2011, J ANAT, V218, P59, DOI 10.1111/j.1469-7580.2010.01319.x; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Thomason JJ, 2001, ANAT REC, V264, P325, DOI 10.1002/ar.10025; Tickhill J, 2007, VIRTUAL PIG HEAD DIG; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438; Wang QA, 2010, ANAT REC, V293, P1477, DOI 10.1002/ar.21203; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; Wang Qian, 2008, P149, DOI 10.1007/978-0-387-76585-3_8; Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	47	25	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31769	10.1371/journal.pone.0031769	http://dx.doi.org/10.1371/journal.pone.0031769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363727	Green Published, gold			2022-12-25	WOS:000302873700094
J	Palaniyandi, S; Mitra, A; Herren, CD; Lockatell, CV; Johnson, DE; Zhu, XP; Mukhopadhyay, S				Palaniyandi, Senthilkumar; Mitra, Arindam; Herren, Christopher D.; Lockatell, C. Virginia; Johnson, David E.; Zhu, Xiaoping; Mukhopadhyay, Suman			BarA-UvrY Two-Component System Regulates Virulence of Uropathogenic E-coli CFT073	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM INVASION; URINARY-TRACT-INFECTION; GENE-EXPRESSION; PROTEIN CSRA; HEMOLYSIN; MOTILITY; IDENTIFICATION; EPIDEMIOLOGY; DETERMINANT; INDUCTION	Uropathogenic Escherichia coli (UPEC), a member of extraintestinal pathogenic E. coli, cause similar to 80% of community-acquired urinary tract infections (UTI) in humans. UPEC initiates its colonization in epithelial cells lining the urinary tract with a complicated life cycle, replicating and persisting in intracellular and extracellular niches. Consequently, UPEC causes cystitis and more severe form of pyelonephritis. To further understand the virulence characteristics of UPEC, we investigated the roles of BarA-UvrY two-component system (TCS) in regulating UPEC virulence. Our results showed that mutation of BarA-UvrY TCS significantly decreased the virulence of UPEC CFT073, as assessed by mouse urinary tract infection, chicken embryo killing assay, and cytotoxicity assay on human kidney and uroepithelial cell lines. Furthermore, mutation of either barA or uvrY gene reduced the production of hemolysin, lipopolysaccharide (LPS), proinflammatory cytokines (TNF-alpha and IL-6) and chemokine (IL-8). The virulence phenotype was restored similar to that of wild-type by complementation of either barA or uvrY gene in trans. In addition, we discussed a possible link between the BarA-UvrY TCS and CsrA in positively and negatively controlling virulence in UPEC. Overall, this study provides the evidences for BarA-UvrY TCS regulates the virulence of UPEC CFT073 and may point to mechanisms by which virulence regulations are observed in different ways may control the long-term survival of UPEC in the urinary tract.	[Palaniyandi, Senthilkumar; Mitra, Arindam; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Palaniyandi, Senthilkumar; Zhu, Xiaoping] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mitra, Arindam] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA; [Lockatell, C. Virginia; Johnson, David E.] Univ Maryland, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21201 USA; [Johnson, David E.] Dept Vet Affairs, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland Baltimore	Palaniyandi, S (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013; Palaniyandi, Senthilkumar/B-9575-2016	Mitra, Arindam/0000-0002-1591-6164; 	United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; University of Maryland; National Institutes of Health [R01 AI65892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065892] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive; USDA-Animal Health; University of Maryland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318, Maryland Agriculture Experimental Station grant from the University of Maryland (to SM) and a National Institutes of Health Grant R01 AI65892 (to XZ). No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1993, J CLIN INVEST, V92, P780, DOI 10.1172/JCI116650; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; BRUMFITT W, 1987, LANCET, V1, P824; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Craig JC, 2009, NEW ENGL J MED, V361, P1748, DOI 10.1056/NEJMoa0902295; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; Forsbach-Birk V, 2004, INT J MED MICROBIOL, V294, P15, DOI 10.1016/j.ijmm.2003.12.003; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; HEDGES S, 1994, INFECT IMMUN, V62, P2315, DOI 10.1128/IAI.62.6.2315-2321.1994; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hedlund M, 1999, MOL MICROBIOL, V33, P693, DOI 10.1046/j.1365-2958.1999.01513.x; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Le Bouguenec C, 2005, INT J MED MICROBIOL, V295, P471, DOI 10.1016/j.ijmm.2005.07.001; MACKMAN N, 1985, MOL GEN GENET, V201, P282, DOI 10.1007/BF00425672; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Mukhopadhyay S, 1997, J BACTERIOL, V179, P330, DOI 10.1128/jb.179.2.330-338.1997; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; Nicolle LE, 2001, INFECT MED, V18, P153; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sahu SC, 2008, ESCHERICHIA COLI STR, P205; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Tomenius H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-27; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; WELCH RA, 1984, INFECT IMMUN, V43, P156, DOI 10.1128/IAI.43.1.156-160.1984; Wong SM, 1998, INFECT IMMUN, V66, P5854, DOI 10.1128/IAI.66.12.5854-5861.1998; Zhang LX, 2003, FRONT BIOSCI-LANDMRK, V8, pE235, DOI 10.2741/1007	57	32	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31348	10.1371/journal.pone.0031348	http://dx.doi.org/10.1371/journal.pone.0031348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363626	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700052
J	Peterson, BL; Larson, J; Buffenstein, R; Park, TJ; Fall, CP				Peterson, Bethany L.; Larson, John; Buffenstein, Rochelle; Park, Thomas J.; Fall, Christopher P.			Blunted Neuronal Calcium Response to Hypoxia in Naked Mole-Rat Hippocampus	PLOS ONE			English	Article							METHYL-D-ASPARTATE; GLUTAMATE RELEASE; SOMATOSENSORY ORGANIZATION; INTRACELLULAR CALCIUM; HETEROCEPHALUS-GLABER; VERTEBRATE NEURONS; BRAIN ISCHEMIA; CA1 NEURONS; TOLERANCE; ANOXIA	Naked mole-rats are highly social and strictly subterranean rodents that live in large communal colonies in sealed and chronically oxygen-depleted burrows. Brain slices from naked mole-rats show extreme tolerance to hypoxia compared to slices from other mammals, as indicated by maintenance of synaptic transmission under more hypoxic conditions and three fold longer latency to anoxic depolarization. A key factor in determining whether or not the cellular response to hypoxia is reversible or leads to cell death may be the elevation of intracellular calcium concentration. In the present study, we used fluorescent imaging techniques to measure relative intracellular calcium changes in CA1 pyramidal cells of hippocampal slices during hypoxia. We found that calcium accumulation during hypoxia was significantly and substantially attenuated in slices from naked mole-rats compared to slices from laboratory mice. This was the case for both neonatal (postnatal day 6) and older (postnatal day 20) age groups. Furthermore, while both species demonstrated more calcium accumulation at older ages, the older naked mole-rats showed a smaller calcium accumulation response than even the younger mice. A blunted intracellular calcium response to hypoxia may contribute to the extreme hypoxia tolerance of naked mole-rat neurons. The results are discussed in terms of a general hypothesis that a very prolonged or arrested developmental process may allow adult naked mole-rat brain to retain the hypoxia tolerance normally only seen in neonatal mammals.	[Peterson, Bethany L.; Larson, John; Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Larson, John; Park, Thomas J.] Univ Illinois, Lab Integrat Neurosci, Chicago, IL 60680 USA; [Larson, John] Univ Illinois, Inst Psychiat, Dept Psychiat, Chicago, IL 60680 USA; [Fall, Christopher P.] Univ Illinois, Dept Bioengn, Chicago, IL 60680 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst, San Antonio, TX 78229 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Fall, Christopher P.] Georgetown Univ, Dept Comp Sci, Washington, DC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Georgetown University	Peterson, BL (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	tpark@uic.edu			National Science Foundation [0744979]; National Institutes of Health-National Institute of Mental Health Neurotechnology [MH-085973]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085973] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0744979] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health-National Institute of Mental Health Neurotechnology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grant 0744979 (TJP, JL), (www.nsf.gov/), National Institutes of Health-National Institute of Mental Health Neurotechnology program through grant MH-085973 (CPF), (www.nimh.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIELI R, 1979, COMP BIOCHEM PHYS A, V63, P569, DOI 10.1016/0300-9629(79)90197-X; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Beierlein M, 2002, J NEUROSCI, V22, P9885; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Bickler PE, 1996, NEUROPHARMACOLOGY, V35, P679, DOI 10.1016/S0028-3908(96)00030-5; Bickler PE, 1998, J EXP BIOL, V201, P1141; Bickler PE, 2004, J EXP BIOL, V207, P3243, DOI 10.1242/jeb.00977; Bickler PE, 2002, J EXP BIOL, V205, P3579; BICKLER PE, 1993, J CEREBR BLOOD F MET, V13, P811, DOI 10.1038/jcbfm.1993.103; Bickler PE, 2003, NEUROSCIENCE, V118, P25, DOI 10.1016/S0306-4522(02)00763-7; Brand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015162; Brett R.A., 1991, P137; Buck LT, 1998, J EXP BIOL, V201, P289; Buck LT, 2004, COMP BIOCHEM PHYS B, V139, P401, DOI 10.1016/j.cbpc.2004.04.002; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 1996, MAMMALIA, V60, P591, DOI 10.1515/mamm.1996.60.4.591; Crish SD, 2003, BRAIN BEHAV EVOLUT, V62, P141, DOI 10.1159/000072723; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Drew KL, 2004, J EXP BIOL, V207, P3155, DOI 10.1242/jeb.01114; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Folkow LP, 2008, NEUROSCI LETT, V446, P147, DOI 10.1016/j.neulet.2008.09.040; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; FRIEDMAN JE, 1993, J NEUROSCI, V13, P63; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hedrick MS, 2005, J EXP BIOL, V208, P681, DOI 10.1242/jeb.01436; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; JOHANSEN K, 1976, RESP PHYSIOL, V28, P303, DOI 10.1016/0034-5687(76)90025-6; Kasaikina MV, 2011, J BIOL CHEM, V286, P17005, DOI 10.1074/jbc.M110.216267; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lavocat R., 1978, P69; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Maclean JN, 2005, IMAGING NEUROSCIENCE, P351; MITANI A, 1990, NEUROSCI LETT, V120, P42, DOI 10.1016/0304-3940(90)90163-4; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; Neher E, 2005, IMAGING NEUROSCIENCE, P245; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; Peterson BL, 2011, NEUROSCIENC IN PRESS; Ross AP, 2006, J CEREBR BLOOD F MET, V26, P1148, DOI 10.1038/sj.jcbfm.9600271; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Shimazaki K, 1998, NEUROREPORT, V9, P1875, DOI 10.1097/00001756-199806010-00038; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Zhao HWW, 2006, J CHEM NEUROANAT, V32, P196, DOI 10.1016/j.jchemneu.2006.09.002	57	42	48	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31568	10.1371/journal.pone.0031568	http://dx.doi.org/10.1371/journal.pone.0031568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363676	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700074
J	Vaccaro, A; Tauffenberger, A; Aggad, D; Rouleau, G; Drapeau, P; Parker, JA				Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Drapeau, Pierre; Parker, J. Alex			Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CORTICAL HYPEREXCITABILITY; DROSOPHILA MODEL; MUTATIONS; INSIGHTS; NEURONS; PROTEIN; ONSET; ALS	Mutations in the DNA/RNA binding proteins TDP-43 and FUS are associated with Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Intracellular accumulations of wild type TDP-43 and FUS are observed in a growing number of late-onset diseases suggesting that TDP-43 and FUS proteinopathies may contribute to multiple neurodegenerative diseases. To better understand the mechanisms of TDP-43 and FUS toxicity we have created transgenic Caenorhabditis elegans strains that express full-length, untagged human TDP-43 and FUS in the worm's GABAergic motor neurons. Transgenic worms expressing mutant TDP-43 and FUS display adult-onset, age-dependent loss of motility, progressive paralysis and neuronal degeneration that is distinct from wild type alleles. Additionally, mutant TDP-43 and FUS proteins are highly insoluble while wild type proteins remain soluble suggesting that protein misfolding may contribute to toxicity. Populations of mutant TDP-43 and FUS transgenics grown on solid media become paralyzed over 7 to 12 days. We have developed a liquid culture assay where the paralysis phenotype evolves over several hours. We introduce C. elegans transgenics for mutant TDP-43 and FUS motor neuron toxicity that may be used for rapid genetic and pharmacological suppressor screening.	[Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Parker, J. Alex] Univ Montreal, Res Ctr, Ctr Hosp, Montreal, PQ, Canada; [Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Drapeau, Pierre; Parker, J. Alex] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada; [Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Drapeau, Pierre; Parker, J. Alex] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Rouleau, Guy] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Vaccaro, A (corresponding author), Univ Montreal, Res Ctr, Ctr Hosp, Montreal, PQ, Canada.	ja.parker@umontreal.ca	Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Vaccaro, Alexandra/0000-0002-3183-7343; Tauffenberger, Arnaud/0000-0003-0207-9659	Montreal University Hospital Foundation; Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research New Investigator; Frick Foundation; ALS Society of Canada	Montreal University Hospital Foundation; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research New Investigator(Canadian Institutes of Health Research (CIHR)); Frick Foundation; ALS Society of Canada	This research was supported by: Montreal University Hospital Foundation (http://fondationduchum.com/fr) to JAP, Natural Sciences and Engineering Research Council Discovery Grant (http://www.nserc-crsng.gc.ca) to JAP, Canadian Institutes of Health Research New Investigator (http://www.cihr-irsc.gc.ca) to JAP, Frick Foundation for ALS Research (http://frick-fondation.ch) to PD and JAP and a Bernice Ramsay Discovery Grant from the ALS Society of Canada (http://www.als.ca/) to JAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash P.E.A., 2010, HUM MOL GENET; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Caramia MD, 2000, NEUROLOGY, V54, P58, DOI 10.1212/WNL.54.1.58; Catoire H, 2008, HUM MOL GENET; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins James J, 2008, WormBook, P1, DOI 10.1895/wormbook.1.137.1; Deng HX, 2011, NATURE; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Duerr Janet S, 2006, WormBook, P1; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Gitcho MA, 2008, ANN NEUROL; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Jorgensen E.M., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.14.1, DOI 10.1895/WORMBOOK.1.14.1]; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kabashi E, 2008, NAT GENET; Kabashi E, 2011, PLOS GENET IN PRESS, VPLoS Genet; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lomen-Hoerth C, 2008, SEMIN NEUROL, V28, P205, DOI 10.1055/s-2008-1062265; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McCaffery JM, 2008, P NATL ACAD SCI US; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Murakami T, 2011, HUM MOL GENET; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Stiernagle Theresa, 2006, WormBook, P1; Swarup V, 2011, BRAIN; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wang JW, 2011, J CLIN INVEST; Zhang T, 2011, HUM MOL GENET	48	64	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31321	10.1371/journal.pone.0031321	http://dx.doi.org/10.1371/journal.pone.0031321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363618	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700047
J	Wu, TJ; Chen, TC; Wang, F; Chan, KM; Soong, RS; Chou, HS; Lee, WC; Yeh, CT				Wu, Ting-Jung; Chen, Tse-Ching; Wang, Frank; Chan, Kun-Ming; Soong, Ruey-Shyang; Chou, Hong-Shiue; Lee, Wei-Chen; Yeh, Chau-Ting			Large Fragment Pre-S Deletion and High Viral Load Independently Predict Hepatitis B Relapse after Liver Transplantation	PLOS ONE			English	Article							VIRUS RECURRENCE; IMMUNE GLOBULIN; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE THERAPY; LOW-RISK; PROPHYLAXIS; REINFECTION; GENOTYPE; IMMUNOGLOBULIN; PREVENTION	Hepatitis B virus (HBV) associated end-stage liver diseases are the leading causes of liver transplantation (LT) in Taiwan. Relapse of hepatitis B occurs after LT, raising the risk of graft failure and reducing patient survival. Although several oral antiviral agents have been approved for anti-HBV treatment, lamivudine (LAM) remained to be the most widely used preventive regimen in Taiwan. While several clinical predictors have been identified for hepatitis B relapse, the predictive roles of the histopathological characteristics in liver explants as well as the genotypic features of the viruses in pre-LT serum samples have not been assessed. Between September 2002 and August 2009, 150 consecutive hepatitis B surface antigen (HBsAg) positive patients undergoing LT were included for outcome analysis following assessment of the clinicopathological and virological factors prior to LT. Kaplan-Meier analyses discovered that pre-operative LAM treatment <= 3 months; membranous distribution and higher expression of tissue HBsAg in liver explants; preoperative viral load >= 10(6) copies/ml; and presence of large fragment (> 100 base pairs) pre-S deletion (LFpreSDel) correlated significantly with hepatitis B relapse. Multivariate Cox regression analysis showed that the presence of LFpreSDel (P = 0.001) and viral load >= 10(6) copies/mL (P = 0.023) were independent predictors for hepatitis B relapse. In conclusion, besides high viral load, LFpreSDel mutation is an important independent predictor for hepatitis B relapse after LT. More aggressive preventive strategies should be applied for patients carrying these risk factors.	[Wu, Ting-Jung; Wang, Frank; Chan, Kun-Ming; Soong, Ruey-Shyang; Chou, Hong-Shiue; Lee, Wei-Chen] Chang Gung Mem Hosp, Dept Gen Surg, Div Liver & Transplantat Surg, Tao Yuan, Taiwan; [Wu, Ting-Jung] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Yeh, Chau-Ting] Chang Gung Med Ctr, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wu, TJ (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Div Liver & Transplantat Surg, Tao Yuan, Taiwan.	weichen@adm.cgmh.org.tw; chautingy@gmail.com			Chang Gung Medical Research Program [CMRPG370693]; national science council [NMRP 98-2314-B-182A-048]	Chang Gung Medical Research Program; national science council(Ministry of Science and Technology, Taiwan)	This study is supported by a grant from Chang Gung Medical Research Program (CMRPG370693) and a grant from the national science council (NMRP 98-2314-B-182A-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus PW, 2008, LIVER TRANSPLANT, V14, pS15, DOI 10.1002/lt.21614; Angus PW, 2000, LIVER TRANSPLANT, V6, P429, DOI 10.1053/jlts.2000.8310; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chun J, 2010, AM J TRANSPLANT, V10, P1649, DOI 10.1111/j.1600-6143.2010.03162.x; Degertekin B, 2010, AM J TRANSPLANT, V10, P1823, DOI 10.1111/j.1600-6143.2010.03046.x; Faria LC, 2008, GASTROENTEROLOGY, V134, P1890, DOI 10.1053/j.gastro.2008.02.064; Fung J, 2011, GASTROENTEROLOGY, V141, P1212, DOI 10.1053/j.gastro.2011.06.083; Gaglio P, 2008, LIVER TRANSPLANT, V14, P1420, DOI 10.1002/lt.21563; Grottola A, 2002, LIVER TRANSPLANT, V8, P443, DOI 10.1053/jlts.2002.32719; Han SHB, 2000, LIVER TRANSPLANT, V6, P741, DOI 10.1053/jlts.2000.18702; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim WR, 2004, LIVER TRANSPLANT, V10, P968, DOI 10.1002/lt.20217; Lake JR, 2008, LIVER TRANSPLANT, V14, pS23, DOI 10.1002/lt.21637; LAKE JR, 1991, HEPATOLOGY, V13, P796, DOI 10.1002/hep.1840130429; Lenci I, 2011, J HEPATOL, V55, P587, DOI 10.1016/j.jhep.2010.12.036; Lo CM, 2005, AM J TRANSPLANT, V5, P1893, DOI 10.1111/j.1600-6143.2005.00952.x; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Lok ASF, 2002, LIVER TRANSPLANT, V8, pS67, DOI 10.1053/jlts.2002.35780; Markowitz JS, 1998, HEPATOLOGY, V28, P585, DOI 10.1002/hep.510280241; Marzano A, 2005, LIVER TRANSPLANT, V11, P402, DOI 10.1002/lt.20402; Marzano A, 2001, J HEPATOL, V34, P903, DOI 10.1016/S0168-8278(01)00080-0; Nath DS, 2006, CLIN TRANSPLANT, V20, P206, DOI 10.1111/j.1399-0012.2005.00467.x; Rosenau J, 2001, J HEPATOL, V34, P895, DOI 10.1016/S0168-8278(01)00089-7; Saab S, 2009, LIVER TRANSPLANT, V15, P1525, DOI 10.1002/lt.21882; Shouval D, 2000, HEPATOLOGY, V32, P1189, DOI 10.1053/jhep.2000.19789; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Steinmuller T, 2002, HEPATOLOGY, V35, P1528, DOI 10.1053/jhep.2002.33681; Tchervenkov J, 1997, ANN SURG, V226, P367; Tchervenkov JI, 1997, ANN SURG, V226, P356, DOI 10.1097/00000658-199709000-00015; TODO S, 1991, HEPATOLOGY, V13, P619, DOI 10.1002/hep.1840130402; Wong SN, 2007, LIVER TRANSPLANT, V13, P374, DOI 10.1002/lt.21041; Woo HY, 2008, J MED VIROL, V80, P1891, DOI 10.1002/jmv.21324; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yi NJ, 2007, LIVER TRANSPLANT, V13, P451, DOI 10.1002/lt.21043; Yuen MF, 2003, HEPATOLOGY, V37, P562, DOI 10.1053/jhep.2003.50098	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32189	10.1371/journal.pone.0032189	http://dx.doi.org/10.1371/journal.pone.0032189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363813	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700154
J	Gray, SA; Weigel, KM; Ali, IKM; Lakey, AA; Capalungan, J; Domingo, GJ; Cangelosi, GA				Gray, Sean A.; Weigel, Kris M.; Ali, Ibne K. M.; Lakey, Annie A.; Capalungan, Jeremy; Domingo, Gonzalo J.; Cangelosi, Gerard A.			Toward Low-Cost Affinity Reagents: Lyophilized Yeast-scFv Probes Specific for Pathogen Antigens	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; ENTAMOEBA-HISTOLYTICA; SURFACE DISPLAY; FLOW-CYTOMETRY; DIAGNOSIS; BANGLADESH; EXPRESSION; AMEBIASIS; LIBRARY; GENES	The generation of affinity reagents, usually monoclonal antibodies, remains a critical bottleneck in biomedical research and diagnostic test development. Recombinant antibody-like proteins such as scFv have yet to replace traditional monoclonal antibodies in antigen detection applications, in large part because of poor performance of scFv in solution. To address this limitation, we have developed assays that use whole yeast cells expressing scFv on their surfaces (yeast-scFv) in place of soluble purified scFv or traditional monoclonal antibodies. In this study, a nonimmune library of human scFv displayed on the surfaces of yeast cells was screened for clones that bind to recombinant cyst proteins of Entamoeba histolytica, an enteric pathogen of humans. Selected yeast-scFv clones were stabilized by lyophilization and used in detection assay formats in which the yeast-scFv served as solid support-bound monoclonal antibodies. Specific binding of antigen to the yeast-scFv was detected by staining with rabbit polyclonal antibodies. In flow cytometry-based assays, lyophilized yeast-scFv reagents retained full binding activity and specificity for their cognate antigens after 4 weeks of storage at room temperature in the absence of desiccants or stabilizers. Because flow cytometry is not available to all potential assay users, an immunofluorescence assay was also developed that detects antigen with similar sensitivity and specificity. Antigen-specific whole-cell yeast-scFv reagents can be selected from nonimmune libraries in 2-3 weeks, produced in vast quantities, and packaged in lyophilized form for extended shelf life. Lyophilized yeast-scFv show promise as low cost, renewable alternatives to monoclonal antibodies for diagnosis and research.	[Gray, Sean A.; Weigel, Kris M.; Lakey, Annie A.; Cangelosi, Gerard A.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ali, Ibne K. M.] Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Capalungan, Jeremy; Domingo, Gonzalo J.] PATH, Seattle, WA USA	Center for Infectious Disease Research; University of Virginia	Gray, SA (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	jerry.cangelosi@seattlebiomed.org		Weigel, Kris/0000-0003-3199-2148; Domingo, Gonzalo/0000-0002-1004-4395	NIAID [R21 AI0744571, U01AI082186]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082186] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by NIAID grant R21 AI0744571 to S.A.G. and by a NIAID grant U01AI082186 to G.A.C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei A, 2011, J MICROBIOL BIOTECHN, V21, P529, DOI 10.4014/jmb.1010.10022; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chatterjee A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000498; Cho YK, 2009, J IMMUNOL METHODS, V341, P117, DOI 10.1016/j.jim.2008.11.005; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Ghosh SK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000750; Gray SA, 2011, BIOTECHNOL BIOENG; Gray SA, 2010, BIOTECHNOL BIOENG, V105, P973, DOI 10.1002/bit.22607; Haque R, 2006, ARCH MED RES, V37, P273, DOI 10.1016/j.arcmed.2005.09.001; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; HAQUE R, 1995, J CLIN MICROBIOL, V33, P2558, DOI 10.1128/JCM.33.10.2558-2561.1995; Haque R, 2010, J CLIN MICROBIOL, V48, P2798, DOI 10.1128/JCM.00152-10; Hobson-Peters J, 2010, J VIROL METHODS, V168, P177, DOI 10.1016/j.jviromet.2010.05.012; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Liu DB, 2011, J BIOL CHEM, V286, P24500, DOI 10.1074/jbc.M110.211847; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Petri WA, 2000, PARASITOL TODAY, V16, P320, DOI 10.1016/S0169-4758(00)01730-0; Scholler N, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-41; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Ta HT, 2011, CIRC RES, V109, P365, DOI 10.1161/CIRCRESAHA.111.249375; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s	24	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32042	10.1371/journal.pone.0032042	http://dx.doi.org/10.1371/journal.pone.0032042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363793	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500107
J	Ye, ZJ; Yuan, ML; Zhou, Q; Du, RH; Yang, WB; Xiong, XZ; Zhang, JC; Wu, C; Qin, SM; Shi, HZ				Ye, Zhi-Jian; Yuan, Ming-Li; Zhou, Qiong; Du, Rong-Hui; Yang, Wei-Bing; Xiong, Xian-Zhi; Zhang, Jian-Chu; Wu, Cong; Qin, Shou-Ming; Shi, Huan-Zhong			Differentiation and Recruitment of Th9 Cells Stimulated by Pleural Mesothelial Cells in Human Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							T-CELLS; TGF-BETA; IL-9; CD4(+)	Newly discovered IL-9-producing CD4(+) helper T cells (Th9 cells) have been reported to contribute to tissue inflammation and immune responses, however, differentiation and immune regulation of Th9 cells in tuberculosis remain unknown. In the present study, our data showed that increased Th9 cells with the phenotype of effector memory cells were found to be in tuberculous pleural effusion as compared with blood. TGF-beta was essential for Th9 cell differentiation from naive CD4(+)T cells stimulated with PMA and ionomycin in vitro for 5 h, and addition of IL-1 beta, IL-4 or IL-6 further augmented Th9 cell differentiation. Tuberculous pleural effusion and supernatants of cultured pleural mesothelial cells were chemotactic for Th9 cells, and this activity was partly blocked by anti-CCL20 antibody. IL-9 promoted the pleural mesothelial cell repairing and inhibited IFN-gamma-induced pleural mesothelial cell apoptosis. Moreover, pleural mesothelial cells promoted Th9 cell differentiation by presenting antigen. Collectively, these data provide new information concerning Th9 cells, in particular the collaborative immune regulation between Th9 cells and pleural mesothelial cells in human M. tuberculosis infection. In particular, pleural mesothelial cells were able to function as antigen-presenting cells to stimulate Th9 cell differentiation.	[Ye, Zhi-Jian; Yuan, Ming-Li; Zhou, Qiong; Yang, Wei-Bing; Xiong, Xian-Zhi; Zhang, Jian-Chu; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Pulm Dis, Hlth Minist,Dept Resp Dis,Union Hosp, Wuhan 430074, Peoples R China; [Du, Rong-Hui] Wuhan Inst TB Prevent & Control, Dept Internal Med, Wuhan, Peoples R China; [Wu, Cong; Qin, Shou-Ming] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Peoples R China	Huazhong University of Science & Technology; Guangxi Medical University	Ye, ZJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Pulm Dis, Hlth Minist,Dept Resp Dis,Union Hosp, Wuhan 430074, Peoples R China.	shihuanzhong@sina.com			National Basic Research Program of China (973 Program) [2012CB518700]; National Science Fund for Distinguished Young Scholars of China [30925032]; National Natural Science Foundation of China [30872343]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700); in part by a grant from the National Science Fund for Distinguished Young Scholars of China (No. 30925032); and in part by a grant from the National Natural Science Foundation of China (No. 30872343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberis MCP, 1997, ACTA CYTOL, V41, P1757; BARNES PF, 1990, J IMMUNOL, V145, P149; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Leard LE, 2004, RESPIROLOGY, V9, P292, DOI 10.1111/j.1440-1843.2004.00602.x; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Mutsaers SE, 2004, RESPIROLOGY, V9, P428, DOI 10.1111/j.1440-1843.2004.00633.x; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Nasreen N, 1999, J INFECT DIS, V180, P1616, DOI 10.1086/315057; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Qin XJ, 2005, EUR RESPIR J, V25, P605, DOI 10.1183/09031936.05.00090804; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yang HB, 2008, CHINESE MED J-PEKING, V121, P579, DOI 10.1097/00029330-200804010-00001; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307	33	50	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31710	10.1371/journal.pone.0031710	http://dx.doi.org/10.1371/journal.pone.0031710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363712	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500079
J	Zhang, C; Xiong, Y; Li, JN; Yang, Y; Liu, L; Wang, W; Wang, L; Li, MH; Fang, ZY				Zhang, Chao; Xiong, Yi; Li, Jiana; Yang, Yang; Liu, Li; Wang, Wen; Wang, Luo; Li, Manhui; Fang, Zhengyu			Deletion and Down-Regulation of HRH4 Gene in Gastric Carcinomas: A Potential Correlation with Tumor Progression	PLOS ONE			English	Article							HISTAMINE-RECEPTOR ANTAGONISTS; COLORECTAL-CANCER; COPY NUMBER; HELICOBACTER-PYLORI; AUTOCRINE REGULATOR; CELL-PROLIFERATION; H-4 RECEPTORS; H4 RECEPTORS; GROWTH; EXPRESSION	Background: Histamine is an established growth factor for gastrointestinal malignancies. The effect of histamine is largely determined locally by the histamine receptor expression pattern. Histamine receptor H4 (HRH4), the newest member of the histamine receptor family, is positively expressed on the epithelium of the gastrointestinal tract, and its function remains to be elucidated. Previously, we reported the decreased expression of HRH4 in colorectal cancers and revealed its correlation with tumor proliferation. In the current study, we aimed to investigate the abnormalities of HRH4 gene in gastric carcinomas (GCs). Methodology/Principal Findings: We analyzed H4R expression in collected GC samples by quantitative PCR, Western blot analysis, and immunostaining. Our results showed that the protein and mRNA levels of HRH4 were reduced in some GC samples, especially in advanced GC samples. Copy number decrease of HRH4 gene was observed (17.6%, 23 out of 131), which was closely correlated with the attenuated expression of H4R. In vitro studies, using gastric cancer cell lines, showed that the alteration of HRH4 expression on gastric cancer cells influences tumor growth upon exposure to histamine. Conclusions/Significance: We show for the first time that deletion of HRH4 gene is present in GC cases and is closely correlated with attenuated gene expression. Down-regulation of HRH4 in gastric carcinomas plays a role in histamine-mediated growth control of GC cells.	[Zhang, Chao; Xiong, Yi; Li, Jiana; Yang, Yang; Liu, Li; Wang, Wen; Wang, Luo; Li, Manhui; Fang, Zhengyu] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center	Zhang, C (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China.	fangzy796@gmail.com	Fang, Zhengyu/GRY-6636-2022		National Natural Science Foundation of China [81001173/H1622]; Fundamental Research Plan of Shenzhen City [JC201005260215A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Plan of Shenzhen City	This work was supported by National Natural Science Foundation of China (81001173/H1622) and Fundamental Research Plan of Shenzhen City(JC201005260215A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMLAND P F, 1987, Tidsskrift for den Norske Laegeforening, V107, P1058; Bach S, 2002, INFECT IMMUN, V70, P988, DOI 10.1128/IAI.70.2.988-992.2002; Backert S, 2005, PROTEOMICS, V5, P3902, DOI 10.1002/pmic.200401240; Blaya Bruno, 2010, Inflammation & Allergy Drug Targets, V9, P146; Boer K, 2008, EUR J CELL BIOL, V87, P227, DOI 10.1016/j.ejcb.2007.12.003; BURTIN C, 1988, LANCET, V2, P1369; BURTIN C, 1982, BRIT J CANCER, V45, P54, DOI 10.1038/bjc.1982.7; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Ciacci C, 1996, DIGEST DIS SCI, V41, P972, DOI 10.1007/BF02091539; Cianchi F, 2005, CLIN CANCER RES, V11, P6807, DOI 10.1158/1078-0432.CCR-05-0675; Cricco GP, 2008, INFLAMM RES, V57, pS23, DOI 10.1007/s00011-007-0611-5; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Fang ZY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-195; Fang ZY, 2011, PATHOL ONCOL RES, V17, P657, DOI 10.1007/s12253-010-9359-2; Fukushima Yasushi, 2004, Nihon Rinsho, V62, P551; Knosel T, 2003, HISTOPATHOLOGY, V43, P323, DOI 10.1046/j.1365-2559.2003.01720.x; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Malaviya R, 2000, LEUKEMIA LYMPHOMA, V36, P367, DOI 10.3109/10428190009148858; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; Medina V, 2008, CANCER BIOL THER, V7, P28, DOI 10.4161/cbt.7.1.5123; Molnar EL, 2001, INFLAMM RES, V50, pS102; NIELSEN HJ, 1991, ACTA CHIR-EUR J SURG, V157, P437; Petit-Bertron AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006504; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; SUONIO E, 1994, AGENTS ACTIONS, V41, pC118, DOI 10.1007/BF02007793; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Yamamoto S, 2010, GENE CHROMOSOME CANC, V49, P487, DOI 10.1002/gcc.20759; Yu B, 2010, BRIT J DERMATOL, V163, P935, DOI 10.1111/j.1365-2133.2010.09928.x	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31207	10.1371/journal.pone.0031207	http://dx.doi.org/10.1371/journal.pone.0031207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363581	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500029
J	Al-Tawashi, A; Jung, SY; Liu, D; Su, B; Qin, J				Al-Tawashi, Azza; Jung, Sung Yun; Liu, Dou; Su, Bing; Qin, Jun			Protein Implicated in Nonsyndromic Mental Retardation Regulates Protein Kinase A (PKA) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-HT1A RECEPTOR GENE; NF-KAPPA-B; NADPH OXIDASE; ANCHORED PKA; C2 DOMAIN; CAMP; FAMILY; PHOSPHODIESTERASES; COMPLEXES; DISEASE	Mutation of the coiled-coil and C2 domain-containing 1A (CC2D1A) gene, which encodes a C2 domain and DM14 domain-containing protein, has been linked to severe autosomal recessive nonsyndromic mental retardation. Using a mouse model that produces a truncated form of CC2D1A that lacks the C2 domain and three of the four DM14 domains, we show that CC2D1A is important for neuronal differentiation and brain development. CC2D1A mutant neurons are hypersensitive to stress and have a reduced capacity to form dendrites and synapses in culture. At the biochemical level, CC2D1A transduces signals to the cyclic adenosine 3',5'-monophosphate (cAMP)-protein kinase A (PKA) pathway during neuronal cell differentiation. PKA activity is compromised, and the translocation of its catalytic subunit to the nucleus is also defective in CC2D1A mutant cells. Consistently, phosphorylation of the PKA target cAMP-responsive element-binding protein, at serine 133, is nearly abolished in CC2D1A mutant cells. The defects in cAMP/PKA signaling were observed in fibroblast, macrophage, and neuronal primary cells derived from the CC2D1A KO mice. CC2D1A associates with the cAMP-PKA complex following forskolin treatment and accumulates in vesicles or on the plasma membrane in wild-type cells, suggesting that CC2D1A may recruit the PKA complex to the membrane to facilitate signal transduction. Together, our data show that CC2D1A is an important regulator of the cAMP/PKA signaling pathway, which may be the underlying cause for impaired mental function in nonsyndromic mental retardation patients with CC2D1A mutation.	[Al-Tawashi, Azza; Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Al-Tawashi, Azza; Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Al-Tawashi, Azza] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal 23955, Saudi Arabia; [Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Liu, Dou; Su, Bing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; King Abdullah University of Science & Technology; Yale University; Yale University	Al-Tawashi, A (corresponding author), Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	azza.altawashi@kaust.edu.sa; Bing.su@yale.edu; jqin@bcm.edu		Jung, Sung Yun/0000-0003-1521-7977	Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology	Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology	It is a pleasure to thank those who instructed A. A. on how to work with neurons: Hsiao-Tuan Chao and Paymaan Jafar-Nejad from Al Zoghbi Laboratory and Zilai Wang from Huffington Center at Baylor College of Medicine. We also thank Professor Kenneth P Minneman, Dean, Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology, for guidance and support in preparing this paper.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Barnette M S, 2000, Curr Opin Pulm Med, V6, P164, DOI 10.1097/00063198-200003000-00014; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; GIBBS CS, 1992, J BIOL CHEM, V267, P4806; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; Lopez-Nicolas R, 2006, J MOL BIOL, V357, P1105, DOI 10.1016/j.jmb.2006.01.018; Manganiello VC, 1999, THROMB HAEMOSTASIS, V82, P407, DOI 10.1055/s-0037-1615860; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Ou XM, 2003, J NEUROSCI, V23, P7415; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Rogaeva A, 2007, J NEUROSCI RES, V85, P2833, DOI 10.1002/jnr.21277; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TASKEN K, 1993, J BIOL CHEM, V268, P21276; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14644	14658		10.1074/jbc.M111.261875	http://dx.doi.org/10.1074/jbc.M111.261875			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22375002	Green Published, hybrid			2022-12-25	WOS:000304003200031
J	Fabrichny, IP; Mondielli, G; Conrod, S; Martin-Eauclaire, MF; Bourne, Y; Marchot, P				Fabrichny, Igor P.; Mondielli, Gregoire; Conrod, Sandrine; Martin-Eauclaire, Marie-France; Bourne, Yves; Marchot, Pascale			Structural Insights into Antibody Sequestering and Neutralizing of Na+ Channel alpha-Type Modulator from Old World Scorpion Venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; PROTEIN RECOGNITION SITES; TOXIN-II; MONOCLONAL-ANTIBODIES; SODIUM-CHANNELS; FUNCTIONAL-EVALUATION; STRUCTURE REFINEMENT; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURES; AMM-VIII	The Old World scorpion Androctonus australis hector (Aah) produces one of the most lethal venoms for humans. Peptidic alpha-toxins AahI to AahIV are responsible for its potency, with AahII accounting for half of it. All four toxins are high affinity blockers of the fast inactivation phase of mammalian voltage-activated Na+ channels. However, the high antigenic polymorphism of alpha-toxins prevents production of a polyvalent neutralizing antiserum, whereas the determinants dictating their trapping by neutralizing antibodies remain elusive. From an anti-AahII mAb, we generated an antigen binding fragment (Fab) with high affinity and selectivity for AahII and solved a 2.3 angstrom-resolution crystal structure of the complex. Sequestering of the C-terminal region of the bound toxin within a groove formed by the Fab combining loops is associated with a toxin orientation and main and side chain conformations that dictate the AahII antigenic specificity and efficient neutralization. From an anti-AahI mAb, we also preformed and crystallized a high affinity AahI-Fab complex. The 1.6 angstrom-resolution structure solved revealed a Fab molecule devoid of a bound AahI and with combining loops involved in packing interactions, denoting expulsion of the bound antigen upon crystal formation. Comparative analysis of the groove-like combining site of the toxin-bound anti-AahII Fab and planar combining surface of the unbound anti-AahI Fab along with complementary data from a flexible docking approach suggests occurrence of distinctive trapping orientations for the two toxins relative to their respective Fab. This study provides complementary templates for designing new molecules aimed at capturing Aah alpha-toxins and suitable for immunotherapy.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, CNRS, UMR 7257, F-13288 Marseille 09, France; [Fabrichny, Igor P.; Mondielli, Gregoire; Conrod, Sandrine; Martin-Eauclaire, Marie-France; Marchot, Pascale] Aix Marseille Univ, CNRS, UMR 6231,CRN2M,CS80011, Inst Federatif Rech Jean Roche,Fac Med Secteur No, F-13344 Marseille 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bourne, Y (corresponding author), Aix Marseille Univ, CNRS, UMR 7257, Campus Luminy Case 932, F-13288 Marseille 09, France.	fabri@ibcgenerium.ru; yves.bourne@afmb.univ-mrs.fr; pascale.marchot@univ-amu.fr	MARCHOT, Pascale/AAC-4752-2022; Bourne, Yves/AAC-4635-2022	MARCHOT, Pascale/0000-0003-0630-0541; Bourne, Yves/0000-0003-3850-0548; Mondielli, Gregoire/0000-0001-9608-7961	CNRS; Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; FRM	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); FRM(Fondation pour la Recherche Medicale)	Recipients of postdoctoral grants from the CNRS and the Fondation pour la Recherche Medicale and Ph.D. grants from the Association Francaise contre les Myopathies and the FRM, respectively.	Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alvarenga L, 2010, VACCINE, V28, P970, DOI 10.1016/j.vaccine.2009.10.135; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; BAHRAOUI E, 1986, MOL IMMUNOL, V23, P357, DOI 10.1016/0161-5890(86)90133-1; BAHRAOUI E, 1988, J IMMUNOL, V141, P214; BAHRAOUI EM, 1986, J IMMUNOL, V136, P3371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben Abderrazek R, 2011, PROTEIN ENG DES SEL, V24, P727, DOI 10.1093/protein/gzr037; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Canul-Tec JC, 2011, J BIOL CHEM, V286, P20892, DOI 10.1074/jbc.M111.238410; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Clot-Faybesse O, 1999, FEBS LETT, V458, P313, DOI 10.1016/S0014-5793(99)01179-5; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2007, TOXICON, V49, P171, DOI 10.1016/j.toxicon.2006.09.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELORI P, 1981, TOXICON, V19, P393, DOI 10.1016/0041-0101(81)90044-1; DEVAUX C, 1993, MOL IMMUNOL, V30, P1061, DOI 10.1016/0161-5890(93)90152-2; Devaux C, 1997, FEBS LETT, V412, P456, DOI 10.1016/S0014-5793(97)00826-0; Devaux C, 2002, J IMMUNOL METHODS, V271, P37, DOI 10.1016/S0022-1759(02)00338-1; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duarte CG, 2010, VACCINE, V28, P1168, DOI 10.1016/j.vaccine.2009.11.039; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ELAYEB M, 1983, MOL IMMUNOL, V20, P697, DOI 10.1016/0161-5890(83)90047-0; ELAYEB M, 1984, MOL IMMUNOL, V21, P223, DOI 10.1016/0161-5890(84)90077-4; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Gazarian KG, 2005, VACCINE, V23, P3357, DOI 10.1016/j.vaccine.2004.12.027; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRANIER C, 1989, MOL IMMUNOL, V26, P503, DOI 10.1016/0161-5890(89)90001-1; Granier C., 2009, ANIMAL TOXINS STAT 2, P123; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; JANIN J, 1990, J BIOL CHEM, V265, P16027; JOVER E, 1978, BIOCHEM BIOPH RES CO, V85, P377, DOI 10.1016/S0006-291X(78)80053-9; Juste M, 2007, CELL MOL LIFE SCI, V64, P206, DOI 10.1007/s00018-006-6401-3; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHARRAT R, 1990, TOXICON, V28, P509, DOI 10.1016/0041-0101(90)90295-I; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marchot P, 1996, PROTEIN SCI, V5, P672; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; MARTIN MF, 1986, TOXICON, V24, P1131, DOI 10.1016/0041-0101(86)90139-X; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Martin-Eauclaire MF, 2006, VACCINE, V24, P1990, DOI 10.1016/j.vaccine.2005.11.016; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; MIKOU A, 1992, J BIOMOL NMR, V2, P57, DOI 10.1007/BF02192800; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quintero-Hernandez V, 2007, MOL IMMUNOL, V44, P1307, DOI 10.1016/j.molimm.2006.05.009; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sami-Merah S, 2008, INT IMMUNOPHARMACOL, V8, P1386, DOI 10.1016/j.intimp.2008.05.011; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sun YM, 2003, J BIOL CHEM, V278, P24125, DOI 10.1074/jbc.M211931200; YAHI N, 1992, TOXICON, V30, P723, DOI 10.1016/0041-0101(92)90006-Q; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; YPEREZ GG, 1988, TOXICON, V26, P1102	76	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14136	14148		10.1074/jbc.M111.315382	http://dx.doi.org/10.1074/jbc.M111.315382			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371498	Green Published, hybrid			2022-12-25	WOS:000303996300066
J	Qin, JD; Berdyshev, E; Poirer, C; Schwartz, NB; Dawson, G				Qin, Jingdong; Berdyshev, Evgeny; Poirer, Christophe; Schwartz, Nancy B.; Dawson, Glyn			Neutral Sphingomyelinase 2 Deficiency Increases Hyaluronan Synthesis by Up-regulation of Hyaluronan Synthase 2 through Decreased Ceramide Production and Activation of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS-IMPERFECTA; SPHINGOSINE 1-PHOSPHATE; CELLS; ACID; RAFTS; APOPTOSIS; FORM; KINASE; SIGNAL; SPHINGOSINE-1-PHOSPHATE	Fibroblasts from the fro/fro mouse, with a deletion in the Smpd3 gene coding for the active site of neutral sphingomyelinase 2 (NSMase2), secreted increased amounts of hyaluronan (HA). This was reversed by transfection with the Smpd3 gene, suggesting a connection between sphingolipid and glycosaminoglycan metabolism. The deficiency of NSMase2 resulted in storage of sphingomyelin (SM) and cholesterol with a 50% reduction in ceramides (Cer). RT-PCR and Western blot analysis showed that increased HA secretion resulted from increased hyaluronan synthase 2 (HAS2) activity localized to sphingolipid-enriched lipid rafts. Although cholesterol levels were also elevated in lipid rafts from mouse fibroblasts deficient in lysosomal acid SMase activity (deletion of the Smpd1(-/-) gene), there was no increase in HA secretion. We then showed that in fro/fro fibroblasts, the reduced ceramide was associated with decreased phosphorylation of protein phosphatase 2A (PP2A) and increased phosphorylation of its substrate Akt-p, together with PI3K, PDK1, mTOR (mammalian target of rapamycin), and p70S6K, although PTEN was unaffected. Exogenous ceramide, as well as inhibitors of Akt (Akt inhibitor VIII), PI 3-kinase (LY294002 and wortmannin), and mTOR (rapamycin) reduced secretion of HA, whereas the NSMase2 inhibitor GW4869 increased HA synthesis and secretion. We propose that NSMase2/Cer are the key mediators of the regulation of HA synthesis, via microdomains and the Akt/mTOR pathway.	[Dawson, Glyn] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA; [Schwartz, Nancy B.; Dawson, Glyn] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Berdyshev, Evgeny] Univ Illinois, Inst Personalized Resp Med, Dept Med, Chicago, IL 60612 USA; [Poirer, Christophe] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University	Dawson, G (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, MC4068,5841 S Maryland Ave, Chicago, IL 60637 USA.	dawg@midway.uchicago.edu			National Institutes of Health from the United States Public Health Service [NS36866-37]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036866] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36866-37 from the United States Public Health Service (to G. D.).	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen SW, 2006, J NEUROCHEM, V97, P631, DOI 10.1111/j.1471-4159.2006.03774.x; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Goswami R, 1999, J NEUROSCI RES, V57, P884, DOI 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1; Goswami R, 2005, J NEUROSCI RES, V81, P541, DOI 10.1002/jnr.20550; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Gulbins Erich, 2002, Subcell Biochem, V36, P229; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; Kilkus J, 2003, J NEUROSCI RES, V72, P65, DOI 10.1002/jnr.10549; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MATUOKA K, 1985, CELL BIOL INT REP, V9, P577, DOI 10.1016/0309-1651(85)90023-2; MOSCATELLI D, 1975, NATURE, V254, P65, DOI 10.1038/254065a0; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Qin JD, 2010, J BIOL CHEM, V285, P14134, DOI 10.1074/jbc.M109.076810; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Sawai H, 2005, CURR PHARM DESIGN, V11, P2479, DOI 10.2174/1381612054367463; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Testai FD, 2004, J NEUROSCI RES, V75, P66, DOI 10.1002/jnr.10816; Tlapak-Simmons V. L., 2011, J GLYCOM LIPIDOM, pS1; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; TURAKAINEN H, 1983, BIOCHEM J, V213, P171, DOI 10.1042/bj2130171; TURAKAINEN H, 1980, BIOCHIM BIOPHYS ACTA, V628, P388, DOI 10.1016/0304-4165(80)90388-8; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; YONEDA M, 1988, J CELL SCI, V90, P275; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	59	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13620	13632		10.1074/jbc.M111.304857	http://dx.doi.org/10.1074/jbc.M111.304857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383528	Green Published, hybrid			2022-12-25	WOS:000303996300018
J	Seo, S; Lomberk, G; Mathison, A; Buttar, N; Podratz, J; Calvo, E; Iovanna, J; Brimijoin, S; Windebank, A; Urrutia, R				Seo, Seungmae; Lomberk, Gwen; Mathison, Angela; Buttar, Navtej; Podratz, Jewel; Calvo, Ezequiel; Iovanna, Juan; Brimijoin, Stephen; Windebank, Anthony; Urrutia, Raul			Kruppel-like Factor 11 Differentially Couples to Histone Acetyltransferase and Histone Methyltransferase Chromatin Remodeling Pathways to Transcriptionally Regulate Dopamine D2 Receptor in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; NEURITE OUTGROWTH; NERVOUS-SYSTEM; FACTOR KLF7; GENE; SP1; FAMILY; NEUROGENESIS; COREPRESSOR; ACTIVATION	The importance of Kruppel-like factor (KLF)-mediated transcriptional pathways in the biochemistry of neuronal differentiation has been recognized relatively recently. Elegant studies have revealed that KLF proteins are important regulators of two major molecular and cellular processes critical for neuronal cell differentiation: neurite formation and the expression of neurotransmitter-related genes. However, whether KLF proteins mediate these key processes in a separate or coordinated fashion remains unknown. Moreover, knowledge on the contribution of chromatin dynamics to the biochemical mechanisms utilized by these proteins to perform their function is absent. Here we report the characterization of two antagonistic, chromatin-mediated mechanisms by which KLF11, also known as TIEG2 (transforming growth factor-beta-inducible early gene 2) and MODYVII (maturity onset diabetes of the young VII), regulates transcription of the fopamine D2 receptor (Drd2) gene. First, KLF11 activates transcription by binding to a distinct Sp-KLF site within the Drd2 promoter (-98 to -94) and recruiting the p300 histone acetyltransferase. Second, Drd2 transcriptional activation is partially antagonized by heterochromatin protein 1 (HP1), the code reader for histone H3 lysine 9 methylation. Interestingly, KLF11 regulates neurotransmitter receptor gene expression in differentiating neuronal cell populations without affecting neurite formation. Overall, these studies highlight histone methylation and acetylation as key biochemical mechanisms modulating KLF-mediated neurotransmitter gene transcription. These data extend our knowledge of chromatin-mediated biochemical events that maintain key phenotypic features of differentiated neuronal cells.	[Urrutia, Raul] Mayo Clin, GI Res Unit, Lab Epigenet & Chromatin Dynam, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Seo, Seungmae; Lomberk, Gwen; Mathison, Angela; Buttar, Navtej; Urrutia, Raul] Mayo Clin, Dept Med, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Seo, Seungmae] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Podratz, Jewel; Windebank, Anthony] Mayo Clin, Dept Neurosci, Rochester, MN 55905 USA; [Brimijoin, Stephen] Mayo Clin, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHU Laval, Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Iovanna, Juan] Parc Sci & Technol Luminy, INSERM U624, Marseille, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Urrutia, R (corresponding author), Mayo Clin, GI Res Unit, Lab Epigenet & Chromatin Dynam, Dept Biochem & Mol Biol, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Iovanna, Juan/M-9805-2017	Lomberk, Gwen/0000-0001-5463-789X; Iovanna, Juan/0000-0003-1822-2237; Mathison, Angela/0000-0002-6763-2710; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK52913, CA110022-01, DK76845, P30DK084567]; Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE [R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, K08DK076845, P30DK084567, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.), CA110022-01 and DK76845 (to N. S. B.), and P30DK084567 (to the Mayo Clinic Center for Cell Signaling in Gastroenterology). This work was also supported by the Mayo Foundation and by the Fraternal Order of Eagles (to G. L.).	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bertolino A, 2009, NEUROSCIENCE, V164, P288, DOI 10.1016/j.neuroscience.2009.04.038; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Caiazzo M, 2011, EXP CELL RES, V317, P464, DOI 10.1016/j.yexcr.2010.11.006; Caiazzo M, 2010, EXP CELL RES, V316, P2365, DOI 10.1016/j.yexcr.2010.05.021; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; D'Alessandro R, 2010, CELL MOL NEUROBIOL, V30, P1295, DOI 10.1007/s10571-010-9602-0; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P7558, DOI 10.1073/pnas.121635798; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; MINOWA T, 1992, BIOCHEMISTRY-US, V31, P8389, DOI 10.1021/bi00151a001; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Noble E P, 2000, Pharmacogenomics, V1, P309, DOI 10.1517/14622416.1.3.309; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Paus S, 2008, MOVEMENT DISORD, V23, P599, DOI 10.1002/mds.21901; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Spittau G, 2010, J NEUROSCI RES, V88, P2017, DOI 10.1002/jnr.22364; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	40	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12723	12735		10.1074/jbc.M112.351395	http://dx.doi.org/10.1074/jbc.M112.351395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375010	Green Published, hybrid			2022-12-25	WOS:000302903700012
J	Wang, DD; Liang, J; Zhang, Y; Gui, B; Wang, F; Yi, X; Sun, LY; Yao, Z; Shang, YF				Wang, Dandan; Liang, Jing; Zhang, Yu; Gui, Bin; Wang, Feng; Yi, Xia; Sun, Luyang; Yao, Zhi; Shang, Yongfeng			Steroid Receptor Coactivator-interacting Protein (SIP) Inhibits Caspase-independent Apoptosis by Preventing Apoptosis-inducing Factor (AIF) from Being Released from Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) PAR POLYMER; CELL-DEATH; OXIDATIVE-PHOSPHORYLATION; BREAST CARCINOGENESIS; NUCLEAR TRANSLOCATION; APAF-1 APOPTOSOME; CALPAIN-I; COMPLEX; CHROMATINOLYSIS; TRANSCRIPTION	Apoptosis-inducing factor (AIF) is a caspase-independent death effector. Normally residing in the mitochondrial intermembrane space, AIF is released and translocated to the nucleus in response to proapoptotic stimuli. Nuclear AIF binds to DNA and induces chromatin condensation and DNA fragmentation, characteristics of apoptosis. Until now, it remained to be clarified how the mitochondrial-nuclear translocation of AIF is regulated. Here we report that steroid receptor coactivator-interacting protein (SIP) interacts directly with AIF in mitochondria and specifically inhibits caspase-independent and AIF-dependent apoptosis. Challenging cells with apoptotic stimuli leads to rapid degradation of SIP, and subsequently AIF is liberated from mitochondria and translocated to the nucleus to induce apoptosis. Together, our data demonstrate that SIP is a novel regulator in caspase-independent and AIF-mediated apoptosis.	[Wang, Dandan; Liang, Jing; Zhang, Yu; Gui, Bin; Wang, Feng; Yi, Xia; Sun, Luyang; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Yao, Zhi; Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn			National Natural Science Foundation of China [81130048, 30921062]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 81130048 and 30921062 from the National Natural Science Foundation of China (to Y. S.) and Grant 973 of Program 2011CB504204 from the Ministry of Science and Technology of China (to Y. S.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Spencer ML, 2004, J BIOL CHEM, V279, P37069, DOI 10.1074/jbc.M402507200; Sun LY, 2011, J BIOL CHEM, V286, P4226, DOI 10.1074/jbc.M110.195115; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193	50	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12612	12621		10.1074/jbc.M111.334151	http://dx.doi.org/10.1074/jbc.M111.334151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371500	hybrid, Green Published			2022-12-25	WOS:000302903700002
J	Branco, RCS; de Oliveira, JC; Grassiolli, S; Miranda, RA; Barella, LF; Gomes, RM; Bataglini, LA; Torrezan, R; Gravena, C; Mathias, PCD				Souto Branco, Renato Chaves; de Oliveira, Julio Cezar; Grassiolli, Sabrina; Miranda, Rosiane Aparecida; Barella, Luiz Felipe; Gomes, Rodrigo Mello; Bataglini, Luiz Augusto; Torrezan, Rosana; Gravena, Clarice; de Freitas Mathias, Paulo Cezar			Maternal Protein Malnutrition Does Not Impair Insulin Secretion from Pancreatic Islets of Offspring after Transplantation into Diabetic Rats	PLOS ONE			English	Article							BETA-CELL; EARLY LACTATION; ADULT-RATS; UNDERNUTRITION; METABOLISM; GROWTH; DIET; TERM; HYPERGLYCEMIA; DYSFUNCTION	Pancreatic islets from adult rats whose mothers were protein restricted during lactation undersecrete insulin. The current work analyzes whether this secretory dysfunction can be improved when the pancreatic islets are grafted into hyperglycemic diabetic rats. Two groups of rats were used: the adult offspring from dams that received a low protein diet (4%) during the initial 2/3 of lactation (LP) and, as a control, the adult offspring from dams that consumed a normal protein diet (23%) during the entire period of lactation (NP). Islets from NP- and LP-rats were transplanted into diabetic recipient rats, which were generated by streptozotocin treatment. The islets were transplanted via the portal vein under anesthesia. The fed blood glucose levels were monitored during the 4 days post-transplantation. Transplanted islets from LP-rats (T LP) decreased the fed glucose levels of diabetic rats 34% (21.37 +/- 0.24 mM, p < 0.05); however, the levels still remained 2-fold higher than those of the sham-operated controls (6.88 +/- 0.39 mM, p < 0.05). Grafts with NP-islets (T NP) produced the same effect as the LP-islets in diabetic rats. The high fasting blood glucose levels of diabetic rats were improved by the transplantations. Islet grafts from both rat groups recovered 50% of the retroperitoneal fat mass of the diabetic rats (0.55 +/- 0.08 g/100 g of body weight for T NP and 0.56 +/- 0.07 g/100 g of body weight for T LP, p, 0.05). Because pancreatic islets from both the NP- and LP-rats were able to regulate fasting blood glucose concentrations in hyperglycemic rats, we propose that the altered function of pancreatic islets from LP-rats is not permanent.	[Souto Branco, Renato Chaves; de Oliveira, Julio Cezar; Miranda, Rosiane Aparecida; Barella, Luiz Felipe; Gomes, Rodrigo Mello; Bataglini, Luiz Augusto; Torrezan, Rosana; Gravena, Clarice; de Freitas Mathias, Paulo Cezar] Univ Estadual Maringa, Lab Secret Cell Biol, Dept Cell Biol & Genet, Maringa, Parana, Brazil; [Grassiolli, Sabrina] Univ Estadual Ponta Grossa, Dev Biol Lab, Dept Biol, Ponta Grossa, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Ponta Grossa	Branco, RCS (corresponding author), Univ Estadual Maringa, Lab Secret Cell Biol, Dept Cell Biol & Genet, Maringa, Parana, Brazil.	pmathias@uem.br	Miranda, Rosiane Aparecida/C-1688-2019; Gomes, Rodrigo Mello/L-2639-2016; de Freitas Mathias, Paulo Cezar PCFM/O-6056-2015; Chaves Souto Branco, Renato/N-7198-2016; Barella, Luiz/C-1181-2014; de Oliveira, Júlio Cezar/G-8527-2012; Grassiolli, Sabrina/AAP-5934-2020; DE FREITAS MATHIAS, PAULO CEZAR/AAQ-9682-2021	Miranda, Rosiane Aparecida/0000-0003-0978-7949; Gomes, Rodrigo Mello/0000-0002-9012-3287; de Freitas Mathias, Paulo Cezar PCFM/0000-0001-6994-4585; Chaves Souto Branco, Renato/0000-0002-6886-7693; Barella, Luiz/0000-0003-2211-3842; de Oliveira, Júlio Cezar/0000-0002-6489-9348; Grassiolli, Sabrina/0000-0001-5647-7877; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao Araucaria	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by the Brazilian Research Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TRANSPL IMMUNOL, V10, P73, DOI 10.1016/S0966-3274(02)00051-5; Barbosa FB, 1999, RES COMMUN MOL PATH, V106, P63; Barbosa FB, 2002, BRIT J NUTR, V87, P147, DOI 10.1079/BJN2001489; BARBOSA FB, 1993, BRAZ J MED BIOL RES, V26, P1355; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bernt E, 1974, METHOD ENZYMAT AN, P1105; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Caldeira JD, 2000, RES COMMUN MOL PATH, V108, P213; Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862, DOI 10.3748/wjg.v13.i20.2862; Da Costa CL, 2004, J NUTR BIOCHEM, V15, P236, DOI [10.1016/j.nutbio.2003.12.004, 10.1016/j.jnutbio.2003.12.004]; Mathias PCD, 2007, TRANSPL P, V39, P193, DOI 10.1016/j.transproceed.2006.10.218; de Oliveira JC, 2011, J NEUROENDOCRINOL, V23, P148, DOI 10.1111/j.1365-2826.2010.02095.x; Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Dufer M, 2010, ISLETS, V2, P156, DOI 10.4161/isl.2.3.11412; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; FISHER RS, 1988, J COMP NEUROL, V272, P489, DOI 10.1002/cne.902720404; Fontaine Magali J, 2003, Hepatobiliary Pancreat Dis Int, V2, P170; GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gravena C, 2002, J ENDOCRINOL, V173, P73, DOI 10.1677/joe.0.1730073; Gravena C, 2007, NUTR NEUROSCI, V10, P79, DOI 10.1080/10284150701308693; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HILLER WFA, 1991, DIABETES, V40, P134, DOI 10.2337/diabetes.40.1.134; Hoet J J, 1992, Bull Mem Acad R Med Belg, V147, P174; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Lesage J, 2006, STRESS, V9, P183, DOI 10.1080/10253890601056192; Malaisse WJ, 2003, INT J MOL MED, V12, P911; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; Morsiani E, 1997, CELL TRANSPLANT, V6, P17, DOI 10.1016/S0963-6897(96)00091-7; Moura AS, 1996, RES COMMUN MOL PATH, V92, P73; Moura AS, 1997, RES COMMUN MOL PATH, V96, P179; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ong KKL, 2000, J PEDIATR ENDOCR MET, V13, P1419; Prestes-Carneiro LE, 2006, J NUTR SCI VITAMINOL, V52, P414, DOI 10.3177/jnsv.52.414; ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066; SAWAYA AL, 2003, CAD SAUDE PUB S1, V19, P21; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SENER A, 1978, METABOLISM, V27, P1505, DOI 10.1016/S0026-0495(78)80023-7; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30685	10.1371/journal.pone.0030685	http://dx.doi.org/10.1371/journal.pone.0030685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383969	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500013
J	De Sutter, J; van de Veire, NR; Struyf, S; Philippe, J; De Buyzere, M; Van Damme, J				De Sutter, Johan; van de Veire, Nico R.; Struyf, Sofie; Philippe, Jan; De Buyzere, Marc; Van Damme, Jo			PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function	PLOS ONE			English	Article							CXC-CHEMOKINE PLATELET-FACTOR-4; HUMAN MONOCYTES; VARIANT; DIFFERENTIATION; CXCL4L1; INHIBITION; RECEPTORS; RELEASE; GROWTH	Background: Platelet-derived chemokines are implicated in several aspects of vascular biology. However, for the chemokine platelet factor 4 variant (PF-4var/CXCL4L1), released by platelets during thrombosis and with different properties as compared to PF-4/CXCL4, its role in heart disease is not yet studied. We evaluated the determinants and prognostic value of the platelet-derived chemokines PF-4var, PF-4 and RANTES/CCL5 in patients with stable coronary artery disease (CAD). Methodology/Principal Findings: From 205 consecutive patients with stable CAD and preserved left ventricular (LV) function, blood samples were taken at inclusion and were analyzed for PF-4var, RANTES, platelet factor-4 and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Patients were followed (median follow-up 2.5 years) for the combined endpoint of cardiac death, non-fatal acute myocardial infarction, stroke or hospitalization for heart failure. Independent determinants of PF-4var levels (median 10 ng/ml; interquartile range 8-16 ng/ml) were age, gender and circulating platelet number. Patients who experienced cardiac events (n = 20) during follow-up showed lower levels of PF-4var (8.5 [5.3-10] ng/ml versus 12 [8-16] ng/ml, p = 0.033). ROC analysis for events showed an area under the curve (AUC) of 0.82 (95% CI 0.73-0.90, p<0.001) for higher NT-proBNP levels and an AUC of 0.32 (95% CI 0.19-0.45, p = 0.009) for lower PF-4var levels. Cox proportional hazard analysis showed that PF-4var has an independent prognostic value on top of NT-proBNP. Conclusions: We conclude that low PF-4var/CXCL4L1 levels are associated with a poor outcome in patients with stable CAD and preserved LV function. This prognostic value is independent of NT-proBNP levels, suggesting that both neurohormonal and platelet-related factors determine outcome in these patients.	[De Sutter, Johan; van de Veire, Nico R.] AZ Maria Middelares Ghent, Dept Cardiol, Ghent, Belgium; [De Sutter, Johan; De Buyzere, Marc] Ghent Univ Hosp, Ctr Heart, Ghent, Belgium; [van de Veire, Nico R.] Free Univ Brussels, Fac Med & Pharm, Brussels, Belgium; [Struyf, Sofie; Van Damme, Jo] Univ Louvain, Rega Inst, Lab Mol Immunol, Louvain, Belgium; [Philippe, Jan] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; Ghent University	De Sutter, J (corresponding author), AZ Maria Middelares Ghent, Dept Cardiol, Ghent, Belgium.	jo.vandamme@rega.kuleuven.be	philippé, jan/AAG-8964-2019; Philippé, Jan/A-1027-2008; Struyf, Sofie/U-2455-2017	philippé, jan/0000-0003-4857-5746; Philippé, Jan/0000-0003-4857-5746; Struyf, Sofie/0000-0003-4558-0769; Van Damme, Jo/0000-0002-6707-1167	Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium) [G.0648.09]; Concerted Research Actions (G.O.A.) of the Regional Government of Flanders [GOA/2007/15]	Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium)(FWO); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	This work was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen, Brussels, Belgium) (G.0648.09) and the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders (GOA/2007/15) [principal recipient is JVD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Coelho AL, 2005, CYTOKINE GROWTH F R, V16, P553, DOI 10.1016/j.cytogfr.2005.03.004; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Greinacher A, 2010, HAMOSTASEOLOGIE, V30, P17; HAN ZC, 1990, BRIT J HAEMATOL, V74, P395, DOI 10.1111/j.1365-2141.1990.tb06325.x; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Lasagni L, 2007, BLOOD, V109, P4127, DOI 10.1182/blood-2006-10-052035; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Petersen F, 1998, J IMMUNOL, V161, P4347; Rudiger A, 2008, INT J CARDIOL, V126, P28, DOI 10.1016/j.ijcard.2007.03.108; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schnabel RB, 2010, EUR HEART J, V31, P3024, DOI 10.1093/eurheartj/ehq322; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Van de Veire NR, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.029; Vandercappellen J, 2007, J LEUKOCYTE BIOL, V82, P1519, DOI 10.1189/jlb.0407206; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100	30	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31343	10.1371/journal.pone.0031343	http://dx.doi.org/10.1371/journal.pone.0031343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384011	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100018
J	Lewis, V; Whitehouse, IJ; Baybutt, H; Manson, JC; Collins, SJ; Hooper, NM				Lewis, Victoria; Whitehouse, Isobel J.; Baybutt, Herbert; Manson, Jean C.; Collins, Steven J.; Hooper, Nigel M.			Cellular Prion Protein Expression Is Not Regulated by the Alzheimer's Amyloid Precursor Protein Intracellular Domain	PLOS ONE			English	Article							WILD-TYPE; TRANSCRIPTIONAL CONTROL; DISEASE; APP; COEXISTENCE; IMPAIRMENT; MECHANISMS; NEPRILYSIN; BRAIN; RISK	There is increasing evidence of molecular and cellular links between Alzheimer's disease (AD) and prion diseases. The cellular prion protein, PrPC, modulates the posttranslational processing of the AD amyloid precursor protein (APP), through its inhibition of the beta-secretase BACE1, and oligomers of amyloid-beta bind to PrPC which may mediate amyloid-beta neurotoxicity. In addition, the APP intracellular domain (AICD), which acts as a transcriptional regulator, has been reported to control the expression of PrPC. Through the use of transgenic mice, cell culture models and manipulation of APP expression and processing, this study aimed to clarify the role of AICD in regulating PrPC. Overexpression of the three major isoforms of human APP (APP(695), APP(751) and APP(770)) in cultured neuronal and non-neuronal cells had no effect on the level of endogenous PrPC. Furthermore, analysis of brain tissue from transgenic mice over-expressing either wild type or familial AD associated mutant human APP revealed unaltered PrPC levels. Knockdown of endogenous APP expression in cells by siRNA or inhibition of gamma-secretase activity also had no effect on PrPC levels. Overall, we did not detect any significant difference in the expression of PrPC in any of the cell or animal-based paradigms considered, indicating that the control of cellular PrPC levels by AICD is not as straightforward as previously suggested.	[Lewis, Victoria; Whitehouse, Isobel J.; Hooper, Nigel M.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Lewis, Victoria; Collins, Steven J.] Univ Edinburgh, Neuropathogenesis Unit, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Baybutt, Herbert; Manson, Jean C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Melbourne	Lewis, V (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	n.m.hooper@leeds.ac.uk		manson, jean/0000-0002-0175-9890; Lewis, Victoria/0000-0003-2936-6308; Hooper, Nigel/0000-0002-5811-3484	Medical Research Council [G0802189]; Alzheimer's Research UK; NHMRC (National Health and Medical Research Council) [567123, 400183]; BBSRC [BBS/E/D/20251969, BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI; MRC [G0802189] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2009B-8] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the financial support of the Medical Research Council (G0802189 to NMH) and Alzheimer's Research UK (NMH and JCM). VL is supported by NHMRC (National Health and Medical Research Council) Training Fellowship (#567123). SJC is supported by NHMRC Practitioner Fellowship (#400183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Del Bo R, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.05.025; DESLYS JP, 1994, J GEN VIROL, V75, P23, DOI 10.1099/0022-1317-75-1-23; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Takahashi RH, 2010, NEUROPATHOLOGY, V3; TANAKA S, 1988, BIOCHEM BIOPH RES CO, V157, P472, DOI 10.1016/S0006-291X(88)80273-0; Taylor DR, 2007, SEMIN CELL DEV BIOL, V18, P638, DOI 10.1016/j.semcdb.2007.07.008; Tsuchiya K, 2004, NEUROPATHOLOGY, V24, P46, DOI 10.1111/j.1440-1789.2003.00513.x; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; Voigtlander T, 2001, ACTA NEUROPATHOL, V101, P417; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; Wisniewski T, 2007, FEBS J, V274, P3784, DOI 10.1111/j.1742-4658.2007.05919.x	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31754	10.1371/journal.pone.0031754	http://dx.doi.org/10.1371/journal.pone.0031754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363722	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700090
J	Miranda, NAF; Perissinotto, R				Miranda, Nelson A. F.; Perissinotto, Renzo			Stable Isotope Evidence for Dietary Overlap between Alien and Native Gastropods in Coastal Lakes of Northern KwaZulu-Natal, South Africa	PLOS ONE			English	Article							TAREBIA-GRANIFERA LAMARCK; POTAMOPYRGUS-ANTIPODARUM; GUT CONTENT; COMPETITIVE INTERACTIONS; BIOMPHALARIA-GLABRATA; BIOLOGICAL-CONTROL; THIARA-GRANIFERA; MIXING MODELS; SNAILS; HABITATS	Background: Tarebia granifera (Lamarck, 1822) is originally from South-East Asia, but has been introduced and become invasive in many tropical and subtropical parts of the world. In South Africa, T. granifera is rapidly invading an increasing number of coastal lakes and estuaries, often reaching very high population densities and dominating shallow water benthic invertebrate assemblages. An assessment of the feeding dynamics of T. granifera has raised questions about potential ecological impacts, specifically in terms of its dietary overlap with native gastropods. Methodology/Principal Findings: A stable isotope mixing model was used together with gut content analysis to estimate the diet of T. granifera and native gastropod populations in three different coastal lakes. Population density, available biomass of food and salinity were measured along transects placed over T. granifera patches. An index of isotopic (stable isotopes) dietary overlap (IDO, %) aided in interpreting interactions between gastropods. The diet of T. granifera was variable, including contributions from microphytobenthos, filamentous algae (Cladophora sp.), detritus and sedimentary organic matter. IDO was significant (>60%) between T. granifera and each of the following gastropods: Haminoea natalensis (Krauss, 1848), Bulinus natalensis (Kuster, 1841) and Melanoides tuberculata (Muller, 1774). However, food did not appear to be limiting. Salinity influenced gastropod spatial overlap. Tarebia granifera may only displace native gastropods, such as Assiminea cf. ovata (Krauss, 1848), under salinity conditions below 20. Ecosystem-level impacts are also discussed. Conclusion/Significance: The generalist diet of T. granifera may certainly contribute to its successful establishment. However, although competition for resources may take place under certain salinity conditions and if food is limiting, there appear to be other mechanisms at work, through which T. granifera displaces native gastropods. Complementary stable isotope and gut content analysis can provide helpful ecological insights, contributing to monitoring efforts and guiding further invasive species research.	[Miranda, Nelson A. F.; Perissinotto, Renzo] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Miranda, NAF (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa.	204507499@ukzn.ac.za	Miranda, Nelson/H-9349-2013	Miranda, Nelson/0000-0002-9308-6688	National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM); World Wide Fund for Nature (WWF)	National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM); World Wide Fund for Nature (WWF)	Funding was provided by the National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM) and the World Wide Fund for Nature (WWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RT, 1952, P US NATL MUS, V102, P72; Aberle N, 2005, FRESHWATER BIOL, V50, P369, DOI 10.1111/j.1365-2427.2004.01325.x; Alfaro AC, 2008, ESTUAR COAST SHELF S, V79, P718, DOI 10.1016/j.ecss.2008.06.016; ALLANSON BR, 1979, MONOGRAPHIAE BIOL, V36, P42; Antonio ES, 2010, ESTUAR COAST SHELF S, V86, P401, DOI 10.1016/j.ecss.2009.05.010; Appleton C. C., 2003, African Journal of Aquatic Science, V28, P69, DOI 10.2989/16085914.2003.9626602; Appleton C.C., 2002, P42; Appleton C. C., 2009, Zoologische Mededelingen (Leiden), V83, P525; Appleton CC, 2005, INVASIVE FRESHWATER; BARNESE LE, 1990, J N AM BENTHOL SOC, V9, P35, DOI 10.2307/1467932; Bate GC, 2008, ENVIRON GEOL, V55, P1089, DOI 10.1007/s00254-007-1057-3; BEGG GW, 1980, STUDIES ECOLOGY MAPU; Ben-Ami F, 2006, NAUTILUS, V120, P156; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; BOLTT RE, 1975, T ROY SOC S AFR, V41, P295, DOI 10.1080/00359197509519445; Brenneis VEF, 2010, OIKOS, V119, P1755, DOI 10.1111/j.1600-0706.2010.18471.x; BROWN KM, 1982, ECOLOGY, V63, P412, DOI 10.2307/1938959; Bruton M.N., 1980, P382; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Bruton MN, 1975, SCIENTIAE, V16, P18; Carlsson Nils O.L., 2006, P61; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Caut S, 2006, ECOL APPL, V16, P1893, DOI 10.1890/1051-0761(2006)016[1893:CSIWBT]2.0.CO;2; CHANIOTIS B N, 1980, Caribbean Journal of Science, V16, P81; Clarke LR, 2005, ECOL FRESHW FISH, V14, P267, DOI 10.1111/j.1600-0633.2005.00103.x; Coat S, 2009, FRESHWATER BIOL, V54, P1028, DOI 10.1111/j.1365-2427.2008.02149.x; Dawson T.E, 2007, STABLE ISOTOPES INDI; de Kock Kenne N., 2006, African Journal of Aquatic Science, V31, P63, DOI 10.2989/16085910609503872; Doi H, 2010, J MOLLUS STUD, V76, P384, DOI 10.1093/mollus/eyq020; Fang L, 2010, FRESHWATER BIOL, V55, P1191, DOI 10.1111/j.1365-2427.2009.02343.x; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Gabler HM, 2010, AQUAT ECOL, V44, P325, DOI 10.1007/s10452-009-9243-x; Gearing JN, 1991, STUDY DIET TROPHIC R; Genner MJ, 2008, BIOL INVASIONS, V10, P41, DOI 10.1007/s10530-007-9105-1; Genner MJ, 2007, MOL ECOL, V16, P517, DOI 10.1111/j.1365-294X.2006.03171.x; Genner MJ, 2004, MOL ECOL, V13, P2135, DOI 10.1111/j.1365-294X.2004.02222.x; GOMEZ JD, 1990, TROP MED PARASITOL, V41, P43; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HART RC, 1979, LAKE SIBAYA, V36, P108; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Humphries P, 2003, DROUGHT AQUATIC ECOS, P1141; KAWATA M, 1992, OECOLOGIA, V91, P245, DOI 10.1007/BF00317791; Kerans BL, 2005, J N AM BENTHOL SOC, V24, P123, DOI 10.1899/0887-3593(2005)024<0123:PADDAE>2.0.CO;2; KILHAM P, 1982, AM MIDL NAT, V108, P202, DOI 10.2307/2425311; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Kurata K, 2001, MAR ECOL PROG SER, V223, P167, DOI 10.3354/meps223167; Larned ST, 2001, BIOTROPICA, V33, P241, DOI 10.1111/j.1744-7429.2001.tb00175.x; Lockwood JL, 2007, INVASION ECOLOGY; Lopez-Lopez Eugenia, 2009, Aquatic Invasions, V4, P435, DOI 10.3391/ai.2009.4.3.2; MacKay F, 2010, ESTUAR COAST SHELF S, V86, P553, DOI 10.1016/j.ecss.2009.11.011; MACNAE WILLIAM, 1962, ANN NATAL MUS, V15, P183; MADSEN H, 1992, HYDROBIOLOGIA, V228, P203, DOI 10.1007/BF00006587; Malaquias MAE, 2004, J MAR BIOL ASSOC UK, V84, P767, DOI 10.1017/S0025315404009890h; Mantel SMK, 2004, J N AM BENTHOL SOC, V23, P728, DOI 10.1899/0887-3593(2004)023<0728:FSIATA>2.0.CO;2; McCarthy TS, 1998, AFR J ECOL, V36, P44, DOI 10.1046/j.1365-2028.1998.89-89089.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; Miranda NAF, 2010, S AFR J SCI, V106, P55, DOI 10.4102/sajs.v106i3/4.156; Miranda NAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024337; Miranda NAF, 2011, ESTUAR COAST SHELF S, V91, P442, DOI 10.1016/j.ecss.2010.11.007; Pape E, 2008, ESTUAR COAST SHELF S, V76, P797, DOI 10.1016/j.ecss.2007.08.007; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PEREZ JG, 1991, MEM I OSWALDO CRUZ, V86, P341, DOI 10.1590/S0074-02761991000300008; Perissinotto R, 2010, MAR ECOL PROG SER, V405, P147, DOI 10.3354/meps08542; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Pillay D, 2009, J EXP MAR BIOL ECOL, V380, P47, DOI 10.1016/j.jembe.2009.08.016; Pointier JP, 2000, ACTA TROP, V77, P53, DOI 10.1016/S0001-706X(00)00123-6; Pointier JP, 1999, MALACOLOGIA, V41, P403; POINTIER JP, 2003, XENOPHORA, V104, P14; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Reise K, 2006, HELGOLAND MAR RES, V60, P77, DOI 10.1007/s10152-006-0024-9; Rudnick D, 2005, FRESHWATER BIOL, V50, P1323, DOI 10.1111/j.1365-2427.2005.01398.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schreiber E. S. G., 2002, Biological Invasions, V4, P317, DOI 10.1023/A:1020925022843; Seuffert ME, 2010, BIOL INVASIONS, V12, P1695, DOI 10.1007/s10530-009-9582-5; Strickland J.D.H., 1972, B FISH RES BOARD CAN, V167, P1; Taylor Ricky, 2006, African Journal of Aquatic Science, V31, P31, DOI 10.2989/16085910609503869; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WIENS JA, 1993, TRENDS ECOL EVOL, V8, P348, DOI 10.1016/0169-5347(93)90216-C; Winsome T, 2006, APPL SOIL ECOL, V32, P38, DOI 10.1016/j.apsoil.2005.01.008; Wojdak JM, 2005, ECOL MONOGR, V75, P489, DOI 10.1890/04-1174; Wong PK, 2009, BIOL INVASIONS, V11, P2223, DOI 10.1007/s10530-008-9378-z; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8; Zambrano L, 2010, HYDROBIOLOGIA, V646, P327, DOI 10.1007/s10750-010-0182-2	90	32	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31897	10.1371/journal.pone.0031897	http://dx.doi.org/10.1371/journal.pone.0031897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363764	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700118
J	Reddy, SB; Anders, RF; Beeson, JG; Farnert, A; Kironde, F; Berenzon, SK; Wahlgren, M; Linse, S; Persson, KEM				Reddy, Sreenivasulu B.; Anders, Robin F.; Beeson, James G.; Farnert, Anna; Kironde, Fred; Berenzon, Sharon Kuhlman; Wahlgren, Mats; Linse, Sara; Persson, Kristina E. M.			High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; SURFACE PROTEIN-2 MSP2; AMYLOID-LIKE FIBRILS; THIOCYANATE ELUTION; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; REDUCED RISK; VACCINE; FORMS; DIVERSITY	Background: Malaria kills almost 1 million people every year, but the mechanisms behind protective immunity against the disease are still largely unknown. Methodology/Principal Findings: In this study, surface plasmon resonance technology was used to evaluate the affinity (measured as k(d)) of naturally acquired antibodies to the Plasmodium falciparum antigens MSP2 and AMA1. Antibodies in serum samples from residents in endemic areas bound with higher affinities to AMA1 than to MSP2, and with higher affinities to the 3D7 allele of MSP2-3D7 than to the FC27 allele. The affinities against AMA1 and MSP2-3D7 increased with age, and were usually within similar range as the affinities for the monoclonal antibodies also examined in this study. The finding of MSP2-3D7 type parasites in the blood was associated with a tendency for higher affinity antibodies to both forms of MSP2 and AMA1, but this was significant only when analyzing antibodies against MSP2-FC27, and individuals infected with both allelic forms of MSP2 at the same time showed the highest affinities. Individuals with the highest antibody affinities for MSP2-3D7 at baseline had a prolonged time to clinical malaria during 40 weeks of follow-up, and among individuals who were parasite positive at baseline higher antibody affinities to all antigens were seen in the individuals that did not experience febrile malaria during follow up. Conclusions/Significance: This study contributes important information for understanding how immunity against malaria arises. The findings suggest that antibody affinity plays an important role in protection against disease, and differs between antigens. In light of this information, antibody affinity measurements would be a key assessment in future evaluation of malaria vaccine formulations.	[Reddy, Sreenivasulu B.; Wahlgren, Mats; Persson, Kristina E. M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia; [Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Farnert, Anna] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Kironde, Fred] Makerere Univ, Dept Biochem, Kampala, Uganda; [Berenzon, Sharon Kuhlman] Swedish Inst Infect Dis Control, Solna, Sweden; [Linse, Sara] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Karolinska Institutet; La Trobe University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Burnet Institute; Karolinska Institutet; Karolinska University Hospital; Makerere University; Swedish Institute for Infectious Disease Control; Lund University	Reddy, SB (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	kristina.persson@ki.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Persson, Kristina E M/0000-0003-2661-3115; Farnert, Anna/0000-0001-7583-282X; Anders, Robin/0000-0002-0693-4547; Linse, Sara/0000-0001-9629-7109	Wenner-Gren Stiftelserna; Vinnova; Jeanssons Stiftelser; Svenska Lakaresallskapet; Stiftelsen Groschinskys Minnesfond; OE och Edla Johanssons Vetenskapliga Stiftelse; Swedish International Development Agency; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Wenner-Gren Stiftelserna; Vinnova(Vinnova); Jeanssons Stiftelser; Svenska Lakaresallskapet; Stiftelsen Groschinskys Minnesfond; OE och Edla Johanssons Vetenskapliga Stiftelse; Swedish International Development Agency; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Financial support has been granted from Wenner-Gren Stiftelserna, Vinnova, Jeanssons Stiftelser, Svenska Lakaresallskapet, Stiftelsen Groschinskys Minnesfond, OE och Edla Johanssons Vetenskapliga Stiftelse, Swedish International Development Agency, Ake Wibergs Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; [Anonymous], 2009, WORLD MAL REP 2009; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bargieri DY, 2007, MEM I OSWALDO CRUZ, V102, P313, DOI 10.1590/S0074-02762007005000039; Bereczky S, 2004, INT J PARASITOL, V34, P935, DOI 10.1016/j.ijpara.2004.04.007; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Breukels MA, 2002, CLIN INFECT DIS, V34, P191, DOI 10.1086/338259; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engelbrecht F, 2000, ACTA TROP, V74, P63, DOI 10.1016/S0001-706X(99)00044-3; FERREIRA MU, 1995, J IMMUNOL METHODS, V187, P297, DOI 10.1016/0022-1759(95)00186-4; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Hearty S, 2010, EXPERT REV VACCINES, V9, P645, DOI [10.1586/erv.10.52, 10.1586/ERV.10.52]; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOMMEL M, 1988, BIOL CELL, V64, P183, DOI 10.1016/0248-4900(88)90078-0; Iber D, 2001, AFFINITY MATURATION; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; KARUSH F, 1970, ANN NY ACAD SCI, V169, P56, DOI 10.1111/j.1749-6632.1970.tb55970.x; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; MACDONALD RA, 1988, J IMMUNOL METHODS, V106, P191, DOI 10.1016/0022-1759(88)90196-2; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; RAY P, 1994, INFECT IMMUN, V62, P2354, DOI 10.1128/IAI.62.6.2354-2361.1994; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; SAUL A, 1987, PARASITE IMMUNOL, V9, P1, DOI 10.1111/j.1365-3024.1987.tb00483.x; SHIMIZU F, 1978, BRIT J EXP PATHOL, V59, P624; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; SMYTHE JA, 1990, MOL BIOCHEM PARASIT, V39, P227, DOI 10.1016/0166-6851(90)90061-P; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; SOOTHILL JF, 1971, CLIN EXP IMMUNOL, V9, P193; Steward MW, 1983, ANTIBODY AFFINITY TH; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V43, P211, DOI 10.1016/0166-6851(90)90146-D; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Yang X, 2007, J PEPT SCI, V13, P839, DOI 10.1002/psc.910; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	61	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32242	10.1371/journal.pone.0032242	http://dx.doi.org/10.1371/journal.pone.0032242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363818	Green Published, gold			2022-12-25	WOS:000302873700159
J	Sun, DL; Chan, CCH; Lee, TMC				Sun, Delin; Chan, Chetwyn C. H.; Lee, Tatia M. C.			Identification and Classification of Facial Familiarity in Directed Lying: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN FACE PERCEPTION; UPSIDE-DOWN FACES; BRAIN POTENTIALS; NEURAL SYSTEMS; RECOGNITION; EXPRESSION; INVERSION; GENDER; WOMEN	Recognizing familiar faces is essential to social functioning, but little is known about how people identify human faces and classify them in terms of familiarity. Face identification involves discriminating familiar faces from unfamiliar faces, whereas face classification involves making an intentional decision to classify faces as "familiar'' or "unfamiliar.'' This study used a directed-lying task to explore the differentiation between identification and classification processes involved in the recognition of familiar faces. To explore this issue, the participants in this study were shown familiar and unfamiliar faces. They responded to these faces (i.e., as familiar or unfamiliar) in accordance with the instructions they were given (i.e., to lie or to tell the truth) while their EEG activity was recorded. Familiar faces (regardless of lying vs. truth) elicited significantly less negative-going N400f in the middle and right parietal and temporal regions than unfamiliar faces. Regardless of their actual familiarity, the faces that the participants classified as "familiar'' elicited more negative-going N400f in the central and right temporal regions than those classified as "unfamiliar.'' The P600 was related primarily with the facial identification process. Familiar faces (regardless of lying vs. truth) elicited more positive-going P600f in the middle parietal and middle occipital regions. The results suggest that N400f and P600f play different roles in the processes involved in facial recognition. The N400f appears to be associated with both the identification (judgment of familiarity) and classification of faces, while it is likely that the P600f is only associated with the identification process (recollection of facial information). Future studies should use different experimental paradigms to validate the generalizability of the results of this study.	[Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Appl Cognit Neurosci Lab, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Sun, DL (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.	chetwyn.chan@inet.polyu.edu.hk; tmclee@hku.hk	Sun, Delin/H-8070-2019; Sun, Delin/A-4154-2010	Sun, Delin/0000-0003-3283-423X; Sun, Delin/0000-0003-3283-423X; Chan, Chetwyn C. H./0000-0003-0307-6337	University of Hong Kong [201007176233]; Hong Kong Polytechnic University; Research Grant Council [PolyU9/CRF/09]	University of Hong Kong(University of Hong Kong); Hong Kong Polytechnic University(Hong Kong Polytechnic University); Research Grant Council(Hong Kong Research Grants Council)	This project was supported by the May Endowed Professorship of The University of Hong Kong awarded to TMC Lee, a Research and Conference Grant (#201007176233) of The University of Hong Kong awarded to DL Sun, an internal research and development grant from The Hong Kong Polytechnic University awarded to CCH Chan, and the Research Grant Council Collaborative Research Fund (PolyU9/CRF/09) awarded to TMC Lee and CCH Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bhatt S, 2009, BRAIN COGNITION, V69, P382, DOI 10.1016/j.bandc.2008.08.033; Boehm SG, 2006, CLIN EEG NEUROSCI, V37, P322, DOI 10.1177/155005940603700410; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; DIRKS J, 1977, CHILD DEV, V48, P124, DOI 10.2307/1128890; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Einav S, 2008, DEV PSYCHOL, V44, P1655, DOI 10.1037/a0013299; Farrow TFD, 2003, PERCEPT MOTOR SKILL, V97, P451, DOI 10.2466/PMS.97.6.451-460; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RN, 2008, NEUROIMAGE, V40, P884, DOI 10.1016/j.neuroimage.2007.12.003; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Jemel B, 1999, PSYCHOPHYSIOLOGY, V36, P437; Jemel B, 2003, NEUROREPORT, V14, P525, DOI 10.1097/01.wnr.0000057864.05120.ba; Keller L, 1998, NATURE, V394, P121, DOI 10.1038/28031; Kiebel SJ, 2004, NEUROIMAGE, V22, P492, DOI 10.1016/j.neuroimage.2004.02.012; Kiebel SJ, 2004, NEUROIMAGE, V22, P503, DOI 10.1016/j.neuroimage.2004.02.013; Lee TMY, 2011, NEURAL CORR IN PRESS; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Rossion B, 2001, J COGNITIVE NEUROSCI, V13, P1019, DOI 10.1162/089892901753165917; SMITH TW, 1992, SOC BIOL, V39, P203; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	31	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31250	10.1371/journal.pone.0031250	http://dx.doi.org/10.1371/journal.pone.0031250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363597	Green Published, gold			2022-12-25	WOS:000302873700040
J	Mau, YS; Collins, PJ; Daglish, GJ; Nayak, MK; Pavic, H; Ebert, PR				Mau, Yosep S.; Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika; Ebert, Paul R.			The rph1 Gene Is a Common Contributor to the Evolution of Phosphine Resistance in Independent Field Isolates of Rhyzopertha Dominica	PLOS ONE			English	Article							LESSER GRAIN BORER; F COLEOPTERA; INSECTICIDE; INHERITANCE; STRAINS; TOXICITY; DAMAGE	Phosphine is the only economically viable fumigant for routine control of insect pests of stored food products, but its continued use is now threatened by the world-wide emergence of high-level resistance in key pest species. Phosphine has a unique mode of action relative to well-characterised contact pesticides. Similarly, the selective pressures that lead to resistance against field sprays differ dramatically from those encountered during fumigation. The consequences of these differences have not been investigated adequately. We determine the genetic basis of phosphine resistance in Rhyzopertha dominica strains collected from New South Wales and South Australia and compare this with resistance in a previously characterised strain from Queensland. The resistance levels range from 225 and 100 times the baseline response of a sensitive reference strain. Moreover, molecular and phenotypic data indicate that high-level resistance was derived independently in each of the three widely separated geographical regions. Despite the independent origins, resistance was due to two interacting genes in each instance. Furthermore, complementation analysis reveals that all three strains contain an incompletely recessive resistance allele of the autosomal rph1 resistance gene. This is particularly noteworthy as a resistance allele at rph1 was previously proposed to be a necessary first step in the evolution of high-level resistance. Despite the capacity of phosphine to disrupt a wide range of enzymes and biological processes, it is remarkable that the initial step in the selection of resistance is so similar in isolated outbreaks.	[Mau, Yosep S.; Ebert, Paul R.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang, Nusa Tenggara T, Indonesia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika] Ecosci Precinct, Dept Employment Econ Dev & Innovat, Brisbane, Qld, Australia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia	University of Queensland; Universitas Nusa Cendana	Mau, YS (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia.	p.ebert@uq.edu	Mau, Yosep Seran/GNP-4795-2022; Mau, Yosep Seran/AAC-4003-2021	Mau, Yosep Seran/0000-0001-6654-5407; Daglish, Gregory/0000-0003-1940-2643; Ebert, Paul/0000-0002-4435-0737	Grain Research Development Corporation [UQ00010]; Australian Research Council [C10027038]; AusAID scholarship; Australian Government	Grain Research Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); AusAID scholarship; Australian Government(Australian GovernmentCGIAR)	Paul Ebert acknowledges financial support from the Grain Research Development Corporation (grant UQ00010, http://www.grdc.com.au/) and the Australian Research Council (grant C10027038, (http://www.arc.gov.au/) and an AusAID scholarship (http://www.ausaid.gov.au/) for Yosep Mau. Patrick Collins, Gregory Daglish and Manoj Nayak acknowledge the support from the Australian Government: Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Acda MA., 2000, THESIS U QUEENSLAND; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Ansell M. R., 1990, P 5 INT WORK C STOR, P961; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; BOLTER CJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P65, DOI 10.1016/0003-9861(90)90232-N; Cha'on U, 2007, TOXICOL SCI, V96, P194, DOI 10.1093/toxsci/kfl187; Champ BR, 1976, REPORT FAO GLOBAL SU; CHAUDHRY MQ, 1992, PESTIC BIOCHEM PHYS, V42, P167, DOI 10.1016/0048-3575(92)90063-6; Chaudhry MQ, 1997, PESTIC SCI, V49, P213, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;213::AID-PS516&gt;3.0.CO;2-#; CHAUDHRY MQ, 1990, J STORED PROD RES, V26, P101, DOI 10.1016/0022-474X(90)90008-G; CHEFURKA W, 1976, PESTIC BIOCHEM PHYS, V6, P65, DOI 10.1016/0048-3575(76)90010-9; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Collins PJ, 1998, STORED GRAIN AUSTR, P55; Daglish GJ, 1998, STORED PRODUCT PROTE, P584; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; FFRENCHCONSTANT RH, 1994, INSECT BIOCHEM MOLEC, V24, P335, DOI 10.1016/0965-1748(94)90026-4; FINNEY D J, 1971, P333; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4; KASHI KP, 1976, PESTIC BIOCHEM PHYS, V6, P350, DOI 10.1016/0048-3575(76)90045-6; Li Yan-Sheng, 1994, Acta Entomologica Sinica, V37, P271; NAKAKITA H, 1976, Journal of Pesticide Science, V1, P235; Nath NS, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/494168; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; Pratt SJ, 2003, J STORED PROD RES, V39, P507, DOI 10.1016/S0022-474X(02)00057-7; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; PRICE NR, 1984, J STORED PROD RES, V20, P163, DOI 10.1016/0022-474X(84)90025-0; PRICE NR, 1981, COMP BIOCHEM PHYS C, V69, P129, DOI 10.1016/0306-4492(81)90113-1; Quistad GB, 2000, PEST MANAG SCI, V56, P779, DOI 10.1002/1526-4998(200009)56:9<779::AID-PS207>3.3.CO;2-L; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; RAJENDRAN S, 1992, B ENTOMOL RES, V82, P119, DOI 10.1017/S000748530005152X; REN YL, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P173; Schlipalius D., 2006, Outlooks on Pest Management, V17, P52, DOI 10.1564/16apr02; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2002, GENETICS, V161, P773; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TAYLOR R W D, 1989, International Pest Control, V31, P10; Tyler P. S., 1983, International Pest Control, V25, P10; TYLER PS, 1983, INT PEST CONTROL, V25, P21; Valmas N, 2008, TOXICOLOGY, V252, P33, DOI 10.1016/j.tox.2008.07.060; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wallbank BE, 2002, P STOR GRAIN AUSTR 2, P105; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	46	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31541	10.1371/journal.pone.0031541	http://dx.doi.org/10.1371/journal.pone.0031541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363668	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500056
J	Wang, YL; Zhou, T				Wang, Yali; Zhou, Tong			A Relative Variation-Based Method to Unraveling Gene Regulatory Networks	PLOS ONE			English	Article							RECONSTRUCTION; INFERENCE; SYSTEMS; SIMULATION; ALGORITHM	Gene regulatory network (GRN) reconstruction is essential in understanding the functioning and pathology of a biological system. Extensive models and algorithms have been developed to unravel a GRN. The DREAM project aims to clarify both advantages and disadvantages of these methods from an application viewpoint. An interesting yet surprising observation is that compared with complicated methods like those based on nonlinear differential equations, etc., methods based on a simple statistics, such as the so-called Z-score, usually perform better. A fundamental problem with the Z-score, however, is that direct and indirect regulations can not be easily distinguished. To overcome this drawback, a relative expression level variation (RELV) based GRN inference algorithm is suggested in this paper, which consists of three major steps. Firstly, on the basis of wild type and single gene knockout/knockdown experimental data, the magnitude of RELV of a gene is estimated. Secondly, probability for the existence of a direct regulation from a perturbed gene to a measured gene is estimated, which is further utilized to estimate whether a gene can be regulated by other genes. Finally, the normalized RELVs are modified to make genes with an estimated zero in-degree have smaller RELVs in magnitude than the other genes, which is used afterwards in queuing possibilities of the existence of direct regulations among genes and therefore leads to an estimate on the GRN topology. This method can in principle avoid the so-called cascade errors under certain situations. Computational results with the Size 100 sub-challenges of DREAM3 and DREAM4 show that, compared with the Z-score based method, prediction performances can be substantially improved, especially the AUPR specification. Moreover, it can even outperform the best team of both DREAM3 and DREAM4. Furthermore, the high precision of the obtained most reliable predictions shows that the suggested algorithm may be very helpful in guiding biological experiment designs.	[Wang, Yali; Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, YL (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	yl-wang06@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602 and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003 and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; LATTIN J, 2003, ANALYZING MULTIVARIA; Ljung L., 1999, SYSTEM IDENTIFICATIO; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Schafer J, 2006, R NEWS, V6, P50; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121; Zhou K., 1996, ROBUST OPTIMAL CONTR; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	27	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31194	10.1371/journal.pone.0031194	http://dx.doi.org/10.1371/journal.pone.0031194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363578	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500028
J	Gupta, SK; Oommen, S; Aubry, MC; Williams, BP; Vlahakis, NE				Gupta, S. K.; Oommen, S.; Aubry, M-C; Williams, B. P.; Vlahakis, N. E.			Integrin alpha 9 beta 1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition	ONCOGENE			English	Article						EMT; alpha 9 beta 1 integrin; lung cancer; metastasis; cell migration	UP-REGULATION; CANCER-CELLS; BETA-CATENIN; VEGF-C; SRC; EXPRESSION; MIGRATION; INVASION; GENE	The integrin alpha 9 beta 1 binds a number of extracellular matrix components to mediate cell adhesion, migration and tissue invasion. Although expressed in a variety of normal human cells including endothelium, it is also expressed in cancer cells. We have previously shown that alpha 9 beta 1 binds VEGF-A to facilitate angiogenesis, an important component of the tumor microenvironment. As alpha 9 beta 1 induces accelerated cancer cell migration, we wished to determine what role it played in cancer growth and metastasis. In this study, we show that alpha 9 beta 1 expression induces molecular changes consistent with epithelial-mesenchymal transition. In addition, we found that alpha 9 beta 1 forms a tri-partite protein complex with beta-catenin and E-cadherin, which dissociates following integrin activation and subsequent src and beta-catenin phosphorylation. These findings were consistent in cells in which: alpha 9 beta 1 was exogenously over-expressed, or when its expression was suppressed in cancer cells endogenously expressing alpha 9 beta 1. These in vitro results are biologically significant as alpha 9 beta 1-expressing cancer cells induce greater tumor growth and metastases in mice as compared to the cells without alpha 9 beta 1 expression or when integrin expression is suppressed. Furthermore, integrin alpha 9 beta 1 is expressed in primary human small cell lung cancer and patients having a high expression of alpha 9 beta 1 demonstrated significantly worse long-term survival compared with patients with low alpha 9 beta 1 expression. These findings highlight a novel mechanism of integrin alpha 9 beta 1 function in human cancer. Oncogene (2013) 32, 141 -150; doi:10.1038/onc.2012.41; published online 27 February 2012	[Gupta, S. K.; Oommen, S.; Williams, B. P.; Vlahakis, N. E.] Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA; [Aubry, M-C] Mayo Clin, Dept Lab Med & Anat Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Vlahakis, NE (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	vlahakis.nicholas@gene.com			NHLBI [K08HL076455-05]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076455] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs Dean Sheppard (UCSF, CA), Debabrata Mukhopadhyay and Edward Leof (Mayo Clinic, Rochester, MN, USA) for helpful discussions; Mark A. Schroeder for help with animal studies; Aaron Bungam for the lung tissue registry. This work was supported by NHLBI Research Grant K08HL076455-05 and Mayo Foundation Research Grants to NEV.	Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Alphonso A, 2009, NEOPLASIA, V11, P1264, DOI 10.1593/neo.91302; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Borok Z, 2009, J CLIN INVEST, V119, P7, DOI 10.1172/JCI38084; Brown MC, 2008, NEURO-ONCOLOGY, V10, P968, DOI 10.1215/15228517-2008-047; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; HIBI K, 1994, ONCOGENE, V9, P611; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim S, 2010, CARCINOGENESIS, V31, P597, DOI 10.1093/carcin/bgq024; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Maschler S, 2005, ONCOGENE, V24, P2032, DOI 10.1038/sj.onc.1208423; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Voulgari A, 2006, BIOCHIM BIOPHYS ACTA, V1796, P75; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009	38	38	40	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					141	150		10.1038/onc.2012.41	http://dx.doi.org/10.1038/onc.2012.41			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22370635	Green Accepted			2022-12-25	WOS:000314075500002
J	Chang, IA; Oh, MJ; Kim, MH; Park, SK; Kim, BG; Namgung, U				Chang, In Ae; Oh, Myung-Jin; Kim, Min Hee; Park, Seung-Kiel; Kim, Byung G.; Namgung, Uk			Vimentin phosphorylation by Cdc2 in Schwann cell controls axon growth via beta 1-integrin activation	FASEB JOURNAL			English	Article						implantation; neurite outgrowth; preinjury; regeneration; sciatic nerve	NEURONAL PROCESS OUTGROWTH; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX; INTERMEDIATE-FILAMENTS; CONDITIONING-LESION; SENSORY AXONS; SCIATIC-NERVE; INTEGRIN; KINASE	Although preconditioning injury on the peripheral nerve induces axonal regenerative capacity in neurons, it is not known whether similar lesion effects occur in glial cells. Here we demonstrate that Schwann cells are activated by peripheral nerve preinjury and primed to mediate axon regeneration. Cdc2, which was induced from Schwann cells after sciatic nerve injury, phosphorylated vimentin almost exclusively in the distal nerve area. Phospho-vimentin-positive Schwann cells showed increased migration activity and were in close contact with process outgrowth of co-cultured neurons. Vimentin phosphorylation by Cdc2 was involved in beta 1-integrin activation leading to FAK phoshorylation and associated with Erk1/2 activation in Schwann cells. Neurite outgrowth of dorsal root ganglion neurons was increased by co-culture with activated Schwann cells, in which phospho-vimentin signaling was transmitted into beta 1-integrin activation. Then neurite outgrowth was suppressed by genetic depletion of phospho-vimentin and beta 1 integrin as well as inhibition of vimentin phosphorylation by Cdc2 inhibitor purvalanol A. The sciatic nerve graft harboring activated Schwann cells into the spinal cord induced Schwann cell migration beyond the graft-host barrier and facilitated regeneration of spinal axons, which was inhibited by purvalanol A pretreatment of the graft. This is the first report to our knowledge demonstrating that activation of phospho-vimentin linked to beta 1-integrin pathway may mediate transcellular signaling to promote axon growth.-Chang, I. A., Oh, M.-J., Kim, M. H., Park, S.-K., Kim, B. G., Namgung, U. Vimentin phosphorylation by Cdc2 in Schwann cell controls axon growth via beta 1-integrin activation. FASEB J. 26, 2401-2413 (2012). www.fasebj.org	[Chang, In Ae; Oh, Myung-Jin; Kim, Min Hee; Namgung, Uk] Daejeon Univ, Dept Oriental Med, Taejon 300716, South Korea; [Park, Seung-Kiel] Chungnam Natl Univ, Coll Med, Dept Biochem, Taejon, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Brain Dis Res Ctr, Inst Med Sci, Suwon 441749, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea	Daejeon University; Chungnam National University; Ajou University; Ajou University	Namgung, U (corresponding author), Daejeon Univ, Dept Oriental Med, Taejon 300716, South Korea.	unamgung@dju.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569	National Research Foundation (NRF); Ministry of Education, Science and Technology, Korea [2010-0023869]; MEST [20090081466]	National Research Foundation (NRF); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors thank Heesup Lee for technical assistance, Dr. Eun-hye Joe (Ajou University, Suwon, Korea) for vimentin antibody, and the Korea Basic Science Institute for the use of their confocal microscope facility. This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology, Korea (2010-0023869) to U.N. and MEST (20090081466) to B.G.K.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BODEGA G, 1994, HISTOCHEMISTRY, V102, P113, DOI 10.1007/BF00269015; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Chernousov MA, 2003, EXP CELL RES, V291, P514, DOI 10.1016/S0014-4827(03)00409-9; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DAHL D, 1981, EUR J CELL BIOL, V24, P191; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DELEON M, 1991, J NEUROSCI RES, V29, P437; DOREE M, 1994, FASEB J, V8, P1114, DOI 10.1096/fasebj.8.14.7958616; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Ekstrom PAR, 2003, MOL CELL NEUROSCI, V22, P383, DOI 10.1016/S1044-7431(02)00034-9; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fawcett J. W., 2001, BRAIN DAMAGE BRAIN R, P145; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2; Han IS, 2007, J CELL SCI, V120, P246, DOI 10.1242/jcs.03322; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Ide C, 1996, NEUROSCI RES, V25, P101; Inoue G, 2010, GLIA, V58, P399, DOI 10.1002/glia.20931; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; LEFCORT F, 1992, DEVELOPMENT, V116, P767; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; NEUBERGER TJ, 1989, J NEUROCYTOL, V18, P695, DOI 10.1007/BF01187088; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Oh MJ, 2009, J NEUROTRAUM, V26, P2071, DOI [10.1089/neu.2008.0800, 10.1089/neu.2008-0800]; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; Polinsky M, 2000, J NEUROSCI, V20, P1044, DOI 10.1523/JNEUROSCI.20-03-01044.2000; Previtali SC, 2001, PROG NEUROBIOL, V64, P35, DOI 10.1016/S0301-0082(00)00045-9; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sandrow HR, 2008, EXP NEUROL, V210, P489, DOI 10.1016/j.expneurol.2007.11.029; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Seo TB, 2006, MED SCI SPORT EXER, V38, P1267, DOI 10.1249/01.mss.0000227311.00976.68; Seo TB, 2009, J NEUROTRAUM, V26, P1733, DOI 10.1089/neu.2008-0711; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Smith DS, 1997, J NEUROSCI, V17, P646; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091	69	40	41	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2401	2413		10.1096/fj.11-199018	http://dx.doi.org/10.1096/fj.11-199018			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22371530				2022-12-25	WOS:000305017200018
J	Morgan, JA; Cheepala, SB; Wang, Y; Neale, G; Adachi, M; Nachagari, D; Leggas, M; Zhao, WC; Boyd, K; Venkataramanan, R; Schuetz, JD				Morgan, Jessica A.; Cheepala, Satish B.; Wang, Yao; Neale, Geoff; Adachi, Masashi; Nachagari, Deepa; Leggas, Mark; Zhao, Wenchen; Boyd, Kelli; Venkataramanan, Raman; Schuetz, John D.			Deregulated Hepatic Metabolism Exacerbates Impaired Testosterone Production in Mrp4-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MULTIDRUG-RESISTANCE PROTEIN-4; MRP4 CONFERS RESISTANCE; RAT LEYDIG-CELLS; HORMONAL-REGULATION; CHORIONIC-GONADOTROPIN; HUMAN CYTOCHROME-P450; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; MOUSE-LIVER	The physiological role of multidrug resistance protein 4 (Mrp4, Abcc4) in the testes is unknown. We found that Mrp4 is expressed primarily in mouse and human Leydig cells; however, there is no current evidence that Mrp4 regulates testosterone production. We investigated its role in Leydig cells, where testosterone production is regulated by cAMP, an intracellular messenger formed when the luteinizing hormone (LH) receptor is activated. Because Mrp4 regulates cAMP, we compared testosterone levels in Mrp4(-/-) and Mrp4(-/-) mice. Young Mrp4(-/-) mice had significantly impaired gametogenesis, reduced testicular testosterone, and disruption of Leydig cell cAMP homeostasis. Both young and adult mice had impaired testosterone production. In Mrp4(-/-) primary Leydig cells treated with LH, intracellular cAMP production was impaired and cAMP-response element-binding protein(CREB) phosphorylation was strongly attenuated. Notably, expression of CREB target genes that regulate testosterone biosynthesis was reduced in Mrp4(-/-) Leydig cells in vivo. Therefore, Mrp4 is required for normal Leydig cell testosterone production. However, adult Mrp4(-/-) mice are fertile, with a normal circulating testosterone concentration. The difference is that in 3-week-old Mrp4(-/-) mice, disruption of gonadal testosterone production up-regulates hepatic Cyp2b10, a known testosterone-metabolizing enzyme. Therefore, defective testicular testosterone production de-regulates hepatic Cyp-mediated testosterone metabolism to disrupt gametogenesis. These findings have important implications for understanding the side effects of therapeutics that disrupt Mrp4 function and are reported to alter androgen production.	[Morgan, Jessica A.; Cheepala, Satish B.; Wang, Yao; Adachi, Masashi; Nachagari, Deepa; Leggas, Mark; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Neale, Geoff] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhao, Wenchen; Venkataramanan, Raman] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15261 USA; [Morgan, Jessica A.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Morgan, James/N-8104-2018; Zhao, Wenchen/D-1867-2017; Morgan, James/GRO-2905-2022	Zhao, Wenchen/0000-0002-0501-8459; Morgan, James/0000-0002-8920-1065	National Institutes of Health [2R01GM60904, P30CA21745, CA21865]; American Lebanese Associated Charities (ALSAC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 2R01GM60904, P30CA21745, and CA21865 and by the American Lebanese Associated Charities (ALSAC).	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; Adachi M, 2002, J BIOL CHEM, V277, P38998, DOI 10.1074/jbc.M203262200; Asada S, 2001, J HEALTH SCI, V47, P60, DOI 10.1248/jhs.47.60; Badri SNP, 2000, ENDOCR RES, V26, P247, DOI 10.3109/07435800009066165; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bendre SV, 2005, MUTAT RES-FUND MOL M, V578, P1, DOI 10.1016/j.mrfmmm.2004.09.018; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Choi MH, 2005, DRUG METAB DISPOS, V33, P714, DOI 10.1124/dmd.104.003327; Conte D, 1999, AM J PHYSIOL-ENDOC M, V277, pE1032, DOI 10.1152/ajpendo.1999.277.6.E1032; Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773; DIDOLKAR AK, 1980, INT J ANDROL, V3, P585, DOI 10.1111/j.1365-2605.1980.tb00146.x; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Faqi AS, 1997, HUM EXP TOXICOL, V16, P505, DOI 10.1177/096032719701600905; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Janke D, 2008, HUM MUTAT, V29, P659, DOI 10.1002/humu.20694; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kim JM, 2001, ENDOCRINOLOGY, V142, P3809, DOI 10.1210/en.142.9.3809; Kishi H, 1997, FEBS LETT, V402, P198, DOI 10.1016/S0014-5793(96)01528-1; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; MCLACHLAN RI, 1994, BIOL REPROD, V50, P271, DOI 10.1095/biolreprod50.2.271; Mendis-Handagama SMLC, 1998, TISSUE CELL, V30, P64, DOI 10.1016/S0040-8166(98)80007-4; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nozaki Y, 2007, J PHARMACOL EXP THER, V322, P1162, DOI 10.1124/jpet.107.121491; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Polifka JE, 2002, TERATOLOGY, V65, P240, DOI 10.1002/tera.10043; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Sakuma T, 2000, ARCH BIOCHEM BIOPHYS, V377, P153, DOI 10.1006/abbi.2000.1747; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; Shalet SM, 2009, PEDIATR BLOOD CANCER, V53, P285, DOI 10.1002/pbc.22000; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhang YY, 2009, EXPERT OPIN DRUG MET, V5, P621, DOI 10.1517/17425250902967648	58	29	29	12	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14456	14466		10.1074/jbc.M111.319681	http://dx.doi.org/10.1074/jbc.M111.319681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22375007	hybrid, Green Published			2022-12-25	WOS:000304003200013
J	Richards, BL; Williams, ID; Vetter, OJ; Williams, GJ				Richards, Benjamin L.; Williams, Ivor D.; Vetter, Oliver J.; Williams, Gareth J.			Environmental Factors Affecting Large-Bodied Coral Reef Fish Assemblages in the Mariana Archipelago	PLOS ONE			English	Article							REMOTE HAWAIIAN ATOLLS; MARINE PROTECTED AREAS; GREAT-BARRIER-REEF; LIFE-HISTORY; CARCHARHINUS-AMBLYRHYNCHOS; HABITAT ASSOCIATIONS; SPECIES RICHNESS; SPATIAL-PATTERNS; NEW-ZEALAND; MOVEMENTS	Large-bodied reef fishes represent an economically and ecologically important segment of the coral reef fish assemblage. Many of these individuals supply the bulk of the reproductive output for their population and have a disproportionate effect on their environment (e.g. as apex predators or bioeroding herbivores). Large-bodied reef fishes also tend to be at greatest risk of overfishing, and their loss can result in a myriad of either cascading (direct) or indirect trophic and other effects. While many studies have investigated habitat characteristics affecting populations of small-bodied reef fishes, few have explored the relationship between large-bodied species and their environment. Here, we describe the distribution of the large-bodied reef fishes in the Mariana Archipelago with an emphasis on the environmental factors associated with their distribution. Of the factors considered in this study, a negative association with human population density showed the highest relative influence on the distribution of large-bodied reef fishes; however, depth, water temperature, and distance to deep water also were important. These findings provide new information on the ecology of large-bodied reef fishes can inform discussions concerning essential fish habitat and ecosystem-based management for these species and highlight important knowledge gaps worthy of additional research.	[Richards, Benjamin L.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Williams, Ivor D.; Vetter, Oliver J.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Richards, Benjamin L.] NOAA Fisheries Serv, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography	Richards, BL (corresponding author), Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA.	benjamin.richards@noaa.gov	/AAZ-4417-2021	/0000-0001-9907-6221; Williams, Dr Gareth J./0000-0001-7837-1619; Williams, Ivor/0000-0002-9444-1020	National Marine Fisheries Service Office of Habitat Conservation; National Oceanic and Atmospheric Administration	National Marine Fisheries Service Office of Habitat Conservation; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The National Marine Fisheries Service Office of Habitat Conservation and National Oceanic and Atmospheric Administration's Coral Reef Conservation Program provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Amesbury J.R., 1989, NATIVE FISHING RIGHT; Asakura Akira, 1994, Natural History Research Special Issue, V1, P1; Ault JS, 1998, FISH B-NOAA, V96, P395; Beger M, 2008, MAR ECOL PROG SER, V361, P1, DOI 10.3354/meps07481; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Bohnsack James A., 2003, Gulf and Caribbean Research, V14, P1; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Burdick D, 2006, STATUS CORAL REEF EC; Cappo M, 2005, MAR FRESHWATER RES, V56, P713, DOI 10.1071/MF04218; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Caselle JE, 1996, ECOLOGY, V77, P2488, DOI 10.2307/2265748; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chittaro PM, 2004, CORAL REEFS, V23, P235, DOI 10.1007/s00338-004-0376-z; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2007, B MAR SCI, V81, P139; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Flores T, 2006, OFFSHORE FISHERIES P; Flores T, 2006, INSHORE FISHERIES PA; Francis Malcolm P., 1993, Fisheries Oceanography, V2, P65, DOI 10.1111/j.1365-2419.1993.tb00121.x; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedlander AM, 2001, AQUARIUM SCI CONSERV, V3, P135; Friedlander AM, 2005, NOAA TECHNICAL MEMOR, V23, P210; Green A, 1997, 278 W PAC REG FISH M; GRIGG RW, 1994, MAR ECOL PROG SER, V103, P25, DOI 10.3354/meps103025; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon Mark A., 1997, P230; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Holland KN, 1996, FISH RES, V25, P279, DOI 10.1016/0165-7836(95)00442-4; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humston R, 2005, MAR ECOL PROG SER, V291, P237, DOI 10.3354/meps291237; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jennings S., 2001, MARINE FISHERIES ECO; Jones R. S., 1968, Micronesica, V4, P309; Kemp JM, 1998, J BIOGEOGR, V25, P919, DOI 10.1046/j.1365-2699.1998.00249.x; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KOSLOW JA, 1988, MAR ECOL PROG SER, V43, P201, DOI 10.3354/meps043201; Kulbicki M, 2005, CYBIUM, V29, P235; Lange M., 2003, ENV MENTAL BIOL FISH, V66, P99; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LEVINS RICHARD, 1968; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Magnuson J.J., 1980, FISH BEHAV ITS USE C, P512; MARAGOS JE, 1993, COAST MANAGE, V21, P235, DOI 10.1080/08920759309362207; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meekan MG, 2003, MAR ECOL PROG SER, V256, P193, DOI 10.3354/meps256193; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Newman SJ, 1996, ENVIRON BIOL FISH, V46, P123, DOI 10.1007/BF00005214; NOAA National Centers for Coastal Ocean Science [NCCOS], 2005, NOAA TECHN MEM NOS N, P8; Pacific Islands Benthic Habitat Mapping Center, 2010, COMM NO MAR ISL CNMI; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Pate FD, 2001, AUST ARCHAEOL, V52, P1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Plotkin JB, 2002, ECOLOGY, V83, P3344, DOI 10.1890/0012-9658(2002)083[3344:STSCOA]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; RAINBIRD P, 1994, J WORLD PREHIST, V8, P293, DOI 10.1007/BF02221052; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Ridgeway G., GEN BOOSTED REGRESSI; Roberts C., 2007, UNNATURAL HIST SEA; Rohmann SO, 2005, CORAL REEFS, V24, P370, DOI 10.1007/s00338-005-0014-4; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; RUSS GR, 1989, MAR ECOL PROG SER, V56, P13, DOI 10.3354/meps056013; SALE PF, 1972, ECOLOGY, V53, P753, DOI 10.2307/1934798; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandin Stuart A., 2010, P71; Schroeder RE, 2003, P 10 INT COR REEF S, P1016; Sheppard C., 1995, MAR POLL B, V30, P766; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Song LM, 2009, ENVIRON BIOL FISH, V85, P153, DOI 10.1007/s10641-009-9474-7; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; SUDEKUM AE, 1991, FISH B-NOAA, V89, P493; THRESHER RE, 1986, B MAR SCI, V38, P253; Valesini FJ, 2004, ESTUAR COAST SHELF S, V60, P737, DOI 10.1016/j.ecss.2004.03.012; Western Pacific Regional Fishery Management Council, 2009, FISH EC PLAN MAR ARC; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams I.D., 2011, J MARINE BIOL, P14; Williaw GJ, 2008, NEW ZEAL J MAR FRESH, V42, P33, DOI 10.1080/00288330809509934; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	121	34	35	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31374	10.1371/journal.pone.0031374	http://dx.doi.org/10.1371/journal.pone.0031374			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384014	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500023
J	Veatch, SL; Machta, BB; Shelby, SA; Chiang, EN; Holowka, DA; Baird, BA				Veatch, Sarah L.; Machta, Benjamin B.; Shelby, Sarah A.; Chiang, Ethan N.; Holowka, David A.; Baird, Barbara A.			Correlation Functions Quantify Super-Resolution Images and Estimate Apparent Clustering Due to Over-Counting	PLOS ONE			English	Article							FC-EPSILON-RI; CELL-MEMBRANES; MAST-CELLS; MODEL; HETEROGENEITY; MICROSCOPY; RECEPTOR; DOMAINS; IGE; LIGANDS	We present an analytical method using correlation functions to quantify clustering in super-resolution fluorescence localization images and electron microscopy images of static surfaces in two dimensions. We use this method to quantify how over-counting of labeled molecules contributes to apparent self-clustering and to calculate the effective lateral resolution of an image. This treatment applies to distributions of proteins and lipids in cell membranes, where there is significant interest in using electron microscopy and super-resolution fluorescence localization techniques to probe membrane heterogeneity. When images are quantified using pair auto-correlation functions, the magnitude of apparent clustering arising from over-counting varies inversely with the surface density of labeled molecules and does not depend on the number of times an average molecule is counted. In contrast, we demonstrate that over-counting does not give rise to apparent co-clustering in double label experiments when pair cross-correlation functions are measured. We apply our analytical method to quantify the distribution of the IgE receptor (Fc epsilon RI) on the plasma membranes of chemically fixed RBL-2H3 mast cells from images acquired using stochastic optical reconstruction microscopy (STORM/dSTORM) and scanning electron microscopy (SEM). We find that apparent clustering of Fc epsilon RI-bound IgE is dominated by over-counting labels on individual complexes when IgE is directly conjugated to organic fluorophores. We verify this observation by measuring pair cross-correlation functions between two distinguishably labeled pools of IgE-Fc epsilon RI on the cell surface using both imaging methods. After correcting for over-counting, we observe weak but significant self-clustering of IgE-Fc epsilon RI in fluorescence localization measurements, and no residual self-clustering as detected with SEM. We also apply this method to quantify IgE-Fc epsilon RI redistribution after deliberate clustering by crosslinking with two distinct trivalent ligands of defined architectures, and we evaluate contributions from both over-counting of labels and redistribution of proteins.	[Veatch, Sarah L.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Machta, Benjamin B.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Veatch, Sarah L.; Shelby, Sarah A.; Chiang, Ethan N.; Holowka, David A.; Baird, Barbara A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	University of Michigan System; University of Michigan; Cornell University; Cornell University	Veatch, SL (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	sveatch@umich.edu	Veatch, Sarah L/G-9512-2016	Veatch, Sarah L/0000-0002-9317-2308; Shelby, Sarah/0000-0001-8484-8356	National Institutes of Health (NIH) [R00GM087810, R01AI18306]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087810] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded through the National Institutes of Health (NIH) (SLV: R00GM087810; BAB: R01AI18306). http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brewster R, 2009, BIOPHYS J, V97, P1087, DOI 10.1016/j.bpj.2009.05.051; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; ERICKSON J, 1987, BIOPHYS J, V52, P657, DOI 10.1016/S0006-3495(87)83258-7; GOMPPER G, 1990, PHYS REV B, V41, P9148, DOI 10.1103/PhysRevB.41.9148; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Heilemann M, 2011, MOLECULES, V16, P3106; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honerkamp-Smith AR, 2009, BBA-BIOMEMBRANES, V1788, P53, DOI 10.1016/j.bbamem.2008.09.010; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; MENDOZA G, 1976, NATURE, V264, P548, DOI 10.1038/264548a0; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sethna JP, 2006, STAT MECH ENTROPY OR, Vxix; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101	34	196	196	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31457	10.1371/journal.pone.0031457	http://dx.doi.org/10.1371/journal.pone.0031457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384026	Green Published, gold, Green Submitted			2022-12-25	WOS:000302918500026
J	Byron, SA; Gartside, M; Powell, MA; Wellens, CL; Gao, F; Mutch, DG; Goodfellow, PJ; Pollock, PM				Byron, Sara A.; Gartside, Michael; Powell, Matthew A.; Wellens, Candice L.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.; Pollock, Pamela M.			FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features	PLOS ONE			English	Article							SYSTEMATIC PELVIC LYMPHADENECTOMY; TRANSMEMBRANE MUTATION; CARCINOMA; DNA; ACTIVATION; SURGERY; TRIAL	Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in endometrial cancer. The aim of this study was to provide insight into the clinicopathological features associated with patterns of mutation in these genes, a necessary step in planning targeted therapies for endometrial cancer. 466 endometrioid endometrial tumors were tested for mutations in FGFR2, KRAS, CTNNB1, and PIK3CA. The relationships between mutation status, tumor microsatellite instability (MSI) and clinicopathological features including overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan-Meier survival analysis and Cox proportional hazard models. Mutations were identified in FGFR2 (48/466); KRAS (87/464); CTNNB1 (88/454) and PIK3CA (104/464). KRAS and FGFR2 mutations were significantly more common, and CTNNB1 mutations less common, in MSI positive tumors. KRAS and FGFR2 occurred in a near mutually exclusive pattern (p = 0.05) and, surprisingly, mutations in KRAS and CTNNB1 also occurred in a near mutually exclusive pattern (p = 0.0002). Multivariate analysis revealed that mutation in KRAS and FGFR2 showed a trend (p = 0.06) towards longer and shorter DFS, respectively. In the 386 patients with early stage disease (stage I and II), FGFR2 mutation was significantly associated with shorter DFS (HR = 3.24; 95% confidence interval, CI, 1.35-7.77; p = 0.008) and OS (HR = 2.00; 95% CI 1.09-3.65; p = 0.025) and KRAS was associated with longer DFS (HR = 0.23; 95% CI 0.05-0.97; p = 0.045). In conclusion, although KRAS and FGFR2 mutations share similar activation of the MAPK pathway, our data suggest very different roles in tumor biology. This has implications for the implementation of anti-FGFR or anti-MEK biologic therapies.	[Byron, Sara A.; Gartside, Michael; Wellens, Candice L.; Pollock, Pamela M.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Gynecol Oncol, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Biostat, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Siteman Canc Ctr, Div Endocrine Oncol, St Louis, MO USA; [Powell, Matthew A.; Gao, Feng; Mutch, David G.; Goodfellow, Paul J.] Washington Univ, Sch Med, St Louis, MO USA	Translational Genomics Research Institute; Siteman Cancer Center; Siteman Cancer Center; Siteman Cancer Center; Washington University (WUSTL)	Byron, SA (corresponding author), Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA.	pamela.pollock@qut.edu.au		Gao, Feng/0000-0002-1425-1623; Pollock, Pamela/0000-0001-8420-1026; Byron, Sara/0000-0003-0093-0374	American Cancer Society [PF-07-215-01-TBE]; V Foundation for Cancer Research; QUT;  [CA71754];  [P50 CA134254]; NATIONAL CANCER INSTITUTE [P50CA134254, R01CA071754] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); V Foundation for Cancer Research; QUT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by PF-07-215-01-TBE from the American Cancer Society (SAB), A V Scholar Grant from The V Foundation for Cancer Research (PMP), CA71754 (PJG), P50 CA134254 (PJG) and a QUT Vice Chancellors' Fellowship (PMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DPJ, 2009, INT J GYNECOL CANCER, V19, P1465, DOI 10.1111/IGC.0b013e3181b89f95; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Catasus L, 2008, MODERN PATHOL, V21, P131, DOI 10.1038/modpathol.3800992; Cheung LWT, 2011, CANC DISCOVERY, P1; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Engelsen IB, 2009, APMIS, V117, P693, DOI 10.1111/j.1600-0463.2009.02467.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Heiskanen M, 2001, ANAL CELL PATHOL, V22, P229, DOI 10.1155/2001/981218; Jang JH, 2001, CANCER RES, V61, P3541; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang S, 2008, INT J GYNECOL CANCER, V18, P1339, DOI 10.1111/j.1525-1438.2007.01172.x; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Konopka B, 2011, HUMAN PATHOLOGY; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Pollock PM, 2007, ONCOGENE; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; Susini T, 2007, CANCER-AM CANCER SOC, V109, P882, DOI 10.1002/cncr.22465; Swisher EM, 1999, CANCER-AM CANCER SOC, V85, P119, DOI 10.1002/(SICI)1097-0142(19990101)85:1<119::AID-CNCR17>3.0.CO;2-5; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107	36	117	120	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30801	10.1371/journal.pone.0030801	http://dx.doi.org/10.1371/journal.pone.0030801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383975	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100007
J	Fan, ZL; Wu, WH; Hildebrand, A; Kasuga, T; Zhang, RF; Xiong, XC				Fan, Zhiliang; Wu, Weihua; Hildebrand, Amanda; Kasuga, Takao; Zhang, Ruifu; Xiong, Xiaochao			A Novel Biochemical Route for Fuels and Chemicals Production from Cellulosic Biomass	PLOS ONE			English	Article							WHITE-ROT FUNGI; ENTNER-DOUDOROFF PATHWAY; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; SPOROTRICHUM-PULVERULENTUM; CELLOBIOSE DEHYDROGENASE; BIOLOGICAL PRETREATMENT; ETHANOL-PRODUCTION; DEGRADATION; WOOD	The conventional biochemical platform featuring enzymatic hydrolysis involves five key steps: pretreatment, cellulase production, enzymatic hydrolysis, fermentation, and product recovery. Sugars are produced as reactive intermediates for subsequent fermentation to fuels and chemicals. Herein, an alternative biochemical route is proposed. Pretreatment, enzymatic hydrolysis and cellulase production is consolidated into one single step, referred to as consolidated aerobic processing, and sugar aldonates are produced as the reactive intermediates for biofuels production by fermentation. In this study, we demonstrate the viability of consolidation of the enzymatic hydrolysis and cellulase production steps in the new route using Neurospora crassa as the model microorganism and the conversion of cellulose to ethanol as the model system. We intended to prove the two hypotheses: 1) cellulose can be directed to produce cellobionate by reducing beta-glucosidase production and by enhancing cellobiose dehydrogenase production; and 2) both of the two hydrolysis products of cellobionate-glucose and gluconate-can be used as carbon sources for ethanol and other chemical production. Our results showed that knocking out multiple copies of beta-glucosidase genes led to cellobionate production from cellulose, without jeopardizing the cellulose hydrolysis rate. Simulating cellobiose dehydrogenase over-expression by addition of exogenous cellobiose dehydrogenase led to more cellobionate production. Both of the two hydrolysis products of cellobionate: glucose and gluconate can be used by Escherichia coli KO 11 for efficient ethanol production. They were utilized simultaneously in glucose and gluconate co-fermentation. Gluconate was used even faster than glucose. The results support the viability of the two hypotheses that lay the foundation for the proposed new route.	[Fan, Zhiliang; Wu, Weihua; Hildebrand, Amanda; Zhang, Ruifu; Xiong, Xiaochao] Univ Calif Davis, Biol & Agr Engn Dept, Davis, CA 95616 USA; [Kasuga, Takao] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kasuga, Takao] ARS, USDA, Davis, CA USA; [Zhang, Ruifu] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangshu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); Nanjing Agricultural University	Fan, ZL (corresponding author), Univ Calif Davis, Biol & Agr Engn Dept, Davis, CA 95616 USA.	jzfan@ucdavis.edu	Zhang, Ruifu/HDN-0340-2022; Zhang, Ruifu/HDN-0417-2022		Agriculture and Food Research Initiative from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-67009-20060]; California Energy Commission [55779A/08-03]	Agriculture and Food Research Initiative from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; California Energy Commission	This project was supported by Agriculture and Food Research Initiative Competitive Grant No. 2011-67009-20060 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture and California Energy Commission grant 55779A/08-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden A., 2002, LIGNOCELLULOSIC BIOM, DOI 10.2172/15001119; AKIN DE, 1993, APPL ENVIRON MICROB, V59, P4274, DOI 10.1128/AEM.59.12.4274-4282.1993; ANDER P, 1977, PHYSIOL PLANTARUM, V41, P239, DOI 10.1111/j.1399-3054.1977.tb04877.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; BRUCHMANN EE, 1969, H-S Z PHYSIOL CHEM, V350, P554, DOI 10.1515/bchm2.1969.350.1.554; BUSWELL JA, 1987, CRC CR REV BIOTECHN, V6, P1, DOI 10.3109/07388558709086984; Cameron MD, 2001, ENZYME MICROB TECH, V28, P129, DOI 10.1016/S0141-0229(00)00307-0; Cullen D, 1997, J BIOTECHNOL, V53, P273, DOI 10.1016/S0168-1656(97)01684-2; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; EBERHART BM, 1973, J BACTERIOL, V116, P295, DOI 10.1128/JB.116.1.295-303.1973; EBERHART BM, 1977, J BACTERIOL, V130, P181, DOI 10.1128/JB.130.1.181-186.1977; ERIKSSON KE, 1980, HOLZFORSCHUNG, V34, P207, DOI 10.1515/hfsg.1980.34.6.207; ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; GOLD MH, 1989, ACS SYM SER, V389, P127; GOLD MH, 1993, MICROBIOL REV, V57, P605, DOI 10.1128/MMBR.57.3.605-622.1993; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Kirk T. K., 1972, Wood and Fiber, V4, P72; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Klemm P, 1996, J BACTERIOL, V178, P61, DOI 10.1128/jb.178.1.61-67.1996; Kurakake M, 2007, CURR MICROBIOL, V54, P424, DOI 10.1007/s00284-006-0568-6; Lee JW, 2007, J MICROBIOL, V45, P485; Luke AK, 2001, ENZYME MICROB TECH, V29, P348, DOI 10.1016/S0141-0229(01)00390-8; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; Ponce E, 2005, CAN J MICROBIOL, V51, P975, DOI 10.1139/w05-101; Porco A, 1997, J BACTERIOL, V179, P1584, DOI 10.1128/jb.179.5.1584-1590.1997; Romero MD, 1999, ENZYME MICROB TECH, V25, P244, DOI 10.1016/S0141-0229(99)00035-6; RUEL K, 1981, HOLZFORSCHUNG, V35, P157, DOI 10.1515/hfsg.1981.35.4.157; Singh OV, 2007, APPL MICROBIOL BIOT, V75, P713, DOI 10.1007/s00253-007-0851-x; STREAMER M, 1975, EUR J BIOCHEM, V59, P607, DOI 10.1111/j.1432-1033.1975.tb02489.x; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tian CG, 2007, EUKARYOT CELL, V6, P1018, DOI 10.1128/EC.00078-07; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; WESTERMARK U, 1975, SVEN PAPPERSTIDN, V78, P653; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; YANG HH, 1980, BIOTECHNOL BIOENG, V22, P65, DOI 10.1002/bit.260220106; Zhang RF, 2011, PROTEIN EXPRES PURIF, V75, P63, DOI 10.1016/j.pep.2010.08.003	42	23	25	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31693	10.1371/journal.pone.0031693	http://dx.doi.org/10.1371/journal.pone.0031693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384058	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916100028
J	Li, SC; Wang, SQ; Deng, QM; Zheng, AP; Zhu, J; Liu, HN; Wang, LX; Gao, FY; Zou, T; Huang, B; Cao, XM; Xu, LZ; Yu, C; Ai, P; Li, P				Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Gao, Fengyan; Zou, Ting; Huang, Bin; Cao, Xuemei; Xu, Lizhi; Yu, Chuang; Ai, Peng; Li, Ping			Identification of Genome-Wide Variations among Three Elite Restorer Lines for Hybrid-Rice	PLOS ONE			English	Article							GENE CONFERRING RESISTANCE; CYTOPLASMIC MALE-STERILITY; DRAFT SEQUENCE; GRAIN WIDTH; ENCODES; RESOURCE; WEIGHT; QTL	Rice restorer lines play an important role in three-line hybrid rice production. Previous research based on molecular tagging has suggested that the restorer lines used widely today have narrow genetic backgrounds. However, patterns of genetic variation at a genome-wide scale in these restorer lines remain largely unknown. The present study performed resequencing and genome-wide variation analysis of three important representative restorer lines, namely, IR24, MH63, and SH527, using the Solexa sequencing technology. With the genomic sequence of the Indica cultivar 9311 as the reference, the following genetic features were identified: 267,383 single-nucleotide polymorphisms (SNPs), 52,847 insertion/deletion polymorphisms (InDels), and 3,286 structural variations (SVs) in the genome of IR24; 288,764 SNPs, 59,658 InDels, and 3,226 SVs in MH63; and 259,862 SNPs, 55,500 InDels, and 3,127 SVs in SH527. Variations between samples were also determined by comparative analysis of authentic collections of SNPs, InDels, and SVs, and were functionally annotated. Furthermore, variations in several important genes were also surveyed by alignment analysis in these lines. Our results suggest that genetic variations among these lines, although far lower than those reported in the landrace population, are greater than expected, indicating a complicated genetic basis for the phenotypic diversity of the restorer lines. Identification of genome-wide variation and pattern analysis among the restorer lines will facilitate future genetic studies and the molecular improvement of hybrid rice.	[Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Xu, Lizhi; Yu, Chuang; Ai, Peng; Li, Ping] Sichuan Agr Univ, Rice Res Inst, Wenjiang, Sichuan, Peoples R China; [Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Zheng, Aiping; Zhu, Jun; Gao, Fengyan; Zou, Ting; Huang, Bin; Cao, Xuemei; Li, Ping] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan, Sichuan, Peoples R China; [Li, Shuangcheng; Wang, Shiquan; Deng, Qiming; Li, Ping] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Li, SC (corresponding author), Sichuan Agr Univ, Rice Res Inst, Wenjiang, Sichuan, Peoples R China.	liping6575@163.com			National Basic Research (973) Program of China [2011CB100101]; National Natural Science Foundation of China [30800084]; Special Programs for GM Crops Initiative of China [2008ZX08001-001]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Programs for GM Crops Initiative of China	This work was supported by the National Basic Research (973) Program of China (2011CB100101), the National Natural Science Foundation of China (30800084), and the Special Programs for GM Crops Initiative of China (2008ZX08001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadikhah A, 2006, PLANT BREEDING, V125, P363, DOI 10.1111/j.1439-0523.2006.01246.x; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cheng ShiHua, 2000, Chinese Journal of Rice Science, V14, P165; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Duan Shi-Hua, 2002, Acta Genetica Sinica, V29, P250; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Shu, 2002, Chinese Journal of Rice Science, V16, P1; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Qu S, 2006, GENETICS GENETICS; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q, 2007, PDS DATA PROCESSING; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang YuPing, 2004, Hybrid Rice, V19, P12; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Xie H, 1994, HYBRID RICE, V3, P31; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhao WM, 2004, NUCLEIC ACIDS RES, V32, pD377, DOI 10.1093/nar/gkh085; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	37	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30952	10.1371/journal.pone.0030952	http://dx.doi.org/10.1371/journal.pone.0030952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383984	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916100011
J	Cantacessi, C; Hofmann, A; Young, ND; Broder, U; Hall, RS; Loukas, A; Gasser, RB				Cantacessi, Cinzia; Hofmann, Andreas; Young, Neil D.; Broder, Ursula; Hall, Ross S.; Loukas, Alex; Gasser, Robin B.			Insights into SCP/TAPS Proteins of Liver Flukes Based on Large-Scale Bioinformatic Analyses of Sequence Datasets	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; ANCYLOSTOMA-SECRETED PROTEIN; PROTEOMIC ANALYSIS; HUMAN HOOKWORM; VENOM ALLERGEN; NECATOR-AMERICANUS; FASCIOLA-HEPATICA; NA-ASP-2 PROTEIN; ADULT STAGE; GENE	Background: SCP/TAPS proteins of parasitic helminths have been proposed to play key roles in fundamental biological processes linked to the invasion of and establishment in their mammalian host animals, such as the transition from free-living to parasitic stages and the modulation of host immune responses. Despite the evidence that SCP/TAPS proteins of parasitic nematodes are involved in host-parasite interactions, there is a paucity of information on this protein family for parasitic trematodes of socio-economic importance. Methodology/Principal Findings: We conducted the first large-scale study of SCP/TAPS proteins of a range of parasitic trematodes of both human and veterinary importance (including the liver flukes Clonorchis sinensis, Opisthorchis viverrini, Fasciola hepatica and F. gigantica as well as the blood flukes Schistosoma mansoni, S. japonicum and S. haematobium). We mined all current transcriptomic and/or genomic sequence datasets from public databases, predicted secondary structures of full-length protein sequences, undertook systematic phylogenetic analyses and investigated the differential transcription of SCP/TAPS genes in O. viverrini and F. hepatica, with an emphasis on those that are up-regulated in the developmental stages infecting the mammalian host. Conclusions: This work, which sheds new light on SCP/TAPS proteins, guides future structural and functional explorations of key SCP/TAPS molecules associated with diseases caused by flatworms. Future fundamental investigations of these molecules in parasites and the integration of structural and functional data could lead to new approaches for the control of parasitic diseases.	[Cantacessi, Cinzia; Young, Neil D.; Hall, Ross S.; Gasser, Robin B.] Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia; [Hofmann, Andreas; Broder, Ursula] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Loukas, Alex] James Cook Univ, Smithfield, Qld, Australia	University of Melbourne; Griffith University; James Cook University	Cantacessi, C (corresponding author), Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia.	robinbg@unimelb.edu.au	Cantacessi, Cinzia/B-7356-2014; Gasser, Robin/ABH-6185-2020; Hofmann, Andreas/M-9870-2019; Young, Neil David/AAU-4572-2020; Hofmann, Andreas/B-9515-2008; Loukas, Alex/B-7355-2014	Cantacessi, Cinzia/0000-0001-6863-2950; Gasser, Robin/0000-0002-4423-1690; Hofmann, Andreas/0000-0003-4408-5467; Young, Neil David/0000-0001-8756-229X; Hofmann, Andreas/0000-0003-4408-5467; Loukas, Alex/0000-0002-0896-8441	Australian Research Council; Melbourne Water Corporation; National Health and Medical Research Council; Victorian Life Sciences Computation Initiative; IBM Collaboratory	Australian Research Council(Australian Research Council); Melbourne Water Corporation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative; IBM Collaboratory(International Business Machines (IBM))	The Gasser Lab is presently supported by funding from the Australian Research Council, Melbourne Water Corporation and the National Health and Medical Research Council (RBG). Support from the Victorian Life Sciences Computation Initiative and IBM Collaboratory is also acknowledged (RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; Asojo OA, 2005, ACTA CRYSTALLOGR F, V61, P391, DOI 10.1107/S1744309105007748; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bower MA, 2008, EXP PARASITOL, V118, P569, DOI 10.1016/j.exppara.2007.11.014; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2011, BIOTECHNOL IN PRESS; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Chen JF, 2010, PARASITOL RES, V106, P1413, DOI 10.1007/s00436-010-1817-y; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Datu BJD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000130; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Hagen J, 2011, PARASITE IM IN PRESS; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Hawdon JM, 1999, MOL BIOCHEM PARASIT, V99, P149, DOI 10.1016/S0166-6851(99)00011-0; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Hotez PJ, 2003, INT J PARASITOL, V33, P1245, DOI 10.1016/S0020-7519(03)00158-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jalkanen J, 2005, BIOL REPROD, V72, P1268, DOI 10.1095/biolreprod.104.035758; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; KASAHARA M, 1989, GENOMICS, V5, P527, DOI 10.1016/0888-7543(89)90019-0; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis F, 1998, CURRENT PROTOCOL S28; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; LU G, 1993, J IMMUNOL, V150, P2823; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mendez S, 2008, PARASITE IMMUNOL, V30, P53, DOI 10.1111/j.1365-3024.2007.00994.x; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moser JM, 2005, MOL BIOCHEM PARASIT, V143, P39, DOI 10.1016/j.molbiopara.2005.04.012; Mulcahy G, 1999, FASCIOLOSIS, P341; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Nithikathkul C, 2007, J HELMINTHOL, V81, P39, DOI 10.1017/S0022149X07212106; Osman A, 2011, BIOTECHNOL IN PRESS; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SKRJABIN KI, 1991, KEYS PARASITIC NEMAT, V3, P230; Tchoubrieva EB, 2010, BIOTECHNOL GENET ENG, V26, P261; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Xiao S, 2008, EXP PARASITOL, V118, P32, DOI 10.1016/j.exppara.2007.05.010; Yamakawa T, 1998, BBA-GENE STRUCT EXPR, V1395, P202, DOI 10.1016/S0167-4781(97)00149-8; Young ND, 2011, NAT GENET IN PRESS; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zhan B, 2003, INT J PARASITOL, V33, P897, DOI 10.1016/S0020-7519(03)00111-5; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	80	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31164	10.1371/journal.pone.0031164	http://dx.doi.org/10.1371/journal.pone.0031164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384000	Green Published, Green Accepted, gold			2022-12-25	WOS:000302875500013
J	David, HN; Haelewyn, B; Degoulet, M; Colomb, DG; Risso, JJ; Abraini, JH				David, Helene N.; Haelewyn, Benoit; Degoulet, Mickael; Colomb, Denis G., Jr.; Risso, Jean-Jacques; Abraini, Jacques H.			Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult	PLOS ONE			English	Article							TRANSIENT CEREBRAL-ISCHEMIA; NITROUS-OXIDE; NOBLE-GASES; FOREBRAIN ISCHEMIA; ARTERY OCCLUSION; BRAIN-INJURY; XENON; RAT; STROKE; ISOFLURANE	In vitro studies have well established the neuroprotective action of the noble gas argon. However, only limited data from in vivo models are available, and particularly whether postexcitotoxic or postischemic argon can provide neuroprotection in vivo still remains to be demonstrated. Here, we investigated the possible neuroprotective effect of postexcitotoxic-postischemic argon both ex vivo in acute brain slices subjected to ischemia in the form of oxygen and glucose deprivation (OGD), and in vivo in rats subjected to an intrastriatal injection of N-methyl-D-aspartate (NMDA) or to the occlusion of middle-cerebral artery (MCAO). We show that postexcitotoxic-postischemic argon reduces OGD-induced cell injury in brain slices, and further reduces NMDA-induced brain damage and MCAO-induced cortical brain damage in rats. Contrasting with its beneficial effect at the cortical level, we show that postischemic argon increases MCAO-induced subcortical brain damage and provides no improvement of neurologic outcome as compared to control animals. These results extend previous data on the neuroprotective action of argon. Particularly, taken together with previous in vivo data that have shown that intraischemic argon has neuroprotective action at both the cortical and subcortical level, our findings on postischemic argon suggest that this noble gas could be administered during but not after ischemia, i.e. before but not after reperfusion has occurred, in order to provide cortical neuroprotection and to avoid increasing subcortical brain damage. Also, the effects of argon are discussed as regards to the oxygen-like chemical, pharmacological, and physical properties of argon.	[David, Helene N.; Abraini, Jacques H.] Univ Laval, Ctr Rech, Ctr Hosp Affilie Univ Hotel Dieu Levis, Levis, PQ, Canada; [Haelewyn, Benoit] Univ Caen Basse Normandie, CURB, Caen, France; [Haelewyn, Benoit; Degoulet, Mickael; Abraini, Jacques H.] Univ Caen Basse Normandie, UMR 6232, Caen, France; [Haelewyn, Benoit; Degoulet, Mickael; Abraini, Jacques H.] CNRS, UMR 6232, Caen, France; [Colomb, Denis G., Jr.] USN, Expt Diving Unit, Panama City, FL USA; [Risso, Jean-Jacques] Inst Rech Biomed Armees, Antenne Toulon, France; [Abraini, Jacques H.] Univ Laval, Ctr Rech, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada	Laval University; Universite de Caen Normandie; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); United States Department of Defense; United States Navy; Laval University	David, HN (corresponding author), Univ Laval, Ctr Rech, Ctr Hosp Affilie Univ Hotel Dieu Levis, Levis, PQ, Canada.	jh.abraini@gmail.com		Degoulet, Mickael/0000-0002-4268-5795	Direction Generale de l'Armement of the French Ministry of Defence; NNOXe Pharmaceuticals (Quebec City, QC, Canada)	Direction Generale de l'Armement of the French Ministry of Defence; NNOXe Pharmaceuticals (Quebec City, QC, Canada)	This work was supported by the Direction Generale de l'Armement of the French Ministry of Defence and NNOXe Pharmaceuticals (Quebec City, QC, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Abraini JH, 2005, ANESTH ANALG, V101, P614, DOI 10.1213/01.ANE.0000159020.86959.83; Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Abraini JH, 1998, BRAIN RES, V808, P300, DOI 10.1016/S0006-8993(98)00760-4; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Haelewyn B, 2008, EXP NEUROL, V213, P238, DOI 10.1016/j.expneurol.2008.05.012; Haelewyn B, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-2; Haelewyn B, 2011, ANESTHESIOLOGY, V115, P1044, DOI 10.1097/ALN.0b013e3182342860; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Lazar RM, 2010, J NEUROL SCI, V292, P72, DOI 10.1016/j.jns.2010.01.024; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Massieu L, 2001, NEUROSCIENCE, V106, P669, DOI 10.1016/S0306-4522(01)00323-2; MICKEL HS, 1987, STROKE, V18, P426, DOI 10.1161/01.STR.18.2.426; Nasu I, 2006, ANESTH ANALG, V103, P413, DOI 10.1213/01.ane.0000223686.50202.38; Natale G, 2006, ANN NY ACAD SCI, V1074, P650, DOI 10.1196/annals.1369.063; Olney JW, 2000, ENVIRON HEALTH PERSP, V108, P383, DOI 10.2307/3454524; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Pavlov BN, 1997, HIGH PRESSURE BIOL M, P133; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sanders RD, 2005, BEST PRACT RES-CLIN, V19, P461, DOI 10.1016/j.bpa.2005.01.005; Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5; Semenov N, 1989, SHORT MOMENT TRIUMPH, P6; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Sucher N J, 1990, Neuroreport, V1, P29, DOI 10.1097/00001756-199009000-00009; Sugaya T, 1997, BRAIN RES BULL, V44, P307, DOI 10.1016/S0361-9230(97)00142-1; TAPPER D, 1974, J PEDIATR SURG, V9, P597, DOI 10.1016/0022-3468(74)90094-3; WHITE PF, 1974, ANESTHESIOLOGY, V40, P52, DOI 10.1097/00000542-197401000-00012; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	46	62	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30934	10.1371/journal.pone.0030934	http://dx.doi.org/10.1371/journal.pone.0030934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383981	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500006
J	Hurlbert, AH; Liang, ZF				Hurlbert, Allen H.; Liang, Zhongfei			Spatiotemporal Variation in Avian Migration Phenology: Citizen Science Reveals Effects of Climate Change	PLOS ONE			English	Article							SWALLOW HIRUNDO-RUSTICA; SPRING ARRIVAL DATES; BIRD MIGRATION; DEPARTURE DATES; MIGRANT BIRDS; LONG-TERM; DISTANCE; TRENDS; TEMPERATURE; RESPONSES	A growing number of studies have documented shifts in avian migratory phenology in response to climate change, and yet there is a large amount of unexplained variation in the magnitude of those responses across species and geographic regions. We use a database of citizen science bird observations to explore spatiotemporal variation in mean arrival dates across an unprecedented geographic extent for 18 common species in North America over the past decade, relating arrival dates to mean minimum spring temperature. Across all species and geographic locations, species shifted arrival dates 0.8 days earlier for every degrees C of warming of spring temperature, but it was common for some species in some locations to shift as much as 3-6 days earlier per degrees C. Species that advanced arrival dates the earliest in response to warming were those that migrate more slowly, short distance migrants, and species with broader climatic niches. These three variables explained 63% of the interspecific variation in phenological response. We also identify a latitudinal gradient in the average strength of phenological response, with species shifting arrival earlier at southern latitudes than northern latitudes for the same degree of warming. This observation is consistent with the idea that species must be more phenologically sensitive in less seasonal environments to maintain the same degree of precision in phenological timing.	[Hurlbert, Allen H.; Liang, Zhongfei] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Hurlbert, AH (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	hurlbert@bio.unc.edu		Hurlbert, Allen/0000-0002-5678-9907	University of North Carolina	University of North Carolina	This study was supported by institutional funds from the University of North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; [Anonymous], 1988, BIRDERS HDB FIELD GU; Askeyev OV, 2009, CENT EUR J BIOL, V4, P595, DOI 10.2478/s11535-009-0046-9; Baillie SR, 2006, J ORNITHOL, V147, P254, DOI 10.1007/s10336-006-0062-8; Barrett RT, 2002, BIRD STUDY, V49, P270, DOI 10.1080/00063650209461275; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Butler CJ, 2003, IBIS, V145, P484, DOI 10.1046/j.1474-919X.2003.00193.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Hurlbert AH, 2007, GLOBAL ECOL BIOGEOGR, V16, P764, DOI 10.1111/j.1466-8238.2007.00335.x; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kaufmann RK, 2011, P NATL ACAD SCI; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; MacMynowski DP, 2007, INT J BIOMETEOROL, V51, P361, DOI 10.1007/s00484-006-0084-1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Marris E, 2010, NATURE, V466, P807, DOI 10.1038/466807a; Mearns L., 2007, N AM REGIONAL CLIMAT, DOI 10.5065/D6RN35ST; Miller-Rushing AJ, 2008, GLOBAL CHANGE BIOL, V14, P1959, DOI 10.1111/j.1365-2486.2008.01619.x; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moller AP, 2008, J EVOLUTION BIOL, V21, P213, DOI 10.1111/j.1420-9101.2007.01450.x; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Moreau R. E., 1972, PALEARCTIC AFRICAN B; Murphy-Klassen HM, 2005, AUK, V122, P1130, DOI 10.1642/0004-8038(2005)122[1130:LTISAD]2.0.CO;2; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry ML, 2007, CLIMATE CHANGE 2007; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; Rubolini D, 2005, BIOL J LINN SOC, V85, P199, DOI 10.1111/j.1095-8312.2005.00484.x; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Rubolini D, 2010, CLIM RES, V42, P45, DOI 10.3354/cr00862; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; SAUER JR, 2011, N AM BREEDING BIRD S; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2007, J ORNITHOL, V148, P503, DOI 10.1007/s10336-007-0193-6; Sparks T.H., 2001, Avian Ecology and Behaviour, V7, P75; Sparks TH, 1999, INT J BIOMETEOROL, V42, P134, DOI 10.1007/s004840050096; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Sparks TH, 2001, INT J BIOMETEOROL, V45, P212, DOI 10.1007/s004840100095; Strode PK, 2003, GLOBAL CHANGE BIOL, V9, P1137, DOI 10.1046/j.1365-2486.2003.00664.x; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Swanson DL, 2009, J FIELD ORNITHOL, V80, P351, DOI 10.1111/j.1557-9263.2009.00241.x; Tottrup AP, 2010, INTEGRATIVE COMP BIO; Tryjanowski P, 2002, IBIS, V144, P62, DOI 10.1046/j.0019-1019.2001.00022.x; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147	67	150	154	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31662	10.1371/journal.pone.0031662	http://dx.doi.org/10.1371/journal.pone.0031662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384050	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500030
J	Haldar, S; Paul, S; Joshi, N; Dasgupta, A; Chattopadhyay, K				Haldar, Shubhasis; Paul, Simantasarani; Joshi, Nidhi; Dasgupta, Anindya; Chattopadhyay, Krishnananda			The Presence of the Iron-Sulfur Motif Is Important for the Conformational Stability of the Antiviral Protein, Viperin	PLOS ONE			English	Article							AMPHIPATHIC ALPHA-HELIX; PARTIALLY FOLDED STATE; 3-DIMENSIONAL STRUCTURES; TRIFLUOROETHANOL; RECOGNITION; ALIGNMENT; VIRUS; MECHANISMS; DATABASE; INHIBIT	Viperin, an antiviral protein, has been shown to contain a CX3CX2C motif, which is conserved in the radical S-adenosylmethionine (SAM) enzyme family. A triple mutant which replaces these three cysteines with alanines has been shown to have severe deficiency in antiviral activity. Since the crystal structure of Viperin is not available, we have used a combination of computational methods including multi-template homology modeling and molecular dynamics simulation to develop a low-resolution predicted structure. The results show that Viperin is an alpha-beta protein containing iron-sulfur cluster at the center pocket. The calculations suggest that the removal of iron-sulfur cluster would lead to collapse of the protein tertiary structure. To verify these predictions, we have prepared, expressed and purified four mutant proteins. In three mutants individual cysteine residues were replaced by alanine residues while in the fourth all the cysteines were replaced by alanines. Conformational analyses using circular dichroism and steady state fluorescence spectroscopy indicate that the mutant proteins are partially unfolded, conformationally unstable and aggregation prone. The lack of conformational stability of the mutant proteins may have direct relevance to the absence of their antiviral activity.	[Haldar, Shubhasis; Dasgupta, Anindya] CSIR, Indian Inst Chem Biol, Div Infect Dis, Kolkata, W Bengal, India; [Dasgupta, Anindya] CSIR, Indian Inst Chem Biol, Div Immunol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Haldar, S (corresponding author), CSIR, Indian Inst Chem Biol, Div Infect Dis, Kolkata, W Bengal, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	CSIR EMPOWER [olp004]	CSIR EMPOWER	The work is supported by CSIR EMPOWER grant (olp004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruccoleri RE, 2000, METH MOL B, V143, P247; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; BUCK M, 1993, BIOCHEMISTRY-US, V32, P669, DOI 10.1021/bi00053a036; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chugh J, 2008, BIOCHEMISTRY-US, V47, P12945, DOI 10.1021/bi801698q; Corpet F, 1999, NUCLEIC ACIDS RES, V27, P263, DOI 10.1093/nar/27.1.263; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; HAMADA D, 1993, BIOCHEMISTRY-US, V32, P10351, DOI 10.1021/bi00090a010; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Niu WL, 2010, J PHYS CHEM B, V114, P16156, DOI 10.1021/jp106041v; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Reyda MR, 2008, ARCH BIOCHEM BIOPHYS, V471, P32, DOI 10.1016/j.abb.2007.12.001; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	42	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31797	10.1371/journal.pone.0031797	http://dx.doi.org/10.1371/journal.pone.0031797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363738	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700100
J	Lee, ASG; Ong, DCT; Wong, JCL; Siu, GKH; Yam, WC				Lee, Ann S. G.; Ong, Danny C. T.; Wong, Joshua C. L.; Siu, Gilman K. H.; Yam, Wing-Cheong			High-Resolution Melting Analysis for the Rapid Detection of Fluoroquinolone and Streptomycin Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							GYRASE MUTATIONS; MOLECULAR CHARACTERIZATION; DRUG SUSCEPTIBILITY; FUNCTIONAL-ANALYSIS; GLOBAL TRENDS; RRS MUTATIONS; GENE; EFFLUX; DIFFERENTIATION; IDENTIFICATION	Background: Molecular methods for the detection of drug-resistant tuberculosis are potentially more rapid than conventional culture-based drug susceptibility testing, facilitating the commencement of appropriate treatment for patients with drug resistant tuberculosis. We aimed to develop and evaluate high-resolution melting (HRM) assays for the detection of mutations within gyrA, rpsL, and rrs, for the determination of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis (MTB). Methodology/Principal Findings: A blinded series of DNA samples extracted from a total of 92 clinical isolates of MTB were analyzed by HRM analysis, and the results were verified using DNA sequencing. The sensitivity and specificity of the HRM assays in comparison with drug susceptibility testing were 74.1% and 100.0% for the detection of fluoroquinolone resistance, and 87.5% and 100.0% for streptomycin resistance. Five isolates with low level resistance to ofloxacin had no mutations detected in gyrA, possibly due to the action of efflux pumps, or false negativity due to mixed infections. One fluoroquinolone-resistant isolate had a mutation in a region of gyrA not encompassed by our assay. Six streptomycin-resistant strains had undetectable mutations by HRM and DNA sequencing, which may be explained by the fact that not all streptomycin-resistant isolates have mutations within rpsL and rrs, and suggesting that other targets may be involved. Conclusion: The HRM assays described here are potentially useful adjunct tests for the efficient determination of fluoroquinolone and streptomycin resistance in MTB, and could facilitate the timely administration of appropriate treatment for patients infected with drug-resistant TB.	[Lee, Ann S. G.; Ong, Danny C. T.; Wong, Joshua C. L.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Siu, Gilman K. H.; Yam, Wing-Cheong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	National Cancer Centre Singapore (NCCS); National University of Singapore; University of Hong Kong	Lee, ASG (corresponding author), Natl Canc Ctr, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	SIU, Kit Hang/L-7796-2017	SIU, Kit Hang/0000-0002-4354-3393	Biomedical Research Council (BMRC) of Singapore [BMRC 07/1/31/19/511]	Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council (BMRC) of Singapore (BMRC 07/1/31/19/511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Castellanos E, 2010, J CLIN MICROBIOL, V48, P1474, DOI 10.1128/JCM.02484-09; Clinical and Laboratory Standards Institute, 2003, M24A NCCLS CLIN LAB; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764; de Oliveira MM, 2003, J MICROBIOL METH, V53, P335, DOI 10.1016/S0167-7012(02)00253-1; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; DOUGLASS J, 1993, J INFECT DIS, V167, P1505, DOI 10.1093/infdis/167.6.1505; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Hu Y, 2011, TUBERCULOSIS, V91, P238, DOI 10.1016/j.tube.2011.03.001; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Katsukawa E, 1997, J APPL MICROBIOL, V83, P634, DOI 10.1046/j.1365-2672.1997.00279.x; Kocagoz T, 1996, ANTIMICROB AGENTS CH, V40, P1768, DOI 10.1128/AAC.40.8.1768; Lau RWT, 2011, ANTIMICROB AGENTS CH, V55, P608, DOI 10.1128/AAC.00920-10; Lee Ann S. G., 2002, International Journal of Infectious Diseases, V6, P48, DOI 10.1016/S1201-9712(02)90136-0; Lee ASG, 2005, J CLIN MICROBIOL, V43, P2026, DOI 10.1128/JCM.43.4.2026-2027.2005; Lee ASG, 2004, ANTIMICROB AGENTS CH, V48, P4447, DOI 10.1128/AAC.48.11.4447-4449.2004; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Perlman DC, 1997, AIDS, V11, P1473, DOI 10.1097/00002030-199712000-00011; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; ROBERTS GD, 1983, J CLIN MICROBIOL, V18, P689, DOI 10.1128/JCM.18.3.689-696.1983; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Singh M, 2011, INDIAN J MED RES, V133, P535; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Telles MAS, 2002, BRAZ J MED BIOL RES, V35, P1127, DOI 10.1590/S0100-879X2002001000003; Tracevska T, 2004, RES MICROBIOL, V155, P830, DOI 10.1016/j.resmic.2004.06.007; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Yam WC, 2006, J MED MICROBIOL, V55, P529, DOI 10.1099/jmm.0.46298-0; Yin XM, 2010, J INFECTION, V61, P150, DOI 10.1016/j.jinf.2010.05.001; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	54	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31934	10.1371/journal.pone.0031934	http://dx.doi.org/10.1371/journal.pone.0031934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363772	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700126
J	Rioux, G; Babin, C; Majeau, N; Leclerc, D				Rioux, Gervais; Babin, Cindy; Majeau, Nathalie; Leclerc, Denis			Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites	PLOS ONE			English	Article							POTEXVIRUS COAT PROTEIN; TRITIUM PLANIGRAPHY; PARTICLES; MOVEMENT; EPITOPES; IMMUNITY; BINDING; CELL; RNA	Papaya mosaic virus has been shown to be an efficient adjuvant and vaccine platform in the design and improvement of innovative flu vaccines. So far, all fusions based on the PapMV platform have been located at the C-terminus of the PapMV coat protein. Considering that some epitopes might interfere with the self-assembly of PapMV CP when fused at the C-terminus, we evaluated other possible sites of fusion using the influenza HA11 peptide antigen. Two out of the six new fusion sites tested led to the production of recombinant proteins capable of self assembly into PapMV nanoparticles; the two functional sites are located after amino acids 12 and 187. Immunoprecipitation of each of the successful fusions demonstrated that the HA11 epitope was located at the surface of the nanoparticles. The stability and immunogenicity of the PapMV-HA11 nanoparticles were evaluated, and we could show that there is a direct correlation between the stability of the nanoparticles at 37 degrees C (mammalian body temperature) and the ability of the nanoparticles to trigger an efficient immune response directed towards the HA11 epitope. This strong correlation between nanoparticle stability and immunogenicity in animals suggests that the stability of any nanoparticle harbouring the fusion of a new peptide should be an important criterion in the design of a new vaccine.	[Rioux, Gervais; Babin, Cindy; Majeau, Nathalie; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada	Laval University	Rioux, G (corresponding author), Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/P-1604-2019; Leclerc, Denis/AAG-6112-2019		National Sciences and Engineering Research Council of Canada (NSERC) [227041-2008]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research project was supported by National Sciences and Engineering Research Council of Canada (NSERC) grant #227041-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Ramirez E, 2008, IMMUNOLOGY, V124, P186, DOI 10.1111/j.1365-2567.2007.02753.x; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; BARATOVA LA, 1992, J GEN VIROL, V73, P229, DOI 10.1099/0022-1317-73-2-229; Cruz SS, 1996, P NATL ACAD SCI USA, V93, P6286, DOI 10.1073/pnas.93.13.6286; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Gagne MEL, 2008, FEBS J, V275, P1474, DOI 10.1111/j.1742-4658.2008.06306.x; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lecours K, 2006, PROTEIN EXPRES PURIF, V47, P273, DOI 10.1016/j.pep.2005.10.013; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Morin H, 2007, J BIOTECHNOL, V128, P423, DOI 10.1016/j.jbiotec.2006.10.013; Plchova H, 2011, PROTEIN EXPRES PURIF, V77, P146, DOI 10.1016/j.pep.2011.01.008; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; SIT TL, 1989, J GEN VIROL, V70, P2325, DOI 10.1099/0022-1317-70-9-2325; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Uhde K, 2005, ARCH VIROL, V150, P327, DOI 10.1007/s00705-004-0402-z; Yang CD, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-62	19	33	35	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31925	10.1371/journal.pone.0031925	http://dx.doi.org/10.1371/journal.pone.0031925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363771	Green Published, gold			2022-12-25	WOS:000302873700125
J	Sangwung, P; Greco, TM; Wang, YZ; Ischiropoulos, H; Sessa, WC; Iwakiri, Y				Sangwung, Panjamaporn; Greco, Todd M.; Wang, Yanzhuang; Ischiropoulos, Harry; Sessa, William C.; Iwakiri, Yasuko			Proteomic Identification of S-Nitrosylated Golgi Proteins: New Insights into Endothelial Cell Regulation by eNOS-Derived NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MATRIX-METALLOPROTEINASE INDUCER; HYPERDYNAMIC CIRCULATION; TRANSPORT; EXPRESSION; COMPLEX; PATIENT; STRESS; LINKS	Background: Endothelial nitric oxide synthase (eNOS) is primarily localized on the Golgi apparatus and plasma membrane caveolae in endothelial cells. Previously, we demonstrated that protein S-nitrosylation occurs preferentially where eNOS is localized. Thus, in endothelial cells, Golgi proteins are likely to be targets for S-nitrosylation. The aim of this study was to identify S-nitrosylated Golgi proteins and attribute their S-nitrosylation to eNOS-derived nitric oxide in endothelial cells. Methods: Golgi membranes were isolated from rat livers. S-nitrosylated Golgi proteins were determined by a modified biotin-switch assay coupled with mass spectrometry that allows the identification of the S-nitrosylated cysteine residue. The biotin switch assay followed by Western blot or immunoprecipitation using an S-nitrosocysteine antibody was also employed to validate S-nitrosylated proteins in endothelial cell lysates. Results: Seventy-eight potential S-nitrosylated proteins and their target cysteine residues for S-nitrosylation were identified; 9 of them were Golgi-resident or Golgi/endoplasmic reticulum (ER)-associated proteins. Among these 9 proteins, S-nitrosylation of EMMPRIN and Golgi phosphoprotein 3 (GOLPH3) was verified in endothelial cells. Furthermore, S-nitrosylation of these proteins was found at the basal levels and increased in response to eNOS stimulation by the calcium ionophore A23187. Immunofluorescence microscopy and immunoprecipitation showed that EMMPRIN and GOLPH3 are co-localized with eNOS at the Golgi apparatus in endothelial cells. S-nitrosylation of EMMPRIN was notably increased in the aorta of cirrhotic rats. Conclusion: Our data suggest that the selective S-nitrosylation of EMMPRIN and GOLPH3 at the Golgi apparatus in endothelial cells results from the physical proximity to eNOS-derived nitric oxide.	[Sangwung, Panjamaporn; Iwakiri, Yasuko] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Greco, Todd M.; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greco, Todd M.; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Greco, Todd M.; Ischiropoulos, Harry] Univ Penn, Philadelphia, PA 19104 USA; [Greco, Todd M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Princeton University; University of Michigan System; University of Michigan; Yale University	Sangwung, P (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA.	yasuko.iwakiri@yale.edu	Sessa, William C/B-6844-2011; Wang, Yanzhuang/AAE-5299-2019; Greco, Todd/E-8279-2010	Sessa, William C/0000-0001-5759-1938; Wang, Yanzhuang/0000-0002-1864-7094; Greco, Todd/0000-0002-5845-713X; Sangwung, Panjamaporn/0000-0002-8145-7947	National Institutes of Health (NIH) [RO1DK082600, KO1DK067933, GM087364, RO1HL054926, HL64793, HL61371, HL081190, HL096670]; American Cancer Society [RGS-09278-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190, R01HL054926, R37HL061371, R01HL064793, R01HL061371, R01HL096670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067933, R01DK082600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants RO1DK082600, KO1DK067933 from the National Institutes of Health (NIH) (to YI), GM087364 from NIH and RGS-09278-01-CSM from the American Cancer Society (to YW), RO1HL054926 from NIH (to HI) and RO1 grants HL64793, HL61371, HL081190, HL096670 from NIH (to WCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BISWAS C, 1995, CANCER RES, V55, P434; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Fernandez-Varo G, 2003, AM J PATHOL, V162, P1985, DOI 10.1016/S0002-9440(10)64331-3; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Guo HM, 1997, J BIOL CHEM, V272, P24; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Iwakiri Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1074, DOI 10.1152/ajpgi.00145.2002; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Iwakiri Y, 2011, NITRIC OXIDE-BIOL CH, V25, P95, DOI 10.1016/j.niox.2011.04.014; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Loureiro-Silva MR, 2006, J HEPATOL, V44, P886, DOI 10.1016/j.jhep.2006.01.032; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Renna M, 2006, INT J BIOCHEM CELL B, V38, P2040, DOI 10.1016/j.biocel.2006.05.016; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; SOHDA M, 1994, BIOCHEM BIOPH RES CO, V205, P1399, DOI 10.1006/bbrc.1994.2821; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Sun JX, 2001, CANCER RES, V61, P2276; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tazi KA, 2002, GASTROENTEROLOGY, V122, P1869, DOI 10.1053/gast.2002.33586; Toki C, 1997, CELL STRUCT FUNCT, V22, P565, DOI 10.1247/csf.22.565; Wang YJ, 2006, 2006 OPTICS VALLEY OF CHINA INTERNATIONAL SYMPOSIUM ON OPTOELECTRONICS, P33; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101	35	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31564	10.1371/journal.pone.0031564	http://dx.doi.org/10.1371/journal.pone.0031564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363674	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700072
J	Tatters, AO; Fu, FX; Hutchins, DA				Tatters, Avery O.; Fu, Fei-Xue; Hutchins, David A.			High CO2 and Silicate Limitation Synergistically Increase the Toxicity of Pseudo-nitzshia fraudulenta	PLOS ONE			English	Article							DOMOIC ACID PRODUCTION; NITZSCHIA-MULTISERIES; CALIFORNIA COAST; IRON LIMITATION; DIATOM; GROWTH; BLOOMS; NEUROTOXIN; SEAWATER; PLANKTON	Anthropogenic CO2 is progressively acidifying the ocean, but the responses of harmful algal bloom species that produce toxins that can bioaccumulate remain virtually unknown. The neurotoxin domoic acid is produced by the globally-distributed diatom genus Pseudo-nitzschia. This toxin is responsible for amnesic shellfish poisoning, which can result in illness or death in humans and regularly causes mass mortalities of marine mammals and birds. Domoic acid production by Pseudo-nitzschia cells is known to be regulated by nutrient availability, but potential interactions with increasing seawater CO2 concentrations are poorly understood. Here we present experiments measuring domoic acid production by acclimatized cultures of Pseudo-nitzschia fraudulenta that demonstrate a strong synergism between projected future CO2 levels (765 ppm) and silicate-limited growth, which greatly increases cellular toxicity relative to growth under modern atmospheric (360 ppm) or pre-industrial (200 ppm) CO2 conditions. Cellular Si:C ratios decrease with increasing CO2, in a trend opposite to that seen for domoic acid production. The coastal California upwelling system where this species was isolated currently exhibits rapidly increasing levels of anthropogenic acidification, as well as widespread episodic silicate limitation of diatom growth. Our results suggest that the current ecosystem and human health impacts of toxic Pseudo-nitzschia blooms could be greatly exacerbated by future ocean acidification and 'carbon fertilization' of the coastal ocean.	[Tatters, Avery O.; Fu, Fei-Xue; Hutchins, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Tatters, AO (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	dahutch@usc.edu	Hutchins, David A/D-3301-2013; Tatters, Avery/V-7723-2019	Hutchins, David A/0000-0002-6637-756X; Tatters, Avery/0000-0002-5616-1044	United States National Science Foundation (NSF) [0850730, 0942379, 0962309]; Division Of Ocean Sciences [0850730] Funding Source: National Science Foundation	United States National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was fully supported by the United States National Science Foundation (NSF) grants OCE 0850730, 0942379, and 0962309. NSF URL: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley R, 2007, CLIMATE CHANGE 2007; Anderson CR, 2006, MAR ECOL PROG SER, V327, P119, DOI 10.3354/meps327119; Anderson CR, 2009, HARMFUL ALGAE, V8, P478, DOI 10.1016/j.hal.2008.10.005; Bates SS, 2006, ECOL STU AN, V189, P81, DOI 10.1007/978-3-540-32210-8_7; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dybas CL, 2006, BIOSCIENCE, V56, P642, DOI 10.1641/0006-3568(2006)56[642:OACCOP]2.0.CO;2; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Firme GF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001824; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hasle Grethe R., 2002, Harmful Algae, V1, P137, DOI 10.1016/S1568-9883(02)00014-8; Howard MDA, 2007, HARMFUL ALGAE, V6, P206, DOI 10.1016/j.hal.2006.06.003; Hutchins DA, 1998, LIMNOL OCEANOGR, V43, P1037, DOI 10.4319/lo.1998.43.6.1037; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Lane JQ, 2009, MAR ECOL PROG SER, V383, P37, DOI 10.3354/meps07999; Lewis E, ORNLCDIAC105; Lundholm N, 2004, MAR ECOL PROG SER, V273, P1, DOI 10.3354/meps273001; Macintyre HL, 2011, J PLANKTON RES, V33, P273, DOI 10.1093/plankt/fbq146; Mafra LL, 2009, J CHROMATOGR A, V1216, P6003, DOI 10.1016/j.chroma.2009.06.050; Maldonado MT, 2002, LIMNOL OCEANOGR, V47, P515, DOI 10.4319/lo.2002.47.2.0515; Milligan AJ, 2004, LIMNOL OCEANOGR, V49, P322, DOI 10.4319/lo.2004.49.2.0322; Pan YL, 1996, MAR ECOL PROG SER, V131, P225, DOI 10.3354/meps131225; Pan YL, 1996, MAR ECOL PROG SER, V131, P235, DOI 10.3354/meps131235; Pan Youlian, 1998, Natural Toxins, V6, P127, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<127::AID-NT9>3.3.CO;2-U; Peng YG, 1996, FUND APPL TOXICOL, V31, P162, DOI 10.1006/faat.1996.0087; Ramsey Una P., 1998, Natural Toxins, V6, P137, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<137::AID-NT28>3.3.CO;2-C; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Schnetzer A, 2007, HARMFUL ALGAE, V6, P372, DOI 10.1016/j.hal.2006.11.004; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Sekula-Wood E, 2011, HARMFUL ALGAE, V10, P567, DOI 10.1016/j.hal.2011.04.009; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Trick CG, 2010, P NATL ACAD SCI USA, V107, P5887, DOI 10.1073/pnas.0910579107; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Utermohl H., 1931, MITTEILUNGEN INT VER, V5, P567, DOI DOI 10.1080/05384680.1958; Wells ML, 2005, LIMNOL OCEANOGR, V50, P1908, DOI 10.4319/lo.2005.50.6.1908; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	42	107	111	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32116	10.1371/journal.pone.0032116	http://dx.doi.org/10.1371/journal.pone.0032116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363805	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700146
J	Wang, WL; Hong, TM; Chang, YL; Wu, CT; Pan, SH; Yang, PC				Wang, Wen-Lung; Hong, Tse-Ming; Chang, Yih-Leong; Wu, Chen-Tu; Pan, Szu-Hua; Yang, Pan-Chyr			Phosphorylation of LCRMP-1 by GSK3 beta Promotes Filopoda Formation, Migration and Invasion Abilities in Lung Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RESPONSE MEDIATOR PROTEIN-1; METASTASIS; MECHANISM; GSK-3	LCRMP-1, a novel isoform of CRMP-1, can promote cancer cell migration, invasion and associate with poor clinical outcome in patients with non-small-cell lung cancer (NSCLC). However, the underlying regulatory mechanisms of LCRMP-1 in cancer cell invasiveness still remain obscure. Here, we report that GSK3 beta can phosphorylate LCRMP-1 at Thr-628 in consensus sequences and this phosphorylation is crucial for function of LCRMP-1 to promote filopodia formation, migration and invasion in cancer cells. Impediment of Thr-628 phosphorylation attenuates the stimulatory effects of LCRMP-1 on filopodia forming, migration and invasion abilities in cancer cells; simultaneously, kinase-dead GSK3 beta diminishes regulation of LCRMP-1 on cancer cell invasion. Furthermore, we also found that patients with low-level Ser-9-phosphorylated GSK3 beta expression and high-level LCRMP-1 expression have worse overall survival than those with high-level inactive GSK3 beta expressions and low-level LCRMP-1 expressions (P<0.0001). Collectively, these results demonstrate that GSK3 beta-dependent phosphorylation of LCRMP-1 provides an important mechanism for regulation of LCRMP-1 on cancer cell invasiveness and clinical outcome.	[Wang, Wen-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hong, Tse-Ming; Pan, Szu-Hua; Yang, Pan-Chyr] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Hong, Tse-Ming] Natl Cheng Kong Univ, Grad Inst Clin Med, Tainan, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Pan, Szu-Hua] Natl Taiwan Univ, Grad Inst Clin Genom, Coll Med, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei 10764, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Wang, WL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	pcyang@ntu.edu.tw		Pan, Szu-Hua/0000-0002-0138-0434; WU, CHEN-TU/0000-0001-8458-4119; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048	National Science Council [NSC 98-2628-B-002-086-MY3, NSC100-3112-B-006-005, NSC100-2321-B-002071]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 98-2628-B-002-086-MY3, NSC100-3112-B-006-005, and NSC100-2321-B-002071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pan SH, 2010, LUNG CANCER, V67, P93, DOI 10.1016/j.lungcan.2009.03.006; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Sobin, 2009, UICC TNM CLASSIFICAT; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Wang LH, 1996, J NEUROSCI, V16, P6197; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	25	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31689	10.1371/journal.pone.0031689	http://dx.doi.org/10.1371/journal.pone.0031689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363707	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700084
J	Zhang, H; Ran, X; Hu, CL; Qin, LP; Lu, Y; Peng, C				Zhang, Hong; Ran, Xia; Hu, Chang-Ling; Qin, Lu-Ping; Lu, Ying; Peng, Cheng			Therapeutic Effects of Liposome-Enveloped Ligusticum chuanxiong Essential Oil on Hypertrophic Scars in the Rabbit Ear Model	PLOS ONE			English	Article							POLYGONUM-CUSPIDATUM; APOPTOSIS; EXPRESSION; FIBROBLASTS; CASPASE-9; POLYDATIN; RHIZOMES; PATHWAY; KELOIDS; MEMORY	Hypertrophic scarring, a common proliferative disorder of dermal fibroblasts, results from an overproduction of fibroblasts and excessive deposition of collagen. Although treatment with surgical excision or steroid hormones can modify the symptoms, numerous treatment-related complications have been described. In view of this, we investigated the therapeutic effects of essential oil (EO) from rhizomes of Ligusticum chuanxiong Hort. (Umbelliferae) on formed hypertrophic scars in a rabbit ear model. EO was prepared as a liposomal formulation (liposome-enveloped essential oil, LEO) and a rabbit ear model with hypertrophic scars was established. LEO (2.5, 5, and 10%) was applied once daily to the scars for 28 days. On postoperative day 56, the scar tissue was excised for masson's trichrome staining, detection of fibroblast apoptosis, assays of the levels of collagens I and III, and analysis of the mRNA expression of matrix metalloproteinase-1 (MMP-1), caspase-3 and -9, and transforming growth factor beta 1 (TGF-beta(1)). In addition, the scar elevation index (SEI) was also determined. As a result, LEO treatment significantly alleviated formed hypertrophic scars on rabbit ears. The levels of TGF-beta(1), MMP-1, collagen I, and collagen III were evidently decreased, and caspase-3 and -9 levels and apoptosis cells were markedly increased in the scar tissue. SEI was also significantly reduced. Histological findings exhibited significant amelioration of the collagen tissue. These results suggest that LEO possesses the favorable therapeutic effects on formed hypertrophic scars in the rabbit ear model and may be an effective cure for human hypertrophic scars.	[Zhang, Hong; Ran, Xia; Hu, Chang-Ling; Qin, Lu-Ping] Second Mil Med Univ, Dept Pharmacognosy, Sch Pharm, Shanghai, Peoples R China; [Zhang, Hong; Peng, Cheng] Chengdu Univ Tradit Chinese Med, Coll Pharm, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Chengdu, Peoples R China; [Ran, Xia] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Lu, Ying] Second Mil Med Univ, Dept Pharmaceut, Sch Pharm, Shanghai, Peoples R China	Naval Medical University; Chengdu University of Traditional Chinese Medicine; East China Normal University; Naval Medical University	Zhang, H (corresponding author), Second Mil Med Univ, Dept Pharmacognosy, Sch Pharm, Shanghai, Peoples R China.	lpqin@smmu.edu.cn; Pengchengchengdu@126.com	Hu, Changling/P-7012-2019	zhang, hong/0000-0002-6191-0046; Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [81173462]; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources [2011012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources	This work was supported by the National Natural Science Foundation of China (No. 81173462) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources (No. 2011012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2005, WOUND REPAIR REGEN, V13, P373, DOI 10.1111/j.1067-1927.2005.130404.x; Beldon P, 2000, Nurs Times, V96, P44; Bloemen MCT, 2009, BURNS, V35, P463, DOI 10.1016/j.burns.2008.07.016; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Chan SSK, 2006, EUR J PHARMACOL, V537, P111, DOI 10.1016/j.ejphar.2006.03.015; *CHIN PHARM COMM, 2005, CHIN PHARM, V1; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1; Dasu MRK, 2004, J PATHOL, V202, P476, DOI 10.1002/path.1539; Du J, 2009, PHYTOMEDICINE, V16, P652, DOI 10.1016/j.phymed.2008.10.001; EGBARIA K, 1990, DRUG DELIV, V5, P287; HAYAKAWA T, 1979, CLIN CHIM ACTA, V93, P119, DOI 10.1016/0009-8981(79)90252-3; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hou YZ, 2004, LIFE SCI, V75, P1775, DOI 10.1016/j.lfs.2004.05.005; Jeong JB, 2009, CANCER EPIDEMIOL, V33, P41, DOI 10.1016/j.canep.2009.04.010; Kryger ZB, 2007, J AM COLL SURGEONS, V205, P78, DOI 10.1016/j.jamcollsurg.2007.03.001; Mazharinia N, 2007, J BURN CARE RES, V28, P312, DOI 10.1097/BCR.0B013E318031A151; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Niu F, 2004, CHINA MED ENG, V12, P12; O'Leary R, 2002, EUR J SURG, V168, P523; Peng C, 2009, PHYTOMEDICINE, V16, P25, DOI 10.1016/j.phymed.2008.10.010; Pirnia F, 2002, CELL DEATH DIFFER, V9, P905, DOI 10.1038/sj.cdd.4401062; Reish RG, 2008, J AM COLL SURGEONS, V206, P719, DOI 10.1016/j.jamcollsurg.2007.11.022; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schaffer M, 1999, CHIRURG, V70, P897, DOI 10.1007/s001040050740; Schmid P, 1998, AM J PATHOL, V152, P485; Sim Y, 2008, ARCH PHARM RES, V31, P497, DOI 10.1007/s12272-001-1184-7; Song BQ, 2009, WOUND REPAIR REGEN, V17, P559, DOI 10.1111/j.1524-475X.2009.00514.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Wang XD, 2001, GENE DEV, V15, P2922; Wu JG, 2011, PHARM BIOL, V49, P764, DOI 10.3109/13880209.2010.542761; Wu JG, 2011, PHARM BIOL, V49, P86, DOI 10.3109/13880209.2010.499517; Wu JG, 2009, PHYTOMEDICINE, V16, P1033, DOI 10.1016/j.phymed.2009.04.005; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yu R, 2010, W CHINA MED J, V25, P1209; Zhang H, 2008, MATURITAS, V61, P334, DOI 10.1016/j.maturitas.2008.09.023; Zhang H, 2008, PHYTOMEDICINE, V15, P587, DOI 10.1016/j.phymed.2007.12.004; Zhang H, 2007, J PHARM PHARMACOL, V59, P301, DOI 10.1211/jpp.59.2.0016	41	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31157	10.1371/journal.pone.0031157	http://dx.doi.org/10.1371/journal.pone.0031157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363569	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700030
J	Catuogno, S; Cerchia, L; Romano, G; Pognonec, P; Condorelli, G; de Franciscis, V				Catuogno, S.; Cerchia, L.; Romano, G.; Pognonec, P.; Condorelli, G.; de Franciscis, V.			miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis	ONCOGENE			English	Article						A549; p53; AP20187	TUMOR-SUPPRESSOR NETWORK; REGULATES APOPTOSIS; SPINDLE CHECKPOINT; DEATH RECEPTORS; DOWN-REGULATION; FEEDBACK LOOP; P53; MYC; MICRORNAS; EXPRESSION	MicroRNAs (miRNAs) constitute a class of small non-coding RNAs that negatively regulate the expression of their target genes. They are involved in many biological processes, including cell proliferation, apoptosis and differentiation, and are considered as promising new therapeutic targets for cancer. However, the identity of miRNAs involved in apoptosis and their respective targets remain largely unknown. Given the elevated complexity of miRNA regulation of gene expression, we performed a functional screening as an alternative strategy to identify those miRNAs that in lung cancer cells may interfere with the apoptotic process. To this aim, we generated a derivative of the non-small cell lung carcinoma A549 cell line in which caspase-8, a critical upstream initiator of apoptosis, can be activated by administration of the small dimerizer drug AP20187. We found a number of miRNAs that may rescue cell viability from caspase-8 activation. They included miRNAs already described as oncogenic such as miR-17, miR-135 and miR-520, but also some miRNAs such as miR-124-1 and miR-34c for which a tumor-suppressive role has instead been described or expected. Among them, nniR-34c-5p markedly increased resistance to paclitaxel-induced apoptosis. We demonstrate that Bmf (Bcl-2-modifying factor) is a target of miR-34c-5p, and that its silencing, together with that of c-myc, a known target of miR-34c-5p, contributes to resistance to apoptosis induced by paclitaxel through p53 downregulation. Oncogene (2013) 32, 341-351; doi:10.1038/onc.2012.51; published online 27 February 2012	[Catuogno, S.; Cerchia, L.; Condorelli, G.; de Franciscis, V.] CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Catuogno, S.; Condorelli, G.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Romano, G.] IRCCS Fdn SDN, Naples, Italy; [Pognonec, P.] Univ Nice Sophia Antipolis, Fac Med, CNRS, Nice 2, France	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	de Franciscis, V (corresponding author), CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, Via Pansini 5, I-80131 Naples, Italy.	defranci@unina.it	Condorelli, Gerolama/AAC-3472-2022; Catuogno, Silvia/AAB-9969-2019	Condorelli, Gerolama/0000-0003-0177-8829; Catuogno, Silvia/0000-0002-1653-4205; Cerchia, Laura/0000-0002-7633-7932	CNR [11-0075]; MIUR grant [MERIT RBNE08YFN3_001, 4971, 10620]; Italian Ministry of Economy and Finance; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	CNR(Consiglio Nazionale delle Ricerche (CNR)); MIUR grant(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Economy and Finance; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by funds from CNR, AICR No. 11-0075 (LC), an MIUR grant, MERIT RBNE08YFN3_001 (VdF), AIRC No. 4971 (LC) and No. 10620 (GC), and from the Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita. We thank ARIAD Pharmaceuticals Inc. for providing the AP20187 dimerizer drug and Soddu for the pLuc-MDM2 expression vector. We also thank Dr Patrick Martin for help with the development of the inducible death vectors; Dr L Baraldi for technical assistance; CL Esposito, S Camorani, I laccarino and P Verde for suggestions and comments; and A Pollice for critically reading the manuscript.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Allen TD, 2011, CANCER RES, V71, P2212, DOI 10.1158/0008-5472.CAN-10-3590; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Carlotti F, 2005, CANCER GENE THER, V12, P627, DOI 10.1038/sj.cgt.7700825; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chang DW, 2003, SCI STKE, V167, pPL1; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dacic S, 2010, MODERN PATHOL, V23, P1577, DOI 10.1038/modpathol.2010.152; DelSal G, 1996, ONCOGENE, V12, P177; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lu WG, 2002, CANCER RES, V62, P1305; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Mellert HS, 2011, J BIOL CHEM, V286, P4264, DOI 10.1074/jbc.M110.184663; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; van Leeuwen I, 2009, ADV CANCER RES, V102, P171, DOI 10.1016/S0065-230X(09)02005-3; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	45	83	87	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 17	2013	32	3					341	351		10.1038/onc.2012.51	http://dx.doi.org/10.1038/onc.2012.51			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370637				2022-12-25	WOS:000314736600008
J	Nie, YH; Ma, RC; Chan, JCN; Xu, HY; Xu, G				Nie, Yaohui; Ma, Ronald C.; Chan, Juliana C. N.; Xu, Haiyan; Xu, Gang			Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes	FASEB JOURNAL			English	Article						G-protein-coupled receptor; cAMP-PKA pathway; IKK beta; JNK; inflammatory cytokines	GASTRIC-INHIBITORY POLYPEPTIDE; LIPOPROTEIN-LIPASE ACTIVITY; GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE; TYPE-2 DIABETES-MELLITUS; HYPERGLYCEMIC OB/OB MICE; TUMOR-NECROSIS-FACTOR; 3T3-L1 CELLS; HIGH-FAT; GLYCEMIC CONTROL; ADIPOSE-TISSUE	Glucose-dependent insulinotropic peptide (GIP) exerts multiple biological effects via the G-protein-coupled receptor GIPR, including glucose-stimulated insulin production and secretion, cell proliferation, and antiapoptosis in pancreatic beta-cells. In an obese state, the circulating level of GIP is elevated. GIPR-knockout mice are resistant to high-fat-diet-induced obesity. The rising evidence suggests a potential role of GIP in adipocyte biology and lipid metabolism. In our study, we overexpressed GIPR in 3T3-L1 CAR adipocytes and demonstrated that GIP impaired the physiological functions of adipocytes as a consequence of increased production of inflammatory cytokines and chemokines and phosphorylation of IkB kinase (IKK)-beta through activation of the cAMP-PKA pathway. Activation of Jun N-terminal kinase (JNK) pathway was also observed during GIP-induced inflammatory responses in adipocytes. The inhibition of JNK blocked GIP-stimulated secretion of inflammatory cytokines and chemokines, as well as phosphorylation of IKK beta. In addition, GIP-induced inflammatory response increased basal glucose uptake but inhibited insulin-stimulated glucose uptake. Moreover, GIP-induced adipocyte inflammation impaired insulin signaling in adipocytes as demonstrated by a reduction of AKT phosphorylation. Our results suggest that GIP might be one of the stimuli attributable to obesity-induced insulin resistance via the induction of adipocyte inflammation.-Nie, Y., Ma, R. C., Chan, J. C., Xu, H., Xu, G. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes. FASEB J. 26, 2383-2393 (2012). www.fasebj.org	[Nie, Yaohui; Ma, Ronald C.; Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, Ronald C.; Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Ma, Ronald C.; Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Nie, Yaohui; Xu, Haiyan] Hallett Ctr Diabet & Endocrinol, Dept Med, Brown Med Sch, Providence, RI USA; [Xu, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Brown University; Chinese University of Hong Kong, Shenzhen	Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	gangxu@cuhk.edu.hk	Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009	Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X	Hong Kong Government Research Grant Committee [478110]; National Natural Science of Foundation of China [81170722]; American Heart Association	Hong Kong Government Research Grant Committee; National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association)	The authors thank the other members of their laboratory for support and helpful discussions. This work was supported by the Hong Kong Government Research Grant Committee (478110) and the National Natural Science of Foundation of China (81170722; to G. X.). The work was also supported by an American Heart Association Scientist Development grant (to H. X.).	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAILEY CJ, 1986, ACTA ENDOCRINOL-COP, V112, P224, DOI 10.1530/acta.0.1120224; Choy Mary, 2007, Cardiol Rev, V15, P264, DOI 10.1097/CRD.0b013e318123f771; CORNELIUS P, 1988, BIOCHEM J, V249, P765, DOI 10.1042/bj2490765; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; DUPRE J, 1976, METABOLISM, V25, P1197, DOI 10.1016/S0026-0495(76)80002-9; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; EGAN JM, 1994, ENDOCRINOLOGY, V135, P2070, DOI 10.1210/en.135.5.2070; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x; Fineman MS, 2003, DIABETES CARE, V26, P2370, DOI 10.2337/diacare.26.8.2370; FLATT PR, 1984, J ENDOCRINOL, V101, P249, DOI 10.1677/joe.0.1010249; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Green BD, 2004, CURR PHARM DESIGN, V10, P3651, DOI 10.2174/1381612043382774; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Iltz JL, 2006, CLIN THER, V28, P652, DOI 10.1016/j.clinthera.2006.05.006; Irwin N, 2007, DIABETES-METAB RES, V23, P572, DOI 10.1002/dmrr.729; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; KNAPPER JME, 1995, J NUTR, V125, P183; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Mohammad S, 2011, J BIOL CHEM, V286, P43062, DOI 10.1074/jbc.M111.289009; MORGAN LM, 1988, BRIT J NUTR, V60, P29, DOI 10.1079/BJN19880073; Mottillo E. P., BIOCH BIOPHYS ACTA, V1801, P1048; Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x; Orlicky DJ, 2001, J LIPID RES, V42, P910; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; RABEN A, 1994, AM J PHYSIOL-ENDOC M, V267, pE549, DOI 10.1152/ajpendo.1994.267.4.E549; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; ROUST LR, 1988, AM J PHYSIOL, V254, pE767, DOI 10.1152/ajpendo.1988.254.6.E767; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; RUIZGRANDE C, 1992, PEPTIDES, V13, P13, DOI 10.1016/0196-9781(92)90134-O; SEMB H, 1987, J BIOL CHEM, V262, P8390; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tchivileva IE, 2009, MOL IMMUNOL, V46, P2256, DOI 10.1016/j.molimm.2009.04.008; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004	54	37	41	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2383	2393		10.1096/fj.11-196782	http://dx.doi.org/10.1096/fj.11-196782			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22366643				2022-12-25	WOS:000305017200016
J	Shim, H; Wang, CT; Chen, YL; Chau, VQ; Fu, KG; Yang, JQ; McQuiston, AR; Fisher, RA; Chen, CK				Shim, Hoon; Wang, Chih-Ting; Chen, Yen-Lin; Chau, Viet Q.; Fu, Kevin G.; Yang, Jianqi; McQuiston, A. Rory; Fisher, Rory A.; Chen, Ching-Kang			Defective Retinal Depolarizing Bipolar Cells in Regulators of G Protein Signaling (RGS) 7 and 11 Double Null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE RETINA; LIGHT RESPONSE; MOUSE; MGLUR6; PHOTOTRANSDUCTION; ACTIVATION; EXPRESSION; DENDRITES; SUBUNITS; RECOVERY	Two members of the R7 subfamily of regulators of G protein signaling, RGS7 and RGS11, are present at dendritic tips of retinal depolarizing bipolar cells (DBCs). Their involvement in the mGluR6/G alpha(o)/TRPM1 pathway that mediates DBC light responses has been implicated. However, previous genetic studies employed an RGS7 mutant mouse that is hypomorphic, and hence the exact role of RGS7 in DBCs remains unclear. We have made a true RGS7-null mouse line with exons 6-8 deleted. The RGS7(-/-) mouse is viable and fertile but smaller in body size. Electroretinogram (ERG) b-wave implicit time in young RGS7(-/-) mice is prolonged at eye opening, but the phenotype disappears at 2 months of age. Expression levels of RGS6 and RGS11 are unchanged in RGS7(-/-) retina, but the G beta 5S level is significantly reduced. By characterizing a complete RGS7 and RGS11 double knock-out (711dKO) mouse line, we found that G beta 5S expression in the retinal outer plexiform layer is eliminated, as is the ERGb-wave. Ultrastructural defects akin to those of G beta 5(-/-) mice are evident in 711dKO mice. In retinas of mice lacking RGS6, RGS7, and RGS11, G beta 5S is undetectable, whereas levels of the photoreceptor-specific G beta 5L remain unchanged. Whereas RGS6 alone sustains a significant amount of G beta 5S expression in retina, the DBC-related defects in G beta 5(-/-) mice are caused solely by a combined loss of RGS7 and RGS11. Our data support the notion that the role of G beta 5 in the retina, and likely in the entire nervous system, is mediated exclusively by R7 RGS proteins.	[Shim, Hoon; Wang, Chih-Ting; Chen, Yen-Lin; Chau, Viet Q.; Fu, Kevin G.; Chen, Ching-Kang] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [McQuiston, A. Rory] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Richmond, VA 23298 USA; [Yang, Jianqi; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Coll Med, Iowa City, IA 52242 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Iowa	Chen, CK (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, 1101 E Marshall St,Rm 2-032B,Box 980614, Richmond, VA 23298 USA.	cjchen@vcu.edu	McQuiston, Adam Rory/A-3072-2008	Chau, Viet/0000-0002-6958-6156; Chen, Yen-Lin/0000-0003-1149-394X; Fisher, Rory/0000-0003-3108-4836	National Institutes of Health [EY013811, MH094626, GM075033]; NINDS/National Institutes of Health Center [5P30NS047463-02]; NATIONAL EYE INSTITUTE [R56EY013811, R01EY013811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/National Institutes of Health Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013811 (to C.-K. C.), MH094626 (to A. R. M.), and GM075033 (to R. A. F.).; Confocal and electron microscopy was performed at the Virginia Commonwealth University Department of Anatomy and Neurobiology Microscopy Facility, supported in part with funding from NINDS/National Institutes of Health Center Core Grant 5P30NS047463-02.	Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Li Q., 2009, 2009 NEUR M PLANN OC; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nawy S, 1999, J NEUROSCI, V19, P2938; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yoshikawa DM, 2000, BIOCHEMISTRY-US, V39, P11340, DOI 10.1021/bi0005557; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	31	37	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14873	14879		10.1074/jbc.M112.345751	http://dx.doi.org/10.1074/jbc.M112.345751			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22371490	Green Published, hybrid			2022-12-25	WOS:000304003200051
J	Zhang, SX; Zhu, C; Ba, Y; Chen, D; Zhou, XL; Cao, R; Wang, LP; Ren, Y; Wu, XZ				Zhang, Shuang-Xia; Zhu, Cong; Ba, Yi; Chen, Dan; Zhou, Xing-Long; Cao, Rui; Wang, Li-Ping; Ren, Yuan; Wu, Xiong-Zhi			Gekko-sulfated Glycopeptide Inhibits Tumor Angiogenesis by Targeting Basic Fibroblast Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; HEPATOMA SMMC-7721 CELLS; HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; DRUG DISCOVERY; THERAPY; DIFFERENTIATION; EXPRESSION; MIGRATION	Basic fibroblast growth factor (bFGF) is a therapeutic target of anti-angiogenesis. Here, we report that a novel sulfated glycopeptide derived from Gekko swinhonis Guenther (GSPP), an anticancer drug in traditional Chinese medicine, inhibits tumor angiogenesis by targeting bFGF. GSPP significantly decreased the production of bFGF in hepatoma cells by suppressing early growth response-1. GSPP inhibited the release of bFGF from extracellular matrix by blocking heparanase enzymatic activity. Moreover, GSPP competitively inhibited bFGF binding to heparin/heparan sulfate via direct binding to bFGF. Importantly, GSPP abrogated the bFGF-stimulated proliferation and migration of endothelial cells, whereas it had no inhibitory effect on endothelial cells in the absence of bFGF. Further study revealed that GSPP prevented bFGF-induced neovascularization and inhibited tumor angiogenesis and tumor growth in a xenograft mouse model. These results demonstrate that GSPP inhibits tumor angiogenesis by blocking bFGF production, release from the extracellular matrix, and binding to its low affinity receptor, heparin/heparan sulfate.	[Wu, Xiong-Zhi] Tianjin Med Univ Canc Inst & Hosp, Zhong Shan Men In Patient Dept, Tianjin 300060, Peoples R China; [Chen, Dan] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin 300070, Peoples R China; [Zhou, Xing-Long; Ren, Yuan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Wu, XZ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Zhong Shan Men In Patient Dept, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ilwxz@163.com	Wu, Xiong-Zhi/P-4045-2019; Ren, Yuan/R-6175-2018	Ren, Yuan/0000-0001-7155-7664	National Science Foundation of China [30801495]; Education Committee of Tianjin [ZD-0715]; Health Bureau of Tianjin [30772484]; Tianjin Medical University [2010ky03]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Committee of Tianjin; Health Bureau of Tianjin; Tianjin Medical University	This work was supported by grants from the National Science Foundation of China (No. 30801495), Education Committee of Tianjin (No. ZD-0715), Health Bureau of Tianjin (No. 30772484), and Tianjin Medical University (No. 2010ky03).	Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen D, 2010, J ETHNOPHARMACOL, V127, P702, DOI 10.1016/j.jep.2009.12.003; DANESI R, 1993, BRIT J CANCER, V68, P932, DOI 10.1038/bjc.1993.457; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gandhi NS, 2010, DRUG DISCOV TODAY, V15, P1058, DOI 10.1016/j.drudis.2010.10.009; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Kathir KM, 2006, BIOCHEMISTRY-US, V45, P899, DOI 10.1021/bi051389b; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; Rusnati M, 2007, CURR PHARM DESIGN, V13, P2025; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang D, 1997, ONCOGENE, V14, P2291, DOI 10.1038/sj.onc.1201069; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; Wu XZ, 2011, MOLECULES, V16, P4958, DOI 10.3390/molecules16064958; Wu XZ, 2006, CELL BIOL INT, V30, P659, DOI 10.1016/j.cellbi.2006.04.005; Zhu G, 2000, J PHARMACEUT BIOMED, V24, P281, DOI 10.1016/S0731-7085(00)00417-9	34	17	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13206	13215		10.1074/jbc.M111.321521	http://dx.doi.org/10.1074/jbc.M111.321521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371501	hybrid, Green Published			2022-12-25	WOS:000302903700058
J	Gallwitz, M; Enoksson, M; Thorpe, M; Hellman, L				Gallwitz, Maike; Enoksson, Mattias; Thorpe, Michael; Hellman, Lars			The Extended Cleavage Specificity of Human Thrombin	PLOS ONE			English	Article							MAST-CELL CHYMASE; SUBSTRATE RECOGNITION PROFILE; PHAGE DISPLAY; ANTITHROMBIN-III; SERINE PROTEASES; BRAIN-INJURY; AMINO-ACIDS; SITE; REVEALS; MOUSE	Thrombin is one of the most extensively studied of all proteases. Its central role in the coagulation cascade as well as several other areas has been thoroughly documented. Despite this, its consensus cleavage site has never been determined in detail. Here we have determined its extended substrate recognition profile using phage-display technology. The consensus recognition sequence was identified as, P2-Pro, P1-Arg, P1'-Ser/Ala/Gly/Thr, P2'-not acidic and P3'-Arg. Our analysis also identifies an important role for a P3'-arginine in thrombin substrates lacking a P2-proline. In order to study kinetics of this cooperative or additive effect we developed a system for insertion of various pre-selected cleavable sequences in a linker region between two thioredoxin molecules. Using this system we show that mutations of P2-Pro and P3'-Arg lead to an approximate 20-fold and 14-fold reduction, respectively in the rate of cleavage. Mutating both Pro and Arg results in a drop in cleavage of 200-400 times, which highlights the importance of these two positions for maximal substrate cleavage. Interestingly, no natural substrates display the obtained consensus sequence but represent sequences that show only 1-30% of the optimal cleavage rate for thrombin. This clearly indicates that maximal cleavage, excluding the help of exosite interactions, is not always desired, which may instead cause problems with dysregulated coagulation. It is likely exosite cooperativity has a central role in determining the specificity and rate of cleavage of many of these in vivo substrates. Major effects on cleavage efficiency were also observed for residues as far away as 4 amino acids from the cleavage site. Insertion of an aspartic acid in position P4 resulted in a drop in cleavage by a factor of almost 20 times.	[Gallwitz, Maike; Enoksson, Mattias; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Gallwitz, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080	Swedish National Research Counsil for Science and Technology [621-2008-3248]	Swedish National Research Counsil for Science and Technology	This work was supported by grants from the Swedish National Research Counsil for Science and Technology, number 621-2008-3248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andersson MK, 2008, MOL IMMUNOL, V45, P2548, DOI 10.1016/j.molimm.2008.01.012; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; CHANG GTG, 1994, THROMB HAEMOSTASIS, V72, P693; CHANG JY, 1985, EUR J BIOCHEM, V151, P225, DOI 10.1111/j.1432-1033.1985.tb09092.x; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; de la Houssaye BA, 1999, J NEUROSCI, V19, P10843, DOI 10.1523/JNEUROSCI.19-24-10843.1999; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Ebert RF, 1991, INDEX VARIANT HUMAN; Fang M, 2003, J PHYSIOL-LONDON, V549, P903, DOI 10.1113/jphysiol.2002.036384; Faraut B, 2003, J CELL PHYSIOL, V196, P105, DOI 10.1002/jcp.10280; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; HAWKINS RL, 1989, DEV BRAIN RES, V45, P203, DOI 10.1016/0165-3806(89)90039-4; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Karlson U., 2003, THESIS UPPSALA U UPP; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; LIOTTA LA, 1981, CANCER RES, V41, P4629; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Marque PE, 2000, J BIOL CHEM, V275, P809, DOI 10.1074/jbc.275.2.809; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; McCarter JD, 2004, J BACTERIOL, V186, P5919, DOI 10.1128/JB.186.17.5919-5925.2004; Muszbek L, 1984, THROMBIN, P83; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; Ohnishi M, 2007, EXP NEUROL, V206, P43, DOI 10.1016/j.expneurol.2007.03.030; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; POZSGAY M, 1981, EUR J BIOCHEM, V115, P491; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ramos-Mandujano G, 2007, GLIA, V55, P917, DOI 10.1002/glia.20513; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Ribeiro MD, 2006, EXP NEUROL, V198, P199, DOI 10.1016/j.expneurol.2005.11.017; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHERAGA HA, 1958, NATURE, V182, P461, DOI 10.1038/182461a0; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; STEPHENS AW, 1988, J BIOL CHEM, V263, P15849; THEUNISSEN HJM, 1993, J BIOL CHEM, V268, P9035; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x	62	80	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31756	10.1371/journal.pone.0031756	http://dx.doi.org/10.1371/journal.pone.0031756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384068	gold, Green Published, Green Submitted			2022-12-25	WOS:000302918500037
J	Marsano, RM; Leronni, D; D'Addabbo, P; Viggiano, L; Tarasco, E; Caizzi, R				Marsano, Rene Massimiliano; Leronni, Daniela; D'Addabbo, Pietro; Viggiano, Luigi; Tarasco, Eustachio; Caizzi, Ruggiero			Mosquitoes LTR Retrotransposons: A Deeper View into the Genomic Sequence of Culex quinquefasciatus	PLOS ONE			English	Article							TERMINAL-REPEAT RETROTRANSPOSONS; TRANSFER-RNA; EVOLUTIONARY ANALYSES; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; IDENTIFICATION; IMPACT; INSULATOR; ELEMENTS; PIPIENS	A set of 67 novel LTR-retrotransposon has been identified by in silico analyses of the Culex quinquefasciatus genome using the LTR_STRUC program. The phylogenetic analysis shows that 29 novel and putatively functional LTR-retrotransposons detected belong to the Ty3/gypsy group. Our results demonstrate that, by considering only families containing potentially autonomous LTR-retrotransposons, they account for about 1% of the genome of C. quinquefasciatus. In previous studies it has been estimated that 29% of the genome of C. quinquefasciatus is occupied by mobile genetic elements. The potential role of retrotransposon insertions strictly associated with host genes is described and discussed along with the possible origin of a retrotransposon with peculiar Primer Binding Site region. Finally, we report the presence of a group of 38 retrotransposons, carrying tandem repeated sequences but lacking coding potential, and apparently lacking "master copy" elements from which they could have originated. The features of the repetitive sequences found in these non-autonomous LTR retrotransposons are described, and their possible role discussed. These results integrate the existing data on the genomics of an important virus-borne disease vector.	[Marsano, Rene Massimiliano; Leronni, Daniela; D'Addabbo, Pietro; Viggiano, Luigi; Caizzi, Ruggiero] Univ Bari Aldo Moro, Sez Genet & Microbiol, Dipartimento Biol, Bari, Italy; [Tarasco, Eustachio] Univ Bari Aldo Moro, Dipartimento Biol & Chim Agroforestale & Ambienta, Sez Entomol & Zool, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Marsano, RM (corresponding author), Univ Bari Aldo Moro, Sez Genet & Microbiol, Dipartimento Biol, Bari, Italy.	r.marsano@biologia.uniba.it	Marsano, René Massimiliano/B-9640-2012; Leronni, Daniela/G-5795-2018; D'Addabbo, Pietro/D-8551-2016; D'Addabbo, Pietro/AAC-7731-2020; Tarasco, Eustachio/T-8588-2019	Marsano, René Massimiliano/0000-0001-8450-1010; Leronni, Daniela/0000-0003-4878-9904; D'Addabbo, Pietro/0000-0003-3325-4931; Caizzi, Ruggiero/0000-0002-4360-2808; Viggiano, Luigi/0000-0002-2067-5166; Tarasco, Eustachio/0000-0001-6310-186X	Fondazione Cassa di Risparmio di Puglia	Fondazione Cassa di Risparmio di Puglia	This work was funded by the Fondazione Cassa di Risparmio di Puglia (granted to RMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TEFAM DATABASE; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bensaadi-Merchermek N, 1997, GENETICA, V100, P141, DOI 10.1023/A:1018321310567; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biedler JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-112; Byarugaba W, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-14; Conte C, 2002, MOL CELL BIOL, V22, P1767, DOI 10.1128/MCB.22.6.1767-1777.2002; Coy MR, 2007, INSECT MOL BIOL, V16, P411, DOI 10.1111/j.1365-2583.2007.00735.x; Darboux I, 2007, CELL MICROBIOL, V9, P2022, DOI 10.1111/j.1462-5822.2007.00934.x; Deragon J. M., 2008, V4, P69, DOI 10.1159/000126007; Diao YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016743; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Feschotte C, 2001, MOL BIOL EVOL, V18, P74, DOI 10.1093/oxfordjournals.molbev.a003721; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; Ganko EW, 2001, GENOME RES, V11, P2066, DOI 10.1101/gr.196201; Gdula DA, 1996, P NATL ACAD SCI USA, V93, P9378, DOI 10.1073/pnas.93.18.9378; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; INOUYE S, 1986, NUCLEIC ACIDS RES, V14, P3031, DOI 10.1093/nar/14.7.3031; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kholod NS, 1999, BIOCHEMISTRY-MOSCOW+, V64, P298; Kidwell MG, 2002, MOBILE DNA, P59; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LOEHR JS, 1968, P NATL ACAD SCI USA, V61, P1115, DOI 10.1073/pnas.61.3.1115; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Marsano RM, 2005, GENE, V357, P115, DOI [10.1016/j.gene.2005.06.010, 10.1016/j.gene.2005.06.005]; McCarthy EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r14; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; MICHAILLE JJ, 1990, NUCLEIC ACIDS RES, V18, P674, DOI 10.1093/nar/18.3.674; Minervini CF, 2007, GENE, V393, P1, DOI 10.1016/j.gene.2006.12.028; Minervini CF, 2010, MOL GENET GENOMICS, V283, P503, DOI 10.1007/s00438-010-0529-4; Minervini CF, 2009, GENE, V440, P42, DOI 10.1016/j.gene.2009.03.021; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pantazidis A, 1999, MOL BIOL EVOL, V16, P909, DOI 10.1093/oxfordjournals.molbev.a026180; RAO PN, 1990, HEREDITAS, V113, P139, DOI 10.1111/j.1601-5223.1990.tb00077.x; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; Sanz-Alferez S, 2003, GENOME, V46, P745, DOI [10.1139/g03-061, 10.1139/G03-061]; Smit A, 1996, REPEATMASKER OPEN 30; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Syomin BV, 2002, MOL GENET GENOMICS, V267, P418, DOI 10.1007/s00438-002-0678-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30770	10.1371/journal.pone.0030770	http://dx.doi.org/10.1371/journal.pone.0030770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383973	Green Published, Green Submitted, gold			2022-12-25	WOS:000302916800007
J	Planer, D; Leibowitz, D; Hadid, A; Erlich, T; Sharon, N; Paltiel, O; Jacoby, E; Lotan, C; Moran, DS				Planer, David; Leibowitz, David; Hadid, Amir; Erlich, Tomer; Sharon, Nir; Paltiel, Ora; Jacoby, Elad; Lotan, Chaim; Moran, Daniel S.			The Effect of Prolonged Physical Activity Performed during Extreme Caloric Deprivation on Cardiac Function	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; OF-ECHOCARDIOGRAPHYS GUIDELINES; TROPONIN-T RELEASE; DIASTOLIC FUNCTION; VENTRICULAR DYSFUNCTION; STANDARDS COMMITTEE; ENDURANCE EXERCISE; STRENUOUS EXERCISE; MARATHON; RESTRICTION	Background: Endurance exercise may induce transient cardiac dysfunction. Data regarding the effect of caloric restriction on cardiac function is limited. We studied the effect of physical activity performed during extreme caloric deprivation on cardiac function. Methods: Thirty-nine healthy male soldiers (mean age 20+/-0.3 years) were studied during a field training exercise lasted 85-103 hours, with negligible food intake and unlimited water supply. Anthropometric measurements, echocardiographic examinations and blood and urine tests were performed before and after the training exercise. Results: Baseline VO2 max was 59+/-5.5 ml/kg/min. Participants' mean weight reduction was 5.7+/-0.9 kg. There was an increase in plasma urea (11.6+/-2.6 to 15.8+/-3.8 mmol/L, p<0.001) and urine osmolarity (692+/-212 to 1094+/-140 mmol/kg, p<0.001) and a decrease in sodium levels (140.5+/-1.0 to 136.6+/-2.1 mmol/L, p<0.001) at the end of the study. Significant alterations in diastolic parameters included a decrease in mitral E wave (93.6 to 83.5 cm/s; p = 0.003), without change in E/A and E/E' ratios, and an increase in iso-volumic relaxation time (73.9 to 82.9 ms, p = 0.006). There was no change in left or right ventricular systolic function, or pulmonary arterial pressure. Brain natriuretic peptide (BNP) levels were significantly reduced post-training (median 9 to 0 pg/ml, p<0.001). There was no elevation in Troponin T or CRP levels. On multivariate analysis, BNP reduction correlated with sodium levels and weight reduction (R = 0.8, p<0.001). Conclusions: Exposure to prolonged physical activity performed under caloric deprivation resulted in minor alterations of left ventricular diastolic function. BNP levels were significantly reduced due to negative water and sodium balance.	[Planer, David; Leibowitz, David; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel; [Hadid, Amir; Erlich, Tomer; Jacoby, Elad; Moran, Daniel S.] Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel; [Sharon, Nir; Paltiel, Ora] Hadassah Hebrew Univ Med Ctr, Brown Sch Publ Hlth, Jerusalem, Israel; [Planer, David] Columbia Univ, Dept Cardiol, Med Ctr, New York, NY USA	Hebrew University of Jerusalem; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Columbia University	Planer, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel.	davidplaner@gmail.com		Jacoby, Elad/0000-0003-1411-8942; ERLICH, TOMER/0000-0003-4151-0018				Alshaher M, 2007, ECHOCARDIOGR-J CARD, V24, P237, DOI 10.1111/j.1540-8175.2007.00380.x; Daneshrad Z, 2000, MOL CELL BIOCHEM, V210, P159, DOI 10.1023/A:1007137909171; DavilaRoman VG, 1997, J AM COLL CARDIOL, V30, P468, DOI 10.1016/S0735-1097(97)00179-4; Epstein Y, 2006, IND HEALTH, V44, P388, DOI 10.2486/indhealth.44.388; Fu F, 2009, INT J SPORTS MED, V30, P168, DOI 10.1055/s-0028-1104586; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hart E, 2007, J AM SOC ECHOCARDIOG, V20, P1393, DOI 10.1016/j.echo.2007.04.032; Konig D, 2003, MED SCI SPORT EXER, V35, P1679, DOI 10.1249/01.MSS.0000089248.37173.E7; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lucia A, 1999, MED SCI SPORT EXER, V31, P1414; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Middleton N, 2008, J AM COLL CARDIOL, V52, P1813, DOI 10.1016/j.jacc.2008.03.069; Middleton N, 2007, INT J CARDIOL, V122, P87, DOI 10.1016/j.ijcard.2006.11.042; Middleton N, 2007, MED SCI SPORT EXER, V39, P83, DOI 10.1249/01.mss.0000239395.93578.60; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Neumayr G, 2005, AM J CARDIOL, V96, P732, DOI 10.1016/j.amjcard.2005.04.054; Ohba H, 2001, AM HEART J, V141, P751, DOI 10.1067/mhj.2001.114371; Scharhag J, 2005, AM HEART J, V150, P1128, DOI 10.1016/j.ahj.2005.01.051; Scharhag J, 2008, MED SCI SPORT EXER, V40, P1408, DOI 10.1249/MSS.0b013e318172cf22; Scharhag J, 2008, CLIN RES CARDIOL, V97, P62, DOI 10.1007/s00392-008-0601-9; Shave RE, 2002, INT J SPORTS MED, V23, P489, DOI 10.1055/s-2002-35069; Shave R, 2007, MED SCI SPORT EXER, V39, P2099, DOI 10.1249/mss.0b013e318153ff78; SHPILBERG O, 1990, EUR J APPL PHYSIOL O, V60, P305, DOI 10.1007/BF00379401; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; van der Meer RW, 2007, DIABETES, V56, P2849, DOI 10.2337/db07-0768; Vidotto C, 2005, INT J SPORTS MED, V26, P645, DOI 10.1055/s-2004-830491	30	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31266	10.1371/journal.pone.0031266	http://dx.doi.org/10.1371/journal.pone.0031266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384007	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916800011
J	Timpka, T; Eriksson, O; Spreco, A; Gursky, EA; Stromgren, M; Holm, E; Ekberg, J; Dahlstrom, O; Valter, L; Eriksson, H				Timpka, Toomas; Eriksson, Olle; Spreco, Armin; Gursky, Elin A.; Stromgren, Magnus; Holm, Einar; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars; Eriksson, Henrik			Age as a Determinant for Dissemination of Seasonal and Pandemic Influenza: An Open Cohort Study of Influenza Outbreaks in Ostergotland County, Sweden	PLOS ONE			English	Article							SPREAD; VACCINATION; SURVEILLANCE; TRANSMISSION; POPULATION; CHILDREN; CLOSURE	An understanding of the occurrence and comparative timing of influenza infections in different age groups is important for developing community response and disease control measures. This study uses data from a Scandinavian county (population 427.000) to investigate whether age was a determinant for being diagnosed with influenza 2005-2010 and to examine if age was associated with case timing during outbreaks. Aggregated demographic data were collected from Statistics Sweden, while influenza case data were collected from a county-wide electronic health record system. A logistic regression analysis was used to explore whether case risk was associated with age and outbreak. An analysis of variance was used to explore whether day for diagnosis was also associated to age and outbreak. The clinical case data were validated against case data from microbiological laboratories during one control year. The proportion of cases from the age groups 10-19 (p<0.001) and 20-29 years old (p<0.01) were found to be larger during the A pH1N1 outbreak in 2009 than during the seasonal outbreaks. An interaction between age and outbreak was observed (p<0.001) indicating a difference in age effects between circulating virus types; this interaction persisted for seasonal outbreaks only (p<0.001). The outbreaks also differed regarding when the age groups received their diagnosis (p<0.001). A post-hoc analysis showed a tendency for the young age groups, in particular the group 10-19 year olds, led outbreaks with influenza type A H1 circulating, while A H3N2 outbreaks displayed little variations in timing. The validation analysis showed a strong correlation (r = 0.625; p<0.001) between the recorded numbers of clinically and microbiologically defined influenza cases. Our findings demonstrate the complexity of age effects underlying the emergence of local influenza outbreaks. Disentangling these effects on the causal pathways will require an integrated information infrastructure for data collection and repeated studies of well-defined communities.	[Timpka, Toomas; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars] Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden; [Timpka, Toomas; Spreco, Armin; Ekberg, Joakim; Dahlstrom, Orjan; Valter, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Timpka, Toomas; Eriksson, Olle; Spreco, Armin; Ekberg, Joakim; Valter, Lars; Eriksson, Henrik] Linkoping Univ, Dept Comp & Informat Sci, S-58183 Linkoping, Sweden; [Gursky, Elin A.] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Social & Econ Geog, Umea, Sweden; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	City Council Ostergotland; Linkoping University; Linkoping University; Umea University; Linkoping University	Timpka, T (corresponding author), Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden.	toomas.timpka@liu.se	Timpka, Toomas/E-8065-2018	Dahlstrom, Orjan/0000-0002-3955-0443; Spreco, Armin/0000-0003-0985-8209	Swedish Civil Contingencies Agency [2010-2788]; Swedish Science Council [2008-5252]	Swedish Civil Contingencies Agency; Swedish Science Council	This study was supported by grants from the Swedish Civil Contingencies Agency (2010-2788) and the Swedish Science Council (2008-5252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Basta Nicole E, 2009, Am J Epidemiol, V170, P679, DOI 10.1093/aje/kwp237; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; FLEMING DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI DOI 10.1017/S0950268807009910; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Karageorgopoulos DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021690; Miller WC, 2010, EPIDEMIOLOGY, V21, P593, DOI 10.1097/EDE.0b013e3181e942e2; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Sebastian R, 2008, VACCINE, V26, P1397, DOI 10.1016/j.vaccine.2007.11.090; Timpka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017941; Timpka Toomas, 2010, AMIA Annu Symp Proc, V2010, P792; Timpka T, 2009, B WORLD HEALTH ORGAN, V87, P305, DOI 10.2471/BLT.07.050203; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31746	10.1371/journal.pone.0031746	http://dx.doi.org/10.1371/journal.pone.0031746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384066	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100033
J	Grant, J				Grant, Jeff			Tachykinins Stimulate a Subset of Mouse Taste Cells	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT GUSTATORY PAPILLAE; SUBSTANCE-P; CHORDA TYMPANI; VANILLOID RECEPTOR; BUD CELLS; GLOSSOPHARYNGEAL NERVES; PAIN PATHWAY; SWEET TASTE; CAPSAICIN	The tachykinins substance P (SP) and neurokinin A (NKA) are present in nociceptive sensory fibers expressing transient receptor potential cation channel, subfamily V, member 1 (TRPV1). These fibers are found extensively in and around the taste buds of several species. Tachykinins are released from nociceptive fibers by irritants such as capsaicin, the active compound found in chili peppers commonly associated with the sensation of spiciness. Using real-time Ca2+-imaging on isolated taste cells, it was observed that SP induces Ca2+ -responses in a subset of taste cells at concentrations in the low nanomolar range. These responses were reversibly inhibited by blocking the SP receptor NK-1R. NKA also induced Ca2+-responses in a subset of taste cells, but only at concentrations in the high nanomolar range. These responses were only partially inhibited by blocking the NKA receptor NK-2R, and were also inhibited by blocking NK-1R indicating that NKA is only active in taste cells at concentrations that activate both receptors. In addition, it was determined that tachykinin signaling in taste cells requires Ca2+-release from endoplasmic reticulum stores. RT-PCR analysis further confirmed that mouse taste buds express NK-1R and NK-2R. Using Ca2+-imaging and single cell RT-PCR, it was determined that the majority of tachykinin-responsive taste cells were Type I (Glial-like) and umami-responsive Type II (Receptor) cells. Importantly, stimulating NK-1R had an additive effect on Ca2+ responses evoked by umami stimuli in Type II (Receptor) cells. This data indicates that tachykinin release from nociceptive sensory fibers in and around taste buds may enhance umami and other taste modalities, providing a possible mechanism for the increased palatability of spicy foods.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA	University of Miami	Grant, J (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA.				National Institute on Deafness and Other Communication Disorders/National Institutes of Health [2R01DC007630, 5R01DC000374, R01DC006308]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R01DC006308, R01DC007630] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders/National Institutes of Health 2R01DC007630 and 5R01DC000374 to SD Roper and R01DC006308 to N Chaudhari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bost KL, 2004, FRONT BIOSCI-LANDMRK, V9, P3331, DOI 10.2741/1484; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Caicedo A, 2000, J NEUROSCI, V20, P7978; Candenas L, 2005, LIFE SCI, V76, P835, DOI 10.1016/j.lfs.2004.10.004; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang GQ, 1996, REGUL PEPTIDES, V63, P85; CHASSAING G, 1991, NEUROPEPTIDES, V19, P91, DOI 10.1016/0143-4179(91)90137-8; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chung KM, 2005, CHEM SENSES, V30, P137, DOI 10.1093/chemse/bji009; Costa RM, 2005, CHEM SENSES, V30, pI198, DOI 10.1093/chemse/bjh183; DAM TV, 1990, BRAIN RES, V531, P333, DOI 10.1016/0006-8993(90)90796-E; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Davis BJ, 1997, NEUROREPORT, V8, P1723, DOI 10.1097/00001756-199705060-00031; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Flynn FW, 2006, BEHAV BRAIN RES, V166, P1, DOI 10.1016/j.bbr.2005.07.022; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Green BG, 2003, PHYSIOL BEHAV, V79, P811, DOI 10.1016/S0031-9384(03)00213-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu XF, 2009, NUTR NEUROSCI, V12, P149, DOI 10.1179/147683009X423319; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Ishida Y, 2002, MOL BRAIN RES, V107, P17, DOI 10.1016/S0169-328X(02)00441-2; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kido MA, 2003, J DENT RES, V82, P393, DOI 10.1177/154405910308200513; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; KING MS, 1993, BRAIN RES, V619, P120, DOI 10.1016/0006-8993(93)91603-P; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Koga T, 2000, J NEUROPHYSIOL, V84, P1404, DOI 10.1152/jn.2000.84.3.1404; LAWLESS H, 1984, PHYSIOL BEHAV, V32, P995, DOI 10.1016/0031-9384(84)90291-9; Lecci A, 2008, EUR REV MED PHARMACO, V12, P69; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; MOUSSAOUI SM, 1992, NEUROSCIENCE, V48, P969, DOI 10.1016/0306-4522(92)90285-A; NAGAHAMA S, 1985, J GEN PHYSIOL, V85, P431, DOI 10.1085/jgp.85.3.431; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; NAGY JI, 1982, NEUROSCIENCE, V7, P3137, DOI 10.1016/0306-4522(82)90236-6; NAKANISHI S, 1993, REGUL PEPTIDES, V46, P37, DOI 10.1016/0167-0115(93)90009-W; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niki M, 2011, CELL MOL NEUROBIOL; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Osada K, 1997, CHEM SENSES, V22, P249, DOI 10.1093/chemse/22.3.249; Park K, 2003, BRAIN RES, V962, P135, DOI 10.1016/S0006-8993(02)03984-7; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; REGOLI D, 1991, ANN NY ACAD SCI, V632, P170, DOI 10.1111/j.1749-6632.1991.tb33105.x; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Simon SA, 2003, AM J PHYSIOL-REG I, V284, pR1494, DOI 10.1152/ajpregu.00544.2002; Simons CT, 2002, CHEM SENSES, V27, P353, DOI 10.1093/chemse/27.4.353; Simons CT, 2003, J NEUROSCI, V23, P978; Smith DV, 1998, ANN NY ACAD SCI, V855, P450, DOI 10.1111/j.1749-6632.1998.tb10605.x; Starostik MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013639; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Toyono T, 2007, CELL TISSUE RES, V328, P57, DOI 10.1007/s00441-006-0351-9; TSUCHIDA K, 1990, EUR J BIOCHEM, V193, P751, DOI 10.1111/j.1432-1033.1990.tb19396.x; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; WANG Y, 1995, J NEUROPHYSIOL, V73, P1468, DOI 10.1152/jn.1995.73.4.1468; Wifall TC, 2007, CHEM SENSES, V32, P161, DOI 10.1093/chemse/bjl043; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; YOSHIE S, 1989, ARCH HISTOL CYTOL, V52, P389, DOI 10.1679/aohc.52.Suppl_389; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	81	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31697	10.1371/journal.pone.0031697	http://dx.doi.org/10.1371/journal.pone.0031697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363709	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700085
J	Kan, SF; Wang, YH; Sun, LL; Jia, P; Qi, YX; Su, JQ; Liu, L; Yang, GH; Liu, LM; Wang, ZY; Wang, JH; Liu, GC; Jin, NY; Li, X; Ding, Z				Kan, Shifu; Wang, Yuhang; Sun, Lili; Jia, Peng; Qi, Yanxin; Su, Jiaqiang; Liu, Lei; Yang, Guohua; Liu, Liming; Wang, Zhuoyue; Wang, Jinhui; Liu, Guangchen; Jin, Ningyi; Li, Xiao; Ding, Zhuang			Attenuation of Vaccinia Tian Tan Strain by Removal of Viral TC7L-TK2L and TA35R Genes	PLOS ONE			English	Article							SMALLPOX VACCINE; VIRUS ANKARA; HOST-RANGE; PROTEIN; RECOMBINANT; VIRULENCE; SYSTEM; MICE; IMMUNOGENICITY; NYVAC	Vaccinia Tian Tan (VTT) was attenuated by deletion of the TC7L-TK2L and TA35R genes to generate MVTT3. The mutant was generated by replacing the open reading frames by a gene encoding enhanced green fluorescent protein (EGFP) flanked by loxP sites. Viruses expressing EGFP were then screened for and purified by serial plaque formation. In a second step the marker EGFP gene was removed by transfecting cells with a plasmid encoding cre recombinase and selecting for viruses that had lost the EGFP phenotype. The MVTT3 mutant was shown to be avirulent and immunogenic. These results support the conclusion that TC7L-TK2L and TA35R deletion mutants can be used as safe viral vectors or as platform for vaccines.	[Kan, Shifu; Wang, Yuhang; Qi, Yanxin; Wang, Zhuoyue; Jin, Ningyi; Ding, Zhuang] Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Peoples R China; [Kan, Shifu; Wang, Yuhang; Sun, Lili; Jia, Peng; Qi, Yanxin; Su, Jiaqiang; Liu, Lei; Yang, Guohua; Liu, Liming; Wang, Zhuoyue; Wang, Jinhui; Liu, Guangchen; Jin, Ningyi; Li, Xiao] Acad Mil Med Sci, Genet Engn Lab PLA, Jilin, Peoples R China; [Sun, Lili] Tumor Hosp Jilin Prov, Dept Head & Neck Surg, Jilin, Peoples R China; [Jia, Peng] Shenzhen Entry Exit Inspect & Quarantine Bur, Anim & Plant Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China; [Su, Jiaqiang; Liu, Lei; Yang, Guohua; Wang, Jinhui; Liu, Guangchen; Li, Xiao] Jilin Univ, Norman Bethune Sch Med Sci, Jilin, Peoples R China	Jilin University; Academy of Military Medical Sciences - China; Jilin University	Kan, SF (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Peoples R China.	skylee528112@gmail.com; Lixiao06@mails.jlu.edu.cn; grammar849@sohu.com	Qi, Yanxin/E-8087-2019	Qi, Yanxin/0000-0001-8801-3655	Genetically Modified Organisms Breeding Major Projects [2009ZX08006-002B]; Key Technologies R&D Programme of Jilin Province [10ZDGG007]	Genetically Modified Organisms Breeding Major Projects; Key Technologies R&D Programme of Jilin Province	This work was supported by Genetically Modified Organisms Breeding Major Projects (2009ZX08006-002B) and Key Technologies R&D Programme of Jilin Province (10ZDGG007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Betakova T, 2000, J VIROL, V74, P4085, DOI 10.1128/JVI.74.9.4085-4092.2000; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Busch CJL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-191; Coulson D, 2011, VIRUS GENES, V42, P171, DOI 10.1007/s11262-010-0560-x; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Gomez CE, 2011, CURR GENE THER, V11, P189; Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695; HOU YT, 1985, J GEN VIROL, V66, P1819, DOI 10.1099/0022-1317-66-8-1819; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Jin Q, 1997, SCI CHINA, V27, P562; KAPLAN C., 1957, JOUR HYG, V55, P494; Kretzschmar M, 2006, PLOS MED, V3, P1341, DOI 10.1371/journal.pmed.0030272; LEE MS, 1992, J VIROL, V66, P2617, DOI 10.1128/JVI.66.5.2617-2630.1992; LIU GQ, 1990, SCI CHINA SER B, V33, P188; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; PAOLETTI E, 1994, DEV BIOL STAND, V82, P65; Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; Rehm KE, 2010, J VIROL, V84, P418, DOI 10.1128/JVI.01802-09; Roper RL, 2006, J VIROL, V80, P306, DOI 10.1128/JVI.80.1.306-313.2006; Steinwaerder DS, 2001, MOL THER, V4, P211, DOI 10.1006/mthe.2001.0447; Tang XA, 2010, VIRUSES-BASEL, V2, P283, DOI 10.3390/v2010283; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; TURNER PC, 1995, J VIROL, V69, P5978, DOI 10.1128/JVI.69.10.5978-5987.1995; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024296; Zhao L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-302; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	43	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31979	10.1371/journal.pone.0031979	http://dx.doi.org/10.1371/journal.pone.0031979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363781	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700131
J	McAllister, LJ; Ogunniyi, AD; Stroeher, UH; Paton, JC				McAllister, Lauren J.; Ogunniyi, Abiodun D.; Stroeher, Uwe H.; Paton, James C.			Contribution of a Genomic Accessory Region Encoding a Putative Cellobiose Phosphotransferase System to Virulence of Streptococcus pneumoniae	PLOS ONE			English	Article							INVASIVE DISEASE; GENE-EXPRESSION; IN-VIVO; DIVERSITY; SEQUENCE; IDENTIFICATION; METABOLISM; DATABASE; SULFATASES; SIGNAL	Streptococcus pneumoniae (the pneumococcus) is a formidable human pathogen, responsible for massive global morbidity and mortality. The ability to utilize carbohydrates in a variety of host niches appears to be integral to pneumococcal pathogenesis. In this study we investigated a genomic island, which includes a ROK family protein, a putative cellobiose phosphotransferase system (PTS) and a putative sulfatase. This accessory region is widespread in the pneumococcus in strains of various serotypes and levels of virulence. We have performed simple bioinformatic analysis of the region and investigated its role in vivo in 2 strains with markedly different virulence profiles (WCH206 of serotype 3, ST180; Menzies5 of serotype 11A, ST662). Deleting and replacing the entire island with an antibiotic resistance cassette caused the virulent serotype 3 strain to become attenuated in a murine pneumonia/sepsis model. Further mutants were constructed and used to show that various components of the island contribute significantly to the fitness of WCH206 in a variety of niches of this model, including the nasopharynx, ears and blood, but especially in the lungs. In addition, the island conferred a competitive advantage in nasopharyngeal colonization for the serotype 11A strain, which was essentially avirulent in the pneumonia/sepsis model. The contribution of this island to both pathogenesis and colonization may explain why this accessory region is widespread in the pneumococcus.	[McAllister, Lauren J.; Ogunniyi, Abiodun D.; Stroeher, Uwe H.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Adelaide	McAllister, LJ (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	james.paton@adelaide.edu.au	Paton, James C/A-9920-2008	Stroeher, Uwe/0000-0001-5705-7751; Ogunniyi, Abiodun/0000-0001-9308-5629	National Health and Medical Research Council (NHMRC) of Australia [565526, 627142]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Program Grant 565526 and Project Grant 627142 from the National Health and Medical Research Council (NHMRC) of Australia supported this research. JCP is a NHMRC Australia Fellow. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dutta PK, 2004, J SCI IND RES INDIA, V63, P20; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Higgins MA, 2009, J BIOL CHEM; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hooper LV, 1996, FASEB J, V10, P1137, DOI 10.1096/fasebj.10.10.8751716; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McAllister LJ, 2011, INFECT IMMUN; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2001, FEMS MICROBIOL LETT, V200, P137, DOI 10.1111/j.1574-6968.2001.tb10705.x; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Shen K, 2006, INFECT IMMUN, V74, P321, DOI 10.1128/IAI.74.1.321-330.2006; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Yu H, 2007, ORG BIOMOL CHEM, V5, P865, DOI 10.1039/b700034k	45	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32385	10.1371/journal.pone.0032385	http://dx.doi.org/10.1371/journal.pone.0032385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363821	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700162
J	Silva, DCN; Jovino, CN; Silva, CAL; Fernandes, HP; Filho, MM; Lucena, SC; Costa, AMDN; Cesar, CL; Barjas-Castro, ML; Santos, BS; Fontes, A				Silva, Diego C. N.; Jovino, Caueh N.; Silva, Carlos A. L.; Fernandes, Heloise P.; Filho, Milton M.; Lucena, Sheyla C.; Costa, Ana Maria D. N.; Cesar, Carlos L.; Barjas-Castro, Maria L.; Santos, Beate S.; Fontes, Adriana			Optical Tweezers as a New Biomedical Tool to Measure Zeta Potential of Stored Red Blood Cells	PLOS ONE			English	Article							SURFACE-CHARGE; SIALIC-ACID; STORAGE; ERYTHROCYTES; TIME	During storage, red blood cells (RBCs) for transfusion purposes suffer progressive deterioration. Sialylated glycoproteins of the RBC membrane are responsible for a negatively charged surface which creates a repulsive electrical zeta potential. These charges help prevent the interaction between RBCs and other cells, and especially among each RBCs. Reports in the literature have stated that RBCs sialylated glycoproteins can be sensitive to enzymes released by leukocyte degranulation. Thus, the aim of this study was, by using an optical tweezers as a biomedical tool, to measure the zeta potential in standard RBCs units and in leukocyte reduced RBC units (collected in CPD-SAGM) during storage. Optical tweezers is a sensitive tool that uses light for measuring cell biophysical properties which are important for clinical and research purposes. This is the first study to analyze RBCs membrane charges during storage. In addition, we herein also measured the elasticity of RBCs also collected in CPD-SAGM. In conclusion, the zeta potential decreased 42% and cells were 134% less deformable at the end of storage. The zeta potential from leukodepleted units had a similar profile when compared to units stored without leukoreduction, indicating that leukocyte lyses were not responsible for the zeta potential decay. Flow cytometry measurements of reactive oxygen species suggested that this decay is due to membrane oxidative damages. These results show that measurements of zeta potentials provide new insights about RBCs storage lesion for transfusion purposes.	[Silva, Diego C. N.; Silva, Carlos A. L.; Filho, Milton M.; Fontes, Adriana] Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil; [Jovino, Caueh N.; Santos, Beate S.] Univ Fed Pernambuco, Dept Ciencias Farmaceut, Recife, PE, Brazil; [Fernandes, Heloise P.; Barjas-Castro, Maria L.] Univ Estadual Campinas, INCTS, Hematol & Transfus Ctr, Campinas, SP, Brazil; [Lucena, Sheyla C.; Costa, Ana Maria D. N.] Fdn Hemope, Recife, PE, Brazil; [Cesar, Carlos L.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Silva, DCN (corresponding author), Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil.	adriana.fontes@pesquisador.cnpq.br	Cesar, Carlos/O-1470-2013; Barjas-Castro, Maria Lourdes/F-9671-2013; Lenz Cesar, Carlos/F-2442-2018; Fontes, Adriana/T-5789-2019; FotonicaUFPE, Inct/J-8388-2013; Santos, Beate/T-5800-2019	Lenz Cesar, Carlos/0000-0001-5573-9636; Fontes, Adriana/0000-0003-4675-2163; Santos, Beate/0000-0002-9909-5462	L'OREAL/UNESCO; Brazilian Academy of Sciences	L'OREAL/UNESCO; Brazilian Academy of Sciences	The authors are grateful to CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Supeior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), and FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco). AF received an award in 2008 given by L'OREAL/UNESCO for young women in Science in partnership with Brazilian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINOFF D, 1977, P NATL ACAD SCI USA, V74, P1521, DOI 10.1073/pnas.74.4.1521; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Barjas-Castro ML, 2002, TRANSFUSION, V42, P1196, DOI 10.1046/j.1537-2995.2002.00201.x; BORN GVR, 1989, J PHYSIOL-LONDON, V419, P169, DOI 10.1113/jphysiol.1989.sp017867; Brandao MM, 2009, CLIN HEMORHEOL MICRO, V43, P217, DOI 10.3233/CH-2009-1211; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; Chelidze T, 2002, J NON-CRYST SOLIDS, V305, P285, DOI 10.1016/S0022-3093(02)01101-8; DANON D, 1976, ANN NY ACAD SCI, V275, P47, DOI 10.1111/j.1749-6632.1976.tb43337.x; DANON D, 1961, CR HEBD ACAD SCI, V253, P1271; Dinu CZ, 2009, SOFT MATTER, V5, P3818, DOI 10.1039/b904639a; DUROCHER JR, 1975, BLOOD, V45, P11; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Fontes A, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044012; Fontes A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870108; Godin C, 1997, EUR BIOPHYS J BIOPHY, V26, P175, DOI 10.1007/s002490050069; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Henon S, 1999, BIOPHYS J, V76, P1145, DOI 10.1016/S0006-3495(99)77279-6; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Jovtchev S, 2000, COLLOID SURFACE A, V164, P95, DOI 10.1016/S0927-7757(99)00345-3; Laliberte M, 2009, P SOC PHOTO-OPT INS, V7386; Mauritz JMA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3458919; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Parrow RL, 2006, TRANSFUS APHER SCI, V34, P5; Perkins TT, 2009, LASER PHOTONICS REV, V3, P203, DOI 10.1002/lpor.200810014; POLLACK W, 1977, INT ARCH ALLER A IMM, V54, P29, DOI 10.1159/000231805; Pozzo LY, 2009, MICRON, V40, P617, DOI 10.1016/j.micron.2009.02.008; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Rookard LE, 2009, BRIT J BIOMED SCI, V66, P93, DOI 10.1080/09674845.2009.11730251; Sze A, 2003, J COLLOID INTERF SCI, V261, P402, DOI 10.1016/S0021-9797(03)00142-5; Wang Shi-Kang, 2006, Cardiovasc Eng, V6, P111, DOI 10.1007/s10558-006-9012-6; YAARI A, 1969, BLOOD-J HEMATOL, V33, P159, DOI 10.1182/blood.V33.2.159.159; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189; Zubair AC, 2010, AM J HEMATOL, V85, P117, DOI 10.1002/ajh.21599	33	24	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31778	10.1371/journal.pone.0031778	http://dx.doi.org/10.1371/journal.pone.0031778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363729	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700095
J	Fan, X; Sha, LN; Zeng, J; Kang, HY; Zhang, HQ; Wang, XL; Zhang, L; Yang, RW; Ding, CB; Zheng, YL; Zhou, YH				Fan, Xing; Sha, Li-Na; Zeng, Jian; Kang, Hou-Yang; Zhang, Hai-Qin; Wang, Xiao-Li; Zhang, Li; Yang, Rui-Wu; Ding, Chun-Bang; Zheng, You-Liang; Zhou, Yong-Hong			Evolutionary Dynamics of the Pgk1 Gene in the Polyploid Genus Kengyilia (Triticeae: Poaceae) and Its Diploid Relatives	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; NUCLEOTIDE DIVERSITY; DUPLICATED GENES; RPB2 GENE; H-GENOME; ELYMUS; WHEAT; LOCI; CONSTITUTION	The level and pattern of nucleotide variation in duplicate gene provide important information on the evolutionary history of polyploids and divergent process between homoeologous loci within lineages. Kengyilia is a group of allohexaploid species with the StYP genomic constitutions in the wheat tribe. To investigate the evolutionary dynamics of the Pgk1 gene in Kengyilia and its diploid relatives, three copies of Pgk1 homoeologues were isolated from all sampled hexaploid Kengyilia species and analyzed with the Pgk1 sequences from 47 diploid taxa representing 18 basic genomes in Triticeae. Sequence diversity patterns and genealogical analysis suggested that (1) Kengyilia species from the Central Asia and the Qinghai-Tibetan plateau have independent origins with geographically differentiated P genome donors and diverged levels of nucleotide diversity at Pgk1 locus; (2) a relatively long-time sweep event has allowed the Pgk1 gene within Agropyron to adapt to cold climate triggered by the recent uplifts of the Qinghai-Tibetan Plateau; (3) sweep event and population expansion might result in the difference in the d(N)/d(S) value of the Pgk1 gene in allopatric Agropyron populations, and this difference may be genetically transmitted to Kengyilia lineages via independent polyploidization events; (4) an 83 bp MITE element insertion has shaped the Pgk1 loci in the P genome lineage with different geographical regions; (5) the St and P genomes in Kengyilia were donated by Pseudoroegneria and Agropyron, respectively, and the Y genome is closely related to the Xp genome of Peridictyon sanctum. The interplay of evolutionary forces involving diverged natural selection, population expansion, and transposable events in geographically differentiated P genome donors could attribute to geographical differentiation of Kengyilia species via independent origins.	[Fan, Xing; Sha, Li-Na; Kang, Hou-Yang; Zhang, Hai-Qin; Zheng, You-Liang; Zhou, Yong-Hong] Sichuan Agr Univ, Triticeae Res Inst, Yaan, Sichuan, Peoples R China; [Fan, Xing; Zheng, You-Liang; Zhou, Yong-Hong] Sichuan Agr Univ, Key Lab Crop Genet Resources & Improvement, Minist Educ, Yaan, Sichuan, Peoples R China; [Zeng, Jian] Sichuan Agr Univ, Coll Resources & Environm, Yaan, Sichuan, Peoples R China; [Wang, Xiao-Li; Zhang, Li; Yang, Rui-Wu; Ding, Chun-Bang] Sichuan Agr Univ, Dept Biol & Sci, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Fan, X (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Yaan, Sichuan, Peoples R China.	zhouyh@sicau.edu.cn	Haiqin, Zhang/ABC-4056-2020		National Trangenic Major Program [20112X08009-001]; National Natural Science Foundation of China [30900087, 30870154]; Special Fund for Agro-Scientific Research in the Public Interest of China [201003021]; Science and Technology Bureau [2060503]; Education Bureau of Sichuan Province	National Trangenic Major Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; Science and Technology Bureau; Education Bureau of Sichuan Province	This research was supported by the National Trangenic Major Program (Nos. 20112X08009-001), the National Natural Science Foundation of China (Nos. 30900087, 30870154), Special Fund for Agro-Scientific Research in the Public Interest of China (Nos. 201003021), and the Science and Technology Bureau (Nos. 2060503) and Education Bureau of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2006, J MOL EVOL, V63, P493, DOI 10.1007/s00239-005-0306-x; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; DEWEY D R, 1984, P209; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan CZ, 2007, GENETICA, V130, P19, DOI 10.1007/s10709-006-0016-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; FU YX, 1993, GENETICS, V133, P693; Gong PC, 2008, PLANT SYST EVOL, V276, P243, DOI 10.1007/s00606-008-0093-0; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen KB, 1996, INT J PLANT SCI, V157, P136, DOI 10.1086/297330; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Love A., 1984, Feddes Repertorium, V95, P425; LU BR, 1990, HEREDITAS, V113, P109, DOI 10.1111/j.1601-5223.1990.tb00074.x; Mason-Gamer R. J., 2005, Czech Journal of Genetics and Plant Breeding, V41, P21; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Palme AE, 2008, MOL BIOL EVOL, V25, P2567, DOI 10.1093/molbev/msn194; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4 MCMC TRA; Rokas A, 2001, HEREDITY, V87, P294, DOI 10.1046/j.1365-2540.2001.00872.x; Rozas J., 2005, DNA SEQUENCE POLYMOR; Salmon A, 2010, NEW PHYTOL, V186, P123, DOI 10.1111/j.1469-8137.2009.03093.x; Slotte T, 2008, MOL BIOL EVOL, V25, P1472, DOI 10.1093/molbev/msn092; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TAJIMA F, 1989, GENETICS, V123, P585; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; Wakeley J, 1997, GENETICS, V145, P847; Wang R.R.-C., 1994, P 2 INT TRIT S LOG U, P20; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; YANG JL, 1992, HEREDITAS, V116, P25, DOI 10.1111/j.1601-5223.1992.tb00200.x; Yen C, 2006, BIOSYSTEMATICS TRITI, V3; Zeng J, 2008, BIOL PLANTARUM, V52, P231, DOI 10.1007/s10535-008-0051-2; Zeng J, 2008, J APPL GENET, V49, P11, DOI 10.1007/BF03195244; Zhang L, 2005, GENET RESOUR CROP EV, V52, P1011, DOI 10.1007/s10722-004-6087-z; Zhang XQ, 2000, GENET RESOUR CROP EV, V47, P451, DOI 10.1023/A:1008788017938; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou YH, 2000, ACTA PHYTOTAX SINICA, V38, P515; ZHOU YH, 1994, GUIHAIA, V14, P163	62	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31122	10.1371/journal.pone.0031122	http://dx.doi.org/10.1371/journal.pone.0031122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363562	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500027
J	Price, HP; Hodgkinson, MR; Curwen, RS; MacLean, LM; Brannigan, JA; Carrington, M; Smith, BA; Ashford, DA; Stark, M; Smith, DF				Price, Helen P.; Hodgkinson, Michael R.; Curwen, Rachel S.; MacLean, Lorna M.; Brannigan, James A.; Carrington, Mark; Smith, Barbara A.; Ashford, David A.; Stark, Meg; Smith, Deborah F.			The Orthologue of Sjogren's Syndrome Nuclear Autoantigen 1 (SSNA1) in Trypanosoma brucei Is an Immunogenic Self-Assembling Molecule	PLOS ONE			English	Article							ACETYLATED ALPHA-TUBULIN; AFRICAN TRYPANOSOMES; PROTEIN; NA14; AUTOANTIBODIES; IDENTIFICATION; TROPOMYOSIN; BIOLOGY; FORM; MICROTUBULES	Primary Sjogren's Syndrome (PSS) is a highly prevalent autoimmune disease, typically manifesting as lymphocytic infiltration of the exocrine glands leading to chronically impaired lacrimal and salivary secretion. Sjogren's Syndrome nuclear autoantigen 1 (SSNA1 or NA14) is a major specific target for autoantibodies in PSS but the precise function and clinical relevance of this protein are largely unknown. Orthologues of the gene are absent from many of the commonly used model organisms but are present in Chlamyodomonas reinhardtii (in which it has been termed DIP13) and most protozoa. We report the functional characterisation of the orthologue of SSNA1 in the kinetoplastid parasite, Trypanosoma brucei. Both TbDIP13 and human SSNA1 are small coiled-coil proteins which are predicted to be remote homologues of the actin-binding protein tropomyosin. We use comparative proteomic methods to identify potential interacting partners of TbDIP13. We also show evidence that TbDIP13 is able to self-assemble into fibril-like structures both in vitro and in vivo, a property which may contribute to its immunogenicity. Endogenous TbDIP13 partially co-localises with acetylated alpha-tubulin in the insect procyclic stage of the parasite. However, deletion of the DIP13 gene in cultured bloodstream and procyclic stages of T. brucei has little effect on parasite growth or morphology, indicating either a degree of functional redundancy or a function in an alternative stage of the parasite life cycle.	[Price, Helen P.; Hodgkinson, Michael R.; Curwen, Rachel S.; MacLean, Lorna M.; Smith, Barbara A.; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Brannigan, James A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ashford, David A.; Stark, Meg] Univ York, Dept Biol, Technol Facil, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of Cambridge; University of York - UK	Price, HP (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	helen.price@york.ac.uk	Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Price, Helen/0000-0003-1537-4390	Wellcome Trust [077503]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust (grant no. 077503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER M, 1994, J STRUCT BIOL, V112, P241, DOI 10.1006/jsbi.1994.1024; Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bizzaro N, 2007, AUTOIMMUN REV, V6, P325, DOI 10.1016/j.autrev.2007.01.006; BLOCH MA, 1995, J CELL SCI, V108, P3541; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1977, Acta Tropica, V34, P21; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; GIBSON W, 1994, MOL BIOCHEM PARASIT, V64, P241, DOI 10.1016/0166-6851(94)00017-4; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HART DT, 1984, MOL BIOCHEM PARASIT, V12, P25, DOI 10.1016/0166-6851(84)90041-0; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Lacomble S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007685; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; Mack GJ, 1998, ARTHRITIS RHEUM, V41, P551; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; Marsden HR, 2010, ANGEW CHEM INT EDIT, V49, P2988, DOI 10.1002/anie.200904943; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Mor F, 2002, EUR J IMMUNOL, V32, P356, DOI 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Navarro M, 1999, EMBO J, V18, P2265, DOI 10.1093/emboj/18.8.2265; Nozawa K, 2004, ARTHRITIS RES THER, V6, pR95, DOI 10.1186/ar1035; Nozawa K, 2009, FRONT BIOSCI-LANDMRK, V14, P3733, DOI [10.2741/4084, 10.2741/3484]; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Price HP, 2007, MOL BIOCHEM PARASIT, V155, P123, DOI 10.1016/j.molbiopara.2007.06.009; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Ramos-Morales F, 1998, J BIOL CHEM, V273, P1634, DOI 10.1074/jbc.273.3.1634; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; SASSE R, 1988, J CELL SCI, V90, P577; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shapiro J, 2005, EUKARYOT CELL, V4, P1591, DOI 10.1128/EC.4.9.1591-1594.2005; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Whitby FG, 2000, PROTEINS, V38, P49; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	63	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31842	10.1371/journal.pone.0031842	http://dx.doi.org/10.1371/journal.pone.0031842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363749	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500093
J	Wu, JG; Zhang, Y; Wang, YS; Kong, RR; Hu, LL; Schuele, R; Du, XJ; Ke, Y				Wu, Jianguo; Zhang, Ying; Wang, Yingshuang; Kong, Ruirui; Hu, Lelin; Schuele, Roland; Du, Xiaojuan; Ke, Yang			Transcriptional Repressor NIR Functions in the Ribosome RNA Processing of Both 40S and 60S Subunits	PLOS ONE			English	Article							SMALL NUCLEOLAR RNA; CELL-CYCLE; U8 SNORNA; PROTEIN-SYNTHESIS; BINDING-PROTEIN; POLYMERASE-I; P53; BIOGENESIS; MDM2; BOP1	Background: NIR was identified as an inhibitor of histone acetyltransferase and it represses transcriptional activation of p53. NIR is predominantly localized in the nucleolus and known as Noc2p, which is involved in the maturation of the 60S ribosomal subunit. However, how NIR functions in the nucleolus remains undetermined. In the nucleolus, a 47S ribosomal RNA precursor (pre-rRNA) is transcribed and processed to produce 18S, 5.8S and 28S rRNAs. The 18S rRNA is incorporated into the 40S ribosomal subunit, whereas the 28S and 5.8S rRNAs are incorporated into the 60S subunit. U3 small nucleolar RNA (snoRNA) directs 18S rRNA processing and U8 snoRNA mediates processing of 28S and 5.8 S rRNAs. Functional disruption of nucleolus often causes p53 activation to inhibit cell proliferation. Methodology/Principal Findings: Western blotting showed that NIR is ubiquitously expressed in different human cell lines. Knock-down of NIR by siRNA led to inhibition of the 18S, 28S and 5.8S rRNAs evaluated by pulse-chase experiment. Pre-rRNA particles (pre-rRNPs) were fractionated from the nucleus by sucrose gradient centrifugation and analysis of the pre-RNPs components showed that NIR existed in the pre-RNPs of both the 60S and 40S subunits and co-fractionated with 32S and 12S pre-rRNAs in the 60S pre-rRNP. Protein-RNA binding experiments demonstrated that NIR is associated with the 32S pre-rRNA and U8 snoRNA. In addition, NIR bound U3 snoRNA. It is a novel finding that depletion of NIR did not affect p53 protein level but de-repressed acetylation of p53 and activated p21. Conclusions: We provide the first evidence for a transcriptional repressor to function in the rRNA biogenesis of both the 40S and 60S subunits. Our findings also suggested that a nucleolar protein may alternatively signal to p53 by affecting the p53 modification rather than affecting p53 protein level.	[Wu, Jianguo; Zhang, Ying; Wang, Yingshuang; Kong, Ruirui; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Genet Lab,Sch Oncol, Beijing 100871, Peoples R China; [Hu, Lelin; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Schuele, Roland] Univ Freiburg, Med Res Ctr, D-79106 Freiburg, Germany	Peking University; Peking University; University of Freiburg	Wu, JG (corresponding author), Peking Univ, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Genet Lab,Sch Oncol, Beijing 100871, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Wu, Jian/AAU-5221-2020; Du, Xiaojuan/AAY-1186-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81071672, 81171877]; Key Construction Program of the National "985'' Project [985-2-016-24]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131]; National Basic Research Program of China (973program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National "985'' Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81071672 and 81171877), the Key Construction Program of the National "985'' Project (Grant No. 985-2-016-24), grant from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2008AA02Z131), and from the National Basic Research Program of China (973program) (Grant No. 2010CB529303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; Chamousset D, 2010, PROTEOMICS, V10, P3045, DOI 10.1002/pmic.201000162; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Ghosh T, 2004, MOL CELL, V13, P817, DOI 10.1016/S1097-2765(04)00127-3; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Heyne K, 2010, NUCLEIC ACIDS RES, V38, P3159, DOI 10.1093/nar/gkq016; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hu L, J BIOL CHEM, V286, P3119; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Peng QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014244; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; PERRY RP, 1970, P NATL ACAD SCI USA, V65, P609, DOI 10.1073/pnas.65.3.609; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tomasevic N, 2002, MOL CELL BIOL, V22, P4101, DOI 10.1128/MCB.22.12.4101-4112.2002; Tomasevic N, 1999, J BIOL CHEM, V274, P35914, DOI 10.1074/jbc.274.50.35914; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Wu LM, 2011, J BIOL CHEM, V286, P2236, DOI 10.1074/jbc.M110.174755; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	49	6	6	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31692	10.1371/journal.pone.0031692	http://dx.doi.org/10.1371/journal.pone.0031692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363708	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500076
J	Nyari, AS; Joseph, L				Nyari, Arpad S.; Joseph, Leo			Evolution in Australasian Mangrove Forests: Multilocus Phylogenetic Analysis of the Gerygone Warblers (Aves: Acanthizidae)	PLOS ONE			English	Article							SPECIES TREES; MOLECULAR PHYLOGENETICS; BIRDS; BIOGEOGRAPHY; SYSTEMATICS; DIVERSIFICATION; SPECIATION; INFERENCE; HISTORY; ORIGIN	The mangrove forests of Australasia have many endemic bird species but their evolution and radiation in those habitats has been little studied. One genus with several mangrove specialist species is Gerygone (Passeriformes: Acanthizidae). The phylogeny of the Acanthizidae is reasonably well understood but limited taxon sampling for Gerygone has constrained understanding of its evolution and historical biogeography in mangroves. Here we report on a phylogenetic analysis of Gerygone based on comprehensive taxon sampling and a multilocus dataset of thirteen loci spread across the avian genome (eleven nuclear and two mitochondrial loci). Since Gerygone includes three species restricted to Australia's coastal mangrove forests, we particularly sought to understand the biogeography of their evolution in that ecosystem. Analyses of individual loci, as well as of a concatenated dataset drawn from previous molecular studies indicates that the genus as currently defined is not monophyletic, and that the Grey Gerygone (G. cinerea) from New Guinea should be transferred to the genus Acanthiza. The multilocus approach has permitted the nuanced view of the group's evolution into mangrove ecosystems having occurred on multiple occasions, in three non-overlapping time frames, most likely first by the G. magnirostris lineage, and subsequently followed by those of G. tenebrosa and G. levigaster.	[Nyari, Arpad S.] Univ Kansas, Biodivers Inst, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Joseph, Leo] Commonwealth Sci & Ind Res Org Ecosyst Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia	University of Kansas; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nyari, AS (corresponding author), Univ Kansas, Biodivers Inst, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	arpinyari@gmail.com	Joseph, Leo/F-9235-2010	Joseph, Leo/0000-0001-7564-1978	CSIRO Ecosystems Science (CES), Atlas of Living Australia; University of Kansas Biodiversity Institute; American Museum of Natural History	CSIRO Ecosystems Science (CES), Atlas of Living Australia; University of Kansas Biodiversity Institute; American Museum of Natural History	CSIRO Ecosystems Science (CES), Atlas of Living Australia provided funding for laboratory work, consumables and travel within Australia. The University of Kansas Biodiversity Institute provided funding for laboratory consumables, sequencing fees and data analysis. The American Museum of Natural History Frank M. Chapman Memorial Fund provided funding for laboratory consumables and sequencing fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Barker FK, 2002, P ROY SOC B-BIOL SCI, V269, P295, DOI 10.1098/rspb.2001.1883; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Christidis L, 2010, MOL PHYLOGENET EVOL, V57, P868, DOI 10.1016/j.ympev.2010.08.029; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Fjeldsa J, 2003, P ROY SOC B-BIOL SCI, V270, pS238, DOI 10.1098/rsbl.2003.0075; Florez-Rodriguez A, 2011, MOL PHYLOGENET EVOL, V58, P297, DOI 10.1016/j.ympev.2010.11.012; FORD J, 1986, EMU, V86, P12, DOI 10.1071/MU9860012; FORD J, 1982, EMU, V82, P12, DOI 10.1071/MU9820012; FORD J, 1983, Records of the Western Australian Museum, V10, P381; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Gardner JL, 2010, MOL PHYLOGENET EVOL, V55, P1087, DOI 10.1016/j.ympev.2010.02.005; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Jennings WB, 2005, EVOLUTION, V59, P2033; Johnstone R., 1990, MANGROVES MANGROVE B; JOHNSTONE R E, 1975, Emu, V75, P185; Jonsson KA, 2008, J AVIAN BIOL, V39, P473, DOI 10.1111/j.0908-8857.2008.04486.x; Jonsson KA, 2010, J BIOGEOGR, V37, P245, DOI 10.1111/j.1365-2699.2009.02220.x; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Li CH, 2010, MOL PHYLOGENET EVOL, V56, P1096, DOI 10.1016/j.ympev.2010.05.017; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Loynes K, 2009, MOL PHYLOGENET EVOL, V53, P212, DOI 10.1016/j.ympev.2009.05.012; Maddison WP, 2017, MESQUITE MODULAR SYS; Marini MA, 2002, AUK, V119, P1114, DOI 10.1642/0004-8038(2002)119[1114:AMATTC]2.0.CO;2; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Norman JA, 2007, MOL PHYLOGENET EVOL, V42, P80, DOI 10.1016/j.ympev.2006.05.032; Noske RA, 1996, WILDLIFE RES, V23, P443, DOI 10.1071/WR9960443; Nyari AS, 2009, ZOOL SCR, V38, P553, DOI 10.1111/j.1463-6409.2009.00397.x; Parra JL, 2009, MOL PHYLOGENET EVOL, V53, P425, DOI 10.1016/j.ympev.2009.07.006; Pasquet E, 2007, MOL PHYLOGENET EVOL, V45, P158, DOI 10.1016/j.ympev.2007.03.010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rambaut A, 2014, TRACER V1 6; Rheindt FE, 2009, MOL PHYLOGENET EVOL, V53, P961, DOI 10.1016/j.ympev.2009.09.001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schodde R., 1982, P191; Schodde R, 1999, DIRECTORY AUSTR BIRD; Schodde R, 1979, MANGROVE ECOSYSTEMS, P141; Schodde R, 1972, BRIDGE BARRIER NATUR, P257; Schodde Richard, 2006, P413; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zwickl D., 2008, GARLI PROGRAM PERFOR	61	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31840	10.1371/journal.pone.0031840	http://dx.doi.org/10.1371/journal.pone.0031840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22363748	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400050
J	Youssef, J; Chen, P; Shenoy, VB; Morgan, JR				Youssef, Jacquelyn; Chen, Peng; Shenoy, Vivek B.; Morgan, Jeffrey R.			Mechanotransduction is enhanced by the synergistic action of heterotypic cell interactions and TGF-beta 1	FASEB JOURNAL			English	Article						3-dimensional cell culture; cell-cell adhesion; cellular mechanics; multicellular aggregate; wound healing	GROWTH-FACTOR-BETA; ADHESION MOLECULES; MECHANICAL CONTROL; TISSUE; CONTRACTION; MYOFIBROBLASTS; EXPRESSION; MATRIX; FIBROBLASTS	With the use of planar substrates and collagen gels, the field of mechanotransduction has focused on the role of extracellular matrix stiffness, mechanical tension, and TGF-beta 1 in generating a more contractile fibroblast. However, little is known about the role of cell-cell interactions in inducing cellular contraction. We used 3-dimensional self-assembled microtissues, in which cell-cell interactions dominate, and a recently developed cell power assay (an assay for mechanotransduction) to quantify the effects of TGF-beta 1 vs. the heterotypic cell interface on the power exerted by pure normal human fibroblast (NHF) and pure rat hepatocyte 35 (H35) microtissues and their mixes. As a control, we found that TGF-beta 1 only doubled the power output of pure NHF and pure H35 microtissues, whereas the heterotypic environment resulted in a 5-fold increase in cell power (0.24 +/- 0.05 to 1.17 +/- 0.13 fJ/h). Seeding TGF-beta 1-treated NHFs with untreated H35 cells demonstrated that the heterotypic environment and TGF-beta 1 synergistically increase cell power by 22x by maximizing heterotypic cell interactions. Using a mathematical simulation of stress generation, we showed that tensile forces can be enhanced by heterotypic cell interactions. These data render a new understanding of how heterotypic cell interactions may increase cellular force generation during wound healing.-Youssef, J., Chen, P., Shenoy, V. B., Morgan, J. R. Mechanotransduction is enhanced by the synergistic action of heterotypic cell interactions and TGF-beta 1. FASEB J. 26, 2522-2530 (2012). www.fasebj.org	[Morgan, Jeffrey R.] Brown Univ, Biomed Ctr, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Youssef, Jacquelyn; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Chen, Peng; Shenoy, Vivek B.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Morgan, JR (corresponding author), Brown Univ, Biomed Ctr, Dept Mol Pharmacol Physiol & Biotechnol, G-B 393,171 Meeting St, Providence, RI 02912 USA.	jeffrey_morgan@brown.edu	Chen, Peng/F-9418-2010; Shenoy, Vivek/ABD-5075-2021	Chen, Peng/0000-0002-6930-1675; Morgan, Jeffrey/0000-0002-7546-3443	National Science Foundation (NSF) [DMR-0520651, CMMI-1129172]; U.S. National Institutes of Health [NIH R01-EB008664-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008664] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1129172] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded in part by the Materials Research Science and Engineering Centers Program of the National Science Foundation (NSF) under award DMR-0520651, NSF CMMI-1129172, and U.S. National Institutes of Health grant NIH R01-EB008664-01A1. J. R. M. has an equity interest in MicroTissues, Inc. This relationship has been reviewed and managed by Brown University in accordance with its conflict of interest policies.	ALBELDA SM, 1993, LAB INVEST, V68, P4; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Carlsson AE, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051912; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chen P, 2011, SOFT MATTER, V7, P355, DOI 10.1039/c0sm00908c; Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fernandez-Gonzalez R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2101pe78; Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; Park JS, 2000, BIOL PHARM BULL, V23, P1517; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; Timoshenko S.P., 1970, THEORY ELASTICITY, V3rd; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Youssef J, 2011, P NATL ACAD SCI USA, V108, P6993, DOI 10.1073/pnas.1102559108; Zemel A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021905	32	11	12	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2522	2530		10.1096/fj.11-199414	http://dx.doi.org/10.1096/fj.11-199414			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22375018	Green Published			2022-12-25	WOS:000305017200028
J	Grou, CP; Francisco, T; Rodrigues, TA; Freitas, MO; Pinto, MP; Carvalho, AF; Domingues, P; Wood, SA; Rodriguez-Borges, JE; Sa-Miranda, C; Fransen, M; Azevedo, JE				Grou, Claudia P.; Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Pinto, Manuel P.; Carvalho, Andreia F.; Domingues, Pedro; Wood, Stephen A.; Rodriguez-Borges, Jose E.; Sa-Miranda, Clara; Fransen, Marc; Azevedo, Jorge E.			Identification of Ubiquitin-specific Protease 9X (USP9X) as a Deubiquitinase Acting on Ubiquitin-Peroxin 5 (PEX5) Thioester Conjugate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAM DEUBIQUITYLATING ENZYME; PTS1 RECEPTOR; CYCLING RECEPTOR; IN-VITRO; EXPRESSION ANALYSIS; TARGETING SIGNAL-1; CONSERVED CYSTEINE; OXIDATIVE STRESS; GEL-FILTRATION; IMPORT	Peroxin 5 (PEX5), the peroxisomal protein shuttling receptor, binds newly synthesized peroxisomal matrix proteins in the cytosol and promotes their translocation across the organelle membrane. During the translocation step, PEX5 itself becomes inserted into the peroxisomal docking/translocation machinery. PEX5 is then monoubiquitinated at a conserved cysteine residue and extracted back into the cytosol in an ATP-dependent manner. We have previously shown that the ubiquitin-PEX5 thioester conjugate (Ub-PEX5) released into the cytosol can be efficiently disrupted by physiological concentrations of glutathione, raising the possibility that a fraction of Ub-PEX5 is nonenzymatically deubiquitinated in vivo. However, data suggesting that Ub-PEX5 is also a target of a deubiquitinase were also obtained in that work. Here, we used an unbiased biochemical approach to identify this enzyme. Our results suggest that ubiquitin-specific protease 9X (USP9X) is by far the most active deubiquitinase acting on Ub-PEX5, both in female rat liver and HeLa cells. We also show that USP9X is an elongated monomeric protein with the capacity to hydrolyze thioester, isopeptide, and peptide bonds. The strategy described here will be useful in identifying deubiquitinases acting on other ubiquitin conjugates.	[Grou, Claudia P.; Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Pinto, Manuel P.; Carvalho, Andreia F.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, IBMC, P-4150180 Oporto, Portugal; [Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Domingues, Pedro] Univ Aveiro, Dept Quim, P-3810193 Aveiro, Portugal; [Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Rodriguez-Borges, Jose E.] Univ Porto, Fac Ciencias, Ctr Invest Quim, Dept Quim & Bioquim, P-4169007 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Cellulaire Mol Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; Universidade de Aveiro; Griffith University; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Francisco, Tânia/AAK-9920-2020; Rodriguez-Borges, José Enrique/Y-5092-2019; Carvalho, Andreia/J-9013-2015; Wood, Stephen A/E-8357-2011; Rodriguez-Borges, J. E./F-2430-2011; Rodrigues, Tony A. Q./K-1141-2014; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013; Fransen, Marc/ADL-0723-2022; Domingues, Pedro/E-5202-2010; Francisco, Tânia FAG/K-5545-2013; Freitas, Marta/J-8699-2013; Fransen, Marc/C-6262-2008; sá Miranda, Maria Clara/K-3920-2013; Azevedo, Jorge E/A-4113-2008	Francisco, Tânia/0000-0003-3571-5164; Rodriguez-Borges, José Enrique/0000-0002-9104-1670; Carvalho, Andreia/0000-0001-8781-5680; Wood, Stephen A/0000-0002-2576-7457; Rodriguez-Borges, J. E./0000-0002-9104-1670; Rodrigues, Tony A. Q./0000-0003-2311-8258; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Domingues, Pedro/0000-0002-8060-7675; Francisco, Tânia FAG/0000-0003-3571-5164; Freitas, Marta/0000-0001-5779-2289; Fransen, Marc/0000-0001-9284-1197; sá Miranda, Maria Clara/0000-0003-0123-5525; Azevedo, Jorge E/0000-0001-7714-5302	Fundacao para a Ciencia e Tecnologia; Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal [PEst-C/SAU/LA0002/2011, PEst-C/QUI/UI0062/2011, PTDC/BIA-BCM/64771/2006]; Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN; Fundo Social Europeu; Programa Ciencia; POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior; National Health and Medical Research Council of Australia; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Onderzoeksproject [G.0754.09]; Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven [OT/09/045]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal; Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN; Fundo Social Europeu; Programa Ciencia(Spanish Government); POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Onderzoeksproject; Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven	This work was supported in part by Fundacao para a Ciencia e Tecnologia and Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal, Grants PEst-C/SAU/LA0002/2011, PEst-C/QUI/UI0062/2011, and PTDC/BIA-BCM/64771/2006.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN and Fundo Social Europeu.; Supported by Programa Ciencia (funded by POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico), by Fundo Social Europeu, and by national funds from Ministerio da Ciencia, Tecnologia e Ensino Superior.; Supported by the National Health and Medical Research Council of Australia.; Supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, Onderzoeksproject G.0754.09, and the Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven Grant OT/09/045.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Gunkel K, 2004, MOL BIOL CELL, V15, P1347, DOI 10.1091/mbc.E03-04-0258; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luddi A, 2009, NEW ENGL J MED, V360, P881, DOI 10.1056/NEJMoa0806218; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Oshima Y, 2008, PLANT CELL PHYSIOL, V49, P671, DOI 10.1093/pcp/pcn038; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	85	62	66	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12815	12827		10.1074/jbc.M112.340158	http://dx.doi.org/10.1074/jbc.M112.340158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371489	hybrid, Green Published			2022-12-25	WOS:000302903700021
J	Telleria, EL; Sant'Anna, MRV; Ortigao-Farias, JR; Pitaluga, AN; Dillon, VM; Bates, PA; Traub-Cseko, YM; Dillon, RJ				Telleria, Erich L.; Sant'Anna, Mauricio R. V.; Ortigao-Farias, Joao R.; Pitaluga, Andre N.; Dillon, Viv M.; Bates, Paul A.; Traub-Csekoe, Yara M.; Dillon, Rod J.			Caspar-like Gene Depletion Reduces Leishmania Infection in Sand Fly Host Lutzomyia longipalpis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL LEISHMANIASIS; BACTERIAL; FLIES; GUT; RESPONSES; IMMUNITY; DIPTERA; MIDGUT; TRANSMISSION; EXPRESSION	Female phlebotomine sand flies Lutzomyia longipalpis naturally harbor populations of the medically important Leishmania infantum (syn. Leishmania chagasi) parasite in the gut, but the extent to which the parasite interacts with the immune system of the insect vector is unknown. To investigate the sand fly immune response and its interaction with the Leishmania parasite, we identified a homologue for caspar, a negative regulator of immune deficiency signaling pathway. We found that feeding antibiotics to adult female L. longipalpis resulted in an up-regulation of caspar expression relative to controls. caspar was differentially expressed when females were fed on Gram-negative and Gram-positive bacterial species. caspar expression was significantly down-regulated in females between 3 and 6 days after a blood feed containing Leishmania mexicana amastigotes. RNA interference was used to deplete caspar expression in female L. longipalpis, which were subsequently fed with Leishmania in a blood meal. Sand fly gut populations of both L. mexicana and L. infantum were significantly reduced in caspar-depleted females. The prevalence of L. infantum infection in the females fell from 85 to 45%. Our results provide the first insight into the operation of immune homeostasis in phlebotomine sand flies during the growth of bacterial and Leishmania populations in the digestive tract. We have demonstrated that the activation of the sand fly immune system, via depletion of a single gene, can lead to the abortion of Leishmania development and the disruption of transmission by the phlebotomine sand fly.	[Sant'Anna, Mauricio R. V.; Bates, Paul A.; Dillon, Rod J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Telleria, Erich L.; Ortigao-Farias, Joao R.; Pitaluga, Andre N.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Dillon, Viv M.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 72B, Merseyside, England	Lancaster University; Fundacao Oswaldo Cruz; University of Liverpool	Dillon, RJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	r.dillon@lancaster.ac.uk	Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021; Telleria, Erich L/F-1580-2015; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; Traub-Cseko, Yara M/F-2723-2015; Pitaluga, Andre/B-2610-2015	Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Telleria, Erich L/0000-0003-0006-0057; Dillon, Rod/0000-0002-3551-0030; Bates, Paul/0000-0001-6861-5421; Pitaluga, Andre/0000-0001-6745-5542	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundacao Oswaldo Cruz; Leverhulme Trust [F/00 808/C]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz; Leverhulme Trust(Leverhulme Trust)	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Fundacao Oswaldo Cruz, and Leverhulme Trust Grant F/00 808/C.	Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Modi G. B., 1997, The molecular biology of insect disease vectors: a methods manual., P21; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nimmo DD, 1997, MED VET ENTOMOL, V11, P324, DOI 10.1111/j.1365-2915.1997.tb00417.x; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Pitaluga AN, 2008, DEV COMP IMMUNOL, V32, P191, DOI 10.1016/j.dci.2007.06.008; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramalho-Ortigao JM, 2001, MEM I OSWALDO CRUZ, V96, P105, DOI 10.1590/S0074-02762001000100012; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Rogers ME, 2004, NATURE, V430, P463, DOI 10.1038/nature02675; Rosetto M, 2003, ITAL J ZOOL, V70, P221, DOI 10.1080/11250000309356520; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Ryu SW, 1999, BIOCHEM BIOPH RES CO, V262, P388, DOI 10.1006/bbrc.1999.1217; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Warburg A, 2011, J VECTOR ECOL, V36, pS10, DOI 10.1111/j.1948-7134.2011.00107.x	43	34	35	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12985	12993		10.1074/jbc.M111.331561	http://dx.doi.org/10.1074/jbc.M111.331561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375009	hybrid, Green Published			2022-12-25	WOS:000302903700037
J	Zhu, JY; Yang, Y; Han, HJ; Betzi, S; Olesen, SH; Marsilio, F; Schonbrunn, E				Zhu, Jin-Yi; Yang, Yan; Han, Huijong; Betzi, Stephane; Olesen, Sanne H.; Marsilio, Frank; Schoenbrunn, Ernst			Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOLPYRUVYL TRANSFERASE MURA; INDUCED-FIT MECHANISM; CRYSTAL-STRUCTURE; BACTERIAL PEPTIDOGLYCAN; DIFFRACTION DATA; ENZYME; TARGET; CRYSTALLOGRAPHY; INACTIVATION; INHIBITOR	The enzyme MurA has been an established antibiotic target since the discovery of fosfomycin, which specifically inhibits MurA by covalent modification of the active site residue Cys-115. Early biochemical studies established that Cys-115 also covalently reacts with substrate phosphoenolpyruvate (PEP) to yield a phospholactoyl adduct, but the structural and functional consequences of this reaction remained obscure. We captured and depicted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by X-ray crystallography. The data suggest that cellular MurA predominantly exists in a tightly locked complex with UDP-N-acetylmuramic acid (UNAM), the product of the MurB reaction, with PEP covalently attached to Cys-115. The uniqueness and rigidity of this "dormant" complex was previously not recognized and presumably accounts for the failure of drug discovery efforts toward the identification of novel and effective MurA inhibitors. We demonstrate that recently published crystal structures of MurA from various organisms determined by different laboratories were indeed misinterpreted and actually contain UNAM and covalently bound PEP. The Cys-115-PEP adduct was also captured in vitro during the reaction of free MurA and substrate UDP-N-acetylglucosamine or isomer UDP-N-acetylgalactosamine. The now available series of crystal structures allows a comprehensive view of the reaction cycle of MurA. It appears that the covalent reaction of MurA with PEP fulfills dual functions by tightening the complex with UNAM for the efficient feedback regulation of murein biosynthesis and by priming the PEP molecule for instantaneous reaction with substrate UDP-N-acetylglucosamine.	[Zhu, Jin-Yi; Yang, Yan; Han, Huijong; Betzi, Stephane; Olesen, Sanne H.; Marsilio, Frank; Schoenbrunn, Ernst] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Schonbrunn, E (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org	Betzi, Stephane/AAC-6103-2022; Zhu, Jinyi/H-6466-2011	Betzi, Stephane/0000-0001-5935-5058; Zhu, Jinyi/0000-0001-5436-4262; Schonbrunn, Ernst/0000-0002-3589-3510; Han, Huijong/0000-0002-1197-3014	National Institutes of Health [5R01GM070633]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM070633.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; BROWN ED, 1994, BIOCHEMISTRY-US, V33, P10638, DOI 10.1021/bi00201a010; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenburg S, 2003, J BIOL CHEM, V278, P49215, DOI 10.1074/jbc.M309741200; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Eschenburg S, 2005, J BIOL CHEM, V280, P14070, DOI 10.1074/jbc.M414412200; Han HJ, 2010, BIOCHEMISTRY-US, V49, P4276, DOI 10.1021/bi100365b; Jackson SG, 2009, BIOCHEMISTRY-US, V48, P11715, DOI 10.1021/bi901524q; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; Samland AK, 1999, BIOCHEMISTRY-US, V38, P13162, DOI 10.1021/bi991041e; Schonbrunn E, 1998, EUR J BIOCHEM, V253, P406, DOI 10.1046/j.1432-1327.1998.2530406.x; Schonbrunn E, 1996, STRUCTURE, V4, P1065, DOI 10.1016/S0969-2126(96)00113-X; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Schonbrunn E, 2000, BIOCHEMISTRY-US, V39, P2164, DOI 10.1021/bi991091j; Skarzynski T, 1998, BIOCHEMISTRY-US, V37, P2572, DOI 10.1021/bi9722608; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Steinbach A, 2008, J MED CHEM, V51, P5143, DOI 10.1021/jm800609p; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; WANKE C, 1993, EUR J BIOCHEM, V218, P861, DOI 10.1111/j.1432-1033.1993.tb18442.x; Yoon HJ, 2008, PROTEINS, V71, P1032, DOI 10.1002/prot.21959	31	32	38	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12657	12667		10.1074/jbc.M112.342725	http://dx.doi.org/10.1074/jbc.M112.342725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378791	Green Published, hybrid			2022-12-25	WOS:000302903700006
J	Lin, JE; Snook, AE; Li, P; Stoecker, BA; Kim, GW; Magee, MS; Garcia, AVM; Valentino, MA; Hyslop, T; Schulz, S; Waldman, SA				Lin, Jieru Egeria; Snook, Adam Eugene; Li, Peng; Stoecker, Brian Arthur; Kim, Gilbert Won; Magee, Michael Sullivan; Garcia, Alex Vladimir Mejia; Valentino, Michael Anthony; Hyslop, Terry; Schulz, Stephanie; Waldman, Scott Arthur			GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity	PLOS ONE			English	Article							GUANYLYL CYCLASE-C; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION PROFILES; TIGHT JUNCTION BARRIER; MUCOSAL INFLAMMATION; COLORECTAL-CANCER; POLYP FORMATION; COLON-CANCER; CELLS; ENTEROTOXIN	The barrier separating mucosal and systemic compartments comprises epithelial cells, annealed by tight junctions, limiting permeability. GUCY2C recently emerged as an intestinal tumor suppressor coordinating AKT1-dependent crypt-villus homeostasis. Here, the contribution of GUCY2C to barrier integrity opposing colitis and systemic tumorigenesis is defined. Mice deficient in GUCY2C (Gucy2c(-/-)) exhibited barrier hyperpermeability associated with reduced junctional proteins. Conversely, activation of GUCY2C in mice reduced barrier permeability associated with increased junctional proteins. Further, silencing GUCY2C exacerbated, while activation reduced, chemical barrier disruption and colitis. Moreover, eliminating GUCY2C amplified, while activation reduced, systemic oxidative DNA damage. This genotoxicity was associated with increased spontaneous and carcinogen-induced systemic tumorigenesis in Gucy2c(-/-) mice. GUCY2C regulated barrier integrity by repressing AKT1, associated with increased junction proteins occludin and claudin 4 in mice and Caco2 cells in vitro. Thus, GUCY2C defends the intestinal barrier, opposing colitis and systemic genotoxicity and tumorigenesis. The therapeutic potential of this observation is underscored by the emerging clinical development of oral GUCY2C ligands, which can be used for chemoprophylaxis in inflammatory bowel disease and cancer.	[Lin, Jieru Egeria; Snook, Adam Eugene; Li, Peng; Stoecker, Brian Arthur; Kim, Gilbert Won; Magee, Michael Sullivan; Garcia, Alex Vladimir Mejia; Valentino, Michael Anthony; Schulz, Stephanie; Waldman, Scott Arthur] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Hyslop, Terry] Thomas Jefferson Univ, Div Biostat, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Lin, JE (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA.	Scott.Waldman@Jefferson.edu	Snook, Adam/P-2585-2015; Magee, Michael/L-8354-2013	Snook, Adam/0000-0001-9216-4560; Magee, Michael/0000-0002-0480-4618; Waldman, Scott/0000-0001-6619-175X	National Institutes of Health (NIH) [CA146033, 5T32 GM08562]; Pennsylvania Department of Health; Targeted Diagnostic and Therapeutics Inc.; NATIONAL CANCER INSTITUTE [RC1CA146033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008562] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Targeted Diagnostic and Therapeutics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by grants from the National Institutes of Health (NIH) (CA146033), the Pennsylvania Department of Health, and Targeted Diagnostic and Therapeutics Inc. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Dr. Garcia and Dr. Li were supported by NIH 5T32 GM08562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; FINK MP, 1990, CRIT CARE MED, V18, P579; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Gong R, 2011, SCIENCE; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hollande Frederic, 2005, Sci STKE, V2005, ppe13, DOI 10.1126/stke.2772005pe13; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Mann EA, 2005, INT J CANCER, V116, P500, DOI 10.1002/ijc.21119; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mazumdar T, 2011, ONCOTARGET, V2, P638; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakazato M, 2001, J GASTROENTEROL, V36, P219, DOI 10.1007/s005350170106; Notterman DA, 2001, CANCER RES, V61, P3124; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Patel BB, 2011, ONCOTARGET, V2, P197, DOI 10.18632/oncotarget.241; Pedersen N, 2010, AM J GASTROENTEROL, V105, P1480, DOI 10.1038/ajg.2009.760; Pitari GM, 2007, CLIN PHARMACOL THER, V82, P441, DOI 10.1038/sj.clpt.6100325; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Shailubhai K, 2000, CANCER RES, V60, P5151; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	38	97	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31686	10.1371/journal.pone.0031686	http://dx.doi.org/10.1371/journal.pone.0031686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384056	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500034
J	Wang, QZ; Xie, B; Wu, CH; Chen, G; Wang, ZW; Cui, J; Hu, TM; Wiatrak, P				Wang, Quanzhen; Xie, Bao; Wu, Chunhui; Chen, Guo; Wang, Zhengwei; Cui, Jian; Hu, Tianming; Wiatrak, Pawel			Models Analyses for Allelopathic Effects of Chicory at Equivalent Coupling of Nitrogen Supply and pH Level on F. arundinacea, T. repens and M. sativa	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; CICHORIUM-INTYBUS; ENZYME-ACTIVITY; PHENOLIC-ACIDS; L.; SOIL; GRASSLANDS; DEPOSITION; NITRATE; IDENTIFICATION	Alllelopathic potential of chicory was investigated by evaluating its effect on seed germination, soluble sugar, malondialdehyde (MDA) and the chlorophyll content of three target plants species (Festuca arundinacea, Trifolium repens and Medicago sativa). The secretion of allelochemicals was regulated by keeping the donor plant (chicory) separate from the three target plant species and using different pH and nitrogen levels. Leachates from donor pots with different pH levels and nitrogen concentrations continuously irrigated the target pots containing the seedlings. The allelopathic effects of the chicory at equivalent coupling of nitrogen supply and pH level on the three target plants species were explored via models analyses. The results suggested a positive effect of nitrogen supply and pH level on allelochemical secretion from chicory plants. The nitrogen supply and pH level were located at a rectangular area defined by 149 to 168 mg/l nitrogen supply combining 4.95 to 7.0 pH value and point located at nitrogen supply 177 mg/l, pH 6.33 when they were in equivalent coupling effects; whereas the inhibitory effects of equivalent coupling nitrogen supply and pH level were located at rectangular area defined by 125 to 131 mg/l nitrogen supply combining 6.71 to 6.88 pH value and two points respectively located at nitrogen supply 180 mg/l with pH 6.38 and nitrogen supply 166 mg/l with pH 7.59. Aqueous extracts of chicory fleshy roots and leaves accompanied by treatment at different sand pH values and nitrogen concentrations influenced germination, seedling growth, soluble sugar, MDA and chlorophyll of F. arundinacea, T. repens and M. sativa. Additionally, we determined the phenolics contents of root and leaf aqueous extracts, which were 0.104% and 0.044% on average, respectively.	[Wang, Quanzhen; Xie, Bao; Wu, Chunhui; Chen, Guo; Wang, Zhengwei; Hu, Tianming] NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China; [Cui, Jian] NW A&F Univ, Coll life Sci, Dept Plant Sci, Yangling, Shaanxi Provinc, Peoples R China; [Wiatrak, Pawel] Clemson Univ, Edisto Res & Educ Ctr, Blackville, SC USA	Northwest A&F University - China; Northwest A&F University - China; Clemson University	Wang, QZ (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China.	wangquanzhen191@163.com			Ministry of Science and Technology of the Peoples Republic of China; International S and T Cooperation Research Project between China and Serbia [2011-1-7]; National Science and Technology Pillar Program of China [2011BAD17B05]	Ministry of Science and Technology of the Peoples Republic of China(Ministry of Science and Technology, China); International S and T Cooperation Research Project between China and Serbia; National Science and Technology Pillar Program of China	The Ministry of Science and Technology of the Peoples Republic of China, International S and T Cooperation Research Project between China and Serbia (grant number: 2011-1-7, (http://www.istcp.org.cn/), and The National Science and Technology Pillar Program of China (grant number: 2011BAD17B05, http://www.most.gov.cn/), funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATO M, 1992, SOIL BIOL BIOCHEM, V24, P455, DOI 10.1016/0038-0717(92)90208-F; Barkosky RR, 2000, J CHEM ECOL, V26, P2095, DOI 10.1023/A:1005564315131; Barry TN, 1998, J AGR SCI, V131, P251, DOI 10.1017/S002185969800584X; Belesky DP, 1999, AGRON J, V91, P450, DOI 10.2134/agronj1999.00021962009100030015x; Cambui CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019211; CHAILLOU S, 1991, J EXP BOT, V42, P189, DOI 10.1093/jxb/42.2.189; Chatterjee S, 1977, REGRESSION ANAL EXAM; Chon SU, 2005, SCI HORTIC-AMSTERDAM, V106, P309, DOI 10.1016/j.scienta.2005.04.005; Chung RS, 2010, IND CROP PROD, V32, P650, DOI 10.1016/j.indcrop.2010.07.021; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DELAUNE RD, 1981, SOIL BIOL BIOCHEM, V13, P533, DOI 10.1016/0038-0717(81)90045-6; Delfini R, 2010, PLANT GROWTH REGUL, V61, P153, DOI 10.1007/s10725-010-9461-1; DESHUSSES J, 1961, Mitt Geb Lebensmittelunters Hyg, V52, P428; Dong J, 2006, EUPHYTICA, V151, P71, DOI 10.1007/s10681-006-9129-0; Ens EJ, 2010, PLANT SOIL, V326, P403, DOI 10.1007/s11104-009-0021-2; Fang CX, 2010, PLANT GROWTH REGUL, V61, P277, DOI 10.1007/s10725-010-9475-8; Fang CX, 2009, PLANT GROWTH REGUL, V57, P163, DOI 10.1007/s10725-008-9333-0; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; GLASS ADM, 1974, PLANT PHYSIOL, V54, P855, DOI 10.1104/pp.54.6.855; Gregory S, 1978, STAT METHODS GEOGRAP; Hadacek F, 2002, CRIT REV PLANT SCI, V21, P273, DOI 10.1080/0735-260291044269; Hassan HA, 2010, FOOD CHEM TOXICOL, V48, P2163, DOI 10.1016/j.fct.2010.05.023; Hogh-Jensen H, 2006, EUR J AGRON, V24, P247, DOI 10.1016/j.eja.2005.10.007; Jung GA, 1996, AGRON J, V88, P104, DOI 10.2134/agronj1996.00021962008800010022x; Kato-Noguchi H, 2010, PLANT GROWTH REGUL, V60, P127, DOI 10.1007/s10725-009-9428-2; Kato-Noguchi H, 2009, PLANT GROWTH REGUL, V59, P153, DOI 10.1007/s10725-009-9398-4; Kidd PS, 2000, PLANT BIOLOGY, V2, P335, DOI 10.1055/s-2000-3706; Lattin J., 2003, ANAL MULTIVARIATE DA; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Le Thi H, 2008, PLANT GROWTH REGUL, V56, P1, DOI 10.1007/s10725-008-9289-0; Lea PJ, 2006, ANN APPL BIOL, V149, P243, DOI 10.1111/j.1744-7348.2006.00101.x; Levang-Brilz N, 2003, PLANT ECOL, V165, P117, DOI 10.1023/A:1021469210691; Mulabagal V, 2009, EUR FOOD RES TECHNOL, V230, P47, DOI 10.1007/s00217-009-1144-7; Nakano H, 2002, PLANT GROWTH REGUL, V37, P113, DOI 10.1023/A:1020579101938; Nasir H, 2005, J CHEM ECOL, V31, P2179, DOI 10.1007/s10886-005-6084-5; Oueslati O, 2005, J AGRON CROP SCI, V191, P249, DOI 10.1111/j.1439-037X.2005.00156.x; Parvez SS, 2004, PLANT GROWTH REGUL, V42, P245, DOI 10.1023/B:GROW.0000026493.95805.a5; Parvez SS, 2003, PLANT GROWTH REGUL, V41, P139, DOI 10.1023/A:1027387126878; Parvez SS, 2003, PLANT GROWTH REGUL, V40, P107, DOI 10.1023/A:1024237426416; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Plumier W., 1972, Revue de l'Agriculture, V25, P567; Rice EL, 1984, ALLELOPATHY; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Salam MA, 2009, PLANT GROWTH REGUL, V58, P137, DOI 10.1007/s10725-009-9360-5; SAS-Institute-Inc, 1988, SAS STAT US GUID; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Sodaeizadeh H, 2009, PLANT GROWTH REGUL, V59, P227, DOI 10.1007/s10725-009-9408-6; Suriguga, 2008, XIBEI ZHIWU XUEBAO, V28, P1689; Turner KE, 1999, AGRON J, V91, P445, DOI 10.2134/agronj1999.00021962009100030014x; Van Waes C, 1998, J SCI FOOD AGR, V76, P107, DOI 10.1002/(SICI)1097-0010(199801)76:1&lt;107::AID-JSFA911&gt;3.0.CO;2-6; VESSEY JK, 1990, J PLANT NUTR, V13, P95, DOI 10.1080/01904169009364061; Viard-Cretat F, 2009, ANN BOT-LONDON, V103, P1271, DOI 10.1093/aob/mcp064; Wang QZ, 2011, AFR J BIOTECHNOL, V10, P1966; Yao HY, 2009, SOIL BIOL BIOCHEM, V41, P1425, DOI 10.1016/j.soilbio.2009.03.020; Zhang YL, 2011, PLANT GROWTH REGUL, V63, P235, DOI 10.1007/s10725-010-9520-7	56	4	4	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31670	10.1371/journal.pone.0031670	http://dx.doi.org/10.1371/journal.pone.0031670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384054	Green Published, gold			2022-12-25	WOS:000302875500033
J	Shi, L; Chang, Y; Yang, YM; Zhang, Y; Yu, FSX; Wu, XY				Shi, Long; Chang, Yuan; Yang, Yongmei; Zhang, Ying; Yu, Fu-Shin X.; Wu, Xinyi			Activation of JNK Signaling Mediates Connective Tissue Growth Factor Expression and Scar Formation in Corneal Wound Healing	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; N-TERMINAL KINASE; EPITHELIAL-CELLS; FACTOR-BETA; MATRIX CONTRACTION; MESANGIAL CELLS; MAP KINASE; PATHWAY; CTGF; FIBROBLASTS	Connective Tissue Growth Factor (CTGF) and Transforming growth factor-beta 1 (TGF-beta 1) are key growth factors in regulating corneal scarring. Although CTGF was induced by TGF-beta 1 and mediated many of fibroproliferative effects of TGF-beta 1, the signaling pathway for CTGF production in corneal scarring remains to be clarified. In the present study, we firstly investigated the effects of c-Jun N-terminal kinase (JNK) on CTGF expression induce by TGF-beta 1 in Telomerase-immortalized human cornea stroma fibroblasts (THSF). Then, we created penetrating corneal wound model and determined the effect of JNK in the pathogenesis of corneal scarring. TGF-beta 1 activated MAPK pathways in THSF cells. JNK inhibitor significantly inhibited CTGF, fibronectin and collagen I expression induced by TGF-beta 1 in THSF. In corneal wound healing, the JNK inhibitor significantly inhibited CTGF expression, markedly improved the architecture of corneal stroma and reduced corneal scar formation, but did not have a measurable impact on corneal wound healing in vivo. Our results indicate that JNK mediates the expression of CTGF and corneal scarring in corneal wound healing, and might be considered as specific targets of drug therapy for corneal scarring.	[Shi, Long; Chang, Yuan; Yang, Yongmei; Zhang, Ying; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Anat, Detroit, MI USA; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Cell Biol, Detroit, MI USA	Shandong University; Wayne State University; Wayne State University; Wayne State University	Shi, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	xywu8868@163.com			Education Ministry Fund of China [20070422081]; Natural Science Foundation of Shandong Province, China [2007GG20002031]	Education Ministry Fund of China; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	Research was supported by the Education Ministry Fund of China (No. 20070422081) and Natural Science Foundation of Shandong Province, China (No. 2007GG20002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Blalock TD, 2004, EXP EYE RES, V78, P1127, DOI 10.1016/j.exer.2004.01.012; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; Cursiefen Claus, 2007, Chem Immunol Allergy, V92, P50, DOI 10.1159/000099253; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Dessein A, 2009, J EXP MED, V206, P2321, DOI 10.1084/jem.20090383; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Guo H, 2008, IMMUNOL CELL BIOL, V86, P271, DOI 10.1038/sj.icb.7100158; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Matsuda A, 1997, INVEST OPHTH VIS SCI, V38, P1555; Munireddy S, 2010, SURG CLIN N AM, V90, P1227, DOI 10.1016/j.suc.2010.08.002; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Peterziel H, 2002, J CELL BIOL, V159, P157, DOI 10.1083/jcb.200203115; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Qi W, 2006, AM J PHYSIOL-RENAL, V290, pF703, DOI 10.1152/ajprenal.00254.2005; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sohn M, 2005, KIDNEY INT, V67, P1286, DOI 10.1111/j.1523-1755.2005.00206.x; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Suk FM, 2009, TOXICOL LETT, V187, P22, DOI 10.1016/j.toxlet.2009.01.019; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wu XY, 2006, CHINESE MED J-PEKING, V119, P57, DOI 10.1097/00029330-200601010-00010; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yamanaka O, 2007, MOL VIS, V13, P1730; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936	44	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32128	10.1371/journal.pone.0032128	http://dx.doi.org/10.1371/journal.pone.0032128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363806	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700147
J	Mueckler, M; Makepeace, C				Mueckler, Mike; Makepeace, Carol			Ligand-Induced Movements of Inner Transmembrane Helices of Glut1 Revealed by Chemical Cross-Linking of Di-Cysteine Mutants	PLOS ONE			English	Article							FACILITATIVE GLUCOSE-TRANSPORTER; ERYTHROCYTE SUGAR-TRANSPORT; SUBSTRATE-BINDING SITE; SCANNING MUTAGENESIS; CYTOCHALASIN-B; ESCHERICHIA-COLI; OUTER HELIX; MOLECULAR-MECHANISM; PERMEATION PATHWAY; HEXOSE TRANSPORTER	The relative orientation and proximity of the pseudo-symmetrical inner transmembrane helical pairs 5/8 and 2/11 of Glut1 were analyzed by chemical cross-linking of di-cysteine mutants. Thirteen functional di-cysteine mutants were created from a C-less Glut1 reporter construct containing cysteine substitutions in helices 5 and 8 or helices 2 and 11. The mutants were expressed in Xenopus oocytes and the sensitivity of each mutant to intramolecular cross-linking by two homobifunctional thiol-specific reagents was ascertained by protease cleavage followed by immunoblot analysis. Five of 9 mutants with cysteine residues predicted to lie in close proximity to each other were susceptible to cross-linking by one or both reagents. None of 4 mutants with cysteine substitutions predicted to lie on opposite faces of their respective helices was susceptible to cross-linking. Additionally, the cross-linking of a di-cysteine pair (A70C/M420C, helices 2/11) predicted to lie near the exoplasmic face of the membrane was stimulated by ethylidene glucose, a non-transported glucose analog that preferentially binds to the exofacial substrate-binding site, suggesting that the binding of this ligand stimulates the closure of helices at the exoplasmic face of the membrane. In contrast, the cross-linking of a second di-cysteine pair (T158C/L325, helices 5/8), predicted to lie near the cytoplasmic face of the membrane, was stimulated by cytochalasin B, a glucose transport inhibitor that competitively inhibits substrate efflux, suggesting that this compound recruits the transporter to a conformational state in which closure of inner helices occurs at the cytoplasmic face of the membrane. This observation provides a structural explanation for the competitive inhibition of substrate efflux by cytochalasin B. These data indicate that the binding of competitive inhibitors of glucose efflux or influx induce occluded states in the transporter in which substrate is excluded from the exofacial or endofacial binding site.	[Mueckler, Mike; Makepeace, Carol] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	mmueckler@.wustl.edu	Mueckler, Mike M/F-6115-2012		National Institutes of Health [R01 DK43695]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded in part by National Institutes of Health R01 DK43695. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alisio A, PROTEIN EXPR PURIF, V70, P81; APPLEMAN JR, 1985, J BIOL CHEM, V260, P4575; APPLEMAN JR, 1989, BIOCHEMISTRY-US, V28, P8221, DOI 10.1021/bi00446a038; BAKER GF, 1978, J PHYSIOL-LONDON, V278, P377, DOI 10.1113/jphysiol.1978.sp012310; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BLOCH R, 1973, BIOCHEMISTRY-US, V12, P4799, DOI 10.1021/bi00747a036; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEVES R, 1978, BIOCHIM BIOPHYS ACTA, V510, P339, DOI 10.1016/0005-2736(78)90034-2; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GIBBS AF, 1988, BIOCHEM J, V256, P421, DOI 10.1042/bj2560421; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; GRIFFIN JF, 1982, P NATL ACAD SCI-BIOL, V79, P3759, DOI 10.1073/pnas.79.12.3759; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inukai K, 1994, BIOCHEM J, V291, P861; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; KARIM AR, 1987, BIOCHIM BIOPHYS ACTA, V902, P402, DOI 10.1016/0005-2736(87)90208-2; Lowe A.G., 1989, RED BLOOD CELL MEMBR, P597; LOWE AG, 1989, BIOCHEM SOC T, V17, P435, DOI 10.1042/bst0170435; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Thorens B, 2009, AM J PHYSL ENDOCRINO; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; WELLNER M, 1995, FEBS LETT, V370, P19, DOI 10.1016/0014-5793(95)00783-6; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	56	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31412	10.1371/journal.pone.0031412	http://dx.doi.org/10.1371/journal.pone.0031412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363641	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500041
J	Semple, JW; Kim, M; Hou, J; McVey, M; Lee, YJ; Tabuchi, A; Kuebler, WM; Chai, ZW; Lazarus, AH				Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Tabuchi, Arata; Kuebler, Wolfgang M.; Chai, Zhong-Wei; Lazarus, Alan H.			Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production	PLOS ONE			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; RESPIRATORY-DISTRESS-SYNDROME; CLASS-II ANTIBODIES; RED-BLOOD-CELLS; GAMMA-GLOBULIN; TRANSFUSION; PLASMA; AUTOANTIBODIES; PATHOGENESIS; ACTIVATION	Transfusion-related acute lung injury (TRALI) is a leading cause of transfusion-associated mortality that can occur with any type of transfusion and is thought to be primarily due to donor antibodies activating pulmonary neutrophils in recipients. Recently, a large prospective case controlled clinical study of cardiac surgery patients demonstrated that despite implementation of male donors, a high incidence of TRALI still occurred and suggested a need for additional interventions in susceptible patient populations. To examine if intravenous immunoglobulin (IVIg) may be effective, a murine model of antibody-mediated acute lung injury that approximates human TRALI was examined. When BALB/c mice were injected with the anti-major histocompatibility complex class I antibody 34-1-2s, mild shock (reduced rectal temperature) and respiratory distress (dyspnea) were observed and pre-treatment of the mice with 2 g/kg IVIg completely prevented these symptoms. To determine IVIg's usefulness to affect severe lung damage, SCID mice, previously shown to be hypersensitive to 34-1-2s were used. SCID mice treated with 34-1-2s underwent severe shock, lung damage (increased wet/dry ratios) and 40% mortality within 2 hours. Treatment with 2 g/kg IVIg 18 hours before 34-1-2s administration completely protected the mice from all adverse events. Treatment with IVIg after symptoms began also reduced lung damage and mortality. While the prophylactic IVIg administration did not affect 34-1-2s-induced pulmonary neutrophil accumulation, bone marrow-derived neutrophils from the IVIg-treated mice displayed no spontaneous ROS production nor could they be stimulated in vitro with fMLP or 34-1-2s. These results suggest that IVIg prevents murine antibody-mediated acute lung injury at the level of neutrophil ROS production and thus, alleviating tissue damage.	[Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Chai, Zhong-Wei; Lazarus, Alan H.] Univ Toronto, Toronto Platelet Immunobiol Grp, Toronto, ON, Canada; [Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Tabuchi, Arata; Kuebler, Wolfgang M.; Chai, Zhong-Wei; Lazarus, Alan H.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Canadian Blood Serv, Toronto, ON, Canada; [Semple, John W.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McVey, Mark] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Blood Services; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Semple, JW (corresponding author), Univ Toronto, Toronto Platelet Immunobiol Grp, Toronto, ON, Canada.	semplej@smh.ca; lazarusa@smh.ca	Semple, John W./Q-2513-2019	Semple, John W./0000-0002-1510-0077; McVey, Mark/0000-0002-0918-7030; Lazarus, Alan/0000-0002-5051-6916; Kuebler, Wolfgang/0000-0003-4100-2961	Canadian Institutes for Health Research; Canadian Blood Services	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services	Canadian Institutes for Health Research; Canadian Blood Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Ballow M, 2003, J AM PHARM ASSOC, V42, P449; Berger-Achituv S, 2008, AM J HEMATOL, V83, P676, DOI 10.1002/ajh.21185; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUSSEL J, 1983, BLOOD, V62, P398; Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x; Chang JS, 2008, BLOOD, V111, P915, DOI 10.1182/blood-2007-04-084061; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Cheema G S, 1999, Curr Opin Pulm Med, V5, P305, DOI 10.1097/00063198-199909000-00007; Cho FN, 2007, J REPROD MED, V52, P661; Cooper N, 2004, BRIT J HAEMATOL, V124, P511, DOI 10.1111/j.1365-2141.2004.04804.x; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Food and Drug Administration, FAT REP FDA FOLL BLO; Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570; Fung YL, 2009, TRANSFUS MED REV, V23, P266, DOI 10.1016/j.tmrv.2009.06.001; Hagiwara S, 2008, INTENS CARE MED, V34, P1812, DOI 10.1007/s00134-008-1161-1; IMBACH P, 1981, LANCET, V1, P1228; JENSEN S, 1990, VOX SANG, V59, P62, DOI 10.1111/j.1423-0410.1990.tb02119.x; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Koch C, 2009, ANN THORAC SURG, V88, P1410, DOI 10.1016/j.athoracsur.2009.07.020; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Macmillan HF, 2010, AUTOIMMUNITY, V43, P619, DOI 10.3109/08916931003599062; Maddur MS, 2011, AUTOIMMUN REV, V10, P809, DOI 10.1016/j.autrev.2011.02.007; Maddur MS, 2010, J CLIN IMMUNOL, V30, pS4, DOI 10.1007/s10875-010-9394-5; Molica S, 1996, HAEMATOLOGICA, V81, P121; MUELLERECKHARDT C, 1985, SCAND J HAEMATOL, V34, P394; Navarrete AM, 2011, VACCINE, V29, P2649, DOI 10.1016/j.vaccine.2011.01.095; Netzer G, 2010, CRIT CARE MED, V38, P981, DOI 10.1097/CCM.0b013e3181cfb2eb; Nicolle AL, 2004, TRANSFUSION MED, V14, P225, DOI 10.1111/j.0958-7578.2004.00504.x; OZATO K, 1980, J IMMUNOL, V125, P2473; Palmer AL, 2005, SOUTH MED J, V98, P1031, DOI 10.1097/01.smj.0000182176.71475.a9; POPOVSKY MA, 1983, AM REV RESPIR DIS, V128, P185, DOI 10.1164/arrd.1983.128.1.185; POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x; Rankin JS, 2005, J HEART VALVE DIS, V14, P783; Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x; Rizk A, 2001, TRANSFUSION, V41, P264, DOI 10.1046/j.1537-2995.2001.41020264.x; ROSSI F, 1989, J IMMUNOL, V143, P4104; Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; SEEGER W, 1990, BLOOD, V76, P1438; Semple JW, 2002, AM J HEMATOL, V69, P225, DOI 10.1002/ajh.10065; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; SULTAN Y, 1984, LANCET, V2, P765; Takeshita S, 2005, APMIS, V113, P269, DOI 10.1111/j.1600-0463.2005.apm_05.x; Tokat O, 2001, J INT MED RES, V29, P252, DOI 10.1177/147323000102900313; Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973; Vlaar APJ, 2010, CRIT CARE MED, V38, P771, DOI 10.1097/CCM.0b013e3181cc4d4b; Voulgari PV, 2010, J RHEUMATOL, V37, P190, DOI 10.3899/jrheum.090725; Win N, 2001, TRANSFUSION, V41, P1421, DOI 10.1046/j.1537-2995.2001.41111421.x; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009	57	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31357	10.1371/journal.pone.0031357	http://dx.doi.org/10.1371/journal.pone.0031357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363629	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600142
J	Zhu, HW; Xia, LM; Zhang, YG; Wang, HH; Xu, WJ; Hu, H; Wang, J; Xin, J; Gang, Y; Sha, SM; Xu, B; Fan, DM; Nie, YZ; Wu, KC				Zhu, Hongwu; Xia, Limin; Zhang, Yongguo; Wang, Honghong; Xu, Wenjing; Hu, Hao; Wang, Jing; Xin, Jing; Gang, Yi; Sha, Sumei; Xu, Bin; Fan, Daiming; Nie, Yongzhan; Wu, Kaichun			Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression	PLOS ONE			English	Article							STRESS-RESPONSE; CISPLATIN RESISTANCE; BREAST-CANCER; CYCLIC-AMP; ATF4; INHIBITOR; ELEMENTS; CHEMORESISTANCE; TRANSLATION; INDUCTION	Background: Multidrug resistance (MDR) in gastric cancer remains a major challenge to clinical treatment. Activating transcription factor 4 (ATF4) is a stress response gene involved in homeostasis and cellular protection. However, the expression and function of ATF4 in gastric cancer MDR remains unknown. In this study, we investigate whether ATF4 play a role in gastric cancer MDR and its potential mechanisms. Methodology/Principal Findings: We demonstrated that ATF4 overexpression confered the MDR phenotype to gastric cancer cells, while knockdown of ATF4 in the MDR variants induced re-sensitization. In this study we also showed that the NAD(+)-dependent histone deacetylase SIRT1 was required for ATF4-induced MDR effect in gastric cancer cells. We demonstrated that ATF4 facilitated MDR in gastric cancer cells through direct binding to the SIRT1 promoter, resulting in SIRT1 up-regulation. Significantly, inhibition of SIRT1 by small interfering RNA (siRNA) or a specific inhibitor (EX-527) reintroduced therapeutic sensitivity. Also, an increased Bcl-2/Bax ratio and MDR1 expression level were found in ATF4-overexpressing cells. Conclusions/Significance: We showed that ATF4 had a key role in the regulation of MDR in gastric cancer cells in response to chemotherapy and these findings suggest that targeting ATF4 could relieve therapeutic resistance in gastric cancer.	[Zhu, Hongwu] Fourth Mil Med Univ, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China; Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhu, HW (corresponding author), Fourth Mil Med Univ, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China.	Yongzhan.nie@gmail.com; kaicwu@fmmu.edu.cn			National Natural Science Foundation of China [81090270, 81090273, 81000864]; Chinese Postdoctoral Science Foundation [20100471776]; National Key and Basic Research Development Program of China [2010CB529302]; National Municipal Science and Technology Project [2009ZX09103-667, 2009ZX09301-009-RC06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key and Basic Research Development Program of China(National Basic Research Program of China); National Municipal Science and Technology Project	This study was supported by combined grants from the National Natural Science Foundation of China (NO. 81090270, NO. 81090273, and NO. 81000864), the Chinese Postdoctoral Science Foundation (NO. 20100471776), the National Key and Basic Research Development Program of China (NO. 2010CB529302), and the National Municipal Science and Technology Project (2009ZX09103-667 and 2009ZX09301-009-RC06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Jansen E, 1997, J BIOL CHEM, V272, P2500; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Larsen AK, 1998, BBA-GENE STRUCT EXPR, V1400, P257, DOI 10.1016/S0167-4781(98)00140-7; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Levenson VV, 2000, CANCER RES, V60, P5027; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Oh WK, 2010, MOL PHARMACOL, V78, P855, DOI 10.1124/mol.110.065961; Olmos Y, 2010, DRUG RESIST UPDAT; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tanabe M, 2003, CANCER RES, V63, P8592; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Zhang DX, 2007, EXPERT REV ANTICANC, V7, P1369, DOI 10.1586/14737140.7.10.1369; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]	42	47	52	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31431	10.1371/journal.pone.0031431	http://dx.doi.org/10.1371/journal.pone.0031431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363646	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600146
J	Yuan, W; Stawiski, E; Janakiraman, V; Chan, E; Durinck, S; Edgar, KA; Kljavin, NM; Rivers, CS; Gnad, F; Roose-Girma, M; Haverty, PM; Fedorowicz, G; Heldens, S; Soriano, RH; Zhang, Z; Wallin, JJ; Johnson, L; Merchant, M; Modrusan, Z; Stern, HM; Seshagiri, S				Yuan, W.; Stawiski, E.; Janakiraman, V.; Chan, E.; Durinck, S.; Edgar, K. A.; Kljavin, N. M.; Rivers, C. S.; Gnad, F.; Roose-Girma, M.; Haverty, P. M.; Fedorowicz, G.; Heldens, S.; Soriano, R. H.; Zhang, Z.; Wallin, J. J.; Johnson, L.; Merchant, M.; Modrusan, Z.; Stern, H. M.; Seshagiri, S.			Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations	ONCOGENE			English	Article						Pik3ca; H1047R; knock-in; mammary gland; Trp53; exome sequencing	TO-MESENCHYMAL TRANSITION; BREAST-CANCER; HIGH-FREQUENCY; PIK3CA GENE; PI3K; EXPRESSION; MICE; P110-ALPHA; INHIBITION; CARCINOMA	Oncogenic mutations in PIK3CA, which encodes the phosphoinositide-3-kinase (PI3K) catalytic subunit p110 alpha, occur in similar to 25% of human breast cancers. In this study, we report the development of a knock-in mouse model for breast cancer where the endogenous Pik3ca allele was modified to allow tissue-specific conditional expression of a frequently found Pik3ca(H1047R) (pik3ca(e20H1047R)) mutant allele. We found that activation of the latent Pik3ca(H1047R) allele resulted in breast tumors with multiple histological types. Whole-exome analysis of the Pik3ca(H1047R)-driven mammary tumors identified multiple mutations, including Trp53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors. Further, we used this model to test the efficacy of GDC-0941, a PI3K inhibitor, in clinical development, and showed that the tumors respond to PI3K inhibition. Oncogene (2013) 32, 318-326; doi:10.1038/onc.2012.53; published online 27 February 2012	[Yuan, W.; Stawiski, E.; Janakiraman, V.; Durinck, S.; Kljavin, N. M.; Rivers, C. S.; Roose-Girma, M.; Fedorowicz, G.; Heldens, S.; Soriano, R. H.; Johnson, L.; Modrusan, Z.; Seshagiri, S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Chan, E.; Merchant, M.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Edgar, K. A.; Wallin, J. J.] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA; [Gnad, F.; Haverty, P. M.; Zhang, Z.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Stern, H. M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com		Wallin, Jeffrey/0000-0002-5952-3813; Seshagiri, Somasekar/0000-0003-4272-6443; Merchant, Mark/0000-0003-0690-8581; Gnad, Florian/0000-0002-2287-2251				Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Amikura T, 2006, GYNECOL ONCOL, V100, P365, DOI 10.1016/j.ygyno.2005.09.010; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Boyault S, 2012, BREAST CANCER RES TR, V132, P29, DOI 10.1007/s10549-011-1518-y; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carter MR, 2006, AM J SURG PATHOL, V30, P300; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fishler T, 2010, ONCOGENE, V29, P4007, DOI 10.1038/onc.2010.163; Folkes A, 2007, PCT Int Appl, P206, Patent No. [WO 2007127175 A2 20071108, 2007127175]; Grochova D, 2008, ONCOGENE, V27, P1243, DOI 10.1038/sj.onc.1210748; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Horn S, 2008, ONCOGENE, V27, P4096, DOI 10.1038/onc.2008.40; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Hynes NE, 2009, CANCER CELL, V15, P353, DOI 10.1016/j.ccr.2009.04.004; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Khan HN, 2003, EUR J SURG ONCOL, V29, P600, DOI 10.1016/S0748-7983(03)00107-0; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Li G, 2002, DEVELOPMENT, V129, P4159; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Salphati L, 2010, DRUG METAB DISPOS, V38, P1436, DOI 10.1124/dmd.110.032912; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tiede B, 2011, CELL RES, V21, P245, DOI 10.1038/cr.2011.11; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Walrath JC, 2010, ADV CANCER RES, V106, P113, DOI 10.1016/S0065-230X(10)06004-5; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	53	53	53	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					318	326		10.1038/onc.2012.53	http://dx.doi.org/10.1038/onc.2012.53			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370636	hybrid, Green Published			2022-12-25	WOS:000314736600006
J	Hasan, S; Santhi, N; Lazar, AS; Slak, A; Lo, JN; von Schantz, M; Archer, SN; Johnston, JD; Dijk, DJ				Hasan, Sibah; Santhi, Nayantara; Lazar, Alpar S.; Slak, Ana; Lo, June; von Schantz, Malcolm; Archer, Simon N.; Johnston, Jonathan D.; Dijk, Derk-Jan			Assessment of circadian rhythms in humans: comparison of real-time fibroblast reporter imaging with plasma melatonin	FASEB JOURNAL			English	Article						sleep; PER3; Bmal1; lentivirus; clock genes	SLEEP-PHASE SYNDROME; INTRINSIC PERIOD; GENE-EXPRESSION; LENGTH POLYMORPHISM; DIURNAL PREFERENCE; SHIFT WORK; CKI-DELTA; CLOCK; PER3; ENTRAINMENT	We compared the period of the rhythm of plasma melatonin, driven by the hypothalamic circadian pacemaker, to in vitro periodicity in cultured peripheral fibroblasts to assess the effects on these rhythms of a polymorphism of PER3 (rs57875989), which is associated with sleep timing. In vitro circadian period was determined using luminometry of cultured fibroblasts, in which the expression of firefly luciferase was driven by the promoter of the circadian gene Arntl (Bmal1). The period of the melatonin rhythm was assessed in a 9-d forced desynchrony protocol, minimizing confounding effects of sleep-wake and light-dark cycles on circadian rhythmicity. In vitro periods (32 participants, 24.61 +/- 0.33 h, mean +/- SD) were longer than in vivo periods (31 participants, 24.16 +/- 0.17 h; P<0.0001) but did not differ between PER3 genotypes (P>0.4). Analyses of replicate in vitro assessments demonstrated that circadian period was reproducible within individuals (intraclass correlation = 0.62), but in vivo and in vitro period assessments did not correlate (P>0.9). In accordance with circadian entrainment theory, in vivo period correlated with the timing of melatonin (P<0.05) at baseline and with diurnal preference (P<0.05). Individual circadian rhythms can be reliably assessed in fibroblasts but may not correlate with physiological rhythms driven by the central circadian pacemaker.-Hasan, S., Santhi, N., Lazar, A. S., Slak, A., Lo, J., von Schantz, M., Archer, S. N., Johnston, J. D., Dijk, D.-J. Assessment of circadian rhythms in humans: comparison of real-time fibroblast reporter imaging with plasma melatonin. FASEB J. 26, 2414-2423 (2012). www.fasebj.org	[Hasan, Sibah; Santhi, Nayantara; Lazar, Alpar S.; Slak, Ana; Lo, June; von Schantz, Malcolm; Archer, Simon N.; Johnston, Jonathan D.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 7XH, Surrey, England; [von Schantz, Malcolm; Archer, Simon N.; Johnston, Jonathan D.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 7XH, Surrey, England	University of Surrey; University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Egerton Rd, Guildford GU2 7XH, Surrey, England.	d.j.dijk@surrey.ac.uk	Johnston, Jonathan D/H-6363-2011; von Schantz, Malcolm/C-5962-2014; Johnston, Jonathan/AAS-6969-2021	Johnston, Jonathan D/0000-0001-8083-9794; von Schantz, Malcolm/0000-0002-9911-9436; Santhi, Nayantara/0000-0003-4568-1447; Lazar, Alpar/0000-0003-3147-8229	UK Biotechnology and Biological Sciences Research Council [BB/F022883/1]; BBSRC [BB/F022883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022883/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Prof. S. A. Brown (Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland) for generously providing the lentiviral plasmids, Dr. E. Maywood (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for providing training related to the real-time luminometry technique, Dr. W. Qasim and E. Chan (Institute of Child Health, University College London, London, UK) for training in lentivirus production, P. McGabe for statistical advice, and the staff of the Surrey Clinical Research Centre for their help. This research was supported by the UK Biotechnology and Biological Sciences Research Council, grant BB/F022883/1.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; [Anonymous], [No title captured], DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177]; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Archer SN, 2010, SLEEP, V33, P695, DOI 10.1093/sleep/33.5.695; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barion A, 2011, DM-DIS MON, V57, P423, DOI 10.1016/j.disamonth.2011.06.003; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; CARSKADON MA, 1980, SLEEP, V2, P309; Clendenen Tess V, 2010, BMC Res Notes, V3, P302, DOI 10.1186/1756-0500-3-302; Czeisler CA, 2000, SCIENCE, V288, P1174; Daan S, 2000, J BIOL RHYTHM, V15, P195, DOI 10.1177/074873040001500301; Davis S, 2006, CANCER CAUSE CONTROL, V17, P539, DOI 10.1007/s10552-005-9010-9; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Hasan S, 2011, AM J PHYSIOL-REG I, V301, pR1821, DOI 10.1152/ajpregu.00260.2011; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lee SK, 2011, BIOCHEM BIOPH RES CO, V416, P337, DOI 10.1016/j.bbrc.2011.11.037; LEWY AJ, 1983, J CLIN ENDOCR METAB, V56, P1103, DOI 10.1210/jcem-56-6-1103; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Loop S, 2005, FEBS J, V272, P3714, DOI 10.1111/j.1742-4658.2005.04798.x; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Munch M, 2005, NEUROBIOL AGING, V26, P1307, DOI 10.1016/j.neurobiolaging.2005.03.004; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pereira DS, 2005, SLEEP, V28, P29; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Reddy AB, 2011, EMBO REP, V12, P612, DOI 10.1038/embor.2011.123; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Sharma VK, 1998, NATURWISSENSCHAFTEN, V85, P183, DOI 10.1007/s001140050481; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takano A, 2004, J BIOL CHEM, V279, P32578, DOI 10.1074/jbc.M403433200; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Veen DR, 2010, J BIOL RHYTHM, V25, P3, DOI 10.1177/0748730409356680; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Viola AU, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.024; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	70	48	58	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2414	2423		10.1096/fj.11-201699	http://dx.doi.org/10.1096/fj.11-201699			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22371527	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000305017200019
J	Brzeska, H; Guag, J; Preston, GM; Titus, MA; Korn, ED				Brzeska, Hanna; Guag, Jake; Preston, G. Michael; Titus, Margaret A.; Korn, Edward D.			Molecular Basis of Dynamic Relocalization of Dictyostelium Myosin IB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ARP2/3 COMPLEX; SH3 DOMAIN; TEDS RULE; WILD-TYPE; ACTIN; LOCALIZATION; ACANTHAMOEBA; MUTANTS; BINDING	Class I myosins have a single heavy chain comprising an N-terminal motor domain with actin-activated ATPase activity and a C-terminal globular tail with a basic region that binds to acidic phospholipids. These myosins contribute to the formation of actin-rich protrusions such as pseudopodia, but regulation of the dynamic localization to these structures is not understood. Previously, we found that Acanthamoeba myosin IC binds to acidic phospholipids in vitro through a short sequence of basic and hydrophobic amino acids, BH site, based on the charge density of the phospholipids. The tail of Dictyostelium myosin IB (DMIB) also contains a BH site. We now report that the BH site is essential for DMIB binding to the plasma membrane and describe the molecular basis of the dynamic relocalization of DMIB in live cells. Endogenous DMIB is localized uniformly on the plasma membrane of resting cells, at active protrusions and cell-cell contacts of randomly moving cells, and at the front of motile polarized cells. The BH site is required for association of DMIB with the plasma membrane at all stages where it colocalizes with phosphoinositide bisphosphate/phosphoinositide trisphosphate (PIP2/PIP3). The charge-based specificity of the BH site allows for in vivo specificity of DMIB for PIP2/PIP3 similar to the PH domain-based specificity of other class I myosins. However, DMIB-head is required for relocalization of DMIB to the front of migrating cells. Motor activity is not essential, but the actin binding site in the head is important. Thus, dynamic relocalization of DMIB is determined principally by the local PIP2/PIP3 concentration in the plasma membrane and cytoplasmic F-actin.	[Brzeska, Hanna; Guag, Jake; Preston, G. Michael; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Titus, Margaret A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov		Korn, Edward/0000-0003-3867-6295	National Institutes of Health [GM046486]; NHLBI Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM046486 (to M. A. T.). This work was also supported by the NHLBI Intramural Research Program, National Institutes of Health.	Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Corner FI, 2005, CURR BIOL, V15, P134, DOI 10.1016/j.cub.2005.01.007; de la Roche MA, 2001, BBA-GEN SUBJECTS, V1525, P245, DOI 10.1016/S0304-4165(01)00110-6; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dormann D, 2002, CURR BIOL, V12, P1178, DOI 10.1016/S0960-9822(02)00950-8; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; Friedman AL, 1998, BIOCHEMISTRY-US, V37, P9679, DOI 10.1021/bi973143f; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-42; GIFFARD RG, 1983, J MUSCLE RES CELL M, V4, P115, DOI 10.1007/BF00711962; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Liu X, 2001, P NATL ACAD SCI USA, V98, P9122, DOI 10.1073/pnas.161285698; Maravillas-Montero JL, 2011, J IMMUNOL, V187, P3053, DOI 10.4049/jimmunol.1004018; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Ostap EM, 1996, J CELL BIOL, V133, P221, DOI 10.1083/jcb.133.2.221; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; PATTERSON B, 1995, GENETICS, V140, P505; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; ROSENFELD SS, 1994, BIOCHEMISTRY-US, V33, P2322, DOI 10.1021/bi00174a045; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Senda S, 2000, FEBS LETT, V484, P125, DOI 10.1016/S0014-5793(00)02137-2; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Stoffler HE, 1998, J CELL SCI, V111, P2779; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Titus MA, 2006, DEV CELL, V11, P594, DOI 10.1016/j.devcel.2006.10.014; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; Yamashita RA, 2000, CELL MOTIL CYTOSKEL, V45, P163, DOI 10.1002/(SICI)1097-0169(200002)45:2<163::AID-CM7>3.0.CO;2-D; Yengo CM, 2008, BIOPHYS J, V94, pL5, DOI 10.1529/biophysj.107.122689	85	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14923	14936		10.1074/jbc.M111.318667	http://dx.doi.org/10.1074/jbc.M111.318667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22367211	hybrid, Green Published			2022-12-25	WOS:000304003200055
J	Gonzalez, DJ; Okumura, CY; Hollands, A; Kersten, R; Akong-Moore, K; Pence, MA; Malone, CL; Derieux, J; Moore, BS; Horswill, AR; Dixon, JE; Dorrestein, PC; Nizet, V				Gonzalez, David J.; Okumura, Cheryl Y.; Hollands, Andrew; Kersten, Roland; Akong-Moore, Kathryn; Pence, Morgan A.; Malone, Cheryl L.; Derieux, Jaclyn; Moore, Bradley S.; Horswill, Alexander R.; Dixon, Jack E.; Dorrestein, Pieter C.; Nizet, Victor			Novel Phenol-soluble Modulin Derivatives in Community-associated Methicillin-resistant Staphylococcus aureus Identified through Imaging Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; METABOLIC EXCHANGE; STREPTOLYSIN-S; VIRULENCE	Staphylococcus aureus causes a wide range of human disease ranging from localized skin and soft tissue infections to potentially lethal systemic infections. S. aureus has the biosynthetic ability to generate numerous virulence factors that assist in circumventing the innate immune system during disease pathogenesis. Recent studies have uncovered a set of extracellular peptides produced by community-associated methicillin-resistant S. aureus (CA-MRSA) with homology to the phenol-soluble modulins (PSMs) from Staphylococcus epidermidis. CA-MRSA PSMs contribute to skin infection and recruit and lyse neutrophils, and truncated versions of these peptides possess antimicrobial activity. In this study, novel CA-MRSA PSM derivatives were discovered by the use of microbial imaging mass spectrometry. The novel PSM derivatives are compared with their parent full-length peptides for changes in hemolytic, cytolytic, and neutrophil-stimulating activity. A potential contribution of the major S. aureus secreted protease aureolysin in processing PSMs is demonstrated. Finally, we show that PSM processing occurs in multiple CA-MRSA strains by structural confirmation of additional novel derivatives. This work demonstrates that IMS can serve as a useful tool to go beyond genome predictions and expand our understanding of the important family of small peptide virulence factors.	[Kersten, Roland; Moore, Bradley S.; Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gonzalez, David J.; Okumura, Cheryl Y.; Hollands, Andrew; Akong-Moore, Kathryn; Pence, Morgan A.; Derieux, Jaclyn; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Malone, Cheryl L.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Iowa	Dorrestein, PC (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,Mail Code 0636, La Jolla, CA 92093 USA.	pdorrestein@ucsd.edu; vnizet@ucsd.edu	Pence, Morgan A./N-1620-2019; Dorrestein, Pieter/ABF-2930-2020; Nizet, Victor/AAF-3190-2019	Pence, Morgan A./0000-0003-0239-0228; Moore, Bradley/0000-0002-4652-1253; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [GM086283, GM094802, AI077780, AR05278]; Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094802, R01GM086283, R01GM090328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants GM086283 and GM094802 (to P. C. D.) and AI077780 and AR05278 (to V. N.).; We appreciate the support of the Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kerr ID, 1996, PROTEIN ENG, V9, P161, DOI 10.1093/protein/9.2.161; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-4; Lipinska U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022864; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	31	41	45	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13889	13898		10.1074/jbc.M112.349860	http://dx.doi.org/10.1074/jbc.M112.349860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371493	hybrid, Green Published			2022-12-25	WOS:000303996300044
J	Eckert, B; Collins, K				Eckert, Barbara; Collins, Kathleen			Roles of Telomerase Reverse Transcriptase N-terminal Domain in Assembly and Activity of Tetrahymena Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT ADDITION PROCESSIVITY; RNA; DNA; BINDING; ELONGATION; SUBUNIT; PROTEINS; LOOP	Telomerase extends chromosome ends by the addition of single-stranded telomeric repeats. To support processive repeat synthesis, it has been proposed that coordination occurs between DNA interactions with the telomerase RNA template, the active site in the telomerase reverse transcriptase (TERT) core, a TERT N-terminal (TEN) domain, and additional subunits of the telomerase holoenzyme required for telomere elongation in vivo. The roles of TEN domain surface residues in primer binding and product elongation have been studied largely using assays of minimal recombinant telomerase enzymes, which lack holoenzyme subunits that properly fold and conformationally stabilize the ribonucleoprotein and/or control its association with telomere substrates in vivo. Here, we use Tetrahymena telomerase holoenzyme reconstitution in vitro to assess TEN domain sequence requirements in the physiological enzyme context. We find that TEN domain sequence substitutions in the Tetrahymena telomerase holoenzyme influence synthesis initiation and elongation rate but not processivity. Functional and direct physical interaction assays pinpoint a conserved TEN domain surface required for holoenzyme subunit association and for high repeat addition processivity. Our results add to the understanding of telomerase holoenzyme architecture and TERT domain functions with direct implications for the unique mechanism of single-stranded repeat synthesis.	[Eckert, Barbara; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54198.	Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Blackburn E. H., 2010, RNA WORLDS, P205; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hardy CD, 2001, J BIOL CHEM, V276, P4863, DOI 10.1074/jbc.M005158200; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lee SR, 2003, J BIOL CHEM, V278, P52531, DOI 10.1074/jbc.M311359200; Licht JD, 1999, GENE DEV, V13, P1116, DOI 10.1101/gad.13.9.1116; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Robart AR, 2010, RNA, V16, P563, DOI 10.1261/rna.1936410; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rosenfeld KK, 2011, J MOL BIOL, V410, P77, DOI 10.1016/j.jmb.2011.04.040; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Zaug AJ, 2008, NAT STRUCT MOL BIOL, V15, P871, DOI 10.1038/nsmb.1462; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020	34	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12805	12814		10.1074/jbc.M112.339853	http://dx.doi.org/10.1074/jbc.M112.339853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367200	Green Published, hybrid			2022-12-25	WOS:000302903700020
J	Mazerik, JN; Tyska, MJ				Mazerik, Jessica N.; Tyska, Matthew J.			Myosin-1A Targets to Microvilli Using Multiple Membrane Binding Motifs in the Tail Homology 1 (TH1) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; DEAFNESS MUTATION; SURFACE-CHARGE; ACTIN BUNDLES; HIGH-AFFINITY; I-TASSER; PROTEIN; CELL	One of the most abundant components of the enterocyte brush border is the actin-based monomeric motor, myosin-1a (Myo1a). Within brush border microvilli, Myo1a carries out a number of critical functions at the interface between membrane and actin cytoskeleton. Proper physiological function of Myo1a depends on its ability to bind to microvillar membrane, an interaction mediated by a C-terminal tail homology 1 (TH1) domain. However, little is known about the mechanistic details of the Myo1a-TH1/membrane interaction. Structure-function analysis of Myo1a-TH1 targeting in epithelial cells revealed that an N-terminal motif conserved among class I myosins and a C-terminal motif unique to Myo1a-TH1 are both required for steady state microvillar enrichment. Purified Myo1a bound to liposomes composed of phosphatidylserine and phosphoinositol 4,5-bisphosphate, with moderate affinity in a charge-dependent manner. Additionally, peptides of the N- and C-terminal regions required for targeting were able to compete with Myo1a for binding to highly charged liposomes in vitro. Single molecule total internal reflection fluorescence microscopy showed that these motifs are also necessary for slowing the membrane detachment rate in cells. Finally, Myo1a-TH1 co-localized with both lactadherin-C2 (a phosphatidylserine-binding protein) and PLC delta 1-PH (a phosphoinositol 4,5-bisphosphate-binding protein) in microvilli, but only lactaderin-C2 expression reduced brush border targeting of Myo1a-TH1. Together, our results suggest that Myo1a targeting to microvilli is driven by membrane binding potential that is distributed throughout TH1 rather than localized to a single motif. These data highlight the diversity of mechanisms that enable different class I myosins to target membranes in distinct biological contexts.	[Mazerik, Jessica N.; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Tyska, MJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 3150 Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	matthew.tyska@vanderbilt.edu			National Institutes of Health [R01-DK075555]; American Heart Association [09GRNT2310188, 11PRE7390066]; Vanderbilt University Medical Center [T32-GM008320]; Vanderbilt University; Tyska laboratory; Vanderbilt University Epithelial Biology Center Imaging Resource; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Vanderbilt University Medical Center; Vanderbilt University; Tyska laboratory; Vanderbilt University Epithelial Biology Center Imaging Resource; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK075555 (to M. J. T.). This work was also supported by American Heart Association Grants 09GRNT2310188 (to M. J. T.) and 11PRE7390066 (to J. N. M.), Vanderbilt University Medical Center Molecular Biophysics Training Program Training Grant T32-GM008320 (to Dr. Walter Chazin), and a Vanderbilt University IDEAs award (to M. J. T.).; We thank all members of the Tyska laboratory for advice and support; Dr. Kristen Verhey, Dr. Chris Yengo, Dr. Kathy Trybus, Dr. Tamas Balla, Dr. Jim Goldenring, and Dr. Todd Graham for generously sharing reagents; and Dr. Ryoma Ohi, Chauca English Moore, and Dr. Elena Krementsova for assistance with SF9 culture and reagents. We also thank the Vanderbilt University Epithelial Biology Center Imaging Resource for generous support.	Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; COLLINS JH, 1984, J BIOL CHEM, V259, P4128; Coluccio L. M., 2008, MYOSIN, P95; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nambiar R, 2010, CELL MOL LIFE SCI, V67, P1239, DOI 10.1007/s00018-009-0254-5; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pyrpassopoulos S, 2010, BIOPHYS J, V99, P3916, DOI 10.1016/j.bpj.2010.10.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Skowron JF, 1999, J EXP ZOOL, V283, P242, DOI 10.1002/(SICI)1097-010X(19990215)283:3<242::AID-JEZ3>3.3.CO;2-6; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Toprak E, 2010, METHOD ENZYMOL, V475, P1, DOI 10.1016/S0076-6879(10)75001-1; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yengo CM, 2008, BIOPHYS J, V94, pL5, DOI 10.1529/biophysj.107.122689; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	57	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13104	13115		10.1074/jbc.M111.336313	http://dx.doi.org/10.1074/jbc.M111.336313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367206	Green Published, hybrid			2022-12-25	WOS:000302903700050
J	Blood, AJ; Kuster, JK; Woodman, SC; Kirlic, N; Makhlouf, ML; Multhaupt-Buell, TJ; Makris, N; Parent, M; Sudarsky, LR; Sjalander, G; Breiter, H; Breiter, HC; Sharma, N				Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Multhaupt-Buell, Trisha J.; Makris, Nikos; Parent, Martin; Sudarsky, Lewis R.; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.; Sharma, Nutan			Evidence for Altered Basal Ganglia-Brainstem Connections in Cervical Dystonia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TOXIN TYPE-A; FOCAL DYSTONIA; DYT1 DYSTONIA; PSYCHIATRIC COMORBIDITY; SPASMODIC TORTICOLLIS; ABNORMAL PLASTICITY; CEREBELLUM; CARRIERS; LESIONS	Background: There has been increasing interest in the interaction of the basal ganglia with the cerebellum and the brainstem in motor control and movement disorders. In addition, it has been suggested that these subcortical connections with the basal ganglia may help to coordinate a network of regions involved in mediating posture and stabilization. While studies in animal models support a role for this circuitry in the pathophysiology of the movement disorder dystonia, thus far, there is only indirect evidence for this in humans with dystonia. Methodology/Principal Findings: In the current study we investigated probabilistic diffusion tractography in DYT1-negative patients with cervical dystonia and matched healthy control subjects, with the goal of showing that patients exhibit altered microstructure in the connectivity between the pallidum and brainstem. The brainstem regions investigated included nuclei that are known to exhibit strong connections with the cerebellum. We observed large clusters of tractography differences in patients relative to healthy controls, between the pallidum and the brainstem. Tractography was decreased in the left hemisphere and increased in the right hemisphere in patients, suggesting a potential basis for the left/right white matter asymmetry we previously observed in focal dystonia patients. Conclusions/Significance: These findings support the hypothesis that connections between the basal ganglia and brainstem play a role in the pathophysiology of dystonia.	[Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA 02129 USA; [Blood, Anne J.; Kuster, John K.; Kirlic, Namik; Breiter, Hans C.] Massachusetts Gen Hosp, Lab Neuroimaging & Genet, Charlestown, MA USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Morphometr Anal, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makhlouf, Miriam L.; Makris, Nikos; Sjalander, Greta; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Woodman, Sandra C.; Kirlic, Namik; Makris, Nikos; Breiter, Henry; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Blood, Anne J.; Kuster, John K.; Multhaupt-Buell, Trisha J.; Sjalander, Greta; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA; [Sudarsky, Lewis R.; Sharma, Nutan] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Blood, Anne J.; Makris, Nikos; Sudarsky, Lewis R.; Breiter, Hans C.; Sharma, Nutan] Harvard Univ, Sch Med, Boston, MA USA; [Kuster, John K.] Boston Univ, Sch Med, Div Grad Med Sci, Boston, MA 02118 USA; [Makhlouf, Miriam L.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Parent, Martin] Univ Laval, Fac Med, Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [Breiter, Hans C.] NW Univ Feinberg, Warren Wright Adolescent Ctr, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL USA; [Breiter, Hans C.] NW Univ Feinberg, Ctr Self Regulat, Chicago, IL USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Massachusetts Institute of Technology (MIT); Laval University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Blood, AJ (corresponding author), Massachusetts Gen Hosp, Mood & Motor Control Lab, Charlestown, MA 02129 USA.	ablood@nmr.mgh.harvard.edu		Kirlic, Namik/0000-0003-4153-8774	National Institute of Neurological Disorders and Stroke [R01NS052368, NINP50NS037409]; Dystonia Medical Research Foundation; National Center for Research Resources [P41 RR14075, UL1 RR025758-01]; Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, P50NS037409, R01NS052368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA026002, R01DA027804] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dystonia Medical Research Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (grant number R01NS052368 to Dr. Blood, and grant number NINP50NS037409 to Dr. Breakefield with Dr. Sharma as PI of the clinical core), and a grant from the Dystonia Medical Research Foundation to Dr. Blood. The general infrastructure of the Martinos Center for Biomedical Imaging in which research on these grants was conducted, was supported by National Center for Research Resources (grant number P41 RR14075 to Dr. Rosen), and the Mental Illness and Neuroscience Discovery (MIND) Institute (Dr. Rosen). Prescreening and exams were conducted in the General Clinical Research Center, funded by National Center for Research Resources (grant number UL1 RR025758-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brighina F, 2009, EXP BRAIN RES, V192, P651, DOI 10.1007/s00221-008-1572-9; Carbon M, 2010, EUR J NEUROL, V17, P58, DOI 10.1111/j.1468-1331.2010.03054.x; Carbon M, 2008, BRAIN, V131, P146, DOI 10.1093/brain/awm243; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Colosimo C, 2005, J NEUROL NEUROSUR PS, V76, P1591, DOI 10.1136/jnnp.2004.056614; Curra A, 2004, MOVEMENT DISORD, V19, pS60, DOI 10.1002/mds.20011; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Eidelberg D, 1998, ANN NEUROL, V44, P303, DOI 10.1002/ana.410440304; Fabbrini G, 2008, EUR J NEUROL, V15, P185, DOI 10.1111/j.1468-1331.2007.02034.x; Fabbrini G, 2010, MOVEMENT DISORD, V25, P459, DOI 10.1002/mds.22983; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Ghilardi MF, 2003, ANN NEUROL, V54, P102, DOI 10.1002/ana.10610; Gilio F, 2000, ANN NEUROL, V48, P20, DOI 10.1002/1531-8249(200007)48:1<20::AID-ANA5>3.0.CO;2-U; Gundel H, 2003, J NERV MENT DIS, V191, P465; Haaland KY, 2004, BRAIN, V127, P1145, DOI 10.1093/brain/awh133; Heiman GA, 2004, NEUROLOGY, V63, P631, DOI 10.1212/01.WNL.0000137113.39225.FA; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; Lehericy S, 2004, NEUROREPORT, V15, P1887; Loher TJ, 2009, MOVEMENT DISORD, V24, P157, DOI 10.1002/mds.22196; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Ochs S, 1997, PROG NEUROBIOL, V52, P391, DOI 10.1016/S0301-0082(97)00022-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Quartarone A, 2008, J NEUROL NEUROSUR PS, V79, P985, DOI 10.1136/jnnp.2007.121632; Quartarone A, 2011, NEUROBIOL DIS, V42, P162, DOI 10.1016/j.nbd.2010.12.011; Ruge D, 2011, MOV DISORD; Ruge D, 2011, BRAIN, V134, P2106, DOI 10.1093/brain/awr122; Stavrinou LC, 2011, CEN EUR NEUROSURG; Stokely ME, 2005, J NEUROSCI RES, V79, P598, DOI 10.1002/jnr.20383; Tamura Y, 2009, BRAIN, V132, P749, DOI 10.1093/brain/awn348; Tan EK, 2005, J NEUROL SCI, V234, P109, DOI 10.1016/j.jns.2005.03.046; Teo JTH, 2009, J NEUROL NEUROSUR PS, V80, P80, DOI 10.1136/jnnp.2008.144626; Turkheimer FE, 2001, NEUROIMAGE, V13, P920, DOI 10.1006/nimg.2001.0764; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Wenzel T, 1998, J PSYCHOSOM RES, V44, P687, DOI 10.1016/S0022-3999(97)00229-8; White T, 2007, SCHIZOPHR RES, V90, P302, DOI 10.1016/j.schres.2006.09.032; Wu Chia-Lun, 1992, Journal of the Formosan Medical Association, V91, P1013; Zadro I, 2008, MOVEMENT DISORD, V23, P919, DOI 10.1002/mds.21981	54	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31654	10.1371/journal.pone.0031654	http://dx.doi.org/10.1371/journal.pone.0031654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384048	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500028
J	Fraser, EE; McGuire, LP; Eger, JL; Longstaffe, FJ; Fenton, MB				Fraser, Erin E.; McGuire, Liam P.; Eger, Judith L.; Longstaffe, Fred J.; Fenton, M. Brock			Evidence of Latitudinal Migration in Tri-colored Bats, Perimyotis subflavus	PLOS ONE			English	Article							PIPISTRELLE PIPISTRELLUS-SUBFLAVUS; FEMALE EASTERN PIPISTRELLES; MALE DAUBENTONS BATS; MYOTIS-LUCIFUGUS; REPRODUCTIVE CONDITION; STABLE HYDROGEN; BROWN BAT; CHIROPTERA; VESPERTILIONIDAE; HIBERNACULA	Background: Annual movements of tri-colored bats (Perimyotis subflavus) are poorly understood. While this species has been considered a regional migrant, some evidence suggests that it may undertake annual latitudinal migrations, similar to other long distance North American migratory bat species. Methodology/Principal Findings: We investigated migration in P. subflavus by conducting stable hydrogen isotope analyses of 184 museum specimen fur samples and comparing these results (delta D-fur) to published interpolated delta D values of collection site growing season precipitation (delta D-precip). Results suggest that the male molt period occurred between June 23 and October 16 and 33% of males collected during the presumed non-molt period were south of their location of fur growth. For the same time period, 16% of females were south of their location of fur growth and in general, had not travelled as far as migratory males. There were strong correlations between delta D-fur from the presumed molt period and both growing season delta D-precip (males - r(2) = 0.86;p<0.01; females - r(2) = 0.75; p<0.01), and latitude of collection (males - r(2) = 0.85; p<0.01; females - r(2) = 0.73; p<0.01). Most migrants were collected at the northern (>40 degrees N; males and females) and southern (<35 degrees N; males only) extents of the species' range. Conclusions/Significance: These results indicate a different pattern of migration for this species than previously documented, suggesting that some P. subflavus engage in annual latitudinal migrations and that migratory tendency varies with latitude and between sexes. We suggest that this species' hibernation ecology makes it particularly susceptible to long winters, making migration from the northern extent of the species' range to more southern hibernacula preferable for some individuals. Fur delta D values for some of the northern individuals may indicate an increase in the currently accepted northern range of this species. Sex-biased differences in migration may be the result of differences in reproductive pressures.	[Fraser, Erin E.; McGuire, Liam P.; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON, Canada; [Eger, Judith L.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	Western University (University of Western Ontario); Royal Ontario Museum; Western University (University of Western Ontario)	Fraser, EE (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	efrase4@uwo.ca	McGuire, Liam/CAE-8434-2022; Longstaffe, Fred J/A-6843-2008		Natural Sciences and Engineering Research Council [s 3331-2010, 3890-2009]; Canadian Foundation for Innovation [2732]; Bat Conservation International	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Bat Conservation International	Funding for this research was provided by the Natural Sciences and Engineering Research Council (MBF, FJL, LPM, EEF; Discovery grant #s 3331-2010 (MBF); 3890-2009 (FJL)), The Canadian Foundation for Innovation (FJL; infrastructure grant # 2732), and Bat Conservation International (EEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. A., 1921, Journal of Mammalogy, V2, P53, DOI 10.2307/1373683; [Anonymous], 2020, ECONOMIST 0326; ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Barbour R. W., 1969, BATS AM; BARCLAY RMR, 1989, BEHAV ECOL SOCIOBIOL, V24, P31, DOI 10.1007/BF00300115; Bisson IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007504; Bowen GJ, 2005, RAPID COMMUN MASS SP, V19, P2371, DOI 10.1002/rcm.2069; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2010, GRIDDED MAPS ISOTOPI; Boyles JG, 2008, FUNCT ECOL, V22, P632, DOI 10.1111/j.1365-2435.2008.01423.x; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Briggler JT, 2003, AM MIDL NAT, V149, P406, DOI 10.1674/0003-0031(2003)149[0406:SUASOC]2.0.CO;2; Britzke ER, 2009, J MAMMAL, V90, P743, DOI 10.1644/08-MAMM-A-211R2.1; Broders HG, 2001, NORTHEAST NAT, V8, P331; CONSTANTINE D. G., 1957, JOUR MAMMAL, V38, P461, DOI 10.2307/1376398; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Davis W. H., 1964, Journal of Mammalogy, V45, P645, DOI 10.2307/1377349; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WAYNE H., 1959, JOUR MAMMAL, V40, P16, DOI 10.2307/1376111; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Dubois JE, 2007, CAN FIELD NAT, V121, P57, DOI 10.22621/cfn.v121i1.393; DWYER P. D., 1963, AUSTRALIAN JOUR ZOOL, V11, P290, DOI 10.1071/ZO9630290; Dzal Y, 2009, ACTA CHIROPTEROL, V11, P307, DOI 10.3161/150811009X485549; Encarnacao JA, 2004, MAMM BIOL, V69, P163, DOI 10.1078/1616-5047-00131; Encarnacao JA, 2006, FOLIA ZOOL, V55, P237; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Ferrara FJ, 2005, WILDLIFE SOC B, V33, P1113, DOI 10.2193/0091-7648(2005)33[1113:IOIDAT]2.0.CO;2; Findley J. S., 1964, Journal of Mammalogy, V45, P461, DOI 10.2307/1377421; Fleming TH, 2003, BAT ECOLOGY, P156; Fraser KC, 2010, BIOTROPICA, V42, P512, DOI 10.1111/j.1744-7429.2009.00608.x; FUJITA M S, 1984, Mammalian Species, P1, DOI 10.2307/3504021; Geluso K, 2005, WEST N AM NATURALIST, V65, P405; GOEHRING HH, 1954, J MAMMAL, V35, P434, DOI 10.2307/1375980; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; Henry M, 2002, J MAMMAL, V83, P767, DOI 10.1644/1545-1542(2002)083<0767:FDAHRO>2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hoofer SR, 2006, J MAMMAL, V87, P981, DOI 10.1644/05-MAMM-A-425R1.1; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; JONES C, 1973, J MAMMAL, V54, P962, DOI 10.2307/1379091; JONES C, 1968, J MAMMAL, V49, P134, DOI 10.2307/1377741; KNOWLES B, 1992, CAN FIELD NAT, V106, P252; KUNZ TH, 1995, OECOLOGIA, V101, P407, DOI 10.1007/BF00329419; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; KURTA A, 1994, AM MIDL NAT, V132, P410, DOI 10.2307/2426599; Kurta A, 2007, AM MIDL NAT, V157, P404, DOI 10.1674/0003-0031(2007)157[404:REACAO]2.0.CO;2; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; LaVal RK, 1980, TERRESTRIAL SERIES; MCNAB BK, 1974, ECOLOGY, V55, P943, DOI 10.2307/1940347; MENU H, 1984, MAMMALIA, V48, P409, DOI 10.1515/mamm.1984.48.3.409; Paritte JM, 2009, AUK, V126, P165, DOI 10.1525/auk.2009.07187; Perry RW, 2007, J MAMMAL, V88, P974, DOI 10.1644/06-MAMM-A-215R.1; Poissant JA, 2010, ECOSCIENCE, V17, P372, DOI 10.2980/17-4-3352; Reynolds DS, 2006, J WILDLIFE MANAGE, V70, P1219, DOI 10.2193/0022-541X(2006)70[1219:MTPIOA]2.0.CO;2; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rodrigues L, 2008, J ZOOL, V274, P116, DOI 10.1111/j.1469-7998.2007.00361.x; Sandel JK, 2001, J MAMMAL, V82, P173, DOI 10.1644/1545-1542(2001)082<0173:UASOWH>2.0.CO;2; Slider RM, 2011, NORTHEAST NAT, V18, P378; Speakman JR, 2003, BAT ECOLOGY, P430; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; Torres-Dowdall J, 2009, WATERBIRDS, V32, P300, DOI 10.1675/063.032.0210; Trombulak SC, 2001, NORTHEAST NAT, V8, P51, DOI 10.2307/3858262; Veilleux JP, 2004, AM MIDL NAT, V152, P196, DOI 10.1674/0003-0031(2004)152[0196:IAIFTS]2.0.CO;2; Veilleux JP, 2003, J MAMMAL, V84, P1068, DOI 10.1644/BEM-021; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wunder MB, 2008, TRACKING ANIMAL MIGR, P1	73	33	33	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31419	10.1371/journal.pone.0031419	http://dx.doi.org/10.1371/journal.pone.0031419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384019	gold, Green Published, Green Submitted			2022-12-25	WOS:000302875500018
J	Gadkari, RA; Srinivasan, N				Gadkari, Rupali A.; Srinivasan, Narayanaswamy			Protein-Protein Interactions in Clathrin Vesicular Assembly: Radial Distribution of Evolutionary Constraints in Interfaces	PLOS ONE			English	Article							COATED VESICLES; MEDIATED ENDOCYTOSIS; MAXIMUM-LIKELIHOOD; BETA-PROPELLER; CRYSTAL-STRUCTURE; MEMBRANE; DOMAIN; RECRUITMENT; RESOLUTION; ADAPTERS	In eukaryotic organisms clathrin-coated vesicles are instrumental in the processes of endocytosis as well as intracellular protein trafficking. Hence, it is important to understand how these vesicles have evolved across eukaryotes, to carry cargo molecules of varied shapes and sizes. The intricate nature and functional diversity of the vesicles are maintained by numerous interacting protein partners of the vesicle system. However, to delineate functionally important residues participating in protein-protein interactions of the assembly is a daunting task as there are no high-resolution structures of the intact assembly available. The two cryoEM structures closely representing intact assembly were determined at very low resolution and provide positions of C alpha atoms alone. In the present study, using the method developed by us earlier, we predict the protein-protein interface residues in clathrin assembly, taking guidance from the available low-resolution structures. The conservation status of these interfaces when investigated across eukaryotes, revealed a radial distribution of evolutionary constraints, i.e., if the members of the clathrin vesicular assembly can be imagined to be arranged in spherical manner, the cargo being at the center and clathrins being at the periphery, the detailed phylogenetic analysis of these members of the assembly indicated high-residue variation in the members of the assembly closer to the cargo while high conservation was noted in clathrins and in other proteins at the periphery of the vesicle. This points to the strategy adopted by the nature to package diverse proteins but transport them through a highly conserved mechanism.	[Gadkari, Rupali A.; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gadkari, RA (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	rupali@mbu.iisc.ernet.in			Department of Biotechnology, New Delhi, India; Mathematical Biology initiative of Department of Science and Technology, New Delhi, India; Microsoft Corporation; Department of Science and Technology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Mathematical Biology initiative of Department of Science and Technology, New Delhi, India; Microsoft Corporation(Microsoft); Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This research is supported by the Department of Biotechnology, New Delhi, India, and also by the Mathematical Biology initiative of Department of Science and Technology, New Delhi, India. The fellowship to RG was initially provided by a grant to NS by Microsoft Corporation and is currently being funded by a research project to RG under the "Women Scientist Scheme WOS-A" of the Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonazzi M, 2011, J CELL BIOL, V195, P525, DOI 10.1083/jcb.201105152; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2010, CURR OPIN CELL BIOL; DeLlano W, 2002, PYMOL MOL GRAPHICS S; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gadkari RA, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-17; Gadkari RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004476; Glaser F, 2005, PROTEINS, V58, P610, DOI 10.1002/prot.20305; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Holzenspies J, 2010, REPRODUCTION    0603; Hubbard S. J., 1993, NACCESS; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Moeller HB, 2008, KIDNEY INT; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PEARSE BMF, 1987, EMBO J, V6, P2507, DOI 10.1002/j.1460-2075.1987.tb02536.x; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Rekha N, 2005, PROTEINS, V58, P339, DOI 10.1002/prot.20319; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHWARTZ AL, 1990, ANNU REV IMMUNOL, V8, P195, DOI 10.1146/annurev.immunol.8.1.195; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Szymkiewicz I, 2004, BIOCHEM J, V383, P1, DOI 10.1042/BJ20040913; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31445	10.1371/journal.pone.0031445	http://dx.doi.org/10.1371/journal.pone.0031445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384024	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000302875500019
J	Uchida, Y; Kudoh, D; Murakami, A; Honda, M; Kitazawa, S				Uchida, Yusuke; Kudoh, Daisuke; Murakami, Akira; Honda, Masaaki; Kitazawa, Shigeru			Origins of Superior Dynamic Visual Acuity in Baseball Players: Superior Eye Movements or Superior Image Processing	PLOS ONE			English	Article							MOTION; TASK; PERCEPTION; BALL	Dynamic visual acuity (DVA) is defined as the ability to discriminate the fine parts of a moving object. DVA is generally better in athletes than in non-athletes, and the better DVA of athletes has been attributed to a better ability to track moving objects. In the present study, we hypothesized that the better DVA of athletes is partly derived from better perception of moving images on the retina through some kind of perceptual learning. To test this hypothesis, we quantitatively measured DVA in baseball players and non-athletes using moving Landolt rings in two conditions. In the first experiment, the participants were allowed to move their eyes (free-eye-movement conditions), whereas in the second they were required to fixate on a fixation target (fixation conditions). The athletes displayed significantly better DVA than the non-athletes in the free-eye-movement conditions. However, there was no significant difference between the groups in the fixation conditions. These results suggest that the better DVA of athletes is primarily due to an improved ability to track moving targets with their eyes, rather than to improved perception of moving images on the retina.	[Uchida, Yusuke; Honda, Masaaki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kudoh, Daisuke; Murakami, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; [Kitazawa, Shigeru] Juntendo Univ, Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 113, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan	Waseda University; Juntendo University; Juntendo University; Osaka University; Osaka University	Uchida, Y (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	y-uchida@aoni.waseda.jp			Waseda University [2008A-899]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI: 23700685, KAKENHI: 21240029]; Grants-in-Aid for Scientific Research [23700685] Funding Source: KAKEN	Waseda University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Waseda University Grant for Special Research Projects (2008A-899) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to YU (KAKENHI: 23700685) and to SK (KAKENHI: 21240029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1979, SCI AM, V240, P108, DOI 10.1038/scientificamerican0179-108; BAHILL AT, 1984, AM SCI, V72, P249; BALL K, 1981, J EXP PSYCHOL HUMAN, V7, P780, DOI 10.1037/0096-1523.7.4.780; BURG A, 1961, J APPL PSYCHOL, V45, P111, DOI 10.1037/h0044200; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DEMER JL, 1993, INVEST OPHTH VIS SCI, V34, P1894; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; GIBSON JJ, 1955, PSYCHOL REV, V62, P32, DOI 10.1037/h0048826; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; Jacob R, 2005, OPTOMETRY VISION SCI, V82, P1060, DOI 10.1097/01.opx.0000192346.84549.6a; Koyama S, 2004, PERCEPTION, V33, P1139, DOI 10.1068/p5195; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Linhart H., 1986, MODEL SELECTION; MILLER J W, 1962, Surv Ophthalmol, V7, P83; Millslagle DG, 2000, PERCEPT MOTOR SKILL, V90, P498, DOI 10.2466/PMS.90.2.498-504; MORRIS GSD, 1977, RES QUART, V48, P480; Rouse M W, 1988, J Am Optom Assoc, V59, P946; SANDERSON FH, 1974, J MOTOR BEHAV, V6, P87, DOI 10.1080/00222895.1974.10734984; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seitz AR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000028; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847	26	22	22	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31530	10.1371/journal.pone.0031530	http://dx.doi.org/10.1371/journal.pone.0031530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZZ	22384033	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500024
J	Berkowitz, SA; Bell, RA; Kravitz, RL; Feldman, MD				Berkowitz, Seth A.; Bell, Robert A.; Kravitz, Richard L.; Feldman, Mitchell D.			Vicarious Experience Affects Patients' Treatment Preferences for Depression	PLOS ONE			English	Article							PRIMARY-CARE; ANTIDEPRESSANT ADHERENCE; PREDICTORS; PARTICIPATION; ATTITUDES; SEVERITY; IMPACT	Purpose: Depression is common in primary care but often under-treated. Personal experiences with depression can affect adherence to therapy, but the effect of vicarious experience is unstudied. We sought to evaluate the association between a patient's vicarious experiences with depression (those of friends or family) and treatment preferences for depressive symptoms. Methods: We sampled 1054 English and/or Spanish speaking adult subjects from July through December 2008, randomly selected from the 2008 California Behavioral Risk Factor Survey System, regarding depressive symptoms and treatment preferences. We then constructed a unidimensional scale using item analysis that reflects attitudes about antidepressant pharmacotherapy. This became the dependent variable in linear regression analyses to examine the association between vicarious experiences and treatment preferences for depressive symptoms. Results: Our sample was 68% female, 91% white, and 13% Hispanic. Age ranged from 18-94 years. Mean PHQ-(score was 4.3; 14.5% of respondents had a PHQ-(score > 9.0, consistent with active depressive symptoms. Analyses controlling for current depression symptoms and socio-demographic factors found that in patients both with (coefficient 1.08, p = 0.03) and without (coefficient 0.77, p = 0.03) a personal history of depression, having a vicarious experience (family and friend, respectively) with depression is associated with a more favorable attitude towards antidepressant medications. Conclusions: Patients with vicarious experiences of depression express more acceptance of pharmacotherapy. Conversely, patients lacking vicarious experiences of depression have more negative attitudes towards antidepressants. When discussing treatment with patients, clinicians should inquire about vicarious experiences of depression. This information may identify patients at greater risk for non-adherence and lead to more tailored patient-specific education about treatment.	[Berkowitz, Seth A.; Feldman, Mitchell D.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Bell, Robert A.] Univ Calif Davis, Dept Commun, Davis, CA 95616 USA; [Bell, Robert A.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Kravitz, Richard L.] Univ Calif Davis, Div Gen Med, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Berkowitz, SA (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.	Seth.Berkowitz@ucsf.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X; Berkowitz, Seth/0000-0003-1030-4297	National Institute of Mental Health [R01MH79387, K24MH72756]; University of California San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079387, K24MH072756] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of California San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded with support from grants #R01MH79387 and K24MH72756 from the National Institute of Mental Health (RLK, PI). This work was also supported by a University of California San Francisco Training in Clinical Research Grant (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambauer KZ, 2007, J CLIN PSYCHIAT, V68, P867, DOI 10.4088/JCP.v68n0607; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A, 1997, SELF EFFICACY EXERCI; Burra TA, 2007, BEHAV MED, V32, P127, DOI 10.3200/BMED.32.4.127-134; Chakraborty K, 2009, SOC PSYCH PSYCH EPID, V44, P482, DOI 10.1007/s00127-008-0468-0; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Demyttenaere K, 2003, EUR NEUROPSYCHOPHARM, V13, pS69, DOI 10.1016/S0924-977X(03)00095-6; Dwight-Johnson M, 2001, MED CARE, V39, P934, DOI 10.1097/00005650-200109000-00004; Feldman MD, 2007, ANN FAM MED, V5, P412, DOI 10.1370/afm.719; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Holma IAK, 2010, J AFFECT DISORDERS, V127, P102, DOI 10.1016/j.jad.2010.04.022; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kilmer Greta, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kravitz RL, 2006, J GEN INTERN MED, V21, P584, DOI 10.1111/j.1525-1497.2006.00411.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin EHB, 2003, GEN HOSP PSYCHIAT, V25, P303, DOI 10.1016/S0163-8343(03)00074-4; Loh A, 2007, PATIENT EDUC COUNS, V65, P69, DOI 10.1016/j.pec.2006.05.007; Shigemura J, 2010, PSYCHIAT CLIN NEUROS, V64, P179, DOI 10.1111/j.1440-1819.2009.02058.x; Sirey JA, 2010, AM J GERIAT PSYCHIAT, V18, P554, DOI 10.1097/JGP.0b013e3181cdeb7d; Trivedi MH, 2007, CNS SPECTRUMS, V12, P9, DOI 10.1017/S1092852900003746; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Wang J, 2008, J AFFECT DISORDERS, V110, P191, DOI 10.1016/j.jad.2008.01.005; Yannacci J., 2006, PRINCIPLES ADULT LEA	24	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31269	10.1371/journal.pone.0031269	http://dx.doi.org/10.1371/journal.pone.0031269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363603	gold, Green Published			2022-12-25	WOS:000302873700042
J	Mark, FC; Lucassen, M; Strobel, A; Barrera-Oro, E; Koschnick, N; Zane, L; Patarnello, T; Portner, HO; Papetti, C				Mark, Felix C.; Lucassen, Magnus; Strobel, Anneli; Barrera-Oro, Esteban; Koschnick, Nils; Zane, Lorenzo; Patarnello, Tomaso; Poertner, Hans O.; Papetti, Chiara			Mitochondrial Function in Antarctic Nototheniids with ND6 Translocation	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; CYTOCHROME-C-OXIDASE; FISH TREMATOMUS-BERNACCHII; LIMITED THERMAL TOLERANCE; COMPLEX-I; COLD ADAPTATION; PAGOTHENIA-BORCHGREVINKI; TEMPERATURE ADAPTATION; MUSCLE MITOCHONDRIA; OXYGEN-CONSUMPTION	Fish of the suborder Notothenioidei have successfully radiated into the Southern Ocean and today comprise the dominant fish sub-order in Antarctic waters in terms of biomass and species abundance. During evolution in the cold and stable Antarctic climate, the Antarctic lineage of notothenioids developed several unique physiological adaptations, which make them extremely vulnerable to the rapid warming of Antarctic waters currently observed. Only recently, a further phenomenon exclusive to notothenioid fish was reported: the translocation of the mitochondrial gene encoding the NADH Dehydrogenase subunit 6 (ND6), an indispensable part of complex I in the mitochondrial electron transport system. This study investigated the potential physiological consequences of ND6 translocation for the function and thermal sensitivity of the electron transport system in isolated liver mitochondria of the two nototheniid species Notothenia coriiceps and Notothenia rossii, with special attention to the contributions of complex I (NADH DH) and complex II (Succinate DH) to oxidative phosphorylation. Furthermore, enzymatic activities of NADH: Cytochrome c Oxidoreductase and Cytochrome C Oxidase were measured in membrane-enriched tissue extracts. During acute thermal challenge (0-15 degrees C), capacities of mitochondrial respiration and enzymatic function in the liver could only be increased until 9 degrees C. Mitochondrial complex I (NADH Dehydrogenase) was fully functional but displayed a higher thermal sensitivity than the other complexes of the electron transport system, which may specifically result from its unique amino acid composition, revealing a lower degree of stability in notothenioids in general. We interpret the translocation of ND6 as functionally neutral but the change in amino acid sequence as adaptive and supportive of cold stenothermy in Antarctic nototheniids. From these findings, an enhanced sensitivity to ocean warming can be deduced for Antarctic notothenioid fish.	[Mark, Felix C.; Lucassen, Magnus; Strobel, Anneli; Koschnick, Nils; Poertner, Hans O.; Papetti, Chiara] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Zane, Lorenzo; Papetti, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Barrera-Oro, Esteban] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Barrera-Oro, Esteban] Inst Antartico Argentino, Buenos Aires, DF, Argentina; [Patarnello, Tomaso] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Padua; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Antartico Argentino; University of Padua	Mark, FC (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	fmark@awi.de	Strobel, Anneli/S-5853-2016; Lucassen, Magnus/ABA-8396-2021; Mark, Felix Christopher/P-4759-2016; Lucassen, Magnus/E-8433-2011; Zane, Lorenzo/G-6249-2010; Pörtner, Hans-O./K-9429-2016	Lucassen, Magnus/0000-0003-4276-4781; Mark, Felix Christopher/0000-0002-5586-6704; Lucassen, Magnus/0000-0003-4276-4781; Zane, Lorenzo/0000-0002-6963-2132; Pörtner, Hans-O./0000-0001-6535-6575; PATARNELLO, Tomaso/0000-0003-1794-5791; Papetti, Chiara/0000-0002-4567-459X	EMBO [ASTF 363-2008]; DFG [PO273/13-1, LU1463/1-2]; Helmholtz Association; Italian National Programme for Antarctic Research (PNRA)	EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); Italian National Programme for Antarctic Research (PNRA)	CP was supported by EMBO grant ASTF 363-2008. AS, HOP and FCM appreciate funding from DFG grant PO273/13-1, and ML from DFG grant LU1463/1-2. The study is a contribution to the PACES research program (work package 1.6) of the Alfred Wegener Institute funded by the Helmholtz Association. It was also supported by the Italian National Programme for Antarctic Research (PNRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova EI, 2010, CONTEMP PROBL ECOL+, V3, P57, DOI 10.1134/S1995425510010108; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Barrera-Oro E, 2003, POLAR BIOL, V26, P631, DOI 10.1007/s00300-003-0520-1; Barrera-Oro E, 2010, POLAR BIOL, V33, P877, DOI 10.1007/s00300-010-0763-6; BARRERAORO ER, 1992, ANTARCT SCI, V4, P131, DOI 10.1017/S095410209200021X; Beers JM, 2011, PHYSIOL BIOCHEM ZOOL, V84, P353, DOI 10.1086/660191; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 1995, MEASUREMENT MITOCHON; Brodte E, 2006, POLAR BIOL, V30, P95, DOI 10.1007/s00300-006-0165-y; BURCHETT MS, 1983, BRIT ANTARCT SURV B, P63; Campbell HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001743; Casaux RJ, 2002, ANTARCT SCI, V14, P221, DOI 10.1017/S0954102002000056; CASAUX RJ, 1990, POLAR BIOL, V11, P63; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; CLARKE A, 1991, AM ZOOL, V31, P81; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; COCCA E, 1995, P NATL ACAD SCI USA, V92, P1817, DOI 10.1073/pnas.92.6.1817; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; Dewitt H.H., 1990, P279; Duchen MR, 1999, PHYSL SOC, P1; DUNN JF, 1989, POLAR BIOL, V9, P213, DOI 10.1007/BF00263769; DUNN JF, 1986, MAR BIOL, V91, P433, DOI 10.1007/BF00392593; Eastman JT, 2011, MAR ECOL PROG SER, V438, P195, DOI 10.3354/meps09287; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Egginton S, 1997, J COMP PHYSIOL B, V167, P129, DOI 10.1007/s003600050056; Everson I., 1968, Bulletin British Antarctic Survey, VNo. 15, P59; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Franklin CE, 2007, J EXP BIOL, V210, P3068, DOI 10.1242/jeb.003137; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GON O, 1990, FISHES SO OCEAN; GONZALEZCABRERA PJ, 1995, J EXP BIOL, V198, P2279; Guderley H, 1996, J EXP BIOL, V199, P1311; Guderley H, 1998, TEMPERATURE GROWTH R, P58; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hagen W, 2000, POLAR BIOL, V23, P785, DOI 10.1007/s003000000153; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; Hardewig I, 1999, AM J PHYSIOL-REG I, V277, pR508, DOI 10.1152/ajpregu.1999.277.2.R508; Heise K, 2008, REPORTS POLAR MARINE, P320; Hilton Z, 2010, J COMP PHYSIOL B, V180, P979, DOI 10.1007/s00360-010-0477-7; Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z; Iftikar FI, 2010, J EXP MAR BIOL ECOL, V395, P232, DOI 10.1016/j.jembe.2010.09.005; JOHNSTON IA, 1994, J EXP BIOL, V195, P293; Johnston IA, 1998, J EXP BIOL, V201, P1; Kamler E, 2001, POLAR BIOL, V24, P735; KARENTZ D, 1991, ANTARCT SCI, V3, P3, DOI 10.1017/S0954102091000032; Lannig G, 2005, POLAR BIOL, V28, P575, DOI 10.1007/s00300-005-0730-9; Lannig G, 2003, MAR BIOL, V142, P589, DOI 10.1007/s00227-002-0967-6; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; LONDRAVILLE RL, 1990, RESP PHYSIOL, V81, P291, DOI 10.1016/0034-5687(90)90110-K; Lowe CJ, 2005, J FISH BIOL, V67, P752, DOI 10.1111/j.0022-1112.2005.00775.x; Lowe CJ, 2005, J COMP PHYSIOL B, V175, P97, DOI 10.1007/s00360-004-0466-9; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Mark FC, 2005, POLAR BIOL, V28, P805, DOI 10.1007/s00300-005-0018-0; Mark FC, 2002, AM J PHYSIOL-REG I, V283, pR1254, DOI 10.1152/ajpregu.00167.2002; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Mayewski PA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000231; McDonald TG, 2003, BASIC RES CARDIOL, V98, P219, DOI 10.1007/s00395-003-0417-8; MOLLER IM, 1982, PHYSIOL PLANTARUM, V54, P267, DOI 10.1111/j.1399-3054.1982.tb00258.x; Mortelette H, 2010, MITOCHONDRION, V10, P555, DOI 10.1016/j.mito.2010.05.002; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; North AW, 1996, MAR BIOL, V126, P125, DOI 10.1007/BF00571384; O'Brien KM, 2000, J EXP BIOL, V203, P1287; Papetti C, 2007, J MOL EVOL, V65, P519, DOI 10.1007/s00239-007-9030-z; Patarnello T, 2011, BIOESSAYS, V33, P260, DOI 10.1002/bies.201000124; Podrabsky JE, 2006, POLAR BIOL, V30, P39, DOI 10.1007/s00300-006-0157-y; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Portner HO, 1999, COMP BIOCHEM PHYS A, V124, P179, DOI 10.1016/S1095-6433(99)00105-1; Portner HO, 2000, ANTARCTIC ECOSYSTEMS, P109; RALPH R, 1968, COMP BIOCHEM PHYSIOL, V27, P299, DOI 10.1016/0010-406X(68)90772-X; Robinson E, 2008, POLAR BIOL, V31, P317, DOI 10.1007/s00300-007-0361-4; Robinson E, 2011, POLAR BIOL, V34, P371, DOI 10.1007/s00300-010-0891-z; Scheffler IE, 1999, MITOCHONDRIA; Seebacher F, 2005, BIOL LETTERS, V1, P151, DOI 10.1098/rsbl.2004.0280; Sidell BD, 2006, J EXP BIOL, V209, P1791, DOI 10.1242/jeb.02091; Sidell BD, 2007, J EXP BIOL, V210, P815; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; SOMERO GN, 1968, COMP BIOCHEM PHYSIOL, V26, P223, DOI 10.1016/0010-406X(68)90327-7; Speers-Roesch B, 2005, COMP BIOCHEM PHYS A, V140, P487, DOI 10.1016/j.cbpb.2005.02.014; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; SUAREZ RK, 1981, J COMP PHYSIOL, V143, P269; TRIGARI G, 1992, LIPIDS, V27, P371, DOI 10.1007/BF02536152; Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734; Urschel MR, 2008, J EXP BIOL, V211, P2638, DOI 10.1242/jeb.018598; Urschel MR, 2009, POLAR BIOL, V32, P1323, DOI 10.1007/s00300-009-0629-y; VANDENTHILLART G, 1978, BIOCHIM BIOPHYS ACTA, V510, P38, DOI 10.1016/0005-2736(78)90128-1; Walker JL, 2006, J BIOL CHEM, V281, P38127, DOI 10.1074/jbc.M609622200; Weinstein RB, 1998, J COMP PHYSIOL B, V168, P190, DOI 10.1007/s003600050136; Windisch HS, 2011, AM J PHYSIOL-REG I, V301, pR1453, DOI 10.1152/ajpregu.00158.2011; WOHLSCHLAG DE, 1963, ECOLOGY, V44, P557, DOI 10.2307/1932535; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026	105	25	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31860	10.1371/journal.pone.0031860	http://dx.doi.org/10.1371/journal.pone.0031860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363756	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700111
J	Rivellini, C; Dina, G; Porrello, E; Cerri, F; Scarlato, M; Domi, T; Ungaro, D; Del Carro, U; Bolino, A; Quattrini, A; Comi, G; Previtali, SC				Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Ungaro, Daniela; Del Carro, Ubaldo; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.			Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies	PLOS ONE			English	Article							PERIPHERAL-NERVE; ACTIVATOR SYSTEM; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; REGENERATION; EXPRESSION; INTEGRINS; MYELINATION; MIGRATION; UPAR	Remodeling of extracellular matrix (ECM) is a critical step in peripheral nerve regeneration. In fact, in human neuropathies, endoneurial ECM enriched in fibrin and vitronectin associates with poor regeneration and worse clinical prognosis. Accordingly in animal models, modification of the fibrinolytic complex activity has profound effects on nerve regeneration: high fibrinolytic activity and low levels of fibrin correlate with better nerve regeneration. The urokinase plasminogen receptor (uPAR) is a major component of the fibrinolytic complex, and binding to urokinase plasminogen activator (uPA) promotes fibrinolysis and cell movement. uPAR is expressed in peripheral nerves, however, little is known on its potential function on nerve development and regeneration. Thus, we investigated uPAR null mice and observed that uPAR is dispensable for nerve development, whereas, loss of uPAR affects nerve regeneration. uPAR null mice showed reduced nerve repair after sciatic nerve crush. This was a consequence of reduced fibrinolytic activity and increased deposition of endoneurial fibrin and vitronectin. Exogenous fibrinolysis in uPAR null mice rescued nerve repair after sciatic nerve crush. Finally, we measured the fibrinolytic activity in sural nerve biopsies from patients with peripheral neuropathies. We showed that neuropathies with defective regeneration had reduced fibrinolytic activity. On the contrary, neuropathies with signs of active regeneration displayed higher fibrinolytic activity. Overall, our results suggest that enforced fibrinolysis may facilitate regeneration and outcome of peripheral neuropathies.	[Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Cerri, Federica; Scarlato, Marina; Ungaro, Daniela; Del Carro, Ubaldo; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Bolino, Alessandra] Dulbecco Telethon Inst, Rome, Italy; [Comi, Giancarlo] Vita e Salute San Raffaele Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University	Rivellini, C (corresponding author), Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy.	previtali.stefano@hsr.it	domi, teuta/K-9646-2016; Cerri, Federica/AAO-1670-2020; Bolino, Alessandra/AAN-5442-2020; Previtali, Stefano/Z-1962-2019; dina, giorgia/AAN-3770-2020; Rivellini, Cristina/AAN-6194-2020; Bolino, Alessandra/O-2933-2013; scarlato, marina/AAB-8949-2019; Del Carro, Ubaldo/AAO-3457-2020; Porrello, Emanuela/J-7362-2016; Quattrini, Angelo/J-8373-2018	domi, teuta/0000-0002-8377-5594; Bolino, Alessandra/0000-0002-8980-4878; Previtali, Stefano/0000-0003-2546-4357; dina, giorgia/0000-0002-9684-2143; Del Carro, Ubaldo/0000-0003-3301-5412; Porrello, Emanuela/0000-0003-0490-1538; Quattrini, Angelo/0000-0002-8226-8320; scarlato, marina/0000-0003-1060-8207	Fondazione Telethon Italy [GGP08037]; Telethon career award;  [GPP10007]	Fondazione Telethon Italy(Fondazione Telethon); Telethon career award(Fondazione Telethon); 	This work was supported by Fondazione Telethon Italy (GGP08037 to SCP; Telethon career award to AB; and GPP10007 to SCP and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Berti C, 2006, NEUROMOL MED, V8, P191, DOI 10.1385/NMM:8:1:191; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Garcia-Monco JC, 2002, J NEUROIMMUNOL, V129, P216, DOI 10.1016/S0165-5728(02)00186-8; Hayden SM, 1996, J NEUROSCI, V16, P2307; Lee JY, 2007, NEUROSCI LETT, V423, P82, DOI 10.1016/j.neulet.2007.06.037; LEFCORT F, 1992, DEVELOPMENT, V116, P767; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Previtali SC, 2008, NEUROLOGY, V71, P322, DOI 10.1212/01.wnl.0000319736.43628.04; Previtali SC, 1998, ANN NEUROL, V44, P611, DOI 10.1002/ana.410440406; Previtali SC, 2000, J CELL BIOL, V151, P1035, DOI 10.1083/jcb.151.5.1035; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Quattrini Angelo, 2003, Critical Reviews in Neurobiology, V15, P1, DOI 10.1615/CritRevNeurobiol.v15.i1.10; SCHERER SS, 2001, GLIAL CELL DEV, P299; Siconolfi LB, 2003, J NEUROSCI RES, V74, P430, DOI 10.1002/jnr.10786; Siconolfi LB, 2001, J NEUROSCI, V21, P4348, DOI 10.1523/JNEUROSCI.21-12-04348.2001; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168	25	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32059	10.1371/journal.pone.0032059	http://dx.doi.org/10.1371/journal.pone.0032059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363796	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700139
J	Serber, DW; Rogala, A; Makarem, M; Rosson, GB; Simin, K; Godfrey, V; Van Dyke, T; Eaves, CJ; Bultman, SJ				Serber, Daniel W.; Rogala, Allison; Makarem, Maisam; Rosson, Gary B.; Simin, Karl; Godfrey, Virginia; Van Dyke, Terry; Eaves, Connie J.; Bultman, Scott J.			The BRG1 Chromatin Remodeler Protects Against Ovarian Cysts, Uterine Tumors, and Mammary Tumors in a Lineage-Specific Manner	PLOS ONE			English	Article							SWI/SNF COMPLEX; RETINOBLASTOMA PROTEIN; ESTROGEN-RECEPTOR; SELF-RENEWAL; EXPRESSION; GLAND; MORPHOGENESIS; CARCINOMA; DELETION; KNOCKOUT	The BRG1 catalytic subunit of SWI/SNF-related complexes is required for mammalian development as exemplified by the early embryonic lethality of Brg1 null homozygous mice. BRG1 is also a tumor suppressor and, in mice, 10% of heterozygous (Brg1(null/+)) females develop mammary tumors. We now demonstrate that BRG1 mRNA and protein are expressed in both the luminal and basal cells of the mammary gland, raising the question of which lineage requires BRG1 to promote mammary homeostasis and prevent oncogenic transformation. To investigate this question, we utilized Wap-Cre to mutate both Brg1 floxed alleles in the luminal cells of the mammary epithelium of pregnant mice where WAP is exclusively expressed within the mammary gland. Interestingly, we found that Brg1(Wap-Cre) conditional homozygotes lactated normally and did not develop mammary tumors even when they were maintained on a Brm-deficient background. However, Brg1(Wap-Cre) mutants did develop ovarian cysts and uterine tumors. Analysis of these latter tissues showed that both, like the mammary gland, contain cells that normally express Brg1 and Wap. Thus, tumor formation in Brg1 mutant mice appears to be confined to particular cell types that require BRG1 and also express Wap. Our results now show that such cells exist both in the ovary and the uterus but not in either the luminal or the basal compartments of the mammary gland. Taken together, these findings indicate that SWI/SNF-related complexes are dispensable in the luminal cells of the mammary gland and therefore argue against the notion that SWI/SNF-related complexes are essential for cell survival. These findings also suggest that the tumor-suppressor activity of BRG1 is restricted to the basal cells of the mammary gland and demonstrate that this function extends to other female reproductive organs, consistent with recent observations of recurrent ARID1A/BAF250a mutations in human ovarian and endometrial tumors.	[Serber, Daniel W.; Rosson, Gary B.; Simin, Karl; Van Dyke, Terry; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Rogala, Allison; Godfrey, Virginia] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Makarem, Maisam; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Serber, DW (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	Scott_Bultman@med.unc.edu		Eaves, Connie/0000-0002-3452-1926	National Institutes of Health (National Cancer Institute) [CA125237]; American Institute for Cancer Research; Canadian Breast Cancer Research Alliance [019343]; Canadian Institutes of Health Research Banting; NATIONAL CANCER INSTITUTE [R01CA125237, ZIABC011353] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research Banting(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (National Cancer Institute grant CA125237) and the American Institute for Cancer Research to SJB, and the Canadian Breast Cancer Research Alliance (#019343) to CJE. MM is a recipient of a Canadian Institutes of Health Research Banting and Best Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, ONCOGENE, V30, P445, DOI 10.1038/onc.2010.424; Alessio N, 2010, ONCOGENE, V29, P5452, DOI 10.1038/onc.2010.285; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; BURDON T, 1991, J BIOL CHEM, V266, P6909; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Cohen SM, 2010, NUCLEIC ACIDS RES, V38, P6906, DOI 10.1093/nar/gkq559; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kuo KT, 2006, MODERN PATHOL, V19, P1570, DOI 10.1038/modpathol.3800687; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Ludwig T, 2001, ONCOGENE, V20, P3937, DOI 10.1038/sj.onc.1204512; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 2000, CANCER RES, V60, P3605; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strober BE, 1996, MOL CELL BIOL, V16, P1576; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Triplett AA, 2005, GENESIS, V43, P1, DOI 10.1002/gene.20149; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; WEN JY, 1995, MOL REPROD DEV, V41, P399, DOI 10.1002/mrd.1080410402; Wiegand KC, N ENGL J MED, V363, P1532; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	56	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31346	10.1371/journal.pone.0031346	http://dx.doi.org/10.1371/journal.pone.0031346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363625	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700051
J	Beattie, BJ; Thorek, DLJ; Schmidtlein, CR; Pentlow, KS; Humm, JL; Hielscher, AH				Beattie, Bradley J.; Thorek, Daniel L. J.; Schmidtlein, Charles R.; Pentlow, Keith S.; Humm, John L.; Hielscher, Andreas H.			Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides	PLOS ONE			English	Article							LUMINESCENCE TOMOGRAPHY; VISIBLE RADIATION; REFRACTIVE-INDEX	There has been recent and growing interest in applying Cerenkov radiation (CR) for biological applications. Knowledge of the production efficiency and other characteristics of the CR produced by various radionuclides would help in accessing the feasibility of proposed applications and guide the choice of radionuclides. To generate this information we developed models of CR production efficiency based on the Frank-Tamm equation and models of CR distribution based on Monte-Carlo simulations of photon and beta particle transport. All models were validated against direct measurements using multiple radionuclides and then applied to a number of radionuclides commonly used in biomedical applications. We show that two radionuclides, Ac-225 and In-111, which have been reported to produce CR in water, do not in fact produce CR directly. We also propose a simple means of using this information to calibrate high sensitivity luminescence imaging systems and show evidence suggesting that this calibration may be more accurate than methods in routine current use.	[Beattie, Bradley J.; Thorek, Daniel L. J.; Schmidtlein, Charles R.; Pentlow, Keith S.; Humm, John L.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hielscher, Andreas H.] Columbia Univ, New York, NY USA	Memorial Sloan Kettering Cancer Center; Columbia University	Beattie, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	beattieb@mskcc.org	Beattie, Bradley J/K-8981-2012; Schmidtlein, Charles/AGW-1825-2022	Beattie, Bradley J/0000-0001-9891-8271; Schmidtlein, Charles/0000-0003-0485-3601	MSKCC's Center for In Vivo Molecular Imaging in Cancer; NIH [P50 CA86438, R24 CA83084, P30 CA08748]; Molecular Imaging Fellowship [R25T]; Molecular Imaging Training in Oncology [5R25CA096945-07]; NATIONAL CANCER INSTITUTE [P30CA008748, R24CA083084, P50CA086438, R25CA096945] Funding Source: NIH RePORTER	MSKCC's Center for In Vivo Molecular Imaging in Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Imaging Fellowship; Molecular Imaging Training in Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by MSKCC's Center for In Vivo Molecular Imaging in Cancer funded by NIH P50 CA86438. DLJT was supported through the R25T Molecular Imaging Fellowship: Molecular Imaging Training in Oncology (5R25CA096945-07). Technical services provided by the Small-Animal Imaging Facility were supported in part by NIH grants R24 CA83084 and P30 CA08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2011, ESTAR STOPP POW RANG; [Anonymous], 2011, XCOM PHOT CROSS SECT; [Anonymous], 2009, IVIS200BR01; [Anonymous], 2011, ICRP COMP SOFT TISS; Axelsson J, 2011, MED PHYS, V38, P4127, DOI 10.1118/1.3592646; BETHE HA, 1953, PHYS REV, V89, P1256, DOI 10.1103/PhysRev.89.1256; BOLIN FP, 1989, APPL OPTICS, V28, P2297, DOI 10.1364/AO.28.002297; Cerenkov PA, 1937, PHYS REV, V52, P0378, DOI 10.1103/PhysRev.52.378; Cherenkov P.A., 1934, DOKL AKAD NAUK SSSR, V2, P451; CRC,, 2005, CRC HDB CHEM PHYS; CSG CSG Inc. and CSGNetwork.Com, 2011, WAT DENS CALC; Dehghani H, 2003, PHYS MED BIOL, V48, P2713, DOI 10.1088/0031-9155/48/16/310; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; FDA, 2001, FDA APPR DRUG PROD; Frank I, 1937, CR ACAD SCI URSS, V14, P109; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; Koziorowski J, 2000, J NUCL MED, V41, p80P; Levin CS, 1999, PHYS MED BIOL, V44, P781, DOI 10.1088/0031-9155/44/3/019; Levin CS, 2000, PHYS MED BIOL, V45, P559, DOI 10.1088/0031-9155/45/2/501; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Lucignani G, 2011, EUR J NUCL MED MOL I, V38, P592, DOI 10.1007/s00259-010-1708-6; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; Nuclear Data WWW Service, 2011, NUCL DAT WWW SERV; Polyanskiy M, 2011, REFRACTIVE INDEX DAT; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Ran C, 2011, MOL IMAGING BIOL; Ritson D, TECHNIQUES HIGH ENER; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROHRLICH F, 1954, PHYS REV, V93, P38, DOI 10.1103/PhysRev.93.38; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Zhong J, 2011, ANN BIOMEDICAL ENG, V39	35	61	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31402	10.1371/journal.pone.0031402	http://dx.doi.org/10.1371/journal.pone.0031402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363636	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500039
J	Marrone, V; Piscopo, M; Romano, G; Ianora, A; Palumbo, A; Costantini, M				Marrone, Vincenzo; Piscopo, Marina; Romano, Giovanna; Ianora, Adrianna; Palumbo, Anna; Costantini, Maria			Defensome against Toxic Diatom Aldehydes in the Sea Urchin Paracentrotus lividus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STRESS-PROTEINS; EXPRESSION; RESPONSES; EMBRYOS; GROWTH; GENE; METALLOTHIONEIN; INDUCTION	Many diatom species produce polyunsaturated aldehydes, such as decadienal, which compromise embryonic and larval development in benthic organisms. Here newly fertilized Paracentrotus lividus sea urchins were exposed to low concentration of decadienal and the expression levels of sixteen genes, implicated in a broad range of functional responses, were followed by Real Time qPCR in order to identify potential decadienal targets. We show that at low decadienal concentrations the sea urchin Paracentrotus lividus places in motion different classes of genes to defend itself against this toxic aldehyde, activating hsp60 and two proteases, hat and BP10, at the blastula stage and hsp56 and several other genes (14-3-3 epsilon, p38 MAPK, MTase, and GS) at the prism stage. At this latter stage all genes involved in skeletogenesis (Nec, uni, SM50 and SM30) were also down-expressed, following developmental abnormalities that mainly affected skeleton morphogenesis. Moreover, sea urchin embryos treated with increasing concentrations of decadienal revealed a dose-dependent response of activated target genes. Finally, we suggest that this orchestrated defense system against decadienal represents part of the chemical defensome of P. lividus affording protection from environmental toxicants.	[Marrone, Vincenzo; Palumbo, Anna; Costantini, Maria] Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy; [Piscopo, Marina] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli	Marrone, V (corresponding author), Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy.	maria.costantini@szn.it	Ianora, Adrianna/O-3408-2019; Romano, Giovanna/F-4561-2015; Costantini, Maria/AGH-4080-2022; PISCOPO, MARINA/AAU-5505-2020	Romano, Giovanna/0000-0002-4898-7153; PISCOPO, MARINA/0000-0003-0560-6952; Palumbo, Anna/0000-0002-5972-5589	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	Funding for this work was provided by the Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluigi MG, 2010, ECOTOXICOLOGY, V19, P520, DOI 10.1007/s10646-009-0433-z; BAUMAN JW, 1993, FUND APPL TOXICOL, V21, P15, DOI 10.1006/faat.1993.1066; Bonaventura R, 2005, BIOCHEM BIOPH RES CO, V328, P150, DOI 10.1016/j.bbrc.2004.12.161; Bonaventura R, 2011, CELL STRESS CHAPERON, V16, P681, DOI 10.1007/s12192-011-0277-3; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Costa C, 2010, MOL DIVERS, V14, P653, DOI 10.1007/s11030-009-9203-3; Cruz-Rodriguez LA, 2002, AQUAT TOXICOL, V60, P157, DOI 10.1016/S0166-445X(02)00008-5; da Silva GFZ, 2006, J BIOL CHEM, V281, P10737, DOI 10.1074/jbc.M510707200; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Geraci F, 2004, BIOCHEM BIOPH RES CO, V322, P873, DOI 10.1016/j.bbrc.2004.08.005; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hallare AV, 2004, CHEMOSPHERE, V56, P659, DOI 10.1016/j.chemosphere.2004.04.007; Horiguchi T, 2010, ECOTOXICOLOGY, V19, P571, DOI 10.1007/s10646-009-0447-6; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Kiyomoto M, 2010, ECOTOXICOLOGY, V19, P563, DOI 10.1007/s10646-009-0452-9; Kobayashi N, 2005, CHEMOSPHERE, V61, P1198, DOI 10.1016/j.chemosphere.2005.02.071; Kodama K, 2010, ECOTOXICOLOGY, V19, P479, DOI 10.1007/s10646-009-0438-7; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LEPAGE T, 1992, DEV BIOL, V150, P23, DOI 10.1016/0012-1606(92)90004-Z; Lhomond G, 1996, EUR J BIOCHEM, V238, P744, DOI 10.1111/j.1432-1033.1996.0744w.x; Matranga V, 2006, MAR BIOL, V149, P25, DOI 10.1007/s00227-005-0212-1; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Matranga V, 2010, ECOTOXICOLOGY, V19, P530, DOI 10.1007/s10646-009-0444-9; NEMER M, 1991, DEV BIOL, V145, P255, DOI 10.1016/0012-1606(91)90124-L; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinsino A, 2008, CELL BIOL TOXICOL, V24, P541, DOI 10.1007/s10565-008-9055-0; Pinsino A, 2011, TOXICOL SCI, V123, P217, DOI 10.1093/toxsci/kfr152; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Roccheri MC, 2004, BIOCHEM BIOPH RES CO, V321, P80, DOI 10.1016/j.bbrc.2004.06.108; Roccheri MC, 2001, BIOCHEM BIOPH RES CO, V287, P1093, DOI 10.1006/bbrc.2001.5503; Romano G, 2011, PLOS ONE, V10; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Romanucci M, 2008, CELL STRESS CHAPERON, V13, P253, DOI 10.1007/s12192-008-0030-8; Russo R, 2003, CELL STRESS CHAPERON, V8, P232, DOI 10.1379/1466-1268(2003)008<0232:STCMBM>2.0.CO;2; Russo R, 2010, CELL STRESS CHAPERON, V15, P993, DOI 10.1007/s12192-010-0210-1; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sugni M, 2010, ECOTOXICOLOGY, V19, P538, DOI 10.1007/s10646-009-0439-6; Teixeira J, 2009, PLANT PHYSIOL BIOCH, V47, P807, DOI 10.1016/j.plaphy.2009.05.002; Tominaga H, 2010, ECOTOXICOLOGY, V19, P577, DOI 10.1007/s10646-010-0462-7; Zito F, 2003, DEV BIOL, V264, P217, DOI 10.1016/j.ydbio.2003.07.015	51	38	39	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31750	10.1371/journal.pone.0031750	http://dx.doi.org/10.1371/journal.pone.0031750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363721	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500084
J	Juric, V; Chen, CC; Lau, LF				Juric, Vladislava; Chen, Chih-Chiun; Lau, Lester F.			TNF alpha-Induced Apoptosis Enabled by CCN1/CYR61: Pathways of Reactive Oxygen Species Generation and Cytochrome c Release	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; TISSUE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; MEDIATED APOPTOSIS; JNK ACTIVATION; LRP; KINASE; P53; BAX; PROLIFERATION	Although TNF alpha is a strong inducer of apoptosis, its cytotoxicity in most normal cells in vitro requires blockade of NF kappa B signaling or inhibition of de novo protein synthesis, typically by the addition of cycloheximide. However, several members of CCN (CYR61/CTGF/NOV) family of extracellular matrix proteins enable TNF alpha-dependent apoptosis in vitro without inhibiting NF kappa B or de novo protein synthesis, and CCN1 (CYR61) is essential for optimal TNF alpha cytotoxicity in vivo. Previous studies showed that CCN1 unmasks the cytotoxicity of TNF alpha by binding integrins alpha(v)beta(5), alpha(6)beta(1), and the cell surface heparan sulfate proteoglycan syndecan 4 to induce the accumulation of a high level of reactive oxygen species (ROS), leading to a biphasic activation of JNK necessary for apoptosis. Here we show for the first time that CCN1 interacts with the low density lipoprotein receptor-related protein 1 (LRP1) in a protein complex, and that binding to LRP1 is critical for CCN1-induced ROS generation and apoptotic synergism with TNF alpha. We also found that neutral sphingomyelinase 1 (nSMase1), which contributes to CCN1-induced ROS generation, is required for CCN1/TNF alpha-induced apoptosis. Furthermore, CCN1 promotes the activation of p53 and p38 MAPK, which mediate enhanced cytochrome c release to amplify the cytotoxicity of TNF alpha. By contrast, LRP1, nSMase1, p53, and p38 MAPK are not required when TNF alpha-dependent apoptosis is facilitated by the presence of cycloheximide, indicating that they function in the CCN1 signaling pathway that converges with TNF alpha-induced signaling events. Since CCN1/CYR61 is a physiological regulator of TNF alpha cytotoxicity at least in some contexts, these findings may reveal important mediators of TNF alpha-induced apoptosis in vivo and identify potential therapeutic targets for thwarting TNF alpha-dependent tissue damage.	[Juric, Vladislava; Chen, Chih-Chiun; Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Juric, V (corresponding author), Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA.	lflau@uic.edu		Lau, Lester/0000-0002-4364-2914	National Institutes of Health [GM78492, HL81390]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM78492 and HL81390 from the National Institutes of Health (http://www.nih.gov/) to LFL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2011, ADV EXP MED BIOL, V691, P595, DOI 10.1007/978-1-4419-6612-4_63; Chen CC, 2010, J CELL COMMUN SIGNAL, V4, P63, DOI 10.1007/s12079-009-0080-4; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Lubel JS, 2007, INTERN MED J, V37, P705, DOI 10.1111/j.1445-5994.2007.01479.x; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Tokushige K, 2000, AM J GASTROENTEROL, V95, P2040; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Valladares A, 2000, ENDOCRINOLOGY, V141, P4383, DOI 10.1210/en.141.12.4383; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2010, MUCOSAL IMMUNOL, V3, P523, DOI 10.1038/mi.2010.35; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	57	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31303	10.1371/journal.pone.0031303	http://dx.doi.org/10.1371/journal.pone.0031303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363611	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600137
J	Kathiria, AS; Butcher, LD; Feagins, LA; Souza, RF; Boland, CR; Theiss, AL				Kathiria, Arwa S.; Butcher, Lindsay D.; Feagins, Linda A.; Souza, Rhonda F.; Boland, C. Richard; Theiss, Arianne L.			Prohibitin 1 Modulates Mitochondrial Stress-Related Autophagy in Human Colonic Epithelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; OXIDATIVE STRESS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; RESPIRATORY-CHAIN; IN-VITRO	Introduction: Autophagy is an adaptive response to extracellular and intracellular stress by which cytoplasmic components and organelles, including damaged mitochondria, are degraded to promote cell survival and restore cell homeostasis. Certain genes involved in autophagy confer susceptibility to Crohn's disease. Reactive oxygen species and pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF alpha), both of which are increased during active inflammatory bowel disease, promote cellular injury and autophagy via mitochondrial damage. Prohibitin (PHB), which plays a role in maintaining normal mitochondrial respiratory function, is decreased during active inflammatory bowel disease. Restoration of colonic epithelial PHB expression protects mice from experimental colitis and combats oxidative stress. In this study, we investigated the potential role of PHB in modulating mitochondrial stress-related autophagy in intestinal epithelial cells. Methods: We measured autophagy activation in response to knockdown of PHB expression by RNA interference in Caco2-BBE and HCT116 WT and p53 null cells. The effect of exogenous PHB expression on TNF alpha- and IFN gamma-induced autophagy was assessed. Autophagy was inhibited using Bafilomycin A(1) or siATG16L1 during PHB knockdown and the affect on intracellular oxidative stress, mitochondrial membrane potential, and cell viability were determined. The requirement of intracellular ROS in siPHB-induced autophagy was assessed using the ROS scavenger N-acetyl-L-cysteine. Results: TNFa and IFN gamma-induced autophagy inversely correlated with PHB protein expression. Exogenous PHB expression reduced basal autophagy and TNF alpha-induced autophagy. Gene silencing of PHB in epithelial cells induces mitochondrial autophagy via increased intracellular ROS. Inhibition of autophagy during PHB knockdown exacerbates mitochondrial depolarization and reduces cell viability. Conclusions: Decreased PHB levels coupled with dysfunctional autophagy renders intestinal epithelial cells susceptible to mitochondrial damage and cytotoxicity. Repletion of PHB may represent a therapeutic approach to combat oxidant and cytokine-induced mitochondrial damage in diseases such as inflammatory bowel disease.	[Kathiria, Arwa S.; Butcher, Lindsay D.; Boland, C. Richard; Theiss, Arianne L.] Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Baylor Res Inst, Dallas, TX USA; [Butcher, Lindsay D.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Feagins, Linda A.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dept Med, Vet Affairs N Texas Hlth Care Syst, Dallas, TX 75390 USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Kathiria, AS (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Baylor Res Inst, Dallas, TX USA.	arianne.theiss@baylorhealth.edu		Theiss, Arianne/0000-0003-2862-0933; Feagins, Linda/0000-0001-7758-3257	National Institutes of Health [K01-DK085222]; Baylor Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant K01-DK085222 (A.L.T.) and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beau I, 2011, INT J BIOCHEM CELL B, V43, P460, DOI 10.1016/j.biocel.2011.01.006; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chang YP, 2011, MICROBES INFECT, V13, P888, DOI 10.1016/j.micinf.2011.05.008; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Du G, 1998, FREE RADICAL BIO MED, V25, P1066, DOI 10.1016/S0891-5849(98)00148-8; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Galluzzi L, 2011, ANTIOXID REDOX SIGNA; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; Henschke P, 2006, PROTEOMICS, V6, P1957, DOI 10.1002/pmic.200500245; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; JUPE ER, 1995, EXP CELL RES, V218, P577, DOI 10.1006/excr.1995.1194; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lapaquette P, 2010, J CLIN GASTROENTEROL, V44, pS26, DOI 10.1097/MCG.0b013e3181dd4fa5; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Lin-Lee YC, 2001, BIOCHEM PHARMACOL, V61, P555, DOI 10.1016/S0006-2952(00)00592-X; Liu XH, 2009, CELL STRESS CHAPERON, V14, P311, DOI 10.1007/s12192-008-0086-5; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; McKenzie SJ, 1996, J CLIN INVEST, V98, P136, DOI 10.1172/JCI118757; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; OMORAIN C, 1985, SCAND J GASTROENTERO, V20, P209, DOI 10.3109/00365528509089659; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roda G, 2010, WORLD J GASTROENTERO, V16, P4264, DOI 10.3748/wjg.v16.i34.4264; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Sasnauskiene A, 2009, APOPTOSIS, V14, P276, DOI 10.1007/s10495-008-0292-8; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; SHIRATORA Y, 1989, DIGESTION, V44, P163, DOI 10.1159/000199906; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2011, INFLAMM BOWEL DIS, V17, P1163, DOI 10.1002/ibd.21469; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Umeno J, 2011, INFLAMM BOWEL DIS; Vanderborght M, 2004, J PEDIATR GASTR NUTR, V38, P355, DOI 10.1097/00005176-200403000-00023; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006	62	53	55	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31231	10.1371/journal.pone.0031231	http://dx.doi.org/10.1371/journal.pone.0031231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363587	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600126
J	Yu, J; Liang, QY; Wang, J; Cheng, Y; Wang, S; Poon, TCW; Go, MYY; Tao, Q; Chang, Z; Sung, JJY				Yu, J.; Liang, Q. Y.; Wang, J.; Cheng, Y.; Wang, S.; Poon, T. C. W.; Go, M. Y. Y.; Tao, Q.; Chang, Z.; Sung, J. J. Y.			Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer	ONCOGENE			English	Article						Zinc-finger protein 331 (ZNF331); gastric cancer; tumor suppressor; methylation; invasion; 2-D gel electrophoresis	HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; CPG ISLAND METHYLATION; ZINC-FINGER PROTEINS; DEAD-BOX PROTEINS; POTENTIAL TARGET; CELL-GROWTH; GENE; REPRESSION; HPNPASE(OLD-35); INVOLVEMENT	Zinc-finger protein 331 (ZNF331), a Kruppel-associated box zinc-finger protein gene, was identified as a putative tumor suppressor in our previous study. However, the role of ZNF331 in tumorigenesis remains elusive. We aimed to clarify its epigenetic regulation and biological functions in gastric cancer. ZNF331 was silenced or downregulated in 71% (12/17) gastric cancer cell lines. A significant downregulation was also detected in paired gastric tumors compared with adjacent non-cancer tissues. In contrast, ZNF331 was readily expressed in various normal adult tissues. The downregulation of ZNF331 was closely linked to the promoter hypermethylation as evidenced by methylation-specific PCR, bisulfite genomic sequencing and reexpression by demethylation agent treatment. DNA sequencing showed no genetic mutation/deletion of ZNF331 in gastric cancer cell lines. Ectopic expression of ZNF331 in the silenced cancer cell lines MKN28 and HCT116 significantly reduced colony formation and cell viability, induced cell cycle arrests and repressed cell migration and invasive ability. Concordantly, knockdown of ZNF331 increased cell viability and colony formation ability of gastric cancer cell line MKN45. Two-dimensional gel electrophoresis and mass spectrometry-based comparative proteomic approach were applied to analyze the molecular basis of the biological functions of ZNF331. In all, 10 downstream targets of ZNF331 were identified to be associated with regulation of cell growth and metastasis. The tumor-suppressive effect of ZNF331 is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1). A novel target of ZNF331 (DSTN) was functionally validated. Overexpression of DSTN in BGC-823 cells increased colony formation and migration ability. In conclusion, our results suggest that ZNF331 possesses important functions for the suppression of gastric carcinogenesis as a novel functional tumor-suppressor gene. Oncogene (2013) 32, 307-317; doi:10.1038/onc.2012.54; published online 27 February 2012	[Yu, J.; Liang, Q. Y.; Wang, J.; Wang, S.; Poon, T. C. W.; Go, M. Y. Y.; Sung, J. J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Cheng, Y.; Tao, Q.] Chinese Univ Hong Kong, Dept Clin Oncol, Canc Epigenet Lab, Shatin, Hong Kong, Peoples R China; [Chang, Z.] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Natl Engn Lab Antitumor Therapeut, Sch Med, Beijing 100084, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Tsinghua University	Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk; jjysung@cuhk.edu.hk	Yu, Jun/D-8569-2015; Sung, Joseph J. Y./R-3203-2018; Cheng, Yingduan/J-5507-2015; Liang, Qiaoyi Jessie/G-9612-2019; WANG, JIA/A-2799-2019; Chang, Zhijie/AAH-8109-2019; Tao, Qian/T-4743-2018	Yu, Jun/0000-0001-5008-2153; Sung, Joseph J. Y./0000-0003-3125-5199; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Tao, Qian/0000-0001-5383-4808; WANG, JIA/0000-0001-5339-8954	National Basic Research Program of China (973 Program) [2010CB529305]; Research Grants Council RGC CERG CUHK [473008]; CUHK Focused Investment Grant [1903026]; RFCID [10090942, 11100022]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Research Grants Council RGC CERG CUHK; CUHK Focused Investment Grant; RFCID	This project was supported by the National Basic Research Program of China (973 Program, 2010CB529305), Research Grants Council RGC CERG CUHK (473008), CUHK Focused Investment Grant (1903026) and RFCID (10090942, 11100022).	Anazawa Y, 2005, CANCER RES, V65, P4578, DOI 10.1158/0008-5472.CAN-04-4564; Choi YJ, 2012, J CELL BIOCHEM, V113, P985, DOI 10.1002/jcb.23428; Estornes Y, 2007, INT J CANCER, V121, P2162, DOI 10.1002/ijc.22911; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fredericks WJ, 2000, MOL CELL BIOL, V20, P5019, DOI 10.1128/MCB.20.14.5019-5031.2000; Freist W, 1996, BIOL CHEM H-S, V377, P343; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jasiulionis MG, 2007, CELL BIOCHEM FUNCT, V25, P109, DOI 10.1002/cbf.1351; Kaneko SJ, 2003, GYNECOL ONCOL, V90, P29, DOI 10.1016/S0090-8258(03)00144-6; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee JH, 2004, ONCOGENE, V23, P4646, DOI 10.1038/sj.onc.1207588; Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699; Leung SY, 2006, MODERN PATHOL, V19, P854, DOI 10.1038/modpathol.3800593; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Meiboom M, 2003, CYTOGENET GENOME RES, V101, P113, DOI 10.1159/000074165; Ohashi Y, 2004, GYNECOL ONCOL, V93, P54, DOI 10.1016/j.ygyno.2004.01.019; Otsubo T, 2004, MODERN PATHOL, V17, P461, DOI 10.1038/modpathol.3800062; PENNACCHIO LA, 1995, GENE, V155, P207, DOI 10.1016/0378-1119(94)00683-J; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Rippe V, 1999, GENE CHROMOSOME CANC, V26, P229, DOI 10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.0.CO;2-J; Sarkar D, 2005, MOL CELL BIOL, V25, P7333, DOI 10.1128/MCB.25.16.7333-7343.2005; Sarkar D, 2003, J BIOL CHEM, V278, P24542, DOI 10.1074/jbc.M302421200; Sohn JH, 2010, MOL CANCER RES, V8, P246, DOI 10.1158/1541-7786.MCR-09-0141; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wu H, 2001, BBA-GENE STRUCT EXPR, V1518, P190, DOI 10.1016/S0167-4781(01)00172-5; Yu J, 2002, BRIT J CANCER, V87, P91, DOI 10.1038/sj.bjc.6600421	35	56	61	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					307	317		10.1038/onc.2012.54	http://dx.doi.org/10.1038/onc.2012.54			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22370639				2022-12-25	WOS:000314736600005
J	Timofeeva, OA; Chasovskikh, S; Lonskaya, I; Tarasova, NI; Khavrutskii, L; Tarasov, SG; Zhang, XP; Korostyshevskiy, VR; Cheema, A; Zhang, LH; Dakshanamurthy, S; Brown, ML; Dritschilo, A				Timofeeva, Olga A.; Chasovskikh, Sergey; Lonskaya, Irina; Tarasova, Nadya I.; Khavrutskii, Lyuba; Tarasov, Sergey G.; Zhang, Xueping; Korostyshevskiy, Valeriy R.; Cheema, Amrita; Zhang, Lihua; Dakshanamurthy, Sivanesan; Brown, Milton L.; Dritschilo, Anatoly			Mechanisms of Unphosphorylated STAT3 Transcription actor Binding to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRUCIFORM STRUCTURES; PROTEINS; GENE; EXPRESSION; IDENTIFICATION; SPECIFICITY; RECOGNITION; ACTIVATORS; ELEMENTS; DOMAINS	Phosphorylation of signal transducer and activator of transcription 3 (STAT3) on a single tyrosine residue in response to growth factors, cytokines, interferons, and oncogenes activates its dimerization, translocation to the nucleus, binding to the interferon gamma (gamma)-activated sequence (GAS) DNA-binding site and activation of transcription of target genes. STAT3 is constitutively phosphorylated in various cancers and drives gene expression from GAS-containing promoters to promote tumorigenesis. Recently, roles for unphosphorylated STAT3 (U-STAT3) have been described in response to cytokine stimulation, in cancers, and in maintenance of heterochromatin stability. However, the mechanisms underlying U-STAT3 binding to DNA has not been fully investigated. Here, we explore STAT3-DNA interactions by atomic force microscopy (AFM) imaging. We observed that U-STAT3 molecules bind to the GAS DNA-binding site as dimers and monomers. In addition, we observed that U-STAT3 binds to AT-rich DNA sequence sites and recognizes specific DNA structures, such as 4-way junctions and DNA nodes, within negatively supercoiled plasmid DNA. These structures are important for chromatin organization and our data suggest a role for U-STAT3 as a chromatin/genome organizer. Unexpectedly, we found that a C-terminal truncated 67.5-kDa STAT3 isoform recognizes single-stranded spacers within cruciform structures that also have a role in chromatin organization and gene expression. This isoform appears to be abundant in the nuclei of cancer cells and, therefore, may have a role in regulation of gene expression. Taken together, our data highlight novel mechanisms by which U-STAT3 binds to DNA and supports U-STAT3 function as a transcriptional activator and a chromatin/genomic organizer.	[Timofeeva, Olga A.; Zhang, Xueping; Cheema, Amrita; Zhang, Lihua; Dakshanamurthy, Sivanesan; Brown, Milton L.; Dritschilo, Anatoly] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA; [Timofeeva, Olga A.; Chasovskikh, Sergey; Zhang, Xueping; Dritschilo, Anatoly] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20057 USA; [Lonskaya, Irina; Brown, Milton L.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Korostyshevskiy, Valeriy R.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20057 USA; [Brown, Milton L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Drug Discovery Program, Washington, DC 20057 USA; [Tarasova, Nadya I.; Khavrutskii, Lyuba] NCI Frederick, Canc & Inflammat Program, Frederick, MD 21702 USA; [Tarasova, Nadya I.] NCI Frederick, Struct Biophys Lab, Biophys Resource Core, Frederick, MD 21702 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Timofeeva, OA (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Res Bldg,R E216,3970 Reservoir Rd NW, Washington, DC 20057 USA.	oat@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022; Korostyshevskiy, Valeriy R./O-5341-2019	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Tarasova, Nadya/0000-0002-4949-0069; Korostyshevskiy, Valeriy/0000-0001-7888-8626	National Institutes of Health [CA56036-08]; American Cancer Society [IRG 97-152-17]; National Institutes of Health of the NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA056036, ZIABC011306, ZICBC010965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institutes of Health of the NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant CA56036-08, American Cancer Society Grant IRG 97-152-17 (to O. T.) and by the National Institutes of Health Intramural Research Program of the NCI Center for Cancer Research.	Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen B, 2010, BIOCHEMISTRY-US, V49, P1590, DOI 10.1021/bi901881c; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Christova R, 2007, J CELL SCI, V120, P3262, DOI 10.1242/jcs.012328; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Hevehan DL, 2002, BLOOD, V99, P1627, DOI 10.1182/blood.V99.5.1627; Humphrey-Dixon EL, 2011, GENOME, V54, P934, DOI [10.1139/g11-058, 10.1139/G11-058]; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; LeBlanc JF, 1998, BIOCHEMISTRY-US, V37, P6015, DOI 10.1021/bi9730792; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P372, DOI 10.1093/nar/30.1.372; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P3433, DOI 10.1093/nar/gkf446; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lobov IB, 2001, J CELL BIOCHEM, V83, P218, DOI 10.1002/jcb.1220; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lu L, 2007, FUNCT INTEGR GENOMIC, V7, P221, DOI 10.1007/s10142-007-0047-6; MOREAU J, 1982, NATURE, V295, P260, DOI 10.1038/295260a0; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; OOSUMI T, 1995, P NATL ACAD SCI USA, V92, P8886, DOI 10.1073/pnas.92.19.8886; Oussatcheva EA, 1999, J MOL BIOL, V292, P75, DOI 10.1006/jmbi.1999.3043; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos Haydee L, 2007, Biochem J, V404, pe1; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Timofeeva OA, 2007, ACS CHEM BIOL, V2, P799, DOI 10.1021/cb700186x; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	53	95	101	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14192	14200		10.1074/jbc.M111.323899	http://dx.doi.org/10.1074/jbc.M111.323899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378781	Green Published, hybrid			2022-12-25	WOS:000303996300071
J	Mouledous, L; Froment, C; Dauvillier, S; Burlet-Schiltz, O; Zajac, JM; Mollereau, C				Mouledous, Lionel; Froment, Carine; Dauvillier, Stephanie; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine			GRK2 Protein-mediated Transphosphorylation Contributes to Loss of Function of mu-Opioid Receptors Induced by Neuropeptide FF (NPFF2) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; CONDITIONED PLACE PREFERENCE; SH-SY5Y NEUROBLASTOMA-CELLS; COUPLED RECEPTORS; BETA-ARRESTINS; PHOSPHORYLATION; DESENSITIZATION; MORPHINE; AGONIST; MECHANISMS	Neuropeptide FF (NPFF) interacts with specific receptors to modulate opioid functions in the central nervous system. On dissociated neurons and neuroblastoma cells (SH-SY5Y) transfected with NPFF receptors, NPFF acts as a functional antagonist of mu-opioid (MOP) receptors by attenuating the opioid-induced inhibition of calcium conductance. In the SH-SY5Y model, MOP and NPFF2 receptors have been shown to heteromerize. To understand the molecular mechanism involved in the anti-opioid activity of NPFF, we have investigated the phosphorylation status of the MOP receptor using phospho-specific antibody and mass spectrometry. Similarly to direct opioid receptor stimulation, activation of the NPFF2 receptor by [D-Tyr-1-(NMe)Phe-3]NPFF (1DMe), an analog of NPFF, induced the phosphorylation of Ser-377 of the human MOP receptor. This heterologous phosphorylation was unaffected by inhibition of second messenger-dependent kinases and, contrarily to homologous phosphorylation, was prevented by inactivation of G(i/o) proteins by pertussis toxin. Using siRNA knockdown we could demonstrate that 1DMe-induced Ser-377 cross-phosphorylation and MOP receptor loss of function were mediated by the G protein receptor kinase GRK2. In addition, mass spectrometric analysis revealed that the phosphorylation pattern of MOP receptors was qualitatively similar after treatment with the MOP agonist Tyr-D-Ala-Gly (NMe)-Phe-Gly-ol (DAMGO) or after treatment with the NPFF agonist 1DMe, but the level of multiple phosphorylation was more intense after DAMGO. Finally, NPFF2 receptor activation was sufficient to recruit beta-arrestin2 to the MOP receptor but not to induce its internalization. These data show that NPFF-induced heterologous desensitization of MOP receptor signaling is mediated by GRK2 and could involve transphosphorylation within the heteromeric receptor complex.	[Mouledous, Lionel; Froment, Carine; Dauvillier, Stephanie; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mouledous, L (corresponding author), Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	lionel.mouledous@ipbs.fr; catherine.mollereau-manaute@ipbs.fr	Zajac, jean-marie/E-5129-2010	Mouledous, Lionel/0000-0002-7675-3493; Mollereau, Catherine/0000-0003-1543-5624; Schiltz, Odile/0000-0002-3606-2356	French Agence Nationale de la Recherche [ANR-09-PIRI-0008-01, piribio09_445026]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherche Grant ANR-09-PIRI-0008-01, piribio09_445026.	Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Chu J, 2008, CELL SIGNAL, V20, P1616, DOI 10.1016/j.cellsig.2008.05.004; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Doll C, 2011, BRIT J PHARMACOL, V164, P298, DOI 10.1111/j.1476-5381.2011.01382.x; DUPOUY V, 1995, REGUL PEPTIDES, V59, P349, DOI 10.1016/0167-0115(95)00091-O; Dupouy V, 1997, EUR J PHARMACOL, V330, P129, DOI 10.1016/S0014-2999(97)01017-0; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Elhabazi K, 2012, BRIT J PHARMACOL, V165, P424, DOI 10.1111/j.1476-5381.2011.01563.x; Estes AM, 2011, AMINO ACIDS, V40, P371, DOI 10.1007/s00726-010-0642-z; Evans RM, 2010, J BIOL CHEM, V285, P1032, DOI 10.1074/jbc.M109.040634; Feng B, 2011, MOL PHARMACOL, V79, P768, DOI 10.1124/mol.110.069096; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; GICQUEL S, 1992, EUR J PHARMACOL, V222, P61, DOI 10.1016/0014-2999(92)90463-E; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kersante F, 2010, NEUROCHEM INT, V56, P768, DOI 10.1016/j.neuint.2010.02.014; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kotlinska J, 2007, PEPTIDES, V28, P2235, DOI 10.1016/j.peptides.2007.08.006; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Marchand S, 2006, PEPTIDES, V27, P964, DOI 10.1016/j.peptides.2005.07.023; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; Mouledous L, 2010, SYNAPSE, V64, P672, DOI 10.1002/syn.20774; Mouton-Barbosa E, 2010, MOL CELL PROTEOMICS, V9, P1006, DOI 10.1074/mcp.M900513-MCP200; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Ozsoy HZ, 2005, MOL PHARMACOL, V68, P447, DOI 10.1124/mol.105.011536; Pak Y, 1997, J BIOL CHEM, V272, P24961, DOI 10.1074/jbc.272.40.24961; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Pao Christina S, 2002, Sci STKE, V2002, ppe42, DOI 10.1126/stke.2002.153.pe42; Parker SL, 2007, REGUL PEPTIDES, V144, P72, DOI 10.1016/j.regpep.2007.06.004; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Roumy M, 2007, J BIOL CHEM, V282, P8332, DOI 10.1074/jbc.M606946200; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Talmont F, 2009, NEUROCHEM INT, V55, P815, DOI 10.1016/j.neuint.2009.08.004; Tan M, 2009, J BIOL CHEM, V284, P6270, DOI 10.1074/jbc.M806742200; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Yang HYT, 2008, NEUROPEPTIDES, V42, P1, DOI 10.1016/j.npep.2007.06.004; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zajac JM, 2001, TRENDS PHARMACOL SCI, V22, P63, DOI 10.1016/S0165-6147(00)01610-2; Zheng H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177089	72	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12736	12749		10.1074/jbc.M111.314617	http://dx.doi.org/10.1074/jbc.M111.314617			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375000	Green Published, hybrid			2022-12-25	WOS:000302903700013
J	Smith, CA; Toth, M; Frase, H; Byrnes, LJ; Vakulenko, SB				Smith, Clyde A.; Toth, Marta; Frase, Hilary; Byrnes, Laura J.; Vakulenko, Sergei B.			Aminoglycoside 2 ''-Phosphotransferase IIIa (APH(2 '')-IIIa) Prefers GTP over ATP STRUCTURAL TEMPLATES FOR NUCLEOTIDE RECOGNITION IN THE BACTERIAL AMINOGLYCOSIDE-2 '' KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; PHOSPHORYL TRANSFER; ACTIVE-SITE; INHIBITORS; ANTIBIOTICS; COMPLEXES; MECHANISM; SUBSTRATE; BINDING	Contrary to the accepted dogma that ATP is the canonical phosphate donor in aminoglycoside kinases and protein kinases, it was recently demonstrated that all members of the bacterial aminoglycoside 2 ''-phosphotransferase IIIa (APH(2 '')) aminoglycoside kinase family are unique in their ability to utilize GTP as a cofactor for antibiotic modification. Here we describe the structural determinants for GTP recognition in these enzymes. The crystal structure of the GTP-dependent APH(2 '')-IIIa shows that although this enzyme has templates for both ATP and GTP binding superimposed on a single nucleotide specificity motif, access to the ATP-binding template is blocked by a bulky tyrosine residue. Substitution of this tyrosine by a smaller amino acid opens access to the ATP template. Similar GTP binding templates are conserved in other bacterial aminoglycoside kinases, whereas in the structurally related eukaryotic protein kinases this template is less conserved. The aminoglycoside kinases are important antibiotic resistance enzymes in bacteria, whose wide dissemination severely limits available therapeutic options, and the GTP binding templates could be exploited as new, previously unexplored targets for inhibitors of these clinically important enzymes.	[Smith, Clyde A.; Byrnes, Laura J.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Toth, Marta; Frase, Hilary; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Stanford University; University of Notre Dame	Smith, CA (corresponding author), 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu			National Institutes of Health [AI057393, 5 P41 RR001209]; Science Undergraduate Laboratory Internship program; Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research); National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Undergraduate Laboratory Internship program; Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research)(United States Department of Energy (DOE)); National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057393 (to S. B. V.) and 5 P41 RR001209 (Center for Research Resources).; Supported by the Science Undergraduate Laboratory Internship program.; Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research) and by the National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences).	Adams J, 2002, CURR OPIN CHEM BIOL, V6, P486, DOI 10.1016/S1367-5931(02)00357-5; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aimes RT, 2000, BIOCHEMISTRY-US, V39, P8325, DOI 10.1021/bi992800w; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Boehr DD, 2005, BIOCHEMISTRY-US, V44, P12445, DOI 10.1021/bi051085p; Boehr DD, 2001, J BIOL CHEM, V276, P23929, DOI 10.1074/jbc.M100540200; Bostrom SL, 2009, BIOCHEM BIOPH RES CO, V390, P1154, DOI 10.1016/j.bbrc.2009.10.107; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Byrnes LJ, 2008, ACTA CRYSTALLOGR F, V64, P126, DOI 10.1107/S1744309108001450; COZZONE AJ, 1993, J CELL BIOCHEM, V51, P7, DOI 10.1002/jcb.240510103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDSON RS, 1991, MAYO CLIN PROC, V66, P1158, DOI 10.1016/S0025-6196(12)65798-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Garcia-Echeverria C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO;2-U; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; Kim C, 2005, BIOORG CHEM, V33, P149, DOI 10.1016/j.bioorg.2004.11.001; Kim S, 2011, PROTEINS, V79, P2983, DOI 10.1002/prot.23119; KOCABIYIK S, 1992, BIOCHEM BIOPH RES CO, V185, P925, DOI 10.1016/0006-291X(92)91715-3; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lee HK, 2002, ANTIMICROB AGENTS CH, V46, P3253, DOI 10.1128/AAC.46.10.3253-3256.2002; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Shugar D, 1996, ACTA BIOCHIM POL, V43, P9; Smith Clyde A., 2002, Current Drug Targets - Infectious Disorders, V2, P143, DOI 10.2174/1568005023342533; Stogios PJ, 2011, J BIOL CHEM, V286, P1966, DOI 10.1074/jbc.M110.194266; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Traxler P, 1999, PHARMACOL THERAPEUT, V82, P195, DOI 10.1016/S0163-7258(98)00044-8; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Wirmer J, 2006, METHOD ENZYMOL, V415, P180, DOI 10.1016/S0076-6879(06)15012-0; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	57	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12893	12903		10.1074/jbc.M112.341206	http://dx.doi.org/10.1074/jbc.M112.341206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367198	Green Published, hybrid			2022-12-25	WOS:000302903700029
J	Mwai, L; Diriye, A; Masseno, V; Muriithi, S; Feltwell, T; Musyoki, J; Lemieux, J; Feller, A; Mair, GR; Marsh, K; Newbold, C; Nzila, A; Carret, CK				Mwai, Leah; Diriye, Abdi; Masseno, Victor; Muriithi, Steven; Feltwell, Theresa; Musyoki, Jennifer; Lemieux, Jacob; Feller, Avi; Mair, Gunnar R.; Marsh, Kevin; Newbold, Chris; Nzila, Alexis; Carret, Celine K.			Genome Wide Adaptations of Plasmodium falciparum in Response to Lumefantrine Selective Drug Pressure	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; PFMDR1 COPY NUMBER; VACUOLAR H+-ATPASE; MALARIA PARASITE; ARTEMETHER-LUMEFANTRINE; MEFLOQUINE RESISTANCE; ANTIMALARIAL-DRUGS; GENE-EXPRESSION; PLASMODIUM-FALCIPARUM-PFMDR1 ALLELES; SACCHAROMYCES-CEREVISIAE	The combination therapy of the Artemisinin-derivative Artemether (ART) with Lumefantrine (LM) (CoartemH) is an important malaria treatment regimen in many endemic countries. Resistance to Artemisinin has already been reported, and it is feared that LM resistance (LMR) could also evolve quickly. Therefore molecular markers which can be used to track CoartemH efficacy are urgently needed. Often, stable resistance arises from initial, unstable phenotypes that can be identified in vitro. Here we have used the Plasmodium falciparum multidrug resistant reference strain V1S to induce LMR in vitro by culturing the parasite under continuous drug pressure for 16 months. The initial IC50 (inhibitory concentration that kills 50% of the parasite population) was 24 nM. The resulting resistant strain V1S(LM), obtained after culture for an estimated 166 cycles under LM pressure, grew steadily in 378 nM of LM, corresponding to 15 times the IC50 of the parental strain. However, after two weeks of culturing V1SLM in drug-free medium, the IC50 returned to that of the initial, parental strain V1S. This transient drug tolerance was associated with major changes in gene expression profiles: using the PFSANGER Affymetrix custom array, we identified 184 differentially expressed genes in V1SLM. Among those are 18 known and putative transporters including the multidrug resistance gene 1 (pfmdr1), the multidrug resistance associated protein and the V-type H+ pumping pyrophosphatase 2 (pfvp2) as well as genes associated with fatty acid metabolism. In addition we detected a clear selective advantage provided by two genomic loci in parasites grown under LM drug pressure, suggesting that all, or some of those genes contribute to development of LM tolerance - they may prove useful as molecular markers to monitor P. falciparum LM susceptibility.	[Mwai, Leah; Diriye, Abdi; Masseno, Victor; Muriithi, Steven; Musyoki, Jennifer; Marsh, Kevin; Nzila, Alexis] Kenya Govt Med Res Ctr, Welcome Trust Res Programme, Kilifi, Kenya; [Mwai, Leah; Marsh, Kevin; Nzila, Alexis] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Feltwell, Theresa] Welcome Trust Sanger Inst, Pathogen Microarrays Grp, Cambridge, England; [Feller, Avi] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Lemieux, Jacob; Newbold, Chris] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Mair, Gunnar R.; Carret, Celine K.] Inst Mol Med, Mol Parasitol Unit, Lisbon, Portugal	Kenya Medical Research Institute; University of Oxford; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Universidade de Lisboa	Mwai, L (corresponding author), Kenya Govt Med Res Ctr, Welcome Trust Res Programme, Kilifi, Kenya.	ccarret@fm.ul.pt		Newbold, Chris/0000-0002-9274-3789; Feller, Avi/0000-0001-7319-5468; Mair, Gunnar/0000-0002-5187-3691	European and Developing Country Clinical Trial Partnership (EDCTP); KEMRI-Wellcome Trust; Portuguese FCT [PTDC_SAU-GMG_104392_2008, PTDC_BIA-BCM_105610_2008]; EDCTP	European and Developing Country Clinical Trial Partnership (EDCTP); KEMRI-Wellcome Trust(Wellcome Trust); Portuguese FCT(Portuguese Foundation for Science and Technology); EDCTP	This study was supported by the European and Developing Country Clinical Trial Partnership (EDCTP) and the KEMRI-Wellcome Trust Programme. LM is an EDCTP funded PhD student. GRM and CKC are supported by Portuguese FCT grants PTDC_SAU-GMG_104392_2008 and PTDC_BIA-BCM_105610_2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2000, CANCER RES, V60, P5761; Almagro-Garcia J, 2009, BIOINFORMATICS, V25, P2732, DOI 10.1093/bioinformatics/btp488; Biagini GA, 2003, TRENDS PARASITOL, V19, P479, DOI 10.1016/j.pt.2003.09.011; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Blackhall WJ, 1998, EXP PARASITOL, V90, P42, DOI 10.1006/expr.1998.4316; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Chakraborti PK, 1999, BIOSCIENCE REP, V19, P293, DOI 10.1023/A:1020598324663; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; CHEVLI R, 1982, ANTIMICROB AGENTS CH, V21, P581, DOI 10.1128/AAC.21.4.581; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2005, MOL MICROBIOL, V57, P874, DOI 10.1111/j.1365-2958.2005.04748.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; GEORGE RCS, 1984, BIOCHIM BIOPHYS ACTA, V803, P174, DOI 10.1016/0167-4889(84)90007-7; GINSBURG H, 1983, BIOCHIM BIOPHYS ACTA, V732, P316, DOI 10.1016/0005-2736(83)90219-5; GINSBURG H, 1984, CHEM PHYS LIPIDS, V35, P331, DOI 10.1016/0009-3084(84)90076-8; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACOBS GH, 1987, AM J TROP MED HYG, V36, P9, DOI 10.4269/ajtmh.1987.36.9; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Kokwaro G, 2007, EXPERT OPIN PHARMACO, V8, P75, DOI 10.1517/14656566.8.1.75; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Lemieux JE, 2009, P NATL ACAD SCI USA, V106, P7559, DOI 10.1073/pnas.0811829106; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; Marchesini N, 2005, J BIOL CHEM, V280, P36841, DOI 10.1074/jbc.M507727200; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; McIntosh MT, 2002, INT J PARASITOL, V32, P1, DOI 10.1016/S0020-7519(01)00325-3; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Myrick A, 2003, MOL MICROBIOL, V49, P671, DOI 10.1046/j.1365-2958.2003.03597.x; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nelson AL, 2005, AM J TROP MED HYG, V72, P586, DOI 10.4269/ajtmh.2005.72.586; Nzila A, 2003, ANTIMICROB AGENTS CH, V47, P2108, DOI 10.1128/AAC.47.7.2108-2112.2003; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; OLLIARO P, 1989, MICROBIOLOGICA, V12, P15; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; PEEL SA, 1993, AM J TROP MED HYG, V48, P385, DOI 10.4269/ajtmh.1993.48.385; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; Porcar I, 2003, J PHARM SCI, V92, P45, DOI 10.1002/jps.10254; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Schlitzer M, 2007, CHEMMEDCHEM, V2, P944, DOI 10.1002/cmdc.200600240; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; TANARIYA P, 1988, EXP PARASITOL, V67, P129, DOI 10.1016/0014-4894(88)90060-4; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uhlemann AC, 2007, J INFECT DIS, V195, P134, DOI 10.1086/509809; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	80	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31623	10.1371/journal.pone.0031623	http://dx.doi.org/10.1371/journal.pone.0031623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384044	Green Submitted, Green Published, gold			2022-12-25	WOS:000302918500031
J	Pan, HP; Li, XC; Ge, DQ; Wang, SL; Wu, QJ; Xie, W; Jiao, XG; Chu, D; Liu, BM; Xu, BY; Zhang, YJ				Pan, Huipeng; Li, Xianchun; Ge, Daqing; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Chu, Dong; Liu, Baiming; Xu, Baoyun; Zhang, Youjun			Factors Affecting Population Dynamics of Maternally Transmitted Endosymbionts in Bemisia tabaci	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PEA APHID; CYTOPLASMIC INCOMPATIBILITY; BACTERIAL ENDOSYMBIONTS; VERTICAL TRANSMISSION; FACULTATIVE SYMBIONTS; NATURAL-POPULATIONS; SECONDARY SYMBIONTS; INFECTION DENSITY; LOW-TEMPERATURES	While every individual of Bemisia tabaci (Hemiptera: Aleyrodidae) harbors the primary symbiont (P-symbiont) Portiera, the infection frequencies of the six secondary symbionts (S-symbionts) including Hamiltonella, Arsenophonus, Cardinium, Wolbachia, Rickettsia and Fritschea vary greatly among different populations. To characterize the factors influencing the infection dynamics of the six S-symbionts in B. tabaci, gene-specific PCR were conducted to screen for the presence of the P-symbiont Portiera and the six S-symbionts in 61 (17 B and 44 Q biotypes) field populations collected from different plant species and locations in China. All individuals of the 61 populations hosted the P-symbiont Portiera, but none of them harbored Arsenophonus and Fritschea. The presence and infection rates of Hamiltonella, Cardinium, Rickettsia, Wolbachia and their co-infections Rickettsia + Hamiltonella (RH), Rickettsia + Cardinium (RC), Hamiltonella + Cardinium (HC) and Rickettsia + Hamiltonella + Cardinium (RHC) varied significantly among the 61 field populations; and the observed variations can be explained by biotypes, sexes, host plants and geographical locations of these field populations. Taken together, at least three factors including biotype, host plant and geographical location affect the infection dynamics of S-symbionts in B. tabaci.	[Pan, Huipeng; Ge, Daqing; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Liu, Baiming; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Chu, Dong] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Arizona; University of Arizona; Shandong Academy of Agricultural Sciences	Pan, HP (corresponding author), Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	lxc@email.arizona.edu; zhangyj@mail.caas.net.cn	CHU, DONG/AAI-1892-2020; Zhang, Youjun/AAY-7948-2020; Chu, Dong/AAS-3914-2020	Zhang, Youjun/0000-0003-3508-6695; Chu, Dong/0000-0001-5716-4979	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2009 CB119200]; National Natural Science Foundation of China [30900153]; Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	This study was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2009 CB119200), the National Natural Science Foundation of China (No. 30900153), and the Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2009, J APPL ENTOMOL, V133, P733, DOI 10.1111/j.1439-0418.2009.01442.x; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Goto S, 2006, APPL ENVIRON MICROB, V72, P4805, DOI 10.1128/AEM.00416-06; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Majerus TMO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000987; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilkinson TL, 2001, J EXP BIOL, V204, P3027; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	51	74	86	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30760	10.1371/journal.pone.0030760	http://dx.doi.org/10.1371/journal.pone.0030760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383972	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916100005
J	Tsujimoto, H; Kotsyfakis, M; Francischetti, IMB; Eum, JH; Strand, MR; Champagne, DE				Tsujimoto, Hitoshi; Kotsyfakis, Michail; Francischetti, Ivo M. B.; Eum, Jai Hoon; Strand, Michael R.; Champagne, Donald E.			Simukunin from the Salivary Glands of the Black Fly Simulium vittatum Inhibits Enzymes That Regulate Clotting and Inflammatory Responses	PLOS ONE			English	Article							NEUTROPHIL SERINE PROTEASES; ALPHA-TRYPSIN INHIBITOR; FACTOR-XA; STRUCTURAL-CHARACTERIZATION; PROTEINASE-INHIBITOR; THROMBIN INHIBITOR; FLIES DIPTERA; TICK; ANTICOAGULANT; IXOLARIS	Background: Black flies (Diptera: Simuliidae) feed on blood, and are important vectors of Onchocerca volvulus, the etiolytic agent of River Blindness. Blood feeding depends on pharmacological properties of saliva, including anticoagulation, but the molecules responsible for this activity have not been well characterized. Methodology/Principal Findings: Two Kunitz family proteins, SV-66 and SV-170, were identified in the sialome of the black fly Simulium vittatum. As Kunitz proteins are inhibitors of serine proteases, we hypothesized that SV-66 and/or 2170 were involved in the anticoagulant activity of black fly saliva. Our results indicated that recombinant (r) SV-66 but not rSV-170 inhibited plasma coagulation. Mutational analysis suggested that SV-66 is a canonical BPTI-like inhibitor. Functional assays indicated that rSV66 reduced the activity of ten serine proteases, including several involved in mammalian coagulation. rSV66 most strongly inhibited the activity of Factor Xa, elastase, and cathepsin G, exhibited lesser inhibitory activity against Factor IXa, Factor XIa, and plasmin, and exhibited no activity against Factor XIIa and thrombin. Surface plasmon resonance studies indicated that rSV-66 bound with highest affinity to elastase (K-D = 0.4 nM) and to the active site of FXa (K-D = 3.07 nM). We propose the name "Simukunin" for this novel protein. Conclusions: We conclude that Simukunin preferentially inhibits Factor Xa. The inhibition of elastase and cathepsin G further suggests this protein may modulate inflammation, which could potentially affect pathogen transmission.	[Tsujimoto, Hitoshi; Eum, Jai Hoon; Strand, Michael R.; Champagne, Donald E.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Tsujimoto, Hitoshi; Strand, Michael R.; Champagne, Donald E.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kotsyfakis, Michail] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Lab Genom & Prote Dis Vectors, CR-37005 Ceske Budejovice, Czech Republic; [Francischetti, Ivo M. B.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsujimoto, H (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21218 USA.	dchampa@uga.edu	Kotsyfakis, Michail/G-9525-2014	Kotsyfakis, Michail/0000-0002-7526-1876	United States Department of Agriculture National Research Initiative [200704549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was in part supported by United States Department of Agriculture National Research Initiative grant 200704549 to M.R. Strand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABEBE M, 1995, J INSECT PHYSIOL, V41, P1001, DOI 10.1016/0022-1910(95)00039-W; Abebe M, 1996, J MED ENTOMOL, V33, P173, DOI 10.1093/jmedent/33.1.173; ABEBE M, 1994, J MED ENTOMOL, V31, P908, DOI 10.1093/jmedent/31.6.908; ALBRECHT GJ, 1983, H-S Z PHYSIOL CHEM, V364, P1697, DOI 10.1515/bchm2.1983.364.2.1697; ALBRECHT GJ, 1983, H-S Z PHYSIOL CHEM, V364, P1703, DOI 10.1515/bchm2.1983.364.2.1703; ANDERSEN JF, 2009, J PROTEOME RES; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; BERNARDO MJ, 1986, J MED ENTOMOL, V23, P666, DOI 10.1093/jmedent/23.6.666; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; CUPP MS, 1994, AM J TROP MED HYG, V50, P241, DOI 10.4269/ajtmh.1994.50.241; Cupp MS, 1998, J EXP BIOL, V201, P1553; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Gray EW, 1999, MAINTENANCE OF HUMAN, ANIMAL, AND PLANT PATHOGEN VECTORS, P83; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; JACOBS JW, 1990, THROMB HAEMOSTASIS, V64, P235; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Lai R, 2004, GENE, V342, P243, DOI 10.1016/j.gene.2004.07.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; LIENER IE, 1986, J NUTR, V116, P920, DOI 10.1093/jn/116.5.920; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Maritz-Olivier C, 2007, TRENDS PARASITOL, V23, P397, DOI 10.1016/j.pt.2007.07.005; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nienaber J, 1999, EXP PARASITOL, V93, P82, DOI 10.1006/expr.1999.4448; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, AM J TROP MED HYG, V82, P1060, DOI 10.4269/ajtmh.2010.09-0769; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Trivedi NN, 2010, AM J RESP CELL MOL, V42, P257, DOI 10.1165/rcmb.2009-0324RT; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; Tschesche H, 1983, Adv Exp Med Biol, V156, P329; Valenzuela JG, 1996, EXP PARASITOL, V83, P184, DOI 10.1006/expr.1996.0065; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x; VINCENT JP, 1973, EUR J BIOCHEM, V38, P365, DOI 10.1111/j.1432-1033.1973.tb03069.x; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	48	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e29964	10.1371/journal.pone.0029964	http://dx.doi.org/10.1371/journal.pone.0029964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383955	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100003
J	Barretti, P; Moraes, TMC; Camargo, CH; Caramori, JCT; Mondelli, AL; Montelli, AC; da Cunha, MDRS				Barretti, Pasqual; Moraes, Taise M. C.; Camargo, Carlos H.; Caramori, Jacqueline C. T.; Mondelli, Alessandro L.; Montelli, Augusto C.; da Cunha, Maria de Lourdes R. S.			Peritoneal Dialysis-Related Peritonitis Due to Staphylococcus aureus: A Single-Center Experience over 15 Years	PLOS ONE			English	Article							BETA-TOXIN; INFECTIONS RECOMMENDATIONS; STRAINS; UPDATE; PREDICTORS; VIRULENCE; OUTCOMES; CELLS	Peritonitis caused by Staphylococcus aureus is a serious complication of peritoneal dialysis (PD), which is associated with poor outcome and high PD failure rates. We reviewed the records of 62 S. aureus peritonitis episodes that occurred between 1996 and 2010 in the dialysis unit of a single university hospital and evaluated the host and bacterial factors influencing peritonitis outcome. Peritonitis incidence was calculated for three subsequent 5-year periods and compared using a Poisson regression model. The production of biofilm, enzymes, and toxins was evaluated. Oxacillin resistance was evaluated based on minimum inhibitory concentration and presence of the mecA gene. Logistic regression was used for the analysis of demographic, clinical, and microbiological factors influencing peritonitis outcome. Resolution and death rates were compared with 117 contemporary coagulase-negative staphylococcus (CoNS) episodes. The incidence of S. aureus peritonitis declined significantly over time from 0.13 in 1996-2000 to 0.04 episodes/patient/year in 2006-2010 (p = 0.03). The oxacillin resistance rate was 11.3%. Toxin and enzyme production was expressive, except for enterotoxin D. Biofilm production was positive in 88.7% of strains. The presence of the mecA gene was associated with a higher frequency of fever and abdominal pain. The logistic regression model showed that diabetes mellitus (p = 0.009) and beta-hemolysin production (p = 0.006) were independent predictors of non-resolution of infection. The probability of resolution was higher among patients aged 41 to 60 years than among those >60 years (p = 0.02). A trend to higher death rate was observed for S. aureus episodes (9.7%) compared to CoNS episodes (2.5%), (p = 0.08), whereas resolution rates were similar. Despite the decline in incidence, S. aureus peritonitis remains a serious complication of PD that is associated with a high death rate. The outcome of this infection is negatively influenced by host factors such as age and diabetes mellitus. In addition, beta-hemolysin production is predictive of non-resolution of infection, suggesting a pathogenic role of this factor in PD-related S. aureus peritonitis.	[Barretti, Pasqual; Moraes, Taise M. C.; Camargo, Carlos H.; Caramori, Jacqueline C. T.; Mondelli, Alessandro L.; Montelli, Augusto C.] Univ Estadual Paulista, Dept Clin Med, Fac Med, UNESP, Botucatu, SP, Brazil; [Moraes, Taise M. C.; Camargo, Carlos H.; Montelli, Augusto C.; da Cunha, Maria de Lourdes R. S.] Univ Estadual Paulista, Dept Microbiol & Imunol, Inst Biociencias, UNESP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Barretti, P (corresponding author), Univ Estadual Paulista, Dept Clin Med, Fac Med, UNESP, Botucatu, SP, Brazil.	cunhamlr@ibb.unesp.br	Barretti, Pasqual/AAK-7934-2021; de Lourdes Ribeiro de Souza da Cunha, Maria/A-6287-2008; Camargo, Carlos/E-6448-2010; Caramori, Jacqueline do Socorr C. T./G-1783-2013; Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; de Lourdes Ribeiro de Souza da Cunha, Maria/0000-0001-9079-2723; Camargo, Carlos/0000-0001-6834-0085; Caramori, Jacqueline do Socorr C. T./0000-0002-0093-9515; Barretti, Pasqual/0000-0003-4979-4836; Lia Mondelli, Alessandro/0000-0002-4401-5656	Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	This work was supported by a grant from the Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funding agency played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALEXANDER W, 1987, DIAGN MICR INFEC DIS, V8, P215, DOI 10.1016/0732-8893(87)90052-6; Barretti P, 2007, PERITON DIALYSIS INT, V27, P332; Barretti P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-212; Bunke CM, 1997, KIDNEY INT, V52, P524, DOI 10.1038/ki.1997.363; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; da Cunha MDRD, 2005, CLIN NEPHROL, V64, P378; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; DONNELLY CB, 1967, APPL MICROBIOL, V15, P1382, DOI 10.1128/AEM.15.6.1382-1387.1967; Fontan MP, 2005, PERITON DIALYSIS INT, V25, P274; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Govindarajulu S, 2010, PERITON DIALYSIS INT, V30, P311, DOI 10.3747/pdi.2008.00258; Han SH, 2007, NEPHROL DIAL TRANSPL, V22, P2653, DOI 10.1093/ndt/gfm242; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; JESSEN OVE, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P316; Keane WF, 2000, PERITON DIALYSIS INT, V20, P396; Koneman EW, 1992, COLOR ATLAS TXB DIAG; Krishnan M, 2002, PERITON DIALYSIS INT, V22, P573; LACHICA RUF, 1971, APPL MICROBIOL, V21, P585, DOI 10.1128/AEM.21.4.585-587.1971; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Martinez-Pulgarin S, 2009, MICROBIOL-SGM, V155, P1505, DOI 10.1099/mic.0.025544-0; MATOS JES, 1995, LETT APPL MICROBIOL, V21, P334, DOI 10.1111/j.1472-765X.1995.tb01073.x; Moraes TP, 2009, PERITON DIALYSIS INT, V29, P492; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Ortiz A, 2006, CURR MED CHEM, V13, P2695, DOI 10.2174/092986706778201576; Peacock SJ, 2000, PERITON DIALYSIS INT, V20, P215; Pimenta-Rodrigues MV, 2011, THESIS U ESTADUAL PA; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Zhong J H, 2000, Adv Perit Dial, V16, P36	33	28	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31780	10.1371/journal.pone.0031780	http://dx.doi.org/10.1371/journal.pone.0031780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363730	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700096
J	de Rooij, MMT; Schimmer, B; Versteeg, B; Schneeberger, P; Berends, BR; Heederik, D; van der Hoek, W; Wouters, IM				de Rooij, Myrna M. T.; Schimmer, Barbara; Versteeg, Bart; Schneeberger, Peter; Berends, Boyd R.; Heederik, Dick; van der Hoek, Wim; Wouters, Inge M.			Risk Factors of Coxiella burnetii (Q Fever) Seropositivity in Veterinary Medicine Students	PLOS ONE			English	Article							NATURAL-HISTORY; NOVA-SCOTIA; SEROPREVALENCE; ANTIBODIES; NETHERLANDS; INFECTION; OUTBREAKS; WORKERS; GOATS	Background: Q fever is an occupational risk for veterinarians, however little is known about the risk for veterinary medicine students. This study aimed to assess the seroprevalence of Coxiella burnetii among veterinary medicine students and to identify associated risk factors. Methods: A cross-sectional study with questionnaire and blood sample collection was performed among all veterinary medicine students studying in the Netherlands in 2006. Serum samples (n = 674), representative of all study years and study directions, were analyzed for C. burnetii IgG and IgM phase I and II antibodies with an immunofluorescence assay (IFA). Seropositivity was defined as IgG phase I and/or II titer of 1: 32 and above. Results: Of the veterinary medicine students 126 (18.7%) had IgG antibodies against C. burnetii. Seropositivity associated risk factors identified were the study direction 'farm animals' (Odds Ratio (OR) 3.27 [95% CI 2.14-5.02]), advanced year of study (OR year 6: 2.31 [1.22-4.39] OR year 3-5 1.83 [1.07-3.10]) having had a zoonosis during the study (OR 1.74 [1.07-2.82]) and ever lived on a ruminant farm (OR 2.73 [1.59-4.67]). Stratified analysis revealed study direction 'farm animals' to be a study-related risk factor apart from ever living on a farm. In addition we identified a clear dose-response relation for the number of years lived on a farm with C. burnetii seropositivity. Conclusions: C. burnetii seroprevalence is considerable among veterinary medicine students and study related risk factors were identified. This indicates Q fever as an occupational risk for veterinary medicine students.	[de Rooij, Myrna M. T.; Heederik, Dick; Wouters, Inge M.] Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Schimmer, Barbara; Versteeg, Bart; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Versteeg, Bart; Schneeberger, Peter] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Berends, Boyd R.] Inst Risk Assessment Sci, Div Vet Publ Hlth, Utrecht, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis; Utrecht University	de Rooij, MMT (corresponding author), Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	i.wouters@uu.nl		Wouters, Inge M./0000-0001-7834-9390; Heederik, Dick/0000-0002-4550-1437; de Rooij, Myrna Maria Theresia/0000-0002-6560-4839				Abe T, 2001, EUR J EPIDEMIOL, V17, P1029, DOI 10.1023/A:1020018907452; Blaauw GJ, 2012, EPIDEMIOL INFECT, V140, P36, DOI 10.1017/S0950268811000021; Bond R, 2010, CLIN DERMATOL, V28, P226, DOI 10.1016/j.clindermatol.2009.12.012; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x; Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; Dorko E, 2008, ANN AGR ENV MED, V15, P119; DUPONT HT, 1994, CLIN DIAGN LAB IMMUN, V1, P189, DOI 10.1128/CDLI.1.2.189-196.1994; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Hatchette T, 2003, VECTOR-BORNE ZOONOT, V3, P11, DOI 10.1089/153036603765627415; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; MARRIE TJ, 1995, EUR J EPIDEMIOL, V11, P47, DOI 10.1007/BF01719945; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2009, CLIN INFECT DIS, V48, P558, DOI 10.1086/596706; RIEMANN HP, 1974, AM J EPIDEMIOL, V100, P197, DOI 10.1093/oxfordjournals.aje.a112028; Samadi S, 2012, OCCUP ENVIRON MED, V69, P48, DOI 10.1136/oem.2010.064089; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2012, EPIDEMIOL INFECT, V140, P27, DOI 10.1017/S0950268811000136; SCHNURRENBERGER PR, 1964, J AM VET MED ASSOC, V144, P381; Sukocheva OA, 2010, QJM-INT J MED, V103, P847, DOI 10.1093/qjmed/hcq113; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Tozer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1287, DOI 10.1007/s10096-011-1225-y; Valencia MDS, 2000, EUR J EPIDEMIOL, V16, P469, DOI 10.1023/A:1007605414042; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; van Duynhoven Y, STORY HUMAN Q FEVER; Wattiau P, 2011, EMERG INFECT DIS DEC; Whelan J, 2011, EMERG INFECT DIS, V17, P1719, DOI 10.3201/eid1709.110051; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	34	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32108	10.1371/journal.pone.0032108	http://dx.doi.org/10.1371/journal.pone.0032108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363803	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700144
J	Frigola, D; Casanellas, L; Sancho, JM; Ibanes, M				Frigola, David; Casanellas, Laura; Sancho, Jose M.; Ibanes, Marta			Asymmetric Stochastic Switching Driven by Intrinsic Molecular Noise	PLOS ONE			English	Article							GENE-EXPRESSION; CELL FATE; ESCHERICHIA-COLI; TOGGLE SWITCH; FLUCTUATING ENVIRONMENTS; DYNAMICS; MEMORY; DIFFERENTIATION; CONSEQUENCES; DECISION	Low-copy-number molecules are involved in many functions in cells. The intrinsic fluctuations of these numbers can enable stochastic switching between multiple steady states, inducing phenotypic variability. Herein we present a theoretical and computational study based on Master Equations and Fokker-Planck and Langevin descriptions of stochastic switching for a genetic circuit of autoactivation. We show that in this circuit the intrinsic fluctuations arising from low-copy numbers, which are inherently state-dependent, drive asymmetric switching. These theoretical results are consistent with experimental data that have been reported for the bistable system of the gallactose signaling network in yeast. Our study unravels that intrinsic fluctuations, while not required to describe bistability, are fundamental to understand stochastic switching and the dynamical relative stability of multiple states.	[Frigola, David; Casanellas, Laura; Sancho, Jose M.; Ibanes, Marta] Univ Barcelona, Dept Estruct & Constituents Mat, Fac Fs, Barcelona, Spain	University of Barcelona	Frigola, D (corresponding author), Univ Barcelona, Dept Estruct & Constituents Mat, Fac Fs, Barcelona, Spain.	mibanes@ub.edu	Ibanes, Marta/A-7657-2008; Frigola Tubert, David/B-6191-2014	Ibanes, Marta/0000-0002-7913-7936; Sancho, Jose Maria/0000-0003-3754-2391; Frigola, David/0000-0001-6025-6110	Ministerio de Ciencia e Innovacion of Spain [FIS2009-13360-C03-01, FPU-AP2009-3736]; Generalitat de Catalunya, Spain [2009SGR14]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya)	The work was supported by Grant FIS2009-13360-C03-01 from Ministerio de Ciencia e Innovacion of Spain; Grant 2009SGR14 from Generalitat de Catalunya, Spain; and Fellowship FPU-AP2009-3736 from Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Allen RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018104; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bialek W, 2000, ADV NEURAL INFORM PR, P103; Canela-Xandri O, 2008, BIOPHYS J, V95, P5111, DOI 10.1529/biophysj.108.133306; Carrillo O, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046110; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardiner C W, 2004, HDB STOCHASTIC METHO; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Press W., 1992, NUMERICAL RECIPES FO; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Turcotte M, 2008, P NATL ACAD SCI USA, V105, P15732, DOI 10.1073/pnas.0806349105; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Warren PB, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.128101; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wolfram Research Inc, 2008, MATH 8 SOFTW; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	42	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31407	10.1371/journal.pone.0031407	http://dx.doi.org/10.1371/journal.pone.0031407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363638	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700055
J	Cambier, L; Rassam, P; Chabi, B; Mezghenna, K; Gross, R; Eveno, E; Auffray, C; Wrutniak-Cabello, C; Lajoix, AD; Pomies, P				Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Mezghenna, Karima; Gross, Rene; Eveno, Eric; Auffray, Charles; Wrutniak-Cabello, Chantal; Lajoix, Anne-Dominique; Pomies, Pascal			M19 Modulates Skeletal Muscle Differentiation and Insulin Secretion in Pancreatic beta-Cells through Modulation of Respiratory Chain Activity	PLOS ONE			English	Article							MITOCHONDRIAL-DNA NUCLEOIDS; MYOBLAST DIFFERENTIATION; EXPRESSION; PROTEINS; RISK	Mitochondrial dysfunction due to nuclear or mitochondrial DNA alterations contributes to multiple diseases such as metabolic myopathies, neurodegenerative disorders, diabetes and cancer. Nevertheless, to date, only half of the estimated 1,500 mitochondrial proteins has been identified, and the function of most of these proteins remains to be determined. Here, we characterize the function of M19, a novel mitochondrial nucleoid protein, in muscle and pancreatic beta-cells. We have identified a 13-long amino acid sequence located at the N-terminus of M19 that targets the protein to mitochondria. Furthermore, using RNA interference and over-expression strategies, we demonstrate that M19 modulates mitochondrial oxygen consumption and ATP production, and could therefore regulate the respiratory chain activity. In an effort to determine whether M19 could play a role in the regulation of various cell activities, we show that this nucleoid protein, probably through its modulation of mitochondrial ATP production, acts on late muscle differentiation in myogenic C2C12 cells, and plays a permissive role on insulin secretion under basal glucose conditions in INS-1 pancreatic beta-cells. Our results are therefore establishing a functional link between a mitochondrial nucleoid protein and the modulation of respiratory chain activities leading to the regulation of major cellular processes such as myogenesis and insulin secretion.	[Cambier, Linda; Rassam, Patrice; Pomies, Pascal] CNRS, CRBM, UMR5237, F-34033 Montpellier, France; [Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, UMR866, F-34060 Montpellier, France; [Mezghenna, Karima; Gross, Rene; Lajoix, Anne-Dominique] CNRS, UMR5232, Ctr Pharmacol & Innovat Diabet, Montpellier, France; [Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Mezghenna, Karima; Gross, Rene; Wrutniak-Cabello, Chantal; Lajoix, Anne-Dominique; Pomies, Pascal] Univ Montpellier I, Montpellier, France; [Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Wrutniak-Cabello, Chantal; Pomies, Pascal] Univ Montpellier 2, Montpellier, France; [Eveno, Eric; Auffray, Charles] CNRS, Inst Biol Sci, Villejuif, France; [Pomies, Pascal] INSERM, U1046, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cambier, L (corresponding author), CNRS, CRBM, UMR5237, BP 5051, F-34033 Montpellier, France.	pascal.pomies@inserm.fr	Pomiès, Pascal/AAC-8037-2020; Chabi, Beatrice/AAI-6545-2020; Linda, Cambier/AAL-9928-2020; Rassam, Patrice/P-6564-2014	Pomiès, Pascal/0000-0002-5301-6087; Chabi, Beatrice/0000-0002-5604-5668; Linda, Cambier/0000-0001-9482-1413; Rassam, Patrice/0000-0002-8630-0957; Gross, Rene/0000-0001-5884-3607; Eveno, Eric/0000-0002-7282-280X	Association Francaise contre les Myopathies (AFM); Institut National de la Sante et de la Recherche Medicale (Inserm)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We acknowledge the support of the Association Francaise contre les Myopathies (AFM) and the Institut National de la Sante et de la Recherche Medicale (Inserm). LC is supported by the AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Fujimoto S, 2007, DIABETES RES CLIN PR, V77, pS2, DOI 10.1016/j.diabres.2007.01.026; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311; Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maier LM, 2005, CURR OPIN IMMUNOL, V17, P601, DOI 10.1016/j.coi.2005.09.013; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rochard P, 1996, J CELL PHYSIOL, V168, P239, DOI 10.1002/(SICI)1097-4652(199608)168:2<239::AID-JCP2>3.0.CO;2-Q; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Sobreira C, 1999, BIOCHEM BIOPH RES CO, V266, P179, DOI 10.1006/bbrc.1999.1758; Sumitani M, 2009, J BIOCHEM, V146, P725, DOI 10.1093/jb/mvp118; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	24	12	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31815	10.1371/journal.pone.0031815	http://dx.doi.org/10.1371/journal.pone.0031815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363741	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500091
J	Migdall-Wilson, J; Bates, C; Schlegel, J; Brandao, L; Linger, RMA; DeRyckere, D; Graham, DK				Migdall-Wilson, Justine; Bates, Christine; Schlegel, Jennifer; Brandao, Luis; Linger, Rachel M. A.; DeRyckere, Deborah; Graham, Douglas K.			Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; PLATELET-AGGREGATION; PLASMA-LEVELS; HUMAN CANCER; CELL-GROWTH; C-MER; PATHWAY; AXL	Mer tyrosine kinase is ectopically expressed in acute lymphoblastic leukemia and associated with enhanced chemoresistance and disease progression. While such effects are generally ascribed to increased engagement of oncogenic pathways downstream of Mer stimulation by its ligand, Gas6, Mer has not been characterized beyond the scope of its signaling activity. The present study explores Mer behavior following prolonged exposure to Gas6, a context similar to the Gas6-enriched microenvironment of the bone marrow, where a steady supply of ligand facilitates continuous engagement of Mer and likely sustains the presence of leukemic cells. Long-term Gas6 exposure induced production of a partially N-glycosylated form of Mer from newly synthesized stores of protein. Preferential expression of the partial Mer glycoform was associated with diminished levels of Mer on the cell surface and altered Mer localization within the nuclear-soluble and chromatin-bound fractions. The presence of Mer in the nucleus is a novel finding for this receptor, and the glycoform-specific preferences observed in each nuclear compartment suggest that glycosylation may influence Mer function within particular subcellular locales. Previous studies have established Mer as an attractive cancer biologic target, and understanding the complexity of its activity has important implications for potential strategies of Mer inhibition in leukemia therapy. Our results identify several novel features of Mer that expand the breadth of its functions and impact the development of therapeutic modalities designed to target Mer.	[Migdall-Wilson, Justine; Bates, Christine; Schlegel, Jennifer; Brandao, Luis; Linger, Rachel M. A.; DeRyckere, Deborah; Graham, Douglas K.] Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Migdall-Wilson, J (corresponding author), Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA.	doug.graham@ucdenver.edu		Maller, Justine/0000-0001-6930-7375	NIH [1R01CA137078]; ACS [RSG-08-291-01-LIB]; NIH/NCRR Colorado CTSI [UL1 RR025780]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA137078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant 1R01CA137078 and ACS Grant RSG-08-291-01-LIB to DKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core, supported in part by NIH/NCRR Colorado CTSI Grant UL1 RR025780. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A; Brandao Luis, 2011, Critical Reviews in Oncogenesis, V16, P47; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Burnier L, 2006, J THROMB HAEMOST, V4, P2283, DOI 10.1111/j.1538-7836.2006.02155.x; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; Clauser S, 2006, ARTERIOSCL THROM VAS, V26, pE22, DOI 10.1161/01.ATV.0000201968.72967.f9; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krysov S, 2010, BLOOD, V115, P4198, DOI 10.1182/blood-2009-12-254847; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu HS, 2010, CARCINOGENESIS, V31, P1456, DOI 10.1093/carcin/bgq100; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MANSFIELD MA, 1995, ANAL BIOCHEM, V229, P140, DOI 10.1006/abio.1995.1391; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Seol KC, 2003, BIOCHEM BIOPH RES CO, V306, P898, DOI 10.1016/S0006-291X(03)01046-5; Shiozawa Y, 2010, EXP HEMATOL, V38, P132, DOI 10.1016/j.exphem.2009.11.002; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stachowiak MK, 1997, MOL NEUROBIOL, V15, P257, DOI 10.1007/BF02740663; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	49	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31635	10.1371/journal.pone.0031635	http://dx.doi.org/10.1371/journal.pone.0031635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363695	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500068
J	Nagarajan, S; Tosh, C; Smith, DK; Peiris, JSM; Murugkar, HV; Sridevi, R; Kumar, M; Katare, M; Jain, R; Syed, Z; Behera, P; Cheung, CL; Khandia, R; Tripathi, S; Guan, Y; Dubey, SC				Nagarajan, Shanmuga; Tosh, Chakradhar; Smith, David K.; Peiris, Joseph Sriyal Malik; Murugkar, Harshad Vinayakrao; Sridevi, Rajangam; Kumar, Manoj; Katare, Megha; Jain, Rajlaxmi; Syed, Zohra; Behera, Padmanava; Cheung, Chung L.; Khandia, Rekha; Tripathi, Sushil; Guan, Yi; Dubey, Shiv Chandra			Avian Influenza (H5N1) Virus of Clade 2.3.2 in Domestic Poultry in India	PLOS ONE			English	Article							WILD BIRDS; HEMAGGLUTININ; VIRULENCE; OUTBREAK	South Asia has experienced regular outbreaks of H5N1 avian influenza virus since its first detection in India and Pakistan in February, 2006. Till 2009, the outbreaks in this region were due to clade 2.2 H5N1 virus. In 2010, Nepal reported the first outbreak of clade 2.3.2 virus in South Asia. In February 2011, two outbreaks of H5N1 virus were reported in the State of Tripura in India. The antigenic and genetic analyses of seven H5N1 viruses isolated during these outbreaks were carried out. Antigenic analysis confirmed 64 to 256-fold reduction in cross reactivity compared with clade 2.2 viruses. The intravenous pathogenicity index of the isolates ranged from 2.80-2.95 indicating high pathogenicity to chickens. Sequencing of all the eight gene-segments of seven H5N1 viruses isolated in these outbreaks was carried out. The predicted amino acid sequence analysis revealed high pathogenicity to chickens and susceptibility to the antivirals, amantadine and oseltamivir. Phylogenetic analyses indicated that these viruses belong to clade 2.3.2.1 and were distinct to the clade 2.3.2.1 viruses isolated in Nepal. Identification of new clade 2.3.2 H5N1 viruses in South Asia is reminiscent of the introduction of clade 2.2 viruses in this region in 2006/7. It is now important to monitor whether the clade 2.3.2.1 is replacing clade 2.2 in this region or co-circulating with it. Continued co-circulation of various subclades of the H5N1 virus which are more adapted to land based poultry in a highly populated region such as South Asia increases the risk of evolution of pandemic H5N1 strains.	[Nagarajan, Shanmuga; Tosh, Chakradhar; Murugkar, Harshad Vinayakrao; Sridevi, Rajangam; Kumar, Manoj; Katare, Megha; Jain, Rajlaxmi; Syed, Zohra; Behera, Padmanava; Khandia, Rekha; Tripathi, Sushil; Dubey, Shiv Chandra] Indian Vet Res Inst, High Secur Anim Dis Lab, Bhopal, India; [Peiris, Joseph Sriyal Malik; Cheung, Chung L.; Guan, Yi] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Smith, David K.] Shantou Univ, Sch Med, Univ Hong Kong,Int Inst Infect & Immun, State Key Lab Emerging Infect Dis,Li Ka Shing Fac, Shantou, Peoples R China	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; ICAR - National Institute of High Security Animal Diseases; University of Hong Kong; Shantou University; University of Hong Kong	Nagarajan, S (corresponding author), Indian Vet Res Inst, High Secur Anim Dis Lab, Bhopal, India.	nagavetbio@gmail.com	Khandia, Rekha/AAE-6122-2022; Cheung, Yiu Man/T-2708-2019; Peiris, Joseph Sriyal Malik/C-4380-2009	Khandia, Rekha/0000-0002-9961-3127; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; , Nagarajan/0000-0002-4408-8708; Smith, David/0000-0003-3608-0586; Tosh, Chakradhar/0000-0003-2889-4707; Guan, Yi/0000-0001-6057-9243	Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700005C]	Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a financial grant from the Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL for Avian influenza diagnosis and research. The study was also supported by a research grant to JSMP and YG from National Institutes of Health, National Institute of Allergy and Infectious Diseases contract HHSN266200700005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Dubey SC, 2009, INDIAN J ANIM SCI, V79, P113; Food and Agricultural Organization, 2010, H5N1 HPAI GLOB OV JU; Food and Agricultural Organization, 2011, H5N1 HPAI GLOB OV AP; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kang HM, 2011, VET MICROBIOL, V147, P170, DOI 10.1016/j.vetmic.2010.05.045; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Nagarajan S, 2012, RES VET SCI, V93, P504, DOI 10.1016/j.rvsc.2011.06.005; Nagarajan S, 2010, VIRUS GENES, V41, P30, DOI 10.1007/s11262-010-0477-4; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Neumann G, 2007, ANTIVIR THER, V12, P617; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tosh C, 2011, VIRUS GENES, V42, P10, DOI 10.1007/s11262-010-0534-z; Tosh C, 2011, VET MICROBIOL, V148, P132, DOI 10.1016/j.vetmic.2010.08.015; WHO, 2005, REC LAB TESTS ID AV; WHO, 2002, WHO MAN AV INFL DIAG; World Organization for Animal Health, 2011, UPD HIGHL PATH AV IN	36	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31844	10.1371/journal.pone.0031844	http://dx.doi.org/10.1371/journal.pone.0031844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363750	Green Published, gold			2022-12-25	WOS:000302871500094
J	Terburg, D; Aarts, H; Putman, P; van Honk, J				Terburg, David; Aarts, Henk; Putman, Peter; van Honk, Jack			In the Eye of the Beholder: Reduced Threat-Bias and Increased Gaze-Imitation towards Reward in Relation to Trait Anger	PLOS ONE			English	Article							SOCIAL COGNITION; SELECTIVE ATTENTION; FACIAL EXPRESSION; VISUAL-ATTENTION; DIRECTION; ANXIETY; FACES; FEAR; EMOTION; CUES	The gaze of a fearful face silently signals a potential threat's location, while the happy-gaze communicates the location of impending reward. Imitating such gaze-shifts is an automatic form of social interaction that promotes survival of individual and group. Evidence from gaze-cueing studies suggests that covert allocation of attention to another individual's gaze-direction is facilitated when threat is communicated and further enhanced by trait anxiety. We used novel eye-tracking techniques to assess whether dynamic fearful and happy facial expressions actually facilitate automatic gaze-imitation. We show that this actual gaze-imitation effect is stronger when threat is signaled, but not further enhanced by trait anxiety. Instead, trait anger predicts facilitated gaze-imitation to reward, and to reward compared to threat. These results agree with an increasing body of evidence on trait anger sensitivity to reward.	[Terburg, David; Aarts, Henk; van Honk, Jack] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Putman, Peter] Leiden Univ, Dept Psychol, Leiden, Netherlands; [van Honk, Jack] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	Utrecht University; Leiden University; Leiden University - Excl LUMC; University of Cape Town	Terburg, D (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	d.terburg@uu.nl		Terburg, David/0000-0003-2356-8734	Hope for Depression Foundation; Utrecht University; Netherlands Organization of Scientific Research [VICI-453-06-002, 056-24-010]	Hope for Depression Foundation; Utrecht University; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by grants from the Hope for Depression Foundation (HDRF, http://www.hopefordepression.org/), Utrecht University High-Potential programme (http://www.uu.nl/university/research/EN/researchatutrechtuniversity/nurturingtalent/Pages/highpotentialprogramme.aspx), and the Netherlands Organization of Scientific Research (http://www.nwo.nl/, VICI-453-06-002 and Brain & Cognition 056-24-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Carlson JM, 2010, PSYCHIAT RES-NEUROIM, V182, P281, DOI 10.1016/j.pscychresns.2010.02.001; Carver CS, 2004, EMOTION, V4, P3, DOI 10.1037/1528-3542.4.1.3; Ekman P., 1976, PICTURES FACIAL AFFE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P307, DOI 10.1016/j.cpr.2007.05.006; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Lundqvist D, KAROLINSKA DIRECTED; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Mathews A, 2003, VIS COGN, V10, P823, DOI 10.1080/13506280344000095; Nummenmaa L, 2006, VISION RES, V46, P3674, DOI 10.1016/j.visres.2006.06.004; Putman P, 2007, BIPOLAR DISORD, V9, P779, DOI 10.1111/j.1399-5618.2007.00425.x; Putman P, 2006, EMOTION, V6, P94, DOI 10.1037/1528-3542.6.1.94; Putman P, 2010, PHYSIOL BEHAV, V99, P294, DOI 10.1016/j.physbeh.2009.11.006; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Spielberger C. D., 1970, SELF EVALUATION QUES; Spielberger CD., 1983, ADV PERSONALITY ASSE, P112; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tobii Technology, 2006, US MAN; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011	36	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31373	10.1371/journal.pone.0031373	http://dx.doi.org/10.1371/journal.pone.0031373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363632	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600143
J	Gustin, JK; Douglas, JL; Bai, Y; Moses, AV				Gustin, Jean K.; Douglas, Janet L.; Bai, Ying; Moses, Ashlee V.			Ubiquitination of BST-2 Protein by HIV-1 Vpu Protein Does Not Require Lysine, Serine, or Threonine Residues within the BST-2 Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GROWTH-HORMONE RECEPTOR; SARCOMA-ASSOCIATED HERPESVIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-TRCP; PARTICLE RELEASE; DOWN-REGULATION; CELL-SURFACE; F-BOX; ENDOPLASMIC-RETICULUM	The cellular protein BST-2/CD317/Tetherin has been shown to inhibit the release of HIV-1 and other enveloped viruses from infected cells. The HIV-1 accessory protein Vpu binds to both BST-2 and beta TrCP, a substrate-recognition subunit for the SCF (Skip1-Cullin1-F-box protein) E3 ubiquitin ligase complex. This interaction leads to both the degradation of BST-2 and the enhancement of viral egress. Recently BST-2 was shown to be ubiquitinated in this process. Here we have confirmed the Vpu- and beta TrCP-dependent multi/polyubiquitination of BST-2. Ubiquitinated BST-2 accumulated in cells treated with a lysosomal inhibitor but not a proteasomal inhibitor. Additionally, we observed that a BST-2 mutant deleted for its cytosolically exposed lysine residues is also ubiquitinated. Subsequent experiments suggested that Vpu promotes BST-2 ubiquitination upon amino acid residues bearing hydroxyl-but not thiol-bearing side chains. However, a BST-2 mutant bearing substitutions for its cytoplasmically exposed Ser, Thr, and Lys residues was still down-regulated, ubiquitinated, and degraded in a Vpu-dependent manner. Our results suggest that Vpu may target either the BST-2 cytoplasmic Tyr residues or the NH2 terminus itself for ubiquitination.	[Gustin, Jean K.; Douglas, Janet L.; Bai, Ying; Moses, Ashlee V.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Oregon Health & Science University	Gustin, JK (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	gustinj@ohsu.edu			National Institutes of Health [R01-AI090490-01A1, 5-R01-AI063938-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063938, R01AI090490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI090490-01A1 and 5-R01-AI063938-03.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Belaidouni N, 2007, BIOCHEM BIOPH RES CO, V357, P688, DOI 10.1016/j.bbrc.2007.03.195; Besnard-Guerin C, 2004, J BIOL CHEM, V279, P788, DOI 10.1074/jbc.M308068200; Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Butticaz C, 2007, J VIROL, V81, P1502, DOI 10.1128/JVI.01711-06; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Geimonen E, 2003, J VIROL, V77, P10760, DOI 10.1128/JVI.77.20.10760-10768.2003; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOTO T, 1994, BLOOD, V84, P1922; Gustin JK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00161; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kumar KGS, 2003, EMBO J, V22, P5480; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lau D, 2011, J VIROL, V85, P9834, DOI 10.1128/JVI.02633-10; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Ritter GD, 1996, J VIROL, V70, P2669, DOI 10.1128/JVI.70.4.2669-2673.1996; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	71	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14837	14850		10.1074/jbc.M112.349928	http://dx.doi.org/10.1074/jbc.M112.349928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383521	Green Published, hybrid			2022-12-25	WOS:000304003200048
J	Montalvo-Ortiz, BL; Castillo-Pichardo, L; Hernandez, E; Humphries-Bickley, T; De La Mota-Peynado, A; Cubano, LA; Vlaar, CP; Dharmawardhane, S				Montalvo-Ortiz, Brenda L.; Castillo-Pichardo, Linette; Hernandez, Eliud; Humphries-Bickley, Tessa; De La Mota-Peynado, Alina; Cubano, Luis A.; Vlaar, Cornelis P.; Dharmawardhane, Suranganie			Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NUCLEOTIDE-EXCHANGE FACTORS; FAMILY SMALL GTPASES; RHO-GTPASES; THERAPEUTIC TARGETS; SIGNALING PATHWAYS; RATIONAL DESIGN; SPLICE VARIANT; VAV PROTEINS; INVASION	The Rho GTPase Rac regulates actin cytoskeleton reorganization to form cell surface extensions (lamellipodia) required for cell migration/invasion during cancer metastasis. Rac hyperactivation and overexpression are associated with aggressive cancers; thus, interference of the interaction of Rac with its direct upstream activators, guanine nucleotide exchange factors (GEFs), is a viable strategy for inhibiting Rac activity. We synthesized EHop-016, a novel inhibitor of Rac activity, based on the structure of the established Rac/Rac GEF inhibitor NSC23766. Herein, we demonstrate that EHop-016 inhibits Rac activity in the MDA-MB-435 metastatic cancer cells that overexpress Rac and exhibits high endogenous Rac activity. The IC50 of 1.1 mu M for Rac inhibition by EHop-016 is similar to 100-fold lower than for NSC23766. EHop-016 is specific for Rac1 and Rac3 at concentrations of <= 5 mu M. At higher concentrations, EHop-016 inhibits the close homolog Cdc42. In MDA-MB-435 cells that demonstrate high active levels of the Rac GEF Vav2, EHop-016 inhibits the association of Vav2 with a nucleotide-free Rac1(G15A), which has a high affinity for activated GEFs. EHop-016 also inhibits the Rac activity of MDA-MB-231 metastatic breast cancer cells and reduces Rac-directed lamellipodia formation in both cell lines. EHop-016 decreases Rac downstream effects of PAK1 (p21-activated kinase 1) activity and directed migration of metastatic cancer cells. Moreover, at effective concentrations (<5 mu M), EHop-016 does not affect the viability of viability of MDA-MB-435 cells by only 20%. Therefore, EHop-016 holds promise as a targeted therapeutic agent for the treatment of metastatic cancers with high Rac activity.	[Montalvo-Ortiz, Brenda L.; Castillo-Pichardo, Linette; Humphries-Bickley, Tessa; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Hernandez, Eliud; Vlaar, Cornelis P.] Univ Puerto Rico, Sch Pharm, Dept Pharmaceut Sci, San Juan, PR 00936 USA; [Castillo-Pichardo, Linette; De La Mota-Peynado, Alina; Cubano, Luis A.] Univ Cent Caribe, Dept Anat & Cell Biol, Bayamon, PR 00960 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Vlaar, CP (corresponding author), POB 365067, San Juan, PR 00936 USA.	cornelis.vlaar@upr.edu; su.d@upr.edu	Vlaar, Cornelis/X-4169-2018	Vlaar, Cornelis/0000-0001-5145-8300	National Institutes of Health, NCRR [G12RR035051, 5U54CA096297, G12RR03035]; Department of Defense/United States Army [W81XWH-07-1-0330, 3SC3GM084824-02S1]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035, G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084824] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense/United States Army; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health, NCRR, Grants G12RR035051 (to the University of Puerto Rico Medical Sciences Campus), 5U54CA096297 (to the University of Puerto Rico Medical Sciences Campus), and G12RR03035 (to Universidad Central del Caribe). This work was also supported by Department of Defense/United States Army Breast Cancer Research Program Grants W81XWH-07-1-0330 and 3SC3GM084824-02S1 (to S. D.). A provisional patent application, number 61/536,069, "Novel Small-Molecule Inhibitors of Rac 1 in Metastatic Breast Cancer," is pending.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Azios NG, 2007, NEOPLASIA, V9, P147, DOI 10.1593/neo.06778; Baranwal S, 2011, CURR DRUG TARGETS, V12, P1194, DOI 10.2174/138945011795906534; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Beausoleil E, 2009, BIOORG MED CHEM LETT, V19, P5594, DOI 10.1016/j.bmcl.2009.08.037; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Binker MG, 2008, EXP PHYSIOL, V93, P1091, DOI 10.1113/expphysiol.2008.043141; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Brantley-Sieders DM, 2009, MOL CANCER RES, V7, P615, DOI 10.1158/1541-7786.MCR-08-0401; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Deacon S. W., 2008, V186, P431, DOI 10.1007/978-3-540-72843-6_18; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Dokmanovic M, 2009, MOL CANCER THER, V8, P1557, DOI 10.1158/1535-7163.MCT-09-0140; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Hernandez E, 2010, P R HEALTH SCI J, V29, P348; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Palmby TR, 2004, MOL CANCER RES, V2, P702; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenblatt AE, 2011, ENDOCR-RELAT CANCER, V18, P207, DOI 10.1677/ERC-10-0049; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schunke D, 2007, CANCER RES, V67, P10694, DOI 10.1158/0008-5472.CAN-07-1621; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stallings-Mann M, 2007, CELLS TISSUES ORGANS, V185, P104, DOI 10.1159/000101310; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Zheng Y., 2010, U.S. Patent, Patent No. [17,826,982, 17826982]; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	87	146	154	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13228	13238		10.1074/jbc.M111.334524	http://dx.doi.org/10.1074/jbc.M111.334524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22383527	hybrid, Green Published			2022-12-25	WOS:000302903700060
J	Mustafa, S; See, HB; Seeber, RM; Armstrong, SP; White, CW; Ventura, S; Ayoub, MA; Pfleger, KDG				Mustafa, Sanam; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; White, Carl W.; Ventura, Sabatino; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.			Identification and Profiling of Novel alpha(1A)-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ENERGY-TRANSFER BRET; BENIGN PROSTATIC HYPERTROPHY; BETA-ARRESTIN; CXCR2 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; LIVE CELLS; PHOSPHORYLATION; SUBTYPES; ALPHA(1)-ADRENOCEPTORS	We have provided the first evidence for specific heteromerization between the alpha(1A)-adrenoceptor (alpha(1A)AR) and CXC chemokine receptor 2 (CXCR2) in live cells. alpha(1A)AR and CXCR2 are both expressed in areas such as the stromal smooth muscle layer of the prostate. By utilizing the G protein-coupled receptor (GPCR) heteromer identification technology on the live cell-based bioluminescence resonance energy transfer (BRET) assay platform, our studies in human embryonic kidney 293 cells have identified norepinephrine-dependent beta-arrestin recruitment that was in turn dependent upon co-expression of alpha(1A)AR with CXCR2. These findings have been supported by co-localization observed using confocal microscopy. This norepinephrine-dependent beta-arrestin recruitment was inhibited not only by the alpha(1)AR antagonist Terazosin but also by the CXCR2-specific allosteric inverse agonist SB265610. Furthermore, Labetalol, which is marketed for hypertension as a nonselective beta-adrenoceptor antagonist with alpha(1)AR antagonist properties, was identified as a heteromer-specific-biased agonist exhibiting partial agonism for inositol phosphate production but essentially full agonism for beta-arrestin recruitment at the alpha(1A)AR-CXCR2 heteromer. Finally, bioluminescence resonance energy transfer studies with both receptors tagged suggest that alpha(1A)AR-CXCR2 heteromerization occurs constitutively and is not modulated by ligand. These findings support the concept of GPCR heteromer complexes exhibiting distinct pharmacology, thereby providing additional mechanisms through which GPCRs can potentially achieve their diverse biological functions. This has important implications for the use and future development of pharmaceuticals targeting these receptors.	[Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia; [Mustafa, Sanam; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [White, Carl W.; Ventura, Sabatino] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Pty Ltd, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Monash University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Lab Mol Endocrinol G Prot Coupled Receptors, B Block, Perth, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Pfleger, Kevin/H-5629-2014; Seeber, Ruth/AAS-9411-2021	Seeber, Ruth/0000-0003-3265-7931; Mustafa, Sanam/0000-0002-8677-5151; White, Carl/0000-0002-4975-6189; Pfleger, Kevin/0000-0001-8261-9189; AYOUB, Mohammed Akli/0000-0003-0022-578X	National Health and Medical Research Council of Australia [566736]; Dimerix Bioscience Pty Ltd.	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dimerix Bioscience Pty Ltd.	This research was funded by National Health and Medical Research Council of Australia Project Grant 566736 and Dimerix Bioscience Pty Ltd. K. D. G. P. is an Australian Research Council Future Fellow (FT100100271) as well as Chief Scientific Officer of Dimerix Bioscience Pty Ltd, a spin-out company of the University of Western Australia that has been assigned the rights to the GPCR-HIT technology. K. D. G. P. has a minor shareholding in Dimerix.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.06.003; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Cotecchia S, 2010, J RECEPT SIG TRANSD, V30, P410, DOI 10.3109/10799893.2010.518152; Dalrymple MB, 2011, J BIOL CHEM, V286, P16726, DOI 10.1074/jbc.M111.223537; ECKERT RE, 1995, UROL INT, V54, P6, DOI 10.1159/000282685; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ford APDW, 1996, MOL PHARMACOL, V49, P209; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gray KT, 2008, BRIT J PHARMACOL, V155, P103, DOI 10.1038/bjp.2008.245; Hennenberg M, 2011, WORLD J UROL, V29, P157, DOI 10.1007/s00345-010-0634-3; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hieble JP, 1996, PHARMACOL RES, V33, P145, DOI 10.1006/phrs.1996.0022; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Kojima Y, 2009, NAT CLIN PRACT UROL, V6, P44, DOI 10.1038/ncpuro1276; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004; Morishima S, 2010, J UROLOGY, V183, P812, DOI 10.1016/j.juro.2009.09.078; MURAMATSU I, 1994, BRIT J UROL, V74, P572, DOI 10.1111/j.1464-410X.1994.tb09186.x; Muramatsu I, 2005, J PHARMACOL SCI, V98, P331, DOI 10.1254/jphs.CPJ05001X; Mustafa S, 2011, JALA-J LAB AUTOM, V16, P285, DOI 10.1016/j.jala.2011.03.002; Nishimune A, 2010, J PHARMACOL SCI, V113, P169, DOI 10.1254/jphs.10093FP; Nishimune A, 2010, INT J UROL, V17, P31, DOI 10.1111/j.1442-2042.2009.02368.x; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Parenty G, 2008, BIOCHEM J, V412, P245, DOI 10.1042/BJ20071689; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramsay D, 2004, MOL PHARMACOL, V66, P228, DOI 10.1124/mol.66.2.228; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shibata K, 1996, BRIT J PHARMACOL, V118, P1403, DOI 10.1111/j.1476-5381.1996.tb15552.x; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Sugimoto N, 2008, J IMMUNOL, V181, P2145, DOI 10.4049/jimmunol.181.3.2145; Suzuki F, 2000, BRIT J PHARMACOL, V129, P1569, DOI 10.1038/sj.bjp.0703242; Thorsteinsson A, 2008, PEDIATR ANESTH, V18, P435, DOI 10.1111/j.1460-9592.2008.02501.x; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trettel F, 2003, J BIOL CHEM, V278, P40980, DOI 10.1074/jbc.M306815200; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Uberti MA, 2003, MOL PHARMACOL, V64, P1379, DOI 10.1124/mol.64.6.1379; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; Wang YF, 2007, EUR J NEUROSCI, V26, P3159, DOI 10.1111/j.1460-9568.2007.05938.x; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	67	45	47	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12952	12965		10.1074/jbc.M111.322834	http://dx.doi.org/10.1074/jbc.M111.322834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371491	Green Published, hybrid			2022-12-25	WOS:000302903700034
J	Yoneda, K; Sakuraba, H; Araki, T; Ohshima, T				Yoneda, Kazunari; Sakuraba, Haruhiko; Araki, Tomohiro; Ohshima, Toshihisa			Crystal Structure of Binary and Ternary Complexes of Archaeal UDP-galactose 4-Epimerase-like L-Threonine Dehydrogenase from Thermoplasma volcanium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL	A gene from the thermophilic archaeon Thermoplasma volcanium encoding an L-threonine dehydrogenase (L-ThrDH) with a predicted amino acid sequence that was remarkably similar to the sequence of UDP-galactose 4-epimerase (GalE) was overexpressed in Escherichia coli, and its product was purified and characterized. The expressed enzyme was moderately thermostable, retaining more than 90% of its activity after incubation for 10 min at up to 70 degrees C. The catalytic residue was assessed using site-directed mutagenesis, and Tyr(137) was found to be essential for catalysis. To clarify the structural basis of the catalytic mechanism, four different crystal structures were determined using the molecular replacement method: L-ThrDH-NAD(+), L-ThrDH in complex with NAD(+) and pyruvate, Y137F mutant in complex with NAD(+) and L-threonine, and Y137F in complex with NAD(+) and L-3-hydroxynorvaline. Each monomer consisted of a Rossmann-fold domain and a C-terminal catalytic domain, and the fold of the catalytic domain showed notable similarity to that of the GalE-like L-ThrDH from the psychrophilic bacterium Flavobacterium frigidimaris KUC-1. The substrate binding model suggests that the reaction proceeds through abstraction of the beta-hydroxyl hydrogen of L-threonine via direct proton transfer driven by Tyr(137). The factors contributing to the thermostability of T. volcanium L-ThrDH were analyzed by comparing its structure to that of F. frigidimaris L-ThrDH. This comparison showed that the presence of extensive inter-and intrasubunit ion pair networks are likely responsible for the thermostability of T. volcanium L-ThrDH. This is the first description of the molecular basis for the substrate recognition and thermostability of a GalE-like L-ThrDH.	[Ohshima, Toshihisa] Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan; [Yoneda, Kazunari; Araki, Tomohiro] Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Kyushu University; Tokai University; Kagawa University	Ohshima, T (corresponding author), Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan.	ohshima@agr.kyushu-u.ac.jp		Yoneda, Kazunari/0000-0001-9152-8772	Agricultural Chemical Research Foundation; Japan Science Society; Tokai University Educational System; Grants-in-Aid for Scientific Research [24780105] Funding Source: KAKEN	Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan); Japan Science Society; Tokai University Educational System; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Agricultural Chemical Research Foundation, the Sasakawa Scientific Research Grant from the Japan Science Society, and the Tokai University Educational System (to K. Y.) and a grant for Scientific Research (A) (to T. O.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AOYAMA Y, 1981, J BIOL CHEM, V256, P2367; ARONSON BD, 1989, J BIOL CHEM, V264, P5226; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bowyer A, 2009, J STRUCT BIOL, V168, P294, DOI 10.1016/j.jsb.2009.07.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeDecker BS, 1996, J MOL BIOL, V264, P1072, DOI 10.1006/jmbi.1996.0697; ELLIOTT WH, 1958, BIOCHIM BIOPHYS ACTA, V29, P446, DOI 10.1016/0006-3002(58)90215-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Higashi N, 2005, J BIOSCI BIOENG, V99, P175, DOI 10.1263/jbb.99.175; Higashi N, 2008, J BIOCHEM, V144, P77, DOI 10.1093/jb/mvn041; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 1997, J MOL BIOL, V270, P259, DOI 10.1006/jmbi.1997.1105; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCGILVRAY D, 1969, BIOCHEM J, V112, P657, DOI 10.1042/bj1120657; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; Ohshima T., 2000, STEREOSELECTIVE BIOC, P877; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Shimizu Y, 2005, EXTREMOPHILES, V9, P317, DOI 10.1007/s00792-005-0447-2; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Ueatrongchit T, 2011, ANAL BIOCHEM, V410, P44, DOI 10.1016/j.ab.2010.11.003; Yoneda K, 2010, FEBS J, V277, P5124, DOI 10.1111/j.1742-4658.2010.07916.x	39	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12966	12974		10.1074/jbc.M111.336958	http://dx.doi.org/10.1074/jbc.M111.336958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22374996	Green Published, hybrid			2022-12-25	WOS:000302903700035
J	Sohle, J; Machuy, N; Smailbegovic, E; Holtzmann, U; Gronniger, E; Wenck, H; Stab, F; Winnefeld, M				Soehle, Joern; Machuy, Nikolaus; Smailbegovic, Elma; Holtzmann, Ursula; Groenniger, Elke; Wenck, Horst; Staeb, Franz; Winnefeld, Marc			Identification of New Genes Involved in Human Adipogenesis and Fat Storage	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; RNA INTERFERENCE; EXPRESSION; OBESITY; TRANSPORT; SWITCH	Since the worldwide increase in obesity represents a growing challenge for health care systems, new approaches are needed to effectively treat obesity and its associated diseases. One prerequisite for advances in this field is the identification of genes involved in adipogenesis and/or lipid storage. To provide a systematic analysis of genes that regulate adipose tissue biology and to establish a target-oriented compound screening, we performed a high throughput siRNA screen with primary (pre)adipocytes, using a druggable siRNA library targeting 7,784 human genes. The primary screen showed that 459 genes affected adipogenesis and/or lipid accumulation after knock-down. Out of these hits, 333 could be validated in a secondary screen using independent siRNAs and 110 genes were further regulated on the gene expression level during adipogenesis. Assuming that these genes are involved in neutral lipid storage and/or adipocyte differentiation, we performed InCell-Western analysis for the most striking hits to distinguish between the two phenotypes. Beside well known regulators of adipogenesis and neutral lipid storage (i.e. PPAR gamma, RXR, Perilipin A) the screening revealed a large number of genes which have not been previously described in the context of fatty tissue biology such as axonemal dyneins. Five out of ten axonemal dyneins were identified in our screen and quantitative RT-PCR-analysis revealed that these genes are expressed in preadipocytes and/or maturing adipocytes. Finally, to show that the genes identified in our screen are per se druggable we performed a proof of principle experiment using an antagonist for HTR2B. The results showed a very similar phenotype compared to knock-down experiments proofing the "druggability''. Thus, we identified new adipogenesis-associated genes and those involved in neutral lipid storage. Moreover, by using a druggable siRNA library the screen data provides a very attractive starting point to identify anti-obesity compounds targeting the adipose tissue.	[Soehle, Joern; Smailbegovic, Elma; Holtzmann, Ursula; Groenniger, Elke; Wenck, Horst; Staeb, Franz; Winnefeld, Marc] Beiersdorf AG, Res & Dev, Hamburg, Germany; [Machuy, Nikolaus] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	Beiersdorf AG; Max Planck Society	Sohle, J (corresponding author), Beiersdorf AG, Res & Dev, Hamburg, Germany.	marc.winnefeld@beiersdorf.com						Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gronniger E, 2010, CELL BIOL INT, V34, P737, DOI 10.1042/CBI20090299; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rosen ED, 2000, GENE DEV, V14, P1293; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sohle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Tuschl Thomas, 2002, Mol Interv, V2, P158, DOI 10.1124/mi.2.3.158; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; World Health Organization, 2000, WHO TECHN REP SER, V894; Xu Y, 2006, EXP CELL RES, V312, P1856, DOI 10.1016/j.yexcr.2006.02.016; Yan C, 2011, J BIOL CHEM     1206	36	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31193	10.1371/journal.pone.0031193	http://dx.doi.org/10.1371/journal.pone.0031193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384002	Green Published, Green Submitted, gold			2022-12-25	WOS:000302918500021
J	Li, YY; Lenaghan, SC; Zhang, MJ				Li, YuanYuan; Lenaghan, Scott C.; Zhang, Mingjun			A Data-Driven Predictive Approach for Drug Delivery Using Machine Learning Techniques	PLOS ONE			English	Article							GIARDIA-LAMBLIA; IN-VITRO; RESISTANT TUBERCULOSIS; METRONIDAZOLE; BENZIMIDAZOLES; INTESTINALIS; ALBENDAZOLE; TINIDAZOLE; INVITRO	In drug delivery, there is often a trade-off between effective killing of the pathogen, and harmful side effects associated with the treatment. Due to the difficulty in testing every dosing scenario experimentally, a computational approach will be helpful to assist with the prediction of effective drug delivery methods. In this paper, we have developed a data-driven predictive system, using machine learning techniques, to determine, in silico, the effectiveness of drug dosing. The system framework is scalable, autonomous, robust, and has the ability to predict the effectiveness of the current drug treatment and the subsequent drug-pathogen dynamics. The system consists of a dynamic model incorporating both the drug concentration and pathogen population into distinct states. These states are then analyzed using a temporal model to describe the drug-cell interactions over time. The dynamic drug-cell interactions are learned in an adaptive fashion and used to make sequential predictions on the effectiveness of the dosing strategy. Incorporated into the system is the ability to adjust the sensitivity and specificity of the learned models based on a threshold level determined by the operator for the specific application. As a proof-of-concept, the system was validated experimentally using the pathogen Giardia lamblia and the drug metronidazole in vitro.	[Li, YuanYuan; Lenaghan, Scott C.; Zhang, Mingjun] Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Li, YY (corresponding author), Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA.	mjzhang@utk.edu		Lenaghan, Scott/0000-0002-7539-1726				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Belhassen S, 2010, MED PHYS, V37, P1309, DOI 10.1118/1.3301610; Bezdek J, ADV APPL PATTERN REC; Blaas SH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-60; BOREHAM PFL, 1988, T ROY SOC TROP MED H, V82, P104, DOI 10.1016/0035-9203(88)90278-7; Cedillo-Rivera R, 2002, J EUKARYOT MICROBIOL, V49, P201, DOI 10.1111/j.1550-7408.2002.tb00523.x; CEDILLORIVERA R, 1992, J MED MICROBIOL, V37, P221, DOI 10.1099/00222615-37-3-221; Citron DM, 2005, ANAEROBE, V11, P315, DOI 10.1016/j.anaerobe.2005.04.005; Craun GF, 1996, WATERBORNE OUTBREAKS; Dasenbrook EC, 2010, AM J RESP CRIT CARE, V181; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; EDLIND TD, 1990, J INFECT DIS, V162, P1408, DOI 10.1093/infdis/162.6.1408; Erah PO, 1997, J ANTIMICROB CHEMOTH, V39, P5, DOI 10.1093/jac/39.1.5; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; GARDUNOESPINOSA J, 1992, REV INVEST CLIN, V44, P235; Green CE, 2009, AM J DRUG ALCOHOL AB, V35, P95, DOI 10.1080/00952990802647503; Harari O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000862; Ibrahim KH, 2004, PHARMACODYNAMICS PUL; KATELARIS PH, 1994, ALIMENT PHARM THERAP, V8, P187, DOI 10.1111/j.1365-2036.1994.tb00277.x; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kempker RR, 2010, J INFECTION, V61, P372, DOI 10.1016/j.jinf.2010.09.021; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kramer M H, 1996, MMWR CDC Surveill Summ, V45, P1; Locarnini S, 2010, J GASTROEN HEPATOL, V25, P649, DOI 10.1111/j.1440-1746.2010.06255.x; MELONI BP, 1990, T ROY SOC TROP MED H, V84, P375, DOI 10.1016/0035-9203(90)90324-8; Mohamed NA, 1999, INT CONF ACOUST SPEE, P3429, DOI 10.1109/ICASSP.1999.757579; Nelson R, 2010, AM J NURS, V110, P55, DOI 10.1097/01.NAJ.0000389678.80144.cb; Ron D, 1996, MACH LEARN, V25, P117, DOI 10.1007/BF00114008; Saritas I, 2009, J INTELL MANUF, V20, P169, DOI 10.1007/s10845-008-0226-x; Sun JK, 2010, DRUG DELIV, V17, P164, DOI 10.3109/10717541003667764; Tomasetti C, 2010, MATH BIOSCI ENG, V7, P905, DOI 10.3934/mbe.2010.7.905; UPCROFT JA, 1993, PARASITOL TODAY, V9, P187, DOI 10.1016/0169-4758(93)90144-5; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001	33	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31724	10.1371/journal.pone.0031724	http://dx.doi.org/10.1371/journal.pone.0031724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384063	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100031
J	Fournier, D; Tindo, M; Kenne, M; Masse, PSM; Van Bossche, V; De Coninck, E; Aron, S				Fournier, Denis; Tindo, Maurice; Kenne, Martin; Masse, Paul Serge Mbenoun; Van Bossche, Vanessa; De Coninck, Eliane; Aron, Serge			Genetic Structure, Nestmate Recognition and Behaviour of Two Cryptic Species of the Invasive Big-Headed Ant Pheidole megacephala	PLOS ONE			English	Article							DIVISION-OF-LABOR; WASMANNIA-AUROPUNCTATA; FIRE ANT; TRAMP ANT; INTRODUCED POPULATIONS; INBREEDING DEPRESSION; CHEMICAL RECOGNITION; COMPETITIVE ABILITY; CLONAL REPRODUCTION; ARGENTINE ANTS	Background: Biological invasions are recognized as a major cause of biodiversity decline and have considerable impact on the economy and human health. The African big-headed ant Pheidole megacephala is considered one of the world's most harmful invasive species. Methodology/Principal Findings: To better understand its ecological and demographic features, we combined behavioural (aggression tests), chemical (quantitative and qualitative analyses of cuticular lipids) and genetic (mitochondrial divergence and polymorphism of DNA microsatellite markers) data obtained for eight populations in Cameroon. Molecular data revealed two cryptic species of P. megacephala, one inhabiting urban areas and the other rainforests. Urban populations belong to the same phylogenetic group than those introduced in Australia and in other parts of the world. Behavioural analyses show that the eight populations sampled make up four mutually aggressive supercolonies. The maximum distance between nests from the same supercolony was 49 km and the closest distance between two nests belonging to two different supercolonies was 46 m. The genetic data and chemical analyses confirmed the behavioural tests as all of the nests were correctly assigned to their supercolony. Genetic diversity appears significantly greater in Africa than in introduced populations in Australia; by contrast, urban and Australian populations are characterized by a higher chemical diversity than rainforest ones. Conclusions/Significance: Overall, our study shows that populations of P. megacephala in Cameroon adopt a unicolonial social structure, like invasive populations in Australia. However, the size of the supercolonies appears several orders of magnitude smaller in Africa. This implies competition between African supercolonies and explains why they persist over evolutionary time scales.	[Fournier, Denis; Van Bossche, Vanessa; Aron, Serge] Univ Libre Bruxelles, Brussels, Belgium; [Tindo, Maurice; Kenne, Martin] Univ Douala, Dept Biol Organismes Anim, Fac Sci, Douala, Cameroon; [Masse, Paul Serge Mbenoun] Univ Yaounde I, Zool Lab, Fac Sci, Yaounde, Cameroon; [De Coninck, Eliane] Royal Museum Cent Africa, Tervuren, Belgium	Universite Libre de Bruxelles; University of Yaounde I; Royal Museum for Central Africa	Fournier, D (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	Denis.Fournier@ulb.ac.be	Fournier, Denis/EZX-2474-2022	Fournier, Denis/0000-0003-4094-0390	Belgian National Fund for Scientific Research; Universite Libre de Bruxelles (ULB)	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles (ULB)	Financial support for this study was provided by grants from the Belgian National Fund for Scientific Research and the Universite Libre de Bruxelles (ULB) to DF and SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEE W. C., 1949; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolton Barry, 1995, P1; BOOMSMA JJ, 1990, INSECT SOC, V37, P363, DOI 10.1007/BF02225998; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; Buczkowski G, 2004, MOL ECOL, V13, P2235, DOI 10.1111/j.1365-294X.2004.02261.x; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Cadotte MW, CONCEPTUAL ECOLOGY I; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CLARK DB, 1982, BIOTROPICA, V14, P196, DOI 10.2307/2388026; Crozier R.H., 1979, P223; Crozier R.H., 1985, P201; d'Ettorre P, 2010, ANT ECOLOGY, P194; Davis M. A., 2009, INVASION BIOL; Dejean A, 2008, CR BIOL, V331, P631, DOI 10.1016/j.crvi.2008.05.004; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; Deyrup M, 2000, T AM ENTOMOL SOC, V126, P293; DEYRUP MA, 1988, FLA ENTOMOL, V71, P163, DOI 10.2307/3495364; Drescher J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013581; Earl DA, 2009, STRUCTURE HARVESTER; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Folgarait PJ, 2004, ANN ENTOMOL SOC AM, V97, P450, DOI 10.1603/0013-8746(2004)097[0450:AGACIA]2.0.CO;2; Foucaud J, 2006, EVOLUTION, V60, P1646, DOI 10.1111/j.0014-3820.2006.tb00509.x; Foucaud J, 2009, MOL ECOL, V18, P5059, DOI 10.1111/j.1365-294X.2009.04440.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; Fournier D, 2008, MOL ECOL RESOUR, V8, P919, DOI 10.1111/j.1755-0998.2008.02116.x; Fournier D, 2008, ANIM BEHAV, V75, P151, DOI 10.1016/j.anbehav.2007.04.023; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Glemin S, 2003, EVOLUTION, V57, P2678; Goodnight KF, 2000, RELATEDNESS 5 0 8; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; GREENSLADE PJ, 1972, INSECT SOC, V19, P195, DOI 10.1007/BF02226626; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Hoffmann BD, 2008, BIOL INVASIONS, V10, P1171, DOI 10.1007/s10530-007-9194-x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kenne M, 1999, INSECT SOC, V46, P179, DOI 10.1007/s000400050130; Krushelnycky PD, 2010, ANT ECOLOGY, P245; Lach L, 2008, AUST J ENTOMOL, V47, P275, DOI 10.1111/j.1440-6055.2008.00659.x; Lach L, 2010, ANT ECOLOGY, P261; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Lockwood J, 2006, INVASION ECOLOGY; Lowe S, 2001, 100 WORLDS WORST INV; MANTEL N, 1967, CANCER RES, V27, P209; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Marzluff John M., 2005, Urban Ecosystems, V8, P157, DOI 10.1007/s11252-005-4378-6; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Mikheyev AS, 2007, DIVERS DISTRIB, V13, P573, DOI 10.1111/j.1472-4642.2007.00370.x; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Moreau CS, 2008, MOL PHYLOGENET EVOL, V48, P224, DOI 10.1016/j.ympev.2008.02.020; Newell W, 1913, US BUREAU ENTOMOLOGY; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Nieminen M, 2001, AM NAT, V157, P237, DOI 10.1086/318630; O'Dowd DJ, 1999, STATUS IMPACT RECOMM; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; PAMILO P, 1991, AM NAT, V138, P412, DOI 10.1086/285224; PAMILO P, 1985, HEREDITAS, V103, P195, DOI 10.1111/j.1601-5223.1985.tb00501.x; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; PASSERA L, 1994, WESTV STUD, P23; PATEL A D, 1990, Psyche (Cambridge), V97, P181, DOI 10.1155/1990/56747; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; PORTER SD, 1988, ANN ENTOMOL SOC AM, V81, P913, DOI 10.1093/aesa/81.6.913; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Roques A, 2010, ALIEN TERRESTRIAL AR; ROSS KG, 1993, GENETICS, V135, P843; Sambrook J., 2001, MOL CLONING LAB MANU; Sax D. F., 2005, SPECIES INVASIONS IN; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Steiner FM, 2007, CURR BIOL, V17, P1903, DOI 10.1016/j.cub.2007.09.061; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; SUAREZ AV, 1999, BIOL INVASIONS, V1, P1; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Tchouto MGP, 2009, SYST BIODIVERS, V7, P21, DOI 10.1017/S1477200008002892; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; Vogel V, 2009, EVOLUTION, V63, P1627, DOI 10.1111/j.1558-5646.2009.00628.x; Werren John H., 1993, P42; Wetterer JK, 2007, PAC SCI, V61, P437, DOI 10.2984/1534-6188(2007)61[437:BAIOPI]2.0.CO;2; Wetterer JK, 1999, FLA ENTOMOL, V82, P381, DOI 10.2307/3496865; Wetterer JK, 2003, SOCIOBIOLOGY, V42, P1; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P39; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; Wilson EO, 1990, SUCCESS DOMINANCE EC	117	27	27	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31480	10.1371/journal.pone.0031480	http://dx.doi.org/10.1371/journal.pone.0031480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22371822	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700063
J	O'Mahony, FC; Faratian, D; Varley, J; Nanda, J; Theodoulou, M; Riddick, ACP; Harrison, DJ; Stewart, GD				O'Mahony, Fiach C.; Faratian, Dana; Varley, James; Nanda, Jyoti; Theodoulou, Marianna; Riddick, Antony C. P.; Harrison, David J.; Stewart, Grant D.			The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-Mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; BIOMARKER; CANCER; DIFFERENTIATION; CLASSIFICATION; MICROARRAYS; DIAGNOSIS	Background: Epithelial-to-mesenchymal transition (EMT) has recently been implicated in the initiation and progression of renal cell carcinoma (RCC). Some mRNA gene expression studies have suggested a link between the EMT phenotype and poorer clinical outcome from RCC. This study evaluated expression of EMT-associated proteins in RCC using in situ automated quantitative analysis immunofluorescence (AQUA) and compared expression levels with clinical outcome. Methods/Principal Findings: Unsupervised hierarchical cluster analysis of pre-existing RCC gene expression array data (GSE16449) from 36 patients revealed the presence of an EMT transcriptional signature in RCC [E-cadherin high/SLUG low/SNAIL low]. As automated immunofluorescence technology is dependent on accurate definition of the tumour cells in which measurements take place is critical, extensive optimisation was carried out resulting in a novel pan-cadherin based tumour mask that distinguishes renal cancer cells from stromal components. 61 patients with ccRCC and clinical follow-up were subsequently assessed for expression of EMT-associated proteins (WT1, SNAIL, SLUG, E-cadherin and phospho-beta-catenin) on tissue microarrays. Using Kaplan-Meier analysis both SLUG (p = 0.029) and SNAIL (p = 0.024) (log rank Mantel-Cox) were significantly associated with prolonged progression free survival (PFS). Using Cox regression univariate and multivariate analysis none of the biomarkers were significantly correlated with outcome. 14 of the 61 patients expressed the gene expression analysis predicted EMT-protein signature [E-cadherin high/SLUG low/SNAIL low], which was not found to be associated to PFS when measured at the protein level. A combination of high expression of SNAIL and low stage was able to stratify patients with greater significance (p = 0.001) then either variable alone (high SNAIL p = 0.024, low stage p = 0.029). Conclusions: AQUA has been shown to have the potential to identify EMT related protein targets in RCC allowing for stratification of patients into high and low risk groups, as well the ability to assess the association of reputed EMT signatures to progression of the disease.	[O'Mahony, Fiach C.; Faratian, Dana; Varley, James; Nanda, Jyoti; Theodoulou, Marianna; Riddick, Antony C. P.; Harrison, David J.; Stewart, Grant D.] Univ Edinburgh, Edinburgh Urol Canc Grp, Div Pathol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	O'Mahony, FC (corresponding author), Univ Edinburgh, Edinburgh Urol Canc Grp, Div Pathol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	grant.stewart@ed.ac.uk		Stewart, Grant D./0000-0003-3188-9140; harrison, david/0000-0001-9041-9988	Chief Scientist Office [ETM37]; Cancer Research UK Experimental Cancer Medicine Centre; Chief Scientist Office [ETM/37] Funding Source: researchfish	Chief Scientist Office; Cancer Research UK Experimental Cancer Medicine Centre; Chief Scientist Office	The work of authors FCO, DF, JN, ACPR, DJH and GDS mentioned above is funded by the Chief Scientist Office, grant number ETM37, and supported by the Cancer Research UK Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Banumathy G, 2010, CANC BIOL THER, V10; Brannon A Rose, 2010, Genes Cancer, V1, P152; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; CancerResearchUK, 2010, KIDN CANC STAT; Chin Arnold I, 2006, Rev Urol, V8, P1; Dubois-Marshall S, 2011, CLIN EXP ME IN PRESS; Etzioni R, 2003, BIOSTATISTICS, V4, P523, DOI 10.1093/biostatistics/4.4.523; Faratian D, 2011, EUR J CANCER, V47, P1420, DOI 10.1016/j.ejca.2011.01.014; Faratian D, 2010, METHODS MOL BIOL, V662, P245, DOI 10.1007/978-1-60761-800-3_12; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Jayson M, 1998, UROLOGY, V51, P203, DOI 10.1016/S0090-4295(97)00506-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Kim MK, 2002, APPL IMMUNOHISTO M M, V10, P332, DOI 10.1097/00022744-200212000-00008; Kluger HM, 2008, LAB INVEST, V88, P962, DOI 10.1038/labinvest.2008.65; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Linehan WM, 2010, ANNU REV MED, V61, P329, DOI 10.1146/annurev.med.042808.171650; Mertz KD, 2007, HUM PATHOL, V38, P1454, DOI 10.1016/j.humpath.2007.05.017; Mikami S, 2011, LAB INVEST; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Renshaw AA, 1999, AM J CLIN PATHOL, V111, P539; Rosner I, 2009, UROL ONCOL-SEMIN ORI, V27, P131, DOI 10.1016/j.urolonc.2008.11.001; Stewart GD, 2011, NAT REV UROL, V8, P255, DOI 10.1038/nrurol.2011.43; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Truong LD, 2011, ARCH PATHOL LAB MED, V135, P92, DOI 10.1043/2010-0478-RAR.1; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhao HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006039	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31557	10.1371/journal.pone.0031557	http://dx.doi.org/10.1371/journal.pone.0031557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363672	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700070
J	Silvestrini, F; Tiburcio, M; Bertuccini, L; Alano, P				Silvestrini, Francesco; Tiburcio, Marta; Bertuccini, Lucia; Alano, Pietro			Differential Adhesive Properties of Sequestered Asexual and Sexual Stages of Plasmodium falciparum on Human Endothelial Cells Are Tissue Independent	PLOS ONE			English	Article							HUMAN BONE-MARROW; HEMATOPOIETIC PROGENITOR CELLS; INFECTED ERYTHROCYTES; TRANSENDOTHELIAL MIGRATION; TRANSMISSION STAGES; IN-VITRO; MALARIA; SEQUESTRATION; GAMETOCYTES; EXPRESSION	The protozoan parasite Plasmodium falciparum, responsible for the most severe form of malaria, is able to sequester from peripheral circulation during infection. The asexual stage parasites sequester by binding to endothelial cell receptors in the microvasculature of various organs. P. falciparum gametocytes, the developmental stages responsible for parasite transmission from humans to Anopheles mosquitoes, also spend the almost ten days necessary for their maturation sequestered away from the peripheral circulation before they are released in blood mainstream. In contrast to those of asexual parasites, the mechanisms and cellular interactions responsible for immature gametocyte sequestration are largely unexplored, and controversial evidence has been produced so far on this matter. Here we present a systematic comparison of cell binding properties of asexual stages and immature and mature gametocytes from the reference P. falciparum clone 3D7 and from a patient parasite isolate on a panel of human endothelial cells from different tissues. This analysis includes assays on human bone marrow derived endothelial cell lines (HBMEC), as this tissue has been proposed as a major site of gametocyte maturation. Our results clearly demonstrate that cell adhesion of asexual stage parasites is consistently more efficient than that, virtually undetectable of immature gametocytes, irrespectively of the endothelial cell lines used and of parasite genotypes. Importantly, immature gametocytes of both lines tested here do not show a higher binding efficiency compared to asexual stages on bone marrow derived endothelial cells, unlike previously reported in the only study on this issue. This indicates that gametocyte-host interactions in this tissue are unlikely to be mediated by the same adhesion processes to specific endothelial receptors as seen with asexual forms.	[Silvestrini, Francesco; Tiburcio, Marta; Alano, Pietro] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Bertuccini, Lucia] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Silvestrini, F (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	francesco.silvestrini@iss.it	ALANO, PIETRO/C-2946-2016; Bertuccini, Lucia/AAI-6683-2021; Silvestrini, Francesco/AAA-4221-2021; Silvestrini, Francesco/C-2963-2016; BERTUCCINI, LUCIA/F-2102-2015	ALANO, PIETRO/0000-0003-0092-9840; Bertuccini, Lucia/0000-0002-4278-2376; Silvestrini, Francesco/0000-0003-3288-5088; Silvestrini, Francesco/0000-0003-3288-5088; Tiburcio, Marta/0000-0002-9103-3777	EU [242095]; PITN [215281]; MALSIG [223044]	EU(European Commission); PITN; MALSIG	This work was supported by EU FP7 grants EVIMalaR (contract 242095), PITN InterMalTraining (contract 215281) and MALSIG (contract 223044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AH, 2010, AM J HEMATOL, V85, P943, DOI 10.1002/ajh.21796; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ALANO P, 1995, EXP PARASITOL, V81, P227, DOI 10.1006/expr.1995.1112; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; Bastianelli G., 1899, ATTI SOC STUDI MALAR, V1, P1; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; DETMAR M, 1992, J INVEST DERMATOL, V98, P147, DOI 10.1111/1523-1747.ep12555746; DLUZEWSKI AR, 1984, T ROY SOC TROP MED H, V78, P622, DOI 10.1016/0035-9203(84)90221-9; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; HAWKING F, 1971, T ROY SOC TROP MED H, V65, P549, DOI 10.1016/0035-9203(71)90036-8; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rogers NJ, 1996, INFECT IMMUN, V64, P1480, DOI 10.1128/IAI.64.4.1480-1483.1996; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Rood PML, 2000, EUR J CLIN INVEST, V30, P618; Rood PML, 1999, EXP HEMATOL, V27, P1306, DOI 10.1016/S0301-472X(99)00068-5; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Sasi P, 2009, J INFECT DIS, V199, P1575, DOI 10.1086/598862; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Schweitzer KM, 1997, LAB INVEST, V76, P25; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; Voermans C, 2000, STEM CELLS, V18, P435, DOI 10.1634/stemcells.18-6-435; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024784	36	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31567	10.1371/journal.pone.0031567	http://dx.doi.org/10.1371/journal.pone.0031567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363675	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700073
J	Benavides, J; Walsh, PD; Meyers, LA; Raymond, M; Caillaud, D				Benavides, Julio; Walsh, Peter D.; Meyers, Lauren Ancel; Raymond, Michel; Caillaud, Damien			Transmission of Infectious Diseases En Route to Habitat Hotspots	PLOS ONE			English	Article							OUTBREAK; SARS; NETWORKS; DYNAMICS; EPIDEMIOLOGY; DEFECATION; CYTOKINES; GORILLAS; BEHAVIOR; MAMMALS	Background: The spread of infectious diseases in wildlife populations is influenced by patterns of between-host contacts. Habitat "hotspots'' - places attracting a large numbers of individuals or social groups - can significantly alter contact patterns and, hence, disease propagation. Research on the importance of habitat hotspots in wildlife epidemiology has primarily focused on how inter-individual contacts occurring at the hotspot itself increase disease transmission. However, in territorial animals, epidemiologically important contacts may primarily occur as animals cross through territories of conspecifics en route to habitat hotspots. So far, the phenomenon has received little attention. Here, we investigate the importance of these contacts in the case where infectious individuals keep visiting the hotspots and in the case where these individuals are not able to travel to the hotspot any more. Methodology and Principal Findings: We developed a simulation epidemiological model to investigate both cases in a scenario when transmission at the hotspot does not occur. We find that (i) hotspots still exacerbate epidemics, (ii) when infectious individuals do not travel to the hotspot, the most vulnerable individuals are those residing at intermediate distances from the hotspot rather than nearby, and (iii) the epidemiological vulnerability of a population is the highest when the number of hotspots is intermediate. Conclusions and Significance: By altering animal movements in their vicinity, habitat hotspots can thus strongly increase the spread of infectious diseases, even when disease transmission does not occur at the hotspot itself. Interestingly, when animals only visit the nearest hotspot, creating additional artificial hotspots, rather than reducing their number, may be an efficient disease control measure.	[Benavides, Julio; Raymond, Michel] Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France; [Walsh, Peter D.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Meyers, Lauren Ancel; Caillaud, Damien] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Div Stat & Sci Computat, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Cambridge; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; The Santa Fe Institute	Benavides, J (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France.	benavidesjulio@yahoo.fr	Caillaud, Damien/AAH-5850-2019; Raymond, Michel/C-9049-2015	Caillaud, Damien/0000-0002-8347-6869; Raymond, Michel/0000-0002-1714-6984; Benavides, Julio/0000-0002-3920-9165; Meyers, Lauren/0000-0002-5828-8874	Ministere Francais de l'Enseignement superieur; Chilean Government; NSF [DEB-0749097]; National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation	Ministere Francais de l'Enseignement superieur; Chilean Government; NSF(National Science Foundation (NSF)); National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received financial support from the Ministere Francais de l'Enseignement superieur, a CONICYT scholarship from the Chilean Government to JB and NSF Grant DEB-0749097 to LAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted as part of the "Efficient Wildlife Disease Control: From Social Network Self-Organization to Optimal Vaccination'' Working Group supported by the National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara. We thank Gaston B., R. Bodenham, A. Courtiol, V. Durand and E. Huchard for their support. This is contribution ISEM 2012-009.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Blake John G., 2011, Diversity, V3, P217, DOI 10.3390/d3020217; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dantzer R, 1999, ADV EXP MED BIOL, V461, P83; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Dybiec B, 2009, J R SOC INTERFACE, V6, P941, DOI 10.1098/rsif.2008.0468; Ezenwa VO, 2004, ETHOLOGY, V110, P851, DOI 10.1111/j.1439-0310.2004.01013.x; Ezenwa VO, 2003, PARASITOLOGY, V126, P379, DOI 10.1017/S0031182002002913; FREESE C H, 1978, Primates, V19, P275, DOI 10.1007/BF02382797; FRISCH HL, 1963, J SOC IND APPL MATH, V11, P894, DOI 10.1137/0111066; Gilbert KA, 1997, ANIM BEHAV, V54, P451, DOI 10.1006/anbe.1996.0439; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Henshaw J., 1971, AFR J ECOL, V9, P73, DOI [10.1111/j.1365-2028.1971.tb00221.x, DOI 10.1111/J.1365-2028.1971.TB00221.X]; Hofle U, 2004, EUR J WILDLIFE RES, V50, P73, DOI 10.1007/s10344-004-0043-2; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Matsubayashi H, 2007, ECOL RES, V22, P742, DOI 10.1007/s11284-006-0313-4; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Vanleeuwe H, 1998, REV ECOL-TERRE VIE, V53, P171; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326	40	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31290	10.1371/journal.pone.0031290	http://dx.doi.org/10.1371/journal.pone.0031290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363606	Green Published, gold			2022-12-25	WOS:000302871500031
J	Calderon, LE; Liu, S; Su, W; Xie, ZW; Guo, ZH; Eberhard, W; Gong, MC				Calderon, Lindsay E.; Liu, Shu; Su, Wen; Xie, Zhongwen; Guo, Zhenheng; Eberhard, Wanda; Gong, Ming C.			iPLA(2)beta Overexpression in Smooth Muscle Exacerbates Angiotensin II-Induced Hypertension and Vascular Remodeling	PLOS ONE			English	Article							INDEPENDENT PHOSPHOLIPASE A(2)BETA; ARACHIDONIC-ACID RELEASE; ACTIVATION; MECHANISM; KINASE; EXPRESSION; CELLS; MICE; HYPERCONTRACTILITY; PHOSPHORYLATION	Objectives: Calcium independent group VIA phospholipase A(2) (iPLA(2)beta) is up-regulated in vascular smooth muscle cells in some diseases, but whether the up-regulated iPLA(2)beta affects vascular morphology and blood pressure is unknown. The current study addresses this question by evaluating the basal-and angiotensin II infusion-induced vascular remodeling and hypertension in smooth muscle specific iPLA(2)beta transgenic (iPLA(2)beta-Tg) mice. Method and Results: Blood pressure was monitored by radiotelemetry and vascular remodeling was assessed by morphologic analysis. We found that the angiotensin II-induced increase in diastolic pressure was significantly higher in iPLA(2)beta-Tg than iPLA(2)beta-Wt mice, whereas, the basal blood pressure was not significantly different. The media thickness and media: lumen ratio of the mesenteric arteries were significantly increased in angiotensin II-infused iPLA(2)beta-Tg mice. Analysis revealed no difference in vascular smooth muscle cell proliferation. In contrast, adenovirus-mediated iPLA(2)beta overexpression in cultured vascular smooth muscle cells promoted angiotensin II-induced [H-3]-leucine incorporation, indicating enhanced hypertrophy. Moreover, angiotensin II infusion-induced c-Jun phosphorylation in vascular smooth muscle cells overexpressing iPLA(2)beta to higher levels, which was abolished by inhibition of 12/15 lipoxygenase. In addition, we found that angiotensin II up-regulated the endogenous iPLA(2)beta protein in-vitro and in-vivo. Conclusion: The present study reports that iPLA(2)beta up-regulation exacerbates angiotensin II-induced vascular smooth muscle cell hypertrophy, vascular remodeling and hypertension via the 12/15 lipoxygenase and c-Jun pathways.	[Calderon, Lindsay E.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Xie, Zhongwen; Eberhard, Wanda; Gong, Ming C.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Liu, Shu; Su, Wen; Guo, Zhenheng] Univ Kentucky, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Calderon, LE (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	mcgong2@uky.edu		Calderon, Lindsay/0000-0003-0919-0077	National Institute of Health (NIH) [HL-082791, HL-088389, T32-HL072743]; American Heart Association (AHA) [09PRE2300152]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389, T32HL072743] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health (NIH) grants HL-082791 to M.C.G. and HL-088389 to Z.G. L.E.C. was supported by an American Heart Association (AHA) Fellowship-09PRE2300152 and a National Institute of Health (NIH) T32-HL072743. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anning PB, 2005, AM J PATHOL, V166, P653, DOI 10.1016/S0002-9440(10)62287-0; Boittin FX, 2008, AM J PHYSIOL-HEART C, V295, pH2466, DOI 10.1152/ajpheart.00639.2008; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; Freeman EJ, 1998, AM J PHYSIOL-CELL PH, V274, pC282, DOI 10.1152/ajpcell.1998.274.1.C282; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jennings BL, 2010, HYPERTENSION, V56, P667, DOI 10.1161/HYPERTENSIONAHA.110.154518; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Li F, 2005, AM J PHYSIOL-HEART C, V288, pH2306, DOI 10.1152/ajpheart.00571.2004; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; McEniery CM, 2005, HYPERTENSION, V46, P221, DOI 10.1161/01.HYP.0000165310.84801.e0; McHowat J, 2011, AM J PHYSIOL-CELL PH, V300, pC825, DOI 10.1152/ajpcell.00502.2010; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; NOZAWA K, 1990, AM J PHYSIOL, V259, pH1774, DOI 10.1152/ajpheart.1990.259.6.H1774; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; Poulsen KA, 2007, AM J PHYSIOL-CELL PH, V293, pC1605, DOI 10.1152/ajpcell.00012.2007; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Strokin M, 2011, AM J PHYSIOL-CELL PH, V300, pC542, DOI 10.1152/ajpcell.00428.2010; Tanaka K, 2011, ARTERIOSCL THROM VAS, V31, P1133, DOI 10.1161/ATVBAHA.110.218370; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yaghini FA, 2007, J BIOL CHEM, V282, P16878, DOI 10.1074/jbc.M610494200; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zafari AM, 1999, ANTIOXID REDOX SIGN, V1, P167, DOI 10.1089/ars.1999.1.2-167; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31850	10.1371/journal.pone.0031850	http://dx.doi.org/10.1371/journal.pone.0031850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363752	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500096
J	Larsen, J; Imanishi, M; Hinjoy, S; Tharavichitkul, P; Duangsong, K; Davis, MF; Nelson, KE; Larsen, AR; Skov, RL				Larsen, Jesper; Imanishi, Maho; Hinjoy, Soawapak; Tharavichitkul, Prasit; Duangsong, Kwanjit; Davis, Meghan F.; Nelson, Kenrad E.; Larsen, Anders R.; Skov, Robert L.			Methicillin-Resistant Staphylococcus aureus ST9 in Pigs in Thailand	PLOS ONE			English	Article							EMERGENCE; CLONES; MEC	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial and community-associated pathogen. Recently, livestock-associated MRSA (LA-MRSA) has emerged and disseminated in Europe and North America and now constitutes a considerable zoonotic burden in humans with risk factors of pig exposure, whereas the extent of the livestock reservoir is relatively unknown on other continents. Methodology/Principal Findings: From March through April 2011, MRSA was identified in pigs from 3 out of 30 production holdings in Chang Mai Province, Thailand. Representative isolates were subjected to molecular characterization and antimicrobial susceptibility testing; all isolates had genotypic and phenotypic characteristics of LA-MRSA previously characterized in the region: they belonged to ST9, lacked the lukF-lukS genes encoding Panton-Valentine leukocidin, and were resistant to multiple non-beta-lactam antimicrobials. However, unlike other Asian LA-MRSA-ST9 variants, they were spa type t337 and harbored a different staphylococcal cassette chromosome mec IX. Conclusions/Significance: A novel MRSA-ST9 lineage has been established in the pig population of Thailand, which differs substantially from LA-MRSA lineages found in other areas of the continent. The emergence of novel LA-MRSA lineages in the animal agriculture setting is worrisome and poses a serious threat to global public health.	[Larsen, Jesper; Larsen, Anders R.; Skov, Robert L.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Imanishi, Maho; Hinjoy, Soawapak; Nelson, Kenrad E.] Johns Hopkins Univ, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hinjoy, Soawapak] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi, Thailand; [Tharavichitkul, Prasit; Duangsong, Kwanjit] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50000, Thailand; [Davis, Meghan F.] Johns Hopkins Univ, Dept Environm Hlth Sci, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ministry of Public Health - Thailand; Chiang Mai University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Larsen, J (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	JRL@ssi.dk	Larsen, Jesper/AAJ-3161-2021; Davis, Meghan F./C-1494-2013; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Davis, Meghan F./0000-0002-3475-4578; Skov, Robert/0000-0002-6079-5381; Larsen, Anders Rhod/0000-0002-1713-8765; Duangsonk, Kwanjit/0000-0002-3325-1688	Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America	Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America	This study was supported by the Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/World Bank, 2010, 169 UN FAO WORLD ORG; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Lim SK, 2011, VET MICROBI IN PRESS; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Nickerson EK, 2011, AM J TROP MED HYG, V84, P313, DOI 10.4269/ajtmh.2011.10-0300; Perazzi B, 2006, J CLIN MICROBIOL, V44, P3634, DOI 10.1128/JCM.00137-06; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	24	46	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31245	10.1371/journal.pone.0031245	http://dx.doi.org/10.1371/journal.pone.0031245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363594	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600129
J	Wu, XS; Chang, XP; Jing, RL				Wu, Xianshan; Chang, Xiaoping; Jing, Ruilian			Genetic Insight into Yield-Associated Traits of Wheat Grown in Multiple Rain-Fed Environments	PLOS ONE			English	Article							BACKCROSS QTL ANALYSIS; GRAIN-YIELD; AGRONOMIC TRAITS; HEXAPLOID WHEAT; DURUM-WHEAT; MOLECULAR-DETECTION; ORYZA-RUFIPOGON; QUALITY TRAITS; CHROMOSOME 3A; MAPPING QTLS	Background: Grain yield is a key economic driver of successful wheat production. Due to its complex nature, little is known regarding its genetic control. The goal of this study was to identify important quantitative trait loci (QTL) directly and indirectly affecting grain yield using doubled haploid lines derived from a cross between Hanxuan 10 and Lumai 14. Methodology/Principal Findings: Ten yield-associated traits, including yield per plant (YP), number of spikes per plant (NSP), number of grains per spike (NGS), one-thousand grain weight (TGW), total number of spikelets per spike (TNSS), number of sterile spikelets per spike (NSSS), proportion of fertile spikelets per spike (PFSS), spike length (SL), density of spikelets per spike (DSS) and plant height (PH), were assessed across 14 (for YP) to 23 (for TGW) year x location x water regime environments in China. Then, the genetic effects were partitioned into additive main effects (a), epistatic main effects (aa) and their environment interaction effects (ae and aae) by using composite interval mapping in a mixed linear model. Conclusions/Significance: Twelve (YP) to 33 (PH) QTLs were identified on all 21 chromosomes except 6D. QTLs were more frequently observed on chromosomes 1B, 2B, 2D, 5A and 6B, and were concentrated in a few regions on individual chromosomes, exemplified by three striking yield-related QTL clusters on chromosomes 2B, 1B and 4B that explained the correlations between YP and other traits. The additive main-effect QTLs contributed more phenotypic variation than the epistasis and environmental interaction. Consistent with agronomic analyses, a group of progeny derived by selecting TGW and NGS, with higher grain yield, had an increased frequency of QTL for high YP, NGS, TGW, TNSS, PFSS, SL, PH and fewer NSSS, when compared to low yielding progeny. This indicated that it is feasible by marker-assisted selection to facilitate wheat production.	[Wu, Xianshan; Chang, Xiaoping; Jing, Ruilian] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wu, XS (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	jingrl@caas.net.cn			National Basic Research Program of China [2010CB951501]; Generation Challenge Program [G7010.02.01]	National Basic Research Program of China(National Basic Research Program of China); Generation Challenge Program	This work was supported by the National Basic Research Program of China (2010CB951501), and the Generation Challenge Program (G7010.02.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki E, 1999, THEOR APPL GENET, V98, P977, DOI 10.1007/s001220051158; Araus JL, 2003, CROP SCI, V43, P170, DOI 10.2135/cropsci2003.0170; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Causse M, 2007, THEOR APPL GENET, V115, P429, DOI 10.1007/s00122-007-0578-1; CECCARELLI S, 1991, EUPHYTICA, V56, P169, DOI 10.1007/BF00042061; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hao ZF, 2003, SCI AGR SIN, V2, P943; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Jing RL, 1999, BIOTECHNOLOGY, V9, P4; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li ZK, 1997, GENETICS, V145, P453; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rattey A, 2009, CROP PASTURE SCI, V60, P717, DOI 10.1071/CP08460; Reynolds M, 2009, ANN APPL BIOL, V155, P309, DOI 10.1111/j.1744-7348.2009.00351.x; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Tan LB, 2008, GENOME, V51, P692, DOI 10.1139/G08-054; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Yang DL, 2007, GENETICS, V176, P571, DOI 10.1534/genetics.106.068361; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Zhou XiaoGuo, 2005, Scientia Agricultura Sinica, V38, P1951; Zhuang JY, 2002, THEOR APPL GENET, V105, P1137, DOI 10.1007/s00122-002-0974-5	49	129	137	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31249	10.1371/journal.pone.0031249	http://dx.doi.org/10.1371/journal.pone.0031249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363596	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600130
J	Peshenko, IV; Olshevskaya, EV; Lim, S; Ames, JB; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Lim, Sunghyuk; Ames, James B.; Dizhoor, Alexander M.			Calcium-Myristoyl Tug Is a New Mechanism for Intramolecular Tuning of Calcium Sensitivity and Target Enzyme Interaction for Guanylyl Cyclase-activating Protein 1 DYNAMIC CONNECTION BETWEEN N-FATTY ACYL GROUP AND EF-HAND CONTROLS CALCIUM SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING-PROPERTIES; GCAP1; CA2+; RECOVERIN; MUTATION; RETGC; RODS	Guanylyl cyclase-activating protein 1 (GCAP1), a myristoylated Ca2+ sensor in vision, regulates retinal guanylyl cyclase (RetGC). We show that protein-myristoyl group interactions control Ca2+ sensitivity, apparent affinity for RetGC, and maximal level of cyclase activation. Mutating residues near the myristoyl moiety affected the affinity of Ca2+ binding to EF-hand 4. Inserting Phe residues in the cavity around the myristoyl group increased both the affinity of GCAP1 for RetGC and maximal activation of the cyclase. NMR spectra show that the myristoyl group in the L80F/L176F/V180F mutant remained sequestered inside GCAP1 in both Ca2+-bound and Mg2+-bound states. This mutant displayed much higher affinity for the cyclase but reduced Ca2+ sensitivity of the cyclase regulation. The L176F substitution improved affinity of myristoylated and non-acylated GCAP1 for the cyclase but simultaneously reduced the affinity of Ca2+ binding to EF-hand 4 and Ca2+ sensitivity of the cyclase regulation by acylated GCAP1. The replacement of amino acids near both ends of the myristoyl moiety (Leu(80) and Val(180)) minimally affected regulatory properties of GCAP1. N-Lauryl- and N-myristoyl-GCAP1 activated RetGC in a similar fashion. Thus, protein interactions with the central region of the fatty acyl chain optimize GCAP1 binding to RetGC and maximize activation of the cyclase. We propose a dynamic connection (or "tug") between the fatty acyl group and EF-hand 4 via the C-terminal helix that attenuates the efficiency of RetGC activation in exchange for optimal Ca2+ sensitivity.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA 19027 USA; [Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522, EY012347]; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) from the NEI. This work was also supported by a formula grant from the Pennsylvania Department of Health.	Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Helten A, 2007, BIOCHEM BIOPH RES CO, V356, P687, DOI 10.1016/j.bbrc.2007.03.023; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; JOHNSON RS, 1994, J BIOL CHEM, V269, P21067; Kawamura S, 2002, ADV EXP MED BIOL, V514, P61; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nakatani K, 2002, ADV EXP MED BIOL, V514, P1; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	69	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13972	13984		10.1074/jbc.M112.341883	http://dx.doi.org/10.1074/jbc.M112.341883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383530	Green Published, hybrid			2022-12-25	WOS:000303996300052
J	Puvirajesinghe, TM; Elantak, L; Lignon, S; Franche, N; Ilbert, M; Ansaldi, M				Puvirajesinghe, Tania M.; Elantak, Latifa; Lignon, Sabrina; Franche, Nathalie; Ilbert, Marianne; Ansaldi, Mireille			DnaJ (Hsp40 Protein) Binding to Folded Substrate Impacts KplE1 Prophage Excision Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR INHIBITOR; ESCHERICHIA-COLI; CHAPERONE MACHINES; IN-VIVO; HSP70; RECOMBINATION; REPLICATION; SPECIFICITY; GROEL; PHAGE	Temperate phages mediate gene transfer and can modify the properties of their host organisms through the acquisition of novel genes, a process called lysogeny. The KplE1 prophage is one of the 10 prophage regions in Escherichia coli K12 MG1655. KplE1 is defective for lysis but fully competent for site-specific recombination. The TorI recombination directionality factor is strictly required for prophage excision from the host genome. We have previously shown that DnaJ promotes KplE1 excision by increasing the affinity of TorI for its site-specific recombination DNA target. Here, we provide evidence of a direct association between TorI and DnaJ using in vitro cross-linking assays and limited proteolysis experiments that show that this interaction allows both proteins to be transiently protected from trypsin digestion. Interestingly, NMR titration experiments showed that binding of DnaJ involves specific regions of the TorI structure. These regions, mainly composed of alpha-helices, are located on a surface opposite the DNA-binding site. Taken together, we propose that DnaJ, without the aid of DnaK/GrpE, is capable of increasing the efficiency of KplE1 excision by causing a conformational stabilization that allows TorI to adopt a more favorable conformation for binding to its specific DNA target.	[Puvirajesinghe, Tania M.; Franche, Nathalie; Ansaldi, Mireille] Aix Marseille Univ, CNRS UMR7283, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Elantak, Latifa] Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Lignon, Sabrina] Aix Marseille Univ, Prote Facil MaP Marseille Prote IBiSA, F-13402 Marseille 20, France; [Ilbert, Marianne] Aix Marseille Univ, Inst Microbiol Mediterranee, Bioenerget & Ingn Prot CNRS UMR7281, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Ansaldi, M (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, CNRS UMR7283, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	ansaldi@imm.cnrs.fr	Puvirajesinghe, Tania/AAD-9137-2020; Ilbert, marianne/ABG-5015-2021; ELANTAK, Latifa/S-7004-2019	ANSALDI, Mireille/0000-0002-2878-0702; ilbert, marianne/0000-0002-9070-2334; Puvirajesinghe, Tania/0000-0002-8304-9824	CNRS; French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie); National Research Agency [ANR-08-BLAN-0122-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie)(Ministry of Research, France); National Research Agency(French National Research Agency (ANR))	This work was supported by CNRS, the French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie), and National Research Agency Grant ANR-08-BLAN-0122-01.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Ansaldi M, 2004, P NATL ACAD SCI USA, V101, P9423, DOI 10.1073/pnas.0401927101; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Champ S, 2011, J BIOL CHEM, V286, P38876, DOI 10.1074/jbc.M111.281865; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; ElAntak L, 2005, J BIOL CHEM, V280, P36802, DOI 10.1074/jbc.M507409200; Erales J, 2009, J BIOL CHEM, V284, P12735, DOI 10.1074/jbc.M808254200; Esposito D, 1997, VIROLOGY, V234, P267, DOI 10.1006/viro.1997.8646; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudd KE, 1999, RES MICROBIOL, V150, P653, DOI 10.1016/S0923-2508(99)00126-6; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025	30	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14169	14177		10.1074/jbc.M111.331462	http://dx.doi.org/10.1074/jbc.M111.331462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378785	hybrid, Green Published			2022-12-25	WOS:000303996300069
J	Cousins, SL; Stephenson, FA				Cousins, Sarah L.; Stephenson, F. Anne			Identification of N-Methyl-D-aspartic Acid (NMDA) Receptor Subtype-specific Binding Sites That Mediate Direct Interactions with Scaffold Protein PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR INTERACTION; SH3 DOMAIN; SUBUNITS; RECOGNITION; EXPRESSION; SURFACE; CELLS; SRC; MECHANISM; RESIDUES	N-methyl-D-aspartate (NMDA) neurotransmitter receptors and the postsynaptic density-95 (PSD-95) membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins are integral components of post-synaptic macromolecular signaling complexes that serve to propagate glutamate responses intracellularly. Classically, NMDA receptor NR2 subunits associate with PSD-95 MAGUKs via a conserved ES(E/D) V amino acid sequence located at their C termini. We previously challenged this dogma to demonstrate a second non-ES(E/D) V PSD-95-binding site in both NMDA receptor NR2A and NR2B subunits. Here, using a combination of co-immunoprecipitations from transfected mammalian cells, yeast two-hybrid interaction assays, and glutathione S-transferase (GST) pulldown assays, we show that NR2A subunits interact directly with PSD-95 via the C-terminal ESDV motif and additionally via an Src homology 3 domain-binding motif that associates with the Src homology 3 domain of PSD-95. Peptide inhibition of co-immunoprecipitations of NR2A and PSD-95 demonstrates that both the ESDV and non-ESDV sites are required for association in native brain tissue. Furthermore, we refine the non-ESDV site within NR2B to residues 1149-1157. These findings provide a molecular basis for the differential association of NMDA receptor subtypes with PSD-95 MAGUK scaffold proteins. These selective interactions may contribute to the organization, lateral mobility, and ultimately the function of NMDA receptor subtypes at synapses. Furthermore, they provide a more general molecular mechanism by which the scaffold, PSD-95, may discriminate between potential interacting partner proteins.	[Cousins, Sarah L.; Stephenson, F. Anne] UCL, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), UCL, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/G003718/1] Funding Source: researchfish; BBSRC [BB/G003718/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arbuckle MI, 2010, EMBO REP, V11, P473, DOI 10.1038/embor.2010.63; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; CHAZOT PL, 1992, J NEUROCHEM, V59, P1176, DOI 10.1111/j.1471-4159.1992.tb08364.x; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Niethammer M, 1996, J NEUROSCI, V16, P2157; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Rutter AR, 2000, J NEUROCHEM, V75, P2501, DOI 10.1046/j.1471-4159.2000.0752501.x; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200	40	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13465	13476		10.1074/jbc.M111.292862	http://dx.doi.org/10.1074/jbc.M111.292862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375001	hybrid, Green Published			2022-12-25	WOS:000302903700080
J	Pasiakos, SM; Karl, JP; Lutz, LJ; Murphy, NE; Margolis, LM; Rood, JC; Cable, SJ; Williams, KW; Young, AJ; McClung, JP				Pasiakos, Stefan M.; Karl, J. Philip; Lutz, Laura J.; Murphy, Nancy E.; Margolis, Lee M.; Rood, Jennifer C.; Cable, Sonya J.; Williams, Kelly W.; Young, Andrew J.; McClung, James P.			Cardiometabolic Risk in US Army Recruits and the Effects of Basic Combat Training	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLACEBO-CONTROLLED TRIAL; PREDICTING BODY DENSITY; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; UNITED-STATES; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; BLOOD-LIPIDS; YOUNG-ADULTS	Background: Cardiometabolic disease risk in US military recruits and the effects of military training have not been determined. This study examined lifestyle factors and biomarkers associated with cardiometabolic risk in US Army recruits (209; 118 male, 91 female, 23 +/- 5 yr) before, during, and after basic combat training (BCT). Methodology/Principal Findings: Anthropometrics; fasting total (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol; triglycerides (TG); glucose; and insulin were measured at baseline and every 3 wks during the 10 wk BCT course. At baseline, 14% of recruits were obese (BMI>30 kg/m(2)), 27% were cigarette smokers, 37% were sedentary, and 34% reported a family history of cardiometabolic disease. TC was above recommended levels in 8%, LDL in 39%, TG in 5%, and glucose in 8% of recruits, and HDL was below recommended levels in 33% of recruits at baseline. By week 9, TC decreased 8%, LDL 10%, TG 13%, glucose 6% and homeostasis model assessment of insulin resistance (HOMA-IR) 40% in men (P<0.05). In women, TC, LDL, glucose and HOMA-IR were decreased from baseline at weeks 3 and 6 (P<0.05), but were not different from baseline levels at week 9. During BCT, body weight declined in men but not women, while body fat percentage declined in both men and women (P<0.05). Conclusions/Significance: At the start of military service, the prevalence of cardiometabolic risk in US military recruits is comparable to that reported in similar, college-aged populations. Military training appears to be an effective strategy that may mitigate risk in young people through improvements in lipid profiles and glycemic control.	[Pasiakos, Stefan M.; Karl, J. Philip; Lutz, Laura J.; Murphy, Nancy E.; Margolis, Lee M.; Young, Andrew J.; McClung, James P.] USA, Environm Med Res Inst, Mil Nutr Div, Natick, MA 01760 USA; [Rood, Jennifer C.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Cable, Sonya J.; Williams, Kelly W.] Directorate Basic Combat Training, Ft Jackson, SC USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Pasiakos, SM (corresponding author), USA, Environm Med Res Inst, Mil Nutr Div, Natick, MA 01760 USA.	james.mcclung@amedd.army.mil	Pasiakos, Stefan M/E-6295-2014; Rood, Jennifer/N-1989-2017; McClung, James P/A-1989-2009	Pasiakos, Stefan M/0000-0002-5378-5820; Rood, Jennifer/0000-0001-5848-2987; Karl, J. Philip/0000-0002-5871-2241; , Lee/0000-0002-0652-1304; Margolis, Lee/0000-0003-1697-825X	United States Army Medical Research and Materiel Command	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was funded by the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, ACSMS GUIDELINES EXE, P55; Benjamin RM, 2011, PUBLIC HEALTH REP, V126, P310, DOI 10.1177/003335491112600302; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bray RM, 2009, 2008 DEP DEFENSE SUR; Burke JD, 2009, J AM DIET ASSOC, V109, P1751, DOI 10.1016/j.jada.2009.07.005; Carroll MD, 2011, AM J CARDIOL, V107, P1868, DOI 10.1016/j.amjcard.2011.03.047; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Department of the Army, 2006, 6009 AR DEP ARM, V600, P9; Department of the Army, 2007, 40501 AR DEP ARM, P40; Department of the Army, 2001, 4025 AR DEP ARM, P40; Department of the Army, 2005, 3022 AR DEP ARM, P30; Dugas LR, 2011, OBESITY, V19, P2099, DOI 10.1038/oby.2011.52; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Halbert JA, 1999, EUR J CLIN NUTR, V53, P514, DOI 10.1038/sj.ejcn.1600784; Harris JR, 2011, J OCCUP ENVIRON MED, V53, P132, DOI 10.1097/JOM.0b013e3182045f2c; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Heyward VH, 1996, SPORTS MED, V22, P146, DOI 10.2165/00007256-199622030-00002; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P62; Knapik JJ, 2007, INT J SPORTS MED, V28, P106, DOI 10.1055/s-2006-924147; Knapik JJ, 2006, SPORTS MED, V36, P613, DOI 10.2165/00007256-200636070-00005; Kuklina EV, 2010, ANN FAM MED, V8, P327, DOI 10.1370/afm.1137; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li CY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-46; Liao Youlian, 2011, Morbidity and Mortality Weekly Report, V60, P1; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McClung JP, 2009, AM J CLIN NUTR, V90, P124, DOI 10.3945/ajcn.2009.27774; McCracken Melissa, 2007, Prev Chronic Dis, V4, pA25; McGill HC, 2000, CIRCULATION, V102, P374; McGraw LK, 2008, J CARDIOVASC NURS, V23, P338, DOI 10.1097/01.JCN.0000317437.75081.e7; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Okosun IS, 2010, J CLIN HYPERTENS, V12, P636, DOI 10.1111/j.1751-7176.2010.00338.x; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Sacheck JM, 2010, MED SCI SPORT EXER, V42, P1039, DOI 10.1249/MSS.0b013e3181c9216b; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Zhao GX, 2011, J AM GERIATR SOC, V59, P132, DOI 10.1111/j.1532-5415.2010.03236.x	52	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31222	10.1371/journal.pone.0031222	http://dx.doi.org/10.1371/journal.pone.0031222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384004	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100016
J	Andernach, IE; Jutavijittum, P; Samountry, B; Yousukh, A; Thammavong, T; Hubschen, JM; Muller, CP				Andernach, Iris E.; Jutavijittum, Prapan; Samountry, Bounthome; Yousukh, Amnat; Thammavong, Te; Huebschen, Judith M.; Muller, Claude P.			A High Variability of Mixed Infections and Recent Recombinations of Hepatitis B Virus in Laos	PLOS ONE			English	Article							GENOTYPE-C; HIGH PREVALENCE; SUBGENOTYPES; MUTATIONS; SUBTYPES; STRAINS; GENESIS	In Lao PDR, where more than 8% of the population are chronic carriers of HBsAg, multiple genotypes and subgenotypes co-circulate and are prone to generate recombinant viruses. Phylogenetic analyses of multiple clones per donor revealed mixed infections of subgenotypes B1, B2, B4, C1, C5, I1 and I2 in almost 6% of HBsAg positive rejected blood donors. Recombination analyses and distance calculations furthermore showed that about 65% (17/26) of the mixed infected donors showed recombinations in the S-gene alone, involving the predominant genotypes B and C. These results suggest that, at least in Laos, hepatitis B virus (HBV) mixed infections lead to frequent recombinations. In many donors with recombinant strains, the recombinant fragment and a non-recombinant strain of the same genotype co-existed (127/185 analysed recombinant fragments). For a large proportion of these (60/127), the most closely related known virus was found, although not always exclusively, in the same donor. Recombinant virus strains are largely distinct. This is reflected in an unexpected diversity in recombination breakpoints and the relatively rare recombinations with identical recombination patterns of the same genotypes in different donors. Recent recombination events would explain the limited spread of each of the recombinants. Using a published mutation rate of 4.2 x 10(-5) mutations per site and year, the observed minimum genetic distances of 0-0.60% between parent strain and recombinant fragment would correspond to 0-71 years of evolution from a most recent common ancestor (MRCA). Thus several lines of evidence are suggestive of recent independent recombination events, a proportion of these even occurring within the same donors. In conclusion, our analyses revealed a high variability of mixed infections as a very probable breeding ground of multiple variable recombination events in Laos that so far have not led to new dominant strains.	[Andernach, Iris E.; Huebschen, Judith M.; Muller, Claude P.] Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg; [Jutavijittum, Prapan; Yousukh, Amnat] Chiang Mai Univ, Dept Pathol, Chiang Mai 50000, Thailand; [Samountry, Bounthome] Univ Hlth Sci, Dept Pathol, Viangchan, Laos; [Thammavong, Te] Natl Blood Transfus Ctr, Viangchan, Laos	Luxembourg Institute of Health; Chiang Mai University	Andernach, IE (corresponding author), Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg.	Claude.Muller@CRP-SANTE.LU	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; 	Ministry of Cooperation of the Grand-Duchy of Luxembourg; National Research Fund, Luxembourg	Ministry of Cooperation of the Grand-Duchy of Luxembourg; National Research Fund, Luxembourg(Luxembourg National Research Fund)	This work was supported by the Ministry of Cooperation of the Grand-Duchy of Luxembourg. I.E.A. was supported by a fellowship from the National Research Fund, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x; Baig S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-128; Bollyky PL, 1996, J MOL EVOL, V42, P97, DOI 10.1007/BF02198834; Bowyer SM, 2000, J GEN VIROL, V81, P379, DOI 10.1099/0022-1317-81-2-379; Cao ZG, 2008, ARCH VIROL, V153, P1807, DOI 10.1007/s00705-008-0176-9; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; GHENDON Y, 1987, J VIROL METHODS, V17, P69, DOI 10.1016/0166-0934(87)90070-X; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huang ZM, 2005, WORLD J GASTROENTERO, V11, P6525, DOI 10.3748/wjg.v11.i41.6525; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jutavijittum P, 2006, HEPATOL RES, V35, P263, DOI 10.1016/j.hepres.2006.04.010; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Kao JH, 2001, HEPATOLOGY, V34, P817, DOI 10.1053/jhep.2001.28188; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Li DD, 2010, J INT MED RES, V38, P195, DOI 10.1177/147323001003800122; Lin CL, 2007, J MED VIROL, V79, P1674, DOI 10.1002/jmv.20985; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Nurainy N, 2008, ARCH VIROL, V153, P1057, DOI 10.1007/s00705-008-0092-z; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Sa-Nguanmoo P, 2010, J MED VIROL, V82, P1341, DOI 10.1002/jmv.21828; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yeh CT, 2010, ANTIVIR THER, V15, P471, DOI 10.3851/IMP1552; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	45	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30245	10.1371/journal.pone.0030245	http://dx.doi.org/10.1371/journal.pone.0030245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383959	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500004
J	Cesqui, B; d'Avella, A; Portone, A; Lacquaniti, F				Cesqui, Benedetta; d'Avella, Andrea; Portone, Alessandro; Lacquaniti, Francesco			Catching a Ball at the Right Time and Place: Individual Factors Matter	PLOS ONE			English	Article							HITTING MOVING-OBJECTS; ARM MOVEMENTS; MANUAL INTERCEPTION; ONLINE CONTROL; COORDINATION; TARGETS; MODEL; SPEED; INFORMATION; HAND	Intercepting a moving object requires accurate spatio-temporal control. Several studies have investigated how the CNS copes with such a challenging task, focusing on the nature of the information used to extract target motion parameters and on the identification of general control strategies. In the present study we provide evidence that the right time and place of the collision is not univocally specified by the CNS for a given target motion; instead, different but equally successful solutions can be adopted by different subjects when task constraints are loose. We characterized arm kinematics of fourteen subjects and performed a detailed analysis on a subset of six subjects who showed comparable success rates when asked to catch a flying ball in three dimensional space. Balls were projected by an actuated launching apparatus in order to obtain different arrival flight time and height conditions. Inter-individual variability was observed in several kinematic parameters, such as wrist trajectory, wrist velocity profile, timing and spatial distribution of the impact point, upper limb posture, trunk motion, and submovement decomposition. Individual idiosyncratic behaviors were consistent across different ball flight time conditions and across two experimental sessions carried out at one year distance. These results highlight the importance of a systematic characterization of individual factors in the study of interceptive tasks.	[Cesqui, Benedetta; d'Avella, Andrea; Portone, Alessandro; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Portone, Alessandro; Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Neurosci Sect, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Cesqui, B (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	davella@hsantalucia.it	d'Avella, Andrea/K-6856-2018; Lacquaniti, Francesco/J-9842-2016	d'Avella, Andrea/0000-0002-3393-4956; Lacquaniti, Francesco/0000-0003-0896-7315	European Union [248311]; Italian Ministry of Health; Italian University Ministry; Italian Space Agency	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Italian University Ministry(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), the Italian Ministry of Health, the Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; ATKESON CG, 1985, J NEUROSCI, V5, P2318; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Beek PJ, 2003, PHILOS T R SOC B, V358, P1511, DOI 10.1098/rstb.2003.1343; Bernstein N.A., 1967, COORDINATION REGULAT; Berret B, 2011, J NEUROPHYSIOL; Bianchi L, 1998, PFLUG ARCH EUR J PHY, V436, P343, DOI 10.1007/s004240050642; Brenner E, 2005, HUMAN VISION ELECT I; Brouwer AM, 2000, EXP BRAIN RES, V133, P242, DOI 10.1007/s002210000371; Brouwer AM, 2006, VISION RES, V46, P382, DOI 10.1016/j.visres.2005.09.002; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Button C, 2002, ACTA PSYCHOL, V109, P75, DOI 10.1016/S0001-6918(01)00052-X; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; d'Avella A, 2011, J NEUROSCI METH, V196, P264, DOI 10.1016/j.jneumeth.2011.01.013; de Lussanet MHE, 2004, EXP BRAIN RES, V157, P181, DOI 10.1007/s00221-004-1832-2; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gray R, 2005, J EXP PSYCHOL HUMAN, V31, P1004, DOI 10.1037/0096-1523.31.5.1004; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; LACQUANITI F, 1994, J NEUROPHYSIOL, V72, P1496, DOI 10.1152/jn.1994.72.4.1496; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1986, NEUROSCIENCE, V17, P313, DOI 10.1016/0306-4522(86)90249-6; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; LAURENT M, 1994, EXP BRAIN RES, V101, P314, DOI 10.1007/BF00228752; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; Liu CK, 2005, LEARNING PHYS BASED; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Mazyn LIN, 2007, J MOTOR BEHAV, V39, P491, DOI 10.3200/JMBR.39.6.491-502; Mazyn LIN, 2007, ACTA PSYCHOL, V126, P59, DOI 10.1016/j.actpsy.2006.10.001; Mazyn LIN, 2006, MOTOR CONTROL, V10, P143, DOI 10.1123/mcj.10.2.143; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MCLEOD P, 1993, NATURE, V362, P23, DOI 10.1038/362023a0; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; Rohrer B, 2006, BIOL CYBERN, V94, P409, DOI 10.1007/s00422-006-0055-y; Rohrer B, 2004, MOTOR CONTROL, V8, P472, DOI 10.1123/mcj.8.4.472; Savelsbergh G, 2002, INTERCEPTIVE ACTION; SAVELSBERGH GJP, 1992, EXP BRAIN RES, V89, P223; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Saville BR, 2009, BIOMETRICS, V65, P369, DOI 10.1111/j.1541-0420.2008.01107.x; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SMEETS JBJ, 1995, BIOL CYBERN, V73, P519, DOI 10.1007/BF00199544; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tresilian JR, 2009, BRAIN RES, V1250, P202, DOI 10.1016/j.brainres.2008.11.001; Tresilian JR, 1999, PERCEPT PSYCHOPHYS, V61, P515, DOI 10.3758/BF03211970; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Vuillerme N, 2001, NEUROSCI LETT, V311, P73, DOI 10.1016/S0304-3940(01)02147-4; Vuillerme N, 2001, NEUROSCI LETT, V303, P83, DOI 10.1016/S0304-3940(01)01722-0; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	70	44	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31770	10.1371/journal.pone.0031770	http://dx.doi.org/10.1371/journal.pone.0031770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384072	Green Submitted, Green Published, gold			2022-12-25	WOS:000302875500040
J	Shapiro, RL; Souda, S; Parekh, N; Binda, K; Kayembe, M; Lockman, S; Svab, P; Babitseng, O; Powis, K; Jimbo, W; Creek, T; Makhema, J; Essex, M; Roberts, DJ				Shapiro, Roger L.; Souda, Sajini; Parekh, Natasha; Binda, Kelebogile; Kayembe, Mukendi; Lockman, Shahin; Svab, Petr; Babitseng, Orphinah; Powis, Kathleen; Jimbo, William; Creek, Tracy; Makhema, Joseph; Essex, Max; Roberts, Drucilla J.			High Prevalence of Hypertension and Placental Insufficiency, but No In Utero HIV Transmission, among Women on HAART with Stillbirths in Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GESTATIONAL HYPERTENSION; INCREASED RISK; PREGNANCY; INFECTION; OUTCOMES; PREECLAMPSIA; DELIVERY	Background: Increased stillbirth rates occur among HIV-infected women, but no studies have evaluated the pathological basis for this increase, or whether highly active antiretroviral therapy (HAART) influences the etiology of stillbirths. It is also unknown whether HIV infection of the fetus is associated with stillbirth. Methods: HIV-infected women and a comparator group of HIV-uninfected women who delivered stillbirths were enrolled at the largest referral hospital in Botswana between January and November 2010. Obstetrical records, including antiretroviral use in pregnancy, were extracted at enrollment. Verbal autopsies; maternal HIV, CD4 and HIV RNA testing; stillbirth HIV PCR testing; and placental pathology (blinded to HIV and treatment status) were performed. Results: Ninety-nine stillbirths were evaluated, including 62 from HIV-infected women (34% on HAART from conception, 8% on HAART started in pregnancy, 23% on zidovudine started in pregnancy, and 35% on no antiretrovirals) and 37 from a comparator group of HIV-uninfected women. Only 2 (3.7%) of 53 tested stillbirths from HIV-infected women were HIV PCR positive, and both were born to women not receiving HAART. Placental insufficiency associated with hypertension accounted for most stillbirths. Placental findings consistent with chronic hypertension were common among HIV-infected women who received HAART and among HIV-uninfected women (65% vs. 54%, p = 0.37), but less common among HIV-infected women not receiving HAART (28%, p = 0.003 vs. women on HAART). Conclusions: In utero HIV infection was rarely associated with stillbirths, and did not occur among women receiving HAART. Hypertension and placental insufficiency were associated with most stillbirths in this tertiary care setting.	[Shapiro, Roger L.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Shapiro, Roger L.; Lockman, Shahin; Powis, Kathleen; Makhema, Joseph; Essex, Max] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Roger L.; Souda, Sajini; Parekh, Natasha; Binda, Kelebogile; Lockman, Shahin; Powis, Kathleen; Makhema, Joseph; Essex, Max] Botswana Harvard Sch Publ Hlth, AIDS Inst Partnership HIV Res & Educ, Boston, MA 02115 USA; [Kayembe, Mukendi] Minist Hlth, Botswana Natl Hlth Lab, Gaborone, Botswana; [Lockman, Shahin] Brigham & Womens Hosp, Infect Dis Unit, Boston, MA 02115 USA; [Svab, Petr; Babitseng, Orphinah] Princess Marina Hosp, Minist Hlth, Gaborone, Botswana; [Powis, Kathleen] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Powis, Kathleen] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Jimbo, William; Creek, Tracy] Ctr Dis Control & Prevent, Atlanta, GA USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital	Shapiro, RL (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	rshapiro@hsph.harvard.edu	Roberts, Drucilla/AAB-6379-2022; Powis, Kathleen/AAU-5123-2021		Centers for Disease Control and Prevention [U2GPS000941]; Doris Duke Charitable Research Foundation; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS000941] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Doris Duke Charitable Research Foundation(Doris Duke Charitable Foundation (DDCF)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by a grant from the Centers for Disease Control and Prevention (U2GPS000941), and by a Research Fellowship from the Doris Duke Charitable Research Foundation (N.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; BACKE E, 1994, AM J PERINAT, V11, P326, DOI 10.1055/s-2007-994545; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; D'costa Grace Francis, 2007, Indian J Pathol Microbiol, V50, P515; GICHANGI PB, 1993, E AFR MED J, V70, P85; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Ladner J, 1998, J ACQ IMMUN DEF SYND, V18, P293, DOI 10.1097/00042560-199807010-00015; LANGSTON C, 1995, J INFECT DIS, V172, P1451, DOI 10.1093/infdis/172.6.1451; Leroy V, 1998, AIDS, V12, P643, DOI 10.1097/00002030-199806000-00014; Pinar H, 2010, CLIN OBSTET GYNECOL, V53, P656, DOI 10.1097/GRF.0b013e3181eb68fe; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; STLOUIS ME, 1993, JAMA-J AM MED ASSOC, V269, P2853, DOI 10.1001/jama.269.22.2853; Suy A, 2006, AIDS, V20, P59, DOI 10.1097/01.aids.0000198090.70325.bd; TEMMERMAN M, 1990, AIDS, V4, P1087, DOI 10.1097/00002030-199011000-00006; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; Wabwire-Mangen F, 1999, J ACQ IMMUN DEF SYND, V22, P379; Wimalasundera RC, 2002, LANCET, V360, P1152, DOI 10.1016/S0140-6736(02)11195-0	23	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31580	10.1371/journal.pone.0031580	http://dx.doi.org/10.1371/journal.pone.0031580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384039	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500026
J	Derenko, M; Malyarchuk, B; Denisova, G; Perkova, M; Rogalla, U; Grzybowski, T; Khusnutdinova, E; Dambueva, I; Zakharov, I				Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria; Rogalla, Urszula; Grzybowski, Tomasz; Khusnutdinova, Elza; Dambueva, Irina; Zakharov, Ilia			Complete Mitochondrial DNA Analysis of Eastern Eurasian Haplogroups Rarely Found in Populations of Northern Asia and Eastern Europe	PLOS ONE			English	Article							VOLGA-URAL REGION; GENETIC-STRUCTURE; GENOME VARIATION; MTDNA SEQUENCES; MODERN HUMANS; SILK ROAD; SOUTH; DIVERSITY; PHYLOGENY; ORIGIN	With the aim of uncovering all of the most basal variation in the northern Asian mitochondrial DNA (mtDNA) haplogroups, we have analyzed mtDNA control region and coding region sequence variation in 98 Altaian Kazakhs from southern Siberia and 149 Barghuts from Inner Mongolia, China. Both populations exhibit the prevalence of eastern Eurasian lineages accounting for 91.9% in Barghuts and 60.2% in Altaian Kazakhs. The strong affinity of Altaian Kazakhs and populations of northern and central Asia has been revealed, reflecting both influences of central Asian inhabitants and essential genetic interaction with the Altai region indigenous populations. Statistical analyses data demonstrate a close positioning of all Mongolic-speaking populations (Mongolians, Buryats, Khamnigans, Kalmyks as well as Barghuts studied here) and Turkic-speaking Sojots, thus suggesting their origin from a common maternal ancestral gene pool. In order to achieve a thorough coverage of DNA lineages revealed in the northern Asian matrilineal gene pool, we have completely sequenced the mtDNA of 55 samples representing haplogroups R11b, B4, B5, F2, M9, M10, M11, M13, N9a and R9c1, which were pinpointed from a massive collection (over 5000 individuals) of northern and eastern Asian, as well as European control region mtDNA sequences. Applying the newly updated mtDNA tree to the previously reported northern Asian and eastern Asian mtDNA data sets has resolved the status of the poorly classified mtDNA types and allowed us to obtain the coalescence age estimates of the nodes of interest using different calibrated rates. Our findings confirm our previous conclusion that northern Asian maternal gene pool consists of predominantly post-LGM components of eastern Asian ancestry, though some genetic lineages may have a pre-LGM/LGM origin.	[Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia; [Rogalla, Urszula; Grzybowski, Tomasz] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland; [Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Res Ctr, Ufa 450001, Russia; [Dambueva, Irina] Russian Acad Sci, Inst Gen & Expt Biol, Ulan Ude, Russia; [Zakharov, Ilia] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Magadan, Russia.	mderenko@mail.ru	Dambueva, Irina/K-3073-2018; Denisova, Galina/AAZ-4310-2020; Malyarchuk, Boris/D-5783-2018; Rogalla, Urszula/E-3342-2014; Dambueva, Irina/AAZ-4313-2020; Derenko, Miroslava/J-1495-2018; Khusnutdinova, Elza Kamilevna/A-4810-2013; Grzybowski, Tomasz/A-1676-2015	Malyarchuk, Boris/0000-0002-0304-0652; Rogalla, Urszula/0000-0002-2778-9844; Derenko, Miroslava/0000-0002-1849-784X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Grzybowski, Tomasz/0000-0001-6228-6460	Russian Foundation for Basic Research [11-04-00620]; Presidium of Russian Academy of Sciences [09-I-P23-10]; Far-Eastern Branch of the Russian Academy of Sciences [09-III-A-06-220]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Far-Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was supported by grants from the Russian Foundation for Basic Research (11-04-00620), the Presidium of Russian Academy of Sciences (09-I-P23-10), and the Far-Eastern Branch of the Russian Academy of Sciences (09-III-A-06-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bodner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-49; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Dancause KN, 2009, J HUM GENET, V54, P86, DOI 10.1038/jhg.2008.12; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; Derenko MV, 1997, MOL BIOL+, V31, P665; Dolukhanov P, 2005, J ARCHAEOL SCI, V32, P1441, DOI 10.1016/j.jas.2005.03.021; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Fu YX, 1997, GENETICS, V147, P915; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Guba Z, 2011, J HUM GENET, V56, P784, DOI 10.1038/jhg.2011.103; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, EUR J HUM GENET, V15, P115, DOI 10.1038/sj.ejhg.5201712; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; LAUKHIN SA, 1993, DOKL AKAD NAUK+, V332, P352; Loo JH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-21; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2002, THESIS I BIOL PROBLE; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Okladnikov AP, 1981, PALEOLITHIC CENTRAL; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Peng MS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-2; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Razafindrazaka H, 2010, EUR J HUM GENET, V18, P575, DOI 10.1038/ejhg.2009.222; RENFREW C, 1994, SCI AM, V270, P116, DOI 10.1038/scientificamerican0194-116; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; TAJIMA F, 1989, GENETICS, V123, P585; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; Wang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021613; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	92	46	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32179	10.1371/journal.pone.0032179	http://dx.doi.org/10.1371/journal.pone.0032179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363811	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700152
J	Forbes, NE; Ping, JH; Dankar, SK; Jia, JJ; Selman, M; Keleta, L; Zhou, Y; Brown, EG				Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Zhou, Yan; Brown, Earl G.			Multifunctional Adaptive NS1 Mutations Are Selected upon Human Influenza Virus Evolution in the Mouse	PLOS ONE			English	Article							VIRAL MESSENGER-RNA; A VIRUS; H5N1 INFLUENZA; PROTEIN INTERACTS; HOST-RANGE; NUCLEOCYTOPLASMIC TRANSPORT; INCREASED VIRULENCE; GENE-EXPRESSION; RIG-I; REPLICATION	The role of the NS1 protein in modulating influenza A virulence and host range was assessed by adapting A/Hong Kong/1/1968 (H3N2) (HK-wt) to increased virulence in the mouse. Sequencing the NS genome segment of mouse-adapted variants revealed 11 mutations in the NS1 gene and 4 in the overlapping NEP gene. Using the HK-wt virus and reverse genetics to incorporate mutant NS gene segments, we demonstrated that all NS1 mutations were adaptive and enhanced virus replication (up to 100 fold) in mouse cells and/or lungs. All but one NS1 mutant was associated with increased virulence measured by survival and weight loss in the mouse. Ten of twelve NS1 mutants significantly enhanced IFN-beta antagonism to reduce the level of IFN beta production relative to HK-wt in infected mouse lungs at 1 day post infection, where 9 mutants induced viral yields in the lung that were equivalent to or significantly greater than HK-wt (up to 16 fold increase). Eight of 12 NS1 mutants had reduced or lost the ability to bind the 30 kDa cleavage and polyadenylation specificity factor (CPSF30) thus demonstrating a lack of correlation with reduced IFN beta production. Mutant NS1 genes resulted in increased viral mRNA transcription (10 of 12 mutants), and protein production (6 of 12 mutants) in mouse cells. Increased transcription activity was demonstrated in the influenza mini-genome assay for 7 of 11 NS1 mutants. Although we have shown gain-of-function properties for all mutant NS genes, the contribution of the NEP mutations to phenotypic changes remains to be assessed. This study demonstrates that NS1 is a multifunctional virulence factor subject to adaptive evolution.	[Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Brown, Earl G.] Univ Ottawa, Fac Med, Emerging Pathogens Res Ctr, Ottawa, ON, Canada; [Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Zhou, Yan; Brown, Earl G.] Univ Ottawa, CIHR, Canadian Influenza Pathogenesis Team, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Saskatchewan; University of Ottawa	Forbes, NE (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	ebrown@uottawa.ca		Selman, Mohammed/0000-0002-3265-2009; Forbes, Nicole/0000-0002-2645-695X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30071, HHSN272200900007C]; Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team [TPA-90188]; CIHR [MOP-74526]; Ontario Graduate Scholarship in Science and Technology	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology	This project has been funded in part through the Influenza Genome Sequencing Project with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract numbers N01-AI-30071 and HHSN272200900007C, http://www.niaid.nih.gov/; the Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB) TPA-90188, and CIHR operating grant MOP-74526 (EGB); http://www.cihr-irsc.gc.ca/. NE Forbes was funded from an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garaigorta U, 2007, NUCLEIC ACIDS RES, V35, P4573, DOI 10.1093/nar/gkm230; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; LAMB RA, 1980, P NATL ACAD SCI-BIOL, V77, P1857, DOI 10.1073/pnas.77.4.1857; Lee JH, 2010, VIROLOGY, V397, P89, DOI 10.1016/j.virol.2009.10.041; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Meunier I, 2011, J GEN VIROL, V92, P1635, DOI 10.1099/vir.0.032193-0; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miller J, 2004, BEHAV RES METH INS C, V36, P11, DOI 10.3758/BF03195545; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Ping JH, 2008, BIOCHEM BIOPH RES CO, V371, P168, DOI 10.1016/j.bbrc.2008.04.045; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Robb NC, 2011, J GEN VIROL; Robb NC, 2011, J VIROL, V85, P5228, DOI 10.1128/JVI.02562-10; Robb NC, 2010, J GEN VIROL, V91, P2331, DOI 10.1099/vir.0.022004-0; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Steidle S, 2010, J VIROL, V84, P12761, DOI 10.1128/JVI.00701-10; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wang ZF, 2010, J VIROL, V84, P11323, DOI 10.1128/JVI.01034-10; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	65	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31839	10.1371/journal.pone.0031839	http://dx.doi.org/10.1371/journal.pone.0031839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363747	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700107
J	Oldenburger, A; Roscioni, SS; Jansen, E; Menzen, MH; Halayko, AJ; Timens, W; Meurs, H; Maarsingh, H; Schmidt, M				Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Halayko, Andrew J.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina			Anti-Inflammatory Role of the cAMP Effectors Epac and PKA: Implications in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; PROTEIN-KINASE-A; NF-KAPPA-B; CIGARETTE-SMOKE; BETA(2)-ADRENOCEPTOR AGONISTS; INTERLEUKIN-8 RELEASE; HISTONE DEACETYLASE; EPITHELIAL-CELLS; INFLAMMATION; SALMETEROL	Cigarette smoke-induced release of pro-inflammatory cytokines including interleukin-8 (IL-8) from inflammatory as well as structural cells in the airways, including airway smooth muscle (ASM) cells, may contribute to the development of chronic obstructive pulmonary disease (COPD). Despite the wide use of pharmacological treatment aimed at increasing intracellular levels of the endogenous suppressor cyclic AMP (cAMP), little is known about its exact mechanism of action. We report here that next to the beta(2)-agonist fenoterol, direct and specific activation of either exchange protein directly activated by cAMP (Epac) or protein kinase A (PKA) reduced cigarette smoke extract (CSE)-induced IL-8 mRNA expression and protein release by human ASM cells. CSE-induced I kappa B alpha-degradation and p65 nuclear translocation, processes that were primarily reversed by Epac activation. Further, CSE increased extracellular signal-regulated kinase (ERK) phosphorylation, which was selectively reduced by PKA activation. CSE decreased Epac1 expression, but did not affect Epac2 and PKA expression. Importantly, Epac1 expression was also reduced in lung tissue from COPD patients. In conclusion, Epac and PKA decrease CSE-induced IL-8 release by human ASM cells via inhibition of NF-kappa B and ERK, respectively, pointing at these cAMP effectors as potential targets for anti-inflammatory therapy in COPD. However, cigarette smoke exposure may reduce anti-inflammatory effects of cAMP elevating agents via down-regulation of Epac1.	[Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol & Internal Med, Winnipeg, MB, Canada; [Timens, Wim] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] COPD, Groningen, Netherlands; [Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] Groningen Res Inst Asthma, Groningen, Netherlands	University of Groningen; University of Manitoba; University of Groningen	Oldenburger, A (corresponding author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.	a.oldenburger@rug.nl	Timens, Wim/K-5570-2013; Schmidt, Martina/C-5339-2018; Maarsingh, Harm/AAD-5642-2019	Timens, Wim/0000-0002-4146-6363; Schmidt, Martina/0000-0003-3075-0630; Halayko, Andrew/0000-0002-7865-4552	School of Behavioral and Cognitive Neurosciences; Nederlands Astma Fonds (NAF) [3.2.09.034]; University of Groningen; Merck-Sharpe and Dohme (Oss, The Netherlands); Canada Research Chairs; Canadian Institutes of Health Research	School of Behavioral and Cognitive Neurosciences; Nederlands Astma Fonds (NAF); University of Groningen; Merck-Sharpe and Dohme (Oss, The Netherlands)(Netherlands Government); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Ubbo Emmius Fellowship from the School of Behavioral and Cognitive Neurosciences to S. S. Roscioni, a grant by the Nederlands Astma Fonds (NAF 2009: project nr: 3.2.09.034) to A. Oldenburger and a Rosalind Franklin Fellowship from the University of Groningen to M. Schmidt. H. Maarsingh is supported by the Merck-Sharpe and Dohme (Oss, The Netherlands). A.J. Halayko is supported by the Canada Research Chairs Program and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2009, PULM PHARMACOL THER, V22, P446, DOI 10.1016/j.pupt.2008.10.006; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Boterman M, 2006, EUR J PHARMACOL, V529, P151, DOI 10.1016/j.ejphar.2005.10.064; Chiu Jou-Chia, 2007, Journal of Microbiology Immunology and Infection, V40, P388; Culpitt S V, 2000, Expert Opin Pharmacother, V1, P1007, DOI 10.1517/14656566.1.5.1007; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Foronjy R, 2008, PULM PHARMACOL THER, V21, P370, DOI 10.1016/j.pupt.2007.10.004; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Hallsworth MP, 2001, BRIT J PHARMACOL, V132, P729, DOI 10.1038/sj.bjp.0703866; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Howarth PH, 2000, RESP MED, V94, pS22, DOI 10.1016/S0954-6111(00)90129-X; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jensen BO, 2004, BLOOD, V104, P2775, DOI 10.1182/blood-2004-03-1058; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Min X, 2008, CHINESE MED J-PEKING, V121, P73, DOI 10.1097/00029330-200801010-00014; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Numanami H, 2003, AM J RESP CELL MOL, V29, P613, DOI 10.1165/rcmb.2003-0113OC; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Oltmanns U, 2008, PULM PHARMACOL THER, V21, P292, DOI 10.1016/j.pupt.2007.07.001; Panettieri RA, 2003, RESP PHYSIOL NEUROBI, V137, P277, DOI 10.1016/S1569-9048(03)00153-8; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Roberts JA, 1999, EUR RESPIR J, V14, P275, DOI 10.1034/j.1399-3003.1999.14b07.x; Roscioni SS, 2011, BRIT J PHARMACOL, V162, P193, DOI 10.1111/j.1476-5381.2010.01011.x; Roscioni SS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-88; Roscioni SS, 2010, J CELL MOL IN PRESS; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Tanino M, 2002, THORAX, V57, P405, DOI 10.1136/thorax.57.5.405; Yamamoto C, 1997, CHEST, V112, P505, DOI 10.1378/chest.112.2.505; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	48	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31574	10.1371/journal.pone.0031574	http://dx.doi.org/10.1371/journal.pone.0031574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363678	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700075
J	Pages, M; Chevret, P; Gros-Balthazard, M; Hughes, S; Alcover, JA; Hutterer, R; Rando, JC; Michaux, J; Hanni, C				Pages, Marie; Chevret, Pascale; Gros-Balthazard, Muriel; Hughes, Sandrine; Antoni Alcover, Josep; Hutterer, Rainer; Carlos Rando, Juan; Michaux, Jacques; Haenni, Catherine			Paleogenetic Analyses Reveal Unsuspected Phylogenetic Affinities between Mice and the Extinct Malpaisomys insularis, an Endemic Rodent of the Canaries	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CYTOCHROME-B; LAVA MOUSE; MITOCHONDRIAL; GENE; SEQUENCES; EVOLUTION; MURIDAE; SYSTEMATICS; VERTEBRATES	Background: The lava mouse, Malpaisomys insularis, was endemic to the Eastern Canary islands and became extinct at the beginning of the 14th century when the Europeans reached the archipelago. Studies to determine Malpaisomys' phylogenetic affinities, based on morphological characters, remained inconclusive because morphological changes experienced by this insular rodent make phylogenetic investigations a real challenge. Over 20 years since its first description, Malpaisomys' phylogenetic position remains enigmatic. Methodology/Principal Findings: In this study, we resolved this issue using molecular characters. Mitochondrial and nuclear markers were successfully amplified from subfossils of three lava mouse samples. Molecular phylogenetic reconstructions revealed, without any ambiguity, unsuspected relationships between Malpaisomys and extant mice (genus Mus, Murinae). Moreover, through molecular dating we estimated the origin of the Malpaisomys/mouse clade at 6.9 Ma, corresponding to the maximal age at which the archipelago was colonised by the Malpaisomys ancestor via natural rafting. Conclusion/Significance: This study reconsiders the derived morphological characters of Malpaisomys in light of this unexpected molecular finding. To reconcile molecular and morphological data, we propose to consider Malpaisomys insularis as an insular lineage of mouse.	[Pages, Marie; Chevret, Pascale; Gros-Balthazard, Muriel; Hughes, Sandrine; Haenni, Catherine] Univ Lyon 1, CNRS UMR 5242, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69365 Lyon, France; [Antoni Alcover, Josep] Inst Mediterrani Estudis Avancats, Esporles, Mallorca, Spain; [Antoni Alcover, Josep] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Hutterer, Rainer] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Carlos Rando, Juan] Univ La Laguna La Laguna, Dept Biol Anim UDI Zool, Tenerife, Canary Islands, Spain; [Carlos Rando, Juan] Isl Ecol & Evolut Res Grp IPNA CSIC, Tenerife, Canary Islands, Spain; [Michaux, Jacques] Univ Montpellier, EPHE ISEM, UMR CNRS 5554, Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); American Museum of Natural History (AMNH); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pages, M (corresponding author), UMR CBGP INRA IRD Cirad Montpellier SupAgro, Campus Int Baillarguet, Montferrier Sur Lez, France.	pascale.chevret@univ-lyon1.fr	Chevret, Pascale/B-7299-2009; gros-balthazard, muriel/L-7907-2019; Alcover, Josep Antoni/Y-3796-2018	gros-balthazard, muriel/0000-0002-2587-3946; Rando, Juan Carlos/0000-0001-7397-869X; Alcover, Josep Antoni/0000-0001-9905-2588	Foundation ARC; F.R.S.-FNRS; Spanish program [N CGL2007-62047/BTE]; Direccion General de Investigacion (MEC); Cabildo Insular de Fuerteventura; French National Center for Scientific Research; University Lyon 1 and ENS de LYON	Foundation ARC; F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Spanish program; Direccion General de Investigacion (MEC)(Spanish Government); Cabildo Insular de Fuerteventura; French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); University Lyon 1 and ENS de LYON	MP held financial support from the Foundation ARC and is currently funded by a F.R.S.-FNRS fellowship (Belgian Fund for Scientific Research). The present study is part of the Spanish program N CGL2007-62047/BTE. The work benefited from the financial support of the Direccion General de Investigacion (MEC), Cabildo Insular de Fuerteventura, French National Center for Scientific Research, University Lyon 1 and ENS de LYON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Jean-Pierre, 1996, Acta Zoologica Cracoviensia, V39, P35; Alcover JA, 2009, PALAEOGEOGR PALAEOCL, V277, P184, DOI 10.1016/j.palaeo.2009.03.016; Atoche P, 1995, EVIDENCIAS ARQUEOLOG; Battistuzzi FU, 2010, MOL BIOL EVOL, V27, P1289, DOI 10.1093/molbev/msq014; Bocherens H, 2006, CR PALEVOL, V5, P885, DOI 10.1016/j.crpv.2006.04.001; BONHOMME F, 1986, CURR TOP MICROBIOL, V127, P19; Bonhomme Francois, 1992, Techniques in the Behavioral and Neural Sciences, V8, P41; BOYE P, 1992, Z SAUGETIERKD, V57, P29; Calvignac S, 2008, MOL ECOL, V17, P1962, DOI 10.1111/j.1365-294X.2008.03631.x; Calvignac S, 2008, MOL BIOL EVOL, V25, P1093, DOI 10.1093/molbev/msn054; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; Chaimanee Y, 1998, THAI STUDIES BIODIVE, P303; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Chevret P, 2003, ZOOL J LINN SOC-LOND, V137, P385, DOI 10.1046/j.1096-3642.2003.00050.x; Cooper Alan, 1994, P149; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Diepenbroek M, PANMAP; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Firmat C, 2011, NATURWISSENSCHAFTEN, V98, P33, DOI 10.1007/s00114-010-0738-z; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Geraads D, 1998, GEOBIOS-LYON, V31, P229, DOI 10.1016/S0016-6995(98)80040-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gonzalez-Ittig R, 2007, GENOME BIOL, V51, P73; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hughes S, 2006, MOL PHYLOGENET EVOL, V40, P285, DOI 10.1016/j.ympev.2006.02.004; Hutterer R., 1988, Palaeovertebrata (Montpellier), V18, P241; Jacobs L.L., 1985, Acta Zoologica Fennica, P149; Jacobs LL, 1978, FOSSIL RODENTS RHIZO, P104; Jacobs LL, 2005, INTERPRETING ESSAYS, P63; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kuss S. E., 1968, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V132, P55; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lopez-Martinez N., 1998, Journal of Mammalian Evolution, V5, P185, DOI 10.1023/A:1020508428859; LOPEZMARTINEZ N, 1987, DONANA ACTA VERTEBRA, V2, P1; MAYHEW DF, 1977, P K NED AKAD B PHYS, V80, P182; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; MICHAUX J, 1991, CR ACAD SCI II, V312, P801; Michaux Jacques, 1997, Geobios Memoire Special (Villeurbanne), V20, P379; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Millien V, 2004, EVOLUTION, V58, P1353; Misonne X, 1969, ANN MUS ROYAL AFR CT, P219; Montgelard Claudine, 1992, Historical Biology, V6, P293; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; NAVARRO JF, 1990, INVESTIGACIONES ARQU, V2, P189; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Pages M, 2009, CONSERV GENET, V10, P217, DOI 10.1007/s10592-008-9549-6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, TRACER V1 4; Ramirez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016072; Rando JC, 2008, IBIS, V150, P188; Rando JC, 2008, QUATERNARY RES, V70, P141, DOI 10.1016/j.yqres.2008.04.012; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Robins JH, 2008, MOL PHYLOGENET EVOL; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rutschmann F., 2005, BAYESIAN MOL DATING; Sato JJ, 2004, CAN J ZOOL, V82, P1343, DOI 10.1139/Z04-112; Shimada T, 2007, ZOOTAXA, P45; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Winkler A.J., 2010, CENOZOIC MAMMALS AFR, P263; Winkler AJ, 2002, J HUM EVOL, V42, P237, DOI 10.1006/jhev.2001.0501; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x	84	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31123	10.1371/journal.pone.0031123	http://dx.doi.org/10.1371/journal.pone.0031123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363563	Green Published, gold			2022-12-25	WOS:000302873700028
J	Westholm, JO; Tronnersjo, S; Nordberg, N; Olsson, I; Komorowski, J; Ronne, H				Westholm, Jakub Orzechowski; Tronnersjo, Susanna; Nordberg, Niklas; Olsson, Ida; Komorowski, Jan; Ronne, Hans			Gis1 and Rph1 Regulate Glycerol and Acetate Metabolism in Glucose Depleted Yeast Cells	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; DOMAIN-CONTAINING PROTEINS; GENE-EXPRESSION DATA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; JMJC-DOMAIN; CALORIC RESTRICTION; SIGNALING PATHWAYS; STATIONARY-PHASE; BUDDING YEAST	Aging in organisms as diverse as yeast, nematodes, and mammals is delayed by caloric restriction, an effect mediated by the nutrient sensing TOR, RAS/cAMP, and AKT/Sch9 pathways. The transcription factor Gis1 functions downstream of these pathways in extending the lifespan of nutrient restricted yeast cells, but the mechanisms involved are still poorly understood. We have used gene expression microarrays to study the targets of Gis1 and the related protein Rph1 in different growth phases. Our results show that Gis1 and Rph1 act both as repressors and activators, on overlapping sets of genes as well as on distinct targets. Interestingly, both the activities and the target specificities of Gis1 and Rph1 depend on the growth phase. Thus, both proteins are associated with repression during exponential growth, targeting genes with STRE or PDS motifs in their promoters. After the diauxic shift, both become involved in activation, with Gis1 acting primarily on genes with PDS motifs, and Rph1 on genes with STRE motifs. Significantly, Gis1 and Rph1 control a number of genes involved in acetate and glycerol formation, metabolites that have been implicated in aging. Furthermore, several genes involved in acetyl CoA metabolism are downregulated by Gis1.	[Westholm, Jakub Orzechowski; Tronnersjo, Susanna; Nordberg, Niklas] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Westholm, Jakub Orzechowski; Komorowski, Jan] Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden; [Tronnersjo, Susanna] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Nordberg, Niklas; Olsson, Ida; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Komorowski, Jan] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Komorowski, Jan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Uppsala University	Westholm, JO (corresponding author), Sloan Kettering Inst, Dept Dev Biol, New York, NY USA.	Hans.Ronne@slu.se	Komorowski, Jan/A-9175-2010; Komorowski, Jan/AAP-1685-2020; Komorowski, Jan/M-2667-2013	Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Ronne, Hans/0000-0002-1645-6091; Westholm, Jakub/0000-0002-6849-6220	Swedish Research Council VR [621-2007-5079, 521-2011-3157]; Swedish Cancer Society; Swedish Foundation for Strategic Research; Agrifungen program; Knut and Alice Wallenberg Foundation	Swedish Research Council VR(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Agrifungen program; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Swedish Research Council VR (621-2007-5079, 521-2011-3157), the Swedish Cancer Society, the Swedish Foundation for Strategic Research, and the Agrifungen program to HR and by a grant from the Knut and Alice Wallenberg Foundation to JK and HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Balciunas D, 1999, MOL GEN GENET, V262, P589; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cameroni E, 2004, CELL CYCLE, V3, P462; Chang Y, 2010, BIOCHEM J, V433, P295; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-219; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Falcon AA, 2010, MOL CELL BIOCHEM, V333, P99, DOI 10.1007/s11010-009-0209-z; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu X, 2001, Pac Symp Biocomput, P127; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Ma J, 2005, TRENDS GENET, V21, P54, DOI 10.1016/j.tig.2004.11.004; Mai B, 2000, MOL CELL BIOL, V20, P478, DOI 10.1128/MCB.20.2.478-487.2000; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Orzechowski J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-484; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215; White WH, 2003, GENETICS, V163, P69; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yu Y, 2010, FEMS YEAST RES, V10, P793, DOI 10.1111/j.1567-1364.2010.00680.x; Zhang NS, 2010, J BIOL CHEM, V285, P6465, DOI 10.1074/jbc.M109.073288; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	83	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31577	10.1371/journal.pone.0031577	http://dx.doi.org/10.1371/journal.pone.0031577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363679	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700076
J	Zheng, SZ; Qian, P; Li, FX; Qian, GS; Wang, CZ; Wu, GM; Li, Q; Chen, Y; Li, J; Li, HN; He, BF; Ji, FY				Zheng, Shizhen; Qian, Pin; Li, Fuxiang; Qian, Guisheng; Wang, Changzheng; Wu, Guoming; Li, Qi; Chen, Yan; Li, Jin; Li, Haining; He, Binfeng; Ji, Fuyun			Association of Mitochondrial DNA Variations with Lung Cancer Risk in a Han Chinese Population from Southwestern China	PLOS ONE			English	Article							MTDNA VARIATION; TOBACCO-SMOKE; REPAIR; DAMAGE; SEQUENCE; POLYMORPHISM; HAPLOGROUPS; DELETIONS; REPLICATION; INVOLVEMENT	Mitochondrial DNA (mtDNA) is particularly susceptible to oxidative damage and mutation due to the high rate of reactive oxygen species (ROS) production and limited DNA-repair capacity in mitochondrial. Previous studies demonstrated that the increased mtDNA copy number for compensation for damage, which was associated with cigarette smoking, has been found to be associated with lung cancer risk among heavy smokers. Given that the common and "non-pathological'' mtDNA variations determine differences in oxidative phosphorylation performance and ROS production, an important determinant of lung cancer risk, we hypothesize that the mtDNA variations may play roles in lung cancer risk. To test this hypothesis, we conducted a case-control study to compare the frequencies of mtDNA haplogroups and an 822 bp mtDNA deletion between 422 lung cancer patients and 504 controls. Multivariate logistic regression analysis revealed that haplogroups D and F were related to individual lung cancer resistance (OR = 0.465, 95%CI = 0.329-0.656, p < 0.001; and OR = 0.622, 95%CI = 0.425-0.909, p = 0.014, respectively), while haplogroups G and M7 might be risk factors for lung cancer (OR = 3.924, 95%CI = 1.757-6.689, p < 0.001; and OR = 2.037, 95%CI = 1.253-3.312, p = 0.004, respectively). Additionally, multivariate logistic regression analysis revealed that cigarette smoking was a risk factor for the 822 bp mtDNA deletion. Furthermore, the increased frequencies of the mtDNA deletion in male cigarette smoking subjects of combined cases and controls with haplogroup D indicated that the haplogroup D might be susceptible to DNA damage from external ROS caused by heavy cigarette smoking.	[Zheng, Shizhen; Li, Fuxiang; Qian, Guisheng; Wang, Changzheng; Wu, Guoming; Li, Qi; Chen, Yan; Li, Jin; Li, Haining; He, Binfeng; Ji, Fuyun] Third Mil Med Univ, Inst Human Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China; [Qian, Pin] Third Mil Med Univ, Ultrasonog Dept, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zheng, SZ (corresponding author), Third Mil Med Univ, Inst Human Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China.	jifuyun@263.net	He, Binfeng/AAM-9190-2021	He, Binfeng/0000-0002-7243-1972	National Natural Science Foundation of China [30772456, 81170044]; Natural Science Foundation of Third Military Medical University [2007XG57, 2010XLC29]; Natural Science Foundation of Chongqing [2009BA5055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Third Military Medical University; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was funded by grants from the National Natural Science Foundation of China (Nos. 30772456, 81170044), grants from the Natural Science Foundation of Third Military Medical University (Nos. 2007XG57, 2010XLC29), as well as grants from the Natural Science Foundation of Chongqing (No. 2009BA5055) awarded to Fuyun Ji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Asami S, 1996, CANCER RES, V56, P2546; Ballinger SW, 1996, CANCER RES, V56, P5692; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015; Chen ZW, 2011, MUTAGENESIS, V26, P437, DOI 10.1093/mutage/ger002; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cote ML, 2009, AM J EPIDEMIOL, V169, P802, DOI 10.1093/aje/kwn417; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Gackowski D, 2003, CANCER RES, V63, P4899; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Horiguchi M, 2001, CANCER RES, V61, P3913; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kiyohara Chikako, 2004, Rev Environ Health, V19, P15; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li FX, 2011, MITOCHONDRION, V11, P553, DOI 10.1016/j.mito.2011.02.003; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rafnar T, 2011, CANCER RES, V71, P1356, DOI 10.1158/0008-5472.CAN-10-2852; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; SARGENTINI NJ, 1992, MUTAT RES, V265, P83, DOI 10.1016/0027-5107(92)90041-Y; Schabath MB, 2002, LUNG CANCER-J IASLC, V37, P35, DOI 10.1016/S0169-5002(02)00034-X; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; TORRONI A, 1994, AM J HUM GENET, V55, P760; Vallyathan Val, 1997, Environmental Health Perspectives, V105, P165, DOI 10.2307/3433405; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Yu M, 2009, EUR J CANC PREV 0715; Zhi XY, 2009, ONCOLOGY PROGR, V7, P379; Zhi XY, 2009, CHINESE PRESCRIPTION, V83, P56	57	33	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31322	10.1371/journal.pone.0031322	http://dx.doi.org/10.1371/journal.pone.0031322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363619	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700048
J	Cabral, A; Suescun, O; Zigman, JM; Perello, M				Cabral, Agustina; Suescun, Olga; Zigman, Jeffrey M.; Perello, Mario			Ghrelin Indirectly Activates Hypophysiotropic CRF Neurons in Rodents	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; GLUCOCORTICOID NEGATIVE FEEDBACK; DIET-INDUCED OBESITY; BLOOD-BRAIN-BARRIER; NPY MESSENGER-RNA; CHRONIC STRESS; PLASMA GHRELIN; NEUROPEPTIDE-Y; ARCUATE NUCLEUS	Ghrelin is a stomach-derived hormone that regulates food intake and neuroendocrine function by acting on its receptor, GHSR ((G) under bar rowth (H) under bar ormone (S) under bar ecretagogue (R) under bar eceptor). Recent evidence indicates that a key function of ghrelin is to signal stress to the brain. It has been suggested that one of the potential stress-related ghrelin targets is the CRF (Corticotropin-Releasing Factor)-producing neurons of the hypothalamic paraventricular nucleus, which secrete the CRF neuropeptide into the median eminence and activate the hypothalamic-pituitary-adrenal axis. However, the neural circuits that mediate the ghrelin-induced activation of this neuroendocrine axis are mostly uncharacterized. In the current study, we characterized in vivo the mechanism by which ghrelin activates the hypophysiotropic CRF neurons in mice. We found that peripheral or intra-cerebro-ventricular administration of ghrelin strongly activates c-fos - a marker of cellular activation - in CRF-producing neurons. Also, ghrelin activates CRF gene expression in the paraventricular nucleus of the hypothalamus and the hypothalamic-pituitary-adrenal axis at peripheral level. Ghrelin administration directly into the paraventricular nucleus of the hypothalamus also induces c-fos within the CRF-producing neurons and the hypothalamic-pituitary-adrenal axis, without any significant effect on the food intake. Interestingly, dual-label immunohistochemical analysis and ghrelin binding studies failed to show GHSR expression in CRF neurons. Thus, we conclude that ghrelin activates hypophysiotropic CRF neurons, albeit indirectly.	[Cabral, Agustina; Perello, Mario] Argentine Res Council CONICET, Neurophysiol Lab, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina; [Cabral, Agustina; Suescun, Olga; Perello, Mario] Prov Buenos Aires CIC PBA, Sci Res Commiss, La Plata, Buenos Aires, Argentina; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Med, Dallas, TX 75390 USA; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Div Endocrinol & Metab, Dept Med, Dallas, TX 75390 USA; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Suescun, Olga] Argentine Res Council CONICET, Lab Reprod Endocrinol, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cabral, A (corresponding author), Argentine Res Council CONICET, Neurophysiol Lab, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina.	marioperello@yahoo.com		Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	Florencio Fiorini Foundation; National Institutes of Health (NIH) [R01DA024680, K08DK068069, R01MH085298]; International Brain Research Organization;  [PICT2010-1954]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK068069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680] Funding Source: NIH RePORTER	Florencio Fiorini Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Brain Research Organization; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by Florencio Fiorini Foundation, International Brain Research Organization and PICT2010-1954 grants to MP and by R01DA024680, K08DK068069 and R01MH085298 National Institutes of Health (NIH) grants to JMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; CASTRO MG, 1990, J MOL ENDOCRINOL, V5, P221, DOI 10.1677/jme.0.0050221; Chuang J.C., 2010, INT J PEPT; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Dimitrov EL, 2007, ENDOCRINOLOGY, V148, P3666, DOI 10.1210/en.2006-1730; Goldstein J, 2007, J MOL NEUROSCI, V31, P69, DOI 10.1007/BF02686119; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Johnstone LE, 2005, STRESS, V8, P59, DOI 10.1080/10253890500095283; Kadar A, 2010, J COMP NEUROL, V518, P3948, DOI 10.1002/cne.22432; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Li C, 2000, BRAIN RES, V854, P122, DOI 10.1016/S0006-8993(99)02324-0; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Melis MR, 2002, NEUROSCI LETT, V329, P339, DOI 10.1016/S0304-3940(02)00673-0; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Mozid AM, 2003, HORM METAB RES, V35, P455; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Olszewski PK, 2003, PEPTIDES, V24, P919, DOI 10.1016/S0196-9781(03)00159-1; Patterson ZR, 2010, EUR J NEUROSCI, V32, P632, DOI 10.1111/j.1460-9568.2010.07310.x; Paxinos G., 2001, MOUSE BRAIN; Perello M., 2011, J COMP NEUROL; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Sarkar S, 2003, ENDOCRINOLOGY, V144, P281, DOI 10.1210/en.2002-220675; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Shrestha YB, 2004, NEUROREPORT, V15, P1365, DOI 10.1097/01.wnr.0000127141.62476.d5; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Stevanovic D, 2007, LIFE SCI, V80, P867, DOI 10.1016/j.lfs.2006.11.018; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Tung YL, 2004, EUR J ENDOCRINOL, V150, P905, DOI 10.1530/eje.0.1500905; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2002, NEUROENDOCRINOLOGY, V76, P316, DOI 10.1159/000066629; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	58	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31462	10.1371/journal.pone.0031462	http://dx.doi.org/10.1371/journal.pone.0031462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363652	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500045
J	Checker, R; Sandur, SK; Sharma, D; Patwardhan, RS; Jayakumar, S; Kohli, V; Sethi, G; Aggarwal, BB; Sainis, KB				Checker, Rahul; Sandur, Santosh K.; Sharma, Deepak; Patwardhan, Raghavendra S.; Jayakumar, S.; Kohli, Vineet; Sethi, Gautam; Aggarwal, Bharat B.; Sainis, Krishna B.			Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-kappa B, AP-1 and NF-AT	PLOS ONE			English	Article							CELL-RECEPTOR STIMULATION; FACTOR-ALPHA GENE; T-CELLS; INHALED CORTICOSTEROIDS; SIGNAL-TRANSDUCTION; OLEANOLIC ACID; CYCLOSPORINE-A; ACTIVATION; RESPONSES; INFLAMMATION	Background: Ursolic acid (UA), a pentacyclic triterpenoid carboxylic acid, is the major component of many plants including apples, basil, cranberries, peppermint, rosemary, oregano and prunes and has been reported to possess antioxidant and anti-tumor properties. These properties of UA have been attributed to its ability to suppress NF-kappa B (nuclear factor kappa B) activation. Since NF-kappa B, in co-ordination with NF-AT (nuclear factor of activated T cells) and AP-1(activator protein-1), is known to regulate inflammatory genes, we hypothesized that UA might exhibit potent anti-inflammatory effects. Methodology/Principal Findings: The anti-inflammatory effects of UA were assessed in activated T cells, B cells and macrophages. Effects of UA on ERK, JNK, NF-kappa B, AP-1 and NF-AT were studied to elucidate its mechanism of action. In vivo efficacy of UA was studied using mouse model of graft-versus-host disease. UA inhibited activation, proliferation and cytokine secretion in T cells, B cells and macrophages. UA inhibited mitogen-induced up-regulation of activation markers and co-stimulatory molecules in T and B cells. It inhibited mitogen-induced phosphorylation of ERK and JNK and suppressed the activation of immunoregulatory transcription factors NF-kappa B, NF-AT and AP-1 in lymphocytes. Treatment of cells with UA prior to allogenic transplantation significantly delayed induction of acute graft-versus-host disease in mice and also significantly reduced the serum levels of pro-inflammatory cytokines IL-6 and IFN-gamma. UA treatment inhibited T cell activation even when added post-mitogenic stimulation demonstrating its therapeutic utility as an anti-inflammatory agent. Conclusions/Significance: The present study describes the detailed mechanism of anti-inflammatory activity of UA. Further, UA may find application in the treatment of inflammatory disorders.	[Checker, Rahul; Sandur, Santosh K.; Sharma, Deepak; Patwardhan, Raghavendra S.; Jayakumar, S.; Sainis, Krishna B.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Biomed Grp, Bombay 400085, Maharashtra, India; [Kohli, Vineet] Bhabha Atom Res Ctr, Div Med, Biomed Grp, Bombay 400085, Maharashtra, India; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); National University of Singapore; University of Texas System; UTMD Anderson Cancer Center	Checker, R (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Biomed Grp, Bombay 400085, Maharashtra, India.	kbsainis@barc.gov.in	Aggarwal, Bharat B/G-3388-2013; Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475; Checker, Rahul/0000-0001-7704-3613; patwardhan, Raghvendra/0000-0001-6608-8779; Sharma, Deepak/0000-0002-7529-5574	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was funded by the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Cha HJ, 1996, CANCER RES, V56, P2281; Checker R, 2008, INT IMMUNOPHARMACOL, V8, P661, DOI 10.1016/j.intimp.2008.01.012; Checker R, 2010, J CELL BIOCHEM, V110, P1082, DOI 10.1002/jcb.22620; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Curry AJ, 2004, TRANSPLANTATION, V78, P807, DOI 10.1097/01.TP.0000131670.99000.54; Dalgleish AG, 2002, ADV CANCER RES, V84, P231, DOI 10.1016/S0065-230X(02)84008-8; DUMONT FJ, 1992, J EXP MED, V176, P751, DOI 10.1084/jem.176.3.751; Edmead CE, 1996, J IMMUNOL, V157, P3290; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khan NM, 2011, FREE RADICAL BIO MED, V51, P115, DOI 10.1016/j.freeradbiomed.2011.03.037; Kunwar A, 2011, RADIAT ENVIRON BIOPH, V50, P271, DOI 10.1007/s00411-011-0352-2; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lewis DB, 2002, CURR OPIN IMMUNOL, V14, P644, DOI 10.1016/S0952-7915(02)00388-6; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu Y, 2011, CLIN EXP IMMUNOL, V164, P282, DOI 10.1111/j.1365-2249.2011.04333.x; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; MURAILLE E, 1995, CELL IMMUNOL, V162, P315, DOI 10.1006/cimm.1995.1084; NAJID A, 1992, FEBS LETT, V299, P213, DOI 10.1016/0014-5793(92)80117-Y; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ricci M, 1997, J INVEST ALLERG CLIN, V7, P144; Ringbom T, 1998, J NAT PROD, V61, P1212, DOI 10.1021/np980088i; Roland NJ, 2004, CHEST, V126, P213, DOI 10.1378/chest.126.1.213; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma D, 2007, MOL IMMUNOL, V44, P2831, DOI 10.1016/j.molimm.2007.01.021; Shishodia S, 2003, CANCER RES, V63, P4375; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Suh N, 1998, CANCER RES, V58, P717; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai SJ, 2008, J FOOD SCI, V73, pH174, DOI 10.1111/j.1750-3841.2008.00864.x; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wilankar C, 2011, FREE RADICAL BIO MED, V51, P129, DOI 10.1016/j.freeradbiomed.2011.03.038; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yuan XL, 2003, J IMMUNOL, V170, P2949, DOI 10.4049/jimmunol.170.6.2949	56	173	181	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31318	10.1371/journal.pone.0031318	http://dx.doi.org/10.1371/journal.pone.0031318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363615	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500034
J	Jiang, GS; Zheng, LD; Pu, JR; Mei, H; Zhao, J; Huang, K; Zeng, FQ; Tong, QS				Jiang, Guosong; Zheng, Liduan; Pu, Jiarui; Mei, Hong; Zhao, Jun; Huang, Kai; Zeng, Fuqing; Tong, Qiangsong			Small RNAs Targeting Transcription Start Site Induce Heparanase Silencing through Interference with Transcription Initiation in Human Cancer Cells	PLOS ONE			English	Article							POLYMERASE-II; GENE PROMOTER; MAMMALIAN HEPARANASE; CHROMOSOMAL DNA; TUMOR INVASION; EXPRESSION; METASTASIS; CLONING; ANGIOGENESIS; METHYLATION	Heparanase (HPA), an endo-h-D-glucuronidase that cleaves the heparan sulfate chain of heparan sulfate proteoglycans, is overexpressed in majority of human cancers. Recent evidence suggests that small interfering RNA (siRNA) induces transcriptional gene silencing (TGS) in human cells. In this study, transfection of siRNA against -9/+10 bp (siH3), but not -174/-155 bp (siH1) or -134/-115 bp (siH2) region relative to transcription start site (TSS) locating at 101 bp upstream of the translation start site, resulted in TGS of heparanase in human prostate cancer, bladder cancer, and gastric cancer cells in a sequence-specific manner. Methylation-specific PCR and bisulfite sequencing revealed no DNA methylation of CpG islands within heparanase promoter in siH3-transfected cells. The TGS of heparanase did not involve changes of epigenetic markers histone H3 lysine 9 dimethylation (H3K9me2), histone H3 lysine 27 trimethylation (H3K27me3) or active chromatin marker acetylated histone H3 (AcH3). The regulation of alternative splicing was not involved in siH3-mediated TGS. Instead, siH3 interfered with transcription initiation via decreasing the binding of both RNA polymerase II and transcription factor II B (TFIIB), but not the binding of transcription factors Sp1 or early growth response 1, on the heparanase promoter. Moreover, Argonaute 1 and Argonaute 2 facilitated the decreased binding of RNA polymerase II and TFIIB on heparanase promoter, and were necessary in siH3-induced TGS of heparanase. Stable transfection of the short hairpin RNA construct targeting heparanase TSS (-9/+10 bp) into cancer cells, resulted in decreased proliferation, invasion, metastasis and angiogenesis of cancer cells in vitro and in athymic mice models. These results suggest that small RNAs targeting TSS can induce TGS of heparanase via interference with transcription initiation, and significantly suppress the tumor growth, invasion, metastasis and angiogenesis of cancer cells.	[Jiang, Guosong; Pu, Jiarui; Mei, Hong; Zhao, Jun; Zeng, Fuqing; Tong, Qiangsong] Huazhong Univ Sci & Technol, Dept Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan] Huazhong Univ Sci & Technol, Dept Pathol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan; Huang, Kai; Tong, Qiangsong] Huazhong Univ Sci & Technol, Human Dis Related Gene Res Grp, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Huang, Kai] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Jiang, GS (corresponding author), Huazhong Univ Sci & Technol, Dept Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	zengfuqingunion@hotmail.com; qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [30200284, 30600278, 30772359, 30972980, 81071997, 81072073]; Program for New Century Excellent Talents in University [NCET-06-0641]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [2008-889]; Fundamental Research Funds for the Central Universities [2010JC025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 30972980, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; Dong J, 2000, GENE, V253, P171, DOI 10.1016/S0378-1119(00)00251-1; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslet.2007.09.028; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Izquierdo M, 2005, CANCER GENE THER, V12, P217, DOI 10.1038/sj.cgt.7700791; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2006, NAT PROTOC, V1, P436, DOI 10.1038/nprot.2006.64; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Komatsu N, 2008, J IMMUNOL METHODS, V331, P82, DOI 10.1016/j.jim.2007.11.014; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Suzuki K, 2009, CURR TOP MED CHEM, V9, P1079, DOI 10.2174/156802609789630875; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Turner AMW, 2009, MOL THER, V17, P360, DOI 10.1038/mt.2008.268; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; WANG Z, 2004, MODERN PATHOL, V18, P205, DOI DOI 10.1038/M0DPATHOL.3800282; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Yamagishi M, 2009, MICROBES INFECT, V11, P500, DOI 10.1016/j.micinf.2009.02.003; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhang ZH, 2007, CANCER BIOL THER, V6, P587, DOI 10.4161/cbt.6.4.3888; Zheng LD, 2010, PATHOL INT, V60, P268, DOI 10.1111/j.1440-1827.2010.02512.x; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	51	48	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31379	10.1371/journal.pone.0031379	http://dx.doi.org/10.1371/journal.pone.0031379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363633	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500038
J	Lagor, WR; Fields, DW; Khetarpal, SA; Kumaravel, A; Lin, W; Weintraub, N; Wu, KJ; Hamm-Alvarez, SF; Drazul-Schrader, D; de la Llera-Moya, M; Rothblat, GH; Rader, DJ				Lagor, William R.; Fields, David W.; Khetarpal, Sumeet A.; Kumaravel, Arthi; Lin, Wen; Weintraub, Nathaniel; Wu, Kaijin; Hamm-Alvarez, Sarah F.; Drazul-Schrader, Denise; de la Llera-Moya, Margarita; Rothblat, George H.; Rader, Daniel J.			The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice	PLOS ONE			English	Article							TRANSFER INHIBITOR PROTEIN; LIPID TRANSFER-REACTIONS; MOUSE SERUM; HDL SUBPOPULATIONS; MOLECULAR-CLONING; HUMAN-PLASMA; DOMAINS; CETP; PARTICIPATION; TRIGLYCERIDE	Apolipoprotein F (apoF) is 29 kilodalton secreted sialoglycoprotein that resides on the HDL and LDL fractions of human plasma. Human ApoF is also known as Lipid Transfer Inhibitor protein (LTIP) based on its ability to inhibit cholesteryl ester transfer protein (CETP)-mediated transfer events between lipoproteins. In contrast to other apolipoproteins, ApoF is predicted to lack strong amphipathic alpha helices and its true physiological function remains unknown. We previously showed that overexpression of Apolipoprotein F in mice reduced HDL cholesterol levels by 20-25% by accelerating clearance from the circulation. In order to investigate the effect of physiological levels of ApoF expression on HDL cholesterol metabolism, we generated ApoF deficient mice. Unexpectedly, deletion of ApoF had no substantial impact on plasma lipid concentrations, HDL size, lipid or protein composition. Sex-specific differences were observed in hepatic cholesterol content as well as serum cholesterol efflux capacity. Female ApoF KO mice had increased liver cholesteryl ester content relative to wild type controls on a chow diet (KO: 3.4+/20.9 mg/dl vs. WT: 1.2+/20.3 mg/dl, p, 0.05). No differences were observed in ABCG1-mediated cholesterol efflux capacity in either sex. Interestingly, ApoB-depleted serum from male KO mice was less effective at promoting ABCA1-mediated cholesterol efflux from J774 macrophages relative to WT controls.	[Lagor, William R.; Fields, David W.; Khetarpal, Sumeet A.; Kumaravel, Arthi; Lin, Wen; Weintraub, Nathaniel; Rader, Daniel J.] Univ Penn, Div Translat Med & Human Genet, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Kaijin; Hamm-Alvarez, Sarah F.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Drazul-Schrader, Denise; de la Llera-Moya, Margarita; Rothblat, George H.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lagor, WR (corresponding author), Univ Penn, Div Translat Med & Human Genet, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	wlagor@mail.med.upenn.edu		Lin, Wen/0000-0003-1257-9841; Lagor, William/0000-0002-1703-5125; Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Heart Blood and Lung Institute of the National Institutes of Health [P01 HL022633-32]; American Heart Association [09POST2060594]; National Center of the American Heart Association [11SDG7210077]; NIH [U01HG004085]; CSD Consortium [U01HG004080]; Children's Hospital Oakland Research Institute (CHORI) [U42RR024244]; Wellcome Trust Sanger Institute (WTSI); University of California at Davis School of Veterinary Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080, U01HG004085] Funding Source: NIH RePORTER	National Heart Blood and Lung Institute of the National Institutes of Health; American Heart Association(American Heart Association); National Center of the American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSD Consortium; Children's Hospital Oakland Research Institute (CHORI); Wellcome Trust Sanger Institute (WTSI); University of California at Davis School of Veterinary Medicine(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was made possible by a Program Project Grant from the National Heart Blood and Lung Institute of the National Institutes of Health (P01 HL022633-32). WRL was supported by a Postdoctoral Fellowship from the Great Rivers Affiliate of the American Heart Association (09POST2060594), as well as a Scientist Development Grant from the National Center of the American Heart Association (11SDG7210077). The authors would like to acknowledge the Gene Therapy Resource Program (GTRP) of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) for providing the gene vectors used in this study. NIH grants to Velocigene at Regeneron Inc. (U01HG004085) and the CSD Consortium (U01HG004080, comprised of teams at Children's Hospital Oakland Research Institute (CHORI), the Wellcome Trust Sanger Institute (WTSI), and the University of California at Davis School of Veterinary Medicine) funded the generation of gene-targeted ES cells for 8500 genes in the Knockout Mouse Project (KOMP) Program archived and distributed by the KOMP Repository at UC Davis and Children's Hospital Oakland Research Institute (CHORI) (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Boone LR, 2011, ATHEROSCLEROSIS; Brown RJ, 2009, J LIPID RES, V50, P1910, DOI 10.1194/jlr.P900020-JLR200; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; COHN JS, 1988, J LIPID RES, V29, P925; Contois JH, 1996, CLIN CHEM, V42, P507; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Davidsson P, 2010, ARTERIOSCL THROM VAS, V30, P156, DOI 10.1161/ATVBAHA.108.179317; DAY JR, 1994, BIOCHEM BIOPH RES CO, V203, P1146, DOI 10.1006/bbrc.1994.2302; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Green PS, 2008, CIRCULATION, V118, P1259, DOI 10.1161/CIRCULATIONAHA.108.770669; Guyard-Dangremont V, 1998, COMP BIOCHEM PHYS B, V120, P517, DOI 10.1016/S0305-0491(98)10038-X; He Y, 2008, J LIPID RES, V49, P1529, DOI 10.1194/jlr.M800087-JLR200; Hogarth CA, 2003, COMP BIOCHEM PHYS B, V135, P219, DOI 10.1016/S1096-4959(03)00046-0; Hoofnagle AF, 2009, J LIPID RES; Izem L, 2009, J LIPID RES, V50, P676, DOI 10.1194/jlr.M800429-JLR200; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; JONES MK, 1992, J LIPID RES, V33, P287; KANE JP, 1979, P NATL ACAD SCI USA, V76, P5957, DOI 10.1073/pnas.76.11.5957; KOREN E, 1982, BIOCHEMISTRY-US, V21, P5347, DOI 10.1021/bi00264a035; Korstanje R, 2004, ARTERIOSCL THROM VAS, V24, P155, DOI 10.1161/01.ATV.0000104241.44819.10; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Lagor WR, 2005, J BIOL CHEM, V280, P36601, DOI 10.1074/jbc.M504346200; LEONG JC, 1977, P NATL ACAD SCI USA, V74, P276, DOI 10.1073/pnas.74.1.276; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Massey JB, 2009, J LIPID RES, V50, P1229, DOI 10.1194/jlr.D800044-JLR200; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; MONTELARO RC, 1979, VIROLOGY, V98, P20, DOI 10.1016/0042-6822(79)90521-X; MORTON RE, 1994, J LIPID RES, V35, P836; MORTON RE, 1993, ARTERIOSCLER THROMB, V13, P1843, DOI 10.1161/01.ATV.13.12.1843; Morton RE, 2003, J LIPID RES, V44, P2287, DOI 10.1194/jlr.M300171-JLR200; Morton RE, 2008, J LIPID RES, V49, P127, DOI 10.1194/jlr.M700258-JLR200; NISHIDE T, 1989, J LIPID RES, V30, P149; OLOFSSON SO, 1978, BIOCHEMISTRY-US, V17, P1032, DOI 10.1021/bi00599a014; Paromov VM, 2003, J BIOL CHEM, V278, P40859, DOI 10.1074/jbc.M306580200; SEGREST JP, 1992, J LIPID RES, V33, P141; Serdyuk AP, 1999, ARTERIOSCL THROM VAS, V19, P718, DOI 10.1161/01.ATV.19.3.718; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tu AY, 2001, BIOCHEM BIOPH RES CO, V287, P921, DOI 10.1006/bbrc.2001.5687; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wang XX, 1999, J BIOL CHEM, V274, P1814, DOI 10.1074/jbc.274.3.1814; Wu KJ, 2009, EXP EYE RES, V89, P319, DOI 10.1016/j.exer.2009.03.020; Wu TY, 2002, J VIROL, V76, P2279, DOI 10.1128/JVI.76.5.2279-2286.2002	47	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31616	10.1371/journal.pone.0031616	http://dx.doi.org/10.1371/journal.pone.0031616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363685	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500062
J	Patten, SA; Jacobs-McDaniels, NL; Zaouter, C; Drapeau, P; Albertson, RC; Moldovan, F				Patten, Shunmoogum A.; Jacobs-McDaniels, Nicole L.; Zaouter, Charlotte; Drapeau, Pierre; Albertson, R. Craig; Moldovan, Florina			Role of Chd7 in Zebrafish: A Model for CHARGE Syndrome	PLOS ONE			English	Article							CRANIAL NERVE ABNORMALITIES; NEURAL CREST; PHENOTYPIC SPECTRUM; RETINAL LAMINATION; N-CADHERIN; INNER-EAR; GENE; EXPRESSION; MUTATIONS; ASSOCIATION	CHARGE syndrome is caused by mutations in the CHD7 gene. Several organ systems including the retina, cranial nerves, inner ear and heart are affected in CHARGE syndrome. However, the mechanistic link between mutations in CHD7 and many of the organ systems dysfunction remains elusive. Here, we show that Chd7 is required for the organization of the neural retina in zebrafish. We observe an abnormal expression or a complete absence of molecular markers for the retinal ganglion cells and photoreceptors, indicating that Chd7 regulates the differentiation of retinal cells and plays an essential role in retinal cell development. In addition, zebrafish with reduced Chd7 display an abnormal organization and clustering of cranial motor neurons. We also note a pronounced reduction in the facial branchiomotor neurons and the vagal motor neurons display aberrant positioning. Further, these fish exhibit a severe loss of the facial nerves. Knock-down of Chd7 results in a curvature of the long body axis and these fish develop irregular shaped vertebrae and have a reduction in bone mineralization. Chd7 knockdown also results in a loss of proper segment polarity illustrated by flawed efnb2a and ttna expression, which is associated with later vascular segmentation defects. These critical roles for Chd7 in retinal and vertebral development were previously unrecognized and our results provide new insights into the role of Chd7 during development and in CHARGE syndrome pathogenesis.	[Patten, Shunmoogum A.; Zaouter, Charlotte; Moldovan, Florina] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Patten, Shunmoogum A.; Moldovan, Florina] Univ Montreal, Fac Dent, Montreal, PQ, Canada; [Jacobs-McDaniels, Nicole L.; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Drapeau, Pierre] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Albertson, R. Craig] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Universite de Montreal; Universite de Montreal; Syracuse University; Universite de Montreal; University of Massachusetts System; University of Massachusetts Amherst	Patten, SA (corresponding author), Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	florina.moldovan@umontreal.ca			Yves Cotrel Foundation; CHU Sainte-Justine and Foundation of the Stars scholarship	Yves Cotrel Foundation; CHU Sainte-Justine and Foundation of the Stars scholarship	Dr. Moldovan was supported by Yves Cotrel Foundation and Dr. Patten was supported by CHU Sainte-Justine and Foundation of the Stars scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2000, EUR J PEDIATR, V159, P569, DOI 10.1007/s004319900409; Akisu M, 1998, TURKISH J PEDIATR, V40, P283; Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Allen MD, 2007, J MOL BIOL, V371, P1135, DOI 10.1016/j.jmb.2007.06.007; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Amiel J, 2001, AM J MED GENET, V99, P124, DOI 10.1002/1096-8628(20010301)99:2<124::AID-AJMG1114>3.0.CO;2-9; Aramaki M, 2006, J PEDIATR-US, V148, P410, DOI 10.1016/j.jpeds.2005.10.044; Aramaki M, 2007, BIRTH DEFECTS RES A, V79, P50, DOI 10.1002/bdra.20330; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; BENBECHER S, 1994, ARCH PEDIATRIE, V1, P1115; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; BYERLY KA, 1993, AM J MED GENET, V45, P751, DOI 10.1002/ajmg.1320450617; Carey JC, 2005, AM J MED GENET A, V133A, P227, DOI 10.1002/ajmg.a.30540; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Childs S, 2002, DEVELOPMENT, V129, P973; Christiansen HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008481; Devriendt K, 1998, CLIN GENET, V53, P408; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jacobs NL, 2011, JOVE-J VIS EXP, DOI 10.3791/2533; Jacobs-McDaniels NL, 2011, DEV DYNAM, V240, P2272, DOI 10.1002/dvdy.22722; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Jyonouchi S, 2009, PEDIATRICS, V123, pE871, DOI 10.1542/peds.2008-3400; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Koizumi K, 2001, DEVELOPMENT, V128, P1391; LACOMBE D, 1994, AM J MED GENET, V49, P351, DOI 10.1002/ajmg.1320490324; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lalani SR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-8; LARISON KD, 1990, DEVELOPMENT, V109, P567; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Link BA, 2000, DEVELOPMENT, V127, P2177; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; MORGAN D, 1993, ARCH OTOLARYNGOL, V119, P49; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Satar B, 2003, OTOL NEUROTOL, V24, P437, DOI 10.1097/00129492-200305000-00014; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shaw KM, 2006, DEV DYNAM, V235, P1753, DOI 10.1002/dvdy.20814; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Souriau J, 2005, AM J MED GENET A, V133A, P278, DOI 10.1002/ajmg.a.30549; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; THOMAS IT, 1987, ANN CLIN LAB SCI, V17, P207; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; VanMeter TD, 1996, CLIN DYSMORPHOL, V5, P187; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vuorela P, 2007, GENET MED, V9, P690, DOI 10.1097/GIM.0b013e318156e68e; Wessels K, 2010, EUR J MED GENET, V53, P280, DOI 10.1016/j.ejmg.2010.07.002; Wincent J, 2009, EUR J MED GENET, V52, P271, DOI 10.1016/j.ejmg.2009.02.005; Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002	70	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31650	10.1371/journal.pone.0031650	http://dx.doi.org/10.1371/journal.pone.0031650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363697	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500070
J	Schneider, RR; Hauer, G; Dawe, K; Adamowicz, W; Boutin, S				Schneider, Richard R.; Hauer, Grant; Dawe, Kimberly; Adamowicz, Wiktor; Boutin, Stan			Selection of Reserves for Woodland Caribou Using an Optimization Approach	PLOS ONE			English	Article							WHITE-TAILED DEER; RANGIFER-TARANDUS; MAXIMIZING RETURN; CONSERVATION; ALBERTA; CANADA; PRECIPITATION; TEMPERATURE; POPULATIONS; DISTURBANCE	Habitat protection has been identified as an important strategy for the conservation of woodland caribou (Rangifer tarandus). However, because of the economic opportunity costs associated with protection it is unlikely that all caribou ranges can be protected in their entirety. We used an optimization approach to identify reserve designs for caribou in Alberta, Canada, across a range of potential protection targets. Our designs minimized costs as well as three demographic risk factors: current industrial footprint, presence of white-tailed deer (Odocoileus virginianus), and climate change. We found that, using optimization, 60% of current caribou range can be protected (including 17% in existing parks) while maintaining access to over 98% of the value of resources on public lands. The trade-off between minimizing cost and minimizing demographic risk factors was minimal because the spatial distributions of cost and risk were similar. The prospects for protection are much reduced if protection is directed towards the herds that are most at risk of near-term extirpation.	[Schneider, Richard R.; Dawe, Kimberly; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hauer, Grant; Adamowicz, Wiktor] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Schneider, RR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ministik99@telus.net	Boutin, Stan A/A-2619-2014	Boutin, Stan A/0000-0001-6317-038X; Adamowicz, Wiktor/0000-0002-7634-2985	Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta-Pacific Forest Industries; Social Science and Humanities Research Council of Canada; Forest Resource Improvement Association of Alberta	Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta-Pacific Forest Industries; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Forest Resource Improvement Association of Alberta	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta, Alberta-Pacific Forest Industries, Social Science and Humanities Research Council of Canada, and the Forest Resource Improvement Association of Alberta. The funders had no input regarding study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Department of Energy, 2007, PREL FISC EV ALB OIL; Alberta Department of Energy, 2007, OS1 ALB DEP EN; Alberta Department of Energy, 2007, OG2 ALB DEP EN; Alberta Woodland Caribou Recovery Team, 2005, ALB WOODL CAR REC PL; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Bowen D, 2002, GEOGR REV, V92, P503, DOI 10.2307/4140932; Charest KS, 2005, THESIS U ALBERTA EDM; Courtois R, 2007, ECOSCIENCE, V14, P491, DOI 10.2980/1195-6860(2007)14[491:EOFDOD]2.0.CO;2; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Dawe K, 2011, THESIS U ALBERTA EDM; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Energy Alberta, 2007, EUB SER PUBL; Environment Canada, 2011, REC STRAT WOODL CAR; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Game ET, 2008, MARXAN USER MANUAL M; GLJ Petroleum Consultants, 2009, CRUD OIL NAT GAS LIQ; GLJ Petroleum Consultants, 2009, NAT GAS SULPH PRIC F; Government of Alberta, 2009, TERMS REF DEV LOW AT; Hauer G., 2010, 1001 U ALB; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; James ARC, 2004, J WILDLIFE MANAGE, V68, P799, DOI 10.2193/0022-541X(2004)068[0799:SSOCFM]2.0.CO;2; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; MOEN AN, 1976, ECOLOGY, V57, P192, DOI 10.2307/1936411; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Natural Regions Committee, 2006, NAT REG SUBR ALB; Perhans K, 2008, CONSERV BIOL, V22, P1331, DOI 10.1111/j.1523-1739.2008.00976.x; *PETR SERV ASS CAN, 2008, WELL COST STUD; Sanchez-Azofeifa GA, 2004, ALBERTA GROUND COVER; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Schneider RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023254; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Schneider RR, 2009, CAN J FOREST RES, V39, P1001, DOI 10.1139/X09-033; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	46	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31672	10.1371/journal.pone.0031672	http://dx.doi.org/10.1371/journal.pone.0031672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363702	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500073
J	Mata-Gomez, MA; Yasui, MT; Guerrero-Rangel, A; Valdes-Rodriguez, S; Winkler, R				Mata-Gomez, Marco A.; Yasui, Matthew T.; Guerrero-Rangel, Armando; Valdes-Rodriguez, Silvia; Winkler, Robert			Accelerated Identification of Proteins by Mass Spectrometry by Employing Covalent Pre-Gel Staining with Uniblue A	PLOS ONE			English	Article							POLYACRYLAMIDE-GELS; STATISTICAL-MODEL; ELECTROPHORESIS; PROTEOMICS; DIGESTION; SEARCH; SILVER; SENSITIVITY; GENERATION; RESISTANCE	Background: The identification of proteins by mass spectrometry is a standard method in biopharmaceutical quality control and biochemical research. Prior to identification by mass spectrometry, proteins are usually pre-separated by electrophoresis. However, current protein staining and de-staining protocols are tedious and time consuming, and therefore prolong the sample preparation time for mass spectrometry. Methodology and Principal Findings: We developed a 1-minute covalent pre-gel staining protocol for proteins, which does not require de-staining before the mass spectrometry analysis. We investigated the electrophoretic properties of derivatized proteins and peptides and studied their behavior in mass spectrometry. Further, we elucidated the preferred reaction of proteins with Uniblue A and demonstrate the integration of the peptide derivatization into typical informatics tools. Conclusions and Significance: The Uniblue A staining method drastically speeds up the sample preparation for the mass spectrometry based identification of proteins. The application of this chemo-proteomic strategy will be advantageous for routine quality control of proteins and for time-critical tasks in protein analysis.	[Mata-Gomez, Marco A.; Winkler, Robert] Tecnol Monterrey, Dept Biotechnol & Food Engn, Monterrey, Nuevo Leon, Mexico; [Yasui, Matthew T.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA; [Guerrero-Rangel, Armando; Valdes-Rodriguez, Silvia; Winkler, Robert] CINVESTAV Unidad Irapuato, Dept Biochem & Biotechnol, Guanajuato, Mexico	Tecnologico de Monterrey; Oregon State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Mata-Gomez, MA (corresponding author), Tecnol Monterrey, Dept Biotechnol & Food Engn, Monterrey, Nuevo Leon, Mexico.	robert.winkler@ira.cinvestav.mx	Winkler, Robert/A-1500-2009	Winkler, Robert/0000-0001-6732-1958; Mata Gomez, Marco A./0000-0002-3457-7030; Valdes, Silvia/0000-0003-3133-9982	research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato	research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato	This work was supported by the research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM) and by institutional funding of the Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V377; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bauer MD, 2000, RAPID COMMUN MASS SP, V14, P924, DOI 10.1002/(SICI)1097-0231(20000530)14:10<924::AID-RCM967>3.0.CO;2-X; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Compton MM, 2002, ELECTROPHORESIS, V23, P3262, DOI 10.1002/1522-2683(200210)23:19<3262::AID-ELPS3262>3.0.CO;2-8; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; JENO P, 1995, ANAL BIOCHEM, V224, P75, DOI 10.1006/abio.1995.1010; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keough T, 1999, P NATL ACAD SCI USA, V96, P7131, DOI 10.1073/pnas.96.13.7131; LABOUESSE J, 1967, EUR J BIOCHEM, V2, P215, DOI 10.1111/j.1432-1033.1967.tb00127.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis K, 2009, CMAJ CANADIAN MED AS, V181; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PARKINSON D, 1984, ANAL BIOCHEM, V141, P121, DOI 10.1016/0003-2697(84)90434-2; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sambrook J, 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Sumpton D, 2009, RAPID COMMUN MASS SP, V23, P1525, DOI 10.1002/rcm.4029; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Valdes-Rodriguez S, 2010, PLANT PHYSIOL BIOCH, V48, P469, DOI 10.1016/j.plaphy.2010.03.012; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Wadman M, 2008, NATURE, V452, P924, DOI 10.1038/452924a; Westermeier R, 2006, PROTEOMICS, P61, DOI 10.1002/pmic.200690121; Winkler R, 2010, MOL BIOSYST, V6, P1810, DOI 10.1039/c003112g; Winkler R, 2010, RAPID COMMUN MASS SP, V24, P285, DOI 10.1002/rcm.4384; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	42	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31438	10.1371/journal.pone.0031438	http://dx.doi.org/10.1371/journal.pone.0031438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363648	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600147
J	Roelfsema, F; Pijl, H; Keenan, DM; Veldhuis, JD				Roelfsema, Ferdinand; Pijl, Hanno; Keenan, Daniel M.; Veldhuis, Johannes D.			Prolactin Secretion in Healthy Adults Is Determined by Gender, Age and Body Mass Index	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; LUTEINIZING-HORMONE; BURST MASS; CIRCADIAN RHYTHMICITY; THYROTROPIN SECRETION; REPLACEMENT THERAPY; METABOLIC-CLEARANCE; LACTOTROPIC AXES; BASAL SECRETION; ENHANCED BASAL	Background: Prolactin (PRL) secretion is quantifiable as mean, peak and nadir PRL concentrations, degree of irregularity (ApEn, approximate entropy) and spikiness (brief staccato-like fluctuations). Hypothesis: Distinct PRL dynamics reflect relatively distinct (combinations of) subject variables, such as gender, age, and BMI. Location: Clinical Research Unit. Subjects: Seventy-four healthy adults aged 22-77 yr (41 women and 33 men), with BMI 18.3-39.4 kg/m(2). Measures: Immunofluorometric PRL assay of 10-min samples collected for 24 hours. Results: Mean 24-h PRL concentration correlated jointly with gender (P<0.0001) and BMI (P = 0.01), but not with age (overall R-2 = 0.308, P<0.0001). Nadir PRL concentration correlated with gender only (P = 0.017) and peak PRL with gender (P<0.001) and negatively with age (P<0.003), overall R-2 = 0.325, P<0.0001. Forward-selection multivariate regression of PRL deconvolution results demonstrated that basal (nonpulsatile) PRL secretion tended to be associated with BMI (R-2 = 0.058, P = 0.03), pulsatile secretion with gender (R-2 = 0.152, P = 0.003), and total secretion with gender and BMI (R-2 = 0.204, P<0.0001). Pulse mass was associated with gender (P = 0.001) and with a negative tendency to age (P = 0.038). In male subjects older than 50 yr (but not in women) approximate entropy was increased (0.942 +/- 0.301 vs. 1.258 +/- 0.267, P = 0.007) compared with younger men, as well as spikiness (0.363 +/- 0.122 vs. 0463 +/- 2.12, P = 0.031). Cosinor analysis disclosed higher mesor and amplitude in females than in men, but the acrophase was gender-independent. The acrophase was determined by age and BMI (R-2 = 0.186, P = 0.001). Conclusion: In healthy adults, selective combinations of gender, age, and BMI specify distinct PRL dynamics, thus requiring balanced representation of these variables in comparative PRL studies.	[Roelfsema, Ferdinand; Pijl, Hanno] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Keenan, Daniel M.] Univ Virginia, Dept Stat, Charlottesville, VA USA; [Veldhuis, Johannes D.] Mayo Clin, Endocrine Res Unit, Mayo Med Sch, Clin Translat Res Ctr, Rochester, MN USA; [Veldhuis, Johannes D.] Mayo Clin, Endocrine Res Unit, Grad Sch, Clin Translat Res Ctr, Rochester, MN USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Virginia; Mayo Clinic; Mayo Clinic	Roelfsema, F (corresponding author), Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands.	f.roelfsema@lumc.nl	Pijl, Hanno/W-8719-2018	Pijl, Hanno/0000-0002-3076-1551				ARNETZ BB, 1986, LIFE SCI, V39, P135, DOI 10.1016/0024-3205(86)90447-9; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P540, DOI 10.1111/j.1365-2265.2010.03836.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BLACKMAN MR, 1986, J GERONTOL, V41, P699, DOI 10.1093/geronj/41.6.699; Camastra S, 2009, INT J OBESITY, V33, P166, DOI 10.1038/ijo.2008.226; CASTELOBRANCO C, 1995, J REPROD MED, V40, P556; Chattopadhyay S, 2008, Q APPL MATH, V66, P401, DOI 10.1090/S0033-569X-08-01024-4; Chehab FF, 1997, NAT MED, V3, P952, DOI 10.1038/nm0997-952; CHRISTENSEN SE, 1985, ACTA ENDOCRINOL-COP, V109, P458, DOI 10.1530/acta.0.1090458; COOPER DS, 1979, J CLIN INVEST, V64, P1669, DOI 10.1172/JCI109629; COPINSCHI G, 1995, HORM RES, V43, P20, DOI 10.1159/000184232; CORENBLUM B, 1981, FERTIL STERIL, V36, P712; Donjacour CEHM, 2011, AM J PHYSIOL-ENDOC M, V300, pE1069, DOI 10.1152/ajpendo.00623.2010; Ernst B, 2009, OBES SURG, V19, P1159, DOI 10.1007/s11695-009-9856-0; FRANCHIMONT P, 1976, CLIN ENDOCRINOL, V5, P643, DOI 10.1111/j.1365-2265.1976.tb03867.x; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; GENAZZANI AD, 1994, J ENDOCRINOL INVEST, V17, P83, DOI 10.1007/BF03347690; GREENSPAN SL, 1990, AM J PHYSIOL, V258, pE799, DOI 10.1152/ajpendo.1990.258.5.E799; HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446; HAUS E, 1989, CHRONOBIOLOGIA, V16, P331; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hudson SB, 2010, J CLIN ENDOCR METAB, V95, P353, DOI 10.1210/jc.2009-1769; Iranmanesh A, 1999, J CLIN ENDOCR METAB, V84, P1083, DOI 10.1210/jc.84.3.1083; Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Keenan DM, 2003, AM J PHYSIOL-REG I, V285, pR664, DOI 10.1152/ajpregu.00195.2003; Kok P, 2004, J CLIN ENDOCR METAB, V89, P4445, DOI 10.1210/jc.2003-032184; Kok SW, 2002, J CLIN ENDOCR METAB, V87, P805, DOI 10.1210/jc.87.2.805; Latta F, 2005, SLEEP, V28, P1519, DOI 10.1093/sleep/28.12.1519; Liu PY, 2006, J CLIN ENDOCR METAB, V91, P4077, DOI 10.1210/jc.2005-2811; Liu PY, 2009, AM J PHYSIOL-ENDOC M, V297, pE538, DOI 10.1152/ajpendo.00071.2009; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Mingrone G, 2008, OBESITY, V16, P1831, DOI 10.1038/oby.2008.297; Molitch ME, 1995, PITUITARY; PERRONE G, 1994, INT J FERTIL MENOP S, V39, P202; Pincus SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE989, DOI 10.1152/ajpendo.1997.273.5.E989; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 1999, AM J PHYSIOL-ENDOC M, V277, pE948, DOI 10.1152/ajpendo.1999.277.5.E948; Pincus SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE107, DOI 10.1152/ajpendo.1996.270.1.E107; Pincus SM, 1996, P NATL ACAD SCI USA, V93, P14100, DOI 10.1073/pnas.93.24.14100; Pincus SM, 2000, METHOD ENZYMOL, V321, P149; Pincus SM, 2008, J PSYCHIATR RES, V42, P337, DOI 10.1016/j.jpsychires.2007.01.001; Pincus SM, 2011, J PSYCHIATR RES, V45, P386, DOI 10.1016/j.jpsychires.2010.07.006; QUIGLEY ME, 1981, J CLIN ENDOCR METAB, V52, P1043, DOI 10.1210/jcem-52-5-1043; Roelfsema F, 2002, CLIN ENDOCRINOL, V56, P79, DOI 10.1046/j.0300-0664.2001.01433.x; Roelfsema F, 2008, J CLIN ENDOCR METAB, V93, P4052, DOI 10.1210/jc.2008-1145; Roelfsema F, 2010, J CLIN ENDOCR METAB, V95, P928, DOI 10.1210/jc.2009-1959; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P3964, DOI 10.1210/jc.2009-1155; SAWIN CT, 1978, J CLIN ENDOCR METAB, V47, P1296, DOI 10.1210/jcem-47-6-1296; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P407, DOI 10.1097/01.ASN.0000043905.35268.86; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; SIEVERTSEN GD, 1980, J CLIN ENDOCR METAB, V50, P846, DOI 10.1210/jcem-50-5-846; SIRAGY HM, 1995, J CLIN ENDOCR METAB, V80, P28, DOI 10.1210/jc.80.1.28; Soldin SJ, 2009, CLIN CHEM, V55, P1061, DOI 10.1373/clinchem.2007.100008; Stanosz S, 2009, METABOLISM, V58, P1, DOI 10.1016/j.metabol.2008.07.016; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P1570, DOI 10.1210/jc.2004-1281; van den Berg G, 1998, EUR J ENDOCRINOL, V138, P164, DOI 10.1530/eje.0.1380164; van der Klaauw AA, 2007, CLIN ENDOCRINOL, V66, P489, DOI 10.1111/j.1365-2265.2006.02757.x; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; vandenBerg G, 1997, EUR J ENDOCRINOL, V136, P394, DOI 10.1530/eje.0.1360394; Veldhuis JD, 1999, J CLIN ENDOCR METAB, V84, P3498, DOI 10.1210/jc.84.10.3498; Veldhuis JD, 1997, AM J PHYSIOL-REG I, V272, pR464, DOI 10.1152/ajpregu.1997.272.2.R464; VELDHUIS JD, 1994, EUR J ENDOCRINOL, V131, P489, DOI 10.1530/eje.0.1310489; Veldhuis JD, 2006, ENDOCR REV, V27, P101, DOI 10.1210/er.2005-0006; Veldhuis JD, 2001, J CLIN ENDOCR METAB, V86, P3772, DOI 10.1210/jc.86.8.3772; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P115, DOI 10.1210/jc.2010-1669; Veldhuis JD, 2009, J CLIN ENDOCR METAB, V94, P4045, DOI 10.1210/jc.2009-1143; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Veldman RG, 2001, J CLIN ENDOCR METAB, V86, P1562, DOI 10.1210/jc.86.4.1562; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Watanobe H, 1999, BIOCHEM BIOPH RES CO, V263, P162, DOI 10.1006/bbrc.1999.1331; Yu WH, 1997, P NATL ACAD SCI USA, V94, P1023, DOI 10.1073/pnas.94.3.1023	72	65	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31305	10.1371/journal.pone.0031305	http://dx.doi.org/10.1371/journal.pone.0031305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363612	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600138
J	Gad, AKB; Ronnlund, D; Spaar, A; Savchenko, AA; Petranyi, G; Blom, H; Szekely, L; Widengren, J; Aspenstrom, P				Gad, Annica K. B.; Ronnlund, Daniel; Spaar, Alexander; Savchenko, Andrii A.; Petranyi, Gabor; Blom, Hans; Szekely, Laszlo; Widengren, Jerker; Aspenstrom, Pontus			Rho GTPases link cellular contractile force to the density and distribution of nanoscale adhesions	FASEB JOURNAL			English	Article						traction force microscopy; STED microscopy	LIGHT-CHAIN KINASE; CYTOSKELETAL DYNAMICS; TRACTION FORCES; FOCAL ADHESIONS; STED MICROSCOPY; TENSION; FIBROBLASTS; CELLS; RAC; ACTIVATION	The ability of cells to adhere and to exert contractile forces governs their capacity to move within an organism. The cytoskeletal regulators of the Rho GTPase proteins are involved in control of the contractile forces of cells. To elucidate the basis of cell migration, we analyzed contractile forces and nanoscale adhesion-related particles in single cells expressing constitutively active variants of Rho GTPases by using traction-force microscopy and ultra-high-resolution stimulated emission depletion microscopy, respectively. RhoAV14 induced large increases in the contractile forces of single cells, with Rac1L61 and RhoDV26 having more moderate effects. The RhoAV14- and RhoDV26-induced forces showed similar spatial distributions and were accompanied by reduced or unaltered cell spreading. In contrast, the Rac1L61-induced force had different, scattered, force distributions that were linked to increased cell spreading. All three of these Rho GTPase activities caused a loss of thick stress fibers and focal adhesions and a more homogenous distribution of nanoscale adhesion-related particles over the ventral surface of the cells. Interestingly, only RhoAV14 increased the density of these particles. Our data suggest a Rac1-specific mode for cells to generate contractile forces. Importantly, increased density and a more homogenous distribution of these small adhesion-related particles promote cellular contractile forces.-Gad, A. K. B., Ronnlund, D., Spaar, A., Savchenko, A. A., Petranyi, G., Blom, H., Szekely, L., Widengren, J., Aspenstrom, P. Rho GTPases link cellular contractile force to the density and distribution of nanoscale adhesions. FASEB J. 26, 2374-2382 (2012). www.fasebj.org	[Gad, Annica K. B.; Savchenko, Andrii A.; Petranyi, Gabor; Szekely, Laszlo; Aspenstrom, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Ronnlund, Daniel; Blom, Hans; Widengren, Jerker] AlbaNova Univ Ctr, Royal Inst Technol, Sch Engn Sci, Dept Biomol Phys, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Gad, AKB (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels 16,Box 280, SE-17177 Stockholm, Sweden.	annica.gad@ki.se	Gad, Annica/X-8294-2018; Gad, Annica/H-8758-2017; Szekely, Laszlo/B-1268-2009	Gad, Annica/0000-0002-1098-9129; Gad, Annica/0000-0002-1098-9129; Szekely, Laszlo/0000-0001-6144-6573; Widengren, Jerker/0000-0003-3200-0374	Swedish Research Council; Karolinska Institutet; Alex and Eva Wallstrom Foundation; O. E. and Edla Johansson Foundation; Magnus Bergvall Foundation; Swedish Society for Medical Research; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Alex and Eva Wallstrom Foundation; O. E. and Edla Johansson Foundation; Magnus Bergvall Foundation; Swedish Society for Medical Research; Swedish Cancer Foundation	The authors thank Dr. Anna Perols [Biotech, Kungliga Tekniska Hogskolan (KTH), Stockholm, Sweden], and Dr. Michael Way (London Research Institute, Cancer Research UK, London, UK), for providing reagents, and Dr. H. Brismar, (KTH and Karolinska Institutet, Stockholm, Sweden) for the use of the Zeiss LSM 510 META microscope. A. G. was supported through a postdoctoral position from the Swedish Research Council. The authors are grateful for the financial support from the Karolinska Institutet (to A. G. and P. A.), the Alex and Eva Wallstrom Foundation (to A. G.), the O. E. and Edla Johansson Foundation (to A. G.), the Magnus Bergvall Foundation (to A. G.), the Swedish Society for Medical Research (to A. G.), the Swedish Cancer Foundation (to P. A. and J. W.), and the Swedish Research Council (to P. A., J. W., and H. B.).	Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blom H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-16; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Gad A, 2004, J BIOL CHEM, V279, P13640, DOI 10.1074/jbc.M314300200; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kekre H.B., 2010, INT J COMPUT THEORY, P695, DOI DOI 10.7763/IJCTE.2010.V2.227; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Munevar S, 2001, MOL BIOL CELL, V12, P3947, DOI 10.1091/mbc.12.12.3947; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Okamura Y, 2011, BIOPHYS J, V100, P1855, DOI 10.1016/j.bpj.2011.02.052; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Ruusala A, 2008, MOL CELL BIOL, V28, P1802, DOI 10.1128/MCB.00201-07; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Saras J, 2004, EXP CELL RES, V299, P356, DOI 10.1016/j.yexcr.2004.05.029; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241	38	15	16	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2374	2382		10.1096/fj.11-195800	http://dx.doi.org/10.1096/fj.11-195800			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22371528				2022-12-25	WOS:000305017200015
J	Starr, AE; Bellac, CL; Dufour, A; Goebeler, V; Overall, CM				Starr, Amanda E.; Bellac, Caroline L.; Dufour, Antoine; Goebeler, Verena; Overall, Christopher M.			Biochemical Characterization and N-terminomics Analysis of Leukolysin, the Membrane-type 6 Matrix Metalloprotease (MMP25) CHEMOKINE AND VIMENTIN CLEAVAGES ENHANCE CELL MIGRATION AND MACROPHAGE PHAGOCYTIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; PROTEOMIC IDENTIFICATION; NEUTROPHIL APOPTOSIS; GELATINASE-A; PROTEINS; MT6-MMP; INSULIN; BINDING; INFLAMMATION; RECOGNITION	The neutrophil-specific protease membrane-type 6 matrix metalloproteinase (MT6-MMP)/MMP-25/leukolysin is implicated in multiple sclerosis and cancer yet remains poorly characterized. To characterize the biological roles of MT6-MMP, it is critical to identify its substrates for which only seven are currently known. Here, we biochemically characterized MT6-MMP, profiled its tissue inhibitor of metalloproteinase inhibitory spectrum, performed degradomics analyses, and screened 26 chemokines for cleavage using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. MT6-MMP processes seven each of the CXC and CC chemokine subfamilies. Notably, cleavage of the neutrophil chemoattractant CXCL5 activates the chemokine, thereby increasing its agonist activity, indicating a feed-forward mechanism for neutrophil recruitment. Likewise, cleavage also activated CCL15 and CCL23 to increase monocyte recruitment. Utilizing the proteomics approach proteomic identification of cleavage site specificity (PICS), we identified 286 peptidic cleavage sites spanning from P6 to P6' from which an unusual glutamate preference in P1 was identified. The degradomics screen terminal amine isotopic labeling of substrates (TAILS), which enriches for neo-N-terminal peptides of cleaved substrates, was used to identify 58 new native substrates in fibroblast secretomes after incubation with MT6-MMP. Vimentin, cystatin C, galectin-1, IGFBP-7, and secreted protein, acidic and rich in cysteine (SPARC) were among those substrates we biochemically confirmed. An extracellular "moonlighting" form of vimentin is a chemoattractant for THP-1 cells, but MT6-MMP cleavage abolished monocyte recruitment. Unexpectedly, the MT6-MMP-cleaved vimentin potently stimulated phagocytosis, which was not a property of the full-length protein. Hence, MT6-MMP regulates neutrophil and monocyte chemotaxis and by generating "eat-me" signals upon vimentin cleavage potentially increases phagocytic removal of neutrophils to resolve inflammation.	[Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, Vancouver, BC V6T 1Z3, Canada; [Starr, Amanda E.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Bellac, Caroline L.; Dufour, Antoine; Goebeler, Verena; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019; Goebeler, Verena/K-4873-2012		Canadian Institutes of Health Research [STP-53877]; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by a Canadian Institutes of Health Research grant, an infrastructure grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and Canadian Institutes of Health Research Strategic Training Program Grant STP-53877.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Clemmons DR, 2007, J CLIN ENDOCR METAB, V92, P2652, DOI 10.1210/jc.2006-2699; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fortin CF, 2010, INT IMMUNOL, V22, P637, DOI 10.1093/intimm/dxq048; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; LIU XJ, 1993, ENDOCRINOLOGY, V132, P1176, DOI 10.1210/en.132.3.1176; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Malik RKJ, 2009, GLYCOBIOLOGY, V19, P1402, DOI 10.1093/glycob/cwp077; Matsuda A, 2003, J BIOL CHEM, V278, P36350, DOI 10.1074/jbc.M301509200; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Oppenheim JJ, 2005, J LEUKOCYTE BIOL, V77, P854, DOI 10.1189/jlb.1004623; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Wuyts A, 1999, J IMMUNOL, V163, P6155; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	62	65	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13382	13395		10.1074/jbc.M111.314179	http://dx.doi.org/10.1074/jbc.M111.314179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367194	Green Published, hybrid			2022-12-25	WOS:000302903700073
J	Shasmal, M; Sengupta, J				Shasmal, Manidip; Sengupta, Jayati			Structural Diversity in Bacterial Ribosomes: Mycobacterial 70S Ribosome Structure Reveals Novel Features	PLOS ONE			English	Article							ACID-FAST BACILLI; MESSENGER-RNA; ESCHERICHIA-COLI; DELAYED-HYPERSENSITIVITY; ANGSTROM RESOLUTION; TRANSLATION INITIATION; ANTIBIOTIC-RESISTANCE; ELECTRON-MICROSCOPY; 80S RIBOSOME; SUBUNIT	Here we present analysis of a 3D cryo-EM map of the 70S ribosome from Mycobacterium smegmatis, a saprophytic cousin of the etiological agent of tuberculosis in humans, Mycobacterium tuberculosis. In comparison with the 3D structures of other prokaryotic ribosomes, the density map of the M. smegmatis 70S ribosome reveals unique structural features and their relative orientations in the ribosome. Dramatic changes in the periphery due to additional rRNA segments and extra domains of some of the peripheral ribosomal proteins like S3, S5, S16, L17, L25, are evident. One of the most notable features appears in the large subunit near L1 stalk as a long helical structure next to helix 54 of the 23S rRNA. The sharp upper end of this structure is located in the vicinity of the mRNA exit channel. Although the M. smegmatis 70S ribosome possesses conserved core structure of bacterial ribosome, the new structural features, unveiled in this study, demonstrates diversity in the 3D architecture of bacterial ribosomes. We postulate that the prominent helical structure related to the 23S rRNA actively participates in the mechanisms of translation in mycobacteria.	[Shasmal, Manidip; Sengupta, Jayati] CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Shasmal, M (corresponding author), CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.	jayati@iicb.res.in			Indian Institute of Chemical Biology, Kolkata, India; Council of Scientific and Industrial Research, Government of India	Indian Institute of Chemical Biology, Kolkata, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Indian Institute of Chemical Biology, Kolkata, India. MS has been awarded a senior research fellowship from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER R, 1979, INT ARCH ALLER A IMM, V59, P328, DOI 10.1159/000232277; BAKER RE, 1973, INFECT IMMUN, V8, P236, DOI 10.1128/IAI.8.2.236-244.1973; BAKER RE, 1972, INFECT IMMUN, V6, P258, DOI 10.1128/IAI.6.3.258-265.1972; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Bruell CM, 2008, BIOCHEMISTRY-US, V47, P8828, DOI 10.1021/bi800527k; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; HONORE N, 1994, ANTIMICROB AGENTS CH, V38, P238, DOI 10.1128/AAC.38.2.238; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; LOECHEL S, 1991, NUCLEIC ACIDS RES, V19, P6905, DOI 10.1093/nar/19.24.6905; LOGE RV, 1974, INFECT IMMUN, V9, P489, DOI 10.1128/IAI.9.3.489-496.1974; LONNROTH I, 1985, FEMS MICROBIOL LETT, V26, P113, DOI 10.1016/0378-1097(85)90134-X; LONNROTH I, 1985, FEMS MICROBIOL LETT, V27, P203, DOI 10.1016/0378-1097(85)90314-3; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Marzi S, 2008, BIOL CHEM, V389, P585, DOI 10.1515/BC.2008.055; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Reblova K, 2010, NUCLEIC ACIDS RES, V38, P1325, DOI 10.1093/nar/gkp1057; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; SURYANARAYANA T, 1984, BIOCHEMISTRY-US, V23, P1047, DOI 10.1021/bi00301a002; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Villa E, 2009, P NATL ACAD SCI US; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	46	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31742	10.1371/journal.pone.0031742	http://dx.doi.org/10.1371/journal.pone.0031742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22384065	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916800018
J	Zhao, JY; Sun, JW; Gu, ZY; Wang, J; Wang, EL; Yang, XY; Qiao, B; Duan, WY; Huang, GY; Wang, HY				Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Qiao, Bin; Duan, Wen-Yuan; Huang, Guo-Ying; Wang, Hong-Yan			Genetic Polymorphisms of the TYMS Gene Are Not Associated with Congenital Cardiac Septal Defects in a Han Chinese Population	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; HEART-DEFECTS; RISK; FOLATE; HOMOCYSTEINE; MULTIVITAMIN; DETERMINANT; SUPPLEMENTS; INTRON	Background: Clinical research indicates that periconceptional administration of folic acid can reduce the occurrence of congenital cardiac septal defects (CCSDs). The vital roles of folate exhibits in three ways: the unique methyl donor for DNA expression regulation, the de novo biosynthesis of purine and pyrimidine for DNA construction, and the serum homocysteine removal. Thymidylate synthase (TYMS) is the solo catalysis enzyme for the de novo synthesis of dTMP, which is the essential precursor of DNA biosynthesis and repair process. To examine the role of TYMS in Congenital Cardiac Septal Defects (CCSDs) risk, we investigated whether genetic polymorphisms in the TYMS gene associated with the CCSDs in a Han Chinese population. Method: Polymorphisms in the noncoding region of TYMS were identified via direct sequencing in 32 unrelated individuals composed of half CCSDs and half control subjects. Nine SNPs and two insertion/deletion polymorphisms were genotyped from two independent case-control studies involving a total of 529 CCSDs patients and 876 healthy control participants. The associations were examined by both single polymorphism and haplotype tests using logistic regression. Result: We found that TYMS polymorphisms were not related to the altered CCSDs risk, and even to the changed risk of VSDs subgroup, when tested in both studied groups separately or in combination. In the haplotype analysis, there were no haplotypes significantly associated with risks for CCSDs either. Conclusion: Our results show no association between common genetic polymorphisms of the regulatory region of the TYMS gene and CCSDs in the Han Chinese population.	[Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Jian-Yuan; Sun, Jing-Wei; Gu, Zhuo-Ya; Wang, Jue; Wang, Er-Li; Yang, Xue-Yan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Qiao, Bin; Duan, Wen-Yuan] Jinan Mil Reg, Gen Hosp, Inst Cardiovasc Dis, Jinan, Peoples R China; [Huang, Guo-Ying] Fudan Univ, Shanghai Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Hong-Yan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhao, Jian-Yuan] Adm Sports Anhui Prov, Inst Sports Sci & Technol, Hefei, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University	Zhao, JY (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	wanghy@fudan.edu.cn	Zhao, Jianyuan/G-8483-2012	Zhao, Jian-Yuan/0000-0001-9861-0330	National Science Fund for Distinguished Young Scholars [81025003]; 973 Program [2010CB529601, 2007CB500902]; National Natural Science Foundation of China [30872129]; Ministry of Education of China [20110071110026, 20090071120037]; Program for Innovative Research Team in University [IRT1010]; Commission for Science and Technology of Shanghai Municipality [10JC1401300, 11XD1400900]; Scientific Research Foundation for Returned Scholars; Natural Science Foundation of Shanghai Municipality [09ZR1404400]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Program for Innovative Research Team in University; Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai)	This work was supported by the grants from the National Science Fund for Distinguished Young Scholars (81025003), the 973 Program (2010CB529601, 2007CB500902), the National Natural Science Foundation of China (30872129), the Doctoral Fund of Ministry of Education of China (20110071110026), the Program for Innovative Research Team in University (IRT1010) and the Commission for Science and Technology of Shanghai Municipality (10JC1401300, 11XD1400900) to HYW, grants from the Scientific Research Foundation for Returned Scholars and Doctoral Fund of Ministry of Education of China (20090071120037) and the Natural Science Foundation of Shanghai Municipality (09ZR1404400) to XYY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYUSAWA D, 1986, J MOL BIOL, V190, P559, DOI 10.1016/0022-2836(86)90241-X; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Blanton SH, 2011, BIRTH DEFECTS RES A, V91, P50, DOI 10.1002/bdra.20740; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; Botto LD, 1996, PEDIATRICS, V98, P911; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huhta JC, 2006, CURR OPIN PEDIATR, V18, P484, DOI 10.1097/01.mop.0000245347.45336.d7; Huhta JC, 2005, FETAL PEDIATR PATHOL, V24, P71, DOI 10.1080/15227950591008240; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; KANEDA S, 1992, SOMAT CELL MOLEC GEN, V18, P409, DOI 10.1007/BF01233080; KANEDA S, 1990, J BIOL CHEM, V265, P20277; Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200; Kim SR, 2006, DRUG METAB PHARMACOK, V21, P509, DOI 10.2133/dmpk.21.509; Lupo PJ, 2011, BIRTH DEFECTS RES A, V91, P61, DOI 10.1002/bdra.20745; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; TAKAYANAGI A, 1992, NUCLEIC ACIDS RES, V20, P4021, DOI 10.1093/nar/20.15.4021; Trinh BN, 2002, HUM GENET, V111, P299, DOI 10.1007/s00439-002-0779-2; Ulrich CM, 2002, CANCER RES, V62, P3361; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; van Beynum IM, 2006, CLIN CHEM LAB MED, V44, P1317, DOI 10.1515/CCLM.2006.254; Volcik KA, 2003, BIRTH DEFECTS RES A, V67, P924, DOI 10.1002/bdra.10029; Wilding CS, 2004, BIRTH DEFECTS RES A, V70, P483, DOI 10.1002/bdra.20038	26	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31644	10.1371/journal.pone.0031644	http://dx.doi.org/10.1371/journal.pone.0031644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384047	gold, Green Submitted, Green Published			2022-12-25	WOS:000302916100027
J	Beriault, DR; Haddad, O; McCuaig, JV; Robinson, ZJ; Russell, D; Lane, EB; Fudge, DS				Beriault, Daniel R.; Haddad, Oualid; McCuaig, John V.; Robinson, Zachary J.; Russell, David; Lane, E. Birgitte; Fudge, Douglas S.			The Mechanical Behavior of Mutant K14-R125P Keratin Bundles and Networks in NEB-1 Keratinocytes	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE-FILAMENTS; MUSCULAR-DYSTROPHY; DOWLING-MEARA; MUTATIONS; CELLS; MICROTUBULES; ORGANIZATION; LETHALITY; KNOCKOUT	Epidermolysis bullosa simplex (EBS) is an inherited skin-blistering disease that is caused by dominant mutations in the genes for keratin K5 or K14 proteins. While the link between keratin mutations and keratinocyte fragility in EBS patients is clear, the exact biophysical mechanisms underlying cell fragility are not known. In this study, we tested the hypotheses that mutant K14-R125P filaments and/or networks in human keratinocytes are mechanically defective in their response to large-scale deformations. We found that mutant filaments and networks exhibit no obvious defects when subjected to large uniaxial strains and have no negative effects on the ability of human keratinocytes to survive large strains. We also found that the expression of mutant K14-R125P protein has no effect on the morphology of the F-actin or microtubule networks or their responses to large strains. Disassembly of the F-actin network with Latrunculin A unexpectedly led to a marked decrease in stretch-induced necrosis in both WT and mutant cells. Overall, our results contradict the hypotheses that EBS mutant keratin filaments and/or networks are mechanically defective. We suggest that future studies should test the alternative hypothesis that keratinocytes in EBS cells are fragile because they possess a sparser keratin network.	[Beriault, Daniel R.; Haddad, Oualid; McCuaig, John V.; Robinson, Zachary J.; Fudge, Douglas S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Russell, David; Lane, E. Birgitte] Univ Dundee, Canc Res United Kingdom UK Cell Struct Res Grp, Coll Life Sci, Dundee, Scotland; [Lane, E. Birgitte] Inst Med Biol, Singapore, Singapore	University of Guelph; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Beriault, DR (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	dfudge@uoguelph.ca	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research Catalyst Grant to Douglas Fudge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONLAMPRECHT I, 1982, DERMATOLOGICA, V164, P221, DOI 10.1159/000250096; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BRODLAND GW, 1990, J BIOMECH ENG-T ASME, V112, P319, DOI 10.1115/1.2891190; COULOMBE M, 1991, TRANSPLANT P, V23, P31; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Hesse M, 2007, EXP CELL RES, V313, P3127, DOI 10.1016/j.yexcr.2007.05.019; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KITAJIMA Y, 1989, ARCH DERMATOL RES, V281, P5, DOI 10.1007/BF00424265; KRAUSE AW, 1984, J HISTOCHEM CYTOCHEM, V32, P1084, DOI 10.1177/32.10.6090533; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Pulkkinen L, 1996, HUM MOL GENET, V5, P1539, DOI 10.1093/hmg/5.10.1539; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Sorensen CB, 1999, J INVEST DERMATOL, V112, P184, DOI 10.1046/j.1523-1747.1999.00495.x; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122; Zhou Q, 2003, MOL BIOL CELL, V14, P2959, DOI 10.1091/mbc.E03-02-0059	30	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31320	10.1371/journal.pone.0031320	http://dx.doi.org/10.1371/journal.pone.0031320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363617	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700046
J	Peuchant, O; Le Roy, C; Herrmann, B; Clerc, M; Bebear, C; de Barbeyrac, B				Peuchant, Olivia; Le Roy, Chloe; Herrmann, Bjorn; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille			MLVA Subtyping of Genovar E Chlamydia trachomatis Individualizes the Swedish Variant and Anorectal Isolates from Men who Have Sex with Men	PLOS ONE			English	Article							GENOME SEQUENCE; TYPING METHODS; STRAINS	This study describes a new multilocus variable number tandem-repeat (VNTR) analysis (MLVA) typing system for the discrimination of Chlamydia trachomatis genovar D to K isolates or specimens. We focused our MLVA scheme on genovar E which predominates in most populations worldwide. This system does not require culture and therefore can be performed directly on DNA extracted from positive clinical specimens. Our method was based on GeneScan analysis of five VNTR loci labelled with fluorescent dyes by multiplex PCR and capillary electrophoresis. This MLVA, called MLVA-5, was applied to a collection of 220 genovar E and 94 non-E genovar C. trachomatis isolates and specimens obtained from 251 patients and resulted in 38 MLVA-5 types. The genetic stability of the MLVA-5 scheme was assessed for results obtained both in vitro by serial passage culturing and in vivo using concomitant and sequential isolates and specimens. All anorectal genovar E isolates from men who have sex with men exhibited the same MLVA-5 type, suggesting clonal spread. In the same way, we confirmed the clonal origin of the Swedish new variant of C. trachomatis. The MLVA-5 assay was compared to three other molecular typing methods, ompA gene sequencing, multilocus sequence typing (MLST) and a previous MLVA method called MLVA-3, on 43 genovar E isolates. The discriminatory index was 0.913 for MLVA-5, 0.860 for MLST and 0.622 for MLVA-3. Among all of these genotyping methods, MLVA-5 displayed the highest discriminatory power and does not require a time-consuming sequencing step. The results indicate that MLVA-5 enables high-resolution molecular epidemiological characterisation of C. trachomatis genovars D to K infections directly from specimens.	[Peuchant, Olivia; Le Roy, Chloe; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille] Univ Bordeaux, USC Mycoplasmal & Chlamydial Infect Humans, French Natl Reference Ctr Chlamydial Infect, Bordeaux, France; [Peuchant, Olivia; Le Roy, Chloe; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille] French Natl Reference Ctr Chlamydial Infect, INRA, USC Mycoplasmal & Chlamydial Infect Humans, Bordeaux, France; [Peuchant, Olivia; Bebear, Cecile; de Barbeyrac, Bertille] CHU Bordeaux, Bacteriol Lab, Bordeaux, France; [Herrmann, Bjorn] Uppsala Univ, Sect Clin Bacteriol, Dept Med Sci, Uppsala, Sweden	UDICE-French Research Universities; Universite de Bordeaux; INRAE; CHU Bordeaux; Uppsala University	Peuchant, O (corresponding author), Univ Bordeaux, USC Mycoplasmal & Chlamydial Infect Humans, French Natl Reference Ctr Chlamydial Infect, Bordeaux, France.	bertille.de.barbeyrac@u-bordeaux2.fr	Bébéar, Cécile/A-6596-2016	Bebear, Cecile/0000-0001-6065-2332	French Institute for Public Health (InVS)	French Institute for Public Health (InVS)	This research was supported by a grant from the French Institute for Public Health (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Bom RJ, 2011, J CLIN MICROBIO 0608; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Christerson L, 2010, EMERG INFECT DIS, V16, P1777, DOI 10.3201/eid1611.100379; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Clerc M, 2011, B EPIDEMIOL HEBD, V26-27-28, P310; de Barbeyrac B, 2007, Euro Surveill, V12, pE11; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Jurstrand M, 2010, SEX TRANSM INFECT, V86, P56, DOI 10.1136/sti.2009.037572; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Lutter EI, 2010, INFECT IMMUN, V78, P3678, DOI 10.1128/IAI.00515-10; Mossman D, 2008, SEX TRANSM DIS, V35, P614, DOI 10.1097/OLQ.0b013e31816b1b80; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; RODRIGUEZ P, 1991, J CLIN MICROBIOL, V29, P1132, DOI 10.1128/JCM.29.6.1132-1136.1991; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Unemo M, 2010, MICROBIOL-SGM, V156, P1394, DOI 10.1099/mic.0.036830-0; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31538	10.1371/journal.pone.0031538	http://dx.doi.org/10.1371/journal.pone.0031538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363667	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700066
J	Sirmaci, A; Edwards, YJK; Akay, H; Tekin, M				Sirmaci, Asli; Edwards, Yvonne J. K.; Akay, Hatice; Tekin, Mustafa			Challenges in Whole Exome Sequencing: An Example from Hereditary Deafness	PLOS ONE			English	Article							DNA-BINDING; LINKER SEQUENCES; ZINC FINGERS; HEARING-LOSS; PROTEIN; MUTATIONS; RECOGNITION; AFFINITY; PEPTIDE; DISEASE	Whole exome sequencing provides unprecedented opportunities to identify causative DNA variants in rare Mendelian disorders. Finding the responsible mutation via traditional methods in families with hearing loss is difficult due to a high degree of genetic heterogeneity. In this study we combined autozygosity mapping and whole exome sequencing in a family with 3 affected children having nonsyndromic hearing loss born to consanguineous parents. Two novel missense homozygous variants, c.508C > A (p.H170N) in GIPC3 and c.1328C > T (p.T443M) in ZNF57, were identified in the same similar to 6 Mb autozygous region on chromosome 19 in affected members of the family. Both variants co-segregated with the phenotype and were absent in 335 ethnicity-matched controls. Biallelic GIPC3 mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss. Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in GIPC3. Identified variant in GIPC3 had a low read depth, which was initially filtered out during the analysis leaving ZNF57 as the only potential causative gene. This study highlights some of the challenges in the analyses of whole exome data in the bid to establish the true causative variant in Mendelian disease.	[Sirmaci, Asli; Edwards, Yvonne J. K.; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sirmaci, Asli; Edwards, Yvonne J. K.; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Akay, Hatice] Veni Vidi Hosp, Radiodiagnost Unit, Diyarbakir, Turkey; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06100 Ankara, Turkey	University of Miami; University of Miami; Veni Vidi Hospital; Ankara University	Sirmaci, A (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mtekin@med.miami.edu	Akay, Hatice/AAD-8547-2021; Tekin, Mustafa/ABG-7627-2020	Akay, Hatice/0000-0002-0854-0904; Tekin, Mustafa/0000-0002-3525-7960; Edwards, Yvonne/0000-0001-8505-3168	National Institutes of Health - National Institute on Deafness and Other Communication Disorders [R01DC009645]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health - National Institute on Deafness and Other Communication Disorders grant R01DC009645 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Jantz D, 2004, P NATL ACAD SCI USA, V101, P7589, DOI 10.1073/pnas.0402191101; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rehman AU, 2011, HUMAN GENETICS; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang YQ, 2010, BMB REP, V43, P212, DOI 10.5483/BMBRep.2010.43.3.212; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zhang W, 2011, BIOCHEM BIOPH RES CO, V413, P58, DOI 10.1016/j.bbrc.2011.08.043; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	41	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32000	10.1371/journal.pone.0032000	http://dx.doi.org/10.1371/journal.pone.0032000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363784	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700132
J	Sogaard, C; Stenbaek, A; Bernard, S; Hadi, M; Driouich, A; Scheller, HV; Sakuragi, Y				Sogaard, Casper; Stenbaek, Anne; Bernard, Sophie; Hadi, Masood; Driouich, Azeddine; Scheller, Henrik Vibe; Sakuragi, Yumiko			GO-PROMTO Illuminates Protein Membrane Topologies of Glycan Biosynthetic Enzymes in the Golgi Apparatus of Living Tissues	PLOS ONE			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; XYLOGLUCAN BIOSYNTHESIS; TRANSMEMBRANE TOPOLOGY; ENDOPLASMIC-RETICULUM; UDP-ARABINOFURANOSE; MOLECULAR-CLONING; PREDICTION; GENE; PLANTS; TRANSLOCATION	The Golgi apparatus is the main site of glycan biosynthesis in eukaryotes. Better understanding of the membrane topology of the proteins and enzymes involved can impart new mechanistic insights into these processes. Publically available bioinformatic tools provide highly variable predictions of membrane topologies for given proteins. Therefore we devised a non-invasive experimental method by which the membrane topologies of Golgi-resident proteins can be determined in the Golgi apparatus in living tissues. A Golgi marker was used to construct a series of reporters based on the principle of bimolecular fluorescence complementation. The reporters and proteins of interest were recombinantly fused to split halves of yellow fluorescent protein (YFP) and transiently co-expressed with the reporters in the Nicotiana benthamiana leaf tissue. Output signals were binary, showing either the presence or absence of fluorescence with signal morphologies characteristic of the Golgi apparatus and endoplasmic reticulum (ER). The method allows prompt and robust determinations of membrane topologies of Golgi-resident proteins and is termed GO-PROMTO (for GOlgi PROtein Membrane TOpology). We applied GO-PROMTO to examine the topologies of proteins involved in the biosynthesis of plant cell wall polysaccharides including xyloglucan and arabinan. The results suggest the existence of novel biosynthetic mechanisms involving transports of intermediates across Golgi membranes.	[Sogaard, Casper; Stenbaek, Anne; Sakuragi, Yumiko] Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Frederiksberg, Denmark; [Sogaard, Casper; Stenbaek, Anne; Sakuragi, Yumiko] Villum Kann Rasmussen Ctr ProAct Plants, Frederiksberg, Denmark; [Bernard, Sophie; Driouich, Azeddine] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire EA 4358, Mont St Aignan, France; [Hadi, Masood] Sandia Natl Labs, Div Technol, Joint BioEnergy Inst, Emeryville, CA USA; [Scheller, Henrik Vibe] Lawrence Berkeley Natl Lab, Feedstocks Div, Joint BioEnergy Inst, Emeryville, CA USA	University of Copenhagen; Villum Fonden; Universite de Rouen Normandie; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Sandia National Laboratories; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory	Sogaard, C (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Frederiksberg, Denmark.	ysa@life.ku.dk	Scheller, Henrik/AAH-4770-2020; Scheller, Henrik V/A-8106-2008; Sakuragi, Yumiko/E-9707-2012	Scheller, Henrik/0000-0002-6702-3560; Scheller, Henrik V/0000-0002-6702-3560; Sakuragi, Yumiko/0000-0002-9405-5197	U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy(United States Department of Energy (DOE))	The Danish Council for Independent Research and Villum Kann Rasmussen foundation for YS. U.S. Department of Energy DE-AC02-05CH11231 for HVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Barber C, 2006, J BIOL CHEM, V281, P17276, DOI 10.1074/jbc.M512727200; Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brach T, 2009, PLANT J, V57, P534, DOI 10.1111/j.1365-313X.2008.03704.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; CHANG XB, 1994, J BIOL CHEM, V269, P18572; Chevalier L, 2010, PLANT J, V64, P977, DOI 10.1111/j.1365-313X.2010.04388.x; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; DRIOUICH A, 1993, TRENDS BIOCHEM SCI, V18, P210, DOI 10.1016/0968-0004(93)90191-O; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jensen JK, 2008, PLANT CELL, V20, P1289, DOI 10.1105/tpc.107.050906; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kauko A, 2010, J MOL BIOL, V397, P190, DOI 10.1016/j.jmb.2010.01.042; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Munoz P, 1996, PLANT PHYSIOL, V112, P1585, DOI 10.1104/pp.112.4.1585; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Norambuena L, 2002, J BIOL CHEM, V277, P32923, DOI 10.1074/jbc.M204081200; Pattathil S, 2005, PLANTA, V221, P538, DOI 10.1007/s00425-004-1471-7; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Sakuragi Y, 2011, METHODS MOL BIOL, V715, P153, DOI 10.1007/978-1-61779-008-9_11; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seshadri K, 1998, PROTEIN SCI, V7, P2026, DOI 10.1002/pro.5560070919; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wallin E, 1997, PROTEIN SCI, V6, P808; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Wulff C, 2000, PLANT PHYSIOL, V122, P867, DOI 10.1104/pp.122.3.867; Yin L, 2011, MOL PLANT, V4, P1024, DOI 10.1093/mp/ssr026; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x; Zeng WQ, 2008, PLANTA, V228, P823, DOI 10.1007/s00425-008-0785-2; ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31324	10.1371/journal.pone.0031324	http://dx.doi.org/10.1371/journal.pone.0031324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363620	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700049
J	Sui, Y; Horne, MK; Stanic, D				Sui, Yi; Horne, Malcolm K.; Stanic, Davor			Reduced Proliferation in the Adult Mouse Subventricular Zone Increases Survival of Olfactory Bulb Interneurons	PLOS ONE			English	Article							EXTERNAL PLEXIFORM LAYER; MICROTUBULE-ASSOCIATED PROTEIN; PRECURSOR CELL-PROLIFERATION; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; NEWBORN NEURONS; MAMMALIAN BRAIN; RAT-BRAIN; TYROSINE-HYDROXYLASE; SENSORY EXPERIENCE	Neurogenesis in the adult brain is largely restricted to the subependymal zone (SVZ) of the lateral ventricle, olfactory bulb (OB) and the dentate subgranular zone, and survival of adult-born cells in the OB is influenced by factors including sensory experience. We examined, in mice, whether survival of adult-born cells is also regulated by the rate of precursor proliferation in the SVZ. Precursor proliferation was decreased by depleting the SVZ of dopamine after lesioning dopamine neurons in the substantia nigra compacta with 6-hydroxydopamine. Subsequently, we examined the effect of reduced SVZ proliferation on the generation, migration and survival of neuroblasts and mature adult-born cells in the SVZ, rostral migratory stream (RMS) and OB. Proliferating cells in the SVZ, measured by 5-bromo-2-deoxyuridine (BrdU) injected 2 hours prior to death or by immunoreactivity against Ki67, were reduced by 47% or 36%, respectively, 7 days after dopamine depletion, and by 29% or 31% 42 days after dopamine depletion, compared to sham-treated animals. Neuroblast generation in the SVZ and their migration along the RMS were not affected, neither 7 nor 42 days after the 6-hydroxydopamine injection, since the number of doublecortin-immunoreactive neuroblasts in the SVZ and RMS, as well as the number of neuronal nuclei-immunoreactive cells in the OB, were stable compared to control. However, survival analysis 15 days after 6-hydroxydopamine and 6 days after BrdU injections showed that the number of BrdU+ cells in the SVZ was 70% higher. Also, 42 days after 6-hydroxydopamine and 30 days after BrdU injections, we found an 82% increase in co-labeled BrdU+/gamma-aminobutyric acid-immunoreactive cell bodies in the granular cell layer, while double-labeled BrdU+/tyrosine hydroxylase-immunoreactive cell bodies in the glomerular layer increased by 148%. We conclude that the number of OB interneurons following reduced SVZ proliferation is maintained through an increased survival of adult-born precursor cells, neuroblasts and interneurons.	[Sui, Yi; Horne, Malcolm K.; Stanic, Davor] Univ Melbourne, Neurodegenerat Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Sui, Yi; Horne, Malcolm K.; Stanic, Davor] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Sui, Y (corresponding author), Univ Melbourne, Neurodegenerat Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	dstanic@unimelb.edu.au	Horne, Malcolm/AAL-5214-2020; Sui, Yi/I-5278-2019	Horne, Malcolm/0000-0001-9427-2100; Sui, Yi/0000-0002-2898-7877; Stanic, Davor/0000-0002-4310-7030	Victorian Government; Operational Infrastructure Support Grant; Department and other Government agencies; National Health and Medical Research Council (NHMRC); NHMRC Australia [ID 300083]	Victorian Government; Operational Infrastructure Support Grant; Department and other Government agencies; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Florey Neuroscience Institutes acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. All funding received through the Department and other Government agencies are expended on the research activities and services to support the science. Y.S. is a recipient of an Australian Postgraduate Award. M.K.H. was supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship. D.S. was supported by an NHMRC Australia CJ Martin Fellowship (ID 300083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Bauer S, 2003, NEUROSCIENCE, V117, P281, DOI 10.1016/S0306-4522(02)00757-1; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Doetsch F, 1997, J NEUROSCI, V17, P5046; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feierstein CE, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00176; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P780, DOI 10.1152/jn.1972.35.6.780; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; GERDES J, 1984, J IMMUNOL, V133, P1710; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hannan AJ, 1999, J NEUROSCI RES, V55, P650, DOI 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.3.CO;2-J; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKOWSKI A, 1978, BRAIN RES, V159, P17, DOI 10.1016/0006-8993(78)90106-3; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Kosaka K, 2007, BRAIN RES, V1167, P42, DOI 10.1016/j.brainres.2007.04.087; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Kosaka T, 2011, NEUROSCI RES, V69, P93, DOI 10.1016/j.neures.2010.10.002; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Ohtani N, 2003, J NEUROSCI, V23, P2840; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PEASE DC, 1962, ANAT REC, V142, P342; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; Rosselli-Austin L, 1979, J Dev Physiol, V1, P295; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shipley MT, 1996, J NEUROBIOL, V30, P123; SHIPLEY MT, 1996, HAND CHEM N, V12, P469; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stanic D, 2010, J COMP NEUROL, V518, P770, DOI 10.1002/cne.22226; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Sultan S, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00052; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Veyrac A, 2005, EXP NEUROL, V194, P444, DOI 10.1016/j.expneurol.2005.03.004; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Winner B, 2009, EXP NEUROL, V219, P543, DOI 10.1016/j.expneurol.2009.07.013; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Yang Z, 2008, J COMP NEUROL, V506, P347, DOI 10.1002/cne.21557; ZAMBONI L, 1967, J CELL BIOL, V35, pA148	90	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31549	10.1371/journal.pone.0031549	http://dx.doi.org/10.1371/journal.pone.0031549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363671	Green Published, gold			2022-12-25	WOS:000302873700069
J	Kleiven, AR; Olsen, EM; Volstad, JH				Kleiven, Alf Ring; Olsen, Esben Moland; Volstad, Jon Helge			Total Catch of a Red-Listed Marine Species Is an Order of Magnitude Higher than Official Data	PLOS ONE			English	Article							LOBSTER HOMARUS-GAMMARUS; RECREATIONAL FISHERY; ESTIMATING ILLEGAL; FISHING EFFORT; ROCK LOBSTER; MANAGEMENT	Accurate information on total catch and effort is essential for successful fisheries management. Officially reported landings, however, may be underestimates of total catch in many fisheries. We investigated the fishery for the nationally red-listed European lobster (Homarus gammarus) in south-eastern Norway. Probability-based strip transect surveys were used to count buoys in the study area in combination with catch per unit effort data obtained independently from volunteer catch diaries, phone interviews, and questionnaires. We estimate that recreational catch accounts for 65% of total catch in the study area. Moreover, our results indicate that only a small proportion (24%) of lobsters landed commercially were sold through the legal market and documented. Total estimated lobster catch was nearly 14 times higher than reported officially. Our study highlights the need for adequate catch monitoring and data collection efforts in coastal areas, presents a clear warning to resource managers that illegal, unreported and unregulated (IUU) fisheries in coastal areas should not be ignored, and shows the potential impact of recreational fisheries.	[Kleiven, Alf Ring; Olsen, Esben Moland] IMR, Arendal, Norway; [Kleiven, Alf Ring] Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway; [Olsen, Esben Moland] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Volstad, Jon Helge] IMR, Bergen, Norway	Institute of Marine Research - Norway; UiT The Arctic University of Tromso; University of Oslo; Institute of Marine Research - Norway	Kleiven, AR (corresponding author), IMR, Arendal, Norway.	alf.ring.kleiven@imr.no	Vølstad, Jon/B-7451-2014; Olsen, Esben Moland/B-1894-2012; Vølstad, Jon Helge/V-2992-2019; Kleiven, Alf/J-3650-2012; Kleiven, Alf Ring/ABK-6111-2022	Vølstad, Jon/0000-0001-8738-8543; Olsen, Esben Moland/0000-0003-3807-7524; Kleiven, Alf/0000-0002-9330-8340; 	Research Council of Norway [178376/S40]	Research Council of Norway(Research Council of Norway)	This research was funded by the Research Council of Norway, project number: 178376/S40 (http://www.forskningsraadet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Ainsworth CH, 2005, FISH RES, V75, P40, DOI 10.1016/j.fishres.2005.05.003; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Cockcroft AC, 1997, S AFR J MARINE SCI, V18, P75; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; HOLLAND S M, 1992, North American Journal of Fisheries Management, V12, P28, DOI 10.1577/1548-8675(1992)012&lt;0028:FTSATO&gt;2.3.CO;2; King DM, 2010, MAR POLICY, V34, P7, DOI 10.1016/j.marpol.2009.04.023; Kleiven AR, 2011, MAR COAST FISH, V3, P383, DOI 10.1080/19425120.2011.638798; Le Gallic B, 2006, MAR POLICY, V30, P689, DOI 10.1016/j.marpol.2005.09.008; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lyle JM, 2005, NEW ZEAL J MAR FRESH, V39, P703, DOI 10.1080/00288330.2005.9517346; McCluskey SM, 2008, FISH FISH, V9, P188, DOI 10.1111/j.1467-2979.2008.00283.x; McPhee D. P., 2002, Pacific Conservation Biology, V8, P40; Moland E, 2011, CAN J FISH AQUAT SCI, V68, P1197, DOI 10.1139/F2011-053; Muller R. G., 2000, 2000 UPDATE STOCK AS; National Research Council, 2006, REV RECR FISH SURV M; Norwegian Ministry of Fisheries and Coastal Affairs, 2010, NORW FISH MAN WEB BA; Olsen, 2009, INTEGRATED COASTAL Z, P178, DOI DOI 10.1002/9781444316285.CH14; Oug E, 2006, NORSK RODLISTE 2006, P197; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Pitcher TJ, 2009, MAR POLICY, V33, P223, DOI 10.1016/j.marpol.2008.06.002; Pollock K. H., 1994, ANGLER SURVEYS THEIR; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Stokke OS, 2009, MAR POLICY, V33, P339, DOI 10.1016/j.marpol.2008.08.002; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Varkey DA, 2010, MAR POLICY, V34, P228, DOI 10.1016/j.marpol.2009.06.009	32	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31216	10.1371/journal.pone.0031216	http://dx.doi.org/10.1371/journal.pone.0031216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363583	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600124
J	Tang, LX; He, RH; Yang, G; Tan, JJ; Zhou, L; Meng, XM; Huang, XR; Lan, HY				Tang, Li-xia; He, Rui-hua; Yang, Guang; Tan, Jia-ju; Zhou, Li; Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao			Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CENTELLA-ASIATICA; HEPATIC FIBROGENESIS; RENAL FIBROSIS; GENE-TRANSFER; SMAD7; CELLS; MICE; RAT; EXPRESSION	Liver fibrosis is a major cause of liver failure, but treatment remains ineffective. In the present study, we investigated the mechanisms and anti-hepatofibrotic activities of asiatic acid (AA) in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4) and in vitro in TGF-beta1-stimulated rat hepatic stellate cell line (HSC-T6). Treatment with AA significantly attenuated CCl4-induced liver fibrosis and functional impairment in a dosage-dependent manner, including blockade of the activation of HSC as determined by inhibiting de novo alpha smooth muscle actin (a-SMA) and collagen matrix expression, and an increase in ALT and AST (all p<0.01). The hepatoprotective effects of AA on fibrosis were associated with upregulation of hepatic Smad7, an inhibitor of TGF-beta signaling, thereby blocking upregulation of TGF-beta1 and CTGF and the activation of TGF-beta/Smad signaling. The anti-fibrosis activity and mechanisms of AA were further detected in vitro in HSC-T6. Addition of AA significantly induced Smad7 expression by HSC-T6 cells, thereby inhibiting TGF-beta1-induced Smad2/3 activation, myofibroblast transformation, and collagen matrix expression in a dosage-dependent manner. In contrast, knockdown of Smad7 in HSC-T6 cells prevented AA-induced inhibition of HSC-T6 cell activation and fibrosis in response to TGF-beta1, revealing an essential role for Smad7 in AA-induced anti-fibrotic activities during liver fibrosis in vivo and in vitro. In conclusion, AA may be a novel therapeutic agent for liver fibrosis. Induction of Smad7-dependent inhibition of TGF-beta/Smad-mediated fibrogenesis may be a central mechanism by which AA protects liver from injury.	[Tang, Li-xia; He, Rui-hua; Yang, Guang; Tan, Jia-ju] First Peoples Hosp Foshan, Inst Med Res, Foshan, Guangdong, Peoples R China; [Zhou, Li] W China Hosp Sichuan Univ, Dept Med, Chengdu, Peoples R China; [Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Sichuan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Tang, LX (corresponding author), First Peoples Hosp Foshan, Inst Med Res, Foshan, Guangdong, Peoples R China.	hylan@cuhk.edu.hk	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755	Guangdong Medical Research Foundation [A2007627, 2008225]; Research Grant Council of Hong Kong [RGC CUHK5/CRF/09, GRF 768207, 767508]	Guangdong Medical Research Foundation; Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by grants from Guangdong Medical Research Foundation (A2007627 to GY and 2008225 to LXT) and Research Grant Council of Hong Kong (RGC CUHK5/CRF/09, GRF 768207 and 767508 to HYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Cheng CL, 2004, LIFE SCI, V74, P2237, DOI 10.1016/j.lfs.2003.09.055; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong MS, 2004, ARCH PHARM RES, V27, P512, DOI 10.1007/BF02980124; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao J, 2006, J PHARM PHARMACOL, V58, P227, DOI 10.1211/jpp.58.2.0010; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kimura Y, 2008, EUR J PHARMACOL, V584, P415, DOI 10.1016/j.ejphar.2008.02.036; Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Latella G, 2009, LIVER INT, V29, P997, DOI 10.1111/j.1478-3231.2009.02011.x; Lee MK, 2009, NAT PROD COMMUN, V4, P765; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Ma KF, 2009, EUR J PHARMACOL, V603, P98, DOI 10.1016/j.ejphar.2008.11.054; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Park BC, 2005, CANCER LETT, V218, P81, DOI 10.1016/j.canlet.2004.06.039; Pittella F, 2009, INT J MOL SCI, V10, P3713, DOI 10.3390/ijms10093713; RUWART MJ, 1989, HEPATOLOGY, V10, P801, DOI 10.1002/hep.1840100509; Schaneberg BT, 2003, PHARMAZIE, V58, P381; Soumyanath A, 2005, J PHARM PHARMACOL, V57, P1221, DOI 10.1211/jpp.57.9.0018; Tang B, 2011, ARCH DERMATOL RES, V303, P563, DOI 10.1007/s00403-010-1114-8; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Won JH, 2010, PLANTA MED, V76, P251, DOI 10.1055/s-0029-1186142; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yun KJ, 2008, INT IMMUNOPHARMACOL, V8, P431, DOI 10.1016/j.intimp.2007.11.003	35	93	106	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31350	10.1371/journal.pone.0031350	http://dx.doi.org/10.1371/journal.pone.0031350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363627	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600034
J	Durand, E; Zoued, A; Spinelli, S; Watson, PJH; Aschtgen, MS; Journet, L; Cambillau, C; Cascales, E				Durand, Eric; Zoued, Abdelrahim; Spinelli, Silvia; Watson, Paul J. H.; Aschtgen, Marie-Stephanie; Journet, Laure; Cambillau, Christian; Cascales, Eric			Structural Characterization and Oligomerization of the TssL Protein, a Component Shared by Bacterial Type VI and Type IVb Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; TAILED PHAGES; TARGET-CELLS; EXPRESSION; DOTU; ICMF; TRANSLOCATION; LIPOPROTEIN; APPARATUS	The Type VI secretion system (T6SS) is a macromolecular system distributed in Gram-negative bacteria, responsible for the secretion of effector proteins into target cells. The T6SS has a broad versatility as it can target both eukaryotic and prokaryotic cells. It is therefore involved in host pathogenesis or killing neighboring bacterial cells to colonize a new niche. At the architecture level, the T6SS core apparatus is composed of 13 proteins, which assemble in two subcomplexes. One of these subcomplexes, composed of subunits that share structural similarities with bacteriophage tail and baseplate components, is anchored to the cell envelope by the membrane subcomplex. This latter is constituted of at least three proteins, TssL, TssM, and TssJ. The crystal structure of the TssJ outer membrane lipoprotein and its interaction with the inner membrane TssM protein have been recently reported. TssL and TssM share sequence homology and characteristics with two components of the Type IVb secretion system (T4bSS), IcmH/DotU and IcmF, respectively. In this study, we report the crystal structure of the cytoplasmic domain of the TssL inner membrane protein from the enteroaggregative Escherichia coli Sci-1 T6SS. It folds as a hook-like structure composed of two three-helix bundles. Two TssL molecules associate to form a functional complex. Although the TssL trans-membrane segment is the main determinant of self-interaction, contacts between the cytoplasmic domains are required for TssL function. Based on sequence homology and secondary structure prediction, we propose that the TssL structure is the prototype for the members of the TssL and IcmH/DotU families.	[Cambillau, Christian] Aix Marseille Univ, CNRS UMR6098, F-13288 Marseille 09, France; [Durand, Eric; Spinelli, Silvia; Watson, Paul J. H.; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Zoued, Abdelrahim; Aschtgen, Marie-Stephanie; Journet, Laure; Cascales, Eric] Aix Marseille Univ, UMR 7255, CNRS, Inst Microbiol Mediterranee,Lab Ingn Syst Macromo, F-13402 Marseille 20, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cambillau, C (corresponding author), Aix Marseille Univ, CNRS UMR6098, 163 Ave Luminy, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr; cascales@imm.cnrs.fr	CASCALES, ERIC/G-7420-2011; Durand, Eric/E-6739-2017	CASCALES, ERIC/0000-0003-0611-9179; Durand, Eric/0000-0002-0577-8220; aschtgen, marie-stephanie/0000-0003-2413-8226; Zoued, Abdelrahim/0000-0002-6973-1755; Journet, Laure/0000-0002-5847-2962	CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Universite de la Mediterranee; Marseille-Nice Genopole, IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite de la Mediterranee; Marseille-Nice Genopole, IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS and funded by a grant from the Agence Nationale de la Recherche (Grant ANR-10-JCJC-1303-03) (to E. C) and by the CNRS, the Universite de la Mediterranee, and grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (Grant FRM DEQ2011-0421282) (to C. C.).	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Battesti A, 2008, PROTEOMICS, V8, P4768, DOI 10.1002/pmic.200800270; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nagai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00136; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao VA, 2011, ACTA CRYSTALLOGR D, V67, P1065, DOI 10.1107/S0907444911046300; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	57	66	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14157	14168		10.1074/jbc.M111.338731	http://dx.doi.org/10.1074/jbc.M111.338731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371492	Green Published, hybrid			2022-12-25	WOS:000303996300068
J	Hausmann, R; Bodnar, M; Woltersdorf, R; Wang, HH; Fuchs, M; Messemer, N; Qin, Y; Gunther, J; Riedel, T; Grohmann, M; Nieber, K; Schmalzing, G; Rubini, P; Illes, P				Hausmann, Ralf; Bodnar, Mandy; Woltersdorf, Ronja; Wang, Haihong; Fuchs, Martin; Messemer, Nanette; Qin, Ying; Guenther, Janka; Riedel, Thomas; Grohmann, Marcus; Nieber, Karen; Schmalzing, Guenther; Rubini, Patrizia; Illes, Peter			ATP Binding Site Mutagenesis Reveals Different Subunit Stoichiometry of Functional P2X2/3 and P2X2/6 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; P2X(3) RECEPTORS; P2Y RECEPTORS; COEXPRESSION; STATE; DESENSITIZATION; PHARMACOLOGY; ARRANGEMENT; PHYSIOLOGY; TRIMERS	The aim of the present experiments was to clarify the subunit stoichiometry of P2X2/3 and P2X2/6 receptors, where the same subunit (P2X2) forms a receptor with two different partners (P2X3 or P2X6). For this purpose, four non-functional Ala mutants of the P2X2, P2X3, and P2X6 subunits were generated by replacing single, homologous amino acids particularly important for agonist binding. Co-expression of these mutants in HEK293 cells to yield the P2X2 WT/P2X3 mutant or P2X2 mutant/P2X3 WT receptors resulted in a selective blockade of agonist responses in the former combination only. In contrast, of the P2X2 WT/P2X6 mutant and P2X2 mutant/P2X6 WT receptors, only the latter combination failed to respond to agonists. The effects of alpha,beta-methylene-ATP and 2-methylthio-ATP were determined by measuring transmembrane currents by the patch clamp technique and intracellular Ca2+ transients by the Ca2+-imaging method. Protein labeling, purification, and PAGE confirmed the assembly and surface trafficking of the investigated WT and WT/mutant combinations in Xenopus laevis oocytes. In conclusion, both electrophysiological and biochemical investigations uniformly indicate that one subunit of P2X2 and two subunits of P2X3 form P2X2/3 heteromeric receptors, whereas two subunits of P2X2 and one subunit of P2X6 constitute P2X2/6 receptors. Further, it was shown that already two binding sites of the three possible ones are sufficient to allow these receptors to react with their agonists.	[Bodnar, Mandy; Wang, Haihong; Fuchs, Martin; Messemer, Nanette; Qin, Ying; Riedel, Thomas; Grohmann, Marcus; Rubini, Patrizia; Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Hausmann, Ralf; Woltersdorf, Ronja; Guenther, Janka; Grohmann, Marcus; Schmalzing, Guenther] Univ Aachen, Dept Mol Pharmacol, Univ Hosp Rhein Westfael TH, D-52074 Aachen, Germany; [Nieber, Karen] Univ Leipzig, Inst Pharm, Dept Pharmacol Nat Sci, D-04103 Leipzig, Germany	Leipzig University; RWTH Aachen University; Leipzig University	Illes, P (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	Peter.Illes@medizin.uni-leipzig.de	Riedel, Thomas/A-5079-2012		Deutsche Forschungsgemeinschaft [FOR 748]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR 748 and the Volkswagen Foundation.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Burnstock G, 2006, PHARMACOL THERAPEUT, V110, P433, DOI 10.1016/j.pharmthera.2005.08.013; Chizh BA, 2001, PHARMACOL REV, V53, P553; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Egan TM, 2004, CURR TOP MED CHEM, V4, P821, DOI 10.2174/1568026043451005; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Fischer W, 2003, J NEUROCHEM, V85, P779, DOI 10.1046/j.1471-4159.2003.01716.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Haines WR, 1999, MOL PHARMACOL, V56, P720; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2001, PHARMACOL REV, V53, P107; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; King BF, 1999, BRIT J PHARMACOL, V128, P981, DOI 10.1038/sj.bjp.0702876; King BF, 2000, J NEUROSCI, V20, P4871; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Koles L, 2007, CURR PHARM DESIGN, V13, P2368; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Le KT, 1998, J NEUROSCI, V18, P7152; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; Majumder P, 2007, PURINERG SIGNAL, V3, P317, DOI 10.1007/s11302-007-9074-y; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; Norenberg W, 2000, N-S ARCH PHARMACOL, V362, P324, DOI 10.1007/s002100000311; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; Soto M, 1996, BIOCHEM BIOPH RES CO, V223, P456, DOI 10.1006/bbrc.1996.0915; Stojilkovic SS, 2010, CELL MOL NEUROBIOL, V30, P1251, DOI 10.1007/s10571-010-9568-y; Torres GE, 1998, MOL PHARMACOL, V54, P989, DOI 10.1124/mol.54.6.989; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Zhou Y, 2003, J NEUROSCI, V23, P9004	58	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13930	13943		10.1074/jbc.M112.345207	http://dx.doi.org/10.1074/jbc.M112.345207			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378790	Green Published, hybrid			2022-12-25	WOS:000303996300048
J	Punchihewa, C; Inoue, A; Hishiki, A; Fujikawa, Y; Connelly, M; Evison, B; Shao, YM; Heath, R; Kuraoka, I; Rodrigues, P; Hashimoto, H; Kawanishi, M; Sato, M; Yagi, T; Fujii, N				Punchihewa, Chandanamali; Inoue, Akira; Hishiki, Asami; Fujikawa, Yoshihiro; Connelly, Michele; Evison, Benjamin; Shao, Youming; Heath, Richard; Kuraoka, Isao; Rodrigues, Patrick; Hashimoto, Hiroshi; Kawanishi, Masanobu; Sato, Mamoru; Yagi, Takashi; Fujii, Naoaki			Identification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; TRANSLESION SYNTHESIS; ONCOGENE ADDICTION; EXCISION-REPAIR; POLYMERASE-ETA; MECHANISMS; RESISTANCE; DOMAINS; COMPLEX; PHOSPHORYLATION	We have discovered that 3,3',5-triiodothyronine (T3) inhibits binding of a PIP-box sequence peptide to proliferating cell nuclear antigen (PCNA) protein by competing for the same binding site, as evidenced by the co-crystal structure of the PCNA-T3 complex at 2.1 angstrom resolution. Based on this observation, we have designed a novel, non-peptide small molecule PCNA inhibitor, T2 amino alcohol (T2AA), a T3 derivative that lacks thyroid hormone activity. T2AA inhibited interaction of PCNA/PIP-box peptide with an IC50 of similar to 1 mu M and also PCNA and full-length p21 protein, the tightest PCNA ligand protein known to date. T2AA abolished interaction of PCNA and DNA polymerase delta in cellular chromatin. De novo DNA synthesis was inhibited by T2AA, and the cells were arrested in S-phase. T2AA inhibited growth of cancer cells with induction of early apoptosis. Concurrently, Chk1 and RPA32 in the chromatin are phosphorylated, suggesting that T2AA causes DNA replication stress by stalling DNA replication forks. T2AA significantly inhibited translesion DNA synthesis on a cisplatin-cross-linked template in cells. When cells were treated with a combination of cisplatin and T2AA, a significant increase in phospho(Ser(139))histone H2AX induction and cell growth inhibition was observed.	[Punchihewa, Chandanamali; Inoue, Akira; Connelly, Michele; Evison, Benjamin; Fujii, Naoaki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Shao, Youming; Heath, Richard] St Jude Childrens Res Hosp, Prot Prod Facil, Memphis, TN 38105 USA; [Hishiki, Asami; Hashimoto, Hiroshi; Sato, Mamoru] Yokohama City Univ, Dept Supramol Biol, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; [Fujikawa, Yoshihiro; Kawanishi, Masanobu; Yagi, Takashi] Osaka Prefecture Univ, Lab Mol & Cellular Genet, Dept Biol, Grad Sch Sci, Sakai, Osaka 5998570, Japan; [Kuraoka, Isao] Osaka Univ, Biol Chem Grp, Div Chem, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yokohama City University; Osaka Metropolitan University; Osaka University	Fujii, N (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	naoaki.fujii@stjude.org	Yagi, Takashi/AAR-7673-2021; Fujii, Naoaki/I-6423-2013	Kuraoka, Isao/0000-0001-6391-3411; Heath, Richard/0000-0002-1795-1254; Hashimoto, Hiroshi/0000-0003-1503-6789	American Lebanese Syrian Associated Charities; American Cancer Society [RSG CDD-120969]; Ministry of Education, Culture, Sports, Science and Technology, Japan [B 19710058]; KAKENHI; Grants-in-Aid for Scientific Research [23770125] Funding Source: KAKEN	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); American Cancer Society(American Cancer Society); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the American Lebanese Syrian Associated Charities, American Cancer Society Research Scholar Grant RSG CDD-120969 (to A. I. and N. F.), Grant-in-aid for Scientific Research for Young Scientists B 19710058 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M. K.), and KAKENHI and the Targeted Proteins Research Program from MEXT, Japan (to A. H., H. H., and M. S.).	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Galea AM, 2010, CHEM BIOL DRUG DES, V75, P578, DOI 10.1111/j.1747-0285.2010.00969.x; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P819, DOI 10.1107/S174430910802277X; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Kawanishi M, 1998, CHEM RES TOXICOL, V11, P1468, DOI 10.1021/tx9801054; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; LEESON PD, 1988, J MED CHEM, V31, P37, DOI 10.1021/jm00396a008; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MATSUMOTO K, 1987, EMBO J, V6, P637, DOI 10.1002/j.1460-2075.1987.tb04802.x; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Ohta S, 2002, J BIOL CHEM, V277, P40362, DOI 10.1074/jbc.M206194200; Sawai T., 2009, GENES ENV, V31, P24; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shimura T, 2008, J MOL BIOL, V375, P1152, DOI 10.1016/j.jmb.2007.11.006; Shivji Mahmud K K, 2006, Methods Mol Biol, V314, P435; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	44	93	94	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14289	14300		10.1074/jbc.M112.353201	http://dx.doi.org/10.1074/jbc.M112.353201			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383522	Green Published, hybrid			2022-12-25	WOS:000303996300080
J	Dahl, JM; Mai, AH; Cherf, GM; Jetha, NN; Garalde, DR; Marziali, A; Akeson, M; Wang, HY; Lieberman, KR				Dahl, Joseph M.; Mai, Ai H.; Cherf, Gerald M.; Jetha, Nahid N.; Garalde, Daniel R.; Marziali, Andre; Akeson, Mark; Wang, Hongyun; Lieberman, Kate R.			Direct Observation of Translocation in Individual DNA Polymerase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID CONFORMATIONAL-CHANGES; EXONUCLEASE ACTIVE-SITE; I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; REPLICATION; NANOPORE; FLUORESCENCE; RESOLUTION; SNAPSHOTS; MOLECULES	Complexes of phi29 DNA polymerase and DNA fluctuate on the millisecond time scale between two ionic current amplitude states when captured atop the alpha-hemolysin nanopore in an applied field. The lower amplitude state is stabilized by complementary dNTP and thus corresponds to complexes in the post-translocation state. We have demonstrated that in the upper amplitude state, the DNA is displaced by a distance of one nucleotide from the post-translocation state. We propose that the upper amplitude state corresponds to complexes in the pre-translocation state. Force exerted on the template strand biases the complexes toward the pre-translocation state. Based on the results of voltage and dNTP titrations, we concluded through mathematical modeling that complementary dNTP binds only to the post-translocation state, and we estimated the binding affinity. The equilibrium between the two states is influenced by active site-proximal DNA sequences. Consistent with the assignment of the upper amplitude state as the pre-translocation state, a DNA substrate that favors the pre-translocation state in complexes on the nanopore is a superior substrate in bulk phase for pyrophosphorolysis. There is also a correlation between DNA sequences that bias complexes toward the pre-translocation state and the rate of exonucleolysis in bulk phase, suggesting that during DNA synthesis the pathway for transfer of the primer strand from the polymerase to exonuclease active site initiates in the pre-translocation state.	[Wang, Hongyun] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Dahl, Joseph M.; Mai, Ai H.; Cherf, Gerald M.; Akeson, Mark; Lieberman, Kate R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Garalde, Daniel R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Comp Engn, Santa Cruz, CA 95064 USA; [Jetha, Nahid N.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of British Columbia	Wang, HY (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	hongwang@soe.ucsc.edu; krlieberman@gmail.com	Akeson, Mark/HCH-3046-2022		National Institutes of Health from NIGMS [1R01GM087484-01A2]; NHGRI [1RC2HG005553, R01HG003248]; National Science Foundation [DMS-0719361]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003248, RC2HG005553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM087484-01A2 from NIGMS (to K. R. L. and M. A.) and 1RC2HG005553 (to M. A.) and R01HG003248 (to N. N. J. and A. M.) from NHGRI. This work was also supported by National Science Foundation Grant DMS-0719361 (to H. W.).	Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; de Vega M, 1999, J MOL BIOL, V292, P39, DOI 10.1006/jmbi.1999.3052; deVega M, 1996, EMBO J, V15, P1182, DOI 10.1002/j.1460-2075.1996.tb00457.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Hariharan C, 2005, BIOCHEMISTRY-US, V44, P15674, DOI 10.1021/bi051462y; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; JOYCE CM, 1989, J BIOL CHEM, V264, P10858; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587	30	25	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13407	13421		10.1074/jbc.M111.338418	http://dx.doi.org/10.1074/jbc.M111.338418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378784	Green Published, hybrid			2022-12-25	WOS:000302903700075
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Cap Snatching of Yeast L-A Double-stranded RNA Virus Can Operate in Trans and Requires Viral Polymerase Actively Engaging in Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; POL FUSION PROTEIN; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; STRUCTURAL BASIS; VACCINIA VIRUS; GUANYLYLTRANSFERASE; RECOGNITION; BINDING; PARTICLES	Eukaryotic mRNA bears a cap structure (m(7)GpppX-) at the 5' terminus crucial for efficient translation and stability. The yeast L-A double-stranded RNA virus furnishes its mRNA with this structure by a novel cap-snatching mechanism in which the virus transfers an m(7)Gp moiety from host mRNA to the diphosphorylated 5' terminus of the viral transcript, thus forming on it an authentic cap structure (referred to as cap0) in the budding yeast. This capping reaction is essential for efficient viral expression. His-154 of the capsid protein Gag is involved in the cap transfer. Here we show that the virus can utilize an externally added viral transcript as acceptor in the capping reaction. The acceptor needs to be 5' diphosphorylated, consistent with the fact that the viral transcript bears diphosphate at the 5' terminus. A 5' triphosphorylated or monophosphorylated transcript does not function as acceptor. N7 methylation at the 5' cap guanine of mRNA is essential for cap donor activity. We also demonstrate that the capping reaction requires the viral polymerase actively engaging in transcription. Because the cap-snatching site of Gag is located at the cytoplasmic surface of the virion, whereas Pol is confined inside the virion, the result indicates coordination between the cap-snatching and polymerization sites. This will allow L-A virus to efficiently produce capsid proteins to form new virions when Pol is actively engaging in transcription. The coordination may also minimize the risk of accidental capping of nonviral RNA when Pol is dormant.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Edificio Dept,Avda Campo Charro S-N, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Spanish Ministry of Education and Science [BFU2010-15768]; Fundacion Ramon Areces	Spanish Ministry of Education and Science(Spanish Government); Fundacion Ramon Areces	This work was supported by Grant BFU2010-15768 from the Spanish Ministry of Education and Science and by Fundacion Ramon Areces.	BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chu C, 2011, P NATL ACAD SCI USA, V108, P10104, DOI 10.1073/pnas.1106610108; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; ESTEBAN R, 1988, P NATL ACAD SCI USA, V85, P4411, DOI 10.1073/pnas.85.12.4411; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; GEORGOPOULOS DE, 1987, YEAST, V3, P117, DOI 10.1002/yea.320030208; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Huang YL, 2005, J BIOL CHEM, V280, P13153, DOI 10.1074/jbc.M412619200; ICHO T, 1989, J BIOL CHEM, V264, P6716; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Maniatis T., 1982, MOL CLONING LABORATO, P156; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARTIN SA, 1975, J BIOL CHEM, V250, P9330; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wickner R.B., 2007, FIELDS VIROLOGY, P737	35	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12797	12804		10.1074/jbc.M111.327676	http://dx.doi.org/10.1074/jbc.M111.327676			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367202	Green Published, hybrid			2022-12-25	WOS:000302903700019
J	Qi, HY; Zhu, HF; Lou, M; Fan, YF; Liu, H; Shen, J; Li, ZJ; Lv, X; Shan, JZ; Zhu, LJ; Chin, YE; Shao, JM				Qi, Hongyan; Zhu, Huifang; Lou, Meng; Fan, Yanfeng; Liu, Hong; Shen, Jing; Li, Zhongjie; Lv, Xue; Shan, Jianzhen; Zhu, Lijun; Chin, Y. Eugene; Shao, Jimin			Interferon Regulatory Factor 1 Transactivates Expression of Human DNA Polymerase eta in Response to Carcinogen N-Methyl-N '-nitro-N-nitrosoguanidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT GENE; GROWTH-FACTOR RECEPTOR; TRANSLESION SYNTHESIS; PROTEIN; BINDING; ACETYLATION; IRF-1; P53; ACTIVATION; CELLS	DNA polymerase eta (Pol eta) implements translesion DNA synthesis but has low fidelity in replication. We have previously shown that Pol eta plays an important role in the genesis of non-targeted mutations at undamaged DNA sites in cells exposed to the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Here, we report that MNNG-induced Pol eta expression in an interferon regulatory factor 1 (IRF1)-dependent manner in human cells. Mutagenesis analysis showed that four critical residues (Arg-82, Cys-83, Asn-86, and Ser-87) located in the IRF family conserved DNA binding domain-helix alpha 3 were involved in DNA binding and POLH transactivation by IRF1. Furthermore, Pol eta up-regulation induced by IRF1 was responsible for the increase of mutation frequency in a SupF shuttle plasmid replicated in the MNNG-exposed cells. Interestingly, IRF1 was acetylated by the histone acetyltransferase CBP in these cells. Lys -> Arg substitution revealed that Lys-78 of helix alpha 3 was the major acetylation site, and the IRF1-K78R mutation partially inhibited DNA binding and its transcriptional activity. Thus, we propose that IRF1 activation is responsible for MNNG-induced Pol eta up-regulation, which contributes to mutagenesis and ultimately carcinogenesis in cells.	[Qi, Hongyan; Zhu, Huifang; Lou, Meng; Fan, Yanfeng; Liu, Hong; Shen, Jing; Li, Zhongjie; Lv, Xue; Shan, Jianzhen; Zhu, Lijun; Shao, Jimin] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Chin, Y. Eugene] Brown Univ, Sch Med, Dept Surg, Providence, RI 02903 USA	Zhejiang University; Brown University	Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China.	Y_Eugene_Chin@brown.edu; shaojimin@zju.edu.cn			National Natural Science Foundation of China [30770831, 81000893, 30800413, 30873094, 81090421]; Ministry of Education of China [J20100041]; Zhejiang Provincial Science Foundation [R207153, 2008C23070, J20110353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Science Foundation	This work was supported by National Natural Science Foundation of China Grants 30770831, 81000893, 30800413, 30873094, and 81090421, Ministry of Education of China Grant J20100041, and Zhejiang Provincial Science Foundation Grants R207153, 2008C23070, and J20110353.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Choi JH, 2005, DNA REPAIR, V4, P211, DOI 10.1016/j.dnarep.2004.09.006; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FENG Z, 1999, CHIN J PHARM TOXICOL, V13, P217; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Gao ZH, 2005, MUTAT RES-FUND MOL M, V570, P175, DOI 10.1016/j.mrfmmm.2004.11.012; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hirsch JD, 2002, ANAL BIOCHEM, V308, P343, DOI 10.1016/S0003-2697(02)00201-4; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; [蒋余圣 JIANG Yusheng], 2006, [中国病理生理杂志, Chinese Journal of Pathophysiology], V22, P1249; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim SH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2562; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li HJ, 2008, MUTAT RES-FUND MOL M, V644, P1, DOI 10.1016/j.mrfmmm.2008.06.013; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Lin YM, 2004, ARTERIOSCL THROM VAS, V24, P257, DOI 10.1161/01.ATV.0000109170.43400.2f; Liu G, 2006, MUTAT RES-FUND MOL M, V596, P12, DOI 10.1016/j.mrfmmm.2005.10.015; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Livneh Z, 2006, CELL CYCLE, V5, P1918, DOI 10.4161/cc.5.17.3193; Luo Yue-qiu, 2003, Zhejiang Da Xue Xue Bao Yi Xue Ban, V32, P398; Marsili G., 2006, ANN NY ACAD SCI, V13, P636; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McAlexander MB, 2001, FEBS LETT, V488, P91, DOI 10.1016/S0014-5793(00)02385-1; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Percario ZA, 1999, CELL GROWTH DIFFER, V10, P263; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Prost S, 1998, FASEB J, V12, P181, DOI 10.1096/fasebj.12.2.181; Shen J, 2006, J PROTEOME RES, V5, P385, DOI 10.1021/pr0502875; Shen J, 2008, J PROTEOME RES, V7, P2999, DOI 10.1021/pr800133q; Shi BS, 2004, MUTAT RES-FUND MOL M, V556, P1, DOI 10.1016/j.mrfmmm.2004.05.014; SMITH HO, 1973, J MOL BIOL, V81, P419, DOI 10.1016/0022-2836(73)90152-6; Suhara W, 2002, J BIOL CHEM, V277, P22304, DOI 10.1074/jbc.M200192200; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; Wang Z, 2003, MUTAT RES-FUND MOL M, V528, P29, DOI 10.1016/S0027-5107(03)00079-4; Yamashita S, 2004, MUTAT RES-FUND MOL M, V549, P185, DOI 10.1016/j.mrfmmm.2003.10.009; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu HF, 2010, ENVIRON TOXICOL PHAR, V29, P79, DOI 10.1016/j.etap.2009.11.001	57	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12622	12633		10.1074/jbc.M111.313429	http://dx.doi.org/10.1074/jbc.M111.313429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367195	Green Published, hybrid			2022-12-25	WOS:000302903700003
J	Toriyama, M; Mizuno, N; Fukami, T; Iguchi, T; Toriyama, M; Tago, K; Itoh, H				Toriyama, Manami; Mizuno, Norikazu; Fukami, Takashi; Iguchi, Tokuichi; Toriyama, Michinori; Tago, Kenji; Itoh, Hiroshi			Phosphorylation of Doublecortin by Protein Kinase A Orchestrates Microtubule and Actin Dynamics to Promote Neuronal Progenitor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA; NEURITE OUTGROWTH; EXCHANGE FACTOR; NEURABIN-II; RAT-BRAIN; RECEPTOR; DCX; DEPHOSPHORYLATION	Doublecortin (DCX) is a microtubule-associated protein that is specifically expressed in neuronal cells. Genetic mutation of DCX causes lissencephaly disease. Although the abnormal cortical lamination in lissencephaly is thought to be attributable to neuronal cell migration defects, the regulatory mechanisms governing interactions between DCX and cytoskeleton in the migration of neuronal progenitor cells remain obscure. In this study we found that the G(s) and protein kinase A (PKA) signal elicited by pituitary adenylate cyclase-activating polypeptide promotes neuronal progenitor cells migration. Stimulation of G(s)-PKA signaling prevented microtubule bundling and induced the dissociation of DCX from microtubules in cells. PKA phosphorylated DCX at Ser-47, and the phospho-mimicking mutant DCX-S47E promoted cell migration. Activation of PKA and DCX-S47E induced lamellipodium formation. Pituitary adenylate cyclase-activating polypeptide and DCX-S47E stimulated the activation of Rac1, and DCX-S47E interacted with Asef2, a guanine nucleotide exchange factor for Rac1. Our data reveal a dual reciprocal role for DCX phosphorylation in the regulation of microtubule and actin dynamics that is indispensable for proper brain lamination.	[Toriyama, Manami; Mizuno, Norikazu; Fukami, Takashi; Iguchi, Tokuichi; Toriyama, Michinori; Tago, Kenji; Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Mizuno, N (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	nmizuno@bs.naist.jp; hitoh@bs.naist.jp		Toriyama, Manami/0000-0002-2754-293X; Iguchi, Tokuichi/0000-0003-4025-8770; TORIYAMA, Michinori/0000-0003-2551-4334	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21370056, 21590094]; Mitsubishi Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Research Grants 21370056 and 21590094 and by the Mitsubishi Foundation.	Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bilimoria PM, 2010, J NEUROSCI, V30, P16766, DOI 10.1523/JNEUROSCI.1362-10.2010; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Cameron DB, 2007, NEUROSCIENCE, V146, P697, DOI 10.1016/j.neuroscience.2007.02.025; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Falluel-Morel A, 2005, P NATL ACAD SCI USA, V102, P2637, DOI 10.1073/pnas.0409681102; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; Jin J, 2010, DEV NEUROBIOL, V70, P929, DOI 10.1002/dneu.20833; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Mizuno N, 2005, P NATL ACAD SCI USA, V102, P12365, DOI 10.1073/pnas.0506101102; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shmueli A, 2006, MOL CELL NEUROSCI, V32, P15, DOI 10.1016/j.mcn.2006.01.014; Shmueli O, 2001, HUM MOL GENET, V10, P1061, DOI 10.1093/hmg/10.10.1061; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; SOLOMON F, 1986, METHOD ENZYMOL, V134, P139; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2006, BIOCHEM BIOPH RES CO, V343, P839, DOI 10.1016/j.bbrc.2006.03.045; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	57	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12691	12702		10.1074/jbc.M111.316307	http://dx.doi.org/10.1074/jbc.M111.316307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367209	Green Published, hybrid			2022-12-25	WOS:000302903700009
J	Yamada, KH; Kozlowski, DA; Seidl, SE; Lance, S; Wieschhaus, AJ; Sundivakkam, P; Tiruppathi, C; Chishti, I; Herman, IM; Kuchay, SM; Chishti, AH				Yamada, Kaori H.; Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Herman, Ira M.; Kuchay, Shafi M.; Chishti, Athar H.			Targeted Gene Inactivation of Calpain-1 Suppresses Cortical Degeneration Due to Traumatic Brain Injury and Neuronal Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MU-CALPAIN; CROSS-TALK; CLEAVAGE; ACTIVATION; INHIBITOR; CASPASE; CALCIUM; PROTEIN; IMPACT	Calpains are calcium-regulated cysteine proteases that have been implicated in the regulation of cell death pathways. Here, we used our calpain-1 null mouse model to evaluate the function of calpain-1 in neural degeneration following a rodent model of traumatic brain injury. In vivo, calpain-1 null mice show significantly less neural degeneration and apoptosis and a smaller contusion 3 days post-injury than wild type littermates. Protection from traumatic brain injury corroborated with the resistance of calpain-1 neurons to apoptosis induced by oxidative stress. Biochemical analysis revealed that caspase-3 activation, extracellular calcium entry, mitochondrial membrane permeability, and release of apoptosis-inducing factor from mitochondria are partially blocked in the calpain-1 null neurons. These findings suggest that the calpain-1 knock-out mice may serve as a useful model system for neuronal protection and apoptosis in traumatic brain injury and other neurodegenerative disorders in which oxidative stress plays a role.	[Yamada, Kaori H.; Wieschhaus, Adam J.; Herman, Ira M.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Univ Illinois, Coll Med, Sackler Sch Program Physiol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Pharmacol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Microbiol, Chicago, IL 60612 USA; [Yamada, Kaori H.; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Kuchay, Shafi M.; Chishti, Athar H.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA	Tufts University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; DePaul University	Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	athar.chishti@tufts.edu		Yamada, Kaori/0000-0003-4075-9866	National Institutes of Health [HL089517, HL095050, HL051445]; DePaul University Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL051445, R01HL051445, R01HL089517, R01HL095050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DePaul University Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089517, HL095050, and HL051445 (to A. H. C.). This work was also supported by DePaul University Research Council (to D. A. K.).	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bertipaglia I., 2007, V45, P29; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dixon C. E., 1996, FLUID PERCUSSION COR, P1337; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gao G, 2000, J CELL BIOCHEM, V80, P53; Geddes JW, 2010, EXP NEUROL, V226, P6, DOI 10.1016/j.expneurol.2010.07.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harper AGS, 2007, CELL CALCIUM, V41, P169, DOI 10.1016/j.ceca.2006.05.008; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Waters SL, 1997, J PHARMACOL EXP THER, V283, P1177; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	57	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13182	13193		10.1074/jbc.M111.302612	http://dx.doi.org/10.1074/jbc.M111.302612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367208	Green Published, hybrid			2022-12-25	WOS:000302903700056
J	Irvine, IC; Brigham, CA; Suding, KN; Martiny, JBH				Irvine, Irina C.; Brigham, Christy A.; Suding, Katharine N.; Martiny, Jennifer B. H.			The Abundance of Pink-Pigmented Facultative Methylotrophs in the Root Zone of Plant Species in Invaded Coastal Sage Scrub Habitat	PLOS ONE			English	Article							BACTERIA; METHYLOBACTERIUM; PHYLLOSPHERE; COMMUNITY; GROWTH; DIVERSITY; INVASION; L.; METHANOTROPHS; POPULATIONS	Pink-pigmented facultative methylotrophic bacteria (PPFMs) are associated with the roots, leaves and seeds of most terrestrial plants and utilize volatile C-1 compounds such as methanol generated by growing plants during cell division. PPFMs have been well studied in agricultural systems due to their importance in crop seed germination, yield, pathogen resistance and drought stress tolerance. In contrast, little is known about the PPFM abundance and diversity in natural ecosystems, let alone their interactions with non-crop species. Here we surveyed PPFM abundance in the root zone soil of 5 native and 5 invasive plant species along ten invasion gradients in Southern California coastal sage scrub habitat. PPFMs were present in every soil sample and ranged in abundance from 10(2) to 10(5) CFU/g dry soil. This abundance varied significantly among plant species. PPFM abundance was 50% higher in the root zones of annual or biennial species (many invasives) than perennial species (all natives). Further, PPFM abundance appears to be influenced by the plant community beyond the root zone; pure stands of either native or invasive species had 50% more PPFMs than mixed species stands. In sum, PPFM abundance in the root zone of coastal sage scrub plants is influenced by both the immediate and surrounding plant communities. The results also suggest that PPFMs are a good target for future work on plant-microorganism feedbacks in natural ecosystems.	[Irvine, Irina C.; Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Irvine, Irina C.; Brigham, Christy A.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA; [Suding, Katharine N.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Irvine; United States Department of the Interior; University of California System; University of California Berkeley	Irvine, IC (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	Irina_Irvine@NPS.gov	Suding, Katharine/O-6290-2017; Martiny, Jennifer/AAB-9323-2019	Suding, Katharine/0000-0002-5357-0176; Martiny, Jennifer/0000-0002-2415-1247	University of California; National Science Foundation [MCB-0701494]	University of California(University of California System); National Science Foundation(National Science Foundation (NSF))	University of California Irvine graduate student support (teaching assistantships, graduate student researcher stipends). National Science Foundation grant number MCB-0701494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P1537, DOI 10.1016/j.soilbio.2005.11.008; Bains G, 2009, PLANT PHYSIOL, V151, P2145, DOI 10.1104/pp.109.146407; Bais HP, 2005, NATURE, V434, P217, DOI 10.1038/nature03356; Balachandar D, 2008, WORLD J MICROB BIOT, V24, P2087, DOI 10.1007/s11274-008-9713-7; Balachandar D, 2008, BRAZ J MICROBIOL, V39, P68, DOI [10.1590/S1517-83822008000100017, 10.1590/S1517-838220080001000017]; Bowler PA, 2000, ENVIRON MANAGE, V26, pS85; Burlage RS, 1998, TECHNIQUES MICROBIAL, P480; Chanprame S, 1996, PLANT CELL REP, V16, P222, DOI 10.1007/BF01890872; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doronina NV, 2002, MICROBIOLOGY+, V71, P116, DOI 10.1023/A:1017966820382; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Irvine IC, 2011, RESTORATION ECOLOGY, DOI [10.1111/j.1526-100X.2011.00850x, DOI 10.1111/J.1526-100X.2011.00850X]; Kalyaeva MA, 2001, RUSS J PLANT PHYSL+, V48, P514, DOI 10.1023/A:1016715800238; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Lidstrom ME, 2006, AEROBIC METHYLOTROPH, P618, DOI DOI 10.1007/0-387-30742-7_20; Madhaiyan M, 2006, CURR MICROBIOL, V53, P270, DOI 10.1007/s00284-005-0452-9; Madhaiyan M, 2005, BIOL FERT SOILS, V41, P350, DOI 10.1007/s00374-005-0838-7; Madhaiyan M, 2004, BOT BULL ACAD SINICA, V45, P315; Madhaiyan M, 2007, J MICROBIOL BIOTECHN, V17, P1645; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Pirttila AM, 2005, TREE PHYSIOL, V25, P289, DOI 10.1093/treephys/25.3.289; Raja P, 2008, BIOL FERT SOILS, V45, P45, DOI 10.1007/s00374-008-0306-2; Reeburgh W. S., 1993, P1; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Romanovskaya V. A., 1996, Mikrobiolohichnyi Zhurnal, V58, P3; Schauer S, 2008, THEOR BIOSCI, V127, P23, DOI 10.1007/s12064-007-0020-x; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Trotsenko YA, 2001, MICROBIOLOGY+, V70, P623, DOI 10.1023/A:1013167612105; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0	36	4	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e31026	10.1371/journal.pone.0031026	http://dx.doi.org/10.1371/journal.pone.0031026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383990	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800009
J	Rosello-Lleti, E; Calabuig, JR; Morillas, P; Cortes, R; Martinez-Dolz, L; Almenar, L; Gonzalez-Juanatey, JR; Lauwers, C; Salvador, A; Portoles, M; Bertomeu, V; Rivera, M				Rosello-Lleti, Esther; Calabuig, Jose R.; Morillas, Pedro; Cortes, Raquel; Martinez-Dolz, Luis; Almenar, Luis; Gonzalez-Juanatey, Jose R.; Lauwers, Catheline; Salvador, Antonio; Portoles, Manuel; Bertomeu, Vicente; Rivera, Miguel			Variability of NT-proBNP and Its Relationship with Inflammatory Status in Patients with Stable Essential Hypertension: A 2-Year Follow-Up Study	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR HYPERTROPHY; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; BIOLOGICAL VARIATION; TERMINAL PROBNP; PLASMA; EXPRESSION; BNP; ACTIVATION	Background: The variability of NT-proBNP levels has been studied in heart failure, yet no data exist on these changes over time in hypertensive patients. Furthermore, studies on the relationship between natriuretic peptides and inflammatory status are limited. Methodology/Principal Findings: 220 clinically and functionally asymptomatic stable patients (age 59613, 120 male) out of 252 patients with essential hypertension were followed up, and NT-proBNP was measured at baseline, 12 and 24 months. No differences in NT-proBNP were found with respect to the basal stage in the hypertrophic group, but significant changes were found in non-hypertrophic subjects. The reproducibility of NT-proBNP measurements was better in patients with hypertrophy than in the non-hypertrophic group for the three intervals (stage I-basal; stage II-stage I; stage II-basal) with a reference change value of 34%, 35% and 41%, respectively, in the hypertrophic group. A more elevated coefficient of correlation was obtained in the hypertrophic group than in patients without hypertrophy: basal versus stage I (r = 0.79, p<0.0001 and r = 0.59, p<0.0001) and stage I versus stage II (r = 0.86, p<0.0001 and r = 0.56, p<0.0001). Finally, levels of NT-proBNP significantly correlated with sTNF-R1 (p<0.0001) and IL-6 (p<0.01) during follow-up. A multivariate linear regression analysis showed that sTNF-R1 is an independent factor of NT-proBNP. Conclusions/Significance: This work shows that there is good stability in NT-proBNP levels in a follow-up study of asymptomatic patients with stable hypertension and left ventricular hypertrophy. As a consequence, assessment of NT-proBNP concentrations may be a useful tool for monitoring the follow-up of hypertensive patients with hypertrophy. Measured variations in peptide levels, exceeding 35% in a 12-month follow-up and 41% in a 24-month follow-up, may indicate an increase in cardiovascular risk, and therefore implies adjustment in the medical treatment. In addition, this study shows a link between neurohormonal and inflammatory activation in these patients.	[Rosello-Lleti, Esther; Cortes, Raquel; Rivera, Miguel] Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain; [Morillas, Pedro; Bertomeu, Vicente] Hosp Univ San Juan, Cardiol Unit, Alicante, Spain; [Martinez-Dolz, Luis; Almenar, Luis; Salvador, Antonio] Hosp Univ la Fe, Cardiol Unit, Valencia, Spain; [Gonzalez-Juanatey, Jose R.] Hosp Clin, Cardiol Unit, Santiago De Compostela, Spain; [Lauwers, Catheline] Hosp San Francesc de Borja, Cardiol Unit, Gandia, Spain; [Portoles, Manuel] Hosp Univ La Fe, Cell Biol & Pathol Unit, Res Ctr, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe	Rosello-Lleti, E (corresponding author), Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain.	rivera_jmi@gva.es	Roselló Lletí, Esther/ABG-8503-2020; Cortes, Raquel/GQH-6347-2022; Roselló-Lletí, Esther/B-2695-2017; CORTES, RAQUEL/K-2777-2014; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009	Roselló Lletí, Esther/0000-0003-2627-6104; Cortes, Raquel/0000-0001-9607-997X; Roselló-Lletí, Esther/0000-0003-2627-6104; CORTES, RAQUEL/0000-0001-9607-997X; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; BERTOMEU MARTINEZ, VICENTE/0000-0002-3553-0963; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III" [REDINSCOR 06/0003/1001]	United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III"	This work was supported by grants from the United States National Institutes of Health "Fondo de Investigaciones Sanitarias del Instituto Carlos III," (REDINSCOR 06/0003/1001 and FIS Project (PI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruins S, 2004, CLIN CHEM, V50, P2052, DOI 10.1373/clinchem.2004.038752; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cortes R, 2008, AM J HYPERTENS, V21, P820, DOI 10.1038/ajh.2008.173; Cortes R, 2007, HEART, V93, P957, DOI 10.1136/hrt.2006.096891; d'Eril GVM, 2003, CLIN CHEM, V49, P1554; deBold AJ, 1996, CARDIOVASC RES, V31, P7, DOI 10.1016/S0008-6363(95)00121-2; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frankenstein L, 2009, CLIN CHEM, V55, P923, DOI 10.1373/clinchem.2008.112052; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; Harada M, 1998, J CARDIOVASC PHARM, V31, pS357, DOI 10.1097/00005344-199800001-00100; HASEGAWA K, 1993, CIRCULATION, V88, P372, DOI 10.1161/01.CIR.88.2.372; Hildebrandt P, 2004, EUR J HEART FAIL, V6, P313, DOI 10.1016/j.ejheart.2004.01.001; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Isnard R, 2008, ARCH CARDIOVASC DIS, V101, P295, DOI 10.1016/j.acvd.2008.05.004; Jankowska EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014506; Jernberg T, 2003, J AM COLL CARDIOL, V42, P1909, DOI 10.1016/j.jacc.2003.07.015; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mayosi BM, 2002, EUR HEART J, V23, P1963, DOI 10.1053/euhj.2002.3288; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Niethammer M, 2008, INT J CARDIOL, V129, P111, DOI 10.1016/j.ijcard.2007.05.061; Nishigaki K, 1996, J AM COLL CARDIOL, V28, P1234, DOI 10.1016/S0735-1097(96)00277-X; Olsen MH, 2005, J HYPERTENS, V23, P1083, DOI 10.1097/01.hjh.0000166851.18463.85; Olsen MH, 2004, J HYPERTENS, V22, P1597, DOI 10.1097/01.hjh.0000125451.28861.2a; Paget V, 2011, HYPERTENSION, V57, P702, DOI 10.1161/HYPERTENSIONAHA.110.163550; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rosello-Lleti E, 2009, AM J HYPERTENS, V22, P444, DOI 10.1038/ajh.2008.369; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schou M, 2007, EUR HEART J, V28, P177, DOI 10.1093/eurheartj/ehl449; Sievers B, 2005, AM HEART J, V150, P737, DOI 10.1016/j.ahj.2004.11.017; Talens-Visconti R, 2006, ECHOCARDIOGR-J CARD, V23, P295, DOI 10.1111/j.1540-8175.2006.00205.x; Toda K, 2010, J CLIN LAB ANAL, V24, P12, DOI 10.1002/jcla.20366; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V38, P2132, DOI 10.1016/S0735-1097(01)01646-1; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e31189	10.1371/journal.pone.0031189	http://dx.doi.org/10.1371/journal.pone.0031189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22384001	Green Published, gold, Green Submitted			2022-12-25	WOS:000302916100015
J	Wey, MCY; Fernandez, E; Martinez, PA; Sullivan, P; Goldstein, DS; Strong, R				Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Martinez, Paul Anthony; Sullivan, Patricia; Goldstein, David S.; Strong, Randy			Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; ENDOGENOUS DOPAMINERGIC NEUROTOXIN; AMYOTROPHIC-LATERAL-SCLEROSIS; ONSET ALZHEIMERS-DISEASE; STRIDE LENGTH REGULATION; TREADMILL GAIT ANALYSIS; L-DOPA; HYDROGEN-PEROXIDE; 3,4-DIHYDROXYPHENYLACETALDEHYDE; SEROTONIN	Previous studies have reported elevated levels of biogenic aldehydes in the brains of patients with Parkinson's disease (PD). In the brain, aldehydes are primarily detoxified by aldehyde dehydrogenases (ALDH). Reduced ALDH1 expression in surviving midbrain dopamine neurons has been reported in brains of patients who died with PD. In addition, impaired complex I activity, which is well documented in PD, reduces the availability of the NAD(+) co-factor required by multiple ALDH isoforms to catalyze the removal of biogenic aldehydes. We hypothesized that chronically decreased function of multiple aldehyde dehydrogenases consequent to exposure to environmental toxins and/or reduced ALDH expression, plays an important role in the pathophysiology of PD. To address this hypothesis, we generated mice null for Aldh1a1 and Aldh2, the two isoforms known to be expressed in substantia nigra dopamine neurons. Aldh1a1(-/-) xAldh2(-/-) mice exhibited age-dependent deficits in motor performance assessed by gait analysis and by performance on an accelerating rotarod. Intraperitoneal administration of L-DOPA plus benserazide alleviated the deficits in motor performance. We observed a significant loss of neurons immunoreactive for tyrosine hydroxylase (TH) in the substantia nigra and a reduction of dopamine and metabolites in the striatum of Aldh1a1(-/-) xAldh2(-/-) mice. We also observed significant increases in biogenic aldehydes reported to be neurotoxic, including 4-hydroxynonenal (4-HNE) and the aldehyde intermediate of dopamine metabolism, 3,4-dihydroxyphenylacetaldehyde (DOPAL). These results support the hypothesis that impaired detoxification of biogenic aldehydes may be important in the pathophysiology of PD and suggest that Aldh1a1(-/-) xAldh2(-/-) mice may be a useful animal model of PD.	[Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Wey, Margaret Chia-Ying; Fernandez, Elizabeth; Martinez, Paul Anthony; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Fernandez, Elizabeth; Strong, Randy] S Texas Vet Hlth Care Network, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA; [Sullivan, Patricia; Goldstein, David S.] Natl Inst Neurol Disorders & Stroke, Clin Neurocardiol Sect, Clin Neurosci Program, Div Intramural Res, Bethesda, MD USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wey, MCY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	FernandezE@uthscsa.edu; Strong@uthscsa.edu			Veteran Affairs Office of Research Development; National Institute of Aging [T32 AG021890-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	Veteran Affairs Office of Research Development; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Veteran Affairs Office of Research & Development (to E.F. and R.S.) and the National Institute of Aging predoctoral training grant T32 AG021890-08 (to M.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Anderson DW, 2011, BRAIN RES, V1408, P81, DOI 10.1016/j.brainres.2011.06.051; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Center for Drug Evaluation and Research, 2005, EST SAF START DOS CL; Chen JB, 2009, INVEST OPHTH VIS SCI, V50, P936, DOI 10.1167/iovs.08-2439; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Fernandez E, 2006, ALCOHOL CLIN EXP RES, V30, P1650, DOI 10.1111/j.1530-0277.2006.00200.x; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Grunblatt E, 2010, J NEURAL TRANSM, V117, P1387, DOI 10.1007/s00702-010-0509-1; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; Hampton TG, 2010, J MOTOR BEHAV, V42, P1, DOI 10.1080/00222890903272025; Hao PP, 2011, CAN J NEUROL SCI, V38, P500, DOI 10.1017/S0317167100011938; Jinsmaa Y, 2011, CHEM-BIOL INTERACT, V192, P118, DOI 10.1016/j.cbi.2011.01.006; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006154; Kamino K, 2000, BIOCHEM BIOPH RES CO, V273, P192, DOI 10.1006/bbrc.2000.2923; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; LAMBERTY Y, 1993, PHYSIOL BEHAV, V54, P339, DOI 10.1016/0031-9384(93)90120-5; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; LEES AJ, 1986, Q J MED, V59, P535; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; MAYEUX R, 1988, MOVEMENT DISORD, V3, P237, DOI 10.1002/mds.870030308; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; OWEN AM, 1995, NEUROPSYCHOLOGY, V9, P126, DOI 10.1037/0894-4105.9.1.126; Panneton WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015251; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Picklo MJ, 2001, J NEUROPATH EXP NEUR, V60, P686, DOI 10.1093/jnen/60.7.686; Pinheiro J., 2011, NLME LINEAR NONLINEA; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Tanila H, 1998, BRAIN RES BULL, V45, P577, DOI 10.1016/S0361-9230(97)00452-8; Team R. D. C, 2011, R LANG ENV STAT COMP; TRUGMAN JM, 1991, BRAIN, V114, P1429, DOI 10.1093/brain/114.3.1429; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Westerlund M, 2005, CELL TISSUE RES, V322, P227, DOI 10.1007/s00441-005-0038-7; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zgaljardic DJ, 2004, J NEURAL TRANSM, V111, P1287, DOI 10.1007/s00702-004-0178-z; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	65	114	116	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31522	10.1371/journal.pone.0031522	http://dx.doi.org/10.1371/journal.pone.0031522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384032	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500023
J	Bassaganya-Riera, J; Viladomiu, M; Pedragosa, M; De Simone, C; Carbo, A; Shaykhutdinov, R; Jobin, C; Arthur, JC; Corl, BA; Vogel, H; Storr, M; Hontecillas, R				Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; De Simone, Claudio; Carbo, Adria; Shaykhutdinov, Rustem; Jobin, Christian; Arthur, Janelle C.; Corl, Benjamin A.; Vogel, Hans; Storr, Martin; Hontecillas, Raquel			Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR gamma to Suppress Colitis	PLOS ONE			English	Article							ACTIVE ULCERATIVE-COLITIS; POLYUNSATURATED FATTY-ACIDS; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; INTESTINAL MUCUS; PIG MODEL; VSLNUMBER-3; CELLS; MICE; ROSIGLITAZONE	Background: Inflammatory bowel disease (IBD) therapies are modestly successful and associated with significant side effects. Thus, the investigation of novel approaches to prevent colitis is important. Probiotic bacteria can produce immunoregulatory metabolites in vitro such as conjugated linoleic acid (CLA), a polyunsaturated fatty acid with potent anti-inflammatory effects. This study aimed to investigate the cellular and molecular mechanisms underlying the anti-inflammatory efficacy of probiotic bacteria using a mouse model of colitis. Methodology/Principal Findings: The immune modulatory mechanisms of VSL#3 probiotic bacteria and CLA were investigated in a mouse model of DSS colitis. Colonic specimens were collected for histopathology, gene expression and flow cytometry analyses. Immune cell subsets in the mesenteric lymph nodes (MLN), spleen, blood and colonic lamina propria cells were phenotypically and functionally characterized. Fecal samples and colonic contents were collected to determine the effect of VSL#3 and CLA on gut microbial diversity and CLA production. CLA and VSL#3 treatment ameliorated colitis and decreased colonic bacterial diversity, a finding that correlated with decreased gut pathology. Colonic CLA concentrations were increased in response to probiotic bacterial treatment, but without systemic distribution in blood. VSL#3 and CLA decreased macrophage accumulation in the MLN of mice with DSS colitis. The loss of PPAR c in myeloid cells abrogated the protective effect of probiotic bacteria and CLA in mice with DSS colitis. Conclusions/Significance: Probiotic bacteria modulate gut microbial diversity and favor local production of CLA in the colon that targets myeloid cell PPAR c to suppress colitis.	[Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Carbo, Adria; Hontecillas, Raquel] Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [De Simone, Claudio] LAquila Univ, Laquila, Italy; [Jobin, Christian; Arthur, Janelle C.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Jobin, Christian; Arthur, Janelle C.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Shaykhutdinov, Rustem; Vogel, Hans; Storr, Martin] Univ Calgary, Dept Biol Sci, Metabol Res Ctr, Calgary, AB T2N 1N4, Canada; [Shaykhutdinov, Rustem; Vogel, Hans; Storr, Martin] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 1N4, Canada; [Storr, Martin] Univ Munich, Dept Med, Div Gastroenterol, Munich, Germany; [Corl, Benjamin A.] Virginia Tech, Dept Dairy Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Calgary; University of Munich; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Corl, Benjamin/P-3150-2016; Viladomiu, Monica/GNM-6447-2022	Corl, Benjamin/0000-0002-6495-3279; Arthur, Janelle/0000-0002-4796-0207				Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2003, J NUTR, V133, P3204, DOI 10.1093/jn/133.10.3204; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bassaganya-Riera J, 2001, J NUTR, V131, P2370, DOI 10.1093/jn/131.9.2370; Bassaganya-Riera J, 2001, J ANIM SCI, V79, P714; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR; Bassaganya-Riera J, 2007, AM J CLIN NUTR, V85, P824, DOI 10.1093/ajcn/85.3.824; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Clarke JM, 2011, AM J CLIN NUTR; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; Collado MC, 2005, J FOOD PROTECT, V68, P1034, DOI 10.4315/0362-028X-68.5.1034; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; Ewaschuk JB, 2006, J NUTR, V136, P1483, DOI 10.1093/jn/136.6.1483; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gorissen L, 2010, APPL MICROBIOL BIOT, V87, P2257, DOI 10.1007/s00253-010-2713-1; Hofmanova J, 2011, J NUTR BIOCH; Huynh HQ, 2009, INFLAMM BOWEL DIS, V15, P760, DOI 10.1002/ibd.20816; Isaacs KL, 2011, PILOT STUDY EFFECT C; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; O'Shea M, 2004, AM J CLIN NUTR, V79, p1199S, DOI 10.1093/ajcn/79.6.1199S; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Sun J, 2007, LETT APPL MICROBIOL, V44, P79, DOI 10.1111/j.1472-765X.2006.02031.x; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366	39	91	95	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31238	10.1371/journal.pone.0031238	http://dx.doi.org/10.1371/journal.pone.0031238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363592	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700037
J	McAllister, SL; Dmitrieva, N; Berkley, KJ				McAllister, Stacy L.; Dmitrieva, Natalia; Berkley, Karen J.			Sprouted Innervation into Uterine Transplants Contributes to the Development of Hyperalgesia in a Rat Model of Endometriosis	PLOS ONE			English	Article							SYMPATHETIC REINNERVATION; CARDIAC TRANSPLANTATION; ESTROUS VARIATIONS; NEUROPATHIC PAIN; PELVIC PAIN; DYSMENORRHEA; HYPERSENSITIVITY; INFLAMMATION; DISTENSION; MECHANISMS	Endometriosis is an enigmatic painful disorder whose pain symptoms remain difficult to alleviate in large part because the disorder is defined by extrauteral endometrial growths whose contribution to pain is poorly understood. A rat model (ENDO) involves autotransplanting on abdominal arteries uterine segments that grow into vascularized cysts that become innervated with sensory and sympathetic fibers. ENDO rats exhibit vaginal hyperalgesia. We used behavioral, physiological, and immunohistochemical methods to test the hypothesis that cyst innervation contributes to the development of this hyperalgesia after transplant. Rudimentary sensory and sympathetic innervation appeared in the cysts at two weeks, sprouted further and more densely into the cyst wall by four weeks, and matured by six weeks post-transplant. Sensory fibers became abnormally functionally active between two and three weeks post-transplant, remaining active thereafter. Vaginal hyperalgesia became significant between four and five weeks post-transplant, and stabilized after six to eight weeks. Removing cysts before they acquired functional innervation prevented vaginal hyperalgesia from developing, whereas sham cyst removal did not. Thus, abnormally-active innervation of ectopic growths occurs before hyperalgesia develops, supporting the hypothesis. These findings suggest that painful endometriosis can be classified as a mixed inflammatory/neuropathic pain condition, which opens new avenues for pain relief. The findings also have implications beyond endometriosis by suggesting that functionality of any transplanted tissue can be influenced by the innervation it acquires.	[McAllister, Stacy L.; Dmitrieva, Natalia; Berkley, Karen J.] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	McAllister, SL (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.	kberkley@psy.fsu.edu			National Institutes of Health [NS 11892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grant NS 11892. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaf V, 2002, HUM REPROD, V17, P1895, DOI 10.1093/humrep/17.7.1895; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Berkley KJ, 2011, PAIN, V152, P1940, DOI 10.1016/j.pain.2011.04.013; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Bradshaw HB, 1999, PAIN, V82, P187, DOI 10.1016/S0304-3959(99)00049-4; Butler JE, 2001, J PHYSIOL-LONDON, V534, P583, DOI 10.1111/j.1469-7793.2001.00583.x; Cason AM, 2003, HORM BEHAV, V44, P123, DOI 10.1016/S0018-506X(03)00121-1; Davis A R, 2001, J Pediatr Adolesc Gynecol, V14, P3, DOI 10.1016/S1083-3188(00)00076-0; de Leon-Casasola O, 2011, PAIN MED, V12, pS100, DOI 10.1111/j.1526-4637.2011.01160.x; De Martin E, 2009, TRANSPL INT, V22, P28; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; DHILLON AP, 1992, J PATHOL, V167, P211, DOI 10.1002/path.1711670209; Dmitrieva N, 2010, PAIN, V151, P703, DOI 10.1016/j.pain.2010.08.037; Durain D, 2004, J MIDWIFERY WOM HEAL, V49, P520, DOI 10.1016/j.jmwh.2004.08.013; Frokjaer JB, 2005, PAIN, V119, P191, DOI 10.1016/j.pain.2005.09.031; Gebhart GF, 1999, CAN J GASTROENTEROL, V13, p7A; Geny B, 2008, J APPL PHYSIOL, V104, P568, DOI [10.1152/japplphysiol.01159.2007, 10.1152/japplphysiol.00694.2007a]; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; GREEN PG, 1993, NEUROSCIENCE, V55, P1037, DOI 10.1016/0306-4522(93)90317-9; Grisk O, 2001, TRANSPLANTATION, V72, P1153, DOI 10.1097/00007890-200109270-00029; Howard FM, 2009, J MINIM INVAS GYN, V16, P540, DOI 10.1016/j.jmig.2009.06.017; Janig W, 1996, PROG BRAIN RES, V113, P61; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; KONDO Y, 1972, ANN SURG, V176, P42, DOI 10.1097/00000658-197207000-00009; Latini C, 2008, CELL TISSUE RES, V334, P1, DOI 10.1007/s00441-008-0657-x; May KE, 2011, HUM REPROD UPDATE, V17, P637, DOI 10.1093/humupd/dmr013; McAllister SL, 2009, PAIN, V147, P255, DOI 10.1016/j.pain.2009.09.022; Mechsner S, 2009, FERTIL STERIL, V92, P1856, DOI 10.1016/j.fertnstert.2008.09.006; Nagabukuro H, 2007, PAIN, V132, pS96, DOI 10.1016/j.pain.2007.04.039; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Sann H, 1998, Z RHEUMATOL, V57, P8; Sauer SK, 2009, DIGEST DIS, V27, P11, DOI 10.1159/000268116; STARK RP, 1991, NEW ENGL J MED, V324, P1791, DOI 10.1056/NEJM199106203242507; Stratton P, 2011, HUM REPROD UPDATE, V17, P327, DOI 10.1093/humupd/dmq050; Tu CH, 2010, PAIN, V150, P462, DOI 10.1016/j.pain.2010.05.026; Tu CH, 2009, NEUROIMAGE, V47, P28, DOI 10.1016/j.neuroimage.2009.03.080; VERNON MW, 1985, FERTIL STERIL, V44, P684; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zhang GH, 2008, AM J PHYSIOL-REG I, V294, pR162, DOI 10.1152/ajpregu.00649.2007	45	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31758	10.1371/journal.pone.0031758	http://dx.doi.org/10.1371/journal.pone.0031758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363725	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700093
J	Pelosi, A; Smith, D; Brammananth, R; Topolska, A; Billman-Jacobe, H; Nagley, P; Crellin, PK; Coppel, RL				Pelosi, Assunta; Smith, Danielle; Brammananth, Rajini; Topolska, Agnieszka; Billman-Jacobe, Helen; Nagley, Phillip; Crellin, Paul K.; Coppel, Ross L.			Identification of a Novel Gene Product That Promotes Survival of Mycobacterium smegmatis in Macrophages	PLOS ONE			English	Article							GLYOXYLATE AMINOTRANSFERASE; CULTURED MACROPHAGES; TUBERCULOSIS; ENTRY; BIOSYNTHESIS; DISRUPTION; EXPRESSION; PROTEIN; CLONING; GROWTH	Background: Bacteria of the suborder Corynebacterineae include significant human pathogens such as Mycobacterium tuberculosis and M. leprae. Drug resistance in mycobacteria is increasingly common making identification of new antimicrobials a priority. Mycobacteria replicate intracellularly, most commonly within the phagosomes of macrophages, and bacterial proteins essential for intracellular survival and persistence are particularly attractive targets for intervention with new generations of anti-mycobacterial drugs. Methodology/Principal Findings: We have identified a novel gene that, when inactivated, leads to accelerated death of M. smegmatis within a macrophage cell line in the first eight hours following infection. Complementation of the mutant with an intact copy of the gene restored survival to near wild type levels. Gene disruption did not affect growth compared to wild type M. smegmatis in axenic culture or in the presence of low pH or reactive oxygen intermediates, suggesting the growth defect is not related to increased susceptibility to these stresses. The disrupted gene, MSMEG_5817, is conserved in all mycobacteria for which genome sequence information is available, and designated Rv0807 in M. tuberculosis. Although homology searches suggest that MSMEG_5817 is similar to the serine: pyruvate aminotransferase of Brevibacterium linens suggesting a possible role in glyoxylate metabolism, enzymatic assays comparing activity in wild type and mutant strains demonstrated no differences in the capacity to metabolize glyoxylate. Conclusions/Significance: MSMEG_5817 is a previously uncharacterized gene that facilitates intracellular survival of mycobacteria. Interference with the function of MSMEG_5817 may provide a novel therapeutic approach for control of mycobacterial pathogens by assisting the host immune system in clearance of persistent intracellular bacteria.	[Pelosi, Assunta; Brammananth, Rajini; Topolska, Agnieszka; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Pelosi, Assunta; Smith, Danielle; Nagley, Phillip] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Pelosi, Assunta; Smith, Danielle; Brammananth, Rajini; Nagley, Phillip; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia	Monash University; Monash University; University of Melbourne; Monash University	Pelosi, A (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Billman-Jacobe, Helen/0000-0001-5713-4657; Crellin, Paul K/0000-0002-2017-4935	National Health and Medical Research Council of Australia; Australian Research Council Centre of Excellence in Structural and Functional Genomics	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Structural and Functional Genomics(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (http://www.nmrc.gov.au) and the Australian Research Council Centre of Excellence in Structural and Functional Genomics (http://www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; GORDON AH, 1994, INFECT IMMUN, V62, P4650, DOI 10.1128/IAI.62.10.4650-4651.1994; Haile Y, 2002, FEMS IMMUNOL MED MIC, V33, P125, DOI 10.1111/j.1574-695X.2002.tb00581.x; HERBERT RA, 1980, ARCH MICROBIOL, V128, P233, DOI 10.1007/BF00406164; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kumar A, 2005, FEMS IMMUNOL MED MIC, V43, P185, DOI 10.1016/j.femsim.2004.08.013; Lagier B, 1998, MOL MICROBIOL, V29, P465, DOI 10.1046/j.1365-2958.1998.00933.x; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Monahan IM, 2001, METHODS MOL MED, V54; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Patterson JH, 2000, J BIOL CHEM, V275, P24900, DOI 10.1074/jbc.M000147200; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robinson N, 2007, INFECT IMMUN, V75, P581, DOI 10.1128/IAI.00997-06; ROWSELL EV, 1972, INT J BIOCHEM, V3, P247, DOI 10.1016/0020-711X(72)90036-5; Sakuraba H, 2004, J BACTERIOL, V186, P5513, DOI 10.1128/JB.186.16.5513-5518.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Singh R, 2005, TUBERCULOSIS, V85, P325, DOI 10.1016/j.tube.2005.08.015; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31788	10.1371/journal.pone.0031788	http://dx.doi.org/10.1371/journal.pone.0031788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363734	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700098
J	Serna-Bolea, C; de Deus, N; Acacio, S; Munoz, J; Nhalungo, D; Letang, E; Alonso, P; Naniche, D				Serna-Bolea, Celia; de Deus, Nilsa; Acacio, Sozinho; Munoz, Jose; Nhalungo, Delino; Letang, Emilio; Alonso, Pedro; Naniche, Denise			Recent HIV-1 Infection: Identification of Individuals with High Viral Load Setpoint in a Voluntary Counselling and Testing Centre in Rural Mozambique	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CAPTURE ENZYME-IMMUNOASSAY; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SUBTYPE-C; SET-POINT; SOUTHERN MOZAMBIQUE; TYPE-1; TRANSMISSION; WOMEN	Background: Identification of recent HIV-infections is important for describing the HIV epidemic and compiling HIV-RNA-setpoint data for future HIV intervention trials. We conducted a study to characterize recent infections, and HIV-RNA-setpoint within the adult population presenting at a voluntary counselling and testing centre (VCT) in southern Mozambique. Methods: All adults attending the Manhic,a District-Hospital VCT between April and October 2009 were recruited if they had at least one positive rapid HIV-serology test. Patients were screened for recent HIV-1 infection by BED-CEIA HIV-incidence test. Clinical examination, assessment of HIV-RNA and CD4 cell counts were performed at enrollment, 4 and 10 months. Results: Of the 492 participants included in this study, the prevalence of recent infections as defined by BED-CEIA test, CD4 counts >200 cells/mu l and HIV-RNA >400 copies/mL, was 11.58% (57/492; 95% CI 8.89-14.74). Due to heterogeneity in HIV-RNA levels in recently infected patients, individuals were categorized as having "high'' HIV-RNA load if their HIV-RNA level was above the median (4.98 log(10) copies/mL) at diagnosis. The "high'' HIV-RNA group sustained a significantly higher HIV-viral load at all visits with a median HIV-RNA-setpoint of 5.22 log(10) copies/mL (IQR 5.18-5.47) as compared to the median of 4.15 log(10) copies/ml (IQR 3.37-4.43) for the other patients (p = 0.0001). Conclusion: The low proportion of recent HIV-infections among HIV-seropositive VCT clients suggests that most of this population attends the VCT at later stages of HIV/AIDS. Characterization of HIV-RNA-setpoint may serve to identify recently infected individuals maintaining HIV viral load>5 log(10) copies/mL as candidates for antiretroviral treatment as prevention interventions.	[Serna-Bolea, Celia; Munoz, Jose; Letang, Emilio; Alonso, Pedro; Naniche, Denise] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [de Deus, Nilsa; Acacio, Sozinho; Nhalungo, Delino; Alonso, Pedro] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [de Deus, Nilsa] Natl Inst Hlth, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Serna-Bolea, C (corresponding author), Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	celia.serna@cresib.cat; dsuzanne@clinic.ub.es	Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Alonso, Pedro L/AAZ-3645-2020; Gutiérrez, José/GSJ-1846-2022; Naniche, Denise S/S-1814-2018; de Deus, Nilsa/P-8430-2015	Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Alonso, Pedro L/0000-0003-3292-3443; Naniche, Denise S/0000-0002-4495-6325; de Deus, Nilsa/0000-0001-6769-7111; Fernandez, Ivette/0000-0001-5179-0477	Spanish Ministry of Health [PI071312, PI070233]; European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium; Spanish Agency for International Cooperation; Generalitat de Catalunya	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium; Spanish Agency for International Cooperation(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Financial support was received from the Spanish Ministry of Health (grant PI071312) and from the European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium. The Centro de Investigacao em Saude de Manhica receives core funding from the Spanish Agency for International Cooperation and the VCT clinic and day hospital from the Generalitat de Catalunya. CSB was supported by a grant from Spanish Ministry of Health (PI070233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024321; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; CDC, 2006, INT REC US BED CAPT; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Davenport MP, 2004, J VIROL, V78, P11340, DOI 10.1128/JVI.78.20.11340-11351.2004; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; [Joint United Nations Programme on HIV/AIDS World Health Organization], AIDS EP UPD DEC 2009; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Laeyendecker O, 2011, AIDS RES HU IN PRESS; Lahuerta M, 2008, AIDS RES HUM RETROV, V24, P327, DOI 10.1089/aid.2007.0134; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lefrere JJ, 1998, J INFECT DIS, V177, P1541, DOI 10.1086/515308; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Marinda ET, 2011, INT J EPIDEMIOL, V40, P945, DOI 10.1093/ije/dyr055; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Perez-Hoyos S, 2011, HIV MED; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 1999, NEW ENGL J MED, V340, P969, DOI 10.1056/NEJM199903253401217; Saathoff E, 2010, JAIDS-J ACQ IMM DEF, V54, P324, DOI 10.1097/QAI.0b013e3181cf30ba; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Truong HHM, 2011, AIDS RES HUM RETROV, V27, P593, DOI [10.1089/aid.2010.0249, 10.1089/AID.2010.0249]; [UNAIDS WHO], 2010, REP GLOB AIDS EP 201; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31859	10.1371/journal.pone.0031859	http://dx.doi.org/10.1371/journal.pone.0031859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363755	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700110
J	Suardi, S; Vimercati, C; Casalone, C; Gelmetti, D; Corona, C; Iulini, B; Mazza, M; Lombardi, G; Moda, F; Ruggerone, M; Campagnani, I; Piccoli, E; Catania, M; Groschup, MH; Balkema-Buschmann, A; Caramelli, M; Monaco, S; Zanusso, G; Tagliavini, F				Suardi, Silvia; Vimercati, Chiara; Casalone, Cristina; Gelmetti, Daniela; Corona, Cristiano; Iulini, Barbara; Mazza, Maria; Lombardi, Guerino; Moda, Fabio; Ruggerone, Margherita; Campagnani, Ilaria; Piccoli, Elena; Catania, Marcella; Groschup, Martin H.; Balkema-Buschmann, Anne; Caramelli, Maria; Monaco, Salvatore; Zanusso, Gianluigi; Tagliavini, Fabrizio			Infectivity in Skeletal Muscle of Cattle with Atypical Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PATHOLOGICAL PRION PROTEIN; EARLY BEHAVIORAL-CHANGES; CHRONIC WASTING DISEASE; SCRAPIE; MICE; BSE; TRANSMISSION; STRAIN; HAMSTERS	The amyloidotic form of bovine spongiform encephalopathy (BSE) termed BASE is caused by a prion strain whose biological properties differ from those of typical BSE, resulting in a clinically and pathologically distinct phenotype. Whether peripheral tissues of BASE-affected cattle contain infectivity is unknown. This is a critical issue since the BASE prion is readily transmissible to a variety of hosts including primates, suggesting that humans may be susceptible. We carried out bioassays in transgenic mice overexpressing bovine PrP (Tgbov XV) and found infectivity in a variety of skeletal muscles from cattle with natural and experimental BASE. Noteworthy, all BASE muscles used for inoculation transmitted disease, although the attack rate differed between experimental and natural cases (similar to 70% versus similar to 10%, respectively). This difference was likely related to different prion titers, possibly due to different stages of disease in the two conditions, i.e. terminal stage in experimental BASE and pre-symptomatic stage in natural BASE. The neuropathological phenotype and PrP res type were consistent in all affected mice and matched those of Tgbov XV mice infected with brain homogenate from natural BASE. The immunohistochemical analysis of skeletal muscles from cattle with natural and experimental BASE showed the presence of abnormal prion protein deposits within muscle fibers. Conversely, Tgbov XV mice challenged with lymphoid tissue and kidney from natural and experimental BASE did not develop disease. The novel information on the neuromuscular tropism of the BASE strain, efficiently overcoming species barriers, underlines the relevance of maintaining an active surveillance.	[Vimercati, Chiara; Moda, Fabio; Ruggerone, Margherita; Campagnani, Ilaria; Piccoli, Elena; Catania, Marcella; Tagliavini, Fabrizio] Fdn Carlo Besta Neurol Inst, IRCCS, Milan, Italy; [Casalone, Cristina; Corona, Cristiano; Iulini, Barbara; Mazza, Maria; Caramelli, Maria] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Gelmetti, Daniela; Lombardi, Guerino] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Groschup, Martin H.; Balkema-Buschmann, Anne] Friedrich Loeffler Inst, Greifswald, Insel Riems, Germany; [Monaco, Salvatore; Zanusso, Gianluigi] Univ Verona, Policlin GB Rossi, I-37100 Verona, Italy	IRCCS Istituto Neurologico Besta; IZS Piemonte Liguria e Valle D'aosta; IZS Lombardia e Emilia; Friedrich Loeffler Institute; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Suardi, S (corresponding author), Fdn Carlo Besta Neurol Inst, IRCCS, Milan, Italy.	ftagliavini@istituto-besta.it	Monaco, Salvatore/K-4659-2018; Moda, Fabio/J-6445-2018; Zanusso, Gianluigi/K-2823-2018; Casalone, Cristina/J-6763-2018; Catania, Marcella/K-1430-2016; Tagliavini, Fabrizio/AAO-7891-2021	Monaco, Salvatore/0000-0003-3191-8597; Moda, Fabio/0000-0002-2820-9880; Zanusso, Gianluigi/0000-0001-5199-6264; Casalone, Cristina/0000-0001-5271-832X; Catania, Marcella/0000-0003-0370-1905; Tagliavini, Fabrizio/0000-0003-1039-7315; Lombardi, Guerino/0000-0003-0977-5761	Italian Ministry of Health (Ricerca Corrente) [PRC IZSLER 003/2002, RFPS-2007-7-638803]	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health (Ricerca Corrente, grant number PRC IZSLER 003/2002 and RFPS-2007-7-638803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Beringue V, 2008, EMERG INFECT DIS, V14, P1898, DOI 10.3201/eid1412.080941; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Buschmann A, 2000, ARCH VIROL, P75; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Fukuda S, 2009, MICROBIOL IMMUNOL, V53, P704, DOI 10.1111/j.1348-0421.2009.00169.x; Giaccone G, 2000, BRAIN PATHOL, V10, P31, DOI 10.1111/j.1750-3639.2000.tb00240.x; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Iwamaru Y, 2010, EMERG INFECT DIS, V16, P1151, DOI 10.3201/eid1607.091882; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Krasemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013906; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Okada H, 2010, J VET MED SCI, V72, P1423, DOI 10.1292/jvms.10-0211; Ono F, 2011, JPN J INFECT DIS, V64, P81; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31449	10.1371/journal.pone.0031449	http://dx.doi.org/10.1371/journal.pone.0031449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363650	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700060
J	Zhu, GP; Bu, WJ; Gao, YB; Liu, GQ				Zhu, Gengping; Bu, Wenjun; Gao, Yubao; Liu, Guoqing			Potential Geographic Distribution of Brown Marmorated Stink Bug Invasion (Halyomorpha halys)	PLOS ONE			English	Article							HEMIPTERA-PENTATOMIDAE; SPECIES DISTRIBUTIONS; HETEROPTERA-PENTATOMIDAE; NICHE CONSERVATISM; ECOLOGICAL NICHES; UNCERTAINTY; PROJECTIONS; PREDICTION; NUMBERS; RECORDS	Background: The Brown Marmorated Stink Bug (BMSB), Halyomorpha halys (Stal) (Hemiptera: Pentatomidae), native to Asia, is becoming an invasive species with a rapidly expanding range in North America and Europe. In the US, it is a household pest and also caused unprecedented damage to agriculture crops. Exploring its climatic limits and estimating its potential geographic distribution can provide critical information for management strategies. Methodology/Principals: We used direct climate comparisons to explore the climatic niche occupied by native and invasive populations of BMSB. Ecological niche modelings based on the native range were used to anticipate the potential distribution of BMSB worldwide. Conversely, niche models based on the introduced range were used to locate the original invasive propagates in Asia. Areas with high invasion potential were identified by two niche modeling algorithms (i.e., Maxent and GARP). Conclusions/Significance: Reduced dimensionality of environmental space improves native model transferability in the invade area. Projecting models from invasive population back to native distributional areas offers valuable information on the potential source regions of the invasive populations. Our models anticipated successfully the current disjunct distribution of BMSB in the US. The original propagates are hypothesized to have come from northern Japan or western Korea. High climate suitable areas at risk of invasion include latitudes between 30 degrees-50 degrees including northern Europe, northeastern North America, southern Australia and the North Island of New Zealand. Angola in Africa and Uruguay in South America also showed high climate suitability.	[Zhu, Gengping] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Bu, Wenjun; Gao, Yubao; Liu, Guoqing] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhu, GP (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/E-4730-2013; Zhu, Gengping/CAF-4192-2022	Zhu, Gengping/0000-0001-6823-5840	Nankai University; National Education Project in Basic Science for Special Subjects [J0630963]; National Natural Science Foundation of China [30725005]	Nankai University; National Education Project in Basic Science for Special Subjects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a postdoctoral fellowship award to GZ in Nankai University and by the National Education Project in Basic Science for Special Subjects (No. J0630963) and National Natural Science Foundation of China (No. 30725005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JR, 2009, FLA ENTOMOL, V92, P483, DOI 10.1653/024.092.0310; [Anonymous], 1997, GAZETTEER CHINA; APHIS, 2004, PEST TRACK PUBL WEBS; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESA, 2011, ENT SOC AM E BRANCH; ESRI, 2006, ARCGIS 9 2; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Harris Anthony C., 2010, Weta, V40, P42; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ji S.L., 2006, NO FRUITS, V5, P25; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jones JR, 2009, FLA ENTOMOL, V92, P177, DOI 10.1653/024.092.0132; JOSIFOV M, 1978, Fragmenta Faunistica (Warsaw), V23, P137; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Khrimian A, 2008, J AGR FOOD CHEM, V56, P197, DOI 10.1021/jf072087e; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Li Q, 1998, PLANT DOCTOR, V11, P17; Li Zhong-xin, 2004, Chinese Journal of Biological Control, V20, P64; Liu XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018429; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2008, J ECON ENTOMOL, V101, P1439, DOI 10.1603/0022-0493(2008)101[1439:TOITHH]2.0.CO;2; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Niva CC, 2003, ZOOL SCI, V20, P963, DOI 10.2108/zsj.20.963; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Peterson AT, 2012, ECOLOGICAL NICHES GE, DOI [10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qiu L.-F., 2007, THESIS CHINESE ACAD; Qiu LF., 2010, N HORT, V9, P181; Qiu LF, 2010, CHINESE AGR SCI B, V26, P211; Rabitsch W, 2008, ZOOTAXA, P1; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Song HW, 1993, ENTOMOLOGICAL KNOWLE, V4, P225; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toyama M, 2011, APPL ENTOMOL ZOOL, V46, P37, DOI 10.1007/s13355-010-0002-1; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; WERMELINGER B, 2008, B SOC ENTOMOL SUISSE, V81, P1; Wyniger Denise, 2010, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V83, P261; Yang S.Y., 2006, SHANXI FRUITS, V3, P10; Yu CL., 2002, CHINA FRUITS, V2, P5; Zhang Cuituan, 1993, Forest Research, V6, P271; Zhang Y.Q., 2006, DECIDUOUS FRUITS, V3, P42	74	149	175	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31246	10.1371/journal.pone.0031246	http://dx.doi.org/10.1371/journal.pone.0031246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363595	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700039
J	Fox, A; Le, NMH; Horby, P; van Doorn, HR; Trung, NV; Ha, NH; Cap, NT; Phu, VD; Ha, NM; Diep, NTN; Bich, VTN; Huong, TTK; Taylor, WR; Farrar, J; Wertheim, H; Kinh, NV				Fox, Annette; Le Nguyen Minh Hoa; Horby, Peter; van Doorn, H. Rogier; Nguyen Vu Trung; Nguyen Hong Ha; Nguyen Trung Cap; Vu Dinh Phu; Nguyen Minh Ha; Diep Nguyen Thi Ngoc; Bich Vu Thi Ngoc; Huong Tran Thi Kieu; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman; Nguyen Van Kinh			Severe Pandemic H1N1 2009 Infection Is Associated with Transient NK and T Deficiency and Aberrant CD8 Responses	PLOS ONE			English	Article							INFLUENZA-A H5N1; CELLULAR IMMUNE-RESPONSES; VIRUS-INFECTION; PROTECTIVE IMMUNITY; HUMAN-DISEASE; HONG-KONG; CELLS; ACTIVATION; MICE; PNEUMONIA	Backgorund: It is unclear why the severity of influenza varies in healthy adults or why the burden of severe influenza shifts to young adults when pandemic strains emerge. One possibility is that cross-protective T cell responses wane in this age group in the absence of recent infection. We therefore compared the acute cellular immune response in previously healthy adults with severe versus mild pandemic H1N1 infection. Methods and Principal Findings: 49 previously healthy adults admitted to the National Hospital of Tropical Diseases, Viet Nam with RT-PCR-confirmed 2009 H1N1 infection were prospectively enrolled. 39 recovered quickly whereas 10 developed severe symptoms requiring supplemental oxygen and prolonged hospitalization. Peripheral blood lymphocyte subset counts and activation (HLADR, CD38) and differentiation (CD27, CD28) marker expression were determined on days 0, 2, 5, 10, 14 and 28 by flow cytometry. NK, CD4 and CD8 lymphopenia developed in 100%, 90% and 60% of severe cases versus 13% (p<0.001), 28%, (p = 0.001) and 18% (p = 0.014) of mild cases. CD4 and NK counts normalized following recovery. B cell counts were not significantly associated with severity. CD8 activation peaked 6-8 days after mild influenza onset, when 13% (6-22%) were HLADR+CD38+, and was accompanied by a significant loss of resting/CD27+CD28+ cells without accumulation of CD27+CD282- or CD272CD282- cells. In severe influenza CD8 activation peaked more than 9 days post-onset, and/or was excessive (30-90% HLADR+CD38+) in association with accumulation of CD27+CD282- cells and maintenance of CD8 counts. Conclusion: Severe influenza is associated with transient T and NK cell deficiency. CD8 phenotype changes during mild influenza are consistent with a rapidly resolving memory response whereas in severe influenza activation is either delayed or excessive, and partially differentiated cells accumulate within blood indicating that recruitment of effector cells to the lung could be impaired.	[Fox, Annette; Horby, Peter; van Doorn, H. Rogier; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dong Da, Ha Noi, Vietnam; [Fox, Annette; Le Nguyen Minh Hoa; Horby, Peter; van Doorn, H. Rogier; Diep Nguyen Thi Ngoc; Bich Vu Thi Ngoc; Huong Tran Thi Kieu; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Nguyen Vu Trung; Nguyen Hong Ha; Nguyen Trung Cap; Vu Dinh Phu; Nguyen Minh Ha; Nguyen Van Kinh] Natl Hosp Trop Dis, Dong Da, Ha Noi, Vietnam; [Taylor, Walter R.] SE Asia Infect Dis Clin Res Network, Jakarta, Indonesia	University of Oxford; University of Oxford; National Hospital of Tropical Diseases	Fox, A (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dong Da, Ha Noi, Vietnam.	afox@oucru.org	Wertheim, Heiman FL/F-3338-2016; Farrar, Jeremy J./HGA-7610-2022; Horby, Peter/D-1585-2013; van Doorn, H. Rogier/H-3080-2019	Wertheim, Heiman FL/0000-0002-5003-5565; van Doorn, H. Rogier/0000-0002-9807-1821; Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146	Wellcome Trust of Great Britain; South East Asian Infectious Diseases Clinical Research Network; European Union [223498]; National Hospital; Ministry of Health of Viet Nam	Wellcome Trust of Great Britain(Wellcome Trust); South East Asian Infectious Diseases Clinical Research Network; European Union(European Commission); National Hospital; Ministry of Health of Viet Nam	This work was funded by the Wellcome Trust of Great Britain and The South East Asian Infectious Diseases Clinical Research Network. AF was supported by the European Union FP7 project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)'' (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the patients for agreeing to participate in the study. We thank the Ministry of Health of Viet Nam and the staff of the National Hospital of Tropical diseases for their continued support for our work and for their dedication to high quality research into infectious diseases in Viet Nam.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; CRISWELL BS, 1979, AM REV RESPIR DIS, V120, P700; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Eichelberger MC, 2006, CELL IMMUNOL, V243, P67, DOI 10.1016/j.cellimm.2006.12.005; Epstein SL, 1998, J IMMUNOL, V160, P322; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fox A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-167; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; HOPESIMPSON RE, 1972, BMJ-BRIT MED J, V4, P490, DOI 10.1136/bmj.4.5838.490-b; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jiang TJ, 2010, CLIN IMMUNOL, V137, P303, DOI 10.1016/j.clim.2010.07.010; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LEWIS DE, 1986, J IMMUNOL, V137, P3777; Lichtner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019872; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Marcelin G, 2010, J INFECT DIS, V202, P1634, DOI 10.1086/657084; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Mathews JD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-128; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MCMICHAEL AJ, 1983, LANCET, V2, P762; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rosenberg YJ, 1997, INT IMMUNOL, V9, P703, DOI 10.1093/intimm/9.5.703; Salazar-Mather TP, 2003, VIRAL IMMUNOL, V16, P291, DOI 10.1089/088282403322396109; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	65	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31535	10.1371/journal.pone.0031535	http://dx.doi.org/10.1371/journal.pone.0031535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363665	Green Published, gold			2022-12-25	WOS:000302871500054
J	Larson, JL; Yuan, GC				Larson, Jessica L.; Yuan, Guo-Cheng			Chromatin States Accurately Classify Cell Differentiation Stages	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; HISTONE MODIFICATIONS; GENE-EXPRESSION; PLURIPOTENT; EPIGENOMICS; DISTINCT; IDENTIFICATION; SIGNATURE; ENHANCERS	Gene expression is controlled by the concerted interactions between transcription factors and chromatin regulators. While recent studies have identified global chromatin state changes across cell-types, it remains unclear to what extent these changes are co-regulated during cell-differentiation. Here we present a comprehensive computational analysis by assembling a large dataset containing genome-wide occupancy information of 5 histone modifications in 27 human cell lines (including 24 normal and 3 cancer cell lines) obtained from the public domain, followed by independent analysis at three different representations. We classified the differentiation stage of a cell-type based on its genome-wide pattern of chromatin states, and found that our method was able to identify normal cell lines with nearly 100% accuracy. We then applied our model to classify the cancer cell lines and found that each can be unequivocally classified as differentiated cells. The differences can be in part explained by the differential activities of three regulatory modules associated with embryonic stem cells. We also found that the "hotspot'' genes, whose chromatin states change dynamically in accordance to the differentiation stage, are not randomly distributed across the genome but tend to be embedded in multi-gene chromatin domains, and that specialized gene clusters tend to be embedded in stably occupied domains.	[Larson, Jessica L.; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Larson, JL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 665 Huntington Ave, Boston, MA 02115 USA.	gcyuan@jimmy.harvard.edu			HSPH; United States National Institutes of Health [HG005085]; NIH [GM074897]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER	HSPH; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an HSPH Career Incubator Award and the United States National Institutes of Health grant HG005085 to GCY, and by a NIH training grant (GM074897) to JLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chang C.-C., LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Durbin R, BIOL SEQUENCE ANAL; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Massague J, 2000, GENE DEV, V14, P627; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pollard KS, 2005, MULTTEST RESAMPLING; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31414	10.1371/journal.pone.0031414	http://dx.doi.org/10.1371/journal.pone.0031414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363642	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500042
J	Larsson, P; Ulfhammer, E; Magnusson, M; Bergh, N; Lunke, S; El-Osta, A; Medcalf, RL; Svensson, PA; Karlsson, L; Jern, S				Larsson, Pia; Ulfhammer, Erik; Magnusson, Mia; Bergh, Niklas; Lunke, Sebastian; El-Osta, Assam; Medcalf, Robert L.; Svensson, Per-Arne; Karlsson, Lena; Jern, Sverker			Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression	PLOS ONE			English	Article							T-PA RELEASE; DEACETYLASE INHIBITOR; IN-VIVO; PROTEIN INTERACTIONS; IMPAIRED CAPACITY; GENE PROMOTER; SP1 SITES; CELLS; TRANSCRIPTION; HYPERTENSION	Aims: Stimulated release of tissue-type plasminogen activator (t-PA) is pivotal for an intravascular fibrinolytic response and protects the circulation from occluding thrombosis. Hence, an impaired t-PA production is associated with increased risk for atherothrombotic events. A pharmacological means to stimulate the production of this enzyme may thus be desirable. We investigated if the anti-epileptic drug valproic acid (VPA) is capable of enhancing t-PA expression in vitro in vascular endothelial cells, and further examined if its histone deacetylase (HDAC)-inhibitory activity is of importance for regulating t-PA expression. Methods and Results: Human endothelial cells were exposed to valproic acid and t-PA mRNA and protein levels were quantified. Potential changes in histone acetylation status globally and at the t-PA promoter were examined by western blot and chromatin immunoprecipitation. Valproic acid dose-dependently stimulated t-PA mRNA and protein expression in endothelial cells reaching a 2-4-fold increase at clinically relevant concentrations and 10-fold increase at maximal concentrations. Transcription profiling analysis revealed that t-PA is selectively targeted by this agent. Augmented histone acetylation was detected at the t-PA transcription start site, and an attenuated VPA-response was observed with siRNA knock of HDAC3, HDAC5 and HDAC7. Conclusions: Valproic acid induces t-PA expression in cultured endothelial cells, and this is associated with increased histone acetylation at the t-PA promoter. Given the apparent potency of valproic acid in stimulating t-PA expression in vitro this substance may be a candidate for pharmacological modulation of endogenous fibrinolysis in man.	[Larsson, Pia; Ulfhammer, Erik; Magnusson, Mia; Bergh, Niklas; Karlsson, Lena; Jern, Sverker] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Lunke, Sebastian; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic, Australia; [Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Svensson, Per-Arne] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Baker Heart and Diabetes Institute; Monash University; University of Gothenburg	Larsson, P (corresponding author), Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden.	sverker.jern@gu.se	Svensson, Per-Arne/R-4626-2019; Medcalf, Robert L/E-9632-2011	El-Osta, Assam/0000-0003-2969-9137; El-Osta, Assam/0000-0001-7968-7375; Svensson, Per-Arne/0000-0002-6731-806X; Ulfhammer, Erik/0000-0002-6326-5175; Bergh, Niklas/0000-0002-7440-2366; Larsson, Pia/0000-0001-9115-4213	Swedish Research Council [15038, 20758]; Swedish Heart-Lung Foundation; Swedish Hypertension Society; Sahlgrenska Academy at Goteborg University; King Gustaf V:s and Queen Victoria Foundation; King Gustaf V:s 80-year Foundation; Petrus and Augusta Hedlund's Foundation; Emelle Foundation; Lars Hierta Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Hypertension Society; Sahlgrenska Academy at Goteborg University; King Gustaf V:s and Queen Victoria Foundation; King Gustaf V:s 80-year Foundation; Petrus and Augusta Hedlund's Foundation; Emelle Foundation; Lars Hierta Memorial Foundation	This work was supported by research grants from the Swedish Research Council (http://www.vr.se/)(project no. 15038 and 20758), the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/), the Swedish Hypertension Society, the Sahlgrenska Academy at Goteborg University, King Gustaf V:s and Queen Victoria Foundation, King Gustaf V:s 80-year Foundation, Petrus and Augusta Hedlund's Foundation, Emelle Foundation, and Lars Hierta Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts J, 1997, NUCLEIC ACIDS RES, V25, P311, DOI 10.1093/nar/25.2.311; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Harikrishnan KN, 2008, CELL CYCLE, V7, P468, DOI 10.4161/cc.7.4.5405; HENDERSON BR, 1992, FEBS LETT, V309, P130, DOI 10.1016/0014-5793(92)81080-6; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2004, HYPERTENSION, V44, P300, DOI 10.1161/01.HYP.0000137380.91476.fb; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; Mariadason JM, 2000, CANCER RES, V60, P4561; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Muldowney JAS, 2007, THROMB HAEMOSTASIS, V97, P263, DOI 10.1160/TH05-02-0092; Newby DE, 2001, CIRCULATION, V103, P1936; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ridderstrale W, 2006, HYPERTENSION, V47, P686, DOI 10.1161/01.HYP.0000210540.35296.62; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Van Guilder GP, 2005, AM J PHYSIOL-ENDOC M, V289, pE807, DOI 10.1152/ajpendo.00072.2005; VanLint C, 1996, GENE EXPRESSION, V5, P245; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	37	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31573	10.1371/journal.pone.0031573	http://dx.doi.org/10.1371/journal.pone.0031573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363677	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500057
J	Sanli, T; Linher-Melville, K; Tsakiridis, T; Singh, G				Sanli, Toran; Linher-Melville, Katja; Tsakiridis, Theodoros; Singh, Gurmit			Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P53 TUMOR-SUPPRESSOR; STRESS; GENE; TARGET; IDENTIFICATION; PHOSPHORYLATION; LOCALIZATION; APOPTOSIS; FAMILY	Background: The sestrin family of stress-responsive genes (SESN1-3) are suggested to be involved in regulation of metabolism and aging through modulation of the AMPK-mTOR pathway. AMP-activated protein kinase (AMPK) is an effector of the tumour suppressor LKB1, which regulates energy homeostasis, cell polarity, and the cell cycle. SESN1/2 can interact directly with AMPK in response to stress to maintain genomic integrity and suppress tumorigenesis. Ionizing radiation (IR), a widely used cancer therapy, is known to increase sestrin expression, and acutely activate AMPK. However, the regulation of AMPK expression by sestrins in response to IR has not been studied in depth. Methods and Findings: Through immunoprecipitation we observed that SESN2 directly interacted with the AMPK alpha 1 beta 1 gamma 1 trimer and its upstream regulator LKB1 in MCF7 breast cancer cells. SESN2 overexpression was achieved using a Flag-tagged SESN2 expression vector or a stably-integrated tetracycline-inducible system, which also increased AMPK alpha 1 and AMPK beta 1 subunit phosphorylation, and co-localized with phosphorylated AMPK alpha-Thr127 in the cytoplasm. Furthermore, enhanced SESN2 expression increased protein levels of LKB1 and AMPK alpha 1 beta 1 gamma 1, as well as mRNA levels of LKB1, AMPK alpha 1, and AMPK beta 1. Treatment of MCF7 cells with IR elevated AMPK expression and activity, but this effect was attenuated in the presence of SESN2 siRNA. In addition, elevated SESN2 inhibited IR-induced mTOR signalling and sensitized MCF7 cells to IR through an AMPK-dependent mechanism. Conclusions: Our results suggest that in breast cancer cells SESN2 is associated with AMPK, it is involved in regulation of basal and IR-induced expression and activation of this enzyme, and it mediates sensitization of cancer cells to IR.	[Sanli, Toran; Linher-Melville, Katja; Singh, Gurmit] McMaster Univ, Res Dept, Juravinski Canc Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Tsakiridis, Theodoros] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	McMaster University; McMaster University	Sanli, T (corresponding author), McMaster Univ, Res Dept, Juravinski Canc Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	gurmit.singh@jcc.hhsc.ca	Singh, Gurmit/C-6744-2014		Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Budanov AV, 2010, ANTIOXID REDOX SIGNA; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Fogarty S, 2009, BIOCHIM BIOPHYS ACTA, V1804, P581; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hay N, 2008, CELL METAB, V8, P184, DOI 10.1016/j.cmet.2008.08.010; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Linher-Melville K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-56; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanli T, 2011, J THORAC ONCOL, V6, P439, DOI 10.1097/JTO.0b013e3182049d8b; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zannella VE, 2011, RADIOTHER ONCOL	35	101	105	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32035	10.1371/journal.pone.0032035	http://dx.doi.org/10.1371/journal.pone.0032035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363791	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500106
J	Semplice, M; Veglio, A; Naldi, G; Serini, G; Gamba, A				Semplice, Matteo; Veglio, Andrea; Naldi, Giovanni; Serini, Guido; Gamba, Andrea			A Bistable Model of Cell Polarity	PLOS ONE			English	Article							MITOTIC SPINDLE ORIENTATION; TUMOR-SUPPRESSOR PTEN; DICTYOSTELIUM CELLS; PLASMA-MEMBRANE; EPITHELIAL MORPHOGENESIS; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; POSITIVE FEEDBACK; RAS; CHEMOTAXIS	Ultrasensitivity, as described by Goldbeter and Koshland, has been considered for a long time as a way to realize bistable switches in biological systems. It is not as well recognized that when ultrasensitivity and reinforcing feedback loops are present in a spatially distributed system such as the cell plasmamembrane, they may induce bistability and spatial separation of the system into distinct signaling phases. Here we suggest that bistability of ultrasensitive signaling pathways in a diffusive environment provides a basic mechanism to realize cell membrane polarity. Cell membrane polarization is a fundamental process implicated in several basic biological phenomena, such as differentiation, proliferation, migration and morphogenesis of unicellular and multicellular organisms. We describe a simple, solvable model of cell membrane polarization based on the coupling of membrane diffusion with bistable enzymatic dynamics. The model can reproduce a broad range of symmetry-breaking events, such as those observed in eukaryotic directional sensing, the apico-basal polarization of epithelium cells, the polarization of budding and mating yeast, and the formation of Ras nanoclusters in several cell types.	[Semplice, Matteo] Univ Insubria, Dept Math & Phys, Como, Italy; [Veglio, Andrea] Inst Pasteur, Genomes & Genet Dept, Unit Phys Biol Syst, Paris, France; [Naldi, Giovanni] Univ Milan, Dept Math F Enriques, Milan, Italy; [Serini, Guido] Univ Turin, Sch Med, Inst Canc Res & Treatment, Lab Cell Adhes Dynam, Candiolo, Italy; [Serini, Guido] Univ Turin, Sch Med, Dept Oncol Sci, Candiolo, Italy; [Gamba, Andrea] Politecn Torino, Dept Math, I-10128 Turin, Italy; [Gamba, Andrea] Inst Canc Res & Treatment, Lab Syst Biol, Candiolo, Italy; [Gamba, Andrea] Ist Nazl Fis Nucl, I-10125 Turin, Italy	University of Insubria; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Milan; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; Polytechnic University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Istituto Nazionale di Fisica Nucleare (INFN)	Semplice, M (corresponding author), Univ Insubria, Dept Math & Phys, Como, Italy.	giovanni.naldi@unimi.it	GAMBA, ANDREA ANTONIO/B-9097-2008; GAMBA, ANDREA ANTONIO/AAJ-3203-2021; Serini, Guido/AAF-2873-2021; Naldi, Giovanni/F-2935-2012	GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; GAMBA, ANDREA ANTONIO/0000-0002-2591-2722; Serini, Guido/0000-0002-3502-8367; Naldi, Giovanni/0000-0001-9191-6003	Italian government; AIRC; FPRC; MIUR (Italy)	Italian government; AIRC(Fondazione AIRC per la ricerca sul cancro); FPRC; MIUR (Italy)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported for GN and MS by the Italian government funding program PRIN "Advanced Numerical Methods for Partial Differential Equations"; this work was supported by AIRC to AG and GS; AG acknowledges financial support from FPRC and MIUR 5x1000 (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Bahler J, 2000, FR MOLEC B, V28, P21; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Calvez V, 2010, CR MATH, V348, P629, DOI 10.1016/j.crma.2010.04.009; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Clarke B. L., 1980, ADV CHEM PHYS, V43, P1; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Das J, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3149861; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; de Candia Antonio, 2007, Sci STKE, V2007, ppl1, DOI 10.1126/stke.3782007pl1; Desai R. C., 2009, DYNAMICS SELF ORG SE; Evans LC, 1996, PARTIAL DIFFERENTIAL; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Flanders H., 1989, DIFFERENTIAL FORMS A; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gamba A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.158101; Gamba A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02019; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goehring NW, 2011, SCIENCE; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Hairer E, 2010, SOLVING ORDINARY DIF, VII; Hawkins RJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040903; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Iglesias PA, 2007, CURR OPIN CELL BIOL, V20, P1; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kortholt A, 2008, CELL SIGNAL, V20, P1415, DOI 10.1016/j.cellsig.2008.02.006; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Krishnan J, 2004, J THEOR BIOL, V229, P85, DOI 10.1016/j.jtbi.2004.03.005; Landau L.D., 1980, COURSE THEORETICAL P, V5; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Meili R, 2002, NAT CELL BIOL, V4, pE171, DOI 10.1038/ncb0702-e171; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; Postma M, 2004, J CELL SCI, V117, P2925, DOI 10.1242/jcs.01143; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Scholl E, 2000, LECT NOTE PHYS, V557; Skupsky R, 2005, BIOPHYS J, V89, P2806, DOI 10.1529/biophysj.105.061564; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Veglio A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031919; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yoshida S, 2008, EMBO REP, V9, P39, DOI 10.1038/sj.embor.7401142; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	76	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30977	10.1371/journal.pone.0030977	http://dx.doi.org/10.1371/journal.pone.0030977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383986	gold, Green Published, Green Submitted			2022-12-25	WOS:000302916100012
J	Cleveland, ZI; Moller, HE; Hedlund, LW; Nouls, JC; Freeman, MS; Qi, Y; Driehuys, B				Cleveland, Zackary I.; Moeller, Harald E.; Hedlund, Laurence W.; Nouls, John C.; Freeman, Matthew S.; Qi, Yi; Driehuys, Bastiaan			In Vivo MR Imaging of Pulmonary Perfusion and Gas Exchange in Rats via Continuous Extracorporeal Infusion of Hyperpolarized Xe-129	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LASER-POLARIZED XE-129; INERT-GAS; LUNG; XENON; NMR; VENTILATION; RELAXATION; MICROSCOPY; PROTEIN	Background: Hyperpolarized (HP) Xe-129 magnetic resonance imaging (MRI) permits high resolution, regional visualization of pulmonary ventilation. Additionally, its reasonably high solubility (> 10%) and large chemical shift range (> 200 ppm) in tissues allow HP Xe-129 to serve as a regional probe of pulmonary perfusion and gas transport, when introduced directly into the vasculature. In earlier work, vascular delivery was accomplished in rats by first dissolving HP Xe-129 in a biologically compatible carrier solution, injecting the solution into the vasculature, and then detecting HP Xe-129 as it emerged into the alveolar airspaces. Although easily implemented, this approach was constrained by the tolerable injection volume and the duration of the HP Xe-129 signal. Methods and Principal Findings: Here, we overcome the volume and temporal constraints imposed by injection, by using hydrophobic, microporous, gas-exchange membranes to directly and continuously infuse Xe-129 into the arterial blood of live rats with an extracorporeal (EC) circuit. The resulting gas-phase Xe-129 signal is sufficient to generate diffusive gas exchange-and pulmonary perfusion-dependent, 3D MR images with a nominal resolution of 2x2x2 mm(3). We also show that the Xe-129 signal dynamics during EC infusion are well described by an analytical model that incorporates both mass transport into the blood and longitudinal relaxation. Conclusions: Extracorporeal infusion of HP Xe-129 enables rapid, 3D MR imaging of rat lungs and, when combined with ventilation imaging, will permit spatially resolved studies of the ventilation-perfusion ratio in small animals. Moreover, EC infusion should allow Xe-129 to be delivered elsewhere in the body and make possible functional and molecular imaging approaches that are currently not feasible using inhaled HP Xe-129.	[Cleveland, Zackary I.; Moeller, Harald E.; Hedlund, Laurence W.; Nouls, John C.; Freeman, Matthew S.; Qi, Yi; Driehuys, Bastiaan] Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA; [Moeller, Harald E.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Freeman, Matthew S.] Duke Univ, Grad Program Med Phys, Durham, NC USA	Duke University; Max Planck Society; Duke University	Cleveland, ZI (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA.	bastiaan.driehuys@duke.edu	Moller, Harald E/A-1565-2008; Möller, Harald/AAB-4679-2019	Moller, Harald E/0000-0002-5659-1925; Möller, Harald/0000-0002-5659-1925; Hedlund, Laurence/0000-0001-5275-0397; Driehuys, Bastiaan/0000-0002-1236-4210	National Cancer Institute (NCI) [R01 CA142842]; National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center [P41 RR005959]; NATIONAL CANCER INSTITUTE [R01CA142842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was conducted at the Duke Center for In Vivo Microscopy (http://www.civm.duhs.duke.edu), a National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center (P41 RR005959) with additional support from the National Cancer Institute (NCI) (R01 CA142842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro V, 2001, CLIN EXP PHARMACOL P, V28, P419, DOI 10.1046/j.1440-1681.2001.3455.x; Amor N, 2009, J MAGN RESON, V201, P93, DOI 10.1016/j.jmr.2009.08.004; Baumer D, 2006, ANGEW CHEM INT EDIT, V45, P7282, DOI 10.1002/anie.200601008; Boutin C, 2011, BIOORGAN MED CHEM, V19, P4135, DOI 10.1016/j.bmc.2011.05.002; Bucholz E, 2008, MAGN RESON MED, V60, P111, DOI 10.1002/mrm.21618; Budilarto SG, 2009, ARTIF ORGANS, V33, P411, DOI 10.1111/j.1525-1594.2009.00751.x; C Lentner, GEIGY SCI TABLES; Chambers JM, 2009, J AM CHEM SOC, V131, P563, DOI 10.1021/ja806092w; Chen BT, 2005, MAGN RESON MED, V53, P69, DOI 10.1002/mrm.20307; CHEN RYZ, 1980, J APPL PHYSIOL, V49, P178, DOI 10.1152/jappl.1980.49.2.178; Cleveland ZI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012192; Cleveland ZI, 2009, J PHYS CHEM B, V113, P12489, DOI 10.1021/jp9049582; Deninger AJ, 2002, MAGN RESON MED, V48, P223, DOI 10.1002/mrm.10206; Dregely I, 2011, J MAGN RESON IMAGING, V33, P1052, DOI 10.1002/jmri.22533; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; Driehuys B, 2008, MAGN RESON MED, V60, P14, DOI 10.1002/mrm.21651; Driehuys B, 2006, P NATL ACAD SCI USA, V103, P18278, DOI 10.1073/pnas.0608458103; Driehuys B, 2009, RADIOLOGY, V252, P386, DOI [10.1148/radiol.2513081550, 10.1148/radiol.2522081550]; Dubois L, 2004, J AM CHEM SOC, V126, P15738, DOI 10.1021/ja046195i; Goodson BM, 2002, J MAGN RESON, V155, P157, DOI 10.1006/jmre.2001.2341; Hirleman E, 2008, PERFUSION-UK, V23, P311, DOI 10.1177/0267659109105079; KAROOR S, 1993, IND ENG CHEM RES, V32, P674, DOI 10.1021/ie00016a014; Kaushik SS, 2011, MAGN RESON MED, V65, P1155, DOI 10.1002/mrm.22697; KETY SS, 1951, PHARMACOL REV, V3, P1; Lei Zhao, 1996, Journal of Magnetic Resonance, Series B, V113, P179, DOI 10.1006/jmrb.1996.0173; Lowery TJ, 2005, PROTEIN SCI, V14, P848, DOI [10.1110/ps.041231005, 10.1110/ps.041231005.]; Mata JF, 2007, J APPL PHYSIOL, V102, P1273, DOI 10.1152/japplphysiol.00418.2006; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Moller HE, 2011, J MAGN RESON, V212, P109, DOI 10.1016/j.jmr.2011.06.017; Moller HE, 2002, MAGN RESON MED, V47, P1029, DOI 10.1002/mrm.10173; Moller HE, 1999, MAGNET RESON MED, V41, P1058, DOI 10.1002/(SICI)1522-2594(199905)41:5<1058::AID-MRM26>3.0.CO;2-C; Mugler JP, 2010, P NATL ACAD SCI USA, V107, P21707, DOI 10.1073/pnas.1011912107; Nouls J, 2011, CONCEPT MAGN RESON B, V39B, P78, DOI 10.1002/cmr.b.20192; Patz S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015009; Petersson J, 2007, J APPL PHYSIOL, V102, P468, DOI 10.1152/japplphysiol.00732.2006; POPOVIC VP, 1964, AM J PHYSIOL, V207, P767, DOI 10.1152/ajplegacy.1964.207.4.767; Probst RJ, 2006, J AM ASSOC LAB ANIM, V45, P49; RHODES CG, 1989, J APPL PHYSIOL, V66, P1905, DOI 10.1152/jappl.1989.66.4.1905; Richter T, 2010, J APPL PHYSIOL, V108, P422, DOI 10.1152/japplphysiol.91257.2008; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Schumichen C, 2003, RESPIRATION, V70, P329, DOI 10.1159/000072892; Song JY, 2009, IEEE T BIO-MED ENG, V56, P1134, DOI 10.1109/TBME.2009.2012721; Stupic KF, 2006, SOLID STATE NUCL MAG, V29, P79, DOI 10.1016/j.ssnmr.2005.08.008; Swanson SD, 1997, MAGNET RESON MED, V38, P695, DOI 10.1002/mrm.1910380503; TRUOG WE, 1979, J APPL PHYSIOL, V47, P1112, DOI 10.1152/jappl.1979.47.5.1112; Unsworth J., 1971, Diffusion processes, P599; Voorhees ME, 1996, INT ANESTHESIOL CLIN, V34, P29, DOI 10.1097/00004311-199603420-00005; WEIBEL ER, 1973, RESP PHYSIOL, V18, P285, DOI 10.1016/0034-5687(73)90094-7; Wickramasinghe SR, 2005, CHEM ENG RES DES, V83, P256, DOI 10.1205/cherd.04195; Wickramasinghe SR, 2005, AICHE J, V51, P656, DOI 10.1002/aic.10327; Wickramasinghe SR, 2002, BIOTECHNOL PROGR, V18, P867, DOI 10.1021/bp010192h; Wickramasinghe SR, 2002, J MEMBRANE SCI, V208, P247, DOI 10.1016/S0376-7388(02)00281-8; Wietholt C, 2003, PROC SPIE, V5031, P252, DOI 10.1117/12.485802; Wolber J, 2000, MAGNET RESON MED, V43, P491, DOI 10.1002/(SICI)1522-2594(200004)43:4<491::AID-MRM1>3.0.CO;2-6; Wolber J, 1999, P NATL ACAD SCI USA, V96, P3664, DOI 10.1073/pnas.96.7.3664; Zheng WZ, 2011, J MAGN RESON, V208, P284, DOI 10.1016/j.jmr.2010.11.006; Zhou X, 2009, P NATL ACAD SCI USA, V106, P16903, DOI 10.1073/pnas.0909147106	57	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31306	10.1371/journal.pone.0031306	http://dx.doi.org/10.1371/journal.pone.0031306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363613	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700045
J	Pinske, C; Sawers, RG				Pinske, Constanze; Sawers, R. Gary			Delivery of Iron-Sulfur Clusters to the Hydrogen-Oxidizing [NiFe]-Hydrogenases in Escherichia coli Requires the A-Type Carrier Proteins ErpA and IscA	PLOS ONE			English	Article							FE-S CLUSTER; NIFE HYDROGENASE; MUTATIONAL ANALYSIS; OXYGEN-TOLERANT; AZOTOBACTER-VINELANDII; NICKEL INCORPORATION; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; MATURATION; OPERON	During anaerobic growth Escherichia coli synthesizes two membrane-associated hydrogen-oxidizing [NiFe]-hydrogenases, termed hydrogenase 1 and hydrogenase 2. Each enzyme comprises a catalytic subunit containing the [NiFe] cofactor, an electron-transferring small subunit with a particular complement of [Fe-S] (iron-sulfur) clusters and a membrane-anchor subunit. How the [Fe-S] clusters are delivered to the small subunit of these enzymes is unclear. A-type carrier (ATC) proteins of the Isc ((i) under bar ron-(s) under bar ulfur-(c) under bar luster) and Suf ((su) under barl (f) under bar ur mobilization) [Fe-S] cluster biogenesis pathways are proposed to traffic preformed [Fe-S] clusters to apoprotein targets. Mutants that could not synthesize SufA had active hydrogenase 1 and hydrogenase 2 enzymes, thus demonstrating that the Suf machinery is not required for hydrogenase maturation. In contrast, mutants devoid of the IscA, ErpA or IscU proteins of the Isc machinery had no detectable hydrogenase 1 or 2 activities. Lack of activity of both enzymes correlated with the absence of the respective [Fe-S]-cluster-containing small subunit, which was apparently rapidly degraded. During biosynthesis the hydrogenase large subunits receive their [NiFe] cofactor from the Hyp maturation machinery. Subsequent to cofactor insertion a specific C-terminal processing step occurs before association of the large subunit with the small subunit. This processing step is independent of small subunit maturation. Using western blotting experiments it could be shown that although the amount of each hydrogenase large subunit was strongly reduced in the iscA and erpA mutants, some maturation of the large subunit still occurred. Moreover, in contrast to the situation in Isc-proficient strains, these processed large subunits were not membrane-associated. Taken together, our findings demonstrate that both IscA and ErpA are required for [Fe-S] cluster delivery to the small subunits of the hydrogen-oxidizing hydrogenases; however, delivery of the Fe atom to the active site might have different requirements.	[Pinske, Constanze; Sawers, R. Gary] Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Pinske, C (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de	Pinske, Constanze/N-1302-2017	Pinske, Constanze/0000-0001-6248-2437	Deutsche Forschungsgemeinschaft [Sa 494/3-1548]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Sa 494/3-1548 from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; BEGG YA, 1977, FEMS MICROBIOL LETT, V2, P47, DOI 10.1111/j.1574-6968.1977.tb00905.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dubini A, 2002, INT J HYDROGEN ENERG, V27, P1413, DOI 10.1016/S0360-3199(02)00112-X; Eitinger T, 2000, ARCH MICROBIOL, V173, P1, DOI 10.1007/s002030050001; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; HORMANN K, 1989, ARCH MICROBIOL, V153, P50, DOI 10.1007/BF00277541; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Pinske C, 2012, J BACTERIOL IN PRESS; Pinske C, 2011, ARCH MICROBIOL, V193, P893, DOI 10.1007/s00203-011-0726-5; Pinske C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022830; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; ROSSMANN R, 1994, EUR J BIOCHEM, V220, P377, DOI 10.1111/j.1432-1033.1994.tb18634.x; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SAWERS RG, 1986, EUR J BIOCHEM, V156, P265, DOI 10.1111/j.1432-1033.1986.tb09577.x; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Sawers RG, 1994, ANTON LEEUW INT J G, V66, P57; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; Soboh B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-173; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	53	26	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31755	10.1371/journal.pone.0031755	http://dx.doi.org/10.1371/journal.pone.0031755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363723	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700091
J	Shaoul, E; Ayalon, A; Tal, Y; Lotan, T				Shaoul, Esther; Ayalon, Ari; Tal, Yossi; Lotan, Tamar			Transdermal Delivery of Scopolamine by Natural Submicron Injectors: In-Vivo Study in Pig	PLOS ONE			English	Article							DRUG-DELIVERY; POSTOPERATIVE NAUSEA; MOTION SICKNESS; PREVENTION; SKIN; PHARMACOKINETICS; MICRONEEDLES; PENETRATION; ATROPINE; SYSTEMS	Transdermal drug delivery has made a notable contribution to medical practice, but has yet to fully achieve its potential as an alternative to oral delivery and hypodermic injections. While transdermal delivery systems would appear to provide an attractive solution for local and systemic drug delivery, only a limited number of drugs can be delivered through the outer layer of the skin. The most difficult to deliver in this way are hydrophilic drugs. The aquatic phylum Cnidaria, which includes sea anemones, corals, jellyfish and hydra, is one of the most ancient multicellular phyla that possess stinging cells containing organelles (cnidocysts), comprising a sophisticated injection system. The apparatus is folded within collagenous microcapsules and upon activation injects a thin tubule that immediately penetrates the prey and delivers its contents. Here we show that this natural microscopic injection system can be adapted for systemic transdermal drug delivery once it is isolated from the cells and uploaded with the drug. Using a topically applied gel containing isolated natural sea anemone injectors and the muscarinic receptor antagonist scopolamine, we found that the formulated injectors could penetrate porcine skin and immediately deliver this hydrophilic drug. An in-vivo study in pigs demonstrated, for the first time, rapid systemic delivery of scopolamine, with T-max of 30 minutes and C-max 5 times higher than in controls treated topically with a scopolamine-containing gel without cnidocysts. The ability of the formulated natural injection system to penetrate a barrier as thick as the skin and systemically deliver an exogenous compound presents an intriguing and attractive alternative for hydrophilic transdermal drug delivery.	[Shaoul, Esther; Ayalon, Ari; Tal, Yossi] NanoCyte Israel Ltd, Caesarea, Israel; [Lotan, Tamar] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel	University of Haifa	Shaoul, E (corresponding author), NanoCyte Israel Ltd, Caesarea, Israel.	lotant@univ.haifa.ac.il		Lotan, Tamar/0000-0002-1679-4904				Apfel CC, 2010, CLIN THER, V32, P1987, DOI 10.1016/j.clinthera.2010.11.014; Ayalon A, 2011, INT J PHARMACEUT, V419, P147, DOI 10.1016/j.ijpharm.2011.07.042; Baroli B, 2010, J PHARM SCI-US, V99, P21, DOI 10.1002/jps.21817; Barry BW, 2004, NAT BIOTECHNOL, V22, P165, DOI 10.1038/nbt0204-165; Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Ceyhan T, 2001, J PHARMACEUT BIOMED, V25, P399, DOI 10.1016/S0731-7085(00)00514-8; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798; Elsayed MMA, 2007, INT J PHARMACEUT, V332, P1, DOI 10.1016/j.ijpharm.2006.12.005; Greenwood PG, 2003, COMP BIOCHEM PHYS A, V134, P275, DOI 10.1016/S1095-6433(02)00262-3; Gupta J, 2011, BIOMATERIALS, V32, P6823, DOI 10.1016/j.biomaterials.2011.05.061; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Kranke P, 2002, ANESTH ANALG, V95, P133, DOI 10.1097/00000539-200207000-00024; Lau OW, 1997, J CHROMATOGR A, V766, P270, DOI 10.1016/S0021-9673(96)01019-9; LOTAN A, 1995, NATURE, V375, P456, DOI 10.1038/375456a0; Lotan T, 2005, PERCUTANEOUS ABSORPT, P521; Lotan T, 2008, MODIFIED RELEASE DRU, P395; LUBBOCK R, 1981, NATURE, V290, P500, DOI 10.1038/290500a0; Nachum Z, 2001, J PHARMACOL EXP THER, V296, P121; Nachum Z, 2006, CLIN PHARMACOKINET, V45, P543, DOI 10.2165/00003088-200645060-00001; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Oertel R, 2001, J CHROMATOGR B, V750, P121, DOI 10.1016/S0378-4347(00)00433-3; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Park JH, 2010, EUR J PHARM BIOPHARM, V76, P282, DOI 10.1016/j.ejpb.2010.07.001; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Renner UD, 2005, THER DRUG MONIT, V27, P655, DOI 10.1097/01.ftd.0000168293.48226.57; Sherman CR, 2002, J TRAVEL MED, V9, P251; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Simon GA, 1998, SKIN PHARMACOL APPL, V11, P80, DOI 10.1159/000029812; Singh Thakur R R, 2011, Recent Pat Drug Deliv Formul, V5, P11; Sivamani RK, 2007, EXPERT OPIN DRUG DEL, V4, P19, DOI 10.1517/17425247.4.1.19; Spinks AB, 2007, COCHRANE DB SYST REV, V18; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Szczepanek S, 2002, J CELL SCI, V115, P745; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411	39	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31922	10.1371/journal.pone.0031922	http://dx.doi.org/10.1371/journal.pone.0031922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363770	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700124
J	Vas, V; Wandhoff, C; Dorr, K; Niebel, A; Geiger, H				Vas, Virag; Wandhoff, Corinna; Doerr, Karin; Niebel, Anja; Geiger, Hartmut			Contribution of an Aged Microenvironment to Aging-Associated Myeloproliferative Disease	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; ELDERLY-PATIENTS; AML1-ETO; NICHE; MICE; LEUKEMOGENESIS; MODEL; DEFICIENCY	The molecular and cellular mechanisms of the age-associated increase in the incidence of acute myeloid leukemia (AML) remain poorly understood. Multiple studies support that the bone marrow (BM) microenvironment has an important influence on leukemia progression. Given that the BM niche itself undergoes extensive functional changes during lifetime, we hypothesized that one mechanism for the age-associated increase in leukemia incidence might be that an aged niche promotes leukemia progression. The most frequent genetic alteration in AML is the t(8;21) translocation, resulting in the expression of the AML1-ETO fusion protein. Expression of the fusion protein in hematopoietic cells results in mice in a myeloproliferative disorder. Testing the role of the age of the niche on leukemia progression, we performed both transplantation and in vitro co-culture experiments. Aged animals transplanted with AML1-ETO positive HSCs presented with a significant increase in the frequency of AML-ETO positive early progenitor cells in BM as well as an increased immature myeloid cell load in blood compared to young recipients. These findings suggest that an aged BM microenvironment allows a relative better expansion of pre-leukemic stem and immature myeloid cells and thus imply that the aged microenvironment plays a role in the elevated incidence of age-associated leukemia.	[Vas, Virag; Wandhoff, Corinna; Doerr, Karin; Niebel, Anja; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Geiger, Hartmut] Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Vas, V (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	hartmut.geiger@uni-ulm.de	Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022	Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Vas, Virag/0000-0002-9722-8188	Deutsche Forschungsgemeinschaft [SFB497, TP10, KFO 142, GE2063/1]; National Institute of Health [HL076604, DK077762]; University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB497, TP10 and KFO 142, GE2063/1 and from the National Institute of Health, HL076604 and DK077762 to H.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tierforschungszentrum of the University of Ulm for supporting our animal work and Deidre Daria for experimental advice.	Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Deguchi K, 2002, LEUKEMIA, V16, P740, DOI 10.1038/sj.leu.2402500; Fenske TS, 2004, P NATL ACAD SCI USA, V101, P15184, DOI 10.1073/pnas.0400751101; Freemont AJ, 2007, J PATHOL, V211, P252, DOI 10.1002/path.2097; Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Greaves M, 2009, HEMATOL-AM SOC HEMAT, P3, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.3; Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351; Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lee Kyoo-Hyung, 1996, Journal of Korean Medical Science, V11, P222; Legrand O, 2000, BLOOD, V96, P870, DOI 10.1182/blood.V96.3.870.015k16_870_877; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nannya Y, 2002, LEUKEMIA LYMPHOMA, V43, P83, DOI 10.1080/10428190210204; Niebuhr B, 2008, BLOOD CELL MOL DIS, V40, P211, DOI 10.1016/j.bcmd.2007.07.018; Nimer SD, 2004, ONCOGENE, V23, P4249, DOI 10.1038/sj.onc.1207673; NOWELL PC, 1977, AM J PATHOL, V89, P459; Plesa C, 2008, CANCER-AM CANCER SOC, V112, P572, DOI 10.1002/cncr.23219; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401; Singbrant S, 2011, J CELL BIOCHEM, V112, P1486, DOI 10.1002/jcb.23085; Suarez L, 2005, HAEMATOLOGICA, V90, P54; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Woolthuis CM, 2011, CURR OPIN IMMUNOL	46	44	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31523	10.1371/journal.pone.0031523	http://dx.doi.org/10.1371/journal.pone.0031523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363661	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700065
J	Zhao, SM; Zhao, Y; Mao, FF; Zhang, CQ; Bai, B; Zhang, H; Shi, CH; Xu, ZK				Zhao, Shanmin; Zhao, Yong; Mao, Fengfeng; Zhang, Caiqin; Bai, Bing; Zhang, Hai; Shi, Changhong; Xu, Zhikai			Protective and Therapeutic Efficacy of Mycobacterium smegmatis Expressing HBHA-hIL12 Fusion Protein against Mycobacterium tuberculosis in Mice	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; CALMETTE-GUERIN VACCINATION; REGULATORY T-CELLS; DNA VACCINES; PHAGOSOME MATURATION; LATENT INFECTION; IMMUNE-RESPONSES; BCG VACCINATION; ACTIVE DISEASE; CHEMOTHERAPY	Tuberculosis (TB) remains a major worldwide health problem. The only vaccine against TB, Mycobacterium bovis Bacille Calmette-Guerin (BCG), has demonstrated relatively low efficacy and does not provide satisfactory protection against the disease. More efficient vaccines and improved therapies are urgently needed to decrease the worldwide spread and burden of TB, and use of a viable, metabolizing mycobacteria vaccine may be a promising strategy against the disease. Here, we constructed a recombinant Mycobacterium smegmatis (rMS) strain expressing a fusion protein of heparin-binding hemagglutinin (HBHA) and human interleukin 12 (hIL-12). Immune responses induced by the rMS in mice and protection against Mycobacterium tuberculosis (MTB) were investigated. Administration of this novel rMS enhanced Th1-type cellular responses (IFN-gamma and IL-2) in mice and reduced bacterial burden in lungs as well as that achieved by BCG vaccination. Meanwhile, the bacteria load in M. tuberculosis infected mice treated with the rMS vaccine also was significantly reduced. In conclusion, the rMS strain expressing the HBHA and human IL-12 fusion protein enhanced immunogencity by improving the Th1-type response against TB, and the protective effect was equivalent to that of the conventional BCG vaccine in mice. Furthermore, it could decrease bacterial load and alleviate histopathological damage in lungs of M. tuberculosis infected mice.	[Zhao, Shanmin; Zhao, Yong; Mao, Fengfeng; Zhang, Caiqin; Bai, Bing; Zhang, Hai; Shi, Changhong] Fourth Mil Med Univ, Lab Anim Ctr, Div Infect & Immunol, Xian 710032, Shaanxi, Peoples R China; [Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhao, SM (corresponding author), Fourth Mil Med Univ, Lab Anim Ctr, Div Infect & Immunol, Xian 710032, Shaanxi, Peoples R China.	changhong@fmmu.edu.cn	, 毛峰峰/AAQ-8349-2020		National Natural Science Foundation of China [30972767]; High Technology Research Project of Shaanxi Province [2007AA02Z473]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research Project of Shaanxi Province	This work was supported by the National Natural Science Foundation of China (No. 30972767) and the High Technology Research Project of Shaanxi Province (2007AA02Z473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Esposito C, 2011, BIOCHEM BIOPH RES CO, V410, P339, DOI 10.1016/j.bbrc.2011.05.159; Fine P., 1999, ISSUES RELATING USE; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Ha SJ, 2005, GENE THER, V12, P634, DOI 10.1038/sj.gt.3302465; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hovav AH, 2007, J VIROL, V81, P74, DOI 10.1128/JVI.01269-06; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Ildiko F, 2011, ACTA MICROBIOL IMM H, V58, P13, DOI 10.1556/AMicr.58.2011.1.2; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Li ZM, 1999, INFECT IMMUN, V67, P4780, DOI 10.1128/IAI.67.9.4780-4786.1999; Lindsey DR, 2009, TUBERCULOSIS, V89, pS46, DOI 10.1016/S1472-9792(09)70011-3; Lowrie DB, 2006, VACCINE, V24, P1983, DOI 10.1016/j.vaccine.2005.11.010; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; Nolan ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013773; Okada M, 2011, HUM VACCINES, V7, P60, DOI 10.4161/hv.7.0.14563; ORME IM, 1988, J IMMUNOL, V140, P3589; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Post FA, 2001, INFECT IMMUN, V69, P1433, DOI 10.1128/IAI.69.3.1433-1439.2001; Repique CJ, 2002, INFECT IMMUN, V70, P3318, DOI 10.1128/IAI.70.7.3318-3323.2002; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shi CH, 2009, TUBERCULOSIS, V89, P54, DOI 10.1016/j.tube.2008.09.005; Silva CL, 2005, GENE THER, V12, P281, DOI 10.1038/sj.gt.3302418; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Takayanagi K, 2011, JPN J INFECT DIS, V64, P133; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Thom M, 2008, TUBERCULOSIS, V88, P324, DOI 10.1016/j.tube.2007.12.002; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Xu ZW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-34; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037; Zhang H, 2010, SCAND J IMMUNOL, V72, P349, DOI 10.1111/j.1365-3083.2010.02448.x	46	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31908	10.1371/journal.pone.0031908	http://dx.doi.org/10.1371/journal.pone.0031908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363768	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700122
J	Jing, XF; Miwa, H; Sawada, T; Nakanishi, I; Kondo, T; Miyajima, M; Sakaguchi, K				Jing, Xuefeng; Miwa, Hideto; Sawada, Takahiro; Nakanishi, Ichiro; Kondo, Tomoyoshi; Miyajima, Masayasu; Sakaguchi, Kazushige			Ephrin-A1-Mediated Dopaminergic Neurogenesis and Angiogenesis in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NEURAL STEM-CELLS; NUCLEOTIDE EXCHANGE FACTOR; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; EPHA RECEPTOR; DIVERSE REGIONS; PRECURSOR CELLS; PROLIFERATION	Cells of the neural stem cell lineage in the adult subventricular zone (SVZ) respond to brain insult by increasing their numbers and migrating through the rostral migratory stream. However, in most areas of the brain other than the SVZ and the subgranular zone of the dentate gyrus, such a regenerative response is extremely weak. Even these two neurogenic regions do not show extensive regenerative responses to repair tissue damage, suggesting the presence of an intrinsic inhibitory microenvironment (niche) for stem cells. In the present study, we assessed the effects of injection of clustered ephrin-A1-Fc into the lateral ventricle of rats with unilateral nigrostriatal dopamine depletion. Ephrin-A1-Fc clustered by anti-IgG(Fc) antibody was injected stereotaxically into the ipsilateral lateral ventricle of rats with unilateral nigrostriatal lesions induced by 6-hydroxydopamine, and histologic analysis and behavioral tests were performed. Clustered ephrin-A1-Fc transformed the subventricular niche, increasing bromodeoxyuridine-positive cells in the subventricular area, and the cells then migrated to the striatum and differentiated to dopaminergic neurons and astrocytes. In addition, clustered ephrin-A1-Fc enhanced angiogenesis in the striatum on the injected side. Along with histologic improvements, behavioral derangement improved dramatically. These findings indicate that the subventricular niche possesses a mechanism for regulating both stem cell and angiogenic responses via an EphA-mediated signal. We conclude that activation of EphA receptor-mediated signaling by clustered ephrin-A1-Fc from within the lateral ventricle could potentially be utilized in the treatment of neurodegenerative diseases such as Parkinson's disease.	[Jing, Xuefeng; Sawada, Takahiro; Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Miwa, Hideto; Nakanishi, Ichiro; Kondo, Tomoyoshi] Wakayama Med Univ, Dept Neurol, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Jing, XF (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan.	ksaka@wakayama-med.ac.jp			Japan Society for the Promotion of Science [19300132]; Wakayama Medical University; CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wakayama Medical University; CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan	This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [project # 19300132 to K. S.]; by a Research Grant on Priority Areas from the Wakayama Medical University [to K. S.]; and by the Research Committee of CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan [to T. K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; BRIGHTMA.MW, 1965, J CELL BIOL, V26, P99, DOI 10.1083/jcb.26.1.99; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Grothe C, 2007, BRAIN RES REV, V54, P80, DOI 10.1016/j.brainresrev.2006.12.001; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu BF, 2006, BRAIN RES, V1106, P30, DOI 10.1016/j.brainres.2006.05.111; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	57	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32019	10.1371/journal.pone.0032019	http://dx.doi.org/10.1371/journal.pone.0032019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363788	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500105
J	Zhang, G; Schetter, A; He, PJ; Funamizu, N; Gaedcke, J; Ghadimi, BM; Ried, T; Hassan, R; Yfantis, HG; Lee, DH; Lacy, C; Maitra, A; Hanna, N; Alexander, HR; Hussain, SP				Zhang, Geng; Schetter, Aaron; He, Peijun; Funamizu, Naotake; Gaedcke, Jochen; Ghadimi, B. Michael; Ried, Thomas; Hassan, Raffit; Yfantis, Harris G.; Lee, Dong H.; Lacy, Curtis; Maitra, Anirban; Hanna, Nader; Alexander, H. Richard; Hussain, S. Perwez			DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							COPY-NUMBER; CANCER; EXPRESSION; GEMCITABINE; MARKERS	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. To identify biologically relevant genes with prognostic and therapeutic significance in PDAC, we first performed the microarray gene-expression profiling in 45 matching pairs of tumor and adjacent non-tumor tissues from resected PDAC cases. We identified 36 genes that were associated with patient outcome and also differentially expressed in tumors as compared with adjacent non-tumor tissues in microarray analysis. Further evaluation in an independent validation cohort (N=27) confirmed that DPEP1 (dipeptidase 1) expression was decreased (T: N ratio similar to 0.1, P < 0.01) in tumors as compared with non-tumor tissues. DPEP1 gene expression was negatively correlated with histological grade (Spearman correlation coefficient = -0.35, P=0.004). Lower expression of DPEP1 in tumors was associated with poor survival (Kaplan Meier log rank) in both test cohort (P=0.035) and validation cohort (P=0.016). DPEP1 expression was independently associated with cancer-specific mortality when adjusted for tumor stage and resection margin status in both univariate (hazard ratio=0.43, 95%CI=0.24-0.76, P=0.004) and multivariate analyses (hazard ratio=0.51, 95%CI=0.27-0.94, P=0.032). We further demonstrated that overexpression of DPEP1 suppressed tumor cells invasiveness and increased sensitivity to chemotherapeutic agent Gemcitabine. Our data also showed that growth factor EGF treatment decreased DPEP1 expression and MEK1/2 inhibitor AZD6244 increased DPEP1 expression in vitro, indicating a potential mechanism for DPEP1 gene regulation. Therefore, we provide evidence that DPEP1 plays a role in pancreatic cancer aggressiveness and predicts outcome in patients with resected PDAC. In view of these findings, we propose that DPEP1 may be a candidate target in PDAC for designing improved treatments.	[Zhang, Geng; Schetter, Aaron; He, Peijun; Funamizu, Naotake; Lacy, Curtis; Hussain, S. Perwez] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gaedcke, Jochen; Ghadimi, B. Michael] Univ Med, Dept Gen & Visceral Surg, Gottingen, Germany; [Ried, Thomas] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Hassan, Raffit] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Yfantis, Harris G.; Lee, Dong H.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Hanna, Nader; Alexander, H. Richard] Univ Maryland, Dept Surg, Div Surg Oncol, Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Hanna, Nader; Alexander, H. Richard] Univ Maryland, Sch Med, Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, G (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	hussainp@mail.nih.gov		Hussain, S. Perwez/0000-0002-2294-522X	National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZIABC010816, ZIABC010833, ZIABC011162] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 2000, PATHOLOGY GENETICS T; AUSTRUY E, 1993, CANCER RES, V53, P2888; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Campagna D, 2008, INT J CLIN EXP PATHO, V1, P32; Collisson EA, 2011, NAT MED; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fukushige S, 1997, GENE CHROMOSOME CANC, V19, P161, DOI 10.1002/(SICI)1098-2264(199707)19:3<161::AID-GCC5>3.0.CO;2-W; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Green AR, 2009, BREAST CANCER RES TR, V113, P59, DOI 10.1007/s10549-008-9905-8; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim HN, 2007, PANCREAS, V34, P325, DOI 10.1097/MPA.0b013e3180317b01; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Kolbert CP, 2008, TECHNOL CANCER RES T, V7, P55, DOI 10.1177/153303460800700107; Lopez-Casas PP, 2010, EXPERT REV MOL DIAGN, V10, P591, DOI 10.1586/ERM.10.43; Mahalingam D, 2009, EXPERT OPIN EMERG DR, V14, P311, DOI 10.1517/14728210902972502; McIver CM, 2004, CANCER LETT, V209, P67, DOI 10.1016/j.canlet.2003.11.033; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okamoto T, 2011, MODERN PATHOL, V24, P267, DOI 10.1038/modpathol.2010.204; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Toiyama Y, 2011, J GASTROENTEROL, V46, P153, DOI 10.1007/s00535-010-0318-1; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Yeh JJ, 2009, FUTURE ONCOL, V5, P313, DOI [10.2217/fon.09.12, 10.2217/FON.09.12]	26	131	136	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31507	10.1371/journal.pone.0031507	http://dx.doi.org/10.1371/journal.pone.0031507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363658	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500049
J	Hasler, R; Jacobs, G; Till, A; Grabe, N; Cordes, C; Nikolaus, S; Lao, KQ; Schreiber, S; Rosenstiel, P				Haesler, Robert; Jacobs, Gunnar; Till, Andreas; Grabe, Nils; Cordes, Christian; Nikolaus, Susanna; Lao, Kaiqin; Schreiber, Stefan; Rosenstiel, Philip			Microbial Pattern Recognition Causes Distinct Functional Micro-RNA Signatures in Primary Human Monocytes	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VIVO; METASTASIS; THOUSANDS; MIRBASE; PCR	Micro-RNAs (miRNAs) are short, non-coding RNAs that regulate gene expression post transcriptionally. Several studies have demonstrated the relevance of miRNAs for a wide range of cellular mechanisms, however, the current knowledge on how miRNAs respond to relevant external stimuli, e. g. in disease scenarios is very limited. To generate a descriptive picture of the miRNA network associated to inflammatory responses, we quantified the levels of 330 miRNAs upon stimulation with a panel of pro-inflammatory components such as microbial pattern molecules (flagellin, diacylated lipopeptide lipopolysaccharide, muramyl dipeptide), infection with Listeria monocytogenes and TNF-alpha as pro-inflammatory control in primary human monocytes using real time PCR. As a result, we found distinct miRNA response clusters for each stimulus used. Additionally, we identified potential target genes of three selected miRNAs miR-129-5p, miR-146a and miR-378 which were part of PAMP-specific response clusters by transfecting THP1 monocytes with the corresponding pre- or anti-miRNAs and microfluidic PCR arrays. The miRNAs induced distinct transcriptomal signatures, e. g. overexpression of miRNA129-5p, which was selectively upregulated by the NOD2-elicitor MDP, led to an upregulation of DEFB1, IRAK1, FBXW7 and IKK gamma (Nemo). Our findings on highly co-regulated clusters of miRNAs support the hypothesis that miRNAs act in functional groups. This study indicates that miRNAs play an important role in fine-tuning inflammatory mechanisms. Further investigation in the field of miRNA responses will help to understand their effects on gene expression and may close the regulatory gap between mRNA and protein expression in inflammatory diseases.	[Haesler, Robert; Jacobs, Gunnar; Till, Andreas; Grabe, Nils; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Schleswig Holst, Germany; [Cordes, Christian; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Otorhinolaryngol Head & Neck, Kiel, Schleswig Holst, Germany; [Nikolaus, Susanna] Univ Hosp Schleswig Holstein, Dept Med 1, Kiel, Schleswig Holst, Germany; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA USA	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Thermo Fisher Scientific; Applied Biosystems	Hasler, R (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Schleswig Holst, Germany.	p.rosenstiel@mucosa.de	Xie, Huangming/B-2260-2012; Häsler, Robert/A-4908-2009; Till, Andreas/E-9661-2013; Till, Andreas/AAO-6375-2021; Rosenstiel, Philip/A-5137-2009	Häsler, Robert/0000-0003-4174-8229; Till, Andreas/0000-0002-0139-9143; Rosenstiel, Philip/0000-0002-9692-8828	Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung); Deutsche Forschungsgemeinschaft [SFB 415]	Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung, www.bmbf.de) and by the SFB 415 "Specificity and Pathophysiology of Pathways'' (Deutsche Forschungsgemeinschaft, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Nahid MA, 2009, J BIOL CHEM; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Saunders MA, 2009, RNA BIOL, V6, P324, DOI 10.4161/rna.6.3.8871; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Waldman SA, 2009, FEBS J, V276, P2157, DOI 10.1111/j.1742-4658.2009.06934.x; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Westfall PH, 1993, RESAMPLING BASED MUL, V1; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707	42	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31151	10.1371/journal.pone.0031151	http://dx.doi.org/10.1371/journal.pone.0031151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363568	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600117
J	Todd, KJ; Lan-Chow-Wing, N; Salin-Cantegrel, A; Cotter, A; Zagami, CJ; Lo, R; Stifani, S				Todd, Keith J.; Lan-Chow-Wing, Nathalie; Salin-Cantegrel, Adele; Cotter, Anthony; Zagami, Chrissandra J.; Lo, Rita; Stifani, Stefano			Establishment of Motor Neuron-V3 Interneuron Progenitor Domain Boundary in Ventral Spinal Cord Requires Groucho-Mediated Transcriptional Corepression	PLOS ONE			English	Article							NEURAL-TUBE; HOMEODOMAIN PROTEIN; NERVOUS-SYSTEM; DIFFERENTIATION; IDENTITY; SPECIFICATION; EXPRESSION; REPRESSION; FAMILY; INHIBITION	Background: Dorsoventral patterning of the developing spinal cord is important for the correct generation of spinal neuronal types. This process relies in part on cross-repressive interactions between specific transcription factors whose expression is regulated by Sonic hedgehog. Groucho/transducin-like Enhancer of split (TLE) proteins are transcriptional corepressors suggested to be recruited by at least certain Sonic hedgehog-controlled transcription factors to mediate the formation of spatially distinct progenitor domains within the ventral spinal cord. The aim of this study was to characterize the involvement of TLE in mechanisms regulating the establishment of the boundary between the most ventral spinal cord progenitor domains, termed pMN and p3. Because the pMN domain gives rise to somatic motor neurons while the p3 domain generates V3 interneurons, we also examined the involvement of TLE in the acquisition of these neuronal fates. Methodology and Principal Findings: A combination of in vivo loss- and gain-of-function studies in the developing chick spinal cord was performed to characterize the role of TLE in ventral progenitor domain formation. It is shown here that TLE overexpression causes increased numbers of p3 progenitors and promotes the V3 interneuron fate while suppressing the motor neuron fate. Conversely, dominant-inhibition of TLE increases the numbers of pMN progenitors and postmitotic motor neurons. Conclusion: Based on these results, we propose that TLE is important to promote the formation of the p3 domain and subsequent generation of V3 interneurons.	[Todd, Keith J.; Lan-Chow-Wing, Nathalie; Salin-Cantegrel, Adele; Cotter, Anthony; Zagami, Chrissandra J.; Lo, Rita; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Todd, KJ (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-84577, MOP-42479]; Fonds de la Recherche en Sante du Quebec (FRSQ); Chercheur National of the FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Chercheur National of the FRSQ	This research was supported by grants from the Canadian Institutes of Health Research-Operating Grants to S. S. (MOP-84577 and MOP-42479). K.J.T. was supported by a Fonds de la Recherche en Sante du Quebec (FRSQ) Postdoctoral Training Award and S. S. was a Chercheur National of the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zhuang BQ, 2006, CURR OPIN NEUROBIOL, V16, P20, DOI 10.1016/j.conb.2005.11.001	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31176	10.1371/journal.pone.0031176	http://dx.doi.org/10.1371/journal.pone.0031176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363571	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600119
J	Gao, P; Xing, AY; Zhou, GY; Zhang, TG; Zhang, JP; Gao, C; Li, H; Shi, DB				Gao, P.; Xing, A-Y; Zhou, G-Y; Zhang, T-G; Zhang, J-P; Gao, C.; Li, H.; Shi, D-B			The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer	ONCOGENE			English	Article						gastric carcinoma; miR-145; metastasis; N-cadherin	N-CADHERIN; TUMOR-METASTASIS; BREAST-CANCER; CELL INVASION; COLON-CANCER; EXPRESSION; GROWTH; METALLOPROTEINASES; PROGRESSION; SIGNATURES	Invasion and metastasis are the major features of malignant tumors that are responsible for 90% of cancer-related deaths. Recently, microRNAs have been discovered to have a role in suppressing tumor metastasis. This study's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis. Here, we demonstrate a stepwise downregulation of miR-145 level in nontumorous gastric mucosa, primary gastric cancers-and their secondary metastases. In vitro analysis of miR-145's ectopic expression and loss-of-function suggests that it suppresses gastric cancer cell migration and invasion. In vivo spontaneous metastasis and experimental metastasis assay further confirm its function in suppressing the invasion-metastasis cascade, including impairing local invasion and inhibiting hematogenous metastasis in gastric cancers. Furthermore, we identified a novel mechanism of miR-145 to suppress metastasis. N-cadherin (CDH2) was proved to be a direct target of miR-145, using luciferase assay and western blot. Re-expressing N-cadherin in miR-145-transfected cells reverses their migration and invasion defects. Although not a direct target of miR-145, matrix metallopeptidase 9 (MMP9), but not MMP2, was also significantly decreased in miR-145-expressing cells. We suggest that miR-145 suppresses tumor metastasis by inhibiting N-cadherin protein translation, and then indirectly downregulates its downstream effector MMP9. Oncogene (2013) 32, 491-501; doi:10.1038/onc.2012.61; published online 27 February 2012	[Gao, P.; Xing, A-Y; Zhou, G-Y; Zhang, T-G; Zhang, J-P; Gao, C.] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Li, H.; Shi, D-B] Shandong Univ, Sch Med, Dept Pathol, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University	Gao, P (corresponding author), Shandong Univ, Qilu Hosp, Dept Pathol, Jinan Wen Hua Xi Rd 107, Jinan 250012, Shandong, Peoples R China.	gaopeng@sdu.edu.cn	邢, 爱艳/AAC-6576-2021		National Natural Science Foundation of China [30972929, 81172351]; Natural Science Foundation of Shandong Province of China [ZR2010HM075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (No. 30972929, 81172351) and the Natural Science Foundation of Shandong Province of China (No. ZR2010HM075). We thank Chun-Ming Wong and Irene Oi-Lin Ng of Department of Pathology, Li Ka Shing Faculty Medicine, University of Hong Kong for useful advice and discussion. Peng Gao was a Cheng Yu Tung Fellow at the University of Hong Kong. The study was approved by the Ethics Committee of Shandong University.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; de Krijger I, 2011, J PATHOL, V224, P438, DOI 10.1002/path.2922; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Desiderio MA, 2007, CELL MOL LIFE SCI, V64, P1341, DOI 10.1007/s00018-007-7050-x; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Parmo-Cabanas M, 2006, J PATHOL, V208, P108, DOI 10.1002/path.1876; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406	32	136	144	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 24	2013	32	4					491	501		10.1038/onc.2012.61	http://dx.doi.org/10.1038/onc.2012.61			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22370644				2022-12-25	WOS:000315551300010
J	Itoh, M; Tahimic, CGT; Ide, S; Otsuki, A; Sasaoka, T; Noguchi, S; Oshimura, M; Goto, Y; Kurimasa, A				Itoh, Masayuki; Tahimic, Candice G. T.; Ide, Shuhei; Otsuki, Akihiro; Sasaoka, Toshikuni; Noguchi, Shigeru; Oshimura, Mitsuo; Goto, Yu-ichi; Kurimasa, Akihiro			Methyl CpG-binding Protein Isoform MeCP2_e2 Is Dispensable for Rett Syndrome Phenotypes but Essential for Embryo Viability and Placenta Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME INACTIVATION PATTERNS; X-CHROMOSOME; IMPRINTED GENES; MOUSE; EXPRESSION; DEFICIENCY; MUTATION	Methyl CpG-binding protein 2 gene (MeCP2) mutations are implicated in Rett syndrome (RTT), one of the common causes of female mental retardation. Two MeCP2 isoforms have been reported: MeCP2_e2 (splicing of all four exons) and MeCP2_e1 (alternative splicing of exons 1, 3, and 4). Their relative expression levels vary among tissues, with MeCP2_e1 being more dominant in adult brain, whereas MeCP2_e2 is expressed more abundantly in placenta, liver, and skeletal muscle. In this study, we performed specific disruption of the MeCP2_e2-defining exon 2 using the Cre-loxP system and examined the consequences of selective loss of MeCP2_e2 function in vivo. We performed behavior evaluation, gene expression analysis, using RTPCR and real-time quantitative PCR, and histological analysis. We demonstrate that selective deletion of MeCP2_e2 does not result in RTT-associated neurological phenotypes but confers a survival disadvantage to embryos carrying a MeCP2_e2 null allele of maternal origin. In addition, we reveal a specific requirement for MeCP2_e2 function in extraembryonic tissue, where selective loss of MeCP2_e2 results in placenta defects and up-regulation of peg-1, as determined by the parental origin of the mutant allele. Taken together, our findings suggest a novel role for MeCP2 in normal placenta development and illustrate how paternal X chromosome inactivation in extraembryonic tissues confers a survival disadvantage for carriers of a mutant maternal MeCP2_e2 allele. Moreover, our findings provide an explanation for the absence of reports on MeCP2_e2-specific exon 2 mutations in RTT. MeCP2_e2 mutations in humans may result in a phenotype that evades a diagnosis of RTT.	[Itoh, Masayuki; Ide, Shuhei; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan; [Tahimic, Candice G. T.; Otsuki, Akihiro; Oshimura, Mitsuo; Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Yonago, Tottori 6838503, Japan; [Oshimura, Mitsuo; Kurimasa, Akihiro] Tottori Univ, Res Core Chromosome Engn Technol, 21st Century Ctr Excellence Program, Yonago, Tottori 6838503, Japan; [Sasaoka, Toshikuni] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 2520374, Japan; [Noguchi, Shigeru] Kanagawa Acad Sci & Technol, Signal Transduct Project, Kawasaki, Kanagawa 2130012, Japan	National Center for Neurology & Psychiatry - Japan; Tottori University; Tottori University; Kitasato University; Kanagawa Academy Science & Technology	Itoh, M (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	itoh@ncnp.go.jp	Otsuki, Akihiro/AAI-5904-2021; Otsuki, Akihiro/C-1179-2009; Otsuki, Akihiro/AAW-8479-2020; , 笹岡俊邦/N-9152-2015	Otsuki, Akihiro/0000-0001-9173-1148; , 笹岡俊邦/0000-0002-7797-4394; Tahimic, Candice/0000-0001-5862-2652	Ministries of Health, Labor, and Welfare [15B-3, 18A-3, H21-Nanchi-Ippan-110, H22-Nanchi-Ippan-133]; Ministries of Education, Culture, Science, Sports, and Technology of Japan [18390304]	Ministries of Health, Labor, and Welfare; Ministries of Education, Culture, Science, Sports, and Technology of Japan	This work was supported by Ministries of Health, Labor, and Welfare Grants 15B-3, 18A-3, H21-Nanchi-Ippan-110, and H22-Nanchi-Ippan-133 and by Ministries of Education, Culture, Science, Sports, and Technology	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Beechey CV, 2000, CYTOGENET CELL GENET, V90, P309, DOI 10.1159/000056794; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bourdon Violaine, 2003, Mol Diagn, V7, P3, DOI 10.2165/00066982-200307010-00002; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Coutinho-Camillo CM, 2003, DIAGN MOL PATHOL, V12, P57, DOI 10.1097/00019606-200303000-00008; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; Itoh M, 2007, J NEUROPATH EXP NEUR, V66, P117, DOI 10.1097/nen.0b013e3180302078; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Looijenga LHJ, 1999, AM J HUM GENET, V64, P1445, DOI 10.1086/302382; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Obata Y, 1998, DEVELOPMENT, V125, P1553; Rett A, 1966, Wien Med Wochenschr, V116, P723; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228	40	43	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13859	13867		10.1074/jbc.M111.309864	http://dx.doi.org/10.1074/jbc.M111.309864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375006	Green Published, hybrid			2022-12-25	WOS:000303996300041
J	Michikawa, M; Ichinose, H; Momma, M; Biely, P; Jongkees, S; Yoshida, M; Kotake, T; Tsumuraya, Y; Withers, SG; Fujimoto, Z; Kaneko, S				Michikawa, Mari; Ichinose, Hitomi; Momma, Mitsuru; Biely, Peter; Jongkees, Seino; Yoshida, Makoto; Kotake, Toshihisa; Tsumuraya, Yoichi; Withers, Stephen G.; Fujimoto, Zui; Kaneko, Satoshi			Structural and Biochemical Characterization of Glycoside Hydrolase Family 79 beta-Glucuronidase from Acidobacterium capsulatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE RESIDUES; ENZYMES; IDENTIFICATION; PURIFICATION; GLUCOSIDASE; HEPARANASE; MODULE; MODEL	We present the first structure of a glycoside hydrolase family 79 beta-glucuronidase from Acidobacterium capsulatum, both as a product complex with beta-D-glucuronic acid (GlcA) and as its trapped covalent 2-fluoroglucuronyl intermediate. This enzyme consists of a catalytic (beta/alpha)(8)-barrel domain and a beta-domain with irregular Greek key motifs that is of unknown function. The enzyme showed beta-glucuronidase activity and trace levels of beta-glucosidase and beta-xylosidase activities. In conjunction with mutagenesis studies, these structures identify the catalytic residues as Glu(173) (acid base) and Glu(287) (nucleophile), consistent with the retaining mechanism demonstrated by H-1 NMR analysis. Glu(45), Tyr(243), Tyr(292)-Gly(294), and Tyr(334) form the catalytic pocket and provide substrate discrimination. Consistent with this, the Y292A mutation, which affects the interaction between the main chains of Gln(293) and Gly(294) and the GlcA carboxyl group, resulted in significant loss of beta-glucuronidase activity while retaining the side activities at wild-type levels. Likewise, although the beta-glucuronidase activity of the Y334F mutant is similar to 200-fold lower (k(cat)/K-m) than that of the wild-type enzyme, the beta-glucosidase activity is actually 3 times higher and the beta-xylosidase activity is only 2.5-fold lower than the equivalent parameters for wild type, consistent with a role for Tyr(334) in recognition of the C6 position of GlcA. The involvement of Glu(45) in discriminating against binding of the O-methyl group at the C4 position of GlcA is revealed in the fact that the E45D mutant hydrolyzes PNP-beta-GlcA approximately 300-fold slower (k(cat)/K-m) than does the wild-type enzyme, whereas 4-O-methyl-GlcA-containing oligosaccharides are hydrolyzed only 7-fold slower.	[Momma, Mitsuru; Fujimoto, Zui] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Michikawa, Mari; Ichinose, Hitomi; Kaneko, Satoshi] Natl Agr & Food Res Org NARO, Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Biely, Peter] Slovak Acad Sci, Inst Chem, SK-84538 Bratislava 45, Slovakia; [Jongkees, Seino; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Fuchu, Tokyo 1838509, Japan; [Kotake, Toshihisa; Tsumuraya, Yoichi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan; Slovak Academy of Sciences; University of British Columbia; Tokyo University of Agriculture & Technology; Saitama University	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; sakaneko@affrc.go.jp	Jongkees, Seino A K/I-7722-2016; Biely, Peter/ABF-3465-2020; Yoshida, Makoto/E-8017-2013; KOTAKE, TOSHIHISA/F-1117-2011	Jongkees, Seino A K/0000-0002-4796-0557; Biely, Peter/0000-0002-9915-7707; KOTAKE, TOSHIHISA/0000-0002-1110-5006; Fujimoto, Zui/0000-0002-3551-6854	Natural Sciences and Engineering Research Council, Canada	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Natural Sciences and Engineering Research Council, Canada.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arul L, 2008, BIOINFORMATION, V3, P194, DOI 10.6026/97320630003194; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eudes A, 2008, PLANT CELL PHYSIOL, V49, P1331, DOI 10.1093/pcp/pcn108; Gandhi NS, 2012, GLYCOBIOLOGY, V22, P35, DOI 10.1093/glycob/cwr095; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Kuroyama H, 2001, CARBOHYD RES, V333, P27, DOI 10.1016/S0008-6215(01)00114-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Ritz K., 1994, BIOMASS COMPOSITIONA, P149; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1995, PROTEIN SCI, V4, P361	31	32	34	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14069	14077		10.1074/jbc.M112.346288	http://dx.doi.org/10.1074/jbc.M112.346288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367201	hybrid, Green Published			2022-12-25	WOS:000303996300060
J	Joe, MK; Kee, C; Tomarev, SI				Joe, Myung Kuk; Kee, Changwon; Tomarev, Stanislav I.			Myocilin Interacts with Syntrophins and Is Member of Dystrophin-associated Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; SKELETAL-MUSCLE ATROPHY; GLUCOCORTICOID-INDUCED MYOPATHY; GLYCOPROTEIN COMPLEX; TRANSCRIPTION FACTORS; GENE-EXPRESSION; TRANSGENIC MICE; MUTATED MOUSE; NON-SECRETION	Genetic studies have linked myocilin to open angle glaucoma, but the functions of the protein in the eye and other tissues have remained elusive. The purpose of this investigation was to elucidate myocilin function(s). We identified alpha 1-syntrophin, a component of the dystrophin-associated protein complex (DAPC), as a myocilin-binding candidate. Myocilin interacted with alpha 1-syntrophin via its N-terminal domain and co-immunoprecipitated with alpha 1-syntrophin from C2C12 myotubes and mouse skeletal muscle. Expression of 15-fold higher levels of myocilin in the muscles of transgenic mice led to the elevated association of alpha 1-syntrophin, neuronal nitric-oxide synthase, and alpha-dystroglycan with DAPC, which increased the binding of laminin to alpha-dystroglycan and Akt signaling. Phosphorylation of Akt and Forkhead box O-class 3, key regulators of muscle size, was increased more than 3-fold, whereas the expression of muscle-specific RING finger protein-1 and atrogin-1, muscle atrophy markers, was decreased by 79 and 88%, respectively, in the muscles of transgenic mice. Consequently, the average size of muscle fibers of the transgenic mice was increased by 36% relative to controls. We suggest that intracellular myocilin plays a role as a regulator of muscle hypertrophy pathways, acting through the components of DAPC.	[Joe, Myung Kuk; Tomarev, Stanislav I.] NEI, Retinal Gangl Cell Biol Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul 135710, South Korea	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sungkyunkwan University (SKKU); Samsung Medical Center	Tomarev, SI (corresponding author), NEI, Retinal Gangl Cell Biol Sect, Lab Retinal Cell & Mol Biol, NIH, Bldg 6,Rm 212A,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov		Kee, Changwon/0000-0002-7419-0316	National Institutes of Health, NEI; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bunnell TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002604; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Carraro L, 2009, PHYSIOL GENOMICS, V38, P138, DOI 10.1152/physiolgenomics.00014.2009; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Glass DJ, 2005, CANCER CELL, V8, P351, DOI 10.1016/j.ccr.2005.10.016; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hasselgren PO, 2010, CURR OPIN CLIN NUTR, V13, P423, DOI 10.1097/MCO.0b013e32833a5107; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015355; Komamura K, 2003, CARDIOVASC DRUG THER, V17, P303, DOI 10.1023/A:1027352703783; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Nakamori M, 2008, NEUROLOGY, V70, P677, DOI 10.1212/01.wnl.0000302174.08951.cf; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Resch ZT, 2010, EXP EYE RES, V91, P901, DOI 10.1016/j.exer.2010.09.017; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Sohn S, 2002, INVEST OPHTH VIS SCI, V43, P3680; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Wakayama Y, 2006, HISTOL HISTOPATHOL, V21, P23, DOI 10.14670/HH-21.23; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wu Y, 2010, ENDOCRINOLOGY, V151, P1050, DOI 10.1210/en.2009-0530; Xiong YM, 2009, J CELL PHYSIOL, V219, P402, DOI 10.1002/jcp.21684; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339	66	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13216	13227		10.1074/jbc.M111.224063	http://dx.doi.org/10.1074/jbc.M111.224063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371502	hybrid, Green Published			2022-12-25	WOS:000302903700059
J	Wilson, ZN; Gilroy, CA; Boitz, JM; Ullman, B; Yates, PA				Wilson, Zachary N.; Gilroy, Caslin A.; Boitz, Jan M.; Ullman, Buddy; Yates, Phillip A.			Genetic Dissection of Pyrimidine Biosynthesis and Salvage in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; DIHYDROFOLATE REDUCTASE; TOXOPLASMA-GONDII; IN-VITRO; DIHYDROOROTATE DEHYDROGENASE; NUCLEOSIDE HYDROLASE; TARGETING CONSTRUCTS; THYMIDYLATE SYNTHASE; PURINE SALVAGE; MAMMALIAN HOST	Protozoan parasites of the Leishmania genus express the metabolic machinery to synthesize pyrimidine nucleotides via both de novo and salvage pathways. To evaluate the relative contributions of pyrimidine biosynthesis and salvage to pyrimidine homeostasis in both life cycle stages of Leishmania donovani, individual mutant lines deficient in either carbamoyl phosphate synthetase (CPS), the first enzyme in pyrimidine biosynthesis, uracil phosphoribosyltransferase (UPRT), a salvage enzyme, or both CPS and UPRT were constructed. The Delta cps lesion conferred pyrimidine auxotrophy and a growth requirement for medium supplementation with one of a plethora of pyrimidine nucleosides or nucleobases, although only dihydroorotate or orotate could circumvent the pyrimidine auxotrophy of the Delta cps/Delta uprt double knockout. The Delta uprt null mutant was prototrophic for pyrimidines but could not salvage uracil or any pyrimidine nucleoside. The capability of the Delta cps parasites to infect mice was somewhat diminished but still robust, indicating active pyrimidine salvage by the amastigote form of the parasite, but the Delta cps/Delta uprt mutant was completely attenuated with no persistent parasites detected after a 4-week infection. Complementation of the Delta cps/Delta uprt clone with either CPS or UPRT restored infectivity. These data establish that an intact pyrimidine biosynthesis pathway is essential for the growth of the promastigote form of L. donovani in culture, that all uracil and pyrimidine nucleoside salvage in the parasite is mediated by UPRT, and that both the biosynthetic and salvage pathways contribute to a robust infection of the mammalian host by the amastigote. These findings impact potential therapeutic design and vaccine strategies for visceral leishmaniasis.	[Wilson, Zachary N.; Gilroy, Caslin A.; Boitz, Jan M.; Ullman, Buddy; Yates, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Yates, PA (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	yatesp@ohsu.edu		Wilson, Zachary/0000-0003-4269-4058	National Institutes of Health, NIAID [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023682, R37AI023682] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI023682.	Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Breton M, 2005, INFECT IMMUN, V73, P6372, DOI 10.1128/IAI.73.10.6372-6382.2005; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FAURE M, 1989, EUR J BIOCHEM, V179, P345, DOI 10.1111/j.1432-1033.1989.tb14560.x; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; FREUND JN, 1987, J MOL BIOL, V193, P1, DOI 10.1016/0022-2836(87)90621-8; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; HAMMOND DJ, 1980, FEBS LETT, V118, P259, DOI 10.1016/0014-5793(80)80233-X; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; IOVANNISCI DM, 1984, MOL CELL BIOL, V4, P1013, DOI 10.1128/MCB.4.6.1013; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; IVANETICH KM, 1990, FASEB J, V4, P1591, DOI 10.1096/fasebj.4.6.2180768; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Nara T, 1998, BBA-PROTEIN STRUCT M, V1387, P462, DOI 10.1016/S0167-4838(98)00127-7; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; OPPERDOES FR, 1988, TRENDS BIOCHEM SCI, V13, P255, DOI 10.1016/0968-0004(88)90158-2; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; PFEFFERKORN ER, 1977, J PROTOZOOL, V24, P449, DOI 10.1111/j.1550-7408.1977.tb04774.x; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; SCHNEIDE.EL, 1974, EXP CELL RES, V84, P311, DOI 10.1016/0014-4827(74)90411-X; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; WAHL GM, 1979, J BIOL CHEM, V254, P8679	58	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12759	12770		10.1074/jbc.M112.346502	http://dx.doi.org/10.1074/jbc.M112.346502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367196	Green Published, hybrid			2022-12-25	WOS:000302903700015
J	Haas, S; Jahnke, HG; Moerbt, N; von Bergen, M; Aharinejad, S; Andrukhova, O; Robitzki, AA				Haas, Sina; Jahnke, Heinz-Georg; Moerbt, Nora; von Bergen, Martin; Aharinejad, Seyedhossein; Andrukhova, Olena; Robitzki, Andrea A.			DIGE Proteome Analysis Reveals Suitability of Ischemic Cardiac In Vitro Model for Studying Cellular Response to Acute Ischemia and Regeneration	PLOS ONE			English	Article							OXIDATIVE STRESS; HEART-FAILURE; REPERFUSION INJURY; ENERGY-METABOLISM; APOPTOSIS; CELLS; CARDIOMYOCYTES; VIVO; TRANSPLANTATION; NUCLEOPHOSMIN	Proteomic analysis of myocardial tissue from patient population is suited to yield insights into cellular and molecular mechanisms taking place in cardiovascular diseases. However, it has been limited by small sized biopsies and complicated by high variances between patients. Therefore, there is a high demand for suitable model systems with the capability to simulate ischemic and cardiotoxic effects in vitro, under defined conditions. In this context, we established an in vitro ischemia/reperfusion cardiac disease model based on the contractile HL-1 cell line. To identify pathways involved in the cellular alterations induced by ischemia and thereby defining disease-specific biomarkers and potential target structures for new drug candidates we used fluorescence 2D-difference gel electrophoresis. By comparing spot density changes in ischemic and reperfusion samples we detected several protein spots that were differentially abundant. Using MALDI-TOF/TOF-MS and ESI-MS the proteins were identified and subsequently grouped by functionality. Most prominent were changes in apoptosis signalling, cell structure and energy-metabolism. Alterations were confirmed by analysis of human biopsies from patients with ischemic cardiomyopathy. With the establishment of our in vitro disease model for ischemia injury target identification via proteomic research becomes independent from rare human material and will create new possibilities in cardiac research.	[Haas, Sina; Jahnke, Heinz-Georg; Robitzki, Andrea A.] Univ Leipzig, Ctr Biotechnol & Biomed, Div Mol Biol Biochem Proc Technol, Leipzig, Germany; [Moerbt, Nora; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, Leipzig, Germany; [von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany; [Aharinejad, Seyedhossein] Med Univ Vienna, Dept Cardiac Surg, Ctr Anat & Cell Biol, Vienna, Austria; [Aharinejad, Seyedhossein; Andrukhova, Olena] Med Univ Vienna, Dept Cardiovasc Res, Ctr Anat & Cell Biol, Vienna, Austria; [Andrukhova, Olena] Univ Vet Med, Inst Pathophysiol, Dept Biomed Sci, Vienna, Austria	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna	Haas, S (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed, Div Mol Biol Biochem Proc Technol, Leipzig, Germany.	andrea.robitzki@bbz.uni-leipzig.de	von Bergen, Martin/D-7960-2011	von Bergen, Martin/0000-0003-2732-2977; Jahnke, Heinz-Georg/0000-0001-6615-7092	European Union [CWB 266753]; BuildMoNa Graduate School of Leipzig	European Union(European Commission); BuildMoNa Graduate School of Leipzig	This work was funded by the European Union (FP6, Project: CWB 266753) and the BuildMoNa Graduate School of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2007, AM J TRANSPLANT, V7, P2012, DOI 10.1111/j.1600-6143.2007.01875.x; Aharinejad S, 2001, TRANSPLANTATION, V72, P1043, DOI 10.1097/00007890-200109270-00011; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Anversa P, 1998, BASIC RES CARDIOL, V93, P8; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Bansal A, 2010, J PROTEOMICS, V73, P2041, DOI 10.1016/j.jprot.2010.06.009; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Brscic E, 2000, AM HEART J, V139, P979, DOI 10.1067/mhj.2000.106165; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; COSTANZO MR, 1995, CIRCULATION, V92, P3593, DOI 10.1161/01.CIR.92.12.3593; De Celle T, 2004, EXP PHYSIOL, V89, P605, DOI 10.1113/expphysiol.2004.027649; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; DRIEDZIC WR, 1994, PHYSIOL REV, V74, P221, DOI 10.1152/physrev.1994.74.1.221; Feuerstein GZ, 1999, CARDIOVASC DRUG THER, V13, P289, DOI 10.1023/A:1007735413477; FLAHERTY JT, 1988, FREE RADICAL BIO MED, V5, P409, DOI 10.1016/0891-5849(88)90115-3; FOWLER NO, 1976, AM J CARDIOL, V37, P223, DOI 10.1016/0002-9149(76)90316-7; GANOTE C, 1993, CARDIOVASC RES, V27, P1387, DOI 10.1093/cvr/27.8.1387; Gu L, 2008, LEUKEMIA, V22, P2091, DOI 10.1038/leu.2008.204; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Inserte J, 2000, AM J PHYSIOL-HEART C, V278, pH94, DOI 10.1152/ajpheart.2000.278.1.H94; Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64; Karwatowska-Prokopczuk E, 1998, CIRC RES, V82, P1139, DOI 10.1161/01.RES.82.11.1139; Kim KS, 2002, BIOCHIMIE, V84, P625, DOI 10.1016/S0300-9084(02)01435-9; Krinke D, 2009, BIOSENS BIOELECTRON, V24, P2798, DOI 10.1016/j.bios.2009.02.006; Lainscak M, 2009, HERZ, V34, P589, DOI 10.1007/s00059-009-3316-4; Liang BT, 1998, P NATL ACAD SCI USA, V95, P6995, DOI 10.1073/pnas.95.12.6995; McGregor E, 2003, HUM MOL GENET, V12, pR135, DOI 10.1093/hmg/ddg278; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; Muscari A, 1995, Cardiologia, V40, P507; Olivetti, 1997, Adv Clin Path, V1, P137; Sakai J, 2003, PROTEOMICS, V3, P1318, DOI 10.1002/pmic.200300432; Santos PM, 2007, OMICS, V11, P233, DOI 10.1089/omi.2007.0009; Sawicki G, 2004, PROTEOMICS, V4, P2195, DOI 10.1002/pmic.200300746; Schwertz H, 2002, PROTEOMICS, V2, P988, DOI 10.1002/1615-9861(200208)2:8<988::AID-PROT988>3.0.CO;2-#; Steel LF, 2003, MOL CELL PROTEOMICS, V2, P262, DOI 10.1074/mcp.M300026-MCP200; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Takemura G, 1998, CIRC RES, V82, P1130, DOI 10.1161/01.RES.82.11.1130; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021; Weekes J, 2003, ALCOHOL ALCOHOLISM, V38, P103, DOI 10.1093/alcalc/agg037; Wei YJ, 2009, MOL CELL BIOCHEM, V332, P103, DOI 10.1007/s11010-009-0179-1; Young J B, 1999, Curr Cardiol Rep, V1, P67, DOI 10.1007/s11886-999-0044-6; Zamilpa R, 2010, PROTEOMICS, V10, P2214, DOI 10.1002/pmic.200900587	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31669	10.1371/journal.pone.0031669	http://dx.doi.org/10.1371/journal.pone.0031669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384053	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500032
J	Hu, ZH; Liu, C; Shi, PC; Liu, HF				Hu, Zhenghui; Liu, Cong; Shi, Pengcheng; Liu, Huafeng			Exploiting Magnetic Resonance Angiography Imaging Improves Model Estimation of BOLD Signal	PLOS ONE			English	Article							CONTROLLED RANDOM SEARCH; HEMODYNAMIC-RESPONSE; OXYGEN DELIVERY; BLOOD-FLOW; ACTIVATION; FMRI	The change of BOLD signal relies heavily upon the resting blood volume fraction (V-0) associated with regional vasculature. However, existing hemodynamic data assimilation studies pretermit such concern. They simply assign the value in a physiologically plausible range to get over ill-conditioning of the assimilation problem and fail to explore actual V-0. Such performance might lead to unreliable model estimation. In this work, we present the first exploration of the influence of V-0 on fMRI data assimilation, where actual V-0 within a given cortical area was calibrated by an MR angiography experiment and then was augmented into the assimilation scheme. We have investigated the impact of V-0 on single-region data assimilation and multi-region data assimilation (dynamic cause modeling, DCM) in a classical flashing checkerboard experiment. Results show that the employment of an assumed V-0 in fMRI data assimilation is only suitable for fMRI signal reconstruction and activation detection grounded on this signal, and not suitable for estimation of unobserved states and effective connectivity study. We thereby argue that introducing physically realistic V-0 in the assimilation process may provide more reliable estimation of physiological information, which contributes to a better understanding of the underlying hemodynamic processes. Such an effort is valuable and should be well appreciated.	[Hu, Zhenghui; Liu, Cong; Liu, Huafeng] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Pengcheng] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY 14623 USA; [Shi, Pengcheng] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Zhejiang University; Rochester Institute of Technology; University of Rochester	Hu, ZH (corresponding author), Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China.	zhenghui@zju.edu.cn; liuhf@zju.edu.cn	Hu, Zhenghui/F-1959-2015; LIU, CONG/J-3588-2016; Liu, Cong/E-9762-2012	Hu, Zhenghui/0000-0002-5775-0481; LIU, CONG/0000-0002-2106-202X; 	National Basic Research Program of China [2010CB732500]; National Natural Science Foundation of China [30800250]; Ministry of Education of China [200803351022]; Zhejiang Provincial Natural Science Foundation of China [Y2080281]; Zhejiang Provincial Qianjiang Talent Plan [2009R10042]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Qianjiang Talent Plan	This work is supported in part by the National Basic Research Program of China under grant 2010CB732500 (http://most.gov.cn/), in part by the National Natural Science Foundation of China under grant 30800250 (http://www.nsfc.gov.cn), in part by Doctoral Fund of Ministry of Education of China under grant 200803351022 (http://www.moe.edu.cn/), in part by Zhejiang Provincial Natural Science Foundation of China under grant Y2080281 (http://www.zjnsf.gov.cn), and in part by Zhejiang Provincial Qianjiang Talent Plan under grant 2009R10042 (http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 1997, J GLOBAL OPTIM, V11, P377, DOI 10.1023/A:1008236920512; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deneux T, 2006, NEUROIMAGE, V32, P1669, DOI 10.1016/j.neuroimage.2006.03.006; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Hettiarachchi IT, 2010, IEEE ENG MED BIO, P2391, DOI 10.1109/IEMBS.2010.5627400; Hu ZH, 2007, LECT NOTES COMPUT SC, V4792, P734; Hu ZH, 2010, IEEE T MED IMAGING, V29, P1870, DOI 10.1109/TMI.2010.2053044; Hu ZH, 2009, I S BIOMED IMAGING, P706, DOI 10.1109/ISBI.2009.5193145; Hu ZH, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/215409; Jiao L, 2010, NATURE, V327, P931; Johnston LA, 2008, NEUROIMAGE, V40, P504, DOI 10.1016/j.neuroimage.2007.11.024; Johnston LA, 2006, LECT NOTES COMPUT SC, V4191, P292; Li XF, 2010, MED IMAGE ANAL, V14, P30, DOI 10.1016/j.media.2009.09.005; Lu HZ, 2005, MAGN RESON MED, V54, P1403, DOI 10.1002/mrm.20705; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P925, DOI 10.1162/089892903770007317; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Riera JJ, 2004, NEUROIMAGE, V21, P547, DOI 10.1016/j.neuroimage.2003.09.052; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Tsoulos IG, 2006, COMPUT PHYS COMMUN, V174, P152, DOI 10.1016/j.cpc.2005.09.007; Worsley K., 2001, FUNCTIONAL MRI INTRO, V61; Zheng Y, 2005, NEUROIMAGE, V28, P925, DOI 10.1016/j.neuroimage.2005.06.042; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078; Zhenghui Hu, 2007, Proceedings 2007 IEEE International Conference on Image Processing, ICIP 2007, P145	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31612	10.1371/journal.pone.0031612	http://dx.doi.org/10.1371/journal.pone.0031612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384043	Green Published, gold, Green Submitted			2022-12-25	WOS:000302875500027
J	Galfre, E; Pitt, SJ; Venturi, E; Sitsapesan, M; Zaccai, NR; Tsaneva-Atanasova, K; O'Neill, S; Sitsapesan, R				Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Tsaneva-Atanasova, Krasimira; O'Neill, Stephen; Sitsapesan, Rebecca			FKBP12 Activates the Cardiac Ryanodine Receptor Ca2+-Release Channel and Is Antagonised by FKBP12.6	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; FK506-BINDING PROTEIN FKBP12.6; SPONTANEOUS CA2+ RELEASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; SELECTIVE BINDING; CONTRACTION; OVEREXPRESSION; INACTIVATION	Changes in FKBP12.6 binding to cardiac ryanodine receptors (RyR2) are implicated in mediating disturbances in Ca2+-homeostasis in heart failure but there is controversy over the functional effects of FKBP12.6 on RyR2 channel gating. We have therefore investigated the effects of FKBP12.6 and another structurally similar molecule, FKBP12, which is far more abundant in heart, on the gating of single sheep RyR2 channels incorporated into planar phospholipid bilayers and on spontaneous waves of Ca2+-induced Ca2+-release in rat isolated permeabilised cardiac cells. We demonstrate that FKBP12 is a high affinity activator of RyR2, sensitising the channel to cytosolic Ca2+, whereas FKBP12.6 has very low efficacy, but can antagonise the effects of FKBP12. Mathematical modelling of the data shows the importance of the relative concentrations of FKBP12 and FKBP12.6 in determining RyR2 activity. Consistent with the single-channel results, physiological concentrations of FKBP12 (3 mu M) increased Ca2+-wave frequency and decreased the SR Ca2+-content in cardiac cells. FKBP12.6, itself, had no effect on wave frequency but antagonised the effects of FKBP12. We provide a biophysical analysis of the mechanisms by which FK-binding proteins can regulate RyR2 single-channel gating. Our data indicate that FKBP12, in addition to FKBP12.6, may be important in regulating RyR2 function in the heart. In heart failure, it is possible that an alteration in the dual regulation of RyR2 by FKBP12 and FKBP12.6 may occur. This could contribute towards a higher RyR2 open probability, 'leaky' RyR2 channels and Ca2+-dependent arrhythmias.	[Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Sitsapesan, Rebecca] Univ Bristol, Sch Physiol & Pharmacol, Ctr Nanosci & Quantum Informat, Bristol, Avon, England; [Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Sitsapesan, Rebecca] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [O'Neill, Stephen] Univ Manchester, Core Technol Facil, Cardiovasc Res Grp, Manchester, Lancs, England	University of Bristol; University of Bristol; University of Bristol; University of Manchester	Galfre, E (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Ctr Nanosci & Quantum Informat, Bristol, Avon, England.	r.sitsapesan@bris.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Pitt, Samantha/0000-0003-2257-1595; Venturi, Elisa/0000-0001-9302-1537; Zaccai, Nathan/0000-0002-1476-2044	British Heart Foundation [FS/08/069/25929, PG/06/127/21677]; Engineering and Physical Sciences Research Council [EP/I018638/1]; EPSRC [EP/I018638/1] Funding Source: UKRI; British Heart Foundation [RG/10/14/28576, PG/10/27/28312] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation)	This work was funded by British Heart Foundation grants (FS/08/069/25929 PG/06/127/21677) to RS and SO and by Engineering and Physical Sciences Research Council grant (EP/I018638/1) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Ahern GP, 1997, NEUROSCI LETT, V225, P81, DOI 10.1016/S0304-3940(97)00193-6; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Carter S, 2011, J MEMBRANE BIOL, V240, P21, DOI 10.1007/s00232-011-9339-9; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Eisner DA, 2009, J MOL CELL CARDIOL, V46, P474, DOI 10.1016/j.yjmcc.2008.12.005; EISNER DA, 1989, J PHYSIOL-LONDON, V411, P393, DOI 10.1113/jphysiol.1989.sp017580; Fulton KF, 2003, BIOCHEMISTRY-US, V42, P2364, DOI 10.1021/bi020564a; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Huang FN, 2006, P NATL ACAD SCI USA, V103, P3456, DOI 10.1073/pnas.0511282103; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; Laver DR, 1998, BIOPHYS J, V74, P2352, DOI 10.1016/S0006-3495(98)77944-5; Lehnart SE, 2004, BIOCHEM BIOPH RES CO, V322, P1267, DOI 10.1016/j.bbrc.2004.08.032; Loughrey CM, 2004, J PHYSIOL-LONDON, V556, P919, DOI 10.1113/jphysiol.2003.057166; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Ng GA, 1998, CARDIOVASC RES, V37, P489, DOI 10.1016/S0008-6363(97)00255-1; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Overend CL, 1997, J PHYSIOL-LONDON, V502, P471, DOI 10.1111/j.1469-7793.1997.471bj.x; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Prestle J, 2001, CIRC RES, V88, P188; Saftenku E, 2001, BIOPHYS J, V80, P2727, DOI 10.1016/S0006-3495(01)76241-8; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Seidler T, 2007, CIRC RES, V101, P1020, DOI 10.1161/CIRCRESAHA.107.154609; Seidler T, 2011, J MOL CELL CARDIOL, V50, P33, DOI 10.1016/j.yjmcc.2010.08.016; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sigalas C, 2009, BRIT J PHARMACOL, V156, P794, DOI 10.1111/j.1476-5381.2008.00092.x; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Smith GL, 2001, J PHYSIOL-LONDON, V534, P37, DOI 10.1111/j.1469-7793.2001.00037.x; Sobie EA, 2006, PROG BIOPHYS MOL BIO, V90, P172, DOI 10.1016/j.pbiomolbio.2005.06.010; Stewart R, 2008, J MEMBRANE BIOL, V222, P65, DOI 10.1007/s00232-008-9102-z; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Trafford AW, 2000, CELL CALCIUM, V28, P269, DOI 10.1054/ceca.2000.0156; VALDEOLMILLOS M, 1989, PFLUG ARCH EUR J PHY, V413, P676, DOI 10.1007/BF00581820; Valdivia HH, 2001, CIRC RES, V88, P134; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zahradnikova A, 1999, PFLUG ARCH EUR J PHY, V438, P283, DOI 10.1007/s004240050911	58	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31956	10.1371/journal.pone.0031956	http://dx.doi.org/10.1371/journal.pone.0031956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363773	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700127
J	Knebel, B; Haas, J; Hartwig, S; Jacob, S; Kollmer, C; Nitzgen, U; Muller-Wieland, D; Kotzka, J				Knebel, Birgit; Haas, Jutta; Hartwig, Sonja; Jacob, Sylvia; Koellmer, Cornelia; Nitzgen, Ulrike; Muller-Wieland, Dirk; Kotzka, Jorg			Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ACID SYNTHESIS; ALPHA-FETOPROTEIN; GENE-EXPRESSION; MICE; CARBOHYDRATE; SENSITIVITY; RECEPTOR	The pathogenesis of fatty liver is not understood in detail, but lipid overflow as well as de novo lipogenesis (DNL) seem to be the key points of hepatocyte accumulation of lipids. One key transcription factor in DNL is sterol regulatory element-binding protein (SREBP)-1c. We generated mice with liver-specific over-expression of mature human SREBP-1c under control of the albumin promoter and a liver-specific enhancer (alb-SREBP-1c) to analyze systemic perturbations caused by this distinct alteration. SREBP-1c targets specific genes and causes key enzymes in DNL and lipid metabolism to be upregulated. The alb-SREBP-1c mice developed hepatic lipid accumulation featuring a fatty liver by the age of 24 weeks under normocaloric nutrition. On a molecular level, clinical parameters and lipid-profiles varied according to the fatty liver phenotype. The desaturation index was increased compared to wild type mice. In liver, fatty acids (FA) were increased by 50% (p<0.01) and lipid composition was shifted to mono unsaturated FA, whereas lipid profile in adipose tissue or serum was not altered. Serum analyses revealed a similar to 2-fold (p<0.01) increase in triglycerides and free fatty acids, and a similar to 3-fold (p<0.01) increase in insulin levels, indicating insulin resistance; however, no significant cytokine profile alterations have been determined. Interestingly and unexpectedly, mice also developed adipositas with considerably increased visceral adipose tissue, although calorie intake was not different compared to control mice. In conclusion, the alb-SREBP-1c mouse model allowed the elucidation of the systemic impact of SREBP-1c as a central regulator of lipid metabolism in vivo and also demonstrated that the liver is a more active player in metabolic diseases such as visceral obesity and insulin resistance.	[Knebel, Birgit; Hartwig, Sonja; Jacob, Sylvia; Koellmer, Cornelia; Nitzgen, Ulrike; Kotzka, Jorg] Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany; [Haas, Jutta; Muller-Wieland, Dirk] Semmelweis Univ, Asklepios Clin St Georg, Fac Med, Inst Diabet Res,Dept Gen Internal Med, Hamburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Asklepios Klinik St. Georg; Semmelweis University	Knebel, B (corresponding author), Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany.	jkotzka@ddz.uni-duesseldorf.de		Kotzka, Jorg/0000-0003-1173-9372	Center for Molecular Medicine Cologne [TV1]; city of Hamburg (Norgenta GmbH) within the LiDia project; German Diabetes Center	Center for Molecular Medicine Cologne; city of Hamburg (Norgenta GmbH) within the LiDia project; German Diabetes Center	The work was supported by the Center for Molecular Medicine Cologne (TV1), the city of Hamburg (Norgenta GmbH) within the LiDia project and the German Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland A, 1997, AM J CLIN NUTR, V65, P1774, DOI 10.1093/ajcn/65.6.1774; Bjorkegren J, 1999, J CLIN INVEST, V103, P1287; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Hernandez C, 2009, CELL METAB, V9, P215, DOI 10.1016/j.cmet.2009.02.001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Hudgins LC, 2000, J LIPID RES, V41, P595; IZBAN MG, 1989, J BIOL CHEM, V264, P9171; Kantartzis K, 2010, DIGEST DIS, V28, P169, DOI 10.1159/000282082; Kohjima M, 2008, INT J MOL MED, V21, P507; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lomvardas S, 2002, MOL CELL, V9, P209, DOI 10.1016/S1097-2765(02)00463-X; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; NAHON JL, 1987, BIOCHIMIE, V69, P445, DOI 10.1016/0300-9084(87)90082-4; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572; Parks EJ, 2002, BRIT J NUTR, V87, pS247, DOI 10.1079/BJN/2002544; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Raabe M, 2002, J BIOL CHEM, V277, P5476; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; TROJAN J, 1995, MOL REPROD DEV, V42, P369, DOI 10.1002/mrd.1080420402; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	66	110	120	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31812	10.1371/journal.pone.0031812	http://dx.doi.org/10.1371/journal.pone.0031812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363740	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700102
J	Pehl, MJ; Jamieson, WD; Kong, K; Forbester, JL; Fredendall, RJ; Gregory, GA; McFarland, JE; Healy, JM; Orwin, PM				Pehl, Michael J.; Jamieson, William David; Kong, Karen; Forbester, Jessica L.; Fredendall, Richard J.; Gregory, Glenn A.; McFarland, Jacob E.; Healy, Jessica M.; Orwin, Paul M.			Genes That Influence Swarming Motility and Biofilm Formation in Variovorax paradoxus EPS	PLOS ONE			English	Article							COLONY MORPHOLOGY; SURFACE; IDENTIFICATION; GENERATION; REGULATOR; VARIANTS	Background: Variovorax paradoxus is an aerobic soil bacterium associated with important biodegradative processes in nature. We use V. paradoxus EPS to study multicellular behaviors on surfaces. Methodology: We recovered flanking sequence from 123 clones in a Tn5 mutant library, with insertions in 29 different genes, selected based on observed surface behavior phenotypes. We identified three genes, Varpa_4665, Varpa_4680, and Varpa_5900, for further examination. These genes were cloned into pBBR1MCS2 and used to complement the insertion mutants. We also analyzed expression of Varpa_4680 and Varpa_5900 under different growth conditions by qPCR. Results: The 29 genes we identified had diverse predicted functions, many in exopolysaccharide synthesis. Varpa_4680, the most commonly recovered insertion site, encodes a putative N-acetyl-L-fucosamine transferase similar to WbuB. Expression of this gene in trans complemented the mutant fully. Several unique insertions were identified in Varpa_5900, which is one of three predicted pilY1 homologs in the EPS genome. No insertions in the two other putative pilY1 homologs present in the genome were identified. Expression of Varpa_5900 altered the structure of the wild type swarm, as did disruption of the chromosomal gene. The swarming phenotype was complemented by expression of Varpa_5900 from a plasmid, but biofilm formation was not restored. Both Varpa_4680 and Varpa_5900 transcripts were downregulated in biofilms and upregulated during swarming when compared to log phase culture. We identified a putative two component system (Varpa_4664-4665) encoding a response regulator (shkR) and a sensor histidine kinase (shkS), respectively. Biofilm formation increased and swarming was strongly delayed in the Varpa_4665 (shkS) mutant. Complementation of shkS restored the biofilm phenotype but swarming was still delayed. Expression of shkR in trans suppressed biofilm formation in either genetic background, and partially restored swarming in the mutant. Conclusions: The data presented here point to complex regulation of these surface behaviors.	[Pehl, Michael J.; Fredendall, Richard J.; Gregory, Glenn A.; McFarland, Jacob E.; Healy, Jessica M.; Orwin, Paul M.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA; [Jamieson, William David; Kong, Karen; Forbester, Jessica L.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Gregory, Glenn A.] Loma Linda Univ, Sch Dent, Loma Linda, CA 92350 USA; [McFarland, Jacob E.] Univ Calif San Francisco, UCSF Sch Pharm, San Francisco, CA 94143 USA; [Healy, Jessica M.] UCD Dept Publ Hlth Sci 5215 VM3A, Davis, CA USA	California State University System; California State University San Bernardino; University of Bath; Loma Linda University; University of California System; University of California San Francisco	Pehl, MJ (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	porwin@csusb.edu	Albers, Pieter/I-2563-2017; Jamieson, David/F-9534-2016	Jamieson, David/0000-0001-8260-5211; Forbester, Jessica/0000-0002-3834-615X	National Institutes of Health [S06 GM073842, R15 GM090242-01]; CSUSB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090242, S06GM073842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSUSB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants S06 GM073842 and R15 GM090242-01. This work was also supported by CSUSB internal grants awarded to MJP, JEM, JMH, and PMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Allen MS, 2004, ENVIRON MICROBIOL, V6, P780, DOI 10.1111/j.1462-2920.2004.00615.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anesti V, 2005, ENVIRON MICROBIOL, V7, P1227, DOI 10.1111/j.1462-2920.2005.00805.x; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Devers M, 2007, GENE, V392, P1, DOI 10.1016/j.gene.2006.09.015; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Govindasamy V, 2008, CURR MICROBIOL, V57, P312, DOI 10.1007/s00284-008-9195-8; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Gualdi L, 2008, MICROBIOL-SGM, V154, P2017, DOI 10.1099/mic.0.2008/018093-0; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Johnson DR, 2005, APPL ENVIRON MICROB, V71, P3866, DOI 10.1128/AEM.71.7.3866-3871.2005; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Kolter R, 2006, NATURE, V441; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Maimaiti J, 2007, ENVIRON MICROBIOL, V9, P435, DOI 10.1111/j.1462-2920.2006.01155.x; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Nishino SF, 2006, APPL ENVIRON MICROB, V72, P1040, DOI 10.1128/AEM.72.2.1040-1044.2006; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; PARKE D, 1990, GENE, V93, P135, DOI 10.1016/0378-1119(90)90147-J; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Rozen S, 2000, Methods Mol Biol, V132, P365; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith A. W, 1989, NUCLEIC ACIDS RES, V17, P25669; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P445, DOI 10.1099/00207713-41-3-445; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07	41	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31832	10.1371/journal.pone.0031832	http://dx.doi.org/10.1371/journal.pone.0031832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363744	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700105
J	Hoffmann, A; Kovermann, M; Lilie, H; Fiedler, M; Balbach, J; Rudolph, R; Pfeifer, S				Hoffmann, Andreas; Kovermann, Michael; Lilie, Hauke; Fiedler, Markus; Balbach, Jochen; Rudolph, Rainer; Pfeifer, Sven			New Binding Mode to TNF-Alpha Revealed by Ubiquitin-Based Artificial Binding Protein	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SMALL-MOLECULE INHIBITION; COMBINATORIAL LIBRARIES; CIRCULAR-DICHROISM; RIBOSOME DISPLAY; PHAGE DISPLAY; SELECTION; AFFINITY; ANTIBODIES; STABILITY	A variety of approaches have been employed to generate binding proteins from non-antibody scaffolds. Utilizing a beta-sheet of the human ubiquitin for paratope creation we obtained binding proteins against tumor necrosis factor (TNF)-alpha. The bioactive form of this validated pharmacological target protein is a non-covalently linked homo-trimer. This structural feature leads to the observation of a certain heterogeneity concerning the binding mode of TNF-alpha binding molecules, for instance in terms of monomer/trimer specificity. We analyzed a ubiquitin-based TNF-alpha binder, selected by ribosome display, with a particular focus on its mode of interaction. Using enzyme-linked immunosorbent assays, specific binding to TNF-alpha with nanomolar affinity was observed. In isothermal titration calorimetry we obtained comparable results regarding the affinity and detected an exothermic reaction with one ubiquitin-derived binding molecule binding one TNF-alpha trimer. Using NMR spectroscopy and other analytical methods the 1:3 stoichiometry could be confirmed. Detailed binding analysis showed that the interaction is affected by the detergent Tween-20. Previously, this phenomenon was reported only for one other type of alternative scaffold-derived binding proteins - designed ankyrin repeat proteins - without further investigation. As demonstrated by size exclusion chromatography and NMR spectroscopy, the presence of the detergent increases the association rate significantly. Since the special architecture of TNF-alpha is known to be modulated by detergents, the access to the recognized epitope is indicated to be restricted by conformational transitions within the target protein. Our results suggest that the ubiquitin-derived binding protein targets a new epitope on TNF-alpha, which differs from the epitopes recognized by TNF-alpha neutralizing antibodies.	[Hoffmann, Andreas; Lilie, Hauke; Rudolph, Rainer; Pfeifer, Sven] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany; [Kovermann, Michael; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, Halle, Germany; [Fiedler, Markus] Scil Prot GmbH, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hoffmann, A (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.	sven.pfeifer@biochemtech.uni-halle.de			BMBF within the UnternehmenRegion Innovation initiative for the Neue Lander [03IP606]; Deutsche Forschungsgemeinschaft [GRK 1026]; Excellence Initiative of the State of Sachsen-Anhalt; European Union	BMBF within the UnternehmenRegion Innovation initiative for the Neue Lander(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the State of Sachsen-Anhalt; European Union(European Commission)	This work was supported by grants from the BMBF (http://www.bmbf.de) InnoProfile program within the UnternehmenRegion Innovation initiative for the Neue Lander (grant number 03IP606), the Deutsche Forschungsgemeinschaft (http://www.dfg.de) (GRK 1026) and the Excellence Initiative of the State of Sachsen-Anhalt. Significant investments into the NMR facility from the European Regional Development Fund (ERDF) by the European Union (http://ec.europa.eu) are also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZANI R, 1995, BIOCHEMISTRY-US, V34, P6344, DOI 10.1021/bi00019a012; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Byla P, 2010, J BIOL CHEM, V285, P12096, DOI 10.1074/jbc.M109.063305; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; CORTI A, 1992, MOL IMMUNOL, V29, P471, DOI 10.1016/0161-5890(92)90004-H; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Fiedler M, 2004, International Patent Application, Patent No. [WO/2004/106368, 2004106368]; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hoffmann A, 2010, PROTEIN EXPRES PURIF, V72, P238, DOI 10.1016/j.pep.2010.03.022; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jonsson A, 2009, BIOTECHNOL APPL BIOC, V54, P93, DOI 10.1042/BA20090085; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Kim HJ, 2009, J AM CHEM SOC, V131, P3565, DOI 10.1021/ja806857r; Kohno T, 2007, J INVEST DERM SYMP P, V12, P5, DOI 10.1038/sj.jidsymp.5650034; Lu RC, 2009, BBA-GEN SUBJECTS, V1790, P134, DOI 10.1016/j.bbagen.2008.10.009; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; Markland W, 1996, BIOCHEMISTRY-US, V35, P8045, DOI 10.1021/bi9526286; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; PETYOVKA N, 1995, J IMMUNOL METHODS, V186, P161, DOI 10.1016/0022-1759(95)00183-B; POIESI C, 1993, CYTOKINE, V5, P539, DOI 10.1016/S1043-4666(05)80002-X; SAIJO S, 1995, J BIOCHEM-TOKYO, V118, P28, DOI 10.1093/oxfordjournals.jbchem.a124887; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; SCHNEIDER DM, 1992, BIOCHEMISTRY-US, V31, P3645, DOI 10.1021/bi00129a013; Silvian LF, 2011, ACS CHEM BIOL, V6, P636, DOI 10.1021/cb2000346; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; VANOSTADE X, 1994, PROTEIN ENG, V7, P5, DOI 10.1093/protein/7.1.5; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	47	74	82	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31298	10.1371/journal.pone.0031298	http://dx.doi.org/10.1371/journal.pone.0031298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363609	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500032
J	Pietila, M; Lehtonen, S; Tuovinen, E; Lahteenmaki, K; Laitinen, S; Leskela, HV; Natynki, A; Pesala, J; Nordstrom, K; Lehenkari, P				Pietila, Mika; Lehtonen, Siri; Tuovinen, Elina; Lahteenmaki, Kaarina; Laitinen, Saara; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Nordstrom, Katrina; Lehenkari, Petri			CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Alpha Secretion from CD200 Receptor Positive Macrophage-Like Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MONOCYTE-DERIVED MACROPHAGES; DIFFERENTIATED THP-1 CELLS; ADAPTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA; STROMAL CELLS; INNATE IMMUNITY; CROHNS-DISEASE; IN-VITRO; ACTIVATION	Human mesenchymal stem cells (hMSCs) display immunosuppressive properties in vitro and the potential has also been transferred successfully to clinical trials for treatment of autoimmune diseases. OX-2 (CD200), a member of the immunoglobulin superfamily, is widely expressed in several tissues and has recently been found from hMSCs. The CD200 receptor (CD200R) occurs only in myeloid-lineage cells. The CD200-CD200R is involved in down-regulation of several immune cells, especially macrophages. The present study on 20 hMSC lines shows that the CD200 expression pattern varied from high (CD200Hi) to medium (CD200Me) and low (CD200Lo) in bone marrow-derived mesenchymal stem cell (BMMSC) lines, whereas umbilical cord blood derived mesenchymal stem cells (UCBMSCs) were constantly negative for CD200. The role of the CD200-CD200R axis in BMMSCs mediated immunosuppression was studied using THP-1 human macrophages. Interestingly, hMSCs showed greater inhibition of TNF-alpha secretion in co-cultures with IFN-gamma primed THP-1 macrophages when compared to LPS activated cells. The ability of CD200Hi BMMSCs to suppress TNF-alpha secretion from IFN-gamma stimulated THP-1 macrophages was significantly greater when compared to CD200Lo whereas UCBMSCs did not significantly reduce TNF-alpha secretion. The interference of CD200 binding to the CD200R by anti-CD200 antibody weakened the capability of BMMSCs to inhibit TNF-alpha secretion from IFN-gamma activated THP-1 macrophages. This study clearly demonstrated that the efficiency of BMMSCs to suppress TNF-alpha secretion of THP-1 macrophages was dependent on the type of stimulus. Moreover, the CD200-CD200r axis could have a previously unidentified role in the BMMSC mediated immunosuppression.	[Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland; [Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Univ Oulu, Div Surg, Inst Clin Med, Dept Surg & Intens Care, Oulu, Finland; [Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Tuovinen, Elina; Lahteenmaki, Kaarina; Laitinen, Saara] Finnish Red Cross Blood Serv, Helsinki, Finland; [Nordstrom, Katrina] Aalto Sch Chem Technol, Dept Biotechnol & Chem Technol, Espoo, Finland	University of Oulu; University of Oulu; University of Oulu; Aalto University	Pietila, M (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland.	mika.pietila@aalto.fi	Lehenkari, Petri/O-3009-2016; Nordstrom, Katrina/K-6822-2012	Lehenkari, Petri/0000-0002-0055-5183; Nordstrom, Katrina/0000-0003-3508-9810; Natynki, Antti/0000-0003-4636-4291; Lehtonen, Siri/0000-0002-5578-8232	Academy of Finland [122561]; Finnish Medical Association	Academy of Finland(Academy of Finland); Finnish Medical Association	This study was funded by the Academy of Finland (Grant: 122561) and by the Finnish Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ASSEFFA A, 1993, ONCOL RES, V5, P11; BARCLAY AN, 1986, BIOCHEM SOC SYMP, P149; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Brown JN, 2010, J LEUKOCYTE BIOL, V87, P655, DOI 10.1189/jlb.0809570; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Campioni D, 2009, CYTOM PART B-CLIN CY, V76B, P225, DOI 10.1002/cyto.b.20461; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kang SS, 2007, INT IMMUNOPHARMACOL, V7, P1488, DOI 10.1016/j.intimp.2007.07.011; Kawasaki BT, 2008, TRENDS IMMUNOL, V29, P464, DOI 10.1016/j.it.2008.07.005; Kawasaki BT, 2007, BIOCHEM BIOPH RES CO, V364, P778, DOI 10.1016/j.bbrc.2007.10.067; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; KOSAKA C, 1992, ATHEROSCLEROSIS, V97, P75, DOI 10.1016/0021-9150(92)90053-J; Laitinen A, 2011, METHODS MOL BIOL, V698, P63, DOI 10.1007/978-1-60761-999-4_6; Langlals CL, 2006, J VIROL, V80, P3098, DOI 10.1128/JVI.80.6.3098-3103.2006; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lepelletier Y, 2010, STEM CELLS DEV, V19, P1075, DOI 10.1089/scd.2009.0212; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Longoni B, 2010, DIABETES TECHNOL THE, V12, P435, DOI 10.1089/dia.2009.0154; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Matsue H, 2005, J INVEST DERMATOL, V125, pX, DOI 10.1111/j.0022-202X.2005.23978.x; MCCAUGHAN GW, 1987, IMMUNOGENETICS, V25, P329, DOI 10.1007/BF00404426; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miettinen JA, 2011, EXP CELL RES, V317, P791, DOI 10.1016/j.yexcr.2010.12.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Salata C, 2009, J CELL PHYSIOL, V219, P698, DOI 10.1002/jcp.21722; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shi DN, 2006, CELL RES, V16, P70, DOI 10.1038/sj.cr.7310009; Simelyte E, 2010, CLIN EXP IMMUNOL, V162, P163, DOI 10.1111/j.1365-2249.2010.04227.x; Simelyte E, 2008, ARTHRITIS RHEUM, V58, P1038, DOI 10.1002/art.23378; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Taylor S, 2011, EXP EYE RES; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503	59	47	50	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31671	10.1371/journal.pone.0031671	http://dx.doi.org/10.1371/journal.pone.0031671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363701	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500072
J	Banada, PP; Chakravorty, S; Shah, D; Burday, M; Mazzella, FM; Alland, D				Banada, Padmapriya P.; Chakravorty, Soumitesh; Shah, Darshini; Burday, Michele; Mazzella, Fermina M.; Alland, David			Highly Sensitive Detection of Staphylococcus aureus Directly from Patient Blood	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; STREAM INFECTIONS; SUSPECTED SEPSIS; FUNGAL PATHOGENS; RAPID DETECTION; MULTIPLEX PCR; AMPLIFICATION; BACTERIAL; DIAGNOSIS	Background: Rapid detection of bloodstream infections (BSIs) can be lifesaving. We investigated the sample processing and assay parameters necessary for highly-sensitive detection of bloodstream bacteria, using Staphylococcus aureus as a model pathogen and an automated fluidic sample processing-polymerase chain reaction (PCR) platform as a model diagnostic system. Methodology/Principal Findings: We compared a short 128 bp amplicon hemi-nested PCR and a relatively shorter 79 bp amplicon nested PCR targeting the S. aureus nuc and sodA genes, respectively. The sodA nested assay showed an enhanced limit of detection (LOD) of 5 genomic copies per reaction or 10 colony forming units (CFU) per ml blood over 50 copies per reaction or 50 CFU/ml for the nuc assay. To establish optimal extraction protocols, we investigated the relative abundance of the bacteria in different components of the blood (white blood cells (WBCs), plasma or whole blood), using the above assays. The blood samples were obtained from the patients who were culture positive for S. aureus. Whole blood resulted in maximum PCR positives with sodA assay (90% positive) as opposed to cell-associated bacteria (in WBCs) (71% samples positive) or free bacterial DNA in plasma (62.5% samples positive). Both the assays were further tested for direct detection of S. aureus in patient whole blood samples that were contemporaneous culture positive. S. aureus was detected in 40/45 of culture-positive patients (sensitivity 89%, 95% CI 0.75-0.96) and 0/59 negative controls with the sodA assay (specificity 100%, 95% CI 0.92-1). Conclusions: We have demonstrated a highly sensitive two-hour assay for detection of sepsis causing bacteria like S. aureus directly in 1 ml of whole blood, without the need for blood culture.	[Banada, Padmapriya P.; Chakravorty, Soumitesh; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA; [Shah, Darshini; Burday, Michele; Mazzella, Fermina M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Banada, PP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA.	allandda@umdnj.edu	Banada, Padmapriya/H-6213-2019	Banada, Padmapriya/0000-0002-5217-6142	National Institutes of Health [U01 AI75490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U01 AI75490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Casalta JP, 2009, EUR J CLIN MICROBIOL, V28, P569, DOI 10.1007/s10096-008-0672-6; Chakravorty S, 2006, FEMS MICROBIOL LETT, V257, P306, DOI 10.1111/j.1574-6968.2006.00187.x; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Corey GR, 2011, INFECT DIS CLIN PRAC, V19, P307; del Rio A, 2009, CLIN INFECT DIS, V48, pS246, DOI 10.1086/598187; Gaibani Paolo, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS13, DOI 10.1016/S0924-8579(09)70559-X; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hein I, 2001, APPL ENVIRON MICROB, V67, P3122, DOI 10.1128/AEM.67.7.3122-3126.2001; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Ivancic-Jelecki J, 2009, J CHROMATOGR A, V1216, P2717, DOI 10.1016/j.chroma.2008.10.087; Jaeger H, 2010, JAIDS-J ACQ IMM DEF, V54, P334, DOI 10.1097/QAI.0b013e3181d04d12; KELLOGG JA, 1984, J CLIN MICROBIOL, V20, P618, DOI 10.1128/JCM.20.4.618-623.1984; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kollef MH, 2003, AM J MED, V115, P582, DOI 10.1016/j.amjmed.2003.09.002; Laforgia N, 1997, ACTA PAEDIATR, V86, P1097, DOI 10.1111/j.1651-2227.1997.tb14815.x; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Paolucci M, 2009, J MED MICROBIOL, V58, P533, DOI 10.1099/jmm.0.003848-0; Planella M, 2001, CLIN TRANSL ONCOL, V3, P163; Rozen S, 2000, Methods Mol Biol, V132, P365; Shang S, 2001, ACTA PAEDIATR, V90, P179, DOI 10.1080/080352501300049389; Sikora A, 2010, CLIN CHEM, V56, P136, DOI 10.1373/clinchem.2009.132951; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Varani S, 2009, J INFECTION, V58, P346, DOI 10.1016/j.jinf.2009.03.001; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31126	10.1371/journal.pone.0031126	http://dx.doi.org/10.1371/journal.pone.0031126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363564	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600114
J	Cartei, V; Cowles, HW; Reby, D				Cartei, Valentina; Cowles, Heidi Wind; Reby, David			Spontaneous Voice Gender Imitation Abilities in Adult Speakers	PLOS ONE			English	Article							SPEAKING FUNDAMENTAL-FREQUENCY; SEXUAL ORIENTATION; VOCAL-TRACT; SPEECH; FEMALE; SIZE; DOMINANCE; ATTRACTIVENESS; IDENTIFICATION; INTONATION	Background: The frequency components of the human voice play a major role in signalling the gender of the speaker. A voice imitation study was conducted to investigate individuals' ability to make behavioural adjustments to fundamental frequency (F0), and formants (Fi) in order to manipulate their expression of voice gender. Methodology/Principal Findings: Thirty-two native British-English adult speakers were asked to read out loud different types of text (words, sentence, passage) using their normal voice and then while sounding as 'masculine' and 'feminine' as possible. Overall, the results show that both men and women raised their F0 and Fi when feminising their voice, and lowered their F0 and Fi when masculinising their voice. Conclusions/Significance: These observations suggest that adult speakers are capable of spontaneous glottal and vocal tract length adjustments to express masculinity and femininity in their voice. These results point to a "gender code", where speakers make a conventionalized use of the existing sex dimorphism to vary the expression of their gender and gender-related attributes.	[Cartei, Valentina; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Cowles, Heidi Wind] Univ Florida, Dept Linguist, Gainesville, FL USA	University of Sussex; State University System of Florida; University of Florida	Cartei, V (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	d.reby@sussex.ac.uk	Cowles, Wind/AGU-9176-2022; reby, david/A-4227-2013	Cowles, Wind/0000-0001-9489-0750; Reby, David/0000-0001-9261-1711; Cartei, Canessa-Pollard, Valentina/0000-0002-3646-7871	School of Psychology of the University of Sussex	School of Psychology of the University of Sussex	The research did not receive any external funding. It is part of the first author's DPhil research project and funded by the postgraduate research fund from the School of Psychology of the University of Sussex. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; BENNETT S, 1981, J ACOUST SOC AM, V69, P231, DOI 10.1121/1.385343; Boersma P, 2001, GLOT INT, V5, P341; BUSBY PA, 1995, J ACOUST SOC AM, V97, P2603, DOI 10.1121/1.412975; BYRD D, 1992, J ACOUST SOC AM, V92, P593, DOI 10.1121/1.404271; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Deterding David, 1997, J INT PHON ASSOC, V27, P47, DOI DOI 10.1017/S0025100300005417; Ericsdotter C, 2001, WORKING PAPERS LUND, P34; Fairbanks G, 1960, VOICE ARTICULATION D, P126; Fant G., 1960, ACOUSTIC THEORY SPEE; Fant G., 1966, SPEECH TRANSMISSION, V7, P22; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; GAUDIO RP, 1994, AM SPEECH, V69, P30, DOI 10.2307/455948; Gaulin SJC, 1985, ETHOL SOCIOBIOL, V6; Goldstein UG, 1980, ARTICULATORY MODEL V; GRADDOL D, 1983, LANG SPEECH, V26, P351, DOI 10.1177/002383098302600403; GUNZBURGER D, 1987, LANG SPEECH, V30, P47; Harrington J, 2008, J ACOUST SOC AM, V123, P2825, DOI 10.1121/1.2897042; Hawkins S., 2005, J INT PHON ASSOC, V35, P183, DOI DOI 10.1017/S0025100305002124; Hecht MA, 1998, PERS SOC PSYCHOL B, V24, P1332, DOI 10.1177/01461672982412007; HENTON C, 1995, LANG COMMUN, V15, P43, DOI 10.1016/0271-5309(94)00011-Z; HENTON CG, 1989, LANG COMMUN, V9, P299, DOI 10.1016/0271-5309(89)90026-8; HERMES DJ, 1991, J ACOUST SOC AM, V90, P97, DOI 10.1121/1.402397; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hirano M., 1981, VOCAL FOLD PHYSL, P33; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; KRAMER C, 1978, SIGNS, V3, P638, DOI 10.1086/493507; Kroos C, 2002, J PHONETICS, V30, P569, DOI 10.1006/jpho.2002.0164; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; LaFrance M, 1999, OPTION OBLIGATION SM; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Linke C E, 1973, Folia Phoniatr (Basel), V25, P173; MAJEWSKI W, 1972, PHONETICA, V25, P119, DOI 10.1159/000259375; MCCONNELLGINET S, 1978, SIGNS, V3, P541, DOI 10.1086/493501; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Munson B, 2007, LANG LINGUIST COMPAS, V1, DOI 10.1111/j.1749-818x.2007.00028.x; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Ohara Yumiko, 2001, MULTILINGUALISM 2 LA, P231; Perry TL, 2001, J ACOUST SOC AM, V109, P2988, DOI 10.1121/1.1370525; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Pisanski K, 2011, J ACOUST SOC AM, V129, P2201, DOI 10.1121/1.3552866; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 2008, ARCH SEX BEHAV, V37, P188, DOI 10.1007/s10508-007-9269-x; RIETVELD ACM, 1985, J PHONETICS, V13, P299, DOI 10.1016/S0095-4470(19)30761-2; Sachs J., 1973, LANGUAGE ATTITUDES C; Simpson AP, 2009, LANG LINGUIST COMPAS, V3, P621, DOI 10.1111/j.1749-818x.2009.00125.x; Simpson AP, 2003, P 6 INT SEM SPEECH P; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; STOPPARD JM, 1993, PERS SOC PSYCHOL B, V19, P143, DOI 10.1177/0146167293192002; Thorsen N, 1980, INTONATION CONTOURS; Titze I. R., 2000, PRINCIPLES VOICE PRO; Tusing KJ, 2000, HUM COMMUN RES, V26, P148, DOI 10.1093/hcr/26.1.148; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Vorperian HK, 2009, J ACOUST SOC AM, V125, P1666, DOI 10.1121/1.3075589; Whiteside S., 1996, TEMPORAL BASED ACOUS, V26, P23, DOI 10.1017/S0025100300005302; Whiteside SP, 2000, SPEECH COMMUN, V32, P267, DOI 10.1016/S0167-6393(00)00013-3; WOLFE VI, 1990, J SPEECH HEAR DISORD, V55, P43, DOI 10.1044/jshd.5501.43; Yehia H, 1998, SPEECH COMMUN, V26, P23, DOI 10.1016/S0167-6393(98)00048-X	68	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31353	10.1371/journal.pone.0031353	http://dx.doi.org/10.1371/journal.pone.0031353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363628	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600141
J	Wang, YF; Li, SJ; Wu, XY; Che, YZ; Li, Q				Wang, Yifan; Li, Shu Jie; Wu, Xingye; Che, Yongzhe; Li, Qiang			Clinicopathological and Biological Significance of Human Voltage-gated Proton Channel Hv1 Protein Overexpression in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR EPITHELIAL-CELLS; CARBOXYL-TERMINAL DOMAIN; VACUOLAR H+-ATPASE; INTRACELLULAR PH; NADPH OXIDASE; ACIDIC PH; HUMAN-NEUTROPHILS; PUMP INHIBITORS; HUMAN-MELANOMA; GROWTH	In our previous work, we showed for the first time that the voltage-gated proton channel Hv1 is specifically expressed in highly metastatic human breast tumor tissues and cell lines. However, the contribution of Hv1 to breast carcinogenesis is not well known. In this study, we showed that Hv1 expression was significantly correlated with the tumor size (p = 0.001), tumor classification (p = 0.000), lymph node status (p = 0.000), clinical stage (p = 0.000), and Her-2 status (p = 0.045). High Hv1 expression was associated significantly with shorter overall (p = 0.000) and recurrence-free survival (p = 0.000). In vitro, knockdown of Hv1 expression in the highly metastatic MDA-MB-231 cells decreased the cell proliferation and invasiveness, inhibited the cell proton secretion and intracellular pH recovery, and blocked the cell capacity of acidifying extracellular milieu. Furthermore, the gelatinase activity in MDA-MB-231 cells that suppressed Hv1 was reduced. In vivo, the breast tumor size of the implantation of the MDA-MB-231 xenografts in nude mice that were knocked down by Hv1 was dramatically smaller than that in the control groups. The results demonstrated that the inhibition of Hv1 function via knockdown of Hv1 expression can effectively retard the cancer growth and suppress the cancer metastasis by the decrease of proton extrusion and the down-regulation of gelatinase activity. Based on these results, we came to the conclusion that Hv1 is a potential biomarker for prognosis of breast cancer and a potential target for anticancer drugs in breast cancer therapy.	[Wang, Yifan; Li, Shu Jie; Li, Qiang] Nankai Univ, Sch Phys Sci, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Wu, Xingye] Tonghua Cent Hosp, Dept Pathol, Tonghua 134000, Peoples R China; [Che, Yongzhe] Nankai Univ, Sch Med, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, SJ (corresponding author), Nankai Univ, Sch Phys Sci, Minist Educ, Key Lab Bioact Mat, 94 Weijin Rd, Tianjin 300071, Peoples R China.	shujieli@nankai.edu.cn; cheli@nankai.edu.cn			National Natural Science Foundation of China [30970579]; National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University	This work was supported by National Natural Science Foundation of China Grant 30970579.; We are deeply grateful to Prof. Wenxin Qin, National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University, for supporting and encouraging the research and many useful discussions on the manuscript.	CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; CLARK RA, 1987, J BIOL CHEM, V262, P4065; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; Fais S, 2010, J INTERN MED, V267, P515, DOI 10.1111/j.1365-2796.2010.02225.x; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fasciglione GF, 2000, BIOPHYS J, V79, P2138, DOI 10.1016/S0006-3495(00)76461-7; Gatenby RA, 2003, CANCER RES, V63, P3847; Giannelli G, 2002, HISTOL HISTOPATHOL, V17, P339, DOI 10.14670/HH-17.339; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GILLIES RJ, 1991, J BIOL CHEM, V266, P1551; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Henderson LM, 1997, BIOCHEM J, V325, P701, DOI 10.1042/bj3250701; Johnson LL, 2000, J BIOL CHEM, V275, P11026, DOI 10.1074/jbc.275.15.11026; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; Li SJ, 2009, ACTA CRYSTALLOGR F, V65, P279, DOI 10.1107/S1744309109003777; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; MONTCOURRIER P, 1994, J CELL SCI, V107, P2381; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; RACKER E, 1972, AM SCI, V60, P56; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROZHIN J, 1994, CANCER RES, V54, P6517; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Wang YF, 2011, BIOCHEM BIOPH RES CO, V412, P353, DOI 10.1016/j.bbrc.2011.07.102; Yeo M, 2004, CLIN CANCER RES, V10, P8687, DOI 10.1158/1078-0432.CCR-04-1065	45	78	79	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13877	13888		10.1074/jbc.M112.345280	http://dx.doi.org/10.1074/jbc.M112.345280			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367212	Green Published, hybrid			2022-12-25	WOS:000303996300043
J	Liang, FC; Bageshwar, UK; Musser, SM				Liang, Fu-Cheng; Bageshwar, Umesh K.; Musser, Siegfried M.			Position-dependent Effects of Polylysine on Sec Protein Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; PROTON-MOTIVE FORCE; BACTERIAL CYTOPLASMIC MEMBRANE; PREPROTEIN TRANSLOCATION; CHARGED RESIDUES; CATALYTIC CYCLE; CHAPERONE SECB; CROSS-LINKING; ATP BINDING; IN-VITRO	The bacterial Sec protein translocation system catalyzes the transport of unfolded precursor proteins across the cytoplasmic membrane. Using a recently developed real time fluorescence-based transport assay, the effects of the number and distribution of positive charges on the transport time and transport efficiency of proOmpA were examined. As expected, an increase in the number of lysine residues generally increased transport time and decreased transport efficiency. However, the observed effects were highly dependent on the polylysine position in the mature domain. In addition, a string of consecutive positive charges generally had a more significant effect on transport time and efficiency than separating the charges into two or more charged segments. Thirty positive charges distributed throughout the mature domain resulted in effects similar to 10 consecutive charges near the N terminus of the mature domain. These data support a model in which the local effects of positive charge on the translocation kinetics dominate over total thermodynamic constraints. The rapid translocation kinetics of some highly charged proOmpA mutants suggest that the charge is partially shielded from the electric field gradient during transport, possibly by the co-migration of counter ions. The transport times of precursors with multiple positively charged sequences, or "pause sites," were fairly well predicted by a local effect model. However, the kinetic profile predicted by this local effect model was not observed. Instead, the transport kinetics observed for precursors with multiple polylysine segments support a model in which translocation through the SecYEG pore is not the rate-limiting step of transport.	[Liang, Fu-Cheng; Bageshwar, Umesh K.; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Coll Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Coll Med, 1114 TAMU, College Stn, TX 77843 USA.	smusser@tamu.edu		Musser, Siegfried/0000-0002-7793-2557	National Institutes of Health [R01 GM065534]; Welch Foundation [BE-1541]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065534 (to S. M. M.). This work was also supported by Welch Foundation Grant BE-1541 (to S. M. M.).	ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; AZZONE G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P1, DOI 10.1016/0005-2728(93)90002-W; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Diamond DL, 1997, J BIOL CHEM, V272, P28994, DOI 10.1074/jbc.272.46.28994; Dominy Clifford N, 2003, Methods Mol Biol, V235, P209; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; GELLER B, 1993, J BIOL CHEM, V268, P9442; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nishiyama KI, 2010, PROTEIN SCI, V19, P2402, DOI 10.1002/pro.520; Nouwen N, 1996, P NATL ACAD SCI USA, V93, P5953, DOI 10.1073/pnas.93.12.5953; Nouwen N, 2009, J MOL BIOL, V386, P1000, DOI 10.1016/j.jmb.2009.01.031; OCHMAN H, 1988, GENETICS, V120, P621; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Randall LL, 1998, PROTEIN SCI, V7, P1195, DOI 10.1002/pro.5560070514; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riondet C, 1999, EUR J BIOCHEM, V262, P595, DOI 10.1046/j.1432-1327.1999.00429.x; Rottenberg H, 1979, Methods Enzymol, V55, P547; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Sato K, 1997, J BIOL CHEM, V272, P5880, DOI 10.1074/jbc.272.9.5880; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; van de Vossenberg JLCM, 1998, MOL MICROBIOL, V29, P1125, DOI 10.1046/j.1365-2958.1998.01001.x; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	62	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12703	12714		10.1074/jbc.M111.240903	http://dx.doi.org/10.1074/jbc.M111.240903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367204	Green Published, hybrid			2022-12-25	WOS:000302903700010
J	Shi, K; Berghuis, AM				Shi, Kun; Berghuis, Albert M.			Structural Basis for Dual Nucleotide Selectivity of Aminoglycoside 2 ''-Phosphotransferase IVa Provides Insight on Determinants of Nucleotide Specificity of Aminoglycoside Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURES; RESISTANCE; BINDING; SUBSTRATE; ATP; CK2; PHOSPHOTRANSFERASE; ENTEROCOCCUS	Enzymatic phosphorylation through a family of enzymes called aminoglycoside O-phosphotransferases (APHs) is a major mechanism by which bacteria confer resistance to aminoglycoside antibiotics. Members of the APH(2 '') subfamily are of particular clinical interest because of their prevalence in pathogenic strains and their broad substrate spectra. APH(2 '') enzymes display differential preferences between ATP or GTP as the phosphate donor, with aminoglycoside 2 ''-phosphotransferase IVa (APH(2 '')-IVa) being a member that utilizes both nucleotides at comparable efficiencies. We report here four crystal structures of APH(2 '')-IVa, two of the wild type enzyme and two of single amino acid mutants, each in complex with either adenosine or guanosine. Together, these structures afford a detailed look at the nucleoside-binding site architecture for this enzyme and reveal key elements that confer dual nucleotide specificity, including a solvent network in the interior of the nucleoside-binding pocket and the conformation of an interdomain linker loop. Steady state kinetic studies, as well as sequence and structural comparisons with members of the APH(2 '') subfamily and other aminoglycoside kinases, rationalize the different substrate preferences for these enzymes. Finally, despite poor overall sequence similarity and structural homology, analysis of the nucleoside-binding pocket of APH(2 '')-IVa shows a striking resemblance to that of eukaryotic casein kinase 2 (CK2), which also exhibits dual nucleotide specificity. These results, in complement with the multitude of existing inhibitors against CK2, can serve as a structural basis for the design of nucleotide-competitive inhibitors against clinically relevant APH enzymes.	[Shi, Kun; Berghuis, Albert M.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Berghuis, AM (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler,Rm 466, Montreal, PQ H3G 0B1, Canada.	albert.berghuis@mcgill.ca	Berghuis, Albert M/A-6495-2008	Berghuis, Albert/0000-0002-2663-025X	Canadian Institute of Health Research (CIHR) [MOP-13107]; CIHR Strategic Training Initiative in Chemical Biology	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) (Grant MOP-13107) (to A. M. B.).; Supported by the CIHR Strategic Training Initiative in Chemical Biology. Recipient of a CIHR Banting and Best Graduate Scholarship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Burk DL, 2002, PHARMACOL THERAPEUT, V93, P283, DOI 10.1016/S0163-7258(02)00197-3; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Chandrakanth RK, 2008, CURR MICROBIOL, V56, P558, DOI 10.1007/s00284-008-9123-y; Chilin A, 2008, J MED CHEM, V51, P752, DOI 10.1021/jm070909t; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fong DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019589; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; GATICA M, 1993, FEBS LETT, V315, P173, DOI 10.1016/0014-5793(93)81157-U; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie Z, 2007, BIOORG MED CHEM LETT, V17, P4191, DOI 10.1016/j.bmcl.2007.05.041; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shakya T, 2011, CHEM BIOL, V18, P1591, DOI 10.1016/j.chembiol.2011.10.018; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith Clyde A., 2002, Current Drug Targets - Infectious Disorders, V2, P143, DOI 10.2174/1568005023342533; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Yadegar A, 2009, MICROB DRUG RESIST, V15, P109, DOI 10.1089/mdr.2009.0897; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zarrilli R, 2005, J ANTIMICROB CHEMOTH, V56, P827, DOI 10.1093/jac/dki347	34	19	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13094	13102		10.1074/jbc.M112.349670	http://dx.doi.org/10.1074/jbc.M112.349670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371504	Green Published, hybrid			2022-12-25	WOS:000302903700049
J	Atencio, CA; Schreiner, CE				Atencio, Craig A.; Schreiner, Christoph E.			Spectrotemporal Processing in Spectral Tuning Modules of Cat Primary Auditory Cortex	PLOS ONE			English	Article							FREQUENCY RESOLVING POWER; FUNCTIONAL-ORGANIZATION; VISUAL-CORTEX; RECEPTIVE-FIELDS; CORTICAL-NEURONS; THALAMOCORTICAL SYSTEM; INTRINSIC CONNECTIONS; FEATURE SELECTIVITY; COCHLEAR IMPLANT; NORMAL-HEARING	Spectral integration properties show topographical order in cat primary auditory cortex (AI). Along the iso-frequency domain, regions with predominantly narrowly tuned (NT) neurons are segregated from regions with more broadly tuned (BT) neurons, forming distinct processing modules. Despite their prominent spatial segregation, spectrotemporal processing has not been compared for these regions. We identified these NT and BT regions with broad-band ripple stimuli and characterized processing differences between them using both spectrotemporal receptive fields (STRFs) and nonlinear stimulus/firing rate transformations. The durations of STRF excitatory and inhibitory subfields were shorter and the best temporal modulation frequencies were higher for BT neurons than for NT neurons. For NT neurons, the bandwidth of excitatory and inhibitory subfields was matched, whereas for BT neurons it was not. Phase locking and feature selectivity were higher for NT neurons. Properties of the nonlinearities showed only slight differences across the bandwidth modules. These results indicate fundamental differences in spectrotemporal preferences - and thus distinct physiological functions for neurons in BT and NT spectral integration modules. However, some global processing aspects, such as spectrotemporal interactions and nonlinear input/output behavior, appear to be similar for both neuronal subgroups. The findings suggest that spectral integration modules in AI differ in what specific stimulus aspects are processed, but they are similar in the manner in which stimulus information is processed.	[Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Otolaryngol HNS, Coleman Mem Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Atencio, CA (corresponding author), Univ Calif San Francisco, UCSF Ctr Integrat Neurosci, Dept Otolaryngol HNS, Coleman Mem Lab, San Francisco, CA 94143 USA.	craig@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health [DC02260, MH077970]; Coleman Memorial Fund; Hearing Research Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coleman Memorial Fund; Hearing Research Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (DC02260, MH077970), the Coleman Memorial Fund, and Hearing Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cheung SW, 2001, J NEUROPHYSIOL, V85, P1732, DOI 10.1152/jn.2001.85.4.1732; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Good PI., 2005, RESAMPLING METHODS P, V3rd ed.; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Langner G, 1997, ACTA OTO-LARYNGOL, P68; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MIDDLEBROOKS JC, 1980, BRAIN RES, V181, P31, DOI 10.1016/0006-8993(80)91257-3; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; PHILLIPS DP, 1992, CEREB CORTEX, V2, P425, DOI 10.1093/cercor/2.5.425; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; Read HL, 2008, NEUROSCIENCE, V152, P151, DOI 10.1016/j.neuroscience.2007.11.026; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Read HL, 2011, HEARING RES, DOI [10.1016/ j.heares.2010.1011.1010, DOI 10.1016/J.HEARES.2010.1011.1010]; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Schreiner CE, 1998, AUDIOL NEURO-OTOL, V3, P104, DOI 10.1159/000013785; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; SUPIN AY, 1994, NEUROSCI LETT, V165, P195, DOI 10.1016/0304-3940(94)90743-9; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TSO DY, 1986, J NEUROSCI, V6, P1160; WINER JA, 1992, MAMMALIAN AUDITORY P, P222; Wise KD, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1511497; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Yuan KX, 2011, J NEUROSCI, V31, P13333, DOI 10.1523/JNEUROSCI.1000-11.2011	75	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e31537	10.1371/journal.pone.0031537	http://dx.doi.org/10.1371/journal.pone.0031537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22384036	Green Submitted, gold, Green Published			2022-12-25	WOS:000302918500028
J	Jackson, MC; Donohue, I; Jackson, AL; Britton, JR; Harper, DM; Grey, J				Jackson, Michelle C.; Donohue, Ian; Jackson, Andrew L.; Britton, J. Robert; Harper, David M.; Grey, Jonathan			Population-Level Metrics of Trophic Structure Based on Stable Isotopes and Their Application to Invasion Ecology	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; CARP CYPRINUS-CARPIO; LAKE NAIVASHA; RATIOS PROVIDE; NICHE OVERLAP; COMPETITION; PREDATOR; FISHERY; IMPACTS; FUTURE	Biological invasions are a significant driver of human-induced global change and many ecosystems sustain sympatric invaders. Interactions occurring among these invaders have important implications for ecosystem structure and functioning, yet they are poorly understood. Here we apply newly developed metrics derived from stable isotope data to provide quantitative measures of trophic diversity within populations or species. We then use these to test the hypothesis that sympatric invaders belonging to the same functional feeding group occupy a smaller isotopic niche than their allopatric counterparts. Two introduced, globally important, benthic omnivores, Louisiana swamp crayfish (Procambarus clarkii) and carp (Cyprinus carpio), are sympatric in Lake Naivasha, Kenya. We applied our metrics to an 8-year data set encompassing the establishment of carp in the lake. We found a strong asymmetric interaction between the two invasive populations, as indicated by inverse correlations between carp abundance and measures of crayfish trophic diversity. Lack of isotopic niche overlap between carp and crayfish in the majority of years indicated a predominantly indirect interaction. We suggest that carp-induced habitat alteration reduced the diversity of crayfish prey, resulting in a reduction in the dietary niche of crayfish. Stable isotopes provide an integrated signal of diet over space and time, offering an appropriate scale for the study of population niches, but few isotope studies have retained the often insightful information revealed by variability among individuals in isotope values. Our population metrics incorporate such variation, are robust to the vagaries of sample size and are a useful additional tool to reveal subtle dietary interactions among species. Although we have demonstrated their applicability specifically using a detailed temporal dataset of species invasion in a lake, they have a wide array of potential ecological applications.	[Jackson, Michelle C.; Grey, Jonathan] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Donohue, Ian; Jackson, Andrew L.] Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Donohue, Ian; Jackson, Andrew L.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Britton, J. Robert] Bournemouth Univ, Ctr Conservat Ecol & Environm Change, Bournemouth, Dorset, England; [Harper, David M.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Grey, Jonathan] Max Planck Inst Limnol, Dept Physiol Ecol, Poln, Germany	University of London; Queen Mary University London; Trinity College Dublin; Trinity College Dublin; Bournemouth University; University of Leicester; Max Planck Society	Jackson, MC (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	j.grey@qmul.ac.uk	Jackson, Andrew L/D-3441-2009; Donohue, Ian/A-7270-2010; Harper, David M/A-1765-2011; Britton, Robert/B-5040-2009; Grey, Jonathan/B-3346-2012; Britton, Robert/AAO-6673-2020	Jackson, Andrew L/0000-0001-7334-0434; Donohue, Ian/0000-0002-4698-6448; Britton, Robert/0000-0003-1853-3086; Grey, Jonathan/0000-0001-9069-2271; Britton, Robert/0000-0003-1853-3086; Jackson, Michelle/0000-0003-2227-1111	British Ecological Society	British Ecological Society	The British Ecological Society provided a small ecological project grant (http://www.britishecologicalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Batschelet E, 1981, CIRCULAR STAT BIOL; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, BIOL INVASIONS, V12, P3439, DOI 10.1007/s10530-010-9742-7; Gherardi F, 2011, FRESHWATER BIOL, V56, P1567, DOI 10.1111/j.1365-2427.2011.02595.x; Grey J, 2002, ISOT ENVIRON HEALT S, V38, P245, DOI 10.1080/10256010208033269; Grey J, 2006, POL J ECOL, V54, P563; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; Hickley P, 2002, HYDROBIOLOGIA, V488, P181, DOI 10.1023/A:1023334715893; Hinojosa-Garro D, 2004, HYDROBIOLOGIA, V515, P115, DOI 10.1023/B:HYDR.0000027323.77213.39; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ings NL, 2010, OECOLOGIA, V163, P127, DOI 10.1007/s00442-009-1558-8; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lohrer AM, 2002, ECOLOGY, V83, P719, DOI 10.2307/3071876; Maguire CM, 2006, FRESHWATER BIOL, V51, P1310, DOI 10.1111/j.1365-2427.2006.01568.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Petr T, 2000, 396 FAO; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricklefs RE, 1998, FUNCT ECOL, V12, P871, DOI 10.1046/j.1365-2435.1998.00263.x; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402	39	244	246	5	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31757	10.1371/journal.pone.0031757	http://dx.doi.org/10.1371/journal.pone.0031757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363724	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700092
J	Konietschke, F; Libiger, O; Hothorn, LA				Konietschke, Frank; Libiger, Ondrej; Hothorn, Ludwig A.			Nonparametric Evaluation of Quantitative Traits in Population-Based Association Studies when the Genetic Model is Unknown	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SAMPLE-SIZE; TESTS	Statistical association between a single nucleotide polymorphism (SNP) genotype and a quantitative trait in genome-wide association studies is usually assessed using a linear regression model, or, in the case of non-normally distributed trait values, using the Kruskal-Wallis test. While linear regression models assume an additive mode of inheritance via equi-distant genotype scores, Kruskal-Wallis test merely tests global differences in trait values associated with the three genotype groups. Both approaches thus exhibit suboptimal power when the underlying inheritance mode is dominant or recessive. Furthermore, these tests do not perform well in the common situations when only a few trait values are available in a rare genotype category (disbalance), or when the values associated with the three genotype categories exhibit unequal variance (variance heterogeneity). We propose a maximum test based on Marcus-type multiple contrast test for relative effect sizes. This test allows model-specific testing of either dominant, additive or recessive mode of inheritance, and it is robust against variance heterogeneity. We show how to obtain mode-specific simultaneous confidence intervals for the relative effect sizes to aid in interpreting the biological relevance of the results. Further, we discuss the use of a related all-pairwise comparisons contrast test with range preserving confidence intervals as an alternative to Kruskal-Wallis heterogeneity test. We applied the proposed maximum test to the Bogalusa Heart Study dataset, and gained a remarkable increase in the power to detect association, particularly for rare genotypes. Our simulation study also demonstrated that the proposed non-parametric tests control family-wise error rate in the presence of non-normality and variance heterogeneity contrary to the standard parametric approaches. We provide a publicly available R library nparcomp that can be used to estimate simultaneous confidence intervals or compatible multiplicity-adjusted p-values associated with the proposed maximum test.	[Konietschke, Frank] Univ Gottingen, Dept Med Stat, Gottingen, Germany; [Libiger, Ondrej; Hothorn, Ludwig A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hothorn, Ludwig A.] Leibniz Univ Hannover, Inst Biostat, Hannover, Germany	University of Gottingen; Scripps Research Institute; Leibniz University Hannover	Konietschke, F (corresponding author), Univ Gottingen, Dept Med Stat, Gottingen, Germany.	hothorn@biostat.uni-hannover.de		Konietschke, Frank/0000-0002-5674-2076	DFG [Br 655/16-1, HO-1687/9]	DFG(German Research Foundation (DFG))	The work was supported by DFG Br 655/16-1 (Frank Konietschke) and DFG HO-1687/9 (Ludwig A. Hothorn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathke AC, RECENT ADV TRENDS NO, P109; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Bretz F, 2001, BIOMETRICAL J, V43, P645, DOI 10.1002/1521-4036(200109)43:5<645::AID-BIMJ645>3.0.CO;2-F; Brown BM, 2002, AUST NZ J STAT, V44, P427, DOI 10.1111/1467-842X.00244; Browne RH, 2010, AM STAT, V64, P30, DOI 10.1198/tast.2010.08261; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Brunner E, 2001, STAT PAP, V42, P1, DOI 10.1007/s003620000039; Fanous AH, 2009, AM J MED GENET B, V150B, P411, DOI 10.1002/ajmg.b.30833; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hasler M, 2008, BIOMETRICAL J, V50, P793, DOI 10.1002/bimj.200710466; Hothorn T, 2007, COIN CONDITIONAL INF; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Konietschke F, 2009, THESIS GEORG AUGUST; KRUGLYAK L, 1995, GENETICS, V139, P1421; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Marcus R, 1982, STATISTICS A, V11, P615; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pfeiffer S, 2010, THESIS U GOTTINGEN; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ryu E, 2009, STAT MED, V28, P3179, DOI 10.1002/sim.3700; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; Thangavelu K, 2007, J STAT PLAN INFER, V137, P720, DOI 10.1016/j.jspi.2006.06.005; Wheeler HE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000685	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31242	10.1371/journal.pone.0031242	http://dx.doi.org/10.1371/journal.pone.0031242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363593	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700038
J	Mast, TG; Fadool, DA				Mast, Thomas Gerald; Fadool, Debra Ann			Mature and Precursor Brain-Derived Neurotrophic Factor Have Individual Roles in the Mouse Olfactory Bulb	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; NERVE GROWTH-FACTOR; KV1.3 CHANNEL; MITRAL CELLS; ALZHEIMERS-DISEASE; NEURONAL APOPTOSIS; STATUS-EPILEPTICUS; CRITICAL PERIOD; NARIS CLOSURE; SPINAL-CORD	Background: Sensory deprivation induces dramatic morphological and neurochemical changes in the olfactory bulb (OB) that are largely restricted to glomerular and granule layer interneurons. Mitral cells, pyramidal-like neurons, are resistant to sensory-deprivation-induced changes and are associated with the precursor to brain-derived neurotrophic factor (proBDNF); here, we investigate its unknown function in the adult mouse OB. Principal Findings: As determined using brain-slice electrophysiology in a whole-cell configuration, brain-derived neurotrophic factor (BDNF), but not proBDNF, increased mitral cell excitability. BDNF increased mitral cell action potential firing frequency and decreased interspike interval in response to current injection. In a separate set of experiments, intranasal delivery of neurotrophic factors to awake, adult mice was performed to induce sustained interneuron neurochemical changes. ProBDNF, but not BDNF, increased activated-caspase 3 and reduced tyrosine hydroxylase immunoreactivity in OB glomerular interneurons. In a parallel set of experiments, short-term sensory deprivation produced by unilateral naris occlusion generated an identical phenotype. Conclusions: Our results indicate that only mature BDNF increases mitral cell excitability whereas proBDNF remains ineffective. Our demonstration that proBDNF activates an apoptotic marker in vivo is the first for any proneurotrophin and establishes a role for proBDNF in a model of neuronal plasticity.	[Mast, Thomas Gerald; Fadool, Debra Ann] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Mast, Thomas Gerald; Fadool, Debra Ann] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Fadool, Debra Ann] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Mast, TG (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	mast@neuro.fsu.edu			U.S. National Institutes of Health (NIH) [R01 DC003387, T32 DC00044]; National Institutes of Deaf and Communications Disorders (NIDCD); Florida State University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003387, T32DC000044] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Deaf and Communications Disorders (NIDCD); Florida State University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the U.S. National Institutes of Health (NIH) [R01 DC003387, and T32 DC00044] from the National Institutes of Deaf and Communications Disorders (NIDCD) and a Dissertation Award from The Florida State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1988, BRAIN RES, V450, P69, DOI 10.1016/0006-8993(88)91545-4; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Biju KC, 2008, NEUROSCI LETT, V447, P42, DOI 10.1016/j.neulet.2008.09.050; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; BRUNJES PC, 1985, DEV BRAIN RES, V22, P1, DOI 10.1016/0165-3806(85)90063-X; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Bush AL, 2008, NEUROSCIENCE, V157, P229, DOI 10.1016/j.neuroscience.2008.08.065; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; Conner JM, 1997, J NEUROSCI, V17, P2295; Cowan CM, 2004, J COMP NEUROL, V474, P136, DOI 10.1002/cne.20120; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Doczi MA, 2008, AM J PHYSIOL-REG I, V295, pR733, DOI 10.1152/ajpregu.00077.2008; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024921; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hamilton KA, 2008, CHEM SENSES, V33, P201, DOI 10.1093/chemse/bjm079; Imamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006729; Jan DD, 2007, J NEUROSCI, V27, P132, DOI 10.1523/JNEUROSCI.2439-06.2007; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Kim HH, 2006, J NEUROSCI, V26, P9548, DOI 10.1523/JNEUROSCI.1727-06.2006; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kupper J, 2002, PFLUG ARCH EUR J PHY, V443, P541, DOI 10.1007/s00424-001-0734-4; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Leon M, 1998, ANN NY ACAD SCI, V855, P104, DOI 10.1111/j.1749-6632.1998.tb10551.x; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; MARGOLIS FL, 1974, BRAIN RES, V81, P469, DOI 10.1016/0006-8993(74)90844-0; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Nakamura Y, 2007, J PHYSIOL-LONDON, V581, P1101, DOI 10.1113/jphysiol.2007.128702; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Nucci C, 2003, EUR J OPHTHALMOL, V13, pS36; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parrish-Aungst S, 2011, BRAIN RES, V1382, P70, DOI 10.1016/j.brainres.2011.01.068; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schulte-Herbruggen O, 2008, J NEUROSCI RES, V86, P2774, DOI 10.1002/jnr.21704; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Speake T, 2004, AM J PHYSIOL-CELL PH, V286, pC611, DOI 10.1152/ajpcell.00292.2003; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; YEH JZ, 1976, J GEN PHYSIOL, V68, P519, DOI 10.1085/jgp.68.5.519	77	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31978	10.1371/journal.pone.0031978	http://dx.doi.org/10.1371/journal.pone.0031978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363780	gold, Green Submitted, Green Published			2022-12-25	WOS:000302873700130
J	Schneider, NA; Low, M; Arlt, D; Part, T				Schneider, Nicole A.; Low, Matthew; Arlt, Debora; Part, Tomas			Contrast in Edge Vegetation Structure Modifies the Predation Risk of Natural Ground Nests in an Agricultural Landscape	PLOS ONE			English	Article							HABITAT FRAGMENTATION; MUSTELA-NIVALIS; FOREST; FARMLAND; BIRDS; RESPONSES; PERMEABILITY; MECHANISMS; INCREASES; SELECTION	Nest predation risk generally increases nearer forest-field edges in agricultural landscapes. However, few studies test whether differences in edge contrast (i.e. hard versus soft edges based on vegetation structure and height) affect edge-related predation patterns and if such patterns are related to changes in nest conspicuousness between incubation and nestling feeding. Using data on 923 nesting attempts we analyse factors influencing nest predation risk at different edge types in an agricultural landscape of a ground-cavity breeding bird species, the Northern Wheatear (Oenanthe oenanthe). As for many other bird species, nest predation is a major determinant of reproductive success in this migratory passerine. Nest predation risk was higher closer to woodland and crop field edges, but only when these were hard edges in terms of ground vegetation structure (clear contrast between tall vs short ground vegetation). No such edge effect was observed at soft edges where adjacent habitats had tall ground vegetation (crop, ungrazed grassland). This edge effect on nest predation risk was evident during the incubation stage but not the nestling feeding stage. Since wheatear nests are depredated by ground-living animals our results demonstrate: (i) that edge effects depend on edge contrast, (ii) that edge-related nest predation patterns vary across the breeding period probably resulting from changes in parental activity at the nest between the incubation and nestling feeding stage. Edge effects should be put in the context of the nest predator community as illustrated by the elevated nest predation risk at hard but not soft habitat edges when an edge is defined in terms of ground vegetation. These results thus can potentially explain previously observed variations in edge-related nest predation risk.	[Schneider, Nicole A.; Low, Matthew; Arlt, Debora; Part, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Arlt, Debora] Univ Reading, Ctr Agri Environm Res, Sch Agr Policy & Dev, Reading, Berks, England	Swedish University of Agricultural Sciences; University of Reading	Schneider, NA (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	nicole.schneider@slu.se		Low, Matthew/0000-0002-7345-6063; Part, Tomas/0000-0001-7388-6672	Swedish Research Council; Helge Ax:son Johnson's Foundation; Formas; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax:son Johnson's Foundation; Formas(Swedish Research Council Formas); Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	This study was supported by the Swedish Research Council (to TP), Formas (to TP and ML), Helge Ax:son Johnson's Foundation, Royal Swedish Academy of Sciences, Alvin's Foundation, and Swedish Ornithological Society (to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Brandt MJ, 2007, ACTA THERIOL, V52, P13, DOI 10.1007/BF03194195; Cain JW, 2006, J WILDLIFE MANAGE, V70, P522, DOI 10.2193/0022-541X(2006)70[522:IOMAON]2.0.CO;2; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Cooch E., 2008, PROGRAM MARK GENTLE; Cramp S., 1985, HDB BIRDS EUROPE MID; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; FenskeCrawford TJ, 1997, CONDOR, V99, P14, DOI 10.2307/1370220; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lopez-Barrera F, 2007, LANDSCAPE ECOL, V22, P189, DOI 10.1007/s10980-006-9020-3; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; MacDonald DW, 2004, BIOLOGIA, V59, P235; Malt JM, 2009, ECOL APPL, V19, P1274, DOI 10.1890/08-0598.1; Manson RH, 1999, LANDSCAPE ECOL, V14, P355, DOI 10.1023/A:1008093823391; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MAYFIELD HF, 1975, WILSON BULL, V87, P456; McDonald PG, 2009, BEHAV ECOL, V20, P821, DOI 10.1093/beheco/arp066; MOLLER AP, 1989, OIKOS, V56, P240, DOI 10.2307/3565342; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NOUR N, 1993, ECOGRAPHY, V16, P111, DOI 10.1111/j.1600-0587.1993.tb00063.x; Oberg M, 2009, THESIS SWEDISH U AGR, P35; Part T, 2002, J AVIAN BIOL, V33, P39, DOI 10.1034/j.1600-048X.2002.330107.x; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Purger JJ, 2008, POL J ECOL, V56, P481; PUSENIUS J, 1993, ANN ZOOL FENN, V30, P143; R Core Team, 2022, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Salek M, 2009, AGR ECOSYST ENVIRON, V134, P8, DOI 10.1016/j.agee.2009.06.018; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Soderstrom B, 1998, OECOLOGIA, V117, P108, DOI 10.1007/s004420050638; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; Vander Haegen WM, 2009, CONDOR, V104, P496; Vergara PM, 2009, ECOL MODEL, V220, P1189, DOI 10.1016/j.ecolmodel.2009.02.015; Weatherhead PJ, 2004, J AVIAN BIOL, V35, P185, DOI 10.1111/j.0908-8857.2004.03336.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winter M, 2000, CONDOR, V102, P256, DOI 10.1650/0010-5422(2000)102[0256:EFEEOM]2.0.CO;2	49	20	20	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31517	10.1371/journal.pone.0031517	http://dx.doi.org/10.1371/journal.pone.0031517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363659	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700064
J	Tabu, C; Breiman, RF; Ochieng, B; Aura, B; Cosmas, L; Audi, A; Olack, B; Bigogo, G; Ongus, JR; Fields, P; Mintz, E; Burton, D; Oundo, J; Feikin, DR				Tabu, Collins; Breiman, Robert F.; Ochieng, Benjamin; Aura, Barrack; Cosmas, Leonard; Audi, Allan; Olack, Beatrice; Bigogo, Godfrey; Ongus, Juliette R.; Fields, Patricia; Mintz, Eric; Burton, Deron; Oundo, Joe; Feikin, Daniel R.			Differing Burden and Epidemiology of Non-Typhi Salmonella Bacteremia in Rural and Urban Kenya, 2006-2009	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; COMMUNITY-ACQUIRED BACTEREMIA; WESTERN KENYA; TRIMETHOPRIM-SULFAMETHOXAZOLE; BACTERIAL-INFECTIONS; FALCIPARUM-MALARIA; INVASIVE BACTERIAL; MALAWIAN CHILDREN; ADULTS; MORTALITY	Background: The epidemiology of non-Typhi Salmonella (NTS) bacteremia in Africa will likely evolve as potential co-factors, such as HIV, malaria, and urbanization, also change. Methods: As part of population-based surveillance among 55,000 persons in malaria-endemic, rural and malaria-nonendemic, urban Kenya from 2006-2009, blood cultures were obtained from patients presenting to referral clinics with fever >= 38.0 degrees C or severe acute respiratory infection. Incidence rates were adjusted based on persons with compatible illnesses, but whose blood was not cultured. Results: NTS accounted for 60/155 (39%) of blood culture isolates in the rural and 7/230 (3%) in the urban sites. The adjusted incidence in the rural site was 568/100,000 person-years, and the urban site was 51/100,000 person-years. In both sites, the incidence was highest in children < 5 years old. The NTS-to-typhoid bacteremia ratio in the rural site was 4.6 and in the urban site was 0.05. S. Typhimurium represented > 85% of blood NTS isolates in both sites, but only 21% (urban) and 64% (rural) of stool NTS isolates. Overall, 76% of S. Typhimurium blood isolates were multi-drug resistant, most of which had an identical profile in Pulse Field Gel Electrophoresis. In the rural site, the incidence of NTS bacteremia increased during the study period, concomitant with rising malaria prevalence (monthly correlation of malaria positive blood smears and NTS bacteremia cases, Spearman's correlation, p = 0.018 for children, p = 0.16 adults). In the rural site, 80% of adults with NTS bacteremia were HIV-infected. Six of 7 deaths within 90 days of NTS bacteremia had HIV/AIDS as the primary cause of death assigned on verbal autopsy. Conclusions: NTS caused the majority of bacteremias in rural Kenya, but typhoid predominated in urban Kenya, which most likely reflects differences in malaria endemicity. Control measures for malaria, as well as HIV, will likely decrease the burden of NTS bacteremia in Africa.	[Tabu, Collins; Oundo, Joe] Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Tabu, Collins] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Breiman, Robert F.; Ochieng, Benjamin; Aura, Barrack; Cosmas, Leonard; Audi, Allan; Olack, Beatrice; Bigogo, Godfrey; Burton, Deron; Oundo, Joe; Feikin, Daniel R.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Nairobi, Kenya; [Breiman, Robert F.; Burton, Deron; Feikin, Daniel R.] Ctr Dis Control & Prevent, Int Emerging Infect Program, Nairobi, Kenya; [Ongus, Juliette R.] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Fields, Patricia; Mintz, Eric] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology; Centers for Disease Control & Prevention - USA	Tabu, C (corresponding author), Field Epidemiol & Lab Training Program, Nairobi, Kenya.	dfeikin@jhsph.edu	Bigogo, Godfrey/W-3591-2019	Tabu, Collins/0000-0002-0537-1172; Audi, Allan/0000-0003-1683-554X	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Breiman RF, PLOS ONE IN PRESS; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Clinical and Laboratory Standard Institute (CBI), 2009, PERF STAND ANT SUS S; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Gilks CF, 1998, BRIT MED BULL, V54, P383, DOI 10.1093/oxfordjournals.bmb.a011695; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Watera C, 2004, AIDS, V18, P1210, DOI 10.1097/00002030-200405210-00018; WHO, 2008, INT MAN CHILDH ILLN; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0	43	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31237	10.1371/journal.pone.0031237	http://dx.doi.org/10.1371/journal.pone.0031237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363591	gold, Green Published, Green Submitted			2022-12-25	WOS:000302873700036
J	Cho, J; Bhatt, R; Elgersma, Y; Silva, AJ				Cho, Jeiwon; Bhatt, Rushi; Elgersma, Ype; Silva, Alcino J.			alpha-Calcium Calmodulin Kinase II Modulates the Temporal Structure of Hippocampal Bursting Patterns	PLOS ONE			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; SPATIAL MEMORY; SYNAPTIC PLASTICITY; FIRING PATTERNS; UNIT-ACTIVITY; RAT-BRAIN; NEURONS; CAMKII; MICE	The alpha calcium calmodulin kinase II (alpha-CaMKII) is known to play a key role in CA1/CA3 synaptic plasticity, hippocampal place cell stability and spatial learning. Additionally, there is evidence from hippocampal electrophysiological slice studies that this kinase has a role in regulating ion channels that control neuronal excitability. Here, we report in vivo single unit studies, with alpha-CaMKII mutant mice, in which threonine 305 was replaced with an aspartate (alpha-CaMKIIT305D mutants), that indicate that this kinase modulates spike patterns in hippocampal pyramidal neurons. Previous studies showed that alpha-CaMKIIT305D mutants have abnormalities in both hippocampal LTP and hippocampal-dependent learning. We found that besides decreased place cell stability, which could be caused by their LTP impairments, the hippocampal CA1 spike patterns of alpha-CaMKIIT305D mutants were profoundly abnormal. Although overall firing rate, and overall burst frequency were not significantly altered in these mutants, inter-burst intervals, mean number of intra-burst spikes, ratio of intra-burst spikes to total spikes, and mean intra-burst intervals were significantly altered. In particular, the intra burst intervals of place cells in alpha-CaMKIIT305D mutants showed higher variability than controls. These results provide in vivo evidence that besides its well-known function in synaptic plasticity, alpha-CaMKII, and in particular its inhibitory phosphorylation at threonine 305, also have a role in shaping the temporal structure of hippocampal burst patterns. These results suggest that some of the molecular processes involved in acquiring information may also shape the patterns used to encode this information.	[Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90024 USA; [Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90024 USA; [Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Cho, Jeiwon] Univ Sci & Technol, Dept Neurosci, Seoul, South Korea; [Bhatt, Rushi] Yahoo SDC, Bangalore, Karnataka, India; [Elgersma, Ype] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Korea Institute of Science & Technology (KIST); Erasmus University Rotterdam; Erasmus MC	Cho, J (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA.	silvaa@mednet.ucla.edu	Elgersma, Ype/F-5164-2013; Silva, Alcino/ABD-7684-2021	Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	National Institutes of Health [R37-AG013622]; NATIONAL INSTITUTE ON AGING [R37AG013622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from National Institutes of Health (R37-AG013622) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKE L, 1995, J NEUROSCI, V15, P6797; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; Churn SB, 2000, P NATL ACAD SCI USA, V97, P5604, DOI 10.1073/pnas.080071697; Devijver PA, PATTERN RECOGNITION; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nassirpour R, 2010, J NEUROSCI, V30, P13419, DOI 10.1523/JNEUROSCI.2966-10.2010; O'Keefe J, 1987, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Sametsky EA, 2009, NEUROBIOL LEARN MEM, V92, P120, DOI 10.1016/j.nlm.2009.02.006; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shyu, 1992, STAT MODELS; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yao WD, 2001, J NEUROPHYSIOL, V85, P1384, DOI 10.1152/jn.2001.85.4.1384	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31649	10.1371/journal.pone.0031649	http://dx.doi.org/10.1371/journal.pone.0031649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363696	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500069
J	Liang, CB; Luo, HS; Liu, Y; Cao, JW; Xia, H				Liang, Chengbai; Luo, Hesheng; Liu, Ying; Cao, Jiwang; Xia, Hong			Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CORTICOTROPIN-RELEASING-FACTOR; UP-REGULATION; MOTILITY; DISTENSION; RECEPTORS; HYPERSENSITIVITY; NEUROPEPTIDES; LOCALIZATION; SENSITIVITY	Objective: To study the relationship between brain-gut peptides, gastrointestinal hormones and altered motility in a rat model of repetitive water avoidance stress (WAS), which mimics the irritable bowel syndrome (IBS). Methods: Male Wistar rats were submitted daily to 1-h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Plasma hormones were determined using Enzyme Immunoassay Kits. Proximal colonic smooth muscle (PCSM) contractions were studied in an organ bath system. PCSM cells were isolated by enzymatic digestion and IKv and IBKca were recorded by the patch-clamp technique. Results: The number of fecal pellets during 1 h of acute restraint stress and the plasma hormones levels of substance P (SP), thyrotropin-releasing hormone (TRH), motilin (MTL), and cholecystokinin (CCK) in WAS rats were significantly increased compared with SWAS rats, whereas vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP) and corticotropin releasing hormone (CRH) in WAS rats were not significantly changed and peptide YY (PYY) in WAS rats was significantly decreased. Likewise, the amplitudes of spontaneous contractions of PCSM in WAS rats were significantly increased comparing with SWAS rats. The plasma of WAS rats (100 mu l) decreased the amplitude of spontaneous contractions of controls. The IKv and IBKCa of PCSMs were significantly decreased in WAS rats compared with SWAS rats and the plasma of WAS rats (100 mu l) increased the amplitude of IKv and IBKCa in normal rats. Conclusion: These results suggest that WAS leads to changes of plasma hormones levels and to disordered myogenic colonic motility in the short term, but that the colon rapidly establishes a new equilibrium to maintain the normal baseline functioning.	[Liang, Chengbai; Luo, Hesheng; Liu, Ying; Cao, Jiwang; Xia, Hong] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Peoples R China	Wuhan University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Peoples R China.	xhnkLHS@126.com			National Natural Science Foundation of China [30871148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30871148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bradesi S, 2007, PAIN, V130, P56, DOI 10.1016/j.pain.2006.10.028; BRADETTE M, 1994, DIGEST DIS SCI, V39, P449, DOI 10.1007/BF02088327; Cassar-Malek I, 1998, PROD ANIM, V11, P365; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Gross KJ, 2007, INFLAMM BOWEL DIS, V13, P918, DOI 10.1002/ibd.20129; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Jaworek J, 2010, J PHYSIOL PHARMACOL, V61, P523; Kamerling IMC, 2003, BRIT J CLIN PHARMACO, V55, P538, DOI 10.1046/j.1365-2125.2003.01812.x; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; KELLOW JE, 1991, GASTROENTEROLOGY, V101, P1621, DOI 10.1016/0016-5085(91)90400-F; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Lee Oh Young, 2010, J Neurogastroenterol Motil, V16, P120, DOI 10.5056/jnm.2010.16.2.120; Maunder RG, 2008, CURR MOL MED, V8, P247, DOI 10.2174/156652408784533832; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; Monnikes H, 2001, DIGEST DIS, V19, P201, DOI 10.1159/000050681; Murray CDR, 2004, GASTROENTEROLOGY, V127, P1695, DOI 10.1053/j.gastro.2004.08.057; NIEDERAU C, 1992, GASTROENTEROLOGY, V102, P1889, DOI 10.1016/0016-5085(92)90310-U; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rettenbacher M, 2001, N-S ARCH PHARMACOL, V364, P291, DOI 10.1007/s002100100454; Rojas-Macias V, 2010, Rev Gastroenterol Mex, V75, P421; Sabate JM, 2002, NEUROGASTROENT MOTIL, V14, P689, DOI 10.1046/j.1365-2982.2002.00370.x; Simren M, 2001, GUT, V48, P20, DOI 10.1136/gut.48.1.20; Sjolund K, 1997, NEUROGASTROENT MOTIL, V9, P143, DOI 10.1046/j.1365-2982.1997.d01-46.x; Van der Veek PPJ, 2006, SCAND J GASTROENTERO, V41, P170, DOI 10.1080/00365520500206210; VASSALLO M, 1992, GASTROENTEROLOGY, V102, P102, DOI 10.1016/0016-5085(92)91789-7; Venkova K, 2010, NEUROPHARMACOLOGY, V58, P1161, DOI 10.1016/j.neuropharm.2010.02.012; Vicari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018647; Vogalis F, 2000, J AUTON PHARMACOL, V20, P207, DOI 10.1046/j.1365-2680.2000.00183.x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; WELGAN P, 1985, PSYCHOSOM MED, V47, P139, DOI 10.1097/00006842-198503000-00005; WHITEHEAD WE, 1992, GUT, V33, P825, DOI 10.1136/gut.33.6.825; Whitehead WE, 1998, GASTROENTEROLOGY, V115, P1263, DOI 10.1016/S0016-5085(98)70099-X; Xu L, 2007, CLIN EXP PHARMACOL P, V34, P120, DOI 10.1111/j.1440-1681.2007.04465.x; Yuan PQ, 2010, PEPTIDES, V31, P322, DOI 10.1016/j.peptides.2009.11.012; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; ZHANG ZB, 1992, BIOMED RES-TOKYO, V13, P275; Zou N, 2008, TRANSL RES, V152, P283, DOI 10.1016/j.trsl.2008.10.002	46	23	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31774	10.1371/journal.pone.0031774	http://dx.doi.org/10.1371/journal.pone.0031774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363728	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500086
J	Liao, CC; Su, TC; Sung, FC; Chou, WH; Chen, TL				Liao, Chien-Chang; Su, Ta-Chen; Sung, Fung-Chang; Chou, Wan-Hsin; Chen, Ta-Liang			Does Hepatitis C Virus Infection Increase Risk for Stroke? A Population-Based Cohort Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ASSOCIATION; SEROPOSITIVITY; COUNTRIES	Background: relationship between hepatitis C virus infection and risk of stroke remains inconsistent. This study evaluates the risk of stroke in association with chronic hepatitis C infection in a longitudinal population-based cohort. Methods: We identified 4,094 adults newly diagnosed with hepatitis C infection in 2002-2004 from the Taiwan National Health Insurance Research Database. Comparison group consisted of 16,376 adults without hepatitis C infection randomly selected from the same dataset, frequency matched by age and sex. Events of stroke from 2002-2008 were ascertained from medical claims (International Classification of Diseases, Ninth Revision, Clinical Modification, ICD-9-CM, codes 430-438). Multivariate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for potential associated factors including HCV infection, age, sex, low-income status, urbanization, cessation of cigarette smoking, alcohol-related illness, obesity, history of chronic diseases and medication use. Findings: During 96,752 person-years of follow-up, there were 1981 newly diagnosed stroke cases. The HRs of stroke associated with medical conditions such as hypertension, diabetes and heart disease were 1.48 (95% CI 1.33 to 1.65), 1.23 (95% CI 1.11 to 1.36) and 1.17 (95% CI 1.06 to 1.30), respectively, after adjustment for covariates. The cumulative risk of stroke for people with hepatitis C and without hepatitis C infections was 2.5% and 1.9%, respectively (p<0.0001). Compared with people without hepatitis C infection, the adjusted HR of stroke was 1.27 (95% CI 1.14 to 1.41) for people with hepatitis C infection. Conclusion: Chronic hepatitis C infection increases stroke risk and should be considered an important and independent risk factor.	[Liao, Chien-Chang; Chou, Wan-Hsin; Chen, Ta-Liang] Taipei Med Univ, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang; Chou, Wan-Hsin; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Cardiol, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Liao, CC (corresponding author), Taipei Med Univ, Ctr Hlth Policy Res, Taipei, Taiwan.	tlc@tmu.edu.tw		SU, TA-CHEN/0000-0001-7523-7166	Foundation for Anesthesia Education and Research at Taipei Medical University, Taiwan; Clinical Trial and Research Center for Excellence, Department of Health, Taiwan [DOH 100-TD-B-111-004]	Foundation for Anesthesia Education and Research at Taipei Medical University, Taiwan; Clinical Trial and Research Center for Excellence, Department of Health, Taiwan	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant at Taipei Medical University, Taiwan, and by the Clinical Trial and Research Center for Excellence, Department of Health, Taiwan (grant DOH 100-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcari CM, 2006, CLIN INFECT DIS, V43, pE53, DOI 10.1086/507031; Aslam F, 2010, ATHEROSCLEROSIS, V209, P340, DOI 10.1016/j.atherosclerosis.2009.10.006; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Biffi A, 2011, STROKE, V42, P1314, DOI 10.1161/STROKEAHA.110.605923; Bilora F, 2008, ANGIOLOGY, V59, P717, DOI 10.1177/0003319707311536; Boddi M, 2010, J CLIN VIROL, V47, P72, DOI 10.1016/j.jcv.2009.10.005; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Flamm SL, 2003, JAMA-J AM MED ASSOC, V289, P2413, DOI 10.1001/jama.289.18.2413; Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3; Freiberg MS, 2007, AIDS, V21, P193, DOI 10.1097/QAD.0b013e3280118a0d; Fukui M, 2003, JAMA-J AM MED ASSOC, V289, P1245, DOI 10.1001/jama.289.10.1245-b; Ishizaka N, 2002, LANCET, V359, P133, DOI 10.1016/S0140-6736(02)07339-7; Ishizaka Y, 2003, CIRC J, V67, P26, DOI 10.1253/circj.67.26; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee MH, 2010, STROKE, V41, P2894, DOI 10.1161/STROKEAHA.110.598136; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oyake N, 2008, J NEPHROL, V21, P345; Rouabhia S, 2010, WORLD J GASTROENTERO, V16, P3427, DOI 10.3748/wjg.v16.i27.3427; Sanyal AJ, 2003, AM J GASTROENTEROL, V98, P2064, DOI [10.1016/S0002-9270(03)00551-3, 10.1111/j.1572-0241.2003.07640.x]; Shah NR, 2010, ANN INTERN MED, V152, DOI 10.7326/0003-4819-152-2-201001190-02004; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Volzke H, 2004, ATHEROSCLEROSIS, V174, P99, DOI 10.1016/j.atherosclerosis.2004.01.010; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006	26	88	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31527	10.1371/journal.pone.0031527	http://dx.doi.org/10.1371/journal.pone.0031527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363662	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500051
J	Pankhurst, MW; Gell, DA; Butler, CW; Kirkcaldie, MTK; West, AK; Chung, RS				Pankhurst, Michael W.; Gell, David A.; Butler, Chris W.; Kirkcaldie, Matthew T. K.; West, Adrian K.; Chung, Roger S.			Metallothionein (MT) -I and MT-II Expression Are Induced and Cause Zinc Sequestration in the Liver after Brain Injury	PLOS ONE			English	Article							IMPAIRED INFLAMMATORY RESPONSE; OXIDATIVE STRESS; CELL-DEATH; HEPATIC ZINC; INDUCTION; INTERLEUKIN-6; MICE; INTERFERENCE; ANTIOXIDANT; DISRUPTION	Experiments with transgenic over-expressing, and null mutant mice have determined that metallothionein-I and -II (MT-I/II) are protective after brain injury. MT-I/II is primarily a zinc-binding protein and it is not known how it provides neuroprotection to the injured brain or where MT-I/II acts to have its effects. MT-I/II is often expressed in the liver under stressful conditions but to date, measurement of MT-I/II expression after brain injury has focused primarily on the injured brain itself. In the present study we measured MT-I/II expression in the liver of mice after cryolesion brain injury by quantitative reverse-transcriptase PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) with the UC1MT antibody. Displacement curves constructed using MT-I/II knockout (MT-I/II 2/2) mouse tissues were used to validate the ELISA. Hepatic MT-I and MT-II mRNA levels were significantly increased within 24 hours of brain injury but hepatic MT-I/II protein levels were not significantly increased until 3 days post injury (DPI) and were maximal at the end of the experimental period, 7 DPI. Hepatic zinc content was measured by atomic absorption spectroscopy and was found to decrease at 1 and 3 DPI but returned to normal by 7DPI. Zinc in the livers of MT-I/II-/- mice did not show a return to normal at 7 DPI which suggests that after brain injury, MT-I/II is responsible for sequestering elevated levels of zinc to the liver. Conclusion: MT-I/II is up-regulated in the liver after brain injury and modulates the amount of zinc that is sequestered to the liver.	[Pankhurst, Michael W.; Gell, David A.; Butler, Chris W.; West, Adrian K.; Chung, Roger S.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Kirkcaldie, Matthew T. K.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Pankhurst, Michael W.] Univ Otago, Dept Anat, Dunedin, New Zealand	University of Tasmania; University of Tasmania; University of Otago	Pankhurst, MW (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	michael.pankhurst@anatomy.otago.ac.nz	Chung, Roger/ABF-8395-2020; Pankhurst, Michael/F-2585-2017; Kirkcaldie, Matthew TK/J-4418-2012; West, Adrian/AAR-8857-2021	Pankhurst, Michael/0000-0002-0976-5742; Kirkcaldie, Matthew TK/0000-0003-3285-0168; Gell, David/0000-0003-0382-1181; Chung, Roger/0000-0002-9286-947X	National Health and Medical Research Council of Australia [490025, 544913]; Australian Research Council [DP0984673]; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by research grants from the National Health and Medical Research Council of Australia (ID# 490025, 544913) and Australian Research Council (DP0984673). RSC holds an Australian Research Council Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Carrasco J, 2003, NEUROBIOL DIS, V13, P22, DOI 10.1016/S0969-9961(03)00015-9; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Cho K, 2004, PATHOBIOLOGY, V71, P223, DOI 10.1159/000078677; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; COYLE P, 1993, J NUTR, V123, P1464, DOI 10.1093/jn/123.9.1464; COYLE P, 1995, BIOCHEM J, V309, P25, DOI 10.1042/bj3090025; DE SK, 1990, J BIOL CHEM, V265, P15267; Ding HQ, 2002, BURNS, V28, P215, DOI 10.1016/S0305-4179(02)00018-9; Emeny RT, 2009, CHEM-BIOL INTERACT, V181, P243, DOI 10.1016/j.cbi.2009.06.018; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Giles GI, 2002, BIOCHEM J, V364, P579, DOI 10.1042/BJ20011882; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hernandez J, 2000, CYTOKINE, V12, P791, DOI 10.1006/cyto.1999.0629; ISZARD MB, 1995, TOXICOL APPL PHARM, V133, P305, DOI 10.1006/taap.1995.1155; Jacob ST, 1999, GENE EXPRESSION, V7, P301; Khatai L, 2004, EUR J BIOCHEM, V271, P2408, DOI 10.1111/j.1432-1033.2004.04160.x; Kimura T, 2008, J HEALTH SCI, V54, P251, DOI 10.1248/jhs.54.251; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; LYNES MA, 1993, TOXICOLOGY, V85, P161, DOI 10.1016/0300-483X(93)90040-Y; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pankhurst NW, 2008, AQUACULTURE, V275, P311, DOI 10.1016/j.aquaculture.2008.01.001; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Penkowa M, 1999, EXP NEUROL, V156, P149, DOI 10.1006/exnr.1998.7009; Penkowa M, 1999, J NEUROSCI, V19, P2535; PHILCOX JC, 1995, BIOCHEM J, V308, P543, DOI 10.1042/bj3080543; Potter EG, 2007, J NEUROTRAUM, V24, P28, DOI 10.1089/neu.2006.0056.R1; Potter EG, 2009, J NEUROSCI RES, V87, P1356, DOI 10.1002/jnr.21963; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Spahl DU, 2003, P NATL ACAD SCI USA, V100, P13952, DOI 10.1073/pnas.2335190100; Span PN, 2003, CLIN CHEM, V49, P1708, DOI 10.1373/49.10.1708; Suemori S, 2006, INVEST OPHTH VIS SCI, V47, P3975, DOI 10.1167/iovs.06-0275; Yang Y, 2001, P NATL ACAD SCI USA, V98, P5556, DOI 10.1073/pnas.101123298; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Zhou ZB, 2003, ACTA PHARMACOL SIN, V24, P764; Zhou ZX, 2004, AM J PATHOL, V164, P1547, DOI 10.1016/S0002-9440(10)63713-3	51	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31185	10.1371/journal.pone.0031185	http://dx.doi.org/10.1371/journal.pone.0031185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363575	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600122
J	Lin, S; Gu, HP; Xu, M; Cui, XJ; Zhang, YY; Gao, W; Yuan, G				Lin, Sen; Gu, Huiping; Xu, Ming; Cui, Xiaojie; Zhang, Youyi; Gao, Wei; Yuan, Gu			The Formation and Stabilization of a Novel G-Quadruplex in the 5 '-Flanking Region of the Relaxin Gene	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RELEVANT G-QUADRUPLEX; AUTOMATED DOCKING; BERBERINE DERIVATIVES; CIRCULAR-DICHROISM; DNA; BINDING; RECOGNITION; PROMOTER; TARGET	It has been reported that binding of STAT3 protein to the 5'-flanking region of the relaxin gene may result in downregulation of the relaxin expression. There is a Guanine(G)-rich segment located in about 3.8 Kb upstream of the relaxin gene and very close to the STAT3's binding site. In our study, NMR spectroscopy revealed the formation of G-quadruplex by this G-rich strand, and the result was confirmed by ESI mass spectrometry and CD spectroscopy. The theoretical structure of RLX G-quadruplex was constructed and refined by molecular modeling. When this relaxin G-quadruplex was stabilized by berberine(Delta Tm=10 degrees C), a natural alkaloid from a Chinese herb, the gene expression could be up-regulated in a dose-dependent manner which was proved by luciferase assay. This result is different from the general G-quadruplex function that inhibiting the telomere replication or down-regulating many oncogenes expression. Therefore, our study reported a novel G- quadruplex in the relaxin gene and complemented the regulation mechanism about gene expression by G- quadruplexes.	[Lin, Sen; Cui, Xiaojie; Yuan, Gu] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Gu, Huiping; Xu, Ming; Zhang, Youyi; Gao, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth,Hosp 3,Minist Educ,Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lin, S (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; guyuan@pku.edu.cn			National Natural Science Foundation of China [90913004, 81070196]; Program for New Century Excellent Talents in University; Beijing Talents Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Talents Foundation	This work was supported by the National Natural Science Foundation of China (no. 90913004 and 81070196) and Program for New Century Excellent Talents in University and Beijing Talents Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Arora A, 2008, FEBS J, V275, P3971, DOI 10.1111/j.1742-4658.2008.06541.x; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bishop GR, 2007, BIOPHYS CHEM, V126, P165, DOI 10.1016/j.bpc.2006.07.009; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cosconati S, 2009, J AM CHEM SOC, V131, P16336, DOI 10.1021/ja9063662; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Grand CL, 2002, EUR J CANCER, V38, pS106; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li HH, 2009, CHEM-EUR J, V15, P2445, DOI 10.1002/chem.200801922; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu XH, 2010, CARDIOVASC RES, V88, P150, DOI 10.1093/cvr/cvq181; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Negri AL, 2004, J NEPHROL, V17, P496; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sherwood O. David, 1994, P861; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zhou J, 2007, CHEM-EUR J, V13, P945, DOI 10.1002/chem.200600424	45	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31201	10.1371/journal.pone.0031201	http://dx.doi.org/10.1371/journal.pone.0031201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22876305	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700031
J	Xu, J; Ji, PF; Zhao, ZX; Zhang, Y; Feng, JX; Wang, J; Li, JT; Zhang, XF; Zhao, L; Liu, GZ; Xu, P; Sun, XW				Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Feng, Jianxin; Wang, Jian; Li, Jiongtang; Zhang, Xiaofeng; Zhao, Lan; Liu, Guangzan; Xu, Peng; Sun, Xiaowen			Genome-Wide SNP Discovery from Transcriptome of Four Common Carp Strains	PLOS ONE			English	Article							ASSOCIATION MAPPING POPULATION; CYPRINUS-CARPIO; LINKAGE MAP; MARKERS; MICROSATELLITE; GENERATION; CATFISH; CONSTRUCTION; SEQUENCES; LOCI	Background: Single nucleotide polymorphisms (SNPs) have been used as genetic marker for genome-wide association studies in many species. Gene-associated SNPs could offer sufficient coverage in trait related research and further more could themselves be causative SNPs for traits. Common carp (Cyprinus carpio) is one of the most important aquaculture species in the world accounting for nearly 14% of freshwater aquaculture production. There are various strains of common carp with different economic traits, however, the genetic mechanism underlying the different traits have not been elucidated yet. In this project, we identified a large number of gene-associated SNPs from four strains of common carp using next-generation sequencing. Results: Transcriptome sequencing of four strains of common carp (mirror carp, purse red carp, Xingguo red carp, Yellow River carp) was performed with Solexa HiSeq2000 platform. De novo assembled transcriptome was used as reference for alignments, and SNP calling was done through BWA and SAMtools. A total of 712,042 Intra-strain SNPs were discovered in four strains, of which 483,276 SNPs for mirror carp, 486,629 SNPs for purse red carp, 478,028 SNPs for Xingguo red carp and 488,281 SNPs for Yellow River carp were discovered, respectively. Besides, 53,893 inter-SNPs were identified. Strain-specific SNPs of four strains were 53,938, 53,866, 48,701, 40,131 in mirror carp, purse red carp, Xingguo red carp and Yellow River carp, respectively. GO and KEGG pathway analysis were done to reveal strain-specific genes affected by strain-specific non-synonymous SNPs. Validation of selected SNPs revealed that 48% percent of SNPs (12 of 25) were tested to be true SNPs. Conclusions: Transcriptome analysis of common carp using RNA-Seq is a cost-effective way of generating numerous reads for SNP discovery. After validation of identified SNPs, these data will provide a solid base for SNP array designing and genome-wide association studies.	[Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Wang, Jian; Li, Jiongtang; Zhao, Lan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Henan, Peoples R China; [Liu, Guangzan] Natl Fish Hatchery Xingguo Red Carp, Xingguo, Jiangxi, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2009AA10Z105, 2011AA100401]; China Ministry of Agriculture "948" Program [2010-Z11]; National Natural Science Foundation [31101893]	National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China); China Ministry of Agriculture "948" Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Department Public Benefit Research Foundation (200903045), National High-tech R&D Program of China (2009AA10Z105 and 2011AA100401), China Ministry of Agriculture "948" Program (2010-Z11) and National Natural Science Foundation (31101893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sun X., 2012, PLANT ANIMAL GENOME; Sun X, 2004, AQUACULTURE, V238, P8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wan Y, 2011, MOL BIOL REPORTS; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang Ya-Qin, 2011, Medical Mycology, V49, P435, DOI 10.3109/13693786.2010.540723; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zheng Xian-Hu, 2011, Yichuan, V33, P1366, DOI 10.3724/SP.J.1005.2011.01366; Zhou Jianfeng, 2004, Genetika, V40, P1389	41	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48140	10.1371/journal.pone.0048140	http://dx.doi.org/10.1371/journal.pone.0048140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22383953	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500040
J	Zhang, XL; Wang, GB; Zhao, LY; Sun, LL; Wang, J; Wu, P; Lu, L; Shi, J				Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie			Clonidine Improved Laboratory-Measured Decision-Making Performance in Abstinent Heroin Addicts	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; VENTROMEDIAL PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; AGONIST CLONIDINE; IMPULSIVITY; COCAINE; DEFICIT; PERSONALITY; DYSFUNCTION; ANTAGONIST	Background: Impulsivity refers to a wide spectrum of actions characterized by quick and nonplanned reactions to external and internal stimuli, without taking into account the possible negative consequences for the individual or others, and decision-making is one of the biologically dissociated impulsive behaviors. Changes in impulsivity may be associated with norepinephrine. Various populations of drug addicts all performed impulsive decision making, which is a key risk factor in drug dependence and relapse. The present study investigated the effects of clonidine, which decreased norepinephrine release through presynaptic alpha-2 receptor activation, on the impaired decision-making performance in abstinent heroin addicts. Methodology/Principal Findings: Decision-making performance was assessed using the original version of Iowa Gambling Task (IGT). Both heroin addicts and normal controls were randomly assigned to three groups receiving clonidine, 0, 75 mu g or 150 mu g orally under double blind conditions. Psychiatric symptoms, including anxiety, depression and impulsivity, were rated on standardized scales. Heroin addicts reported higher scores on the Barratt Impulsiveness Scale and exhibited impaired decision-making on the IGT. A single high-dose of clonidine improved the decision-making performance in heroin addicts. Conclusions/Significance: Our results suggest clonidine may have a potential therapeutic role in heroin addicts by improving the impaired impulsive decision-making. The current findings have important implications for behavioral and pharmacological interventions targeting decision-making in heroin addiction.	[Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Peking University	Zhang, XL (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	shijie@bjmu.edu.cn	SHI, JIE/GXG-3394-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Basic Research Program of China [2009CB522000]; Natural Science Foundation of Beijing Municipality [7092058]; Natural Science Foundation of China [81000571, 91132719]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program of China (No. 2009CB522000), Natural Science Foundation of Beijing Municipality (No. 7092058) and Natural Science Foundation of China (No. 81000571 and 91132719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANAVEKAR SN, 1989, J CLIN PHARMACOL, V29, P321, DOI 10.1002/j.1552-4604.1989.tb03335.x; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1996, ARCH GEN PSYCHIAT, V53, P448; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Arnsten AFT, 1997, PHARMACOL BIOCHEM BE, V58, P55, DOI 10.1016/S0091-3057(96)00477-7; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Brand M, 2008, DRUG ALCOHOL DEPEN, V97, P64, DOI 10.1016/j.drugalcdep.2008.03.017; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; CARLSON S, 1992, BEHAV NEURAL BIOL, V58, P113, DOI 10.1016/0163-1047(92)90327-Z; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Dobrydnjov I, 2004, ANESTH ANALG, V98, P738, DOI 10.1213/01.ANE.0000099719.97261.DA; Economidou D, 2009, BIOL PSYCHIAT, V65, P851, DOI 10.1016/j.biopsych.2008.12.008; Ersche KD, 2005, NEUROPSYCHOPHARMACOL, V30, P2115, DOI 10.1038/sj.npp.1300812; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; [杨会芹 YANG Huiqin], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P4; KAWASAKI H, 1986, JPN J PHARMACOL, V42, P561, DOI 10.1254/jjp.42.561; Kim S, 2010, BIOL PSYCHIAT, V2010, P20; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Mazas CA, 2000, ALCOHOL CLIN EXP RES, V24, P1036, DOI 10.1111/j.1530-0277.2000.tb04647.x; Meana JJ, 1997, BRAIN RES, V744, P216, DOI 10.1016/S0006-8993(96)01080-3; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Morgan MJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1562, DOI 10.1038/sj.npp.1300953; Nieuwenhuis S, 2007, PSYCHOPHARMACOLOGY, V193, P261, DOI 10.1007/s00213-007-0770-7; Passetti F, 2008, DRUG ALCOHOL DEPEN, V94, P82, DOI 10.1016/j.drugalcdep.2007.10.008; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Philipsen A, 2004, J CLIN PSYCHIAT, V65, P1414, DOI 10.4088/JCP.v65n1018; Riekkinen M, 1999, J CLIN PSYCHOPHARM, V19, P444, DOI 10.1097/00004714-199910000-00008; Riekkinen M, 1999, NEUROSCIENCE, V92, P983, DOI 10.1016/S0306-4522(99)00037-8; Shi J, 2007, PHARMACOL BIOCHEM BE, V87, P141, DOI 10.1016/j.pbb.2007.04.010; Sun HS, 2010, BIOL PSYCHIAT, V67, P649, DOI 10.1016/j.biopsych.2009.11.030; Swann AC, 2005, BIOL PSYCHIAT, V57, P1209, DOI 10.1016/j.biopsych.2005.02.007; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wallis JD, 2007, ANN NY ACAD SCI, V1121, P447, DOI 10.1196/annals.1401.009; Watanabe T, 2006, ACTA ANAESTH SCAND, V50, P180, DOI 10.1111/j.1399-6576.2006.00910.x; Zhang XL, 2011, AM J PSYCHIAT, V168, P610, DOI 10.1176/appi.ajp.2010.10040499; Zhu XZ, 2007, CHINESE MENTAL HLTH, V21, P3	52	84	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29084	10.1371/journal.pone.0029084	http://dx.doi.org/10.1371/journal.pone.0029084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22363757	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600002
J	Fu, SM; Xu, J; Li, XB; Xie, YF; Qiu, YF; Du, XY; Yu, S; Bai, YX; Chen, YF; Wang, TK; Wang, ZJ; Yu, YQ; Peng, GN; Huang, KH; Huang, LY; Wang, YF; Chen, ZL				Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Qiu, Yefeng; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Yu, Yaqing; Peng, Guangneng; Huang, Kehe; Huang, Liuyu; Wang, Yufei; Chen, Zeliang			Immunization of Mice with Recombinant Protein CobB or AsnC Confers Protection against Brucella abortus Infection	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; IMMUNE-RESPONSES; GAMMA-INTERFERON; MELITENSIS 16M; BALB/C MICE; LIVE; VACCINATION; IDENTIFICATION; MACROPHAGES; PERSISTENCE	Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-gamma) assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-gamma responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB) or BAB1_1688 (AsnC) plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy.	[Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Huang, Liuyu; Wang, Yufei; Chen, Zeliang] Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Fu, Simei; Xu, Jie; Chen, Yanfen; Yu, Yaqing] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis,Sch Publ Hlth, Changchun 130023, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Ctr Expt Anim, Beijing, Peoples R China; [Xie, Yongfei; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Li, Xianbo; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; Academy of Military Medical Sciences - China; Nanjing Agricultural University; Sichuan Agricultural University	Fu, SM (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China.	yufeiwang21@yahoo.com; zeliangchen@yahoo.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Key Program for Infectious Diseases of China [2008ZX10004-015]; National Basic Research Program of China [2009CB522602]; National Natural Science Foundation of China [30901071, 31000041, 81071320]	National Key Program for Infectious Diseases of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Key Program for Infectious Diseases of China (2008ZX10004-015), National Basic Research Program of China (Grant No. 2009CB522602), and the National Natural Science Foundation of China (30901071, 31000041, 81071320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2010, VACCINE, V28, P1766, DOI 10.1016/j.vaccine.2009.12.012; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Andrews E, 2006, MICROBIOL IMMUNOL, V50, P389, DOI 10.1111/j.1348-0421.2006.tb03805.x; Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Chen ZJ, 2004, PROTEOMICS, V4, P3203, DOI 10.1002/pmic.200300844; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Covert BA, 2001, PROTEOMICS, V1, P574; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; den Hartigh AB, 2008, J BACTERIOL, V190, P4427, DOI 10.1128/JB.00406-08; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gomes MS, 1998, IMMUNOLOGY, V95, P165; Grillo MJ, 2009, VACCINE, V27, P187, DOI 10.1016/j.vaccine.2008.10.065; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; Li B, 2005, INFECT IMMUN, V73, P3734, DOI 10.1128/IAI.73.6.3734-3739.2005; Li B, 2009, INFECT IMMUN, V77, P4356, DOI 10.1128/IAI.00242-09; Mallick AI, 2007, VACCINE, V25, P3692, DOI 10.1016/j.vaccine.2007.01.066; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; Masignani V, 2002, EXPERT OPIN BIOL TH, V2, P895, DOI 10.1517/14712598.2.8.895; Mora M, 2003, DRUG DISCOV TODAY, V8, P459, DOI 10.1016/S1359-6446(03)02689-8; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Wang Y, 2011, VET MICROBIOLOGY; Yang YL, 2011, FEMS IMMUNOL MED MIC, V61, P159, DOI 10.1111/j.1574-695X.2010.00758.x; ZHAN YF, 1993, INFECT IMMUN, V61, P4899, DOI 10.1128/IAI.61.11.4899-4901.1993	40	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e29552	10.1371/journal.pone.0029552	http://dx.doi.org/10.1371/journal.pone.0029552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383953	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800002
